Citrus Sinensis ID: 036639

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670
Protein Sequence
MKKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAGY
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHcccccHHHHHHHHHHHHHcccccccccccccccccccccEEEEcccccccEEEEEccccccccccccccccccccEEEcccccccccccccccccccccEEcccccccccccccccccccccEEEcccccccccccHHHHccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHccccccccccccccccccccccccccccccEEEEcccccccHHHHHHHHcccccccccccEEEEEEccccEEEEEEccccccccHHHHHHHHHHHcccccccccccEEEEEccccEEEEEcccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEcccccEEEccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHHccccccccHHcccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHEHHHHHHHHcccccccccHHHHHHHHHHHccccccccccccccccccccEEEEEEcccccEEEEEEcccccccccccccccccccEEEEccccccccccccccccccccEEEEccccccccccHHHHcccccEEEEcccccccccccHHHHcccccEEEEcccccccccccHHHcccccccEEEEccccccccccHHHHHcccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccEEEEccccEEcHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEccccccccHHHHHHHHHHHHHHHccccEEEEEEEEccccEEEEEEccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHccccccEEcccccHcHEEEccccccEEccccHHHHcccccccccccccccccHccccccccccHHHHHHHHHHHHHcccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHccHHHHccccHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHccccccccccccHHHcccccccccccccccccc
Coil and Loop (DISEMBL)
MKKASLFLLSLALSLLSvssshpndtdalTLFRLQTdthgnllsnwkgadacaaawtgvvcspkservvslslpshslrgpiaplslldqlrfldlhdnrlngtilpltnctnlklaylsgndfsaeiphQISSLKGIlrldlsdnnirgripeQVTNLTRLLTLRLQnneltgripdlssslkdlkelnlsnnelygrvpegllkkfgeqsfigneglcgssplpacsfsgdtppdvasapetvpsnpssmpqrpafgqektrskkgLSTAAIVAIVLGNCVALLVVTSFVVAYCcrgdrssissdkqqrrsgsnygsekrvyanggndsdgtsgtdtsklVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKrlkdanpcarKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLvydylpngslhsllhgnrgpgripldwTTRISLVLGAARGLARIHqeygtakvphgnvkssnvlldkngvacisdfglsllLNPVQAIARlggykapeQAEVKRLSQKADVYSFGVLLLEVLtgrapsqypsptrprvdeeeqavdlpkwVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACvvsqpekrptMAEVAKMIEDIRveqsplgeeydesrnslspslattedglagy
Flexible Loop (DISEMBL)
MKKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLqnneltgripdlssslkdLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASApetvpsnpssmpqRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGdrssissdkqqrrsgsnygsekrvyanggndsdgtsgtdtsKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVkrlkdanpcaRKEFEQYMDVigklkhpnvVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEygtakvphgnvkSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVltgrapsqypsptrprvdeeeqavdlpkwvrsvvkeewtaevfdqelLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLgeeydesrnslspslattedglagy
Low Complexity Region (SEG)
MKKAslfllslalsllsvsssHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPlslldqlrfldlhdNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVtnltrlltlrlqnneltGRIPdlssslkdlkelnlsnnelYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSDKQQRRSGSNYGSEKRVYAnggndsdgtsgtdtsKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAGY
Disordered region (IsUnstruct)
*****LFLLSLALSLLSV*******TDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRI************LNLSNNELYGRVPEGLLKKFGEQSFIGNEGLC*************************************************STAAIVAIVLGNCVALLVVTSFVVAYCCRG******************************************LVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTG********************VDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVS**************************************************
Disordered Region (DISOPRED)
*KKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLP**********************************************AIVAIVLGNCVALLVVTSFVVAYCCRG*******************************************VFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA****RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS********EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI***********************************
Disordered Region (DISEMBL)
MKKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDT**********************************LSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDR*****************SEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS***************AVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS***************SLATTEDGLAGY
Disordered Region (DISPRO)
*KKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNP******************GLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGD**************************************TSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVD*EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR*******************************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAGY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	670	2.2.26 [Sep-21-2011]
Q9M9C5	670	Probable leucine-rich rep	no	no	0.917	0.917	0.466	1e-143
O48788	658	Probable inactive recepto	no	no	0.891	0.907	0.446	1e-130
Q9LVM0	654	Probable inactive recepto	no	no	0.841	0.862	0.445	1e-125
Q9C9Y8	640	Probable inactive recepto	no	no	0.931	0.975	0.410	1e-123
Q9LP77	655	Probable inactive recepto	no	no	0.861	0.880	0.432	1e-121
Q9FHK7	640	Probable leucine-rich rep	no	no	0.889	0.931	0.420	1e-119
Q9SUQ3	638	Probable inactive recepto	no	no	0.820	0.862	0.405	1e-116
Q9LVI6	647	Probable inactive recepto	no	no	0.868	0.899	0.425	1e-115
Q9SH71	587	Putative inactive recepto	no	no	0.852	0.972	0.379	1e-109
Q9FMD7	625	Probable inactive recepto	no	no	0.886	0.950	0.391	1e-107

>sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1

 Score =  508 bits (1307), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 311/666 (46%), Positives = 418/666 (62%), Gaps = 51/666 (7%)

Query: 25  DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAP 84
           D++ L  F+L  D+ G L S     + C   WTGV C+    RV  L L   +L G I+ 
Sbjct: 31  DSETLLNFKLTADSTGKLNSWNTTTNPCQ--WTGVSCN--RNRVTRLVLEDINLTGSISS 86

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           L+ L  LR L L  N L+G I  L+N T LKL +LS N FS   P  I+SL  + RLDLS
Sbjct: 87  LTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLS 146

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL 204
            NN  G+IP  +T+LT LLTLRL++N  +G+IP+++  L DL++ N+S N   G++P  L
Sbjct: 147 FNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNIN--LSDLQDFNVSGNNFNGQIPNSL 204

Query: 205 LKKFGEQSFIGNEGLCGSSPLPACSFSGDTP-----PDVASA-----PETVPSNPSSMPQ 254
             +F E  F  N  LCG+ PL  C+     P     PD A A     PETVPS+P+S+  
Sbjct: 205 -SQFPESVFTQNPSLCGA-PLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSI-- 260

Query: 255 RPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSDKQQRRSG 314
               G +K+ +   +ST +++AI+LG+ + L  V+  ++ Y C   + +++  K  +   
Sbjct: 261 ---HGGDKSNNTSRISTISLIAIILGDFIILSFVS--LLLYYCFWRQYAVNKKKHSKI-- 313

Query: 315 SNYGSEKRVYANGGNDSDGTSGT-------DTSKLVFYERKKQFELEDLLRASAEMLGKG 367
                EK VY++    +   +         D  K+VF+E  ++FELEDLLRASAEMLGKG
Sbjct: 314 --LEGEKIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKG 371

Query: 368 SLGTVYKAVLDDGGIVAVKRLKDANPCA-RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE 426
             GT YKAVL+DG  VAVKRLKDA   A +KEFEQ M+V+G+L+H N+V L+AYY+A+EE
Sbjct: 372 GFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREE 431

Query: 427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGN 486
           KLLVYDY+PNGSL  LLHGNRGPGR PLDWTTR+ +  GAARGLA IH    T K+ HG+
Sbjct: 432 KLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGD 491

Query: 487 VKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVL 546
           +KS+NVLLD++G A +SDFGLS+   P Q +A+  GY+APE  + ++ +QK+DVYSFGVL
Sbjct: 492 IKSTNVLLDRSGNARVSDFGLSIFA-PSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVL 550

Query: 547 LLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEE 606
           LLE+LTG+ P+               AVDLP+WV+SVV+EEWTAEVFD EL+RYK+IEEE
Sbjct: 551 LLEILTGKCPNMV------ETGHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEE 604

Query: 607 LVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR---VEQSPLGEEYDESRNSLSPSLATT 663
           +V +L + +AC     + RP M  V K+IEDIR    E SP     ++  NS   S   +
Sbjct: 605 MVGLLQIAMACTAVAADHRPKMGHVVKLIEDIRGGGSEASPC----NDGINSAVDSPCLS 660

Query: 664 EDGLAG 669
           ED   G
Sbjct: 661 EDTCGG 666

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1

 Score =  467 bits (1201), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 287/643 (44%), Positives = 385/643 (59%), Gaps = 46/643 (7%)

Query: 8   LLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSER 67
           L S+ L    V+S    +  AL  F LQ   H N L  W  +D+ A  W GV C+     
Sbjct: 11  LFSILLLTQRVNSESTAEKQALLTF-LQQIPHENRL-QWNESDS-ACNWVGVECNSNQSS 67

Query: 68  VVSLSLPSHSLRG--PIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDF 124
           + SL LP   L G  P   L  L +LR L L  NRL+G I    +N T+L+  YL  N+F
Sbjct: 68  IHSLRLPGTGLVGQIPSGSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEF 127

Query: 125 SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK 184
           S E P   + L  ++RLD+S NN  G IP  V NLT L  L L NN  +G +P +S  L 
Sbjct: 128 SGEFPTSFTQLNNLIRLDISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLGLV 187

Query: 185 DLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPET 244
           D    N+SNN L G +P  L  +F  +SF GN  LCG    P  SF       V+ +P  
Sbjct: 188 DF---NVSNNNLNGSIPSSL-SRFSAESFTGNVDLCGGPLKPCKSFF------VSPSPSP 237

Query: 245 VPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDR-SS 303
              NPS+           +  K  LS AAIVAI++ + +  L++ + ++  C R  R S+
Sbjct: 238 SLINPSN---------RLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSN 288

Query: 304 ISSDKQQRRSGSNY-------GSEKRVYANGGNDSDGTSGTDTSKLVFYERK-KQFELED 355
            +  KQ + +G          G+        G  S     T+ +KLVF E     F+LED
Sbjct: 289 EARTKQPKPAGVATRNVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLED 348

Query: 356 LLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           LLRASAE+LGKGS+GT YKAVL++G  V VKRLKD    ++KEFE  M+V+GK+KHPNV+
Sbjct: 349 LLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVM-ASKKEFETQMEVVGKIKHPNVI 407

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
            LRAYYY+K+EKLLV+D++P GSL +LLHG+RG GR PLDW  R+ + + AARGLA +H 
Sbjct: 408 PLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHV 467

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLS 535
              +AK+ HGN+K+SN+LL  N   C+SD+GL+ L +      RL GY APE  E ++++
Sbjct: 468 ---SAKLVHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVT 524

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
            K+DVYSFGVLLLE+LTG++P+Q            E+ +DLP+WV SVV+EEWTAEVFD 
Sbjct: 525 FKSDVYSFGVLLLELLTGKSPNQ--------ASLGEEGIDLPRWVLSVVREEWTAEVFDV 576

Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           EL+RY NIEEE+V +L + +ACV + P++RP M EV +MIED+
Sbjct: 577 ELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDV 619

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  449 bits (1155), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 269/604 (44%), Positives = 361/604 (59%), Gaps = 40/604 (6%)

Query: 45  NWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLN 102
           NW   +    +W GV C+     V +L LP   L GPI P +L  L+ LR L L  N L+
Sbjct: 66  NWNSTNHICKSWVGVTCTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLS 125

Query: 103 GTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTR 161
           G + P + +  +L   YL  N+FS E+P  +S    IL  DLS N+  G+IP    NL +
Sbjct: 126 GNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSRQLNIL--DLSFNSFTGKIPATFQNLKQ 183

Query: 162 LLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCG 221
           L  L LQNN+L+G +P+L +    L+ LNLSNN L G +P  L   F   SF GN  LCG
Sbjct: 184 LTGLSLQNNKLSGPVPNLDTV--SLRRLNLSNNHLNGSIPSAL-GGFPSSSFSGNTLLCG 240

Query: 222 SSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGN 281
             PL  C+ S  +PP     P   P    S P  P F   K  SK+ L  + I+ I  G 
Sbjct: 241 L-PLQPCATS--SPP-----PSLTPH--ISTPPLPPF-PHKEGSKRKLHVSTIIPIAAGG 289

Query: 282 CVALLVVTSFVVAYCCRGDRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSK 341
              LL++T  ++  C +         K+ +R  S    +            G    + +K
Sbjct: 290 AALLLLITVIILCCCIK---------KKDKREDSIVKVKTLTEKAKQEFGSGVQEPEKNK 340

Query: 342 LVFYER-KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFE 400
           LVF+      F+LEDLLRASAE+LGKGS GT YKAVL++   V VKRLK+     ++EFE
Sbjct: 341 LVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVA-AGKREFE 399

Query: 401 QYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR 459
           Q M++I ++  HP+VV LRAYYY+K+EKL+V DY P G+L SLLHGNRG  + PLDW +R
Sbjct: 400 QQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSR 459

Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR 519
           + + L AA+G+A +H   G  K  HGN+KSSNV++ +   ACISDFGL+ L+    A  R
Sbjct: 460 VKITLSAAKGIAHLHAA-GGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMR 518

Query: 520 LGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
             GY+APE  E ++ + K+DVYSFGVL+LE+LTG++P Q PS         +  VDLP+W
Sbjct: 519 GAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPS--------RDDMVDLPRW 570

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
           V+SVV+EEWT+EVFD EL+R++NIEEE+V ML + +ACV   PE RPTM +V +MIE+IR
Sbjct: 571 VQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIR 630

Query: 640 VEQS 643
           V  S
Sbjct: 631 VSDS 634

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  444 bits (1142), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 278/677 (41%), Positives = 375/677 (55%), Gaps = 53/677 (7%)

Query: 1   MKKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVV 60
           MK  + FL  L  + +S   S   ++D   L    +    +   NW       A+WTG+ 
Sbjct: 2   MKIIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGIT 61

Query: 61  CSPKSERVVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTI------LPLTNCT 112
           CS  + RV +L LP   L GP+   +   LD LR + L  N L G I      LP     
Sbjct: 62  CSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPF---- 117

Query: 113 NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNEL 172
            ++  Y   N+FS  IP  +S    ++ LDLS N++ G IP  + NLT+L  L LQNN L
Sbjct: 118 -IRSLYFHENNFSGTIPPVLS--HRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSL 174

Query: 173 TGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSG 232
           +G IP+L      LK LNLS N L G VP  + K F   SF GN  LCG+ PL  C    
Sbjct: 175 SGPIPNLP---PRLKYLNLSFNNLNGSVPSSV-KSFPASSFQGNSLLCGA-PLTPC---- 225

Query: 233 DTPPDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFV 292
              P+  +AP   PS  +           +  +KK LST AIV I +G  V L ++ + +
Sbjct: 226 ---PENTTAPS--PSPTTPTEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILA-I 279

Query: 293 VAYCCRGDRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYE-RKKQF 351
           +  CC   R     D  Q  +        R          G    + +KLVF+E     F
Sbjct: 280 ITLCCAKKR-----DGGQDSTAVPKAKPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNF 334

Query: 352 ELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK- 410
           +LEDLLRASAE+LGKGS GT YKA+L++G  V VKRLK+     ++EFEQ M+ +G++  
Sbjct: 335 DLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEV-AAGKREFEQQMEAVGRISP 393

Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
           H NV  LRAYY++K+EKLLVYDY   G+   LLHGN   GR  LDW TR+ + L AARG+
Sbjct: 394 HVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGI 453

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLGGYKAPEQA 529
           + IH   G AK+ HGN+KS NVLL +    C+SDFG++ L++    I +R  GY+APE  
Sbjct: 454 SHIHSASG-AKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAI 512

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
           E ++ +QK+DVYSFGVLLLE+LTG+A          +    E+ VDLPKWV+SVV+EEWT
Sbjct: 513 ETRKHTQKSDVYSFGVLLLEMLTGKAAG--------KTTGHEEVVDLPKWVQSVVREEWT 564

Query: 590 AEVFDQELLRYK-NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEE 648
            EVFD EL++ + N+EEE+V ML + +ACV   P+ RP+M EV  M+E+IR    P G  
Sbjct: 565 GEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIR----PSGSG 620

Query: 649 YDESRNSLSPSLATTED 665
                 + SP +  + D
Sbjct: 621 PGSGNRASSPEMIRSSD 637

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  436 bits (1121), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 280/648 (43%), Positives = 380/648 (58%), Gaps = 71/648 (10%)

Query: 25  DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRG--PI 82
           + D   L  L++   G     W         W GV C  +S RV +L LP  +L G  P 
Sbjct: 34  NADRTALLSLRSAVGGRTF-RWNIKQTSPCNWAGVKC--ESNRVTALRLPGVALSGDIPE 90

Query: 83  APLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
                L QLR L L  N L+G+ LP  L+  +NL+  YL GN FS EIP  + SL  ++R
Sbjct: 91  GIFGNLTQLRTLSLRLNALSGS-LPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVR 149

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV 200
           L+L+ N+  G I    TNLT+L TL L+NN+L+G IPDL   L    + N+SNN L G +
Sbjct: 150 LNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLPLV---QFNVSNNSLNGSI 206

Query: 201 PEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQR--PAF 258
           P+ L ++F   SF+    LCG  PL  C       PD     ETVPS P+S   R  P+ 
Sbjct: 207 PKNL-QRFESDSFL-QTSLCGK-PLKLC-------PD----EETVPSQPTSGGNRTPPSV 252

Query: 259 -GQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRG---------DRSSISS-- 306
            G E+ + K  LS  AI  IV+G CV    +   ++   CR          D S+I    
Sbjct: 253 EGSEEKKKKNKLSGGAIAGIVIG-CVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQE 311

Query: 307 -----DKQQRRSGSNYG---SEKRVYANGGNDSDGTSGTDTSKLVFY-ERKKQFELEDLL 357
                DK+   +G+ Y    +        G  S+G +G  T KLVF+    K F+LEDLL
Sbjct: 312 PEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEG-NGPATKKLVFFGNATKVFDLEDLL 370

Query: 358 RASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           RASAE+LGKG+ GT YKAVLD   +VAVKRLKD    A KEF++ ++++G + H N+V L
Sbjct: 371 RASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVM-MADKEFKEKIELVGAMDHENLVPL 429

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
           RAYY++++EKLLVYD++P GSL +LLHGNRG GR PL+W  R  + +GAARGL  +H + 
Sbjct: 430 RAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQ- 488

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL-----NPVQAIARLGGYKAPEQAEVK 532
           GT+   HGN+KSSN+LL K+  A +SDFGL+ L+     NP +A     GY+APE  + K
Sbjct: 489 GTS-TSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRAT----GYRAPEVTDPK 543

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
           R+SQK DVYSFGV+LLE++TG+APS             E+ VDLP+WV+SV ++EW  EV
Sbjct: 544 RVSQKGDVYSFGVVLLELITGKAPSNSVM--------NEEGVDLPRWVKSVARDEWRREV 595

Query: 593 FDQELLRYKNIEEELVS-MLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
           FD ELL     EEE+++ M+ +GL C    P++RP M+EV + +E++R
Sbjct: 596 FDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1

 Score =  429 bits (1104), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 272/647 (42%), Positives = 379/647 (58%), Gaps = 51/647 (7%)

Query: 4   ASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVC-- 61
           AS F L LA + + VS+   +D  AL  F         L  NW    +  ++W G+ C  
Sbjct: 11  ASFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKL--NWNKNLSLCSSWIGITCDE 68

Query: 62  SPKSERVVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTILP--LTNCTNLKLA 117
           S  + RVV++ LP   L G I P +L  LD L+ L L  N L GT LP  + +  +L+  
Sbjct: 69  SNPTSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGT-LPSDILSLPSLEYL 127

Query: 118 YLSGNDFSAEIP-HQISSL-KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR 175
           YL  N+FS E+  + + S+ K ++ LDLS N++ G IP  + NL+++  L LQNN   G 
Sbjct: 128 YLQHNNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGP 187

Query: 176 IPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTP 235
           I  L   L  +K +NLS N L G +PE L KK  E SFIGN  LCG  PL ACS    +P
Sbjct: 188 IDSLD--LPSVKVVNLSYNNLSGPIPEHL-KKSPEYSFIGNSLLCGP-PLNACSGGAISP 243

Query: 236 PDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVV-TSFVVA 294
                 P T   +P    Q               S A I+AIV+G  VA+L +   F+V 
Sbjct: 244 SSNLPRPLTENLHPVRRRQ---------------SKAYIIAIVVGCSVAVLFLGIVFLVC 288

Query: 295 YCCRGDRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYER-KKQFEL 353
              +  +     +  + + G     + + + +G  D +       +KL F+ER    F+L
Sbjct: 289 LVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPE------KNKLFFFERCNHNFDL 342

Query: 354 EDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHP 412
           EDLL+ASAE+LGKGS GT YKAVL+D   V VKRL++    ++KEFEQ M+++GK+ +H 
Sbjct: 343 EDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREV-VASKKEFEQQMEIVGKINQHS 401

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           N V L AYYY+K+EKLLVY Y+  GSL  ++HGNRG   +  DW TR+ +  G ++ ++ 
Sbjct: 402 NFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGDRGV--DWETRMKIATGTSKAISY 459

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVK 532
           +H    + K  HG++KSSN+LL ++   C+SD  L  L N      R  GY APE  E +
Sbjct: 460 LH----SLKFVHGDIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETR 515

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
           R+SQ++DVYSFGV++LE+LTG+ P      T+P +++E   +DLP+WVRSVV+EEWTAEV
Sbjct: 516 RVSQRSDVYSFGVVILEMLTGKTPL-----TQPGLEDERVVIDLPRWVRSVVREEWTAEV 570

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
           FD ELL+++NIEEE+V ML + LACV   PE RP M EVA+MIED+R
Sbjct: 571 FDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVR 617

Probable leucine-rich repeat receptor-like protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1

 Score =  421 bits (1081), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 246/606 (40%), Positives = 359/606 (59%), Gaps = 56/606 (9%)

Query: 45  NWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLN 102
           NW         WTGV C+    R++++ LP   L G I P  +S L  LR L L  N ++
Sbjct: 47  NWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNGQIPPNTISRLSALRVLSLRSNLIS 106

Query: 103 GTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTR 161
           G          +L   YL  N+ S  +P   S  K +  ++LS+N   G IP  ++ L R
Sbjct: 107 GEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKNLTSVNLSNNGFNGTIPSSLSRLKR 166

Query: 162 LLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN-ELYGRVPEGLLKKFGEQSFIGNEGLC 220
           + +L L NN L+G IPDLS  L  L+ ++LSNN +L G +P+  L++F   S+ G + + 
Sbjct: 167 IQSLNLANNTLSGDIPDLSV-LSSLQHIDLSNNYDLAGPIPD-WLRRFPFSSYTGIDIIP 224

Query: 221 GSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLG 280
                P  +++  TPP  +      PS    +               GLS    + IV+ 
Sbjct: 225 -----PGGNYTLVTPPPPSEQTHQKPSKARFL---------------GLSETVFLLIVIA 264

Query: 281 NCVALLVVTSFVVAYCC------RGDRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGT 334
             + ++   +FV+  C       RGD   IS +K Q++ G     EK  + +   D +  
Sbjct: 265 VSIVVITALAFVLTVCYVRRKLRRGD-GVISDNKLQKKGG--MSPEK--FVSRMEDVN-- 317

Query: 335 SGTDTSKLVFYER-KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP 393
                ++L F+E     F+LEDLLRASAE+LGKG+ GT YKAVL+D   VAVKRLKD   
Sbjct: 318 -----NRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDV-A 371

Query: 394 CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP 453
             +++FEQ M++IG +KH NVV+L+AYYY+K+EKL+VYDY   GS+ SLLHGNRG  RIP
Sbjct: 372 AGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIP 431

Query: 454 LDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP 513
           LDW TR+ + +GAA+G+ARIH+E    K+ HGN+KSSN+ L+     C+SD GL+ +++P
Sbjct: 432 LDWETRMKIAIGAAKGIARIHKE-NNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSP 490

Query: 514 VQ-AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ 572
           +   I+R  GY+APE  + ++ SQ +DVYSFGV+LLE+LTG++P    +         ++
Sbjct: 491 LAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTA--------GDE 542

Query: 573 AVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVA 632
            + L +WV SVV+EEWTAEVFD ELLRY NIEEE+V ML + ++CVV   ++RP M+++ 
Sbjct: 543 IIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLV 602

Query: 633 KMIEDI 638
           ++IE++
Sbjct: 603 RLIENV 608

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1

 Score =  417 bits (1072), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 272/639 (42%), Positives = 367/639 (57%), Gaps = 57/639 (8%)

Query: 25  DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRG--PI 82
           D  AL  FR        LL + K    C   WTGV+C     RV +L LP  +L G  P 
Sbjct: 34  DKSALLSFRSAVGGR-TLLWDVKQTSPCN--WTGVLCD--GGRVTALRLPGETLSGHIPE 88

Query: 83  APLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
                L QLR L L  N L G++ L L +C++L+  YL GN FS EIP  + SL  ++RL
Sbjct: 89  GIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRL 148

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP 201
           +L++N   G I     NLTRL TL L+NN+L+     L      L + N+SNN L G +P
Sbjct: 149 NLAENEFSGEISSGFKNLTRLKTLYLENNKLS---GSLLDLDLSLDQFNVSNNLLNGSIP 205

Query: 202 EGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAF--G 259
           + L +KF   SF+G   LCG  PL  CS  G           TVPS P S+   P    G
Sbjct: 206 KSL-QKFDSDSFVGTS-LCGK-PLVVCSNEG-----------TVPSQPISVGNIPGTVEG 251

Query: 260 QEKTRSKKGLSTAAIVAIVLGNCVAL-LVVTSFVVAYCCRGDRSSISSDKQQRR------ 312
            E+ + +K LS  AI  IV+G  V L L+V   +V +  +G+  + + D    +      
Sbjct: 252 SEEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEI 311

Query: 313 ---SGSNYGSEKRVYANGGNDSD----GTSGTDTSKLVFY-ERKKQFELEDLLRASAEML 364
                +    E R Y N  + S       + +   KLVF+    K F+LEDLLRASAE+L
Sbjct: 312 PGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVL 371

Query: 365 GKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK 424
           GKG+ GT YKAVLD   +VAVKRLKD    A +EF++ ++V+G + H N+V LRAYYY+ 
Sbjct: 372 GKGTFGTAYKAVLDAVTLVAVKRLKDVT-MADREFKEKIEVVGAMDHENLVPLRAYYYSG 430

Query: 425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPH 484
           +EKLLVYD++P GSL +LLHGN+G GR PL+W  R  + LGAARGL  +H +   +   H
Sbjct: 431 DEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSS--H 488

Query: 485 GNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA-RLGGYKAPEQAEVKRLSQKADVYSF 543
           GNVKSSN+LL  +  A +SDFGL+ L++       R  GY+APE  + +R+SQKADVYSF
Sbjct: 489 GNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSF 548

Query: 544 GVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYK-- 601
           GV+LLE+LTG+APS             E+ +DL +WV SV +EEW  EVFD EL+  +  
Sbjct: 549 GVVLLELLTGKAPSNSVM--------NEEGMDLARWVHSVAREEWRNEVFDSELMSIETV 600

Query: 602 -NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
            ++EEE+  ML +G+ C    P+KRP M EV + I+++R
Sbjct: 601 VSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1

 Score =  395 bits (1016), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 243/641 (37%), Positives = 348/641 (54%), Gaps = 70/641 (10%)

Query: 6   LFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKS 65
           LF  SL L  + +SS    D     L  L +     L  +W  +     +WTGV C+   
Sbjct: 5   LFFFSLILCFVLISSQTLEDDKKALLHFLSSFNSSRL--HWNQSSDVCHSWTGVTCNENG 62

Query: 66  ERVVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGN 122
           +R+VS+ LP+    G I P ++  L  L+FL L  N   G      TN  +L   YL  N
Sbjct: 63  DRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHN 122

Query: 123 DFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSS 182
             S  +    S LK +  LDLS+N   G IP  ++ LT L  L L NN  +G IP+L   
Sbjct: 123 HLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNLH-- 180

Query: 183 LKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAP 242
           L  L ++NLSNN+L G +P+ L ++F   +F GN                          
Sbjct: 181 LPKLSQINLSNNKLIGTIPKSL-QRFQSSAFSGN-------------------------- 213

Query: 243 ETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRS 302
                   ++ +R    +++ ++  GLS  A + I+   CV  +   SF++  C    ++
Sbjct: 214 --------NLTER----KKQRKTPFGLSQLAFLLILSAACVLCVSGLSFIMITCF--GKT 259

Query: 303 SISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYE-RKKQFELEDLLRASA 361
            IS   ++R S S  G       N  +  D T   +  K++F+  R   F+L+DLL +SA
Sbjct: 260 RISGKLRKRDSSSPPG-------NWTSRDDNTE--EGGKIIFFGGRNHLFDLDDLLSSSA 310

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E+LGKG+ GT YK  ++D   V VKRLK+     R+EFEQ M++IG ++H NV +L+AYY
Sbjct: 311 EVLGKGAFGTTYKVTMEDMSTVVVKRLKEV-VVGRREFEQQMEIIGMIRHENVAELKAYY 369

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGP-GRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y+K++KL VY Y  +GSL  +LHGNRG   R+PLDW  R+ +  GAARGLA+IH+     
Sbjct: 370 YSKDDKLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDARLRIATGAARGLAKIHE----G 425

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-QAIARLGGYKAPEQAEVKRLSQKAD 539
           K  HGN+KSSN+ LD     CI D GL+ ++  + Q      GY APE  + +R +Q +D
Sbjct: 426 KFIHGNIKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTCLTSGYHAPEITDTRRSTQFSD 485

Query: 540 VYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELL- 598
           VYSFGV+LLE+LTG++P          V    + +DL  W+RSVV +EWT EVFD E+L 
Sbjct: 486 VYSFGVVLLELLTGKSPVSQAE----LVPTGGENMDLASWIRSVVAKEWTGEVFDMEILS 541

Query: 599 RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
           +    EEE+V ML +GLACV  + ++RP +A+V K+IEDIR
Sbjct: 542 QSGGFEEEMVEMLQIGLACVALKQQERPHIAQVLKLIEDIR 582

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1

 Score =  390 bits (1002), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 257/657 (39%), Positives = 377/657 (57%), Gaps = 63/657 (9%)

Query: 6   LFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKS 65
           L +    + L+SV+S    D  AL   R     HG  L     A  C   W GV C  +S
Sbjct: 9   LSVFFFFICLVSVTSDLEADRRALIALR--DGVHGRPLLWNLTAPPCT--WGGVQC--ES 62

Query: 66  ERVVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGN 122
            RV +L LP   L GP+ P+++  L +L  L    N LNG + P   N T L+  YL GN
Sbjct: 63  GRVTALRLPGVGLSGPL-PIAIGNLTKLETLSFRFNALNGPLPPDFANLTLLRYLYLQGN 121

Query: 123 DFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSS 182
            FS EIP  + +L  I+R++L+ NN  GRIP+ V + TRL TL LQ+N+LTG IP++   
Sbjct: 122 AFSGEIPSFLFTLPNIIRINLAQNNFLGRIPDNVNSATRLATLYLQDNQLTGPIPEIK-- 179

Query: 183 LKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAP 242
              L++ N+S+N+L G +P+ L     + +F+GN  LCG  PL AC  +G          
Sbjct: 180 -IKLQQFNVSSNQLNGSIPDPL-SGMPKTAFLGNL-LCGK-PLDACPVNGT--------- 226

Query: 243 ETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRS 302
                N +  P        K +S K LS  AIV IV+G C  LL+V   +V   CR  + 
Sbjct: 227 ----GNGTVTPG------GKGKSDK-LSAGAIVGIVIG-CFVLLLVLFLIVFCLCRKKKK 274

Query: 303 -------SISSDKQQRRSGS---NYGSEKRVYANGGND---SDGTSGTDTSKLVFYERKK 349
                  SI +      S +          V ANG ++   S   +        F +   
Sbjct: 275 EQVVQSRSIEAAPVPTSSAAVAKESNGPPAVVANGASENGVSKNPAAVSKDLTFFVKSFG 334

Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL 409
           +F+L+ LL+ASAE+LGKG+ G+ YKA  D G +VAVKRL+D      KEF + + V+G +
Sbjct: 335 EFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLRDVV-VPEKEFREKLQVLGSI 393

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
            H N+V L AYY++++EKL+V++Y+  GSL +LLHGN+G GR PL+W TR ++ LGAAR 
Sbjct: 394 SHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGSGRSPLNWETRANIALGAARA 453

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQA 529
           ++ +H    T    HGN+KSSN+LL ++  A +SD+ L+ +++P     R+ GY+APE  
Sbjct: 454 ISYLHSRDATTS--HGNIKSSNILLSESFEAKVSDYCLAPMISPTSTPNRIDGYRAPEVT 511

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
           + +++SQKADVYSFGVL+LE+LTG+      SPT  ++ EE   VDLP+WV S+ +++  
Sbjct: 512 DARKISQKADVYSFGVLILELLTGK------SPTHQQLHEE--GVDLPRWVSSITEQQSP 563

Query: 590 AEVFDQELLRYK-NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI-RVEQSP 644
           ++VFD EL RY+ +  E ++ +L++G++C    P+ RPTM EV ++IE++ R   SP
Sbjct: 564 SDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRLIEEVSRSPASP 620

Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica.

Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	670
255575479	676	Protein kinase APK1A, chloroplast precur	0.961	0.952	0.805	0.0
224069764	678	predicted protein [Populus trichocarpa]	0.995	0.983	0.794	0.0
449440185	683	PREDICTED: probable leucine-rich repeat	0.983	0.964	0.769	0.0
225441038	683	PREDICTED: probable leucine-rich repeat	0.959	0.941	0.764	0.0
77417500	682	putative receptor kinase [Malus x domest	0.964	0.947	0.773	0.0
356537030	696	PREDICTED: probable leucine-rich repeat	0.982	0.945	0.719	0.0
357440227	676	hypothetical protein MTR_1g061590 [Medic	0.988	0.979	0.714	0.0
15227998	672	leucine-rich repeat protein kinase-like	0.949	0.946	0.703	0.0
110735702	672	putative receptor-like protein kinase [A	0.949	0.946	0.701	0.0
297823467	674	hypothetical protein ARALYDRAFT_321364 [	0.953	0.948	0.706	0.0

>gi|255575479|ref|XP_002528641.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis] gi|223531930|gb|EEF33744.1| Protein kinase APK1A, chloroplast precursor, putative [Ricinus communis]

 Score = 1043 bits (2697), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 527/654 (80%), Positives = 584/654 (89%), Gaps = 10/654 (1%)

Query: 24  NDTDALTLFRLQTDTHGNLLSNWKGADACA---AAWTGVVCSPKSERVVSLSLPSHSLRG 80
           NDT +LTLFRLQTD HG LL+NW G  AC+   A W GV CS  S RVVSL+LPSHSLRG
Sbjct: 26  NDTHSLTLFRLQTDAHGTLLTNWTGTSACSPGGATWAGVKCS-ASGRVVSLALPSHSLRG 84

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           PI  LSLLDQLR LDLHDNRLNG+IL LTNCTNLKL YL+GNDFS EIP +IS LK +LR
Sbjct: 85  PITSLSLLDQLRVLDLHDNRLNGSILSLTNCTNLKLLYLAGNDFSGEIPPEISLLKRLLR 144

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV 200
           LDLSDNNIRG IP+ ++NLTRLLTLRLQNNEL+G+IPDL+ SL  L+ELNLSNNELYGR+
Sbjct: 145 LDLSDNNIRGVIPDGLSNLTRLLTLRLQNNELSGQIPDLTKSLPLLRELNLSNNELYGRL 204

Query: 201 PEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQ 260
           P+ +LKKFG++ F GNEG+CGSSPLPACSF+G+ P D++S  +TVPSNPSSMPQ P   +
Sbjct: 205 PDNILKKFGDRIFSGNEGICGSSPLPACSFTGNIPADMSS--QTVPSNPSSMPQTPLVFK 262

Query: 261 EKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISS----DKQQRRSGSN 316
           EK++S KGLS  AIVAIV+ NCVALLVVTSF+VAY C  DR++ S       + RRSGS+
Sbjct: 263 EKSQSHKGLSPGAIVAIVVANCVALLVVTSFIVAYYCGRDRNASSKVGSESGKARRSGSS 322

Query: 317 YGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV 376
           YGSEKRVYANGGNDSDGT+ TD S+LVF++ ++QFELEDLLRASAEMLGKGSLGTVYKAV
Sbjct: 323 YGSEKRVYANGGNDSDGTNATDRSRLVFFDTRQQFELEDLLRASAEMLGKGSLGTVYKAV 382

Query: 377 LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN 436
           LDDG  VAVKRLKDANPCARKEFEQYMDVIGKLKH N+V+ RAYYYAKEEKLLVYDYLPN
Sbjct: 383 LDDGCTVAVKRLKDANPCARKEFEQYMDVIGKLKHQNIVRFRAYYYAKEEKLLVYDYLPN 442

Query: 437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK 496
           GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA+IH+EY T+++PHGN+KSSNVLLDK
Sbjct: 443 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAKIHEEYSTSRIPHGNLKSSNVLLDK 502

Query: 497 NGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           NGVACISDFGLSLLLNPV AIAR+GGY+APEQAE+KRL+QKADVYSFGVLLLEVLTGRAP
Sbjct: 503 NGVACISDFGLSLLLNPVHAIARMGGYRAPEQAEIKRLTQKADVYSFGVLLLEVLTGRAP 562

Query: 557 SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLA 616
           SQYPSPTRPR++E+EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLA
Sbjct: 563 SQYPSPTRPRIEEDEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLA 622

Query: 617 CVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAGY 670
           CVV QPEKRPTM EV KMIEDIRVEQSPLGE+YDESR SLSPSLATTEDGL GY
Sbjct: 623 CVVPQPEKRPTMLEVVKMIEDIRVEQSPLGEDYDESRTSLSPSLATTEDGLGGY 676

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224069764|ref|XP_002326408.1| predicted protein [Populus trichocarpa] gi|222833601|gb|EEE72078.1| predicted protein [Populus trichocarpa]

 Score = 1019 bits (2635), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 541/681 (79%), Positives = 597/681 (87%), Gaps = 14/681 (2%)

Query: 1   MKKASLFLLSLALSL---LSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACA--AA 55
           MK       ++ LS+   L+V+++ PNDT ALTLFRLQTDTHGNLLSNW G DAC    +
Sbjct: 1   MKTVFFLYFTIFLSVRTSLTVTAAPPNDTSALTLFRLQTDTHGNLLSNWTGQDACGFPTS 60

Query: 56  WTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLK 115
           W GV CS  S RVVSLSLPS SLRGPI  LSLLDQLR LDLH+NRLNGTI PLTNCT+LK
Sbjct: 61  WLGVGCS-ASGRVVSLSLPSLSLRGPITSLSLLDQLRLLDLHNNRLNGTISPLTNCTHLK 119

Query: 116 LAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR 175
           L YL+GNDFS EIP +ISSLK +LRLDLSDNNI G+IP Q+TNLT+LLTLRLQNNEL+G+
Sbjct: 120 LLYLAGNDFSGEIPPEISSLKRLLRLDLSDNNIHGKIPGQLTNLTKLLTLRLQNNELSGQ 179

Query: 176 IPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTP 235
           IPD S+S  DLKELNLSNNELYGR+P+ LLKK+ ++SF GNEGLCGSSPLP CSF+G+  
Sbjct: 180 IPDFSTSFPDLKELNLSNNELYGRLPDNLLKKYSDRSFSGNEGLCGSSPLPVCSFTGNEQ 239

Query: 236 PDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAY 295
           P    + ETVPSNPSSMPQ P  G++K+   KGLS  AIVAIV+ NCV LLVV SF+VAY
Sbjct: 240 P--VDSDETVPSNPSSMPQTPLLGKDKSHLHKGLSPGAIVAIVMANCVTLLVVISFLVAY 297

Query: 296 CCRGDRSSISSDK------QQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKK 349
            C  DRSS +S K      ++R+SGS+YGSEKRVYAN G DSDGT+ TD SKLVF++RKK
Sbjct: 298 YCGRDRSSSASSKAGSESGKRRKSGSSYGSEKRVYANEGGDSDGTNATDRSKLVFFDRKK 357

Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL 409
           QFELEDLLRASAEMLGKGSLGTVYKAVLDDG  VAVKRLKDANPCARKEFEQYMDVIGKL
Sbjct: 358 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGCTVAVKRLKDANPCARKEFEQYMDVIGKL 417

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           KHPN+V+L AYYYAKEEKLLVYDYLPNGSL+SLLHGNRGPGRIPLDWTTRISLVLGAARG
Sbjct: 418 KHPNIVRLAAYYYAKEEKLLVYDYLPNGSLYSLLHGNRGPGRIPLDWTTRISLVLGAARG 477

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQA 529
           LA+IH+EY  +K+PHGNVKSSNVLLDKNGVACISDFGLSLLLNPV AIARLGGY+APEQA
Sbjct: 478 LAKIHEEYSASKIPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVHAIARLGGYRAPEQA 537

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
           E+KRLSQKADVYSFGVLLLEVLTGR PS+YPSPTRPR+++EEQAVDLPKWVRSVVKEEWT
Sbjct: 538 EIKRLSQKADVYSFGVLLLEVLTGRTPSEYPSPTRPRIEDEEQAVDLPKWVRSVVKEEWT 597

Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEY 649
           +EVFDQELLRYKNIEEELVSMLHVGLACV  QPEKRPTMAEVAKMIEDIRVEQSPLGE+Y
Sbjct: 598 SEVFDQELLRYKNIEEELVSMLHVGLACVFPQPEKRPTMAEVAKMIEDIRVEQSPLGEDY 657

Query: 650 DESRNSLSPSLATTEDGLAGY 670
           DESRNSLSPSLATTEDG+AGY
Sbjct: 658 DESRNSLSPSLATTEDGMAGY 678

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440185|ref|XP_004137865.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Cucumis sativus] gi|449523804|ref|XP_004168913.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Cucumis sativus]

 Score = 1008 bits (2605), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 516/671 (76%), Positives = 570/671 (84%), Gaps = 12/671 (1%)

Query: 4   ASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSP 63
           A +F  SL L L+S S S  +D+ ALT FRLQ D+HG LL NW G+D C ++W GV CS 
Sbjct: 18  AIVFFFSLTL-LVSPSFSLDDDSSALTRFRLQADSHGGLLRNWTGSDPCGSSWRGVQCSV 76

Query: 64  KSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGND 123
              RVV+LSLPS +LRGPI  L+ LDQLR LDLHDNRLNGTI PL NCTNLKL YLSGND
Sbjct: 77  NG-RVVALSLPSMNLRGPIESLAPLDQLRLLDLHDNRLNGTISPLVNCTNLKLLYLSGND 135

Query: 124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
           FS EIP +ISSL+ +LRLDLSDNNIRG IPE ++ L+RLLTLRLQNN L+G +PDLS SL
Sbjct: 136 FSGEIPPEISSLRRLLRLDLSDNNIRGGIPEDISKLSRLLTLRLQNNVLSGTVPDLSVSL 195

Query: 184 KDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAP- 242
            +L ELNL+NNELYGR+P+G++KKFGE+SF GNEG+CGSSPLP CS +G  P   +S P 
Sbjct: 196 VNLTELNLTNNELYGRLPDGMMKKFGEKSFTGNEGVCGSSPLPICSVTGSAP---SSDPT 252

Query: 243 ETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRS 302
            TVPSNPSS+PQ P  G     S+KGLS   IVAIV+ NCVALLV+ SF+VAY C  DR 
Sbjct: 253 RTVPSNPSSLPQNPIIGPNSKESRKGLSPGVIVAIVIANCVALLVIISFIVAYYCARDRD 312

Query: 303 SISSDK------QQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDL 356
             SS        ++R+SGS+YGSEK+VYANGG DSDGT+ TD SKLVF++ KKQFELEDL
Sbjct: 313 RSSSSMTGSESGKRRKSGSSYGSEKKVYANGGGDSDGTNATDRSKLVFFDWKKQFELEDL 372

Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVK 416
           LRASAEMLGKGSLGTVY+AVLDDG  VAVKRLKDANPC RK+FEQYMDVIGKLKH N+V+
Sbjct: 373 LRASAEMLGKGSLGTVYRAVLDDGCTVAVKRLKDANPCPRKDFEQYMDVIGKLKHSNIVR 432

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           LRA+YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH E
Sbjct: 433 LRAFYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHGE 492

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQ 536
           Y  +K+PHGNVKSSNVLLDKNGVACISDFGLSLLLNPV AIARLGGYKAPEQ E KRLSQ
Sbjct: 493 YSASKIPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVHAIARLGGYKAPEQDETKRLSQ 552

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
           KADVYSFGVLLLEVLTGRAPS YPSP+ PR D+EEQ VDLPKWVRSVVKEEWTAEVFD E
Sbjct: 553 KADVYSFGVLLLEVLTGRAPSLYPSPSNPRSDDEEQPVDLPKWVRSVVKEEWTAEVFDPE 612

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSL 656
           LLRYKNIEEELVSMLHVGLACV+ QPEKRPTMAEV KMIEDIRVEQSPLGE+YDESRNSL
Sbjct: 613 LLRYKNIEEELVSMLHVGLACVLPQPEKRPTMAEVVKMIEDIRVEQSPLGEDYDESRNSL 672

Query: 657 SPSLATTEDGL 667
           SPSLATTEDG+
Sbjct: 673 SPSLATTEDGM 683

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225441038|ref|XP_002283857.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400 isoform 1 [Vitis vinifera]

 Score =  979 bits (2532), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 502/657 (76%), Positives = 556/657 (84%), Gaps = 14/657 (2%)

Query: 24  NDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIA 83
           NDT AL+ FR QTD HG L+SNW GADAC+  W GV C     RV  LSLPS SLRGPI 
Sbjct: 31  NDTFALSQFRSQTDVHGTLISNWTGADACSGVWRGVRCF--DGRVAVLSLPSLSLRGPID 88

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            LS L+QLR LDL  NRLNGT+LP+ NCTNLKL YL+GNDFS EIP   SSL+ +LRLDL
Sbjct: 89  ALSGLNQLRILDLQGNRLNGTVLPIANCTNLKLVYLAGNDFSGEIPPDFSSLRRLLRLDL 148

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           SDNN+RG IP  +++L RLLTLRL+NN L+G++PDLS+SL +LKELNLSNN  YG +PEG
Sbjct: 149 SDNNLRGPIPGSLSSLPRLLTLRLENNVLSGQVPDLSASLPNLKELNLSNNGFYGHLPEG 208

Query: 204 LLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQEKT 263
           + KKFG++SF GNEGLCGSSPLPACSF+  +P   A++ +TVPSNPSS+P  P    EK 
Sbjct: 209 MAKKFGDRSFQGNEGLCGSSPLPACSFTEASP--TAASAQTVPSNPSSLPSAPIIDAEKK 266

Query: 264 RSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCC-RGDRSSISSDKQQRRSGSNYGS--- 319
           RS+KGLS  AIVAIV+ N V LLVV SFVVAY C R  R   S+ K     G    S   
Sbjct: 267 RSRKGLSPGAIVAIVIANSVLLLVVASFVVAYYCGRYSREGSSNSKAGSEGGRRRRSGSS 326

Query: 320 ----EKRVYAN--GGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVY 373
               +K+VYA+  GG DSDGT+ TD SKLVF++R+KQFELEDLLRASAEMLGKGSLGTVY
Sbjct: 327 SASEKKKVYASNGGGADSDGTNATDRSKLVFFDRRKQFELEDLLRASAEMLGKGSLGTVY 386

Query: 374 KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY 433
           KAVLDDG  VAVKRLKDANPCARKEFEQYMDVIGKLKHPN+V+ RAYYYAKEEKLLVYDY
Sbjct: 387 KAVLDDGCTVAVKRLKDANPCARKEFEQYMDVIGKLKHPNIVRFRAYYYAKEEKLLVYDY 446

Query: 434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL 493
           LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH+EY  +K+PHGNVKSSN+L
Sbjct: 447 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHEEYTASKIPHGNVKSSNIL 506

Query: 494 LDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTG 553
           LDKNGVACISDFGL+LLLNPV A ARLGGY+APEQ E+KRLSQKADVYSFGVLLLEVLTG
Sbjct: 507 LDKNGVACISDFGLALLLNPVHATARLGGYRAPEQLEIKRLSQKADVYSFGVLLLEVLTG 566

Query: 554 RAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHV 613
           RAPSQYPSP+RPRV+EEEQ VDLPKWVRSVVK+EWTAEVFDQELLRYKNIEEELV+ML V
Sbjct: 567 RAPSQYPSPSRPRVEEEEQGVDLPKWVRSVVKDEWTAEVFDQELLRYKNIEEELVAMLQV 626

Query: 614 GLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAGY 670
           G+ACVV QPEKRPTM+EVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAGY
Sbjct: 627 GMACVVPQPEKRPTMSEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAGY 683

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|77417500|gb|ABA82081.1| putative receptor kinase [Malus x domestica]

 Score =  971 bits (2510), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 506/654 (77%), Positives = 563/654 (86%), Gaps = 8/654 (1%)

Query: 23  PNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPI 82
           PNDT AL  FRLQTD+HG L SNW G+DAC   WTGV CS   +RVV+L LPS +LRGP+
Sbjct: 29  PNDTWALDQFRLQTDSHGYLRSNWTGSDACTPGWTGVRCSTNKDRVVALFLPSLNLRGPL 88

Query: 83  APLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
             L+ LDQLR LDLH+NRLNGT+ PL NCT LKL YL+GND S EIP +ISSL+ +LRLD
Sbjct: 89  DSLASLDQLRLLDLHNNRLNGTVSPLVNCTKLKLLYLAGNDLSGEIPSEISSLRRLLRLD 148

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           LSDNN+RG +P+ +T+LTRLLTLRLQNN L+G +PDLS+SL DLKELN +NNELYGR+PE
Sbjct: 149 LSDNNLRGPVPDNLTHLTRLLTLRLQNNALSGEVPDLSASLADLKELNFTNNELYGRLPE 208

Query: 203 GLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQ-E 261
           GLLKKFG++SF GNEGLCG SPLPACS +G   P  A++ ETVPSNPS +PQ  +  +  
Sbjct: 209 GLLKKFGDESFSGNEGLCGPSPLPACSSTGTRDPPSAASSETVPSNPSQLPQTTSPNEPN 268

Query: 262 KTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDR----SSISSDKQQRRSGSNY 317
           K + +KGLS  AIVAIV+ NCVA+LVV SF+VA+ C  DR    S   S+  +RRSGS+Y
Sbjct: 269 KKQRRKGLSPGAIVAIVIANCVAMLVVVSFIVAHYCARDRGGSSSMAGSESGKRRSGSSY 328

Query: 318 G-SEKRVYANGGNDSDG--TSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYK 374
           G  +K+VYAN G   D   T+ TD SKLVF++R+KQFELEDLLRASAEMLGKGSLGTVYK
Sbjct: 329 GGDQKKVYANSGGGGDSDGTNATDRSKLVFFDRRKQFELEDLLRASAEMLGKGSLGTVYK 388

Query: 375 AVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL 434
           AVLDDG  +AVKRLKDANPC RKEFEQYMDVIGK+KHPNVV+L AYYYAKEEKLLVYDYL
Sbjct: 389 AVLDDGSTMAVKRLKDANPCERKEFEQYMDVIGKVKHPNVVRLSAYYYAKEEKLLVYDYL 448

Query: 435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL 494
           PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH EY +AKVPHGNVKSSNVLL
Sbjct: 449 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHAEYSSAKVPHGNVKSSNVLL 508

Query: 495 DKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR 554
           DKNGVACISDFGLSLLLNPV AIARLGGY+APEQAEVKRLSQKADVYSFGVLLLEVLTGR
Sbjct: 509 DKNGVACISDFGLSLLLNPVHAIARLGGYRAPEQAEVKRLSQKADVYSFGVLLLEVLTGR 568

Query: 555 APSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVG 614
           APSQYPSP  PRV+EEE AVDLPKWVRSVVKEEWT EVFDQELLRYKNIEEELV+MLHVG
Sbjct: 569 APSQYPSPAHPRVEEEEDAVDLPKWVRSVVKEEWTGEVFDQELLRYKNIEEELVAMLHVG 628

Query: 615 LACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLA 668
           LACVV QPEKRPTM+EVAKMIEDIRVE+SPLGE+YD+SRNSLSPSL TTEDGLA
Sbjct: 629 LACVVPQPEKRPTMSEVAKMIEDIRVERSPLGEDYDDSRNSLSPSLVTTEDGLA 682

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356537030|ref|XP_003537034.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g68400-like [Glycine max]

 Score =  963 bits (2490), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 491/682 (71%), Positives = 565/682 (82%), Gaps = 24/682 (3%)

Query: 6   LFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKS 65
           LF+    L + ++S  H NDT ALTLFR Q+D HG LLSNW G DAC AAW GV+CSP  
Sbjct: 20  LFMFLFFLPIFTLSLHH-NDTHALTLFRRQSDLHGYLLSNWTGGDACIAAWRGVLCSPNG 78

Query: 66  ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDF 124
            RV +LSLPS +LRG + PL+ L  LR L+LHDNRLN TI L  +NCTNL+L YLS NDF
Sbjct: 79  -RVTALSLPSLNLRGALDPLTPLTHLRLLNLHDNRLNDTISLLFSNCTNLQLLYLSSNDF 137

Query: 125 SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK 184
           S EIP +ISSLK +LRLDLSDNN+RG++ + ++NLT+L+TL+LQNN L+G IPDLSSS+K
Sbjct: 138 SGEIPPEISSLKSLLRLDLSDNNLRGKV-DVISNLTQLITLKLQNNLLSGEIPDLSSSMK 196

Query: 185 DLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVA----- 239
           +LKELN++NNE YG +P  +LKKF   +F GNEGLCG++PLP CSF+   P D       
Sbjct: 197 NLKELNMTNNEFYGHLPSPMLKKFSSTTFSGNEGLCGATPLPGCSFTTTPPKDNGNNNNN 256

Query: 240 ----SAPETVPSNPSSMPQRPAFGQE-KTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVA 294
               S+  TVPSNPSS P+     +  K +  +GLS  AIVA+V+ NCVALLVV SFVVA
Sbjct: 257 EKEPSSQTTVPSNPSSFPETSVIARPGKEQRHRGLSPGAIVAMVVANCVALLVVASFVVA 316

Query: 295 YCC-RGDRSSISSDKQ---QRRSGSNY-GSEKRVYANGGNDSDGTSGTDTSKLVFYERKK 349
           +CC RG  SS+   ++   +R+SGS+Y GSEK+VY  GG +SDGTSGT+ S+LVF++R+ 
Sbjct: 317 HCCARGRGSSLVGSRESYGKRKSGSSYNGSEKKVY--GGGESDGTSGTNRSRLVFFDRRS 374

Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL 409
           +FELEDLLRASAEMLGKGSLGTVY+ VL+DG IVAVKRLKDANPCAR EFEQYMDVIGKL
Sbjct: 375 EFELEDLLRASAEMLGKGSLGTVYRVVLNDGCIVAVKRLKDANPCARHEFEQYMDVIGKL 434

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           KH NVV+L+AYYYAKEEKLLVYDYL NG LH+LLHGNRGPGRIPLDWTTRISLVLGAARG
Sbjct: 435 KHSNVVRLKAYYYAKEEKLLVYDYLSNGCLHALLHGNRGPGRIPLDWTTRISLVLGAARG 494

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQA 529
           LA+IH EY  AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV AIARLGGY+APEQ 
Sbjct: 495 LAKIHAEYSAAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVHAIARLGGYRAPEQE 554

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPS-QYPSPTRPRVDEE-EQA-VDLPKWVRSVVKE 586
           + KRLSQ+ADVYSFGVLLLEVLTGRAPS QYPSP RPR++EE EQA VDLPKWVRSVV+E
Sbjct: 555 QNKRLSQQADVYSFGVLLLEVLTGRAPSLQYPSPARPRMEEEPEQATVDLPKWVRSVVRE 614

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLG 646
           EWTAEVFDQELLRYKNIEEELVSMLHVGLACV +QPEKRPTM EV KMIE+IRVEQSPLG
Sbjct: 615 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVAAQPEKRPTMEEVVKMIEEIRVEQSPLG 674

Query: 647 EEYDESRNSLSPSLATTEDGLA 668
           E+YDESR+SLSPS+ TTEDGLA
Sbjct: 675 EDYDESRHSLSPSIPTTEDGLA 696

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357440227|ref|XP_003590391.1| hypothetical protein MTR_1g061590 [Medicago truncatula] gi|92870924|gb|ABE80124.1| Protein kinase [Medicago truncatula] gi|355479439|gb|AES60642.1| hypothetical protein MTR_1g061590 [Medicago truncatula]

 Score =  929 bits (2402), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 487/682 (71%), Positives = 550/682 (80%), Gaps = 20/682 (2%)

Query: 1   MKKASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVV 60
           M    +F   L LS+  V     NDT ALTLFR QTDTHG LL+NW G +AC+A+W GV 
Sbjct: 1   MNYVIMFFFFLFLSIYIVPCLTHNDTQALTLFRQQTDTHGQLLTNWTGPEACSASWHGVT 60

Query: 61  CSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAY 118
           C+P + RV +L LPS +LRGPI  LS L  LR LDLH+NRLNGT+    L+NCTNLKL Y
Sbjct: 61  CTPNN-RVTTLVLPSLNLRGPIDALSSLTHLRLLDLHNNRLNGTVSASLLSNCTNLKLLY 119

Query: 119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD 178
           L+GNDFS +IP +ISSL  +LRLDLSDNN+ G IP +++ LT LLTLRLQNN L+G IPD
Sbjct: 120 LAGNDFSGQIPPEISSLNNLLRLDLSDNNLAGDIPNEISRLTNLLTLRLQNNALSGNIPD 179

Query: 179 LSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDV 238
           LSS + +L ELN++NNE YG+VP  +L KFG++SF GNEGLCGS P   CS + ++PP  
Sbjct: 180 LSSIMPNLTELNMTNNEFYGKVPNTMLNKFGDESFSGNEGLCGSKPFQVCSLTENSPP-- 237

Query: 239 ASAP-ETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCC 297
           +S P +TVPSNPSS P      + +++  KGLS   IVAIV+  CVALLVVTSFVVA+CC
Sbjct: 238 SSEPVQTVPSNPSSFPATSVIARPRSQHHKGLSPGVIVAIVVAICVALLVVTSFVVAHCC 297

Query: 298 ---RGDRSS--ISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDT---SKLVFYERKK 349
              RG  S+  + S+  +R+S   YGSEK+VY + G   D + GT     SKLVF++R+ 
Sbjct: 298 ARGRGVNSNSLMGSEAGKRKS---YGSEKKVYNSNGGGGDSSDGTSGTDMSKLVFFDRRN 354

Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL 409
            FELEDLLRASAEMLGKGSLGTVY+AVLDDG  VAVKRLKDANPCAR EFEQYMDVIGKL
Sbjct: 355 GFELEDLLRASAEMLGKGSLGTVYRAVLDDGSTVAVKRLKDANPCARHEFEQYMDVIGKL 414

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           KHPN+VKLRAYYYAKEEKLLVYDYL NGSLH+LLHGNRGPGRIPLDWTTRISLVLGAARG
Sbjct: 415 KHPNIVKLRAYYYAKEEKLLVYDYLSNGSLHALLHGNRGPGRIPLDWTTRISLVLGAARG 474

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQA 529
           LARIH EY  AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV A ARLGGY+APEQ 
Sbjct: 475 LARIHTEYSAAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVHATARLGGYRAPEQT 534

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPS-QYPSP-TRPR-VDEEEQAVDLPKWVRSVVKE 586
           E KRLSQ+ADVYSFGVLLLEVLTG+APS QYPSP  RPR V+EEE  VDLPKWVRSVV+E
Sbjct: 535 EQKRLSQQADVYSFGVLLLEVLTGKAPSLQYPSPANRPRKVEEEETVVDLPKWVRSVVRE 594

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLG 646
           EWT EVFDQELLRYKNIEEELVSMLHVGLACVV QPEKRPTM +V KMIEDIRVEQSPL 
Sbjct: 595 EWTGEVFDQELLRYKNIEEELVSMLHVGLACVVQQPEKRPTMVDVVKMIEDIRVEQSPLC 654

Query: 647 EEYDESRNSLSPSLATTEDGLA 668
           E+YDESRNSLSPS+ TTEDGLA
Sbjct: 655 EDYDESRNSLSPSIPTTEDGLA 676

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15227998|ref|NP_181196.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|4581155|gb|AAD24639.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589543|gb|ACN59305.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330254175|gb|AEC09269.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana]

 Score =  923 bits (2386), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 460/654 (70%), Positives = 538/654 (82%), Gaps = 18/654 (2%)

Query: 24  NDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIA 83
           NDT+ALTLFRLQTDTHGNL  NW G+DAC ++W GV CSP S RV  LSLPS SLRGP+ 
Sbjct: 23  NDTNALTLFRLQTDTHGNLAGNWTGSDACTSSWQGVSCSPSSHRVTELSLPSLSLRGPLT 82

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            LS LDQLR LDLHDNRLNGT+ PLTNC NL+L YL+GND S EIP +IS LK ++RLDL
Sbjct: 83  SLSSLDQLRLLDLHDNRLNGTVSPLTNCKNLRLVYLAGNDLSGEIPKEISFLKRMIRLDL 142

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           SDNNIRG IP ++   TR+LT+R+QNNELTGRIPD S  +K L ELN+S NEL+G V +G
Sbjct: 143 SDNNIRGVIPREILGFTRVLTIRIQNNELTGRIPDFSQ-MKSLLELNVSFNELHGNVSDG 201

Query: 204 LLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQE-K 262
           ++KKFG+ SF GNEGLCGS PLP C+ + D  P+ ++  + VPSNP+S+P  P   +E +
Sbjct: 202 VVKKFGDLSFSGNEGLCGSDPLPVCTITND--PESSNTDQIVPSNPTSIPHSPVSVREPE 259

Query: 263 TRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCC-RGDRS---SISSDKQQRRSGSNYG 318
             S +G+    I+A V+G CVA++V+ SF  A+CC R DR+   S S   +    G   G
Sbjct: 260 IHSHRGIK-PGIIAAVIGGCVAVIVLVSFGFAFCCGRLDRNGERSKSGSVETGFVGGGEG 318

Query: 319 SEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLD 378
             +  Y  GG +SD TS TD S+LVF+ER+KQFEL+DLL+ASAEMLGKGSLGTVYKAVLD
Sbjct: 319 KRRSSYGEGG-ESDATSATDRSRLVFFERRKQFELDDLLKASAEMLGKGSLGTVYKAVLD 377

Query: 379 DGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG 437
           DG   VAVKRLKDANPC RKEFEQYM++IG+LKH NVVKLRAYYYAKEEKLLVY+YLPNG
Sbjct: 378 DGSTTVAVKRLKDANPCPRKEFEQYMEIIGRLKHQNVVKLRAYYYAKEEKLLVYEYLPNG 437

Query: 438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN 497
           SLHSLLHGNRGPGRIPLDWTTRISL+LGAARGLA+IH EY  +K+PHGN+KSSNVLLD+N
Sbjct: 438 SLHSLLHGNRGPGRIPLDWTTRISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRN 497

Query: 498 GVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
           GVA I+DFGLSLLLNPV AIARLGGY+APEQ+E+KRLSQKADVYSFGVLLLEVLTG+APS
Sbjct: 498 GVALIADFGLSLLLNPVHAIARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAPS 557

Query: 558 QYPSPTRPR-------VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSM 610
            +PSP+RPR        +EEE  VDLPKWVRSVVKEEWTAEVFD ELLRYKNIEEE+V+M
Sbjct: 558 IFPSPSRPRSAASVAVEEEEEAVVDLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVAM 617

Query: 611 LHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTE 664
           LH+GLACVV QPEKRPTMAEV KM+E+IRVEQSP+GE++DESRNS+SPSLATT+
Sbjct: 618 LHIGLACVVPQPEKRPTMAEVVKMVEEIRVEQSPVGEDFDESRNSMSPSLATTD 671

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110735702|dbj|BAE99831.1| putative receptor-like protein kinase [Arabidopsis thaliana]

 Score =  922 bits (2382), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 459/654 (70%), Positives = 536/654 (81%), Gaps = 18/654 (2%)

Query: 24  NDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIA 83
           NDT+ALTLFRLQTDTHGNL  NW G+DAC ++W GV CSP S RV  LSLPS SLRGP+ 
Sbjct: 23  NDTNALTLFRLQTDTHGNLAGNWTGSDACTSSWQGVSCSPSSHRVTELSLPSLSLRGPLT 82

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            LS LDQLR LDLHDNRLNGT+ PLTNC NL+L YL+GND S EIP +IS LK ++RLDL
Sbjct: 83  SLSSLDQLRLLDLHDNRLNGTVSPLTNCKNLRLVYLAGNDLSGEIPKEISFLKRMIRLDL 142

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           SDNNIRG IP ++   TR+LT+R+QNNELTGRIPD S  +K L ELN+S NEL+G V +G
Sbjct: 143 SDNNIRGVIPREILGFTRVLTIRIQNNELTGRIPDFSQ-MKSLLELNVSFNELHGNVSDG 201

Query: 204 LLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQE-K 262
           ++KKFG  SF GNEGLCGS PLP C+ + D  P+ ++  + VPSNP+S+P  P   +E +
Sbjct: 202 VVKKFGNLSFSGNEGLCGSDPLPVCTITND--PESSNTDQIVPSNPTSIPHSPVSVREPE 259

Query: 263 TRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCC-RGDRS---SISSDKQQRRSGSNYG 318
             S +G+    I+A V+G CVA++V+ SF  A+CC R DR+   S S   +    G   G
Sbjct: 260 IHSHRGIK-PGIIAAVIGGCVAVIVLVSFGFAFCCGRLDRNGERSKSGSVETGFVGGGEG 318

Query: 319 SEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLD 378
             +  Y  GG +SD TS TD S+LVF+ER+KQFEL+DLL+ASAEMLGKGSLGTVYKAVLD
Sbjct: 319 KRRSSYGEGG-ESDATSATDRSRLVFFERRKQFELDDLLKASAEMLGKGSLGTVYKAVLD 377

Query: 379 DGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG 437
           DG   VAVKRLKDANPC RKEFEQYM++IG+LKH NVVKLRAYYYAKEEKLLVY+YLPNG
Sbjct: 378 DGSTTVAVKRLKDANPCPRKEFEQYMEIIGRLKHQNVVKLRAYYYAKEEKLLVYEYLPNG 437

Query: 438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN 497
           SLHS LHGNRGPGRIPLDWTTRISL+LGAARGLA+IH EY  +K+PHGN+KSSNVLLD+N
Sbjct: 438 SLHSFLHGNRGPGRIPLDWTTRISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRN 497

Query: 498 GVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
           GVA I+DFGLSLLLNPV AIARLGGY+APEQ+E+KRLSQKADVYSFGVLLLEVLTG+APS
Sbjct: 498 GVALIADFGLSLLLNPVHAIARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAPS 557

Query: 558 QYPSPTRPR-------VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSM 610
            +PSP+RPR        +EEE  VDLPKWVRSVVKEEWTAEVFD ELLRYKNIEEE+V+M
Sbjct: 558 IFPSPSRPRSAASVAVEEEEEAVVDLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVAM 617

Query: 611 LHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTE 664
           LH+GLACVV QPEKRPTMAEV KM+E+IRVEQSP+GE++DESRNS+SPSLATT+
Sbjct: 618 LHIGLACVVPQPEKRPTMAEVVKMVEEIRVEQSPVGEDFDESRNSMSPSLATTD 671

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297823467|ref|XP_002879616.1| hypothetical protein ARALYDRAFT_321364 [Arabidopsis lyrata subsp. lyrata] gi|297325455|gb|EFH55875.1| hypothetical protein ARALYDRAFT_321364 [Arabidopsis lyrata subsp. lyrata]

 Score =  900 bits (2326), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 463/655 (70%), Positives = 539/655 (82%), Gaps = 16/655 (2%)

Query: 24  NDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIA 83
           NDT+ALTLFRLQTDTHGNL  NW G+DAC+++W GV CSP S RV  LSLPS SLRGP+ 
Sbjct: 24  NDTNALTLFRLQTDTHGNLAGNWTGSDACSSSWHGVSCSPSSHRVTELSLPSLSLRGPLT 83

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            LS LD LR LDLHDNRLNGT+ PLTNCTNL+L YL+GND S EIP +IS LK ++RLDL
Sbjct: 84  SLSSLDHLRLLDLHDNRLNGTVSPLTNCTNLRLVYLAGNDLSGEIPKEISFLKRMIRLDL 143

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           SDNNIRG IP ++   TR+LT+RLQNNELTGRIPD S  +K L ELN+S NEL+G V +G
Sbjct: 144 SDNNIRGVIPREILGFTRILTIRLQNNELTGRIPDFSQ-MKSLLELNVSFNELHGNVSDG 202

Query: 204 LLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPA-FGQEK 262
           ++KKFG+ SF GNEGLCGS PLP CS + +  P+ ++  + VPSNP+S+P  P   G+ +
Sbjct: 203 VVKKFGDLSFSGNEGLCGSDPLPVCSLTNN--PESSNTDQIVPSNPTSIPHSPVTVGEPE 260

Query: 263 TRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCC-RGDRSSISSDKQQR-RSGSNYGSE 320
               +G+    I A++ G CVA++V+ SF  A+CC R DRS     K     SG   G  
Sbjct: 261 IHGHRGVKPGIIAAVISG-CVAVIVLVSFGFAFCCGRLDRSGGGGSKPGSVESGFVGGEG 319

Query: 321 KRVYANG-GNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDD 379
           KR  + G G +SD TS TD S+LVF+ER+KQFELEDLL+ASAEMLGKGSLGTVYKAVLDD
Sbjct: 320 KRRSSYGEGGESDATSATDRSRLVFFERRKQFELEDLLKASAEMLGKGSLGTVYKAVLDD 379

Query: 380 GGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS 438
           G   VAVKRLKDANPC RKEFEQYM++IG++KH +VVKLRAYYYAKEEKLLVY+YLPNGS
Sbjct: 380 GSTTVAVKRLKDANPCPRKEFEQYMEIIGRIKHQSVVKLRAYYYAKEEKLLVYEYLPNGS 439

Query: 439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG 498
           LHSLLHGNRGPGRIPLDWTTRISL+LGAARGLA+IH EY  +K+PHGN+KSSNVLLD+NG
Sbjct: 440 LHSLLHGNRGPGRIPLDWTTRISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRNG 499

Query: 499 VACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
           VA I+DFGLSLLLNPV AIARLGGY+APEQ+E+KRLSQKADVYSFGVLLLEVLTG+APS 
Sbjct: 500 VALIADFGLSLLLNPVHAIARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAPSI 559

Query: 559 YPSPTRPR-------VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSML 611
           +PSP+RPR        +EEE  VDLPKWVRSVVKEEWTAEVFD ELLRYKNIEEE+V+ML
Sbjct: 560 FPSPSRPRSAASVAVEEEEEAVVDLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVAML 619

Query: 612 HVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDG 666
           H+GLACVV QPEKRPTMAEV KM+E+IRVEQSP+GE++DESRNS+SPSLATTEDG
Sbjct: 620 HIGLACVVPQPEKRPTMAEVVKMVEEIRVEQSPVGEDFDESRNSMSPSLATTEDG 674

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	670
TAIR|locus:2044913	672	AT2G36570 [Arabidopsis thalian	0.952	0.949	0.642	3.9e-218
TAIR|locus:2202359	670	AT1G68400 [Arabidopsis thalian	0.926	0.926	0.434	2.4e-124
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.862	0.878	0.417	1.8e-110
TAIR|locus:2156784	640	RUL1 "REDUCED IN LATERAL GROWT	0.577	0.604	0.437	1.1e-97
TAIR|locus:2088500	647	RLK902 "receptor-like kinase 9	0.870	0.901	0.393	3.7e-96
TAIR|locus:2128414	638	AT4G23740 [Arabidopsis thalian	0.801	0.841	0.391	3.8e-94
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.774	0.793	0.410	7e-93
TAIR|locus:2198090	655	RKL1 "receptor-like kinase 1"	0.873	0.893	0.381	1.1e-92
TAIR|locus:2077898	640	AT3G08680 [Arabidopsis thalian	0.647	0.678	0.433	2.8e-89
TAIR|locus:2075502	627	AT3G02880 [Arabidopsis thalian	0.859	0.918	0.352	1.2e-88

TAIR|locus:2044913 AT2G36570 [Arabidopsis thaliana (taxid:3702)]

 Score = 2107 (746.8 bits), Expect = 3.9e-218, P = 3.9e-218
 Identities = 421/655 (64%), Positives = 493/655 (75%)

Query:    24 NDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIA 83
             NDT+ALTLFRLQTDTHGNL  NW G+DAC ++W GV CSP S RV  LSLPS SLRGP+ 
Sbjct:    23 NDTNALTLFRLQTDTHGNLAGNWTGSDACTSSWQGVSCSPSSHRVTELSLPSLSLRGPLT 82

Query:    84 PXXXXXXXXXXXXXXNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
                            NRLNGT+ PLTNC NL+L YL+GND S EIP +IS LK ++RLDL
Sbjct:    83 SLSSLDQLRLLDLHDNRLNGTVSPLTNCKNLRLVYLAGNDLSGEIPKEISFLKRMIRLDL 142

Query:   144 SDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRVPEG 203
             SDNNIRG IP ++                 GRIP                   +G V +G
Sbjct:   143 SDNNIRGVIPREILGFTRVLTIRIQNNELTGRIPDFSQMKSLLELNVSFNEL-HGNVSDG 201

Query:   204 LLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQE-K 262
             ++KKFG+ SF GNEGLCGS PLP C+ + D  P+ ++  + VPSNP+S+P  P   +E +
Sbjct:   202 VVKKFGDLSFSGNEGLCGSDPLPVCTITND--PESSNTDQIVPSNPTSIPHSPVSVREPE 259

Query:   263 TRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCC-RGDRSSISSDKQQRRSGSNYGSE- 320
               S +G+    I+A V+G CVA++V+ SF  A+CC R DR+   S      +G   G E 
Sbjct:   260 IHSHRGIKPG-IIAAVIGGCVAVIVLVSFGFAFCCGRLDRNGERSKSGSVETGFVGGGEG 318

Query:   321 -KRVYAXXXXXXXXXXXXXXXKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDD 379
              +R                  +LVF+ER+KQFEL+DLL+ASAEMLGKGSLGTVYKAVLDD
Sbjct:   319 KRRSSYGEGGESDATSATDRSRLVFFERRKQFELDDLLKASAEMLGKGSLGTVYKAVLDD 378

Query:   380 GGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS 438
             G   VAVKRLKDANPC RKEFEQYM++IG+LKH NVVKLRAYYYAKEEKLLVY+YLPNGS
Sbjct:   379 GSTTVAVKRLKDANPCPRKEFEQYMEIIGRLKHQNVVKLRAYYYAKEEKLLVYEYLPNGS 438

Query:   439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG 498
             LHSLLHGNRGPGRIPLDWTTRISL+LGAARGLA+IH EY  +K+PHGN+KSSNVLLD+NG
Sbjct:   439 LHSLLHGNRGPGRIPLDWTTRISLMLGAARGLAKIHDEYSISKIPHGNIKSSNVLLDRNG 498

Query:   499 VACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             VA I+DFGLSLLLNPV AIARLGGY+APEQ+E+KRLSQKADVYSFGVLLLEVLTG+APS 
Sbjct:   499 VALIADFGLSLLLNPVHAIARLGGYRAPEQSEIKRLSQKADVYSFGVLLLEVLTGKAPSI 558

Query:   559 YPSPTRPR------VDEEEQAV-DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSML 611
             +PSP+RPR      V+EEE+AV DLPKWVRSVVKEEWTAEVFD ELLRYKNIEEE+V+ML
Sbjct:   559 FPSPSRPRSAASVAVEEEEEAVVDLPKWVRSVVKEEWTAEVFDPELLRYKNIEEEMVAML 618

Query:   612 HVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDG 666
             H+GLACVV QPEKRPTMAEV KM+E+IRVEQSP+GE++DESRNS+SPSLATT DG
Sbjct:   619 HIGLACVVPQPEKRPTMAEVVKMVEEIRVEQSPVGEDFDESRNSMSPSLATT-DG 672

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)]

 Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
 Identities = 287/660 (43%), Positives = 383/660 (58%)

Query:    25 DTDALTLFRLQTDTHGNLLSNWKGA-DACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIA 83
             D++ L  F+L  D+ G L ++W    + C   WTGV C+    RV  L L   +L G I+
Sbjct:    31 DSETLLNFKLTADSTGKL-NSWNTTTNPCQ--WTGVSCN--RNRVTRLVLEDINLTGSIS 85

Query:    84 PXXXXXXXXXXXXXXNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
                            N L+G I  L+N T LKL +LS N FS   P  I+SL  + RLDL
Sbjct:    86 SLTSLTSLRVLSLKHNNLSGPIPNLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDL 145

Query:   144 SDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRVPEG 203
             S NN  G+IP  +                 G+IP                    G++P  
Sbjct:   146 SFNNFSGQIPPDLTDLTHLLTLRLESNRFSGQIPNINLSDLQDFNVSGNNFN--GQIPNS 203

Query:   204 LLKKFGEQSFIGNEGLCGSSPLPACS-FSGDT--P--PDVASA-----PETVPSNPSSMP 253
             L  +F E  F  N  LCG+ PL  C+  S D   P  PD A A     PETVPS+P+S+ 
Sbjct:   204 L-SQFPESVFTQNPSLCGA-PLLKCTKLSSDPTKPGRPDEAKASPLNKPETVPSSPTSI- 260

Query:   254 QRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSDKQQR-R 312
                  G +K+ +   +ST +++AI+LG+ + L  V+  ++ Y C   + +++  K  +  
Sbjct:   261 ----HGGDKSNNTSRISTISLIAIILGDFIILSFVS--LLLYYCFWRQYAVNKKKHSKIL 314

Query:   313 SGSN--YGSEKRVYAXXXXXXXXXXXXXXXKLVFYERKKQFELEDLLRASAEMLGKGSLG 370
              G    Y S     +               K+VF+E  ++FELEDLLRASAEMLGKG  G
Sbjct:   315 EGEKIVYSSNPYPTSTQNNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFG 374

Query:   371 TVYKAVLDDGGIVAVKRLKDANPCA-RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL 429
             T YKAVL+DG  VAVKRLKDA   A +KEFEQ M+V+G+L+H N+V L+AYY+A+EEKLL
Sbjct:   375 TAYKAVLEDGNEVAVKRLKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLL 434

Query:   430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKS 489
             VYDY+PNGSL  LLHGNRGPGR PLDWTTR+ +  GAARGLA IH    T K+ HG++KS
Sbjct:   435 VYDYMPNGSLFWLLHGNRGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKS 494

Query:   490 SNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLE 549
             +NVLLD++G A +SDFGLS+   P Q +A+  GY+APE  + ++ +QK+DVYSFGVLLLE
Sbjct:   495 TNVLLDRSGNARVSDFGLSIFA-PSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLE 553

Query:   550 VLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVS 609
             +LTG+ P+   +           AVDLP+WV+SVV+EEWTAEVFD EL+RYK+IEEE+V 
Sbjct:   554 ILTGKCPNMVET------GHSGGAVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVG 607

Query:   610 MLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTEDGLAG 669
             +L + +AC     + RP M  V K+IEDIR   S      ++  NS   S   +ED   G
Sbjct:   608 LLQIAMACTAVAADHRPKMGHVVKLIEDIRGGGSE-ASPCNDGINSAVDSPCLSEDTCGG 666

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
 Identities = 262/628 (41%), Positives = 351/628 (55%)

Query:    25 DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRG--PI 82
             +  AL  F LQ   H N L  W  +D+ A  W GV C+     + SL LP   L G  P 
Sbjct:    28 EKQALLTF-LQQIPHENRLQ-WNESDS-ACNWVGVECNSNQSSIHSLRLPGTGLVGQIPS 84

Query:    83 APXXXXXXXXXXXXXXNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
                             NRL+G I    +N T+L+  YL  N+FS E P   + L  ++RL
Sbjct:    85 GSLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRL 144

Query:   142 DLSDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRVP 201
             D+S NN  G IP  V                 G +P                    G +P
Sbjct:   145 DISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISLGLVDFNVSNNNLN---GSIP 201

Query:   202 EGLLKKFGEQSFIGNEGLCGSSPLPAC-SFSGDTPPDVASAPETVPSNPSSMPQRPAFGQ 260
               L  +F  +SF GN  LCG  PL  C SF     P    +P  +  NPS+         
Sbjct:   202 SSL-SRFSAESFTGNVDLCGG-PLKPCKSFFVSPSP----SPSLI--NPSN--------- 244

Query:   261 EKTRSKKG-LSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISS-DKQQRRSG---S 315
              +  SKK  LS AAIVAI++ + +  L++ + ++  C R  R S  +  KQ + +G    
Sbjct:   245 -RLSSKKSKLSKAAIVAIIVASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATR 303

Query:   316 NY----GSEKRVYAXXXXXXXXXXXXXXXKLVFYERKK-QFELEDLLRASAEMLGKGSLG 370
             N     G+                     KLVF E     F+LEDLLRASAE+LGKGS+G
Sbjct:   304 NVDLPPGASSSKEEVTGTSSGMGGETERNKLVFTEGGVYSFDLEDLLRASAEVLGKGSVG 363

Query:   371 TVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV 430
             T YKAVL++G  V VKRLKD    ++KEFE  M+V+GK+KHPNV+ LRAYYY+K+EKLLV
Sbjct:   364 TSYKAVLEEGTTVVVKRLKDVM-ASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLV 422

Query:   431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSS 490
             +D++P GSL +LLHG+RG GR PLDW  R+ + + AARGLA +H    +AK+ HGN+K+S
Sbjct:   423 FDFMPTGSLSALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHV---SAKLVHGNIKAS 479

Query:   491 NVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEV 550
             N+LL  N   C+SD+GL+ L +      RL GY APE  E ++++ K+DVYSFGVLLLE+
Sbjct:   480 NILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLEL 539

Query:   551 LTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSM 610
             LTG++P+Q            E+ +DLP+WV SVV+EEWTAEVFD EL+RY NIEEE+V +
Sbjct:   540 LTGKSPNQ--------ASLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQL 591

Query:   611 LHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             L + +ACV + P++RP M EV +MIED+
Sbjct:   592 LQIAMACVSTVPDQRPVMQEVLRMIEDV 619

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)]

 Score = 803 (287.7 bits), Expect = 1.1e-97, Sum P(2) = 1.1e-97
 Identities = 180/411 (43%), Positives = 255/411 (62%)

Query:   248 NPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSD 307
             +PSS   RP   +     ++  S A I+AIV+G  VA+L +    +    +  +      
Sbjct:   242 SPSSNLPRP-LTENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGG 300

Query:   308 KQQRRSGSNYGSEKRVYAXXXXXXXXXXXXXXXKLVFYER-KKQFELEDLLRASAEMLGK 366
             +  R       S+K                   KL F+ER    F+LEDLL+ASAE+LGK
Sbjct:   301 EGVRTQMGGVNSKKP-----QDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGK 355

Query:   367 GSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKE 425
             GS GT YKAVL+D   V VKRL++    ++KEFEQ M+++GK+ +H N V L AYYY+K+
Sbjct:   356 GSFGTAYKAVLEDTTAVVVKRLREV-VASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKD 414

Query:   426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHG 485
             EKLLVY Y+  GSL  ++HGNRG   +  DW TR+ +  G ++ ++ +H    + K  HG
Sbjct:   415 EKLLVYKYMTKGSLFGIMHGNRGDRGV--DWETRMKIATGTSKAISYLH----SLKFVHG 468

Query:   486 NVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGV 545
             ++KSSN+LL ++   C+SD  L  L N      R  GY APE  E +R+SQ++DVYSFGV
Sbjct:   469 DIKSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGV 528

Query:   546 LLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEE 605
             ++LE+LTG+ P      T+P +++E   +DLP+WVRSVV+EEWTAEVFD ELL+++NIEE
Sbjct:   529 VILEMLTGKTPL-----TQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEE 583

Query:   606 ELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR-VEQSPLGEEYDESRNS 655
             E+V ML + LACV   PE RP M EVA+MIED+R ++QS   ++  ++R S
Sbjct:   584 EMVQMLQLALACVARNPESRPKMEEVARMIEDVRRLDQS---QQLQQNRTS 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:2000605 "positive regulation of secondary growth" evidence=IMP

GO:0010089 "xylem development" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)]

 Score = 956 (341.6 bits), Expect = 3.7e-96, P = 3.7e-96
 Identities = 251/638 (39%), Positives = 338/638 (52%)

Query:    25 DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAP 84
             D  AL  FR        LL + K    C   WTGV+C     RV +L LP  +L G I P
Sbjct:    34 DKSALLSFRSAVGGR-TLLWDVKQTSPCN--WTGVLCD--GGRVTALRLPGETLSGHI-P 87

Query:    85 XXXXXXXXXXXXXXNRLNGTI--LPLT--NCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
                            RLNG    LPL   +C++L+  YL GN FS EIP  + SL  ++R
Sbjct:    88 EGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVR 147

Query:   141 LDLSDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRV 200
             L+L++N   G I                     G +                     G +
Sbjct:   148 LNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSL---LDLDLSLDQFNVSNNLLNGSI 204

Query:   201 PEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQ 260
             P+ L +KF   SF+G   LCG  PL  CS  G  P    S P +V + P ++      G 
Sbjct:   205 PKSL-QKFDSDSFVGTS-LCGK-PLVVCSNEGTVP----SQPISVGNIPGTVE-----GS 252

Query:   261 EKTRSKKGLSTAAIVAIVLGNCVAL-LVVTSFVVAYCCRGDRSSISSD----KQQR---- 311
             E+ + +K LS  AI  IV+G  V L L+V   +V +  +G+  + + D    K       
Sbjct:   253 EEKKKRKKLSGGAIAGIVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLATIKHHEVEIP 312

Query:   312 -RSGSNYGSEKRVYAXXXXXXXXXX----XXXXXKLVFY-ERKKQFELEDLLRASAEMLG 365
                 +    E R Y                    KLVF+    K F+LEDLLRASAE+LG
Sbjct:   313 GEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLG 372

Query:   366 KGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE 425
             KG+ GT YKAVLD   +VAVKRLKD    A +EF++ ++V+G + H N+V LRAYYY+ +
Sbjct:   373 KGTFGTAYKAVLDAVTLVAVKRLKDVT-MADREFKEKIEVVGAMDHENLVPLRAYYYSGD 431

Query:   426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHG 485
             EKLLVYD++P GSL +LLHGN+G GR PL+W  R  + LGAARGL  +H +   +   HG
Sbjct:   432 EKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSS--HG 489

Query:   486 NVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA-RLGGYKAPEQAEVKRLSQKADVYSFG 544
             NVKSSN+LL  +  A +SDFGL+ L++       R  GY+APE  + +R+SQKADVYSFG
Sbjct:   490 NVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFG 549

Query:   545 VLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYK--- 601
             V+LLE+LTG+APS         V  EE  +DL +WV SV +EEW  EVFD EL+  +   
Sbjct:   550 VVLLELLTGKAPSN-------SVMNEE-GMDLARWVHSVAREEWRNEVFDSELMSIETVV 601

Query:   602 NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
             ++EEE+  ML +G+ C    P+KRP M EV + I+++R
Sbjct:   602 SVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELR 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)]

 Score = 937 (334.9 bits), Expect = 3.8e-94, P = 3.8e-94
 Identities = 229/585 (39%), Positives = 319/585 (54%)

Query:   101 LNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVXX 158
             LNG I P  ++  + L++  L  N  S E P     LK +  L L DNN+ G +P     
Sbjct:    80 LNGQIPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSV 139

Query:   159 XXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRVPE-GLLKKFGEQSFIGNE 217
                            G IP                    G +P+  +L          N 
Sbjct:   140 WKNLTSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNY 199

Query:   218 GLCGSSP-----LPACSFSG-DTPPDVASAPETVPSNPSSMP-QRPAFGQEKTRSKKGLS 270
              L G  P      P  S++G D  P   +     P  PS    Q+P+    K R   GLS
Sbjct:   200 DLAGPIPDWLRRFPFSSYTGIDIIPPGGNYTLVTPPPPSEQTHQKPS----KARFL-GLS 254

Query:   271 TAAIVAIVLGNCVALLVVTSFVVAYCC------RGDRSSISSDKQQRRSGSNYGSEKRVY 324
                 + IV+   + ++   +FV+  C       RGD   IS +K Q++ G +   EK V 
Sbjct:   255 ETVFLLIVIAVSIVVITALAFVLTVCYVRRKLRRGD-GVISDNKLQKKGGMS--PEKFV- 310

Query:   325 AXXXXXXXXXXXXXXXKLVFYER-KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIV 383
                             +L F+E     F+LEDLLRASAE+LGKG+ GT YKAVL+D   V
Sbjct:   311 --------SRMEDVNNRLSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSV 362

Query:   384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
             AVKRLKD     +++FEQ M++IG +KH NVV+L+AYYY+K+EKL+VYDY   GS+ SLL
Sbjct:   363 AVKRLKDV-AAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLL 421

Query:   444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
             HGNRG  RIPLDW TR+ + +GAA+G+ARIH+E    K+ HGN+KSSN+ L+     C+S
Sbjct:   422 HGNRGENRIPLDWETRMKIAIGAAKGIARIHKE-NNGKLVHGNIKSSNIFLNSESNGCVS 480

Query:   504 DFGLSLLLNPVQA-IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
             D GL+ +++P+   I+R  GY+APE  + ++ SQ +DVYSFGV+LLE+LTG+      SP
Sbjct:   481 DLGLTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGK------SP 534

Query:   563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQP 622
                   +E   + L +WV SVV+EEWTAEVFD ELLRY NIEEE+V ML + ++CVV   
Sbjct:   535 IHTTAGDE--IIHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAA 592

Query:   623 EKRPTMAEVAKMIEDI---RVEQSPLGEEYDESRNSLSPSLATTE 664
             ++RP M+++ ++IE++   R    P  E   +S N  S +   +E
Sbjct:   593 DQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSENGASETSTPSE 637

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 925 (330.7 bits), Expect = 7.0e-93, P = 7.0e-93
 Identities = 230/560 (41%), Positives = 307/560 (54%)

Query:   101 LNGTILPLT--NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVXX 158
             L G I P T     +L++  L  N  S  +P  I SL  +  + L  NN  G +P  V  
Sbjct:    99 LLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSR 158

Query:   159 XXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRVPEGLLKKFGEQSF-IGNE 217
                            G+IP                    G VP   L     +   + N 
Sbjct:   159 QLNILDLSFNSFT--GKIPATFQNLKQLTGLSLQNNKLSGPVPN--LDTVSLRRLNLSNN 214

Query:   218 GLCGSSP-----LPACSFSGDT-----P--PDVASAPETVPSNPSSMPQRPAFGQEKTRS 265
              L GS P      P+ SFSG+T     P  P   S+P    +   S P  P F   K  S
Sbjct:   215 HLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPF-PHKEGS 273

Query:   266 KKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSDKQQRRSGSNYGSEKRVYA 325
             K+ L  + I+ I  G    LL++T  V+  CC          K+ +R  S    +     
Sbjct:   274 KRKLHVSTIIPIAAGGAALLLLIT--VIILCC-------CIKKKDKREDSIVKVKTLTEK 324

Query:   326 XXXXXXXXXXXXXXXKLVFYER-KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVA 384
                            KLVF+      F+LEDLLRASAE+LGKGS GT YKAVL++   V 
Sbjct:   325 AKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVV 384

Query:   385 VKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
             VKRLK+     ++EFEQ M++I ++  HP+VV LRAYYY+K+EKL+V DY P G+L SLL
Sbjct:   385 VKRLKEV-AAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLL 443

Query:   444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
             HGNRG  + PLDW +R+ + L AA+G+A +H   G  K  HGN+KSSNV++ +   ACIS
Sbjct:   444 HGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAA-GGPKFSHGNIKSSNVIMKQESDACIS 502

Query:   504 DFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT 563
             DFGL+ L+    A  R  GY+APE  E ++ + K+DVYSFGVL+LE+LTG++P Q  SP+
Sbjct:   503 DFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQ--SPS 560

Query:   564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPE 623
             R      +  VDLP+WV+SVV+EEWT+EVFD EL+R++NIEEE+V ML + +ACV   PE
Sbjct:   561 R------DDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPE 614

Query:   624 KRPTMAEVAKMIEDIRVEQS 643
              RPTM +V +MIE+IRV  S
Sbjct:   615 VRPTMDDVVRMIEEIRVSDS 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 923 (330.0 bits), Expect = 1.1e-92, P = 1.1e-92
 Identities = 244/640 (38%), Positives = 332/640 (51%)

Query:    25 DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAP 84
             + D   L  L++   G     W         W GV C  +S RV +L LP  +L G I P
Sbjct:    34 NADRTALLSLRSAVGGRTF-RWNIKQTSPCNWAGVKC--ESNRVTALRLPGVALSGDI-P 89

Query:    85 XXXXXXXXXXXXXXNRLNGTI--LP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
                            RLN     LP  L+  +NL+  YL GN FS EIP  + SL  ++R
Sbjct:    90 EGIFGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVR 149

Query:   141 LDLSDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRV 200
             L+L+ N+  G I                     G IP                    G +
Sbjct:   150 LNLASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLPLVQFNVSNNSLN---GSI 206

Query:   201 PEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQ 260
             P+ L ++F   SF+    LCG  PL  C       PD  + P    S  +  P      +
Sbjct:   207 PKNL-QRFESDSFL-QTSLCGK-PLKLC-------PDEETVPSQPTSGGNRTPPSVEGSE 256

Query:   261 EKTRSKK---GLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRS---SISSDKQQRRS- 313
             EK +  K   G     ++  V+G   AL+V+   V+       RS    IS+ KQQ    
Sbjct:   257 EKKKKNKLSGGAIAGIVIGCVVG--FALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEI 314

Query:   314 -GSNYGSEK-RVYAXXXXXXXXXXXX---------XXXKLVFY-ERKKQFELEDLLRASA 361
              G     +   VY+                        KLVF+    K F+LEDLLRASA
Sbjct:   315 PGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASA 374

Query:   362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
             E+LGKG+ GT YKAVLD   +VAVKRLKD    A KEF++ ++++G + H N+V LRAYY
Sbjct:   375 EVLGKGTFGTAYKAVLDAVTVVAVKRLKDVM-MADKEFKEKIELVGAMDHENLVPLRAYY 433

Query:   422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             ++++EKLLVYD++P GSL +LLHGNRG GR PL+W  R  + +GAARGL  +H + GT+ 
Sbjct:   434 FSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQ-GTS- 491

Query:   482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA-RLGGYKAPEQAEVKRLSQKADV 540
               HGN+KSSN+LL K+  A +SDFGL+ L+        R  GY+APE  + KR+SQK DV
Sbjct:   492 TSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDV 551

Query:   541 YSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY 600
             YSFGV+LLE++TG+APS         V  EE  VDLP+WV+SV ++EW  EVFD ELL  
Sbjct:   552 YSFGVVLLELITGKAPSN-------SVMNEE-GVDLPRWVKSVARDEWRREVFDSELLSL 603

Query:   601 KNIEEELVS-MLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
                EEE+++ M+ +GL C    P++RP M+EV + +E++R
Sbjct:   604 ATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005774 "vacuolar membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)]

 Score = 891 (318.7 bits), Expect = 2.8e-89, P = 2.8e-89
 Identities = 206/475 (43%), Positives = 278/475 (58%)

Query:   198 GRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPA 257
             G VP  + K F   SF GN  LCG+ PL  C       P+  +AP   P+ P+  P    
Sbjct:   197 GSVPSSV-KSFPASSFQGNSLLCGA-PLTPC-------PENTTAPSPSPTTPTEGPGTTN 247

Query:   258 FGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCR---GDRSSISSDKQQRRSG 314
              G  +  +KK LST AIV I +G  V L ++ + +   C +   G + S +  K +    
Sbjct:   248 IG--RGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKPGRS 305

Query:   315 SNYGSEKRVYAXXXXXXXXXXXXXXXKLVFYERKK-QFELEDLLRASAEMLGKGSLGTVY 373
              N   E                    KLVF+E     F+LEDLLRASAE+LGKGS GT Y
Sbjct:   306 DNKAEE---------FGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTY 356

Query:   374 KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYD 432
             KA+L++G  V VKRLK+     ++EFEQ M+ +G++  H NV  LRAYY++K+EKLLVYD
Sbjct:   357 KAILEEGTTVVVKRLKEV-AAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYD 415

Query:   433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV 492
             Y   G+   LLHGN   GR  LDW TR+ + L AARG++ IH   G AK+ HGN+KS NV
Sbjct:   416 YYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASG-AKLLHGNIKSPNV 474

Query:   493 LLDKNGVACISDFGLSLLLNPVQAI-ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVL 551
             LL +    C+SDFG++ L++    I +R  GY+APE  E ++ +QK+DVYSFGVLLLE+L
Sbjct:   475 LLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEML 534

Query:   552 TGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYK-NIEEELVSM 610
             TG+A          +    E+ VDLPKWV+SVV+EEWT EVFD EL++ + N+EEE+V M
Sbjct:   535 TGKAAG--------KTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQM 586

Query:   611 LHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTED 665
             L + +ACV   P+ RP+M EV  M+E+IR    P G        + SP +  + D
Sbjct:   587 LQIAMACVSKHPDSRPSMEEVVNMMEEIR----PSGSGPGSGNRASSPEMIRSSD 637

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)]

 Score = 885 (316.6 bits), Expect = 1.2e-88, P = 1.2e-88
 Identities = 221/627 (35%), Positives = 327/627 (52%)

Query:    25 DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRG--PI 82
             ++D   L  ++    G  L  W  + +    W GV C   + RV +L LP   L G  PI
Sbjct:    27 ESDRRALLAVRNSVRGRPLL-WNMSASSPCNWHGVHCD--AGRVTALRLPGSGLFGSLPI 83

Query:    83 APXXXXXXXXXXXXXXNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
                             N L+G I    +N   L+  YL GN FS EIP  + +L  I+R+
Sbjct:    84 GGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIPSLLFTLPSIIRI 143

Query:   142 DLSDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPXXXXXXXXXXXXXXXXXXXYGRVP 201
             +L +N   GRIP+ V                 G IP                    G +P
Sbjct:   144 NLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITLPLQQFNVSSNQLN---GSIP 200

Query:   202 EGLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQE 261
               L   +   +F GN  LCG  PL  C        D A  P T P              E
Sbjct:   201 SSL-SSWPRTAFEGNT-LCGK-PLDTCEAESPNGGD-AGGPNTPP--------------E 242

Query:   262 KTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYC-CRGDRS-------SISSDKQQRRS 313
             K  S K LS  AIV IV+G  V LL++   ++ +C CR  +        ++ +      S
Sbjct:   243 KKDSDK-LSAGAIVGIVIGCVVGLLLL--LLILFCLCRKRKKEENVPSRNVEAPVAAATS 299

Query:   314 GSNYGSEKRVYAXXXXXXXXXXXXXXXKLVFYERK-KQFELEDLLRASAEMLGKGSLGTV 372
              +    E  V                  L F+ +   +F+L+ LL+ASAE+LGKG++G+ 
Sbjct:   300 SAAIPKETVVVVPPAKATGSESGAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSS 359

Query:   373 YKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD 432
             YKA  + G +VAVKRL+D      KEF + + V+G + H N+V L AYY++++EKLLV++
Sbjct:   360 YKASFEHGLVVAVKRLRDV-VVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFE 418

Query:   433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV 492
             Y+  GSL ++LHGN+G GR PL+W TR  + LGAAR ++ +H   GT    HGN+KSSN+
Sbjct:   419 YMSKGSLSAILHGNKGNGRTPLNWETRAGIALGAARAISYLHSRDGTTS--HGNIKSSNI 476

Query:   493 LLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
             LL  +  A +SD+GL+ +++   A  R+ GY+APE  + +++SQKADVYSFGVL+LE+LT
Sbjct:   477 LLSDSYEAKVSDYGLAPIISSTSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLT 536

Query:   553 GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYK-NIEEELVSML 611
             G+      SPT  +++EE   VDLP+WV+SV +++  ++V D EL RY+    E ++ +L
Sbjct:   537 GK------SPTHQQLNEE--GVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLL 588

Query:   612 HVGLACVVSQPEKRPTMAEVAKMIEDI 638
              +G++C    P+ RP+MAEV ++IE++
Sbjct:   589 KIGMSCTAQFPDSRPSMAEVTRLIEEV 615

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046658 "anchored to plasma membrane" evidence=IDA

GO:0005618 "cell wall" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0016020 "membrane" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0005829 "cytosol" evidence=RCA

GO:0009506 "plasmodesma" evidence=IDA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	670
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-41
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-40
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-38
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-36
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-25
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-24
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-23
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-21
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-20
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-19
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	7e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-18
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-18
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	8e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-16
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-16
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-16
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-16
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	8e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-14
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-14
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-14
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-13
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-13
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-12
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-11
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-11
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-11
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	6e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	7e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-09
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	8e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-08
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-08
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-08
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-07
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-07
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-06
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-06
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-06
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	6e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-04
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-04
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	5e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	6e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	6e-04
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	7e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-04
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	0.001
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.002
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.003
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.003
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.003
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.004
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  162 bits (411), Expect = 1e-41
 Identities = 145/577 (25%), Positives = 251/577 (43%), Gaps = 71/577 (12%)

Query: 71  LSLPSHSLRGPIAPLSL-LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
           L + +++L+G I      +  L+ L L  N+  G +        L+   LS N FS  +P
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVP 492

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
            ++ SL  +++L LS+N + G IP+++++  +L++L L +N+L+G+IP   S +  L +L
Sbjct: 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL 552

Query: 190 NLSNNELYGRVPEGLLKKFG-EQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPETVPSN 248
           +LS N+L G +P+ L       Q  I +  L GS P    +F       VA   +    +
Sbjct: 553 DLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP-STGAFLAINASAVAGNIDLCGGD 611

Query: 249 PSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSISSDK 308
            +S    P       R +K  S    +   LG  + L +V    V               
Sbjct: 612 TTS-GLPPC-----KRVRKTPSWWFYITCTLGAFLVLALVAFGFVF-------------- 651

Query: 309 QQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERK--KQFELEDLLRASAE--ML 364
            + R+       KRV      + DG     T +L F++ K  K   + D+L +  E  ++
Sbjct: 652 IRGRNNLEL---KRV-----ENEDG-----TWELQFFDSKVSKSITINDILSSLKEENVI 698

Query: 365 GKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
            +G  G  YK      G+   VK + D N     E        GKL+HPN+VKL     +
Sbjct: 699 SRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM----GKLQHPNIVKLIGLCRS 754

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           ++   L+++Y+   +L  +L          L W  R  + +G A+ L  +H    +  V 
Sbjct: 755 EKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHC-RCSPAVV 805

Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSF 543
            GN+    +++D      +    L  LL           Y APE  E K +++K+D+Y F
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGF 864

Query: 544 GVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK----EEWTAEVFDQELLR 599
           G++L+E+LTG++P+           E      + +W R        + W       ++  
Sbjct: 865 GLILIELLTGKSPADA---------EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915

Query: 600 YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
            +N   E+V ++++ L C  + P  RP   +V K +E
Sbjct: 916 NQN---EIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  146 bits (371), Expect = 3e-40
 Identities = 65/194 (33%), Positives = 99/194 (51%), Gaps = 16/194 (8%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG+G  GTVY A     G  VA+K + K+ +    +E  + ++++ KL HPN+VKL   +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +    LV +Y   GSL  LL  N G     L     + ++L    GL  +H       
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSN----G 112

Query: 482 VPHGNVKSSNVLLDK-NGVACISDFGLSLLLNPVQAIARLG----GYKAPEQAEVKR-LS 535
           + H ++K  N+LLD  NG   ++DFGLS LL   +++ +       Y APE    K   S
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 536 QKADVYSFGVLLLE 549
           +K+D++S GV+L E
Sbjct: 173 EKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  147 bits (373), Expect = 4e-40
 Identities = 92/286 (32%), Positives = 132/286 (46%), Gaps = 45/286 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
           + LG+G+ G VYK  L   G      VAVK LK DA+    +EF +   ++ KL HPNVV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           KL      +E   +V +Y+  G L S L  NR      L  +  +S  L  ARG+  +  
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP----KLSLSDLLSFALQIARGMEYLES 120

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAE 530
           +       H ++ + N L+ +N V  ISDFGLS  L       + GG    +  APE  +
Sbjct: 121 K----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 531 VKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
             + + K+DV+SFGVLL E+ T G  P  Y     P +  EE        V   +K    
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQP--Y-----PGMSNEE--------VLEYLKN--- 218

Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
                  L +  N   EL  ++   L C    PE RPT +E+ +++
Sbjct: 219 ----GYRLPQPPNCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  146 bits (371), Expect = 7e-40
 Identities = 90/286 (31%), Positives = 133/286 (46%), Gaps = 44/286 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
           + LG+G+ G VYK  L   G      VAVK LK DA+    +EF +   ++ KL HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           KL      +E  ++V +Y+P G L   L  NR      L  +  +S  L  ARG+  +  
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEYLES 121

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAE 530
           +       H ++ + N L+ +N V  ISDFGLS  L         GG    +  APE  +
Sbjct: 122 K----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 531 VKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
             + + K+DV+SFGVLL E+ T G  P  YP  +    + E         V   +K+   
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEP--YPGMS----NAE---------VLEYLKK--- 219

Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
                  L +  N   EL  ++   L C    PE RPT +E+ +++
Sbjct: 220 ----GYRLPKPPNCPPELYKLM---LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  141 bits (358), Expect = 5e-38
 Identities = 86/291 (29%), Positives = 133/291 (45%), Gaps = 45/291 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
           + LG+G+ G VYK  L         VAVK LK DA+   RK+F +   V+ KL HPNVV+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG----PGRIPLDWTTRISLVLGAARGLAR 472
           L      +E   LV +Y+  G L   L  +R     P +  L     +S  +  A+G+  
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------AP 526
           +  +    K  H ++ + N L+ ++ V  ISDFGLS  +       +  G K      AP
Sbjct: 121 LASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
           E  +    + K+DV+SFGVLL E+ T G  P  YP              ++ +++R    
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YP---------GLSNEEVLEYLRK--- 222

Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
                      L + +   +EL  ++   L+C    PE RPT +E+ + +E
Sbjct: 223 --------GYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  137 bits (348), Expect = 1e-36
 Identities = 84/287 (29%), Positives = 130/287 (45%), Gaps = 46/287 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVV 415
           + LG+G+ G VYK  L   G      VAVK LK+ A+   R+EF +   ++ KL HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L       E   +V +Y+P G L   L  +       L     + + L  A+G+  +  
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLES 120

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGGY---K--APEQA 529
           +       H ++ + N L+ +N V  ISDFGLS  +        R GG    K  APE  
Sbjct: 121 K----NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 530 EVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
           +  + + K+DV+SFGVLL E+ T G  P  YP  +           ++ + +        
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMS---------NEEVLELLED------ 219

Query: 589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
                   L R +N  +EL  ++   L C    PE RPT +E+ + +
Sbjct: 220 -----GYRLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  137 bits (347), Expect = 1e-36
 Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 36/278 (12%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E LG+GS G VY A     G +VA+K + K      R+   + + ++ KLKHPN+V+L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            +  +++  LV +Y   G L  LL      GR+  D        +     L  +H     
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKKR---GRLSEDEARFYLRQI--LSALEYLHS---- 115

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLSQ 536
             + H ++K  N+LLD++G   ++DFGL+  L+P + +    G   Y APE    K   +
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
             D++S GV+L E+LTG+ P             ++Q ++L K +                
Sbjct: 176 AVDIWSLGVILYELLTGKPP----------FPGDDQLLELFKKIGKPKPPFP-------- 217

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
                +I  E   ++      +V  PEKR T  E  + 
Sbjct: 218 -PPEWDISPEAKDLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  136 bits (346), Expect = 2e-36
 Identities = 70/201 (34%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           LG GS GTVYKA     G IVAVK LK         +   + + ++ +L HPN+V+L   
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +  K+   LV +Y   G L   L         PL       + L   RGL  +H      
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHSN---- 117

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA--RLG--GYKAPEQ-AEVKRLS 535
            + H ++K  N+LLD+NGV  I+DFGL+  L    +     +G   Y APE         
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 536 QKADVYSFGVLLLEVLTGRAP 556
            K DV+S GV+L E+LTG+ P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  122 bits (308), Expect = 3e-31
 Identities = 79/272 (29%), Positives = 135/272 (49%), Gaps = 55/272 (20%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG---KLKHPNVVKL 417
           E+LG+GS G+VY A+  D G ++AVK ++ +   + +E E     I     L+HPN+V+ 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSG-DSEEELEALEREIRILSSLQHPNIVR- 63

Query: 418 RAYYYAKEEK----LLVY-DYLPNGSLHSLLHGNRGPGRIPLD----WTTRISLVLGAAR 468
             YY ++ ++    L ++ +Y+  GSL SLL      G++P      +T +I        
Sbjct: 64  --YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQI------LE 112

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------ 522
           GLA +H       + H ++K +N+L+D +GV  ++DFG +  L  ++     G       
Sbjct: 113 GLAYLHS----NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSP-----------TRPRVDEE 570
           + APE    +   + AD++S G  ++E+ TG+ P S+  +P             P + E 
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEH 228

Query: 571 --EQAVD-LPKWVRSVVKEEWTAEVFDQELLR 599
             E+A D L K +R   K+  TA+    ELL+
Sbjct: 229 LSEEAKDFLRKCLRRDPKKRPTAD----ELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  118 bits (298), Expect = 7e-30
 Identities = 69/290 (23%), Positives = 127/290 (43%), Gaps = 55/290 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           + +GKGS G VY      DG +  +K   L + +   R++    + ++ KL HPN++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP------LDWTTRISLVLGAARGLAR 472
             +  K +  +V +Y   G L   +   +     P      LDW  ++ L       L  
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCL------ALKY 118

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQ 528
           +H      K+ H ++K  N+ L  NG+  + DFG+S +L+    +A+  +G   Y +PE 
Sbjct: 119 LHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
            + K  + K+D++S G +L E+ T + P               +  +L +    ++K ++
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPF--------------EGENLLELALKILKGQY 220

Query: 589 TA--EVFDQELLRYKNIEEELV-SMLHVGLACVVSQPEKRPTMAEVAKMI 635
                 +  EL         LV S+L          PE+RP++A++ +  
Sbjct: 221 PPIPSQYSSEL-------RNLVSSLLQK-------DPEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (296), Expect = 1e-29
 Identities = 73/279 (26%), Positives = 115/279 (41%), Gaps = 47/279 (16%)

Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G VYKA     G  VA+K +K  +   +++    + ++ K KHPN+VK    
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLARIHQEYGT 479
           Y  K+E  +V ++   GSL  LL        +       I+ V     +GL  +H     
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKST--NQTLTESQ---IAYVCKELLKGLEYLHSN--- 117

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLG--GYKAPEQAEVKRLSQ 536
             + H ++K++N+LL  +G   + DFGLS  L+        +G   + APE    K    
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDY 176

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR-----PRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           KAD++S G+  +E+  G+ P     P +                L         E+W+  
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG----PPGLRN------PEKWS-- 224

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
                        +E    L     C+   PEKRPT  +
Sbjct: 225 -------------DEFKDFL---KKCLQKNPEKRPTAEQ 247

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 3e-28
 Identities = 64/203 (31%), Positives = 109/203 (53%), Gaps = 18/203 (8%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLR 418
           +++G+G+ G VYK + L+ G  VA+K++        A K   Q +D++  LKHPN+VK  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-ISLVLGAARGLARIHQEY 477
                 +   ++ +Y  NGSL  ++      G  P       +  VL   +GLA +H++ 
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVL---QGLAYLHEQ- 118

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-QAIARLGG---YKAPEQAEVKR 533
               V H ++K++N+L  K+GV  ++DFG++  LN V +  A + G   + APE  E+  
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
            S  +D++S G  ++E+LTG  P
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 1e-25
 Identities = 87/285 (30%), Positives = 130/285 (45%), Gaps = 47/285 (16%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+    +    VAVK LK     + + F Q   ++ KL+H  +V+L A    
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIP--LDWTTRISLVLGAARGLARIHQEYGTA 480
           +E   +V +Y+  GSL   L    G   R+P  +D   +I      A G+A +       
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI------AEGMAYLESR---- 122

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H ++ + N+L+ +N V  I+DFGL+ L+   +  AR G      + APE A   R +
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182

Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVF 593
            K+DV+SFG+LL E++T GR P  YP  T   V E+ E+   +P                
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVP--YPGMTNREVLEQVERGYRMP---------------- 224

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                R  N  EEL  ++   L C    PE+RPT   +   +ED 
Sbjct: 225 -----RPPNCPEELYDLM---LQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (265), Expect = 2e-25
 Identities = 74/212 (34%), Positives = 107/212 (50%), Gaps = 33/212 (15%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +G G+ G VY AV LD G ++AVK  R++D +P   KE    M V+  LKHPN+VK    
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63

Query: 421 YYAKE---EKLLVY-DYLPNGSLHSLLHGNRGPGRI-PLDWTTRISLVLGAARGLARIHQ 475
           YY  E   EK+ ++ +Y   G+L  LL      GRI         +L L    GLA +H 
Sbjct: 64  YYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQL--LEGLAYLHS 117

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--------VQAIARLGGYKAPE 527
                 + H ++K +N+ LD NGV  + DFG ++ L          VQ++A    Y APE
Sbjct: 118 ----HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 528 QAEVKRLSQK---ADVYSFGVLLLEVLTGRAP 556
                +       AD++S G ++LE+ TG+ P
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  101 bits (253), Expect = 5e-24
 Identities = 68/205 (33%), Positives = 107/205 (52%), Gaps = 20/205 (9%)

Query: 362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKL 417
             +GKGS G V+K V   D  + A+K++ D +   R+E E+ +D   V+ KL    +++ 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEAIDEARVLAKLDSSYIIRY 64

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD--WTTRISLVLGAARGLARIHQ 475
              +  K +  +V +Y  NG LH LL   RG   +P D  W   I ++LG    LA +H 
Sbjct: 65  YESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLG----LAHLHS 119

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQAEV 531
           +    K+ H ++KS N+ LD      I D G++ LL+     A   +G   Y +PE  E 
Sbjct: 120 K----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
           K  ++K+DV++ GV+L E  TG+ P
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  102 bits (255), Expect = 5e-24
 Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 45/238 (18%)

Query: 363 MLGKGSLGTVYKAVLD-----DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
            LG+G  G V     D      G  VAVK L        R +FE+ ++++  L H N+VK
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70

Query: 417 LRAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA---ARGLA 471
            +        +   L+ +YLP+GSL   L  +R       D      L+L +    +G+ 
Sbjct: 71  YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-------DQINLKRLLLFSSQICKGM- 122

Query: 472 RIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN--------------PVQA 516
               +Y G+ +  H ++ + N+L++   +  ISDFGL+ +L               P+  
Sbjct: 123 ----DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF- 177

Query: 517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
                 + APE     + S  +DV+SFGV L E+ T   PSQ P     R+    Q  
Sbjct: 178 ------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ 229

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =   99 bits (250), Expect = 2e-23
 Identities = 77/274 (28%), Positives = 126/274 (45%), Gaps = 37/274 (13%)

Query: 364 LGKGSLGTVYKAVLD-DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG+GS G VYK      G I A+K++  D +   RK+  + +  +   + P VVK    +
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS-LVLGAARGLARIHQEYGTA 480
           Y + E  +V +Y+  GSL  LL   +  G+IP      I+  +L   +GL  +H      
Sbjct: 69  YKEGEISIVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQIL---KGLDYLHT---KR 119

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LG--GYKAPEQAEVKRLSQ 536
            + H ++K SN+L++  G   I+DFG+S +L          +G   Y +PE+ + +  S 
Sbjct: 120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSY 179

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
            AD++S G+ LLE   G+ P  +  P +P         +L + +         AE F  E
Sbjct: 180 AADIWSLGLTLLECALGKFP--FLPPGQPSF------FELMQAICDGPPPSLPAEEFSPE 231

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
                    + +S       C+   P+KRP+ AE
Sbjct: 232 F-------RDFISA------CLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 6e-23
 Identities = 65/201 (32%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
             +GKG  G V       G  VAVK LKD +  A + F     V+  L+HPN+V+L    
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
                  +V +Y+  GSL   L   R  GR  +    ++   L    G+  + ++     
Sbjct: 70  LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK----N 122

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-GYKAPEQAEVKRLSQKADV 540
             H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   + APE    K+ S K+DV
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 541 YSFGVLLLEVLT-GRAPSQYP 560
           +SFG+LL E+ + GR P  YP
Sbjct: 183 WSFGILLWEIYSFGRVP--YP 201

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 8e-23
 Identities = 70/245 (28%), Positives = 117/245 (47%), Gaps = 25/245 (10%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG+ G VYK VL     VAVK  +    P  +++F Q  +++ +  HPN+VKL   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              K+   +V + +P GSL + L   +   R+ +     + + L AA G+     EY  +
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKK--NRLTV--KKLLQMSLDAAAGM-----EYLES 111

Query: 481 K-VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYKAPEQAEVKR 533
           K   H ++ + N L+ +N V  ISDFG+S            G       + APE     R
Sbjct: 112 KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYP----SPTRPRVDEEEQ--AVDL-PKWVRSVVKE 586
            + ++DV+S+G+LL E  +    + YP      TR R++   +  A  L P+ +  ++ +
Sbjct: 172 YTSESDVWSYGILLWETFSLGD-TPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQ 230

Query: 587 EWTAE 591
            W  +
Sbjct: 231 CWAYD 235

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 97.6 bits (244), Expect = 9e-23
 Identities = 69/204 (33%), Positives = 98/204 (48%), Gaps = 23/204 (11%)

Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRA 419
           LGKGS G V      D G + A+K LK      RKE E  +   +++ ++ HP +VKL  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS--LVLGAARGLARIHQE 476
           Y +  EEKL LV +Y P G L S L      GR   +     +  +VL     L  +H  
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKE---GRFSEERARFYAAEIVLA----LEYLHSL 112

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAPEQAEVK 532
                + + ++K  N+LLD +G   ++DFGL+  L +         G   Y APE    K
Sbjct: 113 ----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
              +  D +S GVLL E+LTG+ P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (256), Expect = 2e-22
 Identities = 65/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)

Query: 5   SLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWK-GADACAAAWTGVVCSP 63
              +  L    L+ S  H  + + L  F+   +     LSNW   AD C   W G+ C+ 
Sbjct: 10  PYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL--WQGITCN- 66

Query: 64  KSERVVSLSLPSHSLRGPIAPLSL-LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYL 119
            S RVVS+ L   ++ G I+     L  ++ ++L +N+L+G I P    T  ++L+   L
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPI-PDDIFTTSSSLRYLNL 125

Query: 120 SGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDL 179
           S N+F+  IP    S+  +  LDLS+N + G IP  + + + L  L L  N L G+IP+ 
Sbjct: 126 SNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNS 183

Query: 180 SSSLKDLKELNLSNNELYGRVPEGL 204
            ++L  L+ L L++N+L G++P  L
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPREL 208

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.7 bits (244), Expect = 4e-22
 Identities = 70/290 (24%), Positives = 112/290 (38%), Gaps = 39/290 (13%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHP-NVVKL 417
             LG+GS G VY A   D  +VA+K L    ++     + F + + ++  L HP N+VKL
Sbjct: 6   RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             ++  +    LV +Y+  GSL  LL      G +       I   +     L  +H + 
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLHSK- 120

Query: 478 GTAKVPHGNVKSSNVLLDKNGVAC-ISDFGLSLLL--------NPVQAIARLG--GYKAP 526
               + H ++K  N+LLD++G    + DFGL+ LL         P      +G  GY AP
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 527 EQAEVKRL---SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV 583
           E      L   S  +D++S G+ L E+LTG  P                     K +  +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-------FEGEKNSSATSQTLKIILEL 230

Query: 584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                         L   N E    +   +    +   P+ R + +    
Sbjct: 231 PTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 95.3 bits (237), Expect = 7e-22
 Identities = 82/285 (28%), Positives = 132/285 (46%), Gaps = 46/285 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + LG G  G V+    +    VA+K LK    +P A   F    +++ +L+HP +V+L A
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRLYA 68

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
               +E   ++ +Y+ NGSL   L    G   I L     I +    A G+A I ++   
Sbjct: 69  VV-TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK--- 121

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRL 534
               H +++++N+L+ +     I+DFGL+ L+   +  AR G      + APE       
Sbjct: 122 -NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180

Query: 535 SQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEV 592
           + K+DV+SFG+LL E++T GR P  YP  T P V +  E+   +P               
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIP--YPGMTNPEVIQNLERGYRMP--------------- 223

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                 R  N  EEL  ++     C   +PE+RPT   +  ++ED
Sbjct: 224 ------RPDNCPEELYELM---RLCWKEKPEERPTFEYLRSVLED 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 69/211 (32%), Positives = 106/211 (50%), Gaps = 18/211 (8%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V++ + ++   VAVK LK       K+F     ++ KL+HP +++L A    
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH-QEYGTAKV 482
           +E   +V + +  GSL   L G  G   + L     I +    A G+A +  Q Y     
Sbjct: 73  EEPIYIVTELMKYGSLLEYLQGGAG-RALKL--PQLIDMAAQVASGMAYLEAQNY----- 124

Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H ++ + NVL+ +N +  ++DFGL+ ++      AR G      + APE A   R S K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPTRPRV 567
           +DV+SFG+LL E++T GR P  YP  T   V
Sbjct: 185 SDVWSFGILLTEIVTYGRMP--YPGMTNAEV 213

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.9 bits (225), Expect = 2e-20
 Identities = 81/292 (27%), Positives = 144/292 (49%), Gaps = 49/292 (16%)

Query: 358 RASAEM---LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNV 414
           R S ++   LG G  G V+ A  +    VAVK +K  +  + + F    +V+  L+H  +
Sbjct: 5   RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKL 63

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLL---HGNRGPGRIPLDWTTRISLVLGAARGLA 471
           VKL A    KE   ++ +++  GSL   L    G++ P    +D++ +I      A G+A
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMA 116

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAP 526
            I Q        H +++++N+L+  + V  I+DFGL+ ++   +  AR G      + AP
Sbjct: 117 FIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAP 172

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
           E       + K+DV+SFG+LL+E++T GR P  YP  + P V            +R++ +
Sbjct: 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV------------IRALER 218

Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                      + R +N  EEL +++   + C  ++PE+RPT   +  +++D
Sbjct: 219 --------GYRMPRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 50/285 (17%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIP--LDWTTRISLVLGAARGLARIHQEYGTA 480
           +E   +V +Y+  GSL   L G  G   R+P  +D   +I      A G+A + +     
Sbjct: 72  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI------ASGMAYVER----M 121

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R +
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPS-PTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
            K+DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                
Sbjct: 182 IKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP---------------- 223

Query: 594 DQELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIED 637
                       E    LH +   C   +PE+RPT   +   +ED
Sbjct: 224 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 74/274 (27%), Positives = 127/274 (46%), Gaps = 36/274 (13%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG G+ G V K +    G I+AVK ++ + N   +K+  + +D++ K   P +V     +
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
           Y   +  +  +Y+  GSL  +L      GRIP     +I++     +GL  +H+++   K
Sbjct: 69  YNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAV--AVLKGLTYLHEKH---K 121

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQAEVKRLSQKAD 539
           + H +VK SN+L++  G   + DFG+S  L    A   +G   Y APE+ +    S K+D
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSD 181

Query: 540 VYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE---WTAEVFDQE 596
           ++S G+ L+E+ TGR P  YP    P     E        ++ +V E      +  F  +
Sbjct: 182 IWSLGLSLIELATGRFP--YPPENDPPDGIFEL-------LQYIVNEPPPRLPSGKFSPD 232

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
              + N              C++  P +RP+  E
Sbjct: 233 FQDFVN-------------LCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 87.8 bits (218), Expect = 3e-19
 Identities = 87/301 (28%), Positives = 132/301 (43%), Gaps = 73/301 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPC------ARKEFEQYMDVIGKLKHPNV 414
           E++G G+   VY A+ L +   VA+KR+ D   C       RKE  Q M       HPNV
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEV-QAMSQC---NHPNV 61

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVL-GAARGLAR 472
           VK    +   +E  LV  YL  GSL  ++       G   LD    I+ VL    +GL  
Sbjct: 62  VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAI-IATVLKEVLKGLEY 117

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIAR----LGG---YK 524
           +H   G     H ++K+ N+LL ++G   I+DFG+S  L +      +      G   + 
Sbjct: 118 LHS-NGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173

Query: 525 APE-QAEVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTR----------PRVDEEEQ 572
           APE   +V     KAD++SFG+  +E+ TG AP S+YP P +          P ++    
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP-PMKVLMLTLQNDPPSLETGA- 231

Query: 573 AVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVA 632
             D  K+ +S                 ++    +++S+      C+   P KRPT  E+ 
Sbjct: 232 --DYKKYSKS-----------------FR----KMISL------CLQKDPSKRPTAEELL 262

Query: 633 K 633
           K
Sbjct: 263 K 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 60/235 (25%)

Query: 362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEF------EQYM----DVIGKLK 410
           +++G+GS  TV  A   +     A+K L        K         +Y+    +V+ +L 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKEVLTRLN 59

Query: 411 -HPNVVKLRAYY-YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS--LVLG 465
            HP ++KL  YY +  EE L  V +Y PNG L   +      G +    T   +  ++L 
Sbjct: 60  GHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLA 114

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
               L  +H       + H ++K  N+LLDK+    I+DFG + +L+P  +     G   
Sbjct: 115 ----LEYLHS----KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 523 ---------------------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                                Y +PE    K   + +D+++ G ++ ++LTG+ P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 32/215 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCAR---KEFEQYMDVIGKLKHPNVV 415
           E+LG GS G+VY+ + LDDG   AVK   L D     +   K+ EQ + ++ KL+HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 416 KLRAYYYA---KEEKLLVY-DYLPNGSLHSLLHGNRGPGRIPL--DWTTRISLVLGAARG 469
           +    Y     +E+ L ++ + +P GSL  LL    G    P+   +T +I L      G
Sbjct: 66  Q----YLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILL------G 114

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAP 526
           L  +H         H ++K +N+L+D NGV  ++DFG++  +          G   + AP
Sbjct: 115 LEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170

Query: 527 EQ-AEVKRLSQKADVYSFGVLLLEVLTGRAP-SQY 559
           E  A+       AD++S G  +LE+ TG+ P SQ 
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 86.4 bits (214), Expect = 7e-19
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 26/202 (12%)

Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +G+GS G   KA+L    +DG    +K +     +P  R+E  + + V+  +KHPN+V+ 
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG---PGRIPLDWTTRISLVLGAARGLARIH 474
           +  +       +V DY   G L+  ++  RG   P    LDW  +I L       L  +H
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVH 118

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQAE 530
                 K+ H ++KS N+ L K+G   + DFG++ +LN    +AR  +G   Y +PE  E
Sbjct: 119 DR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICE 174

Query: 531 VKRLSQKADVYSFGVLLLEVLT 552
            +  + K+D+++ G +L E+ T
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 19/202 (9%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V +  L   G     VA+K LK  ++   R +F     ++G+  HPN+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          +++ +Y+ NGSL   L  N G           + ++ G A G+  +  E
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYL-SE 124

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------APEQAE 530
                  H ++ + N+L++ N V  +SDFGLS  L   +A     G K      APE   
Sbjct: 125 MNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 531 VKRLSQKADVYSFGVLLLEVLT 552
            ++ +  +DV+SFG+++ EV++
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 89.1 bits (221), Expect = 2e-18
 Identities = 61/168 (36%), Positives = 81/168 (48%), Gaps = 15/168 (8%)

Query: 88  LDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN 146
           L  L  LDL  N L G I   L N  NL+  +L  N  S  IP  I SL+ ++ LDLSDN
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Query: 147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
           ++ G IPE V  L  L  L L +N  TG+IP   +SL  L+ L L +N+  G +P+ L K
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354

Query: 207 K-------FGEQSFIGN--EGLCGSSPLP-----ACSFSGDTPPDVAS 240
                       +  G   EGLC S  L      + S  G+ P  + +
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402

Length = 968

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 73/285 (25%), Positives = 135/285 (47%), Gaps = 49/285 (17%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+    ++   VAVK LK     + + F +  +++  L+H  +V+L A    
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPL----DWTTRISLVLGAARGLARIHQEYGT 479
           +E   ++ +Y+  GSL   L  + G G++ L    D++ +I      A G+A I ++   
Sbjct: 73  EEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQI------AEGMAYIERK--- 122

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRL 534
               H +++++NVL+ ++ +  I+DFGL+ ++   +  AR G      + APE       
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181

Query: 535 SQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRV-DEEEQAVDLPKWVRSVVKEEWTAEV 592
           + K+DV+SFG+LL E++T G+ P  YP  +   V    ++   +P               
Sbjct: 182 TIKSDVWSFGILLYEIVTYGKIP--YPGMSNSDVMSALQRGYRMP--------------- 224

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                 R +N  +EL  ++     C   + E+RPT   +  +++D
Sbjct: 225 ------RMENCPDELYDIMKT---CWKEKAEERPTFDYLQSVLDD 260

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 88.4 bits (219), Expect = 5e-18
 Identities = 58/139 (41%), Positives = 76/139 (54%), Gaps = 4/139 (2%)

Query: 71  LSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAE 127
           L L  + L G I P SL  L  L FL L  N+L G I   L    +LK  YL  N+ S E
Sbjct: 169 LDLGGNVLVGKI-PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
           IP++I  L  +  LDL  NN+ G IP  + NL  L  L L  N+L+G IP    SL+ L 
Sbjct: 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLI 287

Query: 188 ELNLSNNELYGRVPEGLLK 206
            L+LS+N L G +PE +++
Sbjct: 288 SLDLSDNSLSGEIPELVIQ 306

Length = 968

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 84.5 bits (210), Expect = 5e-18
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 31/209 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPC-ARKEFEQYMDVIGKLKHPNV 414
           E LG+G+ G VYKA     G IVA+K+++     +  P  A +E    + ++ +LKHPN+
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELKHPNI 60

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           VKL    + + +  LV++Y     L   L    GP  +  +    I   L   RGLA  H
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP--LSPNLIKSIMYQL--LRGLAYCH 115

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQA----IARLGGYKAPE-- 527
                 ++ H ++K  N+L++++GV  ++DFGL+     P++     +  L  Y+APE  
Sbjct: 116 S----HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL-WYRAPEIL 170

Query: 528 -QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             +  K  S   D++S G +  E++TG+ 
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 84.2 bits (208), Expect = 5e-18
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 25/211 (11%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           E++G G  G V +  L   G     VA+K LK       R++F     ++G+  HPN++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          +++ +++ NG+L S L  N G         T I LV G  RG+A   + 
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-------FTVIQLV-GMLRGIAAGMKY 121

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL-----NPVQAIARLGG-----YKAP 526
                  H ++ + N+L++ N V  +SDFGLS  L     +P    + LGG     + AP
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS-LGGKIPIRWTAP 180

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
           E    ++ +  +DV+S+G+++ EV++ G  P
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 81/281 (28%), Positives = 128/281 (45%), Gaps = 42/281 (14%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+    +    VAVK LK     + + F +   ++ KL+H  +V+L A   +
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVV-S 71

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +E   +V +Y+  GSL   L    G GR  L     + +    A G+A I +        
Sbjct: 72  EEPIYIVTEYMSKGSLLDFL--KDGEGR-ALKLPNLVDMAAQVAAGMAYIER----MNYI 124

Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H +++S+N+L+    V  I+DFGL+ L+   +  AR G      + APE A   R + K+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVFDQE 596
           DV+SFG+LL E++T GR P  YP      V E+ E+   +P                   
Sbjct: 185 DVWSFGILLTELVTKGRVP--YPGMNNREVLEQVERGYRMP------------------- 223

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                  ++  +S+  + L C    PE+RPT   +   +ED
Sbjct: 224 -----CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 73/303 (24%), Positives = 133/303 (43%), Gaps = 69/303 (22%)

Query: 345 YER-KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM 403
           +ER +++F LE         LG G  G V++ +  +   VA+K LK  +   +++F++ +
Sbjct: 1   WERPREEFTLE-------RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEV 53

Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
             + +L+H +++ L A     E   ++ + +  GSL + L   R P    L   + I + 
Sbjct: 54  QALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMA 110

Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN----------- 512
              A G+A + ++       H ++ + N+L+ ++ V  ++DFGL+ L+            
Sbjct: 111 CQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI 166

Query: 513 PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEE 571
           P +       + APE A     S K+DV+SFG+LL E+ T G+ P  YP           
Sbjct: 167 PYK-------WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP--YPGMN-------- 209

Query: 572 QAVDLPKWVRSVVKEEWTAEVFDQELLRYK-----NIEEELVSMLHVGLACVVSQPEKRP 626
                              EV+DQ    Y+        +E+  ++   L C  ++PE RP
Sbjct: 210 -----------------NHEVYDQITAGYRMPCPAKCPQEIYKIM---LECWAAEPEDRP 249

Query: 627 TMA 629
           +  
Sbjct: 250 SFK 252

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 58/209 (27%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 363 MLGKGSLGTVYKAVLDDGG-----IVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVK 416
           +LG G+ GTVYK V    G      VA+K L++   P A KE      V+  + HP+VV+
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLARIH 474
           L     +  +  L+   +P G L   +  ++     +  L+W  +I      A+G++ + 
Sbjct: 74  LLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------APEQ 528
           ++    ++ H ++ + NVL+       I+DFGL+ LL+  +      G K      A E 
Sbjct: 127 EK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 529 AEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
              +  + K+DV+S+GV + E++T G  P
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 17/213 (7%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           +G G  G V+     +   VA+K +++    + ++F +   V+ KL HP +V+L      
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    LV++++ +G L   L   RG         T + + L    G+A +      + V 
Sbjct: 71  RSPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLES----SNVI 122

Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     + S K+
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE 570
           DV+SFGVL+ EV + G+ P  Y + +   V E 
Sbjct: 183 DVWSFGVLMWEVFSEGKTP--YENRSNSEVVET 213

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 32/209 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGK-------LKHPN 413
           E +G+G+ G VYKA     G  VA+K+++           Q  ++I          KHPN
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRK--------QNKELIINEILIMKDCKHPN 76

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWT-TRISLVLGAA-RGLA 471
           +V     Y   +E  +V +Y+  GSL  ++  N       +     +I+ V     +GL 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN------FVRMNEPQIAYVCREVLQGLE 130

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPE 527
            +H       V H ++KS N+LL K+G   ++DFG +  L         + G   + APE
Sbjct: 131 YLHS----QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPE 186

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             + K    K D++S G++ +E+  G  P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 45/281 (16%)

Query: 364 LGKGSLGTVYKA------VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LKD    ARK+F++  +++  L+H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-------ISLVLGAARGL 470
                  +  ++V++Y+ +G L+  L  +     I +D   R       +S +L  A  +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------ 524
           A       +    H ++ + N L+  N +  I DFG+S  +       R+GG+       
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRW 191

Query: 525 -APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPT-------------RPRVDE 569
             PE    ++ + ++DV+SFGV+L E+ T G+ P    S T             RPRV  
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV-- 249

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSM 610
                  PK V  ++   W  E   Q+ L  K I + L ++
Sbjct: 250 ------CPKEVYDIMLGCWQRE--PQQRLNIKEIYKILHAL 282

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 62/229 (27%), Positives = 105/229 (45%), Gaps = 46/229 (20%)

Query: 362 EMLGKGSLGTVYKAVL--DDGGI--VAVKRLKDANPCARKEFEQYMDVIGKLK---HPNV 414
           ++LG+G  G+V +  L  DDG    VAVK +K        E E+++     +K   HPNV
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNV 63

Query: 415 VKLRAYYYAKEEK------LLVYDYLPNGSLHSLLHGNR---GPGRIPLDWTTRISLVLG 465
           +KL    +           +++  ++ +G LHS L  +R    P ++PL   T +  ++ 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ--TLLKFMVD 121

Query: 466 AARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN------------ 512
            A G+     EY       H ++ + N +L ++   C++DFGLS  +             
Sbjct: 122 IALGM-----EYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176

Query: 513 -PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            PV+ IA        E    +  + K+DV++FGV + E+ T R  + YP
Sbjct: 177 MPVKWIAI-------ESLADRVYTSKSDVWAFGVTMWEIAT-RGQTPYP 217

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 56/214 (26%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG 407
           + F++        E LG+GS G+VYKA+  + G +VA+K +        +E  + + ++ 
Sbjct: 3   EVFDIL-------EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILK 53

Query: 408 KLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GA 466
           +   P +VK    Y+   +  +V +Y   GS+  ++          L     I+ +L   
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN----KTLT-EEEIAAILYQT 108

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG-- 522
            +GL  +H      K  H ++K+ N+LL++ G A ++DFG+S  L    A     +G   
Sbjct: 109 LKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           + APE  +    + KAD++S G+  +E+  G+ P
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.8 bits (202), Expect = 3e-17
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 36/218 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK----------RLKDANPCARKEFEQYMDVIGKLK 410
           E++GKG+ G VY A+ +  G ++AVK          R         K     ++ +  L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 411 HPNVVKLRAYYYAKEEKLLVY----DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
           H N+V+    Y   E          +Y+P GS+ S L   R  GR               
Sbjct: 67  HLNIVQ----YLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVR--FFTEQV 117

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL----LLNPVQAIARLGG 522
             GLA +H +     + H ++K+ N+L+D +G+  ISDFG+S     + +  Q ++  G 
Sbjct: 118 LEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 523 --YKAPEQAEVKR--LSQKADVYSFGVLLLEVLTGRAP 556
             + APE         S K D++S G ++LE+  GR P
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 8e-17
 Identities = 80/296 (27%), Positives = 141/296 (47%), Gaps = 39/296 (13%)

Query: 362 EMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVK 416
           + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++++  L+H N+VK
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 417 LRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLAR 472
            +   Y+  +    LV +YLP GSL   L  H  R   R  L + ++I       +G+  
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGM-- 121

Query: 473 IHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YK 524
              EY G+ +  H ++ + N+L++      I DFGL+ +L  +      R  G     + 
Sbjct: 122 ---EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY 178

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR-VDEEEQAVDLPKWVRSV 583
           APE     + S  +DV+SFGV+L E+ T    S  P     R +  ++Q   +   +  +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238

Query: 584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
           +K           L        E+ +++     C  + P +RP+ +E+A  +E IR
Sbjct: 239 LKNNG-------RLPAPPGCPAEIYAIM---KECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 62/209 (29%), Positives = 109/209 (52%), Gaps = 28/209 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           + +G G+ G VYKA  +  G +VA+K +K       +  +Q + ++ + +HPN+V    Y
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA---Y 65

Query: 421 Y--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPL-DWTTRISLVLGAARGLARIHQE 476
           +  Y + +KL +V +Y   GSL  +    RGP       +  R +L     +GLA +H+ 
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE- 119

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR----LGG--YKAPEQAE 530
             T K+ H ++K +N+LL ++G   ++DFG+S  L     IA+    +G   + APE A 
Sbjct: 120 --TGKI-HRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSFIGTPYWMAPEVAA 174

Query: 531 VKRLS---QKADVYSFGVLLLEVLTGRAP 556
           V+R      K D+++ G+  +E+   + P
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 42/281 (14%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK       + F Q   ++ KL+H  +V L A   +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +E   +V +++  GSL   L    G G+  L     + +    A G+A I +        
Sbjct: 72  EEPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIER----MNYI 124

Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H +++++N+L+  N V  I+DFGL+ L+   +  AR G      + APE A   R + K+
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVFDQE 596
           DV+SFG+LL E++T GR P  YP      V E+ E+   +P                   
Sbjct: 185 DVWSFGILLTELVTKGRVP--YPGMVNREVLEQVERGYRMPC------------------ 224

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
               +   E L  ++ +   C    P++RPT   +   +ED
Sbjct: 225 ---PQGCPESLHELMKL---CWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 44/281 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK-EFEQYMDVIGKLKHPNVVKLRAY 420
           E+LGKG+ G V+K  L D   VAVK  K+  P   K +F     ++ +  HPN+VKL   
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              ++   +V + +P G   S L   +      L     +   L AA G+A +  +    
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLESK---- 112

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-------APEQAEVKR 533
              H ++ + N L+ +N V  ISDFG+S   +    I    G K       APE     R
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQED--DGIYSSSGLKQIPIKWTAPEALNYGR 170

Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
            S ++DV+S+G+LL E  + G  P  YP  T  +  E+     + K  R    ++   +V
Sbjct: 171 YSSESDVWSYGILLWETFSLGVCP--YPGMTNQQAREQ-----VEKGYRMSCPQKCPDDV 223

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
           +                   V   C   +PE RP  +E+ K
Sbjct: 224 Y------------------KVMQRCWDYKPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 82/289 (28%), Positives = 114/289 (39%), Gaps = 50/289 (17%)

Query: 364 LGKGSLGTVYKAV-LDDGGI---VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           LG G+ G+V K V L   G    VAVK LK +     +KEF +   V+ +L HP +V+L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                 E  +LV +  P G L   L   R      L       L    A G+A +  +  
Sbjct: 63  GVCKG-EPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESK-- 114

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI--ARLGG-----YKAPEQAEV 531
                H ++ + NVLL     A ISDFG+S  L        A   G     + APE    
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 532 KRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWT 589
            + S K+DV+S+GV L E  + G  P  Y       V    E    LP+       EE  
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP--YGEMKGAEVIAMLESGERLPR------PEECP 224

Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
            E++                   + L+C   +PE RPT +E+       
Sbjct: 225 QEIYS------------------IMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 69/276 (25%), Positives = 114/276 (41%), Gaps = 72/276 (26%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG+G+ G VYK  L           VA+K LK+ A P  ++EF Q  +++  L+HPN+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLL-----HGNRGPGRI------PLDWTTRISLV 463
           V L      ++   ++++YL +G LH  L     H + G           LD +  + + 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 464 LGAARGLARIHQEYGTAK-VPHGNVKSSNVLLDKNGVACISDFGLSLL------------ 510
           +  A G+     EY ++    H ++ + N L+ +     ISDFGLS              
Sbjct: 131 IQIAAGM-----EYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185

Query: 511 -LNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQY---------- 559
            L PV+       +  PE     + + ++D++SFGV+L E+ +      Y          
Sbjct: 186 SLLPVR-------WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238

Query: 560 -------PSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
                  P P            D P  V +++ E W
Sbjct: 239 IRSRQLLPCP-----------EDCPARVYALMIECW 263

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 72/285 (25%), Positives = 132/285 (46%), Gaps = 53/285 (18%)

Query: 364 LGKGSLG--TVYKAVLDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           LGKG+ G  T+Y+   +D  +V  K   L   +   R++    + ++  L+HPN++   A
Sbjct: 8   LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII---A 63

Query: 420 YY--YAKEEKLLV-YDYLPNGSLHSLL---HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           YY  +  +  LL+  +Y   G+L+  +    G      + L +  +I         ++ I
Sbjct: 64  YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV------SAVSYI 117

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQA 529
           H+    A + H ++K+ N+ L K G+  + DFG+S +L    ++A   +G   Y +PE  
Sbjct: 118 HK----AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +  + + K+D+++ G +L E+LT +           R  +   A +    V  +V+  +T
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLK-----------RTFD---ATNPLNLVVKIVQGNYT 219

Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
             V       Y     EL+S++H   + +   PEKRPT  EV   
Sbjct: 220 PVV-----SVYS---SELISLVH---SLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 363 MLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKL 417
           ++G G  G V    L   G     VA+K LK       R++F     ++G+  HPN++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                  +  ++V +Y+ NGSL + L  + G         T I LV G  RG+A   +  
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-------FTVIQLV-GMLRGIASGMKYL 122

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQAE 530
                 H ++ + N+L++ N V  +SDFGLS +L  +P  A    GG     + APE   
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 531 VKRLSQKADVYSFGVLLLEVLT-GRAP 556
            ++ +  +DV+S+G+++ EV++ G  P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 73/240 (30%), Positives = 113/240 (47%), Gaps = 26/240 (10%)

Query: 362 EMLGKGSLGTVYKAVLDD--GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + +GKG  G V   +L D  G  VAVK +K  N    + F     V+ +L+H N+V+L  
Sbjct: 12  QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
               ++  L +V +Y+  GSL   L   R  GR  L     +   L     +  +     
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-GYKAPEQAEVKRLSQK 537
                H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   + APE    K+ S K
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179

Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPS-PTRPRVDEEEQAVDL------PKWVRSVVKEEWT 589
           +DV+SFG+LL E+ + GR P  YP  P +  V   E+   +      P  V  V+K+ W 
Sbjct: 180 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH 237

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 84/308 (27%), Positives = 140/308 (45%), Gaps = 54/308 (17%)

Query: 364 LGKGSLGTVYKA----VLDDGGI--VAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+G  G V KA    +    G   VAVK LK+ A+    ++     +++ ++ HP+V+K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--GPGRIPLDWTTRIS------------- 461
           L          LL+ +Y   GSL S L  +R  GP  +  D     S             
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-IARL 520
            ++  A  ++R  Q     K+ H ++ + NVL+ +     ISDFGLS  +    + + R 
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187

Query: 521 GG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAV 574
            G     + A E       + ++DV+SFGVLL E++T G  P  YP              
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIA----------- 234

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
             P+ + +++K  +  E       R +N  EE+ +++   L C   +P+KRPT A+++K 
Sbjct: 235 --PERLFNLLKTGYRME-------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKE 282

Query: 635 IEDIRVEQ 642
           +E + V+ 
Sbjct: 283 LEKMMVKS 290

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 21/208 (10%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V++ +L   G     VA+K LK       R++F     ++G+  H N+++
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L       +  +++ +Y+ NG+L   L  + G         +   LV G  RG+A   + 
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-------FSSYQLV-GMLRGIAAGMKY 122

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQA 529
                  H ++ + N+L++ N    +SDFGLS +L  +P       GG     + APE  
Sbjct: 123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182

Query: 530 EVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             ++ +  +DV+SFG+++ EV++ G  P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 78.4 bits (193), Expect = 5e-16
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG G  G VY+ V       VAVK LK+      +EF +   V+ ++KHPN+V+L     
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK- 481
            +    ++ +++  G+L   L   R   R  ++    + +    +  +     EY   K 
Sbjct: 73  REPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAM-----EYLEKKN 124

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQ 536
             H ++ + N L+ +N +  ++DFGLS L+      A  G      + APE     + S 
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 537 KADVYSFGVLLLEVLT-GRAPSQYP 560
           K+DV++FGVLL E+ T G +P  YP
Sbjct: 185 KSDVWAFGVLLWEIATYGMSP--YP 207

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 60/223 (26%), Positives = 107/223 (47%), Gaps = 37/223 (16%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
             LG+G+ G V+          +D  +VAVK LK+ A+  ARK+FE+  +++   +H N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP------------GRIPLDWTTRISL 462
           VK        +  ++V++Y+ +G L+  L  + GP            G + L    +I++
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSH-GPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 463 VLGAA-RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
            + +    LA  H         H ++ + N L+  + V  I DFG+S  +       R+G
Sbjct: 130 QIASGMVYLASQH-------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD-YYRVG 181

Query: 522 G-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
           G       +  PE    ++ + ++DV+SFGV+L E+ T G+ P
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.2 bits (198), Expect = 1e-15
 Identities = 57/193 (29%), Positives = 76/193 (39%), Gaps = 42/193 (21%)

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
           IP+ IS L+ +  ++LS N+IRG IP  + ++T L  L L  N   G IP+    L  L+
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493

Query: 188 ELNLSNNELYGRVPE---GLLKKFGEQSFIGNEGLCGSSPLPACSFSGDTPPDVASAPET 244
            LNL+ N L GRVP    G L      +F  N GLCG   L AC                
Sbjct: 494 ILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG--------------- 538

Query: 245 VPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSI 304
                   P               LS  A + I  G  VA L +     A C    R +I
Sbjct: 539 --------PH--------------LSVGAKIGIAFGVSVAFLFLVIC--AMCWWKRRQNI 574

Query: 305 SSDKQQRRSGSNY 317
              ++     + Y
Sbjct: 575 LRAQRIAAREAPY 587

Length = 623

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 39/278 (14%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +GKG    VYKA+ L DG +VA+K+++     DA   AR++  + +D++ +L HPNV+K 
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAK--ARQDCLKEIDLLKQLDHPNVIKY 67

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
            A +    E  +V +    G L  ++   +   R  +   T     +     L  +H + 
Sbjct: 68  LASFIENNELNIVLELADAGDLSRMIKHFKKQKR-LIPERTIWKYFVQLCSALEHMHSK- 125

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--VQAIARLGG--YKAPEQAEVKR 533
              ++ H ++K +NV +   GV  + D GL    +     A + +G   Y +PE+     
Sbjct: 126 ---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
            + K+D++S G LL E+   ++P            ++     L K +         A+ +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFY---------GDKMNLYSLCKKIEKCDYPPLPADHY 233

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
            +EL        +LVS       C+   PEKRP ++ V
Sbjct: 234 SEEL-------RDLVSR------CINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 25/214 (11%)

Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LKDA+  ARK+F +  +++  L+H ++VK 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP-------GRIPLDWTTRISLVLGAARGL 470
                  +  ++V++Y+ +G L+  L  + GP       G  P + T   S +L  A+ +
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNRPAELTQ--SQMLHIAQQI 129

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------ 524
           A       +    H ++ + N L+ +N +  I DFG+S  +       R+GG+       
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRW 188

Query: 525 -APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             PE    ++ + ++DV+S GV+L E+ T G+ P
Sbjct: 189 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 78.7 bits (194), Expect = 4e-15
 Identities = 51/150 (34%), Positives = 73/150 (48%), Gaps = 6/150 (4%)

Query: 63  PKS----ERVVSLSLPSHSLRGPIAPLSL-LDQLRFLDLHDNRLNGTI-LPLTNCTNLKL 116
           P S    ++++SL L  +SL G I  L + L  L  L L  N   G I + LT+   L++
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV 336

Query: 117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRI 176
             L  N FS EIP  +     +  LDLS NN+ G IPE + +   L  L L +N L G I
Sbjct: 337 LQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEI 396

Query: 177 PDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
           P    + + L+ + L +N   G +P    K
Sbjct: 397 PKSLGACRSLRRVRLQDNSFSGELPSEFTK 426

Length = 968

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 18/202 (8%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVI---GKLKHPNVVKLRA 419
           LGKGS G+VYK   L D    A+K +   +  ++KE E  ++ I     + HPN++  + 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGS-MSQKEREDAVNEIRILASVNHPNIISYKE 66

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGR-IPLD--WTTRISLVLGAARGLARIHQE 476
            +    +  +V +Y P G L   +   +   + IP    W   I L+    RGL  +H++
Sbjct: 67  AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGLQALHEQ 122

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--YKAPEQAEVKRL 534
               K+ H ++KS+N+LL  N +  I D G+S +L    A  ++G   Y APE  + +  
Sbjct: 123 ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPY 178

Query: 535 SQKADVYSFGVLLLEVLTGRAP 556
           S K+D++S G LL E+ T   P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKL 417
           E +GKGS GTV K     DG I+  K + D      KE +Q +    ++ +LKHPN+V+ 
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEI-DYGNMTEKEKQQLVSEVNILRELKHPNIVR- 63

Query: 418 RAYYY------AKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGL 470
              YY      + +   +V +Y   G L  L+    +    I  ++  RI   L  A  L
Sbjct: 64  ---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA--L 118

Query: 471 ARIH-QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKA 525
              H +      V H ++K +N+ LD N    + DFGL+ +L    + A+  +G   Y +
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PEQ       +K+D++S G L+ E+     P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 59/214 (27%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKRLK----DANPCARKE-----FEQYMDVIGKLKHP 412
           ++G GS G+VY  +    G ++AVK+++     A+   RK        + + ++ +L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           N+V+        +   +  +Y+P GS+ +LL+ N G     L    R + V    +GL  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETL---VR-NFVRQILKGLNY 121

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-------- 524
           +H       + H ++K +N+L+D  G   ISDFG+S  L       +  G +        
Sbjct: 122 LHNR----GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVF 177

Query: 525 --APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             APE  +    ++KAD++S G L++E+LTG+ P
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 74.6 bits (183), Expect = 7e-15
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 23/207 (11%)

Query: 362 EMLGKGSLGTVY--KAVLDDGGIVAVKRLKDANPCARKEFEQY-MDVIGKLKHPNVVKLR 418
           + +G+GS G +Y  KA  D    V  +      P   KE  +  + ++ K+KHPN+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRG----PGRIPLDWTTRISLVLGAARGLARIH 474
           A +       +V +Y   G L   ++  RG      +I L W  +ISL      GL  IH
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWFVQISL------GLKHIH 118

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPVQAIAR--LGG--YKAPEQA 529
                 K+ H ++KS N+ L KNG VA + DFG++  LN    +A   +G   Y +PE  
Sbjct: 119 DR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP 556
           + +  + K D++S G +L E+ T + P
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.9 bits (186), Expect = 8e-15
 Identities = 60/219 (27%), Positives = 109/219 (49%), Gaps = 19/219 (8%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG G+ G V K      G++  ++L   +  P  R +  + + V+ +   P +V     +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
           Y+  E  +  +++  GSL  +L   +   RIP +   ++S+ +   RGLA + +++   +
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAV--LRGLAYLREKH---Q 124

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQAEVKRLSQKAD 539
           + H +VK SN+L++  G   + DFG+S  L    A + +G   Y +PE+ +    S ++D
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 184

Query: 540 VYSFGVLLLEVLTGRAPSQYPSPT-------RPRVDEEE 571
           ++S G+ L+E+  GR P   P          RP VD EE
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEE 223

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 70/258 (27%), Positives = 120/258 (46%), Gaps = 27/258 (10%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK--EFEQYMDVIGKLKHPNVVKLRA 419
           E +GKGS G V+K + +    V   ++ D      +  + +Q + V+ +   P V K   
Sbjct: 10  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            Y    +  ++ +YL  GS   LL     PG  PLD T   +++    +GL  +H E   
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALDLLE----PG--PLDETQIATILREILKGLDYLHSE--- 120

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR---LGG--YKAPEQAEVKRL 534
            K  H ++K++NVLL ++G   ++DFG++  L   Q I R   +G   + APE  +    
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAY 178

Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR---------PRVDEEEQAVDLPKWVRSVVK 585
             KAD++S G+  +E+  G  P     P +         P   E   +  L ++V + + 
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN 238

Query: 586 EEWTAEVFDQELLRYKNI 603
           +E +     +ELL++K I
Sbjct: 239 KEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 75.2 bits (185), Expect = 8e-15
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG+G+ G+V K  L + G++   +    D NP  +K+  + +++    K P +VK    +
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 422 YAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS-LVLG-----AARGLARI 473
             +    +    +Y   GSL S+    +  G        RI   VLG       +GL+ +
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIYKKVKKRG-------GRIGEKVLGKIAESVLKGLSYL 121

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--YKAPEQAEV 531
           H      K+ H ++K SN+LL + G   + DFG+S  L    A    G   Y APE+ + 
Sbjct: 122 HSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQG 177

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV 567
           K  S  +DV+S G+ LLEV   R P  +P    P +
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFP--FPPEGEPPL 211

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 36/265 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKH---PNVVK 416
           E++G+G+ G VY+   +  G +VA+K +  D       + ++ + ++ +L+    PN+ K
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWT---TRISLVLGAARGLARI 473
               Y       ++ +Y   GS+ +L+      G I   +     R  LV      L  I
Sbjct: 67  YYGSYLKGPRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLV-----ALKYI 117

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----QAIARLGGYKAPEQ- 528
           H+      V H ++K++N+L+   G   + DFG++ LLN              + APE  
Sbjct: 118 HK----VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR----------PRVDEEEQAVDLPK 578
            E K    KAD++S G+ + E+ TG  P       R          PR+++   +  L +
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLRE 233

Query: 579 WVRSVVKEEWTAEVFDQELLRYKNI 603
           +V + + EE    +  +ELL+ K I
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 77/301 (25%), Positives = 135/301 (44%), Gaps = 34/301 (11%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG G+ G V K +    G++  ++L   +  P  R +  + + V+ +   P +V     +
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL-VLGAARGLARIHQEYGTA 480
           Y+  E  +  +++  GSL  +L   +  GRIP +   +IS+ VL   RGL  + +++   
Sbjct: 69  YSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVL---RGLTYLREKH--- 119

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQAEVKRLSQKA 538
           K+ H +VK SN+L++  G   + DFG+S  L    A + +G   Y +PE+ +    + ++
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQS 179

Query: 539 DVYSFGVLLLEVLTGRAPSQYPSPTR-----PRVDEEEQAVDLPKWVRSVVKEEWTA-EV 592
           D++S G+ L+E+  GR P   P          R   E +A +  + V     +      +
Sbjct: 180 DIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAI 239

Query: 593 FDQELLRYKNIEEELVSMLHVGL----------ACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           F  ELL Y  I  E    L  G            C+   P++R  + E+ K     R E 
Sbjct: 240 F--ELLDY--IVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295

Query: 643 S 643
            
Sbjct: 296 E 296

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 58/205 (28%), Positives = 101/205 (49%), Gaps = 23/205 (11%)

Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E+LG G+ GTVYKA  L    I+AVK +  D     +K+    ++++ K   P ++    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            ++ +    +  +++  GSL           +IP     RI++ +   +GL  +     +
Sbjct: 67  AFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAV--VKGLTYLW----S 113

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL----GGYKAPEQAEVKRLS 535
            K+ H +VK SN+L++  G   + DFG+S  L  V +IA+       Y APE+   ++  
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL--VNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYP 560
             +DV+S G+  +E+  GR P  YP
Sbjct: 172 IHSDVWSLGISFMELALGRFP--YP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 63/297 (21%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG--------KLKHPNV 414
           +G+G+ G VYKA     G IVA+K++K       +   + +            +L HPN+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKELNHPNI 60

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI-SLVLGAARGLARI 473
           +KL   +  K +  LV++++       +    RG   +P      I S +    +GLA  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG---LPES---LIKSYLYQLLQGLAFC 114

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV------QAIARLGGYKAPE 527
           H       + H ++K  N+L++  GV  ++DFGL+              + R   Y+APE
Sbjct: 115 HS----HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW--YRAPE 168

Query: 528 -QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
                K  S   D++S G +  E+L+ R       P  P   E +Q   + + + +   E
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELLSRR-------PLFPGKSEIDQLFKIFRTLGTPDPE 221

Query: 587 EWTAEVFDQELLRYK----------------NIEEELVSMLHVGLACVVSQPEKRPT 627
            W    F      YK                N   + + +L      +   P KR T
Sbjct: 222 VWP--KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLS---QMLHYDPHKRIT 273

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 66/296 (22%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRA 419
           E++G+G+ G VYKA     G +VA+K + D      +E ++  +++ K   HPN+     
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 420 YYYAK-----EEKL-LVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVL-GAARGLA 471
            +  K     +++L LV +    GS+  L+ G R  G R+  +W   I+ +L    RGLA
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW---IAYILRETLRGLA 127

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KA 525
            +H+     KV H ++K  N+LL KN    + DFG+S  L+    + R   +       A
Sbjct: 128 YLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD--STLGRRNTFIGTPYWMA 181

Query: 526 PE------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR-----PRVDEEEQAV 574
           PE      Q +      ++DV+S G+  +E+  G+ P     P R     PR        
Sbjct: 182 PEVIACDEQPDAS-YDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR-------- 232

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
           + P  ++S   E W+ +  D        I E           C++   E+RP M E
Sbjct: 233 NPPPTLKS--PENWSKKFND-------FISE-----------CLIKNYEQRPFMEE 268

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 60/278 (21%), Positives = 127/278 (45%), Gaps = 31/278 (11%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG G+ G+V K      G V  K+     A    RK+  + + ++ + + P +V     +
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +    +  +++  GSL  +    +  G IP++   +I++ +    GL  +   Y   +
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAV--VEGLTYL---YNVHR 124

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPV-QAIARLGGYKAPEQAEVKRLSQKAD 539
           + H ++K SN+L++  G   + DFG+S  L+N +         Y +PE+ +  + + K+D
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 540 VYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE---WTAEVFDQE 596
           V+S G+ ++E+  G+ P  + +      D+    +DL   ++ +V+E      +  F ++
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---LQQIVQEPPPRLPSSDFPED 241

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
           L  + +              C++  P +RPT  ++  M
Sbjct: 242 LRDFVDA-------------CLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLR 418
            ++G+G+ G V K      G IVA+K+ K++  +   +K   + + V+ +L+H N+V L+
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
             +  K    LV++Y+    L  L      PG +P D        L   + +A  H    
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQL--LQAIAYCHSH-- 119

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEVK 532
              + H ++K  N+L+ ++GV  + DFG +  L   +  + L        Y+APE   V 
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARAL-RARPASPLTDYVATRWYRAPELL-VG 175

Query: 533 RLS--QKADVYSFGVLLLEVLTGRA 555
             +  +  DV++ G ++ E+L G  
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 35/220 (15%)

Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LK+A+  AR++F++  +++  L+H ++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL--HG----------NRGPGRIPLDWTTRISLVLG 465
                     L+V++Y+ +G L+  L  HG          +  PG++ L     I+  + 
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 466 AAR-GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
           +    LA +H         H ++ + N L+ +  V  I DFG+S  +       R+GG  
Sbjct: 133 SGMVYLASLH-------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRT 184

Query: 523 -----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
                +  PE    ++ + ++D++SFGV+L E+ T G+ P
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 58/232 (25%), Positives = 103/232 (44%), Gaps = 47/232 (20%)

Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEF---- 399
           YE+  Q             +G+G+ G VYKA     G +VA+K+++  N   ++ F    
Sbjct: 1   YEKIAQ-------------IGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITA 45

Query: 400 --EQYMDVIGKLKHPNVVKLRAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
             E  + ++ KL+HPN+V+L+    +K +    +V++Y+ +  L  LL       +    
Sbjct: 46  IRE--IKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLD--SPEVKFTES 100

Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
                   L    GL  +H       + H ++K SN+L++ +GV  ++DFGL+       
Sbjct: 101 QIKCYMKQL--LEGLQYLHS----NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154

Query: 516 AIARLGG------YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
           + A          Y+ PE    A   R   + D++S G +L E+  G+   Q
Sbjct: 155 S-ADYTNRVITLWYRPPELLLGA--TRYGPEVDMWSVGCILAELFLGKPIFQ 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 71/228 (31%), Positives = 105/228 (46%), Gaps = 24/228 (10%)

Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARK-EFEQYMDVIGKLKHPNVVKLRA 419
           E +G+G+ G V+   L  D   VAVK  ++  P   K +F Q   ++ +  HPN+V+L  
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
               K+   +V + +  G   + L    GP    L     I +V  AA G+     EY  
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR-TEGP---RLKVKELIQMVENAAAGM-----EYLE 111

Query: 480 AK-VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-------APEQAEV 531
           +K   H ++ + N L+ +  V  ISDFG+S         A  GG K       APE    
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNY 170

Query: 532 KRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLP 577
            R S ++DV+SFG+LL E  + G  P  Y + +  +  E  EQ V LP
Sbjct: 171 GRYSSESDVWSFGILLWEAFSLGAVP--YANLSNQQTREAIEQGVRLP 216

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 52/278 (18%), Positives = 106/278 (38%), Gaps = 59/278 (21%)

Query: 372 VYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKL- 428
           +YK + ++  ++     K            E  +  + ++   N++K+  +     + L 
Sbjct: 36  IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 429 ---LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHG 485
              L+ +Y   G L  +L   +      L + T++ + +   +GL  +++       P+ 
Sbjct: 96  RLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNK---PYK 147

Query: 486 NVKSSNVLLDKNGVACISDFGL-SLLLNP----VQAIARLGGYKAPEQAE--VKRLSQKA 538
           N+ S + L+ +N    I   GL  +L +P    V  +     Y + +         + K 
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203

Query: 539 DVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELL 598
           D+YS GV+L E+ TG+ P +  +                           T E++D  L+
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLT---------------------------TKEIYD--LI 234

Query: 599 RYKNIEEELVSMLHVGLACVVS-----QPEKRPTMAEV 631
             KN   +L     + + C+V         KRP + E+
Sbjct: 235 INKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 61/225 (27%), Positives = 111/225 (49%), Gaps = 17/225 (7%)

Query: 352 ELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKL 409
           EL+D        LG G+ G V+K      G++  ++L   +  P  R +  + + V+ + 
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
             P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ +   +G
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKG 115

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPE 527
           L  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G   Y +PE
Sbjct: 116 LTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 172

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ 572
           + +    S ++D++S G+ L+E+  GR    YP P  P   E E 
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGR----YPIPP-PDAKELEL 212

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 49/164 (29%), Positives = 78/164 (47%), Gaps = 17/164 (10%)

Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG---PGRIPLDWTTRIS 461
           ++ K+KHPN+V  +  + A     +V +Y   G L   +   RG   P    L W  ++ 
Sbjct: 51  LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110

Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARL 520
           L      G+  IH++    +V H ++KS N+ L +NG   + DFG + LL +P       
Sbjct: 111 L------GVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160

Query: 521 GG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS 561
            G   Y  PE  E    + K+D++S G +L E+ T + P Q  S
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 72/240 (30%), Positives = 116/240 (48%), Gaps = 24/240 (10%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E++G+G  G V +     G  VAVK +K D    A   F +   V+ KL H N+V+L   
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV 67

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
                   +V + +  G+L + L   RG   + +    + SL    A G+  +  +    
Sbjct: 68  IL-HNGLYIVMELMSKGNLVNFLR-TRGRALVSVIQLLQFSL--DVAEGMEYLESK---- 119

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-GYKAPEQAEVKRLSQKAD 539
           K+ H ++ + N+L+ ++GVA +SDFGL+ + +     ++L   + APE  + K+ S K+D
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSD 179

Query: 540 VYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-------EQAVDLPKWVRSVVKEEWTAE 591
           V+S+GVLL EV + GRAP  YP  +   V E        E     P  V  ++   W  E
Sbjct: 180 VWSYGVLLWEVFSYGRAP--YPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETE 237

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 62/225 (27%), Positives = 111/225 (49%), Gaps = 21/225 (9%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIV-AVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + LGKG+ G+VYK +    G+  A+K ++ + +     +    +D++ K   P +V    
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            ++ +    +  +Y+  GSL  L  G      IP D   RI+  +   +GL  + +E+  
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV--VKGLKFLKEEH-- 122

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG----GYKAPEQAEVKRLS 535
             + H +VK +NVL++ NG   + DFG+S   N V ++A+       Y APE+ +    +
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 536 Q------KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
           Q      ++DV+S G+ +LE+  GR P  YP  T   +  +  A+
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYP--YPPETYANIFAQLSAI 222

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 56/221 (25%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD--------VIGKLKHPNV 414
           LG+G+   VYKA   + G IVA+K++K      RKE +  ++        ++ +LKHPN+
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA------- 467
           + L   +  K    LV++++    L  ++                 S+VL  A       
Sbjct: 65  IGLLDVFGHKSNINLVFEFME-TDLEKVIKDK--------------SIVLTPADIKSYML 109

Query: 468 ---RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-------LLLNPVQAI 517
              RGL  +H  +    + H ++K +N+L+  +GV  ++DFGL+         +   Q +
Sbjct: 110 MTLRGLEYLHSNW----ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH-QVV 164

Query: 518 ARLGGYKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
            R   Y+APE    A  +      D++S G +  E+L    
Sbjct: 165 TRW--YRAPELLFGA--RHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 28/209 (13%)

Query: 366 KGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFE----QYMDVIGKLKHPNVVKLRAY 420
           KG+ G+VY A     G   A+K LK ++  A+ +      +   ++ + + P V KL   
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLARIHQEYG 478
           + +K+   LV +YL  G   SL+   +  G +P DW  +    +VL    G+  +HQ   
Sbjct: 66  FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVL----GVEDLHQR-- 116

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGG---YKAPEQAEVKR 533
              + H ++K  N+L+D+ G   ++DFGLS   L N      +  G   Y APE      
Sbjct: 117 --GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVG 169

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
             + +D +S G ++ E L G  P    +P
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 46/225 (20%)

Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V++A        +   +VAVK LK+ A+   + +F++   ++ +  HPN+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 417 LRAYYYAKEEKLLVYDYLPNGSL------------HSLLHGNR-----GPGRIPLDWTTR 459
           L       +   L+++Y+  G L             SL H        G   +PL  T +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR 519
           + +    A G+A + +     K  H ++ + N L+ +N V  I+DFGLS      + I  
Sbjct: 133 LCIAKQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLS------RNIYS 182

Query: 520 LGGYKA------------PEQAEVKRLSQKADVYSFGVLLLEVLT 552
              YKA            PE     R + ++DV+++GV+L E+ +
Sbjct: 183 ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 33/216 (15%)

Query: 364 LGKGSLGTV----YKAVLDDGG-IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V    Y    D  G +VAVK LK +        +++ ++++  L H N+VK 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 418 RAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---GLAR 472
           +     +  K   L+ +Y+P GSL   L         P        L+L A +   G+A 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL---------PKHKLNLAQLLLFAQQICEGMAY 122

Query: 473 IH-QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
           +H Q Y      H ++ + NVLLD + +  I DFGL+  +       R+         + 
Sbjct: 123 LHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY 177

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
           A E  +  + S  +DV+SFGV L E+LT     Q P
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 22/210 (10%)

Query: 357 LRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG------KL 409
           L +    +G GS G VY A  + +  +VA+K++  +    ++  E++ D+I       KL
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYS---GKQSNEKWQDIIKEVRFLQKL 72

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           +HPN ++ R  Y  +    LV +Y   GS   LL  ++ P    L      ++  GA +G
Sbjct: 73  RHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAVTHGALQG 127

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPE-- 527
           LA +H       + H +VK+ N+LL + G+  + DFG + ++ P         + APE  
Sbjct: 128 LAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVI 183

Query: 528 -QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              +  +   K DV+S G+  +E+   + P
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 69.2 bits (170), Expect = 5e-13
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 33/213 (15%)

Query: 364 LGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRA 419
           + KG+ G V+ A     G I A+K +K A+   + + +Q +   D++ + + P VVKL  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 420 YY-YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS--LVLGAARGLARIHQ 475
           YY +  ++ L LV +YLP G L SLL      G +  D        +VL     L  +H 
Sbjct: 59  YYSFQGKKNLYLVMEYLPGGDLASLLENV---GSLDEDVARIYIAEIVLA----LEYLHS 111

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS----------LLLNPVQAIARLG--GY 523
                 + H ++K  N+L+D NG   ++DFGLS          L  +  +    +G   Y
Sbjct: 112 N----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            APE    +  S+  D +S G +L E L G  P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.5 bits (170), Expect = 6e-13
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 15/208 (7%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA+K++       ++     + V+ + KHPN+V     
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 134

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+    +     + APE    K    
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 31/208 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGI----VAVKRLKDANPCARKEFEQ---YMDVIGKLKHPN 413
           ++LG G  GTV+K + + +G      VA+K ++D +   R+ F++   +M  +G L H  
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAY 70

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG---PGRIPLDWTTRISLVLGAARGL 470
           +V+L         +L V    P GSL   +  +R    P R+ L+W  +I      A+G+
Sbjct: 71  IVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRL-LNWCVQI------AKGM 122

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP---- 526
             + +E+      H N+ + N+LL  + +  I+DFG++ LL P         +K P    
Sbjct: 123 YYL-EEHRMV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 527 --EQAEVKRLSQKADVYSFGVLLLEVLT 552
             E     R + ++DV+S+GV + E+++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 25/225 (11%)

Query: 359 ASAEMLGKGSLGTV----YKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNV 414
              + LG G  G V    ++  +D    VA+K +++    +  +F +   V+ KL HPN+
Sbjct: 7   TFLKELGSGQFGVVHLGKWRGKID----VAIKMIREGA-MSEDDFIEEAKVMMKLSHPNL 61

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+L      +    +V +Y+ NG L + L   +G              +L     +    
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT--------EWLLDMCSDVCEAM 113

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQA 529
           +   +    H ++ + N L+ ++ V  +SDFGL+  +   Q  +  G      +  PE  
Sbjct: 114 EYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVF 173

Query: 530 EVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQA 573
           +  R S K+DV+SFGVL+ EV + G+ P  Y   +   V E   A
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMP--YERFSNSEVVESVSA 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 69.1 bits (170), Expect = 8e-13
 Identities = 48/160 (30%), Positives = 84/160 (52%), Gaps = 31/160 (19%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARK--EFEQYMDV-----IGKLK-HP 412
           + LG G+ G+VY A   + G +VA+K++K      +K   +E+ M++     + KL  HP
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMK------KKFYSWEECMNLREVKSLRKLNEHP 58

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           N+VKL+  +   +E   V++Y+  G+L+ L+   +G    P   +   S++    +GLA 
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAH 114

Query: 473 IHQEYGTAKVPHG----NVKSSNVLLDKNGVACISDFGLS 508
           IH+        HG    ++K  N+L+    V  I+DFGL+
Sbjct: 115 IHK--------HGFFHRDLKPENLLVSGPEVVKIADFGLA 146

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 87/326 (26%), Positives = 139/326 (42%), Gaps = 82/326 (25%)

Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARK------ 397
           +   + L     + LG+G+ G V KA        ++   VAVK LKD +   +       
Sbjct: 8   ELPRDRL--TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVS 64

Query: 398 EFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG------- 450
           E E  M +IGK  H N++ L      +    +V +Y  +G+L   L   R PG       
Sbjct: 65  EMEM-MKMIGK--HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121

Query: 451 -RIPLDWTTRISLVLGA---ARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDF 505
            R P +  T+  LV  A   ARG+     E+  + K  H ++ + NVL+ ++ V  I+DF
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGM-----EFLASKKCIHRDLAARNVLVTEDHVMKIADF 176

Query: 506 GLSLLLNPVQAIARLGGYK------------APEQAEVKRLSQKADVYSFGVLLLEVLTG 553
           GL+      + I  +  Y+            APE    +  + ++DV+SFGVLL E+ T 
Sbjct: 177 GLA------RDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT- 229

Query: 554 RAPSQYPS-PTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLH 612
              S YP  P        E+   L       +KE +  E       + +N  +EL  ++ 
Sbjct: 230 LGGSPYPGIPV-------EELFKL-------LKEGYRME-------KPQNCTQELYHLM- 267

Query: 613 VGLACVVSQPEKRPTMAEVAKMIEDI 638
               C    P +RPT  +   ++ED+
Sbjct: 268 --RDCWHEVPSQRPTFKQ---LVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 22/221 (9%)

Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKA-VLDDGGIVAVKRL-KDANPCARKEFEQYMD 404
           +K   +L DL       +G G+ G VYK      G ++AVK++ +  N    K     +D
Sbjct: 8   QKYPADLNDLENLG--EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLD 65

Query: 405 VIGKLKH--PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           V+ K  H  P +VK   Y+    +  +  + L +  L  LL   +GP  IP D   ++  
Sbjct: 66  VVLK-SHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGP--IPEDILGKM-- 119

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
            +   + L  + +++G   V H +VK SN+LLD +G   + DFG+S  L   +A  R  G
Sbjct: 120 TVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG 176

Query: 523 ---YKAPEQAEVKRLSQK----ADVYSFGVLLLEVLTGRAP 556
              Y APE+ +    + K    ADV+S G+ L+E+ TG+ P
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 41/282 (14%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKR-----LKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +G+G    VY+A  L DG  VA+K+     L DA   AR +  + +D++ +L HPNV+K 
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQLNHPNVIKY 67

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
            A +    E  +V +    G L  ++ H  +    IP     +  + L +A  L  +H  
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA--LEHMH-- 123

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVK 532
             + +V H ++K +NV +   GV  + D GL    +    A   L G   Y +PE+    
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
             + K+D++S G LL E+   ++P          + ++ +  D P            ++ 
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP---------LPSDH 232

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
           + +EL        +LV+M      C+   PEKRP +  V  +
Sbjct: 233 YSEEL-------RQLVNM------CINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 66/300 (22%), Positives = 121/300 (40%), Gaps = 60/300 (20%)

Query: 362 EMLGKGSLGTVYKAVLDDGG--IVAVKRLKDANPCARKEFEQYMDVIGK----------- 408
           E LG G+ G VYK    + G  ++A+K +   NP   K+  +    IG            
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL------HGNRGPGRIPLDWTTRISL 462
           L+HPN+V+    +   +   +V D +    L                 RI   W   + +
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI---WNIFVQM 122

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           VL     L  +H+E    ++ H ++  +N++L ++    I+DFGL+    P   +  + G
Sbjct: 123 VLA----LRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVG 175

Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
              Y  PE  + +   +KADV++FG +L ++ T + P                + ++   
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--------------YSTNMLSL 221

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGL--ACVVSQPEKRPTMAEVAKMIED 637
              +V+              Y+ + E + S     +  +C+    E RP + +V+ MI D
Sbjct: 222 ATKIVEAV------------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTV+ A+ +  G  VA+K++       ++     + V+ +LK+PN+V     
Sbjct: 25  EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +   +E  +V +YL  GSL  ++          +D     ++     + L  +H      
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLHAN---- 134

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +V H ++KS NVLL  +G   ++DFG    + P Q+    +     + APE    K    
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 23/209 (11%)

Query: 362 EMLGKGSLGTVY--KAVL--DDGGIVAVKRLKDANPCARKEFEQYM--DVIGKLKHPNVV 415
           ++LG+GS G V+  + +   D G + A+K LK A    R      M  D++ ++ HP +V
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 416 KLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA-ARGLARI 473
           KL  Y +  E KL L+ D+L  G L + L       +  +     +   L   A  L  +
Sbjct: 62  KLH-YAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHL 114

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGG--YKAPEQA 529
           H    +  + + ++K  N+LLD+ G   ++DFGLS   + +  +A +  G   Y APE  
Sbjct: 115 H----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             +  +Q AD +SFGVL+ E+LTG  P Q
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 30/207 (14%)

Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDAN------PCARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA   + G  VA+K++            A +E +     +   +HP VVK
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVVK 63

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L   +      +LV +Y+P   L  +L     P  +P         +L   +G+A +H  
Sbjct: 64  LLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERP--LPEAQVKSYMRML--LKGVAYMHAN 118

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-------QAIARLGGYKAPEQA 529
                + H ++K +N+L+  +GV  I+DFGL+ L +         Q   R   Y+APE  
Sbjct: 119 ----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW--YRAPELL 172

Query: 530 EVKR-LSQKADVYSFGVLLLEVLTGRA 555
              R      D+++ G +  E+L G  
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 36/219 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFE---QYMDVIGKLKHPNVV 415
           E +GKGS G VYKA+      +VA+K   L++A      E E   Q +  + + + P + 
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQCRSPYIT 62

Query: 416 KLRAYY--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL-VLGAARGLA 471
           K   YY  + K  KL ++ +Y   GS   LL     PG++   +   I   VL    GL 
Sbjct: 63  K---YYGSFLKGSKLWIIMEYCGGGSCLDLLK----PGKLDETYIAFILREVL---LGLE 112

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KA 525
            +H+E       H ++K++N+LL + G   ++DFG+S  L     +++   +       A
Sbjct: 113 YLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLT--STMSKRNTFVGTPFWMA 166

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           PE  +     +KAD++S G+  +E+  G  P     P R
Sbjct: 167 PEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 44/280 (15%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+         VA+K + +      ++F +   V+ KL HP +V+L      
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70

Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           ++   +V +++ NG L + L   +G  ++  D    +S+      G+  + +        
Sbjct: 71  QKPLYIVTEFMENGCLLNYLRQRQG--KLSKD--MLLSMCQDVCEGMEYLERN----SFI 122

Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+   GV  +SDFG++  +   +  +  G      +  PE     + S K+
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQEL 597
           DV+SFGVL+ EV T G+ P            E++   ++   V  + +           L
Sbjct: 183 DVWSFGVLMWEVFTEGKMPF-----------EKKSNYEV---VEMISR--------GFRL 220

Query: 598 LRYKNIEEELVSML--HVGLACVVSQPEKRPTMAEVAKMI 635
            R K     L SM    V  +C   +PE RPT AE+ + I
Sbjct: 221 YRPK-----LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 28/215 (13%)

Query: 362 EMLGKGSLGTVYKAVL-----DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVV 415
           E LG+ + G +YK  L     D   +VA+K LKD  NP    EF+Q   ++ +L HPN+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL-----HGNRGPG-------RIPLDWTTRISLV 463
            L      ++   ++++YL  G LH  L     H + G         +  LD    + + 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----VQAIA 518
           +  A G+  +   +      H ++ + N+L+ +     ISD GLS  +       VQ  +
Sbjct: 131 IQIAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 519 RLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            L   +  PE     + S  +D++SFGV+L E+ +
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 20/211 (9%)

Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +GKGS G V+K + +    +VA+K   L++A     ++ +Q + V+ +   P V K  
Sbjct: 10  ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYY 68

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
             Y    +  ++ +YL  GS   LL         P D     +++    +GL  +H E  
Sbjct: 69  GSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSE-- 120

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR---LGG--YKAPEQAEVKR 533
             K  H ++K++NVLL + G   ++DFG++  L   Q I R   +G   + APE  +   
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQSA 177

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
              KAD++S G+  +E+  G  P+    P R
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMR 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 61/231 (26%), Positives = 109/231 (47%), Gaps = 25/231 (10%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L +   P A  EF     ++  + HP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLARI 473
           +L     +   +L V   +P+G L   +H ++     ++ L+W  +I      A+G+  +
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
            +     ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 126 EER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 181

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               ++ + ++DV+S+GV + E++T         PTR   D  E+   LP+
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 232

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 68.5 bits (167), Expect = 3e-12
 Identities = 45/132 (34%), Positives = 71/132 (53%), Gaps = 3/132 (2%)

Query: 65  SERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDF 124
              +  L L  + +    +PL  L  L+ LDL  N L+     L+N +NL    LSGN  
Sbjct: 139 KSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI 198

Query: 125 SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK 184
           S ++P +I  L  +  LDLS+N+I   +   ++NL  L  L L NN+L   +P+   +L 
Sbjct: 199 S-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLS 255

Query: 185 DLKELNLSNNEL 196
           +L+ L+LSNN++
Sbjct: 256 NLETLDLSNNQI 267

Length = 394

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 65/280 (23%), Positives = 119/280 (42%), Gaps = 42/280 (15%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+ KL H  +V+L      
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 424 KEEKLLVYDYLPNGSLHSLLH-GNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +    +V +Y+ NG L + L    +      L     + +      G+A +  +    + 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESK----QF 121

Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H ++ + N L+D  G   +SDFGLS  +   +  + +G      +  PE     + S K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
           +DV++FGVL+ EV + G+ P +       R +  E    + + +R               
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYE-------RFNNSETVEKVSQGLR--------------- 219

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
           L R     E++ ++++   +C   + E+RPT  ++   IE
Sbjct: 220 LYRPHLASEKVYAIMY---SCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 39/228 (17%)

Query: 359 ASAEMLGKGSLGTVYKAVL--DDGGI-VAVKRLKDANPCARKEFEQYMD---VIGKLKHP 412
           A  + LG+G  G+V +  L  DD  + VAVK +K A  C R E E ++     + +  HP
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHP 60

Query: 413 NVVKLRAYYYAKEEK------LLVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLVLG 465
           NV++L        E       +++  ++ +G LHS LL+   G     L     +  +  
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-------------LLLN 512
            A G+  +     +    H ++ + N +L++N   C++DFGLS             +   
Sbjct: 121 IASGMEYL----SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM 176

Query: 513 PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
           PV+ I       A E    +  + K+DV+SFGV + E+ T R  + YP
Sbjct: 177 PVKWI-------AIESLADRVYTTKSDVWSFGVTMWEIAT-RGQTPYP 216

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 55/284 (19%)

Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKRL------KDANPCARKEFEQYMDVIGKLKHPNVV 415
           ++G+G+ G V+      D  +V +K++      KD    A+ E      V+  L HPN++
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNE----CQVLKLLSHPNII 62

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG---PGRIPLDWTTRISLVLGAARGLAR 472
           +    +   +  ++V +Y P G+L   +             L +  +I L       L  
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILL------ALHH 116

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPVQAIARLGG---YKAPEQ 528
           +H +     + H ++K+ N+LLDK+  V  I DFG+S +L+       + G   Y +PE 
Sbjct: 117 VHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
            E K  +QK+D+++ G +L E+ +              +    +A +LP  V  ++   +
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELAS--------------LKRAFEAANLPALVLKIMSGTF 218

Query: 589 TAEVFDQELLRYKNIEEELV-SMLHVGLACVVSQPEKRPTMAEV 631
            A + D    RY     +L+ SML++        P KRP ++++
Sbjct: 219 -APISD----RYSPDLRQLILSMLNL-------DPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 18/210 (8%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK--EFEQYMDVIGKLKHPNVVKLRA 419
           E +GKGS G VYK + +    V   ++ D      +  + +Q + V+ +   P + +   
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            Y    +  ++ +YL  GS   LL     PG  PL+ T   +++    +GL  +H E   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLK----PG--PLEETYIATILREILKGLDYLHSE--- 120

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR---LGG--YKAPEQAEVKRL 534
            +  H ++K++NVLL + G   ++DFG++  L   Q I R   +G   + APE  +    
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAY 178

Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
             KAD++S G+  +E+  G  P+    P R
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMR 208

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 66.4 bits (162), Expect = 5e-12
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 14/202 (6%)

Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           +LGKG+ G VY A  L     +A+K + + +    +   + + +   LKH N+V+     
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
                  +  + +P GSL +LL    GP  +  +  T I        GL  +H      +
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDN----Q 128

Query: 482 VPHGNVKSSNVLLDK-NGVACISDFGLSLLL---NPV-QAIARLGGYKAPEQAE--VKRL 534
           + H ++K  NVL++  +GV  ISDFG S  L   NP  +       Y APE  +   +  
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188

Query: 535 SQKADVYSFGVLLLEVLTGRAP 556
              AD++S G  ++E+ TG+ P
Sbjct: 189 GAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 31/214 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRL------KDANPCARKEFEQYMDVIGKLKHPNVV 415
           E+LGKG+ GTVY  + + G ++AVK++        A     ++ ++ +D++  LKH N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-GPGRIPL--DWTTRISLVLGAARGLAR 472
           +            +  +++P GS+ S+L  NR GP   P+   +T +I        G+A 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQI------LDGVAY 117

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----------NPVQAIARLGG 522
           +H       V H ++K +NV+L  NG+  + DFG +  L          N ++++     
Sbjct: 118 LHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           + APE        +K+D++S G  + E+ TG+ P
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 63/275 (22%), Positives = 105/275 (38%), Gaps = 45/275 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI----VAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           + LG GS G V +      G     VAVK LK         +F +   ++  L H N+++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPL----DWTTRISLVLGAARGLAR 472
           L          + V +  P GSL   L      G   +    D+  +I      A G+  
Sbjct: 61  LYGVVLTHPLMM-VTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQI------ANGMRY 112

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-------A 525
           +  +    +  H ++ + N+LL  +    I DFGL   L   +    +  +        A
Sbjct: 113 LESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCA 168

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP------SQYPSPTRPRVDEE----EQAV 574
           PE    +  S  +DV+ FGV L E+ T G  P      SQ       ++D+E    E+  
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----ILKKIDKEGERLERPE 224

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVS 609
             P+ + +V+ + W       +   +  + E L  
Sbjct: 225 ACPQDIYNVMLQCWAHNP--ADRPTFAALREFLPE 257

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.7 bits (162), Expect = 6e-12
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA+K++       ++     + V+ + K+PN+V     
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLH----SN 134

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+    +     + APE    K    
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLR 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 74/298 (24%), Positives = 129/298 (43%), Gaps = 51/298 (17%)

Query: 363 MLGKGSLGTVYKAVL--DDGGI--VAVKRLKDANPCARKEFEQYMDVIGKLK---HPNVV 415
           MLGKG  G+V +A L  +DG    VAVK LK A+  +  + E+++     +K   HPNV+
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 416 KLRAYYYAKEEK------LLVYDYLPNGSLHSLLHGNR-GPGRIPLDWTTRISLVLGAAR 468
           KL         K      +++  ++ +G LH+ L  +R G     L   T +  ++  A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 469 GLARIHQEYGTAK-VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP- 526
           G+     EY ++K   H ++ + N +L++N   C++DFGLS  +       +    K P 
Sbjct: 125 GM-----EYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 527 -----EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR 581
                E       +  +DV++FGV + E++T R  + Y       V+  E    L K  R
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMT-RGQTPYAG-----VENSEIYNYLIKGNR 233

Query: 582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
                +   +V++               ++     C   +P+ RP+   +   +E I 
Sbjct: 234 LKQPPDCLEDVYE---------------LMC---QCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 38/216 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKE---FEQYMDVIGKLKHPNVV 415
           ++LG+G+ G VY    +D G  +AVK++     +P  +KE    E  + ++  L+H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 416 KLRAYYYAKEEKLLVY---DYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGL 470
           +   YY    +   +    +Y+P GS+   L  +G        L  T           G+
Sbjct: 68  Q---YYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-------ALTETVTRKYTRQILEGV 117

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------- 522
             +H    +  + H ++K +N+L D  G   + DFG S  L   Q I   G         
Sbjct: 118 EYLH----SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKSVTGT 170

Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             + +PE    +   +KADV+S G  ++E+LT + P
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 66.3 bits (161), Expect = 8e-12
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 15/208 (7%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 135

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLGG---YKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+  + + G   + APE    K    
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLR 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 65.6 bits (160), Expect = 9e-12
 Identities = 81/302 (26%), Positives = 134/302 (44%), Gaps = 68/302 (22%)

Query: 362 EMLGKGSLGTVYKA-VLDDGGI---VAVK---RLKDANPCARKEFEQYMD---VIGKLKH 411
            ++GKG  G VY   ++D  G     AVK   R+ D      +E EQ++    ++    H
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL-----EEVEQFLKEGIIMKDFSH 55

Query: 412 PNVVKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAAR 468
           PNV+ L       E   L+V  Y+ +G L    +  R     P   T +  I   L  A+
Sbjct: 56  PNVLSLLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNP---TVKDLIGFGLQVAK 109

Query: 469 GLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKA 525
           G+     EY  + K  H ++ + N +LD++    ++DFGL+  +      ++    G K 
Sbjct: 110 GM-----EYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164

Query: 526 P------EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
           P      E  + ++ + K+DV+SFGVLL E++T  AP  YP      VD    + D+  +
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPD-----VD----SFDITVY 214

Query: 580 V---RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
           +   R +++ E+  +                  +  V L+C   +PE RPT +E+   IE
Sbjct: 215 LLQGRRLLQPEYCPD-----------------PLYEVMLSCWHPKPEMRPTFSELVSRIE 257

Query: 637 DI 638
            I
Sbjct: 258 QI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 9e-12
 Identities = 77/285 (27%), Positives = 126/285 (44%), Gaps = 51/285 (17%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL-RA 419
           LG G+ G VYKA   + G+ A  ++      + +E E +M   D++ + KHPN+V L  A
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEA 70

Query: 420 YYYAKEEKLLVY-DYLPNGSLHSL-LHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
           Y+Y  E KL +  ++   G+L S+ L   RG     + +  R  L       L  +H   
Sbjct: 71  YFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH- 122

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAPEQAEVKR 533
              KV H ++K+ N+LL  +G   ++DFG+S    + +Q      G   + APE    + 
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 534 LSQ-----KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
                   KAD++S G+ L+E+     P    +P R  V  +    + P   +     +W
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKILKSEPPTLDQP---SKW 234

Query: 589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
           ++  F+  L                   C+V  P+ RPT AE+ K
Sbjct: 235 SSS-FNDFLKS-----------------CLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 30/231 (12%)

Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRA 419
           LGKG  G V    V   G + A K+L       RK  +  +    ++ K+    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLL--HGNRG-PGRIPLDWTTRISLVLGAARGLARIHQE 476
            +  K++  LV   +  G L   +   G  G P    + +  +I        GL  +HQ 
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIIC------GLEHLHQR 114

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLG--GYKAPEQAEVKR 533
               ++ + ++K  NVLLD +G   ISD GL++ L   + I  R G  GY APE  + + 
Sbjct: 115 ----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV 170

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE-------QAVDLP 577
                D ++ G  L E++ GR+P +     + +V++EE        AV+ P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFR---QRKEKVEKEELKRRTLEMAVEYP 218

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 78/293 (26%), Positives = 125/293 (42%), Gaps = 58/293 (19%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKH-PNVVKLR 418
           E LG+G+ G V K   +  G I+AVKR++   N   +K     +D+  +    P  V   
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVT-- 64

Query: 419 AYYYA--KEEKLLVYDYLPNGSL-----HSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
            +Y A  +E  + +   + + SL          G      IP D   +I++     + L 
Sbjct: 65  -FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLT----IPEDILGKIAV--SIVKALE 117

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG--YKAPE- 527
            +H       V H +VK SNVL+++NG   + DFG+S  L++ V      G   Y APE 
Sbjct: 118 YLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPER 174

Query: 528 ---QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
              +   K    K+DV+S G+ ++E+ TGR P  Y S   P     +Q       ++ VV
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP--YDSWKTPF----QQ-------LKQVV 221

Query: 585 KE---EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
           +E   +  AE F  E   + N              C+    ++RP   E+ + 
Sbjct: 222 EEPSPQLPAEKFSPEFQDFVN-------------KCLKKNYKERPNYPELLQH 261

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 78/282 (27%), Positives = 121/282 (42%), Gaps = 48/282 (17%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG+   G VYK  L      +    VA+K LKD A    R+EF+    +  +L+HPN+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP----GRIPLDWTTRISL-------- 462
           V L      ++   +++ Y  +  LH  L   R P    G    D T + +L        
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLV-MRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLL-DKNGVACISDFGL----------SLLL 511
           V   A G+  +   +    V H ++ + NVL+ DK  V  ISD GL           L+ 
Sbjct: 130 VTQIAAGMEFLSSHH----VVHKDLATRNVLVFDKLNVK-ISDLGLFREVYAADYYKLMG 184

Query: 512 NPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP-SQYPSPTRPRVDE 569
           N +  I     + +PE     + S  +D++S+GV+L EV + G  P   Y +     +  
Sbjct: 185 NSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240

Query: 570 EEQAV----DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEEL 607
             Q +    D P WV +++ E W    F     R+K+I   L
Sbjct: 241 NRQVLPCPDDCPAWVYTLMLECWNE--FPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG------KLKHPNVVK 416
           +G GS G VY A       +VAVK++  +    ++  E++ D+I       +LKHPN ++
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYS---GKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
            +  Y  +    LV +Y   GS   LL  ++ P    L      ++  GA +GLA +H  
Sbjct: 86  YKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSH 140

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPE---QAEVKR 533
                + H ++K+ N+LL + G   ++DFG +   +P  +      + APE     +  +
Sbjct: 141 ---NMI-HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQ 196

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQY 559
              K DV+S G+  +E L  R P  +
Sbjct: 197 YDGKVDVWSLGITCIE-LAERKPPLF 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 70/300 (23%), Positives = 111/300 (37%), Gaps = 63/300 (21%)

Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRL---KDANPCARKEFEQYMDVIGKLKHPNV 414
           LG+G  G V+ A            +V VK L   KD N  +  EF + +D+  KL H NV
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKNV 70

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGL 470
           V+L       E   ++ +Y   G L   L   +         PL    +++L    A G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL------------LLNPVQAIA 518
             +      A+  H ++ + N L+       +S   LS              L P++   
Sbjct: 131 DHLS----NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR--- 183

Query: 519 RLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLP 577
               + APE  +    S K+DV+SFGVL+ EV T G  P  +   +   V    QA  L 
Sbjct: 184 ----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP--FYGLSDEEVLNRLQAGKL- 236

Query: 578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                    E             +     L  ++     C    P+ RP+ +E+   + +
Sbjct: 237 ---------ELPVP---------EGCPSRLYKLM---TRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 54/212 (25%), Positives = 95/212 (44%), Gaps = 41/212 (19%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +G+GS G V+K    + G IVA+K+  ++  +P  +K   + + ++ +LKHPN+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +  K +  LV++Y  +  L+ L    + P  +P     +I  +    + +   H+     
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKI--IWQTLQAVNFCHKH---- 119

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----------YKAPE-- 527
              H +VK  N+L+ K G   + DFG + +L          G           Y+APE  
Sbjct: 120 NCIHRDVKPENILITKQGQIKLCDFGFARILTG-------PGDDYTDYVATRWYRAPELL 172

Query: 528 ----QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
               Q          DV++ G +  E+LTG+ 
Sbjct: 173 VGDTQ-----YGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 25/220 (11%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E LG+G+  TVYK      G IVA+K +  DA         + + ++ +LKH N+V+L  
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             + + + +LV++Y+ +  L   +  HG RG     LD  T  S      +G+A  H+  
Sbjct: 66  VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGA----LDPNTVKSFTYQLLKGIAFCHEN- 119

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPEQAEVKR 533
              +V H ++K  N+L++K G   ++DFGL+     PV   +       Y+AP+     R
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 534 L-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ 572
             S   D++S G ++ E++TGR       P  P  + E+Q
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGR-------PLFPGTNNEDQ 209

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 22/203 (10%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG------KLKHPNVVK 416
           +G GS G VY A  +    +VA+K++  +    ++  E++ D+I       ++KHPN ++
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYS---GKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
            +  Y  +    LV +Y   GS   LL  ++ P    L      ++  GA +GLA +H  
Sbjct: 90  YKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSH 144

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPE---QAEVKR 533
                + H ++K+ N+LL + G   ++DFG + + +P  +      + APE     +  +
Sbjct: 145 ----NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQ 200

Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
              K DV+S G+  +E+   + P
Sbjct: 201 YDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 28/216 (12%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRAY 420
           LG G+ G VYKA   + G +A  ++ +    + +E E YM   +++    HP +VKL   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGA 77

Query: 421 YYAKEEKLLVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
           +Y   +  ++ ++ P G++ + +L  +RG     +    R  L       L  +H    +
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLH----S 128

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KAPEQAEVKR 533
            K+ H ++K+ NVLL  +G   ++DFG+S     V+ + R   +       APE    + 
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 534 LSQ-----KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           +       KAD++S G+ L+E+     P    +P R
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 35/216 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V KA +   G+    A+KR+K+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 417 L------RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP-----------LDWTTR 459
           L      R Y Y      L  +Y P+G+L   L  +R     P           L     
Sbjct: 73  LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAI 517
           +      ARG+  + Q+    +  H ++ + N+L+ +N VA I+DFGLS    +   + +
Sbjct: 127 LHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 518 ARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            RL   + A E       +  +DV+S+GVLL E+++
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.4 bits (157), Expect = 4e-11
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 22/203 (10%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG------KLKHPNVVK 416
           +G GS G VY A  +    +VA+K++   +   ++  E++ D+I       +L+HPN ++
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
            +  Y  +    LV +Y   GS   +L  ++ P    L      ++  GA +GLA +H  
Sbjct: 80  YKGCYLREHTAWLVMEYCL-GSASDILEVHKKP----LQEVEIAAICHGALQGLAYLH-- 132

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPE---QAEVKR 533
             + +  H ++K+ N+LL + G   ++DFG + L++P  +      + APE     +  +
Sbjct: 133 --SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQ 190

Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
              K DV+S G+  +E+   + P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 362 EMLGKGSLGTVY-------------KAVLDDGG----IVAVKRLK-DANPCARKEFEQYM 403
           E LG+G  G V+                LD  G    +VAVK L+ DAN  AR +F + +
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRIS 461
            ++ +LK PN+++L A     +   ++ +Y+ NG L+  L  H  +         T   S
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----VQA 516
            ++  A  +A   +   +    H ++ + N L+ KN    I+DFG+S  L       +Q 
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 517 IARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            A L   + + E   + + +  +DV++FGV L E+LT
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 63.7 bits (155), Expect = 5e-11
 Identities = 47/213 (22%), Positives = 93/213 (43%), Gaps = 29/213 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVI------GKLKHPNV 414
           + LG G+  + Y+A  +  G ++AVK++      + ++ E    +        +L HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           +++           L  +++  GS+  LL    G           I+      RGL+ +H
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGA----FKEAVIINYTEQLLRGLSYLH 120

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPVQAIARLGGYK--------- 524
           +     ++ H +VK +N+L+D  G    I+DFG +  L         G ++         
Sbjct: 121 EN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTGAGEFQGQLLGTIAF 174

Query: 525 -APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            APE    ++  +  DV+S G +++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 64.6 bits (157), Expect = 6e-11
 Identities = 35/120 (29%), Positives = 59/120 (49%), Gaps = 5/120 (4%)

Query: 77  SLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLK 136
           S    +  L+ L  L   + +   +   I  L +  NLK   LS N     +P  + +L 
Sbjct: 107 SNISELLELTNLTSLDLDNNNITDIPPLIGLLKS--NLKELDLSDNKIE-SLPSPLRNLP 163

Query: 137 GILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            +  LDLS N++   +P+ ++NL+ L  L L  N+++  +P     L  L+EL+LSNN +
Sbjct: 164 NLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 56/216 (25%), Positives = 101/216 (46%), Gaps = 28/216 (12%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRAY 420
           LG G+ G VYKA   + G++A  ++ D    + +E E YM   D++    HPN+VKL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARIHQEYGT 479
           +Y +    ++ ++   G++ +++     P   P     +I +V       L  +H+    
Sbjct: 71  FYYENNLWILIEFCAGGAVDAVMLELERPLTEP-----QIRVVCKQTLEALNYLHEN--- 122

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KAP-----EQ 528
            K+ H ++K+ N+L   +G   ++DFG+S      + I R   +       AP     E 
Sbjct: 123 -KIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCET 179

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++ +    KADV+S G+ L+E+     P    +P R
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 62.8 bits (153), Expect = 9e-11
 Identities = 80/303 (26%), Positives = 133/303 (43%), Gaps = 60/303 (19%)

Query: 352 ELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLK-DANPCARKEFEQYMDVIGKL 409
           +L+DL       +G+G+ GTV K +    G I+AVKR++   +   +K     +DV+ + 
Sbjct: 5   DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59

Query: 410 KH-PNVVKLRAYYYA--KEEKLLVYDYLPNGSL---HSLLHGNRGPGRIPLDWTTRISL- 462
              P +VK   +Y A  +E    +   L + SL   +  ++       IP +   +I++ 
Sbjct: 60  SDCPYIVK---FYGALFREGDCWICMELMDISLDKFYKYVY-EVLKSVIPEEILGKIAVA 115

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL-- 520
            + A   L          K+ H +VK SN+LLD+NG   + DFG+S  L  V +IA+   
Sbjct: 116 TVKALNYLKEEL------KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRD 167

Query: 521 GG---YKAPEQAEVKRLSQ---KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
            G   Y APE+ +         ++DV+S G+ L EV TG+    +P P    V ++   V
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK----FPYPKWNSVFDQLTQV 223

Query: 575 ---DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
              D P    S  +E      F    + + N+             C++    KRP   E+
Sbjct: 224 VKGDPPILSNSEERE------FSPSFVNFINL-------------CLIKDESKRPKYKEL 264

Query: 632 AKM 634
            + 
Sbjct: 265 LEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 40/227 (17%)

Query: 363 MLGKGSLGTVYKAVLDD------GGI-VAVKRL-KDANPCARKEFEQYMDVIGKLKHPNV 414
            LG G+ G VY+    D      G I VAVK L K A    +KEF +   ++    HPN+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARG 469
           VKL       E + ++ + +  G L S L   R      P    L     + + L  A+G
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPL---LTLKELLDICLDVAKG 118

Query: 470 ---LARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-----ISDFGLSLLLNPVQAIARLG 521
              L ++H         H ++ + N L+ + G        I DFGL+  +       + G
Sbjct: 119 CVYLEQMH-------FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG 171

Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPS 561
                  + APE     + + ++DV+SFGVL+ E+LT G+ P  YP+
Sbjct: 172 EGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--YPA 216

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 27/237 (11%)

Query: 362 EMLGKGSLGTVYKA----VLDDGGI----VAVKRLKDANPCARKEFEQYMDVIGKLKHPN 413
           E LG+G+   ++K     V D G +    V +K L  ++    + F +   ++ +L H +
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +V         +E ++V +Y+  GSL + L  N+    I + W       L  A+ LA  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWK------LEVAKQLAWA 112

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVAC--------ISDFGLSLLLNPVQAIARLGGYKA 525
                   + HGNV + NVLL +             +SD G+S+ + P + +     +  
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVP 172

Query: 526 PE-QAEVKRLSQKADVYSFGVLLLEVLTG--RAPSQYPSPTRPRVDEEEQAVDLPKW 579
           PE     + LS  AD +SFG  L E+ +G  +  S   S  + +  E+   +  PKW
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKW 229

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 72/298 (24%), Positives = 118/298 (39%), Gaps = 58/298 (19%)

Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKDANPCA----RKEFEQYMDVIGKLKHPN 413
           LG+GS G VY+ +            VA+K +   N  A    R EF     V+ +    +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFLNEASVMKEFNCHH 70

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAAR 468
           VV+L       +  L+V + +  G L S L   R      PG  P      I +    A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------ 522
           G+A +  +    K  H ++ + N ++ ++    I DFG++  +       R GG      
Sbjct: 131 GMAYLAAK----KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE-TDYYRKGGKGLLPV 185

Query: 523 -YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
            + APE  +    + K+DV+SFGV+L E+ T    P Q  S         E+ +      
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--------NEEVLKF---- 233

Query: 581 RSVVKEEWTAEVFDQELLRY-KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                      V D   L   +N  ++L+ ++     C    P+ RPT  E+   ++D
Sbjct: 234 -----------VIDGGHLDLPENCPDKLLELM---RMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 1e-10
 Identities = 57/195 (29%), Positives = 91/195 (46%), Gaps = 27/195 (13%)

Query: 378 DDGGIVAVKRLKDANPCA---RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL-VYDY 433
             G  VA+K L+   P     R  F +   +  +L HPN+V L     A    L  V++Y
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL 493
           +P  +L  +L  +   G +P   T R  L+L     LA  H       + H ++K  N++
Sbjct: 61  VPGRTLREVLAAD---GALPAGETGR--LMLQVLDALACAHN----QGIVHRDLKPQNIM 111

Query: 494 LDKNGV---ACISDFGLSLLLNPVQAIAR---------LGG--YKAPEQAEVKRLSQKAD 539
           + + GV   A + DFG+  LL  V+             LG   Y APEQ   + ++  +D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 540 VYSFGVLLLEVLTGR 554
           +Y++G++ LE LTG+
Sbjct: 172 LYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 22/203 (10%)

Query: 364 LGKGSLGTVYKAVLDDGGIV-AVKRLKDANPCARKEFEQYM----DVIGKLKHPNVVKLR 418
           LG G  G V    +       A+K +K  +       ++++    +++ +  HP +VKL 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETG-QQEHIFSEKEILEECNHPFIVKLY 59

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLARIHQE 476
             +  K+   ++ +Y   G L ++L      G    ++T R  I+ V+ A   L      
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDR---GLFD-EYTARFYIACVVLAFEYLHNRGII 115

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKR 533
           Y        ++K  N+LLD NG   + DFG +  L   Q      G   Y APE    K 
Sbjct: 116 YR-------DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG 168

Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
                D +S G+LL E+LTGR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 46/113 (40%), Positives = 61/113 (53%), Gaps = 4/113 (3%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR-LDL 143
           L  L  L  LDL+ NRL   I  L   TNL    L  N+ + +IP  I  LK  L+ LDL
Sbjct: 89  LLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDL 147

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           SDN I   +P  + NL  L  L L  N+L+  +P L S+L +L  L+LS N++
Sbjct: 148 SDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI 198

Length = 394

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 19/200 (9%)

Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK-LKHPNVVKLRAYY 421
           +G+GS G V  A     G  VAVK++ D     R+E      VI +  +HPN+V++ + Y
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL-VLGAARGLARIHQEYGTA 480
              +E  +V ++L  G+L  ++       R+  +    + L VL A   L+ +H      
Sbjct: 86  LVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKA---LSFLH----AQ 134

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGL-SLLLNPVQAIARLGG---YKAPEQAEVKRLSQ 536
            V H ++KS ++LL  +G   +SDFG  + +   V     L G   + APE         
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 537 KADVYSFGVLLLEVLTGRAP 556
           + D++S G++++E++ G  P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 44/150 (29%), Positives = 76/150 (50%), Gaps = 12/150 (8%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +G+G+ GTV+KA   +   IVA+KR  L D +        + + ++ +LKH N+V+L 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++ ++  LV++Y  +  L        G     +D     S +    +GLA  H    
Sbjct: 66  DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSH-- 118

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
              V H ++K  N+L++KNG   ++DFGL+
Sbjct: 119 --NVLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 26/207 (12%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DAN-----PCARKEFEQYMDVIGKLKHPNV 414
           E +G+G+ G VYKA     G +VA+K+++ D         A +E    + ++ +L HPN+
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELNHPNI 61

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           VKL    + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSG-IPLPLIK--SYLFQLLQGLAFCH 117

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQA----IARLGGYKAPE-Q 528
                 +V H ++K  N+L++  G   ++DFGL+     PV+     +  L  Y+APE  
Sbjct: 118 SH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL-WYRAPEIL 172

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRA 555
              K  S   D++S G +  E++T RA
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRA 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 50/229 (21%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIG-------------K 408
           LG+G+ G V KA     G IVA+K++K         +  Q + + G             +
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KH N++ L   Y   +   LV D +    L  ++       +I L  +    ++L    
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR-----KIRLTESQVKCILLQILN 130

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-------------------L 509
           GL  +H+ Y      H ++  +N+ ++  G+  I+DFGL+                    
Sbjct: 131 GLNVLHKWY----FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 510 LLNPVQAIARLGGYKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
                  +  L  Y+APE    AE  +     D++S G +  E+LTG+ 
Sbjct: 187 REEMTSKVVTL-WYRAPELLMGAE--KYHFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 364 LGKGSLGTVYKAVLD---DGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           LG G+ GTV K +         VAVK LK  + +P  + E  +  +V+ +L +P +V++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
               A E  +LV +    G L+  L  N+      +       LV   + G+  + +   
Sbjct: 63  GICEA-ESWMLVMELAELGPLNKFLQKNKH-----VTEKNITELVHQVSMGMKYLEE--- 113

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKAPEQAEV 531
                H ++ + NVLL     A ISDFGLS  L   +   +          + APE    
Sbjct: 114 -TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 532 KRLSQKADVYSFGVLLLEVLT-GRAP 556
            + S K+DV+SFGVL+ E  + G+ P
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 42/223 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-----KDANP-CARKEFEQYMDVIGKLKHPNV 414
             LG+G+ G VYKA  +  G +VA+K++     KD  P  A +E    + ++ KLKHPNV
Sbjct: 14  GKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKILKKLKHPNV 69

Query: 415 VKL--RAYYYAKEE---KLLVYDYLP--NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           V L   A     +    +  VY   P  +  L  LL        + L  +     +L   
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS----VKLTESQIKCYMLQLL 125

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---- 522
            G+  +H+      + H ++K++N+L+D  G+  I+DFGL+     P       GG    
Sbjct: 126 EGINYLHE----NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181

Query: 523 ----------YKAPEQ-AEVKRLSQKADVYSFGVLLLEVLTGR 554
                     Y+ PE     +R +   D++  G +  E+ T R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 30/204 (14%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLK--------DANPCARKEFEQYMDVIGKLKHPNVV 415
           LGKGS GTVY  ++ D   VA +RLK        + NP    +  Q   ++ KL HP +V
Sbjct: 8   LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI-----PLDWTTRISLVLGAARGL 470
           K  A +  ++   ++ +Y     L   L   +  G+        +W  ++ L      G+
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAP 526
             +HQ     ++ H ++K+ N+ L KN +  I DFG+S LL+          G   Y +P
Sbjct: 120 HYMHQR----RILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Query: 527 EQAEVKRLSQKADVYSFGVLLLEV 550
           E  + +    K+D++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 21/200 (10%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKGS G V       DG    +K+L  ++A+   RK  EQ   ++ +LKHPN+V  R  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 421 YYAKEEKL-LVYDYLPNGSLHSLLHGNRG---PGRIPLDWTTRISLVLGAARGLARIHQE 476
           +  ++  L +V  +   G L+  L   +G   P    ++W  +I      A  L  +H++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI------AMALQYLHEK 121

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL-NPVQAIARLGG---YKAPEQAEVK 532
           +    + H ++K+ NV L +  +  + D G++ +L N     + L G   Y +PE    K
Sbjct: 122 H----ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 533 RLSQKADVYSFGVLLLEVLT 552
             + K+DV++ G  + E+ T
Sbjct: 178 PYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 364 LGKGSLGTVYKAV--LDDGGI-VAVKRLKDANPCA-RKEFEQYMDVIGKLKHPNVVKLRA 419
           LG G+ G V K V  +    I VA+K LK+ N  + R E  +  +++ +L +P +V++  
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
              A E  +LV +    G L+  L G +    I +  +  + L+   + G+  +  +   
Sbjct: 63  VCEA-EALMLVMEMASGGPLNKFLSGKKD--EITV--SNVVELMHQVSMGMKYLEGK--- 114

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI--ARLGG-----YKAPEQAEVK 532
               H ++ + NVLL     A ISDFGLS  L    +   AR  G     + APE    +
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173

Query: 533 RLSQKADVYSFGVLLLEVLT-GRAP 556
           + S ++DV+S+G+ + E  + G+ P
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 63/274 (22%), Positives = 119/274 (43%), Gaps = 38/274 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           + +G G+ G VYKA  ++ G + A+K +K          +Q + ++   KH N+V     
Sbjct: 15  QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y  +++  +  ++   GSL  + H         + + +R +L     +GL  +H +    
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK---G 126

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQAEVKR--- 533
           K+ H ++K +N+LL  NG   ++DFG+S  +    A  +  +G   + APE A V+R   
Sbjct: 127 KM-HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
            +Q  D+++ G+  +E+   + P     P R      +     PK               
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKL-------------- 231

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT 627
            ++ +++ N     V M       +   P+KRPT
Sbjct: 232 -KDKMKWSNSFHHFVKM------ALTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 70/309 (22%), Positives = 116/309 (37%), Gaps = 77/309 (24%)

Query: 362 EMLGKGSLGTVYKAVL----DDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
             +G+G  G VY+ V     ++   VAVK  K   +P  R++F Q   ++ +  HP++VK
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA---ARGLARI 473
           L      +    +V +  P G L S L  N+             SL+L +   +  LA +
Sbjct: 72  LIGVI-TENPVWIVMELAPLGELRSYLQVNK-------YSLDLASLILYSYQLSTALAYL 123

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN------------PVQAIARLG 521
                + +  H ++ + NVL+       + DFGLS  L             P++      
Sbjct: 124 E----SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK------ 173

Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPK-- 578
            + APE    +R +  +DV+ FGV + E+L  G  P Q        +   E    LP   
Sbjct: 174 -WMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG-VKNNDVIGRIENGERLPMPP 231

Query: 579 ----WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
                + S++ + W  +                              P KRP   E+   
Sbjct: 232 NCPPTLYSLMTKCWAYD------------------------------PSKRPRFTELKAQ 261

Query: 635 IEDIRVEQS 643
           + DI  E+ 
Sbjct: 262 LSDILQEEK 270

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 30/244 (12%)

Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGG----IVAVKRLKD-ANPCARKEFEQY 402
           K+ EL+ +      +LG G+ GTVYK + + DG      VA+K L++  +P A KE    
Sbjct: 5   KETELKKVK-----VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDE 59

Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRI 460
             V+  +  P V +L         +L V   +P G L   +  N+     +  L+W  +I
Sbjct: 60  AYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI 118

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                 A+G++ + +     ++ H ++ + NVL+       I+DFGL+ LL+  +     
Sbjct: 119 ------AKGMSYLEE----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA 168

Query: 521 GGYKAP------EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
            G K P      E    +R + ++DV+S+GV + E++T  A      P R   D  E+  
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE 228

Query: 575 DLPK 578
            LP+
Sbjct: 229 RLPQ 232

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 55/209 (26%), Positives = 98/209 (46%), Gaps = 29/209 (13%)

Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           AE LG+G+     + VL     VAVK L+ D    AR +F + + ++ +LK+PN+++L  
Sbjct: 30  AEFLGEGAPEFDGQPVL-----VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLL----------HGNRGPGRIPLDWTTRISLVLGAARG 469
              + +   ++ +Y+ NG L+  L          H N  P       +  I+ +L  A  
Sbjct: 85  VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP-------SVSIANLLYMAVQ 137

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----VQAIARLG-GY 523
           +A   +   +    H ++ + N L+  +    I+DFG+S  L       +Q  A L   +
Sbjct: 138 IASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW 197

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            A E   + + +  +DV++FGV L E+ T
Sbjct: 198 MAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L +   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 73  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
            +     ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 126 EER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 60.6 bits (148), Expect = 6e-10
 Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 44/213 (20%)

Query: 364 LGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V        G   A+K L  A     K+ E  ++   ++  ++HP +V L  
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 420 YYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTT----RISLVLGAARGLARI 473
            +  +++  L  V +Y+P G L S L   R  GR P         ++ L L        +
Sbjct: 69  SF--QDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVLALE------YL 117

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----------Y 523
           H       + + ++K  N+LLD +G   I+DFG +          R+ G          Y
Sbjct: 118 HSL----DIVYRDLKPENLLLDSDGYIKITDFGFA---------KRVKGRTYTLCGTPEY 164

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            APE    K   +  D ++ G+L+ E+L G  P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 6e-10
 Identities = 55/243 (22%), Positives = 103/243 (42%), Gaps = 27/243 (11%)

Query: 321 KRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDG 380
           K +  +   DSD T           + K ++E  + +R     LG GS G V  A   + 
Sbjct: 5   KNLQLHKKKDSDSTKEPKR------KNKMKYEDFNFIRT----LGTGSFGRVILATYKNE 54

Query: 381 GI--VAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP 435
               VA+KR + +    +K+ +       ++  + HP  V L   +  +    LV +++ 
Sbjct: 55  DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114

Query: 436 NGSLHSLLHGN-RGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL 494
            G   + L  N R P  +   +  +I L+    + L  ++++          +K  N+LL
Sbjct: 115 GGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD----------LKPENLLL 164

Query: 495 DKNGVACISDFGLSLLLNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTG 553
           DK+G   ++DFG + +++     +     Y APE        + AD ++ G+ + E+L G
Sbjct: 165 DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Query: 554 RAP 556
             P
Sbjct: 225 CPP 227

Length = 340

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 72/288 (25%), Positives = 130/288 (45%), Gaps = 41/288 (14%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +G+G    VY+A  L D   VA+K+++     DA   AR++  + +D++ +L HPNV+K 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK--ARQDCVKEIDLLKQLNHPNVIKY 67

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGR-IPLDWTTRISLVLGAARGLARIHQE 476
              +    E  +V +    G L  ++   +   R IP     +  + L +A  +  +H  
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA--VEHMH-- 123

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVK 532
             + +V H ++K +NV +   GV  + D GL    +    A   L G   Y +PE+    
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
             + K+D++S G LL E+   ++P          + ++ +  D P     +  E ++   
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP----PLPTEHYS--- 234

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV 640
              E LR      ELVSM      C+   P++RP +  V ++ + + V
Sbjct: 235 ---EKLR------ELVSM------CIYPDPDQRPDIGYVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 68/237 (28%), Positives = 102/237 (43%), Gaps = 41/237 (17%)

Query: 356 LLRASAEMLGKGSLGTVYKAVL--DDGGI----VAVKRL-KDANPCARKEFEQYMDVIGK 408
           LLRA    LG G+ G VY+ +    DG      VAVK L +  +     +F     ++ K
Sbjct: 10  LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-PGR-IPLDWTTRISLVLGA 466
             H N+V+L    + +  + ++ + +  G L S L  NR  P R   L     +  +L  
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL----TMKDLLFC 121

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGGY 523
           AR +A+  +        H ++ + N LL   G   VA I+DFG++      + I R   Y
Sbjct: 122 ARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA------RDIYRASYY 175

Query: 524 K------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRV 567
           +             PE       + K DV+SFGVLL E+ + G  P  YP  T   V
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP--YPGRTNQEV 230

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 17/211 (8%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           + +G G+ G VYKA  L  G + AVK +K          +Q + ++ + KH N+V     
Sbjct: 15  QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y ++E+  +  +Y   GSL  + H       + + +  R +L     +GLA +H +    
Sbjct: 75  YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK---G 126

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQAEVKR--- 533
           K+ H ++K +N+LL  NG   ++DFG++  +    A  +  +G   + APE A V++   
Sbjct: 127 KM-HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
            +Q  D+++ G+  +E+   + P     P R
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMR 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 60.4 bits (146), Expect = 7e-10
 Identities = 64/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)

Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G  G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSEMEMMKMIGK- 79

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 80  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      +AR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 139 LV-SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197

Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 241

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 72/297 (24%), Positives = 134/297 (45%), Gaps = 61/297 (20%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V +A++   G+    A+K LK+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 417 L------RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP-----------LDWTTR 459
           L      R Y Y      +  +Y P G+L   L  +R     P           L     
Sbjct: 68  LLGACENRGYLY------IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAI 517
           +      A G+  + ++    +  H ++ + NVL+ +N  + I+DFGLS    +   + +
Sbjct: 122 LQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM 177

Query: 518 ARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVD 575
            RL   + A E       + K+DV+SFGVLL E+++ G  P  Y   T   + E+     
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP--YCGMTCAELYEK----- 230

Query: 576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVA 632
           LP+  R               + + +N ++E+  ++     C   +P +RP  A+++
Sbjct: 231 LPQGYR---------------MEKPRNCDDEVYELMR---QCWRDRPYERPPFAQIS 269

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRA 419
           E +GKG+ G VYK     DG + AVK L D      +E E   +++  L  HPNVVK   
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 420 YYYAKEEKL-----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +Y  ++ +     LV +    GS+  L+ G    G+  LD      ++ GA  GL  +H
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGALLGLQHLH 145

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP-------- 526
                 ++ H +VK +N+LL   G   + DFG+S  L   + + R      P        
Sbjct: 146 NN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVI 200

Query: 527 --EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             EQ        + DV+S G+  +E+  G  P
Sbjct: 201 ACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 35/239 (14%)

Query: 356 LLRASAEMLGKGSLGTVYKAVLDDGGIV-AVKRLKDANPCARKEFEQYMD---VIGKLKH 411
           LLR     +GKG+ G V      D   + A+K +       +      ++   ++ +L H
Sbjct: 4   LLRV----IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH 59

Query: 412 PNVVKLRAYYYAKEEKL-LVYDYLPNGSL--HSLLHGNR-GPGRIPLDWTTRISLVLGAA 467
           P +V L  Y +  EE + LV D L  G L  H L    +    ++   W   I L     
Sbjct: 60  PFLVNLW-YSFQDEENMYLVVDLLLGGDLRYH-LSQKVKFSEEQVKF-WICEIVL----- 111

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLG--GYK 524
             L  +H    +  + H ++K  N+LLD+ G   I+DF ++  + P     +  G  GY 
Sbjct: 112 -ALEYLH----SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE-----EEQAVDLPK 578
           APE    +  S   D +S GV   E L G+ P  Y   +R   D+     E   V  P 
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRP--YRGHSRTIRDQIRAKQETADVLYPA 223

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 48/219 (21%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVI-GK-----------LK 410
           +G G+ G V  AV    G  VA+K++ +        F+   D+I  K           L+
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FD---DLIDAKRILREIKLLRHLR 57

Query: 411 HPNVVKLRAYYYAK-----EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL- 464
           H N++ L             +  +V + +    LH ++   +     PL     I   L 
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ-----PLT-DDHIQYFLY 110

Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-LGG- 522
              RGL  +H    +A V H ++K SN+L++ N    I DFGL+  ++P +     L   
Sbjct: 111 QILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166

Query: 523 -----YKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
                Y+APE      R ++  D++S G +  E+LT + 
Sbjct: 167 VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 38/227 (16%)

Query: 364 LGKGSLGTVYKAVLDDGGI----------VAVKRLKDANPCARKEFE------QYMDVIG 407
           LG+G  G V  A  +  GI          VAVK LKD      K+        + M +IG
Sbjct: 20  LGEGCFGQVVMA--EAIGIDKDKPNKPVTVAVKMLKD--DATDKDLSDLVSEMEMMKMIG 75

Query: 408 KLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTR 459
           K  H N++ L           ++ +Y   G+L   L   R PG        ++P +  T 
Sbjct: 76  K--HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133

Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR 519
             LV   A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +
Sbjct: 134 KDLV-SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192

Query: 520 LGG------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE    +  + ++DV+SFGVLL E+ T    S YP
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT-LGGSPYP 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 49/129 (37%), Positives = 71/129 (55%), Gaps = 6/129 (4%)

Query: 70  SLSLPSHSLRGPIAPLSLL--DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAE 127
           SL L ++++   I PL  L    L+ LDL DN++     PL N  NLK   LS ND  ++
Sbjct: 120 SLDLDNNNI-TDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFND-LSD 177

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
           +P  +S+L  +  LDLS N I   +P ++  L+ L  L L NN +   +    S+LK+L 
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235

Query: 188 ELNLSNNEL 196
            L LSNN+L
Sbjct: 236 GLELSNNKL 244

Length = 394

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 61/269 (22%), Positives = 116/269 (43%), Gaps = 41/269 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E++G G+ G VYK      G +A  ++ D      +E +Q ++++ K  H     +  YY
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR--NIATYY 69

Query: 422 YA---------KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
            A          ++  LV ++   GS+  L+   +G   +  +W   I   +   RGL+ 
Sbjct: 70  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREI--LRGLSH 126

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KAP 526
           +HQ     KV H ++K  NVLL +N    + DFG+S  L+  + + R   +       AP
Sbjct: 127 LHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMAP 180

Query: 527 E-----QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR----------PRVDEEE 571
           E     +        K+D++S G+  +E+  G  P     P R          PR+  ++
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKK 240

Query: 572 QAVDLPKWVRSVVKEEWTAEVFDQELLRY 600
            +     ++ S + +  +     ++L+++
Sbjct: 241 WSKKFQSFIESCLVKNHSQRPTTEQLMKH 269

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 41/216 (18%)

Query: 365 GKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQY--------------MDVIGKLK 410
           G+G+ G VYKA   +G        KD    A K+F+                + ++ +LK
Sbjct: 9   GRGTYGRVYKAKRKNG--------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 411 HPNVVKLRAYYYAKEEKL--LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           H NVV L   +    +K   L++DY  +     ++  +R   R+ +  +   SL+     
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQ-IIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLN-PVQAIARLGG- 522
           G+  +H  +    V H ++K +N+L+     + GV  I D GL+ L N P++ +A L   
Sbjct: 120 GVHYLHSNW----VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 523 -----YKAPEQAEVKRLSQKA-DVYSFGVLLLEVLT 552
                Y+APE     R   KA D+++ G +  E+LT
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 55/296 (18%)

Query: 364 LGKGSLGTVYKAVLDDGGIVA---VKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G  G V       G   A   VK L+  A P  +  F Q +    +L HPNV++   
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
                   LLV ++ P G L + L  NRG             +    A GL  +HQ    
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---- 118

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSL-------------LLNPVQAIARLGGYKAP 526
           A   H ++   N  L  +    I D+GL+L                P++ +A       P
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLA-------P 171

Query: 527 EQAE-------VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
           E  E        K  ++K++++S GV + E+ T        +  +P  D  ++ V     
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT--------AADQPYPDLSDEQV----- 218

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
           ++ VV+E+       Q  L+Y +   E++        C +  PE RPT  EV +++
Sbjct: 219 LKQVVREQDIKLPKPQLDLKYSDRWYEVMQF------CWL-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 52/200 (26%), Positives = 99/200 (49%), Gaps = 19/200 (9%)

Query: 364 LGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKE--FEQYMDVIGKLKHPNVVKLRAY 420
           +G+GS G V  A +   G +VAVK++ D     R+E  F + + ++   +H NVV++   
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFNEVV-IMRDYQHENVVEMYNS 85

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V ++L  G+L  ++   R      ++     ++ L   + L+ +H +    
Sbjct: 86  YLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQ---- 135

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVKRLSQ 536
            V H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE         
Sbjct: 136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 537 KADVYSFGVLLLEVLTGRAP 556
           + D++S G++++E++ G  P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 61/232 (26%), Positives = 104/232 (44%), Gaps = 31/232 (13%)

Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV----YKAVLDDGGIVAVKRLKDANPCAR 396
           K+V   RK Q + ED      +++G+G+ G V    +K+      + A+K L       R
Sbjct: 30  KIVRKIRKLQMKAEDY--DVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKR 84

Query: 397 KE---FEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP 453
            +   F +  D++     P VV+L   +   +   +V +Y+P G L +L+     P +  
Sbjct: 85  SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA 144

Query: 454 LDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP 513
             +T  + L L A   +  IH++          VK  N+LLDK+G   ++DFG  + ++ 
Sbjct: 145 KFYTAEVVLALDAIHSMGLIHRD----------VKPDNMLLDKHGHLKLADFGTCMKMDE 194

Query: 514 ---VQAIARLG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              V+    +G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 31/213 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +G G+ G V  A+    G  VA+K++  A   P   K   + + ++   KH N++ +R
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 419 AYYYAKEEKL----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARI 473
                         +V D L    LH ++H ++     PL     I   L    RGL  I
Sbjct: 71  DILRPPGADFKDVYVVMD-LMESDLHHIIHSDQ-----PLT-EEHIRYFLYQLLRGLKYI 123

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPV-------QAIARLGGYK 524
           H    +A V H ++K SN+L++++    I DFG+   L  +P        + +A    Y+
Sbjct: 124 H----SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR-WYR 178

Query: 525 APE-QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           APE    +   +   D++S G +  E+L GR  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ 210

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 53/293 (18%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V KA +   G+    A+KR+K+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 417 L------RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
           L      R Y Y      L  +Y P+G+L   L  +R     P       +    +++ L
Sbjct: 61  LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 471 ARI-------HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG 521
                            +  H ++ + N+L+ +N VA I+DFGLS    +   + + RL 
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 174

Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKW 579
             + A E       +  +DV+S+GVLL E+++ G  P  Y   T   + E+     LP+ 
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEK-----LPQG 227

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVA 632
            R         EV+  +L+R                 C   +P +RP+ A++ 
Sbjct: 228 YRLEKPLNCDDEVY--DLMR----------------QCWREKPYERPSFAQIL 262

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 363 MLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLR 418
           +LGKG  G V    V   G + A K+L+      RK     ++   ++ K+    VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 419 AYYYAKEEKLLVYDYLPNGSL--HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
             Y  K+   LV   +  G L  H    G  G      +    +        GL  +HQE
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRAVFYAAEICCGLEDLHQE 121

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLG--GYKAPEQAEVKR 533
               ++ + ++K  N+LLD +G   ISD GL++ +   Q I  R+G  GY APE  + +R
Sbjct: 122 ----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 177

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQ 558
            +   D ++ G LL E++ G++P Q
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQ 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 42/217 (19%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFE---------QYMDVIGKLKHPNV 414
           +G+G+ G VYKA   DG        KD    A K+ E         + + ++ +LKHPNV
Sbjct: 9   VGRGTYGHVYKAKRKDG--------KDDRDYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 415 VKLRAYY--YAKEEKLLVYDYLPNG-----SLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           + L+  +  +A  +  L++DY  +        H     N+ P ++P       SL+    
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK--SLLYQIL 118

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLN-PVQAIARLGG 522
            G+  +H  +    V H ++K +N+L+     + G   I+D G + L N P++ +A L  
Sbjct: 119 DGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 523 ------YKAPEQAEVKRLSQKA-DVYSFGVLLLEVLT 552
                 Y+APE     R   KA D+++ G +  E+LT
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 42/217 (19%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFE---------QYMDVIGKLKHPNV 414
           +G+G+ G VYKA   DG        KD    A K+ E         + + ++ +LKHPNV
Sbjct: 9   VGRGTYGHVYKAKRKDG--------KDEKEYALKQIEGTGISMSACREIALLRELKHPNV 60

Query: 415 VKLRAYYYAKEEK--LLVYDYLPNG-----SLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           + L+  + +  ++   L++DY  +        H     N+ P ++P       SL+    
Sbjct: 61  IALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK--SLLYQIL 118

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLN-PVQAIARLGG 522
            G+  +H  +    V H ++K +N+L+     + G   I+D G + L N P++ +A L  
Sbjct: 119 DGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 523 ------YKAPEQAEVKRLSQKA-DVYSFGVLLLEVLT 552
                 Y+APE     R   KA D+++ G +  E+LT
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 33/195 (16%)

Query: 450 GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS- 508
            + PL     IS     ARG+  +     + K  H ++ + N+LL +N V  I DFGL+ 
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLAR 221

Query: 509 -LLLNP---VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT 563
            +  +P    +  ARL   + APE    K  + ++DV+SFGVLL E+ +  A S YP   
Sbjct: 222 DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA-SPYPG-- 278

Query: 564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPE 623
             ++D EE    L +  R    E  T E++                   + L C  + PE
Sbjct: 279 -VQID-EEFCRRLKEGTRMRAPEYATPEIY------------------SIMLDCWHNNPE 318

Query: 624 KRPTMAEVAKMIEDI 638
            RPT +E+ +++ D+
Sbjct: 319 DRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 8e-09
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 23/203 (11%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLR 418
            ++G+GS G V K    + G IVA+K+  ++  +   +K   + + ++ +L+H N+V L 
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
             +  K+   LV++++ +  L  L     G     LD +     +    RG+   H    
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH-- 119

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI------ARLGGYKAPEQAEVK 532
              + H ++K  N+L+ ++GV  + DFG +  L     +       R   Y+APE   V 
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW--YRAPELL-VG 174

Query: 533 --RLSQKADVYSFGVLLLEVLTG 553
             +  +  D+++ G L+ E+LTG
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.9 bits (137), Expect = 8e-09
 Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 23/219 (10%)

Query: 363 MLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLR 418
           +LGKG  G V    V   G + A KRL+      RK     ++   ++ K+    VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---GLARIHQ 475
             Y  K+   LV   +  G L   ++    PG            +  AA    GL  +H+
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG------FEEERALFYAAEILCGLEDLHR 120

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLG--GYKAPEQAEVK 532
           E       + ++K  N+LLD  G   ISD GL++ +   ++I  R+G  GY APE    +
Sbjct: 121 E----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ 176

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE 571
           R +   D +  G L+ E++ G++P +     + +V  EE
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFR---GRKEKVKREE 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 57.3 bits (138), Expect = 8e-09
 Identities = 70/244 (28%), Positives = 107/244 (43%), Gaps = 38/244 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIG-KLKHPNVVK 416
           +MLGKGS G V+ A L       A+K LK        + E  M    V+    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---GLARI 473
           L   +  KE    V +YL  G L  + H  +   +  L   T       AA    GL  +
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDL--MFH-IQSCHKFDLPRAT-----FYAAEIICGLQFL 112

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG--GYKAPEQA 529
           H +     + + ++K  N+LLD +G   I+DFG+    +L   +     G   Y APE  
Sbjct: 113 HSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE--QAVDL-----PKWVRS 582
             ++ +   D +SFGVLL E+L G++P           DEEE  Q++ +     P+W+  
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFH-------GHDEEELFQSIRMDNPCYPRWLTR 221

Query: 583 VVKE 586
             K+
Sbjct: 222 EAKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.8 bits (137), Expect = 8e-09
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 363 MLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLR 418
           +LGKG  G V    V   G + A K+L+      RK     ++   ++ K+    VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---GLARIHQ 475
             Y  K+   LV   +  G L   ++ N G      +       V  AA    GL  +H+
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEE-----RAVFYAAEITCGLEDLHR 120

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLG--GYKAPEQAEVK 532
           E    ++ + ++K  N+LLD  G   ISD GL++ +   + I  R+G  GY APE  + +
Sbjct: 121 E----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNE 176

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQ 558
           R +   D +  G L+ E++ G++P +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 25/206 (12%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANP-CARKEFEQYMDVIGKLKHPNV 414
           E +G+G+ G VYK      G IVA+K+++     +  P  A +E    + ++ +L+HPN+
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE----ISLLKELQHPNI 61

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V L+     +    L++++L   S+    + +  P    +D     S +    +G+   H
Sbjct: 62  VCLQDVLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQA----IARLGGYKAPE-Q 528
                 +V H ++K  N+L+D  GV  ++DFGL+     PV+     +  L  Y+APE  
Sbjct: 119 SR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL-WYRAPEVL 173

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGR 554
               R S   D++S G +  E+ T +
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 63/272 (23%), Positives = 106/272 (38%), Gaps = 53/272 (19%)

Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL-- 439
           VAVK L+ DA+  AR++F + + ++ +L  PN+ +L           ++ +Y+ NG L  
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 440 ----HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD 495
               H             L ++T + +    A G+    +   +    H ++ + N L+ 
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGM----RYLESLNFVHRDLATRNCLVG 164

Query: 496 KNGVACISDFGLSLLL----------NPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGV 545
           KN    I+DFG+S  L               I     + A E   + + + K+DV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGV 220

Query: 546 LLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF-DQELLRY--- 600
            L E+LT  R    Y   T  +V E                       F D     Y   
Sbjct: 221 TLWEILTLCREQP-YEHLTDQQVIEN------------------AGHFFRDDGRQIYLPR 261

Query: 601 -KNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
             N  +++  ++   L C     E RPT  E+
Sbjct: 262 PPNCPKDIYELM---LECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 59/213 (27%), Positives = 88/213 (41%), Gaps = 38/213 (17%)

Query: 363 MLGKGSLGTVYKAVLDDGG-IVAVKRLK----------DANPCARKEFEQYMDVIGKLKH 411
           +LGKGS G V  A L     + AVK LK          +     ++            KH
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLAL------AGKH 55

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD----WTTRISLVLGAA 467
           P + +L + +  K+    V +Y+  G L  + H  R  GR        +   I L     
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRS-GRFDEPRARFYAAEIVL----- 107

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GY 523
            GL  +H+      + + ++K  NVLLD  G   I+DFG+    +L  V      G   Y
Sbjct: 108 -GLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDY 162

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            APE    +      D ++ GVLL E+L G++P
Sbjct: 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 57.7 bits (139), Expect = 1e-08
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
            H  +VK    + + ++ LL+ +Y   G L+  +   R    +P        L       
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK-QRLKEHLPFQEYEVGLLFYQIVLA 181

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS------LLLNPVQAIARLGGY 523
           L  +H    + K+ H ++KS+N+ L   G+  + DFG S      + L+   +      Y
Sbjct: 182 LDEVH----SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS--------------PTRPRVDE 569
            APE  E KR S+KAD++S GV+L E+LT   P + PS              P    V  
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSS 297

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRY-KNIEEELV 608
             +A+  P   ++      T ++   E L+Y  N+ +++V
Sbjct: 298 GMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIV 337

Length = 478

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.8 bits (137), Expect = 1e-08
 Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 28/162 (17%)

Query: 408 KLKHPNVVKLRAYYYAKEEKLLVYDYLP--NGSLHSLLHGNRGPGRIPLDWT-TRISLVL 464
            + HP+V++++    +     +V   LP  +  L++ L     P  +P+D        +L
Sbjct: 113 NVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRP--LPIDQALIIEKQIL 167

Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--- 521
               GL  +H +    ++ H +VK+ N+ ++     CI D G +    PV A A LG   
Sbjct: 168 ---EGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAG 218

Query: 522 --GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS 561
                APE     + + KAD++S G++L E+L       YPS
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEMLA------YPS 254

Length = 357

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 58/230 (25%), Positives = 101/230 (43%), Gaps = 44/230 (19%)

Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKD-------ANPCARKEFEQYMDVIGK 408
           LG+G  G V +A          D    VAVK LKD       A+  +  E  + +     
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG---- 75

Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIP---LDWT 457
            KH N++ L      +    ++ +Y   G+L   L   R PG        ++P   L + 
Sbjct: 76  -KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI 517
             +S     ARG+    +   + +  H ++ + NVL+ ++ V  I+DFGL+  ++ +   
Sbjct: 135 DLVSCAYQVARGM----EYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY 190

Query: 518 ARLGG------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
            +         + APE    +  + ++DV+SFG+L+ E+ T G +P  YP
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP--YP 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 44/223 (19%)

Query: 352 ELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD------ 404
           E E L R     +G+G+ G VY+A     G IVA+K+++          +   D      
Sbjct: 8   EFEKLNR-----IGEGTYGIVYRARDTTSGEIVALKKVR---------MDNERDGIPISS 53

Query: 405 -----VIGKLKHPNVVKLRAYYYAK--EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWT 457
                ++  L+HPN+V+L+     K  +   LV +Y     L SLL     P        
Sbjct: 54  LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSES---- 108

Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA- 516
               L+L   RGL  +H+ +    + H ++K SN+LL   G   I+DFGL+         
Sbjct: 109 QVKCLMLQLLRGLQYLHENF----IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164

Query: 517 ----IARLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGR 554
               +  L  Y+APE        +   D+++ G +L E+L  +
Sbjct: 165 MTPKVVTL-WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 39/224 (17%)

Query: 357 LRASAE------MLGKGSLGTV----YKAVLDDGGIVAVKRLKDANPCARKE---FEQYM 403
           LR  AE      ++G+G+ G V    +K+      + A+K L       R +   F +  
Sbjct: 38  LRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
           D++     P VV+L  +Y  ++++ L  V +Y+P G L +L+     P +    +T  + 
Sbjct: 95  DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV 152

Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIA 518
           L L A   +  IH++          VK  N+LLDK+G   ++DFG  + +N    V+   
Sbjct: 153 LALDAIHSMGFIHRD----------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 519 RLG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            +G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 32/224 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAY 420
           E +GKG+ G V+K +    G  A  ++ D      +E E   +++  L  HPNVVK    
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 421 YYAKEEK-----LLVYDYLPNGSLHSLLHG--NRGPGRI--PLDWTTRISLVLGAA-RGL 470
           YY K+ K      LV +    GS+  L+ G   RG  R+  P+     I+ +L  A  GL
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE-RMEEPI-----IAYILHEALMGL 137

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP---- 526
             +H      K  H +VK +N+LL   G   + DFG+S  L   + + R      P    
Sbjct: 138 QHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR-LRRNTSVGTPFWMA 192

Query: 527 ------EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
                 EQ        + DV+S G+  +E+  G  P     P R
Sbjct: 193 PEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)

Query: 363 MLGKGSLGTVYKAVLDDGG----IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +LG G  G + +  L         VA+  L+   +   R+ F      +G+  H N+V+L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                     ++V +Y+ NG+L S L  + G     L     + ++ G A G+  +  E 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYL-SEM 126

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLGG-----YKAPEQAEV 531
           G     H  + +  VL++ + V  IS F   L  +  +AI   + G     + APE  + 
Sbjct: 127 GYV---HKGLAAHKVLVNSDLVCKISGFR-RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 532 KRLSQKADVYSFGVLLLEVLT-GRAP 556
              S  +DV+SFG+++ EV++ G  P
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (137), Expect = 2e-08
 Identities = 69/293 (23%), Positives = 110/293 (37%), Gaps = 71/293 (24%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKE---FEQYMDVIGKLKHPNVVKLRA 419
           +G+G+ G V+     D G + A+K L+ ++   R +        D++     P +VKL  
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67

Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWT----TRISLVLGAARGLARIH 474
           Y +  EE L LV +Y+P G L +LL   R     P +        + L L +   L  IH
Sbjct: 68  YSFQDEEHLYLVMEYMPGGDLMNLL--IR-KDVFPEETARFYIAELVLALDSVHKLGFIH 124

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-------------------LLLNPVQ 515
           ++          +K  N+L+D +G   ++DFGL                    L  + V 
Sbjct: 125 RD----------IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 516 AIARLG--------------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQY 559
              R                 Y APE         + D +S GV+L E+L G  P  S  
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 560 PSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD--QELL-----RYKNIEE 605
              T  ++   ++++  P           + E  D    LL     R  + EE
Sbjct: 235 LQETYNKIINWKESLRFPP------DPPVSPEAIDLICRLLCDPEDRLGSFEE 281

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 59/236 (25%), Positives = 95/236 (40%), Gaps = 52/236 (22%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIV-AVKRL-KDA----NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LGKG +G V+   L   G + A+K L K      N   R   EQ  +++  L HP + 
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ--EILATLDHPFLP 64

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLARI 473
            L A +  +    LV DY P G L  LL   R PG+   +   R   + VL A   L  +
Sbjct: 65  TLYASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCLSEEVARFYAAEVLLA---LEYL 119

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-----PVQAIARLGGYKAPEQ 528
           H       + + ++K  N+LL ++G   +SDF LS   +       +A+ +     +   
Sbjct: 120 H----LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 529 AEVKRLSQKA----------------------------DVYSFGVLLLEVLTGRAP 556
              +  S++                             D ++ G+LL E+L G  P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 23/218 (10%)

Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYM----DVIGKLKHPNVVKLR 418
           LGKG  G V    V + G + A K+L D     +K  E+      +++ K+  P +V L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKL-DKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 419 AYYYAKEEKLLVYDYLPNGSL--HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
             + +K    LV   +  G L  H    G RG     L+    I        G+  +H  
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-----LEMERVIHYSAQITCGILHLH-- 112

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGGYKAPEQAEVKR 533
             +  + + ++K  NVLLD  G   +SD GL++ L     +   A   GY APE  + + 
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE 571
            S   D ++ G  + E++ GR P +     + +V +EE
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFK---DHKEKVAKEE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 65/245 (26%), Positives = 107/245 (43%), Gaps = 45/245 (18%)

Query: 331 SDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRL- 388
           S  +S +  S       K   ELE + R     +G G+ GTVYK +    G + A+K + 
Sbjct: 54  SSSSSSSSASGSAPSAAKSLSELERVNR-----IGSGAGGTVYKVIHRPTGRLYALKVIY 108

Query: 389 ---KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG 445
              +D     R++  + ++++  + HPNVVK    +    E  ++ +++  GSL     G
Sbjct: 109 GNHEDT---VRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE----G 161

Query: 446 NRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF 505
                   L    R  L      G+A +H+      + H ++K SN+L++      I+DF
Sbjct: 162 THIADEQFLADVARQIL-----SGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADF 212

Query: 506 GLSLLLN--------PVQAIARLGGYKAPEQAEVKRLSQKA------DVYSFGVLLLEVL 551
           G+S +L          V  IA    Y +PE+     L+  A      D++S GV +LE  
Sbjct: 213 GVSRILAQTMDPCNSSVGTIA----YMSPERINTD-LNHGAYDGYAGDIWSLGVSILEFY 267

Query: 552 TGRAP 556
            GR P
Sbjct: 268 LGRFP 272

Length = 353

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 17/187 (9%)

Query: 382 IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH 440
           +VAVK L+ DAN  AR +F + + ++ +LK PN+++L      ++   ++ +Y+ NG L+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 441 SLL----------HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSS 490
             L          +GN              S +L  A  +A   +   +    H ++ + 
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167

Query: 491 NVLLDKNGVACISDFGLSLLLNP-----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFG 544
           N L+ +N    I+DFG+S  L       +Q  A L   + A E   + + +  +DV++FG
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227

Query: 545 VLLLEVL 551
           V L E+L
Sbjct: 228 VTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 24/206 (11%)

Query: 363 MLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIG-KLKHPNVVKL 417
           +LGKGS G V  A L       A+K LK        + E  M    V+    +HP +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---GLARIH 474
              +  KE    V +YL  G L   +   +  GR              AA    GL  +H
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARAR-----FYAAEIICGLQFLH 113

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS----LLLNPVQAIARLGGYKAPEQAE 530
                  + + ++K  NVLLDK+G   I+DFG+                   Y APE  +
Sbjct: 114 ----KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILK 169

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAP 556
            ++ ++  D +SFGVLL E+L G++P
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 31/215 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E++G G+ G VYK      G +A  ++ D      +E +  ++++ K  H     +  YY
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHR--NIATYY 79

Query: 422 YA---------KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
            A          ++  LV ++   GS+  L+   +G   +  DW   I   +   RGLA 
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREI--LRGLAH 136

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KAP 526
           +H      KV H ++K  NVLL +N    + DFG+S  L+  + + R   +       AP
Sbjct: 137 LHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMAP 190

Query: 527 E-----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E     +        ++D++S G+  +E+  G  P
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 62/235 (26%), Positives = 100/235 (42%), Gaps = 35/235 (14%)

Query: 364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM------DVIGKLKHPNVVK 416
           LG+G  G V  A     G + A+K LK  +  AR E E  M      +     +HP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L A +  ++    V +Y   G L   +H +       + +   + L      GL  +H+ 
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL------GLQYLHEN 120

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQAEVK 532
               K+ + ++K  N+LLD  G   I+DFGL    +      +   G   + APE     
Sbjct: 121 ----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET 176

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
             ++  D +  GVL+ E+L G +P  +P       D+EE+  D      S+V +E
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESP--FPG------DDEEEVFD------SIVNDE 217

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 72/295 (24%), Positives = 119/295 (40%), Gaps = 52/295 (17%)

Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H ++ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 134 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 188

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV 583
           APE  +    +  +D++SFGV+L E+ +    P Q  S         EQ +         
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQVLKF------- 233

Query: 584 VKEEWTAEVFDQELL-RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                   V D   L +  N  E +  ++ +   C    P+ RPT  E+  +++D
Sbjct: 234 --------VMDGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 7e-08
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 10/162 (6%)

Query: 79  RGPIAPLSLLDQLRFLDLHDNRLNGT----ILPLTNCTNLKLAYLSG----NDFSAEIPH 130
           +GP     L+  L FL L+ + L+      +L   +  N  L YLS      D       
Sbjct: 4   KGPQHCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGI 63

Query: 131 QISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIP-DLSSSLKDLKEL 189
             ++   ++ +DLS  NI G+I   +  L  + T+ L NN+L+G IP D+ ++   L+ L
Sbjct: 64  TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123

Query: 190 NLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFS 231
           NLSNN   G +P G +    E   + N  L G  P    SFS
Sbjct: 124 NLSNNNFTGSIPRGSIPNL-ETLDLSNNMLSGEIPNDIGSFS 164

Length = 968

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 18/232 (7%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL 417
           E LG GS G V  A     G   A+K LK       K+ +       ++ +L HP +V +
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              +  +     + +++  G L + L   R  GR P D    ++    A   LA    EY
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPND----VAKFYHAELVLAF---EY 133

Query: 478 GTAK-VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--YKAPEQAEVKRL 534
             +K + + ++K  N+LLD  G   ++DFG +  + P +     G   Y APE  + K  
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFTLCGTPEYLAPEVIQSKGH 192

Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
            +  D ++ GVLL E + G  P    +P R         +  P W     ++
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244

Length = 329

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 65/268 (24%), Positives = 121/268 (45%), Gaps = 41/268 (15%)

Query: 361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKE---FEQYMDVIGKLKHPNV 414
            ++LG+G+ G VY    +D G  +A K+++    +P   KE    E  + ++  L+H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 415 VKLRAYYYAKEEKLLV--YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           V+       + EK L    +Y+P GS+   L   +  G +    T + +  +    G++ 
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQI--LEGMSY 121

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-------QAIARLGGYKA 525
           +H       + H ++K +N+L D  G   + DFG S  L  +       +++     + +
Sbjct: 122 LHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPS----------PTRPRVDEE--EQ 572
           PE    +   +KADV+S G  ++E+LT + P ++Y +          PT P++     E 
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH 237

Query: 573 AVDLPKWVRSVVKEEWTAEVFDQELLRY 600
           A D    +    +   +AE    ELLR+
Sbjct: 238 ARDFLGCIFVEARHRPSAE----ELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 54.2 bits (131), Expect = 8e-08
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 49/214 (22%)

Query: 367 GSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQY-------MDVIGKLKHPNVVKLR 418
           G+ G VY+A     G IVA+K+LK       KE E +       ++++ KL+HPN+V ++
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLK-----MEKEKEGFPITSLREINILLKLQHPNIVTVK 70

Query: 419 AYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
                       +V +Y+ +  L SL+   + P            L+L    G+A +H  
Sbjct: 71  EVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS----EVKCLMLQLLSGVAHLHDN 125

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------------- 522
           +    + H ++K+SN+LL+  G+  I DFGL          AR  G              
Sbjct: 126 W----ILHRDLKTSNLLLNNRGILKICDFGL----------AREYGSPLKPYTQLVVTLW 171

Query: 523 YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
           Y+APE     K  S   D++S G +  E+LT + 
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 24/219 (10%)

Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQ-------YMDVIGKLKHPNVV 415
           ++G+G  G VY     D G +   +  D      K+ E         + ++     P +V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +   ++  ++   + D +  G LH  L  HG      +   + T I L      GL  +
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-YATEIIL------GLEHM 113

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQAEV 531
           H  +    V + ++K +N+LLD++G   ISD GL+   +  +  A +G  GY APE  + 
Sbjct: 114 HNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 169

Query: 532 -KRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVD 568
                  AD +S G +L ++L G +P  Q+ +  +  +D
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 32/209 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKD-----ANPCARKEFEQYMDVIGKLKHPNVV 415
             +G+G  G V+ A   D G IVA+KR+K       N    +      D++   K   +V
Sbjct: 7   TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN--EVRHVLTERDILTTTKSEWLV 64

Query: 416 KLRAYYYAKEEKLLVY---DYLPNGSLHSLLHGNR----GPGRIPLDWTTRISLVLGAAR 468
           KL    YA ++   +Y   +Y+P G   +LL+          R    +   +   + A  
Sbjct: 65  KL---LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF---YMAEMFEAVDALH 118

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-LLNPVQAIARLGGYKAPE 527
            L  IH++          +K  N L+D +G   ++DFGLS  ++    ++     Y APE
Sbjct: 119 ELGYIHRD----------LKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPE 168

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K      D +S G +L E L G  P
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKE--FEQYMDVIGKLKHPNVVKLRAY 420
           +G+GS G V  A     G  VAVK++ D     R+E  F + + ++    H NVV +   
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFNEVV-IMRDYHHENVVDMYNS 87

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V ++L  G+L  ++   R      ++     ++ L   R L+ +H      
Sbjct: 88  YLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLH----NQ 137

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGL-SLLLNPVQAIARLGG---YKAPEQAEVKRLSQ 536
            V H ++KS ++LL  +G   +SDFG  + +   V     L G   + APE         
Sbjct: 138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT 197

Query: 537 KADVYSFGVLLLEVLTGRAP 556
           + D++S G++++E++ G  P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 36/235 (15%)

Query: 363 MLGKGSLGTVY---KAVLDDGGIVAVK-------RLKDANPCARKEFEQYMDVIGKLKHP 412
           ++G+G  G VY   KA  D G + A+K       ++K     A  E    + ++     P
Sbjct: 1   IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCP 57

Query: 413 NVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARG 469
            +V + +Y +   +KL  + D +  G LH  L  HG      +   +   I L      G
Sbjct: 58  FIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF-YAAEIIL------G 109

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPE 527
           L  +H  +    V + ++K +N+LLD++G   ISD GL+   +  +  A +G  GY APE
Sbjct: 110 LEHMHNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165

Query: 528 --QAEVKRLSQKADVYSFGVLLLEVLTGRAPS-QYPSPTRPRVDE--EEQAVDLP 577
             Q  V   S  AD +S G +L ++L G +P  Q+ +  +  +D      AV+LP
Sbjct: 166 VLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 20/195 (10%)

Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH 440
           VAVK LK DA      +    M+++  + KH N++ L           ++ +Y   G+L 
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 441 SLLHGNRGPG--------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV 492
             L   R PG        ++P +  +   LV   A  +AR  +   + K  H ++ + NV
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLV-SCAYQVARGMEYLASKKCIHRDLAARNV 171

Query: 493 LLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEVKRLSQKADVYSFGVL 546
           L+ ++ V  I+DFGL+  ++ +    +         + APE    +  + ++DV+SFGVL
Sbjct: 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 231

Query: 547 LLEVLT-GRAPSQYP 560
           L E+ T G +P  YP
Sbjct: 232 LWEIFTLGGSP--YP 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 32/215 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN------PCARKEFEQYMDVIGKLKH-PN 413
           E +G+G+ G VYKA   + G +VA+K+ +         P A +E    + ++  L     
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE----ISLLQMLSESIY 62

Query: 414 VVKLRAYYYAKEEK-----LLVYDYLPNGSLHSLLHGN-RGPGRIPLDWTTRISLVLGAA 467
           +V+L    + +E+       LV++YL +  L   +  N RGPGR PL   T  S +    
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGR-PLPAKTIKSFMYQLL 120

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-ISDFGLSLLLN-PVQA----IARLG 521
           +G+A  H+      V H ++K  N+L+DK      I+D GL    + PV++    I  L 
Sbjct: 121 KGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL- 175

Query: 522 GYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
            Y+APE        S   D++S G +  E+   + 
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 14/201 (6%)

Query: 363 MLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLR 418
           +LGKG  G V    V   G + A K+L+      RK     ++   ++ K+    VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
             Y  K+   LV   +  G L   ++    PG    D    I        GL  + +E  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPG---FDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLG--GYKAPEQAEVKRLS 535
             ++ + ++K  N+LLD  G   ISD GL++ +   + +  R+G  GY APE    ++ +
Sbjct: 122 --RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 536 QKADVYSFGVLLLEVLTGRAP 556
              D +  G L+ E++ G++P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 56/203 (27%), Positives = 85/203 (41%), Gaps = 20/203 (9%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD----VIGKLKHPNVVKLR 418
           +GKGS G V  A    DG   AVK L+      +KE +  M     ++  +KHP +V L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +   ++   V DY+  G L   L   R  P      +   I+  LG    L  I+++ 
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD- 121

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQAEVKR 533
                    +K  N+LLD  G   ++DFGL    +   +  +   G   Y APE    + 
Sbjct: 122 ---------LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
             +  D +  G +L E+L G  P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 18/204 (8%)

Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMD----VIGKLKHPNVVK 416
           +++GKGS G V  A    DG   AVK L+      +KE    M     ++  LKHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L   +   E+   V DY+  G L    H  R   R  L+   R       A  +  +H  
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGEL--FFHLQR--ERCFLEPRARF-YAAEVASAIGYLH-- 113

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQAEVK 532
             +  + + ++K  N+LLD  G   ++DFGL    + P +  +   G   Y APE    +
Sbjct: 114 --SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE 171

Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
              +  D +  G +L E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 48/153 (31%), Positives = 78/153 (50%), Gaps = 19/153 (12%)

Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E LG+GS  TVYK     +G +VA+K  RL++          +   ++  LKH N+V L 
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIRE-ASLLKGLKHANIVLLH 69

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVL-GAARGLARIHQ 475
              + KE   LV++Y     +H+ L  + ++ PG +  +    + L L    RGL+ IHQ
Sbjct: 70  DIIHTKETLTLVFEY-----VHTDLCQYMDKHPGGLHPE---NVKLFLFQLLRGLSYIHQ 121

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
            Y    + H ++K  N+L+   G   ++DFGL+
Sbjct: 122 RY----ILHRDLKPQNLLISDTGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 23/206 (11%)

Query: 364 LGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRA 419
           LGKG  G V    +   G + A K+L       RK +E  M    ++ K+    +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 420 YYYAKEEKLLVYDYLPNGSL----HSLLHGNRG-PGRIPLDWTTRISLVLGAARGLARIH 474
            +  K +  LV   +  G L    +++   N G P      +T +I        GL  +H
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIIS------GLEHLH 114

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGGYKAPEQAE 530
           Q     ++ + ++K  NVLLD +G   ISD GL++ L    +  +  A   G+ APE  +
Sbjct: 115 QR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQ 170

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAP 556
            +      D ++ GV L E++  R P
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 34/210 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK--RLKDAN----PCARKEFEQYMDVIGKLKHPNV 414
           E +G+G+ G VYKA     G IVA+K  RL+  +      A +E    + ++ +L HPN+
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELNHPNI 60

Query: 415 VKLRAYYYAKEEKL-LVYDYLP---NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
           V+L    ++ E KL LV+++L       + S       P  I        S +    +G+
Sbjct: 61  VRLLDVVHS-ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK-------SYLYQLLQGI 112

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQA----IARLGGYKA 525
           A  H      +V H ++K  N+L+D+ G   ++DFGL+     PV+     +  L  Y+A
Sbjct: 113 AYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL-WYRA 167

Query: 526 PE-QAEVKRLSQKADVYSFGVLLLEVLTGR 554
           PE     ++ S   D++S G +  E++  R
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 39/230 (16%)

Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVL--DDGGIVAVKRLKDANPCARKE---FEQ 401
            K + + ED      +++G+G+ G V + V       + A+K L       R +   F +
Sbjct: 36  TKLRMKAEDFDVI--KVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE 92

Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDW--- 456
             D++       +V+L  +Y  +++K L  V +Y+P G L +L+        IP  W   
Sbjct: 93  ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARF 146

Query: 457 -TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-- 513
            T  + L L A   +  IH++          VK  N+LLDK+G   ++DFG  + ++   
Sbjct: 147 YTAEVVLALDAIHSMGFIHRD----------VKPDNMLLDKSGHLKLADFGTCMKMDANG 196

Query: 514 -VQAIARLG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            V+    +G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 29/238 (12%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIG-KLKHPNVVK 416
           ++LGKGS G V  A L   G   AVK LK        + E  M    V+    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L   +  KE    V ++L  G L  + H  +  GR  L   T  +  +    GL  +H +
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDLYRATFYAAEIVC--GLQFLHSK 115

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLS----LLLNPVQAIARLGGYKAPEQAEVK 532
                + + ++K  NV+LD++G   I+DFG+        N          Y APE  +  
Sbjct: 116 G----IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ----AVDLPKWVRSVVKE 586
           + +   D +SFGVLL E+L G++P           DE+E      VD P + R + KE
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGD-------DEDELFESIRVDTPHYPRWITKE 222

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 58/239 (24%), Positives = 115/239 (48%), Gaps = 43/239 (17%)

Query: 361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLK---DANPCARK--EFEQYMDVIGKLKHPNV 414
            ++LG+G+ G VY     D G  +AVK++    D+   +++    E  + ++  L+H  +
Sbjct: 7   GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66

Query: 415 VKLRAYYYA-----KEEKLLVY-DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           V+    YY      +E+KL ++ +Y+P GS+   L   +  G +  + T R +  +   +
Sbjct: 67  VQ----YYGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQI--LQ 117

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----QAIARLGG-- 522
           G++ +H       + H ++K +N+L D  G   + DFG S  +  +      I  + G  
Sbjct: 118 GVSYLHSNM----IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173

Query: 523 -YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPS----------PTRPRVDE 569
            + +PE    +   +KADV+S    ++E+LT + P ++Y +          PT+P + +
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPD 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 18/200 (9%)

Query: 364 LGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           +G G+ G V+           A+K +        K+ +   +   V+ ++ HP +++L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLARIHQEY 477
             + +    ++ +Y+P G L S L   R  GR    ++    L   +     L  +H   
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYL---RNSGR----FSNSTGLFYASEIVCALEYLH--- 118

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-LLNPVQAIARLGGYKAPEQAEVKRLSQ 536
            + ++ + ++K  N+LLDK G   ++DFG +  L +    +     Y APE  + K  ++
Sbjct: 119 -SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNK 177

Query: 537 KADVYSFGVLLLEVLTGRAP 556
             D ++ G+L+ E+L G  P
Sbjct: 178 AVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.0 bits (124), Expect = 6e-07
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 26/206 (12%)

Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           ++G GS G VY+A+ +D    VA+K+ L+D     R+     + ++  L H N++ L+ Y
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE-----LLIMKNLNHINIIFLKDY 127

Query: 421 YYA----KEEKLL----VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           YY     K EK +    V +++P      + H  R    +PL      S  L   R LA 
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAY 185

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVAC-ISDFGLSL-LLNPVQAIARLGG--YKAPE- 527
           IH ++    + H ++K  N+L+D N     + DFG +  LL   ++++ +    Y+APE 
Sbjct: 186 IHSKF----ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPEL 241

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTG 553
                  +   D++S G ++ E++ G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 50/211 (23%), Positives = 99/211 (46%), Gaps = 24/211 (11%)

Query: 361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKE---FEQYMDVIGKLKHPNV 414
            ++LG+G+ G VY     D G  +AVK+++    +P   KE    E  + ++  L H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66

Query: 415 VKLRAYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           V+         E+ L    +++P GS+   L   +  G +  + T + +  +    G++ 
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQI--LEGVSY 121

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-------QAIARLGGYKA 525
           +H    +  + H ++K +N+L D  G   + DFG S  L  +       +++     + +
Sbjct: 122 LH----SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    +   +KAD++S G  ++E+LT + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 27/208 (12%)

Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 1   KLLGKGTFGKVILVREKA---SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +  K+    V +Y+  G L    H +R   R+  +  TR     GA     L  
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRE--RVFSEDRTRF---YGAEIVSALDY 110

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    + K+ + ++K  N++LDK+G   I+DFGL    +     +    G   Y APE 
Sbjct: 111 LH----SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV 166

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.4 bits (123), Expect = 6e-07
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 25/201 (12%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +G G+ G V  A     G  VA+K++    + P   K   + + ++  L+H N++ L   
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           + +  E +     L    LH LL         PL+       +    RGL  +H    +A
Sbjct: 78  FISPLEDIYFVTELLGTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH----SA 127

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPE-QAEVKR 533
            V H ++K SN+L+++N    I DFGL+ + +P     ++ G      Y+APE     ++
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQK 182

Query: 534 LSQKADVYSFGVLLLEVLTGR 554
              + D++S G +  E+L G+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 32/200 (16%)

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD----WTTRISLVLGAA 467
           PN+V L  Y  +++   LV  +   G L S +        IP +    W   + + L A 
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDA- 100

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---QAIARLGGYK 524
                +H+E    +  + N    N+LLD  G   ++ F     +      +A+  +  Y 
Sbjct: 101 -----LHREGIVCRDLNPN----NILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM--YC 149

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE   +   ++  D +S G +L E+LTG+   +      P        +++P+W    V
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVE----CHPSGINTHTTLNIPEW----V 201

Query: 585 KEEWTAEVFDQELLRYKNIE 604
            EE  A    Q+LL++   E
Sbjct: 202 SEE--ARSLLQQLLQFNPTE 219

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.5 bits (121), Expect = 8e-07
 Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 28/208 (13%)

Query: 362 EMLGKGSLGTVYKAVL----DDGGIVAVKR----LKDANPCARK--EFEQYMDVIGKLKH 411
           E LG+G+   +YK VL    D   +   +     LK      R    F +   ++ +L H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
            ++VKL       +E ++V +Y+  G L   LH  +    + L W       L  A+ LA
Sbjct: 61  KHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNN--VSLHW------KLDVAKQLA 111

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-------ISDFGLSLLLNPVQAIARLGGYK 524
                    K+ HGNV   N+L+ + G+         +SD G+ + +   +       + 
Sbjct: 112 SALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI 171

Query: 525 APEQAE--VKRLSQKADVYSFGVLLLEV 550
           APE        L+  AD +SFG  LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 31/79 (39%), Positives = 44/79 (55%), Gaps = 6/79 (7%)

Query: 484 HGNVKSSNVLLDKNGVACISDFGLS-LLLNPV-----QAIARLGGYKAPEQAEVKRLSQK 537
           H ++KS+N+LL  NG+  + DFG S +    V     +       Y APE    K  S+K
Sbjct: 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK 225

Query: 538 ADVYSFGVLLLEVLTGRAP 556
           AD++S GVLL E+LT + P
Sbjct: 226 ADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 39/212 (18%)

Query: 364 LGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V    Y    D+ G  VAVK LK  +      + ++ ++++  L H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 418 RAYYYAKEEK----LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +      E+      L+ ++LP+GSL   L  N+   +I L    + ++ +   +G+  +
Sbjct: 72  KGI--CTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQI--CKGMDYL 125

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK--------- 524
               G+ +  H ++ + NVL++      I DFGL+      +AI     Y          
Sbjct: 126 ----GSRQYVHRDLAARNVLVESEHQVKIGDFGLT------KAIETDKEYYTVKDDLDSP 175

Query: 525 ----APEQAEVKRLSQKADVYSFGVLLLEVLT 552
               APE     +    +DV+SFGV L E+LT
Sbjct: 176 VFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 20/205 (9%)

Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMD----VIGKLKHPNVVK 416
           +++GKGS G V  A    DG   AVK L+      RKE +  M     ++  +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARGLARIHQ 475
           L   +   E+   V D++  G L   L   R  P      +   I+  LG    +     
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI----- 115

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS----LLLNPVQAIARLGGYKAPEQAEV 531
                 + + ++K  N+LLD  G   ++DFGL        +          Y APE    
Sbjct: 116 -----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK 170

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
           +      D +  G +L E+L G  P
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 17/205 (8%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKE--FEQYMDVIGKLKHPNVVKLRAYY 421
           +G+GS G V  A     G     ++ D     R+E  F + + ++   +H NVV++   Y
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHQNVVEMYKSY 87

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
              EE  ++ ++L  G+L  ++   R      L+     ++     + L  +H +     
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQTR------LNEEQIATVCESVLQALCYLHSQ----G 137

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVKRLSQK 537
           V H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE         +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197

Query: 538 ADVYSFGVLLLEVLTGRAPSQYPSP 562
            D++S G++++E++ G  P    SP
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 29/211 (13%)

Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKH----PNV 414
           LG G+ G V+        D G + A+K LK A    + K  E        L+     P +
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 415 VKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA-ARGLAR 472
           V L  Y +  + KL L+ DY+  G L + L+               + + +      L  
Sbjct: 68  VTLH-YAFQTDTKLHLILDYVNGGELFTHLYQR---EHFTES---EVRVYIAEIVLALDH 120

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIARLGG--YKAPE 527
           +HQ      + + ++K  N+LLD  G   ++DFGLS         +A +  G   Y APE
Sbjct: 121 LHQ----LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176

Query: 528 QAEVKRL--SQKADVYSFGVLLLEVLTGRAP 556
                     +  D +S GVL  E+LTG +P
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 25/210 (11%)

Query: 363 MLGKGSLGTVYKAVLDD--GGIVAVKRLKDANPCARKE---FEQYMDVIGKLKHPNVVKL 417
           ++G+G  G V + V +   G I A+K +K +   A++    FE+  D++     P + +L
Sbjct: 8   LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
           +  +  K+   LV +Y P G L SLL  NR   +   D   +  L    A  +  IH  +
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDED-MAQFYL----AELVLAIHSVH 119

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIARLG--GYKAPEQAEVK 532
               V H ++K  NVL+D+ G   ++DFG +  L     V +   +G   Y APE     
Sbjct: 120 QMGYV-HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178

Query: 533 RLSQKA------DVYSFGVLLLEVLTGRAP 556
               K       D +S GV+  E++ GR+P
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.3 bits (118), Expect = 3e-06
 Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 31/221 (14%)

Query: 355 DLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHP 412
           +LL    +      +  + K       +VAVK+  L   +    K  +Q +    +L+HP
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVL-GAARG 469
           N++     +    E  +V   +  GS   LL  H   G   +P      I+ +L      
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LP---ELAIAFILKDVLNA 113

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF--GLSLL----------LNPVQAI 517
           L  IH +       H +VK+S++LL  +G   +S     +S++            P  ++
Sbjct: 114 LDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169

Query: 518 ARLGGYKAPE--QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             L  + +PE  Q  ++  ++K+D+YS G+   E+  G  P
Sbjct: 170 KNL-PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 54/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +G G+ GTVYKA     G  VA+K ++     D  P +       +  +    HPN+V+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 418 R----AYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
                     +E K+ LV++++ +  L + L     PG +P +  T   L+    RGL  
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPG-LPAE--TIKDLMRQFLRGLDF 123

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS------LLLNPVQAIARLGGYKAP 526
           +H       + H ++K  N+L+   G   ++DFGL+      + L PV        Y+AP
Sbjct: 124 LH----ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTL---WYRAP 176

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVL 551
           E       +   D++S G +  E+ 
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 34/213 (15%)

Query: 364 LGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFE----QYMDVIGKLKHPNVVKLR 418
           +G+G+ G VYKA   D G +VA+K+++  N   ++ F     + + ++ +L H N+V L+
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 419 AYYYAKEEKL----------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
                K++ L          LV++Y+ +  L  LL      G +        S +     
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLES----GLVHFSEDHIKSFMKQLLE 127

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-----PVQAIARLGGY 523
           GL   H++       H ++K SN+LL+  G   ++DFGL+ L N     P         Y
Sbjct: 128 GLNYCHKK----NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183

Query: 524 KAPE--QAEVKRLSQKADVYSFGVLLLEVLTGR 554
           + PE    E +R     DV+S G +L E+ T +
Sbjct: 184 RPPELLLGE-ERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)

Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P + P      I +    A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 134 YLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 188

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 36/216 (16%)

Query: 362 EMLGKGSLGTVYKAVL---DDGGIVAVKRLKDANPCARKE---FEQYMDVIGKLKHPNVV 415
           +++G+G+ G V  AV+   + G + A+K L       R E   F +  DV+       + 
Sbjct: 7   KVIGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT 64

Query: 416 KLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLD----WTTRISLVLGAARGL 470
            L  Y +  E  L LV DY   G L +LL  ++   R+P D    +   + L + +   L
Sbjct: 65  NLH-YAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVLAIDSVHQL 121

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIARLG--GYKA 525
             +H++          +K  NVLLDKNG   ++DFG  L L     VQ+   +G   Y +
Sbjct: 122 GYVHRD----------IKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 526 PE--QAE---VKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE  QA      R   + D +S GV + E+L G  P
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.8 bits (119), Expect = 5e-06
 Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 46/231 (19%)

Query: 363 MLGKGSLGTVYKAVLDD---GGIVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNVVK 416
           ++GKG +G VY A   D      VA+K++++    NP  +K F +   +   L HP +V 
Sbjct: 9   LIGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66

Query: 417 LRAYYYAKEEKLLVY---DYLPNGSLHSLLHGNRGPGRIPLDWT------TRISLVLGAA 467
           +   Y    +   VY    Y+   +L SLL        +  +          +S+     
Sbjct: 67  V---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-----------PVQA 516
             +  +H    +  V H ++K  N+LL   G   I D+G ++                + 
Sbjct: 124 ATIEYVH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 517 I--------ARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           I         ++ G   Y APE+      S+  D+Y+ GV+L ++LT   P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 17/201 (8%)

Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRA 419
           +GKGS G V +    D   I A+K ++ A+  +R E    +    V+ ++  P +V L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            + + E+  LV  ++  G L    H  +  GR  L      +  L  A  L  +H+    
Sbjct: 61  SFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTAELLCA--LENLHK---- 111

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLL----LNPVQAIARLGGYKAPEQAEVKRLS 535
             V + ++K  N+LLD  G   + DFGL  L     +          Y APE       +
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 536 QKADVYSFGVLLLEVLTGRAP 556
           +  D ++ GVLL E+LTG  P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 57/270 (21%), Positives = 103/270 (38%), Gaps = 68/270 (25%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA-----NPCARKEFEQYMDVIGKLKHPNVVKL 417
           +G G+ G V     +D   + A+K L+ A     N  A  + E+  D++ +  +  VVKL
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAER--DILAEADNEWVVKL 66

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
              +  K+    V DY+P G + SLL         +   +   ++  + +   +  IH++
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGL----------------------------- 507
                     +K  N+L+D++G   ++DFGL                             
Sbjct: 127 ----------IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 508 --SLLLNPVQAIARL----------------GGYKAPEQAEVKRLSQKADVYSFGVLLLE 549
              +    ++ + R                   Y APE       +Q  D +S GV+L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 550 VLTGRAPSQYPSP--TRPRVDEEEQAVDLP 577
           +L G+ P    +P  T+ +V   E  + +P
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTLHIP 266

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 48.8 bits (116), Expect = 5e-06
 Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 33/192 (17%)

Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LL 510
           PL     I      ARG+  +     + K  H ++ + N+LL +N V  I DFGL+  + 
Sbjct: 170 PLTMEDLICYSFQVARGMEFL----ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225

Query: 511 LNP---VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR 566
            +P    +  ARL   + APE    K  + ++DV+SFGVLL E+ +  A S YP     +
Sbjct: 226 KDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGA-SPYPGV---Q 281

Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP 626
           ++EE     L    R    E  T E++                   + LAC    P++RP
Sbjct: 282 INEE-FCQRLKDGTRMRAPENATPEIY------------------RIMLACWQGDPKERP 322

Query: 627 TMAEVAKMIEDI 638
           T + + +++ D+
Sbjct: 323 TFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 48.7 bits (117), Expect = 5e-06
 Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 41/215 (19%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPC-ARKEFEQYMDVIGKLKHPNVVKLRA 419
           LGKG+ G V+KA+      +VA+K++ DA  N   A++ F + M +     HPN+VKL  
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 420 YYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLARIHQ 475
              A+ +K   LV++Y+    LH+++  N     I  D   R  +  +L   + L  IH 
Sbjct: 75  VIKAENDKDIYLVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLL---KALKYIH- 124

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--------NPVQA--IA-RLGGYK 524
              +  V H ++K SN+LL+ +    ++DFGL+  L        NPV    +A R   Y+
Sbjct: 125 ---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW--YR 179

Query: 525 APEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
           AP   E+     R ++  D++S G +L E+L G+ 
Sbjct: 180 AP---EILLGSTRYTKGVDMWSVGCILGEMLLGKP 211

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 62/213 (29%), Positives = 92/213 (43%), Gaps = 35/213 (16%)

Query: 363 MLGKGSLGTVYKAVL----DDGGIVAVKRLKDA------NPCARKEFEQYMDVIGKLKHP 412
           +LGKG  G V++       D G I A+K LK A         A  + E+  +++  +KHP
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER--NILEAVKHP 60

Query: 413 NVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLD----WTTRISLVLGAA 467
            +V L  Y +    KL L+ +YL  G L   +H  R  G    D    + + ISL L   
Sbjct: 61  FIVDL-IYAFQTGGKLYLILEYLSGGEL--FMHLER-EGIFMEDTACFYLSEISLALEHL 116

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL---SLLLNPV-QAIARLGGY 523
                I+++          +K  N+LLD  G   ++DFGL   S+    V         Y
Sbjct: 117 HQQGIIYRD----------LKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEY 166

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            APE        +  D +S G L+ ++LTG  P
Sbjct: 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 31/210 (14%)

Query: 364 LGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDVIGKLK---------HPN 413
           +GKG+ G VY+    D   I A+K L      A+KE       IG+            P 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAH---TIGERNILVRTLLDESPF 57

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLA 471
           +V L+  +    +  LV DY+  G L   L      GR   D        LVL     L 
Sbjct: 58  IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE---GRFSEDRAKFYIAELVLA----LE 110

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS---LLLNPV-QAIARLGGYKAPE 527
            +H+      + + ++K  N+LLD  G   + DFGLS   L  N           Y APE
Sbjct: 111 HLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166

Query: 528 -QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              + K  ++  D +S GVL+ E+  G +P
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 43/148 (29%), Positives = 71/148 (47%), Gaps = 19/148 (12%)

Query: 426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHG 485
           E ++V +++ +G L   L   +G  R+P+ W   +      A+ LA          + HG
Sbjct: 90  ENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITV------AQQLASALSYLEDKNLVHG 141

Query: 486 NVKSSNVLLDKNGVA-------CISDFGLSL-LLNPVQAIARLGGYKAPE-QAEVKRLSQ 536
           NV + N+LL + G+A        +SD G+S   L+  + + R+  + APE       LS 
Sbjct: 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIP-WIAPECVPGGNSLST 200

Query: 537 KADVYSFGVLLLEV-LTGRAPSQYPSPT 563
            AD +SFG  LLE+   G  P +  +P+
Sbjct: 201 AADKWSFGTTLLEICFDGEVPLKERTPS 228

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 79/311 (25%), Positives = 132/311 (42%), Gaps = 54/311 (17%)

Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK- 397
           Y+ K +F   +L  +  + LG G+ G V +A        D  + VAVK LK   P A   
Sbjct: 26  YDLKWEFPRNNL--SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK---PTAHSS 80

Query: 398 EFEQYMD---VIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP 453
           E E  M    ++  L  H N+V L          L++ +Y   G L + L   R      
Sbjct: 81  EREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESF 137

Query: 454 LDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-LLN 512
           L     +S     A+G+A +     +    H ++ + NVLL    +  I DFGL+  ++N
Sbjct: 138 LTLEDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193

Query: 513 P----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPR 566
                V+  ARL   + APE       + ++DV+S+G+LL E+ + G  P  YP      
Sbjct: 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP--YPGMP--- 248

Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP 626
           VD +            ++KE +        + + ++   E+  ++     C  + P KRP
Sbjct: 249 VDSK---------FYKLIKEGY-------RMAQPEHAPAEIYDIMK---TCWDADPLKRP 289

Query: 627 TMAEVAKMIED 637
           T  ++ ++I  
Sbjct: 290 TFKQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 43.3 bits (103), Expect = 9e-06
 Identities = 21/57 (36%), Positives = 26/57 (45%)

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            LDLS+N +          L  L  L L  N LT   P+  S L  L+ L+LS N L
Sbjct: 4   SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.8 bits (113), Expect = 9e-06
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKE---FEQYMDVIGKLKHPNVVKL 417
           +++G+G+ G V    L +   + A+K L       R E   F +  DV+    +  +  L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              +  +    LV DY   G L +LL  ++   R+P D   R  L       +  +HQ +
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPED-MARFYLA-EMVIAIDSVHQLH 122

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLG--GYKAPEQAEVK 532
                 H ++K  N+L+D NG   ++DFG  L L     VQ+   +G   Y +PE  +  
Sbjct: 123 YV----HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 533 -----RLSQKADVYSFGVLLLEVLTGRAP 556
                +   + D +S GV + E+L G  P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 67/252 (26%), Positives = 112/252 (44%), Gaps = 39/252 (15%)

Query: 364 LGKGSLGTVYK--AVLDDGGIVAVKRLK----DANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+G+  TVYK  + L D  +VA+K ++    +  PC A +E     D    LKH N+V 
Sbjct: 14  LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKD----LKHANIVT 68

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLH--GNRGPGRIPLDWTTRISLVL-GAARGLARI 473
           L    + ++   LV++YL +  L   L   GN             + L L    RGL   
Sbjct: 69  LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGN-------SINMHNVKLFLFQLLRGLNYC 120

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-Q 528
           H+     KV H ++K  N+L+++ G   ++DFGL+   + P +  +       Y+ P+  
Sbjct: 121 HRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
                 S + D++  G +  E+ TGR       P  P    EEQ   + + + +  +E W
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR-------PLFPGSTVEEQLHFIFRILGTPTEETW 229

Query: 589 TAEVFDQELLRY 600
              + ++E   Y
Sbjct: 230 PGILSNEEFKSY 241

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD----VIGKLKHPNVVK 416
           +++GKGS G V  A    +    AVK L+      +KE +  M     ++  +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L   +   ++   V DY+  G L    H  R   R  L+   R       A  L  +H  
Sbjct: 61  LHFSFQTADKLYFVLDYINGGEL--FYHLQRE--RCFLEPRARF-YAAEIASALGYLH-- 113

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQAEVK 532
             +  + + ++K  N+LLD  G   ++DFGL    +      +   G   Y APE    +
Sbjct: 114 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
              +  D +  G +L E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 47/168 (27%)

Query: 362 EMLGKGSLGTVYKAV--LDDGGIVAVKRL-------KDANPCARKEFEQYMDVIGKLKHP 412
           +++GKG+ G V + V   D G I A+K L       KD     + E     DV+ +   P
Sbjct: 7   KVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE----RDVLAESDSP 61

Query: 413 NVVKLRAYYYAKEEKLLVY---DYLPNGSLHSLLHGNRGPGRIPLD---------WTTRI 460
            VV L   YY+ ++   +Y   ++LP G L ++L        I  D         +    
Sbjct: 62  WVVSL---YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMAEC 110

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
            L + A   L  IH++          +K  N+L+D+ G   +SDFGLS
Sbjct: 111 VLAIEAVHKLGFIHRD----------IKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 29/164 (17%)

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNP---VQAIARLG-GYKAPEQAEVKRL 534
           K  H ++ + N+LL +N V  I DFGL+  +  +P    +  ARL   + APE    +  
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258

Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
           + ++DV+SFGVLL E+ +  A S YP     ++DEE        + R +           
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FCRRL----------- 295

Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 296 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 15/149 (10%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRA 419
           LG G+ G V  A  +D   + A+K L+  +   R +        D++ +  +  VVKL  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            +  K+    V DY+P G + SLL      P  +   +   ++L + +   +  IH++  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD-- 126

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGL 507
                   +K  N+L+D +G   ++DFGL
Sbjct: 127 --------IKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 63/243 (25%), Positives = 106/243 (43%), Gaps = 28/243 (11%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +++G+G+ G V    +     I A+K L       R E   + +    L + +   +   
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 421 YYAKEEK---LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI--SLVLGAARGLARIHQ 475
           +YA +++    LV DY   G L +LL  ++   R+P D        +VL     +  IHQ
Sbjct: 67  HYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYIAEMVLA----IHSIHQ 120

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN---PVQAIARLG--GYKAPE--- 527
            +      H ++K  NVLLD NG   ++DFG  L +N    VQ+   +G   Y +PE   
Sbjct: 121 LHYV----HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176

Query: 528 --QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS--PTRPRVDEEEQAVDLPKWVRSV 583
             +  + +   + D +S GV + E+L G  P    S   T  ++   E+    P  +  V
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDV 236

Query: 584 VKE 586
            +E
Sbjct: 237 SEE 239

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 364 LGKGSLGTVYKAV-LDDGG-IVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA  L +GG  VA+KR++     +  P +       +  +   +HPNVV+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 417 L----RAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           L          +E KL LV++++ +  L + L     PG       T   ++    RGL 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLD 124

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN---PVQAIARLGGYKAPEQ 528
            +H      +V H ++K  N+L+  +G   ++DFGL+ + +    + ++     Y+APE 
Sbjct: 125 FLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGR 554
                 +   D++S G +  E+   +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 44/160 (27%), Positives = 77/160 (48%), Gaps = 28/160 (17%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL-----KDANP-CARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA       IVA+K++     K+  P  A +E +    ++  LKH NVV 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVVN 75

Query: 417 LRAYYYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           L      K            LV+++  +  L  LL  +    +  L    ++  +L    
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKFTLSEIKKVMKML--LN 130

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
           GL  IH      K+ H ++K++N+L+ K+G+  ++DFGL+
Sbjct: 131 GLYYIH----RNKILHRDMKAANILITKDGILKLADFGLA 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 29/215 (13%)

Query: 364 LGKG--SLGTVYKAVLDDGGIVAVKRLKDANPCAR---KEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  +L +VY A     G +   R+ D   C     K  +  + +    +HPN++   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
             +       ++  ++  GS +SLL      G   +      +++ GA RGL  +HQ   
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEG---MSEALIGNILFGALRGLNYLHQN-- 120

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-------------QAIARLGGYKA 525
                H N+K+S++L+  +G+  +S  GLS L + V             Q    +  + +
Sbjct: 121 --GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 526 PE--QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
           PE  + ++   + K+D+YS G+   E+ TGR P Q
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKH----P 412
           ++LG G+ G V+     +  D G + A+K LK A    + K  E        L+H    P
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 413 NVVKLRAYYYAKEEKL-LVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLVLGAARGL 470
            +V L  Y +  + KL L+ DY+  G L + L    R   +    ++  I L L     L
Sbjct: 66  FLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGG---YKA 525
             I+++          +K  N+LLD NG   ++DFGLS     + V+      G   Y A
Sbjct: 125 GIIYRD----------IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 526 PE--QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           P+  +       +  D +S GVL+ E+LTG +P
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 49/221 (22%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKH 411
           E++GKGS G V  A+    G  VA+K++ D        FE   D         ++  L+H
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-------FEHVSDATRILREIKLLRLLRH 58

Query: 412 PNVVKLRAYYYAKEEK----LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS---LVL 464
           P++V+++        +    + V   L    LH ++  N        D  T       + 
Sbjct: 59  PDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN--------DDLTPEHHQFFLY 110

Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAI----- 517
              R L  IH    TA V H ++K  N+L + +    I DFGL+     +   AI     
Sbjct: 111 QLLRALKYIH----TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDY 166

Query: 518 --ARLGGYKAPE--QAEVKRLSQKADVYSFGVLLLEVLTGR 554
              R   Y+APE   +   + +   D++S G +  EVLTG+
Sbjct: 167 VATRW--YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 23/155 (14%)

Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVK--RLK--DANPC-ARKEFEQYMDVIGKLKHPNVV 415
           + LG+GS  TVYK      G +VA+K  RL+  +  P  A +E      ++  LKH N+V
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIV 66

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            L    + K+   LV++Y     L + L  + +   G + +    R+ L     RGLA  
Sbjct: 67  TLHDIIHTKKTLTLVFEY-----LDTDLKQYMDDCGGGLSMH-NVRLFL-FQLLRGLAYC 119

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
           HQ     +V H ++K  N+L+ + G   ++DFGL+
Sbjct: 120 HQR----RVLHRDLKPQNLLISERGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 1   KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+  +   R     GA     L  
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARF---YGAEIVSALDY 110

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H E     V + ++K  N++LDK+G   I+DFGL    +     +    G   Y APE 
Sbjct: 111 LHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 167

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 33/163 (20%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPCA--R-----KEFEQYMDVIGKLK 410
           +G+G+ GTVYKA  L+ G  VA+K+++     +  P +  R     K+ E +       +
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESF-------E 59

Query: 411 HPNVVKLR----AYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           HPN+V+L          +E KL LV++++ +  L + L     PG +P +    +   L 
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPG-LPPETIKDLMRQL- 116

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
             RG+  +H    + ++ H ++K  N+L+  +G   I+DFGL+
Sbjct: 117 -LRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIADFGLA 154

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 29/218 (13%)

Query: 364 LGKGSLGTVYKAVLD-DGGIVAVKRLK----DANPC-ARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+  TV+K        +VA+K ++    +  PC A +E    + ++  LKH N+V L
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE----VSLLKNLKHANIVTL 68

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + +    LV++YL +     L +     G +      +I  +    RGL+  H+  
Sbjct: 69  HDIIHTERCLTLVFEYLDSDLKQYLDNC----GNLMSMHNVKI-FMFQLLRGLSYCHKR- 122

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              K+ H ++K  N+L+++ G   ++DFGL+   + P +  +       Y+ P+      
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE 570
             S   D++  G +L E+ TGR    +P  T   V EE
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR--PMFPGST---VKEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 21/154 (13%)

Query: 362 EMLGKGSLGTVYK--AVLDDGGIVAVKRLK----DANPC-ARKEFEQYMDVIGKLKHPNV 414
           E LG+G+  TV+K  + L +  +VA+K ++    +  PC A +E    + ++  LKH N+
Sbjct: 12  EKLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANI 66

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V L    +  +   LV++YL       L       G I      +I L     RGLA  H
Sbjct: 67  VTLHDIVHTDKSLTLVFEYLDK----DLKQYMDDCGNIMSMHNVKIFL-YQILRGLAYCH 121

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
           +     KV H ++K  N+L+++ G   ++DFGL+
Sbjct: 122 RR----KVLHRDLKPQNLLINERGELKLADFGLA 151

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 34/215 (15%)

Query: 362 EMLGKGSLGTVY---KAV-LDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKH----P 412
           ++LG G+ G V+   K    D G + A+K L+ A    + K  E        L+H    P
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 413 NVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLL----HGNRGPGRIPLDWTTRISLVLGAA 467
            +V L  Y +  E KL L+ DY+  G + + L    + +    R    ++  I L L   
Sbjct: 66  FLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRF---YSGEIILALEHL 121

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGG--- 522
             L  ++++          +K  N+LLD  G   ++DFGLS   L    +      G   
Sbjct: 122 HKLGIVYRD----------IKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171

Query: 523 YKAPEQAEVKRLSQKA-DVYSFGVLLLEVLTGRAP 556
           Y APE    K    KA D +S G+L+ E+LTG +P
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 46/158 (29%), Positives = 76/158 (48%), Gaps = 23/158 (14%)

Query: 360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVV 415
           S +++G+G+ G V      D G I A+K+L+ +    +++        D++ +  +P VV
Sbjct: 5   SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVV 64

Query: 416 KLRAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLD-WTTRISLVLGAARGLA- 471
           KL  YY  ++E    L+ +YLP G + +LL        +  D +T   +    A   LA 
Sbjct: 65  KL--YYSFQDENYLYLIMEYLPGGDMMTLL--------MKKDTFTEEETRFYIAETILAI 114

Query: 472 -RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
             IH+        H ++K  N+LLD  G   +SDFGL 
Sbjct: 115 DSIHK----LGYIHRDIKPDNLLLDAKGHIKLSDFGLC 148

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 37/121 (30%), Positives = 59/121 (48%), Gaps = 13/121 (10%)

Query: 448 GPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL 507
                PLD    +      A+G+  +     +    H +V + NVLL    VA I DFGL
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL----ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258

Query: 508 SL-LLNP----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
           +  ++N     V+  ARL   + APE       + ++DV+S+G+LL E+ + G++P  YP
Sbjct: 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP--YP 316

Query: 561 S 561
            
Sbjct: 317 G 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 27/208 (12%)

Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 1   KLLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+  +   R     GA     L  
Sbjct: 58  TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARF---YGAEIVSALGY 110

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS----LLLNPVQAIARLGGYKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL          ++       Y APE 
Sbjct: 111 LH----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 51/223 (22%)

Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG GS G V+ AV  D    VAVK++   +P + K   + + +I +L H N+VK      
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66

Query: 423 AKEEKLLVYDYL-PNGS-----LHSLLHGNR----------------GPGRIPLDWTTRI 460
                  VY+ L P+GS     + SL   N                   G +  +     
Sbjct: 67  -------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLF 119

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNP------ 513
              L   RGL  IH    +A V H ++K +NV ++    V  I DFGL+ +++P      
Sbjct: 120 MYQL--LRGLKYIH----SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173

Query: 514 -VQAIARLGGYKAPEQAEVKRLSQKA-DVYSFGVLLLEVLTGR 554
            +        Y++P          KA D+++ G +  E+LTG+
Sbjct: 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 40/154 (25%), Positives = 70/154 (45%), Gaps = 21/154 (13%)

Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD----WTTRISLVLGA 466
           HP +V L + +  +     V +Y+  G L  + H  R   ++P +    ++  ISL L  
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEEHARFYSAEISLALN- 110

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG--- 522
                 +H+      + + ++K  NVLLD  G   ++D+G+    L P    +   G   
Sbjct: 111 -----YLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPN 161

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           Y APE    +      D ++ GVL+ E++ GR+P
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 23/215 (10%)

Query: 360 SAEMLGKGSLGTVYKAVLDDGGI-----VAVKRLKD-ANPCARKEFEQYMDVIGKLKHPN 413
            +++L +G+ G ++  +L D        V VK +KD A+        Q   ++  L H N
Sbjct: 10  LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQN 69

Query: 414 VVK-LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-GPGRIPLDWTTR--ISLVLGAARG 469
           ++  L       E   ++Y Y+  G+L   L   R G    P   +T+  + + +  A G
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------- 522
           ++ +H+      V H ++ + N ++D+     I+D  LS  L P+     LG        
Sbjct: 130 MSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC-LGDNENRPVK 184

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
           + A E    K  S  +DV+SFGVLL E++T G+ P
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 27/208 (12%)

Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 1   KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+   +T   +   GA     L  
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RV---FTEERARFYGAEIVSALEY 110

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL----GGYKAPEQ 528
           +H       V + ++K  N++LDK+G   I+DFGL        A  +       Y APE 
Sbjct: 111 LHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 43.3 bits (102), Expect = 3e-04
 Identities = 55/204 (26%), Positives = 85/204 (41%), Gaps = 18/204 (8%)

Query: 362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL----KHPNVVK 416
            +LGKGS G V  A L + G + AVK LK        + E  M     L     HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L   +   +    V +++  G L   +  +R   R         +  + +A  L  +H +
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSA--LMFLHDK 115

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GYKAPEQAEVK 532
                + + ++K  NVLLD  G   ++DFG+    + N        G   Y APE  +  
Sbjct: 116 ----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM 171

Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
                 D ++ GVLL E+L G AP
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.0 bits (101), Expect = 4e-04
 Identities = 38/124 (30%), Positives = 53/124 (42%), Gaps = 4/124 (3%)

Query: 83  APLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
             + LL  L  LDL +N +   +  L+N  NL    LS N    ++P  I +L  +  LD
Sbjct: 203 PEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNN-KLEDLPESIGNLSNLETLD 261

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           LS+N I   I     +LT L  L L  N L+     L + L  L EL L+       +  
Sbjct: 262 LSNNQIS-SISSLG-SLTNLRELDLSGNSLS-NALPLIALLLLLLELLLNLLLTLKALEL 318

Query: 203 GLLK 206
            L  
Sbjct: 319 KLNS 322

Length = 394

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.8 bits (101), Expect = 4e-04
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 30/212 (14%)

Query: 364 LGKGSLGTV----YKAVLDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+G+ G V         ++   VA+K++ +       A++   +   +     H N+  
Sbjct: 8   LGQGAYGIVCSARNAETSEEET-VAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 417 L---RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           L      +     +L +Y+ L    LH ++   +     PL      S +     GL  I
Sbjct: 67  LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYI 121

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG------YKA 525
           H    +A V H ++K  N+L++ +    I DFGL+     NP +    +        Y+A
Sbjct: 122 H----SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 526 PE-QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE     +  ++  DV+S G +L E+L GR P
Sbjct: 178 PEIMLSFQSYTKAIDVWSVGCILAELL-GRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 37.7 bits (88), Expect = 5e-04
 Identities = 13/42 (30%), Positives = 19/42 (45%), Gaps = 1/42 (2%)

Query: 22 HPNDTDALTLFRLQ-TDTHGNLLSNWKGADACAAAWTGVVCS 62
            +D DAL  F+          LS+W  + +   +WTGV C 
Sbjct: 1  LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 36/171 (21%), Positives = 59/171 (34%), Gaps = 40/171 (23%)

Query: 40  GNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAP-----LSLLDQLRFL 94
            N L       A   A    +    +  +  L+L ++ +           L     L  L
Sbjct: 146 RNRLEG-----ASCEALAKAL--RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVL 198

Query: 95  DLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRI-- 152
           DL++N L                          +   ++SLK +  L+L DNN+      
Sbjct: 199 DLNNNGLT--------DEGASA-----------LAETLASLKSLEVLNLGDNNLTDAGAA 239

Query: 153 ---PEQVTNLTRLLTLRLQNNELTGR-IPDLSSSLKD---LKELNLSNNEL 196
                 ++    LLTL L  N++T     DL+  L +   L EL+L  N+ 
Sbjct: 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 31/211 (14%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKR----LKDANPCARK---EFEQYMDVIGK 408
           E LG+G+   +Y  +L      +D G    K     LK  +P  R     F +   ++ +
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           + H ++V L        E ++V +++  G L   +H        P  W  +++  L +A 
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP--WKFKVAKQLASA- 117

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-------ISDFGLSL-LLNPVQAIARL 520
            L+ +  +     + HGNV + N+LL + G+         +SD G+ + +L+  + + R+
Sbjct: 118 -LSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI 172

Query: 521 GGYKAPEQAE-VKRLSQKADVYSFGVLLLEV 550
             + APE  E  K LS  AD +SFG  L E+
Sbjct: 173 -PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 15/149 (10%)

Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRA 419
           LG G+ G V  A  +D   + A+K L+  +   R +        D++ +  +  VV+L  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            +  K+    V DY+P G + SLL      P  +   +   ++  + +   +  IH++  
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD-- 126

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGL 507
                   +K  N+L+D++G   ++DFGL
Sbjct: 127 --------IKPDNILIDRDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 27/207 (13%)

Query: 362 EMLGKGSLGTVYKA---VLDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVK 416
           E +G+G+ G VYKA   V ++   +A+K  RL+  +        + + ++ +++H N+V+
Sbjct: 8   EKIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR 65

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLARIH 474
           L+   ++++   LV++YL    L    H +  P   + P    T +  +L   RG+A  H
Sbjct: 66  LQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH 119

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVAC-ISDFGLSLLLN-PVQA----IARLGGYKAPE- 527
               + +V H ++K  N+L+D+   A  ++DFGL+     PV+     +  L  Y+APE 
Sbjct: 120 ----SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL-WYRAPEI 174

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               +  S   D++S G +  E++  +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 27/75 (36%), Positives = 40/75 (53%), Gaps = 4/75 (5%)

Query: 486 NVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GYKAPEQAEVKRLSQKADVY 541
           ++K  NV+LD  G   I+DFG+    + + V      G   Y APE    +   +  D +
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 185

Query: 542 SFGVLLLEVLTGRAP 556
           +FGVLL E+L G+AP
Sbjct: 186 AFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 62/267 (23%), Positives = 104/267 (38%), Gaps = 56/267 (20%)

Query: 360 SAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVV 415
           S +++G+G+ G V      D G I A+K L+ A+   +++        D++ +     VV
Sbjct: 5   SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD-WTTRISLVLGAARGLARIH 474
           K+   +  K    L+ ++LP G + +LL             +     L + A   L  IH
Sbjct: 65  KMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--------------SLLLNPVQ----- 515
           ++          +K  N+LLD  G   +SDFGL              +L  NP       
Sbjct: 125 RD----------IKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 516 ------------------AIARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA 555
                             A + +G   Y APE       ++  D +S GV++ E+L G  
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Query: 556 P--SQYPSPTRPRVDEEEQAVDLPKWV 580
           P  S+ P  T  +V   ++ +  P  V
Sbjct: 235 PFCSETPQETYRKVMNWKETLVFPPEV 261

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 23/155 (14%)

Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVK----RLKDANP-CARKEFEQYMDVIGKLKHPNVV 415
           E LG+GS  TVYK +   +G +VA+K    + ++  P  A +E      ++  LKH N+V
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIRE----ASLLKGLKHANIV 66

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLH--GNRGPGRIPLDWTTRISLVLGAARGLARI 473
            L    + KE    V++Y+       ++   G   P  + L        +    RGLA I
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYI 119

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
           H ++    + H ++K  N+L+   G   ++DFGL+
Sbjct: 120 HGQH----ILHRDLKPQNLLISYLGELKLADFGLA 150

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 35/97 (36%), Positives = 52/97 (53%), Gaps = 16/97 (16%)

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--------VQAIA- 518
           RGL  IH    +A V H ++K SN+LL+ N    I DFGL+ + +P         + +A 
Sbjct: 117 RGLKYIH----SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 519 RLGGYKAPEQAEVKRLSQKA-DVYSFGVLLLEVLTGR 554
           R   Y+APE     +   KA D++S G +L E+L+ R
Sbjct: 173 RW--YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 47/201 (23%), Positives = 93/201 (46%), Gaps = 19/201 (9%)

Query: 363 MLGKGSLGTVYKAVLDDGG-IVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           ++G+G+ G V K    +   IVA+K+ KD+  N   ++   + + ++  LK  N+V+L+ 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            +  + +  LV++Y+    L  L      P  +P +     S +    + +   H+    
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVR--SYIYQLIKAIHWCHKN--- 119

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLL------NPVQAIARLGGYKAPEQAEVKR 533
             + H ++K  N+L+  N V  + DFG +  L      N  + +A    Y++PE      
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR-WYRSPELLLGAP 177

Query: 534 LSQKADVYSFGVLLLEVLTGR 554
             +  D++S G +L E+  G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 46/214 (21%)

Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQ--Y--MDVIGKLKHPNVVKLR 418
           +G G+ G V  A     G  VA+K+L  + P       +  Y  + ++  + H NV+ L 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKL--SRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 419 AYYYAKEEKLLVYD-YLPN----GSLHSLLHGNRGPGRIPLDWTTRIS------LVLGAA 467
             +          D YL        L++++               ++S      LV    
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGADLNNIVK------------CQKLSDDHIQFLVYQIL 128

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
           RGL  IH    +A + H ++K SN+ ++++    I DFGL+           + G     
Sbjct: 129 RGLKYIH----SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATR 179

Query: 523 -YKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGR 554
            Y+APE        +Q  D++S G ++ E+LTG+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 37/158 (23%), Positives = 69/158 (43%), Gaps = 21/158 (13%)

Query: 405 VIGKLKHPNVVKLRAYY-YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++  + HP++++L+  + Y K   L++  Y  +  L+  L   R    I       I  +
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYCYLAAKR---NIA------ICDI 184

Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA-RLGG 522
           L   R + R  Q     ++ H ++K+ N+ ++  G  C+ DFG +    PV   A +  G
Sbjct: 185 LAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDINANKYYG 242

Query: 523 Y------KAPEQAEVKRLSQKADVYSFGVLLLEVLTGR 554
           +       APE           D++S G++L E+ T  
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 41.7 bits (98), Expect = 0.001
 Identities = 30/101 (29%), Positives = 49/101 (48%), Gaps = 10/101 (9%)

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
           RGL  +H    +A + H ++K  N+L++ N V  I DFGL+ +  P ++           
Sbjct: 114 RGLKYLH----SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 523 YKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
           Y+APE     +  +   D++S G +  E+L  R   Q  SP
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 55/224 (24%), Positives = 98/224 (43%), Gaps = 35/224 (15%)

Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK---DANPCARKEFEQYM 403
           K  +E+ D  R   + +G G+ GTV  A+    G  VA+K+L     +   A++ + + +
Sbjct: 8   KTIWEVPDRYR-DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE-L 65

Query: 404 DVIGKLKHPNVVKLRAYYYAKE------EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWT 457
            ++  +KH NV+ L   +          +  LV  ++       + H      RI     
Sbjct: 66  RLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF--- 122

Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI 517
               LV    +GL  IH     A + H ++K  N+ ++++    I DFGL+      Q  
Sbjct: 123 ----LVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTD 169

Query: 518 ARLGG------YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGR 554
           + + G      Y+APE        +Q  D++S G ++ E+LTG+
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 41/163 (25%), Positives = 70/163 (42%), Gaps = 28/163 (17%)

Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAAR 468
           HPN+V  RA + A  E  +V  ++  GS   L+  H   G   + + +     ++ G  +
Sbjct: 58  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVLK 112

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------- 521
            L  IH         H +VK+S++L+  +G   +S  GL   L+ +    RL        
Sbjct: 113 ALDYIHH----MGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166

Query: 522 ------GYKAPE--QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                  + +PE  Q  ++    K+D+YS G+   E+  G  P
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)

Query: 359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHPNV 414
            S + +G G+ G+V  A+    G  VA+K+L     +   A++ + + + ++  ++H NV
Sbjct: 18  TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRE-LTLLKHMQHENV 76

Query: 415 VKLRAYYYAKEEKLLVYD-YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L   + +        D YL    + + L    G    PL       LV     GL  I
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYI 133

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KAPE 527
           H    +A + H ++K  N+ ++++    I DFGL+       A A + GY      +APE
Sbjct: 134 H----SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPE 184

Query: 528 QA-EVKRLSQKADVYSFGVLLLEVLTGR 554
                   +Q  D++S G ++ E+LTG+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 15/139 (10%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
            L L ++S+   ++ LS L  L  L+L +N+L      + N +NL+   LS N  S    
Sbjct: 213 ELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS--SI 270

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR-----------IPD 178
             + SL  +  LDLS N++   +P     L  LL   L N  LT +             +
Sbjct: 271 SSLGSLTNLRELDLSGNSLSNALPLI--ALLLLLLELLLNLLLTLKALELKLNSILLNNN 328

Query: 179 LSSSLKDLKELNLSNNELY 197
           + S+ +      LS  E  
Sbjct: 329 ILSNGETSSPEALSILESL 347

Length = 394

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.003
 Identities = 21/60 (35%), Positives = 26/60 (43%)

Query: 113 NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNEL 172
           NLK   LS N  +         L  +  LDLS NN+    PE  + L  L +L L  N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.5 bits (83), Expect = 0.003
 Identities = 17/37 (45%), Positives = 26/37 (70%), Gaps = 2/37 (5%)

Query: 160 TRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           T L TL L NN++T  +P LS+ L +L+ L+LS N++
Sbjct: 1   TNLETLDLSNNQIT-DLPPLSN-LPNLETLDLSGNKI 35

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 62/269 (23%), Positives = 106/269 (39%), Gaps = 66/269 (24%)

Query: 360 SAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKE---FEQYMDVIGKLKHPNVV 415
           S +++G+G+ G V      D G + A+K L+ A+   +++        D++ +     VV
Sbjct: 5   SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 416 KLRAYYYAKEEKL---LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---G 469
           K+   +Y+ ++KL   L+ ++LP G + +LL        +  D  T        A     
Sbjct: 65  KM---FYSFQDKLNLYLIMEFLPGGDMMTLL--------MKKDTLTEEETQFYIAETVLA 113

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-------------- 515
           +  IHQ        H ++K  N+LLD  G   +SDFGL   L                  
Sbjct: 114 IDSIHQ----LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 516 -----------------------AIARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEV 550
                                  A + +G   Y APE       ++  D +S GV++ E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 551 LTGRAP--SQYPSPTRPRVDEEEQAVDLP 577
           L G  P  S+ P  T  +V   ++ +  P
Sbjct: 230 LIGYPPFCSETPQETYKKVMNWKETLIFP 258

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 72/293 (24%), Positives = 111/293 (37%), Gaps = 57/293 (19%)

Query: 364 LGKGSLGTVYKAVLDDG---GIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G  G V    ++ G     V VK L+  A+   + +F +       L+H N+++   
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
                   LLV ++ P G L   L   R    +  D TT   +    A GL  +H+    
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI 122

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLL-------LNPVQAIARLGGYKAPEQAE-- 530
               H ++   N LL  +    I D+GLS         + P Q    L  + APE  +  
Sbjct: 123 ----HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR-WIAPELVDEV 177

Query: 531 -----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE-------EQAVDLPK 578
                V   +++++V+S GV + E+      SQ   P R   DE+       EQ + LPK
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF--ELGSQ---PYRHLSDEQVLTYTVREQQLKLPK 232

Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
               +   +   EV                 M    L     QPE+RP+  EV
Sbjct: 233 PRLKLPLSDRWYEV-----------------MQFCWL-----QPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 24/206 (11%)

Query: 363 MLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIGKL-KHPNVVKL 417
           +LGKGS G V  A       + A+K LK        + E  M    V+    K P + +L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-GPGRIP--LDWTTRISLVLGAARGLARIH 474
            + +   +    V +Y+  G L  + H  + G  + P  + +   IS+      GL  +H
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISV------GLFFLH 118

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG--GYKAPEQAE 530
           +      + + ++K  NV+LD  G   I+DFG+    +++ V      G   Y APE   
Sbjct: 119 RR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAP 556
            +   +  D +++GVLL E+L G+ P
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 25/75 (33%), Positives = 37/75 (49%), Gaps = 4/75 (5%)

Query: 486 NVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GYKAPEQAEVKRLSQKADVY 541
           ++K  NV+LD  G   I+DFG+    +          G   Y APE    +   +  D +
Sbjct: 126 DLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWW 185

Query: 542 SFGVLLLEVLTGRAP 556
           +FGVLL E+L G+ P
Sbjct: 186 AFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	670
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.91
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
PLN03150	623	hypothetical protein; Provisional	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK10345	210	hypothetical protein; Provisional	99.78
smart00090	237	RIO RIO-like kinase.	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.71
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.5
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.5
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.45
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
PLN03150	623	hypothetical protein; Provisional	99.42
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.42
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.3
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.28
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.25
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.24
KOG1243	690	consensus Protein kinase [General function predict	99.23
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.23
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.14
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.13
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.11
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.08
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.08
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.07
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.06
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.04
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.02
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.99
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.98
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.97
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.91
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.87
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.86
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.84
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.8
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.8
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.79
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.75
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.7
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.66
COG4248	637	Uncharacterized protein with protein kinase and he	98.64
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.63
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.63
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.6
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.58
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.57
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.55
PRK09902	216	hypothetical protein; Provisional	98.54
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.33
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.3
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.29
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.27
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.24
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.21
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.19
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.18
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.18
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.09

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.4e-61  Score=574.07  Aligned_cols=496  Identities=26%  Similarity=0.432  Sum_probs=309.9

Q ss_pred             EEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           68 VVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      +..|+|++|.+.+.+|.....++|+.|||++|++++.++. +.++++|+.|+|++|+++|.+|..+.++++|++|+|++|
T Consensus       454 L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  533 (968)
T PLN00113        454 LQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN  533 (968)
T ss_pred             CcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCC
Confidence            3444444444444444433334555555555555554433 555555666666666666556666666666666666666


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcch-hhhhcCcccccccCCCcCCCCC
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG-LLKKFGEQSFIGNEGLCGSSPL  225 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~-~~~~~~~~~~~~n~~~c~~~~~  225 (670)
                      .++|.+|..+.++++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|.. .+..+....+.||+.+|+..+.
T Consensus       534 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~  613 (968)
T PLN00113        534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTT  613 (968)
T ss_pred             cccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccc
Confidence            666666666666666666666666666666655555566666666666666666532 1233444455566666552110


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCcccccccCCCchhhhHHHHHHHHHHHHHHHHHhheeeecCcCCCcC
Q 036639          226 PACSFSGDTPPDVASAPETVPSNPSSMPQRPAFGQEKTRSKKGLSTAAIVAIVLGNCVALLVVTSFVVAYCCRGDRSSIS  305 (670)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~ps~p~~~~~~~~~~~~~~~~~~~~~~~~iv~~v~g~~~~~~~~~~~~~~~~~~~~~~~~~  305 (670)
                      ..                           .+....    ..+......++++++++++++++++ ++++++++|++....
T Consensus       614 ~~---------------------------~~~c~~----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  661 (968)
T PLN00113        614 SG---------------------------LPPCKR----VRKTPSWWFYITCTLGAFLVLALVA-FGFVFIRGRNNLELK  661 (968)
T ss_pred             cC---------------------------CCCCcc----ccccceeeeehhHHHHHHHHHHHHH-HHHHHHHhhhccccc
Confidence            00                           000000    0011112233333333333222222 222222222211110


Q ss_pred             chhhhccCCCCCCCccceecCCCCCCCCCCCCCCCceeeecccccccHHHHHHHH--HhHcCCCCceEEEEEEE-cCCCE
Q 036639          306 SDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRAS--AEMLGKGSLGTVYKAVL-DDGGI  382 (670)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~lg~G~~g~Vy~~~~-~~g~~  382 (670)
                      .     .....     ..+           .   .........+.+.++++...+  .+.||+|+||.||+|+. .++..
T Consensus       662 ~-----~~~~~-----~~~-----------~---~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~  717 (968)
T PLN00113        662 R-----VENED-----GTW-----------E---LQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQ  717 (968)
T ss_pred             c-----ccccc-----ccc-----------c---ccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcE
Confidence            0     00000     000           0   000000011234444443332  35799999999999996 57899


Q ss_pred             EEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHH
Q 036639          383 VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL  462 (670)
Q Consensus       383 vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i  462 (670)
                      ||||+++.....    ...|++++++++|||||+++++|.+.+..++||||+++|+|.++++        .++|..+.++
T Consensus       718 vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i  785 (968)
T PLN00113        718 FVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKI  785 (968)
T ss_pred             EEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHH
Confidence            999999754321    2345888999999999999999999999999999999999999995        2789999999


Q ss_pred             HHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccccccccCcccCccccccCCCCCchhHHH
Q 036639          463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYS  542 (670)
Q Consensus       463 ~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS  542 (670)
                      +.|+++||+|||..+ .++|+||||||+||+++.++.+++. ||............++..|+|||++.+..++.|+||||
T Consensus       786 ~~~ia~~L~yLH~~~-~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S  863 (968)
T PLN00113        786 AIGIAKALRFLHCRC-SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYG  863 (968)
T ss_pred             HHHHHHHHHHhccCC-CCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhh
Confidence            999999999999653 3589999999999999999988876 77665544444456778899999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcc-cchHHHHHHHHHHHhhccCCC
Q 036639          543 FGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY-KNIEEELVSMLHVGLACVVSQ  621 (670)
Q Consensus       543 ~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~l~~~cl~~d  621 (670)
                      |||++|||+||+.||+...         .....+.+|.+...........+|+.+... ....++..++.+++.+||+.|
T Consensus       864 ~Gvvl~el~tg~~p~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~  934 (968)
T PLN00113        864 FGLILIELLTGKSPADAEF---------GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD  934 (968)
T ss_pred             HHHHHHHHHhCCCCCCccc---------CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC
Confidence            9999999999999985321         123345566655444333334444443221 223456678889999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhccC
Q 036639          622 PEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       622 P~~RPt~~evl~~L~~i~~~~  642 (670)
                      |++||||+||+++|+++....
T Consensus       935 P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        935 PTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             chhCcCHHHHHHHHHHhhccc
Confidence            999999999999999886544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-52  Score=434.75  Aligned_cols=282  Identities=40%  Similarity=0.705  Sum_probs=244.0

Q ss_pred             cccccHHHHHHHHH-----hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEE
Q 036639          348 KKQFELEDLLRASA-----EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY  422 (670)
Q Consensus       348 ~~~~~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~  422 (670)
                      .+.|+++++..++.     +.||+|+||.||+|.+++|+.||||++........++|..|++++.+++|||+|+++|||.
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            45688999988873     6999999999999999999999999988655321566999999999999999999999999


Q ss_pred             eCC-eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          423 AKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       423 ~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                      +.+ +.+||||||++|+|.++++.....   +++|..|++||.++|+||+|||+.+. ++||||||||+|||+|+++++|
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~-~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCP-PPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCC-CCEecCCCCHHHeeECCCCCEE
Confidence            999 599999999999999999976532   68999999999999999999999864 5799999999999999999999


Q ss_pred             EEecccccccCc-cccc----cccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccch
Q 036639          502 ISDFGLSLLLNP-VQAI----ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       502 l~DFG~a~~~~~-~~~~----~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      |+|||+|+.... ....    .+|.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...        ......+
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~--------~~~~~~l  289 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR--------PRGELSL  289 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC--------CcccccH
Confidence            999999977654 2221    78899999999999999999999999999999999998876532        1223348


Q ss_pred             hHHHHHHhhhccccccccHhhhcccch-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNI-EEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ..|......+....+++|+.+...... .+++.++.+++.+|++.+|++||+|.||+++|+.+...
T Consensus       290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            899988888888899999998743333 27888999999999999999999999999999766543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=389.82  Aligned_cols=254  Identities=33%  Similarity=0.505  Sum_probs=207.5

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcch--HHHHHHHHHHHhccCCCCeeeEEEEEEeCC-eeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA--RKEFEQYMDVIGKLKHPNVVKLRAYYYAKE-EKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~  435 (670)
                      .+.+.+|+|+||+||+|.++....||||++...+...  .++|.+|+.++.+++|||||+++|+|.+.. ..++|||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            3456799999999999999854459999998654322  569999999999999999999999999988 7899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCCCCCeEeCCCC-cEEEEecccccccCc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK-VPHGNVKSSNVLLDKNG-VACISDFGLSLLLNP  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~  513 (670)
                      +|+|.++++...   ...+++..+++++.|||+||.|||+.    + ||||||||+||||+.++ ++||+|||+++....
T Consensus       124 ~GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~----~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  124 GGSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSE----GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC----CCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            999999998741   23699999999999999999999998    6 99999999999999998 999999999987653


Q ss_pred             ----cccccccCcccCccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 ----VQAIARLGGYKAPEQAE--VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 ----~~~~~~~~~y~aPE~~~--~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                          .....||..|||||++.  ...|+.|+|||||||++|||+||+.||....+              ...........
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------------~~~~~~v~~~~  262 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------------VQVASAVVVGG  262 (362)
T ss_pred             ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------------HHHHHHHHhcC
Confidence                22357888999999999  56899999999999999999999999976522              11111111111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      .          +......+...+..++.+||..||++||++.|++..|+.+.....
T Consensus       263 ~----------Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  263 L----------RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             C----------CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence            1          001111134456667779999999999999999999999876554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-47  Score=371.50  Aligned_cols=256  Identities=26%  Similarity=0.435  Sum_probs=209.0

Q ss_pred             ccHHHHHHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCC-CCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC-ee
Q 036639          351 FELEDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE-EK  427 (670)
Q Consensus       351 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-~~  427 (670)
                      +.+.|+  ...+.||+|..|+||++.++ +++.+|+|++.. .++...+++.+|++++++.+||+||.++|.|+..+ ..
T Consensus        76 i~~~dl--e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   76 ISLSDL--ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             cCHHHh--hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            455565  34588999999999999965 789999999953 35567889999999999999999999999999999 59


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      .++||||++|+|.+++...+     .+++...-+|+.+|++||.|||+.   .+||||||||+||||+..|++||+|||.
T Consensus       154 sI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~---~~IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEE---RKIIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhc---cCeeeccCCHHHeeeccCCCEEeccccc
Confidence            99999999999999998653     488999999999999999999974   3999999999999999999999999999


Q ss_pred             ccccCcc--ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          508 SLLLNPV--QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       508 a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ++.+...  ..+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||...         ..........+..++.
T Consensus       226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---------~~~~~~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---------NPPYLDIFELLCAIVD  296 (364)
T ss_pred             cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---------CCCCCCHHHHHHHHhc
Confidence            9887653  5678999999999999999999999999999999999999998653         1112233333333333


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      +...      .+.. ....+   ++..++..||++||.+|||++|+++|=
T Consensus       297 ~ppP------~lP~-~~fS~---ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  297 EPPP------RLPE-GEFSP---EFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             CCCC------CCCc-ccCCH---HHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            2111      0100 01233   344555699999999999999999873

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-46  Score=384.21  Aligned_cols=259  Identities=28%  Similarity=0.417  Sum_probs=215.7

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEE
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  429 (670)
                      .++++.-.....+.||+|.||+||+|.++....||+|.++.... ..++|.+|+++|++|+|+|||+++|+|...+..||
T Consensus       200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            45555555678899999999999999999888999999987533 56889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      |||||+.|+|.++|+...   ...+...+.+.++.|||+|++||+++    ++|||||.++||||+++..+||+|||+|+
T Consensus       279 VtE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~----~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESK----NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhC----CccchhhhhhheeeccCceEEEccccccc
Confidence            999999999999998732   23588899999999999999999998    99999999999999999999999999999


Q ss_pred             ccCccccccccC-----cccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          510 LLNPVQAIARLG-----GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       510 ~~~~~~~~~~~~-----~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ...+........     .|.|||.+..++++.|||||||||+||||+| |+.||...+              ..+.+..+
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------------n~ev~~~l  417 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------------NEEVLELL  417 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------------HHHHHHHH
Confidence            766555444333     3999999999999999999999999999999 888886542              22222222


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      -+..           +.+....+...+.++|..||+.+|++|||++.+...|+++...
T Consensus       418 e~Gy-----------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  418 ERGY-----------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             hccC-----------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            2211           1122334455677788899999999999999999999988754

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-45  Score=381.32  Aligned_cols=241  Identities=25%  Similarity=0.411  Sum_probs=205.4

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      ..++.||+|||+.||.++. .+|..||+|++.+.   ....++.+.+|+++.+.|+|||||+++++|++.++.|||.|+|
T Consensus        21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC  100 (592)
T KOG0575|consen   21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC  100 (592)
T ss_pred             eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence            4467899999999999996 88999999999863   3446788999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++++|.++++..+     ++++.++..++.||+.||.|||+.    +|+|||||..|+|++++.++||+|||+|..+...
T Consensus       101 ~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~----~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen  101 HRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSL----GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             CCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhc----CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999998543     799999999999999999999998    9999999999999999999999999999988743


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ....||+.|+|||++.....+..+||||+||+||-|++|++||+..              .+....+.+...++..
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------------~vkety~~Ik~~~Y~~  237 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------------TVKETYNKIKLNEYSM  237 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------------hHHHHHHHHHhcCccc
Confidence                3578999999999999999999999999999999999999999753              2223333322222211


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                               ...+..+.   .+|+.++|+.||.+|||+++|+.+
T Consensus       238 ---------P~~ls~~A---~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  238 ---------PSHLSAEA---KDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ---------ccccCHHH---HHHHHHHhcCCcccCCCHHHHhcC
Confidence                     11223333   345669999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=365.14  Aligned_cols=191  Identities=28%  Similarity=0.437  Sum_probs=174.5

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.||+|+||+||+|+++ ++..||||.+.+.  .....+.+..|+++|+.++|||||.++++++.++..|+|||||.+|
T Consensus        15 ~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gG   94 (429)
T KOG0595|consen   15 SREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGG   94 (429)
T ss_pred             hhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCC
Confidence            456999999999999954 6899999999866  4556677899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC------CcEEEEeccccccc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN------GVACISDFGLSLLL  511 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DFG~a~~~  511 (670)
                      ||.++++..+     .+++.....++.|+|.||++||++    +||||||||.|||++..      -.+||+|||+|+.+
T Consensus        95 DLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~----~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   95 DLSDYIRRRG-----RLPEATARHFMQQLASALQFLHEN----NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999765     589999999999999999999998    99999999999999865      45899999999999


Q ss_pred             Ccc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          512 NPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       512 ~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .+.   +...|++-|||||++..++|+.|+|+||+|+|+|++++|+.||+..
T Consensus       166 ~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  166 QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            764   4567888899999999999999999999999999999999999754

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-46  Score=368.53  Aligned_cols=246  Identities=24%  Similarity=0.429  Sum_probs=195.6

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcc-------hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPC-------ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      .+.+.||+|+||.|-+|. .++|+.||||++++....       ....+++|+++|++|+|||||++.++|+..+..|||
T Consensus       175 ii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmV  254 (475)
T KOG0615|consen  175 IISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMV  254 (475)
T ss_pred             EeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEE
Confidence            356889999999999999 668999999999754211       234467999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC---CcEEEEeccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN---GVACISDFGL  507 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~  507 (670)
                      |||++||+|.+++-.+.     .+.+..-..++.|++.|+.|||++    ||+||||||+|||+..+   ..+||+|||+
T Consensus       255 lE~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~----GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  255 LEYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQ----GIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             EEEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHc----CcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999997665     466777789999999999999998    99999999999999766   6799999999


Q ss_pred             ccccCc---cccccccCcccCccccccCCC---CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          508 SLLLNP---VQAIARLGGYKAPEQAEVKRL---SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       508 a~~~~~---~~~~~~~~~y~aPE~~~~~~~---~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      |+....   .....||+.|.|||++.+..+   ..|+||||+|||||-+++|.+||........          +   ..
T Consensus       326 AK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------l---~e  392 (475)
T KOG0615|consen  326 AKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------L---KE  392 (475)
T ss_pred             hhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------H---HH
Confidence            999864   346789999999999976543   3488999999999999999999975421110          1   11


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ++....+..     ....+..+.++   .++++.+||..||++|||+.|+++|
T Consensus       393 QI~~G~y~f-----~p~~w~~Isee---a~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  393 QILKGRYAF-----GPLQWDRISEE---ALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             HHhcCcccc-----cChhhhhhhHH---HHHHHHHhhEeCcccCcCHHHHhcC
Confidence            111111110     00111223344   4455669999999999999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-45  Score=346.08  Aligned_cols=255  Identities=24%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             HHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEE-EEEeCCe-eEEEEe
Q 036639          358 RASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRA-YYYAKEE-KLLVYD  432 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~-~~~~~~~-~~lv~e  432 (670)
                      |.+.++||+|.||+||++. ..+|..||.|.+.-.  +...+++...|+.+|++|+|||||++++ -+.+..+ .+||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            4667899999999999999 678999999999743  4445678899999999999999999998 4444444 789999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      ||+.|+|...++..+. ....+++..+++++.|+++||.++|......-|+||||||.||+++.+|.+||+|||+++.+.
T Consensus       101 ~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9999999999986543 234689999999999999999999996543349999999999999999999999999999987


Q ss_pred             cc----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          513 PV----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       513 ~~----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ..    ....||+.||+||.+...+|+.||||||+||++|||+.-++||.+.              ++...-.++...+.
T Consensus       180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------------n~~~L~~KI~qgd~  245 (375)
T KOG0591|consen  180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------------NLLSLCKKIEQGDY  245 (375)
T ss_pred             chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------------cHHHHHHHHHcCCC
Confidence            64    4578999999999999999999999999999999999999999764              22222222222211


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      . .+.+         +-...++..|+..|+..||+.||+...++..+..
T Consensus       246 ~-~~p~---------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  246 P-PLPD---------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             C-CCcH---------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            0 0110         1122356667779999999999986555555544

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-44  Score=388.74  Aligned_cols=254  Identities=27%  Similarity=0.424  Sum_probs=212.1

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||+||+|+..      +.+.||||.+++.... ...+|++|+++++.++|||||+++|+|.+++..|+|+
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF  568 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF  568 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence            34578999999999999843      3567999999987655 7899999999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEE
Q 036639          432 DYLPNGSLHSLLHGNRGPG---------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI  502 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl  502 (670)
                      |||..|||.+||+......         +.+++..+.+.||.|||.|++||-++    .+|||||..+|+||.++..|||
T Consensus       569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~----~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH----HFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----cccccchhhhhceeccceEEEe
Confidence            9999999999998543211         23488999999999999999999998    9999999999999999999999


Q ss_pred             EecccccccCcccccccc------CcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccc
Q 036639          503 SDFGLSLLLNPVQAIARL------GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVD  575 (670)
Q Consensus       503 ~DFG~a~~~~~~~~~~~~------~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  575 (670)
                      +|||+++.+...+.+..-      ..|||||.+..++|+.+||||||||+|||++| |+.||.+.+..            
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~------------  712 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ------------  712 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH------------
Confidence            999999988665544322      24999999999999999999999999999999 99999765321            


Q ss_pred             hhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                         .+-..+....        +  .+..+.+..++..||+.||+..|++||+++||-..|+.....
T Consensus       713 ---EVIe~i~~g~--------l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  713 ---EVIECIRAGQ--------L--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ---HHHHHHHcCC--------c--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence               1112222211        1  223445566788899999999999999999999999987643

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2e-43  Score=336.21  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=205.8

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      |+.-.++|+|+||+||+++.+ +|+.||||++...  ++...+-..+|++++++++|+|+|.++++|......++|+|||
T Consensus         4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~   83 (396)
T KOG0593|consen    4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC   83 (396)
T ss_pred             HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence            344468999999999999954 6999999999753  3455677889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC-c
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-P  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~-~  513 (670)
                      +..-|.++ ....    .-++.....+++.|+++|+.|+|.+    ++|||||||+||||+.+|.+||||||+|+.+. +
T Consensus        84 dhTvL~eL-e~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~----n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   84 DHTVLHEL-ERYP----NGVPSELVKKYLYQLLKAIHFCHKN----NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             chHHHHHH-Hhcc----CCCCHHHHHHHHHHHHHHhhhhhhc----CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            77545444 4332    1378899999999999999999998    99999999999999999999999999999887 3


Q ss_pred             cc---cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc-c
Q 036639          514 VQ---AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE-W  588 (670)
Q Consensus       514 ~~---~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  588 (670)
                      .+   .+..|.+|+|||.+.+ .+|+..+||||+||++.||+||.+.|.+.++.+....+....+++...-.++...+ +
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            33   3567888999999876 78999999999999999999999999877655444443333344333333333222 1


Q ss_pred             ccccccHhh-------hcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQEL-------LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~-------~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...+.-++.       .+++...   .-+++++..||+.||.+|++.+|++.|
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s---~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKIS---NVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeeeecCCCCCccchhhhcccch---HHHHHHHHHHhcCCccccccHHHHhcC
Confidence            111111111       1122222   256788889999999999999999874

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=340.76  Aligned_cols=240  Identities=27%  Similarity=0.376  Sum_probs=198.7

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.++||+|+||+||.++ .++++.+|+|++++...   ...+....|..++.+++||+||+++-.|.+.+..|+|+||+.
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence            34789999999999999 55799999999987533   235677889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      ||.|...|+...     .+++..+.-++..|+.||.|||+.    +||||||||+|||+|++|+++|+|||+++....  
T Consensus       109 GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~----gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  109 GGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSK----GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             CccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            999999998654     588899999999999999999998    999999999999999999999999999996533  


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....||+.|||||++.+..|+..+|.||+||++|||++|.+||...              +..++.+.+......  
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------------~~~~~~~~I~~~k~~--  243 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------------DVKKMYDKILKGKLP--  243 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------------cHHHHHHHHhcCcCC--
Confidence              34568899999999999999999999999999999999999999764              334444444443200  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC----CHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP----TMAEVAK  633 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~evl~  633 (670)
                            ........+.++   ++...+..||++|.    .++++-+
T Consensus       244 ------~~p~~ls~~ard---ll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  244 ------LPPGYLSEEARD---LLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             ------CCCccCCHHHHH---HHHHHhccCHHHhcCCCCChHHhhc
Confidence                  011113344444   44489999999995    4555544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-43  Score=351.79  Aligned_cols=264  Identities=21%  Similarity=0.310  Sum_probs=203.6

Q ss_pred             HHHHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchH-HHHHHHHHHHhccC-CCCeeeEEEEEEeCC-eeEEE
Q 036639          355 DLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLK-HPNVVKLRAYYYAKE-EKLLV  430 (670)
Q Consensus       355 ~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~-~~~lv  430 (670)
                      .-+|.+.++||.|.||.||+|+ ..+|..||||++++.-.... -.-.+|++.|++|+ |||||++.+++.+.+ ..|+|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            4467888999999999999999 66799999999987644332 23358999999998 999999999999988 89999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||| ..+|+++++..+    ..+++..+..|+.||++||+|+|.+    |+.|||+||+|||+.....+||+|||+||.
T Consensus        89 fE~M-d~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~----GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   89 FEFM-DCNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKH----GFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             HHhh-hhhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhc----CcccccCChhheEecccceeEecccccccc
Confidence            9999 559999998753    3799999999999999999999998    999999999999999899999999999999


Q ss_pred             cCc---cccccccCcccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          511 LNP---VQAIARLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       511 ~~~---~~~~~~~~~y~aPE~~-~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      +..   -..+..|.+|+|||++ +.+.|+.+.||||+|||++|+.+-++.|.+.+..+...       .+...+..-..+
T Consensus       160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~-------KIc~VLGtP~~~  232 (538)
T KOG0661|consen  160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY-------KICEVLGTPDKD  232 (538)
T ss_pred             cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH-------HHHHHhCCCccc
Confidence            865   3457788999999987 45679999999999999999999999997654322111       111111100011


Q ss_pred             cccc-----ccccHhhhcc--cc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          587 EWTA-----EVFDQELLRY--KN----IEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       587 ~~~~-----~~~d~~~~~~--~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .|..     ..+.-.+...  ..    ......+.++++.+|+++||.+||||+|++++
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1111     0000000000  00    11133456777789999999999999999986

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-42  Score=343.19  Aligned_cols=252  Identities=27%  Similarity=0.439  Sum_probs=199.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC--eeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE--EKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~~~  435 (670)
                      ..++.||+|+||+||++... +|...|||.+...+....+.+.+|+.+|.+++|||||+++|.....+  ..++.|||++
T Consensus        20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~   99 (313)
T KOG0198|consen   20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP   99 (313)
T ss_pred             hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence            45688999999999999955 59999999997654333677899999999999999999999865555  5889999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccCc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNP-  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~-  513 (670)
                      +|+|.+++....+    .+++..+..+..||++||+|||++    +|+||||||+||||+. ++.+||+|||+++.... 
T Consensus       100 ~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~----g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen  100 GGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSK----GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             CCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999987652    489999999999999999999988    9999999999999999 79999999999987662 


Q ss_pred             ------cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          514 ------VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       514 ------~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                            .....+|+.|||||++..+ ....++||||+||++.||+||++||...             .....++-....+
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------------~~~~~~~~~ig~~  238 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------------FEEAEALLLIGRE  238 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------------cchHHHHHHHhcc
Confidence                  2346788899999999853 3446999999999999999999999642             0111111111111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .....     +  .....++..+++   ..|+..||++||||+|+++|.--....
T Consensus       239 ~~~P~-----i--p~~ls~~a~~Fl---~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  239 DSLPE-----I--PDSLSDEAKDFL---RKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             CCCCC-----C--CcccCHHHHHHH---HHHhhcCcccCcCHHHHhhChhhhccc
Confidence            11111     1  112344445544   499999999999999999987655433

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.8e-42  Score=346.21  Aligned_cols=260  Identities=27%  Similarity=0.401  Sum_probs=199.1

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~  433 (670)
                      +..++||+|.||.||+|+ ..+|+.||+|++....  .....-..+||.||++|+||||+++.+...+.  ...|||+||
T Consensus       120 eki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY  199 (560)
T KOG0600|consen  120 EKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY  199 (560)
T ss_pred             HHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence            445789999999999999 6789999999997543  44567788999999999999999999998887  689999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |+. ||..++...    ...++..++..++.|++.||+|+|..    +|+|||||.+|||||.+|.+||+|||+|+++..
T Consensus       200 Mdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~----gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  200 MDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSR----GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             ccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhc----CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            976 999888754    24689999999999999999999998    999999999999999999999999999998765


Q ss_pred             cc-----cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 VQ-----AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 ~~-----~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ..     ...-|.+|+|||.+.+. .|+.++|+||.||||.||++|++.|.+.+..       ++...+.+....-..+.
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-------eQl~kIfklcGSP~e~~  343 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-------EQLHKIFKLCGSPTEDY  343 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-------HHHHHHHHHhCCCChhc
Confidence            43     33456679999998764 6999999999999999999999998765321       11111111111111122


Q ss_pred             ccc------ccccHhhhcccchHHH----HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTA------EVFDQELLRYKNIEEE----LVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~------~~~d~~~~~~~~~~~~----~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      |..      ..+.+.......+.|.    ....++|+..+|..||.+|.||.+++++
T Consensus       344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            220      1111111000111111    1345667778999999999999999874

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=354.82  Aligned_cols=242  Identities=24%  Similarity=0.419  Sum_probs=204.4

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .-++||+|+.|.||.|. ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|...++.++|||||++|+
T Consensus       277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs  356 (550)
T KOG0578|consen  277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS  356 (550)
T ss_pred             chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence            34789999999999999 66789999999987666567788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----  514 (670)
                      |.+.+....      +++.++..|++++++||+|||.+    +|+|||||.+|||++.+|.+||+|||++..+...    
T Consensus       357 LTDvVt~~~------~~E~qIA~Icre~l~aL~fLH~~----gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  357 LTDVVTKTR------MTEGQIAAICREILQGLKFLHAR----GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             hhhhhhccc------ccHHHHHHHHHHHHHHHHHHHhc----ceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            999998764      89999999999999999999998    9999999999999999999999999999887653    


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....||+.|||||+.....|++|+||||||++++||+-|.+||....+.+...               .+..+     -.
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly---------------LIa~n-----g~  486 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---------------LIATN-----GT  486 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH---------------HHhhc-----CC
Confidence            35678999999999999999999999999999999999999997543221111               11111     11


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +.+........+.++|++   +||..|+++|++|.|+|+|
T Consensus       487 P~lk~~~klS~~~kdFL~---~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLD---RCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCcCCccccCHHHHHHHH---HHhhcchhcCCCHHHHhcC
Confidence            222223334444555554   9999999999999999986

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=347.86  Aligned_cols=241  Identities=24%  Similarity=0.352  Sum_probs=198.1

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc---chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP---CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+++.||.|.|++|++|+ ..+++.||||++.+..-   ...+-+..|-++|.+| .||.|++|+-.|.+....|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            456889999999999999 56799999999975421   1234567788899999 899999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.++|+..+     .+++.....++.+|+.||+|||+.    |||||||||+|||+|+||++||+|||.|+.+.+
T Consensus       156 A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~----GIIHRDlKPENILLd~dmhikITDFGsAK~l~~  226 (604)
T KOG0592|consen  156 APNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSN----GIIHRDLKPENILLDKDGHIKITDFGSAKILSP  226 (604)
T ss_pred             cCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence            99999999999775     589999999999999999999998    999999999999999999999999999987743


Q ss_pred             c-----------------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccch
Q 036639          514 V-----------------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       514 ~-----------------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      .                 ..+.||..|.+||++.....++.+|||+||||+|+|+.|++||...+..             
T Consensus       227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-------------  293 (604)
T KOG0592|consen  227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-------------  293 (604)
T ss_pred             hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------------
Confidence            1                 2366788899999999999999999999999999999999999764211             


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ..+..++.-++         .-.+...+.+.   +|+.+.|..||.+|+|++|+.+|
T Consensus       294 -liFqkI~~l~y---------~fp~~fp~~a~---dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  294 -LIFQKIQALDY---------EFPEGFPEDAR---DLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -HHHHHHHHhcc---------cCCCCCCHHHH---HHHHHHHccCccccccHHHHhhC
Confidence             11222222111         11122333333   45558999999999999999886

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-41  Score=317.55  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             HHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          357 LRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +|...+.+|+|.||.||+|+ ..+|+.||||+++....  .......+|++.|+.++|+||+.++++|...+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            35667899999999999999 56899999999985532  2345678999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |+. +|...++...    ..+.-..+..++.++++||+|+|++    .|+||||||.|+|++++|.+||+|||+|+...+
T Consensus        83 m~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~----~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSK----WILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             ccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhh----hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            965 9999998654    3688899999999999999999998    999999999999999999999999999998865


Q ss_pred             cc----cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-----------CCCCcccccccchh
Q 036639          514 VQ----AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPT-----------RPRVDEEEQAVDLP  577 (670)
Q Consensus       514 ~~----~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~-----------~~~~~~~~~~~~~~  577 (670)
                      ..    ....|..|+|||.+.+. .|+..+||||.|||+.||+-|.+-|.+.++.           .+..+.+.+...++
T Consensus       154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            32    23567789999998764 5999999999999999999999777665432           11111222222233


Q ss_pred             HHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       578 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +++.-..-.   ....+      .-...+..+.++++..|+..||.+|+|+.|+++|
T Consensus       234 dY~~~~~~P---~~~~~------~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFP---KPPLN------NLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCC---CCccc------cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            332211000   00000      0112223455788889999999999999999987

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=335.25  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=200.4

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||.|..++||+|+ ...+..||||++.-+... ..+.+++|+..++.++||||++++..|..+...|+||.||.+
T Consensus        29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~  108 (516)
T KOG0582|consen   29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG  108 (516)
T ss_pred             eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence            445679999999999999 667899999999865433 358899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |++.++++.....   -+++..+..|.+++++||.|||.+    |.||||||+.|||||.+|.+||+|||.+..+...  
T Consensus       109 GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~----G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  109 GSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQN----GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             CcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhc----CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            9999999876433   388999999999999999999998    9999999999999999999999999987655321  


Q ss_pred             ------ccccccCcccCccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          515 ------QAIARLGGYKAPEQAE--VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       515 ------~~~~~~~~y~aPE~~~--~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                            ..+.+++.|||||++.  ...|+.|+|||||||+..||.+|..||....+..............+.        
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~--------  253 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLL--------  253 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcc--------
Confidence                  4557888999999954  356999999999999999999999999765433221111111100000        


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         ....+.+.     ....-..+.+++-.||..||++|||+++++++
T Consensus       254 ---t~~~~~d~-----~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 ---TSGLDKDE-----DKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ---cccCChHH-----hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence               00111110     01111256667779999999999999999974

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=365.00  Aligned_cols=253  Identities=25%  Similarity=0.442  Sum_probs=212.3

Q ss_pred             HHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.++||.|.||+||+|+++-    ...||||.++... ...+.+|..|+.||.+++||||++|.|+.......+||+|||
T Consensus       633 Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyM  712 (996)
T KOG0196|consen  633 IEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYM  712 (996)
T ss_pred             EEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhh
Confidence            45789999999999999652    3579999999753 346789999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|..||+.+.+    .+.+.+..-++++||.|+.||-+.    ++|||||.++||||+.+..+|++|||+++.++++
T Consensus       713 ENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm----~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  713 ENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhc----CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            99999999998764    488999999999999999999998    9999999999999999999999999999988553


Q ss_pred             c-cccccC------cccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          515 Q-AIARLG------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       515 ~-~~~~~~------~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      . ....|.      .|.|||.+...+++.+||||||||||||.++ |..||...+..               .+-+.+.+
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---------------dVIkaIe~  849 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------------DVIKAIEQ  849 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---------------HHHHHHHh
Confidence            3 222232      3999999999999999999999999999887 99998765321               11122222


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCC
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL  645 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~  645 (670)
                      ++          +.+...++...+.+||+.||++|-.+||.+.|++.+|+++...-...
T Consensus       850 gy----------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  850 GY----------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             cc----------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence            21          22334566778889999999999999999999999999997655433

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=346.69  Aligned_cols=240  Identities=27%  Similarity=0.394  Sum_probs=199.9

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHH
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS  441 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  441 (670)
                      +-||.|+.|.||+|+++ ++.||||+++.-       -+.+|+-|++|+||||+.+.|+|.....+|||||||+.|-|..
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~  201 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE  201 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence            67999999999999997 789999998632       2457888999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---ccccc
Q 036639          442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIA  518 (670)
Q Consensus       442 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~  518 (670)
                      .|+..+     ++.-.....|..+||.|+.|||.+    .|||||||.-||||+.+..+||+|||.++....   ...+.
T Consensus       202 VLka~~-----~itp~llv~Wsk~IA~GM~YLH~h----KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  202 VLKAGR-----PITPSLLVDWSKGIAGGMNYLHLH----KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHhccC-----ccCHHHHHHHHHHhhhhhHHHHHh----hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhh
Confidence            999765     577888899999999999999998    999999999999999999999999999987754   34578


Q ss_pred             ccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhh
Q 036639          519 RLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELL  598 (670)
Q Consensus       519 ~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  598 (670)
                      ||..|||||++...+.++|+||||||||||||+||..||...+..-..   ..-+.+                     ..
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---wGVGsN---------------------sL  328 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---WGVGSN---------------------SL  328 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---EeccCC---------------------cc
Confidence            899999999999999999999999999999999999999754221110   000100                     01


Q ss_pred             cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          599 RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ...-...+..-|.-|+.+||...|..||++.+++.||+....+.
T Consensus       329 ~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  329 HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            11122233334455667999999999999999999999877665

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-40  Score=338.45  Aligned_cols=258  Identities=18%  Similarity=0.301  Sum_probs=202.9

Q ss_pred             ccccHHHHHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcch---HHHHHHHHHHHhccCCCCeeeEEEEEEe--
Q 036639          349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA---RKEFEQYMDVIGKLKHPNVVKLRAYYYA--  423 (670)
Q Consensus       349 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~nIv~l~~~~~~--  423 (670)
                      +.++.+++.......+|+|++|.||+|.+ +|+.||||+++......   .+.+.+|++++.+++||||+++++++.+  
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            34455555433346799999999999998 58999999998653322   4678899999999999999999999877  


Q ss_pred             --CCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          424 --KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       424 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                        ....++||||+++|+|.+++....     .+++.....++.+++.||+|||+.   .+++||||||+||++++++.+|
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~~~~Hrdlkp~nill~~~~~~k  163 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKY---TNKPYKNLTSVSFLVTENYKLK  163 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhc---CCCCCCcCChhhEEECCCCcEE
Confidence              346789999999999999997653     588999999999999999999985   2788999999999999999999


Q ss_pred             EEecccccccCcc-ccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          502 ISDFGLSLLLNPV-QAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       502 l~DFG~a~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      |+|||+++..... ....++..|+|||.+.+  ..++.++|||||||++|||+||+.||....              ...
T Consensus       164 l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--------------~~~  229 (283)
T PHA02988        164 IICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--------------TKE  229 (283)
T ss_pred             EcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--------------HHH
Confidence            9999999865432 23456778999999976  679999999999999999999999996431              111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ............. ++      .   .....+.+++.+||+.||++|||++|+++.|+.+.
T Consensus       230 ~~~~i~~~~~~~~-~~------~---~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        230 IYDLIINKNNSLK-LP------L---DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHHhcCCCCC-CC------C---cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            2222211111100 00      0   12234566777999999999999999999998875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=347.48  Aligned_cols=257  Identities=25%  Similarity=0.344  Sum_probs=203.2

Q ss_pred             HHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      ...+++.||+|.||+||+|+|.  ..||||+++....  ...+.|++|+..+++-+|.||+-+.|||..+.. .||+.+|
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwC  469 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWC  469 (678)
T ss_pred             Hhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhc
Confidence            3356789999999999999986  3599999986543  356889999999999999999999999999888 9999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      +|-+|+.++|..+    ..++..+.+.|+.||++|+.|||.+    +|||||||..|||+.++++|||+|||++......
T Consensus       470 eGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK----~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  470 EGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAK----NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             cCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhh----hhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            9999999999754    3588999999999999999999999    9999999999999999999999999998654321


Q ss_pred             ------ccccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          515 ------QAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       515 ------~~~~~~~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                            ....+...|||||+++.   .+|++.+||||||+|+|||+||..||... ..+..+.....+.-.++       
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmVGrG~l~pd-------  613 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMVGRGYLMPD-------  613 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEecccccCcc-------
Confidence                  12233345999999863   46899999999999999999999999732 22221111111100000       


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCC
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL  645 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~  645 (670)
                                 ..  .....+.+++.+|+..||..++++||.+.+|+..|+++.....+.
T Consensus       614 -----------~s--~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki  660 (678)
T KOG0193|consen  614 -----------LS--KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKI  660 (678)
T ss_pred             -----------ch--hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccccc
Confidence                       00  011233445666777999999999999999999999887654333

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-40  Score=349.11  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=199.1

Q ss_pred             HHHHHHHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCC
Q 036639          354 EDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKE  425 (670)
Q Consensus       354 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~  425 (670)
                      ..-.+.+.+.||+|+||.||+|..      .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            333456678899999999999974      235689999997543 22346788999999999 8999999999887654


Q ss_pred             -eeEEEEeccCCCChHHHhccCCCC-------------------------------------------------------
Q 036639          426 -EKLLVYDYLPNGSLHSLLHGNRGP-------------------------------------------------------  449 (670)
Q Consensus       426 -~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  449 (670)
                       ..++||||+++|+|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             578999999999999998753210                                                       


Q ss_pred             --CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc------cccccC
Q 036639          450 --GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ------AIARLG  521 (670)
Q Consensus       450 --~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~------~~~~~~  521 (670)
                        ...++++.....++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++......      ...++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence              012478889999999999999999998    99999999999999999999999999998653221      122345


Q ss_pred             cccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcc
Q 036639          522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY  600 (670)
Q Consensus       522 ~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  600 (670)
                      .|+|||++.+..++.++|||||||++|||++ |..||......              ..+...........       . 
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--------------~~~~~~~~~~~~~~-------~-  298 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--------------EEFCQRLKDGTRMR-------A-  298 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--------------HHHHHHHhcCCCCC-------C-
Confidence            6999999998899999999999999999997 99998653110              00111111110000       0 


Q ss_pred             cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          601 KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       601 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                        .......+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       299 --~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         299 --PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             --CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence              011123466788899999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=349.51  Aligned_cols=242  Identities=26%  Similarity=0.379  Sum_probs=198.5

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC----Cc-chHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA----NP-CARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+++.||+|.||.|+.|. ..+|+.||+|++...    .. ...+.+.+|+.++++++ ||||+++++++......++||
T Consensus        20 ~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivm   99 (370)
T KOG0583|consen   20 ELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVM   99 (370)
T ss_pred             eeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEE
Confidence            456789999999999998 457899999977653    22 23566778999999998 999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-CcEEEEecccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLL  510 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~  510 (670)
                      ||+.+|+|.+++....     .+.+.....++.|++.|++|+|+.    +|+||||||+|||+|.+ +++||+|||++..
T Consensus       100 Ey~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~----gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~  170 (370)
T KOG0583|consen  100 EYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSR----GIVHRDLKPENILLDGNEGNLKLSDFGLSAI  170 (370)
T ss_pred             EecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence            9999999999998743     478899999999999999999998    99999999999999999 9999999999998


Q ss_pred             cC----ccccccccCcccCccccccCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          511 LN----PVQAIARLGGYKAPEQAEVKR-LS-QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       511 ~~----~~~~~~~~~~y~aPE~~~~~~-~~-~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ..    ......|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..              +.+...+.+.
T Consensus       171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--------------~~~~l~~ki~  236 (370)
T KOG0583|consen  171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--------------NVPNLYRKIR  236 (370)
T ss_pred             cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--------------cHHHHHHHHh
Confidence            72    245678899999999999877 86 7899999999999999999999763              2333333322


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....         -.....  -.++..++.+|+..||.+|+|+.|++++
T Consensus       237 ~~~~~---------~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  237 KGEFK---------IPSYLL--SPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             cCCcc---------CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            22111         001110  2234556679999999999999999953

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.8e-41  Score=341.39  Aligned_cols=241  Identities=24%  Similarity=0.389  Sum_probs=204.8

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      |.+.+.||+|.||.||||+. .+.+.||+|.+.+...  ...+.+.+|++++++++|||||.++++|+...+.++|.||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            45678899999999999994 4789999999986533  34567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      .+ +|..++....     .+++..+..++.+++.||.|||+.    +|+|||+||.|||++..|.+|++|||+|+.+...
T Consensus        84 ~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~----rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   84 VG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSN----RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhc----CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            66 9999998765     599999999999999999999998    9999999999999999999999999999988653


Q ss_pred             c----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 Q----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ~----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .    ...||+-|||||...+..|+..+|+||+|||+||+++|++||...              .+...++.+..+... 
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------------si~~Lv~~I~~d~v~-  218 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------------SITQLVKSILKDPVK-  218 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------------HHHHHHHHHhcCCCC-
Confidence            3    467899999999999999999999999999999999999999643              344444444443211 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                                 ........+..++...|.+||.+|.|-.+++.|
T Consensus       219 -----------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 -----------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -----------CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                       011222345566679999999999999999875

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=371.94  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=207.2

Q ss_pred             HHhHcCCCCceEEEEEEEcC--CC----EEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLDD--GG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      ..+.||+|+||.||+|...+  |.    .||||.+++. +.....+|.+|..+|++++|||||+++|+|.+....+|++|
T Consensus       696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le  775 (1025)
T KOG1095|consen  696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE  775 (1025)
T ss_pred             eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence            35689999999999999543  43    4999999865 45567899999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          433 YLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      ||++|+|..||++.+..  ....+...+.+.++.|||+|+.||+++    ++|||||.++|+||++...|||+|||+|+.
T Consensus       776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~----~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK----HFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC----CCcCcchhhhheeecccCcEEEcccchhHh
Confidence            99999999999976421  134688999999999999999999998    999999999999999999999999999995


Q ss_pred             cCccccccc----c--CcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          511 LNPVQAIAR----L--GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       511 ~~~~~~~~~----~--~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      +...+.+..    .  ..|||||.+..+.++.|+|||||||+|||++| |..||...+..           ++   +...
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-----------~v---~~~~  917 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-----------EV---LLDV  917 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-----------HH---HHHH
Confidence            544332211    1  24999999999999999999999999999999 78888654211           11   1111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ....           +......+...+.++|..||+.+|++||++..+++.+..+....
T Consensus       918 ~~gg-----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  918 LEGG-----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             HhCC-----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            1111           12233445566778999999999999999999999999887654

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=337.78  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=205.9

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.++||+|.||+|.+++...+..||||+++..... .+++|.+|+++|.+++|||||+++|+|..++..++|+|||++|
T Consensus       541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG  620 (807)
T KOG1094|consen  541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG  620 (807)
T ss_pred             ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence            357899999999999999988899999999976544 4589999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccccc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI  517 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  517 (670)
                      +|.+|+.++..+.   +.-..-.+|+.||+.|++||.+-    ++|||||.++|+|+|.++++||+|||+++.+...+.+
T Consensus       621 DLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~----nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  621 DLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESL----NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             cHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhh----chhhccccccceeecCcccEEecCcccccccccCCce
Confidence            9999998775322   34556678999999999999987    9999999999999999999999999999977554443


Q ss_pred             ccc------CcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          518 ARL------GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT--GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       518 ~~~------~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ...      ..|||||.+..++++.++|||+||+++||+++  ...||...+..           ...+-...+.+....
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-----------~vven~~~~~~~~~~  762 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-----------QVVENAGEFFRDQGR  762 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-----------HHHHhhhhhcCCCCc
Confidence            322      35999999999999999999999999999876  67788643211           111112222222111


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ..+.       ....-+...+.+++++||..|-++||+++++..+|++.
T Consensus       763 ~~~l-------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  763 QVVL-------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ceec-------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1111       11233445677899999999999999999999999864

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-40  Score=344.81  Aligned_cols=246  Identities=26%  Similarity=0.359  Sum_probs=205.9

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +++.||.|+.|.|.+|+ ..+|+.+|||++.+..   ......+++|+-+|+.+.||||+++++++++..+.|+|.||++
T Consensus        16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~   95 (786)
T KOG0588|consen   16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP   95 (786)
T ss_pred             ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence            46789999999999999 5689999999998652   2235678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|-|++++-..+     ++++.+..+++.||+.|+.|+|..    +|+|||+||+|+|+|..+++||+|||+|....+. 
T Consensus        96 gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~----~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   96 GGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAF----NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             CchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhh----cceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            999999998665     588999999999999999999998    9999999999999999999999999999876553 


Q ss_pred             --ccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        +...|.+.|.|||++.+.+| +.++||||+|||||-|+||+.||++.              ++...+.+.....+.. 
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------------Nir~LLlKV~~G~f~M-  231 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------------NIRVLLLKVQRGVFEM-  231 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------------cHHHHHHHHHcCcccC-
Confidence              46778888999999999998 47999999999999999999999854              3334333333322111 


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                              ..++..+.+.   |+.+|+..||++|.|++||++|---..-
T Consensus       232 --------Ps~Is~eaQd---LLr~ml~VDp~~RiT~~eI~kHP~l~g~  269 (786)
T KOG0588|consen  232 --------PSNISSEAQD---LLRRMLDVDPSTRITTEEILKHPFLSGY  269 (786)
T ss_pred             --------CCcCCHHHHH---HHHHHhccCccccccHHHHhhCchhhcC
Confidence                    1233444444   5559999999999999999998654443

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=343.77  Aligned_cols=253  Identities=31%  Similarity=0.444  Sum_probs=204.0

Q ss_pred             HHHhHcCCCCceEEEEEEEcC--C--CE-EEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD--G--GI-VAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      ...++||+|+||.||+|.+..  +  .. ||||..+..   .....++|.+|+++++.++|||||+++|++......++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            345899999999999999543  2  23 899999852   345678899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      ||+|.||+|.++|+....    .++..+++.++.++|.||+|||+.    +++||||.++|+|++.++.+||+|||+++.
T Consensus       240 mEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k----~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSK----NCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             EEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHC----CCcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999998752    489999999999999999999998    999999999999999999999999999887


Q ss_pred             cCcccccc----ccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHh-
Q 036639          511 LNPVQAIA----RLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV-  584 (670)
Q Consensus       511 ~~~~~~~~----~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  584 (670)
                      -.......    --..|+|||.+....|++++|||||||++||+++ |..||.+....               .++..+ 
T Consensus       312 ~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---------------~v~~kI~  376 (474)
T KOG0194|consen  312 GSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---------------EVKAKIV  376 (474)
T ss_pred             CcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---------------HHHHHHH
Confidence            65222111    1235999999999999999999999999999999 88898764211               122222 


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP  644 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~  644 (670)
                      ...+....       ......   .+..++.+||..+|++||||.++.+.++.+......
T Consensus       377 ~~~~r~~~-------~~~~p~---~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  377 KNGYRMPI-------PSKTPK---ELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             hcCccCCC-------CCCCHH---HHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            22222111       112233   344455599999999999999999999999876654

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=353.62  Aligned_cols=268  Identities=19%  Similarity=0.283  Sum_probs=215.1

Q ss_pred             ccccHHHHHHHHHhHcCCCCceEEEEEEEcCC-CEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEE-EEEeC-
Q 036639          349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDG-GIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRA-YYYAK-  424 (670)
Q Consensus       349 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~-~~~~~-  424 (670)
                      ..|++.....++.+.|.+|||+.||.|+...+ ..||+|++-..+....+.+.+|+++|++|. |+|||.+++ ..... 
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            34555555566778999999999999996655 999999998778888899999999999996 999999999 33221 


Q ss_pred             -----CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc
Q 036639          425 -----EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV  499 (670)
Q Consensus       425 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  499 (670)
                           -+.+|+||||.+|.|-+++.....   ..+.+.++++|+.|+++|+++||..  +++|||||||-+||||+.++.
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~  184 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGN  184 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCC
Confidence                 367899999999999999985432   2389999999999999999999987  678999999999999999999


Q ss_pred             EEEEecccccccCc-------------cccccccCcccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 036639          500 ACISDFGLSLLLNP-------------VQAIARLGGYKAPEQA---EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT  563 (670)
Q Consensus       500 ~kl~DFG~a~~~~~-------------~~~~~~~~~y~aPE~~---~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~  563 (670)
                      .||||||.+.....             .-....|+.|+|||.+   .+..+++|+|||++||+||-|+....||+.....
T Consensus       185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l  264 (738)
T KOG1989|consen  185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL  264 (738)
T ss_pred             EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence            99999999864321             1124567889999986   5677999999999999999999999999754111


Q ss_pred             CCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                                                 .+++.... ++........|.+||..||+.||.+||++-||+..+.++.....
T Consensus       265 ---------------------------aIlng~Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  265 ---------------------------AILNGNYS-FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             ---------------------------eEEecccc-CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                                       01111111 11123344567778889999999999999999999999998876


Q ss_pred             CCCCcc
Q 036639          644 PLGEEY  649 (670)
Q Consensus       644 ~~~~~~  649 (670)
                      +..+-+
T Consensus       317 ~~~~~~  322 (738)
T KOG1989|consen  317 PIPDIY  322 (738)
T ss_pred             Cccccc
Confidence            665544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=311.83  Aligned_cols=200  Identities=26%  Similarity=0.382  Sum_probs=179.5

Q ss_pred             ccHHHHHHHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcch---HHHHHHHHHHHhccCCCCeeeEEEEEEeCCe
Q 036639          351 FELEDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCA---RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE  426 (670)
Q Consensus       351 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~  426 (670)
                      +.+++.  .+.+.||.|.||+|.+++. .+|..+|+|++++.....   .+...+|..+|+.+.||+++++++.|.+...
T Consensus        41 ~~l~df--e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~  118 (355)
T KOG0616|consen   41 YSLQDF--ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN  118 (355)
T ss_pred             cchhhh--hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence            344444  4567899999999999995 468999999998765433   3556789999999999999999999999999


Q ss_pred             eEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       427 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      .||||||++||.|..+++..+     .++.....-++.+|+.||+|||+.    +|++|||||+|||+|.+|.+||+|||
T Consensus       119 lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~----~iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  119 LYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSL----DIIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             EEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhc----CeeeccCChHHeeeccCCcEEEEecc
Confidence            999999999999999999765     589999999999999999999998    99999999999999999999999999


Q ss_pred             cccccCc-cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 036639          507 LSLLLNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS  561 (670)
Q Consensus       507 ~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~  561 (670)
                      .|+.+.. .-...||+.|+|||.+....++.++|-|||||++|||+.|.+||....
T Consensus       190 FAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  190 FAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             ceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence            9998865 446789999999999999999999999999999999999999997653

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-39  Score=318.80  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=211.1

Q ss_pred             HHHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          356 LLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       356 ~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+|++.+.||+|.||.|-+|. ...|+.||||.+++.   +.++.-.+++|++||+.|+||||+.++.+|++.+...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            456777899999999999999 578999999999865   3345566889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||..+|.|++|+.+.+     .+++.....+++||..|+.|+|.+    +++|||||.+|||+|.++++||+|||++..+
T Consensus       133 EYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHkn----rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  133 EYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKN----RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhc----cceecccchhheeecCCCCeeeeccchhhhh
Confidence            9999999999998765     599999999999999999999988    9999999999999999999999999999887


Q ss_pred             Ccc---ccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          512 NPV---QAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       512 ~~~---~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ...   +.+.|++-|.+||++.+.+| .+.+|-||+||+||-|+.|..||++.              +....++++-...
T Consensus       204 ~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------------Dhk~lvrQIs~Ga  269 (668)
T KOG0611|consen  204 ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------------DHKRLVRQISRGA  269 (668)
T ss_pred             ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------------hHHHHHHHhhccc
Confidence            654   46778888999999999988 58999999999999999999999875              2233344433332


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCC
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL  645 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~  645 (670)
                      +...         ...    ....-|+++||..+|++|.|+.+|..|..--.....+.
T Consensus       270 YrEP---------~~P----SdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy~~~V  314 (668)
T KOG0611|consen  270 YREP---------ETP----SDASGLIRWMLMVNPERRATIEDIASHWWVNWGYNMPV  314 (668)
T ss_pred             ccCC---------CCC----chHHHHHHHHHhcCcccchhHHHHhhhheeeccccccc
Confidence            2111         011    11223677899999999999999999976433333333

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.6e-39  Score=332.97  Aligned_cols=257  Identities=21%  Similarity=0.343  Sum_probs=194.8

Q ss_pred             HHHhHcCCCCceEEEEEEEcC-----------------CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD-----------------GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAY  420 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~  420 (670)
                      .+.+.||+|+||.||+|.+++                 +..||+|.+.... .....++.+|++++.+++||||++++++
T Consensus         8 ~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~   87 (304)
T cd05096           8 LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGV   87 (304)
T ss_pred             eeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEE
Confidence            445789999999999998532                 3479999997643 3345679999999999999999999999


Q ss_pred             EEeCCeeEEEEeccCCCChHHHhccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccC
Q 036639          421 YYAKEEKLLVYDYLPNGSLHSLLHGNRG--------------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGN  486 (670)
Q Consensus       421 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~D  486 (670)
                      +.+.+..++||||+++|+|.+++.....              .....++|..+.+++.|++.||+|||+.    +|+|||
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~ivH~d  163 (304)
T cd05096          88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL----NFVHRD  163 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC----CccccC
Confidence            9999999999999999999999864321              1113478899999999999999999998    999999


Q ss_pred             CCCCCeEeCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCC
Q 036639          487 VKSSNVLLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT--GRAPSQ  558 (670)
Q Consensus       487 lkp~NIll~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--g~~p~~  558 (670)
                      |||+|||++.++.+||+|||+++......      ...++..|+|||++....++.++||||||+++|||++  +..||.
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            99999999999999999999998664322      1223456999999988889999999999999999987  456665


Q ss_pred             CCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          559 YPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      ..+.           ......+......... ...   ...   .......+.+++.+||+.||++|||+.||.+.|++
T Consensus       244 ~~~~-----------~~~~~~~~~~~~~~~~-~~~---~~~---~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         244 ELTD-----------EQVIENAGEFFRDQGR-QVY---LFR---PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCH-----------HHHHHHHHHHhhhccc-ccc---ccC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            3211           0111111111111100 000   000   01122356778889999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=331.90  Aligned_cols=240  Identities=26%  Similarity=0.407  Sum_probs=201.1

Q ss_pred             HhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|.||.||+|. ..+++.||+|++.-... ...+++++|+.++..++++||.++++.+..+...+++||||.+|+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            3689999999999999 45789999999985533 346889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----V  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~  514 (670)
                      +.+.++...     .+++..+.-++++++.||.|||.+    +.+|||||+.|||+..+|.+||+|||.+..+..    .
T Consensus        98 v~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~----~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   98 VLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSE----KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             hhhhhccCC-----CCccceeeeehHHHHHHhhhhhhc----ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence            999998764     347777788899999999999998    999999999999999999999999999987754    3


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ..+.||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+....+.+..+.+......                .++
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP----------------~L~  232 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP----------------RLD  232 (467)
T ss_pred             ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC----------------ccc
Confidence            5678899999999999889999999999999999999999999887665444332221110                000


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          .  ...   ..+.+++..||..||+.||+|.++++|
T Consensus       233 ----~--~~S---~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  233 ----G--DFS---PPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ----c--ccC---HHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                0  111   234445669999999999999999985

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6e-39  Score=337.16  Aligned_cols=194  Identities=26%  Similarity=0.414  Sum_probs=170.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||+|+||.||+++.. +|..||+|.+... .....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   87 (331)
T cd06649           8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   87 (331)
T ss_pred             eEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCC
Confidence            44578999999999999965 6889999998754 233456799999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--c
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--V  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--~  514 (670)
                      ++|.+++....     .+++..+..++.|++.||.|||+.   .+|+||||||+|||++.++.+||+|||++.....  .
T Consensus        88 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  159 (331)
T cd06649          88 GSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREK---HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA  159 (331)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhc---CCEEcCCCChhhEEEcCCCcEEEccCccccccccccc
Confidence            99999997643     488999999999999999999985   2699999999999999999999999999976543  2


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ....++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            2345778899999999889999999999999999999999999643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.1e-39  Score=337.22  Aligned_cols=238  Identities=22%  Similarity=0.280  Sum_probs=192.2

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||++.. .+|+.||||+++...   ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999995 578999999997532   223456778999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....    
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~  151 (323)
T cd05571          81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSC----DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc
Confidence            9999987643     588999999999999999999998    999999999999999999999999999875422    


Q ss_pred             cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      .....++..|+|||++.+..++.++|||||||++|||+||+.||....              .............     
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------------~~~~~~~~~~~~~-----  212 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------------HEKLFELILMEEI-----  212 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------------HHHHHHHHHcCCC-----
Confidence            223457888999999998999999999999999999999999996431              1111111111110     


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                          .......+   .+.+++.+||+.||++||     ++.|+++|
T Consensus       213 ----~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         213 ----RFPRTLSP---EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             ----CCCCCCCH---HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                00011222   345566799999999999     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-38  Score=339.96  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=197.8

Q ss_pred             HHHHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeE
Q 036639          357 LRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  428 (670)
                      .+.+.+.||+|+||.||+|..      .++..||||+++... ....+.+.+|++++..+ +||||++++++|.+.+..+
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            446678999999999999973      245689999997543 33456788999999999 8999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCCC-----------------------------------------------------------
Q 036639          429 LVYDYLPNGSLHSLLHGNRGP-----------------------------------------------------------  449 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------------  449 (670)
                      +||||+++|+|.++++.....                                                           
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence            999999999999998653210                                                           


Q ss_pred             -----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc--
Q 036639          450 -----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--  516 (670)
Q Consensus       450 -----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  516 (670)
                                 ....+++..+.+++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++.......  
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                       012578899999999999999999987    999999999999999999999999999986643221  


Q ss_pred             ----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          517 ----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       517 ----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ...+..|+|||++.+..++.++|||||||++|||++ |..||......          ..+.+.    +.......
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----------~~~~~~----~~~~~~~~  337 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----------SKFYKM----IKEGYRML  337 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----------HHHHHH----HHhCccCC
Confidence                122345999999999999999999999999999998 88888543110          011111    11111000


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                             .....   ..++.+++.+||+.||++|||+.||+++|++.
T Consensus       338 -------~~~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 -------SPECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -------CCCCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence                   00011   13466778899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-39  Score=329.71  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=217.2

Q ss_pred             cccccHHHHHHHHHhHcCCCCceEEEEEEEcC---C--CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEE
Q 036639          348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDD---G--GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYY  421 (670)
Q Consensus       348 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---g--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~  421 (670)
                      .+++++........++||.|.||.||+|.+.+   |  -.||||..+.. .+...+.|..|.-+|+.++|||||+++|+|
T Consensus       381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence            34677766666778999999999999999543   3  35999999874 555678999999999999999999999999


Q ss_pred             EeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       422 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                      .+. ..++|||.++-|.|.++++.++.    .++......++.||..||+|||+.    ++|||||..+||||.....+|
T Consensus       461 ~e~-P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSk----rfVHRDIAaRNiLVsSp~CVK  531 (974)
T KOG4257|consen  461 VEQ-PMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESK----RFVHRDIAARNILVSSPQCVK  531 (974)
T ss_pred             ecc-ceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhh----chhhhhhhhhheeecCcceee
Confidence            754 58999999999999999987652    588899999999999999999998    999999999999999999999


Q ss_pred             EEecccccccCccccccccCc-----ccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccc
Q 036639          502 ISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVD  575 (670)
Q Consensus       502 l~DFG~a~~~~~~~~~~~~~~-----y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  575 (670)
                      |+|||+++.++....+..+.+     |||||.+...+++.++|||-|||.|||++. |..||.+....+... ..+.+..
T Consensus       532 LaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-~iEnGeR  610 (974)
T KOG4257|consen  532 LADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-HIENGER  610 (974)
T ss_pred             ecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-EecCCCC
Confidence            999999999987766555443     999999999999999999999999999987 999998764332221 1122211


Q ss_pred             hhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      +                        +..+.+...+..++.+||.+||.+||++.|+...|.++..+++
T Consensus       611 l------------------------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek  654 (974)
T KOG4257|consen  611 L------------------------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK  654 (974)
T ss_pred             C------------------------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence            1                        1223344456678889999999999999999999999987653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=317.17  Aligned_cols=260  Identities=23%  Similarity=0.286  Sum_probs=196.5

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCC--CCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe-----CCeeEEEEe
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-----KEEKLLVYD  432 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-----~~~~~lv~e  432 (670)
                      .+.||+|+||.|+.+.. .+|+.||||++..  ......++..+|+++++.++|+||+.+++.+..     -...|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            46799999999999994 5799999999983  344567888999999999999999999999865     246799999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      +| +.+|...++..+     .++......++.|+++||.|+|+.    +|+||||||+|+|++.+...||+|||+|+...
T Consensus       107 lM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSA----nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  107 LM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSA----NVIHRDLKPSNLLLNADCDLKICDFGLARYLD  176 (359)
T ss_pred             HH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcc----cccccccchhheeeccCCCEEeccccceeecc
Confidence            99 669999998764     488899999999999999999998    99999999999999999999999999999885


Q ss_pred             c------cccccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH-----
Q 036639          513 P------VQAIARLGGYKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV-----  580 (670)
Q Consensus       513 ~------~~~~~~~~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  580 (670)
                      .      ...+..|..|+|||.+. ...|+.+.||||.|||+.||++|++.|.+.+.........+..+......     
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            3      13456778899999874 56799999999999999999999999977643221111111111111111     


Q ss_pred             ----HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 ----RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ----~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          +..+.......-.. -...++.....   .++++.+||..||.+|+|++|+++|
T Consensus       257 s~~ar~yi~slp~~p~~~-f~~~fp~a~p~---AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQP-FSSIFPNANPL---AIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             cHHHHHHHHhCCCCCCCC-HHHHcCCCCHH---HHHHHHHHhccCccccCCHHHHhcC
Confidence                11111100000000 00012233333   4455569999999999999999987

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.9e-40  Score=343.07  Aligned_cols=241  Identities=20%  Similarity=0.281  Sum_probs=194.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||.||+|+.. +++.||||+++...   ....+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        21 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~  100 (329)
T PTZ00263         21 EMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFV  100 (329)
T ss_pred             EEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCC
Confidence            34578999999999999964 68999999997532   223467889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....
T Consensus       101 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263        101 VGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSK----DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             CCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999997643     478888999999999999999998    9999999999999999999999999999876542


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+++.|+|||++.+..++.++|||||||++|||+||+.||....+              .............    
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------------~~~~~~i~~~~~~----  233 (329)
T PTZ00263        172 TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------------FRIYEKILAGRLK----  233 (329)
T ss_pred             cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------------HHHHHHHhcCCcC----
Confidence             235678889999999988999999999999999999999999964311              1111111111000    


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                           .......   .+.+++.+||+.||++||+     ++|+++|
T Consensus       234 -----~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 -----FPNWFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----CCCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 0001112   3456777999999999997     6888876

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=336.23  Aligned_cols=240  Identities=20%  Similarity=0.292  Sum_probs=194.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|... +|+.||+|++....   ....+.+.+|++++++++||||+++++++.+....++||||++
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   84 (291)
T cd05612           5 RIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVP   84 (291)
T ss_pred             eeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCC
Confidence            4578999999999999965 68999999996432   1234668899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 ~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          85 GGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSK----EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            999999997653     588899999999999999999998    9999999999999999999999999999876442 


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....+++.|+|||++.+..++.++|||||||++|||+||+.||.....              .............   + 
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------------~~~~~~i~~~~~~---~-  217 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------------FGIYEKILAGKLE---F-  217 (291)
T ss_pred             ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHhCCcC---C-
Confidence            234578889999999988899999999999999999999999964311              1111111111100   0 


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                           .....   ..+.+++.+||+.||.+||+     ++|+++|
T Consensus       218 -----~~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 -----PRHLD---LYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -----CccCC---HHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                 00111   23456777999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-40  Score=305.58  Aligned_cols=262  Identities=21%  Similarity=0.307  Sum_probs=205.7

Q ss_pred             HHHHHHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----Ce
Q 036639          353 LEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EE  426 (670)
Q Consensus       353 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~  426 (670)
                      +.+-+|++.+.||.|||+-||+++ ..++..||+|++........+...+|++..++++||||++++++....     .+
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            344455667889999999999999 778999999999877766788999999999999999999999887543     35


Q ss_pred             eEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       427 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      .|++++|...|+|.+.+......+ ..+++.+.+.|+.+|.+||++||+.  .++++||||||.|||+++++.++|.|||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg-~~~sE~~iL~if~gic~gL~~lH~~--~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKG-NFVSEAQILWIFLGICRGLEALHEK--EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcC-CccCHHHHHHHHHHHHHHHHHHhcc--CCcccccCCCcceeEecCCCceEEEecc
Confidence            899999999999999987654322 3589999999999999999999998  3469999999999999999999999999


Q ss_pred             cccccCc-------------cccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccc
Q 036639          507 LSLLLNP-------------VQAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       507 ~a~~~~~-------------~~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~  570 (670)
                      .+....-             ......|..|+|||.+.   +...++++|||||||++|+|+.|..||+..-.        
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------  246 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------  246 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence            9886532             11233466799999884   45678999999999999999999999975311        


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                       ++..+.            -.+....+..+ +.......+.+++..|++.||.+||++.|++.+++.+.
T Consensus       247 -~GgSla------------LAv~n~q~s~P-~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 -QGGSLA------------LAVQNAQISIP-NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -cCCeEE------------EeeeccccccC-CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence             111111            01111111111 11113345667777999999999999999999998753

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=331.56  Aligned_cols=236  Identities=23%  Similarity=0.322  Sum_probs=190.2

Q ss_pred             cCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ||+|+||.||+|... +++.||+|+++..   .......+..|++++.+++||||+++++++.+.+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999954 6889999998743   223446678899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----cc
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----VQ  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~~  515 (670)
                      .+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....    ..
T Consensus        81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  151 (312)
T cd05585          81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKF----NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN  151 (312)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccc
Confidence            99997543     488999999999999999999998    999999999999999999999999999976432    22


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||++.+..++.++|||||||++|||+||+.||...              ..............       
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~--------------~~~~~~~~~~~~~~-------  210 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE--------------NVNEMYRKILQEPL-------  210 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC--------------CHHHHHHHHHcCCC-------
Confidence            345788899999999999999999999999999999999999643              11222222222110       


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPT---MAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  634 (670)
                        .......   ..+.+++.+||+.||++||+   +.|+++|
T Consensus       211 --~~~~~~~---~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         211 --RFPDGFD---RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             --CCCCcCC---HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence              0001122   23456677999999999974   6777765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.4e-38  Score=331.51  Aligned_cols=197  Identities=25%  Similarity=0.392  Sum_probs=172.2

Q ss_pred             HHHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          356 LLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       356 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      -.|.+.+.||+|+||.||++... ++..||+|.+... .....+.+.+|++++++++|+||++++++|.+.++.++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            34566788999999999999965 6889999998754 233456789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.+++....     .+++.....++.|++.||+|||+.   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          85 MDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999997543     478899999999999999999975   2799999999999999999999999999976533


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                        .....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         157 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence              22345777899999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3e-38  Score=321.44  Aligned_cols=248  Identities=21%  Similarity=0.329  Sum_probs=196.6

Q ss_pred             HHHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          358 RASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.+.||+|+||.||+|.++    .+..||+|.++... ......+.+|+..+.+++||||+++++++...+..++|||
T Consensus         7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   86 (266)
T cd05064           7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE   86 (266)
T ss_pred             eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence            345678999999999999853    35789999998653 2334678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++|+|.+++....    ..+++..++.++.|++.||+|||+.    +++||||||+||+++.++.+|++|||.+....
T Consensus        87 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~----~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          87 YMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEM----GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             eCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            999999999997543    2588999999999999999999988    99999999999999999999999999876543


Q ss_pred             ccc-----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          513 PVQ-----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       513 ~~~-----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ...     ...++..|+|||.+.+..++.++|||||||++||+++ |+.||.....              ...... +.+
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------------~~~~~~-~~~  223 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------------QDVIKA-VED  223 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------------HHHHHH-HHC
Confidence            221     1223456999999998999999999999999999875 9999864311              111111 111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ....          .........+.+++.+||+.+|++||+++|+++.|.++
T Consensus       224 ~~~~----------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         224 GFRL----------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCC----------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            1000          00111223466777899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=324.92  Aligned_cols=194  Identities=29%  Similarity=0.398  Sum_probs=170.9

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcch---HHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCA---RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.++||+|+||+||+|+ ..+|..+|+|++++.....   .+.+..|-++|...++|+||+++-.|.+.+..||||||+
T Consensus       144 e~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEyl  223 (550)
T KOG0605|consen  144 ELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYL  223 (550)
T ss_pred             hhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEec
Confidence            456789999999999999 5579999999999765433   456778999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      +||++..+|....     .+++.....++.+.+.|+.-+|..    |+|||||||+|+|||..|++||+|||++.-+.. 
T Consensus       224 PGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~----gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  224 PGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQL----GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK  294 (550)
T ss_pred             CCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHc----CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence            9999999998665     588889999999999999999998    999999999999999999999999999852210 


Q ss_pred             ------------------------c--------------------------ccccccCcccCccccccCCCCCchhHHHH
Q 036639          514 ------------------------V--------------------------QAIARLGGYKAPEQAEVKRLSQKADVYSF  543 (670)
Q Consensus       514 ------------------------~--------------------------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~  543 (670)
                                              .                          ....|||.|||||++.+..|+..+|.||+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence                                    0                          01245777999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCC
Q 036639          544 GVLLLEVLTGRAPSQYPS  561 (670)
Q Consensus       544 Gvvl~elltg~~p~~~~~  561 (670)
                      |||||||+.|.+||...+
T Consensus       375 G~ImyEmLvGyPPF~s~t  392 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSET  392 (550)
T ss_pred             HHHHHHHHhCCCCCCCCC
Confidence            999999999999998653

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-38  Score=328.13  Aligned_cols=245  Identities=22%  Similarity=0.283  Sum_probs=193.3

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||++.. .+|+.||+|.+.....   .....+.+|++++.+++|+||+++++++.+.+..++||||+++
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05631           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence            46799999999999995 5799999999875321   2334577899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||++......  
T Consensus        85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05631          85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRE----RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET  157 (285)
T ss_pred             CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence            99998876432   12588999999999999999999998    9999999999999999999999999999875432  


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....++..|+|||++.+..++.++|||||||++|||++|+.||......           .....+........     
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~-----  221 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----------VKREEVDRRVKEDQ-----  221 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----------hhHHHHHHHhhccc-----
Confidence             2345678899999999999999999999999999999999999754211           00011111111100     


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                         ........   ..+.+++.+||+.||++||+     ++|++++
T Consensus       222 ---~~~~~~~s---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 ---EEYSEKFS---EDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ---ccCCccCC---HHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence               00001112   24556777999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.5e-39  Score=336.83  Aligned_cols=238  Identities=23%  Similarity=0.320  Sum_probs=192.2

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||++.. .+|+.||||++....   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999995 468999999997532   223467788999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....    
T Consensus        81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~  151 (328)
T cd05593          81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSG----KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT  151 (328)
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc
Confidence            9999887543     588999999999999999999998    999999999999999999999999999876432    


Q ss_pred             cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||.....              ............   .+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------------~~~~~~~~~~~~---~~  214 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------------EKLFELILMEDI---KF  214 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------------HHHHHHhccCCc---cC
Confidence            1234578889999999988999999999999999999999999964311              111111111110   00


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                            ......   .+.+++.+||+.||++||     ++.|+++|
T Consensus       215 ------p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 ------PRTLSA---DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             ------CCCCCH---HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                  011222   345566799999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=317.33  Aligned_cols=256  Identities=27%  Similarity=0.447  Sum_probs=199.7

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhc--cCCCCeeeEEEEEEeCC----eeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK--LKHPNVVKLRAYYYAKE----EKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~e~~  434 (670)
                      .+.||+|.||+||+|.++ |..||||++...+   ++.+.+|.++.+.  |+|+||+.+++.-..+.    +.+||++|.
T Consensus       216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYH  291 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYH  291 (513)
T ss_pred             EEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecc
Confidence            367999999999999998 8999999998664   4556677777764  59999999998765443    568999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHh----CCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE----YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +.|+|+|||...      .++....++++..+|.||+|||..    .++|.|.|||||+.||||.+++...|+|+|+|..
T Consensus       292 e~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  292 EHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             cCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            999999999875      489999999999999999999976    3578899999999999999999999999999977


Q ss_pred             cCc--------cccccccCcccCccccccCC----C--CCchhHHHHHHHHHHHHcC----------CCCCCCCCCCCCC
Q 036639          511 LNP--------VQAIARLGGYKAPEQAEVKR----L--SQKADVYSFGVLLLEVLTG----------RAPSQYPSPTRPR  566 (670)
Q Consensus       511 ~~~--------~~~~~~~~~y~aPE~~~~~~----~--~~ksDVwS~Gvvl~elltg----------~~p~~~~~~~~~~  566 (670)
                      ...        .....||..|||||++....    +  -..+||||||.|+||+.-+          +.||.+.-+.++.
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence            644        23467888999999985432    2  2469999999999999753          4566655444443


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ++...+.          +    ..+-+.+.+...-...+.+..+.++|..||..+|..|.|+-.+-+.|.++..
T Consensus       446 ~eeMrkV----------V----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  446 FEEMRKV----------V----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHhcc----------e----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            3222111          1    0111111111112345778889999999999999999999999999998874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=318.85  Aligned_cols=252  Identities=23%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc--------------chHHHHHHHHHHHhccCCCCeeeEEEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP--------------CARKEFEQYMDVIGKLKHPNVVKLRAYYYA  423 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~  423 (670)
                      .+.+.||+|.||.|-+|+ ..+++.||||++.+...              ...+.+.+|+.+|++++|||||+++++..+
T Consensus       100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD  179 (576)
T KOG0585|consen  100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD  179 (576)
T ss_pred             ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence            456789999999999999 45799999999964311              123588999999999999999999999887


Q ss_pred             C--CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          424 K--EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       424 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                      .  +..|||+|||..|.+...-..     ...+...+.++++.++..||+|||.+    +||||||||+|+||+++|++|
T Consensus       180 P~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Q----giiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  180 PESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQ----GIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             cccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEEcCCCcEE
Confidence            5  478999999998887543221     11389999999999999999999998    999999999999999999999


Q ss_pred             EEecccccccCc---------cccccccCcccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCc
Q 036639          502 ISDFGLSLLLNP---------VQAIARLGGYKAPEQAEVKR----LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVD  568 (670)
Q Consensus       502 l~DFG~a~~~~~---------~~~~~~~~~y~aPE~~~~~~----~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~  568 (670)
                      |+|||.+.....         -....||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+.        
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~--------  322 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD--------  322 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc--------
Confidence            999999986621         12367899999999987632    357899999999999999999999754        


Q ss_pred             ccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          569 EEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                            .......++..+.         + .++...+.-..+-+|+.++|.+||++|.+..+|..|..-....+.
T Consensus       323 ------~~~~l~~KIvn~p---------L-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  323 ------FELELFDKIVNDP---------L-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             ------hHHHHHHHHhcCc---------c-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence                  1122222222221         1 111122333445566779999999999999999998766555443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-39  Score=299.18  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             ccccHHHHHHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC
Q 036639          349 KQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK  424 (670)
Q Consensus       349 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  424 (670)
                      +.++++++  .+++.||+|.||.||.|+ .+++-.||+|++.+..   .....++.+|+++-+.|+||||++++++|.+.
T Consensus        17 ~~~~l~df--eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   17 KTWTLDDF--EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccchhhc--cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            35666666  578999999999999999 5578899999997642   23567899999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      ...||++||.++|.+...+.+.+.   ..++......++.|+|.||.|+|..    +|+||||||+|+|++.++..||+|
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k----~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLK----RVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccC----CcccCCCCHHHhccCCCCCeeccC
Confidence            999999999999999999985542   2477888889999999999999988    999999999999999999999999


Q ss_pred             cccccccCc--cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          505 FGLSLLLNP--VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       505 FG~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      ||.+.....  .....||.-|.+||...+...+.++|+|++|++.||++.|.+||....              ..+..+.
T Consensus       168 fGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------------~~etYkr  233 (281)
T KOG0580|consen  168 FGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------------HSETYKR  233 (281)
T ss_pred             CCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------------hHHHHHH
Confidence            999876542  345678888999999999999999999999999999999999996431              1111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      +.+-    +..++     ..+..+.   .+++.+|+..+|.+|.+..|++.|--
T Consensus       234 I~k~----~~~~p-----~~is~~a---~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  234 IRKV----DLKFP-----STISGGA---ADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             HHHc----cccCC-----cccChhH---HHHHHHHhccCccccccHHHHhhhHH
Confidence            1111    11111     2333333   44666999999999999999998743

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-38  Score=333.00  Aligned_cols=238  Identities=22%  Similarity=0.289  Sum_probs=191.3

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||++.. .+|+.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999995 478999999997532   223456778999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|..++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....    
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  151 (323)
T cd05595          81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  151 (323)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc
Confidence            9999887543     588999999999999999999998    999999999999999999999999999876422    


Q ss_pred             cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||.....              .............    
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------------~~~~~~~~~~~~~----  213 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------------ERLFELILMEEIR----  213 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------------HHHHHHHhcCCCC----
Confidence            1234577889999999988999999999999999999999999964311              1111111111100    


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                           ......+   .+.+++.+||+.||++||     ++.+++++
T Consensus       214 -----~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         214 -----FPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             -----CCCCCCH---HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence                 0011222   344566699999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5e-38  Score=335.09  Aligned_cols=260  Identities=24%  Similarity=0.308  Sum_probs=199.7

Q ss_pred             cHHHHHHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEe
Q 036639          352 ELEDLLRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYA  423 (670)
Q Consensus       352 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  423 (670)
                      .+..-.+.+.+.||+|+||.||+|...      ++..||||+++... ....+.+.+|+++++.+ +|+||++++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            344445567789999999999999832      24579999997543 23356788999999999 89999999999999


Q ss_pred             CCeeEEEEeccCCCChHHHhccCCC-------------------------------------------------------
Q 036639          424 KEEKLLVYDYLPNGSLHSLLHGNRG-------------------------------------------------------  448 (670)
Q Consensus       424 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  448 (670)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999999864210                                                       


Q ss_pred             ----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc--
Q 036639          449 ----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--  516 (670)
Q Consensus       449 ----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  516 (670)
                                ....++++..+.+++.|+++||+|||+.    +|+||||||+|||+++++.+||+|||+++.......  
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK----NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                      0112478889999999999999999998    999999999999999999999999999986543221  


Q ss_pred             ----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          517 ----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       517 ----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ..++..|+|||++....++.++|||||||++|||++ |+.||......              ..............
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--------------~~~~~~~~~~~~~~  335 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--------------SKFYKMVKRGYQMS  335 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--------------HHHHHHHHcccCcc
Confidence                122346999999988899999999999999999997 99998643110              00111111111000


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      .       ....   ..++.+++.+||+.||++|||+.||++.|+++.
T Consensus       336 ~-------~~~~---~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         336 R-------PDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             C-------CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            0       0011   134566777999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=312.18  Aligned_cols=269  Identities=26%  Similarity=0.408  Sum_probs=200.6

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhc--cCCCCeeeEEEEEEeCC----eeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK--LKHPNVVKLRAYYYAKE----EKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~e~  433 (670)
                      ..+++|+|+||.||+|++. ++.||||++...   .++.|..|-+|.+.  ++|+||++++++-....    +.+||+||
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            3467999999999999987 599999999854   56778888777764  58999999999876554    78999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHh-----CCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE-----YGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      .+.|+|.++|+.+.      ++|....+|+..+++||+|||+.     .++++|+|||||++||||.+|+++.|+|||+|
T Consensus       290 h~kGsL~dyL~~nt------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  290 HPKGSLCDYLKANT------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             ccCCcHHHHHHhcc------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999774      99999999999999999999986     35688999999999999999999999999999


Q ss_pred             cccCcc------ccccccCcccCccccccCC-CC-----CchhHHHHHHHHHHHHcCCCCCCC-C-CCCCCCCccccccc
Q 036639          509 LLLNPV------QAIARLGGYKAPEQAEVKR-LS-----QKADVYSFGVLLLEVLTGRAPSQY-P-SPTRPRVDEEEQAV  574 (670)
Q Consensus       509 ~~~~~~------~~~~~~~~y~aPE~~~~~~-~~-----~ksDVwS~Gvvl~elltg~~p~~~-~-~~~~~~~~~~~~~~  574 (670)
                      ..+...      ....||..|||||++.+.. +.     .+.||||+|.|||||+++..-++. . .+....++..-...
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            887542      2357888899999997543 22     368999999999999998765532 1 11222222111111


Q ss_pred             chhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .-...++..+-.+.....+......    ...+.-+.+.+..||..||+.|.|+.=|.+.+.++.-..
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            1112222222111111111111111    134455667777999999999999999999998886443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-38  Score=327.99  Aligned_cols=267  Identities=18%  Similarity=0.226  Sum_probs=194.1

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|+||.||+++.+ +++.||||+++...  ....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07848           4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE   83 (287)
T ss_pred             eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence            34577999999999999965 68899999997542  2345678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      ++.+..+....     ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++..... 
T Consensus        84 ~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          84 KNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKN----DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            87776554332     2488899999999999999999988    9999999999999999999999999999876432 


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchh-HHHHHHhhhccc
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP-KWVRSVVKEEWT  589 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  589 (670)
                          ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..............++ .+..........
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence                123567789999999988899999999999999999999999975422110000000000000 000000000000


Q ss_pred             cccccHhhhcccc-----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKN-----IEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....+.......     .......+.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000000000     00112347778889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-37  Score=319.81  Aligned_cols=251  Identities=25%  Similarity=0.418  Sum_probs=198.0

Q ss_pred             HHHhHcCCCCceEEEEEEEcC-C-----CEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD-G-----GIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|.... +     ..||+|.++... .....++.+|++++.+++||||+++++++.+.+..+++|
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   87 (283)
T cd05048           8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF   87 (283)
T ss_pred             chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence            456789999999999998542 2     579999997543 234567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcE
Q 036639          432 DYLPNGSLHSLLHGNRGPGR-----------IPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVA  500 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~  500 (670)
                      ||+++++|.+++........           ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.+
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH----HFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccccceEEEcCCCcE
Confidence            99999999999975422111           3578899999999999999999998    99999999999999999999


Q ss_pred             EEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccc
Q 036639          501 CISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQA  573 (670)
Q Consensus       501 kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  573 (670)
                      ||+|||+++......      ...++..|+|||.+.+..++.++|||||||++|||+| |..||......          
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----------  233 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----------  233 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----------
Confidence            999999997653322      1233456999999988899999999999999999998 99998653110          


Q ss_pred             cchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          574 VDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                       ++..    .+.......          ........+.+++.+||+.||++||+++||+++|+.+
T Consensus       234 -~~~~----~i~~~~~~~----------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         234 -EVIE----MIRSRQLLP----------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             -HHHH----HHHcCCcCC----------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence             1111    111111000          0112234566778899999999999999999999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.9e-40  Score=321.00  Aligned_cols=269  Identities=23%  Similarity=0.321  Sum_probs=193.0

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe-----eEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE-----KLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-----~~lv~e~~  434 (670)
                      .+++|+|.||.||+|.. .+++.||||++-...    +.-.+|+++|++++|||||+++-+|.....     ..+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            36899999999999994 467999999986443    233468999999999999999988875432     24899999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-CcEEEEecccccccCc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLNP  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~  513 (670)
                      |. +|.+.++... .....++...+.-+..|+.+||+|||+.    +|+||||||.|+|+|.+ |.+||+|||.|+.+..
T Consensus       105 P~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~----~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~  178 (364)
T KOG0658|consen  105 PE-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSH----GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK  178 (364)
T ss_pred             hH-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhc----CcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence            76 9999988421 1123577788899999999999999997    99999999999999977 8999999999998865


Q ss_pred             cc---cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccch-hHHHHHHhhhcc
Q 036639          514 VQ---AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDL-PKWVRSVVKEEW  588 (670)
Q Consensus       514 ~~---~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  588 (670)
                      .+   .+..+..|+|||.+.+. .|+.+.||||.|||+.||+-|++.|.+.+..........-.+.. .+.+..+. .++
T Consensus       179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn-~~y  257 (364)
T KOG0658|consen  179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN-PNY  257 (364)
T ss_pred             CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC-ccc
Confidence            33   45556779999998764 69999999999999999999999998764432222111111000 01111111 111


Q ss_pred             ccccccHhhhccc----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhcc
Q 036639          589 TAEVFDQELLRYK----NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRVE  641 (670)
Q Consensus       589 ~~~~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~  641 (670)
                      . +.-.+.+....    .......+.++++.++++++|.+|.++.|++.|  .++++..
T Consensus       258 ~-~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  258 T-EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             c-cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            1 11111111111    111222456677779999999999999999974  5555544

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.5e-38  Score=304.41  Aligned_cols=193  Identities=27%  Similarity=0.396  Sum_probs=166.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~  434 (670)
                      .-+.|++|.||.||+|+. ++++.||+|+++....  .-.-.-.+|+.++.+++|||||.+..+...  -+..|+|||||
T Consensus        80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~  159 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV  159 (419)
T ss_pred             HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence            457899999999999994 5789999999985431  223445789999999999999999988764  35789999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      +. +|..+++...    .++...++.-+..|+++|++|||..    .|+|||||++|+|++..|.+||+|||+|+.+...
T Consensus       160 Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~----wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  160 EH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDN----WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             Hh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhc----eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            66 9999998764    3688899999999999999999998    9999999999999999999999999999988654


Q ss_pred             ----ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 036639          515 ----QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPS  561 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~  561 (670)
                          ....-|..|+|||.+.+. .|++..|+||+|||+.||+++++.|.+.+
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s  282 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS  282 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence                345567789999998765 58999999999999999999999987653

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.3e-37  Score=315.75  Aligned_cols=251  Identities=24%  Similarity=0.388  Sum_probs=204.5

Q ss_pred             HHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          356 LLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       356 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ..|.+.+.||.|+||.||+|...+++.||+|.+.........++..|+.+++.++|+||+++++++.+.+..++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            34567789999999999999988899999999987765567789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.++++....   ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||.+.......
T Consensus        86 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          86 KGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQ----NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999976432   2589999999999999999999988    99999999999999999999999999997664321


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ...++..|+|||.+....++.++||||||+++|+|++ |+.||....              ....+...... ...
T Consensus       159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------------~~~~~~~~~~~-~~~  223 (261)
T cd05148         159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------------NHEVYDQITAG-YRM  223 (261)
T ss_pred             ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------------HHHHHHHHHhC-CcC
Confidence                1223456999999988889999999999999999998 899986431              01111111111 000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                                .........+.+++.+||+.||++|||+.++++.|+.+
T Consensus       224 ----------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ----------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                      00112223566788899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-38  Score=322.39  Aligned_cols=243  Identities=33%  Similarity=0.528  Sum_probs=187.6

Q ss_pred             HhHcCCCCceEEEEEEEc-----CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLD-----DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.||.|.||.||+|.+.     .+..|+||.++... ....+++.+|++.+++++||||++++|++...+..++|+||+
T Consensus         4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~   83 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC   83 (259)
T ss_dssp             EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred             eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence            357999999999999976     35789999997543 334788999999999999999999999999888899999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.++++...   ...+++..+..|+.|+++||+|||+.    +++|+||+++||++++++.+||+|||++......
T Consensus        84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~----~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSN----NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHT----TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             ccccccccccccc---cccccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccc
Confidence            9999999998762   23589999999999999999999998    9999999999999999999999999999877321


Q ss_pred             ------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 ------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 ------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                            ........|+|||.+....++.++||||||+++|||+| |+.||...              .............
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------------~~~~~~~~~~~~~  222 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------------DNEEIIEKLKQGQ  222 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------------CHHHHHHHHHTTE
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc--------------ccccccccccccc
Confidence                  12233446999999998889999999999999999999 67887532              1112222221111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      ...           ........+.+++.+||+.||++|||++|+++.|
T Consensus       223 ~~~-----------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 RLP-----------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ETT-----------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cce-----------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            100           0111123456678899999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=9.2e-38  Score=315.91  Aligned_cols=241  Identities=26%  Similarity=0.408  Sum_probs=195.1

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      .+.||+|+||.||++.++++..+|+|.+.... ...+++.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~   87 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLL   87 (256)
T ss_pred             eeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHH
Confidence            46799999999999998888899999987543 24577899999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc----
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----  516 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----  516 (670)
                      ++++....    .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||.++.......    
T Consensus        88 ~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (256)
T cd05114          88 NYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERN----SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS  159 (256)
T ss_pred             HHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence            99975431    488999999999999999999988    999999999999999999999999999986543221    


Q ss_pred             -ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          517 -IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       517 -~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                       ..++..|+|||.+.+..++.++||||||+++|||++ |+.||....              ....+.........   ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--------------~~~~~~~i~~~~~~---~~  222 (256)
T cd05114         160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--------------NYEVVEMISRGFRL---YR  222 (256)
T ss_pred             CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--------------HHHHHHHHHCCCCC---CC
Confidence             122346999999988889999999999999999999 899986431              11111111111110   00


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      +        ......+.+++.+||+.+|++||+++|+++.|
T Consensus       223 ~--------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 P--------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C--------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0        01123567788899999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-38  Score=334.88  Aligned_cols=192  Identities=25%  Similarity=0.413  Sum_probs=163.1

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC-----eeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE-----EKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv  430 (670)
                      .+.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|++++++++||||+++++++....     ..|+|
T Consensus         3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv   82 (338)
T cd07859           3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV   82 (338)
T ss_pred             EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence            3457899999999999995 47899999998743  2223456889999999999999999999886432     47999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||++ ++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          83 FELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTA----NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99995 68999887543     488999999999999999999998    999999999999999999999999999986


Q ss_pred             cCcc-------ccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNPV-------QAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~~-------~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ....       ....++..|+|||++.+  ..++.++|||||||++|||+||+.||...
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence            5321       22357778999999865  67899999999999999999999999654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-38  Score=331.38  Aligned_cols=248  Identities=21%  Similarity=0.263  Sum_probs=196.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|... +++.||||+++...   ....+.+.+|++++..++||||+++++++.+.+..|+||||++
T Consensus         5 ~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   84 (333)
T cd05600           5 ILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVP   84 (333)
T ss_pred             EEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCC
Confidence            3467999999999999965 68999999997532   2234668889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-c
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-V  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-~  514 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++..... .
T Consensus        85 g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~  155 (333)
T cd05600          85 GGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHEL----GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA  155 (333)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEEEeCcCCccccccc
Confidence            999999997543     488899999999999999999998    999999999999999999999999999986644 2


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..              .........  .. .+.
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--------------~~~~~i~~~--~~-~~~  218 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN--------------ETWENLKYW--KE-TLQ  218 (333)
T ss_pred             CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH--------------HHHHHHHhc--cc-ccc
Confidence            3456788899999999889999999999999999999999999654211              111111100  00 000


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..... .........+.+++.+||..+|++||+++|++++
T Consensus       219 ~~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00000 0000112345567779999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-38  Score=337.07  Aligned_cols=187  Identities=18%  Similarity=0.295  Sum_probs=163.8

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |.+.+.||+|+||.||++.. .+++.||+|...      ...+.+|++++++++||||+++++++......++|+|++. 
T Consensus        94 y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             cEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            45567899999999999995 578999999754      3456789999999999999999999999999999999994 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      ++|..++....     .+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus       167 ~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~----~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        167 TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHEN----RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            78988886543     478999999999999999999998    999999999999999999999999999975432   


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                        .....+|+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~  286 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK  286 (391)
T ss_pred             cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence              12346788899999999889999999999999999999999887543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.4e-38  Score=316.75  Aligned_cols=247  Identities=25%  Similarity=0.407  Sum_probs=198.5

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++
T Consensus         9 ~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05072           9 KLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS   87 (261)
T ss_pred             EEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence            45578999999999999988888999999875432 46788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.++++...   ...+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||+++......   
T Consensus        88 L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          88 LLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERK----NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence            999997543   12578899999999999999999987    99999999999999999999999999998764322   


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ...++..|+|||++....++.++|||||||++|||+| |+.||.....           .....    .....+... 
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----------~~~~~----~~~~~~~~~-  224 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----------SDVMS----ALQRGYRMP-  224 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----------HHHHH----HHHcCCCCC-
Confidence              1223446999999988889999999999999999999 9999854210           01111    111111100 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                            ...   .....+.+++.+||..+|++||+++++++.|+++
T Consensus       225 ------~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         225 ------RME---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ------CCC---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                  001   1123466778899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-38  Score=325.96  Aligned_cols=245  Identities=20%  Similarity=0.344  Sum_probs=206.2

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe-eEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE-KLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-~~lv~e~  433 (670)
                      |...+++|+|+||.++.++.+ +++.||+|.+.-..  ...++...+|+.++++++|||||.+.+.|..++. .+|||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            456789999999999999954 67899999987443  3345578899999999999999999999999888 8999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |+||++.+.+.+.+   ...+++..+.+|+.|++.|+.|||+.    .|+|||||+.|||++.++.|||+|||+|+.+.+
T Consensus        86 ~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~----~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHEN----RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             cCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhh----hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999998765   34689999999999999999999987    999999999999999999999999999999876


Q ss_pred             cc----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          514 VQ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       514 ~~----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ..    ...||+.||.||.+.+.+|+.|+||||+||++|||++-+++|...              ++...+.+..+... 
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~--------------~m~~Li~ki~~~~~-  223 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS--------------NMSELILKINRGLY-  223 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc--------------chHHHHHHHhhccC-
Confidence            54    467899999999999999999999999999999999999999754              34444444443321 


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          +      +-......++..++..|++.+|+.||++.+++.+
T Consensus       224 ----~------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  224 ----S------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----C------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                1      0111223345556679999999999999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=329.95  Aligned_cols=241  Identities=23%  Similarity=0.360  Sum_probs=187.7

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus        77 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  156 (353)
T PLN00034         77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG  156 (353)
T ss_pred             hhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence            35678999999999999954 68999999996543 23457789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.+..         ...+..+..++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++.....  
T Consensus       157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        157 GSLEGTH---------IADEQFLADVARQILSGIAYLHRR----HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             Ccccccc---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9986532         245677889999999999999998    9999999999999999999999999999876432  


Q ss_pred             --ccccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 --QAIARLGGYKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                        ....++..|+|||++..     ...+.++|||||||++|||++|+.||.....           ..............
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----------~~~~~~~~~~~~~~  292 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----------GDWASLMCAICMSQ  292 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----------ccHHHHHHHHhccC
Confidence              23467788999998743     2345689999999999999999999963210           11111111111000


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      . ..          ........+.+++.+||+.||++|||+.|+++|
T Consensus       293 ~-~~----------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 P-PE----------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C-CC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0 00          001112345667779999999999999999987

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.4e-39  Score=337.45  Aligned_cols=241  Identities=20%  Similarity=0.280  Sum_probs=194.1

Q ss_pred             HHHhHcCCCCceEEEEEEEcC--CCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD--GGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|..++  +..||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        33 ~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey  112 (340)
T PTZ00426         33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF  112 (340)
T ss_pred             EEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeC
Confidence            445789999999999998543  3689999986431   22346788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        113 VIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSL----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999997654     488999999999999999999998    999999999999999999999999999987654


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....+++.|+|||++.+..++.++|||||||++|||+||+.||...++.              ............   
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------------~~~~~i~~~~~~---  246 (340)
T PTZ00426        184 RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------------LIYQKILEGIIY---  246 (340)
T ss_pred             CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------------HHHHHHhcCCCC---
Confidence             23456788899999999888999999999999999999999999653210              111111111100   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      +      .....+   .+.+++.+|++.||++|+     +++|+++|
T Consensus       247 ~------p~~~~~---~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 F------PKFLDN---NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C------CCCCCH---HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            0      011222   244566799999999995     89999886

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=301.57  Aligned_cols=246  Identities=24%  Similarity=0.328  Sum_probs=198.7

Q ss_pred             HHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          358 RASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      |.+.+.||+|+|+.||++. ..+|+.+|+|++...  .....+++++|+.|.+.|+||||+++.+.+.+....|+|+|+|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            4567889999999999998 457999999988632  3336789999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEeccccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLL  511 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~  511 (670)
                      +|++|..-+-..     ...++...-..+.||+++|.|+|.+    +|||||+||+|+++-.   .--+||+|||+|..+
T Consensus        93 ~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n----~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   93 TGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSN----GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             cchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhc----CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999996544322     1367778888999999999999998    9999999999999953   335999999999988


Q ss_pred             Cccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          512 NPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       512 ~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ....   ...||++|||||++...+|+..+|||+.|||||-|+.|.+||.+.+.              .+.+..+...  
T Consensus       164 ~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------------~rlye~I~~g--  227 (355)
T KOG0033|consen  164 NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------------HRLYEQIKAG--  227 (355)
T ss_pred             CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------------HHHHHHHhcc--
Confidence            7433   46789999999999999999999999999999999999999976421              1222222222  


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         .+|-.-..+..+.++.+.+   +++||..||.+|.|+.|.++|
T Consensus       228 ---~yd~~~~~w~~is~~Ak~L---vrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  228 ---AYDYPSPEWDTVTPEAKSL---IRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ---ccCCCCcccCcCCHHHHHH---HHHHhccChhhhccHHHHhCC
Confidence               2232223344556666655   459999999999999999875

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8e-38  Score=308.41  Aligned_cols=268  Identities=21%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCC-eeeEEEEEEeCC------eeE
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPN-VVKLRAYYYAKE------EKL  428 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~------~~~  428 (670)
                      ...++||+|+||+||+|+ ..+|+.||+|+++-...  .......+|+.++++++|+| ||.+++++....      ..+
T Consensus        14 ~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~   93 (323)
T KOG0594|consen   14 EKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY   93 (323)
T ss_pred             HHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence            344679999999999999 56799999999975432  34566789999999999999 999999998877      788


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +|+||++ -+|..++....... ..++...+..++.|+++||+|||++    +|+||||||.||||+++|.+||+|||+|
T Consensus        94 lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~----~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   94 LVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSH----GILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCcceEEECCCCcEeeeccchH
Confidence            9999995 49999998765321 2466688999999999999999998    9999999999999999999999999999


Q ss_pred             cccC-cc---ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          509 LLLN-PV---QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       509 ~~~~-~~---~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      +... +.   .....|..|+|||++.+. .|+...||||+|||++||+++++.|.+.+..       .+...+.+.+..-
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-------~ql~~If~~lGtP  240 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-------DQLFRIFRLLGTP  240 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-------HHHHHHHHHcCCC
Confidence            9665 22   233456779999999876 6999999999999999999999999776431       1111111111111


Q ss_pred             hhhcccccc----ccHhhhccc---chHHH----HHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036639          584 VKEEWTAEV----FDQELLRYK---NIEEE----LVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIR  639 (670)
Q Consensus       584 ~~~~~~~~~----~d~~~~~~~---~~~~~----~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~  639 (670)
                      ..+.|....    ++.....+.   .....    .....+++.+|++.+|.+|.|++.++.|  +..+.
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence            112222111    111111111   11111    1256677889999999999999999998  55443

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=314.88  Aligned_cols=247  Identities=28%  Similarity=0.424  Sum_probs=199.2

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.+.||+|++|.||+|...+++.||+|.++.... ..+++.+|++++++++|+||+++++++...+..++||||+++++
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   87 (261)
T cd05068           9 QLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS   87 (261)
T ss_pred             eeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCc
Confidence            44578999999999999987788999999976543 46778999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc--
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--  516 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  516 (670)
                      |.+++....   ...+++..+..++.|++.||.|||+.    +++||||||+||++++++.+||+|||+++.......  
T Consensus        88 L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          88 LLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQ----NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             HHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            999997543   22589999999999999999999988    999999999999999999999999999987653211  


Q ss_pred             ccc---cCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          517 IAR---LGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       517 ~~~---~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                      ..+   ...|+|||+..+..++.++||||||+++|||+| |+.||.....              .... ..+......  
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------------~~~~-~~~~~~~~~--  223 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------------AEVL-QQVDQGYRM--  223 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------------HHHH-HHHHcCCCC--
Confidence            112   235999999998899999999999999999999 9989864310              0111 111111100  


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                              .........+.+++.+|++.+|++||++.++++.|++.
T Consensus       224 --------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         224 --------PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             --------CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                    00111224567788899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.3e-38  Score=324.14  Aligned_cols=193  Identities=24%  Similarity=0.346  Sum_probs=164.9

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||+|+||.||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+....++||||++ 
T Consensus         8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   86 (288)
T cd07871           8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-   86 (288)
T ss_pred             eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-
Confidence            34578999999999999954 68999999997542 2234567889999999999999999999999999999999997 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++.....  
T Consensus        87 ~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          87 SDLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKR----KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            49999886543    2478899999999999999999998    9999999999999999999999999998765321  


Q ss_pred             --ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 --QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                        ....++..|+|||.+.+ ..++.++||||+||++|||+||+.||...
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~  207 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS  207 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              22345677999998865 56899999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2e-37  Score=319.20  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=202.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.+.||+|+||.||++...      ++..||+|.+........+.+.+|++++++++||||+++++++...+..++|||
T Consensus         8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (288)
T cd05093           8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFE   87 (288)
T ss_pred             eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence            45678999999999999842      345699999987665566789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          433 YLPNGSLHSLLHGNRG--------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      |+++++|.+++.....        .....+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~----~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEecc
Confidence            9999999999975431        1123589999999999999999999988    999999999999999999999999


Q ss_pred             cccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchh
Q 036639          505 FGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLP  577 (670)
Q Consensus       505 FG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  577 (670)
                      ||+++......      ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....              .
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------------~  229 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------------N  229 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------------H
Confidence            99998654321      1222456999999998899999999999999999999 8988864311              1


Q ss_pred             HHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       578 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ......... ....       ....   ....+.+++.+||+.||.+|||+.||++.|+++...
T Consensus       230 ~~~~~i~~~-~~~~-------~~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         230 EVIECITQG-RVLQ-------RPRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHHHHHcC-CcCC-------CCCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            111111111 1000       0001   123467788899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.3e-37  Score=317.28  Aligned_cols=251  Identities=22%  Similarity=0.392  Sum_probs=199.1

Q ss_pred             HHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+.+.||+|+||.||+|...      +++.||||.++..... ..+.+.+|++++++++|+||+++++++......++|
T Consensus         7 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   86 (280)
T cd05049           7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMV   86 (280)
T ss_pred             hhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEE
Confidence            456788999999999999853      3478999999865443 457899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          431 YDYLPNGSLHSLLHGNRG---------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                      |||+++++|.++++....         .....+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+|
T Consensus        87 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~k  162 (280)
T cd05049          87 FEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ----HFVHRDLATRNCLVGYDLVVK  162 (280)
T ss_pred             EecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeeccccccceEEEcCCCeEE
Confidence            999999999999975431         1223578999999999999999999988    999999999999999999999


Q ss_pred             EEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccccccc
Q 036639          502 ISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAV  574 (670)
Q Consensus       502 l~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  574 (670)
                      |+|||+++......      ....+..|+|||++.+..++.++|||||||++|||++ |+.||.....            
T Consensus       163 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~------------  230 (280)
T cd05049         163 IGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN------------  230 (280)
T ss_pred             ECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH------------
Confidence            99999997653221      2223456999999999999999999999999999999 9999864311            


Q ss_pred             chhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                        ...+.... ......          ........+.+++.+||..||++||++.||++.|++
T Consensus       231 --~~~~~~~~-~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         231 --EEVIECIT-QGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             --HHHHHHHH-cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence              11111111 110000          001112346677889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-37  Score=315.22  Aligned_cols=246  Identities=26%  Similarity=0.390  Sum_probs=197.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|... +++.||+|.+.... ...+++.+|++++++++|+||+++++++...+..+++|||+++++
T Consensus        10 ~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (263)
T cd05052          10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN   88 (263)
T ss_pred             EeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence            4467999999999999954 58899999987543 245678999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc--
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--  516 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  516 (670)
                      |.+++....   ...+++..++.++.|+++||+|||+.    +++||||||+||++++++.+||+|||++........  
T Consensus        89 L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          89 LLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             HHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            999997543   22588999999999999999999988    999999999999999999999999999987654221  


Q ss_pred             ---ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          517 ---IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       517 ---~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ...+..|+|||.+.+..++.++|||||||++|||+| |..||....              ........ ....... 
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------------~~~~~~~~-~~~~~~~-  225 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------------LSQVYELL-EKGYRME-  225 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------------HHHHHHHH-HCCCCCC-
Confidence               122346999999998899999999999999999998 888885431              11111111 1111000 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                            .....   ...+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       226 ------~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 ------RPEGC---PPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ------CCCCC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                  00111   23466677799999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.7e-38  Score=343.57  Aligned_cols=246  Identities=23%  Similarity=0.303  Sum_probs=196.1

Q ss_pred             HHHhHcCCCCceEEEEEEEc-C-CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-D-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||+|+||.||+|... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..|+||||+++
T Consensus        70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~g  149 (478)
T PTZ00267         70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG  149 (478)
T ss_pred             EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCC
Confidence            34578999999999999843 4 678999987665555556788899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.++++.... ...++++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       150 g~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        150 GDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSR----KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999998864321 223588999999999999999999998    9999999999999999999999999999876432  


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ....+++.|+|||++.+..++.++|||||||++|||+||+.||....              ....+..........
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------------~~~~~~~~~~~~~~~  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------------QREIMQQVLYGKYDP  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCCCC
Confidence                23357888999999998999999999999999999999999996431              111122211111100


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        +      ....   ...+.+++.+||..||++||++++++.+
T Consensus       291 --~------~~~~---s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        291 --F------PCPV---SSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             --C------CccC---CHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence              0      0011   1345667779999999999999999764

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.9e-37  Score=332.08  Aligned_cols=262  Identities=23%  Similarity=0.333  Sum_probs=202.1

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccC-CCCeeeEEEEE
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLK-HPNVVKLRAYY  421 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~  421 (670)
                      ++++..-.+.+.+.||+|+||.||+|...      .+..||||+++... ....+.+.+|+++++++. ||||+++++++
T Consensus        31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~  110 (400)
T cd05105          31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC  110 (400)
T ss_pred             ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence            45555555567789999999999999842      13469999997543 234567899999999996 99999999999


Q ss_pred             EeCCeeEEEEeccCCCChHHHhccCCCC----------------------------------------------------
Q 036639          422 YAKEEKLLVYDYLPNGSLHSLLHGNRGP----------------------------------------------------  449 (670)
Q Consensus       422 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------  449 (670)
                      .+.+..++|||||++|+|.++++.....                                                    
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence            9999999999999999999998653210                                                    


Q ss_pred             ---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q 036639          450 ---------------------------------------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSS  490 (670)
Q Consensus       450 ---------------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~  490 (670)
                                                             ....+++..+..++.|+++||+|||+.    +|+||||||+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dikp~  266 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK----NCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChH
Confidence                                                   012478888999999999999999998    9999999999


Q ss_pred             CeEeCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036639          491 NVLLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPT  563 (670)
Q Consensus       491 NIll~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~  563 (670)
                      |||++.++.+||+|||+++......      ...++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            9999999999999999998653321      1223456999999988899999999999999999997 88898643110


Q ss_pred             CCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                                    ..+..........          .........+.+++.+||+.||++|||+.+|.++|+++.
T Consensus       347 --------------~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 --------------STFYNKIKSGYRM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             --------------HHHHHHHhcCCCC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                          0011111111000          001112245677888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.1e-37  Score=325.82  Aligned_cols=256  Identities=27%  Similarity=0.352  Sum_probs=197.6

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC-Cee
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK-EEK  427 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~-~~~  427 (670)
                      .|++.+.||+|+||.||+|...      +++.||+|+++.... ...+.+..|++++.++ +|+||++++++|... ...
T Consensus         8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~   87 (337)
T cd05054           8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL   87 (337)
T ss_pred             HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence            4567789999999999999732      357899999975432 2345677899999999 899999999988754 567


Q ss_pred             EEEEeccCCCChHHHhccCCCC--------------------------------------------------------CC
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGP--------------------------------------------------------GR  451 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~  451 (670)
                      +++|||+++++|.+++......                                                        ..
T Consensus        88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (337)
T cd05054          88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK  167 (337)
T ss_pred             EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence            8999999999999998643210                                                        01


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc------cccccCcccC
Q 036639          452 IPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKA  525 (670)
Q Consensus       452 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~a  525 (670)
                      ..++|..+.+++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++.+....      ...++..|+|
T Consensus       168 ~~l~~~~~~~~~~qi~~aL~~lH~~----~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         168 EPLTLEDLISYSFQVARGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            2588999999999999999999988    99999999999999999999999999998763321      1223456999


Q ss_pred             ccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchH
Q 036639          526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIE  604 (670)
Q Consensus       526 PE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  604 (670)
                      ||++.+..++.++|||||||++|||++ |..||......              ......+.......          ...
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------------~~~~~~~~~~~~~~----------~~~  299 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------------EEFCRRLKEGTRMR----------APE  299 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------------HHHHHHHhccCCCC----------CCc
Confidence            999999999999999999999999998 99998643110              00111111110000          001


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          605 EELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       605 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      .....+.+++.+||+.+|++||++.||+++|+++..
T Consensus       300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            122356778889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.5e-38  Score=328.16  Aligned_cols=238  Identities=24%  Similarity=0.320  Sum_probs=190.8

Q ss_pred             hHcCCCCceEEEEEEE----cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          362 EMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.||+|+||.||+++.    .+++.||||+++...    ......+..|+++++.++||||+++++++...+..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4699999999999985    357899999997532    22345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++....     .+.+.....++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQ----GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            99999999987543     477888889999999999999998    999999999999999999999999999875422


Q ss_pred             ----cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          514 ----VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       514 ----~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                          .....++..|+|||++.+..++.++|||||||++|||++|+.||....              ....+.........
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------------~~~~~~~~~~~~~~  218 (323)
T cd05584         153 EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------------RKKTIDKILKGKLN  218 (323)
T ss_pred             CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------------HHHHHHHHHcCCCC
Confidence                123457788999999998889999999999999999999999996531              11112222111100


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                               ......   ..+.+++.+||+.||++||     ++++++++
T Consensus       219 ---------~~~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         219 ---------LPPYLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ---------CCCCCC---HHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                     001112   2355677799999999999     89998875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.2e-37  Score=323.26  Aligned_cols=251  Identities=22%  Similarity=0.346  Sum_probs=197.4

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCC----EEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGG----IVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      +...+.||+|+||.||+|.+. ++.    .||+|.++... ....+++.+|+.+++.++||||+++++++... ..++|+
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            344578999999999999853 344    48999997543 34567889999999999999999999998764 567999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++|+|.+++....    ..+++...+.++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++..
T Consensus        88 e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          88 QLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEER----RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhc----CeeccccchhheEecCCCcEEEccccccccc
Confidence            9999999999998653    2478899999999999999999998    9999999999999999999999999999876


Q ss_pred             Ccccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          512 NPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       512 ~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      .....      ...+..|+|||++....++.++|||||||++|||+| |+.||....              .... ....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------------~~~~-~~~~  224 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------------ASEI-SSIL  224 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------------HHHH-HHHH
Confidence            53221      122346999999998999999999999999999998 999986431              0011 1111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ......          .....+...+.+++.+||+.+|++||++.+++.++..+....
T Consensus       225 ~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         225 EKGERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             hCCCCC----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            111000          000111234667888999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-38  Score=331.29  Aligned_cols=238  Identities=22%  Similarity=0.296  Sum_probs=189.1

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|+.+ +++.||||+++...   ....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999964 68999999997531   22345667788888766 699999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~----~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~  151 (320)
T cd05590          81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK  151 (320)
T ss_pred             chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence            99999987654     488999999999999999999988    999999999999999999999999999875422   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||....              ..............   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------------~~~~~~~i~~~~~~---  214 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------------EDDLFEAILNDEVV---  214 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------------HHHHHHHHhcCCCC---
Confidence             223457888999999998899999999999999999999999996531              11111221111100   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM------AEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  634 (670)
                            ......   ..+.+++.+||+.||++||++      +++++|
T Consensus       215 ------~~~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         215 ------YPTWLS---QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             ------CCCCCC---HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                  001112   234567779999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.2e-38  Score=331.52  Aligned_cols=238  Identities=22%  Similarity=0.302  Sum_probs=190.1

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|+.. +++.||||+++...   ....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999964 58899999997532   22345567788888766 799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|..++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++.....   
T Consensus        81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~  151 (321)
T cd05591          81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRH----GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV  151 (321)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence            99999887553     488999999999999999999998    999999999999999999999999999875432   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||+||+.||.....              .............   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------------~~~~~~i~~~~~~---  214 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------------DDLFESILHDDVL---  214 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------------HHHHHHHHcCCCC---
Confidence             2234567889999999988999999999999999999999999965411              1111222211110   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-------TMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~  634 (670)
                            ......   ..+.+++.+||+.||++||       ++++++++
T Consensus       215 ------~p~~~~---~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 ------YPVWLS---KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             ------CCCCCC---HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                  000111   2355677799999999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-38  Score=331.34  Aligned_cols=239  Identities=23%  Similarity=0.284  Sum_probs=190.7

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||++.. .+|+.||+|+++...   ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999995 578999999997532   223456678999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|..++....     .+++..+..++.|++.||+|||+.   .+|+||||||+|||++.++.+||+|||+++....    
T Consensus        81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence            9999887543     588999999999999999999973   2899999999999999999999999999875422    


Q ss_pred             cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      .....++..|+|||++.+..++.++|||||||++|||+||+.||.....              ............     
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------------~~~~~~i~~~~~-----  213 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------------EKLFELILMEEI-----  213 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------------HHHHHHHhcCCC-----
Confidence            1234578889999999988999999999999999999999999964311              111111111100     


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                          ........   .+.+++.+||+.||++|+     ++.++++|
T Consensus       214 ----~~p~~~~~---~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         214 ----RFPRTLSP---EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ----CCCCCCCH---HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                00011122   345566799999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-37  Score=316.26  Aligned_cols=260  Identities=23%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             HHHhHcCCCCceEEEEEEE-----cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-----DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv  430 (670)
                      .+.+.||+|+||+||++..     .+++.||+|.++... ....+.+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            4457899999999988653     357899999997643 23457788999999999999999999988764  357899


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++++|.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||+++.
T Consensus        87 ~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          87 MEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             ecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999754      389999999999999999999998    999999999999999999999999999987


Q ss_pred             cCcccc-------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchhHHHHH
Q 036639          511 LNPVQA-------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLPKWVRS  582 (670)
Q Consensus       511 ~~~~~~-------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  582 (670)
                      ......       ..++..|+|||.+....++.++||||||+++|||+||+.||............... ...... +..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~  235 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR-LIE  235 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh-hhh
Confidence            643221       12334599999998888999999999999999999999998654221110000000 000000 001


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ......          ...........+.+++.+||+.+|++|||+++|++.|+++.
T Consensus       236 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         236 LLERGM----------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhcCC----------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            110000          00001112245667788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-37  Score=317.46  Aligned_cols=264  Identities=27%  Similarity=0.412  Sum_probs=197.7

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-----CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-----DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv  430 (670)
                      +.+.+.||+|+||.||++..+     +++.||+|+++.......+.+.+|++++++++||||+++++++...  ...++|
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   85 (284)
T cd05081           6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLV   85 (284)
T ss_pred             ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEE
Confidence            345678999999999999742     5789999999876655667899999999999999999999987643  467899


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++++|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||+++.
T Consensus        86 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~  157 (284)
T cd05081          86 MEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSK----RYVHRDLATRNILVESENRVKIGDFGLTKV  157 (284)
T ss_pred             EEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHhhEEECCCCeEEECCCccccc
Confidence            99999999999997543    2488999999999999999999998    999999999999999999999999999987


Q ss_pred             cCcccc-------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCC-CcccccccchhHHHHH
Q 036639          511 LNPVQA-------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR-VDEEEQAVDLPKWVRS  582 (670)
Q Consensus       511 ~~~~~~-------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  582 (670)
                      ......       ......|+|||++.+..++.++|||||||++|||++|..|+......... ................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence            643221       11122499999998888999999999999999999998776433111000 0000000011111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      .......          ..........+.+++.+||..+|++|||+.||++.|+.++
T Consensus       238 ~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         238 LLKNNGR----------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             HHhcCCc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            1111100          0001111234667888999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.9e-37  Score=330.07  Aligned_cols=192  Identities=27%  Similarity=0.366  Sum_probs=168.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|.. .+++.||||+++...   ......+..|++++.+++|+||+++++.+.+....|+||||++
T Consensus         5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (363)
T cd05628           5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP   84 (363)
T ss_pred             EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence            356899999999999985 468999999997532   2234567889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          85 GGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQL----GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999997643     588999999999999999999998    9999999999999999999999999998754321 


Q ss_pred             --------------------------------------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 036639          515 --------------------------------------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP  556 (670)
Q Consensus       515 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p  556 (670)
                                                            ....||..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                                  123577889999999989999999999999999999999999


Q ss_pred             CCCC
Q 036639          557 SQYP  560 (670)
Q Consensus       557 ~~~~  560 (670)
                      |...
T Consensus       236 f~~~  239 (363)
T cd05628         236 FCSE  239 (363)
T ss_pred             CCCC
Confidence            9653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-38  Score=324.84  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=213.9

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEcC-CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeE
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  428 (670)
                      .|+++.-.....++||-|.||.||.|.|+. .-.||||.++.... ..++|..|+.+|+.++|||+|+++|+|......|
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            455554444557899999999999999875 45799999986543 6789999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      ||+|||.+|+|.+||++..   +..++-...+.++.||+.|++||..+    ++|||||..+|+||.++..+||+|||++
T Consensus       340 IiTEfM~yGNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkk----nFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             EEEecccCccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhccccccceEEeeccchh
Confidence            9999999999999999764   33567777889999999999999998    9999999999999999999999999999


Q ss_pred             cccCcccccccc-----CcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          509 LLLNPVQAIARL-----GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       509 ~~~~~~~~~~~~-----~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      +++..+......     ..|.|||.+....++.|+|||+|||+|||+.| |..||.+.              ++.. +..
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi--------------dlSq-VY~  477 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI--------------DLSQ-VYG  477 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc--------------cHHH-HHH
Confidence            999765433222     23999999999999999999999999999998 88887643              2222 222


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ++...+.          ....+.|...+.+||++||++.|.+||++.|+-+.++.+..+.
T Consensus       478 LLEkgyR----------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  478 LLEKGYR----------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             HHhcccc----------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            2322221          1234456667888999999999999999999999998876543

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-37  Score=315.42  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=195.3

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~   90 (267)
T cd06646          11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGG   90 (267)
T ss_pred             cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCC
Confidence            35568899999999999995 57899999999765444556788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.++++...     .+++..+..++.|++.||.|||+.    +|+||||||+||+++.++.+||+|||++......  
T Consensus        91 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          91 GSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSK----GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999987543     478999999999999999999988    9999999999999999999999999999866432  


Q ss_pred             --ccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          515 --QAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                        ....++..|+|||.+.   ...++.++|||||||++|||++|+.||....+.........              ....
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--------------~~~~  227 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--------------SNFQ  227 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--------------CCCC
Confidence              2234567799999874   44578899999999999999999999864322111000000              0000


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      ..    ..   .........+.+++.+||..+|++|||++++++++
T Consensus       228 ~~----~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         228 PP----KL---KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CC----CC---ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            00    00   00011123456777899999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3.2e-38  Score=329.35  Aligned_cols=237  Identities=24%  Similarity=0.300  Sum_probs=186.1

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|+.. +|+.||+|+++...   ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999965 68999999997532   12345566677777654 899999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05620          81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSK----GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN  151 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence            99999987543     478899999999999999999998    999999999999999999999999999875321   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||.....              ............    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------------~~~~~~~~~~~~----  213 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------------DELFESIRVDTP----  213 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHhCCC----
Confidence             2334578889999999999999999999999999999999999964311              111111111100    


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA-EVAK  633 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  633 (670)
                         ...  ....   .++.+++.+||+.||++||++. ++++
T Consensus       214 ---~~~--~~~~---~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         214 ---HYP--RWIT---KESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             ---CCC--CCCC---HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence               000  0112   2345567799999999999984 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.8e-37  Score=315.27  Aligned_cols=251  Identities=23%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             HHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +++.+.||+|+||.||+|...      ++..||+|++.... .....++.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   87 (277)
T cd05062           8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI   87 (277)
T ss_pred             ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence            455678999999999999753      35679999986543 23456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          431 YDYLPNGSLHSLLHGNRGP-----GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      |||+++++|.++++.....     ....+++..+..++.|+++||+|||+.    +++||||||+||++++++.+||+||
T Consensus        88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~~vH~dlkp~Nil~~~~~~~~l~df  163 (277)
T cd05062          88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDF  163 (277)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCcchheEEEcCCCCEEECCC
Confidence            9999999999998753311     123467889999999999999999987    9999999999999999999999999


Q ss_pred             ccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhH
Q 036639          506 GLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       506 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      |+++......      ...++..|+|||++.+..++.++|||||||++|||++ |..||.....              ..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------------~~  229 (277)
T cd05062         164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------------EQ  229 (277)
T ss_pred             CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------------HH
Confidence            9987653321      1123456999999998889999999999999999999 6888854311              11


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      ......... ....          .......+.+++.+||+.+|++|||+.|++++|++
T Consensus       230 ~~~~~~~~~-~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         230 VLRFVMEGG-LLDK----------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHHcCC-cCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            111111111 0000          01112346678889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.3e-37  Score=312.99  Aligned_cols=240  Identities=23%  Similarity=0.335  Sum_probs=189.9

Q ss_pred             hHcCCCCceEEEEEEEcC-------------CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeE
Q 036639          362 EMLGKGSLGTVYKAVLDD-------------GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  428 (670)
                      +.||+|+||.||+|.+.+             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999998532             2358999987665555667888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc-------EE
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV-------AC  501 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-------~k  501 (670)
                      +||||+++++|..++....    ..+++..+.+++.|+++||+|||+.    +|+||||||+|||++.++.       +|
T Consensus        81 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDK----DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhC----CeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999887543    2488999999999999999999988    9999999999999987664       89


Q ss_pred             EEecccccccCccccccccCcccCccccc-cCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCCCCCcccccccchhHH
Q 036639          502 ISDFGLSLLLNPVQAIARLGGYKAPEQAE-VKRLSQKADVYSFGVLLLEVL-TGRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       502 l~DFG~a~~~~~~~~~~~~~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      ++|||++..........++..|+|||.+. +..++.++|||||||++|||+ +|+.||......           ..   
T Consensus       153 l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-----------~~---  218 (262)
T cd05077         153 LSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-----------EK---  218 (262)
T ss_pred             eCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-----------HH---
Confidence            99999998776555566777899999886 466899999999999999998 588777532100           00   


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                       ........  .       ...   .....+.+++.+||+.||++||++.+++++++
T Consensus       219 -~~~~~~~~--~-------~~~---~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 -ERFYEGQC--M-------LVT---PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -HHHHhcCc--c-------CCC---CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence             00001000  0       000   11234567788999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=334.25  Aligned_cols=268  Identities=22%  Similarity=0.248  Sum_probs=202.8

Q ss_pred             HHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-C-----CCeeeEEEEEEeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-H-----PNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~nIv~l~~~~~~~~~~~lv  430 (670)
                      |.+.+.||+|.||.|-+|. .++++.||||++++... ...+-..|+.+|..|+ |     -|+|+++++|..+++.|||
T Consensus       188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            3455789999999999999 56799999999987643 4566778999999996 4     3899999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC--cEEEEecccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG--VACISDFGLS  508 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a  508 (670)
                      +|.+ .-+|.++++.+...   .++...+..++.||+.||.+||+.    +|||+||||+||||.+-+  .+||+|||.+
T Consensus       267 fELL-~~NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l----~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHEL----GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999 55999999987643   589999999999999999999987    999999999999997544  6999999999


Q ss_pred             cccCcc-ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh-
Q 036639          509 LLLNPV-QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE-  586 (670)
Q Consensus       509 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  586 (670)
                      ...... ..+..+..|+|||++.+.+|+.+.||||||||+.||+||.+.|.+.+..+......+-.+..+.++-+.... 
T Consensus       339 c~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  339 CFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             cccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            887653 345566679999999999999999999999999999999888866544322222222222222222111110 


Q ss_pred             -------ccc------cc--------c--------ccHh-hh----cc-cchH-HHHHHHHHHHhhccCCCCCCCCCHHH
Q 036639          587 -------EWT------AE--------V--------FDQE-LL----RY-KNIE-EELVSMLHVGLACVVSQPEKRPTMAE  630 (670)
Q Consensus       587 -------~~~------~~--------~--------~d~~-~~----~~-~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~e  630 (670)
                             .+.      .+        .        .+.. ..    .. .... ..-..+++++.+||.+||.+|+|..|
T Consensus       419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q  498 (586)
T KOG0667|consen  419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ  498 (586)
T ss_pred             ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence                   000      00        0        0000 00    00 0111 33456889999999999999999999


Q ss_pred             HHHH
Q 036639          631 VAKM  634 (670)
Q Consensus       631 vl~~  634 (670)
                      +++|
T Consensus       499 al~H  502 (586)
T KOG0667|consen  499 ALNH  502 (586)
T ss_pred             HhcC
Confidence            9986

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.3e-37  Score=326.72  Aligned_cols=247  Identities=19%  Similarity=0.268  Sum_probs=192.4

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||++... +++.||||+++...   ....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999954 68999999997532   22345678899999888 799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence            99999886543     589999999999999999999998    999999999999999999999999999875321   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||+||+.||.........      ......+....+.+...   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~---  222 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP------DQNTEDYLFQVILEKQI---  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc------cccchHHHHHHHHcCCC---
Confidence             22345788899999999999999999999999999999999999643211100      01111222222221110   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT------MAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~  634 (670)
                           .......   ..+.+++.+||+.||++||+      ++|+++|
T Consensus       223 -----~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         223 -----RIPRSLS---VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -----CCCCCCC---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                 0001112   23556777999999999997      6788765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.2e-38  Score=327.66  Aligned_cols=237  Identities=25%  Similarity=0.351  Sum_probs=186.3

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhc-cCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGK-LKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|+.. +++.||||+++...   ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999965 57899999997531   1233456667777765 4899999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  151 (316)
T cd05619          81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSK----GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA  151 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence            99999997543     488999999999999999999998    999999999999999999999999999875321   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||.....              ............   .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------------~~~~~~i~~~~~---~  214 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------------EELFQSIRMDNP---C  214 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHhCCC---C
Confidence             2234578889999999988999999999999999999999999964311              111111111100   0


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA-EVAK  633 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  633 (670)
                      +.      ....   ..+.+++.+||+.||++||++. ++.+
T Consensus       215 ~~------~~~~---~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YP------RWLT---REAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CC------ccCC---HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            00      0112   2345667799999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.2e-37  Score=317.53  Aligned_cols=244  Identities=22%  Similarity=0.290  Sum_probs=190.3

Q ss_pred             cCCCCceEEEEEEE-cCCCEEEEEEeCCCCcc---hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANPC---ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ||+|+||+||++.. .+|+.||+|.+......   ..+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            69999999999995 47899999999754221   235667899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      ..++..... ....+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++.......    
T Consensus        81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  155 (280)
T cd05608          81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQR----RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK  155 (280)
T ss_pred             HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence            988754321 123589999999999999999999998    99999999999999999999999999997654322    


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||......          .............         
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~~---------  216 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----------VENKELKQRILND---------  216 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----------hhHHHHHHhhccc---------
Confidence            345677899999999999999999999999999999999999643111          0000111111100         


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      .....   ......+.+++.+||+.||++||     +++|+++|
T Consensus       217 ~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         217 SVTYP---DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCCCc---ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            00000   11123455677799999999999     77888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.3e-38  Score=328.37  Aligned_cols=237  Identities=26%  Similarity=0.339  Sum_probs=184.9

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|... +++.||||+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999954 68899999997532   12334455666666644 899999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~  151 (316)
T cd05592          81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKK----GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG  151 (316)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence            99999987543     488899999999999999999998    999999999999999999999999999975432   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||.....              ............   .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------------~~~~~~i~~~~~---~  214 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------------DELFDSILNDRP---H  214 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHcCCC---C
Confidence             2234578889999999988999999999999999999999999965311              111111111100   0


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA-EVAK  633 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  633 (670)
                      +.      .....   .+.+++.+||+.||++||++. ++++
T Consensus       215 ~~------~~~~~---~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FP------RWISK---EAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CC------CCCCH---HHHHHHHHHccCCHHHcCCChHHHHc
Confidence            00      11122   344566799999999999875 5554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-37  Score=325.77  Aligned_cols=247  Identities=20%  Similarity=0.286  Sum_probs=191.0

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|... +++.||+|+++..   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36899999999999954 6889999999754   222345677888888776 799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|..++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~  151 (329)
T cd05618          81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  151 (329)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence            99999886543     588999999999999999999998    999999999999999999999999999875422   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||+||+.||........      .......++.........   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~~~~~~~~~~i~~~~~---  222 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN------PDQNTEDYLFQVILEKQI---  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCC------cccccHHHHHHHHhcCCC---
Confidence             2234578889999999999999999999999999999999999964311110      001111222221111100   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT------MAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~~  634 (670)
                           ......   ...+.+++.+||+.||++||+      +.|+++|
T Consensus       223 -----~~p~~~---~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 -----RIPRSL---SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -----CCCCCC---CHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                 000111   234556777999999999998      4677765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=331.17  Aligned_cols=241  Identities=24%  Similarity=0.335  Sum_probs=194.1

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK  424 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~  424 (670)
                      .+.+++.  .+.++||+|.||+|+++..+ +++.+|||++++...   .+.+....|.+|+... +||.++.++.+|...
T Consensus       364 ~~~l~~F--~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  364 PLTLDDF--RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             cccccce--EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            4555554  45688999999999999955 688999999997643   2445566777777766 599999999999999


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      ++.|.||||+.||++..+.+..      .+++..+.-++..|+.||.|||++    +||+||||.+|||+|.+|++||+|
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~----~IIYRDlKLdNiLLD~eGh~kiAD  511 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHEN----GIIYRDLKLDNLLLDTEGHVKIAD  511 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhc----CceeeecchhheEEcccCcEEecc
Confidence            9999999999999966665544      489999999999999999999998    999999999999999999999999


Q ss_pred             cccccccC----ccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          505 FGLSLLLN----PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       505 FG~a~~~~----~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ||+++...    ...++.||+.|||||++.+..|+..+|-|||||+||||+.|..||.+.+..              ..+
T Consensus       512 FGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe--------------e~F  577 (694)
T KOG0694|consen  512 FGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE--------------EVF  577 (694)
T ss_pred             cccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHH
Confidence            99998754    245678999999999999999999999999999999999999999765211              111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM  628 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  628 (670)
                      ..++.++         ........   .+.+.++.++|..+|++|.-+
T Consensus       578 dsI~~d~---------~~yP~~ls---~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVNDE---------VRYPRFLS---KEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcCC---------CCCCCccc---HHHHHHHHHHhccCcccccCC
Confidence            2222111         11111222   345566779999999999865

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8.8e-37  Score=314.93  Aligned_cols=251  Identities=24%  Similarity=0.405  Sum_probs=200.4

Q ss_pred             HhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.||+|+||.||+|...      ++..|++|.++.......+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (291)
T cd05094          10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM   89 (291)
T ss_pred             eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence            467999999999999842      35679999998766556678999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEE
Q 036639          435 PNGSLHSLLHGNRG-----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS  503 (670)
Q Consensus       435 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~  503 (670)
                      ++++|.+++.....           .....+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~  165 (291)
T cd05094          90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ----HFVHRDLATRNCLVGANLLVKIG  165 (291)
T ss_pred             CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccCcceEEEccCCcEEEC
Confidence            99999999975431           1122488999999999999999999988    99999999999999999999999


Q ss_pred             ecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccch
Q 036639          504 DFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       504 DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      |||++.......      ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....              
T Consensus       166 dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------------  231 (291)
T cd05094         166 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------------  231 (291)
T ss_pred             CCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------------
Confidence            999997654321      1223456999999998899999999999999999999 9999864311              


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ...+.. .........          .......+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus       232 ~~~~~~-~~~~~~~~~----------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         232 TEVIEC-ITQGRVLER----------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHHHHH-HhCCCCCCC----------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            111111 111111000          01112346678889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-37  Score=309.04  Aligned_cols=243  Identities=26%  Similarity=0.402  Sum_probs=195.3

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ++.+.||+|+||.||++..+++..+|+|.+..... ...++.+|++++++++|+||+++++++...+..++||||+++++
T Consensus         7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd05059           7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC   85 (256)
T ss_pred             chhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence            46688999999999999988778899999875432 45678889999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccccc-
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-  517 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-  517 (670)
                      |.+++.....    .+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||+++........ 
T Consensus        86 L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          86 LLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESN----GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999975431    588999999999999999999998    9999999999999999999999999999866432211 


Q ss_pred             ----cccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          518 ----ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       518 ----~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                          ..+..|+|||.+.+..++.++||||||+++|||+| |+.||......           ..   ... .......  
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----------~~---~~~-~~~~~~~--  220 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-----------EV---VES-VSAGYRL--  220 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-----------HH---HHH-HHcCCcC--
Confidence                12235999999998899999999999999999999 78888643110           01   111 1111000  


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                           ....   .....+.+++.+||..+|++|||+.|+++.|
T Consensus       221 -----~~~~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 -----YRPK---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----CCCC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 0001   1223566788899999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7e-37  Score=314.52  Aligned_cols=265  Identities=23%  Similarity=0.331  Sum_probs=199.5

Q ss_pred             HHHHHHHhHcCCCCceEEEEEEE-----cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--Ce
Q 036639          355 DLLRASAEMLGKGSLGTVYKAVL-----DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EE  426 (670)
Q Consensus       355 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~  426 (670)
                      +..+++.+.||+|+||.||++..     .++..||+|.++... ....+.+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            34456678899999999999984     357889999997543 33456899999999999999999999998875  56


Q ss_pred             eEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       427 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      .++||||+++++|.+++....    ..+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccchheEEEcCCCCEEECCCc
Confidence            789999999999999986542    2489999999999999999999998    99999999999999999999999999


Q ss_pred             cccccCccc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCC-cccccccchhH
Q 036639          507 LSLLLNPVQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV-DEEEQAVDLPK  578 (670)
Q Consensus       507 ~a~~~~~~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~  578 (670)
                      +++......       ...++..|+|||++.+..++.++|||||||++|||+|++.|+.......... ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR  234 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence            998764321       1233445999999988889999999999999999999887653321110000 00001111111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      .+.. .......          +........+.+++.+||+.+|++|||++++++.++++
T Consensus       235 ~~~~-~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         235 LVRV-LEEGKRL----------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHH-HHcCccC----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1111 1111000          00111234577788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=9.3e-37  Score=310.50  Aligned_cols=254  Identities=20%  Similarity=0.363  Sum_probs=200.4

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||.||+|.. .+++.||||.++..   .......+.+|+++++.++||||+++++++.+.+..++|+||+
T Consensus         5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   84 (267)
T cd08228           5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence            3456799999999999995 47899999988642   2233457889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++++|.+++..... ....+++..+..++.|+++||+|||+.    +++|+||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          85 DAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            99999998864321 122478899999999999999999988    9999999999999999999999999998876542


Q ss_pred             c----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 Q----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ~----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .    ...++..|+|||.+.+..++.++||||||+++|||++|+.||.....            ....+.......... 
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------------~~~~~~~~~~~~~~~-  226 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------------NLFSLCQKIEQCDYP-  226 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------------cHHHHHHHHhcCCCC-
Confidence            2    23466679999999888899999999999999999999999854311            111111111110000 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ..         ........+.+++.+||..+|++||++.||++.+++++
T Consensus       227 ~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         227 PL---------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CC---------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            00         01112245667788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-37  Score=325.84  Aligned_cols=238  Identities=23%  Similarity=0.343  Sum_probs=187.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHH---hccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVI---GKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.||+|+||.||+|.. .+|+.||||+++...   ....+.+..|++++   +.++||||+++++++.+.+..|+||||
T Consensus         4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~   83 (324)
T cd05589           4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY   83 (324)
T ss_pred             EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence            46799999999999995 468999999997532   22334566666554   566899999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|..+++..      .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||+++....
T Consensus        84 ~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~----~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          84 AAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHEN----KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             CCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999888643      489999999999999999999998    999999999999999999999999999875432


Q ss_pred             ----cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          514 ----VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       514 ----~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                          .....++..|+|||.+.+..++.++|||||||++|||++|+.||.....              .............
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------------~~~~~~i~~~~~~  219 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------------EEVFDSIVNDEVR  219 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHhCCCC
Confidence                2234577889999999988999999999999999999999999965311              1111111111100


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                               ......   ..+.+++.+||+.||++||     ++.+++++
T Consensus       220 ---------~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         220 ---------YPRFLS---REAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ---------CCCCCC---HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                     001112   2345677799999999999     57777775

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-37  Score=310.69  Aligned_cols=247  Identities=25%  Similarity=0.439  Sum_probs=197.3

Q ss_pred             HHHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|.+..    ...||||.++... .....++..|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   86 (266)
T cd05033           7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEY   86 (266)
T ss_pred             eeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEc
Confidence            456789999999999999642    4579999987543 33456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++....+    .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||+++....
T Consensus        87 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          87 MENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             CCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999976432    588999999999999999999997    999999999999999999999999999987742


Q ss_pred             cc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          514 VQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       514 ~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ..      ....+..|+|||.+.+..++.++||||||+++|||++ |..||.....           ..+..    ....
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----------~~~~~----~~~~  223 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----------QDVIK----AVED  223 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----------HHHHH----HHHc
Confidence            11      1122346999999998899999999999999999998 9988853210           01111    1111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      .+...          ........+.+++.+||+.+|++||+++||+++|+++
T Consensus       224 ~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 GYRLP----------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11000          0011223566788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.6e-37  Score=320.82  Aligned_cols=192  Identities=26%  Similarity=0.334  Sum_probs=163.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.+++.++||||+++++++.+....++||||++ +
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~   87 (303)
T cd07869           9 KLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-T   87 (303)
T ss_pred             EeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-c
Confidence            4578999999999999965 789999999975432 234567789999999999999999999999999999999995 6


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++....    ..++...+..++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++.....   
T Consensus        88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  159 (303)
T cd07869          88 DLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQR----YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHT  159 (303)
T ss_pred             CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCcc
Confidence            8888876543    2478889999999999999999998    9999999999999999999999999998754321   


Q ss_pred             -ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 -QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                       ....++..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         160 YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             22345677999998865 45889999999999999999999999753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.9e-37  Score=309.55  Aligned_cols=248  Identities=29%  Similarity=0.415  Sum_probs=196.7

Q ss_pred             HHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .|.+.+.||+|+||.||+|...++..||+|+++.... ..+++.+|++++++++|+||+++++++. ....++||||+++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (262)
T cd05071           7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK   84 (262)
T ss_pred             HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence            3556678999999999999987777899999986433 4567899999999999999999999874 4567999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      |+|.+++.....   ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||.++...... 
T Consensus        85 ~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          85 GSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHC----CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            999999975431   2478999999999999999999998    99999999999999999999999999998664322 


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ...++..|+|||+..+..++.++||||||+++|||+| |+.||.....              ...... .......
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------------~~~~~~-~~~~~~~  222 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------------REVLDQ-VERGYRM  222 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------------HHHHHH-HhcCCCC
Confidence                1223446999999988889999999999999999999 7888854311              011111 1110000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                                ....+....+.+++.+|++.+|++||++.++++.|++.
T Consensus       223 ----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         223 ----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             ----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                      01112334567888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=302.28  Aligned_cols=244  Identities=25%  Similarity=0.402  Sum_probs=210.0

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.++||+|.||.||+|.++ .|+.||||.+.-..  +.+++.+|+.++++.+.|++|++||.|......++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            355678999999999999954 69999999998654  678999999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |++.++++..+    .++.+..+..++.+.++||+|||..    .-+|||||+.|||++.+|.+||+|||.|..+..   
T Consensus       113 GSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~----~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  113 GSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDL----KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             CcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHH----HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999998654    3699999999999999999999998    889999999999999999999999999987654   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....||+-|||||++..-.|+.++||||+|++..||..|++||....+.+..+.......                  
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PP------------------  246 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPP------------------  246 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCC------------------
Confidence             4456789999999999999999999999999999999999999988777665543322211                  


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           ..+...++...++.+++.+||...|++|-|+.++++|
T Consensus       247 -----PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  247 -----PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -----CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence                 1112234444567778889999999999999999876

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-36  Score=320.55  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=206.8

Q ss_pred             ccccHHHHHHHHHhHcCCCCceEEEEEEEc--------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEE
Q 036639          349 KQFELEDLLRASAEMLGKGSLGTVYKAVLD--------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLR  418 (670)
Q Consensus       349 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~  418 (670)
                      .+|++....+.+.+.||+|+||.||+|+..        .+..||+|.++... ....+++.+|+++++++ +||||++++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~   84 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLL   84 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeee
Confidence            356666777788899999999999999742        12369999887542 23457889999999999 799999999


Q ss_pred             EEEEeCCeeEEEEeccCCCChHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCC
Q 036639          419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNV  487 (670)
Q Consensus       419 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dl  487 (670)
                      +++...+..++++||+++|+|.+++.....           .....+++..+..++.|++.||+|||+.    +++||||
T Consensus        85 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----givH~dl  160 (334)
T cd05100          85 GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ----KCIHRDL  160 (334)
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----Ceecccc
Confidence            999999999999999999999999975431           1123588999999999999999999998    9999999


Q ss_pred             CCCCeEeCCCCcEEEEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 036639          488 KSSNVLLDKNGVACISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP  560 (670)
Q Consensus       488 kp~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~  560 (670)
                      ||+||+++.++.+||+|||+++.......      ...+..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986643221      112345999999998899999999999999999998 88887542


Q ss_pred             CCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          561 SPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                                    .......... .......          .......+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus       241 --------------~~~~~~~~~~-~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         241 --------------PVEELFKLLK-EGHRMDK----------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             --------------CHHHHHHHHH-cCCCCCC----------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence                          1112221111 1111000          01112356678889999999999999999999999985


Q ss_pred             cC
Q 036639          641 EQ  642 (670)
Q Consensus       641 ~~  642 (670)
                      ..
T Consensus       296 ~~  297 (334)
T cd05100         296 VT  297 (334)
T ss_pred             hc
Confidence            44

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.4e-37  Score=310.36  Aligned_cols=243  Identities=25%  Similarity=0.350  Sum_probs=195.2

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||+||+|...++..||+|.++.... ..+++.+|+.++.+++||||+++++++.+....++||||+++|+|
T Consensus         8 ~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l   86 (256)
T cd05113           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL   86 (256)
T ss_pred             EeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcH
Confidence            4567999999999999987777899999875433 457789999999999999999999999998899999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc---
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA---  516 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---  516 (670)
                      .+++.....    .+++..++.++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||.++.......   
T Consensus        87 ~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          87 LNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESK----QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             HHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999975431    489999999999999999999988    999999999999999999999999999886543221   


Q ss_pred             --ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          517 --IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       517 --~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                        ..++..|+|||...+..++.++|||||||++|||+| |+.||.....              ...........+..   
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------------~~~~~~~~~~~~~~---  221 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------------SETVEKVSQGLRLY---  221 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------------HHHHHHHhcCCCCC---
Confidence              122345999999988889999999999999999999 9999854311              11111111111100   


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                           .   .......+.+++.+||+.+|++|||+.++++.|+
T Consensus       222 -----~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 -----R---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----C---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                 0   0011245667888999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=5.6e-37  Score=309.37  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=192.7

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            3689999999999995 478999999887543 33456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc---
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA---  516 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---  516 (670)
                      .+++....    ..+++..++.++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++........   
T Consensus        81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESK----HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99997532    2478999999999999999999988    999999999999999999999999999876543211   


Q ss_pred             ---ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          517 ---IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       517 ---~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ......|+|||.+.+..++.++||||||+++|||++ |..||.....               .............. 
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---------------~~~~~~~~~~~~~~-  216 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---------------QQTREAIEQGVRLP-  216 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---------------HHHHHHHHcCCCCC-
Confidence               111235999999998889999999999999999998 8888853210               00111111110000 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                               ........+.+++.+||+.+|++|||+.||++.|++
T Consensus       217 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  252 (252)
T cd05084         217 ---------CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS  252 (252)
T ss_pred             ---------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence                     001112356678889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.7e-37  Score=313.96  Aligned_cols=239  Identities=21%  Similarity=0.336  Sum_probs=187.6

Q ss_pred             HcCCCCceEEEEEEEcC-------------------------CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeE
Q 036639          363 MLGKGSLGTVYKAVLDD-------------------------GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL  417 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l  417 (670)
                      .||+|+||.||+|.+..                         ...||+|++.........++.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997421                         13589999976544455678889999999999999999


Q ss_pred             EEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       418 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      ++++.+....++||||+++|+|..++....    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDK----NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcC----CccCCCCCcccEEEecc
Confidence            999999999999999999999999987533    1478899999999999999999987    99999999999999865


Q ss_pred             C-------cEEEEecccccccCccccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCCCCCc
Q 036639          498 G-------VACISDFGLSLLLNPVQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVL-TGRAPSQYPSPTRPRVD  568 (670)
Q Consensus       498 ~-------~~kl~DFG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~ell-tg~~p~~~~~~~~~~~~  568 (670)
                      +       .+|++|||.+..........++..|+|||.+.+ ..++.++|||||||++||++ +|+.||....+.     
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----  228 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-----  228 (274)
T ss_pred             CcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-----
Confidence            4       389999999876554444556777999998865 56899999999999999994 789888643111     


Q ss_pred             ccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          569 EEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                            .....    ......   +.      .   .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       229 ------~~~~~----~~~~~~---~~------~---~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 ------EKERF----YEKKHR---LP------E---PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             ------HHHHH----HHhccC---CC------C---CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                  01111    111000   00      0   01124667888999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2e-37  Score=319.52  Aligned_cols=261  Identities=21%  Similarity=0.305  Sum_probs=187.1

Q ss_pred             HHHhHcCCCCceEEEEEEE-c-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhcc---CCCCeeeEEEEEEe-----CCe
Q 036639          359 ASAEMLGKGSLGTVYKAVL-D-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKL---KHPNVVKLRAYYYA-----KEE  426 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~-----~~~  426 (670)
                      .+.+.||+|+||+||+|+. . +++.||+|+++...  ......+.+|+++++.+   +||||+++++++..     ...
T Consensus         4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~   83 (290)
T cd07862           4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK   83 (290)
T ss_pred             ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence            4457899999999999985 3 46889999987432  22334566677777665   69999999999863     346


Q ss_pred             eEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       427 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      .++||||++ ++|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||
T Consensus        84 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~----~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          84 LTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             EEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            789999996 69999987543   12488999999999999999999998    99999999999999999999999999


Q ss_pred             cccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          507 LSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       507 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      +++.....   ....++..|+|||.+.+..++.++|||||||++|||++|++||........       ...+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-------~~~i~~~~~~~  228 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-------LGKILDVIGLP  228 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-------HHHHHHHhCCC
Confidence            99866432   234567789999999888899999999999999999999999975422100       00000000000


Q ss_pred             hhhcccccc-ccHh-hh--cccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEV-FDQE-LL--RYKNI----EEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~-~d~~-~~--~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .++.|.... .... ..  .....    ......+.+++.+||+.||++|||+.|+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            001111000 0000 00  00000    0111234567789999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.7e-37  Score=332.54  Aligned_cols=192  Identities=27%  Similarity=0.391  Sum_probs=167.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ..+.||+|+||+||+|+. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            346799999999999984 568999999997542   2234678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++++||+|||+++....  
T Consensus        85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~----givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          85 GGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKM----GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999997643     478888999999999999999998    999999999999999999999999999753210  


Q ss_pred             -------------------------------------------------cccccccCcccCccccccCCCCCchhHHHHH
Q 036639          514 -------------------------------------------------VQAIARLGGYKAPEQAEVKRLSQKADVYSFG  544 (670)
Q Consensus       514 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~G  544 (670)
                                                                       .....+|..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence                                                             0123577889999999988899999999999


Q ss_pred             HHHHHHHcCCCCCCCC
Q 036639          545 VLLLEVLTGRAPSQYP  560 (670)
Q Consensus       545 vvl~elltg~~p~~~~  560 (670)
                      |++|||+||+.||...
T Consensus       236 ~il~elltG~~Pf~~~  251 (381)
T cd05626         236 VILFEMLVGQPPFLAP  251 (381)
T ss_pred             hHHHHHHhCCCCCcCC
Confidence            9999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.1e-37  Score=309.40  Aligned_cols=247  Identities=27%  Similarity=0.433  Sum_probs=197.2

Q ss_pred             HHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.++||+|+||.||+|..++++.||+|.+..... ..+++.+|++++++++|+||+++++++. .+..+++|||+++
T Consensus         7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05067           7 TLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN   84 (260)
T ss_pred             HceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence            3456688999999999999988899999999986543 4578899999999999999999999864 5578999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++....   ...+++..+..++.|++.||+|||+.    +++||||||+||++++++.++|+|||++....... 
T Consensus        85 ~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          85 GSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERK----NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999987543   22588999999999999999999987    99999999999999999999999999997665221 


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ...++..|+|||++....++.++||||||+++||+++ |+.||.....              ....... ......
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------------~~~~~~~-~~~~~~  222 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------------PEVIQNL-ERGYRM  222 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------------HHHHHHH-HcCCCC
Confidence                1223456999999988889999999999999999999 9999864321              1111111 111000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      ..       ...   ...++.+++.+||..+|++|||++++++.|+.
T Consensus       223 ~~-------~~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PR-------PDN---CPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CC-------CCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            00       011   12346677889999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=8.5e-38  Score=326.53  Aligned_cols=238  Identities=24%  Similarity=0.327  Sum_probs=190.3

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|... +++.||||+++...   ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999965 58899999997532   22345667888888877 799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|..++....     .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||+++....   
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHER----GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            99999987653     589999999999999999999988    999999999999999999999999999875322   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||....              ..............   
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------------~~~~~~~i~~~~~~---  214 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------------EDELFQSILEDEVR---  214 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------------HHHHHHHHHcCCCC---
Confidence             122346778999999999999999999999999999999999996431              11111111111100   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM-----AEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  634 (670)
                      +      .....   ..+.+++.+||+.||++||++     .+++++
T Consensus       215 ~------~~~~~---~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 Y------PRWLS---KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             C------CCcCC---HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0      01112   245567779999999999999     888775

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.9e-36  Score=307.04  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=196.9

Q ss_pred             HHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.+.||+|+||.||+|...++..||+|.++.... ..+.+.+|++++++++|+||+++++++. ....+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~   84 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK   84 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence            4567789999999999999988888999999976543 4567999999999999999999999875 4568999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA  516 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  516 (670)
                      ++|.++++...   ...+++..+..++.|++.||+|||+.    +++||||||+||++++++.++|+|||++........
T Consensus        85 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          85 GSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERM----NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            99999997543   12478999999999999999999998    999999999999999999999999999987643221


Q ss_pred             -----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          517 -----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       517 -----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                           ..++..|+|||+..+..++.++||||||+++|||++ |..||.....              ........ .....
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------------~~~~~~~~-~~~~~  222 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------------REVLEQVE-RGYRM  222 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------------HHHHHHHH-cCCCC
Confidence                 122346999999988889999999999999999999 8888854310              11111111 11000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      .          ........+.+++.+|+..+|++|||+.++.+.|++
T Consensus       223 ~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 P----------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             C----------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0          001112346678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.4e-38  Score=330.86  Aligned_cols=234  Identities=26%  Similarity=0.343  Sum_probs=187.3

Q ss_pred             hHcCCCCceEEEEEEE----cCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          362 EMLGKGSLGTVYKAVL----DDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.||+|+||.||++..    .+|+.||+|+++....  .....+..|++++++++||||+++++++.+.+..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999874    3689999999975321  234567789999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            999999986543     589999999999999999999998    9999999999999999999999999999865432 


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....++..|+|||.+.+..++.++|||||||++|||+||+.||.....              .............  
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------------~~~~~~i~~~~~~--  216 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------------KETMTMILKAKLG--  216 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------------HHHHHHHHcCCCC--
Confidence               234567789999999988899999999999999999999999965311              1111111111100  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE  630 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  630 (670)
                             ......   ..+.+++.+||+.||++||++.+
T Consensus       217 -------~p~~~~---~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 -------MPQFLS---PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             -------CCCCCC---HHHHHHHHHHhhcCHhHcCCCCC
Confidence                   001112   23456777999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.8e-36  Score=311.34  Aligned_cols=251  Identities=24%  Similarity=0.311  Sum_probs=196.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+.+.||+|+||.||+|...      +++.||+|+++.... ...+.+.+|+.++..++||||+++++++......+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            466789999999999999853      257899999985432 2346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc
Q 036639          431 YDYLPNGSLHSLLHGNRG-----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV  499 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  499 (670)
                      +||+++++|.+++.....           .....+++..+..++.|++.||+|||+.    +|+||||||+||++++++.
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~----gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH----HVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc----CccccccchhheEecCCCc
Confidence            999999999999853210           1123478889999999999999999988    9999999999999999999


Q ss_pred             EEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccccc
Q 036639          500 ACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQ  572 (670)
Q Consensus       500 ~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  572 (670)
                      +||+|||+++......      ...++..|+|||++....++.++|||||||++|||+| |..||....           
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----------  231 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----------  231 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----------
Confidence            9999999988654322      1223457999999988889999999999999999998 777875431           


Q ss_pred             ccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          573 AVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                         ...+.......... .          ........+.+++.+||+.+|++||+++||++.|+.
T Consensus       232 ---~~~~~~~i~~~~~~-~----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         232 ---NQDVIEMIRNRQVL-P----------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---HHHHHHHHHcCCcC-C----------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               11122221111100 0          001122345677889999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.6e-36  Score=324.79  Aligned_cols=261  Identities=21%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             ccHHHHHHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccC-CCCeeeEEEEEE
Q 036639          351 FELEDLLRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLK-HPNVVKLRAYYY  422 (670)
Q Consensus       351 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~  422 (670)
                      +++..-.+.+.+.||+|+||.||+|.+.      .++.||||+++.... ...+.+.+|++++.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4444445567789999999999999854      246899999985432 23457889999999997 999999999999


Q ss_pred             eCCeeEEEEeccCCCChHHHhccCCC------------------------------------------------------
Q 036639          423 AKEEKLLVYDYLPNGSLHSLLHGNRG------------------------------------------------------  448 (670)
Q Consensus       423 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  448 (670)
                      ..+..++||||+++|+|.++++..+.                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999975421                                                      


Q ss_pred             ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCC
Q 036639          449 ---------------------------------------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKS  489 (670)
Q Consensus       449 ---------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp  489 (670)
                                                             .....+++...+.++.|++.||+|||+.    +++||||||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrdlkp  267 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK----NCVHRDLAA  267 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----CcCcccCCc
Confidence                                                   0112467888999999999999999987    999999999


Q ss_pred             CCeEeCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 036639          490 SNVLLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSP  562 (670)
Q Consensus       490 ~NIll~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~  562 (670)
                      +|||+++++.+||+|||+++......      ...++..|+|||.+....++.++|||||||++|||++ |+.||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            99999999999999999998653211      1234556999999988889999999999999999998 8888854310


Q ss_pred             CCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                                    ...............       .....   ...+.+++.+||..+|++||++.||++.|+++.
T Consensus       348 --------------~~~~~~~~~~~~~~~-------~p~~~---~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 --------------NEQFYNAIKRGYRMA-------KPAHA---SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             --------------hHHHHHHHHcCCCCC-------CCCCC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                          011111111111000       00111   234566777999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-36  Score=311.97  Aligned_cols=245  Identities=23%  Similarity=0.316  Sum_probs=190.0

Q ss_pred             cCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ||+|+||.||++.. .+|+.||+|++.....   ...+.+..|++++++++||||+++++++.+..+.++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            69999999999995 4689999999964321   1234556799999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---A  516 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~  516 (670)
                      .+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.++|+|||++.......   .
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~  153 (277)
T cd05607          81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSM----DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQ  153 (277)
T ss_pred             HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeec
Confidence            98886443   23588999999999999999999998    99999999999999999999999999987664322   2


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      ..++..|+|||++.+..++.++||||+||++|||++|+.||......          ...............     .. 
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----------~~~~~~~~~~~~~~~-----~~-  217 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----------VAKEELKRRTLEDEV-----KF-  217 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----------hhHHHHHHHhhcccc-----cc-
Confidence            45677899999998888999999999999999999999998643110          000111111111100     00 


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                        ......   .++.+++.+||+.||++||+++|+++.+.
T Consensus       218 --~~~~~~---~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         218 --EHQNFT---EESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             --ccccCC---HHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence              001112   23556777999999999999987765444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=4.8e-37  Score=317.62  Aligned_cols=242  Identities=26%  Similarity=0.401  Sum_probs=195.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++....+.++||||+++++
T Consensus        24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~  103 (296)
T cd06654          24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS  103 (296)
T ss_pred             eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCC
Confidence            346799999999999995 5789999999987655566788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++.......   
T Consensus       104 L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~----gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654         104 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             HHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence            99998653      378899999999999999999998    99999999999999999999999999987654322   


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                       ...++..|+|||.+.+..++.++|||||||++|||++|+.||....+..             .+.. ..... ...   
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------------~~~~-~~~~~-~~~---  235 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------------ALYL-IATNG-TPE---  235 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------------hHHH-HhcCC-CCC---
Confidence             2356677999999988889999999999999999999999996532110             0000 00000 000   


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        .   .........+.+++.+||..+|++|||+.|++++
T Consensus       236 --~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 --L---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             --C---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence              0   0011112345667789999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.2e-37  Score=315.87  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=199.1

Q ss_pred             HHHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCee
Q 036639          356 LLRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       356 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  427 (670)
                      -.+.+.+.||+|+||.||++...      ....||+|.+.... .....++.+|++++.++ +|+||+++++++...+..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            33455678999999999999854      23679999987542 23446688999999999 799999999999999999


Q ss_pred             EEEEeccCCCChHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC
Q 036639          428 LLVYDYLPNGSLHSLLHGNRG-----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK  496 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~  496 (670)
                      +++|||+++|+|.++++....           .....+++..++.++.|++.||+|||+.    +|+||||||+||+++.
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~Nil~~~  167 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK----KCIHRDLAARNVLVTE  167 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CccccccceeeEEEcC
Confidence            999999999999999975320           1223588999999999999999999987    9999999999999999


Q ss_pred             CCcEEEEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcc
Q 036639          497 NGVACISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE  569 (670)
Q Consensus       497 ~~~~kl~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~  569 (670)
                      ++.+||+|||+++.......      ...+..|+|||++.+..++.++|||||||++|||++ |..||....        
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------  239 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--------  239 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC--------
Confidence            99999999999987643221      122346999999988899999999999999999998 888885431        


Q ss_pred             cccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                            ...... ........          .........+.+++.+||..+|++|||+.|+++.|+++.
T Consensus       240 ------~~~~~~-~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         240 ------VEELFK-LLKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             ------HHHHHH-HHHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                  111111 11111100          001112235667888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.8e-38  Score=328.41  Aligned_cols=244  Identities=22%  Similarity=0.300  Sum_probs=192.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||++.. .+|+.||+|+++...   ....+.+.+|+.+++.++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (330)
T cd05601           5 VKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQP   84 (330)
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCC
Confidence            456899999999999995 478999999997542   2244668899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++.......
T Consensus        85 ~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~----~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          85 GGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQM----GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            999999997652    2588999999999999999999998    99999999999999999999999999998764322


Q ss_pred             -----cccccCcccCccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          516 -----AIARLGGYKAPEQAE------VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       516 -----~~~~~~~y~aPE~~~------~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                           ...++..|+|||++.      ...++.++|||||||++|||++|+.||.....              ...+....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------------~~~~~~i~  222 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------------AKTYNNIM  222 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------------HHHHHHHH
Confidence                 235677899999986      45678999999999999999999999964311              11111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .......     .........   .+.+++..|+. +|++|||++++++|
T Consensus       223 ~~~~~~~-----~~~~~~~~~---~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         223 NFQRFLK-----FPEDPKVSS---DFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             cCCCccC-----CCCCCCCCH---HHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            1100000     000111222   34556668997 99999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-36  Score=309.38  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=192.4

Q ss_pred             HHhHcCCCCceEEEEEEEcC-CC--EEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeE
Q 036639          360 SAEMLGKGSLGTVYKAVLDD-GG--IVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKL  428 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~  428 (670)
                      +++.||+|+||.||+|...+ +.  .||+|.++..  .....+.+..|+++++.++|+||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            45789999999999999654 33  6999998754  233456788999999999999999999987542      2468


Q ss_pred             EEEeccCCCChHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      ++|||+++|+|.+++..... .....+++.....++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK----SFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhheEEcCCCCEEECCCCc
Confidence            99999999999998753321 1233589999999999999999999997    999999999999999999999999999


Q ss_pred             ccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          508 SLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       508 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ++......      ....+..|+|||+.....++.++||||||+++|||++ |+.||.....              ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------------~~~~  224 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------------SEIY  224 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------------HHHH
Confidence            98764322      1123446999999998899999999999999999999 7888854211              0111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      . .........       ...   .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus       225 ~-~~~~~~~~~-------~~~---~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         225 D-YLRQGNRLK-------QPP---DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             H-HHHcCCCCC-------CCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1 111111000       001   1123466788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.3e-36  Score=312.26  Aligned_cols=249  Identities=26%  Similarity=0.395  Sum_probs=193.8

Q ss_pred             HHhHcCCCCceEEEEEEE-----cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVL-----DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.||+|+||.||+|..     .++..||+|.+.... .....++.+|++++++++||||+++++++......++||||
T Consensus         9 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   88 (283)
T cd05090           9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEY   88 (283)
T ss_pred             eeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEc
Confidence            447899999999999984     246789999997543 23346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          434 LPNGSLHSLLHGNRG------------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                      +++++|.+++.....            .....+++...+.++.|++.||+|||+.    +++||||||+||++++++.+|
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~nili~~~~~~k  164 (283)
T cd05090          89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH----FFVHKDLAARNILIGEQLHVK  164 (283)
T ss_pred             CCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc----CeehhccccceEEEcCCCcEE
Confidence            999999999853221            0123478899999999999999999998    999999999999999999999


Q ss_pred             EEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccccccc
Q 036639          502 ISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAV  574 (670)
Q Consensus       502 l~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  574 (670)
                      |+|||+++......      ...++..|+|||++.+..++.++||||||+++|||++ |..||....+            
T Consensus       165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------------  232 (283)
T cd05090         165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------------  232 (283)
T ss_pred             eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------------
Confidence            99999998653321      1223446999999988889999999999999999999 8888854311            


Q ss_pred             chhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                         ..+...........       .....   ...+.+++.+||+.||++||++.+|+++|+.
T Consensus       233 ---~~~~~~~~~~~~~~-------~~~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 ---QEVIEMVRKRQLLP-------CSEDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHHHHcCCcCC-------CCCCC---CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence               01111111110000       00111   2345567779999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.2e-36  Score=316.35  Aligned_cols=263  Identities=24%  Similarity=0.340  Sum_probs=202.9

Q ss_pred             ccHHHHHHHHHhHcCCCCceEEEEEEEc--------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEE
Q 036639          351 FELEDLLRASAEMLGKGSLGTVYKAVLD--------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAY  420 (670)
Q Consensus       351 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~  420 (670)
                      +++..-.|.+.+.||+|+||.||++...        ++..||+|.++... .....++..|++++.++ +||||++++++
T Consensus        13 ~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             ceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3333344566789999999999999842        23579999998542 23456788899999999 79999999999


Q ss_pred             EEeCCeeEEEEeccCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCC
Q 036639          421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKS  489 (670)
Q Consensus       421 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp  489 (670)
                      +...+..++||||+++|+|.+++......           ....+++..++.++.|++.||+|||+.    +++||||||
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp  168 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK----KCIHRDLAA  168 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC----CcccccccH
Confidence            99999999999999999999999764321           112588999999999999999999987    999999999


Q ss_pred             CCeEeCCCCcEEEEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 036639          490 SNVLLDKNGVACISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSP  562 (670)
Q Consensus       490 ~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~  562 (670)
                      +||+++.++.+||+|||.++.......      ...+..|+|||++.+..++.++|||||||++|||++ |+.||.... 
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-  247 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-  247 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-
Confidence            999999999999999999976543211      112346999999988889999999999999999998 888875321 


Q ss_pred             CCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                                   ..... .........+          ........+.+++.+||..+|++|||+.||++.|+++....
T Consensus       248 -------------~~~~~-~~~~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         248 -------------VEELF-KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             -------------HHHHH-HHHHcCCCCC----------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                         11111 1111111100          01112235666788999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-38  Score=320.77  Aligned_cols=240  Identities=24%  Similarity=0.428  Sum_probs=197.5

Q ss_pred             hHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||.|.||-||-|+ ..+...||||++.....   ....++.+|+..|++++|||++.+.|+|......+|||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            679999999999999 56789999999975433   34578899999999999999999999999999999999999 66


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccccc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI  517 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  517 (670)
                      +-.+++.-.+    .++....+..|..+++.||+|||+.    +.||||||+.|||+++.|.|||+|||.|....+...+
T Consensus       111 SAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~----~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsF  182 (948)
T KOG0577|consen  111 SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPANSF  182 (948)
T ss_pred             cHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHh----hHHhhhccccceEecCCCeeeeccccchhhcCchhcc
Confidence            8888887654    3688899999999999999999998    9999999999999999999999999999999999999


Q ss_pred             cccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          518 ARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       518 ~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      .||+.|||||++.   .+.|+-|+||||+||++.||.-+++|+..++.....+.              +. .+      +
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH--------------IA-QN------e  241 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------------IA-QN------E  241 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH--------------HH-hc------C
Confidence            9999999999874   56799999999999999999999999865422111110              00 10      0


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +.......+.+.   |..++-.||+.-|.+|||.+++++|
T Consensus       242 sPtLqs~eWS~~---F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 SPTLQSNEWSDY---FRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCCCchhHHH---HHHHHHHHHhhCcccCCcHHHHhhc
Confidence            001111223333   4445559999999999999998875

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=330.56  Aligned_cols=192  Identities=26%  Similarity=0.394  Sum_probs=168.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|+.. +|+.||||++....   ......+.+|++++..++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (364)
T cd05599           5 SIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLP   84 (364)
T ss_pred             EEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCC
Confidence            3478999999999999954 68999999997532   2234567889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++.......
T Consensus        85 ~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          85 GGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKL----GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999997643     488999999999999999999998    99999999999999999999999999987542110


Q ss_pred             ------------------------------------------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcC
Q 036639          516 ------------------------------------------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTG  553 (670)
Q Consensus       516 ------------------------------------------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg  553 (670)
                                                                ...+|+.|+|||++....++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence                                                      12478889999999988999999999999999999999


Q ss_pred             CCCCCCC
Q 036639          554 RAPSQYP  560 (670)
Q Consensus       554 ~~p~~~~  560 (670)
                      ..||...
T Consensus       236 ~~Pf~~~  242 (364)
T cd05599         236 YPPFCSD  242 (364)
T ss_pred             CCCCCCC
Confidence            9999654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-36  Score=309.56  Aligned_cols=255  Identities=22%  Similarity=0.370  Sum_probs=200.7

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      |.+.+.||+|+||.||++.. .+++.||||.+....   .....++.+|+++++.++|+||+++++++.+.+..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            34567899999999999994 579999999886532   22446788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++..... ....+++..+..++.|+++||+|||+.    +++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          84 ADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             cCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999874321 123589999999999999999999988    999999999999999999999999999876643


Q ss_pred             cc----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          514 VQ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       514 ~~----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ..    ...++..|+|||++.+..++.++||||||+++|||++|..||.....            .............+.
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~~  226 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------------NLYSLCKKIEQCDYP  226 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------------hHHHHhhhhhcCCCC
Confidence            22    23566779999999888899999999999999999999999864311            011111111100000


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                            ..    ........+.+++.+||..+|++|||+.+|++.++++.
T Consensus       227 ------~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         227 ------PL----PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ------CC----CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                  00    00112234566777999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=308.30  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=193.9

Q ss_pred             hHcCCCCceEEEEEEEc-CCC--EEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGG--IVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|... ++.  .+++|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999965 344  47889887532 33456788999999999 799999999999999999999999999


Q ss_pred             CChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          437 GSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       437 g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      |+|.++++.....           ....+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccccceEEEcCCCeEEECCC
Confidence            9999999754311           112478999999999999999999987    9999999999999999999999999


Q ss_pred             ccccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          506 GLSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       506 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      |++......   .....+..|+|||++....++.++|||||||++|||+| |..||....              ......
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--------------~~~~~~  222 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------------CAELYE  222 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--------------HHHHHH
Confidence            998643321   11122346999999988889999999999999999997 999985431              111111


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ... ..+..+          ........+.+++.+||..+|.+|||+.|+++.|+++.
T Consensus       223 ~~~-~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 KLP-QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHh-CCCCCC----------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            111 111000          00111234667888999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=330.69  Aligned_cols=243  Identities=22%  Similarity=0.357  Sum_probs=194.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|... +|+.||||+++...   ......+..|++++..++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (350)
T cd05573           5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMP   84 (350)
T ss_pred             EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCC
Confidence            4568999999999999965 78999999997532   2345678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++.......
T Consensus        85 ~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          85 GGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKL----GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999997653     588999999999999999999997    99999999999999999999999999998664322


Q ss_pred             ---------------------------------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 036639          516 ---------------------------------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP  562 (670)
Q Consensus       516 ---------------------------------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~  562 (670)
                                                       ...++..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                             23467789999999999999999999999999999999999975421


Q ss_pred             CCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 036639          563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-MAEVAKM  634 (670)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~  634 (670)
                                    .........  +.....   ........   ..+.+++.+|+. ||.+||+ ++|++++
T Consensus       236 --------------~~~~~~i~~--~~~~~~---~p~~~~~~---~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 --------------QETYNKIIN--WKESLR---FPPDPPVS---PEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             --------------HHHHHHHhc--cCCccc---CCCCCCCC---HHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence                          111111111  000000   00000112   335556668997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.4e-37  Score=321.69  Aligned_cols=245  Identities=20%  Similarity=0.278  Sum_probs=190.7

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|.. .+++.||+|+++...   ....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999999999995 467899999998542   22345678899998888 699999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|..++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHER----GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            99999887543     589999999999999999999998    999999999999999999999999999875321   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||+||+.||.......        ......+..........   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~---  220 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--------DMNTEDYLFQVILEKPI---  220 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--------ccccHHHHHHHHHhCCC---
Confidence             223457888999999999999999999999999999999999996432111        11111222221111100   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM------AEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  634 (670)
                           .......   ..+.+++.+||..||++|+++      +++++|
T Consensus       221 -----~~p~~~~---~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         221 -----RIPRFLS---VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             -----CCCCCCC---HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                 0001112   234556779999999999984      577665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.6e-37  Score=322.09  Aligned_cols=234  Identities=23%  Similarity=0.314  Sum_probs=184.0

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHH-HHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMD-VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|.. .+|+.||+|++....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999995 478999999997531   123344555554 46778999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|..++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++....   
T Consensus        81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  151 (325)
T cd05604          81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSI----NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD  151 (325)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence            99999887543     588999999999999999999988    999999999999999999999999999875422   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||...+              .............   .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------------~~~~~~~~~~~~~---~  214 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------------VAEMYDNILHKPL---V  214 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------------HHHHHHHHHcCCc---c
Confidence             223457788999999999999999999999999999999999996431              1111222221110   0


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE  630 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  630 (670)
                      +      .....   ..+.+++.+|++.+|++||++.+
T Consensus       215 ~------~~~~~---~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         215 L------RPGAS---LTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             C------CCCCC---HHHHHHHHHHhccCHHhcCCCCC
Confidence            0      01111   23456777999999999998853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.7e-37  Score=323.57  Aligned_cols=238  Identities=24%  Similarity=0.319  Sum_probs=185.7

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHH-HHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMD-VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|... +|+.||||++.....   ...+++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36899999999999964 789999999974321   12234444444 56788999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (323)
T cd05575          81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK  151 (323)
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence            99999987543     588899999999999999999998    999999999999999999999999999875422   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||....              .............    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------------~~~~~~~i~~~~~----  213 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------------TAEMYDNILNKPL----  213 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------------HHHHHHHHHcCCC----
Confidence             123457788999999999999999999999999999999999996431              1111122111110    


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH----HHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA----EVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~----evl~~  634 (670)
                           ......   ...+.+++.+||+.||++||++.    |++++
T Consensus       214 -----~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         214 -----RLKPNI---SVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             -----CCCCCC---CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence                 001112   22455677799999999999984    65543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.3e-37  Score=324.28  Aligned_cols=244  Identities=22%  Similarity=0.302  Sum_probs=190.0

Q ss_pred             HHhHcCCCCceEEEEEEE----cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+.||+|+||.||+++.    .+++.||+|++.+..    ....+.+..|++++.++ +|+||+++++++...+..++|
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (332)
T cd05614           4 LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLI   83 (332)
T ss_pred             EEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEE
Confidence            457899999999999984    358899999986431    22345678899999999 599999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          84 LDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKL----GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999987543     488999999999999999999988    999999999999999999999999999986


Q ss_pred             cCcc-----ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          511 LNPV-----QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       511 ~~~~-----~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ....     ....++..|+|||++.+. .++.++|||||||++|||+||+.||......          ...........
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----------~~~~~~~~~~~  224 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----------NTQSEVSRRIL  224 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----------CCHHHHHHHHh
Confidence            5321     134578889999998765 4789999999999999999999999643111          01111111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      ...       +.+  .....   ..+.+++.+||+.||++||     +++|+++|
T Consensus       225 ~~~-------~~~--~~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 KCD-------PPF--PSFIG---PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             cCC-------CCC--CCCCC---HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            110       000  01112   2345567799999999999     78888875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-36  Score=314.87  Aligned_cols=262  Identities=24%  Similarity=0.354  Sum_probs=203.2

Q ss_pred             ccHHHHHHHHHhHcCCCCceEEEEEEEc--------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEE
Q 036639          351 FELEDLLRASAEMLGKGSLGTVYKAVLD--------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAY  420 (670)
Q Consensus       351 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~  420 (670)
                      +++..-.+.+.+.||+|+||.||+|+..        ++..||+|.+.... ....+++.+|+.+++.+ +||||++++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            4445555567789999999999999741        24579999987542 23456789999999999 89999999999


Q ss_pred             EEeCCeeEEEEeccCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCC
Q 036639          421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKS  489 (670)
Q Consensus       421 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp  489 (670)
                      +......++||||+++|+|.+++......           ....+++..+..++.|+++||+|||+.    +++||||||
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~----givH~dlkp  165 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ----KCIHRDLAA  165 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC----Ceeeccccc
Confidence            99999999999999999999999764321           123578899999999999999999998    999999999


Q ss_pred             CCeEeCCCCcEEEEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 036639          490 SNVLLDKNGVACISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSP  562 (670)
Q Consensus       490 ~NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~  562 (670)
                      +||++++++.+||+|||+++.......      ..++..|+|||++.+..++.++||||||+++|||++ |..||...  
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~--  243 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI--  243 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC--
Confidence            999999999999999999987643221      123346999999988889999999999999999998 77777532  


Q ss_pred             CCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                                  ........ +.......       ..   ......+.+++.+||+.+|++|||+.|+++.|+++..-
T Consensus       244 ------------~~~~~~~~-~~~~~~~~-------~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         244 ------------PVEELFKL-LKEGHRMD-------KP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             ------------CHHHHHHH-HHcCCcCC-------CC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                        11111111 11111000       00   11223456677799999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.7e-36  Score=313.80  Aligned_cols=256  Identities=23%  Similarity=0.355  Sum_probs=197.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCC--EEEEEEeCCC-CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGG--IVAVKRLKDA-NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|... ++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|+||
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~   84 (297)
T cd05089           5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY   84 (297)
T ss_pred             eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence            34567999999999999865 343  4788888743 333456789999999999 799999999999999999999999


Q ss_pred             cCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEE
Q 036639          434 LPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI  502 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl  502 (670)
                      +++++|.++++.....           ....+++..+..++.|++.||+|||+.    +|+||||||+|||+++++.+||
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK----QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCcCCcceEEECCCCeEEE
Confidence            9999999999754311           112488999999999999999999987    9999999999999999999999


Q ss_pred             EecccccccCccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhH
Q 036639          503 SDFGLSLLLNPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       503 ~DFG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      +|||++.......   ....+..|+|||++....++.++|||||||++|||+| |..||....              ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--------------~~~  226 (297)
T cd05089         161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--------------CAE  226 (297)
T ss_pred             CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------------HHH
Confidence            9999987543211   1112345999999988889999999999999999998 999986431              111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      ....... .....       ....   ....+.+++.+||+.+|.+|||++++++.|+.+.....
T Consensus       227 ~~~~~~~-~~~~~-------~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         227 LYEKLPQ-GYRME-------KPRN---CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             HHHHHhc-CCCCC-------CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            1111111 10000       0011   12345667789999999999999999999999886553

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.1e-37  Score=326.58  Aligned_cols=240  Identities=22%  Similarity=0.279  Sum_probs=188.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCC-CCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKH-PNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||+|+.. +++.||||+++...   ....+.+..|.+++..++| ++|+++++++.+.+..|+||||+
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   83 (324)
T cd05587           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV   83 (324)
T ss_pred             EEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCC
Confidence            4568999999999999954 57899999997532   2244567788899998876 56888999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.... 
T Consensus        84 ~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          84 NGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999987543     478999999999999999999998    999999999999999999999999999875321 


Q ss_pred             ---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 ---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                         .....++..|+|||++.+..++.++|||||||++|||+||+.||.....              ............  
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------------~~~~~~i~~~~~--  218 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------------DELFQSIMEHNV--  218 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHcCCC--
Confidence               2234578889999999998999999999999999999999999964311              111111111100  


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM-----AEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  634 (670)
                             .......   ..+.+++.+||..||++|++.     +++++|
T Consensus       219 -------~~~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         219 -------SYPKSLS---KEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -------CCCCCCC---HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                   0001112   235567779999999999976     666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.7e-36  Score=303.96  Aligned_cols=242  Identities=29%  Similarity=0.426  Sum_probs=193.9

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      +.||+|+||.||+|...+++.||+|.++.... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988899999999876532 23457889999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-----
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-----  515 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----  515 (670)
                      +++....    ..+++..+..++.|++.||.|+|+.    +++||||||+||+++.++.+||+|||++.......     
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            9987543    2478999999999999999999987    99999999999999999999999999987643321     


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      .......|+|||++.+..++.++||||||+++||+++ |..||.....              ... ...........   
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------------~~~-~~~~~~~~~~~---  214 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------------QQA-REQVEKGYRMS---  214 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------------HHH-HHHHHcCCCCC---
Confidence            1122346999999998889999999999999999999 9989864311              011 11111111000   


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                             ........+.+++.+|+..+|++||++.|+++.|.
T Consensus       215 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         215 -------CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                   00112245667888999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=309.20  Aligned_cols=250  Identities=24%  Similarity=0.373  Sum_probs=195.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-C---CCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe------e
Q 036639          360 SAEMLGKGSLGTVYKAVLD-D---GGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE------K  427 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~------~  427 (670)
                      +.+.||+|+||.||+|... +   +..||+|+++...  ....+.+..|++.++.++||||+++++++.....      .
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   82 (273)
T cd05035           3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP   82 (273)
T ss_pred             cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence            4578999999999999854 2   3679999997543  2234678899999999999999999998876554      7


Q ss_pred             EEEEeccCCCChHHHhccCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGP-GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      ++++||+++|+|..++...... ....+++.....++.|++.||+|||+.    +++||||||+||++++++.+||+|||
T Consensus        83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR----NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchheEEECCCCeEEECCcc
Confidence            8999999999999998654321 223589999999999999999999998    99999999999999999999999999


Q ss_pred             cccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHH
Q 036639          507 LSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       507 ~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +++.......      ...+..|+|||++....++.++|||||||++|||++ |..||.....              .+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------------~~~  224 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------------HEI  224 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------------HHH
Confidence            9987643221      123446999999988889999999999999999999 8888854311              111


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ......... ..          ........+.+++.+||+.||++|||+.|++++|+++
T Consensus       225 ~~~~~~~~~-~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         225 YDYLRHGNR-LK----------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHHHcCCC-CC----------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111111110 00          0111234567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.9e-37  Score=337.82  Aligned_cols=246  Identities=25%  Similarity=0.339  Sum_probs=193.7

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC--------ee
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE--------EK  427 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--------~~  427 (670)
                      .+.+.||+|+||+||+|. ..+|+.||||++...  .......+.+|+..+..++|+||+++.+.+...+        ..
T Consensus        35 ~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i  114 (496)
T PTZ00283         35 WISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMI  114 (496)
T ss_pred             EEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEE
Confidence            345679999999999998 457999999998654  2334567888999999999999999988775432        36


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      ++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+
T Consensus       115 ~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~----~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        115 ALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSK----HMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence            799999999999999875432 223588999999999999999999998    999999999999999999999999999


Q ss_pred             ccccCc------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          508 SLLLNP------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       508 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      ++....      .....++..|+|||++.+..++.++|||||||++|||++|+.||...              .....+.
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~--------------~~~~~~~  255 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--------------NMEEVMH  255 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC--------------CHHHHHH
Confidence            976542      12345788899999999999999999999999999999999999643              1112222


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ........ . +      ....   ...+.+++.+||+.||++||++.+++++
T Consensus       256 ~~~~~~~~-~-~------~~~~---~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTLAGRYD-P-L------PPSI---SPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHhcCCCC-C-C------CCCC---CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            22211110 0 0      0111   2345667779999999999999999875

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-37  Score=314.99  Aligned_cols=246  Identities=24%  Similarity=0.296  Sum_probs=193.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||++.. .+++.||||++.....   .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05605           4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccC
Confidence            446799999999999995 4689999999975321   123456789999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||++++++.++|+|||++.......
T Consensus        84 ~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          84 GGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRE----RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             CCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHC----CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999998886432   12588999999999999999999998    99999999999999999999999999998764322


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ...++..|+|||++.+..++.++|||||||++|||++|+.||......           .....+...+....  . 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~--~-  222 (285)
T cd05605         157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----------VKREEVERRVKEDQ--E-  222 (285)
T ss_pred             ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----------hHHHHHHHHhhhcc--c-
Confidence               235677899999998888999999999999999999999999753110           00011111111100  0 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                              .........+.+++.+||..||++||     ++++++++
T Consensus       223 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         223 --------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             --------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                    00011123455677899999999999     88898776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.3e-37  Score=326.98  Aligned_cols=190  Identities=23%  Similarity=0.310  Sum_probs=161.9

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~l  429 (670)
                      .+.+.||+|+||.||++.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++....      ..|+
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l  103 (359)
T cd07876          24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL  103 (359)
T ss_pred             EEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEE
Confidence            3457899999999999995 46899999999753  2234567889999999999999999999986543      4699


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+++ +|.+.++.       .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++
T Consensus       104 v~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~----~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         104 VMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             EEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            9999965 67666642       377888999999999999999998    99999999999999999999999999997


Q ss_pred             ccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          510 LLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       510 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....   ....++..|+|||.+.+..++.++|||||||++|||+||+.||...
T Consensus       172 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         172 TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             ccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            65432   2345677899999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-37  Score=290.98  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=195.2

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC-----Cc---chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA-----NP---CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~---~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  429 (670)
                      ..+.||+|..++|.++.. .+|+.+|+|++...     .+   ...+.-.+|+.+++++ .||+|+++.++|+.+...++
T Consensus        21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl  100 (411)
T KOG0599|consen   21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL  100 (411)
T ss_pred             hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence            357899999999999884 57899999998532     11   1234566889999988 69999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      |+|.|+.|.|.+++...-     .+++....+|+.|+.+|++|||..    .||||||||+|||+|++.++||+|||.+.
T Consensus       101 VFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~----~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen  101 VFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHAR----NIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             hhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHh----hhhhcccChhheeeccccceEEeccceee
Confidence            999999999999998653     689999999999999999999998    99999999999999999999999999999


Q ss_pred             ccCccc---cccccCcccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          510 LLNPVQ---AIARLGGYKAPEQAEV------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       510 ~~~~~~---~~~~~~~y~aPE~~~~------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      .+.+.+   ...||++|+|||.+..      ..|+..+|+|++|||||-|+.|.+||...              ...-.+
T Consensus       172 ~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--------------kQmlML  237 (411)
T KOG0599|consen  172 QLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--------------KQMLML  237 (411)
T ss_pred             ccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--------------HHHHHH
Confidence            988765   4689999999998853      35888999999999999999999999532              000112


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +.++...+..     .-   +...+......+++.+||+.||++|.|++|+++|
T Consensus       238 R~ImeGkyqF-----~s---peWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  238 RMIMEGKYQF-----RS---PEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHHhccccc-----CC---cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            2222222110     00   1112222334556779999999999999999985

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-36  Score=306.78  Aligned_cols=245  Identities=27%  Similarity=0.401  Sum_probs=194.6

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEE-eCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY-AKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~-~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||.||++... |..||+|.++...  ..+.+.+|+.++++++|+||+++++++. ..+..++|+||++++
T Consensus         9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~   85 (256)
T cd05082           9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   85 (256)
T ss_pred             eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence            45578999999999999875 7889999987543  3567899999999999999999999765 456789999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-c
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-A  516 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  516 (670)
                      +|.++++...   ...+++.....++.|++.||+|||+.    +++||||||+||++++++.+||+|||+++...... .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  158 (256)
T cd05082          86 SLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEAN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT  158 (256)
T ss_pred             cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeccccchheEEEcCCCcEEecCCccceeccccCCC
Confidence            9999997643   22478999999999999999999988    99999999999999999999999999988654322 2


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...+..|+|||++....++.++|||||||++|||++ |+.||...              ........ +...+.....  
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------------~~~~~~~~-~~~~~~~~~~--  221 (256)
T cd05082         159 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------------PLKDVVPR-VEKGYKMDAP--  221 (256)
T ss_pred             CccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------------CHHHHHHH-HhcCCCCCCC--
Confidence            233456999999988889999999999999999998 99888532              11111111 1111111100  


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                              ......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       222 --------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 --------DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                    11123456677899999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.6e-36  Score=307.45  Aligned_cols=247  Identities=21%  Similarity=0.313  Sum_probs=195.7

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            567788999999999999965 5788999999766655667888999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      ++|..++....    .++++..+..++.|+++||+|||+.    +++||||||+||+++.++.+||+|||++.....   
T Consensus        87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHEN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999876432    2589999999999999999999998    999999999999999999999999999876532   


Q ss_pred             -cccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 -VQAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                       .....++..|+|||++.     +..++.++|||||||++|||++|+.||....+              ...+.......
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------------~~~~~~~~~~~  224 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------------MRVLLKIAKSE  224 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------------HHHHHHHhhcC
Confidence             22345677899999873     44578899999999999999999999864311              01111111111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      ....      ......   ...+.+++.+||+.+|++||++.+++++-
T Consensus       225 ~~~~------~~~~~~---~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         225 PPTL------AQPSRW---SSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CCCC------CCcccc---CHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            0000      000111   12456677799999999999999998763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-36  Score=315.93  Aligned_cols=258  Identities=25%  Similarity=0.363  Sum_probs=198.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCC--EEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGG--IVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|... ++.  .+|+|.++... ....+.+.+|++++.++ +|+||+++++++...+..++||||
T Consensus        10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   89 (303)
T cd05088          10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   89 (303)
T ss_pred             eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence            34578999999999999964 454  46888876532 23456788999999999 899999999999999999999999


Q ss_pred             cCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEE
Q 036639          434 LPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI  502 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl  502 (670)
                      +++++|.++++.....           ....+++..++.++.|++.||+|||+.    +++||||||+|||+++++.+||
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC----CccccccchheEEecCCCcEEe
Confidence            9999999999754311           112578999999999999999999987    9999999999999999999999


Q ss_pred             EecccccccCccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhH
Q 036639          503 SDFGLSLLLNPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       503 ~DFG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      +|||++.......   ....+..|+|||++.+..++.++|||||||++|||+| |..||.....              ..
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------------~~  231 (303)
T cd05088         166 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------------AE  231 (303)
T ss_pred             CccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------------HH
Confidence            9999987442211   1122346999999988889999999999999999998 9999864311              11


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCC
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL  645 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~  645 (670)
                      .... ........       ....   ....+.+++.+||+.+|++||++++++++|+++.....+.
T Consensus       232 ~~~~-~~~~~~~~-------~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~  287 (303)
T cd05088         232 LYEK-LPQGYRLE-------KPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY  287 (303)
T ss_pred             HHHH-HhcCCcCC-------CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence            1111 11110000       0001   1224567888999999999999999999999987666433

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.1e-36  Score=308.15  Aligned_cols=247  Identities=22%  Similarity=0.421  Sum_probs=196.4

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CC---CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DG---GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      ...+.||+|+||.||+|... ++   ..||+|.++.. .....+++..|++++++++|+||+++++++...+..++||||
T Consensus         8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (268)
T cd05063           8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEY   87 (268)
T ss_pred             eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEc
Confidence            34578999999999999964 33   37999998754 233457789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++....    ..+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          88 MENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDM----NYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            99999999997543    2488999999999999999999988    999999999999999999999999999986643


Q ss_pred             ccc-------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          514 VQA-------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       514 ~~~-------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ...       ......|+|||++....++.++|||||||++|||+| |+.||....              ..........
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--------------~~~~~~~i~~  225 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--------------NHEVMKAIND  225 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--------------HHHHHHHHhc
Confidence            211       111235999999988889999999999999999998 999985431              1111111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ..           ..+........+.+++.+||+.+|++||++.+|++.|+++
T Consensus       226 ~~-----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 GF-----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CC-----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            10           0001111234567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=304.89  Aligned_cols=246  Identities=30%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus         9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (256)
T cd05039           9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS   86 (256)
T ss_pred             cceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence            45678999999999999876 78999999986654 56788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc-c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-I  517 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~  517 (670)
                      |.++++...   ...+++..+..++.|++.||.|||+.    +++||||||+||+++.++.+||+|||.++....... .
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~  159 (256)
T cd05039          87 LVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEK----NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSG  159 (256)
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CccchhcccceEEEeCCCCEEEcccccccccccccccC
Confidence            999997543   12589999999999999999999998    999999999999999999999999999987743222 2


Q ss_pred             cccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          518 ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       518 ~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      .....|+|||++....++.++||||||+++||+++ |+.||.....               ..+.......+....    
T Consensus       160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---------------~~~~~~~~~~~~~~~----  220 (256)
T cd05039         160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---------------KDVVPHVEKGYRMEA----  220 (256)
T ss_pred             CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---------------HHHHHHHhcCCCCCC----
Confidence            23346999999988889999999999999999997 9988853310               111111111111100    


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                            .......+.+++.+||..+|++|||+.|++++|+.+
T Consensus       221 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         221 ------PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                  011123566778899999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.3e-36  Score=305.87  Aligned_cols=241  Identities=27%  Similarity=0.371  Sum_probs=190.3

Q ss_pred             HcCCCCceEEEEEEE---cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          363 MLGKGSLGTVYKAVL---DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .||+|+||.||+|.+   +++..||+|+++...  ....+++..|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999974   357899999987543  234578899999999999999999999875 45678999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-  516 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  516 (670)
                      +|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~  151 (257)
T cd05116          81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEET----NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY  151 (257)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence            9999997543     488999999999999999999988    999999999999999999999999999987643221 


Q ss_pred             ------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          517 ------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       517 ------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                            ..++..|+|||.+....++.++|||||||++|||+| |+.||.....           ..+...    +.....
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----------~~~~~~----i~~~~~  216 (257)
T cd05116         152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----------NEVTQM----IESGER  216 (257)
T ss_pred             eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHH----HHCCCC
Confidence                  112346999999988889999999999999999998 9999864311           111111    111111


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ..       .....   ...+.+++.+||+.||++||++.+|.+.|++.
T Consensus       217 ~~-------~~~~~---~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         217 ME-------CPQRC---PPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CC-------CCCCC---CHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            00       00111   23455677799999999999999999999863

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-37  Score=329.57  Aligned_cols=192  Identities=25%  Similarity=0.368  Sum_probs=167.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||++.. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||||++
T Consensus         5 ~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~   84 (377)
T cd05629           5 TVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLP   84 (377)
T ss_pred             EeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCC
Confidence            357899999999999985 578999999986432   2234668889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        85 gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          85 GGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKL----GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999997543     478888999999999999999998    9999999999999999999999999998632110 


Q ss_pred             --------------------------------------------------ccccccCcccCccccccCCCCCchhHHHHH
Q 036639          515 --------------------------------------------------QAIARLGGYKAPEQAEVKRLSQKADVYSFG  544 (670)
Q Consensus       515 --------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~G  544 (670)
                                                                        ....++..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence                                                              013477889999999988999999999999


Q ss_pred             HHHHHHHcCCCCCCCC
Q 036639          545 VLLLEVLTGRAPSQYP  560 (670)
Q Consensus       545 vvl~elltg~~p~~~~  560 (670)
                      |++|||+||+.||...
T Consensus       236 vil~elltG~~Pf~~~  251 (377)
T cd05629         236 AIMFECLIGWPPFCSE  251 (377)
T ss_pred             hhhhhhhcCCCCCCCC
Confidence            9999999999999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.1e-36  Score=305.57  Aligned_cols=254  Identities=23%  Similarity=0.408  Sum_probs=201.7

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   84 (267)
T cd08224           5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELA   84 (267)
T ss_pred             eeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecC
Confidence            34567999999999999965 8999999988642   2234568899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++++|.+++..... ....+++..+..++.+++.||+|||+.    +|+||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          85 DAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSK----RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             CCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            99999999865321 223588999999999999999999998    9999999999999999999999999998765432


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ....++..|+|||.+.+..++.++|||||||++|||++|+.||....            ............... .
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~~~~~-~  226 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------------MNLYSLCKKIEKCDY-P  226 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------------ccHHHHHhhhhcCCC-C
Confidence                22346667999999988889999999999999999999999986431            111111111111100 0


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ..         ........+.+++.+||..+|++|||+.+|++.|+++.
T Consensus       227 ~~---------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         227 PL---------PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CC---------ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            00         00112234667778999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-36  Score=317.58  Aligned_cols=193  Identities=24%  Similarity=0.404  Sum_probs=159.7

Q ss_pred             HhHcCCCCceEEEEEEEc---CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD---DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  435 (670)
                      +++||+|+||+||+|...   +++.||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            457999999999999854   46889999997543  34567889999999999999999999865  456789999995


Q ss_pred             CCChHHHhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe----CCCCcEEEEeccc
Q 036639          436 NGSLHSLLHGNRG----PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGL  507 (670)
Q Consensus       436 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~  507 (670)
                       ++|.+++.....    .....+++..+..++.|++.||+|||+.    +|+||||||+|||+    +.++.+||+|||+
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence             588888764321    1123588899999999999999999998    99999999999999    4567899999999


Q ss_pred             ccccCcc-------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          508 SLLLNPV-------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       508 a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ++.....       ....++..|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            9876432       23456778999999876 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-36  Score=311.13  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=192.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCC----EEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGG----IVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      ...+.||+|+||+||+|.+. +++    .|++|.+..... ....++..|+..+++++||||+++++++. ....++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence            34578999999999999953 454    478888764322 23467778888999999999999999875 455789999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||+++...
T Consensus        89 ~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          89 LSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEH----RMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             eCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            999999999997543    2589999999999999999999988    99999999999999999999999999998654


Q ss_pred             ccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          513 PVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       513 ~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ...      ...++..|+|||++.+..++.++|||||||++||++| |+.||....+           ..+.+.    ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----------~~~~~~----~~  225 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----------HEVPDL----LE  225 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----------HHHHHH----HH
Confidence            321      1234456999999988899999999999999999998 9999864311           011111    11


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .....  ..+        ......+.+++.+||..+|++|||+.|+++.|..+...
T Consensus       226 ~~~~~--~~~--------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         226 KGERL--AQP--------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCCcC--CCC--------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            11000  000        00123456677899999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.2e-37  Score=326.93  Aligned_cols=190  Identities=21%  Similarity=0.289  Sum_probs=162.6

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~l  429 (670)
                      .+.+.||+|+||.||++.. ..++.||||++...  .....+.+.+|+.+++.++||||+++++++...      ...|+
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~l  106 (364)
T cd07875          27 QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYI  106 (364)
T ss_pred             eEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEE
Confidence            4457899999999999995 46889999999753  223456788899999999999999999987543      35799


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+++ +|.+++..       .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++
T Consensus       107 v~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         107 VMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             EEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            9999965 77777643       377889999999999999999998    99999999999999999999999999998


Q ss_pred             ccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          510 LLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       510 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....   ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            76542   2345677899999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-36  Score=311.12  Aligned_cols=250  Identities=22%  Similarity=0.383  Sum_probs=196.7

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      ...+.||+|+||.||++...      ++..||+|.+........+.+.+|+++++.++|+||+++++++.+....+++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   87 (280)
T cd05092           8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE   87 (280)
T ss_pred             eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence            34578999999999999732      356899999987766667889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEE
Q 036639          433 YLPNGSLHSLLHGNRG----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI  502 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl  502 (670)
                      |+++++|.+++.....          .....+++..+..++.|++.||+|||+.    +++||||||+|||+++++.+||
T Consensus        88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL----HFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC----CeecccccHhhEEEcCCCCEEE
Confidence            9999999999975431          0112478999999999999999999988    9999999999999999999999


Q ss_pred             EecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccc
Q 036639          503 SDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVD  575 (670)
Q Consensus       503 ~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  575 (670)
                      +|||++.......      ...++..|+|||++.+..++.++|||||||++|||++ |+.||.....             
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------------  230 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-------------  230 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-------------
Confidence            9999987653321      1223456999999998899999999999999999998 8988853211             


Q ss_pred             hhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                       .......... ....       .....   ...+.+++.+||+.||++||++.||++.|+.
T Consensus       231 -~~~~~~~~~~-~~~~-------~~~~~---~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         231 -TEAIECITQG-RELE-------RPRTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -HHHHHHHHcC-ccCC-------CCCCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence             0111111111 0000       00111   1235567779999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.9e-36  Score=310.93  Aligned_cols=253  Identities=30%  Similarity=0.413  Sum_probs=198.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|...      ....|++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            34578999999999999853      235799998875432 33567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCe
Q 036639          432 DYLPNGSLHSLLHGNRG-------------------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV  492 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NI  492 (670)
                      ||+++++|.+++.....                   .....+++..++.++.|++.||+|||+.    +++||||||+||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~ivH~dikp~ni  158 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM----KLVHRDLAARNV  158 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC----CeehhhhhhheE
Confidence            99999999999864321                   1123578999999999999999999987    999999999999


Q ss_pred             EeCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 036639          493 LLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRP  565 (670)
Q Consensus       493 ll~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~  565 (670)
                      ++++++.+||+|||+++......      ....+..|+|||++.+..++.++||||||+++|||+| |+.||....+   
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---  235 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP---  235 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH---
Confidence            99999999999999997653221      1223456999999988889999999999999999999 9999854311   


Q ss_pred             CCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          566 RVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                                  ..+.......+...          ........+.+++.+||+.+|++||++.|+++.|+++..
T Consensus       236 ------------~~~~~~~~~~~~~~----------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ------------ERLFNLLKTGYRME----------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ------------HHHHHHHhCCCCCC----------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                        11111111111100          001112356678889999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.9e-37  Score=326.53  Aligned_cols=244  Identities=20%  Similarity=0.282  Sum_probs=191.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++||||+
T Consensus        46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~  125 (370)
T cd05596          46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM  125 (370)
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence            44578999999999999954 6899999999643   1223455788999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.+++...      .++......++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++......
T Consensus       126 ~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         126 PGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999998754      367788889999999999999998    9999999999999999999999999999876432


Q ss_pred             -----ccccccCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          515 -----QAIARLGGYKAPEQAEVK----RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       515 -----~~~~~~~~y~aPE~~~~~----~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                           ....+++.|+|||++...    .++.++|||||||++|||++|+.||.....              .........
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------------~~~~~~i~~  261 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------------VGTYSKIMD  261 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------------HHHHHHHHc
Confidence                 234578889999998643    478999999999999999999999965311              111112211


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEK--RPTMAEVAKM  634 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  634 (670)
                      ...... +.    ......   ..+.+++.+||..+|++  |||++|+++|
T Consensus       262 ~~~~~~-~~----~~~~~s---~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         262 HKNSLT-FP----DDIEIS---KQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCcCC-CC----CcCCCC---HHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            100000 00    001112   23455667999999988  9999999886

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.6e-37  Score=312.01  Aligned_cols=240  Identities=23%  Similarity=0.364  Sum_probs=190.6

Q ss_pred             hHcCCCCceEEEEEEEcC--------CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          362 EMLGKGSLGTVYKAVLDD--------GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.||+|+||.||+|....        ...||+|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            368999999999998532        234889988765555567888999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc--------EEEEec
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV--------ACISDF  505 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DF  505 (670)
                      +++|+|.++++....    .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.        ++++||
T Consensus        81 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~----~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          81 VKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDK----GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             CCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999976532    478999999999999999999998    9999999999999987765        699999


Q ss_pred             ccccccCccccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          506 GLSLLLNPVQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGR-APSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       506 G~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      |.+..........++..|+|||++.+ ..++.++|||||||++|||++|. .||....+              .... ..
T Consensus       153 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------------~~~~-~~  217 (258)
T cd05078         153 GISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------------QKKL-QF  217 (258)
T ss_pred             ccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------------HHHH-HH
Confidence            99987766666677888999999976 45799999999999999999995 45432110              0000 00


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      .....  . +         ......++.+++.+||+.||++|||++++++.|+
T Consensus       218 ~~~~~--~-~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 YEDRH--Q-L---------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHccc--c-C---------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11100  0 0         0011134667888999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.7e-36  Score=304.38  Aligned_cols=242  Identities=25%  Similarity=0.387  Sum_probs=189.7

Q ss_pred             HcCCCCceEEEEEEEc---CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          363 MLGKGSLGTVYKAVLD---DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .||+|+||.||+|.+.   ++..||+|++.... ....+++.+|++++++++|+||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999853   35679999997653 234567899999999999999999999875 457899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc--
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--  516 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  516 (670)
                      |.+++....    ..+++..+.+++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++........  
T Consensus        81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGK----NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhc----CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999987533    2589999999999999999999988    999999999999999999999999999976543211  


Q ss_pred             -----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          517 -----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       517 -----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                           ...+..|+|||.+....++.++|||||||++||+++ |+.||.....              ..... .+......
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------------~~~~~-~~~~~~~~  217 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------------PEVMS-FIEQGKRL  217 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------------HHHHH-HHHCCCCC
Confidence                 111346999999988889999999999999999996 9999864311              11111 11111000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      . .         ......++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       218 ~-~---------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 D-C---------PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             C-C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            0 0         011123455677799999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.4e-36  Score=305.19  Aligned_cols=246  Identities=27%  Similarity=0.393  Sum_probs=194.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.+.||+|++|.||+|....+..||+|.+..... ..+.+.+|++++++++|+|++++++++. .+..++||||++++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~   85 (260)
T cd05069           8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG   85 (260)
T ss_pred             eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence            345577999999999999987777899999875432 4567889999999999999999999875 45688999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.++++...   ...+++..+..++.|++.||+|||+.    +++|+||||+||++++++.++|+|||++.......  
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          86 SLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERM----NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            9999997543   22478999999999999999999987    99999999999999999999999999997654322  


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ...++..|+|||+..+..++.++||||||+++|||+| |+.||.....              ...... ........
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------------~~~~~~-~~~~~~~~  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------------REVLEQ-VERGYRMP  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHHH-HHcCCCCC
Confidence               1223456999999988889999999999999999999 8888864311              011111 11111000


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                                ........+.+++.+||..||++||++++|++.|++
T Consensus       224 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 ----------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                      001122346667779999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.8e-36  Score=313.32  Aligned_cols=257  Identities=23%  Similarity=0.341  Sum_probs=196.3

Q ss_pred             HHHhHcCCCCceEEEEEEEcC-----------------CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD-----------------GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAY  420 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~  420 (670)
                      .+.+.||+|+||.||+|...+                 +..||+|.+.... ....+++.+|++++++++||||++++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   87 (296)
T cd05051           8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGV   87 (296)
T ss_pred             cccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            456789999999999998542                 2468999987553 3346788999999999999999999999


Q ss_pred             EEeCCeeEEEEeccCCCChHHHhccCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe
Q 036639          421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPG------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL  494 (670)
Q Consensus       421 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll  494 (670)
                      +...+..++++||+++++|.+++.......      ...+++..++.++.|++.||+|||+.    +|+||||||+||++
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~----~i~H~dlkp~Nili  163 (296)
T cd05051          88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL----NFVHRDLATRNCLV  163 (296)
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc----Cccccccchhceee
Confidence            999999999999999999999997654211      22589999999999999999999988    99999999999999


Q ss_pred             CCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCCCC
Q 036639          495 DKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT--GRAPSQYPSPTRPR  566 (670)
Q Consensus       495 ~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--g~~p~~~~~~~~~~  566 (670)
                      +.++.++|+|||+++......      ....+..|+|||++.+..++.++|||||||++|||++  |..||.....    
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~----  239 (296)
T cd05051         164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD----  239 (296)
T ss_pred             cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh----
Confidence            999999999999988653321      1223456999999988889999999999999999998  6677643210    


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                             .....................       .......++.+++.+||+.||++|||+.||++.|++
T Consensus       240 -------~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         240 -------QQVIENAGHFFRDDGRQIYLP-------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             -------HHHHHHHHhccccccccccCC-------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                   011111111100000000000       001112457778889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=3e-36  Score=314.47  Aligned_cols=262  Identities=23%  Similarity=0.359  Sum_probs=201.5

Q ss_pred             cHHHHHHHHHhHcCCCCceEEEEEEEc--------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEE
Q 036639          352 ELEDLLRASAEMLGKGSLGTVYKAVLD--------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYY  421 (670)
Q Consensus       352 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~  421 (670)
                      .+....+.+.+.||+|+||.||+++..        ....||+|.++... .....++..|+++++++ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            333344456789999999999999742        24579999987543 23456788999999999 699999999999


Q ss_pred             EeCCeeEEEEeccCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q 036639          422 YAKEEKLLVYDYLPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSS  490 (670)
Q Consensus       422 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~  490 (670)
                      ...+..++||||+++|+|.+++......           ....+++..+..++.|++.||.|||+.    +++||||||+
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~----gi~H~dlkp~  163 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR----RCIHRDLAAR  163 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC----Ceeeccccce
Confidence            9999999999999999999999754311           123588999999999999999999987    9999999999


Q ss_pred             CeEeCCCCcEEEEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 036639          491 NVLLDKNGVACISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPT  563 (670)
Q Consensus       491 NIll~~~~~~kl~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~  563 (670)
                      ||+++.++.+||+|||+++.......      ...+..|+|||++.+..++.++|||||||++|||++ |..||....  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~--  241 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP--  241 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC--
Confidence            99999999999999999987643211      112245999999988889999999999999999999 888885431  


Q ss_pred             CCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       564 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                                  ...... .........          .......++.+++.+||..+|++|||+.|+++.|+++....
T Consensus       242 ------------~~~~~~-~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         242 ------------VEELFK-LLREGHRMD----------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             ------------HHHHHH-HHHcCCCCC----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence                        111111 111111100          00111234556778999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.7e-36  Score=308.61  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=195.2

Q ss_pred             HHHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          357 LRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .|.+.+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            446678999999999999995 4689999999976654455678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     .+++.....++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||++...... 
T Consensus        90 ~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          90 GGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSK----GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            999999987543     588999999999999999999998    9999999999999999999999999998765321 


Q ss_pred             ---ccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          515 ---QAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                         ....++..|+|||++.   ...++.++|||||||++|||++|+.||....+...              +........
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--------------~~~~~~~~~  226 (267)
T cd06645         161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------------LFLMTKSNF  226 (267)
T ss_pred             cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--------------HHhhhccCC
Confidence               2345677899999874   45688999999999999999999999854321100              000000000


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ......    ......   ..+.+++.+||+.+|++||++++|+++
T Consensus       227 ~~~~~~----~~~~~~---~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         227 QPPKLK----DKMKWS---NSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCccc----ccCCCC---HHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            000000    000111   235567779999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=310.57  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=197.4

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEE
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.+.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++|+||+++++++......++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~   86 (277)
T cd05032           7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLV   86 (277)
T ss_pred             HeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEE
Confidence            3445678999999999999854      24689999987543 2345678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          430 VYDYLPNGSLHSLLHGNRGP-----GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      ||||+++|+|.+++......     ....+++..+..++.|++.||.|||+.    +++||||||+||+++.++.+||+|
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          87 VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK----KFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CccccccChheEEEcCCCCEEECC
Confidence            99999999999998754321     122478899999999999999999987    999999999999999999999999


Q ss_pred             cccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchh
Q 036639          505 FGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLP  577 (670)
Q Consensus       505 FG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  577 (670)
                      ||+++......      ...++..|+|||.+....++.++|||||||++||++| |+.||.....           ....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-----------~~~~  231 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----------EEVL  231 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-----------HHHH
Confidence            99987654322      2233557999999988889999999999999999998 8888854311           0111


Q ss_pred             HHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       578 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      +..    .......          ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus       232 ~~~----~~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 KFV----IDGGHLD----------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHH----hcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111    1110000          001113456678889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.9e-37  Score=339.26  Aligned_cols=193  Identities=19%  Similarity=0.285  Sum_probs=159.4

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCC------CCeeeEEEEEEeC-CeeEE
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH------PNVVKLRAYYYAK-EEKLL  429 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~nIv~l~~~~~~~-~~~~l  429 (670)
                      |.+.+.||+|+||+||+|.. .+++.||||+++.... ...++..|+++++.++|      .+++++++++... .+.++
T Consensus       131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i  209 (467)
T PTZ00284        131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI  209 (467)
T ss_pred             EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence            44567899999999999995 4688999999975322 34456667777776654      4689999988765 57889


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-----------
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-----------  498 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-----------  498 (670)
                      |||++ +++|.+++....     .+++..+..|+.||+.||+|||+.   .+|+||||||+|||++.++           
T Consensus       210 v~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        210 VMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTE---LHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEecCCccccccccccc
Confidence            99998 778998887543     588999999999999999999974   2899999999999998765           


Q ss_pred             -----cEEEEecccccccCc-cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          499 -----VACISDFGLSLLLNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       499 -----~~kl~DFG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                           .+||+|||.+..... .....+|..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       281 ~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             CCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                 499999998865432 23456788999999999999999999999999999999999999764

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.5e-36  Score=309.26  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=194.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus         9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   88 (277)
T cd05036           9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILL   88 (277)
T ss_pred             EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEE
Confidence            34568999999999999964      35789999887543 334567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEecc
Q 036639          432 DYLPNGSLHSLLHGNRG--PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFG  506 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG  506 (670)
                      ||+++++|.++++....  .....+++..++.++.||+.||+|||+.    +++||||||+||+++.++   .+||+|||
T Consensus        89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN----HFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999976532  1123589999999999999999999998    999999999999998765   59999999


Q ss_pred             cccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHH
Q 036639          507 LSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       507 ~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +++.......      ......|+|||++.+..++.++|||||||++|||++ |..||.....              ...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------------~~~  230 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------------QEV  230 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------------HHH
Confidence            9987633221      112346999999998899999999999999999997 9999864311              111


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      .......... .          ........+.+++.+||+.+|++||++.+|+++|++
T Consensus       231 ~~~~~~~~~~-~----------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         231 MEFVTGGGRL-D----------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             HHHHHcCCcC-C----------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            1111111000 0          001112356678889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-36  Score=308.88  Aligned_cols=245  Identities=23%  Similarity=0.352  Sum_probs=191.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|++++++++||||+++++++...+..++||||++++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   84 (279)
T cd06619           5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGG   84 (279)
T ss_pred             heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCC
Confidence            456899999999999984 57899999998654 2334567889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--c
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--Q  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--~  515 (670)
                      +|..+.         .+++.....++.|++.||+|||+.    +|+|+||||+||+++.++.+||+|||++......  .
T Consensus        85 ~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~  151 (279)
T cd06619          85 SLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSL----KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAK  151 (279)
T ss_pred             ChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccccc
Confidence            997652         367888899999999999999998    9999999999999999999999999999865432  3


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||++.+..++.++||||||+++|||++|+.||........       ................      .
T Consensus       152 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~~~~~------~  218 (279)
T cd06619         152 TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQG-------SLMPLQLLQCIVDEDP------P  218 (279)
T ss_pred             CCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccc-------ccchHHHHHHHhccCC------C
Confidence            34567789999999988899999999999999999999999965321110       0000111111111100      0


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ... ...   ...++.+++.+||+.+|++||+++|++++
T Consensus       219 ~~~-~~~---~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         219 VLP-VGQ---FSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CCC-CCc---CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000 001   11245667779999999999999999986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.2e-36  Score=310.52  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=200.9

Q ss_pred             HHHhHcCCCCceEEEEEEEc-----CCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-----DGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv  430 (670)
                      .+.+.||+|+||.||+|.+.     ++..||||.++..... ..+++.+|+++++.++|+||+++++++..  ....++|
T Consensus         7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05038           7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI   86 (284)
T ss_pred             hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence            44578999999999999853     3688999999865443 46789999999999999999999999887  5578999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++++|.+++.....    .+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.++|+|||.+..
T Consensus        87 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          87 MEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQ----RYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999976532    489999999999999999999987    999999999999999999999999999987


Q ss_pred             cCcccc-------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccc-cchhHHHHH
Q 036639          511 LNPVQA-------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQA-VDLPKWVRS  582 (670)
Q Consensus       511 ~~~~~~-------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~  582 (670)
                      ......       ......|+|||.+.+..++.++||||||+++|||+||+.|+................ .....+. .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  237 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-E  237 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-H
Confidence            753211       122335999999988899999999999999999999999986542211110000000 0111111 1


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      .+.....          .........++.+++.+||+.+|++||||.||+++|+.++
T Consensus       238 ~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         238 LLKEGER----------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             HHHcCCc----------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            1111100          0001112245778888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.3e-37  Score=321.11  Aligned_cols=233  Identities=23%  Similarity=0.305  Sum_probs=182.1

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHH-HHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYM-DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|+.. +|+.||+|++.....   ....++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999964 689999999875321   1233444454 457888999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      ++|..++....     .+....+..++.||+.||+|||+.    +|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  151 (321)
T cd05603          81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSL----NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE  151 (321)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence            99998886543     478888899999999999999987    999999999999999999999999999875422   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||...+              ............     
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------------~~~~~~~i~~~~-----  212 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------------VSQMYDNILHKP-----  212 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------------HHHHHHHHhcCC-----
Confidence             223456788999999998899999999999999999999999996431              111111111110     


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA  629 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  629 (670)
                          ......   ....+.+++.+||+.||.+||++.
T Consensus       213 ----~~~~~~---~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 ----LQLPGG---KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ----CCCCCC---CCHHHHHHHHHHccCCHhhcCCCC
Confidence                000011   123455677799999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-36  Score=343.01  Aligned_cols=259  Identities=22%  Similarity=0.313  Sum_probs=199.3

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||.||+|... +|+.||||++....   ....+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus         5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~   84 (932)
T PRK13184          5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI   84 (932)
T ss_pred             EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence            34578999999999999954 68999999997532   224567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          435 PNGSLHSLLHGNRGP------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      ++|+|.+++......      .....++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++
T Consensus        85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~----GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK----GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC----CccccCCchheEEEcCCCCEEEEecCcc
Confidence            999999998642211      122456788899999999999999998    9999999999999999999999999999


Q ss_pred             cccCc----------------------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 036639          509 LLLNP----------------------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR  566 (670)
Q Consensus       509 ~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~  566 (670)
                      +....                      .....+++.|+|||++.+..++.++|||||||++|||+||+.||.......  
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k--  238 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK--  238 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh--
Confidence            86521                      011347888999999999999999999999999999999999996431110  


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhccCCC
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-TMAEVAKMIEDIRVEQSP  644 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~~~  644 (670)
                               ...  ......  .     ......   .+....+.+++.+|++.||++|| +++++++.|+........
T Consensus       239 ---------i~~--~~~i~~--P-----~~~~p~---~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~  296 (932)
T PRK13184        239 ---------ISY--RDVILS--P-----IEVAPY---REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPE  296 (932)
T ss_pred             ---------hhh--hhhccC--h-----hhcccc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCcc
Confidence                     000  000000  0     000000   11122355677799999999996 678888888887665443

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-37  Score=331.19  Aligned_cols=193  Identities=25%  Similarity=0.376  Sum_probs=167.4

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||.||+|+. .+++.||||++.+..   ....+.+.+|++++++++|+||+++++.+.+.+..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (376)
T cd05598           4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI   83 (376)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence            3457899999999999995 468999999997532   123456888999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.+++....     .++......++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++..... 
T Consensus        84 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          84 PGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            9999999997643     478888899999999999999998    999999999999999999999999999753210 


Q ss_pred             ----------------------------------------------cccccccCcccCccccccCCCCCchhHHHHHHHH
Q 036639          514 ----------------------------------------------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLL  547 (670)
Q Consensus       514 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl  547 (670)
                                                                    .....++..|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence                                                          0123577889999999999999999999999999


Q ss_pred             HHHHcCCCCCCCC
Q 036639          548 LEVLTGRAPSQYP  560 (670)
Q Consensus       548 ~elltg~~p~~~~  560 (670)
                      |||++|+.||...
T Consensus       235 yell~G~~Pf~~~  247 (376)
T cd05598         235 YEMLVGQPPFLAD  247 (376)
T ss_pred             eehhhCCCCCCCC
Confidence            9999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-36  Score=318.24  Aligned_cols=261  Identities=24%  Similarity=0.321  Sum_probs=198.0

Q ss_pred             HHHHHHHHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC
Q 036639          353 LEDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK  424 (670)
Q Consensus       353 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~  424 (670)
                      +..-.+++.+.||+|+||.||+|..      .+++.||||+++.... .....+.+|++++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            3334567788999999999999973      3478899999975432 2345688999999999 689999999988765


Q ss_pred             -CeeEEEEeccCCCChHHHhccCCCCC-----------------------------------------------------
Q 036639          425 -EEKLLVYDYLPNGSLHSLLHGNRGPG-----------------------------------------------------  450 (670)
Q Consensus       425 -~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------------------------------------------  450 (670)
                       ...++||||+++|+|.++++......                                                     
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             45789999999999999986532100                                                     


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc------
Q 036639          451 ---------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ------  515 (670)
Q Consensus       451 ---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~------  515 (670)
                               ...+++..+..++.|+++||+|||+.    +|+||||||+||++++++.+||+|||++.......      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                     12368888999999999999999988    99999999999999999999999999998653221      


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..||......              ........+......  
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~--  303 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRA--  303 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--------------HHHHHHHhccCCCCC--
Confidence            1223446999999988889999999999999999997 88888543110              001111111100000  


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                           ...   ....+.+++..||+.||++|||+.||+++|+.+...
T Consensus       304 -----~~~---~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         304 -----PDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             -----CCC---CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                 000   112467788899999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=312.99  Aligned_cols=259  Identities=20%  Similarity=0.313  Sum_probs=194.2

Q ss_pred             HHHHHhHcCCCCceEEEEEEEcC---------------CCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEE
Q 036639          357 LRASAEMLGKGSLGTVYKAVLDD---------------GGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAY  420 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~  420 (670)
                      .+.+.+.||+|+||.||++...+               ...||+|.++.. .......+.+|++++++++|+||++++++
T Consensus         6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~   85 (295)
T cd05097           6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGV   85 (295)
T ss_pred             hCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            34556789999999999987532               235899999754 23345678999999999999999999999


Q ss_pred             EEeCCeeEEEEeccCCCChHHHhccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeE
Q 036639          421 YYAKEEKLLVYDYLPNGSLHSLLHGNRG-------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL  493 (670)
Q Consensus       421 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIl  493 (670)
                      +...+..++||||+++++|.+++.....       .....+++..+..++.|++.||+|||+.    +++||||||+||+
T Consensus        86 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~----~i~H~dlkp~Nil  161 (295)
T cd05097          86 CVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL----NFVHRDLATRNCL  161 (295)
T ss_pred             EcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc----CeeccccChhhEE
Confidence            9999999999999999999999864321       0112478899999999999999999998    9999999999999


Q ss_pred             eCCCCcEEEEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCCC
Q 036639          494 LDKNGVACISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT--GRAPSQYPSPTRP  565 (670)
Q Consensus       494 l~~~~~~kl~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--g~~p~~~~~~~~~  565 (670)
                      +++++.+||+|||++........      ..++..|+|||+.....++.++|||||||++|||++  |..||.....   
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~---  238 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD---  238 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence            99999999999999976533221      122446999999988889999999999999999998  5566653211   


Q ss_pred             CCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          566 RVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                              ................ ..+.      .........+.+++.+||+.||++||++.+|++.|++
T Consensus       239 --------~~~~~~~~~~~~~~~~-~~~~------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 --------EQVIENTGEFFRNQGR-QIYL------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --------HHHHHHHHHhhhhccc-cccC------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                    0111111111110000 0000      0000112357778889999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2e-36  Score=306.28  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=194.4

Q ss_pred             hHcCCCCceEEEEEEEcC--C--CEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLDD--G--GIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|++++++++||||+++++++.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999999643  3  3699999987655 566789999999999999999999999988 888999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++.....   ..+++.....++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||+++...... 
T Consensus        80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESK----RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhC----CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999976531   3589999999999999999999998    99999999999999999999999999998764421 


Q ss_pred             ------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          516 ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       516 ------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                            ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....              ............
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------------~~~~~~~~~~~~  218 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------------SQILKKIDKEGE  218 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHHHHHhcCC
Confidence                  1234557999999998899999999999999999999 9999853311              111111111100


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      ..          .........+.+++.+||+.+|++||++.|+++.|.
T Consensus       219 ~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RL----------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cC----------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00          000111235667788999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-36  Score=304.21  Aligned_cols=246  Identities=32%  Similarity=0.435  Sum_probs=197.8

Q ss_pred             hHcCCCCceEEEEEEEcC----CCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLDD----GGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|....    +..|++|.++..... ..+.+.+|++.+..++|+||+++++++.+....++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            368999999999999653    789999999865433 367889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          437 GSLHSLLHGNRGP----GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       437 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      ++|.+++......    ....+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||.+....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~----~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK----KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC----CcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999865211    023689999999999999999999997    99999999999999999999999999998775


Q ss_pred             cc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          513 PV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       513 ~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ..      ....++..|+|||.+....++.++||||+|+++|||++ |..||....              ..........
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------------~~~~~~~~~~  222 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------------NEEVLEYLRK  222 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------------HHHHHHHHHc
Confidence            43      22345567999999988889999999999999999999 688986531              1111111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                       ....          ........++.+++.+||..+|++|||+.|++++|+
T Consensus       223 -~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 -GYRL----------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCC----------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             1000          001111245667888999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-36  Score=304.64  Aligned_cols=247  Identities=29%  Similarity=0.440  Sum_probs=198.7

Q ss_pred             HHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.+.||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||++++
T Consensus         8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   86 (261)
T cd05034           8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG   86 (261)
T ss_pred             eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCC
Confidence            345678999999999999988888999999985443 4678999999999999999999999999989999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.+++.....   ..+++..+..++.+++.||+|||+.    +++|+||||+||++++++.+||+|||.++......  
T Consensus        87 ~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          87 SLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESR----NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99999976431   2589999999999999999999988    99999999999999999999999999988764321  


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....+..|+|||.+.+..++.++||||||+++||++| |+.||.....              ......... .....
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------------~~~~~~~~~-~~~~~  224 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------------REVLEQVER-GYRMP  224 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------------HHHHHHHHc-CCCCC
Confidence               1223346999999998889999999999999999999 9999854310              011111111 00000


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                             .   .......+.+++.+|+..+|++||+++|+++.|+.
T Consensus       225 -------~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 -------R---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -------C---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                   0   00112346677889999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-36  Score=303.41  Aligned_cols=243  Identities=29%  Similarity=0.382  Sum_probs=192.5

Q ss_pred             hHcCCCCceEEEEEEEc-C---CCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-D---GGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|.+. .   +..||+|.+..... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            36999999999999843 2   26899999986543 34567899999999999999999999876 4567999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA  516 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  516 (670)
                      ++|.+++....     .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||+++.......
T Consensus        80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~----~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESK----HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhc----CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999997653     588999999999999999999988    999999999999999999999999999986643221


Q ss_pred             c-------cccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          517 I-------ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       517 ~-------~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      .       .++..|+|||...+..++.++||||||+++|||++ |+.||.....           ..+..++    ....
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----------~~~~~~~----~~~~  215 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------AEVIAML----ESGE  215 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----------HHHHHHH----HcCC
Confidence            1       11235999999998899999999999999999998 9999864311           1111111    1111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ...          ........+.+++.+||..+|++||++.++++.|+++.
T Consensus       216 ~~~----------~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLP----------RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCC----------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            000          00111235667888999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-36  Score=305.81  Aligned_cols=243  Identities=22%  Similarity=0.333  Sum_probs=192.8

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc-----chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP-----CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      ...+.||+|++|.||++.. .+++.||+|.+.....     ...+.+.+|++++++++||||+++++++.+.+..++|+|
T Consensus         5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   84 (263)
T cd06625           5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME   84 (263)
T ss_pred             cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence            3467899999999999995 4689999999864321     123568889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.+++....     .+++.....++.|++.||+|||+.    +|+||||+|+||++++++.++|+|||+++...
T Consensus        85 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          85 YMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             ECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999987643     478889999999999999999998    99999999999999999999999999987654


Q ss_pred             cc-------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          513 PV-------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       513 ~~-------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ..       ....++..|+|||.+.+..++.++||||||+++|||++|+.||.....             . ........
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------------~-~~~~~~~~  221 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------------M-AAIFKIAT  221 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------------H-HHHHHHhc
Confidence            32       123355679999999988899999999999999999999999864311             0 00111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...... +         .......+.+++.+||..+|++|||+.|++++
T Consensus       222 ~~~~~~-~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 QPTNPQ-L---------PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             cCCCCC-C---------CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            100000 0         01112345567779999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-36  Score=316.29  Aligned_cols=244  Identities=23%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc---hHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC---ARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|.||.||+++.+ +|+.+|+|.+.+....   ..+.+.+|+.+|+++. |||||.+.+.|++....++|||+
T Consensus        38 ~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL  117 (382)
T KOG0032|consen   38 ELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMEL  117 (382)
T ss_pred             EehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEe
Confidence            34578999999999999965 5999999999865443   4468999999999998 99999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC----CcEEEEeccccc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN----GVACISDFGLSL  509 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~  509 (670)
                      +.||.|.+.+...      .+++.....++.|++.+++|||+.    +|+||||||+|+|+...    +.+|++|||++.
T Consensus       118 ~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~----gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  118 CEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSL----GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             cCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhC----CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999999999765      288999999999999999999997    99999999999999643    479999999999


Q ss_pred             ccCc---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          510 LLNP---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       510 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ....   .....||+.|+|||++....|+..+||||+||++|.|++|.+||...+....              .......
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------------~~~i~~~  253 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------------FLAILRG  253 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------------HHHHHcC
Confidence            8876   3456789999999999999999999999999999999999999976522110              1122222


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ++     +-....+....+.+.+   ++..|+..||.+|+|+.++++|
T Consensus       254 ~~-----~f~~~~w~~is~~akd---~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  254 DF-----DFTSEPWDDISESAKD---FIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CC-----CCCCCCccccCHHHHH---HHHHhcccCcccCCCHHHHhcC
Confidence            21     1111122333444444   5559999999999999999996

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.2e-36  Score=309.38  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=196.7

Q ss_pred             HHHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeE
Q 036639          356 LLRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       356 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~  428 (670)
                      -.|.+.+.||+|+||.||+|..+      .+..||+|.++.... .....+.+|+.++++++||||+++++++.+....+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            34456688999999999999743      245899999875432 23456788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEE
Q 036639          429 LVYDYLPNGSLHSLLHGNRG-----PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS  503 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~  503 (670)
                      +||||+++|+|.++++....     .......+..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK----KFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCCChheEEEcCCCcEEEC
Confidence            99999999999999975321     1123467788899999999999999988    99999999999999999999999


Q ss_pred             ecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccch
Q 036639          504 DFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       504 DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      |||+++......      ...++..|+|||.+.+..++.++|||||||++|||++ |..||....              .
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------------~  227 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------------N  227 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------------H
Confidence            999998653321      1122446999999998899999999999999999998 788885421              1


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      .+............           ........+.+++.+||+.||++|||+.|+++.|++..
T Consensus       228 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         228 EQVLKFVMDGGYLD-----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             HHHHHHHHcCCCCC-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            11111111111000           00111235667788999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.2e-37  Score=321.43  Aligned_cols=240  Identities=23%  Similarity=0.298  Sum_probs=188.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||+|+.. +++.||||++++..   ....+.+..|..++..+ +|++|+++++++.+.+..++||||+
T Consensus         4 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~   83 (323)
T cd05616           4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYV   83 (323)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCC
Confidence            3567999999999999955 67899999997542   12334566677777776 5899999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++.... 
T Consensus        84 ~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          84 NGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999987543     488999999999999999999988    999999999999999999999999999975432 


Q ss_pred             ---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 ---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                         .....+++.|+|||++.+..++.++|||||||++|||+||+.||.....              ............. 
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------------~~~~~~i~~~~~~-  219 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------------DELFQSIMEHNVA-  219 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------------HHHHHHHHhCCCC-
Confidence               2234578889999999999999999999999999999999999965311              1111111111100 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM-----AEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  634 (670)
                        +      .....   ..+.+++.+|++.||++|++.     .++.++
T Consensus       220 --~------p~~~s---~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         220 --Y------PKSMS---KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             --C------CCcCC---HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence              0      01112   234567779999999999984     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.9e-36  Score=303.71  Aligned_cols=246  Identities=26%  Similarity=0.361  Sum_probs=188.7

Q ss_pred             hHcCCCCceEEEEEEEc----CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEEEEeccC
Q 036639          362 EMLGKGSLGTVYKAVLD----DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLLVYDYLP  435 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~  435 (670)
                      +.||+|+||.||+|...    ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            36899999999999853    2457999998643 23345678899999999999999999998764 556789999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|.+++....    ....+..+..++.|+++||+|||+.    +++||||||+|||+++++.+||+|||+++......
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASK----KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999997543    1367788899999999999999987    99999999999999999999999999997653211


Q ss_pred             --------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          516 --------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR-APSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       516 --------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                              ...++..|+|||.+....++.++|||||||++|||++|+ +||...              ............
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~--------------~~~~~~~~~~~~  218 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--------------DSFDITVYLLQG  218 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC--------------CHHHHHHHHhcC
Confidence                    122345699999998889999999999999999999965 455322              111111111111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ....           ........+.+++.+||..+|++||++.||++.|+++..
T Consensus       219 ~~~~-----------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 RRLL-----------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCC-----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            0000           000112346678889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.6e-37  Score=328.29  Aligned_cols=192  Identities=25%  Similarity=0.368  Sum_probs=166.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ..+.||+|+||+||+|+. .+++.||+|++....   ....+.+.+|++++++++|+||+++++++.+.+..|+||||++
T Consensus         5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~   84 (382)
T cd05625           5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP   84 (382)
T ss_pred             EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence            346899999999999995 568899999997542   2234578889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++.....  
T Consensus        85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~----~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          85 GGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999987543     478888899999999999999998    999999999999999999999999999753210  


Q ss_pred             -------------------------------------------------cccccccCcccCccccccCCCCCchhHHHHH
Q 036639          514 -------------------------------------------------VQAIARLGGYKAPEQAEVKRLSQKADVYSFG  544 (670)
Q Consensus       514 -------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~G  544 (670)
                                                                       .....+|..|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                             0113467789999999989999999999999


Q ss_pred             HHHHHHHcCCCCCCCC
Q 036639          545 VLLLEVLTGRAPSQYP  560 (670)
Q Consensus       545 vvl~elltg~~p~~~~  560 (670)
                      |++|||++|+.||...
T Consensus       236 vil~elltG~~Pf~~~  251 (382)
T cd05625         236 VILYEMLVGQPPFLAQ  251 (382)
T ss_pred             HHHHHHHhCCCCCCCC
Confidence            9999999999999654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.1e-37  Score=326.09  Aligned_cols=193  Identities=24%  Similarity=0.354  Sum_probs=167.4

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      |.+.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus        45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey  124 (370)
T cd05621          45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY  124 (370)
T ss_pred             CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence            445678999999999999965 6889999998642   122345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.+++...      .+++.....++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||++.....
T Consensus       125 ~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~----~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~  194 (370)
T cd05621         125 MPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSM----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE  194 (370)
T ss_pred             CCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence            9999999999754      378888999999999999999998    999999999999999999999999999987643


Q ss_pred             c-----ccccccCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 V-----QAIARLGGYKAPEQAEVK----RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ~-----~~~~~~~~y~aPE~~~~~----~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .     ....++..|+|||++.+.    .++.++||||+||++|||++|+.||...
T Consensus       195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence            2     234578889999998654    3789999999999999999999999653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.7e-36  Score=313.68  Aligned_cols=244  Identities=25%  Similarity=0.380  Sum_probs=196.4

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus        21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~  100 (297)
T cd06656          21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  100 (297)
T ss_pred             ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCC
Confidence            34457899999999999995 57999999999866555667788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++...      .+++..+..++.|++.||.|||+.    +++||||||+||+++.++.++|+|||++....... 
T Consensus       101 ~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~----~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656         101 GSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            9999998653      378899999999999999999988    99999999999999999999999999987654322 


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ...++..|+|||.+.+..++.++|||||||++|++++|+.||....+........              ... ... 
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~--------------~~~-~~~-  234 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------------TNG-TPE-  234 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec--------------cCC-CCC-
Confidence               2345667999999998889999999999999999999999996543211100000              000 000 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          ..   ........+.+++.+||+.+|++||++++++++
T Consensus       235 ----~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         235 ----LQ---NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ----CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00   001111234557779999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.7e-36  Score=307.57  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=186.4

Q ss_pred             HcCCCCceEEEEEEEcC---CCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          363 MLGKGSLGTVYKAVLDD---GGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998543   45799999875432 234578889999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.++++..........++..+..++.|++.||+|||+.    +++||||||+||+++.++++||+|||++.......   
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN----NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC----CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999764432233567888889999999999999988    99999999999999999999999999987543321   


Q ss_pred             ---cccccCcccCccccccC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          516 ---AIARLGGYKAPEQAEVK-------RLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~-------~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                         ...++..|+|||++...       .++.++||||||+++|||++ |+.||......           .....   ..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-----------~~~~~---~~  223 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-----------QVLTY---TV  223 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-----------HHHHH---Hh
Confidence               12345569999988532       35789999999999999996 99999643110           00000   00


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      ... .....++...  ....   ..+.+++..|+ .+|++|||++||++.|+
T Consensus       224 ~~~-~~~~~~~~~~--~~~~---~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         224 REQ-QLKLPKPRLK--LPLS---DRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hcc-cCCCCCCccC--CCCC---hHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            000 0000111110  0111   23455666898 58999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.9e-37  Score=328.06  Aligned_cols=263  Identities=22%  Similarity=0.285  Sum_probs=191.3

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC-----eeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE-----EKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~  431 (670)
                      +.+.||+|+||.||++.. .+|+.||||++...  .....+.+.+|+++++.++|+||+++++++...+     ..|+|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            457899999999999995 57899999998753  2234567889999999999999999999998776     789999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+. ++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..
T Consensus        84 e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          84 ELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSA----GILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             eccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9996 58888876543     588999999999999999999998    9999999999999999999999999999865


Q ss_pred             Cccc-----cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccc--cccchhH-----
Q 036639          512 NPVQ-----AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE--QAVDLPK-----  578 (670)
Q Consensus       512 ~~~~-----~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~--~~~~~~~-----  578 (670)
                      ....     ...++..|+|||.+.+. .++.++|||||||++|||++|+.||...++.........  .......     
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  233 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC  233 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            4321     23456779999998764 479999999999999999999999975432110000000  0000000     


Q ss_pred             -HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          579 -WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       579 -~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       .....+..............  ....+....+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         234 EGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             00000000000000000000  0000112346678889999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.7e-36  Score=303.95  Aligned_cols=242  Identities=26%  Similarity=0.393  Sum_probs=196.2

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.||+|++|.||+|... +++.|++|.+...  .....+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08529           5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG   84 (256)
T ss_pred             eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence            467999999999999954 6899999998643  3345678889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.++++...   ...+++..+..++.|++.||.|||+.    +++|+||||+||+++.++.+||+|||+++......  
T Consensus        85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~----~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSK----KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            9999998642   12588999999999999999999987    99999999999999999999999999988764422  


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                        ...++..|+|||+..+..++.++||||||+++|||+||+.||.....              ........... ...  
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------~~~~~~~~~~~-~~~--  220 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------------GALILKIIRGV-FPP--  220 (256)
T ss_pred             hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHcCC-CCC--
Confidence              23456779999999988899999999999999999999999964310              01111111110 000  


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                              ........+.+++.+||+.+|++||++.|++++
T Consensus       221 --------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 --------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             --------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                    001122456778889999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-36  Score=304.02  Aligned_cols=238  Identities=24%  Similarity=0.389  Sum_probs=189.7

Q ss_pred             hHcCCCCceEEEEEEEcC-C----------CEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          362 EMLGKGSLGTVYKAVLDD-G----------GIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.||+|+||.||+|...+ +          ..|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            368999999999999654 3          25888887755433 6788999999999999999999999988 778999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-------cEEEE
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-------VACIS  503 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~  503 (670)
                      |||+++|+|.+++.....    .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++       .+||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDK----KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC----CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999976532    588999999999999999999987    999999999999999888       79999


Q ss_pred             ecccccccCccccccccCcccCccccccC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          504 DFGLSLLLNPVQAIARLGGYKAPEQAEVK--RLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       504 DFG~a~~~~~~~~~~~~~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      |||++..........+...|+|||++...  .++.++||||||+++|||++ |..||......           ....+.
T Consensus       151 Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----------~~~~~~  219 (259)
T cd05037         151 DPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----------EKERFY  219 (259)
T ss_pred             CCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----------hHHHHH
Confidence            99999887665555566779999998776  78999999999999999999 46666543110           000111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      .   ... ..        ....    ...+.+++.+||..+|++|||+.||++.|+
T Consensus       220 ~---~~~-~~--------~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 Q---DQH-RL--------PMPD----CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             h---cCC-CC--------CCCC----chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0   000 00        0000    145677888999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-36  Score=314.20  Aligned_cols=193  Identities=25%  Similarity=0.407  Sum_probs=168.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||++... ++..||+|.++... .....++.+|++++.+++||||+++++++.+.+..++||||++++
T Consensus         5 ~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~   84 (308)
T cd06615           5 KLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   84 (308)
T ss_pred             EEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCC
Confidence            4567999999999999954 68889999987542 234467889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--cc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--VQ  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--~~  515 (670)
                      +|.++++...     .+++.....++.|+++||.|||+.   .+++||||||+||+++.++.+||+|||++.....  ..
T Consensus        85 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  156 (308)
T cd06615          85 SLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  156 (308)
T ss_pred             cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhh---CCEEECCCChHHEEEecCCcEEEccCCCcccccccccc
Confidence            9999997653     478999999999999999999984   2899999999999999999999999999876543  22


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ...++..|+|||.+.+..++.++||||||+++|||+||+.||...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~  201 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP  201 (308)
T ss_pred             cCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence            345677899999998888999999999999999999999998643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=5.8e-37  Score=321.36  Aligned_cols=236  Identities=23%  Similarity=0.283  Sum_probs=182.9

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHH-HHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYM-DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~-~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|+.. +++.||+|++.....   ....++..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36899999999999955 678999999974321   1223334443 456778999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+.......++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~----giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            99999997643     477788888999999999999998    999999999999999999999999999875422   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++|||++|+.||....              .............    
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------------~~~~~~~i~~~~~----  213 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------------TAEMYDNILNKPL----  213 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--------------HHHHHHHHHhCCc----
Confidence             223457888999999999999999999999999999999999996431              1111111111110    


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVA  632 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  632 (670)
                           ........   .+.+++.+||+.||.+||++.+.+
T Consensus       214 -----~~~~~~~~---~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         214 -----QLKPNITN---SARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -----CCCCCCCH---HHHHHHHHHcccCHHHCCCCCCCH
Confidence                 00111222   344566699999999999887433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=327.01  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=206.6

Q ss_pred             HHHHHHHHhHcCCCCceEEEEEEE-cCC----CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCee
Q 036639          354 EDLLRASAEMLGKGSLGTVYKAVL-DDG----GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       354 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  427 (670)
                      +|...+..++||+|+||+||+|.+ .+|    -+||+|++... .....+++.+|+-+|.+++|||+++++|+|.... .
T Consensus       694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            344445568999999999999994 444    36999998754 4446789999999999999999999999998776 7


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      .||++||+.|+|.++++.++.    .+.-...+.|..|||+||.|||.+    +++||||..+||||.+-..+||.|||+
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~q----rlVHrdLaaRNVLVksP~hvkitdfgl  844 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQ----RLVHRDLAARNVLVKSPNHVKITDFGL  844 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhc----chhhhhhhhhheeecCCCeEEEEecch
Confidence            899999999999999998653    588899999999999999999988    999999999999999999999999999


Q ss_pred             ccccCcccccccc------CcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          508 SLLLNPVQAIARL------GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       508 a~~~~~~~~~~~~------~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ++....++....+      ..|||=|.+....|+.++|||||||++||++| |..|+++...           .++++.+
T Consensus       845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----------~eI~dll  913 (1177)
T KOG1025|consen  845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----------EEIPDLL  913 (1177)
T ss_pred             hhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----------HHhhHHH
Confidence            9998765543322      23999999999999999999999999999999 8999876521           1222221


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                          +..          .+.....-+..++..++.+||..|+..||+++++...+.++..
T Consensus       914 ----e~g----------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  914 ----EKG----------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ----hcc----------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                110          0122334455677778889999999999999999999888754

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.8e-36  Score=309.22  Aligned_cols=249  Identities=24%  Similarity=0.381  Sum_probs=195.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCC----EEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGG----IVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      ..+.||+|+||+||+|.+ .+|+    .||+|+++... ....+++.+|+.++..++|+||+++++++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~   89 (279)
T cd05109          11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQL   89 (279)
T ss_pred             eeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEc
Confidence            457899999999999984 3454    48999987543 33456788999999999999999999998754 57899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.++++...    ..+++..++.++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++....
T Consensus        90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          90 MPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEV----RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             CCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            99999999997643    2488999999999999999999998    999999999999999999999999999987643


Q ss_pred             ccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          514 VQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       514 ~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ...      ...+..|+|||...+..++.++|||||||++|||+| |..||....           ...+..++.    .
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----------~~~~~~~~~----~  226 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-----------AREIPDLLE----K  226 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----------HHHHHHHHH----C
Confidence            221      122446999999988899999999999999999998 888885421           011111111    1


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .....          ........+.+++.+||..||++||++.|+++.|+++....
T Consensus       227 ~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         227 GERLP----------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCcCC----------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            10000          00112234667888999999999999999999999887554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-36  Score=311.36  Aligned_cols=256  Identities=24%  Similarity=0.324  Sum_probs=199.6

Q ss_pred             cHHHHHHHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEe
Q 036639          352 ELEDLLRASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYA  423 (670)
Q Consensus       352 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~  423 (670)
                      ++..-.+.+.+.||+|+||.||++...      .+..||||.++... ....+.+.+|+++++++ +|+||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            334444556789999999999999741      34579999987543 33456789999999999 79999999999999


Q ss_pred             CCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEE
Q 036639          424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS  503 (670)
Q Consensus       424 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~  503 (670)
                      .+..++||||+++|+|.++++....   ..+++..+..++.|++.||+|||+.    +|+|+||||+||+++.++.+||+
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeehhhhccceEEEcCCCeEEEC
Confidence            9999999999999999999975431   2389999999999999999999998    99999999999999999999999


Q ss_pred             ecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccch
Q 036639          504 DFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       504 DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      |||+++......      ...++..|+|||.+....++.++|||||||++|||+| |+.||.....              
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------------  249 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------------  249 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------------
Confidence            999998654321      1223456999999998889999999999999999998 9999864311              


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ...........+...       .....   ...+.+++.+||..+|++|||+.||++.|++.
T Consensus       250 ~~~~~~~~~~~~~~~-------~~~~~---~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         250 DSKFYKLIKEGYRMA-------QPEHA---PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             hHHHHHHHHcCCcCC-------CCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            011111111111000       00011   13466777899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.4e-36  Score=307.42  Aligned_cols=246  Identities=22%  Similarity=0.324  Sum_probs=195.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++|+||+++++++...+..++||||+++
T Consensus        14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (292)
T cd06644          14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPG   93 (292)
T ss_pred             hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCC
Confidence            456788999999999999964 5899999999877666677889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      ++|..++....    ..+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++.....   
T Consensus        94 ~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          94 GAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSM----KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC----CeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            99998876432    1488999999999999999999987    999999999999999999999999999875432   


Q ss_pred             -cccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 -VQAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                       .....++..|+|||++.     ...++.++|||||||++|||++|+.||....+              ...+.......
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------------~~~~~~~~~~~  231 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------------MRVLLKIAKSE  231 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------------HHHHHHHhcCC
Confidence             12334567799999884     34578899999999999999999999864311              01111111110


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..      ...   ........+.+++.+||..+|++||+++|++++
T Consensus       232 ~~------~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         232 PP------TLS---QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             Cc------cCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            00      000   001112345667789999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.9e-36  Score=306.39  Aligned_cols=249  Identities=27%  Similarity=0.334  Sum_probs=184.1

Q ss_pred             HcCCCCceEEEEEEEcC---CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          363 MLGKGSLGTVYKAVLDD---GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .||+|+||.||+|...+   ...+|+|.+.... ......+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   4578999876543 2334678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----  514 (670)
                      |.+++...........++.....++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+++.....    
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA----DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc----CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999765432223456788899999999999999998    9999999999999999999999999998764322    


Q ss_pred             --ccccccCcccCccccc-------cCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          515 --QAIARLGGYKAPEQAE-------VKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~-------~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                        ....++..|+|||++.       ...++.++|||||||++|||++ |..||.....              ........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------------~~~~~~~~  223 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------------EQVLKQVV  223 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------------HHHHHHHh
Confidence              1122345699999864       2456889999999999999999 7778753311              00111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      .+.. ....++..     .......+.+++..|| .||++|||++||++.|.
T Consensus       224 ~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         224 REQD-IKLPKPQL-----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             hccC-ccCCCCcc-----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            1110 00001000     0011123444666788 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.8e-37  Score=334.66  Aligned_cols=264  Identities=20%  Similarity=0.269  Sum_probs=184.6

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--------CeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--------EEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--------~~~~l  429 (670)
                      .+.+.||+|+||.||+|.. .+++.||||++....    ....+|+.+++.++||||+++++++...        ...++
T Consensus        69 ~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         69 KLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            3457899999999999995 468999999986432    2345799999999999999999987542        24579


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLS  508 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a  508 (670)
                      ||||+++ +|.+++..... ....+++..+..++.|++.||+|||+.    +|+||||||+|||++.++ .+||+|||++
T Consensus       145 vmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~----~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        145 VMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSK----FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            9999974 78777653211 123588999999999999999999998    999999999999999665 7999999999


Q ss_pred             cccCcc---ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccccc-chhHHHHHH
Q 036639          509 LLLNPV---QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV-DLPKWVRSV  583 (670)
Q Consensus       509 ~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~  583 (670)
                      +.....   ....+++.|+|||++.+ ..++.++|||||||++|||+||.+||................. .....+.. 
T Consensus       219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~-  297 (440)
T PTZ00036        219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE-  297 (440)
T ss_pred             hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH-
Confidence            876432   23456778999999865 4689999999999999999999999975432110000000000 00000000 


Q ss_pred             hhhcccc----ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTA----EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~----~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ....+..    .+....+.. ........++.+++.+||+.||.+|||+.|+++|
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~-~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKK-VFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hchhhhcccCCccCchhHHH-HhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            0000000    000000000 0000112356677889999999999999999975

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.2e-36  Score=303.51  Aligned_cols=244  Identities=25%  Similarity=0.414  Sum_probs=196.5

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |...+.||+|+||.||+|... +++.|++|.++....  .+++.+|++++++++|+||+++++++.+....++++||+++
T Consensus         5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   82 (256)
T cd06612           5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA   82 (256)
T ss_pred             chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCC
Confidence            345678999999999999966 489999999975532  67899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++....    ..+++..+..++.|++.||.|||+.    +++||||+|+||+++.++.+||+|||++....... 
T Consensus        83 ~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          83 GSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSN----KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999987533    2589999999999999999999988    99999999999999999999999999998765422 


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ...++..|+|||++.+..++.++||||||+++|||++|+.||....+.....              . .... ....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------------~-~~~~-~~~~  218 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------------M-IPNK-PPPT  218 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------------h-hccC-CCCC
Confidence               2345677999999988899999999999999999999999986532211000              0 0000 0000


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +       .........+.+++.+||+.+|++|||+.||+++
T Consensus       219 ~-------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         219 L-------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             C-------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            0       0001112345667779999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4e-36  Score=308.15  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=199.0

Q ss_pred             HHHhHcCCCCceEEEEEEEcC-----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD-----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|...+     +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. ....++++
T Consensus         9 ~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   88 (280)
T cd05043           9 TLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLY   88 (280)
T ss_pred             EEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEE
Confidence            345789999999999999765     6889999987543 3345678899999999999999999998776 46789999


Q ss_pred             eccCCCChHHHhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          432 DYLPNGSLHSLLHGNRGP---GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      ||+++++|.+++......   ....+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||++
T Consensus        89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kl~d~g~~  164 (280)
T cd05043          89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR----GVIHKDIAARNCVIDEELQVKITDNALS  164 (280)
T ss_pred             EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCHhhEEEcCCCcEEECCCCCc
Confidence            999999999998754321   113589999999999999999999987    9999999999999999999999999999


Q ss_pred             cccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          509 LLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       509 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      +.+....      ...++..|+|||++.+..++.++||||||+++||+++ |+.||....+           ..+..++.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~~~  233 (280)
T cd05043         165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----------FEMAAYLK  233 (280)
T ss_pred             ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----------HHHHHHHH
Confidence            8654321      1233456999999988889999999999999999999 9999864311           11111111


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                          .....          .........+.+++.+||..||++|||+.||++.|+++..
T Consensus       234 ----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         234 ----DGYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ----cCCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                11000          0001112346678889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.4e-36  Score=306.16  Aligned_cols=251  Identities=27%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             HHHHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          358 RASAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            3456789999999999998543    3479999987654 3456789999999999999999999998875 55789999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.+++....    ..+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~----~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          87 LAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK----RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             cCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            999999999997543    2489999999999999999999987    99999999999999999999999999998664


Q ss_pred             cccc-----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          513 PVQA-----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       513 ~~~~-----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ....     ......|+|||.+....++.++||||||+++||+++ |..||......              .........
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------------~~~~~~~~~  224 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------------DVIGRIENG  224 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHHHcC
Confidence            3321     122346999999988889999999999999999986 99998644210              111111111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ... .       ....   ....+.+++.+|+..+|++|||+.++++.|++++.++
T Consensus       225 ~~~-~-------~~~~---~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~  269 (270)
T cd05056         225 ERL-P-------MPPN---CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE  269 (270)
T ss_pred             CcC-C-------CCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            000 0       0011   1234666777999999999999999999999988664

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-36  Score=317.18  Aligned_cols=193  Identities=23%  Similarity=0.319  Sum_probs=163.0

Q ss_pred             HhHcCCC--CceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKG--SLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .++||+|  +|++||++.. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   82 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA   82 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence            4679999  7899999985 578999999997542  2234567889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++.....   ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.++++||+.......  
T Consensus        83 ~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~----~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          83 YGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999999965431   2488999999999999999999988    999999999999999999999999986543321  


Q ss_pred             ---------cccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 ---------VQAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ---------~~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                               .....++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                     111234456999999875  45899999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.9e-36  Score=309.60  Aligned_cols=251  Identities=24%  Similarity=0.390  Sum_probs=196.5

Q ss_pred             HHHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +++.+.||+|+||.||+|...      ++..||+|.+.... ....+++.+|++++++++||||+++++++.+....++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv   86 (288)
T cd05050           7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL   86 (288)
T ss_pred             ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence            345578999999999999853      46789999997543 23456799999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeE
Q 036639          431 YDYLPNGSLHSLLHGNRG-----------------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL  493 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIl  493 (670)
                      |||+++|+|.+++.....                 .....+++..++.++.|++.||+|||+.    +++||||||+||+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~----~i~H~dl~p~nil  162 (288)
T cd05050          87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER----KFVHRDLATRNCL  162 (288)
T ss_pred             EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CeecccccHhheE
Confidence            999999999999974321                 1123478899999999999999999988    9999999999999


Q ss_pred             eCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q 036639          494 LDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPR  566 (670)
Q Consensus       494 l~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~  566 (670)
                      +++++.+||+|||++.......      ....+..|+|||.+.+..++.++|||||||++|||++ |..||....     
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-----  237 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-----  237 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-----
Confidence            9999999999999987653221      1223346999999988899999999999999999998 878875431     


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                               .............. .          ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus       238 ---------~~~~~~~~~~~~~~-~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 ---------HEEVIYYVRDGNVL-S----------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---------HHHHHHHHhcCCCC-C----------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                     11112111111100 0          001112356678889999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.5e-36  Score=306.45  Aligned_cols=260  Identities=20%  Similarity=0.345  Sum_probs=202.5

Q ss_pred             HHHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          357 LRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.+.||+|+||+||++.. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            346678999999999999995 468999999886542 335678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++++|.+++....     .+++.....++.+++.||.|||+.   .+++||||||+||++++++.++|+|||++..... 
T Consensus        86 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          86 DCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNV---HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHh---cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999987643     588999999999999999999974   3899999999999999999999999999876532 


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++|||||||++||++||+.||........   .......+..++.....+... . 
T Consensus       158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-~-  232 (284)
T cd06620         158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD---GQDDPMGILDLLQQIVQEPPP-R-  232 (284)
T ss_pred             ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh---hhhhhhHHHHHHHHHhhccCC-C-
Confidence             2234567789999999888899999999999999999999999975422110   001111122222222221100 0 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                          +    ...+....+.+++.+||+.||++|||+.|++++..-
T Consensus       233 ----~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         233 ----L----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             ----C----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence                0    001122346677789999999999999999997543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-36  Score=329.10  Aligned_cols=186  Identities=23%  Similarity=0.247  Sum_probs=161.6

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |.+.+.||+|+||.||++... .++.||||...      ...+.+|++++++++|+|||++++++...+..++|||++ .
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~  243 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R  243 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence            345578999999999999965 57899999643      234578999999999999999999999999999999999 5


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++....    ..++|..++.|+.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       244 ~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        244 SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGE----GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            78988886542    2589999999999999999999998    9999999999999999999999999999865332  


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~  558 (670)
                          ....+|..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence                12357888999999999999999999999999999999887654

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.4e-36  Score=310.55  Aligned_cols=257  Identities=23%  Similarity=0.350  Sum_probs=194.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-----------------CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-----------------DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAY  420 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~  420 (670)
                      .+.+.||+|+||.||++...                 ++..||+|+++.. .....+++.+|++++++++|+||++++++
T Consensus         8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~   87 (296)
T cd05095           8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV   87 (296)
T ss_pred             eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            45578999999999998632                 2346999999754 33345789999999999999999999999


Q ss_pred             EEeCCeeEEEEeccCCCChHHHhccCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe
Q 036639          421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPG------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL  494 (670)
Q Consensus       421 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll  494 (670)
                      +...+..++||||+++++|.+++.......      ...+++.....++.|++.||+|||+.    +++||||||+||++
T Consensus        88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dlkp~Nili  163 (296)
T cd05095          88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL----NFVHRDLATRNCLV  163 (296)
T ss_pred             EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC----CeecccCChheEEE
Confidence            999999999999999999999987643211      12478889999999999999999998    99999999999999


Q ss_pred             CCCCcEEEEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCCCC
Q 036639          495 DKNGVACISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT--GRAPSQYPSPTRPR  566 (670)
Q Consensus       495 ~~~~~~kl~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt--g~~p~~~~~~~~~~  566 (670)
                      +.++.++|+|||+++.......      ...+..|+|||......++.++|||||||++|||+|  |..||......   
T Consensus       164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~---  240 (296)
T cd05095         164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE---  240 (296)
T ss_pred             cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH---
Confidence            9999999999999986543221      122346999999888889999999999999999998  67777543111   


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                              ...................       +....+...+.+++.+||+.||++||++.||++.|++
T Consensus       241 --------~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         241 --------QVIENTGEFFRDQGRQVYL-------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --------HHHHHHHHHHhhccccccC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                    0001011111110000000       0011122456778889999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-36  Score=319.12  Aligned_cols=187  Identities=21%  Similarity=0.292  Sum_probs=161.0

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .|.+.+.||+|+||.||+|... +++.||+|+....      ....|+.++++++|+||+++++++......++|+||+ 
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-  139 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-  139 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-
Confidence            3556788999999999999965 5789999986433      2346899999999999999999999999999999999 


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      .++|.+++....    ..+++..+..|+.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....  
T Consensus       140 ~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  211 (357)
T PHA03209        140 SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQ----RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP  211 (357)
T ss_pred             CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence            568888886532    2589999999999999999999998    999999999999999999999999999975432  


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~  558 (670)
                       .....++..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence             223457788999999998999999999999999999999766553

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-36  Score=306.46  Aligned_cols=247  Identities=23%  Similarity=0.460  Sum_probs=195.5

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CC---CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DG---GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|... ++   ..||||.++.. .....+++..|+.+++.++||||+++++++.+....++||||
T Consensus         7 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   86 (269)
T cd05065           7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEF   86 (269)
T ss_pred             EEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEec
Confidence            34578999999999999964 33   36999999764 334567899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++....+    .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++.....
T Consensus        87 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~----g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          87 MENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             CCCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHC----CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999975432    478999999999999999999988    999999999999999999999999999876543


Q ss_pred             ccc---c----cc--cCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          514 VQA---I----AR--LGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       514 ~~~---~----~~--~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ...   .    .+  +..|+|||++.+..++.++|||||||++||+++ |..||.....           .+...++   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----------~~~~~~i---  224 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------QDVINAI---  224 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----------HHHHHHH---
Confidence            211   1    11  235999999998899999999999999999887 9999864311           0111111   


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                       ...+..          +...+....+.+++.+||+.+|++||++++|++.|+++
T Consensus       225 -~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 -EQDYRL----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -HcCCcC----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence             111100          00111223456778899999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.3e-36  Score=307.47  Aligned_cols=242  Identities=26%  Similarity=0.395  Sum_probs=195.2

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      |...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            445678999999999999854 67899999987543 3345678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++...      .+++..+..++.|+++||.|||+.    +++|+||+|+||++++++.++|+|||++.......
T Consensus        86 ~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~----~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          86 GGSALDLLKPG------PLEETYIATILREILKGLDYLHSE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcC----CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999998643      478999999999999999999987    99999999999999999999999999997764322


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ...++..|+|||++.+..++.++|||||||++|||+||+.||....+..           ...    .........
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----------~~~----~~~~~~~~~  220 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----------VLF----LIPKNSPPT  220 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----------HHh----hhhcCCCCC
Confidence                2345667999999998889999999999999999999999986432110           000    011110000


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                                ........+.+++.+||+.+|++||++.|++++
T Consensus       221 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 ----------LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ----------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                      001122346677789999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=299.68  Aligned_cols=242  Identities=28%  Similarity=0.445  Sum_probs=194.2

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      ++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            368999999999999777999999998765443 5678999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-----
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-----  515 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----  515 (670)
                      +++....    ..+++.....++.+++.||+|||+.    +++||||||+||+++.++.+||+|||.+.......     
T Consensus        81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~----~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESK----NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9997543    1478899999999999999999988    99999999999999999999999999998654211     


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+..|+|||.+.+..++.++|||||||++|||+| |..||.....              .. ...........   
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------------~~-~~~~~~~~~~~---  214 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------------QQ-TRERIESGYRM---  214 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------------HH-HHHHHhcCCCC---
Confidence             1112345999999988889999999999999999999 7888754311              00 01111110000   


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                             .........+.+++.+||..+|++|||+.||++.|+
T Consensus       215 -------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         215 -------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                   000111235667888999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-35  Score=303.69  Aligned_cols=242  Identities=26%  Similarity=0.398  Sum_probs=196.5

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      |...+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+....++||||++
T Consensus         6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06640           6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence            455678999999999999964 68899999987543 3345778899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++...      ++++.....++.|++.||+|||+.    +++|+||+|+||+++.++.++|+|||++.......
T Consensus        86 ~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~----~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          86 GGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999998753      378889999999999999999987    99999999999999999999999999997664322


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ...++..|+|||++.+..++.++|||||||++|||+||+.||....+...              . ......... 
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------------~-~~~~~~~~~-  219 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------------L-FLIPKNNPP-  219 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------------h-hhhhcCCCC-
Confidence                23456679999999888899999999999999999999999865421100              0 000000000 


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                               .........+.+++.+||+.+|++||++.+++++
T Consensus       220 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 ---------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ---------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                     0112233456678889999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-36  Score=316.05  Aligned_cols=192  Identities=24%  Similarity=0.353  Sum_probs=163.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++...+..++||||+++ 
T Consensus        10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   88 (309)
T cd07872          10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-   88 (309)
T ss_pred             EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-
Confidence            3468999999999999954 68899999987543 22345677899999999999999999999999999999999975 


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        89 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          89 DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT  160 (309)
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence            8888876543    2478899999999999999999998    9999999999999999999999999998765322   


Q ss_pred             -ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 -QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                       ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  208 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS  208 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             22345677999998864 46899999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.5e-36  Score=305.67  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=190.9

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC------CeeEE
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK------EEKLL  429 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~------~~~~l  429 (670)
                      |.+.+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.++.++ +|+||+++++++...      ...++
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   86 (272)
T cd06637           8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL   86 (272)
T ss_pred             hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence            45568899999999999995 468899999987543 2456788999999998 799999999998753      45789


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+++++|.+++....   ...+++..+..++.|++.||+|||+.    +|+|+||||+||++++++.+||+|||++.
T Consensus        87 v~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~----~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          87 VMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             EEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            999999999999987643   22588999999999999999999998    99999999999999999999999999998


Q ss_pred             ccCcc----ccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          510 LLNPV----QAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       510 ~~~~~----~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      .....    ....++..|+|||++.     ...++.++|||||||++|||++|+.||....+.             ....
T Consensus       160 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------------~~~~  226 (272)
T cd06637         160 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------------RALF  226 (272)
T ss_pred             ecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------------HHHH
Confidence            65432    2345667799999985     345888999999999999999999998543110             0000


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        ...........+      ..   ....+.+++.+||..+|.+|||+.|++++
T Consensus       227 --~~~~~~~~~~~~------~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         227 --LIPRNPAPRLKS------KK---WSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             --HHhcCCCCCCCC------CC---cCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence              000100000000      11   12346677789999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-36  Score=323.73  Aligned_cols=188  Identities=22%  Similarity=0.283  Sum_probs=164.1

Q ss_pred             HHHHhHcCCCCceEEEEEEEc---CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          358 RASAEMLGKGSLGTVYKAVLD---DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      |.+.+.||+|+||.||++...   .++.||+|.+...     +...+|++++++++||||+++++++......++|||++
T Consensus        94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~  168 (392)
T PHA03207         94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY  168 (392)
T ss_pred             eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc
Confidence            445678999999999999753   3578999998743     34568999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      . ++|.+++....     .+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....
T Consensus       169 ~-~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~----givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        169 K-CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGR----GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             C-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            5 68988885332     589999999999999999999998    9999999999999999999999999999765432


Q ss_pred             ------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 ------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                            ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~  290 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK  290 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                  1345788899999999899999999999999999999999999764

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.1e-36  Score=312.76  Aligned_cols=241  Identities=25%  Similarity=0.399  Sum_probs=194.5

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  103 (296)
T cd06655          24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL  103 (296)
T ss_pred             EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence            45799999999999984 57899999999765555567889999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .+++...      .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++.......    
T Consensus       104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655         104 TDVVTET------CMDEAQIAAVCRECLQALEFLHAN----QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            9998653      388999999999999999999998    99999999999999999999999999987654322    


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||......              ......... ....    
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~--------------~~~~~~~~~-~~~~----  234 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--------------RALYLIATN-GTPE----  234 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHhc-CCcc----
Confidence            234566799999999888999999999999999999999999653210              000000000 0000    


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       .......   ...+.+++.+||..||++|||+.+++++
T Consensus       235 -~~~~~~~---~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 -LQNPEKL---SPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             -cCCcccC---CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence             0000111   1235567779999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.8e-37  Score=323.75  Aligned_cols=190  Identities=21%  Similarity=0.283  Sum_probs=162.1

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~l  429 (670)
                      ...+.||+|+||.||++.. ..++.||||++...  .....+.+.+|+.+++.++||||+++++++...      ...++
T Consensus        20 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   99 (355)
T cd07874          20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYL   99 (355)
T ss_pred             eEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEE
Confidence            3457899999999999985 46899999999754  223446778899999999999999999988643      35689


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+++ +|.+.+..       .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++
T Consensus       100 v~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~----givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874         100 VMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             Ehhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            9999965 67776643       378889999999999999999998    99999999999999999999999999998


Q ss_pred             ccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          510 LLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       510 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....   ....++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            76442   2345677899999999889999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.8e-36  Score=313.38  Aligned_cols=193  Identities=24%  Similarity=0.407  Sum_probs=158.7

Q ss_pred             HhHcCCCCceEEEEEEEc---CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD---DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  435 (670)
                      +.+||+|+||+||+|...   ++..||+|.+....  ....+.+|++++++++||||+++++++..  ....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999964   45789999987543  33567889999999999999999999864  457789999996


Q ss_pred             CCChHHHhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe----CCCCcEEEEeccc
Q 036639          436 NGSLHSLLHGNRG----PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGL  507 (670)
Q Consensus       436 ~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~  507 (670)
                       ++|.+++.....    .....+++..+..++.|++.||+|||+.    +|+||||||+|||+    +.++.+||+|||+
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC----CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence             588887753221    1223588999999999999999999998    99999999999999    5667899999999


Q ss_pred             ccccCcc-------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          508 SLLLNPV-------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       508 a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ++.....       ....++..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            9876432       22345778999999876 45899999999999999999999999654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=321.56  Aligned_cols=240  Identities=28%  Similarity=0.414  Sum_probs=196.0

Q ss_pred             HcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHH
Q 036639          363 MLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS  441 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  441 (670)
                      +||+|.||+||-|+. .+...+|||.+...+....+-+.+|+.+.++|+|.|||+++|.+.++++.-|.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999995 4567799999988776677888999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccCc----ccc
Q 036639          442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNP----VQA  516 (670)
Q Consensus       442 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~----~~~  516 (670)
                      +++...++  ..-.+.++-.+..||++||.|||+.    .|||||||-+||||+. .|.+||+|||.++.+..    .+.
T Consensus       662 LLrskWGP--lKDNEstm~fYtkQILeGLkYLHen----~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET  735 (1226)
T KOG4279|consen  662 LLRSKWGP--LKDNESTMNFYTKQILEGLKYLHEN----KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET  735 (1226)
T ss_pred             HHHhccCC--CccchhHHHHHHHHHHHHhhhhhhc----ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence            99988752  2236778888999999999999998    9999999999999964 78999999999987643    456


Q ss_pred             ccccCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          517 IARLGGYKAPEQAEVK--RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      +.||..|||||++..+  .|+.++|||||||++.||.||++||.........                         .|.
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA-------------------------MFk  790 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA-------------------------MFK  790 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh-------------------------hhh
Confidence            7888899999999654  4899999999999999999999999643211100                         000


Q ss_pred             Hhhh-cccch-HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036639          595 QELL-RYKNI-EEELVSMLHVGLACVVSQPEKRPTMAEVAK  633 (670)
Q Consensus       595 ~~~~-~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  633 (670)
                      -.+- .-+.+ ++...+...++++|+.+||.+||+|+++++
T Consensus       791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            0000 01112 222344556777999999999999999987

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-36  Score=320.81  Aligned_cols=192  Identities=25%  Similarity=0.319  Sum_probs=163.7

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeE
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKL  428 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~  428 (670)
                      |...+.||+|+||.||+|.. .+++.||||++....  ....+.+.+|++++++++||||+++++++...      ...+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07878          17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY   96 (343)
T ss_pred             hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence            45568899999999999995 578899999997542  22345677899999999999999999987543      3568


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +++|++ +++|.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||++
T Consensus        97 ~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          97 LVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSA----GIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             EEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCChhhEEECCCCCEEEcCCccc
Confidence            999998 78999888643      488999999999999999999998    9999999999999999999999999999


Q ss_pred             cccCcc-ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          509 LLLNPV-QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       509 ~~~~~~-~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      +..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       166 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         166 RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             eecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            876542 33457788999999876 56899999999999999999999999653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=7.5e-36  Score=303.93  Aligned_cols=247  Identities=23%  Similarity=0.419  Sum_probs=195.4

Q ss_pred             HHHhHcCCCCceEEEEEEEc-C---CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-D---GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|... +   +..||+|.++... ....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (267)
T cd05066           7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY   86 (267)
T ss_pred             EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence            45678999999999999853 2   3479999987543 23456889999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++....    ..+++..+..++.|++.||+|||+.    +++||||||+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          87 MENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            99999999997543    2478999999999999999999988    999999999999999999999999999987643


Q ss_pred             ccc-------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          514 VQA-------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       514 ~~~-------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ...       ...+..|+|||++.+..++.++||||||+++||+++ |+.||......           +....    +.
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-----------~~~~~----~~  223 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-----------DVIKA----IE  223 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-----------HHHHH----Hh
Confidence            221       111345999999998889999999999999999887 99998643110           11111    11


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      +.+..          +........+.+++.+|++.+|++||++.++++.|+++
T Consensus       224 ~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         224 EGYRL----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCcC----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            11100          00011123456777899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=303.58  Aligned_cols=246  Identities=26%  Similarity=0.364  Sum_probs=196.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      |.+.+.||+|+||.||++... ++..||+|.+........+.+..|++++++++|+||+++++++......++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            567788999999999999964 6899999999866655667899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++....    ..+++..+..++.|++.||.|||+.    +|+|+||||+||+++.++.++|+|||++......  
T Consensus        87 ~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          87 GALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSH----KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            99999987543    2588999999999999999999998    9999999999999999999999999998765332  


Q ss_pred             --ccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 --QAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                        ....++..|+|||.+.     ...++.++||||||+++|||++|+.||......              ..........
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------------~~~~~~~~~~  224 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------------RVLLKILKSE  224 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------------HHHHHHhcCC
Confidence              2334677899999874     345788999999999999999999998643110              1111111110


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..      .+.....   ....+.+++.+||+.+|.+||++.+++++
T Consensus       225 ~~------~~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         225 PP------TLDQPSK---WSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CC------CcCCccc---CCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            00      0000011   11245567779999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=8.6e-36  Score=301.39  Aligned_cols=243  Identities=25%  Similarity=0.448  Sum_probs=195.0

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||.||++.+.+++.+|+|.++.... ...++.+|++++++++||||+++++++......++||||+++++|
T Consensus         8 ~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   86 (256)
T cd05112           8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCL   86 (256)
T ss_pred             EEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcH
Confidence            3467999999999999987788999999875433 456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .+++.....    .+++..+..++.+++.||+|||+.    +++||||||+||+++.++.+||+|||.++......    
T Consensus        87 ~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          87 SDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESS----NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             HHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            999875432    478999999999999999999988    99999999999999999999999999987653321    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+.+|+|||++.+..++.++||||||+++|||++ |+.||....              ....... ..+...  ..
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------------~~~~~~~-~~~~~~--~~  221 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------------NSEVVET-INAGFR--LY  221 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------------HHHHHHH-HhCCCC--CC
Confidence             1223356999999988889999999999999999998 899986431              0111111 111100  00


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      .+.     .   ....+.+++.+||+.+|++|||+.|++++|.
T Consensus       222 ~~~-----~---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         222 KPR-----L---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             CCC-----C---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence            000     0   1235677888999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-35  Score=302.53  Aligned_cols=244  Identities=23%  Similarity=0.382  Sum_probs=192.5

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.+.||+|+||+||+|...+|+.+|+|.+.....      ...+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence            34578999999999999988899999999864321      123568889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+|+||+|+||++++++.+||+|||++....
T Consensus        83 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          83 FVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNN----CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            999999999997543     478899999999999999999988    99999999999999999999999999987642


Q ss_pred             c----------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          513 P----------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       513 ~----------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      .          .....++..|+|||++.+..++.++||||||+++|||++|+.||.....             .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------------~~~~~~~  220 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------------LAAMFYI  220 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------------HHHHHHh
Confidence            1          1123456779999999988899999999999999999999999964311             0000000


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ......... +.      ..   ....+.+++.+||+.+|++||++.|++++
T Consensus       221 ~~~~~~~~~-~~------~~---~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         221 GAHRGLMPR-LP------DS---FSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             hhccCCCCC-CC------CC---CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000000000 00      11   12345567779999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.1e-36  Score=308.86  Aligned_cols=245  Identities=24%  Similarity=0.317  Sum_probs=191.7

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||++.. .+++.||||.+.....   .....+..|+.++++++|++|+++++.+.+.+..++||||+++
T Consensus         5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g   84 (285)
T cd05630           5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG   84 (285)
T ss_pred             eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence            46799999999999995 4789999999865322   1234567899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++....   ...+++..+..++.|++.||.|||+.    +|+||||||+||++++++.++|+|||++....... 
T Consensus        85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~----~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999886432   22488999999999999999999987    99999999999999999999999999987654322 


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                        ...++..|+|||++.+..++.++|||||||++|||++|+.||......        .   ........... ... .+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~--------~---~~~~~~~~~~~-~~~-~~  224 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK--------I---KREEVERLVKE-VQE-EY  224 (285)
T ss_pred             ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc--------c---hHHHHHhhhhh-hhh-hc
Confidence              235677899999999889999999999999999999999999653110        0   00000000000 000 00


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                            ....   ...+.+++.+||+.||++|||     ++|+++|
T Consensus       225 ------~~~~---~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         225 ------SEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ------CccC---CHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                  0011   123556777999999999999     8899885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-36  Score=317.23  Aligned_cols=239  Identities=21%  Similarity=0.292  Sum_probs=187.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|+||+||+|.. .+|+.||+|+++...   ....+.+..|.+++..+. |++|+++.+++.+.+..|+||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~   84 (323)
T cd05615           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN   84 (323)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence            46799999999999995 468999999997532   223456777888888775 5788889999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....  
T Consensus        85 ~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          85 GGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999987543     588999999999999999999998    999999999999999999999999999876432  


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....++..|+|||++.+..++.++|||||||++|||+||+.||.....              ...+.........  
T Consensus       156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------------~~~~~~i~~~~~~--  219 (323)
T cd05615         156 VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------------DELFQSIMEHNVS--  219 (323)
T ss_pred             ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------------HHHHHHHHhCCCC--
Confidence              2234578889999999988899999999999999999999999965311              1111111111100  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM-----AEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  634 (670)
                             ......   ..+.+++.+||+.+|++|++.     +++.+|
T Consensus       220 -------~p~~~~---~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         220 -------YPKSLS---KEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             -------CCccCC---HHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                   001111   245567779999999999974     455544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-35  Score=302.94  Aligned_cols=243  Identities=23%  Similarity=0.365  Sum_probs=196.8

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      |.+.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.+....++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            455678999999999999954 68999999987543 3345678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++...      .+++..+..++.|++.||.|||+.    +++||||+|+||++++++.++|+|||+++..... 
T Consensus        83 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          83 GGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEE----GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             CCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            99999999754      488999999999999999999988    9999999999999999999999999999876543 


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....++..|+|||++.+..++.++||||||+++|||+||+.||....+.              ... ..........
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------------~~~-~~~~~~~~~~  217 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------------RVL-FLIPKNNPPS  217 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------------HHH-HHhhhcCCCC
Confidence               2344566799999999888999999999999999999999999643211              000 1111111111


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...      ..   ....+.+++.+||..+|++|||+++++++
T Consensus       218 ~~~------~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         218 LEG------NK---FSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             Ccc------cc---cCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            000      00   12245567779999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-36  Score=315.57  Aligned_cols=245  Identities=24%  Similarity=0.352  Sum_probs=199.4

Q ss_pred             HHHhHcCCCCceEEEEEEEc--CC--CEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD--DG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      ...+.||+|.||.|++|.|.  .|  ..||||.++..... ...+|.+|+.+|.+|+|+|++++||+..+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            55688999999999999976  34  35999999876544 67899999999999999999999999987 677899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      ++.|+|.+.|++..   ...+-......++.|||.|+.||..+    ++|||||..+|+||-..-.+||+|||+.+.+..
T Consensus       192 aplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLesk----rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESK----RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             cccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhh----hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            99999999998732   33577888999999999999999998    999999999999999999999999999998865


Q ss_pred             cccccc-c------CcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          514 VQAIAR-L------GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       514 ~~~~~~-~------~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      .+.... +      ..|+|||.+....++.++|||+|||++|||+| |..||.+....           .+.+.      
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~-----------qIL~~------  327 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI-----------QILKN------  327 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH-----------HHHHh------
Confidence            443222 1      23999999999999999999999999999999 77888654211           11111      


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                             +| .-.+......+.+++.+++..||..+|++|||+..+.+.+-
T Consensus       328 -------iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  328 -------ID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             -------cc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence                   11 01112233455667788888999999999999999975443

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-36  Score=307.97  Aligned_cols=247  Identities=28%  Similarity=0.476  Sum_probs=193.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHH--HHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARK--EFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||+||++... +++.||+|++.........  ...+|+.++++++||||+++++++.+....++||||+++
T Consensus         3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~   82 (260)
T PF00069_consen    3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG   82 (260)
T ss_dssp             EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred             EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence            3468999999999999965 5678999999877543322  335699999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc----C
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----N  512 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~----~  512 (670)
                      ++|.+++....     .+++..+..++.|+++||+|||+.    +|+|+||||+||++++++.++|+|||.+...    .
T Consensus        83 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~----~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   83 GSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSK----GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             EBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHT----TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             ccccccccccc-----cccccccccccccccccccccccc----cccccccccccccccccccccccccccccccccccc
Confidence            99999998332     589999999999999999999998    9999999999999999999999999999753    2


Q ss_pred             ccccccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          513 PVQAIARLGGYKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       513 ~~~~~~~~~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      ......++..|+|||.+. +..++.++||||+|+++|+|++|..||...           ...+.............   
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----------~~~~~~~~~~~~~~~~~---  219 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----------NSDDQLEIIEKILKRPL---  219 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----------SHHHHHHHHHHHHHTHH---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc-----------cchhhhhhhhhcccccc---
Confidence            233455677899999998 888999999999999999999999998643           00011111111111000   


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        ....   .........+.+++.+||+.||++||++.|++++
T Consensus       220 --~~~~---~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  220 --PSSS---QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             --HHHT---TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             --cccc---cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0000   0000011456677779999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-35  Score=300.62  Aligned_cols=243  Identities=23%  Similarity=0.342  Sum_probs=194.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||||++++
T Consensus         4 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   83 (255)
T cd08219           4 VLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGG   83 (255)
T ss_pred             EEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCC
Confidence            4578999999999999954 6899999998643 2334577889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.+++.....   ..+++.....++.|++.||.|||+.    +|+|+||||+||++++++.++++|||.+.......  
T Consensus        84 ~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          84 DLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEK----RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             cHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            99998865431   2478899999999999999999988    99999999999999999999999999997664322  


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                        ...++..|+|||++.+..++.++||||||+++|+|++|+.||...+              ............. .. +
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------------~~~~~~~~~~~~~-~~-~  220 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------------WKNLILKVCQGSY-KP-L  220 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------------HHHHHHHHhcCCC-CC-C
Confidence              3456677999999988889999999999999999999999996431              1111111111110 00 0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .      ..   ....+.+++.+||+.||++|||+.|++..
T Consensus       221 ~------~~---~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 P------SH---YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C------cc---cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0      01   11235567779999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-35  Score=294.35  Aligned_cols=245  Identities=24%  Similarity=0.342  Sum_probs=196.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcch---HHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCA---RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +..+.||+|.-|+||+++++ ++..+|+|++.+.....   ..+.+.|.+||+.++||.++.+|+.|+.++..|+|||||
T Consensus        80 ~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC  159 (459)
T KOG0610|consen   80 RLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC  159 (459)
T ss_pred             HHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence            45688999999999999976 46899999998764332   345678899999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      +||+|..+++.+.+   ..++...+.-++..|+-||+|||-.    |||.|||||+||||.++|++.|+||.++..... 
T Consensus       160 pGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHml----GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  160 PGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHML----GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             CCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhh----ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999987653   3588999999999999999999988    999999999999999999999999988643210 


Q ss_pred             ----------------------------------c-------------------------ccccccCcccCccccccCCC
Q 036639          514 ----------------------------------V-------------------------QAIARLGGYKAPEQAEVKRL  534 (670)
Q Consensus       514 ----------------------------------~-------------------------~~~~~~~~y~aPE~~~~~~~  534 (670)
                                                        .                         ..+.||-.|+|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                              0                         01223445999999999999


Q ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHH
Q 036639          535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVG  614 (670)
Q Consensus       535 ~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  614 (670)
                      +.++|.|+|||++|||+.|+.||.+.+...              .+..++.+.         + .++...+....+.+||
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~--------------Tl~NIv~~~---------l-~Fp~~~~vs~~akDLI  368 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--------------TLRNIVGQP---------L-KFPEEPEVSSAAKDLI  368 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchh--------------hHHHHhcCC---------C-cCCCCCcchhHHHHHH
Confidence            999999999999999999999998763321              122222211         0 1111112334566677


Q ss_pred             hhccCCCCCCCCC----HHHHHHH
Q 036639          615 LACVVSQPEKRPT----MAEVAKM  634 (670)
Q Consensus       615 ~~cl~~dP~~RPt----~~evl~~  634 (670)
                      ++.|.+||++|.-    |+||-+|
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHHhccChhhhhccccchHHhhcC
Confidence            8999999999998    8888764

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8e-36  Score=306.75  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=191.2

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||++.. .+++.||+|.+.....   .....+.+|++++++++|+||+++.+++...+..++||||+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   84 (285)
T cd05632           5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG   84 (285)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence            36799999999999995 4789999999875422   2234577899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++....   ...+++..+..++.|++.||.|||+.    +|+||||||+||++++++.+||+|||++......  
T Consensus        85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~----~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRE----NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99998886432   12589999999999999999999988    9999999999999999999999999998765432  


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....++..|+|||++.+..++.++|||||||++|||++|+.||......           .....+.......  ...+
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~-----------~~~~~~~~~~~~~--~~~~  224 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK-----------VKREEVDRRVLET--EEVY  224 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHHhhhcc--cccc
Confidence             2235677899999998889999999999999999999999999643110           0000111111100  0000


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                            .....   ..+.+++..||+.||++||+     +.+++++
T Consensus       225 ------~~~~~---~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 ------SAKFS---EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ------CccCC---HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                  01111   23456777999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.2e-35  Score=301.28  Aligned_cols=245  Identities=26%  Similarity=0.422  Sum_probs=194.9

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.+.||+|+||.||++...++..||+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+++++
T Consensus         9 ~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~   86 (260)
T cd05073           9 KLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGS   86 (260)
T ss_pred             eEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence            4457899999999999998778889999987543 245678899999999999999999999887 77899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc--
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--  516 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--  516 (670)
                      |.+++....   ...+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||.+........  
T Consensus        87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          87 LLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             HHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhC----CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            999997643   12478899999999999999999987    999999999999999999999999999876543221  


Q ss_pred             ---ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          517 ---IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       517 ---~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ..++..|+|||++....++.++|||||||++||++| |+.||...+.           ..+..    .....+....
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----------~~~~~----~~~~~~~~~~  224 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----------PEVIR----ALERGYRMPR  224 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----------HHHHH----HHhCCCCCCC
Confidence               122345999999988889999999999999999999 8989864311           01111    1111111000


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                                .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       225 ----------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ----------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ----------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                      01122346677789999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-36  Score=320.78  Aligned_cols=194  Identities=24%  Similarity=0.331  Sum_probs=167.4

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .|.+.+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus        44 ~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (371)
T cd05622          44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME  123 (371)
T ss_pred             hcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence            3445678999999999999965 6889999998642   12234567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++|+|.+++...      .++...+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++...
T Consensus       124 y~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         124 YMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            99999999999754      377888889999999999999998    99999999999999999999999999998764


Q ss_pred             cc-----ccccccCcccCccccccC----CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          513 PV-----QAIARLGGYKAPEQAEVK----RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       513 ~~-----~~~~~~~~y~aPE~~~~~----~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..     ....+|+.|+|||++...    .++.++|||||||++|||++|+.||...
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence            32     234578889999998653    3789999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-36  Score=321.64  Aligned_cols=191  Identities=26%  Similarity=0.370  Sum_probs=167.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||++... +++.||||+++...   ......+..|++++..++|+||+++++.+.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (360)
T cd05627           6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG   85 (360)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            467999999999999954 68999999997432   22346778899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++......  
T Consensus        86 g~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~----givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          86 GDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQL----GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             ccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            99999997543     488999999999999999999998    9999999999999999999999999998754211  


Q ss_pred             -------------------------------------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 036639          515 -------------------------------------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS  557 (670)
Q Consensus       515 -------------------------------------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~  557 (670)
                                                           ....+|..|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence                                                 1235778899999999999999999999999999999999999


Q ss_pred             CCC
Q 036639          558 QYP  560 (670)
Q Consensus       558 ~~~  560 (670)
                      ...
T Consensus       237 ~~~  239 (360)
T cd05627         237 CSE  239 (360)
T ss_pred             CCC
Confidence            654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=299.29  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=195.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|+||.||+|.. .+++.+++|.+........+.+.+|++++++++||||+++++++.+....+++|||+++++|
T Consensus         8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l   87 (262)
T cd06613           8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL   87 (262)
T ss_pred             EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence            46799999999999995 46789999999876555678899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~  515 (670)
                      .+++....    ..+++..+..++.|++.||+|||+.    +++|+||||+||++++++.+||+|||.+......    .
T Consensus        88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLHET----GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence            99987642    2588999999999999999999987    9999999999999999999999999998766432    2


Q ss_pred             cccccCcccCccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 AIARLGGYKAPEQAEVK---RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                      ...++..|+|||.+...   .++.++||||||+++|||+||+.||....+.              ...............
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--------------~~~~~~~~~~~~~~~  225 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--------------RALFLISKSNFPPPK  225 (262)
T ss_pred             cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHhccCCCcc
Confidence            23456679999998776   7899999999999999999999998643211              000000011000000


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          .   .........+.+++.+||..+|++|||+.+|+++
T Consensus       226 ----~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         226 ----L---KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ----c---cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                0   0111122346678889999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6e-36  Score=307.69  Aligned_cols=267  Identities=22%  Similarity=0.311  Sum_probs=193.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++|+||+++++++......++||||++
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~   83 (286)
T cd07847           4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD   83 (286)
T ss_pred             eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence            34567999999999999965 68999999986432  2234668899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|..++....     .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++.......
T Consensus        84 ~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          84 HTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKH----NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            988888775432     489999999999999999999997    99999999999999999999999999998765432


Q ss_pred             ----cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh-hhccc
Q 036639          516 ----AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV-KEEWT  589 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  589 (670)
                          ...++..|+|||++.+ ..++.++||||||+++|||++|+.||........................... ...+.
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence                2345667999999865 45789999999999999999999999754221100000000000000000000 00000


Q ss_pred             cccccHhhhcccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNI----EEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....+........    ......+.+++.+||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000000000000    0112356678889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-36  Score=303.99  Aligned_cols=242  Identities=21%  Similarity=0.281  Sum_probs=197.4

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|.|+.|-+|+ .-+|..||||++.+..  ......+-+|++-|+.++|||||++|++.......|||+|.-+
T Consensus        21 DLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD  100 (864)
T KOG4717|consen   21 DLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGD  100 (864)
T ss_pred             hhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecC
Confidence            446789999999999999 4589999999998653  3355678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC-CCCcEEEEecccccccCcc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~  514 (670)
                      +|+|++||.++..    -+.+....+++.||+.|+.|+|+.    .+|||||||+||.+- .-|-+||+|||++..+.+.
T Consensus       101 ~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqL----HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen  101 GGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQL----HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             CchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhh----hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999976542    488899999999999999999987    899999999998764 5688999999999988776


Q ss_pred             cc---ccccCcccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 QA---IARLGGYKAPEQAEVKRLS-QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ~~---~~~~~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      ..   ..|...|-|||++.+..|+ +++||||+|||||.|++|+.||+..++.+....+......+              
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv--------------  238 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV--------------  238 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC--------------
Confidence            54   4556669999999999987 58899999999999999999998653332221111111111              


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                                  ......++.+|+..||..||++|.+.+|+..+
T Consensus       239 ------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  239 ------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ------------chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                        11122345557779999999999999999864

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-35  Score=301.53  Aligned_cols=241  Identities=24%  Similarity=0.380  Sum_probs=191.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcc---------hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPC---------ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  429 (670)
                      +...||+|++|.||+|.. .+++.||+|.+......         ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus         4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (267)
T cd06628           4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI   83 (267)
T ss_pred             ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence            456799999999999985 46889999988654322         12568889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+++++|.+++....     .+++..+..++.|++.||+|||+.    +++||||+|+||++++++.+||+|||.++
T Consensus        84 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~----~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          84 FLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNR----GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             EEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhc----CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999997643     478889999999999999999987    99999999999999999999999999988


Q ss_pred             ccCcc----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHH
Q 036639          510 LLNPV----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       510 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      .....          ....++..|+|||.+.+..++.++|||||||++|||++|+.||.....              ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------------~~~  220 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------------LQA  220 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------------HHH
Confidence            76421          112356679999999988899999999999999999999999964311              000


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +.....  .....+.         ......+.+++.+||+.||++||++.|++++
T Consensus       221 ~~~~~~--~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         221 IFKIGE--NASPEIP---------SNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             HHHHhc--cCCCcCC---------cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            111000  0000000         1112345567779999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-35  Score=301.44  Aligned_cols=246  Identities=27%  Similarity=0.432  Sum_probs=192.1

Q ss_pred             HcCCCCceEEEEEEEcC-------CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          363 MLGKGSLGTVYKAVLDD-------GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .||+|+||.||+|...+       ++.||+|.+.... .....++.+|+++++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999998542       2579999886543 234678889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-----cEEEEeccc
Q 036639          435 PNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-----VACISDFGL  507 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG~  507 (670)
                      ++++|.+++......  ....+++..+..++.|++.||+|||+.    +++|+||||+||+++.++     .+||+|||+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM----HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC----CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999753211  123478999999999999999999987    999999999999999887     899999999


Q ss_pred             ccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          508 SLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       508 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ++......      ....+..|+|||++.+..++.++|||||||++|||+| |+.||.....              ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------------~~~~  223 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------------QEVL  223 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------------HHHH
Confidence            87653321      1223456999999998999999999999999999998 9999853310              0111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      .. +.....       ......   ....+.+++.+||..+|++||++.++++.|++
T Consensus       224 ~~-~~~~~~-------~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         224 QH-VTAGGR-------LQKPEN---CPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             HH-HhcCCc-------cCCccc---chHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            11 111000       000011   12345678889999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-35  Score=298.30  Aligned_cols=245  Identities=21%  Similarity=0.343  Sum_probs=197.5

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||.|+||.||.++ ..+++.|++|.+...  .....+++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            345789999999999999 456899999998643  23445678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++....   ...+++..+..++.|+++||+|||+.    +++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          83 GGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKA----GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             CCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999997653   22578999999999999999999987    99999999999999999999999999987664322


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ...++..|+|||...+..++.++||||||+++|||++|+.||....              ............+...
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------------~~~~~~~~~~~~~~~~  221 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------------PLNLVVKIVQGNYTPV  221 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------------HHHHHHHHHcCCCCCC
Confidence                3456778999999988889999999999999999999999986431              1122222222111100


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                                 .......+.+++.+||..+|++||+++|+++++
T Consensus       222 -----------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 -----------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -----------ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                       011123456677799999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=8.3e-36  Score=308.46  Aligned_cols=240  Identities=22%  Similarity=0.352  Sum_probs=193.0

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      ..||+|+||.||++.. .+++.||+|.+........+.+.+|+.++..++||||+++++++...+..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            4799999999999995 478999999997654445677889999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----cc
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----QA  516 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~~  516 (670)
                      +++...      .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++......    ..
T Consensus       107 ~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         107 DIVSQT------RLNEEQIATVCESVLQALCYLHSQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             HHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            987643      378999999999999999999988    9999999999999999999999999998755322    23


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......              ..+.. ........     
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------------~~~~~-~~~~~~~~-----  236 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------------QAMKR-LRDSPPPK-----  236 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHH-HhccCCCC-----
Confidence            45677899999998888999999999999999999999998643110              00111 00100000     


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ........   ..+.+++.+||+.+|++||+++|++++
T Consensus       237 ~~~~~~~~---~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         237 LKNAHKIS---PVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccccCCCC---HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00001111   235567779999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.9e-35  Score=304.38  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=187.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhcc---CCCCeeeEEEEEEeC-----Cee
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKL---KHPNVVKLRAYYYAK-----EEK  427 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~-----~~~  427 (670)
                      .+.+.||+|+||+||+|... +++.||+|.++...  ......+.+|+++++++   +||||+++++++...     ...
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~   82 (288)
T cd07863           3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV   82 (288)
T ss_pred             eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence            34567999999999999954 68999999987532  12234556677777655   799999999988652     357


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      ++||||++ ++|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          83 TLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             EEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccCc
Confidence            89999997 58988887543   12488999999999999999999998    999999999999999999999999999


Q ss_pred             ccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH-
Q 036639          508 SLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV-  583 (670)
Q Consensus       508 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-  583 (670)
                      ++.....   ....++..|+|||++.+..++.++||||+||++|||++|++||.......          .+.+..... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~----------~~~~~~~~~~  224 (288)
T cd07863         155 ARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----------QLGKIFDLIG  224 (288)
T ss_pred             cccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH----------HHHHHHHHhC
Confidence            9876532   22345777999999988899999999999999999999999986432110          010110000 


Q ss_pred             --hhhccccc------cccHhhhc-c-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 --VKEEWTAE------VFDQELLR-Y-KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 --~~~~~~~~------~~d~~~~~-~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        ....|...      .+.+.... . ....+....+.+++.+||+.||++|||+.|++.|
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         225 LPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             CCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              00011100      00000000 0 0000112345677789999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-35  Score=301.15  Aligned_cols=249  Identities=24%  Similarity=0.366  Sum_probs=196.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCC----EEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGG----IVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.+.||+|+||.||+|... +|.    .||+|.+..... ....++.+|+.++++++||||+++++++.. ...++|||
T Consensus        10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e   88 (279)
T cd05057          10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQ   88 (279)
T ss_pred             EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEe
Confidence            45678999999999999954 333    689998876543 345778899999999999999999999987 78899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++|+|.+++.....    .+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||.++...
T Consensus        89 ~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          89 LMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEK----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             cCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhC----CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999976532    488999999999999999999997    99999999999999999999999999998765


Q ss_pred             cccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          513 PVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       513 ~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ....      ...+..|+|||.+....++.++||||||+++||++| |+.||....              ...+......
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--------------~~~~~~~~~~  226 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--------------AVEIPDLLEK  226 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--------------HHHHHHHHhC
Confidence            3221      112345999999988889999999999999999999 999986431              1111111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ....           .........+.+++.+||..+|++|||+.++++.|+++...
T Consensus       227 ~~~~-----------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         227 GERL-----------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CCCC-----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            1000           00001113456677899999999999999999999998543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.3e-35  Score=300.56  Aligned_cols=244  Identities=24%  Similarity=0.350  Sum_probs=189.9

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      ..||+|+||.||+|.. ++++.||+|.+........+.+.+|+.++++++|+||+++++++...+..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            4699999999999994 467899999998766556778999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccCcc----c
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~----~  515 (670)
                      +++.....  ....++..+..++.|++.||+|||+.    +|+||||||+||+++. ++.+||+|||.+......    .
T Consensus        94 ~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~----~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          94 ALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDN----QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             HHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            99975431  11127888899999999999999987    9999999999999986 679999999998765321    2


Q ss_pred             cccccCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 AIARLGGYKAPEQAEVKR--LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      ...++..|+|||++....  ++.++||||||+++|||++|+.||......           ....+.......   ...+
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----------~~~~~~~~~~~~---~~~~  233 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----------QAAMFKVGMFKI---HPEI  233 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----------hhhHhhhhhhcc---CCCC
Confidence            234667899999986543  789999999999999999999998542110           000000000000   0000


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .      ...   ...+.+++.+||+.+|++|||+.|++++
T Consensus       234 ~------~~~---~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         234 P------ESL---SAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             C------ccc---CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            0      011   2235567779999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.5e-36  Score=307.62  Aligned_cols=241  Identities=22%  Similarity=0.366  Sum_probs=192.9

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ...||+|+||.||++.. .++..||||.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            45799999999999995 46899999998765555667789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~  515 (670)
                      .+++...      .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||++......    .
T Consensus       107 ~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         107 TDIVTHT------RMNEEQIATVCLSVLRALSYLHNQ----GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCc
Confidence            9988643      378899999999999999999998    9999999999999999999999999998754321    2


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||...+..++.++||||||+++|||++|+.||.....              ...+.. .....     ..
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------------~~~~~~-~~~~~-----~~  236 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP--------------LQAMRR-IRDNL-----PP  236 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHH-HHhcC-----CC
Confidence            23466779999999888899999999999999999999999864311              000111 11100     00


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .........   ..+.+++.+||..||++|||++|++++
T Consensus       237 ~~~~~~~~~---~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         237 RVKDSHKVS---SVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccccccccC---HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            000001112   234456679999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=3.2e-35  Score=299.47  Aligned_cols=248  Identities=23%  Similarity=0.298  Sum_probs=183.6

Q ss_pred             HcCCCCceEEEEEEEcCC---CEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          363 MLGKGSLGTVYKAVLDDG---GIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .||+|+||.||++...++   ..+++|.++... ....+.+.+|+++++.++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999985433   356677776443 2345788999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----  513 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-----  513 (670)
                      |.++++..... ....++.....++.|+++||+|||+.    +++||||||+|||++.++.+||+|||++.....     
T Consensus        82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~----~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKH----NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHC----CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            99999764321 22466778889999999999999987    999999999999999999999999999864321     


Q ss_pred             -cccccccCcccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          514 -VQAIARLGGYKAPEQAEV-------KRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~-------~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                       .....++..|+|||++..       ..++.++|||||||++|||++ |..||....              ....+....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------------~~~~~~~~~  222 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------------DREVLNHVI  222 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------------HHHHHHHHH
Confidence             122345667999998743       245789999999999999997 466774321              111222222


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      .+.. ....++....  ...   ..+.+++..|| .+|++||+++||++.|.
T Consensus       223 ~~~~-~~~~~~~~~~--~~~---~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         223 KDQQ-VKLFKPQLEL--PYS---ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             hhcc-cccCCCccCC--CCc---HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2111 1112221111  112   23445666898 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.6e-35  Score=304.72  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=193.3

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCC----EEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGG----IVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      ..+.||+|+||.||+|.+ .+|.    .||+|.+..... ....++.+|+.+++.++||||+++++++... ..++++||
T Consensus        11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~   89 (303)
T cd05110          11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL   89 (303)
T ss_pred             eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence            457899999999999985 3454    579998875432 2345788999999999999999999998754 46799999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhc----CeeccccccceeeecCCCceEEccccccccccC
Confidence            99999999987543    2478999999999999999999998    999999999999999999999999999987643


Q ss_pred             ccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          514 VQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       514 ~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ...      ...+..|+|||++.+..++.++|||||||++|||++ |+.||....           ......+    ...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----------~~~~~~~----~~~  226 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----------TREIPDL----LEK  226 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----------HHHHHHH----HHC
Confidence            221      223446999999998899999999999999999998 888985431           0011111    111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ....          .........+.+++..||..+|++||+++|+++.|+++...
T Consensus       227 ~~~~----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         227 GERL----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1000          00011123566788899999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=311.53  Aligned_cols=192  Identities=26%  Similarity=0.343  Sum_probs=165.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||++... +++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..|+||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (331)
T cd05597           5 ILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYV   84 (331)
T ss_pred             EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCC
Confidence            4578999999999999954 6899999999742   22234568889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++.......
T Consensus        85 g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQL----GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999997532    1478899999999999999999998    99999999999999999999999999987654322


Q ss_pred             -----cccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          516 -----AIARLGGYKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       516 -----~~~~~~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                           ...++..|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence                 2357888999999863     4578899999999999999999999964

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=314.97  Aligned_cols=237  Identities=21%  Similarity=0.297  Sum_probs=181.4

Q ss_pred             cCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc---hHHHHHHHHHHHhcc---CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          364 LGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC---ARKEFEQYMDVIGKL---KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       364 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ||+|+||+||+|+.. +++.||||++......   ....+..|..++.+.   +||||+++++++.+....|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999954 6899999999643211   223344556666554   699999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~----~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~  151 (330)
T cd05586          81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKY----DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK  151 (330)
T ss_pred             ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence            99999987543     488999999999999999999998    999999999999999999999999999876432   


Q ss_pred             -cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                       .....++..|+|||++.+. .++.++|||||||++|||+||+.||....              ..............  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------------~~~~~~~i~~~~~~--  215 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------------TQQMYRNIAFGKVR--  215 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------------HHHHHHHHHcCCCC--
Confidence             2234578889999998754 48999999999999999999999996431              11111111111000  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC----CHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP----TMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~evl~~  634 (670)
                           +.. ....+   .+.+++.+||+.||++||    ++.|+++|
T Consensus       216 -----~~~-~~~~~---~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         216 -----FPK-NVLSD---EGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             -----CCC-ccCCH---HHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence                 000 01122   344566799999999998    56777664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-36  Score=305.93  Aligned_cols=252  Identities=22%  Similarity=0.357  Sum_probs=198.8

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCC--CCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCe
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEE  426 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~  426 (670)
                      .+.+.+-.|.+.+.||+||.+.||++...+.+.||+|++..  .+.....-|.+|+..|.+|+ |.+||++++|-..++.
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            45666777788899999999999999988889999998763  45556788999999999994 9999999999999999


Q ss_pred             eEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       427 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      .||||||= ..+|..+|+....   ....| .+..+..|++.++.++|++    ||||.||||.|+|+ -.|.+||+|||
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~----gIVHSDLKPANFLl-VkG~LKLIDFG  504 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQH----GIVHSDLKPANFLL-VKGRLKLIDFG  504 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHh----ceeecCCCcccEEE-EeeeEEeeeec
Confidence            99999986 5699999987652   23445 7778899999999999998    99999999999999 56899999999


Q ss_pred             cccccCcc------ccccccCcccCccccccCC-----------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 036639          507 LSLLLNPV------QAIARLGGYKAPEQAEVKR-----------LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE  569 (670)
Q Consensus       507 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~-----------~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~  569 (670)
                      +|..+..+      +...||..||+||.+....           ++.++||||+|||||+|+.|+.||...         
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~---------  575 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI---------  575 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH---------
Confidence            99988653      3467899999999885332           568999999999999999999999532         


Q ss_pred             cccccchhHHHHHHhhhccccccccHhh-hcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          570 EEQAVDLPKWVRSVVKEEWTAEVFDQEL-LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             ...+..+      ..+.|+.. ..++...+ -..++++|..||+.||.+|||..|+++|
T Consensus       576 -------~n~~aKl------~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  576 -------INQIAKL------HAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -------HHHHHHH------HhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                   2111111      11111110 01111111 1127778889999999999999999985

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.4e-35  Score=302.96  Aligned_cols=245  Identities=23%  Similarity=0.381  Sum_probs=194.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      |...+.||+|+||.||+|... +++.||+|++.....   ...+++.+|+++++.++||||+++++++.+.+..++|+||
T Consensus        17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   96 (307)
T cd06607          17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY   96 (307)
T ss_pred             hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence            445578999999999999954 689999999864322   2345788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      ++ |++.+++....    ..+++..+..++.|++.||.|||+.    +|+||||+|+||++++++.+||+|||++.....
T Consensus        97 ~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~----~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          97 CL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSH----ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             hC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            96 57777775432    2489999999999999999999987    999999999999999999999999999987766


Q ss_pred             cccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 VQAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .....++..|+|||++.   ...++.++||||||+++|||+||+.||.....              ........... ..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------------~~~~~~~~~~~-~~  232 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------MSALYHIAQND-SP  232 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------------HHHHHHHhcCC-CC
Confidence            66666778899999874   45688999999999999999999999864311              01011111000 00


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      ..         ........+.+++.+||..+|++||++.+|+.+.
T Consensus       233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         233 TL---------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CC---------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            00         0111223567778899999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.6e-35  Score=297.86  Aligned_cols=244  Identities=21%  Similarity=0.397  Sum_probs=196.1

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|+||.||++.. .+|+.||+|.+...  .....+++.+|++++++++||||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08218           3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE   82 (256)
T ss_pred             eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence            3457899999999999994 47899999998643  23345688999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++.....   ..+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          83 GGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999875431   2478899999999999999999987    99999999999999999999999999997664422


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ...++..|+|||+..+..++.++|||||||+++||+||+.||...              +....+......... .
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~--------------~~~~~~~~~~~~~~~-~  220 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--------------NMKNLVLKIIRGSYP-P  220 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC--------------CHHHHHHHHhcCCCC-C
Confidence                234566799999998888999999999999999999999998532              111222222211110 0


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                                ........+.+++.+||+.+|++||++.||+++
T Consensus       221 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         221 ----------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ----------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                      001112346667779999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4e-35  Score=296.65  Aligned_cols=244  Identities=23%  Similarity=0.329  Sum_probs=193.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~  434 (670)
                      .+.+.||+|++|.||++... +++.||+|.+....  ....+.+.+|++++++++|+|++++++.+.. ....+++|||+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (257)
T cd08223           3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC   82 (257)
T ss_pred             eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence            34578999999999999954 57899999986532  2345678899999999999999999998764 44678999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++++|.+++....   ...+++..+..++.+++.||+|||+.    +++||||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~----~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          83 EGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEK----HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999997643   12589999999999999999999998    9999999999999999999999999999766432


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ....++..|+|||+..+..++.++||||||++++||++|+.||...              +........... ...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~--------------~~~~~~~~~~~~-~~~  220 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK--------------DMNSLVYRIIEG-KLP  220 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------------CHHHHHHHHHhc-CCC
Confidence                2234567799999999889999999999999999999999998643              111111111111 110


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .          ........+.+++.+|++.+|++|||+.|++++
T Consensus       221 ~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 P----------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             C----------CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0          001122346677889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.3e-35  Score=301.52  Aligned_cols=250  Identities=23%  Similarity=0.364  Sum_probs=194.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +++.+.||+|+||.||++... +|+.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            456788999999999999965 7899999998754 23345678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +++|.++++...  ....+++..+..++.+++.||.|||+.   .+|+||||||+||+++.++.+||+|||++.....  
T Consensus        83 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          83 AGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEE---HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            999999987642  122589999999999999999999974   3899999999999999999999999999876533  


Q ss_pred             cccccccCcccCccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 VQAIARLGGYKAPEQAEVKR------LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~------~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||.....           ......+.......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~  226 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----------ANIFAQLSAIVDGD  226 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----------hhHHHHHHHHhhcC
Confidence            22334566799999985443      58899999999999999999999954210           01111111111110


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ...          ........+.+++.+||+.+|++||++++++.+
T Consensus       227 -~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 -PPT----------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -CCC----------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             000          011122345567779999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.6e-35  Score=311.41  Aligned_cols=193  Identities=24%  Similarity=0.322  Sum_probs=165.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||++..+ +++.||+|++.+..   ......+.+|+.++..++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~   84 (332)
T cd05623           5 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYV   84 (332)
T ss_pred             EEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccC
Confidence            3467999999999999965 57889999986421   1233457889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++...... 
T Consensus        85 ~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~----~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          85 GGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            999999997532    1488899999999999999999998    9999999999999999999999999998765322 


Q ss_pred             ----ccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 ----QAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                          ....++..|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence                1245788899999985     346889999999999999999999999643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.9e-35  Score=298.51  Aligned_cols=242  Identities=21%  Similarity=0.369  Sum_probs=186.4

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-----cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv  430 (670)
                      ...+.||+|+||.||+|.. .+++.||+|++....     ....+.+.+|+.++++++||||+++++++.+.  ...+++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            3457899999999999995 468999999986432     12335688899999999999999999988763  567899


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +||+++++|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~----~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          85 MEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            99999999999997543     478899999999999999999987    999999999999999999999999999876


Q ss_pred             cCcc-------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          511 LNPV-------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       511 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ....       ....++..|+|||++.+..++.++|||||||++|||++|+.||.....              ...+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------------~~~~~~~  221 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------------MAAIFKI  221 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------------HHHHHHH
Confidence            5321       123456679999999988899999999999999999999999864210              1111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....     .+.+  .....+.   +.+++ +||..+|++||+++||++|
T Consensus       222 ~~~~~-----~~~~--~~~~~~~---~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         222 ATQPT-----NPQL--PSHISEH---ARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             hcCCC-----CCCC--chhcCHH---HHHHH-HHhcCChhhCcCHHHHhcC
Confidence            11100     0000  0011122   22333 6888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4e-35  Score=296.28  Aligned_cols=243  Identities=28%  Similarity=0.445  Sum_probs=192.2

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ++.+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|+.++++++||||+++++++... ..++||||+++++
T Consensus         9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~   84 (254)
T cd05083           9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGN   84 (254)
T ss_pred             eeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence            4567899999999999975 57889999987543  456788999999999999999999998654 4799999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-ccc
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-QAI  517 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  517 (670)
                      |.+++....   ...+++..+..++.|++.||.|||+.    +++||||||+||+++.++.+||+|||++...... ...
T Consensus        85 L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~----~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~  157 (254)
T cd05083          85 LVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESK----KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS  157 (254)
T ss_pred             HHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence            999997543   22478999999999999999999987    9999999999999999999999999998765432 122


Q ss_pred             cccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          518 ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       518 ~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      .....|+|||.+.+..++.++||||||+++|||++ |+.||....              ..... ......+....    
T Consensus       158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------------~~~~~-~~~~~~~~~~~----  218 (254)
T cd05083         158 KLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--------------LKEVK-ECVEKGYRMEP----  218 (254)
T ss_pred             CCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--------------HHHHH-HHHhCCCCCCC----
Confidence            23346999999988889999999999999999998 999986431              11111 11111111000    


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                            .......+.+++.+||+.+|++||+++++++.|++
T Consensus       219 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 ------PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                  01112345677889999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-35  Score=312.41  Aligned_cols=193  Identities=25%  Similarity=0.320  Sum_probs=166.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+++.. +++.||+|++.+..   ......+.+|..++..++|+||+++++++.+.+..|+||||++
T Consensus         5 i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~   84 (331)
T cd05624           5 IIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYV   84 (331)
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            4568999999999999954 68899999987521   2234557889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++......
T Consensus        85 gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~----~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          85 GGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQL----HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             CCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999997632    1478899999999999999999998    99999999999999999999999999997664322


Q ss_pred             -----cccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          516 -----AIARLGGYKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       516 -----~~~~~~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                           ...++..|+|||++.+     ..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence                 2357888999999865     46789999999999999999999999643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.6e-36  Score=308.76  Aligned_cols=192  Identities=24%  Similarity=0.358  Sum_probs=163.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||++ +
T Consensus        10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~   88 (301)
T cd07873          10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-K   88 (301)
T ss_pred             EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-c
Confidence            3467999999999999954 68899999987432 2234567889999999999999999999999999999999996 5


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++....    ..+++..+..++.|+++||+|||+.    +|+||||||+||++++++.+||+|||++......   
T Consensus        89 ~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          89 DLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRR----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT  160 (301)
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence            8998886543    2478899999999999999999998    9999999999999999999999999998765322   


Q ss_pred             -ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 -QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                       ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~  208 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS  208 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             12345667999998865 45788999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.6e-35  Score=296.80  Aligned_cols=251  Identities=22%  Similarity=0.378  Sum_probs=193.6

Q ss_pred             HHHhHcCCCCceEEEEEEEcC--CCEEEEEEeCCCC----------cchHHHHHHHHHHHhc-cCCCCeeeEEEEEEeCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD--GGIVAVKRLKDAN----------PCARKEFEQYMDVIGK-LKHPNVVKLRAYYYAKE  425 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~nIv~l~~~~~~~~  425 (670)
                      .+.+.||+|+||.||+|....  ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++...+
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            456789999999999999654  7889999885321          1233456778887765 79999999999999999


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.   .+++|+||+|+||+++.++.+||+||
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKE---KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccC---CceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999998854221 123588999999999999999999963   28999999999999999999999999


Q ss_pred             ccccccCccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          506 GLSLLLNPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       506 G~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      |.+.......   ...++..|+|||.+.+..++.++||||||+++|||++|+.||....              .......
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------------~~~~~~~  224 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------------MLSLATK  224 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------------HHHHHHH
Confidence            9998765432   3445667999999998889999999999999999999999985431              1111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      .....+. ...         .......+.+++.+||+.||++||++.||.+++++
T Consensus       225 ~~~~~~~-~~~---------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         225 IVEAVYE-PLP---------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             HhhccCC-cCC---------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            1111110 000         00112345667779999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-35  Score=303.48  Aligned_cols=194  Identities=25%  Similarity=0.371  Sum_probs=164.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|++|.||+|... +++.||||+++...  ....+.+.+|+.++++++||||+++++++.+++..++||||++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (285)
T cd07861           4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-   82 (285)
T ss_pred             EeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-
Confidence            3467999999999999964 68999999986432  2234678899999999999999999999999999999999997 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++.....  ...+++..+..++.|+++||+|||+.    +++||||||+||+++.++.+||+|||++....... 
T Consensus        83 ~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          83 MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSR----RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            689888865431  23588999999999999999999988    99999999999999999999999999987654321 


Q ss_pred             ---cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          516 ---AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                         ...++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence               2234667999998865 45789999999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=6.8e-35  Score=297.81  Aligned_cols=250  Identities=25%  Similarity=0.399  Sum_probs=192.6

Q ss_pred             HHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------ee
Q 036639          360 SAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EK  427 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~  427 (670)
                      +.+.||+|+||.||+|.+.    +++.||||++...  .....+++.+|++++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4578999999999999853    3688999998754  2334567889999999999999999999886542      24


Q ss_pred             EEEEeccCCCChHHHhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          428 LLVYDYLPNGSLHSLLHGNR-GPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      ++++||+++|+|.+++.... ......+++.....++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~nili~~~~~~kl~dfg  158 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK----NFIHRDLAARNCMLNENMTVCVADFG  158 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CEeecccchhhEEEcCCCCEEECccc
Confidence            78999999999998875332 11223578899999999999999999987    99999999999999999999999999


Q ss_pred             cccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHH
Q 036639          507 LSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       507 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +++......      ...+...|++||.+....++.++||||||+++|||++ |+.||.....              ...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------------~~~  224 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------------SEI  224 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------------HHH
Confidence            998664322      1223346999999988889999999999999999999 8888754310              111


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ...........           ........+.+++.+||+.+|++||++.|+++.|+++
T Consensus       225 ~~~~~~~~~~~-----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         225 YNYLIKGNRLK-----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHHHcCCcCC-----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11111110000           0011224577788899999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.4e-36  Score=307.09  Aligned_cols=266  Identities=21%  Similarity=0.329  Sum_probs=191.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (286)
T cd07846           5 NLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDH   84 (286)
T ss_pred             EeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCc
Confidence            4478999999999999965 589999999865322  2356788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.++.....     .+++..+..++.|++.||+|||+.    +++|+||+|+||++++++.++|+|||++....... 
T Consensus        85 ~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~----~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          85 TVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             cHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            99988776432     489999999999999999999988    99999999999999999999999999987654322 


Q ss_pred             ---cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc-ccc
Q 036639          516 ---AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE-WTA  590 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  590 (670)
                         ...++..|+|||++.+ ..++.++||||||+++|||++|++||..................+........... ...
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07846         156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA  235 (286)
T ss_pred             ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence               2335667999999865 45788999999999999999999988643210000000000000000000000000 000


Q ss_pred             ccccHhhhccc----chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYK----NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ....+......    ........+.+++.+||..+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000000000    001123456778889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.9e-34  Score=299.81  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=197.5

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +...+.||+|+||.||++.. .++..||+|++.....   ...+.+.+|++++++++|||++++++++.+....++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            34567899999999999995 4689999999874322   2345788899999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      ++ |+|.+++....    .++++..+..++.|++.||.|||+.    +|+||||+|+||+++.++.+||+|||++.....
T Consensus       107 ~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~----~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (317)
T cd06635         107 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGSASIASP  177 (317)
T ss_pred             CC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence            96 58887775432    2589999999999999999999988    999999999999999999999999999987766


Q ss_pred             cccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 VQAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .....++..|+|||++.   ...++.++|||||||++|||++|+.||....              ...............
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--------------~~~~~~~~~~~~~~~  243 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------------AMSALYHIAQNESPT  243 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--------------HHHHHHHHHhccCCC
Confidence            66667788899999973   4568999999999999999999999985421              001111111111000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                                .........+.+++.+||+.+|++||++.++++++-.....
T Consensus       244 ----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         244 ----------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             ----------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence                      00111223456677799999999999999999987655433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4e-36  Score=313.36  Aligned_cols=242  Identities=23%  Similarity=0.381  Sum_probs=193.4

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCC----CCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe--eEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKD----ANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE--KLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~--~~lv~e~  433 (670)
                      ..+||+|+|-+||+|... +|..||--.++.    ..+...+.|..|+.+|+.|+|||||+++.+|.+...  ..+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            457999999999999954 677787443331    233455889999999999999999999999988765  6689999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccC
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLN  512 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~  512 (670)
                      +..|+|..|+++.+     .++......|++||++||.|||++  .|+|||||||.+||||+. -|.|||+|+|+|....
T Consensus       125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            99999999999876     478889999999999999999997  689999999999999975 5899999999999886


Q ss_pred             ccc--cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          513 PVQ--AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       513 ~~~--~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      ...  ...|||.|||||... ..|++.+||||||+.|+||+|+..||..-             .+-...+++......+.
T Consensus       198 ~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------------~n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  198 KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------------TNPAQIYKKVTSGIKPA  263 (632)
T ss_pred             ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------------CCHHHHHHHHHcCCCHH
Confidence            543  467999999999987 88999999999999999999999999633             23333333333332111


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       .+.    +.  ...++++   ++.+|+.. .++|||+.|+|++
T Consensus       264 -sl~----kV--~dPevr~---fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  264 -ALS----KV--KDPEVRE---FIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -Hhh----cc--CCHHHHH---HHHHHhcC-chhccCHHHHhhC
Confidence             111    11  1233344   55599999 9999999999984

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.9e-35  Score=299.24  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=194.1

Q ss_pred             HHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      ..+.||+|+||.||+|+.+      +.+.|++|.+...... ..+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus         9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   88 (275)
T cd05046           9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE   88 (275)
T ss_pred             eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence            3467999999999999954      2467999998765433 45789999999999999999999999999899999999


Q ss_pred             ccCCCChHHHhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          433 YLPNGSLHSLLHGNRGPG----RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      |+++|+|.++++......    ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.++++|||++
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA----RFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc----CcccCcCccceEEEeCCCcEEEcccccc
Confidence            999999999997554211    12589999999999999999999988    9999999999999999999999999998


Q ss_pred             cccCccc-----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          509 LLLNPVQ-----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       509 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      .......     ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....              ...+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------------~~~~~~  230 (275)
T cd05046         165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------------EEVLNR  230 (275)
T ss_pred             cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------------HHHHHH
Confidence            7543211     1223445999999988889999999999999999999 7788853210              111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      .........          ........+.+++.+||+.+|++|||+.|++++|+
T Consensus       231 ~~~~~~~~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGKLELP----------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCcCCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111110000          00111235667788999999999999999999886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.1e-35  Score=298.13  Aligned_cols=241  Identities=20%  Similarity=0.275  Sum_probs=186.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-----cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  431 (670)
                      +.+.||+|+||.||++.. .+|+.||||.+....     ....+.+.+|+.++++++||||+++++++.+.  ...+++|
T Consensus         6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~   85 (265)
T cd06652           6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM   85 (265)
T ss_pred             EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence            356899999999999995 468999999885321     12345788899999999999999999998764  4678999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++++|.+++....     .+++....+++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||+++..
T Consensus        86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          86 EHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSN----MIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            9999999999987543     478888999999999999999988    9999999999999999999999999998765


Q ss_pred             Cc-------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          512 NP-------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       512 ~~-------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ..       .....++..|+|||.+.+..++.++|||||||++|||++|+.||.....              ...+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------------~~~~~~~~  222 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA--------------MAAIFKIA  222 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch--------------HHHHHHHh
Confidence            32       1223466679999999888899999999999999999999999863210              00111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .... ..         .........+.+++.+|+. +|++||+++|++++
T Consensus       223 ~~~~-~~---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         223 TQPT-NP---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             cCCC-CC---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            1000 00         0011122345556668884 89999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5e-35  Score=297.53  Aligned_cols=250  Identities=28%  Similarity=0.405  Sum_probs=195.7

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||.|+||+||+|.. .++..||+|++.... ....+.+.+|++.++.++|+||+++++.+...+..++|+||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   83 (267)
T cd06610           4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG   83 (267)
T ss_pred             eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence            3457799999999999995 468899999997543 23567889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.++++....  ...+++.....++.|++.||+|||+.    +++||||||+||++++++.+||+|||++....... 
T Consensus        84 ~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~----~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          84 GSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSN----GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             CcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999976431  12588999999999999999999987    99999999999999999999999999987665422 


Q ss_pred             -------cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          516 -------AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       516 -------~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                             ...++..|+|||++... .++.++|||||||++|||++|+.||.......          .+    .......
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----------~~----~~~~~~~  223 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----------VL----MLTLQND  223 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----------hH----HHHhcCC
Confidence                   22456679999998766 78999999999999999999999996442211          01    1111110


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..      ..............+.+++.+||+.||++||+++|++++
T Consensus       224 ~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 PP------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CC------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00      000000001122345677779999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.6e-35  Score=330.84  Aligned_cols=249  Identities=18%  Similarity=0.269  Sum_probs=189.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~  434 (670)
                      +.+.||+|+||+||+|... ++..||+|.+...  .......+..|+.++++++|||||+++++|.+.  ...|+||||+
T Consensus        17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~   96 (1021)
T PTZ00266         17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFC   96 (1021)
T ss_pred             EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCC
Confidence            3468999999999999954 6788999998753  223456788999999999999999999988654  5689999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCC---CCCccccCCCCCCeEeCCC--------------
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG---TAKVPHGNVKSSNVLLDKN--------------  497 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~---~~~ivH~Dlkp~NIll~~~--------------  497 (670)
                      ++|+|.++|..... ....+++..++.|+.||+.||+|||+...   ..+||||||||+||||+.+              
T Consensus        97 ~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~  175 (1021)
T PTZ00266         97 DAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL  175 (1021)
T ss_pred             CCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccccc
Confidence            99999999875321 11258999999999999999999998520   1259999999999999642              


Q ss_pred             ---CcEEEEecccccccCcc---ccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 036639          498 ---GVACISDFGLSLLLNPV---QAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE  569 (670)
Q Consensus       498 ---~~~kl~DFG~a~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~  569 (670)
                         +.+||+|||++......   ....+++.|+|||++.+  ..++.++||||||||+|||+||+.||....        
T Consensus       176 ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~--------  247 (1021)
T PTZ00266        176 NGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN--------  247 (1021)
T ss_pred             CCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC--------
Confidence               34899999999876432   23457888999999854  458999999999999999999999996431        


Q ss_pred             cccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           .....+.. +.....       + .   .......+.+|+..||..+|.+||++.|++.+
T Consensus       248 -----~~~qli~~-lk~~p~-------l-p---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 -----NFSQLISE-LKRGPD-------L-P---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             -----cHHHHHHH-HhcCCC-------C-C---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence                 11111111 111100       0 0   00112345667779999999999999999953

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.2e-35  Score=301.55  Aligned_cols=247  Identities=26%  Similarity=0.394  Sum_probs=188.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEE-----eCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYY-----AKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~-----~~~~~~lv~e  432 (670)
                      +.+.||+|+||.||++.. .+++.||+|++..... ...++..|+.+++++ +||||+++++++.     ..+..++|||
T Consensus        22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e  100 (286)
T cd06638          22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE  100 (286)
T ss_pred             eeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence            446799999999999995 4688999999875332 346788899999999 6999999999885     3456899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.++++.... ....+++..+..++.|+++||.|||+.    +++||||||+||++++++.+||+|||+++...
T Consensus       101 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638         101 LCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVN----KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             ecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhC----CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            9999999998864321 123578899999999999999999988    99999999999999999999999999987654


Q ss_pred             cc----ccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          513 PV----QAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       513 ~~----~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ..    ....++..|+|||++.     ...++.++|||||||++|||++|+.||........              ....
T Consensus       176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--------------~~~~  241 (286)
T cd06638         176 STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--------------LFKI  241 (286)
T ss_pred             cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--------------Hhhc
Confidence            32    2335677899999875     34578999999999999999999999864321100              0000


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      .... .....++     ..   ....+.+++.+||+.||++|||+.||+++.
T Consensus       242 ~~~~-~~~~~~~-----~~---~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         242 PRNP-PPTLHQP-----EL---WSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             cccC-CCcccCC-----CC---cCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            0000 0000000     00   112466778899999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.2e-35  Score=293.87  Aligned_cols=244  Identities=32%  Similarity=0.443  Sum_probs=194.5

Q ss_pred             HHhHcCCCCceEEEEEEEcC-----CCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLDD-----GGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.||+|+||.||++...+     +..||+|+++..... ..+.+..|++.+..++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            34679999999999999653     388999999765433 567899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++.....   ..+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.++|+|||+++....
T Consensus        83 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~----~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       83 MEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESK----NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             cCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcC----CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999976431   1289999999999999999999998    999999999999999999999999999987654


Q ss_pred             ccc-----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 VQA-----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 ~~~-----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ...     ..++..|+|||.+.+..++.++||||+|+++|||++ |+.||...              .............
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------------~~~~~~~~~~~~~  221 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------------SNEEVLEYLKKGY  221 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------------CHHHHHHHHhcCC
Confidence            321     124467999999988889999999999999999998 77877532              1111111111111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      . ..          ........+.+++.+|+..+|++|||+.|+++.|
T Consensus       222 ~-~~----------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      222 R-LP----------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             C-CC----------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0 00          0011223466678899999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.2e-35  Score=302.26  Aligned_cols=267  Identities=21%  Similarity=0.286  Sum_probs=193.8

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+.++++++||||+++++++......++||||+ 
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-   81 (286)
T cd07832           3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-   81 (286)
T ss_pred             eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence            3457799999999999995 478999999997543  234578899999999999999999999999999999999999 


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++....    ..+++..+..++.|+++||+|||+.    +++|+||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          82 PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHAN----GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            999999987543    2589999999999999999999988    99999999999999999999999999998765432


Q ss_pred             -----cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccccc--chhHHHHHHhhhc
Q 036639          516 -----AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV--DLPKWVRSVVKEE  587 (670)
Q Consensus       516 -----~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  587 (670)
                           ...++..|+|||.+.+. .++.++||||+|+++|||+||++||.................  ....|..-.....
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence                 23456679999998654 468999999999999999999877754321100000000000  0000000000000


Q ss_pred             cccccccHhhh-cc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELL-RY-KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~-~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +....+..... .. ....+....+.+++.+||..+|++|||++++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000000 00 0001112556778889999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.5e-35  Score=297.82  Aligned_cols=247  Identities=25%  Similarity=0.395  Sum_probs=190.6

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc----------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCee
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP----------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  427 (670)
                      ...+.||+|+||.||+|.. .+|+.||+|.++....          ...+.+..|+.+++.++|+||+++++++...+..
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   83 (272)
T cd06629           4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL   83 (272)
T ss_pred             eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence            3457899999999999984 4689999998863211          0124678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      ++||||+++++|.++++...     .+++..+..++.|++.||.|||+.    +++||||+|+||+++.++.++|+|||+
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          84 SIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSK----GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             EEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            99999999999999997653     588899999999999999999987    999999999999999999999999999


Q ss_pred             ccccCcc------ccccccCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHH
Q 036639          508 SLLLNPV------QAIARLGGYKAPEQAEVKR--LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       508 a~~~~~~------~~~~~~~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      ++.....      ....++..|+|||.+....  ++.++||||||+++||+++|+.||.....             ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------------~~~~  221 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------------IAAM  221 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------------HHHH
Confidence            9765431      1234566799999987654  88999999999999999999999853210             0011


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      . ...... ....+....     ..+....+.+++.+||..+|++|||++||+++
T Consensus       222 ~-~~~~~~-~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         222 F-KLGNKR-SAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             H-Hhhccc-cCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            0 000000 000011000     01112355667779999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.7e-35  Score=302.28  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=194.7

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||++++
T Consensus        22 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  101 (293)
T cd06647          22 TRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGG  101 (293)
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCC
Confidence            4457899999999999984 468899999987655445677899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.+++...      .+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||++.......  
T Consensus       102 ~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~----gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647         102 SLTDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             cHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            999998754      378899999999999999999988    99999999999999999999999999887654322  


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                        ...++..|+|||.+....++.++||||||+++||+++|+.||............              ....  ..  
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--------------~~~~--~~--  233 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNG--TP--  233 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--------------hcCC--CC--
Confidence              234566799999998888999999999999999999999999654221110000              0000  00  


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           ...........+.+++.+||..+|++||++.+++.|
T Consensus       234 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 -----ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 000001112235567779999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-35  Score=297.73  Aligned_cols=245  Identities=22%  Similarity=0.373  Sum_probs=193.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC------cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN------PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      ..+.||+|++|.||++.. .+++.||+|++....      ....+.+.+|++++++++|+||+++++++.+.+..++|+|
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e   83 (268)
T cd06630           4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE   83 (268)
T ss_pred             ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence            457799999999999994 678999999987432      1134678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEeccccccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLL  511 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~  511 (670)
                      |+++++|.+++....     ++++..+..++.|++.||+|||+.    +++|+||||+||+++.++ .+||+|||.+...
T Consensus        84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~----~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          84 WMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHEN----QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             ccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999997543     588999999999999999999998    999999999999998776 5999999998776


Q ss_pred             Cccc--------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          512 NPVQ--------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       512 ~~~~--------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ....        ...++..|+|||.+.+..++.++||||+|+++|||++|+.||......           .........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~  223 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----------NHLALIFKI  223 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----------chHHHHHHH
Confidence            4321        224566799999998888999999999999999999999998643110           111111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ........          ........+.+++.+|+..+|++|||+.|++++
T Consensus       224 ~~~~~~~~----------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         224 ASATTAPS----------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             hccCCCCC----------CchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            10000000          011122346667789999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-34  Score=301.47  Aligned_cols=246  Identities=18%  Similarity=0.235  Sum_probs=190.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||++... +++.||+|.+.....   ...+.+.+|+++++.++||||+++++.+..+++.++||||++
T Consensus         5 ~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (305)
T cd05609           5 TIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVE   84 (305)
T ss_pred             EeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            3467999999999999954 578999999875432   234577889999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +++|.+++....     .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||+++....  
T Consensus        85 g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          85 GGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999997543     588999999999999999999987    999999999999999999999999999864210  


Q ss_pred             -----------------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccch
Q 036639          514 -----------------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       514 -----------------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                                       .....++..|+|||++....++.++|||||||++|||++|+.||.+..              .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------------~  221 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------------P  221 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------H
Confidence                             011234567999999988889999999999999999999999986431              1


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      ...............    .  ....   ....+.+++.+||+.+|++||++.++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~~~----~--~~~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         222 EELFGQVISDDIEWP----E--GDEA---LPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHHHHHhcccCCC----C--cccc---CCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            111111111110000    0  0001   12235667779999999999996655555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.7e-35  Score=299.41  Aligned_cols=245  Identities=23%  Similarity=0.357  Sum_probs=189.6

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEe------CCeeEE
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYA------KEEKLL  429 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~------~~~~~l  429 (670)
                      +.+.+.||+|+||.||+|.. .+++.||+|.+..... ...++..|+.++.++ +|+||+++++++..      ....++
T Consensus        18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i   96 (282)
T cd06636          18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL   96 (282)
T ss_pred             hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence            34557899999999999995 5689999999865432 446788899999988 79999999999853      457799


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      +|||+++|+|.+++.....   ..+++..+..++.|++.||+|||+.    +|+|+||||+||++++++.++|+|||++.
T Consensus        97 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~----~ivH~dl~~~nili~~~~~~~l~dfg~~~  169 (282)
T cd06636          97 VMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAH----KVIHRDIKGQNVLLTENAEVKLVDFGVSA  169 (282)
T ss_pred             EEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence            9999999999999975432   2477888999999999999999998    99999999999999999999999999987


Q ss_pred             ccCc----cccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          510 LLNP----VQAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       510 ~~~~----~~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ....    .....++..|+|||.+.     ...++.++|||||||++|||++|+.||....+....              
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~--------------  235 (282)
T cd06636         170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL--------------  235 (282)
T ss_pred             hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh--------------
Confidence            6532    22345677899999875     346888999999999999999999999643211000              


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .. .........         ........+.+++.+||+.||.+|||+.|++++
T Consensus       236 ~~-~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         236 FL-IPRNPPPKL---------KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             hh-HhhCCCCCC---------cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            00 000000000         001122356678889999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-34  Score=297.24  Aligned_cols=241  Identities=22%  Similarity=0.370  Sum_probs=194.0

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|++|.||++.. .+++.|++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            36899999999999995 57899999998765544566788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~  515 (670)
                      .+++...      .+++..+..++.|++.||+|||+.    +++||||+|+||+++.++.++|+|||.+......    .
T Consensus       104 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648         104 TDIVTHT------RMNEEQIATVCLAVLKALSFLHAQ----GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             HHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            9998763      378899999999999999999998    9999999999999999999999999988754332    2


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||....+              .......... ....    
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------------~~~~~~~~~~-~~~~----  234 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------------LQAMKRIRDN-LPPK----  234 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------------HHHHHHHHhc-CCCC----
Confidence            23466789999999888899999999999999999999999864311              1111111111 0000    


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ...   .......+.+++.+||+.+|++|||+.|++++
T Consensus       235 -~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         235 -LKN---LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -Ccc---cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence             000   00112346677889999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.5e-35  Score=294.63  Aligned_cols=242  Identities=27%  Similarity=0.401  Sum_probs=192.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-----cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      ..+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|++++++++|+||+++++++.+....++++||
T Consensus         4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (258)
T cd06632           4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL   83 (258)
T ss_pred             ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence            3467999999999999965 78999999986433     22446788999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++....     .+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        84 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          84 VPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDR----NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999997543     478999999999999999999988    999999999999999999999999999876543


Q ss_pred             c---ccccccCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          514 V---QAIARLGGYKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       514 ~---~~~~~~~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      .   ....++..|+|||.+.... ++.++||||||+++|+|++|+.||.....              .............
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------------~~~~~~~~~~~~~  220 (258)
T cd06632         155 FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------------VAAVFKIGRSKEL  220 (258)
T ss_pred             cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------------HHHHHHHHhcccC
Confidence            2   2344666799999987666 89999999999999999999999864310              0111110100000


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .. +.      ...   ...+.+++.+||+.+|++||++.+++++
T Consensus       221 ~~-~~------~~~---~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         221 PP-IP------DHL---SDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CC-cC------CCc---CHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            00 00      011   1334567779999999999999999874

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.6e-35  Score=301.45  Aligned_cols=245  Identities=28%  Similarity=0.422  Sum_probs=188.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC-----CeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK-----EEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~-----~~~~lv~e~  433 (670)
                      .+.||+|+||.||++.. .+++.||+|++..... ...++.+|+.+++++ +||||+++++++...     +..++||||
T Consensus        27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey  105 (291)
T cd06639          27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLEL  105 (291)
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence            35799999999999995 5689999999875432 356778899999998 899999999998754     357999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.++++.... ....+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||++.....
T Consensus       106 ~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~----~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~  180 (291)
T cd06639         106 CNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNN----RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS  180 (291)
T ss_pred             CCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence            999999998864321 122588999999999999999999987    999999999999999999999999999886543


Q ss_pred             c----ccccccCcccCccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          514 V----QAIARLGGYKAPEQAEVK-----RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       514 ~----~~~~~~~~y~aPE~~~~~-----~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      .    ....++..|+|||.+...     .++.++|||||||++|||++|+.||....+.              ..+....
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--------------~~~~~~~  246 (291)
T cd06639         181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--------------KTLFKIP  246 (291)
T ss_pred             ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--------------HHHHHHh
Confidence            2    223456679999987543     3689999999999999999999998643110              0011111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .. ......        ...+....+.+++.+||+.+|++||++.|++++
T Consensus       247 ~~-~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         247 RN-PPPTLL--------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             cC-CCCCCC--------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            00 000000        011122356778889999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.4e-35  Score=293.63  Aligned_cols=244  Identities=23%  Similarity=0.401  Sum_probs=194.0

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ...+.||+|+||.||++.. .+++.+|+|.+....  ....+.+.+|++++++++||||+++++.+...+..++||||++
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08220           3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP   82 (256)
T ss_pred             eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence            3456799999999999995 478999999987542  2345678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-CcEEEEecccccccCcc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLNPV  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~  514 (670)
                      +++|.+++....   ...+++..+..++.++++||+|||+.    +++|+||||+||+++++ +.+||+|||.+......
T Consensus        83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          83 GGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTK----LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999997643   22478999999999999999999998    99999999999999865 46899999999876532


Q ss_pred             c---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 Q---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      .   ...++..|+|||.+.+..++.++||||||+++|+|++|+.||....              .............. .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------------~~~~~~~~~~~~~~-~  220 (256)
T cd08220         156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------------LPALVLKIMSGTFA-P  220 (256)
T ss_pred             ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------------hHHHHHHHHhcCCC-C
Confidence            2   2445677999999998889999999999999999999999986431              11111111111100 0


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..          ......+.+++.+||+.+|++|||+.|++++
T Consensus       221 ~~----------~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         221 IS----------DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CC----------CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            00          0112345567779999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-35  Score=305.48  Aligned_cols=191  Identities=26%  Similarity=0.350  Sum_probs=162.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++.+....++|+||++ 
T Consensus         4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   82 (284)
T cd07839           4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-   82 (284)
T ss_pred             eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-
Confidence            3467999999999999964 68999999987432  2234567789999999999999999999999999999999996 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++....    ..+++..+..++.||++||.|||+.    +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        83 ~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          83 QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSH----NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            58888876432    2489999999999999999999998    9999999999999999999999999999865432  


Q ss_pred             --ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          515 --QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                        ....++..|+|||.+.+. .++.++|||||||++|||+||+.|+..
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence              123446679999988664 478999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-34  Score=294.62  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=197.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ...+.||+|++|.||++... +++.||+|.+.... ....+++.+|++++++++||||+++++++......++++||+++
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            45678999999999999965 68999999987653 33456788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ-EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      ++|.+++....    ..++......++.|++.||+|||+ .    +++|+||||+||++++++.+||+|||.+...... 
T Consensus        84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~----~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          84 GSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKH----KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCC----CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999997653    258889999999999999999998 6    9999999999999999999999999998766432 


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....         ........+........ ....
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~  225 (265)
T cd06605         156 AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND---------PPDGIFELLQYIVNEPP-PRLP  225 (265)
T ss_pred             hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc---------ccccHHHHHHHHhcCCC-CCCC
Confidence             124566779999999988999999999999999999999999864321         01111122222111110 0000


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                               .......+.+++.+||..+|++|||+.|++++
T Consensus       226 ---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 ---------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             ---------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                     00022345667779999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=296.05  Aligned_cols=243  Identities=23%  Similarity=0.377  Sum_probs=192.7

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccC---CCCeeeEEEEEEeCCeeEEEEe
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLK---HPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      |...+.||+|+||.||+|.. .+++.||+|.++... ....+++.+|++++++++   |||++++++++.+....++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            34567899999999999995 578999999987542 334567889999999986   9999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.++++..      .+++.....++.|++.||.|||+.    +|+|+||+|+||+++.++.++|+|||++....
T Consensus        83 ~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          83 YAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKV----GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             cCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999998653      488999999999999999999988    99999999999999999999999999988764


Q ss_pred             ccc----cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          513 PVQ----AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       513 ~~~----~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ...    ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.......              .... ....
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--------------~~~~-~~~~  217 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR--------------AMML-IPKS  217 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh--------------hhhc-cccC
Confidence            322    2345667999998865 447899999999999999999999996532111              0000 0000


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...     .+..    ......+.+++.+||+.||++||++.|++++
T Consensus       218 ~~~-----~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 KPP-----RLED----NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCC-----CCCc----ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            000     0000    0022346677889999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=302.95  Aligned_cols=244  Identities=25%  Similarity=0.323  Sum_probs=192.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc---hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC---ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ..+.||+|+||.||+|... +++.||+|.+......   ..+.+..|+++++.++|+||+++++++.+....++||||+.
T Consensus         5 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   84 (316)
T cd05574           5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCP   84 (316)
T ss_pred             EeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecC
Confidence            3467999999999999965 5899999999765322   44678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++....   ...+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          85 GGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLL----GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             CCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            999999987542   12588999999999999999999988    99999999999999999999999999987543211


Q ss_pred             ---------------------------------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 036639          516 ---------------------------------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP  562 (670)
Q Consensus       516 ---------------------------------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~  562 (670)
                                                       ...++..|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                             12356679999999988899999999999999999999999965421


Q ss_pred             CCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 036639          563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT----MAEVAKM  634 (670)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~~  634 (670)
                      .              ............          ..........+.+++.+||..||++|||    ++|++++
T Consensus       238 ~--------------~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         238 D--------------ETFSNILKKEVT----------FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             H--------------HHHHHHhcCCcc----------CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            1              111111111100          0001112235666777999999999999    6666664

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=310.60  Aligned_cols=245  Identities=23%  Similarity=0.356  Sum_probs=198.7

Q ss_pred             HHHhHcCCCCceEEEEEEEcC-CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+...||.|+||.||+|..++ +-..|-|++........+++.-|++||+.++||+||++++.|+..+..+++.|||.||
T Consensus        35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG  114 (1187)
T KOG0579|consen   35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG  114 (1187)
T ss_pred             HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence            455679999999999999654 5556788888777677889999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC----c
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN----P  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~----~  513 (670)
                      .+..++-+-.    ..+...++.-+++|++.||.|||++    +|||||||+.|||++-+|.++|+|||.+....    .
T Consensus       115 AVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~----~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qk  186 (1187)
T KOG0579|consen  115 AVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQ----NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQK  186 (1187)
T ss_pred             hHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhc----chhhhhccccceEEEecCcEeeecccccccchhHHhh
Confidence            9998876543    2589999999999999999999998    99999999999999999999999999986553    3


Q ss_pred             cccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          514 VQAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      .+.+.||+.|||||+..     ..+|+.++||||||++|.||..+.+|-...++.+..+              .+.+.+.
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll--------------KiaKSeP  252 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--------------KIAKSEP  252 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH--------------HHhhcCC
Confidence            56788999999999864     5689999999999999999999999975543332211              1111110


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                            +.+..   .......+-+++.+||..||..||++.++++|
T Consensus       253 ------PTLlq---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 ------PTLLQ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ------CcccC---cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                  11111   12223345566679999999999999999874

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.9e-34  Score=293.92  Aligned_cols=242  Identities=27%  Similarity=0.408  Sum_probs=194.0

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++.+++||||+++++++...+..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            34557899999999999985 468899999986443 2344678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++...      .+++.....++.|++.|+.|||+.    +++|+||||+||+++.++.++|+|||++.......
T Consensus        86 ~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          86 GGSALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccC----CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999998643      478999999999999999999987    99999999999999999999999999987654321


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ...++..|+|||.+.+..++.++|||||||++|||++|..||......              ..... ...... .
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------------~~~~~-~~~~~~-~  219 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------------KVLFL-IPKNNP-P  219 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------------HHHHH-HhcCCC-C
Confidence                234566799999998888999999999999999999999998543110              11111 111000 0


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .++         ......+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~---------~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         220 TLE---------GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCC---------cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            000         1112345567779999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-34  Score=294.56  Aligned_cols=245  Identities=24%  Similarity=0.349  Sum_probs=193.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~  434 (670)
                      +.+.||.|+||.||++.. .+++.||+|.+....  ....+.+..|++++++++|+||+++++++..  ....+++|||+
T Consensus         4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~   83 (265)
T cd08217           4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYC   83 (265)
T ss_pred             eeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhc
Confidence            446799999999999984 578999999987532  3345678889999999999999999998764  34678999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----HhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH-----QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ++++|.+++..... ....+++..++.++.|++.||+|||     +.    +++|+||||+||+++.++.+||+|||++.
T Consensus        84 ~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~----~i~h~dl~p~nili~~~~~~kl~d~g~~~  158 (265)
T cd08217          84 EGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGN----TVLHRDLKPANIFLDANNNVKLGDFGLAK  158 (265)
T ss_pred             cCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccC----cceecCCCHHHEEEecCCCEEEecccccc
Confidence            99999999975421 1236899999999999999999999     55    99999999999999999999999999998


Q ss_pred             ccCccc----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          510 LLNPVQ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       510 ~~~~~~----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ......    ...++..|+|||.+....++.++||||||+++|+|++|+.||....              ....... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------------~~~~~~~-~~  223 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------------QLQLASK-IK  223 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------------HHHHHHH-Hh
Confidence            765432    2456777999999988889999999999999999999999986431              0111111 11


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...... +         .......+.+++.+|++.+|++|||++||+++
T Consensus       224 ~~~~~~-~---------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 EGKFRR-I---------PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             cCCCCC-C---------ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            110000 0         01122356677889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.3e-35  Score=295.87  Aligned_cols=245  Identities=29%  Similarity=0.420  Sum_probs=193.5

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc--hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC--ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ...+.||+|+||.||+|... +++.||+|.++.....  ..+.+..|++++++++|+||+++++++.+.+..++|+||++
T Consensus         3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (264)
T cd06626           3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS   82 (264)
T ss_pred             eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence            44578999999999999954 7899999999765442  56789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++....     .+++..+..++.+++.||+|||+.    +++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          83 GGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSH----GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999997643     478889999999999999999998    99999999999999999999999999988764321


Q ss_pred             --------cccccCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          516 --------AIARLGGYKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       516 --------~~~~~~~y~aPE~~~~~~---~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                              ...++..|+|||++.+..   ++.++||||||+++||+++|+.||.....          ....   .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----------~~~~---~~~~~  220 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----------EFQI---MFHVG  220 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----------hHHH---HHHHh
Confidence                    134556799999998766   88999999999999999999999964310          0000   00000


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..  .    .+.+....   .....+.+++.+||+.+|++|||+.|++.+
T Consensus       221 ~~--~----~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         221 AG--H----KPPIPDSL---QLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             cC--C----CCCCCccc---ccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            00  0    00000001   112334567779999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3e-35  Score=302.82  Aligned_cols=192  Identities=25%  Similarity=0.395  Sum_probs=166.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||.||+|... +++.||+|+++..  .....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~   84 (288)
T cd07833           5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVER   84 (288)
T ss_pred             EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCC
Confidence            4567999999999999965 6889999998753  233457889999999999999999999999999999999999998


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      +.+..+.....     .+++..+..++.|++.||+|||+.    +++|+||+|+||++++++.+||+|||++....... 
T Consensus        85 ~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          85 TLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSH----NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            77776665432     478999999999999999999998    99999999999999999999999999988765432 


Q ss_pred             ----cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          516 ----AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                          ...++..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                23456679999999877 7899999999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2e-34  Score=297.36  Aligned_cols=241  Identities=23%  Similarity=0.389  Sum_probs=193.0

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ...||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            36899999999999986 57899999998755544567789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~  515 (670)
                      .+++...      .+++.....++.|++.||+|||+.    +++||||+|+||++++++.++|+|||++......    .
T Consensus       105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~----givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~  174 (292)
T cd06657         105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  174 (292)
T ss_pred             HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence            9987543      378899999999999999999998    9999999999999999999999999988765332    2


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||.....              ...+.. ......     .
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------------~~~~~~-~~~~~~-----~  234 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------------LKAMKM-IRDNLP-----P  234 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHH-HHhhCC-----c
Confidence            24466789999999888899999999999999999999999864311              011111 111100     0


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ........   ...+.+++.+||+.+|.+||++.|++++
T Consensus       235 ~~~~~~~~---~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         235 KLKNLHKV---SPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             ccCCcccC---CHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            00000111   1234556779999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-34  Score=296.59  Aligned_cols=244  Identities=26%  Similarity=0.434  Sum_probs=196.1

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      ...+.||+|++|.||+|..+ +++.|++|++..... ..+.+.+|++.++.++|+||+++++++......++|+||++++
T Consensus        22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~  100 (286)
T cd06614          22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG  100 (286)
T ss_pred             hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence            34578999999999999966 689999999986544 5677889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++....    ..+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.++|+|||++......   
T Consensus       101 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~----gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  172 (286)
T cd06614         101 SLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQ----NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK  172 (286)
T ss_pred             cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence            9999998653    2589999999999999999999987    9999999999999999999999999988765432   


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....++..|+|||++.+..++.++|||||||++|||++|+.||....+.              .......... .... 
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------------~~~~~~~~~~-~~~~-  236 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------------RALFLITTKG-IPPL-  236 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------------HHHHHHHhcC-CCCC-
Confidence             2234566799999998888999999999999999999999998643110              1111111110 0000 


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .........+.+++.+||+.+|.+|||+.+++++
T Consensus       237 -------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         237 -------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                   0001112345567779999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=9.6e-35  Score=300.76  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=191.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc-----hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC-----ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.||+|+||.||+|... +|+.||||+++.....     ....+..|++++++++|+||+++++++.+.+..++||||
T Consensus         4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   83 (298)
T cd07841           4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF   83 (298)
T ss_pred             eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcc
Confidence            3467999999999999954 6899999999754322     345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      + +++|.+++....    ..+++..+..++.|+++||+|||+.    +|+|+||||+||+++.++.+||+|||+++....
T Consensus        84 ~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          84 M-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSN----WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             c-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9 999999997543    2589999999999999999999998    999999999999999999999999999987654


Q ss_pred             cc----cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH---hh
Q 036639          514 VQ----AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV---VK  585 (670)
Q Consensus       514 ~~----~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~  585 (670)
                      ..    ...++..|+|||.+.+ ..++.++|||||||++|||++|.+||....+..          .+.+.....   ..
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~----------~~~~~~~~~~~~~~  224 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID----------QLGKIFEALGTPTE  224 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH----------HHHHHHHHcCCCch
Confidence            32    1234556999998854 457899999999999999999987775432110          000000000   00


Q ss_pred             hccc-----cccccHhhhc----ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          586 EEWT-----AEVFDQELLR----YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       586 ~~~~-----~~~~d~~~~~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..+.     ..........    ..........+.+++.+||+.||++|||++||+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         225 ENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000     0000000000    00001123456778889999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=302.08  Aligned_cols=197  Identities=26%  Similarity=0.401  Sum_probs=164.5

Q ss_pred             HHhHcCCCCceEEEEEEEc---CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD---DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  431 (670)
                      +.+.||+|+||.||+|...   +++.||+|.+....   ....+.+.+|+.++.+++||||+++++++.+.  ...++||
T Consensus         4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~   83 (316)
T cd07842           4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF   83 (316)
T ss_pred             EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEE
Confidence            4467999999999999964   47999999998632   33446778899999999999999999999988  7899999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC----CCcEEEEeccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK----NGVACISDFGL  507 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFG~  507 (670)
                      ||+++ +|.+++..........++...+..++.|++.||+|||+.    +|+||||||+||+++.    ++.+||+|||+
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          84 DYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN----WVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             eCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC----CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99964 777777544322233688899999999999999999988    9999999999999999    89999999999


Q ss_pred             ccccCcc-------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 036639          508 SLLLNPV-------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPS  561 (670)
Q Consensus       508 a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~  561 (670)
                      +......       ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            8875432       12345667999998765 457899999999999999999999997653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-35  Score=301.74  Aligned_cols=192  Identities=27%  Similarity=0.382  Sum_probs=162.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      ..+.||+|++|.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++.+.+..++||||+++ 
T Consensus         9 ~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   87 (291)
T cd07844           9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-   87 (291)
T ss_pred             EEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-
Confidence            3467999999999999965 689999999875322 2234567899999999999999999999999999999999974 


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++.....    .+++.....++.|+++||.|||+.    +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        88 ~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  159 (291)
T cd07844          88 DLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQR----RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT  159 (291)
T ss_pred             CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence            99998875431    578999999999999999999988    9999999999999999999999999998764321   


Q ss_pred             -ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 -QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                       ....++..|+|||++.+ ..++.++||||+|+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             11234567999998865 45889999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2e-34  Score=292.64  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=198.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|++|.||+|... +++.||||++..... ...+.+.+|++.+.+++|+||+++++++...+..++||||++++
T Consensus         5 ~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06623           5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG   84 (264)
T ss_pred             eeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCC
Confidence            4578999999999999965 599999999986543 45678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ-EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      +|.+++....     .+++..+..++.|+++||+|||+ .    +++||||+|+||+++.++.++|+|||.+....... 
T Consensus        85 ~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~----~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          85 SLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccC----CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            9999997643     58999999999999999999999 7    99999999999999999999999999998765432 


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ...++..|+|||.+....++.++||||||+++|||+||+.||.....           ............... .. 
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----------~~~~~~~~~~~~~~~-~~-  222 (264)
T cd06623         156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----------PSFFELMQAICDGPP-PS-  222 (264)
T ss_pred             cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----------cCHHHHHHHHhcCCC-CC-
Confidence               23456679999999988899999999999999999999999865421           011111111111100 00 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .+      ..  .....+.+++.+||..+|++||++.|++++
T Consensus       223 ~~------~~--~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LP------AE--EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CC------cc--cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00      00  022356667779999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=296.07  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=190.9

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCC------eeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKE------EKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~------~~~lv  430 (670)
                      .+.+.||+|++|.||+|... +++.|++|++..... ..+++.+|+++++++ +|+||+++++++....      ..++|
T Consensus         9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv   87 (275)
T cd06608           9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLV   87 (275)
T ss_pred             eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEE
Confidence            45678999999999999964 678999999876543 457789999999999 7999999999997654      47999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++++|.+++..... ....+++..+..++.|++.||.|||+.    +++|+||+|+||++++++.+||+|||++..
T Consensus        88 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~----~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          88 MELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHEN----KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            999999999999865321 123588999999999999999999988    999999999999999999999999999876


Q ss_pred             cCcc----ccccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          511 LNPV----QAIARLGGYKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       511 ~~~~----~~~~~~~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      ....    ....++..|+|||++..     ..++.++|||||||++|||+||+.||......              ....
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------------~~~~  228 (275)
T cd06608         163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------------RALF  228 (275)
T ss_pred             cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------------HHHH
Confidence            5432    23345677999998753     34788999999999999999999999643110              0001


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..... .....        .........+.+++.+||..||++|||+.|++++
T Consensus       229 ~~~~~-~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         229 KIPRN-PPPTL--------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             Hhhcc-CCCCC--------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11110 00000        0111122356677789999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.5e-35  Score=302.89  Aligned_cols=240  Identities=21%  Similarity=0.274  Sum_probs=192.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||++... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   84 (290)
T cd05580           5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVP   84 (290)
T ss_pred             EEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCC
Confidence            4467999999999999954 68999999987532   2235678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     .+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.+||+|||++...... 
T Consensus        85 ~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~----~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  155 (290)
T cd05580          85 GGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSL----DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT  155 (290)
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEeeCCCccccCCCC
Confidence            999999997653     588999999999999999999997    9999999999999999999999999999876543 


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....              ............      
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------~~~~~~~~~~~~------  215 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------------IQIYEKILEGKV------  215 (290)
T ss_pred             CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHHHhcCCc------
Confidence            234567789999999888889999999999999999999999864310              011111111100      


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                         .......   ..+.+++.+||..||++|+     +++|++++
T Consensus       216 ---~~~~~~~---~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         216 ---RFPSFFS---PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ---cCCccCC---HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence               0001112   2345567799999999999     77777765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-34  Score=295.00  Aligned_cols=255  Identities=24%  Similarity=0.323  Sum_probs=194.0

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~~  436 (670)
                      .+.||.|++|.||++.. .+++.||+|.+..... ....++.+|++++++++||||++++++|.+.  ...++||||+++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   85 (287)
T cd06621           6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG   85 (287)
T ss_pred             EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence            35799999999999996 4689999999875432 3457789999999999999999999998654  468999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++..... ....+++.....++.|++.||+|||+.    +++|+||+|+||+++.++.++|+|||++......  
T Consensus        86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~----~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSR----KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            999998764321 123578899999999999999999998    9999999999999999999999999998765432  


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......      .....+...+....   .. .. ..
T Consensus       161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~---~~-~~-~~  229 (287)
T cd06621         161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP------PLGPIELLSYIVNM---PN-PE-LK  229 (287)
T ss_pred             ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC------CCChHHHHHHHhcC---Cc-hh-hc
Confidence            2334566799999999889999999999999999999999999754220      00111122221110   00 00 00


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...   .........+.+++.+||+.+|++|||+.|++++
T Consensus       230 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         230 DEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             cCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            000   0001112356678889999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.3e-35  Score=301.17  Aligned_cols=193  Identities=26%  Similarity=0.392  Sum_probs=163.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.||.|++|.||+|... +|+.||||+++...  ....+.+.+|++++++++||||+++++++.+.+..++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            3467999999999999954 68999999987432  2234678899999999999999999999999999999999995 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++....   ...+++..+..++.|++.||+|||+.    +++||||+|+||+++.++.+||+|||++....... 
T Consensus        83 ~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~----~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          83 QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            68999887543   12588999999999999999999987    99999999999999999999999999987654321 


Q ss_pred             ---cccccCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          516 ---AIARLGGYKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                         ...++..|+|||.+.+.. ++.++||||||+++|||+||+.||...
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence               223456799999886544 688999999999999999999999653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.6e-34  Score=293.49  Aligned_cols=240  Identities=22%  Similarity=0.281  Sum_probs=182.0

Q ss_pred             HcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHH---hccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          363 MLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVI---GKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l---~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .||+|+||.||++.. .+++.||+|.+.....   .....+.+|..++   ...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            389999999999995 4689999999865321   1122333444333   33479999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     .+++.....++.|++.||+|||+.    +|+||||||+||++++++.++|+|||++...... 
T Consensus        81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~  151 (279)
T cd05633          81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (279)
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence            999999987543     589999999999999999999998    9999999999999999999999999998765432 


Q ss_pred             -ccccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 -QAIARLGGYKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       ....++..|+|||.+. +..++.++|||||||++|||++|+.||......           .. ..+...... .... 
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----------~~-~~~~~~~~~-~~~~-  217 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----------DK-HEIDRMTLT-VNVE-  217 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----------CH-HHHHHHhhc-CCcC-
Confidence             2345677899999986 456899999999999999999999999653111           00 111111000 0000 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      +      ....   ...+.+++.+||..||++||     |++|+++|
T Consensus       218 ~------~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 L------PDSF---SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             C------cccc---CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            0      0111   22455667799999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2e-34  Score=296.86  Aligned_cols=251  Identities=25%  Similarity=0.336  Sum_probs=188.1

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+. 
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-   86 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-   86 (288)
T ss_pred             HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence            457899999999999995 468999999987543 234567889999999996 9999999999999999999999985 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      +++.++...........+++.....++.+++.||+|||+.   .+++||||||+||+++.++.+||+|||+++.....  
T Consensus        87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  163 (288)
T cd06616          87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE---LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA  163 (288)
T ss_pred             CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc---CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence            4665543211000123589999999999999999999975   38999999999999999999999999999765432  


Q ss_pred             -ccccccCcccCccccccC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 -QAIARLGGYKAPEQAEVK---RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                       ....++..|+|||++...   .++.++|||||||++|||++|+.||....             .....+......... 
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------------~~~~~~~~~~~~~~~-  229 (288)
T cd06616         164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------------SVFDQLTQVVKGDPP-  229 (288)
T ss_pred             cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------------hHHHHHhhhcCCCCC-
Confidence             233466779999998765   68999999999999999999999986431             000111111110000 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           .+.. .........+.+++.+||+.+|++|||++||+++
T Consensus       230 -----~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 -----ILSN-SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             -----cCCC-cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0000 0001122346677779999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=4.9e-34  Score=287.10  Aligned_cols=244  Identities=28%  Similarity=0.419  Sum_probs=198.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ..+.||+|++|.||++... +++.|++|++........+.+.+|++++++++|+||+++++++......++++||+++++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            3467999999999999965 789999999987655566889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---Q  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---~  515 (670)
                      |.+++....    ..+++..+..++.+++.||+|||..    +++||||+|+||++++++.++|+|||.+......   .
T Consensus        84 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~----~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  155 (253)
T cd05122          84 LKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSN----GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN  155 (253)
T ss_pred             HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcC----CEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence            999987652    2589999999999999999999997    9999999999999999999999999999877654   3


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||.+....++.++||||||+++|+|++|+.||...+.              ......... ........ 
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------------~~~~~~~~~-~~~~~~~~-  219 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------------MKALFKIAT-NGPPGLRN-  219 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------------HHHHHHHHh-cCCCCcCc-
Confidence            45566779999999888899999999999999999999999864311              011111110 00000000 


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .......+.+++.+||..||++|||+.|++++
T Consensus       220 -------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         220 -------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   00012346667779999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.3e-34  Score=290.94  Aligned_cols=235  Identities=22%  Similarity=0.286  Sum_probs=183.8

Q ss_pred             cCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCCChHH
Q 036639          364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS  441 (670)
Q Consensus       364 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  441 (670)
                      ||+|+||.||++.. .+++.+|+|.+.......   .  |+.....+ +||||+++++++...+..++||||+++++|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            69999999999995 468899999987542211   1  22222222 69999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccCcccccccc
Q 036639          442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPVQAIARL  520 (670)
Q Consensus       442 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~  520 (670)
                      ++....     .+++..+..++.|+++||.|||+.    +++||||||+||+++.++ .++|+|||+++.........++
T Consensus        99 ~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~  169 (267)
T PHA03390         99 LLKKEG-----KLSEAEVKKIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGT  169 (267)
T ss_pred             HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCC
Confidence            997653     589999999999999999999998    999999999999999998 9999999999887766666778


Q ss_pred             CcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcc
Q 036639          521 GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY  600 (670)
Q Consensus       521 ~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  600 (670)
                      ..|+|||++.+..++.++||||||+++|||++|+.||......         ......+.... ...         .   
T Consensus       170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---------~~~~~~~~~~~-~~~---------~---  227 (267)
T PHA03390        170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---------ELDLESLLKRQ-QKK---------L---  227 (267)
T ss_pred             CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---------hhhHHHHHHhh-ccc---------C---
Confidence            8899999999888999999999999999999999999743211         11112221111 000         0   


Q ss_pred             cchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 036639          601 KNIEEELVSMLHVGLACVVSQPEKRPT-MAEVAKM  634 (670)
Q Consensus       601 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~  634 (670)
                      .........+.+++.+||+.+|++||+ ++|++++
T Consensus       228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            000112234556777999999999996 6998864

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-34  Score=296.76  Aligned_cols=265  Identities=18%  Similarity=0.243  Sum_probs=187.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeC--CeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAK--EEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||+|.. .+++.||+|+++... ........+|+.++.++. |+||+++++++.+.  +..++|+||+
T Consensus         3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~   82 (282)
T cd07831           3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM   82 (282)
T ss_pred             eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence            346799999999999995 468999999987542 222334457888888885 99999999999987  8899999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      + ++|.+++....    ..+++..+..++.|++.||+|||+.    +++||||||+||+++. +.+||+|||+++.....
T Consensus        83 ~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          83 D-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRN----GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             C-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            6 58888876532    2589999999999999999999998    9999999999999999 99999999999876432


Q ss_pred             c---cccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchhHHHHHHhhhccc
Q 036639          515 Q---AIARLGGYKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       515 ~---~~~~~~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  589 (670)
                      .   ...++..|+|||++. ...++.++|||||||++|||++|+.||...+........... ......+..........
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            2   234567799999764 455789999999999999999999999654221100000000 00001110000000000


Q ss_pred             cccccHhhhc--ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLR--YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...+......  ..........+.+++.+||..+|++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0000000000  00001223567778889999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=280.02  Aligned_cols=274  Identities=20%  Similarity=0.298  Sum_probs=207.2

Q ss_pred             cHHHHHHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEE
Q 036639          352 ELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       352 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~l  429 (670)
                      .++|+..-+.+.||+|+|+.|--+. ..+|..||||++.+.....+..+-+|++++...+ |+||++++++|+++...||
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            4677777789999999999999998 7899999999999887778889999999998884 9999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEecc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFG  506 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG  506 (670)
                      |||.|.||+|...|++.+     .+.+.+..++..+|+.||.|||.+    ||.|||+||+|||...-.   -+||+||.
T Consensus       154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~k----gIAHRDlKPENiLC~~pn~vsPvKiCDfD  224 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTK----GIAHRDLKPENILCESPNKVSPVKICDFD  224 (463)
T ss_pred             EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhc----CcccccCCccceeecCCCCcCceeeeccc
Confidence            999999999999998765     588999999999999999999998    999999999999996654   48999998


Q ss_pred             cccccCc--cc---------cccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccc
Q 036639          507 LSLLLNP--VQ---------AIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       507 ~a~~~~~--~~---------~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~  570 (670)
                      +..-+..  .-         ...|+..|||||+..     ...|+.++|.||+|||+|-|++|.+||.+.=..+-.-...
T Consensus       225 LgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrG  304 (463)
T KOG0607|consen  225 LGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRG  304 (463)
T ss_pred             cccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCC
Confidence            8754321  11         123344599999763     3458999999999999999999999998753333222222


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHhhhcc
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK--MIEDIRVE  641 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~i~~~  641 (670)
                      +....-.+.+-..+.+..    +.-.-..+..+..+..+++   ...+..|+.+|.++.++++  +.+.+..+
T Consensus       305 e~Cr~CQ~~LFesIQEGk----YeFPdkdWahIS~eakdli---snLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  305 EVCRVCQNKLFESIQEGK----YEFPDKDWAHISSEAKDLI---SNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             CccHHHHHHHHHHHhccC----CcCChhhhHHhhHHHHHHH---HHHHhccHHhhhhhhhccCCccccccchh
Confidence            222222222222222211    1111112333444444444   4677799999999999998  34444443

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=293.93  Aligned_cols=242  Identities=23%  Similarity=0.293  Sum_probs=185.3

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcch---HHHHHHHHHHH-hccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCA---RKEFEQYMDVI-GKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~e~~~l-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||.||+|.. .+|+.||||+++......   ...+..|..++ ...+|+||+++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999999999995 468999999997543211   22334444443 445899999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA  516 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  516 (670)
                      ++|.+++....     .+++..+..++.|++.||.|||+.    +++||||+|+||++++++.+||+|||+++.......
T Consensus        82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  152 (260)
T cd05611          82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQR----GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK  152 (260)
T ss_pred             CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence            99999997543     478899999999999999999998    999999999999999999999999999987655555


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      ..++..|+|||.+.+..++.++||||||+++|||+||..||.....              .............   +...
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------------~~~~~~~~~~~~~---~~~~  215 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------------DAVFDNILSRRIN---WPEE  215 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------------HHHHHHHHhcccC---CCCc
Confidence            5677889999999888889999999999999999999999964311              1111111111000   0000


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           ........+.+++.+||+.+|++||++.++.+.
T Consensus       216 -----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         216 -----VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             -----ccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence                 000112345667779999999999977544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.9e-34  Score=296.10  Aligned_cols=247  Identities=24%  Similarity=0.342  Sum_probs=185.8

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHH-HhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDV-IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||.||++... +|+.||+|+++.... ....++..|+.+ ++.++||||+++++++...+..+++|||++ 
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-   83 (283)
T cd06617           5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-   83 (283)
T ss_pred             EEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-
Confidence            3467999999999999964 699999999975432 233455556654 566689999999999999999999999996 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      |+|.+++...... ...+++..++.++.|++.||+|||++   .+++||||||+||+++.++.+||+|||++....... 
T Consensus        84 ~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          84 TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSK---LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhc---CCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            6888887653322 23689999999999999999999985   389999999999999999999999999998764322 


Q ss_pred             --cccccCcccCcccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          516 --AIARLGGYKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~----~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                        ...++..|+|||.+.+    ..++.++|||||||++|||++|+.||.....            .. ..+........ 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------------~~-~~~~~~~~~~~-  225 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------------PF-QQLKQVVEEPS-  225 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------------CH-HHHHHHHhcCC-
Confidence              2345677999998864    4568999999999999999999999853210            00 11111111100 


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....      ..   ....+.+++.+||..+|++||++.+++++
T Consensus       226 ~~~~~------~~---~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 PQLPA------EK---FSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CCCCc------cc---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000      01   11345667779999999999999999885

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.6e-34  Score=298.81  Aligned_cols=267  Identities=18%  Similarity=0.202  Sum_probs=190.8

Q ss_pred             HHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          358 RASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+++.+|.|+++.||++.. +++.||||+++..  .....+.+.+|+++++.++|+||+++++++.+.+..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            34556677777766666665 6899999999754  33355789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++.....   ..+++.....++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||.+...... 
T Consensus        83 ~~~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~----~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~  155 (314)
T cd08216          83 YGSCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSK----GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG  155 (314)
T ss_pred             CCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence            9999999986431   2478889999999999999999998    9999999999999999999999999988654321 


Q ss_pred             ----------ccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          515 ----------QAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       515 ----------~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                                ....++..|+|||++..  ..++.++|||||||++|||++|+.||..........+...  ...+.++..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~  233 (314)
T cd08216         156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLLDK  233 (314)
T ss_pred             ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcccccc
Confidence                      12234556999999865  3588999999999999999999999975422110000000  000000000


Q ss_pred             -Hhhh---cccc---ccccHhh---hcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          583 -VVKE---EWTA---EVFDQEL---LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       583 -~~~~---~~~~---~~~d~~~---~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ....   ....   ...+...   ...........++.+++.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             0000   0000   0000000   0000111122456778889999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=276.47  Aligned_cols=253  Identities=25%  Similarity=0.382  Sum_probs=192.7

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCe
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEE  426 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~  426 (670)
                      +.++.|+  .....||.|..|.||+++. .+|...|||.+.... ....+++...++++.+-+ .|.||+.+|||..+..
T Consensus        88 ~~dindl--~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d  165 (391)
T KOG0983|consen   88 QADINDL--ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD  165 (391)
T ss_pred             ccChHHh--hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence            3455665  3457799999999999995 468999999998653 334566777777776654 8999999999999999


Q ss_pred             eEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       427 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      .++.||.| ..-+..+++..+.    ++++...-++...+.+||.||.++   .+|+|||+||+|||+|+.|++|++|||
T Consensus       166 V~IcMelM-s~C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeK---H~viHRDvKPSNILlDe~GniKlCDFG  237 (391)
T KOG0983|consen  166 VFICMELM-STCAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGNIKLCDFG  237 (391)
T ss_pred             HHHHHHHH-HHHHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHh---cceeecccCccceEEccCCCEEeeccc
Confidence            99999998 4456666665442    588888889999999999999998   499999999999999999999999999


Q ss_pred             cccccCccc---cccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          507 LSLLLNPVQ---AIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       507 ~a~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ++-.+..+.   ...|.+.|||||.+.   ...|+.++|||||||+++||.||+.||.+....          .+   .+
T Consensus       238 IsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----------Fe---~l  304 (391)
T KOG0983|consen  238 ISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----------FE---VL  304 (391)
T ss_pred             ccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----------HH---HH
Confidence            998775543   345667799999985   346899999999999999999999999764111          01   11


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...+.++.      +.+.....   ....+.++...||+.|+.+||...++++|
T Consensus       305 tkvln~eP------P~L~~~~g---FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  305 TKVLNEEP------PLLPGHMG---FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHHHhcCC------CCCCcccC---cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            11111111      11111111   22345566679999999999999999886

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7.3e-34  Score=298.32  Aligned_cols=192  Identities=25%  Similarity=0.331  Sum_probs=160.4

Q ss_pred             hHcCCC--CceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKG--SLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G--~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..||+|  +||+||++.. .+|+.||+|++....  ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999995 479999999987543  22346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++.....   ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.++++||+.+......  
T Consensus        84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~----~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~  156 (328)
T cd08226          84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQN----GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ  156 (328)
T ss_pred             CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence            999999876431   2478899999999999999999987    9999999999999999999999999865432110  


Q ss_pred             ---------ccccccCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 ---------QAIARLGGYKAPEQAEVK--RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ---------~~~~~~~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                               ....++..|+|||++.+.  .++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                     111234459999998763  4789999999999999999999999653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=6.3e-35  Score=301.09  Aligned_cols=191  Identities=25%  Similarity=0.324  Sum_probs=160.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++|+||+++++++...+..++|+||+. ++
T Consensus        10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~   88 (291)
T cd07870          10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD   88 (291)
T ss_pred             EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence            46799999999999985 468999999987543 2233567789999999999999999999999999999999995 67


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----  514 (670)
                      |.+++....    ..+.+..+..++.|++.||+|||+.    +|+|+||||+||+++.++.+||+|||+++.....    
T Consensus        89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQ----HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            877765432    1467888889999999999999988    9999999999999999999999999998764321    


Q ss_pred             ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ....++..|+|||.+.+. .++.++|||||||++|||+||+.||...
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             CCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            223356679999998653 5788999999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.9e-34  Score=289.07  Aligned_cols=240  Identities=23%  Similarity=0.294  Sum_probs=192.1

Q ss_pred             cCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ||.|++|.||++... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999965 58999999997542   23456789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---cc
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---QA  516 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~  516 (670)
                      .+++....     .+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.+||+|||++......   ..
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~  151 (262)
T cd05572          81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNR----GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT  151 (262)
T ss_pred             HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccc
Confidence            99997653     478899999999999999999987    9999999999999999999999999999877543   22


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      ..++..|+|||.+....++.++||||||+++|||++|+.||.....            +..............       
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------------~~~~~~~~~~~~~~~-------  212 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------------DPMEIYNDILKGNGK-------  212 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------------CHHHHHHHHhccCCC-------
Confidence            3456779999999888899999999999999999999999965421            111222221110000       


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                      .   .........+.+++.+||+.+|++||+     ++|++++
T Consensus       213 ~---~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         213 L---EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             C---CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            0   000011235667777999999999999     6777663

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.1e-33  Score=292.21  Aligned_cols=194  Identities=27%  Similarity=0.395  Sum_probs=164.9

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEe
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYD  432 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e  432 (670)
                      |...+.||+|+||.||+|... +++.||+|.++....  .....+.+|++++.+++||||+++++++...  ...++|||
T Consensus         7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e   86 (293)
T cd07843           7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME   86 (293)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence            455688999999999999965 688999999975432  2234567899999999999999999999877  88999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |++ ++|.+++....    ..+++.....++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||+++...
T Consensus        87 ~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          87 YVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDN----WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             hcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            996 59999887543    1589999999999999999999988    99999999999999999999999999988764


Q ss_pred             cc----ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          513 PV----QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       513 ~~----~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..    ....++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            43    123456679999998654 4689999999999999999999999654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.5e-34  Score=294.44  Aligned_cols=242  Identities=24%  Similarity=0.297  Sum_probs=187.5

Q ss_pred             cCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ||+|+||+||++.. .+|+.||+|.+....   ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999999999984 468999999986432   12344567899999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---cc
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---QA  516 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~  516 (670)
                      .+++.....   ..+++..+..++.|++.||.|||+.    +++||||+|+||++++++.+||+|||.+......   ..
T Consensus        81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  153 (277)
T cd05577          81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQR----RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG  153 (277)
T ss_pred             HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccc
Confidence            999875432   3588999999999999999999998    9999999999999999999999999998765432   22


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      ..++..|+|||++.+..++.++|||||||++|+|++|+.||.......          .. ..+.......        .
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----------~~-~~~~~~~~~~--------~  214 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----------EK-EELKRRTLEM--------A  214 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----------cH-HHHHhccccc--------c
Confidence            345567999999988889999999999999999999999996542110          00 0000000000        0


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      .......   ...+.+++.+||+.+|++||     ++.++++|
T Consensus       215 ~~~~~~~---~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         215 VEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             ccCCccC---CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            0000111   22345667799999999999     67777653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.8e-34  Score=301.74  Aligned_cols=265  Identities=26%  Similarity=0.342  Sum_probs=189.8

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC--CeeEEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK--EEKLLVY  431 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~--~~~~lv~  431 (670)
                      |.+.+.||+|+||.||+|... +|+.||||++...  .......+.+|+.+++++ +||||+++++++...  ...++||
T Consensus         9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~   88 (337)
T cd07852           9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF   88 (337)
T ss_pred             HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence            456788999999999999965 6889999998642  223445677899999999 999999999998654  3679999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||++ ++|..++...      .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++..
T Consensus        89 e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          89 EYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSG----NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             cccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            9996 5999988653      478899999999999999999987    9999999999999999999999999999865


Q ss_pred             Cccc---------cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchh-HHH
Q 036639          512 NPVQ---------AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP-KWV  580 (670)
Q Consensus       512 ~~~~---------~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~  580 (670)
                      ....         ...++..|+|||.+.+ ..++.++||||||+++|||+||+.||.................... ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            4321         2345667999998754 4578999999999999999999999965422110000000000000 000


Q ss_pred             HHHhhhcccccccc----Hhhhcc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFD----QELLRY-KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d----~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      . ..........++    ...... .........+.+++.+||+.||++|||+.+++++
T Consensus       238 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 E-SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             H-HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0 000000000000    000000 0000123456778889999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-34  Score=307.23  Aligned_cols=190  Identities=22%  Similarity=0.308  Sum_probs=161.9

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~l  429 (670)
                      ...+.||+|+||.||+|.. .+|+.||+|.+...  .....+.+.+|+.++++++|+||+++++++...      ...|+
T Consensus        19 ~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   98 (353)
T cd07850          19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL   98 (353)
T ss_pred             EEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEE
Confidence            3457899999999999995 47899999998643  233446677899999999999999999988643      35699


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+. ++|.+.+..       .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++
T Consensus        99 v~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          99 VMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             EEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            999995 588887753       277888999999999999999998    99999999999999999999999999998


Q ss_pred             ccCccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          510 LLNPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       510 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ......   ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            765432   234567799999999899999999999999999999999999654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=297.15  Aligned_cols=193  Identities=26%  Similarity=0.378  Sum_probs=164.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||.|++|.||+|.. .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..+++|||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            456799999999999995 479999999987543  2234678889999999999999999999999999999999994 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++.....   ..+++..+..++.|+++||+|||+.    +++||||+|+||+++.++.++|+|||+++.....  
T Consensus        82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~----~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSH----RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            699999875431   2589999999999999999999987    9999999999999999999999999999765422  


Q ss_pred             --ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 --QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                        ....++..|+|||++.+. .++.++||||||+++|||+||+.||...
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              122346679999988654 5789999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=6.7e-34  Score=295.88  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=194.9

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +...+.||+|+||.||+|.. .+++.||+|.+...   .....+++.+|+++++.++|+|++++++++......++||||
T Consensus        17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   96 (308)
T cd06634          17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY   96 (308)
T ss_pred             HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence            45567899999999999995 46889999998642   222345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +. |++.+++....    ..+++..+..++.|++.||.|||+.    +++||||||+||+++.++.+||+|||++.....
T Consensus        97 ~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          97 CL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             cC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            96 68888775432    2478999999999999999999987    999999999999999999999999999987766


Q ss_pred             cccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 VQAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .....++..|+|||.+.   ...++.++|||||||++|||++|+.||.....              ............ .
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------------~~~~~~~~~~~~-~  232 (308)
T cd06634         168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------MSALYHIAQNES-P  232 (308)
T ss_pred             cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------------HHHHHHHhhcCC-C
Confidence            66666788899999874   35678899999999999999999999854210              000111111100 0


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ..         ........+.+++.+||..+|++||++++++++-....
T Consensus       233 ~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         233 AL---------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             Cc---------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence            00         00112234566777999999999999999998855444

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.5e-34  Score=290.76  Aligned_cols=243  Identities=25%  Similarity=0.409  Sum_probs=193.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.||+|+||.||++... +|..||+|.+....  ....+.+.+|++++++++|+||+++++.+......++|+||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   83 (257)
T cd08225           4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDG   83 (257)
T ss_pred             EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCC
Confidence            3467999999999999964 68899999986532  22456788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccCccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPVQ  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~  515 (670)
                      ++|.+++....   ...+++..+..++.|+++||+|||+.    +++|+||||+||++++++ .+||+|||.+.......
T Consensus        84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~----~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          84 GDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDR----KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999987543   12478999999999999999999988    999999999999999886 46999999987765422


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                          ...++..|+|||+.....++.++||||||+++|||++|+.||...              ...+.+........ ..
T Consensus       157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~--------------~~~~~~~~~~~~~~-~~  221 (257)
T cd08225         157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--------------NLHQLVLKICQGYF-AP  221 (257)
T ss_pred             ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc--------------cHHHHHHHHhcccC-CC
Confidence                234566799999998888999999999999999999999998643              11222222222111 00


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      . .      ....   ..+.+++.+||..+|++|||+.|++++
T Consensus       222 ~-~------~~~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 I-S------PNFS---RDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             C-C------CCCC---HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            0 0      0111   245567779999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.3e-35  Score=281.96  Aligned_cols=198  Identities=25%  Similarity=0.386  Sum_probs=167.4

Q ss_pred             HHHHhHcCCCCceEEEEEEEc---C--CCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD---D--GGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLL  429 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~---~--g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~l  429 (670)
                      |+....||+|.||.||+|...   +  ...+|+|+++....  .......+|+.+++.++||||+.+..++.. +...++
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            456678999999999999633   2  23799999985522  233556789999999999999999999887 778899


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC----CcEEEEec
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN----GVACISDF  505 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DF  505 (670)
                      ++||.+. +|.++|+-++......++-.....|+.||+.|+.|||++    =|+||||||.||||..+    |.+||+||
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N----WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN----WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh----heeeccCCcceEEEeccCCccCeeEeecc
Confidence            9999966 999999876655556788899999999999999999998    79999999999999877    89999999


Q ss_pred             ccccccCc-------cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          506 GLSLLLNP-------VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       506 G~a~~~~~-------~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      |+++.+..       .+...-|..|+|||.+.+. .|+++.||||.|||+.||+|-.+.|.+.
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            99998753       3345567789999998765 5899999999999999999999888654

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.9e-35  Score=295.70  Aligned_cols=242  Identities=22%  Similarity=0.299  Sum_probs=194.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||.|+||.||+|... +++.||+|.+.....   ...+.+.+|++++++++||||+++++++.+....++|+||++
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   83 (258)
T cd05578           4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLL   83 (258)
T ss_pred             EEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCC
Confidence            4578999999999999965 689999999975432   345788999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     ++++.....++.|+++||.|||+.    +++|+||+|+||++++++.++|+|||.+...... 
T Consensus        84 ~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~----~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          84 GGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSK----GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            999999997652     588999999999999999999987    9999999999999999999999999998876543 


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....++..|+|||.+....++.++||||||+++|+|++|+.||......            ...++......  ....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------------~~~~~~~~~~~--~~~~  220 (258)
T cd05578         155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------------IRDQIRAKQET--ADVL  220 (258)
T ss_pred             cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------------HHHHHHHHhcc--cccc
Confidence              2344566799999998888999999999999999999999999754211            11111111110  0000


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH--HHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM--AEVAK  633 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl~  633 (670)
                      +         .......+.+++.+||+.||.+||++  +|+++
T Consensus       221 ~---------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         221 Y---------PATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             C---------cccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            0         01112456677789999999999999  66654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-34  Score=318.66  Aligned_cols=194  Identities=18%  Similarity=0.273  Sum_probs=154.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEcC--CCEEEEE------------------EeCCCCcchHHHHHHHHHHHhccCCCCeeeE
Q 036639          358 RASAEMLGKGSLGTVYKAVLDD--GGIVAVK------------------RLKDANPCARKEFEQYMDVIGKLKHPNVVKL  417 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l  417 (670)
                      |.+.+.||+|+||+||++..+.  +..+++|                  .+.. .......+.+|++++++++||||+++
T Consensus       150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l  228 (501)
T PHA03210        150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHENILKI  228 (501)
T ss_pred             cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCCcCcE
Confidence            4566889999999999987532  2222222                  1111 11234568899999999999999999


Q ss_pred             EEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       418 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      ++++...+..|+|+|++ .++|.+++..................++.|++.||+|||+.    +|+||||||+|||++.+
T Consensus       229 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~----gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        229 EEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK----KLIHRDIKLENIFLNCD  303 (501)
T ss_pred             eEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCC
Confidence            99999999999999999 45787777543211111234566778999999999999998    99999999999999999


Q ss_pred             CcEEEEecccccccCccc-----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCC
Q 036639          498 GVACISDFGLSLLLNPVQ-----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS  557 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~  557 (670)
                      +.+||+|||+++......     ...++..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999998764322     245788899999999999999999999999999999988654

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=302.09  Aligned_cols=242  Identities=24%  Similarity=0.333  Sum_probs=197.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|.|+.|.+|+. .+|..||||.+.+..  ......+.+|+++|..++|||||+++.+.......|+||||+.+
T Consensus        60 i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~  139 (596)
T KOG0586|consen   60 IIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASG  139 (596)
T ss_pred             eeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccC
Confidence            457899999999999994 479999999998753  33445688999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |.+++++..+.     .........++.|+.+|++|+|++    .|+|||||++||||+.++++||+|||++..+..   
T Consensus       140 ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k----~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~  210 (596)
T KOG0586|consen  140 GELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSK----NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM  210 (596)
T ss_pred             chhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhc----ceeccccchhhcccccccceeeeccccceeeccccc
Confidence            99999998765     355578889999999999999998    999999999999999999999999999998865   


Q ss_pred             cccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                      .+...+++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.............++               
T Consensus       211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp---------------  275 (596)
T KOG0586|consen  211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP---------------  275 (596)
T ss_pred             ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc---------------
Confidence            346778888999999998776 5899999999999999999999986532211111111111111               


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                              -....   ++-+++++++..+|.+|++++++.++-.
T Consensus       276 --------~~ms~---dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  276 --------FYMSC---DCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             --------ceeec---hhHHHHHHhhccCccccCCHHHhhhhcc
Confidence                    11122   2334666899999999999999998643

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-34  Score=300.23  Aligned_cols=192  Identities=28%  Similarity=0.403  Sum_probs=160.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||+|.. .+|+.||+|+++....  .....+.+|++++++++|+||+++++++...  +..++||||+
T Consensus        11 ~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~   90 (309)
T cd07845          11 KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC   90 (309)
T ss_pred             EeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecC
Confidence            346799999999999996 4689999999874322  2234566899999999999999999998765  4679999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      . ++|.+++....    ..+++..+..++.|+++||+|||+.    +++||||||+||++++++.+||+|||.+......
T Consensus        91 ~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          91 E-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHEN----FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             C-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            6 58988887543    2589999999999999999999998    9999999999999999999999999999876532


Q ss_pred             c----cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 Q----AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ~----~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .    ....+..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            1    1223556999999865 45789999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=296.74  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=191.1

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~  435 (670)
                      .+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++|+|++++++++.+.  +..++|+||++
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   83 (287)
T cd07840           4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD   83 (287)
T ss_pred             eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence            467999999999999965 58999999998653  33456788999999999999999999999988  88999999997


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      + +|.+++....    ..+++..+..++.|+++||+|||+.    +++|+||||+||++++++.+||+|||++.......
T Consensus        84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~----~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSN----GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            4 8988886542    2589999999999999999999988    99999999999999999999999999998765432


Q ss_pred             -----cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh----h
Q 036639          516 -----AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV----K  585 (670)
Q Consensus       516 -----~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~  585 (670)
                           ...++..|+|||.+.+ ..++.++||||||+++|||+||+.||.......           ....+....    .
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-----------~~~~~~~~~~~~~~  223 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-----------QLEKIFELCGSPTD  223 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-----------HHHHHHHHhCCCch
Confidence                 2234556999998764 457899999999999999999999986542110           000000000    0


Q ss_pred             hccc-------------cccccHhhhcccchHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          586 EEWT-------------AEVFDQELLRYKNIEE-ELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       586 ~~~~-------------~~~~d~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..|.             .......+.  ..... +...+.+++.+||..+|++||++++++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         224 ENWPGVSKLPWFENLKPKKPYKRRLR--EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhccccccchhhhhccccccchhHHH--HHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            0000             000000000  00001 13467788889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7.1e-34  Score=293.78  Aligned_cols=196  Identities=26%  Similarity=0.331  Sum_probs=162.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCe-----eEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEE-----KLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~-----~~lv  430 (670)
                      +.+.||+|+||.||+|... +++.||+|.++....  .....+.+|+.+++.++ |+||+++++++...+.     .|+|
T Consensus         5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv   84 (295)
T cd07837           5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV   84 (295)
T ss_pred             EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence            4567999999999999954 689999999865422  23467888999999995 6999999999987665     7999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEeccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSL  509 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~  509 (670)
                      |||+++ +|.+++..........+++..+..++.||+.||+|||+.    +|+||||||+||+++. ++.+||+|||+++
T Consensus        85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~----~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH----GVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEecCCCeEEEeecccce
Confidence            999975 898888654322234689999999999999999999988    9999999999999998 8899999999987


Q ss_pred             ccCcc----ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          510 LLNPV----QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       510 ~~~~~----~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....    ....++..|+|||++.+ ..++.++||||||+++|||++|..||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            65321    12234567999998864 45799999999999999999999999653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.2e-34  Score=288.92  Aligned_cols=240  Identities=27%  Similarity=0.366  Sum_probs=189.9

Q ss_pred             cCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ||+|+||.||+++.. +|+.||+|.+.....   ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999976 599999999975533   3456788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-----  514 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-----  514 (670)
                      .++++...     .+++..+..++.|+++||+|||+.    +++||||+|+||++++++.++|+|||++......     
T Consensus        81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  151 (265)
T cd05579          81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSN----GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL  151 (265)
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence            99997643     589999999999999999999988    9999999999999999999999999998765332     


Q ss_pred             -------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 -------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 -------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                             ....++..|+|||......++.++||||||+++||+++|+.||....              ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------------~~~~~~~~~~~~  217 (265)
T cd05579         152 NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------------PEEIFQNILNGK  217 (265)
T ss_pred             ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHhcCC
Confidence                   12234567999999988889999999999999999999999986431              111111111110


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      ..          ..........+.+++.+||+.+|++|||+.++.+.|+
T Consensus       218 ~~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         218 IE----------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             cC----------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            00          0000001234566777999999999999955554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.7e-34  Score=303.95  Aligned_cols=265  Identities=21%  Similarity=0.276  Sum_probs=189.2

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEe----CCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA----KEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~   87 (334)
T cd07855           8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM   87 (334)
T ss_pred             eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence            3456799999999999995 469999999987542  2345677889999999999999999998763    34679999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+. ++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||++...
T Consensus        88 e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          88 DLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSA----NVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             ehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            9995 68999987543     489999999999999999999988    9999999999999999999999999999765


Q ss_pred             Cccc--------cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccc-hhHHHH
Q 036639          512 NPVQ--------AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD-LPKWVR  581 (670)
Q Consensus       512 ~~~~--------~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~  581 (670)
                      ....        ...++..|+|||.+.. ..++.++|||||||++|||++|+.||.................. ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            3311        2345667999998765 46899999999999999999999999654221000000000000 000000


Q ss_pred             HHhhhccccccccHhhhc-ccc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          582 SVVKEEWTAEVFDQELLR-YKN----IEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~-~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .. .........+..... ...    .......+.+++.+||+.+|++|||+++++.+
T Consensus       238 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RI-GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hh-chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00 000000000000000 000    01123456778889999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.1e-33  Score=291.45  Aligned_cols=249  Identities=24%  Similarity=0.385  Sum_probs=193.6

Q ss_pred             cHHHHHHHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCee
Q 036639          352 ELEDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       352 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  427 (670)
                      .+++. +...+.||+|+||+||+|.. .+|+.||+|++.....   ...+.+.+|+++++.++|||++++++++.+....
T Consensus        18 ~~~~~-~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          18 DPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             CHHHH-hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            34444 33456799999999999995 4689999999874322   2335678899999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      ++||||+. |++.+++....    .++++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.+||+|||+
T Consensus        97 ~lv~e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~----gi~H~dl~p~nili~~~~~~kL~dfg~  167 (313)
T cd06633          97 WLVMEYCL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSH----NMIHRDIKAGNILLTEPGQVKLADFGS  167 (313)
T ss_pred             EEEEecCC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChhhEEECCCCCEEEeecCC
Confidence            99999995 57888776432    2588999999999999999999988    999999999999999999999999999


Q ss_pred             ccccCccccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          508 SLLLNPVQAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       508 a~~~~~~~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      +..........++..|+|||++.   ...++.++|||||||++|||++|..||.....              ........
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------------~~~~~~~~  233 (313)
T cd06633         168 ASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------------MSALYHIA  233 (313)
T ss_pred             CcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHHH
Confidence            87765555566777899999974   45688999999999999999999999864311              11111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...... ...      ...   ...+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~-~~~------~~~---~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         234 QNDSPT-LQS------NEW---TDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             hcCCCC-CCc------ccc---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111000 000      011   1235567779999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.3e-34  Score=292.44  Aligned_cols=194  Identities=27%  Similarity=0.404  Sum_probs=165.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      ..+.||.|++|.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+++ 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-   82 (284)
T cd07836           4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-   82 (284)
T ss_pred             EeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-
Confidence            3467999999999999964 689999999975432 2346677899999999999999999999999999999999975 


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++.....  ...+++..+..++.|++.||+|||+.    +++||||||+||++++++.+||+|||+++.....   
T Consensus        83 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          83 DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHEN----RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            89888865431  23589999999999999999999987    9999999999999999999999999999765332   


Q ss_pred             -ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 -QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                       ....++..|++||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  204 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT  204 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence             12334667999998865 35789999999999999999999999754

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-36  Score=330.86  Aligned_cols=241  Identities=28%  Similarity=0.415  Sum_probs=192.4

Q ss_pred             HhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+||.|.||.||-|. .++|...|||.++-..  ....+.+.+|+.++..++|||+|+++|+-..++..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            4689999999999999 6789999999887443  234467889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+.++..+     ..++.....+..|++.|++|||++    |||||||||.||+++.+|.+|++|||.|..+...   
T Consensus      1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~----gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEH----GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhc----CceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            9999998665     356666777888999999999998    9999999999999999999999999999887542   


Q ss_pred             -----ccccccCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          515 -----QAIARLGGYKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       515 -----~~~~~~~~y~aPE~~~~~~---~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                           ....||+.|||||++.+..   -.-+.||||+|||++||+||+.||...+..          ..+--.+...-  
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne----------~aIMy~V~~gh-- 1458 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE----------WAIMYHVAAGH-- 1458 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch----------hHHHhHHhccC--
Confidence                 2457889999999997543   467899999999999999999999643211          11100010000  


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .+.+  ......+-.++++   .||..||++|.++.|++++
T Consensus      1459 -------~Pq~--P~~ls~~g~dFle---~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 -------KPQI--PERLSSEGRDFLE---HCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             -------CCCC--chhhhHhHHHHHH---HHHhcCchhhhHHHHHHHh
Confidence                   0000  0113444455555   9999999999999988776

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=283.69  Aligned_cols=242  Identities=28%  Similarity=0.469  Sum_probs=195.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++++++|+|++++++++.+.+..+++|||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            34578999999999999854 688999999986643  356789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++....     .+++..+..++.|++.||.|||+.    +|+||||||+||+++.++.++|+|||.+.......
T Consensus        83 ~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          83 NGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQ----GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            999999987643     589999999999999999999988    99999999999999999999999999998775433


Q ss_pred             c----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 A----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ~----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      .    ..++..|+|||...+..++.++||||+|+++|+|++|+.||....             ........ ....  ..
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-------------~~~~~~~~-~~~~--~~  217 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-------------PMAALFRI-VQDD--HP  217 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-------------HHHHHHHH-hccC--CC
Confidence            2    345667999999988888999999999999999999999986431             11111111 1000  00


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .+.      ...   ...+.+++.+||..+|++|||+.|++.+
T Consensus       218 ~~~------~~~---~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         218 PLP------EGI---SPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCC------CCC---CHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            000      111   2345567779999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.2e-34  Score=299.87  Aligned_cols=256  Identities=20%  Similarity=0.273  Sum_probs=188.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcch--------------HHHHHHHHHHHhccCCCCeeeEEEEEEeC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCA--------------RKEFEQYMDVIGKLKHPNVVKLRAYYYAK  424 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~nIv~l~~~~~~~  424 (670)
                      +.+.||+|+||+||+|... +++.||||.++......              ...+.+|++++++++|+||+++++++...
T Consensus        13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   92 (335)
T PTZ00024         13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG   92 (335)
T ss_pred             hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence            4567999999999999954 68999999986542211              12577899999999999999999999999


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      +..++||||++ |+|.+++....     .+++.....++.|++.||+|||+.    +++||||+|+||+++.++.+||+|
T Consensus        93 ~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~----~i~H~dl~~~nill~~~~~~kl~d  162 (335)
T PTZ00024         93 DFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKW----YFMHRDLSPANIFINSKGICKIAD  162 (335)
T ss_pred             CcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHeEECCCCCEEECC
Confidence            99999999996 69999986543     488899999999999999999987    999999999999999999999999


Q ss_pred             cccccccCcc------------------ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 036639          505 FGLSLLLNPV------------------QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRP  565 (670)
Q Consensus       505 FG~a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~  565 (670)
                      ||++......                  ....++..|+|||.+.+. .++.++|||||||++|||+||+.||........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9998765410                  112235569999998754 468999999999999999999999965421100


Q ss_pred             CCcccccccchhHHHHHHhhhcccccc-----------ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          566 RVDEEEQAVDLPKWVRSVVKEEWTAEV-----------FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             ...+...........|....           .......  ........+.+++.+||+.+|++|||++|++.+
T Consensus       243 -------~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        243 -------LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT--IFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             -------HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH--hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence                   00000000000000010000           0000000  000112346678889999999999999999975

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.3e-34  Score=298.38  Aligned_cols=192  Identities=24%  Similarity=0.346  Sum_probs=159.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC--------eeE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE--------EKL  428 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--------~~~  428 (670)
                      ..+.||+|+||.||+|... +++.||||.+....  ......+.+|++++++++||||+++++++...+        ..+
T Consensus        16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   95 (310)
T cd07865          16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY   95 (310)
T ss_pred             EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence            3467999999999999954 68999999986432  222345678999999999999999999987654        349


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +||||+. ++|.+++....    ..+++..+..++.|++.||+|||+.    +++|+||||+||+++.++.+||+|||++
T Consensus        96 lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          96 LVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRN----KILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             EEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence            9999996 58888876432    2488999999999999999999998    9999999999999999999999999999


Q ss_pred             cccCccc--------cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          509 LLLNPVQ--------AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       509 ~~~~~~~--------~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .......        ...++..|+|||.+.+. .++.++||||||+++|||+||+.||...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            7664321        12345569999988654 4788999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=302.66  Aligned_cols=258  Identities=22%  Similarity=0.278  Sum_probs=189.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----CeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e  432 (670)
                      +.+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|+.++++++|+||+++++++...     ...++|+|
T Consensus         9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   88 (336)
T cd07849           9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQE   88 (336)
T ss_pred             EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEeh
Confidence            457899999999999984 578999999987432 23456678899999999999999999987654     35799999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |++ ++|.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~----~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          89 LME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             hcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            996 4888887643      488999999999999999999998    99999999999999999999999999987654


Q ss_pred             ccc-------cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          513 PVQ-------AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       513 ~~~-------~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ...       ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......           .....+....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-----------~~~~~~~~~~  226 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-----------HQLNLILGVL  226 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHHHc
Confidence            321       2345677999998754 56899999999999999999999999653210           0000000000


Q ss_pred             hhccc---cccccH-------hhh--cccc----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036639          585 KEEWT---AEVFDQ-------ELL--RYKN----IEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIR  639 (670)
Q Consensus       585 ~~~~~---~~~~d~-------~~~--~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~  639 (670)
                      .....   ....+.       ...  ....    .......+.+++.+||+.+|++|||+.|++++  ++...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~  299 (336)
T cd07849         227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH  299 (336)
T ss_pred             CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence            00000   000000       000  0000    00112346778889999999999999999998  55444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.4e-33  Score=291.29  Aligned_cols=249  Identities=14%  Similarity=0.169  Sum_probs=175.2

Q ss_pred             HHHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCCCcchH-----------HHHHHHHHHHhccCCCCeeeEEEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDANPCAR-----------KEFEQYMDVIGKLKHPNVVKLRAYYYA  423 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~nIv~l~~~~~~  423 (670)
                      .+.+.||+|+||.||+|...+    +..+|+|..........           .....+...+..++|+||+++++++..
T Consensus        15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~   94 (294)
T PHA02882         15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF   94 (294)
T ss_pred             EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence            445789999999999999654    45667776432221111           111223344566789999999997765


Q ss_pred             CC----eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc
Q 036639          424 KE----EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV  499 (670)
Q Consensus       424 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  499 (670)
                      ..    ..++++|++. .++.+.+....     ..++..+..++.|+++||+|||+.    +|+||||||+|||++.++.
T Consensus        95 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         95 KRCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEH----GISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             ecCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCc
Confidence            43    4468888874 46766665432     356788899999999999999988    9999999999999999999


Q ss_pred             EEEEecccccccCc-----------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCc
Q 036639          500 ACISDFGLSLLLNP-----------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVD  568 (670)
Q Consensus       500 ~kl~DFG~a~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~  568 (670)
                      ++|+|||+++....           .....+|..|+|||+..+..++.++|||||||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999999976532           1123577889999999999999999999999999999999999975421110000


Q ss_pred             ccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          569 EEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       569 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      .     ....++......         .. .....   ...+.+++..|+..+|++||+++++++.+
T Consensus       245 ~-----~~~~~~~~~~~~---------~~-~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        245 A-----AKCDFIKRLHEG---------KI-KIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             H-----hHHHHHHHhhhh---------hh-ccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            0     000111111110         00 01112   23466677799999999999999999876

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=293.66  Aligned_cols=266  Identities=23%  Similarity=0.279  Sum_probs=193.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|++|.||++... +++.+++|+++....  .....+.+|++++++++|+||+++++++......++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            3467999999999999954 789999999875432  2456788899999999999999999999999999999999965


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                       +|.+++....    ..+++..+..++.|++.||+|||+.    +|+|+||||+||+++.++.+||+|||.+....... 
T Consensus        83 -~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          83 -DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSH----GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             -CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHC----CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence             8888886542    2589999999999999999999998    99999999999999999999999999987765432 


Q ss_pred             ---cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccc-hhHHHHHHhh--hcc
Q 036639          516 ---AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD-LPKWVRSVVK--EEW  588 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~  588 (670)
                         ...++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+.............. .+.+......  ...
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence               23355669999998766 7899999999999999999999998654211000000000000 0000000000  000


Q ss_pred             ccccccHhhhc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLR-YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....+..... ..........+.+++.+||+.||.+||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            00000000000 00011223467788889999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-33  Score=289.70  Aligned_cols=240  Identities=21%  Similarity=0.287  Sum_probs=182.3

Q ss_pred             HcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcc---hHHHHHHHH---HHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          363 MLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPC---ARKEFEQYM---DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .||+|+||.||+|.. .+++.||+|.+......   ....+..|.   ..++..+||||+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            389999999999995 46899999998754211   122233343   33444579999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++.....  
T Consensus        81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~  151 (278)
T cd05606          81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  151 (278)
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence            999999886543     589999999999999999999997    999999999999999999999999999876543  


Q ss_pred             cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                      .....++..|+|||.+.+. .++.++||||+||++|||++|+.||.......           ... ........     
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----------~~~-~~~~~~~~-----  214 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----------KHE-IDRMTLTM-----  214 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----------hHH-HHHHhhcc-----
Confidence            2234567789999998744 68999999999999999999999996542110           000 00000000     


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                       ....  ....   ...+.+++.+|+..+|.+||     ++.|++++
T Consensus       215 -~~~~--~~~~---s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         215 -AVEL--PDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -CCCC--CCcC---CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             0000  0011   23456677799999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.2e-33  Score=282.35  Aligned_cols=242  Identities=26%  Similarity=0.390  Sum_probs=196.0

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~  435 (670)
                      .+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|++++++++|+||+++++.+.+.  ...++|+||++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~   84 (260)
T cd06606           5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS   84 (260)
T ss_pred             eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence            467999999999999965 789999999976542  3567889999999999999999999999988  88999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +++|.+++....     .+++..+..++.|+++||+|||+.    +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            999999997653     589999999999999999999997    99999999999999999999999999988775432


Q ss_pred             ------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          516 ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       516 ------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                            ...++..|+|||......++.++||||||+++|+|++|+.||....             ...............
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------------~~~~~~~~~~~~~~~  222 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------------NPMAALYKIGSSGEP  222 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------------chHHHHHhccccCCC
Confidence                  2445667999999988889999999999999999999999996542             000111111100000


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..          ........+.+++.+|++.+|++||++.|++++
T Consensus       223 ~~----------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         223 PE----------IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             cC----------CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            00          001112356667779999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-33  Score=296.13  Aligned_cols=265  Identities=22%  Similarity=0.299  Sum_probs=197.7

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC-----eeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE-----EKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv  430 (670)
                      .+.+.||+|++|.||+|... +++.||||++....  ....+.+.+|+++++.++|+||+++++++....     ..|+|
T Consensus         3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv   82 (330)
T cd07834           3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV   82 (330)
T ss_pred             eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence            45578999999999999964 58999999997643  335578899999999999999999999988775     78999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||++ ++|.+++....     .+++..+..++.+++.||+|||+.    +|+||||||+||+++.++.++|+|||++..
T Consensus        83 ~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~----gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          83 TELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSA----NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             ecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99997 58999887543     589999999999999999999998    999999999999999999999999999987


Q ss_pred             cCccc-------cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccc-----------
Q 036639          511 LNPVQ-------AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE-----------  571 (670)
Q Consensus       511 ~~~~~-------~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~-----------  571 (670)
                      .....       ...++..|+|||++.+. .++.++||||||+++|+|++|+.||..............           
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65432       23456679999999877 789999999999999999999999965421100000000           


Q ss_pred             --cccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhcc
Q 036639          572 --QAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRVE  641 (670)
Q Consensus       572 --~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~  641 (670)
                        .......++... ...   .  .....  .........+.+++.+||+.+|++|||+++++++  ++.++..
T Consensus       233 ~~~~~~~~~~~~~~-~~~---~--~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         233 FITSEKARNYLKSL-PKK---P--KKPLS--KLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hccccchhhHHhhc-ccC---C--cchhH--HhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence              000000000000 000   0  00000  0000112346677889999999999999999996  6666543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-34  Score=300.63  Aligned_cols=263  Identities=22%  Similarity=0.308  Sum_probs=191.6

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----CeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv  430 (670)
                      .+.+.||+|+||+||+|.. .+++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ...++|
T Consensus         8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv   87 (337)
T cd07858           8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV   87 (337)
T ss_pred             eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence            3446799999999999994 57899999998753  222445677899999999999999999988654     347999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +||+. ++|.+++....     .+++.....++.|++.||.|||+.    +++||||||+||+++.++.+||+|||+++.
T Consensus        88 ~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          88 YELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSA----NVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            99995 68998887543     588999999999999999999988    999999999999999999999999999987


Q ss_pred             cCcc----ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCC----------ccc---cc
Q 036639          511 LNPV----QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV----------DEE---EQ  572 (670)
Q Consensus       511 ~~~~----~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~----------~~~---~~  572 (670)
                      ....    ....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+......          ...   ..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         158 TSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             cCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            6443    22345667999998764 468999999999999999999999996532100000          000   00


Q ss_pred             ccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036639          573 AVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIR  639 (670)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~  639 (670)
                      ......++....      ...+.....  ........+.+++.+||+.+|++|||++|++++  ++.+.
T Consensus       238 ~~~~~~~~~~~~------~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~  298 (337)
T cd07858         238 NEKARRYIRSLP------YTPRQSFAR--LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH  298 (337)
T ss_pred             chhhhHHHHhcC------cccccCHHH--HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence            000000000000      000000000  001122446678889999999999999999998  65543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-33  Score=286.80  Aligned_cols=256  Identities=24%  Similarity=0.310  Sum_probs=189.0

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhcc---CCCCeeeEEEEEEeCCe-----eEE
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKL---KHPNVVKLRAYYYAKEE-----KLL  429 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~~~~-----~~l  429 (670)
                      .+.||+|+||.||+|..+ +++.||+|+++....  .....+.+|++++.++   +|+||+++++++...+.     .++
T Consensus         4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l   83 (287)
T cd07838           4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL   83 (287)
T ss_pred             EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence            467999999999999976 589999999974322  2234566777777655   69999999999998776     899


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      +|||+. ++|.+++.....   ..+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.+||+|||.+.
T Consensus        84 ~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~----~i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          84 VFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             Eehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhEEEccCCCEEEeccCcce
Confidence            999996 589998875431   2489999999999999999999998    99999999999999999999999999998


Q ss_pred             ccCccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh--
Q 036639          510 LLNPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV--  584 (670)
Q Consensus       510 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  584 (670)
                      ......   ...++..|+|||++.+..++.++|||||||++|||++|+.||.......          .+.+......  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~----------~~~~~~~~~~~~  225 (287)
T cd07838         156 IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD----------QLDKIFDVIGLP  225 (287)
T ss_pred             eccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH----------HHHHHHHHcCCC
Confidence            764332   2335667999999998889999999999999999999999986532110          0111111000  


Q ss_pred             -hhcccccc------ccHhhhc--ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 -KEEWTAEV------FDQELLR--YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 -~~~~~~~~------~d~~~~~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ...+....      +......  ..........+.+++.+||+.||++||++.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence             00000000      0000000  00011223456678889999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-33  Score=283.00  Aligned_cols=242  Identities=20%  Similarity=0.322  Sum_probs=187.5

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC-----CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA-----NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv  430 (670)
                      .+.+.||+|+||.||+|.. .+++.||+|.+...     .....+.+.+|++++++++|+||+++++++.+.  ...+++
T Consensus         5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (264)
T cd06653           5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF   84 (264)
T ss_pred             eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence            3457899999999999995 46899999987532     122346788999999999999999999998764  457899


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +||+++++|.+++....     .+++.....++.|++.||.|||+.    +++|+||||+||+++.++.++|+|||+++.
T Consensus        85 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~----~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          85 VEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSN----MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            99999999999987543     478889999999999999999988    999999999999999999999999999986


Q ss_pred             cCcc-------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          511 LNPV-------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       511 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ....       ....++..|+|||++.+..++.++|||||||++|||++|+.||.....              ...+...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------~~~~~~~  221 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA--------------MAAIFKI  221 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH--------------HHHHHHH
Confidence            5321       123466779999999888899999999999999999999999864310              0111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..... ...+      .....+   .+.+++.+||. +|.+||++.+++.|
T Consensus       222 ~~~~~-~~~~------p~~~~~---~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         222 ATQPT-KPML------PDGVSD---ACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HcCCC-CCCC------CcccCH---HHHHHHHHHhc-CcccCccHHHHhcC
Confidence            11100 0000      111222   34456668998 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.1e-33  Score=292.44  Aligned_cols=247  Identities=25%  Similarity=0.362  Sum_probs=187.2

Q ss_pred             HHHhHcCCCCceEEEEEEEcC-CCEEEEEEeCCCC-cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD-GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|+||.||+|..++ ++.||||.++... .....++..|+.++.+.. |+||+++++++.+....+++|||++
T Consensus        18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   97 (296)
T cd06618          18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS   97 (296)
T ss_pred             eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence            556889999999999999764 8999999997543 223456667777776664 9999999999999999999999984


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                       +++.+++....    ..+++..+..++.|++.||+|||+.   .+|+||||+|+||++++++.+||+|||++.......
T Consensus        98 -~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~---~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          98 -TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEK---HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             -cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh---CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence             57777765532    1589999999999999999999974   389999999999999999999999999987654322


Q ss_pred             ---cccccCcccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          516 ---AIARLGGYKAPEQAEVKR----LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~----~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                         ...++..|+|||.+.+..    ++.++||||||+++|||++|+.||.....          .   ............
T Consensus       170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~---~~~~~~~~~~~~  236 (296)
T cd06618         170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT----------E---FEVLTKILQEEP  236 (296)
T ss_pred             cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh----------H---HHHHHHHhcCCC
Confidence               223456799999987553    78999999999999999999999854210          0   011111111110


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      . .        ..........+.+++.+||..||++||++.+++++-
T Consensus       237 ~-~--------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         237 P-S--------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             C-C--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            0 0        000001123466677799999999999999999863

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.6e-33  Score=282.95  Aligned_cols=245  Identities=23%  Similarity=0.410  Sum_probs=197.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||.||++... +++.||+|++.....  ...+.+.+|+++++.++|+|++++++.+...+..++|+||+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~   83 (258)
T cd08215           4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG   83 (258)
T ss_pred             EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCC
Confidence            4467999999999999954 689999999976533  4567889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++..... ....+++..+..++.+++.||+|||+.    +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        84 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~----~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          84 GDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSR----KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD  158 (258)
T ss_pred             CcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence            999999976431 123689999999999999999999998    99999999999999999999999999998764432 


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                         ...++..|+|||......++.++||||+|+++++|++|+.||....              ............. ...
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------------~~~~~~~~~~~~~-~~~  223 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------------LLELALKILKGQY-PPI  223 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------------HHHHHHHHhcCCC-CCC
Confidence               2345667999999988889999999999999999999999986431              1111111111110 000


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                              .  ......+.+++.+||..+|++|||+.|++++
T Consensus       224 --------~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 --------P--SQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --------C--CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    0  0112345667779999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.8e-33  Score=282.79  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||.||++.. .+++.+|+|.+....  .....++.+|++++++++|+||+++++++.+....++|+||+++
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   83 (256)
T cd08530           4 VLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPF   83 (256)
T ss_pred             EeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCC
Confidence            356799999999999984 478899999987542  23456778899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++..... ....+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.+||+|||++....... 
T Consensus        84 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~----~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  158 (256)
T cd08530          84 GDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQ----KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMA  158 (256)
T ss_pred             CCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhC----CcccCCCCcceEEEecCCcEEEeeccchhhhccCCc
Confidence            999999876321 123588999999999999999999988    99999999999999999999999999998765431 


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                       ...++..|+|||.+.+..++.++|+||||+++|||++|+.||.....              ...... ........   
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------------~~~~~~-~~~~~~~~---  220 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------------QDLRYK-VQRGKYPP---  220 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------------HHHHHH-HhcCCCCC---
Confidence             23456679999999988899999999999999999999999964311              111111 11110000   


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .......++.+++.+|+..+|++||++.|++++
T Consensus       221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         221 -------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             -------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                   011223456778889999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=314.94  Aligned_cols=262  Identities=27%  Similarity=0.364  Sum_probs=206.8

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEc----C----CCEEEEEEeCCC-CcchHHHHHHHHHHHhcc-CCCCeeeEEE
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLD----D----GGIVAVKRLKDA-NPCARKEFEQYMDVIGKL-KHPNVVKLRA  419 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~  419 (670)
                      .|++..-...+.+.||.|+||.|++|...    .    ...||||.++.. .....+.+..|++++..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45555444466779999999999999843    1    357999999864 334678899999999998 6999999999


Q ss_pred             EEEeCCeeEEEEeccCCCChHHHhccCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCC
Q 036639          420 YYYAKEEKLLVYDYLPNGSLHSLLHGNR---------GPGR--IPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVK  488 (670)
Q Consensus       420 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlk  488 (670)
                      +|..++..++|+||+..|+|.++++..+         ....  ..+.....+.++.|||.|++||++.    +++||||.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~----~~vHRDLA  445 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV----PCVHRDLA  445 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC----Cccchhhh
Confidence            9999999999999999999999998776         1111  2388899999999999999999998    89999999


Q ss_pred             CCCeEeCCCCcEEEEecccccccCcccccc--cc-----CcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 036639          489 SSNVLLDKNGVACISDFGLSLLLNPVQAIA--RL-----GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP  560 (670)
Q Consensus       489 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~-----~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~  560 (670)
                      .+|||+.++..+||+|||+|+.......+.  ++     ..|||||.+....|+.|+|||||||+|||++| |..||.+.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999999765533322  11     23999999999999999999999999999999 78887542


Q ss_pred             CCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          561 SPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      .             ..... -..++++.          +......+..++.++|+.||+.+|++||++.|+.+.++...
T Consensus       526 ~-------------~~~~l-~~~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  526 P-------------PTEEL-LEFLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             C-------------cHHHH-HHHHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            1             01111 11222221          11122233456778889999999999999999999999853

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.1e-33  Score=288.35  Aligned_cols=244  Identities=24%  Similarity=0.330  Sum_probs=188.8

Q ss_pred             HHhHcCCCCceEEEEEEE----cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+.||+|+||.||++..    .+|+.||+|+++...    ....+.+.+|++++.++ +|+||+++++++......++|
T Consensus         4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (290)
T cd05613           4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI   83 (290)
T ss_pred             eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence            456799999999999985    368999999997532    12346788899999999 599999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++++|.+++....     .+++.....++.|+++||+|||+.    +++||||||+|||+++++.+||+|||++..
T Consensus        84 ~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          84 LDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999987543     478889999999999999999987    999999999999999999999999999986


Q ss_pred             cCccc-----cccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          511 LNPVQ-----AIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       511 ~~~~~-----~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      .....     ...++..|+|||.+..  ..++.++||||||+++|+|+||+.||.....          ...........
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----------~~~~~~~~~~~  224 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----------KNSQAEISRRI  224 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----------cccHHHHHHHh
Confidence            54321     2345677999999865  3468899999999999999999999863211          01111111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      ......   +         .......+.+++.+||+.||++||     ++++++++
T Consensus       225 ~~~~~~---~---------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         225 LKSEPP---Y---------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             hccCCC---C---------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            111000   0         001112455677799999999997     77887775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-33  Score=289.13  Aligned_cols=193  Identities=22%  Similarity=0.344  Sum_probs=160.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.||+|++|+||+|... +|+.||+|.+.....  ...+.+.+|++++++++||||+++++++.+....++||||++ 
T Consensus         6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-   84 (294)
T PLN00009          6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-   84 (294)
T ss_pred             EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-
Confidence            3467999999999999964 789999999865422  234678889999999999999999999999999999999995 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccCcc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~-  514 (670)
                      ++|.+++....   ...+++.....++.|++.||+|||+.    +++||||+|+||+++. ++.+||+|||++...... 
T Consensus        85 ~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         85 LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSH----RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            58888876433   12357888889999999999999998    9999999999999985 557999999999765322 


Q ss_pred             ---ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 ---QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                         ....++..|+|||++.+ ..++.++|||||||++|+|+||+.||...
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence               12344667999998865 45789999999999999999999999653

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-34  Score=302.46  Aligned_cols=194  Identities=29%  Similarity=0.473  Sum_probs=168.8

Q ss_pred             HhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEEEEe
Q 036639          361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLVYD  432 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~lv~e  432 (670)
                      .+.||+|+||.||+++ ..+|+.||||.++... ....+..-+|++++++++|+|||++++.-++..      ...+|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            3679999999999999 5689999999998743 335677889999999999999999999866543      5689999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC--CCC--cEEEEecccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD--KNG--VACISDFGLS  508 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFG~a  508 (670)
                      ||.+|||...+....  +..-+++...+.++.+++.||.|||++    +|+||||||.||++-  ++|  .-||+|||.|
T Consensus        98 yC~gGsL~~~L~~PE--N~~GLpE~e~l~lL~d~~~al~~LrEn----~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSPE--NAYGLPESEFLDLLSDLVSALRHLREN----GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             ecCCCcHHHHhcCcc--cccCCCHHHHHHHHHHHHHHHHHHHHc----CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            999999999998654  344699999999999999999999988    999999999999983  334  4799999999


Q ss_pred             cccCccc---cccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          509 LLLNPVQ---AIARLGGYKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       509 ~~~~~~~---~~~~~~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      +.+++..   ...||..|.+||... ...|+..+|.|||||++||++||..||...
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF  227 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence            9987644   567899999999998 488999999999999999999999999653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=284.94  Aligned_cols=269  Identities=22%  Similarity=0.295  Sum_probs=203.3

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCC--C----CeeeEEEEEEeCCeeEE
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH--P----NVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----nIv~l~~~~~~~~~~~l  429 (670)
                      +|.+...+|+|.||.|-.+... .+..||||+++.... .++...-|+++++++.+  |    -+|.+.++|.-.++.|+
T Consensus        90 Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi  168 (415)
T KOG0671|consen   90 RYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI  168 (415)
T ss_pred             ceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence            3455678999999999999844 578999999986543 56677789999999942  2    48889999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-------------
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-------------  496 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-------------  496 (670)
                      |+|.+ |-++.+++..+.   ..+++...+..++.|++++++|||+.    +++|.||||+|||+.+             
T Consensus       169 vfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~----kl~HTDLKPENILfvss~~~~~~~~k~~~  240 (415)
T KOG0671|consen  169 VFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDL----KLTHTDLKPENILFVSSEYFKTYNPKKKV  240 (415)
T ss_pred             EEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhc----ceeecCCChheEEEeccceEEEeccCCcc
Confidence            99999 779999998764   45788999999999999999999998    9999999999999932             


Q ss_pred             -------CCcEEEEecccccccCccc-cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCc
Q 036639          497 -------NGVACISDFGLSLLLNPVQ-AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVD  568 (670)
Q Consensus       497 -------~~~~kl~DFG~a~~~~~~~-~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~  568 (670)
                             +..+||+|||.|+...... ....|..|+|||++.+-.++.++||||+||||+|+.||...|+.....+....
T Consensus       241 ~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaM  320 (415)
T KOG0671|consen  241 CFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAM  320 (415)
T ss_pred             ceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHH
Confidence                   2258999999999876544 56778899999999999999999999999999999999999976542211100


Q ss_pred             ccccccchhHHHHHHh------hh---ccccc--------ccc---HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 036639          569 EEEQAVDLPKWVRSVV------KE---EWTAE--------VFD---QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM  628 (670)
Q Consensus       569 ~~~~~~~~~~~~~~~~------~~---~~~~~--------~~d---~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  628 (670)
                      -....+.+|..+....      ..   +|...        +++   +..........+...+++|+.+||..||.+|+|+
T Consensus       321 MerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl  400 (415)
T KOG0671|consen  321 MERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITL  400 (415)
T ss_pred             HHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccH
Confidence            0111112222211111      00   11110        111   0011112334667789999999999999999999


Q ss_pred             HHHHHH
Q 036639          629 AEVAKM  634 (670)
Q Consensus       629 ~evl~~  634 (670)
                      .|++.|
T Consensus       401 ~EAL~H  406 (415)
T KOG0671|consen  401 REALSH  406 (415)
T ss_pred             HHHhcC
Confidence            999875

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2e-33  Score=294.63  Aligned_cols=264  Identities=23%  Similarity=0.308  Sum_probs=189.2

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~  434 (670)
                      .+.+.||.|+||.||+|.. .+++.||||++....  ....+.+..|++++++++||||+++++++.. ....++++||+
T Consensus        13 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~   92 (328)
T cd07856          13 VDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL   92 (328)
T ss_pred             EEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh
Confidence            3457899999999999984 479999999886432  2245678889999999999999999999876 45788999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                       +++|.++++..      .+++.....++.|+++||+|||+.    +|+||||+|+||++++++.+||+|||.+......
T Consensus        93 -~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~----~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~  161 (328)
T cd07856          93 -GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSA----GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ  161 (328)
T ss_pred             -ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEeECCCCCEEeCccccccccCCC
Confidence             56899888643      377888889999999999999998    9999999999999999999999999999865432


Q ss_pred             -ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchhHHHHHHhhhccccc
Q 036639          515 -QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  591 (670)
                       ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||.............+. .....++.......... +
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  240 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL-R  240 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH-H
Confidence             23345667999998765 56899999999999999999999999653210000000000 00001111111000000 0


Q ss_pred             cccHhhhccc-chH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYK-NIE----EELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~-~~~----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .+........ ...    .....+.+++.+||+.+|++|||++|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000 000    112456677889999999999999999887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=7e-34  Score=300.13  Aligned_cols=190  Identities=27%  Similarity=0.391  Sum_probs=159.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--------------
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--------------  424 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--------------  424 (670)
                      +.+.||.|+||.||+|.. .+|+.||+|.+........+.+.+|++++++++||||+++++++...              
T Consensus         9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (342)
T cd07854           9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL   88 (342)
T ss_pred             EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccccc
Confidence            456799999999999995 46899999999766555667888999999999999999999876654              


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEE
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACIS  503 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~  503 (670)
                      ...++||||++ ++|.+++...      .+++.....++.|+++||.|||+.    +|+||||||+||+++. ++.+||+
T Consensus        89 ~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          89 NSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCceEEEC
Confidence            35789999996 5998888643      378999999999999999999988    9999999999999984 5578999


Q ss_pred             ecccccccCcc-------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          504 DFGLSLLLNPV-------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       504 DFG~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      |||.++.....       ....++..|+|||.+.. ..++.++|||||||++|||++|+.||...
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999765321       11234667999998654 56889999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-33  Score=291.72  Aligned_cols=194  Identities=27%  Similarity=0.387  Sum_probs=161.8

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC---------
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE---------  425 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~---------  425 (670)
                      |.+.+.||+|+||.||+|... +|+.||+|+++...  ......+.+|++++++++||||+++++++.+..         
T Consensus         9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~   88 (302)
T cd07864           9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK   88 (302)
T ss_pred             hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence            345678999999999999965 68999999997532  223456788999999999999999999987654         


Q ss_pred             -eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          426 -EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       426 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                       ..++|+||+++ ++.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|
T Consensus        89 ~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          89 GAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKK----NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             CcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCcEEeCc
Confidence             78999999976 7777776432    2589999999999999999999998    999999999999999999999999


Q ss_pred             cccccccCccc-----cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          505 FGLSLLLNPVQ-----AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       505 FG~a~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ||++.......     ....+..|+|||.+.+ ..++.++|||||||++|||++|++||...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99998764322     1233556999998764 45789999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=275.28  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=189.6

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ..||.|+||+|++-.++ .|+..|||+++.... ...+++..|.+...+- +.||||+++|.+..++..++.||.| ..+
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DIS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhh
Confidence            67999999999999854 799999999986543 4667788888766544 7999999999999999999999999 457


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---Q  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---~  515 (670)
                      |..+.+.-..-....+++...-.|.....+||.||.+.   ..|||||+||+|||+|..|.+||+|||++-.+..+   .
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~---lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT  225 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE---LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT  225 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH---hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence            76654321111123578888888999999999999988   48999999999999999999999999999876543   2


Q ss_pred             cccccCcccCccccc--cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 AIARLGGYKAPEQAE--VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~--~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      ...|...|||||.+.  +..|+-+|||||+|++|||+.||+.||..-             ..+.+.+..........-..
T Consensus       226 ~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-------------~svfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  226 VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-------------DSVFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-------------HHHHHHHHHHHcCCCCeecC
Confidence            345666799999985  345899999999999999999999998531             11222233333322221111


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +.      ...+....+..++..|+..|-.+||...++.++
T Consensus       293 ~~------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 DK------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cc------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11      111233456777779999999999999998764

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=288.34  Aligned_cols=265  Identities=23%  Similarity=0.324  Sum_probs=191.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|++|+||+|... +++.||||++..... .......+|+..+.+++ |+||+++++++.+.+..++||||+ +
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~   81 (283)
T cd07830           3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-E   81 (283)
T ss_pred             eheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-C
Confidence            4567999999999999965 578999999875432 22334557889999998 999999999999999999999999 8


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      |+|.+++....   ...+++..+..++.|++.+|.|||+.    +++|+||+|+||++++++.++|+|||.+....... 
T Consensus        82 ~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~----~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          82 GNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKH----GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP  154 (283)
T ss_pred             CCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence            89999887643   12589999999999999999999988    99999999999999999999999999998765422 


Q ss_pred             --cccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccccc--chhHHHHHHhhhcccc
Q 036639          516 --AIARLGGYKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV--DLPKWVRSVVKEEWTA  590 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~-~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  590 (670)
                        ...++..|+|||++. ...++.++||||||++++||++|+.||.................  .-..|...........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence              234566799999874 45579999999999999999999999865422110000000000  0000110000000000


Q ss_pred             cc----ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EV----FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~----~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..    ....+..  ........+.+++.+||+.+|++|||++|++.+
T Consensus       235 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         235 FRFPQFAPTSLHQ--LIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccHHH--HcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00    0000000  000112457788889999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.7e-34  Score=314.29  Aligned_cols=239  Identities=26%  Similarity=0.376  Sum_probs=175.9

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC---------------
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK---------------  424 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~---------------  424 (670)
                      +.||+||||.||+++.+ ||+.||||++.-. .......+.+|+..+++|+|||||+++..+.+.               
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            68999999999999955 8999999999755 223446788999999999999999985443110               


Q ss_pred             --------------------------------------------------------------------------------
Q 036639          425 --------------------------------------------------------------------------------  424 (670)
Q Consensus       425 --------------------------------------------------------------------------------  424 (670)
                                                                                                      
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                                            


Q ss_pred             ------------------------CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCC
Q 036639          425 ------------------------EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA  480 (670)
Q Consensus       425 ------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  480 (670)
                                              ...||-||||+..++.++++.+....    .....++++.+|++||+|+|++    
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~----  716 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQ----  716 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhC----
Confidence                                    01267889999888888887654110    3567899999999999999998    


Q ss_pred             CccccCCCCCCeEeCCCCcEEEEecccccccC----------------------ccccccccCcccCccccccC---CCC
Q 036639          481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLN----------------------PVQAIARLGGYKAPEQAEVK---RLS  535 (670)
Q Consensus       481 ~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~----------------------~~~~~~~~~~y~aPE~~~~~---~~~  535 (670)
                      +||||||||.||++|++..|||+|||+|....                      ......||.-|+|||++.+.   .|+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999998721                      01123456669999998654   499


Q ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc--cccccHhhhcccchHHHHHHHHHH
Q 036639          536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT--AEVFDQELLRYKNIEEELVSMLHV  613 (670)
Q Consensus       536 ~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~d~~~~~~~~~~~~~~~l~~l  613 (670)
                      .|+||||+|||++||+.   ||...             .+-...+...-.....  ...++          +....-.++
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~Ts-------------MERa~iL~~LR~g~iP~~~~f~~----------~~~~~e~sl  850 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTS-------------MERASILTNLRKGSIPEPADFFD----------PEHPEEASL  850 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCch-------------HHHHHHHHhcccCCCCCCccccc----------ccchHHHHH
Confidence            99999999999999985   45421             0111111111111111  11111          222233457


Q ss_pred             HhhccCCCCCCCCCHHHHHHH
Q 036639          614 GLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       614 ~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +.+|++.||.+||||.|+++.
T Consensus       851 I~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  851 IRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHhcCCCccCCCHHHHhhc
Confidence            779999999999999999863

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=270.98  Aligned_cols=245  Identities=18%  Similarity=0.262  Sum_probs=190.2

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC----CeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK----EEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~----~~~~lv~e~  433 (670)
                      ..++||-|-.|.|-.+.. .+|+.+|+|++...     ...++|+++.-.. .|||||.++++|++.    ....+|||.
T Consensus        66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~  140 (400)
T KOG0604|consen   66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC  140 (400)
T ss_pred             hhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence            458999999999999985 47899999999743     4556777766544 599999999998753    456799999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLL  510 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~  510 (670)
                      |+||.|.+.+++.+   ...+++.+.-.|+.||..|+.|||+.    +|.||||||+|+|...   +-.+||+|||+|+.
T Consensus       141 meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~----nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  141 MEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSM----NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             ccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhc----chhhccCChhheeeecCCCCcceEecccccccc
Confidence            99999999998764   34689999999999999999999998    9999999999999964   45699999999998


Q ss_pred             cCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          511 LNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       511 ~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ....   ..-..|+.|.|||++...+|+..+|+||+||+||-|+.|.+||.....           ..+....+..+...
T Consensus       214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-----------~aispgMk~rI~~g  282 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----------LAISPGMKRRIRTG  282 (400)
T ss_pred             cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-----------ccCChhHHhHhhcc
Confidence            7642   334567889999999999999999999999999999999999975421           12222222222211


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .    +.-.-..+....   +...++++.+|+.+|++|.|++|++++
T Consensus       283 q----y~FP~pEWs~VS---e~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  283 Q----YEFPEPEWSCVS---EAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             C----ccCCChhHhHHH---HHHHHHHHHHhcCCchhheeHHHhhcC
Confidence            0    110111122223   334456668999999999999999986

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-33  Score=296.85  Aligned_cols=266  Identities=21%  Similarity=0.285  Sum_probs=188.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~lv  430 (670)
                      ..+.||+|+||.||+|.. .+|+.||||++....  ......+.+|++++++++||||+++++++....      ..++|
T Consensus        19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   98 (342)
T cd07879          19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV   98 (342)
T ss_pred             EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence            346899999999999995 478999999987532  223456789999999999999999999987543      46899


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +||+. .+|..+...       .+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||+++.
T Consensus        99 ~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~----~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          99 MPYMQ-TDLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHSA----GIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             ecccc-cCHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            99995 477776531       378899999999999999999998    999999999999999999999999999986


Q ss_pred             cCcc-ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccc-cccchhHHHHHHhh--
Q 036639          511 LNPV-QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE-QAVDLPKWVRSVVK--  585 (670)
Q Consensus       511 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--  585 (670)
                      .... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............. .....+.+......  
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         167 ADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             CCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence            5432 22345667999999865 4689999999999999999999999975421100000000 00000000000000  


Q ss_pred             -hcccc---ccccHhhh-cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhc
Q 036639          586 -EEWTA---EVFDQELL-RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRV  640 (670)
Q Consensus       586 -~~~~~---~~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~  640 (670)
                       ..+..   ........ ..+.   ....+.+++.+||+.||++||+++|++.+  ++..+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPK---ASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcC---CCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence             00000   00000000 0001   12346678889999999999999999976  766653

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-33  Score=296.74  Aligned_cols=190  Identities=25%  Similarity=0.346  Sum_probs=161.7

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEEE
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~lv  430 (670)
                      +.+.||+|+||.||++. ..+|+.||||++....  ....+.+.+|++++++++||||+++++++....      ..++|
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07880          19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV   98 (343)
T ss_pred             EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEE
Confidence            34679999999999998 4578999999986432  223456889999999999999999999987653      45899


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+ +++|.+++...      .+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++..
T Consensus        99 ~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~----gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          99 MPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            9999 77999888643      488999999999999999999988    999999999999999999999999999987


Q ss_pred             cCccc-cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNPVQ-AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~~~-~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..... ...++..|+|||.+.+ ..++.++||||||+++|++++|+.||...
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            65432 3455678999998865 45889999999999999999999999653

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=286.01  Aligned_cols=191  Identities=25%  Similarity=0.369  Sum_probs=170.2

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      ++||+|+||.||-++. .+|+.||+|.+.+..   ........+|-.++.+++.+.||.+--.|+..+..|+|+..|.||
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            6799999999999994 579999999886432   223445678899999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.-+|.....   ..+++...+-++.+|+-||++||+.    +||.||+||+|||+|+.|+++|+|.|+|..+....  
T Consensus       271 DLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~----~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~  343 (591)
T KOG0986|consen  271 DLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRR----RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPI  343 (591)
T ss_pred             ceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhc----ceeeccCChhheeeccCCCeEeeccceEEecCCCCcc
Confidence            99988876543   3589999999999999999999998    99999999999999999999999999999886543  


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                       ...||.||||||++....|+...|-||+||++|||+.|+.||..
T Consensus       344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence             34789999999999999999999999999999999999999964

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-33  Score=296.92  Aligned_cols=188  Identities=26%  Similarity=0.344  Sum_probs=159.5

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEEEE
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLLVY  431 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~  431 (670)
                      .+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|++++.+++||||+++++++...      ...++++
T Consensus        22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  101 (345)
T cd07877          22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  101 (345)
T ss_pred             EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence            46799999999999984 578999999997532  22346678899999999999999999988643      3467888


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      +++ +++|.+++...      .+++..+..++.|+++||+|||+.    +|+||||||+||++++++.+||+|||+++..
T Consensus       102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            887 78999888643      388999999999999999999998    9999999999999999999999999998876


Q ss_pred             Ccc-ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          512 NPV-QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       512 ~~~-~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                      ... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         171 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            433 23456777999998865 5688999999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-33  Score=278.25  Aligned_cols=235  Identities=26%  Similarity=0.330  Sum_probs=189.5

Q ss_pred             cCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      ||+|+||.||++... +++.||+|.+.....   .....+..|++++++++|+||+++++.+......++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999965 589999999875432   2446788999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~  515 (670)
                      .+++....     .+++.....++.|++.||.|||+.    +++|+||+|+||+++.++.++|+|||++......    .
T Consensus        81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~----~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~  151 (250)
T cd05123          81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSL----GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN  151 (250)
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcceEEEcCCCcEEEeecCcceecccCCCccc
Confidence            99997653     488999999999999999999997    9999999999999999999999999999876442    2


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||...+...+.++|+||||+++||+++|+.||.....              ............       
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------------~~~~~~~~~~~~-------  210 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------------KEIYEKILKDPL-------  210 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------------HHHHHHHhcCCC-------
Confidence            34456679999999888899999999999999999999999964311              111111111110       


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCH---HHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM---AEVAK  633 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~---~evl~  633 (670)
                        ......   ...+.+++.+||..||++||++   +++++
T Consensus       211 --~~~~~~---~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         211 --RFPEFL---SPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             --CCCCCC---CHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence              000111   2345567779999999999999   55554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.5e-33  Score=292.83  Aligned_cols=191  Identities=24%  Similarity=0.314  Sum_probs=158.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-C--CCEEEEEEeCCCC--cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeC----CeeEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-D--GGIVAVKRLKDAN--PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAK----EEKLL  429 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~----~~~~l  429 (670)
                      +.+.||+|+||.||++... +  +..||+|++....  ....+.+.+|+++++++ +||||+++++++...    ...++
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~   83 (332)
T cd07857           4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYL   83 (332)
T ss_pred             EEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEE
Confidence            3467999999999999954 4  7899999987532  22356778899999999 599999999875432    45688


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ++||+. ++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++
T Consensus        84 ~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          84 YEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSA----NVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            999985 68999886543     588999999999999999999988    99999999999999999999999999998


Q ss_pred             ccCcc--------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          510 LLNPV--------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       510 ~~~~~--------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....        ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            65421        12346777999998765 56899999999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.8e-33  Score=286.58  Aligned_cols=248  Identities=23%  Similarity=0.291  Sum_probs=191.1

Q ss_pred             HHhHcCCCCceEEEEEEE----cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+.||+|++|.||++..    .+++.||||+++...    ....+.+.+|++++.++ +||||+++++.+......++|
T Consensus         4 ~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   83 (288)
T cd05583           4 LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLI   83 (288)
T ss_pred             EEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEE
Confidence            346799999999999984    357889999987532    12345688899999999 599999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++++|.+++....     .+++.....++.|+++||.|||+.    +++||||||+||+++.++.++|+|||+++.
T Consensus        84 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~----~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          84 LDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQL----GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999987543     478899999999999999999987    999999999999999999999999999876


Q ss_pred             cCccc-----cccccCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          511 LNPVQ-----AIARLGGYKAPEQAEVKR--LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       511 ~~~~~-----~~~~~~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      .....     ...++..|+|||...+..  .+.++||||||+++|||+||..||......          ..........
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----------~~~~~~~~~~  224 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----------NSQSEISRRI  224 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----------chHHHHHHHH
Confidence            54322     234566799999987655  788999999999999999999998532110          0111111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ......         .....   ...+.+++.+||+.||++|||+.++.+.|+..
T Consensus       225 ~~~~~~---------~~~~~---~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         225 LKSKPP---------FPKTM---SAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             HccCCC---------CCccc---CHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence            111000         00011   12355677799999999999988887776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=287.14  Aligned_cols=258  Identities=25%  Similarity=0.365  Sum_probs=192.1

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.||+|++|.||+|... +++.||+|.+....  ....+.+..|++++++++|+||+++++++.+.+..++|+||++ +
T Consensus         4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~   82 (282)
T cd07829           4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-M   82 (282)
T ss_pred             ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-c
Confidence            467999999999999955 59999999998653  3345677889999999999999999999999999999999997 5


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||+|+||++++++.+||+|||.++......  
T Consensus        83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~----~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSH----RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            9999998652    2589999999999999999999998    99999999999999999999999999998764322  


Q ss_pred             --cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc--c
Q 036639          516 --AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT--A  590 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  590 (670)
                        ....+..|+|||.+.+. .++.++|||||||++||+++|+.||........       ...+...........|.  .
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ-------LFKIFQILGTPTEESWPGVT  227 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHHHhCCCcHHHHHhhc
Confidence              22334569999998766 789999999999999999999999865321100       00000000000000000  0


Q ss_pred             cc--ccHhhhccc------chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EV--FDQELLRYK------NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~--~d~~~~~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..  ++.......      ........+.+++.+||..+|++||++++++.+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         228 KLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00  000000000      000112457778889999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.2e-33  Score=286.29  Aligned_cols=240  Identities=23%  Similarity=0.335  Sum_probs=192.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||++... +|+.||+|++....   ....+.+.+|++++++++ |+||+++++++.+.+..++||||+
T Consensus         5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd05581           5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYA   84 (280)
T ss_pred             EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCC
Confidence            4467999999999999954 79999999987532   223467888999999998 999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++++|.+++....     .+++..+..++.|++.||+|||+.    +++|+||+|+||+++.++.++|+|||++......
T Consensus        85 ~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~----~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          85 PNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSK----GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999997653     589999999999999999999988    9999999999999999999999999998765432


Q ss_pred             c------------------------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccc
Q 036639          515 Q------------------------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       515 ~------------------------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~  570 (670)
                      .                        ...++..|+|||......++.++||||||++++++++|+.||.....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------  227 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE--------  227 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------
Confidence            2                        12345679999999888899999999999999999999999864410        


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM----AEVAKM  634 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~evl~~  634 (670)
                            ...+.......+.            ........+.+++.+||..+|++||++    +|++++
T Consensus       228 ------~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         228 ------YLTFQKILKLEYS------------FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ------HHHHHHHHhcCCC------------CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                  0111111111110            000112345667779999999999999    777764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.3e-33  Score=292.16  Aligned_cols=264  Identities=23%  Similarity=0.304  Sum_probs=184.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCC--------eeE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE--------EKL  428 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--------~~~  428 (670)
                      +.+.||+|+||.||+|... +++.||||++.....  .....+.+|++++++++||||+++++++.+..        ..+
T Consensus        12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   91 (311)
T cd07866          12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY   91 (311)
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence            3467999999999999954 689999999864322  12346778999999999999999999875543        468


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +|+||+.+ +|...+....    ..+++..+..++.|+++||+|||+.    +|+|+||||+||++++++.+||+|||++
T Consensus        92 lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~----~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          92 MVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHEN----HILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             EEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEECcCccc
Confidence            99999964 7777766432    2589999999999999999999998    9999999999999999999999999999


Q ss_pred             cccCccc---------------cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc
Q 036639          509 LLLNPVQ---------------AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ  572 (670)
Q Consensus       509 ~~~~~~~---------------~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  572 (670)
                      +......               ...++..|+|||.+.+ ..++.++|||||||++|||++|++||...............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            7653321               1123556999998765 45899999999999999999999999654221000000000


Q ss_pred             -----ccchhHHHHHHhhhc-cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          573 -----AVDLPKWVRSVVKEE-WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       573 -----~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           ....+.|........ ............  ........+.+++.+||..||++|||+.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE--RFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHH--HcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence                 000000000000000 000000000000  001112456778889999999999999999865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.1e-32  Score=275.29  Aligned_cols=179  Identities=21%  Similarity=0.265  Sum_probs=153.6

Q ss_pred             CCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHHHhcc
Q 036639          367 GSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG  445 (670)
Q Consensus       367 G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  445 (670)
                      |.+|.||++.. .+++.||+|+++...     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999995 578999999997543     233445555556799999999999999999999999999999999875


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-ccccccCccc
Q 036639          446 NRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-QAIARLGGYK  524 (670)
Q Consensus       446 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~y~  524 (670)
                      ..     .+++.....++.|+++||+|||+.    +|+||||||+||+++.++.++++|||.+...... ....++..|+
T Consensus        79 ~~-----~l~~~~~~~~~~ql~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~  149 (237)
T cd05576          79 FL-----NIPEECVKRWAAEMVVALDALHRE----GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC  149 (237)
T ss_pred             hc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCcccc
Confidence            43     488999999999999999999987    9999999999999999999999999987665442 2233455699


Q ss_pred             CccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       525 aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                      |||......++.++||||+|+++|||++|+.|+..
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence            99999888899999999999999999999988753

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-33  Score=296.47  Aligned_cols=263  Identities=21%  Similarity=0.261  Sum_probs=189.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe------eEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE------KLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~------~~lv  430 (670)
                      ..+.||+|++|.||+|... +++.||||++...  .....+.+.+|+.++++++|+||+++++++...+.      .++|
T Consensus        19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv   98 (343)
T cd07851          19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV   98 (343)
T ss_pred             EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence            3467999999999999964 6889999998753  22234667789999999999999999998876654      8999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +||+ +++|.+++...      .+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++..
T Consensus        99 ~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~----gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          99 THLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSA----GIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            9999 67999998753      489999999999999999999998    999999999999999999999999999987


Q ss_pred             cCcc-ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchhHHHHHHhhhc
Q 036639          511 LNPV-QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLPKWVRSVVKEE  587 (670)
Q Consensus       511 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  587 (670)
                      .... ....++..|+|||.+.+ ..++.++|||||||++|||+||+.||............... ......+......+.
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         168 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             ccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence            6432 23445667999998864 46789999999999999999999999643211000000000 000001111000000


Q ss_pred             cccccccH-hhhcccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQ-ELLRYKNI----EEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~-~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      . ...... ........    ......+.+++.+||..+|++|||+.||+++
T Consensus       248 ~-~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         248 A-RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             H-HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0 000000 00000000    0113456778889999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=269.78  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=197.9

Q ss_pred             ccccHHHHHHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHH---HHHHHHHhccCCCCeeeEEEEEEeC
Q 036639          349 KQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEF---EQYMDVIGKLKHPNVVKLRAYYYAK  424 (670)
Q Consensus       349 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~---~~e~~~l~~l~h~nIv~l~~~~~~~  424 (670)
                      ...+.++.  .+-++||+|.||.|-+++ ..+|+.+|+|++++.-...++++   ..|-++++..+||.+..+--.|...
T Consensus       163 ~kvTm~dF--dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  163 NKVTMEDF--DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             ceeccchh--hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            34555555  456899999999999999 55799999999997654444444   4577899999999999998889999


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      ++.|.||||..||.|.-.+...+     .+++....-+-..|+.||.|||+.    +||.||||.+|.|+|.||++||+|
T Consensus       241 drlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~----~ivYRDlKLENLlLDkDGHIKitD  311 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSR----NIVYRDLKLENLLLDKDGHIKITD  311 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhC----CeeeeechhhhheeccCCceEeee
Confidence            99999999999999988887654     477888888889999999999998    999999999999999999999999


Q ss_pred             cccccccC----ccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          505 FGLSLLLN----PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       505 FG~a~~~~----~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ||+++.--    ....+.||+.|+|||++....|+.++|.|.+|||||||++|+.||...+..           .+   +
T Consensus       312 FGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----------kL---F  377 (516)
T KOG0690|consen  312 FGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----------KL---F  377 (516)
T ss_pred             cccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----------HH---H
Confidence            99998643    245678999999999999999999999999999999999999999754211           11   1


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      .-++.+         ++.....+..+...++.   ..|..||.+|.     .+.||.++
T Consensus       378 eLIl~e---------d~kFPr~ls~eAktLLs---GLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  378 ELILME---------DLKFPRTLSPEAKTLLS---GLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             HHHHhh---------hccCCccCCHHHHHHHH---HHhhcChHhhcCCCchhHHHHHhh
Confidence            111111         11222234455555544   78899999995     46666654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.7e-33  Score=280.13  Aligned_cols=245  Identities=24%  Similarity=0.329  Sum_probs=187.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-----CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-----NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.+.||+|+||.||++... .+..+++|.++..     ......++..|+.++++++||||+++++++.+....++|||
T Consensus         3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (260)
T cd08222           3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE   82 (260)
T ss_pred             eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence            44578999999999999854 3455666665432     12234467788999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.+++..... ....+++..+..++.|++.||.|||+.    +++|+||||+||+++. +.+||+|||.+....
T Consensus        83 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~----~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          83 YCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQR----RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             eCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHc----CccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999998875321 123589999999999999999999988    9999999999999975 569999999987664


Q ss_pred             cc----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          513 PV----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       513 ~~----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ..    ....++..|+|||...+..++.++||||||+++|+|++|..||....              ............ 
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------------~~~~~~~~~~~~-  221 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------------FLSVVLRIVEGP-  221 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------------HHHHHHHHHcCC-
Confidence            32    23345677999999988889999999999999999999999985321              111111111110 


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ... +         .......+.+++.+||..+|++||++.|++++
T Consensus       222 ~~~-~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         222 TPS-L---------PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCC-C---------cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            000 0         11122356677889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=9.6e-33  Score=314.03  Aligned_cols=140  Identities=26%  Similarity=0.395  Sum_probs=125.7

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||+|... +++.||||+++...   ......+..|++++..++||||+++++++......|+||||+++
T Consensus         9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g   88 (669)
T cd05610           9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG   88 (669)
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence            467999999999999965 78999999997543   22346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ++|.+++....     .+++..++.++.||+.||+|||..    +|+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~----gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          89 GDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRH----GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999997543     478889999999999999999987    99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.2e-33  Score=304.76  Aligned_cols=245  Identities=22%  Similarity=0.289  Sum_probs=197.1

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.++||+|+||.|..++. .+++.||+|++++..   .....-|..|-++|..-+.+-|+.+.-.|.+..+.|+||||
T Consensus        77 feilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY  156 (1317)
T KOG0612|consen   77 FEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDY  156 (1317)
T ss_pred             hHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEec
Confidence            35678999999999999995 468999999998732   23456789999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |+||+|-.++....     .++......++..|+.||.-||+.    |+|||||||+|||+|..|++||+|||.+..+..
T Consensus       157 ~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~m----gyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  157 MPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSM----GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             ccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhc----cceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            99999999998654     478888888999999999999998    999999999999999999999999999988864


Q ss_pred             -----cccccccCcccCccccc----c-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          514 -----VQAIARLGGYKAPEQAE----V-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       514 -----~~~~~~~~~y~aPE~~~----~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                           .....|||.|++||++.    + +.|++.+|.||+||++|||+.|..||...              .+...+..+
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------------slveTY~KI  293 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------------SLVETYGKI  293 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------------HHHHHHHHH
Confidence                 33567999999999984    3 56999999999999999999999999754              344444444


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT---MAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~~  634 (670)
                      +.........     ....+.++...+++   +.+ -+|+.|..   ++++-.|
T Consensus       294 m~hk~~l~FP-----~~~~VSeeakdLI~---~ll-~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  294 MNHKESLSFP-----DETDVSEEAKDLIE---ALL-CDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             hchhhhcCCC-----cccccCHHHHHHHH---HHh-cChhhhcccccHHHHHhC
Confidence            4332111110     01124455555554   322 27999988   8888775

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=272.71  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=187.4

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC-------cchHHHHHHHHHHHhccCCCCeeeEEEEEE-eCCeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPNVVKLRAYYY-AKEEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~-~~~~~~lv  430 (670)
                      .-+.||+|||++||+|. +...+.||||+-.-..       ....+...+|.+|.+.|+||.||++|+||. +.+..|-|
T Consensus       467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV  546 (775)
T KOG1151|consen  467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV  546 (775)
T ss_pred             HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence            35689999999999999 6678899999864221       112345667899999999999999999996 45677899


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC---CCCcEEEEeccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGL  507 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~  507 (670)
                      +|||+|.+|.-+++.++     .+++.....|+.||+.||.||.+.  +++|||-||||.|||+-   ..|.+||+|||+
T Consensus       547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            99999999999998776     588999999999999999999998  67999999999999994   357899999999


Q ss_pred             ccccCccc-----------cccccCcccCcccccc----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc
Q 036639          508 SLLLNPVQ-----------AIARLGGYKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ  572 (670)
Q Consensus       508 a~~~~~~~-----------~~~~~~~y~aPE~~~~----~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  572 (670)
                      ++.++...           ...||.+|++||.+.-    .+++.|+||||.|||+|..+.|+.||...-..         
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---------  690 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---------  690 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---------
Confidence            99886422           2456778999998743    35789999999999999999999999643110         


Q ss_pred             ccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          573 AVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       573 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                              ..++.++..-..-...+..-+....+...   ++++||++.-++|....++..+
T Consensus       691 --------QdILqeNTIlkAtEVqFP~KPvVsseAka---FIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  691 --------QDILQENTILKATEVQFPPKPVVSSEAKA---FIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             --------HHHHhhhchhcceeccCCCCCccCHHHHH---HHHHHHHhhhhhhhhHHHHccC
Confidence                    01111111100000001111222334444   5559999999999998888653

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=7e-33  Score=290.46  Aligned_cols=236  Identities=22%  Similarity=0.273  Sum_probs=185.8

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +...+|.|+|+.|-.+. ..+++..+||++.+..    .+..+|+.++... +||||+++.+.+.+..+.|+|||++.++
T Consensus       326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~  401 (612)
T KOG0603|consen  326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGG  401 (612)
T ss_pred             cccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhcccc
Confidence            44569999999999998 4578999999998652    3345567666555 6999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe-CCCCcEEEEecccccccCccc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL-DKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      -+.+.+...+      .....+..|+.+++.|+.|||++    +|+||||||+|||+ ++.++++|+|||.++...... 
T Consensus       402 ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~----gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~  471 (612)
T KOG0603|consen  402 ELLRRIRSKP------EFCSEASQWAAELVSAVDYLHEQ----GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCD  471 (612)
T ss_pred             HHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhc----CeeecCCChhheeecCCCCcEEEEEechhhhCchhhc
Confidence            8888877554      23367778999999999999998    99999999999999 699999999999999887652 


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...-|..|.|||++....|++++|+||||++||+|++|+.||......          .+    +...+....    +. 
T Consensus       472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------~e----i~~~i~~~~----~s-  532 (612)
T KOG0603|consen  472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------IE----IHTRIQMPK----FS-  532 (612)
T ss_pred             ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------HH----HHHhhcCCc----cc-
Confidence            224566799999999999999999999999999999999999754211          00    111111000    00 


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                           ....++.++   |+.+||+.||.+||+|.|+..+=-
T Consensus       533 -----~~vS~~AKd---Ll~~LL~~dP~~Rl~~~~i~~h~w  565 (612)
T KOG0603|consen  533 -----ECVSDEAKD---LLQQLLQVDPALRLGADEIGAHPW  565 (612)
T ss_pred             -----cccCHHHHH---HHHHhccCChhhCcChhhhccCcc
Confidence                 123344444   555999999999999999988743

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=4.7e-33  Score=282.20  Aligned_cols=240  Identities=22%  Similarity=0.341  Sum_probs=188.9

Q ss_pred             HhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .++||+|.||+||-|. .++|+.||||++.+..  ......++.|+.||+.++||.||.+.-.|+..+..++|||.+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            5899999999999999 5589999999997643  23457899999999999999999999999999999999999955 


Q ss_pred             ChHHH-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEecccccccCc
Q 036639          438 SLHSL-LHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNP  513 (670)
Q Consensus       438 ~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~  513 (670)
                      +..+. +....+    .+++.....++.||+.||.|||.+    +|+|+||||+|||+.+..   .+||+|||.|+.+.+
T Consensus       648 DMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~k----nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  648 DMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFK----NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhc----ceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            55554 443332    478888888999999999999998    999999999999996543   699999999999976


Q ss_pred             c---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 V---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .   ....||+.|+|||++....|...-|+||.|||+|.-++|..||....             ++.+.+.         
T Consensus       720 ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-------------dIndQIQ---------  777 (888)
T KOG4236|consen  720 KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-------------DINDQIQ---------  777 (888)
T ss_pred             hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-------------chhHHhh---------
Confidence            4   45789999999999999999999999999999999999999996431             1111110         


Q ss_pred             ccccHhhhcc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRY-KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         +..+... ..+.+.....++++...|+..-.+|-+....+.|
T Consensus       778 ---NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  778 ---NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             ---ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence               0000000 1122223344556667778888888888776654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=270.75  Aligned_cols=259  Identities=21%  Similarity=0.285  Sum_probs=201.7

Q ss_pred             HHHHHHHHHhHcCCCCceEEEEEEEcC------CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-
Q 036639          353 LEDLLRASAEMLGKGSLGTVYKAVLDD------GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-  424 (670)
Q Consensus       353 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-  424 (670)
                      ++..+.+....+.+|.||.||+|.|.+      .+.|-+|.++... ......+..|.-.+..+.|||+.++.+++.+. 
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence            333334445678999999999997543      4567788887543 33445677777778888999999999988654 


Q ss_pred             CeeEEEEeccCCCChHHHhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRG---PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                      ...+++|.++.-|+|..|+...++   .....+...+...++.|++.|++|||.+    +|||.||..+|.+||+..++|
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~----~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH----GVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc----CcccchhhhhcceehhheeEE
Confidence            577899999999999999984332   2344677788899999999999999998    999999999999999999999


Q ss_pred             EEecccccccCcccc------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccccccc
Q 036639          502 ISDFGLSLLLNPVQA------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAV  574 (670)
Q Consensus       502 l~DFG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  574 (670)
                      |+|=.+++.+-+.+.      ..+...||+||.+....|+.++|||||||+||||+| |+.||...+|.           
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-----------  505 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-----------  505 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-----------
Confidence            999999998765332      234445999999999999999999999999999999 89998644221           


Q ss_pred             chhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                          .+..++++++          +..+...+..+++.+|..||+.+|++||+++|++.-|.+...
T Consensus       506 ----Em~~ylkdGy----------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  506 ----EMEHYLKDGY----------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             ----HHHHHHhccc----------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                1222233322          112233455678889999999999999999999999988754

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=3.6e-32  Score=240.47  Aligned_cols=191  Identities=27%  Similarity=0.392  Sum_probs=164.0

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      --++||+|.||+||+|+ .++++.||+|+++-.  +........+|+-+++.++|.|||+++++...+....+|+|||. 
T Consensus         6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-   84 (292)
T KOG0662|consen    6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-   84 (292)
T ss_pred             HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-
Confidence            34789999999999999 667899999998743  44456778899999999999999999999999999999999994 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      .+|..+.....+    .++......++.|+++||.|.|++    ++.|||+||.|.|++.+|+.|++|||+++...-.  
T Consensus        85 qdlkkyfdslng----~~d~~~~rsfmlqllrgl~fchsh----nvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   85 QDLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSH----NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             HHHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhh----hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            589988876543    488899999999999999999998    9999999999999999999999999999877532  


Q ss_pred             --ccccccCcccCccccccCC-CCCchhHHHHHHHHHHHHc-CCCCCCC
Q 036639          515 --QAIARLGGYKAPEQAEVKR-LSQKADVYSFGVLLLEVLT-GRAPSQY  559 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~ellt-g~~p~~~  559 (670)
                        ....-|..|++|.++.+.+ |+...|+||-|||+.|+.. |++.|.+
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg  205 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG  205 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence              2234567799999998765 7899999999999999987 4444543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=4.9e-34  Score=265.25  Aligned_cols=195  Identities=25%  Similarity=0.382  Sum_probs=161.4

Q ss_pred             HHHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeC--CCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe--------CC
Q 036639          357 LRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--------KE  425 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--------~~  425 (670)
                      .|.-..++|+|.||+||+|+. ++|+.||+|++-  ...........+|++++..++|+|++.+++.|..        +.
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            344457899999999999994 568889988763  2233345667889999999999999999888753        23


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ..|+||++|+. +|..++....    +.++..++.+++.++..||.|+|+.    .|+|||+||+|+||+.+|.+||+||
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~----kilHRDmKaaNvLIt~dgilklADF  168 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRN----KILHRDMKAANVLITKDGILKLADF  168 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHh----hHHhhcccHhhEEEcCCceEEeecc
Confidence            47999999965 8988886542    3588899999999999999999998    9999999999999999999999999


Q ss_pred             ccccccCcccc--------ccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          506 GLSLLLNPVQA--------IARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       506 G~a~~~~~~~~--------~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      |+++.......        ..-|..|++||.+.+ ..|+++.|||.-||||.||+||.+-+++.
T Consensus       169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn  232 (376)
T KOG0669|consen  169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN  232 (376)
T ss_pred             ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence            99987654322        223667999998865 46999999999999999999999888765

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=288.51  Aligned_cols=243  Identities=25%  Similarity=0.387  Sum_probs=202.0

Q ss_pred             HhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEe-----CCeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYA-----KEEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~-----~~~~~lv~e~  433 (670)
                      .+.+|+|.+|.||+++ .++|+.+|+|+...... ..++++.|.++++.+ +|||++.++|+|.-     ++..+|||||
T Consensus        24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf  102 (953)
T KOG0587|consen   24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEF  102 (953)
T ss_pred             EEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence            3679999999999999 67899999999875433 567888899999888 69999999999864     4688999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |.+|+..++++...   ...+.|..+.-|++.+++||.+||..    .++|||||-.|||++.++.+||.|||.+..++.
T Consensus       103 C~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~n----kviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen  103 CGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNN----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             cCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhc----ceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            99999999998765   23689999999999999999999998    999999999999999999999999999988754


Q ss_pred             ----cccccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          514 ----VQAIARLGGYKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       514 ----~~~~~~~~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                          .....||+.|||||++..     ..|+..+|+||+|++..||--|.+|+.++.+.+..+.+.....          
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPP----------  245 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP----------  245 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCC----------
Confidence                345678889999999853     3477899999999999999999999988877665554332221          


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                                +.+.   ......+++.+++..||..|-++||++.++++|
T Consensus       246 ----------PkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  246 ----------PKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ----------cccc---chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                      1112   223344567778889999999999999998764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-32  Score=243.51  Aligned_cols=203  Identities=27%  Similarity=0.370  Sum_probs=166.3

Q ss_pred             ccHHHHHHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCC-CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCee
Q 036639          351 FELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA-NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       351 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~  427 (670)
                      |++.+-.-.....||+|++|.|-+-+ ..+|+..|+|+++.. .....++..+|+++..+- .+|.+|.++|.+.+....
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            55544433556889999999999888 457999999999854 233456677788776554 799999999999999999


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      ++.||.| ..+|..+.++.-. ....+++...-+|+..+.+||.|||++   ..++|||+||+|||++.+|++|++|||.
T Consensus       121 wIcME~M-~tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~k---L~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSK---LSVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHH---hhhhhccCCcceEEEccCCcEEEccccc
Confidence            9999999 4588777553221 122588899999999999999999999   5899999999999999999999999999


Q ss_pred             ccccCcccc---ccccCcccCccccc----cCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 036639          508 SLLLNPVQA---IARLGGYKAPEQAE----VKRLSQKADVYSFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       508 a~~~~~~~~---~~~~~~y~aPE~~~----~~~~~~ksDVwS~Gvvl~elltg~~p~~  558 (670)
                      +-.+.++-.   ..|...|||||.+.    ...|+-|+||||+|+++.||.+++.||+
T Consensus       196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            988765432   44666799999874    3468999999999999999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8.9e-31  Score=261.51  Aligned_cols=236  Identities=28%  Similarity=0.382  Sum_probs=190.6

Q ss_pred             CceEEEEEEEc-CCCEEEEEEeCCCCcch-HHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHHHhcc
Q 036639          368 SLGTVYKAVLD-DGGIVAVKRLKDANPCA-RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG  445 (670)
Q Consensus       368 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  445 (670)
                      +||.||+|... +|+.||+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 58999999998665444 68999999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---ccccccCc
Q 036639          446 NRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---QAIARLGG  522 (670)
Q Consensus       446 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~~  522 (670)
                      ..     .+++..+..++.++++++.|||+.    +++|+||+|+||+++.++.++|+|||.+......   ....++..
T Consensus        81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~  151 (244)
T smart00220       81 RG-----RLSEDEARFYARQILSALEYLHSN----GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPE  151 (244)
T ss_pred             cc-----CCCHHHHHHHHHHHHHHHHHHHHc----CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcC
Confidence            53     278999999999999999999998    9999999999999999999999999999877653   33455667


Q ss_pred             ccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccc
Q 036639          523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKN  602 (670)
Q Consensus       523 y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  602 (670)
                      |++||......++.++||||||++++++++|..||....             ..................         .
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------------~~~~~~~~~~~~~~~~~~---------~  209 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------------QLLELFKKIGKPKPPFPP---------P  209 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------------cHHHHHHHHhccCCCCcc---------c
Confidence            999999988889999999999999999999999986420             111111111111100000         0


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          603 IEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       603 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .......+.+++.+|+..+|++||++.+++++
T Consensus       210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence            00022456778889999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.2e-30  Score=282.14  Aligned_cols=259  Identities=18%  Similarity=0.290  Sum_probs=173.1

Q ss_pred             HHHhHcCCCCceEEEEEEE-----------------cCCCEEEEEEeCCCCcchHHHH--------------HHHHHHHh
Q 036639          359 ASAEMLGKGSLGTVYKAVL-----------------DDGGIVAVKRLKDANPCARKEF--------------EQYMDVIG  407 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~e~~~l~  407 (670)
                      .+.++||+|+||+||+|.+                 ..++.||||++........++|              ..|+.++.
T Consensus       148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~  227 (507)
T PLN03224        148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA  227 (507)
T ss_pred             eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence            3457899999999999963                 2356899999975433233333              34666677


Q ss_pred             ccCCCCe-----eeEEEEEEe--------CCeeEEEEeccCCCChHHHhccCCCC-------------------CCCCCC
Q 036639          408 KLKHPNV-----VKLRAYYYA--------KEEKLLVYDYLPNGSLHSLLHGNRGP-------------------GRIPLD  455 (670)
Q Consensus       408 ~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~  455 (670)
                      +++|.++     ++++++|..        .+..++||||+++++|.++++...+.                   ....++
T Consensus       228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~  307 (507)
T PLN03224        228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD  307 (507)
T ss_pred             HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence            7766554     677787753        35679999999999999998753211                   012356


Q ss_pred             HHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc-----ccccCcccCccccc
Q 036639          456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-----IARLGGYKAPEQAE  530 (670)
Q Consensus       456 ~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~y~aPE~~~  530 (670)
                      |..+..++.|+++||.|||+.    +|+||||||+|||++.++.+||+|||+++.......     ...++.|+|||.+.
T Consensus       308 ~~~~~~i~~ql~~aL~~lH~~----~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        308 INVIKGVMRQVLTGLRKLHRI----GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC----CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            788999999999999999988    999999999999999999999999999976543211     22357799999875


Q ss_pred             cCC--------------------C--CCchhHHHHHHHHHHHHcCCC-CCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          531 VKR--------------------L--SQKADVYSFGVLLLEVLTGRA-PSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       531 ~~~--------------------~--~~ksDVwS~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ...                    +  ..+.||||+||++|||++|.. ||..........  ......+..|. ......
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~--~~~~~~~~~~r-~~~~~~  460 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL--RQYDNDLNRWR-MYKGQK  460 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHH--hhccchHHHHH-hhcccC
Confidence            322                    1  235799999999999999875 664321111000  00011112221 111111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQP---EKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~evl~~  634 (670)
                      +...       ......   ....+++.+|+..+|   .+|+|++|+++|
T Consensus       461 ~~~~-------~~d~~s---~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        461 YDFS-------LLDRNK---EAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             CCcc-------cccccC---hHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            1111       111122   234456668888765   689999999987

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-30  Score=262.91  Aligned_cols=268  Identities=22%  Similarity=0.269  Sum_probs=194.0

Q ss_pred             HHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-----C---CCeeeEEEEEEe----C
Q 036639          358 RASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-----H---PNVVKLRAYYYA----K  424 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~nIv~l~~~~~~----~  424 (670)
                      |-+.++||-|.|++||++. ..+.+.||+|+.+... ...+....||++|++++     |   .+||+++++|..    +
T Consensus        80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG  158 (590)
T KOG1290|consen   80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNG  158 (590)
T ss_pred             EEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCC
Confidence            3456789999999999999 4567899999998654 25567788999999883     3   479999999975    4


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-------
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-------  497 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-------  497 (670)
                      .+.|||+|++ |.+|..+|....-   .-++...+.+|+.||+.||.|||+.|   +|||.||||+|||+-.+       
T Consensus       159 ~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec---gIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  159 QHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC---GIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             cEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc---CccccCCCcceeeeeccccchhhh
Confidence            5889999999 7799999986542   24889999999999999999999997   89999999999999211       


Q ss_pred             ----C---------------------------------------------------------------------------
Q 036639          498 ----G---------------------------------------------------------------------------  498 (670)
Q Consensus       498 ----~---------------------------------------------------------------------------  498 (670)
                          +                                                                           
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                0                                                                           


Q ss_pred             --------------------------------------------------------------------------------
Q 036639          499 --------------------------------------------------------------------------------  498 (670)
Q Consensus       499 --------------------------------------------------------------------------------  498 (670)
                                                                                                      
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                            


Q ss_pred             cEEEEecccccccCc-cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchh
Q 036639          499 VACISDFGLSLLLNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP  577 (670)
Q Consensus       499 ~~kl~DFG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  577 (670)
                      .+||+|||-|.+... ......|..|+|||++.+..|++.+|||||+|+++||+||...|+..+......+ ......+.
T Consensus       392 ~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rD-EDHiA~i~  470 (590)
T KOG1290|consen  392 RVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRD-EDHIALIM  470 (590)
T ss_pred             eEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCcc-HHHHHHHH
Confidence            022233333222211 1112224459999999999999999999999999999999999987654432211 11111122


Q ss_pred             HHHHHHh-----hhccccccccH------------------hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          578 KWVRSVV-----KEEWTAEVFDQ------------------ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       578 ~~~~~~~-----~~~~~~~~~d~------------------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..+..+.     ...+..+.|+.                  -..++....++..+|.+++.-||+.+|++||||.+.++|
T Consensus       471 ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  471 ELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence            2221111     11122222222                  222355667888999999999999999999999999975

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=272.44  Aligned_cols=203  Identities=22%  Similarity=0.314  Sum_probs=177.7

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEcCC-CEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDG-GIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE  425 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  425 (670)
                      +..++++  .....||-|+||.|-++..+.. ..+|+|.+++..   ....+.+..|-.+|...+.|.||++|-.|.+..
T Consensus       416 ~v~l~dl--~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  416 QVKLSDL--KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             ccchhhh--hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            4455555  3346899999999999996643 348999988653   334566778999999999999999999999999


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ..|++||-|-||.|...++...     .++..+..-++..+.+|++|||++    +||.|||||+|.++|.+|-+||.||
T Consensus       494 yvYmLmEaClGGElWTiLrdRg-----~Fdd~tarF~~acv~EAfeYLH~k----~iIYRDLKPENllLd~~Gy~KLVDF  564 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRG-----SFDDYTARFYVACVLEAFEYLHRK----GIIYRDLKPENLLLDNRGYLKLVDF  564 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcC-----CcccchhhhhHHHHHHHHHHHHhc----CceeccCChhheeeccCCceEEeeh
Confidence            9999999999999999998765     578888889999999999999998    9999999999999999999999999


Q ss_pred             ccccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 036639          506 GLSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT  563 (670)
Q Consensus       506 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~  563 (670)
                      |+|+.+...   -.+.||+.|.|||++.....+.++|.||+|+++|||+||.+||.+.++.
T Consensus       565 GFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm  625 (732)
T KOG0614|consen  565 GFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM  625 (732)
T ss_pred             hhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence            999998764   3578999999999999999999999999999999999999999876443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=284.78  Aligned_cols=240  Identities=27%  Similarity=0.368  Sum_probs=181.7

Q ss_pred             HHhHcCCCCceE-EEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGT-VYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      ..+++|.|+.|+ ||+|... |+.||||++-..   ...-..+|+..++.- +|||||++++.-.++...||..|.| ..
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~  587 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-AC  587 (903)
T ss_pred             cHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hh
Confidence            356799998875 7999986 899999998644   345667899988877 5999999999999999999999999 56


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---C--CcEEEEecccccccC
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---N--GVACISDFGLSLLLN  512 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DFG~a~~~~  512 (670)
                      +|.+++.... .......-...+.+..|+++||++||+-    +||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       588 sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHsl----~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  588 SLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHSL----KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHhc----ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            9999998741 1111111144577889999999999996    9999999999999976   3  469999999999885


Q ss_pred             cc-------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          513 PV-------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTG-RAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       513 ~~-------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ..       ....||-||+|||++....-+.++||||+|||+|+.+|| .+||...-.         ...+       ++
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~---------R~~N-------Il  726 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE---------RQAN-------IL  726 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH---------hhhh-------hh
Confidence            43       234577889999999988888899999999999999996 899965311         1111       11


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..+..-.       ......++  ...+|+.+|+.++|..||+|.+|+.|
T Consensus       727 ~~~~~L~-------~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  727 TGNYTLV-------HLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             cCcccee-------eeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            1111100       01111111  34456679999999999999999864

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=263.75  Aligned_cols=192  Identities=26%  Similarity=0.326  Sum_probs=164.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc---hHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC---ARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +..+||+|.||.|.+|..+ +.+.+|||++++.-..   +.+--..|-++|+.- +-|.++++..+|..-+..|.||||+
T Consensus       353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv  432 (683)
T KOG0696|consen  353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV  432 (683)
T ss_pred             eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence            3468999999999999955 5678999999865221   222223455666655 5789999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC--
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN--  512 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~--  512 (670)
                      .||+|--.++.-.     .+.++.+.-+|..||-||-+||++    +|+.||||.+|||+|.+|++||+|||+++.--  
T Consensus       433 nGGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~k----gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  433 NGGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             cCchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcC----CeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999988887654     477788889999999999999998    99999999999999999999999999998642  


Q ss_pred             --ccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          513 --PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       513 --~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                        ....+.||+.|+|||++...+|+..+|.|||||+||||+.|++||++.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence              244678899999999999999999999999999999999999999875

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=1.6e-30  Score=288.58  Aligned_cols=259  Identities=19%  Similarity=0.223  Sum_probs=161.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-C----CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEE------EEeCCeeE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-D----GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY------YYAKEEKL  428 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~------~~~~~~~~  428 (670)
                      +.+.||+|+||.||+|.+. +    +..||||++.....  .+....+  .+....+.++..++..      .......+
T Consensus       136 l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  211 (566)
T PLN03225        136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYW  211 (566)
T ss_pred             EeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceE
Confidence            4578999999999999964 4    68999999875321  1111111  1122222233222211      24556789


Q ss_pred             EEEeccCCCChHHHhccCCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeE
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPG---------------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL  493 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIl  493 (670)
                      +||||+++++|.+++.......               ........+..++.|++.||+|||+.    +|+||||||+|||
T Consensus       212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~----gIiHRDLKP~NIL  287 (566)
T PLN03225        212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST----GIVHRDVKPQNII  287 (566)
T ss_pred             EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC----CEEeCcCCHHHEE
Confidence            9999999999999987542100               00112234567999999999999988    9999999999999


Q ss_pred             eCC-CCcEEEEecccccccCc-----cccccccCcccCccccccC----------------------CCCCchhHHHHHH
Q 036639          494 LDK-NGVACISDFGLSLLLNP-----VQAIARLGGYKAPEQAEVK----------------------RLSQKADVYSFGV  545 (670)
Q Consensus       494 l~~-~~~~kl~DFG~a~~~~~-----~~~~~~~~~y~aPE~~~~~----------------------~~~~ksDVwS~Gv  545 (670)
                      ++. ++.+||+|||+++....     .....+++.|+|||.+...                      .++.++|||||||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            986 57999999999986532     2234567889999965321                      2445679999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCCc-ccccccchhHHHHHHhhhccccccccHhhhc-ccchHHHHHHHHHHHhhccCCCCC
Q 036639          546 LLLEVLTGRAPSQYPSPTRPRVD-EEEQAVDLPKWVRSVVKEEWTAEVFDQELLR-YKNIEEELVSMLHVGLACVVSQPE  623 (670)
Q Consensus       546 vl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~  623 (670)
                      ++|||+++..+++....  .... ......+...|.......      ..++... ............+++.+||+.||+
T Consensus       368 iL~el~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        368 IFLQMAFPNLRSDSNLI--QFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHhCcCCCchHHH--HHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            99999997665432100  0000 000011122222111110      0000000 000001112334678899999999


Q ss_pred             CCCCHHHHHHH
Q 036639          624 KRPTMAEVAKM  634 (670)
Q Consensus       624 ~RPt~~evl~~  634 (670)
                      +|||++|+++|
T Consensus       440 kR~ta~e~L~H  450 (566)
T PLN03225        440 QRISAKAALAH  450 (566)
T ss_pred             cCCCHHHHhCC
Confidence            99999999987

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.1e-30  Score=270.19  Aligned_cols=196  Identities=25%  Similarity=0.409  Sum_probs=169.3

Q ss_pred             HhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchH---HHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCAR---KEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||-|+||+|.+++ .++...||+|.+++.+...+   ..++.|-+||+..+.+-||+|+-.|.+.+..|+||||++|
T Consensus       634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG  713 (1034)
T KOG0608|consen  634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG  713 (1034)
T ss_pred             EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence            3579999999999998 56678899999987654333   4567789999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC----
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN----  512 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~----  512 (670)
                      |++-.+|-...     .+.+.....++..+..|+++.|..    |+|||||||+|||||.||++||+|||++.-+.    
T Consensus       714 GDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkm----GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd  784 (1034)
T KOG0608|consen  714 GDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKM----GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  784 (1034)
T ss_pred             ccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhc----cceecccCccceEEccCCceeeeeccccccceeccc
Confidence            99999887654     477788888889999999999988    99999999999999999999999999985321    


Q ss_pred             -----c-------------------------------------cccccccCcccCccccccCCCCCchhHHHHHHHHHHH
Q 036639          513 -----P-------------------------------------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEV  550 (670)
Q Consensus       513 -----~-------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~el  550 (670)
                           .                                     .....||+.|+|||++....|+.-+|.||.|||||||
T Consensus       785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM  864 (1034)
T ss_pred             cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence                 0                                     0123467889999999999999999999999999999


Q ss_pred             HcCCCCCCCCCCCCC
Q 036639          551 LTGRAPSQYPSPTRP  565 (670)
Q Consensus       551 ltg~~p~~~~~~~~~  565 (670)
                      +.|+.||...++...
T Consensus       865 ~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGET  879 (1034)
T ss_pred             hhCCCCccCCCCCcc
Confidence            999999987766543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-31  Score=250.96  Aligned_cols=191  Identities=24%  Similarity=0.391  Sum_probs=161.7

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC-----eeEEEEec
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE-----EKLLVYDY  433 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~  433 (670)
                      +.||-|+||.||-+.. ++|+.||+|++...  .....+.+-+|++++...+|.|++..++...-..     +.|+++|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            5699999999999994 57999999999753  2335577889999999999999999988765443     56889999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      | ..+|..++-..+     .++-..+.-++.||++||.|||+.    +|.||||||.|.|++.+...||+|||+++..+.
T Consensus       139 m-QSDLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHsA----~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  139 M-QSDLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHTA----NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             H-HhhhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhhc----chhhccCCCccEEeccCceEEecccccccccch
Confidence            9 558888886543     577788888999999999999998    999999999999999999999999999998776


Q ss_pred             ccccc-----ccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 036639          514 VQAIA-----RLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSP  562 (670)
Q Consensus       514 ~~~~~-----~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~  562 (670)
                      .+...     -|..|+|||.+.+. .|+.+.||||.|||+.||+.++..|+..++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P  263 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP  263 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh
Confidence            55433     34569999999875 589999999999999999999999876544

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=8.9e-30  Score=233.81  Aligned_cols=188  Identities=20%  Similarity=0.342  Sum_probs=161.4

Q ss_pred             HHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCC--eeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKE--EKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~--~~~lv~e~  433 (670)
                      |++.+++|+|.+++||.|. ..+.+.++||+++..   ..+.+.+|+.+++.|+ ||||+++++...++.  ...+|+||
T Consensus        40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~  116 (338)
T KOG0668|consen   40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY  116 (338)
T ss_pred             HHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence            5677899999999999999 667899999999854   5688999999999997 999999999998765  45699999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccC
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLN  512 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~  512 (670)
                      +.+.+...+..        .+....+..++.+++.||.|+|+.    ||+|||+||.|+++|... ..+|+|+|+|-+..
T Consensus       117 v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~----GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  117 VNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSM----GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhc----CcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99988877654        366678888999999999999998    999999999999999755 59999999999887


Q ss_pred             ccccc---cccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          513 PVQAI---ARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       513 ~~~~~---~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      +...+   ..+..|--||.+.. ..|+..-|+|||||++..|+..+.||...
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG  236 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  236 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC
Confidence            65433   33445889998864 45888999999999999999999998654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2.2e-30  Score=262.83  Aligned_cols=270  Identities=21%  Similarity=0.230  Sum_probs=200.7

Q ss_pred             HHHHHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC------CCCeeeEEEEEEeCCee
Q 036639          355 DLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK------HPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       355 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~nIv~l~~~~~~~~~~  427 (670)
                      +-+|.+....|+|-|++|.+|.. ..|+.||||++.+... ..+.-..|+++|.+|+      --|+++++-.|...++.
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            34455667789999999999994 4588999999987643 4566678999999995      35899999999999999


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFG  506 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG  506 (670)
                      |||+|-+ ..+|.+.|+...  ..+-+....+..++.|+..||..|...    +|+|.||||+||||++.. .+||||||
T Consensus       510 ClVFE~L-slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c----~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  510 CLVFEPL-SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKC----GVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             EEEehhh-hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhc----CeeecccCccceEeccCcceeeeccCc
Confidence            9999988 569999998765  234577888999999999999999986    999999999999999764 58999999


Q ss_pred             cccccCcccc--ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          507 LSLLLNPVQA--IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       507 ~a~~~~~~~~--~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      .|......+.  +--+.-|.|||++.+-.|+...|+||.||+||||.||+..|.+.+...+.--..+-.+.++.-+  +-
T Consensus       583 SA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km--lR  660 (752)
T KOG0670|consen  583 SASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM--LR  660 (752)
T ss_pred             cccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH--hh
Confidence            9988765443  2233459999999999999999999999999999999999977654322111111111111110  00


Q ss_pred             hhccccccccH--------------------------------hhhccc----chHHHHHHHHHHHhhccCCCCCCCCCH
Q 036639          585 KEEWTAEVFDQ--------------------------------ELLRYK----NIEEELVSMLHVGLACVVSQPEKRPTM  628 (670)
Q Consensus       585 ~~~~~~~~~d~--------------------------------~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~  628 (670)
                      +..+....||.                                .+...+    .....+.++.+|+-.|+..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            00001111111                                111111    122345667788889999999999999


Q ss_pred             HHHHHH
Q 036639          629 AEVAKM  634 (670)
Q Consensus       629 ~evl~~  634 (670)
                      .|+|+|
T Consensus       741 nqAL~H  746 (752)
T KOG0670|consen  741 NQALKH  746 (752)
T ss_pred             HHHhcC
Confidence            999986

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=9.3e-28  Score=233.78  Aligned_cols=207  Identities=34%  Similarity=0.533  Sum_probs=180.7

Q ss_pred             cCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHH
Q 036639          364 LGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS  441 (670)
Q Consensus       364 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  441 (670)
                      ||+|.+|.||++... +++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999965 4899999999866432 35789999999999999999999999999999999999999999999


Q ss_pred             HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccCcc----cc
Q 036639          442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNPV----QA  516 (670)
Q Consensus       442 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~~----~~  516 (670)
                      ++....    ..+++..+..++.++++++++||+.    +++|+||+|.||+++. ++.++|+|||.+......    ..
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~----~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLHSN----GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            997642    2488999999999999999999998    9999999999999999 899999999999876543    23


Q ss_pred             ccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          517 IARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ......|++||..... .++.+.|+|++|++++++                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4456679999998876 788999999999999999                                             


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                                  ..+.+++..|+..+|++||++.++++++
T Consensus       188 ------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                        1345577799999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2e-29  Score=259.11  Aligned_cols=191  Identities=20%  Similarity=0.350  Sum_probs=167.5

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---c-----hHHHHHHHHHHHhccC---CCCeeeEEEEEEeCCe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---C-----ARKEFEQYMDVIGKLK---HPNVVKLRAYYYAKEE  426 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~-----~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~  426 (670)
                      .+.+.+|.|+||.|+.|.++ +...|+||.+.+..-   .     ....+..|+.||..++   |+||++++++|++++.
T Consensus       564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~  643 (772)
T KOG1152|consen  564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY  643 (772)
T ss_pred             eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence            45678999999999999966 467899999876421   0     1123567999999997   9999999999999999


Q ss_pred             eEEEEecc-CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          427 KLLVYDYL-PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       427 ~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      .||+||-. ++.+|.++|....     .+++.....|+.||+.|+++||++    +|||||||-+||.++.+|-+||+||
T Consensus       644 yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~----~ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  644 YYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQ----GIVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             eEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhcccccccc----CceecccccccEEEecCCeEEEeec
Confidence            99999964 6779999998665     589999999999999999999998    9999999999999999999999999


Q ss_pred             ccccccC--ccccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCC
Q 036639          506 GLSLLLN--PVQAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       506 G~a~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~  558 (670)
                      |.+....  +...+.||.+|.|||++.+.+| ...-|||++|++||.++...-||.
T Consensus       715 gsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9997764  5678899999999999999887 567899999999999999988875

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=237.29  Aligned_cols=191  Identities=22%  Similarity=0.307  Sum_probs=165.7

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      -.+||+|.|+.|..+++ ++.+.+|+|++++...   .+..=++.|-.+.... +||.+|-+..+|......+.|.||++
T Consensus       255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~  334 (593)
T KOG0695|consen  255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN  334 (593)
T ss_pred             eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence            46799999999999994 5789999999986422   2233345566666555 79999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC---
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN---  512 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~---  512 (670)
                      +|+|--.++..+     .+++....-+...|..||.|||+.    |||.||||.+|||+|..|++||+|||+++.--   
T Consensus       335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~r----giiyrdlkldnvlldaeghikltdygmcke~l~~g  405 (593)
T KOG0695|consen  335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHER----GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhc----CeeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence            999977776554     588999999999999999999998    99999999999999999999999999998642   


Q ss_pred             -ccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          513 -PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       513 -~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                       ....+.||+.|+|||++.+..|...+|.|++||+|+||+.|+.||+-.
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv  454 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV  454 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence             245678999999999999999999999999999999999999999754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=229.33  Aligned_cols=259  Identities=18%  Similarity=0.330  Sum_probs=188.7

Q ss_pred             cccccHHHHHHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEE-EEeC
Q 036639          348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAY-YYAK  424 (670)
Q Consensus       348 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~-~~~~  424 (670)
                      .+..+++|. |.+.+.||+|.||.+-+++++ ..+.+|+|-+..... ..++|.+|...--.| .|.||+.-++. |...
T Consensus        17 l~kv~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~   94 (378)
T KOG1345|consen   17 LKKVDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS   94 (378)
T ss_pred             ccccchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence            345566654 577899999999999999965 578899999986543 568898988766556 58999998764 6667


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC--CCCcEEE
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD--KNGVACI  502 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kl  502 (670)
                      +..+.++||++.|+|.+-+...+      +.+....+++.|++.|+.|+|+.    ++||||||.+||||-  +..++||
T Consensus        95 d~YvF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsk----nlVHRdlK~eNiLif~~df~rvKl  164 (378)
T KOG1345|consen   95 DAYVFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSK----NLVHRDLKAENILIFDADFYRVKL  164 (378)
T ss_pred             ceEEEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhcc----chhhcccccceEEEecCCccEEEe
Confidence            77889999999999999887653      67788889999999999999998    999999999999993  3447999


Q ss_pred             EecccccccCc-cccccccCcccCccccccC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccch
Q 036639          503 SDFGLSLLLNP-VQAIARLGGYKAPEQAEVK-----RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       503 ~DFG~a~~~~~-~~~~~~~~~y~aPE~~~~~-----~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      +|||+.+..+. ......+..|.+||.....     ...+.+|||.||+++|.++||+.||+........      ..+.
T Consensus       165 cDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~------Y~~~  238 (378)
T KOG1345|consen  165 CDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP------YWEW  238 (378)
T ss_pred             eecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch------HHHH
Confidence            99999988765 3344556679999976432     3578899999999999999999999744222111      1112


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      .+|......      ...   ..+....+.+.++++   +-+..+|++|=-..++.++..
T Consensus       239 ~~w~~rk~~------~~P---~~F~~fs~~a~r~Fk---k~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  239 EQWLKRKNP------ALP---KKFNPFSEKALRLFK---KSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             HHHhcccCc------cCc---hhhcccCHHHHHHHH---HhcCCcccccchhHHHHHHHH
Confidence            222211111      011   112223344444444   788999999955555555443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=9.4e-29  Score=238.36  Aligned_cols=260  Identities=21%  Similarity=0.257  Sum_probs=185.2

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEEEEe
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLLVYD  432 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e  432 (670)
                      +.+|.|+- .|..+.. -.++.||+|++...  .....+...+|...+..++|+||++++.+|.-.      .+.|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            45777777 5555552 35899999988643  233457778899999999999999999998643      35699999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      || ..+|...++.       .++-.+...|..|++.|+.|||+.    +|+||||||+||++..+..+||.|||+|+...
T Consensus       102 ~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~----~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen  102 LM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSA----GIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             hh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhc----ceeecccCcccceecchhheeeccchhhcccC
Confidence            99 5699988873       367788999999999999999998    99999999999999999999999999998776


Q ss_pred             cc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccc--------hhHHHH
Q 036639          513 PV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD--------LPKWVR  581 (670)
Q Consensus       513 ~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~  581 (670)
                      ..   ..+..+..|.|||++.+..+.+.+||||.||++.||++|+..|.+....+.-....+..+.        +...++
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r  249 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR  249 (369)
T ss_pred             cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence            54   3345566799999999888999999999999999999999988654322111111111111        111111


Q ss_pred             HHhh--hccccccccHhhh-----cc-cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          582 SVVK--EEWTAEVFDQELL-----RY-KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       582 ~~~~--~~~~~~~~d~~~~-----~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ....  +++..-.+...+.     .. ....-.....-+++.+||..+|++|.+++++++|
T Consensus       250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            1111  0000000000000     00 0111112234456779999999999999999987

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=4.2e-27  Score=232.41  Aligned_cols=192  Identities=32%  Similarity=0.477  Sum_probs=169.6

Q ss_pred             HHhHcCCCCceEEEEEEEcC-CCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDD-GGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      ..+.||.|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            34679999999999999764 899999999876554 5788999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++.....    .+++.....++.+++.++.+||..    +++|+||+|+||+++.++.++|+|||.+......   
T Consensus        83 ~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~----~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       83 DLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSL----GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            99999986541    178899999999999999999988    9999999999999999999999999999877543   


Q ss_pred             --ccccccCcccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          515 --QAIARLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~-~~~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                        ....+...|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence              234556679999998 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=5.6e-29  Score=259.96  Aligned_cols=243  Identities=24%  Similarity=0.365  Sum_probs=195.4

Q ss_pred             HHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ..+.+|.|.||.||+++ ...++..|+|+++-....+..-+++|+-+++..+|||||.++|.+..++..++.||||.+|+
T Consensus        19 llqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggs   98 (829)
T KOG0576|consen   19 LLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGS   98 (829)
T ss_pred             heeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCc
Confidence            34679999999999999 55799999999987665677788899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----V  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~  514 (670)
                      |++.-+...     ++++.++-...+..++||+|||+.    +-+|||||-.||++++.|.+|++|||.+..+..    .
T Consensus        99 lQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~----gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   99 LQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQ----GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             ccceeeecc-----cchhHHHHHHHhhhhccchhhhcC----CcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            999987654     688888889999999999999998    889999999999999999999999999876643    4


Q ss_pred             ccccccCcccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 QAIARLGGYKAPEQA---EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~---~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      ..+.||+.|||||+.   ..+.|..++|||+.|+...|+---++|-....+.+..+               ++.    ..
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~---------------LmT----kS  230 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF---------------LMT----KS  230 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH---------------Hhh----cc
Confidence            567899999999986   45679999999999999999988887754332221110               010    11


Q ss_pred             cccHhhhccc-chHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036639          592 VFDQELLRYK-NIEEELVSMLHVGLACVVSQPEKRPTMAEVAK  633 (670)
Q Consensus       592 ~~d~~~~~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  633 (670)
                      .+++...+++ ...+   .+-+++..|+..+|++|||++.++.
T Consensus       231 ~~qpp~lkDk~kws~---~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 GFQPPTLKDKTKWSE---FFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCCcccCCccchH---HHHHHHHHHhcCCCccCCChhhhee
Confidence            2222222211 1222   3445666899999999999988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.6e-26  Score=231.28  Aligned_cols=190  Identities=24%  Similarity=0.395  Sum_probs=161.0

Q ss_pred             HHHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEe
Q 036639          358 RASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +...++||.|.|++||++.+.    ..+.||+|.+....  ....+..|++.|..+ .+.||+++.+++...+...+|+|
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            345689999999999999843    46789999997654  456789999999999 49999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEeccccccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLL  511 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~  511 (670)
                      |++.....++...        ++...+..++..+..||+++|.+    |||||||||+|+|.+. -+.-.|.|||+|...
T Consensus       116 ~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~----GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  116 YFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKN----GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             ccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhcc----CccccCCCccccccccccCCceEEechhHHHH
Confidence            9999999998863        66788999999999999999998    9999999999999985 467899999998721


Q ss_pred             C-----------------c-------------------------------cccccccCcccCcccccc-CCCCCchhHHH
Q 036639          512 N-----------------P-------------------------------VQAIARLGGYKAPEQAEV-KRLSQKADVYS  542 (670)
Q Consensus       512 ~-----------------~-------------------------------~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS  542 (670)
                      +                 +                               .....||+||+|||++.. ..-++++||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            0                 0                               001346888999999864 44688999999


Q ss_pred             HHHHHHHHHcCCCCCCCCC
Q 036639          543 FGVLLLEVLTGRAPSQYPS  561 (670)
Q Consensus       543 ~Gvvl~elltg~~p~~~~~  561 (670)
                      .|||++-+++++.||....
T Consensus       264 ~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             ccceeehhhccccccccCc
Confidence            9999999999999997653

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3e-26  Score=267.38  Aligned_cols=191  Identities=18%  Similarity=0.201  Sum_probs=136.4

Q ss_pred             ccCC-CCeeeEEEEE-------EeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCC
Q 036639          408 KLKH-PNVVKLRAYY-------YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT  479 (670)
Q Consensus       408 ~l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  479 (670)
                      .++| +||++++++|       ......+.++||+ +++|.+++....    ..+++..++.++.||++||+|||+.   
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQ---   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhC---
Confidence            3455 6888888877       2234567788887 669999997532    2589999999999999999999988   


Q ss_pred             CCccccCCCCCCeEeCC-------------------CCcEEEEecccccccCcc--------------------cccccc
Q 036639          480 AKVPHGNVKSSNVLLDK-------------------NGVACISDFGLSLLLNPV--------------------QAIARL  520 (670)
Q Consensus       480 ~~ivH~Dlkp~NIll~~-------------------~~~~kl~DFG~a~~~~~~--------------------~~~~~~  520 (670)
                       +|+||||||+||||+.                   ++.+|++|||+++.....                    ....+|
T Consensus       100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt  178 (793)
T PLN00181        100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM  178 (793)
T ss_pred             -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence             9999999999999954                   445667777776542110                    012356


Q ss_pred             CcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcc
Q 036639          521 GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY  600 (670)
Q Consensus       521 ~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  600 (670)
                      +.|||||++.+..++.++|||||||+||||++|..|+....                ..+......     .+.+..   
T Consensus       179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------------~~~~~~~~~-----~~~~~~---  234 (793)
T PLN00181        179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------------RTMSSLRHR-----VLPPQI---  234 (793)
T ss_pred             cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------------HHHHHHHHh-----hcChhh---
Confidence            67999999999999999999999999999999887764210                000000000     011100   


Q ss_pred             cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          601 KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       601 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         .........++.+||+.+|.+||+|.|++++
T Consensus       235 ---~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        235 ---LLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             ---hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence               0112234467778999999999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=4.2e-25  Score=209.86  Aligned_cols=169  Identities=23%  Similarity=0.277  Sum_probs=126.1

Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA  516 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  516 (670)
                      |+|.++++...    ..+++..++.++.|+++||+|||+.    +      ||+|||++.++.+|+  ||++....... 
T Consensus         1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~----~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-   63 (176)
T smart00750        1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQ----A------KSGNILLTWDGLLKL--DGSVAFKTPEQ-   63 (176)
T ss_pred             CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc----C------CcccEeEcCccceee--ccceEeecccc-
Confidence            68999997542    2589999999999999999999987    4      999999999999999  99998765433 


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      ..++..|+|||++.+..++.++|||||||++|||+||+.||.....             ....+.............+. 
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------------~~~~~~~~~~~~~~~~~~~~-  129 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------------LSAILEILLNGMPADDPRDR-  129 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------------hcHHHHHHHHHhccCCcccc-
Confidence            3567889999999999999999999999999999999999864311             11111111111000000000 


Q ss_pred             hhcccchHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          597 LLRYKNIEEEL--VSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       597 ~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                          .......  ..+.+++.+||..+|++||++.|+++++..+..
T Consensus       130 ----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 ----SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ----ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence                0011111  257788889999999999999999999987753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.4e-25  Score=209.58  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=192.9

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCee
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~  427 (670)
                      -+++.++  .+..+|.....|+.|+|++. |..+++|+++-...  ...++|.+|.-.++.+.||||.++++.|..+.+.
T Consensus       186 gid~~~l--nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnl  262 (448)
T KOG0195|consen  186 GIDVSSL--NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL  262 (448)
T ss_pred             Ccchhhh--hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence            3444444  34467899999999999998 55677788764433  2346899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      .++..||+.|+|+..+++..   ...++..+..+++.++|+|++|||+.  .+-|..--|.+..|++|++.+++|+= +-
T Consensus       263 v~isq~mp~gslynvlhe~t---~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarism-ad  336 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISM-AD  336 (448)
T ss_pred             eEeeeeccchHHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheec-cc
Confidence            99999999999999999764   34577889999999999999999997  33455557899999999999988752 22


Q ss_pred             ccccCccccccccCcccCccccccCCC---CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          508 SLLLNPVQAIARLGGYKAPEQAEVKRL---SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       508 a~~~~~~~~~~~~~~y~aPE~~~~~~~---~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      +++.-+.......+.||+||.++..+-   -.++|+|||.+++|||.|+..||..-++.+......-++.      +.. 
T Consensus       337 ~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl------rv~-  409 (448)
T KOG0195|consen  337 TKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL------RVH-  409 (448)
T ss_pred             ceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc------ccc-
Confidence            222222233445677999999986654   3579999999999999999999987655433322211110      000 


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                              +      .+.   ....+.+++.-|+..||.+||.+..++-.|+++.
T Consensus       410 --------i------ppg---is~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  410 --------I------PPG---ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             --------C------CCC---ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                    0      111   2234666777899999999999999999998764

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=5.3e-24  Score=255.30  Aligned_cols=184  Identities=34%  Similarity=0.589  Sum_probs=130.6

Q ss_pred             cCCCcchHHHHHHHHhccCCCCCCCCCCCCCCCCCCCcceEEecCCCCcEEEEEcCCCCccccCCC-CCCCCCccEEEcc
Q 036639           19 SSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLH   97 (670)
Q Consensus        19 ~~~~~~~~~~l~~~~~~~~~~~~~l~~W~~~~~~~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~   97 (670)
                      +-..+.|.++|+.||..+.+|...+.+|...++| |.|.||+|+. .++|+.|+|++|++.|.++. +..+++|+.|+|+
T Consensus        24 ~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~-c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls  101 (968)
T PLN00113         24 SMLHAEELELLLSFKSSINDPLKYLSNWNSSADV-CLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLS  101 (968)
T ss_pred             cCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCC-CcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECC
Confidence            3446789999999999997787888999766665 7999999985 46899999999999988776 7888888888888


Q ss_pred             CCCCccccCC--CccccccceeeccCCcccc----------------------cCCccccCCCCCCEEeCCCCcccccCC
Q 036639           98 DNRLNGTILP--LTNCTNLKLAYLSGNDFSA----------------------EIPHQISSLKGILRLDLSDNNIRGRIP  153 (670)
Q Consensus        98 ~N~l~~~~~~--~~~l~~L~~L~l~~N~l~g----------------------~~p~~~~~l~~L~~L~l~~N~l~g~~p  153 (670)
                      +|+++|.+|.  +.++++|++|+|++|+++|                      .+|..++++++|++|+|++|.+++.+|
T Consensus       102 ~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  181 (968)
T PLN00113        102 NNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP  181 (968)
T ss_pred             CCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence            8888876654  3366666666666665555                      445555555566666666666655566


Q ss_pred             CCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          154 EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       154 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      ..+.++++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..+
T Consensus       182 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l  232 (968)
T PLN00113        182 NSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI  232 (968)
T ss_pred             hhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhH
Confidence            666666666666666666665566556666666666666666666666544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.2e-23  Score=214.47  Aligned_cols=163  Identities=21%  Similarity=0.293  Sum_probs=125.1

Q ss_pred             HHHhHcCCCCceEEEEEEEc--CCCEEEEEEeCCC-----CcchHHHHHHHHHHHhccCCCCeee-EEEEEEeCCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD--DGGIVAVKRLKDA-----NPCARKEFEQYMDVIGKLKHPNVVK-LRAYYYAKEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~-l~~~~~~~~~~~lv  430 (670)
                      .+.+.||+|+||+||+|...  +++.||||++...     .....+.+.+|++++++++|+||++ +++    .+..++|
T Consensus        21 ~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LV   96 (365)
T PRK09188         21 VETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLV   96 (365)
T ss_pred             eEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEE
Confidence            34577999999999999864  5788899987533     1223567999999999999999985 443    2467999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCCCeEeCCCCcEEEEeccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNV-KSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~a~  509 (670)
                      |||+++++|... ...        .   ...++.+++++|+|||+.    +|+|||| ||+|||++.++.+||+|||+|+
T Consensus        97 mE~~~G~~L~~~-~~~--------~---~~~~~~~i~~aL~~lH~~----gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         97 RGWTEGVPLHLA-RPH--------G---DPAWFRSAHRALRDLHRA----GITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEccCCCCHHHh-Ccc--------c---hHHHHHHHHHHHHHHHHC----CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            999999999732 111        1   146788999999999998    9999999 9999999999999999999998


Q ss_pred             ccCcc------------ccccccCcccCccccccCC------CCCchhHH
Q 036639          510 LLNPV------------QAIARLGGYKAPEQAEVKR------LSQKADVY  541 (670)
Q Consensus       510 ~~~~~------------~~~~~~~~y~aPE~~~~~~------~~~ksDVw  541 (670)
                      .....            ....++..|+|||++...+      .+..+|-|
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            65432            2234566799999885432      33446665

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=9.9e-21  Score=197.43  Aligned_cols=256  Identities=19%  Similarity=0.191  Sum_probs=189.2

Q ss_pred             HHHHhHcCCCCceEEEEEEEcCC--CEEEEEEeCCCCcchHHHHHHHHHHHhccCC----CCeeeEEEEE-EeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLDDG--GIVAVKRLKDANPCARKEFEQYMDVIGKLKH----PNVVKLRAYY-YAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~nIv~l~~~~-~~~~~~~lv  430 (670)
                      |.+.+.||+|+||.||++.....  ..+|+|............+..|..++..+.+    +++..+++.. ......++|
T Consensus        20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iV   99 (322)
T KOG1164|consen   20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIV   99 (322)
T ss_pred             eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEE
Confidence            34567899999999999996543  5799998876533223377888888888863    6899999988 477789999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-----CcEEEEec
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-----GVACISDF  505 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DF  505 (670)
                      |+.+ |.+|.++.....   ...++..+...|+.|++.+|++||+.    |++||||||.|+++...     ..+.|.||
T Consensus       100 M~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~----G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen  100 MSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSK----GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             Eecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhc----CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            9998 889999886543   23589999999999999999999998    99999999999999865     35999999


Q ss_pred             cccc--ccC-c-----------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccc
Q 036639          506 GLSL--LLN-P-----------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE  571 (670)
Q Consensus       506 G~a~--~~~-~-----------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~  571 (670)
                      |+++  ... .           .....||..|+++....+...+.+.|+||++.++.|++.|..||.......       
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~-------  244 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD-------  244 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc-------
Confidence            9998  321 1           112347788999999999999999999999999999999999996542110       


Q ss_pred             cccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          572 QAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                         ...+ +.......    ....   .......+...+.+   .+-..+..++|....+...+++.....
T Consensus       245 ---~~~~-~~~~~~~~----~~~~---~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  245 ---LKSK-FEKDPRKL----LTDR---FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             ---hHHH-HHHHhhhh----cccc---ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence               0111 11111110    0000   11122334444444   344468999999999999998887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.9e-20  Score=195.42  Aligned_cols=254  Identities=27%  Similarity=0.362  Sum_probs=190.4

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc---hHHHHHHHHHHHhccCCC-CeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC---ARKEFEQYMDVIGKLKHP-NVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ..+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+++......+++++|+.
T Consensus         4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            3467899999999999977  88999999765332   367899999999999988 79999999977777899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccCcc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPV  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~  514 (670)
                      ++++.+++......  ..+.......+..|++.++.|+|+.    +++|||+||+||+++..+ .++++|||.++.....
T Consensus        82 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~----~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          82 GGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSK----GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            99999777654311  2578889999999999999999998    899999999999999988 7999999998755432


Q ss_pred             ----------ccccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          515 ----------QAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       515 ----------~~~~~~~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                                ....++..|+|||.+.+   ..++...|+||+|++++++++|..||......           .......
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-----------~~~~~~~  224 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-----------SATSQTL  224 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-----------ccHHHHH
Confidence                      34567778999999987   57889999999999999999999997543211           0011111


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..+...... ......... ........+.+++..|+..+|..|.++.+....
T Consensus       225 ~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         225 KIILELPTP-SLASPLSPS-NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHhcCCc-ccccccCcc-ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            111111100 000000000 001112345566778999999999999988775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.7e-22  Score=223.70  Aligned_cols=246  Identities=20%  Similarity=0.250  Sum_probs=177.6

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeC----CC-Cc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLK----DA-NP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~----~~-~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+|.|++|.|+.+.. ......+.|...    .. .. .....+..|+.+-..+.|+|++..+..+.+....+-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            46799999998887773 334444444332    11 11 1112256677777888999998888777776666666999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |++ +|..++....     .+....+-.++.|+..|+.|+|+.    ||.|||+|++|++++.+|.+||+|||.+.....
T Consensus       403 ~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~----GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  403 CPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSM----GLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             ccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhc----CceeccCccccEEEecCCceEEeecCcceeecc
Confidence            999 9999998652     377788889999999999999998    999999999999999999999999999875532


Q ss_pred             --------cccccccCcccCccccccCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          514 --------VQAIARLGGYKAPEQAEVKRLSQ-KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       514 --------~~~~~~~~~y~aPE~~~~~~~~~-ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                              .....+..+|+|||.+.+..|++ ..||||.|+++..|.+|+.||.............    ....+.    
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----~~~~~~----  544 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----NYSDQR----  544 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh----cccccc----
Confidence                    12345666799999999999986 5799999999999999999998764332221000    000000    


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK  633 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  633 (670)
                               ........-..........++.+||+.||.+|.|+++|++
T Consensus       545 ---------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 ---------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                     0000000011222334556778999999999999999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.1e-21  Score=189.46  Aligned_cols=165  Identities=14%  Similarity=0.188  Sum_probs=129.3

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHH---------HHHHHHHHhccCCCCeeeEEEEEEeC------
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKE---------FEQYMDVIGKLKHPNVVKLRAYYYAK------  424 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~nIv~l~~~~~~~------  424 (670)
                      +.+.+|.|+||.||++.. ++..+|||.+..........         +++|++.+.+++|++|..+.+++...      
T Consensus        35 ~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~  113 (232)
T PRK10359         35 TIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLR  113 (232)
T ss_pred             EEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccccccc
Confidence            457899999999999766 57789999997554333222         68899999999999999999987644      


Q ss_pred             --CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEE
Q 036639          425 --EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI  502 (670)
Q Consensus       425 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl  502 (670)
                        ...++||||++|.+|.++..         ++.    ....+++.+|..+|+.    +++|||+||+||+++.++ ++|
T Consensus       114 ~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~----gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        114 YAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQH----GMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             ccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHc----CCccCCCChHHEEEeCCC-EEE
Confidence              35789999999999988732         222    3456899999999998    999999999999999988 999


Q ss_pred             EecccccccCccccccccCcccCccccccCCCCCchhHHHHHHHHHHHH
Q 036639          503 SDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVL  551 (670)
Q Consensus       503 ~DFG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ell  551 (670)
                      +|||............        .+.....+..++||||||+++..+.
T Consensus       176 iDfg~~~~~~e~~a~d--------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAKD--------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhHH--------HHHHHhHhcccccccceeEeehHHH
Confidence            9999887653322111        1334455678999999999987664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=5.3e-21  Score=182.89  Aligned_cols=140  Identities=18%  Similarity=0.224  Sum_probs=108.0

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc--h------------------------HHHHHHHHHHHhccCCCCee
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC--A------------------------RKEFEQYMDVIGKLKHPNVV  415 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~nIv  415 (670)
                      ..||+|+||.||+|...+|+.||||+++.....  .                        ......|++.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            579999999999999878999999999754211  1                        11224589999999887764


Q ss_pred             eEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HHhCCCCCccccCCCCCCeEe
Q 036639          416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI-HQEYGTAKVPHGNVKSSNVLL  494 (670)
Q Consensus       416 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~ivH~Dlkp~NIll  494 (670)
                      ....+..  ...++||||++++++........     .++......++.|++.+|.|+ |+.    +|+||||||+|||+
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~----giiHrDlkP~NIli  151 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDC----RLVHADLSEYNLLY  151 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEE
Confidence            4333322  23389999999887765432222     478899999999999999999 566    99999999999999


Q ss_pred             CCCCcEEEEecccccccCc
Q 036639          495 DKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       495 ~~~~~~kl~DFG~a~~~~~  513 (670)
                      + ++.++|+|||+|.....
T Consensus       152 ~-~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             E-CCcEEEEEccccccCCC
Confidence            8 57899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=7.2e-20  Score=177.72  Aligned_cols=257  Identities=16%  Similarity=0.196  Sum_probs=191.9

Q ss_pred             HHHHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          357 LRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .|+++++||+|.||+++.|. +-+++.||||.-...+  ..-++..|.+..+.| ..+.|..++-+..++.+-.||+|.+
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            35678999999999999999 6679999999876443  345677777777777 4789999888888888889999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-----cEEEEeccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-----VACISDFGLSL  509 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFG~a~  509 (670)
                       |.+|.++..-...    .++..++..+|.|++.-++|+|++    .+|.|||||+|+||..-+     .+.|+|||+|+
T Consensus       107 -GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k----~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  107 -GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEK----DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             -CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhc----ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence             8899999876542    589999999999999999999998    999999999999997543     58999999999


Q ss_pred             ccCc-----------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          510 LLNP-----------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       510 ~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      .+.+           .....||..||+--...+..-+.+-|+=|+|-++.+.+-|..||++......           ..
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-----------K~  246 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-----------KE  246 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-----------HH
Confidence            7643           2345678889999999999999999999999999999999999987522110           00


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      -...+-......    +-..-..+.+++...-++.+++   .+-.+-|..+-+...+.++....
T Consensus       247 kYeKIGe~Kr~T----~i~~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  247 KYEKIGETKRST----PIEVLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             HHHHhccccccC----CHHHHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHhc
Confidence            011110000000    0000112345555555555554   36777788877777776665443

>PLN03150 hypothetical protein; Provisional

Probab=99.84  E-value=8e-21  Score=213.60  Aligned_cols=165  Identities=34%  Similarity=0.558  Sum_probs=90.7

Q ss_pred             cCCCcchHHHHHHHHhccCCCCCCCCCCCCCCCCC---CCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEE
Q 036639           19 SSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACA---AAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLD   95 (670)
Q Consensus        19 ~~~~~~~~~~l~~~~~~~~~~~~~l~~W~~~~~~~---~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~   95 (670)
                      ..+.+.|.++|+.+|..+..+..  .+|.+ ++|.   |.|.||.|......            +       ...++.| 
T Consensus       367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g-~~C~p~~~~w~Gv~C~~~~~~------------~-------~~~v~~L-  423 (623)
T PLN03150        367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG-DPCVPQQHPWSGADCQFDSTK------------G-------KWFIDGL-  423 (623)
T ss_pred             cccCchHHHHHHHHHHhcCCccc--CCCCC-CCCCCcccccccceeeccCCC------------C-------ceEEEEE-
Confidence            34567799999999998864432  48975 5552   37999999632110            0       0012233 


Q ss_pred             ccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccccccc
Q 036639           96 LHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR  175 (670)
Q Consensus        96 L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  175 (670)
                                            +|++|.|+|.+|..+++|++|+.|+|++|+|+|.+|..++++++|+.|+|++|+|+|.
T Consensus       424 ----------------------~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~  481 (623)
T PLN03150        424 ----------------------GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS  481 (623)
T ss_pred             ----------------------ECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCC
Confidence                                  3444444444455555555555555555555555555555555555555555555555


Q ss_pred             CCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcccccccCCCcCCCCCCCC
Q 036639          176 IPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGNEGLCGSSPLPAC  228 (670)
Q Consensus       176 ~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~c~~~~~~~~  228 (670)
                      +|..++.+++|+.|+|++|+|+|.+|..+..   ......+.+|+++|+...++.|
T Consensus       482 iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C  537 (623)
T PLN03150        482 IPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC  537 (623)
T ss_pred             CchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCC
Confidence            5555555555555555555555555554422   1223456778888885444444

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=2e-21  Score=213.95  Aligned_cols=244  Identities=23%  Similarity=0.288  Sum_probs=173.9

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc-chHHHHHHHHHH--HhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP-CARKEFEQYMDV--IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~--l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.||++.|=.|.+|+.++|. |+||++-+.++ ...+.|.++++-  ...++|||++++.-+.......|||-+|.. 
T Consensus        27 ~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-  104 (1431)
T KOG1240|consen   27 YVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK-  104 (1431)
T ss_pred             eecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-
Confidence            3567999999999999998887 89999876543 234444444433  444589999998888777777889999984 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc--Ccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPV  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~--~~~  514 (670)
                      -+|+|.+....     -+...+..-|+.|++.||..+|..    +|+|||||.+||||+.-.-+.|+||..-+..  ..+
T Consensus       105 hnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~----gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  105 HNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKL----GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             hhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHc----CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            49999987554     467778888999999999999998    9999999999999999999999999765432  111


Q ss_pred             ---------ccccccCcccCcccccc----------CC-CCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccc
Q 036639          515 ---------QAIARLGGYKAPEQAEV----------KR-LSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQA  573 (670)
Q Consensus       515 ---------~~~~~~~~y~aPE~~~~----------~~-~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  573 (670)
                               +...+-..|+|||.+..          .. .+++.||||.||++.||++ |++||...             
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------------  242 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------------  242 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------------
Confidence                     11122234999997643          12 5789999999999999998 68777532             


Q ss_pred             cchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          574 VDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                       .+..+-+        ....+++..-. .++  -..+.++++.|++.||++|.+|++.++.-..+.
T Consensus       243 -QL~aYr~--------~~~~~~e~~Le-~Ie--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~  296 (1431)
T KOG1240|consen  243 -QLLAYRS--------GNADDPEQLLE-KIE--DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV  296 (1431)
T ss_pred             -HHHhHhc--------cCccCHHHHHH-hCc--CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence             1111100        00111111000 000  013455777999999999999999999854443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=8.9e-21  Score=176.20  Aligned_cols=191  Identities=21%  Similarity=0.265  Sum_probs=160.0

Q ss_pred             HHHhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCC-CCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH-PNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.++||.|.||.+|.|. ..+|..||||.-+...  ...++..|.++...|+| ..|..+..|..+..+..+||+.+ |
T Consensus        18 ~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-G   94 (341)
T KOG1163|consen   18 KLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-G   94 (341)
T ss_pred             EEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-C
Confidence            345789999999999999 7789999999976543  23467778888888875 57777888888889999999999 8


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC---CcEEEEecccccccCc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN---GVACISDFGLSLLLNP  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~~  513 (670)
                      .+|.++..-...    .++..+.+-++-|++.-++|+|.+    +++||||||+|+|..-+   ..+.++|||+|+...+
T Consensus        95 PsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r----~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   95 PSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLR----NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhh----ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            899999875431    488899999999999999999998    99999999999999643   4689999999987643


Q ss_pred             -----------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 -----------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 -----------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                                 .....||..|.+--...+..-+.+-|+=|+|.+|.++--|..||++.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl  224 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL  224 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence                       23456777788887777777788999999999999999999999875

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=7.9e-20  Score=175.47  Aligned_cols=139  Identities=21%  Similarity=0.269  Sum_probs=110.5

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc--h------------------------HHHHHHHHHHHhccCCCCee
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC--A------------------------RKEFEQYMDVIGKLKHPNVV  415 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~nIv  415 (670)
                      ..||+|+||.||+|...+|+.||||+++.....  .                        ...+..|.+.+.++.|++|.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            569999999999999778999999998754211  0                        12235788999999999875


Q ss_pred             eEEEEEEeCCeeEEEEeccCCCChHHH-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCCeE
Q 036639          416 KLRAYYYAKEEKLLVYDYLPNGSLHSL-LHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ-EYGTAKVPHGNVKSSNVL  493 (670)
Q Consensus       416 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~ivH~Dlkp~NIl  493 (670)
                      ....+...  ..++||||++++++... +...      .++......++.+++.++.++|+ .    +|+||||||+||+
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~----givHrDlkP~NIl  150 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEA----GLVHGDLSEYNIL  150 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhC----CEecCCCChhhEE
Confidence            54444333  34899999988865433 3322      36778889999999999999999 6    9999999999999


Q ss_pred             eCCCCcEEEEecccccccCc
Q 036639          494 LDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       494 l~~~~~~kl~DFG~a~~~~~  513 (670)
                      ++ ++.++|+|||++.....
T Consensus       151 l~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EE-CCCEEEEEcccceecCC
Confidence            98 89999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=5.2e-20  Score=194.45  Aligned_cols=215  Identities=27%  Similarity=0.413  Sum_probs=161.8

Q ss_pred             HhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCcccc
Q 036639          406 IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHG  485 (670)
Q Consensus       406 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~  485 (670)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+...    ...++|.....+++++++||+|+|..   +...|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcC---cceeee
Confidence            35678999999999999999999999999999999999863    34699999999999999999999987   233899


Q ss_pred             CCCCCCeEeCCCCcEEEEecccccccCcc------ccccccCcccCccccccCC-------CCCchhHHHHHHHHHHHHc
Q 036639          486 NVKSSNVLLDKNGVACISDFGLSLLLNPV------QAIARLGGYKAPEQAEVKR-------LSQKADVYSFGVLLLEVLT  552 (670)
Q Consensus       486 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~------~~~~~~~~y~aPE~~~~~~-------~~~ksDVwS~Gvvl~ellt  552 (670)
                      .+++.|.++|....+||+|||+.......      .......-|.|||.+....       .+.++||||||++++|+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            99999999999999999999998877431      1111122399999987531       4678999999999999999


Q ss_pred             CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 036639          553 GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVA  632 (670)
Q Consensus       553 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  632 (670)
                      .+.||........       ..++...+..     .....+.+.+....   +....++.++..||..+|++||++++|-
T Consensus       154 r~~~~~~~~~~~~-------~~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~  218 (484)
T KOG1023|consen  154 RSGPFDLRNLVED-------PDEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIR  218 (484)
T ss_pred             ccCccccccccCC-------hHHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHH
Confidence            9999975421111       1122222222     11111222221111   2223577788899999999999999999


Q ss_pred             HHHHhhhccC
Q 036639          633 KMIEDIRVEQ  642 (670)
Q Consensus       633 ~~L~~i~~~~  642 (670)
                      ..++.+....
T Consensus       219 ~~~~~~~~~~  228 (484)
T KOG1023|consen  219 SKLLTINKGG  228 (484)
T ss_pred             hhhhhhcccc
Confidence            9999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.6e-19  Score=169.03  Aligned_cols=179  Identities=20%  Similarity=0.197  Sum_probs=136.7

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc----hHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC----ARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ...|++|+||+||.+.. .+.+++.+.+......    ....+.+|++++++++ |++|++++++    +..+++|||++
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            45799999999997776 5788888887754331    1235889999999995 5889999886    45699999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCC-CCCCeEeCCCCcEEEEecccccccCcc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNV-KSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      |.+|...+..            ....++.|++++|.++|+.    ||+|||| ||+|||++.++.++|+|||++......
T Consensus        82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~----GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRC----GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             CccHHhhhhh------------hhHHHHHHHHHHHHHHHHC----cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            9998754321            1135778999999999998    9999999 799999999999999999999855432


Q ss_pred             cc-----------------ccccCcccCcccccc-CCCC-CchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          515 QA-----------------IARLGGYKAPEQAEV-KRLS-QKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       515 ~~-----------------~~~~~~y~aPE~~~~-~~~~-~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..                 ...++.|++|+...- ...+ ...+.++-|.-+|.++|++.+....
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            21                 123555777775432 1333 4678889999999999999887543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=4.3e-21  Score=202.15  Aligned_cols=186  Identities=30%  Similarity=0.361  Sum_probs=159.0

Q ss_pred             HcCCCCceEEEEEE----EcCCCEEEEEEeCCCCcc--hHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          363 MLGKGSLGTVYKAV----LDDGGIVAVKRLKDANPC--ARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~----~~~g~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+|+|.||.|+++.    .+.|..+|+|++++....  .+.....|..++...+ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999876    335788999998765322  1224556778888886 9999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|...+....     .+.......+...++-+++++|..    +|+|||+|++||+++.+|++++.|||+++..-...
T Consensus        81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l----~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKL----GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchh----HHHHhcccccceeecccCccccCCchhhhHhHhhh
Confidence            999998887554     466677777788899999999998    99999999999999999999999999999887766


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                      ...|+..|||||++.  .....+|-||||++++||+||..||..
T Consensus       152 ~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  152 IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            668888999999998  667899999999999999999999964

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=1.4e-19  Score=180.16  Aligned_cols=194  Identities=21%  Similarity=0.317  Sum_probs=128.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccC----------CCCeeeEEEEEE----
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLK----------HPNVVKLRAYYY----  422 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~nIv~l~~~~~----  422 (670)
                      ++.||.|+++.||.++.. +|+.+|||++....   ....+++++|.-....+.          |-.++-.++...    
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            357999999999999965 68999999985322   224466666664444432          212222222221    


Q ss_pred             -----eCC--------eeEEEEeccCCCChHHHhcc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccC
Q 036639          423 -----AKE--------EKLLVYDYLPNGSLHSLLHG---NRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGN  486 (670)
Q Consensus       423 -----~~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~D  486 (670)
                           ...        ..+++|+-+ .+||.+++..   ... ....+....++.+..|+++.+++||+.    |++|+|
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~----GlVHgd  170 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSY----GLVHGD  170 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHT----TEEEST
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhc----ceEecc
Confidence                 111        236788877 5688887652   111 112344566778889999999999998    999999


Q ss_pred             CCCCCeEeCCCCcEEEEecccccccCcccc-ccccCcccCcccccc--------CCCCCchhHHHHHHHHHHHHcCCCCC
Q 036639          487 VKSSNVLLDKNGVACISDFGLSLLLNPVQA-IARLGGYKAPEQAEV--------KRLSQKADVYSFGVLLLEVLTGRAPS  557 (670)
Q Consensus       487 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~ksDVwS~Gvvl~elltg~~p~  557 (670)
                      |||+|++++.+|.++|+||+.....+.... ...+..|.+||....        ..++.+.|.|++|+++|.|++++.||
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf  250 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPF  250 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-ST
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCC
Confidence            999999999999999999998877765443 344466999997643        24789999999999999999999999


Q ss_pred             CCC
Q 036639          558 QYP  560 (670)
Q Consensus       558 ~~~  560 (670)
                      ...
T Consensus       251 ~~~  253 (288)
T PF14531_consen  251 GLS  253 (288)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            754

>PRK10345 hypothetical protein; Provisional

Probab=99.78  E-value=1.7e-18  Score=166.95  Aligned_cols=133  Identities=14%  Similarity=0.166  Sum_probs=105.2

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-----CCCCeeeEEEEEEeCC---eeE-EEEe
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-----KHPNVVKLRAYYYAKE---EKL-LVYD  432 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~nIv~l~~~~~~~~---~~~-lv~e  432 (670)
                      +.||+|+||.||. .-.++.. +||++........+++.+|+++++.+     .||||++++|+++++.   ..+ +|+|
T Consensus         8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            5799999999996 3234444 79998765444667899999999999     5799999999998874   434 7899


Q ss_pred             c--cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHHhCCCCCccccCCCCCCeEeCCC----CcEEEEec
Q 036639          433 Y--LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL-ARIHQEYGTAKVPHGNVKSSNVLLDKN----GVACISDF  505 (670)
Q Consensus       433 ~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DF  505 (670)
                      |  +++|+|.+++....      +++.  ..++.+++.++ +|||++    +|+||||||+|||++..    ..++|+||
T Consensus        86 ~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~----~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         86 FDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDN----RIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             CCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHC----CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            9  55799999996532      4444  35677888888 999998    99999999999999743    37999995


Q ss_pred             ccc
Q 036639          506 GLS  508 (670)
Q Consensus       506 G~a  508 (670)
                      +.+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=9.9e-18  Score=165.83  Aligned_cols=142  Identities=20%  Similarity=0.246  Sum_probs=109.9

Q ss_pred             HHHHhHcCCCCceEEEEEE--EcCCCEEEEEEeCCCCcc------------------------hHHHHHHHHHHHhccCC
Q 036639          358 RASAEMLGKGSLGTVYKAV--LDDGGIVAVKRLKDANPC------------------------ARKEFEQYMDVIGKLKH  411 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h  411 (670)
                      +.+.+.||+|+||.||+|.  ..+|+.||||+++.....                        ....+..|++.+.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4566889999999999998  568999999998743210                        11235789999999975


Q ss_pred             C--CeeeEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC-ccccCCC
Q 036639          412 P--NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK-VPHGNVK  488 (670)
Q Consensus       412 ~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~-ivH~Dlk  488 (670)
                      .  .+.+++++    ...++||||+++.+|........     .........++.|++.++++||..    + |+|||||
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----g~iiH~Dik  176 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKE----GELVHGDLS  176 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhc----CCEEeCCCC
Confidence            3  34444443    23589999999988876543221     345556788999999999999998    8 9999999


Q ss_pred             CCCeEeCCCCcEEEEecccccccCc
Q 036639          489 SSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       489 p~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |+||+++ ++.++|+|||.+.....
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhccCC
Confidence            9999999 88999999999876543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=4.4e-18  Score=191.96  Aligned_cols=195  Identities=25%  Similarity=0.388  Sum_probs=155.0

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC---CCCeeeEEEEEEeCCe
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK---HPNVVKLRAYYYAKEE  426 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~  426 (670)
                      .+++....+.+.+.+|+|+||+||+|...+|+.||+|+-+.....   +|.--.+++.+|+   -+.|+++..++.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            455555555667889999999999999888999999998766432   2222233444444   3455666666666778


Q ss_pred             eEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-------CCc
Q 036639          427 KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-------NGV  499 (670)
Q Consensus       427 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-------~~~  499 (670)
                      .++|+||.+.|+|.+++...+     .++|.....++.|+++-+++||..    +||||||||+|+||..       ...
T Consensus       769 S~lv~ey~~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~----~IIHgDiKPDNfll~~~~~~~~~~~~  839 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAM----GIIHGDIKPDNFLLRREICADSDSKG  839 (974)
T ss_pred             ceeeeeccccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhc----ceecccCCcceeEeecccCCCCcccc
Confidence            899999999999999998544     589999999999999999999998    9999999999999942       335


Q ss_pred             EEEEecccccccCc------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 036639          500 ACISDFGLSLLLNP------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP  556 (670)
Q Consensus       500 ~kl~DFG~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p  556 (670)
                      ++|+|||.+..+.-      ......|-++--+|...+..++...|-|.+.-+++-|+.|+..
T Consensus       840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            89999999876532      2234456678899999999999999999999999999999843

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=3.7e-17  Score=160.12  Aligned_cols=134  Identities=19%  Similarity=0.372  Sum_probs=114.0

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc--------hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC--------ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.||+|++|.||+|.. +|..|++|+.......        ....+.+|++++..++|++|.....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 5788999987643211        124577899999999999998888787788888999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +++++|.+++....        + .+..++.+++.+|.++|+.    +++|||++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~----~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSA----GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhC----CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999986432        2 7889999999999999998    999999999999999 78999999998865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=4.9e-17  Score=157.63  Aligned_cols=131  Identities=18%  Similarity=0.325  Sum_probs=107.9

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCc--------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANP--------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .||+|+||.||+|.+ +|..|++|+......        ...+++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999995 478899998653211        11356778999999999887666666666677789999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ++++|.+++....      .      .++.+++.+|.++|+.    +++|||++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~----gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKA----GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHC----CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999875431      0      7899999999999998    999999999999999 899999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.71  E-value=7e-17  Score=156.33  Aligned_cols=137  Identities=18%  Similarity=0.196  Sum_probs=108.2

Q ss_pred             HHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc----------------------hHHHHHHHHHHHhccCCC--C
Q 036639          358 RASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC----------------------ARKEFEQYMDVIGKLKHP--N  413 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~--n  413 (670)
                      +.+.+.||+|+||.||++..++|+.||||+++.....                      ....+..|+.++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            4556889999999999999888999999987643210                      112356788888888877  4


Q ss_pred             eeeEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeE
Q 036639          414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL  493 (670)
Q Consensus       414 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIl  493 (670)
                      +++.++    ....++||||+++++|..+...           .....++.+++.++.++|+.    +|+||||||+||+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~----gi~H~Dl~p~Nil  157 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKH----GIIHGDLSEFNIL  157 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHC----CCCcCCCCcccEE
Confidence            455444    2456899999999999775431           23457888999999999997    9999999999999


Q ss_pred             eCCCCcEEEEecccccccCc
Q 036639          494 LDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       494 l~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++.++|+|||.+.....
T Consensus       158 l~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             EcCCCcEEEEECCccccCCC
Confidence            99999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=1e-16  Score=159.26  Aligned_cols=196  Identities=20%  Similarity=0.272  Sum_probs=132.7

Q ss_pred             CCCCeeeEEEEEEeC---------------------------CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHH
Q 036639          410 KHPNVVKLRAYYYAK---------------------------EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL  462 (670)
Q Consensus       410 ~h~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i  462 (670)
                      +|||||++.++|.+.                           ...|+||.-++ .+|.+++-...      .+.....-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence            599999999887542                           13489998884 49999987553      556677788


Q ss_pred             HHHHHHHHHHHHHhCCCCCccccCCCCCCeEe--CCCC--cEEEEecccccccCc---------cc-cccccCcccCccc
Q 036639          463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLL--DKNG--VACISDFGLSLLLNP---------VQ-AIARLGGYKAPEQ  528 (670)
Q Consensus       463 ~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DFG~a~~~~~---------~~-~~~~~~~y~aPE~  528 (670)
                      +.|+++|+.|||.+    +|.|||+|++|||+  |+|+  ...|+|||.+---+.         .+ ...|...-||||+
T Consensus       347 laQlLEav~hL~~h----gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi  422 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKH----GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI  422 (598)
T ss_pred             HHHHHHHHHHHHHc----cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence            89999999999998    99999999999999  4444  478999998753322         11 1233445899998


Q ss_pred             cccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccc
Q 036639          529 AEVKR------LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKN  602 (670)
Q Consensus       529 ~~~~~------~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  602 (670)
                      ....+      --.|+|.|+.|.+.||+++..-||.......         .+...+     .+......-         
T Consensus       423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---------L~~r~Y-----qe~qLPalp---------  479 (598)
T KOG4158|consen  423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---------LDTRTY-----QESQLPALP---------  479 (598)
T ss_pred             hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---------echhhh-----hhhhCCCCc---------
Confidence            86432      1358999999999999999999997521110         011111     010000000         


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          603 IEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       603 ~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                       +.....+-+++...|+.||++|++..-....|+=...
T Consensus       480 -~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw  516 (598)
T KOG4158|consen  480 -SRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLW  516 (598)
T ss_pred             -ccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHh
Confidence             0111123346667889999999998776666654443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=2.4e-16  Score=175.73  Aligned_cols=132  Identities=20%  Similarity=0.330  Sum_probs=108.9

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEE-eCCCC-------cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKR-LKDAN-------PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~~-------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.||+|+||+||++.+.+.. +++|+ +.+..       ....+.+.+|++++..++|++++....++.+....++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            578999999999999976444 44443 22211       1123568899999999999999988888888788899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      |+++++|.+++.             ....++.+++++|.|||+.    +++||||||+|||+ +++.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~----giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKA----GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhC----CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999999875             3467899999999999998    99999999999999 6789999999999764

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=1.9e-17  Score=171.51  Aligned_cols=118  Identities=21%  Similarity=0.301  Sum_probs=103.5

Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      +.|+.|++|...+|.+|+...+.  ....++...+.++.|++.|+.|   +    +.+|+|+||.||+...+..+||+||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k----~~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---K----GLIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---c----cchhhhccccccccccchhhhhhhh
Confidence            57899999999999999975542  2346788999999999999999   5    8999999999999999999999999


Q ss_pred             ccccccCccc----------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc
Q 036639          506 GLSLLLNPVQ----------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT  552 (670)
Q Consensus       506 G~a~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt  552 (670)
                      |+........          ...+|..||+||.+.+..|+.|+||||+|++++|+++
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            9987765433          3456777999999999999999999999999999997

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.64  E-value=1.4e-17  Score=147.18  Aligned_cols=149  Identities=23%  Similarity=0.407  Sum_probs=136.0

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..++.|.|++|.++..+|.+..|.+|+.|+|++|++...+..++.+++|+.|+++-|++. .+|..|++++.|+.|||.+
T Consensus        33 s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty  111 (264)
T KOG0617|consen   33 SNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY  111 (264)
T ss_pred             hhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence            578999999999999988899999999999999999999999999999999999999998 8999999999999999999


Q ss_pred             Cccc-ccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccC
Q 036639          146 NNIR-GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNE  217 (670)
Q Consensus       146 N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~  217 (670)
                      |+++ ..+|..|..++.|+.|+|++|.|. .+|..++.+++|+.|.+.+|.|- ++|.++  +..+...-..||.
T Consensus       112 nnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  112 NNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             cccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            9996 478999999999999999999999 88889999999999999999998 889877  3344555566665

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=1.3e-15  Score=140.10  Aligned_cols=136  Identities=19%  Similarity=0.197  Sum_probs=114.2

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCC--CCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH--PNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.||+|.++.||++...+ ..+++|.......  ...+..|+..+..++|  .+++++++++...+..+++|||++++.+
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            568999999999999864 7899999876543  5678899999999976  5899999988888889999999988776


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      ..+            +......++.+++++|+++|... ..+++|+|++|+||++++.+.+++.|||.++....
T Consensus        81 ~~~------------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~~  141 (155)
T cd05120          81 DEV------------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPP  141 (155)
T ss_pred             ccC------------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEEEecccccCCCh
Confidence            543            34567788999999999999751 23799999999999999989999999999876543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=2.6e-15  Score=143.94  Aligned_cols=137  Identities=23%  Similarity=0.306  Sum_probs=98.6

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc--hHHH----------------------HHHHHHHHhccCCC--Ce
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC--ARKE----------------------FEQYMDVIGKLKHP--NV  414 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~--nI  414 (670)
                      .+.||+|+||+||+|...+|+.||||+++.....  ....                      ...|.+.+.++.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            3579999999999999878999999998753221  1111                      13455566655433  34


Q ss_pred             eeEEEEEEeCCeeEEEEeccCCCChHH-HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCCe
Q 036639          415 VKLRAYYYAKEEKLLVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ-EYGTAKVPHGNVKSSNV  492 (670)
Q Consensus       415 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~ivH~Dlkp~NI  492 (670)
                      .+.+++    ...++||||++++++.. .+....      .. .....++.+++.++.++|. .    +|+||||||+||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~----~ivH~Dl~p~Ni  146 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREA----GLVHGDLSEYNI  146 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhcc----CcCcCCCChhhE
Confidence            455443    24689999999855432 111111      11 5567899999999999998 6    999999999999


Q ss_pred             EeCCCCcEEEEecccccccCc
Q 036639          493 LLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       493 ll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++ ++.++|+|||.+.....
T Consensus       147 li~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EEE-CCcEEEEECcccccccC
Confidence            999 99999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.61  E-value=8.5e-15  Score=145.25  Aligned_cols=136  Identities=19%  Similarity=0.247  Sum_probs=106.8

Q ss_pred             HhHcC-CCCceEEEEEEEcCCCEEEEEEeCCCC-------------cchHHHHHHHHHHHhccCCCCe--eeEEEEEEeC
Q 036639          361 AEMLG-KGSLGTVYKAVLDDGGIVAVKRLKDAN-------------PCARKEFEQYMDVIGKLKHPNV--VKLRAYYYAK  424 (670)
Q Consensus       361 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~nI--v~l~~~~~~~  424 (670)
                      +..|| .|+.|+||.+... +..++||.+....             ......+.+|++++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            46788 8999999999886 7789999885321             1233567889999999998875  6777765443


Q ss_pred             C----eeEEEEeccCC-CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc
Q 036639          425 E----EKLLVYDYLPN-GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV  499 (670)
Q Consensus       425 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~  499 (670)
                      .    ..++||||+++ .+|.+++...      +++..    .+.+++.+|.+||+.    ||+||||||.|||++.++.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~----GI~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDA----GVYHADLNAHNILLDPDGK  180 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHC----CCCCCCCCchhEEEcCCCC
Confidence            2    23599999997 6999888643      23332    356899999999998    9999999999999999999


Q ss_pred             EEEEeccccccc
Q 036639          500 ACISDFGLSLLL  511 (670)
Q Consensus       500 ~kl~DFG~a~~~  511 (670)
                      ++|+|||.+...
T Consensus       181 v~LIDfg~~~~~  192 (239)
T PRK01723        181 FWLIDFDRGELR  192 (239)
T ss_pred             EEEEECCCcccC
Confidence            999999988764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=3.2e-16  Score=173.40  Aligned_cols=157  Identities=24%  Similarity=0.360  Sum_probs=115.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.+..|+||.||.++++ +.+.+|+| +.+...     +.+-  ++.....|.+|                     |+
T Consensus        87 ~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv---------------------gD  137 (1205)
T KOG0606|consen   87 TIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV---------------------GD  137 (1205)
T ss_pred             eeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee---------------------ch
Confidence            3578999999999999966 46788884 433221     1110  33333344443                     44


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC------
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN------  512 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~------  512 (670)
                      -...++...     +++.        +.+.+++|+|+.    +|+|||+||+|.+|+.-|++|++|||+.+...      
T Consensus       138 c~tllk~~g-----~lPv--------dmvla~Eylh~y----givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  138 CATLLKNIG-----PLPV--------DMVLAVEYLHSY----GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             hhhhcccCC-----CCcc--------hhhHHhHhhccC----CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence            444444322     1221        126789999998    99999999999999999999999999987431      


Q ss_pred             -------------ccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 036639          513 -------------PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP  562 (670)
Q Consensus       513 -------------~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~  562 (670)
                                   .+....+|+.|+|||++....|...+|.|++|+|+||.+-|+.||.+..+
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp  263 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP  263 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence                         12234688899999999999999999999999999999999999987643

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.50  E-value=4e-16  Score=138.08  Aligned_cols=136  Identities=27%  Similarity=0.399  Sum_probs=127.3

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccc-cCCccccCCCCCCEEeCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSA-EIPHQISSLKGILRLDLS  144 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~  144 (670)
                      ..+..|++.+|++...++.++.+++|+.|+++-|++.-.+..|+.++.|+.|||++|+++. .+|..|..+..|..|+|+
T Consensus        56 ~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~  135 (264)
T KOG0617|consen   56 KNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLG  135 (264)
T ss_pred             hhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhc
Confidence            3577899999999998888999999999999999998887889999999999999999974 579999999999999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      .|.|. .+|+.++++++|+.|.+..|.+- .+|..++.+..|+.|.+.+|+|+ .+|+++
T Consensus       136 dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel  192 (264)
T KOG0617|consen  136 DNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPEL  192 (264)
T ss_pred             CCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhh
Confidence            99999 99999999999999999999998 89999999999999999999999 788776

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.50  E-value=8.8e-15  Score=145.72  Aligned_cols=93  Identities=23%  Similarity=0.284  Sum_probs=78.9

Q ss_pred             ccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcC
Q 036639          132 ISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFG  209 (670)
Q Consensus       132 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~  209 (670)
                      |..|++|+.|+|++|+|++.-+.+|..+..|+.|.|..|+|.-.--..|.++.+|++|+|.+|+||-.-|..+  +..++
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~  349 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS  349 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence            5678899999999999999989999999999999999999985556678899999999999999996666655  23456


Q ss_pred             cccccccCCCcCCCC
Q 036639          210 EQSFIGNEGLCGSSP  224 (670)
Q Consensus       210 ~~~~~~n~~~c~~~~  224 (670)
                      ...+.+|||.|.|.-
T Consensus       350 ~l~l~~Np~~CnC~l  364 (498)
T KOG4237|consen  350 TLNLLSNPFNCNCRL  364 (498)
T ss_pred             eeehccCcccCccch
Confidence            677889999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.45  E-value=5.5e-15  Score=164.15  Aligned_cols=245  Identities=25%  Similarity=0.344  Sum_probs=178.4

Q ss_pred             HhHcCCCCceEEEEEEEc--CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD--DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|.|+.|-.....  ....+|+|.+....  ....+....|..+-..+. |+|++.+++...+.+..+++.+|..
T Consensus        25 ~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~  104 (601)
T KOG0590|consen   25 SRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSD  104 (601)
T ss_pred             cccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccc
Confidence            355999999999988853  34567777776442  234455566777777776 9999999999999999999999999


Q ss_pred             CCChHHHh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccC
Q 036639          436 NGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIH-QEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLN  512 (670)
Q Consensus       436 ~g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~  512 (670)
                      ++++.+.+ +...    ...+......+..|+..++.|+| ..    ++.|+|+||+|.+++..+ ..+++|||+|....
T Consensus       105 g~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~----~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  105 GGSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPEN----GVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccccccccccCCc----cCCCCcchhhhhhhhccCccccCccc----ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999988 4322    13455667788999999999999 65    999999999999999999 99999999998765


Q ss_pred             c-c------ccccc-cCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          513 P-V------QAIAR-LGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       513 ~-~------~~~~~-~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      . .      ....+ ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........         ...|....
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---------~~~~~~~~  247 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---------YSSWKSNK  247 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc---------ceeecccc
Confidence            4 1      12345 7789999999874 4567899999999999999999999765332211         11111110


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..         .....+.....   ...++...++..+|..|.+.+++...
T Consensus       248 ~~---------~~~~~~~~~~~---~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 GR---------FTQLPWNSISD---QAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cc---------cccCccccCCh---hhhhcccccccCCchhcccccccccc
Confidence            00         00001111222   23345557888999999998887653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=3.5e-13  Score=145.28  Aligned_cols=141  Identities=23%  Similarity=0.277  Sum_probs=98.4

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchH----------------------------------------HHHHH
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR----------------------------------------KEFEQ  401 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~~~~  401 (670)
                      +.||.|++|.||+|++++|+.||||+.+.......                                        -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            56999999999999999999999999865321000                                        02334


Q ss_pred             HHHHHhcc----CCCCeeeEEEEE-EeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHH
Q 036639          402 YMDVIGKL----KHPNVVKLRAYY-YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR-GLARIHQ  475 (670)
Q Consensus       402 e~~~l~~l----~h~nIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~  475 (670)
                      |++.+.++    +|.+-+.+-.++ ......++||||++|++|.++......    ..   .+.+++..+++ .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence            44444444    232222322222 224457999999999999887653211    12   23456666665 4677887


Q ss_pred             hCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       476 ~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      .    |++|+|++|.||+++.++.++++|||++..+.+
T Consensus       276 ~----g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D----GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C----CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            6    999999999999999999999999999987754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.42  E-value=2.9e-13  Score=152.70  Aligned_cols=92  Identities=33%  Similarity=0.523  Sum_probs=57.4

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      .+|+.|+|++|+|.|.+|. ++.+++|+.|+|++|+|+|.+|. ++++++|+.|+|++|+|+|.+|..+++|++|+.|+|
T Consensus       418 ~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L  497 (623)
T PLN03150        418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL  497 (623)
T ss_pred             eEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence            3689999999999998776 66666666666666666555442 555555555555555555555555555555555555


Q ss_pred             CCCcccccCCCCCc
Q 036639          144 SDNNIRGRIPEQVT  157 (670)
Q Consensus       144 ~~N~l~g~~p~~~~  157 (670)
                      ++|+|+|.+|..+.
T Consensus       498 s~N~l~g~iP~~l~  511 (623)
T PLN03150        498 NGNSLSGRVPAALG  511 (623)
T ss_pred             cCCcccccCChHHh
Confidence            55555555554443

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.42  E-value=1.4e-14  Score=151.45  Aligned_cols=136  Identities=29%  Similarity=0.422  Sum_probs=97.0

Q ss_pred             cEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCccc--------------------
Q 036639           67 RVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS--------------------  125 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~--------------------  125 (670)
                      ..+.|+|++|++...+-+ +-+|+.|-+||||+|+|...+|.+.+|.+|+.|+|++|.|.                    
T Consensus       127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~  206 (1255)
T KOG0444|consen  127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN  206 (1255)
T ss_pred             CcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence            456677777776654444 66777777778888877777776777777777777777543                    


Q ss_pred             -----ccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCC
Q 036639          126 -----AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV  200 (670)
Q Consensus       126 -----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~i  200 (670)
                           .-+|.++.+|.+|..+|||.|+|. ..|+.+.++.+|+.|+||+|+|+ .+........+|++|+||.|+|+ .+
T Consensus       207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~L  283 (1255)
T KOG0444|consen  207 TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VL  283 (1255)
T ss_pred             ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cc
Confidence                 136667777777888888888887 77888888888888888888777 45444555667777888888887 77


Q ss_pred             cchhh
Q 036639          201 PEGLL  205 (670)
Q Consensus       201 p~~~~  205 (670)
                      |..++
T Consensus       284 P~avc  288 (1255)
T KOG0444|consen  284 PDAVC  288 (1255)
T ss_pred             hHHHh
Confidence            77664

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=1.5e-13  Score=133.94  Aligned_cols=205  Identities=21%  Similarity=0.328  Sum_probs=141.9

Q ss_pred             HHHHhccCCCCeeeEEEEEEeCC-----eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC
Q 036639          403 MDVIGKLKHPNVVKLRAYYYAKE-----EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY  477 (670)
Q Consensus       403 ~~~l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~  477 (670)
                      .+-+-.+.|.|||++..|+.+..     +..++.|||..|++..+|++.+. ....+......+|+.||..||.|||+. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~-  195 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC-  195 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence            44555667999999999987643     46789999999999999986543 234577778889999999999999997 


Q ss_pred             CCCCccccCCCCCCeEeCCCCcEEEEecccccccC--------ccccccccCcccCccccccCCCCCchhHHHHHHHHHH
Q 036639          478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN--------PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLE  549 (670)
Q Consensus       478 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~e  549 (670)
                       .++|+|+++..+-|++..+|-+|++--.-.....        ....-.+-++|.|||+-.....+.++|||+||...+|
T Consensus       196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence             6799999999999999999888875321111100        1112234568999999888888899999999999999


Q ss_pred             HHcCCCCC-CCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH
Q 036639          550 VLTGRAPS-QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM  628 (670)
Q Consensus       550 lltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  628 (670)
                      |..+..-- ...+..    ...+   .+.    ..+      ......+.            ..++..|++..|..||+|
T Consensus       275 mailEiq~tnseS~~----~~ee---~ia----~~i------~~len~lq------------r~~i~kcl~~eP~~rp~a  325 (458)
T KOG1266|consen  275 MAILEIQSTNSESKV----EVEE---NIA----NVI------IGLENGLQ------------RGSITKCLEGEPNGRPDA  325 (458)
T ss_pred             HHHheeccCCCccee----ehhh---hhh----hhe------eeccCccc------------cCcCcccccCCCCCCcch
Confidence            98876421 111000    0000   000    000      00000000            124558999999999999


Q ss_pred             HHHHHHHHhhh
Q 036639          629 AEVAKMIEDIR  639 (670)
Q Consensus       629 ~evl~~L~~i~  639 (670)
                      .+++.|.-.+.
T Consensus       326 r~llfHpllfe  336 (458)
T KOG1266|consen  326 RLLLFHPLLFE  336 (458)
T ss_pred             hhhhcCceeee
Confidence            99988765444

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.37  E-value=2.5e-14  Score=149.46  Aligned_cols=153  Identities=24%  Similarity=0.333  Sum_probs=135.0

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .++..+||+.|+|.-.+.-+..+++|+.|+||+|+|+..-...+...+|+.|+||+|+|+ .+|+.++.|++|+.|.+.+
T Consensus       222 ~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~  300 (1255)
T KOG0444|consen  222 HNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANN  300 (1255)
T ss_pred             hhhhhccccccCCCcchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhcc
Confidence            467889999999987665699999999999999999987666777889999999999999 7999999999999999999


Q ss_pred             Cccc-ccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCcC
Q 036639          146 NNIR-GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLCG  221 (670)
Q Consensus       146 N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c~  221 (670)
                      |+|+ ..||+.|++|.+|+.+..++|.|. .+|..++.+..|+.|.|+.|+|- .+|+.+  +..+....+-.||.+--
T Consensus       301 NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVM  377 (1255)
T KOG0444|consen  301 NKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVM  377 (1255)
T ss_pred             CcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccC
Confidence            9876 369999999999999999999998 89999999999999999999997 889776  44555566677887654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=9.3e-13  Score=139.73  Aligned_cols=198  Identities=20%  Similarity=0.196  Sum_probs=152.6

Q ss_pred             ccHHHHHHHHHhHcCC--CCceEEEEEEE---cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEE
Q 036639          351 FELEDLLRASAEMLGK--GSLGTVYKAVL---DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYY  422 (670)
Q Consensus       351 ~~~~~~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~  422 (670)
                      +++.+....+.+.+|.  |.+|.||.+..   .++..+|+|+-+..  .+.....-.+|+....++ .|+|.++....++
T Consensus       109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e  188 (524)
T KOG0601|consen  109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE  188 (524)
T ss_pred             cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence            4455555555678999  99999999986   36888999985432  223333444566656666 4999999999999


Q ss_pred             eCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHHhCCCCCccccCCCCCCeEeCCC-
Q 036639          423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR----GLARIHQEYGTAKVPHGNVKSSNVLLDKN-  497 (670)
Q Consensus       423 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-  497 (670)
                      ..+..++-+|++ +.+|.++.+....    .++....+.+..+..+    ||.++|..    .++|-|+||.||+...+ 
T Consensus       189 ~~~~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~----~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  189 GSGILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSN----NIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cCCcceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCC----cccccccchhheeccccc
Confidence            999999999999 5788888775432    2455666667777777    99999988    99999999999999999 


Q ss_pred             CcEEEEecccccccCcccc---------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 036639          498 GVACISDFGLSLLLNPVQA---------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~~~---------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~  558 (670)
                      ...+++|||+...+.....         ..+...|++||... ..++.++|||++|.+..|..++..+..
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhccccc
Confidence            8899999999887754321         13344599999886 567899999999999999999876653

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=8.7e-12  Score=117.41  Aligned_cols=131  Identities=15%  Similarity=0.132  Sum_probs=96.3

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCee-eEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV-KLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      +.++.|.++.||++... ++.|++|....... ....+..|++++..+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46889999999999976 77899999865432 234567889999888655544 454443  33458999999998876


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCC-CCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG-TAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +.-             .....++.+++++|+.||...- ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430             0113456789999999998711 12369999999999998 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.30  E-value=9.7e-13  Score=137.10  Aligned_cols=137  Identities=27%  Similarity=0.279  Sum_probs=96.5

Q ss_pred             cEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCcccc-CCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           67 RVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      .++.|.|+.|.++..++. |.+|++|+.|||..|+|.-.- ..|.+|++|+.|-|..|.++..-.+.|..|.++++|+|+
T Consensus       198 sL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~  277 (873)
T KOG4194|consen  198 SLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLE  277 (873)
T ss_pred             hheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecc
Confidence            455555555555543333 555666666666666664321 235556666666666666665555667778888888888


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      .|+++..--.++.+|++|+.|+||+|.|....++.+...++|+.|+|++|+|+ .+|+.-
T Consensus       278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~s  336 (873)
T KOG4194|consen  278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGS  336 (873)
T ss_pred             cchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhH
Confidence            88888777778888999999999999998888888888889999999999998 555443

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.28  E-value=4.3e-14  Score=140.97  Aligned_cols=161  Identities=20%  Similarity=0.267  Sum_probs=123.9

Q ss_pred             CCCCCcceEEec-CCCC---cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccc
Q 036639           51 ACAAAWTGVVCS-PKSE---RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSA  126 (670)
Q Consensus        51 ~~~~~w~gv~C~-~~~~---~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g  126 (670)
                      .|.|+..-..|- +.-+   .+..|+..+|+++..++.++++.+|..|++.+|.+...++..-++++|+.||+..|.++ 
T Consensus       118 ~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-  196 (565)
T KOG0472|consen  118 KLDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-  196 (565)
T ss_pred             hhhccccceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-
Confidence            344555544443 2222   35667788899998888899999999999999999988877767999999999999886 


Q ss_pred             cCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcC-CCCCCCEEEccCCCCcCCCcchh-
Q 036639          127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSS-SLKDLKELNLSNNELYGRVPEGL-  204 (670)
Q Consensus       127 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l~l~~N~l~g~ip~~~-  204 (670)
                      .+|+.+++|.+|.-|+|..|+|. .+| +|..|..|..|+++.|++. .+|++.. .+.+|.+|||.+|+++ ++|+++ 
T Consensus       197 tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~c  272 (565)
T KOG0472|consen  197 TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEIC  272 (565)
T ss_pred             cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHH
Confidence            78999999999999999999998 777 7888888888888888887 6776644 7888888888888887 788765 


Q ss_pred             -hhhcCccccccc
Q 036639          205 -LKKFGEQSFIGN  216 (670)
Q Consensus       205 -~~~~~~~~~~~n  216 (670)
                       +.++....++.|
T Consensus       273 lLrsL~rLDlSNN  285 (565)
T KOG0472|consen  273 LLRSLERLDLSNN  285 (565)
T ss_pred             HhhhhhhhcccCC
Confidence             334444454444

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.25  E-value=5.1e-12  Score=137.71  Aligned_cols=140  Identities=17%  Similarity=0.188  Sum_probs=90.2

Q ss_pred             hHcCCCCceEEEEEEEcC-CCEEEEEEeCCCCcc----------------------------------hHH------HHH
Q 036639          362 EMLGKGSLGTVYKAVLDD-GGIVAVKRLKDANPC----------------------------------ARK------EFE  400 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~------~~~  400 (670)
                      +.||.|++|.||+|++++ |+.||||+.+..-..                                  ..+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999887 999999999754110                                  011      123


Q ss_pred             HHHHHHhcc----CCCCeeeEEEEEEe-CCeeEEEEeccCCCChHHHh--ccCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 036639          401 QYMDVIGKL----KHPNVVKLRAYYYA-KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI  473 (670)
Q Consensus       401 ~e~~~l~~l----~h~nIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L  473 (670)
                      +|+..+.++    .+.+.+.+-.++.+ ....+|||||++|+.+.++-  .... .....+.......++.|       +
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Q-------i  276 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQ-------V  276 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHH-------H
Confidence            333333333    24444444444433 45678999999999998752  2211 00011111222222222       3


Q ss_pred             HHhCCCCCccccCCCCCCeEeCCCC----cEEEEecccccccCc
Q 036639          474 HQEYGTAKVPHGNVKSSNVLLDKNG----VACISDFGLSLLLNP  513 (670)
Q Consensus       474 H~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~a~~~~~  513 (670)
                      +..    |++|+|+||.||+++.++    .+++.|||++..+..
T Consensus       277 f~~----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 FRD----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HhC----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            334    999999999999999988    999999999987754

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.24  E-value=8.4e-12  Score=130.24  Aligned_cols=157  Identities=23%  Similarity=0.230  Sum_probs=94.6

Q ss_pred             CCCCCCCcceEEecCC--------------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCCCccccc
Q 036639           49 ADACAAAWTGVVCSPK--------------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTN  113 (670)
Q Consensus        49 ~~~~~~~w~gv~C~~~--------------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~  113 (670)
                      +.+|+|.-.=.-|+..              ...+..|+|++|.|+..-.. |.++++|+.++|..|.|+..+.-..-..+
T Consensus        47 pa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sgh  126 (873)
T KOG4194|consen   47 PATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGH  126 (873)
T ss_pred             CCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccc
Confidence            4567776666677642              12456799999988875444 78888888888888888754322223334


Q ss_pred             cceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccC
Q 036639          114 LKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN  193 (670)
Q Consensus       114 L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  193 (670)
                      |+.|+|.+|.++..--.++.-++.|+.||||.|.|+-.--+.|..-.+|++|+|++|+|+..--..|..+.+|.+|.|+.
T Consensus       127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr  206 (873)
T KOG4194|consen  127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR  206 (873)
T ss_pred             eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence            66666666666655555566666666666666666632223444445566666666666544444555555666666666


Q ss_pred             CCCcCCCcchhhh
Q 036639          194 NELYGRVPEGLLK  206 (670)
Q Consensus       194 N~l~g~ip~~~~~  206 (670)
                      |+++ .+|...|+
T Consensus       207 Nrit-tLp~r~Fk  218 (873)
T KOG4194|consen  207 NRIT-TLPQRSFK  218 (873)
T ss_pred             Cccc-ccCHHHhh
Confidence            6665 45544434

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.23  E-value=6.3e-11  Score=126.96  Aligned_cols=162  Identities=19%  Similarity=0.276  Sum_probs=127.0

Q ss_pred             EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCH
Q 036639          377 LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDW  456 (670)
Q Consensus       377 ~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~  456 (670)
                      ..++.+|.|...+...........+.++.++.++||||+++++.++..+..|||+|-+.  .|..++++.        ..
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HH
Confidence            45688899988876654445667788899999999999999999999999999999873  466666542        23


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc----ccccCcccCccccccC
Q 036639          457 TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVK  532 (670)
Q Consensus       457 ~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~----~~~~~~y~aPE~~~~~  532 (670)
                      ......+.||+.||.|||+.|   +++|++|.-.-|+|++.|..||++|-++........    ..-...|..|+.+...
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~---~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s  180 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC---NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS  180 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC---CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc
Confidence            455667889999999999875   899999999999999999999999998866543321    1112237777765322


Q ss_pred             CCCCchhHHHHHHHHHHHHcC
Q 036639          533 RLSQKADVYSFGVLLLEVLTG  553 (670)
Q Consensus       533 ~~~~ksDVwS~Gvvl~elltg  553 (670)
                      .  -..|.|-||++++|++.|
T Consensus       181 ~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  181 E--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             c--cchhhhhHHHHHHHHhCc
Confidence            2  356999999999999999

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.23  E-value=2.3e-13  Score=135.82  Aligned_cols=133  Identities=28%  Similarity=0.443  Sum_probs=100.3

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      +++.|++.+|.+...++..-+++.|++||+..|-+...+++++.+.+|..|||..|.+. .+| +|.++..|.+|+++.|
T Consensus       161 ~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N  238 (565)
T KOG0472|consen  161 KLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGEN  238 (565)
T ss_pred             HHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhccc
Confidence            46667777777777666644477888888888877777777888888888888888877 456 7777888888888888


Q ss_pred             cccccCCCCCc-ccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          147 NIRGRIPEQVT-NLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       147 ~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      .|. .+|.+.. ++.+|.+|||..|++. ..|+.++-+.+|..||+|+|.++ .+|.++
T Consensus       239 ~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sL  294 (565)
T KOG0472|consen  239 QIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSL  294 (565)
T ss_pred             HHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCccc
Confidence            877 6776655 7778888888888887 77777777777888888888887 556555

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=2.4e-10  Score=104.30  Aligned_cols=132  Identities=21%  Similarity=0.359  Sum_probs=101.4

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeC-CC--Cc-----chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLK-DA--NP-----CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~-~~--~~-----~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+++|+-+.+|.+.+. |..+++|.-. +.  .+     -..+...+|+.++.+++--.|.-.+=+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999875 4446666543 22  11     12345678899998887555555555667788889999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      +|..|.+.+...            ...++..+-+-+.-||..    +|+|+||.++||++..+. +.++|||++....
T Consensus        82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~----givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKA----GIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             CChhHHHHHHhc------------chHHHHHHHHHHHHHHhc----CeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            999999888653            246777788888999998    999999999999997655 9999999997554

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=3e-10  Score=107.69  Aligned_cols=137  Identities=14%  Similarity=0.176  Sum_probs=98.7

Q ss_pred             hHcCCCCceEEEEEEEcC-------CCEEEEEEeCCC-------------C---------cchHHHHH----HHHHHHhc
Q 036639          362 EMLGKGSLGTVYKAVLDD-------GGIVAVKRLKDA-------------N---------PCARKEFE----QYMDVIGK  408 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~-------------~---------~~~~~~~~----~e~~~l~~  408 (670)
                      ..||.|-=+.||.|...+       +..+|||+.+..             +         ....+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999998543       579999987421             0         11133344    78999988


Q ss_pred             cCC--CCeeeEEEEEEeCCeeEEEEeccCCCChHH-HhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HHhCCCCCccc
Q 036639          409 LKH--PNVVKLRAYYYAKEEKLLVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLVLGAARGLARI-HQEYGTAKVPH  484 (670)
Q Consensus       409 l~h--~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~ivH  484 (670)
                      +..  -++.+++++    ...++||||+.+..+.. .++..      .++......+..+++.+|..+ |..    +|+|
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~----glVH  148 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKEC----NLVH  148 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhC----Ceec
Confidence            853  466667754    56789999997654422 22221      244455667788999999999 666    9999


Q ss_pred             cCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          485 GNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       485 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |||++.||+++ ++.++|+|||.+.....
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999999996 57899999998876643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.14  E-value=2.6e-10  Score=112.29  Aligned_cols=144  Identities=20%  Similarity=0.207  Sum_probs=110.8

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCC--CCeeeEEEEEEeCC---eeEEEEeccC
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKH--PNVVKLRAYYYAKE---EKLLVYDYLP  435 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~---~~~lv~e~~~  435 (670)
                      +.|+.|.++.||++...+|+.+++|....... ....++..|.++++.+++  .++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            45899999999999987778999999865432 135678899999999875  34677777766542   5689999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY--------------------------------------  477 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------  477 (670)
                      +.++.+.+...      .++...+..++.+++++|++||+..                                      
T Consensus        84 G~~l~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLRP------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCCC------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            98887765321      3667777888888888888888531                                      


Q ss_pred             --------------CCCCccccCCCCCCeEeCC--CCcEEEEeccccccc
Q 036639          478 --------------GTAKVPHGNVKSSNVLLDK--NGVACISDFGLSLLL  511 (670)
Q Consensus       478 --------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~  511 (670)
                                    ....++|+|++|.||+++.  ++.+.|+||+.+..-
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                          1245789999999999998  667899999987654

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.13  E-value=3.4e-12  Score=140.00  Aligned_cols=150  Identities=33%  Similarity=0.422  Sum_probs=124.7

Q ss_pred             CcEEEEEcCCCCccccCCC-C-------------------------CCCCCccEEEccCCCCcccc-CCCccccccceee
Q 036639           66 ERVVSLSLPSHSLRGPIAP-L-------------------------SLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAY  118 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~-------------------------~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~  118 (670)
                      ..+..|+|..|+|...++. +                         ..+..|+.|.|.+|.|+... |.+.+...|+.|+
T Consensus       310 ~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLh  389 (1081)
T KOG0618|consen  310 KSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLH  389 (1081)
T ss_pred             ceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeee
Confidence            3578899999988754332 0                         13467888999999998765 6699999999999


Q ss_pred             ccCCcccccCCc-cccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          119 LSGNDFSAEIPH-QISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       119 l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      |++|+|. .+|+ .+.+|..|+.|+||+|+|+ .+|..+.++..|++|...+|+|. .+| .+..++.|+.+|||.|+|+
T Consensus       390 LsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~  465 (1081)
T KOG0618|consen  390 LSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLS  465 (1081)
T ss_pred             ecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhh
Confidence            9999998 5665 4788999999999999999 89999999999999999999999 788 7888999999999999996


Q ss_pred             -CCCcchhh-hhcCcccccccCCC
Q 036639          198 -GRVPEGLL-KKFGEQSFIGNEGL  219 (670)
Q Consensus       198 -g~ip~~~~-~~~~~~~~~~n~~~  219 (670)
                       +.+|..+- .++..+.+.||.|+
T Consensus       466 ~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  466 EVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             hhhhhhhCCCcccceeeccCCccc
Confidence             45665543 56777888999864

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.11  E-value=1e-10  Score=132.03  Aligned_cols=107  Identities=26%  Similarity=0.325  Sum_probs=54.4

Q ss_pred             CCccEEEccCCCCccccCCCccccccceeeccCCcccccCCcccc-----------------CCCCCCEEeCCCCccccc
Q 036639           89 DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQIS-----------------SLKGILRLDLSDNNIRGR  151 (670)
Q Consensus        89 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~-----------------~l~~L~~L~l~~N~l~g~  151 (670)
                      .+|+.|+|++|+|++.+..   ..+|+.|++++|+|++ +|....                 ..++|+.|+|++|+|+ .
T Consensus       342 ~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l~~~L~~LdLs~N~Lt~LP~l~s~L~~LdLS~N~Ls-s  416 (788)
T PRK15387        342 SGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGNRLT-S  416 (788)
T ss_pred             cccceEecCCCccCCCCCC---Ccccceehhhcccccc-CcccccccceEEecCCcccCCCCcccCCCEEEccCCcCC-C
Confidence            3678888888888764321   1234444555555542 343211                 0134445555555554 2


Q ss_pred             CCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          152 IPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       152 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      +|..   ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.+|..+
T Consensus       417 IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L  465 (788)
T PRK15387        417 LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL  465 (788)
T ss_pred             CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence            4432   123455555555555 455555555555555555555555555443

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.08  E-value=1.3e-10  Score=132.11  Aligned_cols=118  Identities=24%  Similarity=0.393  Sum_probs=64.9

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      .+..|+|++|++...+..+.  .+|+.|+|++|+|+..+..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|+|++|
T Consensus       242 ~L~~L~Ls~N~L~~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N  314 (754)
T PRK15370        242 TIQEMELSINRITELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSN  314 (754)
T ss_pred             cccEEECcCCccCcCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCC
Confidence            57788888888875332232  478888888888875443342  477888888888774 554432  24555555555


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +|+ .+|..+.  ++|+.|++++|+|++ +|..+  .++|+.|+|++|+|+
T Consensus       315 ~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l--~~sL~~L~Ls~N~L~  359 (754)
T PRK15370        315 SLT-ALPETLP--PGLKTLEAGENALTS-LPASL--PPELQVLDVSKNQIT  359 (754)
T ss_pred             ccc-cCCcccc--ccceeccccCCcccc-CChhh--cCcccEEECCCCCCC
Confidence            555 2333221  344444444444442 33322  134444444444444

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.08  E-value=3e-10  Score=129.11  Aligned_cols=124  Identities=27%  Similarity=0.402  Sum_probs=81.7

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      ..+.|+|++++|+..+..+  .++|+.|+|++|+|+..+..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|
T Consensus       179 ~~~~L~L~~~~LtsLP~~I--p~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N  251 (754)
T PRK15370        179 NKTELRLKILGLTTIPACI--PEQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSIN  251 (754)
T ss_pred             CceEEEeCCCCcCcCCccc--ccCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCC
Confidence            4677888887777643323  2467788888888776544332  47777788888777 4665553  36777777777


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      +++ .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+
T Consensus       252 ~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l  302 (754)
T PRK15370        252 RIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHL  302 (754)
T ss_pred             ccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccc
Confidence            777 5666553  36777777777777 4665542  46777777777777 455444

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.07  E-value=1.1e-10  Score=124.28  Aligned_cols=241  Identities=19%  Similarity=0.195  Sum_probs=166.6

Q ss_pred             hHcCCCCceEEEEEEE--cCCCEEEEEEeCCCCcchHHHH--HHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVL--DDGGIVAVKRLKDANPCARKEF--EQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..||.|.|+.|+....  .++..|++|.+.+.......++  ..|+.+...+ .|.+++.....+......|+--|||++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~  350 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG  350 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence            5689999999999874  4678999999876543333222  2344444444 588999988888877788899999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-CcEEEEecccccccCccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~~~~  515 (670)
                      +++...+.-..     .++...++++..|++.++.++|+.    .++|+|+||+||++..+ +.-+++|||.+..+.-..
T Consensus       351 ~s~~l~~~~~~-----~~d~~~~~~~~~q~~~~l~~i~s~----~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~  421 (524)
T KOG0601|consen  351 GSSSLRSVTSQ-----MLDEDPRLRLTAQILTALNVIHSK----LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS  421 (524)
T ss_pred             cchhhhhHHHH-----hcCcchhhhhHHHHHhccccccch----hhhcccccccceeeccchhhhhccccccccccceec
Confidence            98877663221     366778899999999999999987    99999999999999886 788999999987543222


Q ss_pred             -cccccCccc--CccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 -AIARLGGYK--APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 -~~~~~~~y~--aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       ....+-++.  +++......+..+.|+||||..+.|.+++...-....                .|.          .+
T Consensus       422 ~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----------------~~~----------~i  475 (524)
T KOG0601|consen  422 GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----------------QSL----------TI  475 (524)
T ss_pred             ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----------------cce----------ee
Confidence             122222333  5666667778899999999999999999874321110                000          00


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ............   ..+..+...+...++..||.+.++..+....+.
T Consensus       476 ~~~~~p~~~~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  476 RSGDTPNLPGLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ecccccCCCchH---HhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            000011111111   223334446778899999999998877665543

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.06  E-value=8.1e-11  Score=109.36  Aligned_cols=111  Identities=31%  Similarity=0.381  Sum_probs=37.1

Q ss_pred             CCCCCCCCccEEEccCCCCccccCCCc-cccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCC-cccc
Q 036639           83 APLSLLDQLRFLDLHDNRLNGTILPLT-NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLT  160 (670)
Q Consensus        83 ~~~~~l~~L~~L~L~~N~l~~~~~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~  160 (670)
                      +.+.+..+++.|+|++|.|+.. ..++ .+.+|+.|||++|.++. ++ .+..+++|+.|+|++|+|+ .+++.+ ..++
T Consensus        13 ~~~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp   88 (175)
T PF14580_consen   13 AQYNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLP   88 (175)
T ss_dssp             ------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-T
T ss_pred             cccccccccccccccccccccc-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCC
Confidence            3455666778888888888653 4565 47788888888888874 43 4777888888888888888 454444 3578


Q ss_pred             cccceecccccccccCC-CCcCCCCCCCEEEccCCCCc
Q 036639          161 RLLTLRLQNNELTGRIP-DLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       161 ~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +|+.|+|++|+|...-- ..+..+++|+.|+|.+|.++
T Consensus        89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            88888888888873211 23567888888888888876

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=1.9e-09  Score=97.87  Aligned_cols=142  Identities=17%  Similarity=0.297  Sum_probs=105.6

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeC-CC--C-----cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK-DA--N-----PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~-~~--~-----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      ..+-||+-+.|+++.+. |+..+||.-. +.  .     .-.++...+|++.+.+++--.|.-..=++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            45789999999999987 7777777543 22  1     12346678899999988755555555567777778899999


Q ss_pred             cCC-CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEeccccc
Q 036639          434 LPN-GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSL  509 (670)
Q Consensus       434 ~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~  509 (670)
                      +++ .++.+++......   +..-.....++..|-+.+.-||..    +|+||||..+||++..++   .+.++|||++.
T Consensus        92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~n----diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDN----DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhC----CeecccccccceEEecCCCcCceEEEeecchh
Confidence            976 4788888654321   122223367888899999999998    999999999999997665   36899999986


Q ss_pred             cc
Q 036639          510 LL  511 (670)
Q Consensus       510 ~~  511 (670)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            54

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.04  E-value=9.5e-11  Score=108.88  Aligned_cols=123  Identities=28%  Similarity=0.363  Sum_probs=53.5

Q ss_pred             CcEEEEEcCCCCccccCCCCC-CCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccc-cCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLS-LLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~l  143 (670)
                      .++..|+|.+|.++. +..++ .+.+|+.|||++|.|+.. ..+..+++|+.|+|++|+++. +...+ ..+++|+.|+|
T Consensus        19 ~~~~~L~L~~n~I~~-Ie~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~L   95 (175)
T PF14580_consen   19 VKLRELNLRGNQIST-IENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELYL   95 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-
T ss_pred             ccccccccccccccc-ccchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEEC
Confidence            357889999999986 56676 589999999999999864 578899999999999999994 55455 46999999999


Q ss_pred             CCCcccccCC-CCCcccccccceecccccccccCCC----CcCCCCCCCEEEcc
Q 036639          144 SDNNIRGRIP-EQVTNLTRLLTLRLQNNELTGRIPD----LSSSLKDLKELNLS  192 (670)
Q Consensus       144 ~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~l~l~  192 (670)
                      ++|+|...-- ..+..+++|+.|+|.+|.++. -+.    .+..+++|+.||-.
T Consensus        96 ~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   96 SNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEETTE
T ss_pred             cCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeCCE
Confidence            9999974211 356788999999999999984 343    25668889888753

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.02  E-value=5.1e-10  Score=126.50  Aligned_cols=37  Identities=41%  Similarity=0.527  Sum_probs=24.9

Q ss_pred             cccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcc
Q 036639          161 RLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       161 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~  202 (670)
                      +|+.|+|++|+|++ +|..   .++|+.|++++|+|+ .+|.
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~  419 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPM  419 (788)
T ss_pred             ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCc
Confidence            56777777777773 5543   356777888888887 4664

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.99  E-value=1.7e-11  Score=127.92  Aligned_cols=124  Identities=31%  Similarity=0.466  Sum_probs=53.2

Q ss_pred             CCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCC
Q 036639           75 SHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPE  154 (670)
Q Consensus        75 ~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~  154 (670)
                      .|.+.-.++.+.+|..|++|||+.|+++-.+..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|++. .+|.
T Consensus       107 ~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slps  183 (722)
T KOG0532|consen  107 HNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPS  183 (722)
T ss_pred             hccceecchhhhhhhHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchH
Confidence            33333333334444455555555555444433333333 444444444444 44444444444444444444444 4444


Q ss_pred             CCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          155 QVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       155 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      .++.+.+|+.|.+..|++. .+|..+..| .|..||+|.|+++ .||..+
T Consensus       184 ql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~f  230 (722)
T KOG0532|consen  184 QLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDF  230 (722)
T ss_pred             HhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhh
Confidence            4444444444444444443 233333311 3334444444444 444333

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.98  E-value=5.2e-11  Score=130.87  Aligned_cols=125  Identities=28%  Similarity=0.408  Sum_probs=109.9

Q ss_pred             cEEEEEcCCCCccccC-CCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           67 RVVSLSLPSHSLRGPI-APLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      .+..|.|.+|.|+... |.+-+..+|+.|+|++|+|...+.. +.++..|+.|+||+|.|+ .+|..+.++..|++|...
T Consensus       360 ~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ah  438 (1081)
T KOG0618|consen  360 ALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAH  438 (1081)
T ss_pred             HHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhc
Confidence            5777889999999754 5599999999999999999887744 999999999999999999 799999999999999999


Q ss_pred             CCcccccCCCCCcccccccceeccccccccc-CCCCcCCCCCCCEEEccCCC
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGR-IPDLSSSLKDLKELNLSNNE  195 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~  195 (670)
                      +|+|. ..| .+.+++.|+.+|||.|+|+-. +|...- -++|++|||++|.
T Consensus       439 sN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  439 SNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNT  487 (1081)
T ss_pred             CCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCc
Confidence            99999 788 899999999999999999843 444432 3899999999997

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.97  E-value=5.1e-11  Score=114.96  Aligned_cols=129  Identities=27%  Similarity=0.298  Sum_probs=98.8

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      .++.|||++|.++..-.+...++.++.|+||+|.|...- .+..|++|+.||||+|.|+ .+...--.|.+.+.|.|++|
T Consensus       285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N  362 (490)
T KOG1259|consen  285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN  362 (490)
T ss_pred             hhhhccccccchhhhhhhhhhccceeEEeccccceeeeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence            467788888888876566778888888888888886543 3788888888888888887 45555566788888888888


Q ss_pred             cccccCCCCCcccccccceecccccccccC-CCCcCCCCCCCEEEccCCCCcCC
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRI-PDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      .|...  +.+.+|.+|.+||+++|+|...- -..+++++-|+.|.|-+|.|.+.
T Consensus       363 ~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  363 KIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             hHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            87622  45677888888999999887322 13478888888888888888854

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.94  E-value=7.6e-11  Score=123.12  Aligned_cols=135  Identities=24%  Similarity=0.357  Sum_probs=121.4

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..++.|+|+.|+++-.+..+..|+ |+.|-+++|+++..+.+++.+..|..||.+.|.+- .+|..+++|.+|+.|.+..
T Consensus       121 ~~lt~l~ls~NqlS~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrR  198 (722)
T KOG0532|consen  121 EALTFLDLSSNQLSHLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRR  198 (722)
T ss_pred             hHHHHhhhccchhhcCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhh
Confidence            467889999999998777776664 89999999999998888999999999999999998 7999999999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK  206 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~  206 (670)
                      |++. .+|.++..| .|..||+|+|+++ .||..|..|..|++|-|.+|.|. +.|..++.
T Consensus       199 n~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~  255 (722)
T KOG0532|consen  199 NHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE  255 (722)
T ss_pred             hhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence            9999 788888855 6899999999999 89999999999999999999998 77776644

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=1.9e-08  Score=100.95  Aligned_cols=142  Identities=13%  Similarity=0.080  Sum_probs=101.0

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc-----------hHHHHHHHHHHHhccCCC--CeeeEEEEEEe----
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC-----------ARKEFEQYMDVIGKLKHP--NVVKLRAYYYA----  423 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~--nIv~l~~~~~~----  423 (670)
                      ++.+-......|++..+ +|+.|.||+.......           ....+.+|...+.++...  ..++++++.+.    
T Consensus        27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            34455445555777766 4788999987543311           111477888888877433  33445666543    


Q ss_pred             -CCeeEEEEeccCCC-ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-----
Q 036639          424 -KEEKLLVYDYLPNG-SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-----  496 (670)
Q Consensus       424 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----  496 (670)
                       ....++|+|++++. +|.+++....   ..+.+...+..++.+++..+.-||..    ||+|+|++++|||++.     
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~----Gi~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAA----GINHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC----cCccCCCChhhEEEeccccCC
Confidence             23578999999875 8999885321   11345567778999999999999998    9999999999999975     


Q ss_pred             --CCcEEEEecccccc
Q 036639          497 --NGVACISDFGLSLL  510 (670)
Q Consensus       497 --~~~~kl~DFG~a~~  510 (670)
                        +..+.++||+.+..
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46799999998854

>PLN03210 Resistant to P

Probab=98.91  E-value=3.7e-09  Score=128.16  Aligned_cols=89  Identities=26%  Similarity=0.271  Sum_probs=49.1

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      .++.|+|.+|.+......+..+++|+.|+|++|...+.++.++.+++|+.|+|++|.....+|..++++++|+.|+|++|
T Consensus       612 ~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c  691 (1153)
T PLN03210        612 NLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC  691 (1153)
T ss_pred             CCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence            45666666666554333355566666666665544344455555666666666665544555655655666666666554


Q ss_pred             cccccCCCC
Q 036639          147 NIRGRIPEQ  155 (670)
Q Consensus       147 ~l~g~~p~~  155 (670)
                      ..-+.+|..
T Consensus       692 ~~L~~Lp~~  700 (1153)
T PLN03210        692 ENLEILPTG  700 (1153)
T ss_pred             CCcCccCCc
Confidence            332344443

syringae 6; Provisional

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=9.1e-09  Score=97.31  Aligned_cols=126  Identities=24%  Similarity=0.328  Sum_probs=82.7

Q ss_pred             EEEEEEEcCCCEEEEEEeCCC---------------C------c-----chHHHHHHHHHHHhccCCC--CeeeEEEEEE
Q 036639          371 TVYKAVLDDGGIVAVKRLKDA---------------N------P-----CARKEFEQYMDVIGKLKHP--NVVKLRAYYY  422 (670)
Q Consensus       371 ~Vy~~~~~~g~~vavK~~~~~---------------~------~-----~~~~~~~~e~~~l~~l~h~--nIv~l~~~~~  422 (670)
                      .||.|...+|..||||..+..               .      .     ......++|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999988999999987421               0      0     0123467899999999755  566666542 


Q ss_pred             eCCeeEEEEeccC--CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HHhCCCCCccccCCCCCCeEeCCCCc
Q 036639          423 AKEEKLLVYDYLP--NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI-HQEYGTAKVPHGNVKSSNVLLDKNGV  499 (670)
Q Consensus       423 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~~ivH~Dlkp~NIll~~~~~  499 (670)
                         ..+|||||++  +..+..+....       +.......++.+++..+..+ |..    +|+|||+.+.||+++++ .
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~----givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKA----GIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCT----TEEESS-STTSEEEETT-C
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhc----CceecCCChhhEEeecc-e
Confidence               4579999998  55555443322       11233456677777766665 555    99999999999999877 9


Q ss_pred             EEEEecccccccC
Q 036639          500 ACISDFGLSLLLN  512 (670)
Q Consensus       500 ~kl~DFG~a~~~~  512 (670)
                      +.|+|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PLN03210 Resistant to P

Probab=98.86  E-value=8.3e-09  Score=125.18  Aligned_cols=125  Identities=25%  Similarity=0.258  Sum_probs=65.2

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      .+..|++.++.+...++.+ ...+|+.|+|++|+|......+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|
T Consensus       590 ~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c  667 (1153)
T PLN03210        590 KLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDC  667 (1153)
T ss_pred             ccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCC
Confidence            3555555555554433223 34556666666666554444455566666666665544444542 555566666666655


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCC
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN  194 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  194 (670)
                      ..-..+|..+.++++|+.|+|++|..-+.+|..+ ++++|+.|++++|
T Consensus       668 ~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc  714 (1153)
T PLN03210        668 SSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGC  714 (1153)
T ss_pred             CCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCC
Confidence            4444556666666666666666543333445433 3444444444443

syringae 6; Provisional

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.85  E-value=1.8e-09  Score=82.42  Aligned_cols=39  Identities=41%  Similarity=0.562  Sum_probs=14.4

Q ss_pred             ccCCCCCCEEeCCCCcccccCCCCCcccccccceecccc
Q 036639          132 ISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNN  170 (670)
Q Consensus       132 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  170 (670)
                      |.++++|++|+|++|+++...|..|.++++|++|+|++|
T Consensus        21 f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen   21 FSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             TTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred             HcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence            333333333333333333333333333333333333333

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.84  E-value=6.6e-10  Score=124.21  Aligned_cols=192  Identities=26%  Similarity=0.299  Sum_probs=135.0

Q ss_pred             hHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCcc---hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPC---ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +-+.+|.++.++.+. -..|...+.|+.......   ..+....+-.+.-..+||-++....-+......+|+++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            467889999998877 333544444444322111   1122222333333345566666554455567789999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|...++....     .+..-.......+..+++|||..    .+.|+|++|.|++...++..+++|||......-    
T Consensus       890 ~~~Skl~~~~~-----~saepaRs~i~~~vqs~e~L~s~----~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  890 DLPSKLHNSGC-----LSAEPARSPILERVQSLESLHSS----LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             CchhhhhcCCC-----cccccccchhHHHHhhhhccccc----hhhcccccccchhhcccCCcccCccccccccccccCc
Confidence            99999986642     22223334455677889999987    689999999999999999999999984332110    


Q ss_pred             -------------------------------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 036639          514 -------------------------------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP  562 (670)
Q Consensus       514 -------------------------------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~  562 (670)
                                                     .....+++.|.+||...+......+|.|++|++++|.++|.+||....+
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcch
Confidence                                           1123456679999999999999999999999999999999999976543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.83  E-value=2.6e-09  Score=81.54  Aligned_cols=61  Identities=44%  Similarity=0.581  Sum_probs=56.0

Q ss_pred             CCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCC
Q 036639          136 KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       136 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      ++|++|+|++|+|+...+..|.++++|++|+|++|+++...|..|..+++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4789999999999966667899999999999999999988888999999999999999986

...

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.80  E-value=3.7e-08  Score=95.57  Aligned_cols=139  Identities=21%  Similarity=0.289  Sum_probs=100.3

Q ss_pred             HHHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCC--------------------C--cchHHHHHHHHHHHhccCCC
Q 036639          355 DLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--------------------N--PCARKEFEQYMDVIGKLKHP  412 (670)
Q Consensus       355 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--------------------~--~~~~~~~~~e~~~l~~l~h~  412 (670)
                      +..+++++.||-|--+.||.|....|.++|||.=+..                    +  ...+...++|.++|.+|.-.
T Consensus        90 ~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          90 GIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             ChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            4456778999999999999999999999999953210                    0  11234567899999998644


Q ss_pred             --CeeeEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCC
Q 036639          413 --NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSS  490 (670)
Q Consensus       413 --nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~  490 (670)
                        .|.+.+++    +...+||||+++-.|...-          ++....-.++..|++-+..+-..    ||||+|+.+-
T Consensus       170 G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~----GiVHGDlSef  231 (304)
T COG0478         170 GVKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRR----GIVHGDLSEF  231 (304)
T ss_pred             CCCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHc----CccccCCchh
Confidence              67776654    4568999999886665432          11222334444555555555554    9999999999


Q ss_pred             CeEeCCCCcEEEEeccccccc
Q 036639          491 NVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       491 NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||++++||.+.++||--+...
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             eEEEecCCCEEEEeCcccccC
Confidence            999999999999999765544

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.80  E-value=5.3e-08  Score=101.61  Aligned_cols=171  Identities=26%  Similarity=0.313  Sum_probs=129.2

Q ss_pred             CceEEEEEE-EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe----CCeeEEEEeccCC-CChHH
Q 036639          368 SLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA----KEEKLLVYDYLPN-GSLHS  441 (670)
Q Consensus       368 ~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~~-g~L~~  441 (670)
                      ...+.|++. ..||..|++|+++............-++..+++.|+|||++.++|..    +...++||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            446789998 45899999999954433333344556788999999999999998863    3467899999876 67777


Q ss_pred             HhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          442 LLHGNRG----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       442 ~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      +......          ......++...|.++.|+..||.++|+.    |+.-+-|.+.+|+++.+.+++|+..|....+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss----GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS----GLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc----CceeecccHhHeEeeCcceEEEecccceeee
Confidence            6542221          1123467789999999999999999998    9999999999999999999999988877665


Q ss_pred             CccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCC
Q 036639          512 NPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA  555 (670)
Q Consensus       512 ~~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~  555 (670)
                      ..+..          |-+..   -.+-|.=.||.+++-|.||..
T Consensus       444 ~~d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDPT----------EPLES---QQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCCC----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence            43320          11111   236788899999999999954

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.79  E-value=7.5e-10  Score=115.60  Aligned_cols=135  Identities=26%  Similarity=0.325  Sum_probs=98.4

Q ss_pred             CCcEEEEEcCCCCccccCCC-CCCC---CCccEEEccCCCCcccc-----CCCccc-cccceeeccCCccccc----CCc
Q 036639           65 SERVVSLSLPSHSLRGPIAP-LSLL---DQLRFLDLHDNRLNGTI-----LPLTNC-TNLKLAYLSGNDFSAE----IPH  130 (670)
Q Consensus        65 ~~~v~~l~l~~~~l~~~~~~-~~~l---~~L~~L~L~~N~l~~~~-----~~~~~l-~~L~~L~l~~N~l~g~----~p~  130 (670)
                      ..+++.|+|++|.+.+..+. +..+   ++|++|+|++|++++..     ..+..+ ++|+.|+|++|.+++.    ++.
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            35789999999988764443 3333   44999999999887421     125566 8899999999998843    344


Q ss_pred             cccCCCCCCEEeCCCCcccc----cCCCCCcccccccceeccccccccc----CCCCcCCCCCCCEEEccCCCCcCC
Q 036639          131 QISSLKGILRLDLSDNNIRG----RIPEQVTNLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       131 ~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      .+..+.+|++|+|++|.+++    .++..+..+++|+.|+|++|.+++.    ++..+..+++|+.|++++|.+++.
T Consensus       160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~  236 (319)
T cd00116         160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDA  236 (319)
T ss_pred             HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchH
Confidence            56677889999999999884    2334455667899999999988743    334466778899999999988753

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.75  E-value=1.4e-09  Score=113.51  Aligned_cols=132  Identities=27%  Similarity=0.291  Sum_probs=96.7

Q ss_pred             CcEEEEEcCCCCccccC----C-CCCCC-CCccEEEccCCCCcccc-----CCCccccccceeeccCCccccc----CCc
Q 036639           66 ERVVSLSLPSHSLRGPI----A-PLSLL-DQLRFLDLHDNRLNGTI-----LPLTNCTNLKLAYLSGNDFSAE----IPH  130 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~----~-~~~~l-~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~g~----~p~  130 (670)
                      .+++.|++++|.+.+..    . .+..+ ++|+.|+|++|.+++..     ..+..+++|+.|+|++|.+++.    ++.
T Consensus       108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~  187 (319)
T cd00116         108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE  187 (319)
T ss_pred             CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence            45899999999887421    1 14556 88999999999998532     1266778899999999999853    444


Q ss_pred             cccCCCCCCEEeCCCCccccc----CCCCCcccccccceecccccccccCCCCcC-----CCCCCCEEEccCCCCc
Q 036639          131 QISSLKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELTGRIPDLSS-----SLKDLKELNLSNNELY  197 (670)
Q Consensus       131 ~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-----~l~~L~~l~l~~N~l~  197 (670)
                      .+..+++|+.|+|++|.+++.    ++..+..+++|++|++++|++++.....+.     ..+.|+.|++++|.++
T Consensus       188 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~  263 (319)
T cd00116         188 GLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT  263 (319)
T ss_pred             HHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence            566677999999999998743    344566788899999999998853222111     2478999999999887

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.70  E-value=2.6e-09  Score=103.33  Aligned_cols=105  Identities=25%  Similarity=0.285  Sum_probs=88.0

Q ss_pred             CCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceec
Q 036639           88 LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRL  167 (670)
Q Consensus        88 l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  167 (670)
                      ...|+.||||+|.|+....+..-++.++.|+||+|.+. .+ ..+..|++|+.||||+|.++ .+-.+=.+|.+++.|.|
T Consensus       283 Wq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  283 WQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             HhhhhhccccccchhhhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            46789999999999887667778899999999999998 33 34888999999999999998 56666678889999999


Q ss_pred             ccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          168 QNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       168 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +.|.+.. + ..+..+-+|..||+++|++.
T Consensus       360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie  387 (490)
T KOG1259|consen  360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIE  387 (490)
T ss_pred             hhhhHhh-h-hhhHhhhhheeccccccchh
Confidence            9999862 2 23566778999999999986

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.66  E-value=9.3e-09  Score=110.81  Aligned_cols=129  Identities=37%  Similarity=0.503  Sum_probs=104.0

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCC-CccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLD-QLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      ..++.|++.+|.+....+....+. +|+.|++++|++...+.++.++++|+.|++++|+++ .+|...+.+++|+.|+++
T Consensus       116 ~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls  194 (394)
T COG4886         116 TNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS  194 (394)
T ss_pred             cceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheecc
Confidence            358899999999988766677774 999999999999877667899999999999999998 678777788899999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +|+++ .+|..+..+..|++|++++|++. .++..+..+.++..+.+++|++.
T Consensus       195 ~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~  245 (394)
T COG4886         195 GNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE  245 (394)
T ss_pred             CCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee
Confidence            99998 78877767777888888888544 45555666667777777777665

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.64  E-value=2.7e-07  Score=93.97  Aligned_cols=269  Identities=13%  Similarity=0.153  Sum_probs=152.9

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEE----E--EeCCe-eEEEEe
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAY----Y--YAKEE-KLLVYD  432 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~----~--~~~~~-~~lv~e  432 (670)
                      +..||+|+-+.+|-.---  +..+-|+.....+....+..   ..|... .||-+-.-+.+    .  -++.. .-+.|+
T Consensus        16 gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecchh--hchhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            456999999999965411  12345777655443332222   222222 45533321111    1  11222 446777


Q ss_pred             ccCCC-ChHHHhcc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          433 YLPNG-SLHSLLHG-NRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       433 ~~~~g-~L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      .+++. ....+... .+........|...++.++.+|.+.+-||+.    |.+-+|+.++|+||++++.+.|.|=..-..
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~----Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH----GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc----CCcccccCccceeeecCceEEEEcccceee
Confidence            77653 23333321 2222344689999999999999999999998    888899999999999999999997432222


Q ss_pred             cCccc---cccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          511 LNPVQ---AIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTG-RAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       511 ~~~~~---~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      .....   .-.+...|.+||.-.     +..-+...|-|.+||++++++.| ++||.+..-........+  .++....-
T Consensus       167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~Ia~g~f  244 (637)
T COG4248         167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TDIAHGRF  244 (637)
T ss_pred             ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hhhhccee
Confidence            22211   234555699999654     34457889999999999999886 999976422111111000  00100000


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHhhhccCC
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVS--QPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      ...++......-.+.-..+.-....++.++.   +|+..  .+.-|||++--+..|.+++++..
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~---qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQ---QAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHH---HHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence            0000000000000000011112233444443   67664  35689999999999888877653

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.63  E-value=2.1e-09  Score=107.93  Aligned_cols=133  Identities=21%  Similarity=0.251  Sum_probs=93.3

Q ss_pred             CccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCC-CCcccccCCCCCcccccccceec
Q 036639           90 QLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS-DNNIRGRIPEQVTNLTRLLTLRL  167 (670)
Q Consensus        90 ~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~-~N~l~g~~p~~~~~l~~L~~L~l  167 (670)
                      .-..|+|..|+|+.+++. |+.+++|+.|||++|+|+-+-|+.|.+|.+|..|-+- +|+|+..--..|++|.+|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            445667777777766654 7778888888888888887778888888777665554 47888433356788888888888


Q ss_pred             ccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhc---CcccccccCCCcCCC
Q 036639          168 QNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKF---GEQSFIGNEGLCGSS  223 (670)
Q Consensus       168 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~~n~~~c~~~  223 (670)
                      .-|++.-...+.|..+++|..|.+-+|.+. .|+..-++.+   ...-..-|+..|.|.
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCn  205 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCN  205 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccc
Confidence            888887666677788888888888888876 6665333322   233446678778754

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.63  E-value=7.5e-09  Score=111.78  Aligned_cols=92  Identities=27%  Similarity=0.408  Sum_probs=74.6

Q ss_pred             HHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccccc-------------cccCcccCcccc
Q 036639          463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-------------ARLGGYKAPEQA  529 (670)
Q Consensus       463 ~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-------------~~~~~y~aPE~~  529 (670)
                      +.+++.|+.|+|..   .++||++|.|++|.++..+..||+.|+.+........+             .....|.|||++
T Consensus       105 l~~v~dgl~flh~s---Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~  181 (700)
T KOG2137|consen  105 LGNVADGLAFLHRS---AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL  181 (700)
T ss_pred             hhcccchhhhhccC---cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence            44556999999987   79999999999999999999999999988765441111             112349999999


Q ss_pred             ccCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 036639          530 EVKRLSQKADVYSFGVLLLEVLT-GRAPS  557 (670)
Q Consensus       530 ~~~~~~~ksDVwS~Gvvl~ellt-g~~p~  557 (670)
                      .....+.++|+||+||++|.+.. |+.-+
T Consensus       182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~  210 (700)
T KOG2137|consen  182 LGTTNTPASDVFSLGVLIYTIYNGGKSII  210 (700)
T ss_pred             ccccccccccceeeeeEEEEEecCCcchh
Confidence            98888999999999999999994 44443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.60  E-value=2.2e-08  Score=107.97  Aligned_cols=137  Identities=31%  Similarity=0.389  Sum_probs=114.7

Q ss_pred             cceEEecCCCCcEE---EEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCcccc-ccceeeccCCcccccCCcc
Q 036639           56 WTGVVCSPKSERVV---SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCT-NLKLAYLSGNDFSAEIPHQ  131 (670)
Q Consensus        56 w~gv~C~~~~~~v~---~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~-~L~~L~l~~N~l~g~~p~~  131 (670)
                      +.+..+..  ..+.   .|++..|.+...+..+..++.++.|++.+|+++...+....++ +|+.|++++|.+. .+|..
T Consensus        82 ~l~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~  158 (394)
T COG4886          82 SLDGSENL--LNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSP  158 (394)
T ss_pred             cccccccc--cCCCCCceeeccccccccCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchh-hhhhh
Confidence            45555443  2333   5888888887777777778999999999999998877777775 9999999999998 68888


Q ss_pred             ccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          132 ISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       132 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      ++.+++|+.|++++|+++ .+|...+.++.|+.|++++|+++ .+|.....+..|++|++++|.+.
T Consensus       159 ~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~  222 (394)
T COG4886         159 LRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII  222 (394)
T ss_pred             hhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce
Confidence            999999999999999999 78888779999999999999999 78877666777999999999643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.58  E-value=5.5e-07  Score=87.41  Aligned_cols=107  Identities=23%  Similarity=0.316  Sum_probs=83.8

Q ss_pred             HHHHHHHHHHHhccC--CCCeeeEEEEEEeCC----eeEEEEeccCC-CChHHHhccCCCCCCCCCCHHHHHHHHHHHHH
Q 036639          396 RKEFEQYMDVIGKLK--HPNVVKLRAYYYAKE----EKLLVYDYLPN-GSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR  468 (670)
Q Consensus       396 ~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  468 (670)
                      .....+|...+.++.  .=.+.+.+++.+...    ..++|+|++++ .+|.+++....     ..+......++.++++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence            345777887777774  334556677766532    45899999987 48999987632     1445667889999999


Q ss_pred             HHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEeccccccc
Q 036639          469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLL  511 (670)
Q Consensus       469 ~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~  511 (670)
                      .++-||+.    ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       130 ~i~~lH~~----gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  130 LIAKLHDA----GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHC----cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999998    999999999999999887   8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=5.1e-07  Score=98.21  Aligned_cols=149  Identities=21%  Similarity=0.360  Sum_probs=93.9

Q ss_pred             cHHHHHHHHH-hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc--------------------------h----HH---
Q 036639          352 ELEDLLRASA-EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC--------------------------A----RK---  397 (670)
Q Consensus       352 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~----~~---  397 (670)
                      .+++....+. +-++.++-|.||+|++++|+.||||+.+..-..                          .    .+   
T Consensus       120 ~iee~F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~  199 (517)
T COG0661         120 PIEELFSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE  199 (517)
T ss_pred             CHHHHHHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence            3444444443 567788999999999999999999988532100                          0    01   


Q ss_pred             -------HHHHHHHHHhcc----C-CCCeeeEEEEEEeCCeeEEEEeccCCCChHHHh--ccCCCCCCCCCCHHHHHHHH
Q 036639          398 -------EFEQYMDVIGKL----K-HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLV  463 (670)
Q Consensus       398 -------~~~~e~~~l~~l----~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~l~~~~~~~i~  463 (670)
                             ++.+|..-+.++    + .+++.-..=|++-.....|+|||++|-.+.+..  +...      .+   +..++
T Consensus       200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g------~d---~k~ia  270 (517)
T COG0661         200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG------ID---RKELA  270 (517)
T ss_pred             HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC------CC---HHHHH
Confidence                   122333333333    1 333322222233356778999999998888874  3321      33   22333


Q ss_pred             HHHHHH-HHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          464 LGAARG-LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       464 ~~ia~~-L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      ..++++ +..+-..    ++.|.|..|.||+++.+|++.+.|||+.....+
T Consensus       271 ~~~~~~f~~q~~~d----gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         271 ELLVRAFLRQLLRD----GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHHHHHHHHHHhc----CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            333332 2222223    999999999999999999999999999987754

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.55  E-value=6.2e-08  Score=67.77  Aligned_cols=40  Identities=28%  Similarity=0.658  Sum_probs=29.9

Q ss_pred             cchHHHHHHHHhccC-CCCCCCCCCCCCC-CCCCCcceEEec
Q 036639           23 PNDTDALTLFRLQTD-THGNLLSNWKGAD-ACAAAWTGVVCS   62 (670)
Q Consensus        23 ~~~~~~l~~~~~~~~-~~~~~l~~W~~~~-~~~~~w~gv~C~   62 (670)
                      ++|.++|+.||.++. +|...+.+|.... ..+|+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence            478999999999997 4678999998763 566899999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=2.2e-06  Score=81.56  Aligned_cols=139  Identities=19%  Similarity=0.184  Sum_probs=102.9

Q ss_pred             CCCCceEEEEEEEcCCCEEEEEEeCCC------CcchHHHHHHHHHHHhccCC--CCeeeEEEEEEeC----CeeEEEEe
Q 036639          365 GKGSLGTVYKAVLDDGGIVAVKRLKDA------NPCARKEFEQYMDVIGKLKH--PNVVKLRAYYYAK----EEKLLVYD  432 (670)
Q Consensus       365 g~G~~g~Vy~~~~~~g~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~----~~~~lv~e  432 (670)
                      |+||-+.|+...+. |+.+-+|+-...      .+.....|.+|...+.++..  -.+.+++.+....    -..+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            67888899998876 447888887521      13356789999999988853  2355555222221    23579999


Q ss_pred             ccCC-CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc--EEEEeccccc
Q 036639          433 YLPN-GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV--ACISDFGLSL  509 (670)
Q Consensus       433 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~  509 (670)
                      -+++ -+|.+++....   ..+.+...+..+..++++.++-||+.    ++.|+|+.+.||+++.++.  ++++||.-++
T Consensus       106 ~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~----Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        106 DMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSV----NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             eCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            7753 68988886532   12456777889999999999999998    9999999999999987677  9999998765


Q ss_pred             cc
Q 036639          510 LL  511 (670)
Q Consensus       510 ~~  511 (670)
                      ..
T Consensus       179 ~~  180 (216)
T PRK09902        179 RR  180 (216)
T ss_pred             hh
Confidence            43

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=4.1e-06  Score=82.43  Aligned_cols=140  Identities=15%  Similarity=0.177  Sum_probs=87.4

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCC--eeeEEEEEEeCCeeEEEEeccCCCC-
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPN--VVKLRAYYYAKEEKLLVYDYLPNGS-  438 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~-  438 (670)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            46899999999984   25567889887533  3456789999998886433  4677888777777889999998863 


Q ss_pred             hHHH---------------------hccCCCCCCCCCCHHHHHH-H---H-------HHHHH-HHHHHHHhCCCCCcccc
Q 036639          439 LHSL---------------------LHGNRGPGRIPLDWTTRIS-L---V-------LGAAR-GLARIHQEYGTAKVPHG  485 (670)
Q Consensus       439 L~~~---------------------l~~~~~~~~~~l~~~~~~~-i---~-------~~ia~-~L~~LH~~~~~~~ivH~  485 (670)
                      +...                     +|.....   ......... +   +       ..+.+ ...+|...-....++|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            2111                     1111000   011111100 0   0       00111 12223222223457899


Q ss_pred             CCCCCCeEeCCCCcEEEEecccccc
Q 036639          486 NVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       486 Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |+.|.||++++++ +.|+||+.+..
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcCc
Confidence            9999999999888 99999997754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.33  E-value=1.5e-07  Score=96.08  Aligned_cols=131  Identities=27%  Similarity=0.353  Sum_probs=79.9

Q ss_pred             CcEEEEEcCCCCccccCCC---CCCCCCccEEEccCCCCccccCC---------------------------Cccccccc
Q 036639           66 ERVVSLSLPSHSLRGPIAP---LSLLDQLRFLDLHDNRLNGTILP---------------------------LTNCTNLK  115 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~---~~~l~~L~~L~L~~N~l~~~~~~---------------------------~~~l~~L~  115 (670)
                      .+|+.|||+.|-|..--+-   ...|++|+.|+|+.|+|.-...+                           +..+++|.
T Consensus       146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~  225 (505)
T KOG3207|consen  146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE  225 (505)
T ss_pred             CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence            4678888888777653222   56677888888888877643321                           12345566


Q ss_pred             eeeccCCcccccCCccccCCCCCCEEeCCCCcccccCC--CCCcccccccceeccccccccc-CCCC-----cCCCCCCC
Q 036639          116 LAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP--EQVTNLTRLLTLRLQNNELTGR-IPDL-----SSSLKDLK  187 (670)
Q Consensus       116 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~L~l~~N~l~g~-~p~~-----~~~l~~L~  187 (670)
                      .|+|..|..-+.--....-+..|+.|||++|++- ..+  ..++.++.|+.|+++.+.++.. +|+.     ...+++|+
T Consensus       226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~  304 (505)
T KOG3207|consen  226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLE  304 (505)
T ss_pred             HhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccce
Confidence            6666666422222233344566777777777765 333  4566777777777777777632 2333     34567777


Q ss_pred             EEEccCCCCc
Q 036639          188 ELNLSNNELY  197 (670)
Q Consensus       188 ~l~l~~N~l~  197 (670)
                      +|++..|++.
T Consensus       305 ~L~i~~N~I~  314 (505)
T KOG3207|consen  305 YLNISENNIR  314 (505)
T ss_pred             eeecccCccc
Confidence            7777777764

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.30  E-value=8.1e-09  Score=110.90  Aligned_cols=126  Identities=27%  Similarity=0.271  Sum_probs=89.2

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCcc-ccCCCCCCEEeCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQ-ISSLKGILRLDLSD  145 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l~~  145 (670)
                      .+...+.+.|.|...-..+..++.|++|||++|+++..- .+..|+.|++|||++|+|. .+|.. -.++. |+.|.|.|
T Consensus       165 ~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrn  241 (1096)
T KOG1859|consen  165 KLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRN  241 (1096)
T ss_pred             hHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecc
Confidence            455566677777765555777888888888888887543 5777888888888888887 44432 23344 88888888


Q ss_pred             CcccccCCCCCcccccccceecccccccccCC-CCcCCCCCCCEEEccCCCCc
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIP-DLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~  197 (670)
                      |.++..  -.+.+|.+|+.|||++|-|++--- ..+..|..|..|+|.+|.+.
T Consensus       242 N~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  242 NALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             cHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            887732  346788888888888888875321 12455677888888888775

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.29  E-value=2.3e-08  Score=86.07  Aligned_cols=93  Identities=26%  Similarity=0.398  Sum_probs=64.5

Q ss_pred             CccccccceeeccCCcccccCCccccC-CCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCC
Q 036639          108 LTNCTNLKLAYLSGNDFSAEIPHQISS-LKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL  186 (670)
Q Consensus       108 ~~~l~~L~~L~l~~N~l~g~~p~~~~~-l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  186 (670)
                      +.....|+..+|++|.|. .+|..|.. ++.++.|+|++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|
T Consensus        49 l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l  125 (177)
T KOG4579|consen   49 LSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKL  125 (177)
T ss_pred             HhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhH
Confidence            344455555666666666 45555543 346777777777777 67777888888888888888887 566666667778


Q ss_pred             CEEEccCCCCcCCCcchh
Q 036639          187 KELNLSNNELYGRVPEGL  204 (670)
Q Consensus       187 ~~l~l~~N~l~g~ip~~~  204 (670)
                      ..|+..+|.+. +||..+
T Consensus       126 ~~Lds~~na~~-eid~dl  142 (177)
T KOG4579|consen  126 DMLDSPENARA-EIDVDL  142 (177)
T ss_pred             HHhcCCCCccc-cCcHHH
Confidence            88888888776 677554

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.27  E-value=3.7e-08  Score=84.85  Aligned_cols=111  Identities=22%  Similarity=0.215  Sum_probs=87.1

Q ss_pred             CcEEEEEcCCCCccccCCC---CCCCCCccEEEccCCCCccccCCCcc-ccccceeeccCCcccccCCccccCCCCCCEE
Q 036639           66 ERVVSLSLPSHSLRGPIAP---LSLLDQLRFLDLHDNRLNGTILPLTN-CTNLKLAYLSGNDFSAEIPHQISSLKGILRL  141 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~---~~~l~~L~~L~L~~N~l~~~~~~~~~-l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L  141 (670)
                      ...-.++|+++.|--....   +.....|+..+|++|.|...++.|.. .+.++.|+|++|.++ .+|.++..++.|+.|
T Consensus        27 kE~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   27 KELHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             HHhhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            4456678888876532222   56677888889999999877766544 458889999999998 688889999999999


Q ss_pred             eCCCCcccccCCCCCcccccccceecccccccccCCCC
Q 036639          142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDL  179 (670)
Q Consensus       142 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~  179 (670)
                      +++.|.|. ..|.-|..|.+|-.|+..+|.+. .||..
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d  141 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD  141 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence            99999998 77888888999999999988887 66643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.24  E-value=1.2e-05  Score=77.58  Aligned_cols=137  Identities=21%  Similarity=0.332  Sum_probs=90.8

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc-------------------hHHH-----HHHHHHHHhccC--CCCeee
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC-------------------ARKE-----FEQYMDVIGKLK--HPNVVK  416 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-------------------~~~~-----~~~e~~~l~~l~--h~nIv~  416 (670)
                      .|.+|.-+.||+|...++..||||+.+.....                   ..++     ..+|..-|.++.  +=.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            57788889999999888999999998633111                   1111     134555555552  344455


Q ss_pred             EEEEEEeCCeeEEEEeccCCCC-hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC
Q 036639          417 LRAYYYAKEEKLLVYDYLPNGS-LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD  495 (670)
Q Consensus       417 l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~  495 (670)
                      .+++.    ...|||||+.... -.-.|+.      .++.......+..++++.+.-|-..   .++||+||+.-|||+.
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~~---a~LVHgDLSEyNiL~~  201 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYKE---AGLVHGDLSEYNILVH  201 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHHh---cCcccccchhhheEEE
Confidence            55443    3469999995431 1111111      1223335566677777777777764   3999999999999998


Q ss_pred             CCCcEEEEecccccccCc
Q 036639          496 KNGVACISDFGLSLLLNP  513 (670)
Q Consensus       496 ~~~~~kl~DFG~a~~~~~  513 (670)
                       ++.+.|+|||-|.....
T Consensus       202 -~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -CCeEEEEECccccccCC
Confidence             89999999998876653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.21  E-value=5e-08  Score=104.98  Aligned_cols=127  Identities=30%  Similarity=0.276  Sum_probs=100.4

Q ss_pred             CCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCC-Ccccccccceec
Q 036639           89 DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQ-VTNLTRLLTLRL  167 (670)
Q Consensus        89 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~L~l  167 (670)
                      ..|.+.+++.|+|......+.-++.|+.|||++|+|+..  +.+..|++|++|||++|.|+ .+|.. ...+ +|..|.|
T Consensus       164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l  239 (1096)
T KOG1859|consen  164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL  239 (1096)
T ss_pred             hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence            467778889999887666788899999999999999854  28889999999999999999 66643 3344 4999999


Q ss_pred             ccccccccCCCCcCCCCCCCEEEccCCCCcCC---CcchhhhhcCcccccccCCCcC
Q 036639          168 QNNELTGRIPDLSSSLKDLKELNLSNNELYGR---VPEGLLKKFGEQSFIGNEGLCG  221 (670)
Q Consensus       168 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~---ip~~~~~~~~~~~~~~n~~~c~  221 (670)
                      ++|.++...  .+.+|.+|..|||++|-|.+.   .|-+.+..+....+.|||--|.
T Consensus       240 rnN~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  240 RNNALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             cccHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            999998332  366789999999999998764   3444455666677789997665

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.19  E-value=1.5e-05  Score=76.13  Aligned_cols=122  Identities=17%  Similarity=0.257  Sum_probs=77.1

Q ss_pred             eEEEEEEEcCCCEEEEEEeCCCCcchHHHHH---------HHHHHHhccC---CCCeeeEEEEEEe-----CCeeEEEEe
Q 036639          370 GTVYKAVLDDGGIVAVKRLKDANPCARKEFE---------QYMDVIGKLK---HPNVVKLRAYYYA-----KEEKLLVYD  432 (670)
Q Consensus       370 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~---------~e~~~l~~l~---h~nIv~l~~~~~~-----~~~~~lv~e  432 (670)
                      ..|.+... +|+.+++|..+.......+.|.         +++..+.+++   -.....++.+.+.     ....+++||
T Consensus        45 ~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~E  123 (229)
T PF06176_consen   45 NYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLME  123 (229)
T ss_pred             cEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEE
Confidence            33444444 4788999988765443333332         3333333342   2233333333322     234568999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |++|..|.++..         ++.    .++..+.+++.-+|..    |+.|+|..|.|++++.++ ++++||+..+.
T Consensus       124 YIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~----G~~HGD~hpgNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  124 YIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKH----GFYHGDPHPGNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EecCeecccchh---------cCH----HHHHHHHHHHHHHHHc----CCccCCCCcCcEEEECCc-EEEEECccccc
Confidence            999988876532         221    2445677889999998    999999999999998554 99999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.18  E-value=2.2e-05  Score=78.49  Aligned_cols=142  Identities=18%  Similarity=0.182  Sum_probs=86.5

Q ss_pred             cCCCCc-eEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccCCCChHH
Q 036639          364 LGKGSL-GTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS  441 (670)
Q Consensus       364 lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~  441 (670)
                      |..|.+ ..||+.... +..++||+.....   ..++.+|++++..+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 789999865 4788899887543   345677888887773 4456678887777677899999999877764


Q ss_pred             Hh-------------------ccCCCCCCCCCC--HHHHHHHHHH--------------------HHHHHHHHHHh---C
Q 036639          442 LL-------------------HGNRGPGRIPLD--WTTRISLVLG--------------------AARGLARIHQE---Y  477 (670)
Q Consensus       442 ~l-------------------~~~~~~~~~~l~--~~~~~~i~~~--------------------ia~~L~~LH~~---~  477 (670)
                      ..                   +.... ...+..  ..........                    +...+..|-..   .
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            32                   11110 000111  0011100000                    11112222111   1


Q ss_pred             CCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       478 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      ..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            234689999999999999988889999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.18  E-value=1.5e-05  Score=86.44  Aligned_cols=147  Identities=18%  Similarity=0.223  Sum_probs=90.4

Q ss_pred             HHHHHHHHH-hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcch-------------------------------HH---
Q 036639          353 LEDLLRASA-EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA-------------------------------RK---  397 (670)
Q Consensus       353 ~~~~~~~~~-~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------~~---  397 (670)
                      ++++...+. +.||.-..|.||+|++++|+.||||+-+..-...                               .+   
T Consensus       157 ie~if~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~  236 (538)
T KOG1235|consen  157 IEDIFSEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLP  236 (538)
T ss_pred             HHHHHHhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhH
Confidence            344444443 5678888999999999999999999875321100                               01   


Q ss_pred             ---HHHHHHHHHh----ccCCCC------eeeEEEEEEeCCeeEEEEeccCCCChHHH--hccCCCCCCCCCCHHHHHHH
Q 036639          398 ---EFEQYMDVIG----KLKHPN------VVKLRAYYYAKEEKLLVYDYLPNGSLHSL--LHGNRGPGRIPLDWTTRISL  462 (670)
Q Consensus       398 ---~~~~e~~~l~----~l~h~n------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~l~~~~~~~i  462 (670)
                         +|.+|++-..    .+.|-+      |.+++-  .-.....|+||||+|.-+.+.  +.+..      ++-.   .+
T Consensus       237 ~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~---~i  305 (538)
T KOG1235|consen  237 QELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKRG------ISPH---DI  305 (538)
T ss_pred             hhcchHHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHcC------CCHH---HH
Confidence               1223332222    223444      333322  223467899999999877654  33332      3333   33


Q ss_pred             HHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC----CCcEEEEecccccccCc
Q 036639          463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK----NGVACISDFGLSLLLNP  513 (670)
Q Consensus       463 ~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DFG~a~~~~~  513 (670)
                      +..+.++...+--.   .|++|+|=.|.||+++.    ++.+.+-|||+......
T Consensus       306 ~~~l~~~~~~qIf~---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  306 LNKLVEAYLEQIFK---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHHHHHHHHHh---cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            44443333222111   38999999999999984    67899999999887754

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.09  E-value=3.8e-07  Score=93.20  Aligned_cols=131  Identities=24%  Similarity=0.229  Sum_probs=92.4

Q ss_pred             cEEEEEcCCCCccccC--CCCCCCCCccEEEccCCCCccccC--C-CccccccceeeccCCcccccCCccc-cCCCCCCE
Q 036639           67 RVVSLSLPSHSLRGPI--APLSLLDQLRFLDLHDNRLNGTIL--P-LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILR  140 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~--~~~~~l~~L~~L~L~~N~l~~~~~--~-~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~  140 (670)
                      .+..+.|.+....-..  .....+++++.||||.|-|..--+  . ...|++|+.|+|+.|+|.-..-... ..++.|+.
T Consensus       122 kL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~  201 (505)
T KOG3207|consen  122 KLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQ  201 (505)
T ss_pred             hhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhhe
Confidence            4556666655444322  236789999999999999875321  2 6789999999999999975444333 35788999


Q ss_pred             EeCCCCccccc-CCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          141 LDLSDNNIRGR-IPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       141 L~l~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      |.|++..|+-. +-..+..+++|+.|+|..|..-+.-.....-++.|+.|||++|++-
T Consensus       202 L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li  259 (505)
T KOG3207|consen  202 LVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI  259 (505)
T ss_pred             EEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc
Confidence            99999998732 2223456789999999999633333334455778999999999875

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	670
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-40
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-29
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-29
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-24
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-24
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-24
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-19
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		6e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-15
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-15
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		7e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		9e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-13
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-13
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-13
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-13
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-13
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-13
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-13
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		8e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-13
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-13
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		9e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-13
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		9e-13
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-13
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-11
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-10
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		5e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		6e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-10
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-10
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-10
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-10
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-10
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-10
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-10
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-10
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-10
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-10
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-10
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-10
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-10
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-10
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-10
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-09
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-09
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-09
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-09
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		9e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-08
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-08
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-08
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-08
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-08
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-08
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-08
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-08
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-08
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		8e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		9e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-07
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		3e-07
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-07
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-07
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-07
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-07
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-07
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-07
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-07
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		6e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		6e-07
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		8e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-06
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-06
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-06
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-06
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-06
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-06
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-06
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-06
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-06
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		5e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-06
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		5e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		6e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-06
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		7e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		9e-06
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-05
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-05
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-05
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-05
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-05
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-05
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-05
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-05
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-05
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		4e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		6e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		7e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-04
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-04
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		3e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		4e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		5e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 171/300 (57%), Gaps = 22/300 (7%)
Query: 349 KQFELEDLLRAS-----AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK-EFEQY 402
           K+F L +L  AS       +LG+G  G VYK  L DG +VAVKRLK+      + +F+  
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTE 77
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++I    H N+++LR +     E+LLVY Y+ NGS+ S L   R   + PLDW  R  +
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRI 136
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-----PVQAI 517
            LG+ARGLA +H ++   K+ H +VK++N+LLD+   A + DFGL+ L++        A+
Sbjct: 137 ALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 195
Query: 518 ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
               G+ APE     + S+K DV+ +GV+LLE++TG+         R   D++   +D  
Sbjct: 196 RGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---ARLANDDDVMLLD-- 250
Query: 578 KWVRSVVKEEWTAEVFDQELL-RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
            WV+ ++KE+    + D +L   YK+  EE+  ++ V L C  S P +RP M+EV +M+E
Sbjct: 251 -WVKGLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 109/300 (36%), Positives = 171/300 (57%), Gaps = 22/300 (7%)
Query: 349 KQFELEDLLRAS-----AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK-EFEQY 402
           K+F L +L  AS       +LG+G  G VYK  L DG +VAVKRLK+      + +F+  
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTE 85
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++I    H N+++LR +     E+LLVY Y+ NGS+ S L   R   + PLDW  R  +
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRI 144
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-----PVQAI 517
            LG+ARGLA +H ++   K+ H +VK++N+LLD+   A + DFGL+ L++        A+
Sbjct: 145 ALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 518 ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
               G+ APE     + S+K DV+ +GV+LLE++TG+         R   D++   +D  
Sbjct: 204 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL---ARLANDDDVMLLD-- 258
Query: 578 KWVRSVVKEEWTAEVFDQELL-RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
            WV+ ++KE+    + D +L   YK+  EE+  ++ V L C  S P +RP M+EV +M+E
Sbjct: 259 -WVKGLLKEKKLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  125 bits (315), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 148/290 (51%), Gaps = 21/290 (7%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           ++G G  G VYK VL DG  VA+KR    +    +EFE  ++ +   +HP++V L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
            + E +L+Y Y+ NG+L   L+G+  P  + + W  R+ + +GAARGL  +H    T  +
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH----TRAI 160
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLS-----LLLNPVQAIAR-LGGYKAPEQAEVKRLSQ 536
            H +VKS N+LLD+N V  I+DFG+S     L    +  + +   GY  PE     RL++
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
           K+DVYSFGV+L EVL  R+      P         + V+L +W           ++ D  
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLP--------REMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE-DIRVEQSPL 645
           L   K   E L       + C+    E RP+M +V   +E  +R+++S +
Sbjct: 273 LAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  125 bits (315), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 94/290 (32%), Positives = 148/290 (51%), Gaps = 21/290 (7%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           ++G G  G VYK VL DG  VA+KR    +    +EFE  ++ +   +HP++V L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
            + E +L+Y Y+ NG+L   L+G+  P  + + W  R+ + +GAARGL  +H    T  +
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH----TRAI 160
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLS-----LLLNPVQAIAR-LGGYKAPEQAEVKRLSQ 536
            H +VKS N+LLD+N V  I+DFG+S     L    +  + +   GY  PE     RL++
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTE 220
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
           K+DVYSFGV+L EVL  R+      P         + V+L +W           ++ D  
Sbjct: 221 KSDVYSFGVVLFEVLCARSAIVQSLP--------REMVNLAEWAVESHNNGQLEQIVDPN 272
Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE-DIRVEQSPL 645
           L   K   E L       + C+    E RP+M +V   +E  +R+++S +
Sbjct: 273 LAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESVI 321

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 155/309 (50%), Gaps = 35/309 (11%)
Query: 344 FYERKK---QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA----R 396
           FYE K     F+ E  +      +G+G  G VYK  +++   VAVK+L           +
Sbjct: 17  FYELKNVTNNFD-ERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELK 74
Query: 397 KEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDW 456
           ++F+Q + V+ K +H N+V+L  +    ++  LVY Y+PNGSL   L  +   G  PL W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSW 132
Query: 457 TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL---SLLLNP 513
             R  +  GAA G+  +H+ +      H ++KS+N+LLD+   A ISDFGL   S     
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI----HRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 514 VQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE 570
               +R+ G   Y APE A    ++ K+D+YSFGV+LLE++TG           P VDE 
Sbjct: 189 TVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG----------LPAVDEH 237
Query: 571 -EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
            E  + L        +E+   +  D+++    +   E  +M  V   C+  +  KRP + 
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE--AMYSVASQCLHEKKNKRPDIK 295
Query: 630 EVAKMIEDI 638
           +V ++++++
Sbjct: 296 KVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  111 bits (277), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 95/309 (30%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 344 FYERKK---QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA----R 396
           FYE K     F+ E  +      +G+G  G VYK  +++   VAVK+L           +
Sbjct: 17  FYELKNVTNNFD-ERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELK 74
Query: 397 KEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDW 456
           ++F+Q + V+ K +H N+V+L  +    ++  LVY Y+PNGSL   L  +   G  PL W
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSW 132
Query: 457 TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL---SLLLNP 513
             R  +  GAA G+  +H+ +      H ++KS+N+LLD+   A ISDFGL   S     
Sbjct: 133 HMRCKIAQGAANGINFLHENHHI----HRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 514 VQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE 570
                R+ G   Y APE A    ++ K+D+YSFGV+LLE++TG           P VDE 
Sbjct: 189 TVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG----------LPAVDEH 237
Query: 571 -EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
            E  + L        +E+   +  D+++    +   E  +M  V   C+  +  KRP + 
Sbjct: 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE--AMYSVASQCLHEKKNKRPDIK 295
Query: 630 EVAKMIEDI 638
           +V ++++++
Sbjct: 296 KVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 94/309 (30%), Positives = 154/309 (49%), Gaps = 35/309 (11%)
Query: 344 FYERKK---QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA----R 396
           FYE K     F+ E  +      +G+G  G VYK  +++   VAVK+L           +
Sbjct: 11  FYELKNVTNNFD-ERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELK 68
Query: 397 KEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDW 456
           ++F+Q + V+ K +H N+V+L  +    ++  LVY Y+PNGSL   L  +   G  PL W
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL--SCLDGTPPLSW 126
Query: 457 TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL----LLN 512
             R  +  GAA G+  +H+ +      H ++KS+N+LLD+   A ISDFGL+        
Sbjct: 127 HMRCKIAQGAANGINFLHENHHI----HRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 513 PVQAIARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE 570
            V     +G   Y APE A    ++ K+D+YSFGV+LLE++TG           P VDE 
Sbjct: 183 XVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG----------LPAVDEH 231
Query: 571 -EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
            E  + L        +E+   +  D+++    +   E  +M  V   C+  +  KRP + 
Sbjct: 232 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE--AMYSVASQCLHEKKNKRPDIK 289
Query: 630 EVAKMIEDI 638
           +V ++++++
Sbjct: 290 KVQQLLQEM 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 88/286 (30%), Positives = 144/286 (50%), Gaps = 35/286 (12%)
Query: 365 GKGSLGTVYKAVLDDGGIVAVKRLKDANPCA----RKEFEQYMDVIGKLKHPNVVKLRAY 420
           G+G  G VYK  +++   VAVK+L           +++F+Q + V  K +H N+V+L  +
Sbjct: 31  GEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGF 89
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
               ++  LVY Y PNGSL   L  +   G  PL W  R  +  GAA G+  +H+ +   
Sbjct: 90  SSDGDDLCLVYVYXPNGSLLDRL--SCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI- 146
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGL---SLLLNPVQAIARLGG---YKAPEQAEVKRL 534
              H ++KS+N+LLD+   A ISDFGL   S         +R+ G   Y APE A    +
Sbjct: 147 ---HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE-ALRGEI 202
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
           + K+D+YSFGV+LLE++TG           P VDE  +    P+ +  + +E    E   
Sbjct: 203 TPKSDIYSFGVVLLEIITG----------LPAVDEHRE----PQLLLDIKEEIEDEEKTI 248
Query: 595 QELLRYKNIEEELVSM---LHVGLACVVSQPEKRPTMAEVAKMIED 637
           ++ +  K  + +  S+     V   C+  +  KRP + +V +++++
Sbjct: 249 EDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 136/282 (48%), Gaps = 39/282 (13%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK--EFEQYMDVIGKLKHPNVVKLRA 419
           E +G GS GTV++A    G  VAVK L + +  A +  EF + + ++ +L+HPN+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
                    +V +YL  GSL+ LLH  +   R  LD   R+S+    A+G+  +H     
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNR--N 157
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLL----LNPVQAIARLGGYKAPEQAEVKRLS 535
             + H N+KS N+L+DK     + DFGLS L        ++ A    + APE    +  +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 536 QKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
           +K+DVYSFGV+L E+ T + P  +  P+     V  + + +++P                
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---------------- 261
Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
                  +N+  ++ +++     C  ++P KRP+ A +  ++
Sbjct: 262 -------RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLL 293

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/294 (27%), Positives = 143/294 (48%), Gaps = 46/294 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+ A  +    VAVK +K  +  + + F    +V+  L+H  +VKL A    
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV-T 253
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGR-IP--LDWTTRISLVLGAARGLARIHQEYGTA 480
           KE   ++ +++  GSL   L  + G  + +P  +D++ +I      A G+A I Q     
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQR---- 303
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+  + V  I+DFGL+ ++   +  AR G      + APE       +
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 363
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL+E++T GR P  YP  + P V            +R++ +         
Sbjct: 364 IKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV------------IRALER--------G 401
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEE 648
             + R +N  EEL +++   + C  ++PE+RPT   +  +++D         EE
Sbjct: 402 YRMPRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLDDFYTATESQXEE 452

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 39/282 (13%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK--EFEQYMDVIGKLKHPNVVKLRA 419
           E +G GS GTV++A    G  VAVK L + +  A +  EF + + ++ +L+HPN+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
                    +V +YL  GSL+ LLH  +   R  LD   R+S+    A+G+  +H     
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNR--N 157
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----YKAPEQAEVKRLS 535
             + H ++KS N+L+DK     + DFGLS L       ++       + APE    +  +
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSN 217
Query: 536 QKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
           +K+DVYSFGV+L E+ T + P  +  P+     V  + + +++P                
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP---------------- 261
Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
                  +N+  ++ +++     C  ++P KRP+ A +  ++
Sbjct: 262 -------RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLL 293

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 141/284 (49%), Gaps = 46/284 (16%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+ A  +    VAVK +K  +  + + F    +V+  L+H  +VKL A    
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV-T 80
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGR-IP--LDWTTRISLVLGAARGLARIHQEYGTA 480
           KE   ++ +++  GSL   L  + G  + +P  +D++ +I      A G+A I Q     
Sbjct: 81  KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQR---- 130
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+  + V  I+DFGL+ ++   +  AR G      + APE       +
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL+E++T GR P  YP  + P V            +R++ +         
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV------------IRALER--------G 228
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             + R +N  EEL +++   + C  ++PE+RPT   +  +++D 
Sbjct: 229 YRMPRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLDDF 269

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK  N  + + F Q   V+ KL+H  +V+L A   +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 250
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 251 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 302
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL  L+   +  AR G      + APE A   R + K
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 363 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 402
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 403 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 445

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIVAVKRLKDANPCARKE-FEQYMDVIGKLKHPNVVKLR 418
           E++G G  G VY+A    D+  + A +   D +     E   Q   +   LKHPN++ LR
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    LV ++   G L+ +L G R P  I ++W  +I      ARG+  +H E  
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDE-A 125
Query: 479 TAKVPHGNVKSSNVLLDK--------NGVACISDFGLSLLLNPVQAIARLGGYK--APEQ 528
              + H ++KSSN+L+ +        N +  I+DFGL+   +    ++  G Y   APE 
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEV 185
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                 S+ +DV+S+GVLL E+LTG  P
Sbjct: 186 IRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 73  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 124
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H N++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R V           
Sbjct: 185 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYRMV----------- 226
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
               R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 227 ----RPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 263

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVER----MNY 301
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 362 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 401
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 402 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVER----MNY 301
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 362 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 401
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 402 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 332
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVER----MNY 384
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSP-TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 445 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 484
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 485 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 250 EEPIYIVGEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVER----MNY 301
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 362 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 401
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 402 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 85  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 136
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R             
Sbjct: 197 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR------------- 236
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 237 --MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 275

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 86  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 137
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R             
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR------------- 237
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 238 --MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 276

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 83  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 134
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R             
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR------------- 234
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 235 --MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 273

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 128
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R V           
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYRMV----------- 230
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
               R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 231 ----RPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 73
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 74  EEPIXIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVER----MNY 125
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 186 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 225
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 226 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 268

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 128
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R             
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR------------- 228
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 229 --MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 78  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 129
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R V           
Sbjct: 190 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYRMV----------- 231
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
               R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 232 ----RPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 268

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 87  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 138
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R             
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR------------- 238
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 239 --MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 277

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 79  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 130
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R V           
Sbjct: 191 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYRMV----------- 232
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
               R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 233 ----RPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 269

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 40/283 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A  
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +      
Sbjct: 78  -TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER----N 129
Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQ 536
             H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 537 KADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R              
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR-------------- 228
Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
            ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 229 -MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 82  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 133
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R             
Sbjct: 194 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR------------- 233
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 234 --MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 272

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 83  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 134
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R             
Sbjct: 195 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYR------------- 234
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             ++R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 235 --MVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 273

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 77  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 128
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R V           
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYRMV----------- 230
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
               R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 231 ----RPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 76
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASGMAYVER----MNY 128
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 189 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 228
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 229 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 271

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A 
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +E   ++ +Y+ NGSL   L   + P  I L     + +    A G+A I +     
Sbjct: 72  V-TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFIEER---- 123
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       +
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL E++T GR P  YP  T P V +     +L +  R V           
Sbjct: 184 IKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQ-----NLERGYRMV----------- 225
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
               R  N  EEL  ++ +   C   +PE RPT   +  ++ED 
Sbjct: 226 ----RPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 262

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 131/290 (45%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 80
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLP----QLVDMSAQIASGMAYVER----MNY 132
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 193 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 232
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 233 -------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 275

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 50/292 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 80
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIP--LDWTTRISLVLGAARGLARIHQEYGTA 480
           +E   +V +Y+  GSL   L G  G   R+P  +D + +I      A G+A + +     
Sbjct: 81  EEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI------ASGMAYVER----M 130
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R +
Sbjct: 131 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 190
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
            K+DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                
Sbjct: 191 IKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP---------------- 232
Query: 594 DQELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                       E    LH +   C   +PE+RPT   +   +ED      P
Sbjct: 233 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 275

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 72
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 73  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 124
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 185 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 224
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 225 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVIEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 74
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 126
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 187 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 226
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 227 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 269

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVCEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ K++H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  GSL   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H ++ ++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  G L   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVMEYMSKGCLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 138/284 (48%), Gaps = 56/284 (19%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+ A  +    VAVK +K  +  + + F    +V+  L+H  +VKL A    
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV-T 247
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGR-IP--LDWTTRISLVLGAARGLARIHQEYGTA 480
           KE   ++ +++  GSL   L  + G  + +P  +D++ +I      A G+A I Q     
Sbjct: 248 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQR---- 297
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLS 535
              H +++++N+L+  + V  I+DFGL          AR+G      + APE       +
Sbjct: 298 NYIHRDLRAANILVSASLVCKIADFGL----------ARVGAKFPIKWTAPEAINFGSFT 347
Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
            K+DV+SFG+LL+E++T GR P  YP  + P V            +R++ +         
Sbjct: 348 IKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV------------IRALER--------G 385
Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             + R +N  EEL +++   + C  ++PE+RPT   +  +++D 
Sbjct: 386 YRMPRPENCPEELYNIM---MRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L A   +
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPG-RIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
           +E   +V +Y+  G L   L G  G   R+P      + +    A G+A + +       
Sbjct: 84  EEPIYIVTEYMSKGCLLDFLKGEMGKYLRLP----QLVDMAAQIASGMAYVER----MNY 135
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
            H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E+ T GR P  YP    R  +D+ E+   +P                  
Sbjct: 196 SDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP------------------ 235
Query: 596 ELLRYKNIEEELVSMLH-VGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     E    LH +   C    PE+RPT   +   +ED      P
Sbjct: 236 -------CPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTEP 278

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 44/289 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+    +    VA+K LK     + + F +   ++ KLKH  +V+L A   +
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVV-S 74
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +E   +V +Y+  GSL   L    G GR  L     + +    A G+A I +        
Sbjct: 75  EEPIYIVTEYMNKGSLLDFLKD--GEGR-ALKLPNLVDMAAQVAAGMAYIER----MNYI 127
Query: 484 HGNVKSSNVLLDKNGVAC-ISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQK 537
           H +++S+N+L+  NG+ C I+DFGL+ L+   +  AR G      + APE A   R + K
Sbjct: 128 HRDLRSANILVG-NGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVFDQ 595
           +DV+SFG+LL E++T GR P  YP      V E+ E+   +P                  
Sbjct: 187 SDVWSFGILLTELVTKGRVP--YPGMNNREVLEQVERGYRMP------------------ 226
Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                   ++  +S+  + + C    PE+RPT   +   +ED      P
Sbjct: 227 ------CPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEP 269

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 24/231 (10%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L   G     VA+K LK       R++F     ++G+  HPNV+ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          +++ +++ NGSL S L  N G         T I LV G  RG+A   + 
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-------FTVIQLV-GMLRGIAAGMKY 150
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL-----NPVQAIARLGG-----YKAP 526
                  H ++ + N+L++ N V  +SDFGLS  L     +P    A LGG     + AP
Sbjct: 151 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA-LGGKIPIRWTAP 209
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
           E  + ++ +  +DV+S+G+++ EV++      +    +  ++  EQ   LP
Sbjct: 210 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 260

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 24/231 (10%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           E++G G  G V +  L   G     VA+K LK       R+EF     ++G+ +HPN+++
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          +++ +++ NG+L S L  N G         T I LV G  RG+A   + 
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-------FTVIQLV-GMLRGIASGMRY 133
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL-----NPVQAIARLGG-----YKAP 526
                  H ++ + N+L++ N V  +SDFGLS  L     +P +  + LGG     + AP
Sbjct: 134 LAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTET-SSLGGKIPIRWTAP 192
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
           E    ++ +  +D +S+G+++ EV++      +    +  ++  EQ   LP
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLP 243

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 125/260 (48%), Gaps = 48/260 (18%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCAR-------KEFEQYMDVIGKLKHPNVV 415
           +GKG  G V+K  ++ D  +VA+K L   +           +EF++ + ++  L HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSL-HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           KL  Y        +V +++P G L H LL         P+ W+ ++ L+L  A G+  + 
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQ 139
Query: 475 QEYGTAKVPHGNVKSSNVLL---DKNGVAC--ISDFGLSLLLNPVQAIARLGG---YKAP 526
            +     + H +++S N+ L   D+N   C  ++DFGLS     V +++ L G   + AP
Sbjct: 140 NQ--NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAP 195
Query: 527 EQ--AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS-------------PTRPRVDEEE 571
           E   AE +  ++KAD YSF ++L  +LTG  P    S               RP + E  
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE-- 253
Query: 572 QAVDLPKWVRSVVKEEWTAE 591
              D P  +R+V++  W+ +
Sbjct: 254 ---DCPPRLRNVIELCWSGD 270

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 108/230 (46%), Gaps = 22/230 (9%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           E++G G  G V +  L   G     VA+K LK       R+EF     ++G+ +HPN+++
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          +++ +++ NG+L S L  N G         T I LV G  RG+A   + 
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRLNDGQ-------FTVIQLV-GMLRGIASGMRY 131
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGG-----YKAPE 527
                  H ++ + N+L++ N V  +SDFGLS  L    +     + LGG     + APE
Sbjct: 132 LAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
               ++ +  +D +S+G+++ EV++      +    +  ++  EQ   LP
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDYRLP 241

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 24/231 (10%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L   G     VA+K LK       R++F     ++G+  HPNV+ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          +++ +++ NGSL S L  N G         T I LV G  RG+A   + 
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ-------FTVIQLV-GMLRGIAAGMKY 124
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL-----NPVQAIARLGG-----YKAP 526
                  H  + + N+L++ N V  +SDFGLS  L     +P    A LGG     + AP
Sbjct: 125 LADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA-LGGKIPIRWTAP 183
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
           E  + ++ +  +DV+S+G+++ EV++      +    +  ++  EQ   LP
Sbjct: 184 EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP 234

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 7   QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 64
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 124
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H N+ + N+L++      I DFGL+ +L   +   ++
Sbjct: 125 ------CKGMEYL----GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 174
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 175 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 221

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 383 VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L          ++V +Y+ NGSL +
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  + G           I  ++G  RG+    +        H ++ + NVL+D N V  
Sbjct: 140 FLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCK 191
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR 554
           +SDFGLS +L  +P  A    GG     + APE    +  S  +DV+SFGV++ EVL   
Sbjct: 192 VSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 555 APSQYPSPTRPRVDEEEQAVDLP 577
               +    R  +   E+   LP
Sbjct: 252 ERPYWNMTNRDVISSVEEGYRLP 274

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 383 VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L          ++V +Y+ NGSL +
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  + G           I  ++G  RG+    +        H ++ + NVL+D N V  
Sbjct: 140 FLRTHDG--------QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCK 191
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR 554
           +SDFGLS +L  +P  A    GG     + APE    +  S  +DV+SFGV++ EVL   
Sbjct: 192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 555 APSQYPSPTRPRVDEEEQAVDLP 577
               +    R  +   E+   LP
Sbjct: 252 ERPYWNMTNRDVISSVEEGYRLP 274

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 6   QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 124 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 130/282 (46%), Gaps = 41/282 (14%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+    ++   VAVK LK      +   E+  +++  L+H  +V+L A    
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEE-ANLMKTLQHDKLVRLYAVVTR 79
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +E   ++ +Y+  GSL   L  + G G++ L     I      A G+A I ++       
Sbjct: 80  EEPIYIITEYMAKGSLLDFLKSDEG-GKVLL--PKLIDFSAQIAEGMAYIERK----NYI 132
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H +++++NVL+ ++ +  I+DFGL+ ++   +  AR G      + APE       + K+
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVFDQE 596
           DV+SFG+LL E++T G+ P  YP  T   V     Q   +P                   
Sbjct: 193 DVWSFGILLYEIVTYGKIP--YPGRTNADVMTALSQGYRMP------------------- 231
Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
             R +N  +EL  ++ +   C   + E+RPT   +  +++D 
Sbjct: 232 --RVENCPDELYDIMKM---CWKEKAEERPTFDYLQSVLDDF 268

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 116/232 (50%), Gaps = 26/232 (11%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEF 399
           +E +   + E+      + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++F
Sbjct: 2   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 400 EQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLD 455
           E+ ++++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L 
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQ 121
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
           +T++I       +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +
Sbjct: 122 YTSQI------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 171
Query: 516 AIARLGG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
              ++         + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 172 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 136/294 (46%), Gaps = 52/294 (17%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCAR-------KEFEQYMDVIGKLKHPNVV 415
           +GKG  G V+K  ++ D  +VA+K L   +           +EF++ + ++  L HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSL-HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           KL  Y        +V +++P G L H LL         P+ W+ ++ L+L  A G+  + 
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQ 139
Query: 475 QEYGTAKVPHGNVKSSNVLL---DKNGVAC--ISDFGLSLLLNPVQAIARLGG---YKAP 526
            +     + H +++S N+ L   D+N   C  ++DFG S     V +++ L G   + AP
Sbjct: 140 NQ--NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAP 195
Query: 527 EQ--AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           E   AE +  ++KAD YSF ++L  +LTG  P             +E +    K++  + 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPF------------DEYSYGKIKFINMIR 243
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           +E     + +    R +N+ E           C    P+KRP  + + K + ++
Sbjct: 244 EEGLRPTIPEDCPPRLRNVIE----------LCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 9   QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 126
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 127 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 11  QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 68
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 128
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 129 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 178
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 179 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 225

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 116/232 (50%), Gaps = 26/232 (11%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEF 399
           +E +   + E+      + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++F
Sbjct: 30  FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 89
Query: 400 EQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLD 455
           E+ ++++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L 
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
           +T++I       +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +
Sbjct: 150 YTSQI------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
Query: 516 AIARLGG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
              ++         + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 200 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 10  QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 67
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 127
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 128 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 177
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 178 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 224

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 5   QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 62
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 122
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 123 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 173 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 4   QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 61
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 121
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 122 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 171
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 172 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 218

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 116/232 (50%), Gaps = 26/232 (11%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEF 399
           +E +   + E+      + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++F
Sbjct: 6   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 65
Query: 400 EQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLD 455
           E+ ++++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L 
Sbjct: 66  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 125
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
           +T++I       +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +
Sbjct: 126 YTSQI------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 175
Query: 516 AIARLGG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
              ++         + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 176 EXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 227

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 124/260 (47%), Gaps = 48/260 (18%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCAR-------KEFEQYMDVIGKLKHPNVV 415
           +GKG  G V+K  ++ D  +VA+K L   +           +EF++ + ++  L HPN+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSL-HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           KL  Y        +V +++P G L H LL         P+ W+ ++ L+L  A G+  + 
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQ 139
Query: 475 QEYGTAKVPHGNVKSSNVLL---DKNGVAC--ISDFGLSLLLNPVQAIARLGG---YKAP 526
            +     + H +++S N+ L   D+N   C  ++DF LS     V +++ L G   + AP
Sbjct: 140 NQ--NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAP 195
Query: 527 EQ--AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS-------------PTRPRVDEEE 571
           E   AE +  ++KAD YSF ++L  +LTG  P    S               RP + E  
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE-- 253
Query: 572 QAVDLPKWVRSVVKEEWTAE 591
              D P  +R+V++  W+ +
Sbjct: 254 ---DCPPRLRNVIELCWSGD 270

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 6   QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 124 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 6   QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 124 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 12  QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 69
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 129
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 130 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 179
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 180 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 226

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 24  QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 81
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 142 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 238

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 114/227 (50%), Gaps = 28/227 (12%)
Query: 350 QFELEDLLRASAEMLGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMD 404
           QFE   L     + LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++
Sbjct: 24  QFEERHL--KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 81
Query: 405 VIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRI 460
           ++  L+H N+VK +   Y+  +    L+ +YLP GSL   L  H  R      L +T++I
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 141
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                  +G+  +    GT +  H ++ + N+L++      I DFGL+ +L   +   ++
Sbjct: 142 ------CKGMEYL----GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 521 GG-------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                    + APE     + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 238

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L   G     VA+K LK       R++F     ++G+  HPN++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L       +  +++ +Y+ NGSL + L  N G         T I LV G  RG+    + 
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-------FTVIQLV-GMLRGIGSGMKY 146
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQA 529
                  H ++ + N+L++ N V  +SDFG+S +L  +P  A    GG     + APE  
Sbjct: 147 LSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 206
Query: 530 EVKRLSQKADVYSFGVLLLEVLT 552
             ++ +  +DV+S+G+++ EV++
Sbjct: 207 AYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L   G     VA+K LK       R++F     ++G+  HPN++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L       +  +++ +Y+ NGSL + L  N G         T I LV G  RG+    + 
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-------FTVIQLV-GMLRGIGSGMKY 131
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQA 529
                  H ++ + N+L++ N V  +SDFG+S +L  +P  A    GG     + APE  
Sbjct: 132 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 530 EVKRLSQKADVYSFGVLLLEVLT 552
             ++ +  +DV+S+G+++ EV++
Sbjct: 192 AYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 20/203 (9%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L   G     VA+K LK       R++F     ++G+  HPN++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L       +  +++ +Y+ NGSL + L  N G         T I LV G  RG+    + 
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFLRKNDGR-------FTVIQLV-GMLRGIGSGMKY 125
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQA 529
                  H ++ + N+L++ N V  +SDFG+S +L  +P  A    GG     + APE  
Sbjct: 126 LSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 530 EVKRLSQKADVYSFGVLLLEVLT 552
             ++ +  +DV+S+G+++ EV++
Sbjct: 186 AYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 363 MLGKGSLGTVYKAVLDDGGI----VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           ++G G  G V    L   G     VA+K LK       R++F     ++G+  HPN++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                  +  ++V +Y+ NGSL + L  N G         T I LV G  RG++   +  
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQ-------FTVIQLV-GMLRGISAGMKYL 140
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQAE 530
                 H ++ + N+L++ N V  +SDFGLS +L  +P  A    GG     + APE   
Sbjct: 141 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 200
Query: 531 VKRLSQKADVYSFGVLLLEVLT 552
            ++ +  +DV+S+G+++ EV++
Sbjct: 201 FRKFTSASDVWSYGIVMWEVVS 222

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 364 LGKGSLGTV----YKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           LGKG+ G+V    Y  + D+ G +VAVK+L+ +     ++FE+ ++++  L+H N+VK +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 419 AYYYA--KEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
              Y+  +    L+ ++LP GSL   L  H  R      L +T++I       +G+  + 
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI------CKGMEYL- 133
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKAPE 527
              GT +  H ++ + N+L++      I DFGL+ +L   +   ++         + APE
Sbjct: 134 ---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPE 190
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
                + S  +DV+SFGV+L E+ T    S+ P
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 223

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 28/205 (13%)
Query: 362 EMLGKGSLGTVYKAVL----DDGGIVAVKRLKDANPCA--RKEFEQYMDVIGKLKHPNVV 415
           + +G+GS G   KA+L    +DG    +K +  +   +  R+E  + + V+  +KHPN+V
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG----PGRIPLDWTTRISLVLGAARGLA 471
           + R  +       +V DY   G L   ++  +G      +I LDW  +I L       L 
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQICL------ALK 139
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPE 527
            +H      K+ H ++KS N+ L K+G   + DFG++ +LN    +AR  +G   Y +PE
Sbjct: 140 HVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPE 195
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
             E K  + K+D+++ G +L E+ T
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCT 220

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 134/286 (46%), Gaps = 49/286 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V+    ++   VAVK LK      +   E+  +++  L+H  +V+L A    
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEE-ANLMKTLQHDKLVRLYAVVTK 78
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPL----DWTTRISLVLGAARGLARIHQEYGT 479
           +E   ++ +++  GSL   L  + G G++ L    D++ +I      A G+A I ++   
Sbjct: 79  EEPIYIITEFMAKGSLLDFLKSDEG-GKVLLPKLIDFSAQI------AEGMAYIERK--- 128
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRL 534
               H +++++NVL+ ++ +  I+DFGL+ ++   +  AR G      + APE       
Sbjct: 129 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 187
Query: 535 SQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEV 592
           + K++V+SFG+LL E++T G+ P  YP  T   V     Q   +P               
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIP--YPGRTNADVMSALSQGYRMP--------------- 230
Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                 R +N  +EL  ++ +   C   + E+RPT   +  +++D 
Sbjct: 231 ------RMENCPDELYDIMKM---CWKEKAEERPTFDYLQSVLDDF 267

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           +G G  G V+     +   VA+K +++    + ++F +  +V+ KL HP +V+L      
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    LV++++ +G L   L   RG         T + + L    G+A + +    A V 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEE----ASVI 125
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     R S K+
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           DV+SFGVL+ EV + G+ P +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYE 206

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 109/235 (46%), Gaps = 42/235 (17%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF--EQYMDVIGKLKHPNVVKL-- 417
           E++G+G  G VYK  LD+   VAVK    AN   R+ F  E+ +  +  ++H N+ +   
Sbjct: 19  ELIGRGRYGAVYKGSLDERP-VAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 418 ---RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
              R     + E LLV +Y PNGSL   L  +        DW +   L     RGLA +H
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYLH 128
Query: 475 QE-----YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL------LLNPVQ----AIAR 519
            E     +    + H ++ S NVL+  +G   ISDFGLS+      L+ P +    AI+ 
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 520 LGG--YKAPEQAE-------VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRP 565
           +G   Y APE  E        +   ++ D+Y+ G++  E+   R    +P  + P
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RCTDLFPGESVP 242

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 21/204 (10%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           +++G G  G VYK +L          VA+K LK       R +F     ++G+  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L       +  +++ +Y+ NG+L   L    G   +       + LV G  RG+A   +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSV-------LQLV-GMLRGIAAGMK 161
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQ 528
                   H ++ + N+L++ N V  +SDFGLS +L  +P       GG     + APE 
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 529 AEVKRLSQKADVYSFGVLLLEVLT 552
              ++ +  +DV+SFG+++ EV+T
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           +G G  G V+     +   VA+K +K+ +  +  +F +  +V+ KL HP +V+L      
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    LV++++ +G L   L   RG         T + + L    G+A + +    A V 
Sbjct: 94  QAPICLVFEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEE----ACVI 145
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     R S K+
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           DV+SFGVL+ EV + G+ P +
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYE 226

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 64  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 123
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 124 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 175
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 176 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 106
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 107 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 158
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           +G G  G V+     +   VA+K +++    + ++F +  +V+ KL HP +V+L      
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    LV++++ +G L   L   RG         T + + L    G+A + +    A V 
Sbjct: 72  QAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEE----ACVI 123
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     R S K+
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           DV+SFGVL+ EV + G+ P +
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYE 204

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           +G G  G V+     +   VA+K +++    + ++F +  +V+ KL HP +V+L      
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    LV++++ +G L   L   RG         T + + L    G+A + +    A V 
Sbjct: 74  QAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEE----ACVI 125
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     R S K+
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           DV+SFGVL+ EV + G+ P +
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYE 206

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           +G G  G V+     +   VA+K +++    + ++F +  +V+ KL HP +V+L      
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    LV++++ +G L   L   RG         T + + L    G+A + +    A V 
Sbjct: 77  QAPICLVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEE----ACVI 128
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     R S K+
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           DV+SFGVL+ EV + G+ P +
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYE 209

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E++G+G+ G V KA       VA+K+++  +   RK F   +  + ++ HPN+VKL  Y 
Sbjct: 15  EVVGRGAFGVVCKAKWRAKD-VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKL--YG 69
Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR---ISLVLGAARGLARIHQEYG 478
                  LV +Y   GSL+++LHG       PL + T    +S  L  ++G+A +H    
Sbjct: 70  ACLNPVCLVMEYAEGGSLYNVLHGAE-----PLPYYTAAHAMSWCLQCSQGVAYLHSMQP 124
Query: 479 TAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPVQAIAR-LGGYKAPEQAEVKRLSQ 536
            A + H ++K  N+LL   G V  I DFG +  +       +    + APE  E    S+
Sbjct: 125 KALI-HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 183
Query: 537 KADVYSFGVLLLEVLTGRAP 556
           K DV+S+G++L EV+T R P
Sbjct: 184 KCDVFSWGIILWEVITRRKP 203

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 110/215 (51%), Gaps = 12/215 (5%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYM 403
           +++K  EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + +
Sbjct: 58  QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 117
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
            V+ +   P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ 
Sbjct: 118 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA 174
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
           +   +GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G  
Sbjct: 175 V--IKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 229
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            Y +PE+ +    S ++D++S G+ L+E+  GR P
Sbjct: 230 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E++G+G+ G V KA       VA+K+++  +   RK F   +  + ++ HPN+VKL  Y 
Sbjct: 14  EVVGRGAFGVVCKAKWRAKD-VAIKQIESES--ERKAFIVELRQLSRVNHPNIVKL--YG 68
Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR---ISLVLGAARGLARIHQEYG 478
                  LV +Y   GSL+++LHG       PL + T    +S  L  ++G+A +H    
Sbjct: 69  ACLNPVCLVMEYAEGGSLYNVLHGAE-----PLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 479 TAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPVQAIAR-LGGYKAPEQAEVKRLSQ 536
            A + H ++K  N+LL   G V  I DFG +  +       +    + APE  E    S+
Sbjct: 124 KALI-HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 537 KADVYSFGVLLLEVLTGRAP 556
           K DV+S+G++L EV+T R P
Sbjct: 183 KCDVFSWGIILWEVITRRKP 202

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 22/212 (10%)
Query: 364 LGKGSLGTV----YKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           LGKG+ G+V    Y  + D+ G +VAVK+L+ + P  +++F++ + ++  L    +VK R
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 419 AYYY--AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
              Y   + E  LV +YLP+G L   L  +R             S +L  +  + +  + 
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEY 126
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL--LNPVQAIARLGG-----YKAPEQA 529
            G+ +  H ++ + N+L++      I+DFGL+ L  L+    + R  G     + APE  
Sbjct: 127 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS 561
                S+++DV+SFGV+L E+ T    S  PS
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 218

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 74  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 133
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 134 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 185
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 186 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 110/215 (51%), Gaps = 12/215 (5%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYM 403
           +++K  EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + +
Sbjct: 23  QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 82
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
            V+ +   P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ 
Sbjct: 83  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA 139
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
           +   +GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G  
Sbjct: 140 V--IKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 194
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            Y +PE+ +    S ++D++S G+ L+E+  GR P
Sbjct: 195 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 113/225 (50%), Gaps = 22/225 (9%)
Query: 364 LGKGSLGTV----YKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           LGKG+ G+V    Y  + D+ G +VAVK+L+ + P  +++F++ + ++  L    +VK R
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 419 AYYY--AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
              Y   ++   LV +YLP+G L   L  +R      LD +  +       +G+  +   
Sbjct: 78  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYL--- 130
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL--LNPVQAIARLGG-----YKAPEQA 529
            G+ +  H ++ + N+L++      I+DFGL+ L  L+    + R  G     + APE  
Sbjct: 131 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
                S+++DV+SFGV+L E+ T    S  PS    R+   E+ V
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDV 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 110/215 (51%), Gaps = 12/215 (5%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYM 403
           +++K  EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + +
Sbjct: 15  QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 74
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
            V+ +   P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ 
Sbjct: 75  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA 131
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
           +   +GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G  
Sbjct: 132 V--IKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 186
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            Y +PE+ +    S ++D++S G+ L+E+  GR P
Sbjct: 187 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 91/178 (51%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGL+ +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 116/237 (48%), Gaps = 19/237 (8%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYM 403
           ++ K  EL+D        LG G+ G V K      G++  ++L   +  P  R +  + +
Sbjct: 6   QKAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIREL 65
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
            V+ +   P +V     +Y+  E  +  +++  GSL  +L   +   RIP +   ++S+ 
Sbjct: 66  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIA 122
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
           +   RGLA + +++   ++ H +VK SN+L++  G   + DFG+S  L    A + +G  
Sbjct: 123 V--LRGLAYLREKH---QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR 177
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT-------RPRVDEEE 571
            Y APE+ +    S ++D++S G+ L+E+  GR P   P          RP VD EE
Sbjct: 178 SYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEE 234

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 364 LGKGSLGTV----YKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           LGKG+ G+V    Y  + D+ G +VAVK+L+ + P  +++F++ + ++  L    +VK R
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 419 AYYY--AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
              Y   ++   LV +YLP+G L   L  +R      LD +  +       +G+  +   
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYL--- 143
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL--LNPVQAIARLGG-----YKAPEQA 529
            G+ +  H ++ + N+L++      I+DFGL+ L  L+    + R  G     + APE  
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS 561
                S+++DV+SFGV+L E+ T    S  PS
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 105/203 (51%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTV----YKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           LGKG+ G+V    Y  + D+ G +VAVK+L+ + P  +++F++ + ++  L    +VK R
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 419 AYYY--AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
              Y   ++   LV +YLP+G L   L  +R      LD +  +       +G+  +   
Sbjct: 79  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYL--- 131
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL--LNPVQAIARLGG-----YKAPEQA 529
            G+ +  H ++ + N+L++      I+DFGL+ L  L+    + R  G     + APE  
Sbjct: 132 -GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 530 EVKRLSQKADVYSFGVLLLEVLT 552
                S+++DV+SFGV+L E+ T
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V +Y+ NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGL  +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGK 408
            EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + + V+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
              P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IK 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAP 526
           GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G   Y +P
Sbjct: 116 GLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E+ +    S ++D++S G+ L+E+  GR P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           +G G  G V+     +   VA+K +++    + ++F +  +V+ KL HP +V+L      
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    LV +++ +G L   L   RG         T + + L    G+A + +    A V 
Sbjct: 75  QAPICLVTEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLEE----ACVI 126
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     R S K+
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           DV+SFGVL+ EV + G+ P +
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYE 207

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGK 408
            EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + + V+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
              P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IK 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAP 526
           GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G   Y +P
Sbjct: 116 GLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E+ +    S ++D++S G+ L+E+  GR P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 25/214 (11%)
Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LKDA+  ARK+F +  +++  L+H ++VK 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP-------GRIPLDWTTRISLVLGAARGL 470
                  +  ++V++Y+ +G L+  L  + GP       G  P + T   S +L  A+ +
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNPPTELTQ--SQMLHIAQQI 137
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKA----- 525
           A       +    H ++ + N L+ +N +  I DFG+S  +       R+GG+       
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRW 196
Query: 526 --PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             PE    ++ + ++DV+S GV+L E+ T G+ P
Sbjct: 197 MPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGK 408
            EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + + V+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
              P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IK 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAP 526
           GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G   Y +P
Sbjct: 116 GLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E+ +    S ++D++S G+ L+E+  GR P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LKD    ARK+F++  +++  L+H ++VK 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-------ISLVLGAARGL 470
                  +  ++V++Y+ +G L+  L  +     I +D   R       +S +L  A  +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKA----- 525
           A       +    H ++ + N L+  N +  I DFG+S  +       R+GG+       
Sbjct: 143 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-YYRVGGHTMLPIRW 201
Query: 526 --PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             PE    ++ + ++DV+SFGV+L E+ T G+ P
Sbjct: 202 MPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGK 408
            EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + + V+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
              P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IK 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAP 526
           GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G   Y +P
Sbjct: 116 GLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E+ +    S ++D++S G+ L+E+  GR P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGK 408
            EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + + V+ +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
              P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ +   +
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IK 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAP 526
           GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A + +G   Y +P
Sbjct: 116 GLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E+ +    S ++D++S G+ L+E+  GR P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 311
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 312 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 368
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H N+ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 369 AMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 424
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 425 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 469
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 470 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 519
Query: 643 S 643
           S
Sbjct: 520 S 520

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 363 MLGKGSLGTVYKAVLDDGG----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           ++G G  G V    L   G     VA+K LK       R++F     ++G+  HPNVV L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                  +  ++V +++ NG+L + L  + G         T I LV G  RG+A   +  
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQ-------FTVIQLV-GMLRGIAAGMRYL 161
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGG-----YKAPEQAE 530
                 H ++ + N+L++ N V  +SDFGLS ++  +P       GG     + APE  +
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 531 VKRLSQKADVYSFGVLLLEVLT 552
            ++ +  +DV+S+G+++ EV++
Sbjct: 222 YRKFTSASDVWSYGIVMWEVMS 243

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 383 VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V + + NGSL S
Sbjct: 47  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 106
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 107 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 158
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 159 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 383 VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V + + NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/301 (25%), Positives = 137/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 272
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  +     + +    + 
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISS 329
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H N+ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 330 AMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 385
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 430
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 431 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 480
Query: 643 S 643
           S
Sbjct: 481 S 481

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 12/209 (5%)
Query: 352 ELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKL 409
           EL+D        LG G+ G V+K      G+V  ++L   +  P  R +  + + V+ + 
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
             P +V     +Y+  E  +  +++  GSL  +L   +  GRIP     ++S+ +   +G
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAV--IKG 119
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPE 527
           L  + +++   K+ H +VK SN+L++  G   + DFG+S  L    A   +G   Y +PE
Sbjct: 120 LTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPE 176
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           + +    S ++D++S G+ L+E+  GR P
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 90/178 (50%), Gaps = 16/178 (8%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS 441
           VA+K LK       R++F     ++G+  HPN+++L       +  ++V + + NGSL S
Sbjct: 76  VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDS 135
Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  +           T I LV G  RG+A   +        H ++ + N+L++ N V  
Sbjct: 136 FLRKHDAQ-------FTVIQLV-GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCK 187
Query: 502 ISDFGLSLLL--NPVQAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +SDFGLS +L  +P  A    GG     + +PE    ++ +  +DV+S+G++L EV++
Sbjct: 188 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E++G G+   V  A        VA+KR+  +    +  E  + +  + +  HPN+V    
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 420 YYYAKEEKLLVYDYLPNGSL-----HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +  K+E  LV   L  GS+     H +  G    G   LD +T  +++     GL  +H
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG--VLDESTIATILREVLEGLEYLH 133
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-------LGG--YKA 525
           +        H +VK+ N+LL ++G   I+DFG+S  L     I R       +G   + A
Sbjct: 134 KNGQI----HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 526 PEQAE-VKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVDEEEQAVDLPKWVRSV 583
           PE  E V+    KAD++SFG+  +E+ TG AP  +YP      +  +     L   V+  
Sbjct: 190 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ-- 247
Query: 584 VKEEWTAEVFDQELL-RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                     D+E+L +Y     +++S+      C+   PEKRPT AE+ +
Sbjct: 248 ----------DKEMLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 80/291 (27%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E++G G+   V  A        VA+KR+  +    +  E  + +  + +  HPN+V    
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 420 YYYAKEEKLLVYDYLPNGSL-----HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +  K+E  LV   L  GS+     H +  G    G   LD +T  +++     GL  +H
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG--VLDESTIATILREVLEGLEYLH 138
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-------LGG--YKA 525
           +        H +VK+ N+LL ++G   I+DFG+S  L     I R       +G   + A
Sbjct: 139 KNGQI----HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 526 PEQAE-VKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVDEEEQAVDLPKWVRSV 583
           PE  E V+    KAD++SFG+  +E+ TG AP  +YP      +  +     L   V+  
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ-- 252
Query: 584 VKEEWTAEVFDQELL-RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                     D+E+L +Y     +++S+      C+   PEKRPT AE+ +
Sbjct: 253 ----------DKEMLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 79/325 (24%), Positives = 138/325 (42%), Gaps = 59/325 (18%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL 409
           F   DL+    E+LGKG  G   K    + G ++ +K L   +   ++ F + + V+  L
Sbjct: 7   FRPSDLI--HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           +HPNV+K     Y  +    + +Y+  G+L  ++       + P  W+ R+S     A G
Sbjct: 65  EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM--DSQYP--WSQRVSFAKDIASG 120
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL----------LNPVQAIAR 519
           +A +H    +  + H ++ S N L+ +N    ++DFGL+ L          L  ++   R
Sbjct: 121 MAYLH----SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 520 LGGYK--------APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE 571
              Y         APE    +   +K DV+SFG++L E++ GR  +          D   
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD--------PDYLP 227
Query: 572 QAVDLPKWVRSVVKEEWTAEVFDQELLRY--KNIEEELVSMLHVGLACVVSQPEKRPTMA 629
           + +D    VR               L RY   N      S   + + C    PEKRP+  
Sbjct: 228 RTMDFGLNVRGF-------------LDRYCPPNCPP---SFFPITVRCCDLDPEKRPSFV 271
Query: 630 EVAKMIEDIRVEQS---PLGEEYDE 651
           ++   +E +R+  +   PLG + ++
Sbjct: 272 KLEHWLETLRMHLAGHLPLGPQLEQ 296

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 17/217 (7%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A   +   I+A+K L  A         +  + +
Sbjct: 2   KRQWALEDF--EIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYI 114
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
              A  L+  H    + KV H ++K  N+LL   G   I+DFG S+     +  A  G  
Sbjct: 115 TELANALSYCH----SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 7   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 64
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH +        +    I +    AR
Sbjct: 65  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTAR 119
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 120 GMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 82/304 (26%), Positives = 132/304 (43%), Gaps = 42/304 (13%)
Query: 343 VFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQ 401
           ++++   ++E+E         LG G  G VY  V     + VAVK LK+ +    +EF +
Sbjct: 19  LYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKE-DTMEVEEFLK 77
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRI 460
              V+ ++KHPN+V+L      +    +V +Y+P G+L   L   NR          T +
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREE-------VTAV 130
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
            L+  A + ++   +        H ++ + N L+ +N V  ++DFGLS L+      A  
Sbjct: 131 VLLYMATQ-ISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHA 189
Query: 521 GG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAV 574
           G      + APE       S K+DV++FGVLL E+ T G +P        P +D  +   
Sbjct: 190 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSP-------YPGIDLSQVYD 242
Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
            L K  R    E    +V+  EL+R                AC    P  RP+ AE  + 
Sbjct: 243 LLEKGYRMEQPEGCPPKVY--ELMR----------------ACWKWSPADRPSFAETHQA 284
Query: 635 IEDI 638
            E +
Sbjct: 285 FETM 288

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 27  KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 139
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 140 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 195
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 6   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G ++  L           D     + 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-----KFDEQRTATY 118
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 119 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 174
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 104/209 (49%), Gaps = 23/209 (11%)
Query: 362 EMLGKGSLGTVY--KAVL--DDGGIVAVKRLKDANPCARKEFEQYM--DVIGKLKHPNVV 415
           ++LG+GS G V+  + V   D G + A+K LK A    R      M  D++  + HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 416 KLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA-ARGLARI 473
           KL  Y +  E KL L+ D+L  G L + L       +  +     +   L   A GL  +
Sbjct: 94  KLH-YAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALGLDHL 146
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGG--YKAPEQA 529
           H    +  + + ++K  N+LLD+ G   ++DFGLS   + +  +A +  G   Y APE  
Sbjct: 147 H----SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVV 202
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             +  S  AD +S+GVL+ E+LTG  P Q
Sbjct: 203 NRQGHSHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 66
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 123
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 124 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 179
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 224
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 225 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 274
Query: 643 S 643
           S
Sbjct: 275 S 275

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 6   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G ++  L           D     + 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS-----KFDEQRTATY 118
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G
Sbjct: 119 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXG 173
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 18  KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 130
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 131 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 186
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 70
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 127
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 128 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 228
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 229 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 278
Query: 643 S 643
           S
Sbjct: 279 S 279

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 6   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 118
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 119 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 174
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH +        +    I +    AR
Sbjct: 77  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTAR 131
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL---LLNPVQAIARLGG--- 522
           G+  +H       + H ++KS+N+ L ++    I DFGL+      +      +L G   
Sbjct: 132 GMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 67
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 124
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 125 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 225
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 226 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 275
Query: 643 S 643
           S
Sbjct: 276 S 276

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 4   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 116
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 117 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 172
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 67
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 124
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 125 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 180
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 225
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 226 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 275
Query: 643 S 643
           S
Sbjct: 276 S 276

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 132/301 (43%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 5   KWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 63
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAA 467
           +KHPN+V+L      +    ++ +++  G+L   L   NR              ++L  A
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMA 115
Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
             ++   +        H ++ + N L+ +N +  ++DFGLS L+      A  G      
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
           + APE     + S K+DV++FGVLL E+ T      Y     P +D        P  V  
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT------YGMSPYPGID--------PSQVYE 221
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 222 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 271
Query: 643 S 643
           S
Sbjct: 272 S 272

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 78
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 79  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 135
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 136 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 191
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 192 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 236
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 237 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 286
Query: 643 S 643
           S
Sbjct: 287 S 287

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + +
Sbjct: 2   KRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYI 114
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
              A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P    A L G 
Sbjct: 115 TELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGT 169
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 137/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 70
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  +     + +    + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISS 127
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 128 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 228
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 229 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 278
Query: 643 S 643
           S
Sbjct: 279 S 279

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 6   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 118
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 119 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 174
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 42/302 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 63
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAA 467
           +KHPN+V+L      +    ++ +++  G+L   L   NR              ++L  A
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQ--------EVSAVVLLYMA 115
Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
             ++   +        H ++ + N L+ +N +  ++DFGLS L+      A  G      
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIK 175
Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVR 581
           + APE     + S K+DV++FGVLL E+ T G +P        P +D        P  V 
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGID--------PSQVY 220
Query: 582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
            ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E
Sbjct: 221 ELLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE 270
Query: 642 QS 643
            S
Sbjct: 271 SS 272

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 27  KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 139
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+   P      L G
Sbjct: 140 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRDDLCG 194
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 195 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 137/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  +     + +    + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISS 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 123 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 223
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 224 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 273
Query: 643 S 643
           S
Sbjct: 274 S 274

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 2   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 114
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S    P      L G
Sbjct: 115 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-CHAPSSRRTTLSG 169
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 137/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  +     + +    + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISS 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 123 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 223
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 224 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 273
Query: 643 S 643
           S
Sbjct: 274 S 274

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 3   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 115
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G
Sbjct: 116 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCG 170
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 171 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 137/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  +     + +    + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISS 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 123 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 223
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 224 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 273
Query: 643 S 643
           S
Sbjct: 274 S 274

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 137/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  +     + +    + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISS 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 123 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 223
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 224 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 273
Query: 643 S 643
           S
Sbjct: 274 S 274

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 19/217 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 6   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 118
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G
Sbjct: 119 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCG 173
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 174 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 1   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 58
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 59  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 113
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G
Sbjct: 114 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCG 168
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
              Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 169 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 2   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 114
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G
Sbjct: 115 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCG 169
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
              Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 70
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 127
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 128 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKW 183
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 228
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E
Sbjct: 229 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 17/218 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 4   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 116
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 117 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 172
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 17/222 (7%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN---PCARKEFEQYM 403
           K++F ++D        LGKG  G VY A    +  I+A+K L  +         +  + +
Sbjct: 8   KRKFTIDDF--DIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN++++  Y++ ++   L+ ++ P G L+  L  +   GR   D     + +
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---GR--FDEQRSATFM 120
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
              A  L   H+     KV H ++K  N+L+   G   I+DFG S+    ++     G  
Sbjct: 121 EELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTL 176
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT 563
            Y  PE  E K   +K D++  GVL  E L G  P   PS T
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 218

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 112/239 (46%), Gaps = 26/239 (10%)
Query: 362 EMLGKGSLGTVYKAVLDD--GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + +GKG  G V   +L D  G  VAVK +K  N    + F     V+ +L+H N+V+L  
Sbjct: 199 QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
               ++  L +V +Y+  GSL   L   R  GR  L     +   L     +  +     
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 308
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-GYKAPEQAEVKRLSQK 537
                H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   + APE    K+ S K
Sbjct: 309 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 366
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPS-PTRPRVDEEEQAVDL------PKWVRSVVKEEW 588
           +DV+SFG+LL E+ + GR P  YP  P +  V   E+   +      P  V  V+K  W
Sbjct: 367 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCW 423

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 70
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 127
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 128 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 228
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E
Sbjct: 229 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E    + ++ KL H N+V+LR 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIVRLRY 80
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 138
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 139 H-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 70
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 71  IKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 127
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 128 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 183
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 184 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 228
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E
Sbjct: 229 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE 277

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIVRLRY 80
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 138
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 139 H-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 17/222 (7%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN---PCARKEFEQYM 403
           K++F ++D        LGKG  G VY A    +  I+A+K L  +         +  + +
Sbjct: 9   KRKFTIDDF--DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 66
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN++++  Y++ ++   L+ ++ P G L+  L  +   GR   D     + +
Sbjct: 67  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---GR--FDEQRSATFM 121
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
              A  L   H+     KV H ++K  N+L+   G   I+DFG S+    ++     G  
Sbjct: 122 EELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTL 177
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT 563
            Y  PE  E K   +K D++  GVL  E L G  P   PS T
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT 219

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 76
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++    Y  A +   +V  +    SL+  LH +        +    I +    AR
Sbjct: 77  TRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTAR 131
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL---LLNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+      +      +L G   
Sbjct: 132 GMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 4   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 116
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G
Sbjct: 117 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCG 171
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
              Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 66
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 67  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 123
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 124 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 179
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 180 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 224
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 225 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 274
Query: 643 S 643
           S
Sbjct: 275 S 275

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP 412
           +++     +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H 
Sbjct: 52  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHC 107
Query: 413 NVVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
           N+V+LR ++Y+  EK       LV DY+P        H +R    +P+ +       L  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 165
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGG 522
            R LA IH  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      
Sbjct: 166 FRSLAYIH-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 523 YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGR 554
           Y+APE        +   DV+S G +L E+L G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 362 EMLGKGSLGTVYKAVLDD--GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + +GKG  G V   +L D  G  VAVK +K  N    + F     V+ +L+H N+V+L  
Sbjct: 27  QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
               ++  L +V +Y+  GSL   L   R  GR  L     +   L     +  +     
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 136
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL-GGYKAPEQAEVKRLSQK 537
                H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   + APE    K+ S K
Sbjct: 137 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 194
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPS-PTR---PRVDE 569
           +DV+SFG+LL E+ + GR P  YP  P +   PRV++
Sbjct: 195 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEK 229

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + +
Sbjct: 6   KRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 63
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYI 118
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
              A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G  
Sbjct: 119 TELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 19/218 (8%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + +
Sbjct: 2   KRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYI 114
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
              A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G 
Sbjct: 115 TELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGT 169
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 67
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 68  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 124
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 125 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKW 180
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 181 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 225
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E 
Sbjct: 226 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQES 275
Query: 643 S 643
           S
Sbjct: 276 S 276

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 99/219 (45%), Gaps = 19/219 (8%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 2   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 59
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 60  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 114
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
           +   A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G
Sbjct: 115 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCG 169
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
              Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 362 EMLGKGSLGTVYKAVLDD--GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + +GKG  G V   +L D  G  VAVK +K  N    + F     V+ +L+H N+V+L  
Sbjct: 12  QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
               ++  L +V +Y+  GSL   L   R  GR  L     +   L     +  +     
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 121
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL-GGYKAPEQAEVKRLSQK 537
                H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   + APE    K+ S K
Sbjct: 122 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK 179
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPS-PTR---PRVDE 569
           +DV+SFG+LL E+ + GR P  YP  P +   PRV++
Sbjct: 180 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEK 214

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 126
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 127 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 227
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E
Sbjct: 228 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE 276

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 364 LGKGSLGTVYKAVLD-----DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V     D      G +VAVK LK D  P  R  ++Q +D++  L H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 418 RAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +     + EK   LV +Y+P GSL   L       R  +     +        G+A +H 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKAPEQ 528
           ++      H N+ + NVLLD + +  I DFGL+  +       R+         + APE 
Sbjct: 136 QHYI----HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
            +  +    +DV+SFGV L E+LT    SQ P PT+
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSP-PTK 226

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 17/217 (7%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + +
Sbjct: 1   KRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 58
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 59  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYI 113
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
              A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G  
Sbjct: 114 TELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 169
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 114
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 172
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 173 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 228
Query: 530 -EVKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP 412
           +++     +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H 
Sbjct: 54  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHC 109
Query: 413 NVVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
           N+V+LR ++Y+  EK       LV DY+P        H +R    +P+ +       L  
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 167
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGG 522
            R LA IH  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      
Sbjct: 168 FRSLAYIH-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 223
Query: 523 YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGR 554
           Y+APE        +   DV+S G +L E+L G+
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LK+A+  AR++F++  +++  L+H ++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL--HG----------NRGPGRIPLDWTTRISLVLG 465
                     L+V++Y+ +G L+  L  HG          +  PG  PL     +++   
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG--PLGLGQLLAVASQ 143
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A G+  +          H ++ + N L+ +  V  I DFG+S  +       R+GG   
Sbjct: 144 VAAGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTM 198
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               +  PE    ++ + ++DV+SFGV+L E+ T G+ P
Sbjct: 199 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 19/218 (8%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + +
Sbjct: 2   KRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYI 114
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
              A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G 
Sbjct: 115 TELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGT 169
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP 412
           +++     +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H 
Sbjct: 46  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHC 101
Query: 413 NVVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
           N+V+LR ++Y+  EK       LV DY+P        H +R    +P+ +       L  
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 159
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGG 522
            R LA IH  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      
Sbjct: 160 FRSLAYIH-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 215
Query: 523 YKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGR 554
           Y+APE        +   DV+S G +L E+L G+
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 100/216 (46%), Gaps = 26/216 (12%)
Query: 364 LGKGSLGTVYKAVLD-----DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V     D      G +VAVK LK D  P  R  ++Q +D++  L H +++K 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 418 RAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +     + EK   LV +Y+P GSL   L       R  +     +        G+A +H 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKAPEQ 528
           ++      H N+ + NVLLD + +  I DFGL+  +       R+         + APE 
Sbjct: 136 QHYI----HRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
            +  +    +DV+SFGV L E+LT    SQ P PT+
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSP-PTK 226

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 19/218 (8%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + +
Sbjct: 2   KRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 59
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 60  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYI 114
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
              A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G 
Sbjct: 115 TELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGT 169
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 137/299 (45%), Gaps = 40/299 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 123 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 223
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E
Sbjct: 224 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE 272

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 134/302 (44%), Gaps = 42/302 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 5   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 63
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAA 467
           +KHPN+V+L      +    ++ +++  G+L   L   NR              ++L  A
Sbjct: 64  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--------VSAVVLLYMA 115
Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
             ++   +        H ++ + N L+ +N +  ++DFGLS L+      A  G      
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIK 175
Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVR 581
           + APE     + S K+DV++FGVLL E+ T G +P        P +D        P  V 
Sbjct: 176 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP-------YPGID--------PSQVY 220
Query: 582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
            ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +  E
Sbjct: 221 ELLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE 270
Query: 642 QS 643
            S
Sbjct: 271 SS 272

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 73/296 (24%), Positives = 136/296 (45%), Gaps = 40/296 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGK 408
           ++E+E         LG G  G VY+ V     + VAVK LK+ +    +EF +   V+ +
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           +KHPN+V+L      +    ++ +++  G+L   L   R   R  ++    + +    + 
Sbjct: 66  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISS 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----Y 523
            +  + ++       H ++ + N L+ +N +  ++DFGLS L+      A  G      +
Sbjct: 123 AMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE     + S K+DV++FGVLL E+ T G +P  YP             +DL + V  
Sbjct: 179 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YP------------GIDLSQ-VYE 223
Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           ++++++  E       R +   E++  ++    AC    P  RP+ AE+ +  E +
Sbjct: 224 LLEKDYRME-------RPEGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYMD 404
           +Q+ LED        LGKG  G VY A       I+A+K L  A         +  + ++
Sbjct: 6   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           +   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + + 
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYIT 118
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--G 522
             A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +  A  G   
Sbjct: 119 ELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLD 174
Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 175 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LK+A+  AR++F++  +++  L+H ++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL--HG----------NRGPGRIPLDWTTRISLVLG 465
                     L+V++Y+ +G L+  L  HG          +  PG  PL     +++   
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG--PLGLGQLLAVASQ 166
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A G+  +          H ++ + N L+ +  V  I DFG+S  +       R+GG   
Sbjct: 167 VAAGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTM 221
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               +  PE    ++ + ++DV+SFGV+L E+ T G+ P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V+ A         D  +VAVK LK+A+  AR++F++  +++  L+H ++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL--HG----------NRGPGRIPLDWTTRISLVLG 465
                     L+V++Y+ +G L+  L  HG          +  PG  PL     +++   
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPG--PLGLGQLLAVASQ 137
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A G+  +          H ++ + N L+ +  V  I DFG+S  +       R+GG   
Sbjct: 138 VAAGMVYL----AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGRTM 192
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               +  PE    ++ + ++DV+SFGV+L E+ T G+ P
Sbjct: 193 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQ----IMRKLDHCNIVRLRY 80
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 81  FFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 138
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 139 H-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 194
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 25/262 (9%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNV 414
           L    E +GKGS G V+K + +    V   ++ D        ++ +Q + V+ +   P V
Sbjct: 28  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 87
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            K    Y    +  ++ +YL  GS   LL     PG  PLD T   +++    +GL  +H
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PG--PLDETQIATILREILKGLDYLH 141
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAE 530
            E    K  H ++K++NVLL ++G   ++DFG++  L   Q           + APE  +
Sbjct: 142 SE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 197
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR---------PRVDEEEQAVDLPKWVR 581
                 KAD++S G+  +E+  G  P     P +         P   E   +  L ++V 
Sbjct: 198 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 257
Query: 582 SVVKEEWTAEVFDQELLRYKNI 603
           + + +E +     +ELL++K I
Sbjct: 258 ACLNKEPSFRPTAKELLKHKFI 279

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 63  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 118
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 119 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 176
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 177 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 232
Query: 530 -EVKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/246 (28%), Positives = 116/246 (47%), Gaps = 29/246 (11%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP 412
           +++     +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H 
Sbjct: 97  QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHC 152
Query: 413 NVVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
           N+V+LR ++Y+  EK       LV DY+P        H +R    +P+ +       L  
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL-- 210
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGG 522
            R LA IH  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      
Sbjct: 211 FRSLAYIH-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 266
Query: 523 YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR 581
           Y+APE        +   DV+S G +L E+L G+       P  P     +Q V++ K + 
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-------PIFPGDSGVDQLVEIIKVLG 319
Query: 582 SVVKEE 587
           +  +E+
Sbjct: 320 TPTREQ 325

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 92
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 150
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 151 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 206
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 30  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 85
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 86  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 143
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 144 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 199
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 200 FGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 17/216 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 3   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 115
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I++FG S+     +     G 
Sbjct: 116 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGT 171
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V+      +G   A+K LK       K+ E   D   ++  + HP ++++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLH-GNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            +   ++  ++ DY+  G L SLL    R P  +   +   + L L           EY 
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL-----------EYL 122
Query: 479 TAK-VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-AIARLGGYKAPEQAEVKRLSQ 536
            +K + + ++K  N+LLDKNG   I+DFG +  +  V   +     Y APE    K  ++
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYNK 182
Query: 537 KADVYSFGVLLLEVLTGRAP 556
             D +SFG+L+ E+L G  P
Sbjct: 183 SIDWWSFGILIYEMLAGYTP 202

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
              +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+L
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRL 78
Query: 418 RAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           R ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 136
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPE 527
            IH  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE
Sbjct: 137 YIH-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 528 QAE-VKRLSQKADVYSFGVLLLEVLTGR 554
                   +   DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 93
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 94  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 151
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 152 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 207
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 208 FGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
              +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+L
Sbjct: 24  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRL 79
Query: 418 RAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           R ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 137
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPE 527
            IH  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE
Sbjct: 138 YIH-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 193
Query: 528 QAE-VKRLSQKADVYSFGVLLLEVLTGR 554
                   +   DV+S G +L E+L G+
Sbjct: 194 LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 99
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 100 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 157
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 158 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 213
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 214 FGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 92
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 93  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 150
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 151 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 206
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 207 FGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
            +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+LR 
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRLRY 88
Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA I
Sbjct: 89  FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYI 146
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPEQA 529
           H  +G   + H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE  
Sbjct: 147 H-SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELI 202
Query: 530 E-VKRLSQKADVYSFGVLLLEVLTGR 554
                 +   DV+S G +L E+L G+
Sbjct: 203 FGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
              +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+L
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRL 78
Query: 418 RAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           R ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 136
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPE 527
            IH  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE
Sbjct: 137 YIH-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 192
Query: 528 QAE-VKRLSQKADVYSFGVLLLEVLTGR 554
                   +   DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
              +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+L
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRL 78
Query: 418 RAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           R ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 136
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPE 527
            IH  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE
Sbjct: 137 YIH-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 528 QAE-VKRLSQKADVYSFGVLLLEVLTGR 554
                   +   DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
              +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+L
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRL 78
Query: 418 RAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           R ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 136
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPE 527
            IH  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE
Sbjct: 137 YIH-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 192
Query: 528 QAE-VKRLSQKADVYSFGVLLLEVLTGR 554
                   +   DV+S G +L E+L G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYMD 404
           +Q+ LED        LGKG  G VY A       I+A+K L  A         +  + ++
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           +   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + + 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYIT 115
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
             A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G  
Sbjct: 116 ELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTL 170
Query: 523 -YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L            +  + +
Sbjct: 6   KRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREV 63
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-----FDEQRTATYI 118
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-- 521
              A  L+  H    + +V H ++K  N+LL  NG   I+DFG S+     +     G  
Sbjct: 119 TELANALSYCH----SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 522 GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            Y  PE  E +   +K D++S GVL  E L G  P +
Sbjct: 175 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGG----IVAVKRLKDANPCARKEFEQYM-- 403
           QFEL        ++LG+GS G V+      G     + A+K LK A    R      M  
Sbjct: 25  QFEL-------LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER 77
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLD-WTTRIS 461
           D++ ++ HP +VKL  Y +  E KL L+ D+L  G L + L          +  +   ++
Sbjct: 78  DILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIAR 519
           L L     L  I++          ++K  N+LLD+ G   ++DFGLS   + +  +A + 
Sbjct: 137 LALDHLHSLGIIYR----------DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 520 LGG--YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            G   Y APE    +  +Q AD +SFGVL+ E+LTG  P Q
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
              +++G GS G VY+A L D G +VA+K++        +E +    ++ KL H N+V+L
Sbjct: 27  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQ----IMRKLDHCNIVRL 82
Query: 418 RAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           R ++Y+  EK       LV DY+P        H +R    +P+ +       L   R LA
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLA 140
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLL---NPVQAIARLGGYKAPE 527
            IH  +G     H ++K  N+LLD +  V  + DFG +  L    P  +      Y+APE
Sbjct: 141 YIH-SFGIC---HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPE 196
Query: 528 QAE-VKRLSQKADVYSFGVLLLEVLTGR 554
                   +   DV+S G +L E+L G+
Sbjct: 197 LIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG------KLKHPNVVK 416
           +G GS G VY A  + +  +VA+K++  +    ++  E++ D+I       KL+HPN ++
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYS---GKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
            R  Y  +    LV +Y   GS   LL  ++ P    L      ++  GA +GLA +H  
Sbjct: 119 YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH-- 171
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPE---QAEVKR 533
             +  + H +VK+ N+LL + G+  + DFG + ++ P         + APE     +  +
Sbjct: 172 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 229
Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
              K DV+S G+  +E+   + P
Sbjct: 230 YDGKVDVWSLGITCIELAERKPP 252

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 25/262 (9%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNV 414
           L    E +GKGS G V+K + +    V   ++ D        ++ +Q + V+ +   P V
Sbjct: 8   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            K    Y    +  ++ +YL  GS   LL     PG  PLD T   +++    +GL  +H
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PG--PLDETQIATILREILKGLDYLH 121
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAE 530
            E    K  H ++K++NVLL ++G   ++DFG++  L   Q           + APE  +
Sbjct: 122 SE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 177
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR---------PRVDEEEQAVDLPKWVR 581
                 KAD++S G+  +E+  G  P     P +         P   E   +  L ++V 
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 237
Query: 582 SVVKEEWTAEVFDQELLRYKNI 603
           + + +E +     +ELL++K I
Sbjct: 238 ACLNKEPSFRPTAKELLKHKFI 259

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 17/218 (7%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQY 402
           +K+Q+ LED        LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 4   KKRQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATY 116
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H    + +V H ++K  N+LL   G   I++FG S+     +     G 
Sbjct: 117 ITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGT 172
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYMD 404
           +Q+ LED        LGKG  G VY A       I+A+K L  A         +  + ++
Sbjct: 3   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           +   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + + 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYIT 115
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--G 522
             A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G   
Sbjct: 116 ELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLD 171
Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           Y  PE  E +   +K D++S GVL  E L G+ P
Sbjct: 172 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 25/262 (9%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNV 414
           L    E +GKGS G V+K + +    V   ++ D        ++ +Q + V+ +   P V
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            K    Y    +  ++ +YL  GS   LL     PG  PLD T   +++    +GL  +H
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PG--PLDETQIATILREILKGLDYLH 136
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAE 530
            E    K  H ++K++NVLL ++G   ++DFG++  L   Q           + APE  +
Sbjct: 137 SE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK 192
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR---------PRVDEEEQAVDLPKWVR 581
                 KAD++S G+  +E+  G  P     P +         P   E   +  L ++V 
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252
Query: 582 SVVKEEWTAEVFDQELLRYKNI 603
           + + +E +     +ELL++K I
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFI 274

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGG----IVAVKRLKDANPCARKEFEQYM-- 403
           QFEL        ++LG+GS G V+      G     + A+K LK A    R      M  
Sbjct: 26  QFEL-------LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER 78
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLD-WTTRIS 461
           D++ ++ HP +VKL  Y +  E KL L+ D+L  G L + L          +  +   ++
Sbjct: 79  DILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 137
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIAR 519
           L L     L  I++          ++K  N+LLD+ G   ++DFGLS   + +  +A + 
Sbjct: 138 LALDHLHSLGIIYR----------DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 187
Query: 520 LGG--YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            G   Y APE    +  +Q AD +SFGVL+ E+LTG  P Q
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 40/282 (14%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VAVK +K+ +  +  EF Q    + KL HP +VK       
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    +V +Y+ NG L + L  + G G  P   +  + +      G+A +     + +  
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSH-GKGLEP---SQLLEMCYDVCEGMAFLE----SHQFI 126
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L+D++    +SDFG++  +   Q ++ +G      + APE     + S K+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQEL 597
           DV++FG+L+ EV + G+ P  Y   T   V               V+K      ++   L
Sbjct: 187 DVWAFGILMWEVFSLGKMP--YDLYTNSEV---------------VLKVSQGHRLYRPHL 229
Query: 598 LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
                      ++  +  +C    PEKRPT  ++   IE +R
Sbjct: 230 AS--------DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGG----IVAVKRLKDANPCARKEFEQYM-- 403
           QFEL        ++LG+GS G V+      G     + A+K LK A    R      M  
Sbjct: 25  QFEL-------LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMER 77
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLD-WTTRIS 461
           D++ ++ HP +VKL  Y +  E KL L+ D+L  G L + L          +  +   ++
Sbjct: 78  DILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 136
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIAR 519
           L L     L  I++          ++K  N+LLD+ G   ++DFGLS   + +  +A + 
Sbjct: 137 LALDHLHSLGIIYR----------DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 520 LGG--YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            G   Y APE    +  +Q AD +SFGVL+ E+LTG  P Q
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 136
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +V H N+KS N+LL  +G   ++DFG    + P Q+    +     + APE    K    
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG------KLKHPNVVK 416
           +G GS G VY A  + +  +VA+K++   +   ++  E++ D+I       KL+HPN ++
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
            R  Y  +    LV +Y   GS   LL  ++ P    L      ++  GA +GLA +H  
Sbjct: 80  YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH-- 132
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPE---QAEVKR 533
             +  + H +VK+ N+LL + G+  + DFG + ++ P         + APE     +  +
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
              K DV+S G+  +E+   + P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 117/262 (44%), Gaps = 25/262 (9%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNV 414
           L    E +GKGS G V+K + +    V   ++ D        ++ +Q + V+ +   P V
Sbjct: 8   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            K    Y    +  ++ +YL  GS   LL     PG  PLD T   +++    +GL  +H
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLE----PG--PLDETQIATILREILKGLDYLH 121
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAE 530
            E    K  H ++K++NVLL ++G   ++DFG++  L   Q           + APE  +
Sbjct: 122 SE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK 177
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR---------PRVDEEEQAVDLPKWVR 581
                 KAD++S G+  +E+  G  P     P +         P   E   +  L ++V 
Sbjct: 178 QSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 237
Query: 582 SVVKEEWTAEVFDQELLRYKNI 603
           + + +E +     +ELL++K I
Sbjct: 238 ACLNKEPSFRPTAKELLKHKFI 259

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 19/218 (8%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN---PCARKEFEQYM 403
           K+Q+ LED        LGKG  G VY A       I+A+K L            +  + +
Sbjct: 6   KRQWTLEDF--DIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREV 63
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           ++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +
Sbjct: 64  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR-----FDEQRTATYI 118
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
              A  L+  H    + +V H ++K  N+LL  NG   I+DFG S +  P      L G 
Sbjct: 119 TELANALSYCH----SKRVIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGT 173
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             Y  PE  E +   +K D++S GVL  E L G  P +
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 136/307 (44%), Gaps = 52/307 (16%)
Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+G  G V KA             VAVK LK+ A+P   ++     +V+ ++ HP+V+K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--GPGRI---------PLDWTTRISLVLG 465
           L          LL+ +Y   GSL   L  +R  GPG +          LD     +L +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 466 ----AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-LLNPVQAIARL 520
                A  +++  Q     K+ H ++ + N+L+ +     ISDFGLS  +      + R 
Sbjct: 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 521 GG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD 575
            G     + A E       + ++DV+SFGVLL E++T       P P  P          
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---LGGNPYPGIP---------- 257
Query: 576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
            P+ + +++K           + R  N  EE+  ++   L C   +P+KRP  A+++K +
Sbjct: 258 -PERLFNLLKT-------GHRMERPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDL 306
Query: 636 EDIRVEQ 642
           E + V++
Sbjct: 307 EKMMVKR 313

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 136/307 (44%), Gaps = 52/307 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+G  G V KA             VAVK LK+ A+P   ++     +V+ ++ HP+V+K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--GPGRI---------PLDWTTRISLVLG 465
           L          LL+ +Y   GSL   L  +R  GPG +          LD     +L +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 466 ----AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-LLNPVQAIARL 520
                A  +++  Q     K+ H ++ + N+L+ +     ISDFGLS  +      + R 
Sbjct: 151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 521 GG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD 575
            G     + A E       + ++DV+SFGVLL E++T       P P  P          
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---LGGNPYPGIP---------- 257
Query: 576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
            P+ + +++K           + R  N  EE+  ++   L C   +P+KRP  A+++K +
Sbjct: 258 -PERLFNLLKT-------GHRMERPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDL 306
Query: 636 EDIRVEQ 642
           E + V++
Sbjct: 307 EKMMVKR 313

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           +G GS GTVYK      G VAVK LK  D  P   + F   + V+ K +H N++ L   Y
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNIL-LFMGY 100
Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             K+   +V  +    SL+  LH      ++       I +    A+G+  +H       
Sbjct: 101 MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM----FQLIDIARQTAQGMDYLH----AKN 152
Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG---YKAPEQAEVKR-- 533
           + H ++KS+N+ L +     I DFGL+ +    +  Q + +  G   + APE   ++   
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 534 -LSQKADVYSFGVLLLEVLTGRAP 556
             S ++DVYS+G++L E++TG  P
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYMD 404
           +Q+ LED        LGKG  G VY A       I+A+K L  A         +  + ++
Sbjct: 6   RQWALEDF--EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           +   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + + 
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYIT 118
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
             A  L+  H    + +V H ++K  N+LL   G   I+DFG S +  P      L G  
Sbjct: 119 ELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTL 173
Query: 523 -YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            Y  PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +GKG  G V++     G  VAVK    +D     R E E Y  V+  L+H N++   A
Sbjct: 43  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVM--LRHENILGFIA 98
Query: 420 Y----YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
                 ++  +  L+  Y   GSL+  L          LD  + + +VL  A GLA +H 
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 476 E-YGTAKVP---HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--------Y 523
           E +GT   P   H ++KS N+L+ KNG  CI+D GL+++ +       +G         Y
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 212
Query: 524 KAPE------QAEVKRLSQKADVYSFGVLLLEV 550
            APE      Q +     ++ D+++FG++L EV
Sbjct: 213 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +GKG  G V++     G  VAVK    +D     R E E Y  V+  L+H N++   A
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVM--LRHENILGFIA 69
Query: 420 Y----YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
                 ++  +  L+  Y   GSL+  L          LD  + + +VL  A GLA +H 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHI 123
Query: 476 E-YGTAKVP---HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--------Y 523
           E +GT   P   H ++KS N+L+ KNG  CI+D GL+++ +       +G         Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 524 KAPE------QAEVKRLSQKADVYSFGVLLLEV 550
            APE      Q +     ++ D+++FG++L EV
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +GKG  G V++     G  VAVK    +D     R E E Y  V+  L+H N++   A
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVM--LRHENILGFIA 69
Query: 420 Y----YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
                 ++  +  L+  Y   GSL+  L          LD  + + +VL  A GLA +H 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHI 123
Query: 476 E-YGTAKVP---HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--------Y 523
           E +GT   P   H ++KS N+L+ KNG  CI+D GL+++ +       +G         Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 524 KAPE------QAEVKRLSQKADVYSFGVLLLEV 550
            APE      Q +     ++ D+++FG++L EV
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 135
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARLGG---YKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+  + + G   + APE    K    
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 34/228 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK-DAN-----PCARKEFEQYMDVIGKLKHPNVV 415
           E +G+G+ G VYKA    G IVA+KR++ DA        A +E    + ++ +L HPN+V
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHHPNIV 82
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
            L    +++    LV++++    L  +L  N+   +   D   +I L     RG+A  HQ
Sbjct: 83  SLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ---DSQIKIYLY-QLLRGVAHCHQ 137
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAE 530
                ++ H ++K  N+L++ +G   ++DFGL+     PV++         Y+AP+    
Sbjct: 138 H----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
            K+ S   D++S G +  E++TG+       P  P V +++Q   LPK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK-------PLFPGVTDDDQ---LPK 231

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V     
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 136
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+    +     + APE    K    
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLR 224

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 135
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+    +     + APE    K    
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 34/228 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK-DAN-----PCARKEFEQYMDVIGKLKHPNVV 415
           E +G+G+ G VYKA    G IVA+KR++ DA        A +E    + ++ +L HPN+V
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHHPNIV 82
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
            L    +++    LV++++    L  +L  N+   +   D   +I L     RG+A  HQ
Sbjct: 83  SLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQ---DSQIKIYLY-QLLRGVAHCHQ 137
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPEQAE- 530
                ++ H ++K  N+L++ +G   ++DFGL+     PV++         Y+AP+    
Sbjct: 138 H----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
            K+ S   D++S G +  E++TG+       P  P V +++Q   LPK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK-------PLFPGVTDDDQ---LPK 231

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++          +D     ++     + L  +H    + 
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLH----SN 135
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+    +     + APE    K    
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           K D++S G++ +E++ G  P    +P R
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 17/215 (7%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDD-GGIVAVKRLKDAN---PCARKEFEQYMDV 405
           Q+ LED        LGKG  G VY A       I+A+K L  A         +  + +++
Sbjct: 1   QWALEDF--EIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEI 58
Query: 406 IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
              L+HPN+++L  Y++      L+ +Y P G+++  L           D     + +  
Sbjct: 59  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITE 113
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GY 523
            A  L+  H    + +V H ++K  N+LL   G   I+DFG S+     +     G   Y
Sbjct: 114 LANALSYCH----SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY 169
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
             PE  E +   +K D++S GVL  E L G+ P +
Sbjct: 170 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 72/239 (30%), Positives = 110/239 (46%), Gaps = 26/239 (10%)
Query: 362 EMLGKGSLGTVYKAVLDD--GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + +GKG  G V   +L D  G  VAVK +K  N    + F     V+ +L+H N+V+L  
Sbjct: 18  QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 72
Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
               ++  L +V +Y+  GSL   L   R  GR  L     +   L     +  +     
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 127
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL-GGYKAPEQAEVKRLSQK 537
                H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   + APE       S K
Sbjct: 128 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTK 185
Query: 538 ADVYSFGVLLLEVLT-GRAPSQYPS-PTRPRVDEEEQAVDL------PKWVRSVVKEEW 588
           +DV+SFG+LL E+ + GR P  YP  P +  V   E+   +      P  V  V+K  W
Sbjct: 186 SDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW 242

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 8   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 66  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 120
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 121 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 81/307 (26%), Positives = 135/307 (43%), Gaps = 52/307 (16%)
Query: 364 LGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+G  G V KA             VAVK LK+ A+P   ++     +V+ ++ HP+V+K
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--GPGRI---------PLDWTTRISLVLG 465
           L          LL+ +Y   GSL   L  +R  GPG +          LD     +L +G
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 466 ----AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-LLNPVQAIARL 520
                A  +++  Q      + H ++ + N+L+ +     ISDFGLS  +      + R 
Sbjct: 151 DLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 521 GG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD 575
            G     + A E       + ++DV+SFGVLL E++T       P P  P          
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---LGGNPYPGIP---------- 257
Query: 576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
            P+ + +++K           + R  N  EE+  ++   L C   +P+KRP  A+++K +
Sbjct: 258 -PERLFNLLKT-------GHRMERPDNCSEEMYRLM---LQCWKQEPDKRPVFADISKDL 306
Query: 636 EDIRVEQ 642
           E + V++
Sbjct: 307 EKMMVKR 313

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 88
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 89  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 143
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 144 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 30  WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 87
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 88  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 142
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 143 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 5   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 62
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 63  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 117
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 118 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 61  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 116 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 115/276 (41%), Gaps = 36/276 (13%)
Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG+   G VYK  L      +    VA+K LKD A    R+EF     +  +L+HPNV
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLL-----HGNRGPG------RIPLDWTTRISLV 463
           V L       +   +++ Y  +G LH  L     H + G        +  L+    + LV
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
              A G+  +     +  V H ++ + NVL+       ISD GL   +        LG  
Sbjct: 152 AQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 207
Query: 523 -----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP-SQYPSPTRPRVDEEEQAV- 574
                + APE     + S  +D++S+GV+L EV + G  P   Y +     +    Q + 
Sbjct: 208 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 267
Query: 575 ---DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEEL 607
              D P WV +++ E W    F     R+K+I   L
Sbjct: 268 CPDDCPAWVYALMIECWNE--FPSRRPRFKDIHSRL 301

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 104/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 8   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 65
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 66  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 120
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 121 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 115/276 (41%), Gaps = 36/276 (13%)
Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG+   G VYK  L      +    VA+K LKD A    R+EF     +  +L+HPNV
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLL-----HGNRGPG------RIPLDWTTRISLV 463
           V L       +   +++ Y  +G LH  L     H + G        +  L+    + LV
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
              A G+  +     +  V H ++ + NVL+       ISD GL   +        LG  
Sbjct: 135 AQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 523 -----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP-SQYPSPTRPRVDEEEQAV- 574
                + APE     + S  +D++S+GV+L EV + G  P   Y +     +    Q + 
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLP 250
Query: 575 ---DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEEL 607
              D P WV +++ E W    F     R+K+I   L
Sbjct: 251 CPDDCPAWVYALMIECWNE--FPSRRPRFKDIHSRL 284

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 361 AEMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNV 414
            ++LG G+ GTVYK +    G      VA+K L +   P A  EF     ++  + HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLAR 472
           V+L     +   +L V   +P+G L   +H ++     ++ L+W  +I      A+G+  
Sbjct: 103 VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 155
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------ 526
           + +     ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      
Sbjct: 156 LEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 211
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
           E    ++ + ++DV+S+GV + E++T         PTR   D  E+   LP+
Sbjct: 212 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 263

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 109/232 (46%), Gaps = 25/232 (10%)
Query: 361 AEMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNV 414
            ++LG G+ GTVYK +    G      VA+K L +   P A  EF     ++  + HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLAR 472
           V+L     +   +L V   +P+G L   +H ++     ++ L+W  +I      A+G+  
Sbjct: 80  VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMY 132
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------ 526
           + +     ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      
Sbjct: 133 LEER----RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 188
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
           E    ++ + ++DV+S+GV + E++T         PTR   D  E+   LP+
Sbjct: 189 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 240

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 105/227 (46%), Gaps = 25/227 (11%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARK-EFEQYMDVIGKLKH 411
           EDL+    E +G+G+ G V+   L  D  +VAVK  ++  P   K +F Q   ++ +  H
Sbjct: 114 EDLVLG--EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           PN+V+L      K+   +V + +  G   + L       R+     T + +V  AA G+ 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV----KTLLQMVGDAAAGM- 226
Query: 472 RIHQEYGTAKV-PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------- 522
               EY  +K   H ++ + N L+ +  V  ISDFG+S        +    G        
Sbjct: 227 ----EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR--EEADGVXAASGGLRQVPVK 280
Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
           + APE     R S ++DV+SFG+LL E  +  A S YP+ +  +  E
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFSLGA-SPYPNLSNQQTRE 326

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 106/226 (46%), Gaps = 23/226 (10%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARK-EFEQYMDVIGKLKH 411
           EDL+    E +G+G+ G V+   L  D  +VAVK  ++  P   K +F Q   ++ +  H
Sbjct: 114 EDLVLG--EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171
Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           PN+V+L      K+   +V + +  G   + L       R+     T + +V  AA G+ 
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV----KTLLQMVGDAAAGM- 226
Query: 472 RIHQEYGTAKV-PHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------Y 523
               EY  +K   H ++ + N L+ +  V  ISDFG+S         A  GG       +
Sbjct: 227 ----EYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKW 281
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
            APE     R S ++DV+SFG+LL E  +  A S YP+ +  +  E
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFSLGA-SPYPNLSNQQTRE 326

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 110/244 (45%), Gaps = 36/244 (14%)
Query: 343 VFYERKKQFEL-------EDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA 395
           ++++  KQ+E        ED      E LG G+ G VYKA   +  ++A  ++ D    +
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTK--S 74
Query: 396 RKEFEQYM---DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
            +E E YM   D++    HPN+VKL   +Y +    ++ ++   G++ +++     P   
Sbjct: 75  EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT- 133
Query: 453 PLDWTTRISLVLGAA-RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL 511
                ++I +V       L  +H      K+ H ++K+ N+L   +G   ++DFG+S   
Sbjct: 134 ----ESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVS--A 183
Query: 512 NPVQAIARLGGY------KAP-----EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
              + I R   +       AP     E ++ +    KADV+S G+ L+E+     P    
Sbjct: 184 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243
Query: 561 SPTR 564
           +P R
Sbjct: 244 NPMR 247

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 110/244 (45%), Gaps = 36/244 (14%)
Query: 343 VFYERKKQFEL-------EDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA 395
           ++++  KQ+E        ED      E LG G+ G VYKA   +  ++A  ++ D    +
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTK--S 74
Query: 396 RKEFEQYM---DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
            +E E YM   D++    HPN+VKL   +Y +    ++ ++   G++ +++     P   
Sbjct: 75  EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT- 133
Query: 453 PLDWTTRISLVLGAA-RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL 511
                ++I +V       L  +H      K+ H ++K+ N+L   +G   ++DFG+S   
Sbjct: 134 ----ESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVS--A 183
Query: 512 NPVQAIARLGGY------KAP-----EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
              + I R   +       AP     E ++ +    KADV+S G+ L+E+     P    
Sbjct: 184 KNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243
Query: 561 SPTR 564
           +P R
Sbjct: 244 NPMR 247

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++    Y  A +   +V  +    SL+  LH          +    I +    A+
Sbjct: 61  TRHVNILLFMGYSTAPQLA-IVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL---LNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+ +    +      +L G   
Sbjct: 116 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 115/235 (48%), Gaps = 25/235 (10%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +G+G+ G VYKA  + G   A+K  RL+  +        + + ++ +LKH N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
             + K+  +LV+++L +  L  LL    G     L+  T  S +L    G+A  H     
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQA----IARLGGYKAPE-QAEVKR 533
            +V H ++K  N+L+++ G   I+DFGL+     PV+     I  L  Y+AP+     K+
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-WYRAPDVLMGSKK 177
Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
            S   D++S G +  E++ G       +P  P V E +Q + + + + +   + W
Sbjct: 178 YSTTIDIWSVGCIFAEMVNG-------TPLFPGVSEADQLMRIFRILGTPNSKNW 225

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 23/234 (9%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +G+G+ G VYKA  + G   A+K  RL+  +        + + ++ +LKH N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
             + K+  +LV+++L +  L  LL    G     L+  T  S +L    G+A  H     
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVKRL 534
            +V H ++K  N+L+++ G   I+DFGL+     PV+          Y+AP+     K+ 
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
           S   D++S G +  E++ G       +P  P V E +Q + + + + +   + W
Sbjct: 179 STTIDIWSVGCIFAEMVNG-------TPLFPGVSEADQLMRIFRILGTPNSKNW 225

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 88
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 89  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 143
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL---LLNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+      +      +L G   
Sbjct: 144 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 110/244 (45%), Gaps = 36/244 (14%)
Query: 343 VFYERKKQFEL-------EDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA 395
           ++++  KQ+E        ED      E LG G+ G VYKA   +  ++A  ++ D    +
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGE-LGDGAFGKVYKAQNKETSVLAAAKVIDTK--S 74
Query: 396 RKEFEQYM---DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
            +E E YM   D++    HPN+VKL   +Y +    ++ ++   G++ +++     P   
Sbjct: 75  EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT- 133
Query: 453 PLDWTTRISLVLGAA-RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL 511
                ++I +V       L  +H      K+ H ++K+ N+L   +G   ++DFG+S   
Sbjct: 134 ----ESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVS--A 183
Query: 512 NPVQAIARLGGY------KAP-----EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
              + I R   +       AP     E ++ +    KADV+S G+ L+E+     P    
Sbjct: 184 KNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243
Query: 561 SPTR 564
           +P R
Sbjct: 244 NPMR 247

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 23/234 (9%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +G+G+ G VYKA  + G   A+K  RL+  +        + + ++ +LKH N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
             + K+  +LV+++L +  L  LL    G     L+  T  S +L    G+A  H     
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR--- 119
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVKRL 534
            +V H ++K  N+L+++ G   I+DFGL+     PV+          Y+AP+     K+ 
Sbjct: 120 -RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
           S   D++S G +  E++ G       +P  P V E +Q + + + + +   + W
Sbjct: 179 STTIDIWSVGCIFAEMVNG-------APLFPGVSEADQLMRIFRILGTPNSKNW 225

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 23  WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 80
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 81  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 135
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL---LLNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+      +      +L G   
Sbjct: 136 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 192 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGK 408
           +E+ D      + +G GS GTVYK      G VAVK L    P  +  + F+  + V+ K
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
            +H N++ L   Y  K +  +V  +    SL+  LH          +    I +    A+
Sbjct: 61  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQ 115
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL---LLNPVQAIARLGG--- 522
           G+  +H +     + H ++KS+N+ L ++    I DFGL+      +      +L G   
Sbjct: 116 GMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           + APE   ++     S ++DVY+FG++L E++TG+ P
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 26/216 (12%)
Query: 364 LGKGSLGTVYKAVLD-----DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V     D      G +VAVK LK DA P  R  ++Q +D++  L H +++K 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 418 RAYY--YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +            LV +Y+P GSL   L       R  +     +        G+A +H 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKAPEQ 528
           ++      H ++ + NVLLD + +  I DFGL+  +       R+         + APE 
Sbjct: 153 QHYI----HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPEC 208
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
            +  +    +DV+SFGV L E+LT    SQ P PT+
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSP-PTK 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G  G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 86
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 87  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 146 LV-SCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 248

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G  G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 145
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 146 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 205 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 307

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDAN---PCARKEFEQYMD 404
           + F ++D        LGKG  G VY A       IVA+K L  +         +  + ++
Sbjct: 18  RHFTIDDF--EIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIE 75
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           +   L HPN+++L  Y+Y +    L+ +Y P G L+  L  +        D     +++ 
Sbjct: 76  IQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS-----CTFDEQRTATIME 130
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--G 522
             A  L   H +    KV H ++K  N+LL   G   I+DFG S+    ++     G   
Sbjct: 131 ELADALMYCHGK----KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLD 186
Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
           Y  PE  E +  ++K D++  GVL  E+L G  P +
Sbjct: 187 YLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G  G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 88
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 89  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 148 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 250

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 41/279 (14%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKR-----LKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +G+G    VY+A  L DG  VA+K+     L DA   AR +  + +D++ +L HPNV+K 
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK--ARADCIKEIDLLKQLNHPNVIKY 97
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
            A +    E  +V +    G L  ++ H  +    IP     +  + L +A  L  +H  
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--LEHMH-- 153
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-LGG---YKAPEQAEVK 532
             + +V H ++K +NV +   GV  + D GL    +     A  L G   Y +PE+    
Sbjct: 154 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 211
Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
             + K+D++S G LL E+   ++P            ++     L K +         ++ 
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPF---------YGDKMNLYSLCKKIEQCDYPPLPSDH 262
Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           + +EL        +LV+M      C+   PEKRP +  V
Sbjct: 263 YSEEL-------RQLVNM------CINPDPEKRPDVTYV 288

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G  G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 91
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 92  -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 151 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 253

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A           +   VAVK LKD A      +    M+++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG        R+P +  T   LV  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV-S 161
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
               LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +      
Sbjct: 162 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL 221
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 222 PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++ +Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +       
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 131/304 (43%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 94
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 146
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +L     ++    G K P     
Sbjct: 147 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMA 206
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 259
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 260 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 300
Query: 646 GEEY 649
           GE Y
Sbjct: 301 GEHY 304

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V KA +   G+    A+KR+K+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 417 L------RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP-----------LDWTTR 459
           L      R Y Y      L  +Y P+G+L   L  +R     P           L     
Sbjct: 88  LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAI 517
           +      ARG+  + Q+    +  H N+ + N+L+ +N VA I+DFGLS    +   + +
Sbjct: 142 LHFAADVARGMDYLSQK----QFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 197
Query: 518 ARL-GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            RL   + A E       +  +DV+S+GVLL E+++
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 16/214 (7%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNV 414
           L    + +GKGS G VYK + +    V   ++ D        ++ +Q + V+ +   P +
Sbjct: 20  LFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    Y    +  ++ +YL  GS   LL     PG  PL+ T   +++    +GL  +H
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLK----PG--PLEETYIATILREILKGLDYLH 133
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAE 530
            E    +  H ++K++NVLL + G   ++DFG++  L   Q           + APE  +
Sbjct: 134 SE----RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK 189
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
                 KAD++S G+  +E+  G  P+    P R
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR 223

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G V++     G  VAVK        +  +E E Y  V+  L+H N++     
Sbjct: 10  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILG---- 62
Query: 421 YYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           + A + K         LV DY  +GSL   L+      R  +     I L L  A GLA 
Sbjct: 63  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 116
Query: 473 IHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA------RLGG 522
           +H E     G   + H ++KS N+L+ KNG  CI+D GL++  +            R+G 
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176
Query: 523 --YKAPE----QAEVKRLS--QKADVYSFGVLLLEV 550
             Y APE       +K     ++AD+Y+ G++  E+
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G V++     G  VAVK        +  +E E Y  V+  L+H N++     
Sbjct: 15  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILG---- 67
Query: 421 YYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           + A + K         LV DY  +GSL   L+      R  +     I L L  A GLA 
Sbjct: 68  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 121
Query: 473 IHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA------RLGG 522
           +H E     G   + H ++KS N+L+ KNG  CI+D GL++  +            R+G 
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181
Query: 523 --YKAPE----QAEVKRLS--QKADVYSFGVLLLEV 550
             Y APE       +K     ++AD+Y+ G++  E+
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G V++     G  VAVK        +  +E E Y  V+  L+H N++     
Sbjct: 48  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILG---- 100
Query: 421 YYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           + A + K         LV DY  +GSL   L+      R  +     I L L  A GLA 
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 154
Query: 473 IHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA------RLGG 522
           +H E     G   + H ++KS N+L+ KNG  CI+D GL++  +            R+G 
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 523 --YKAPE----QAEVKRLS--QKADVYSFGVLLLEV 550
             Y APE       +K     ++AD+Y+ G++  E+
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++  Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKDANPCARKEFE------QYMDVIGKL 409
           LG+G+ G V  A           +   VAVK LKD      K+        + M +IGK 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGK- 99
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRIS 461
            H N++ L           ++  Y   G+L   L   R PG        R+P +  T   
Sbjct: 100 -HKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV      LAR  +   + K  H ++ + NVL+ +N V  I+DFGL+  +N +    +  
Sbjct: 159 LV-SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 522 G------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                  + APE    +  + ++DV+SFGVL+ E+ T G +P  YP
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YP 261

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G V++     G  VAVK        +  +E E Y  V+  L+H N++     
Sbjct: 12  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILG---- 64
Query: 421 YYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           + A + K         LV DY  +GSL   L+      R  +     I L L  A GLA 
Sbjct: 65  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 118
Query: 473 IHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA------RLGG 522
           +H E     G   + H ++KS N+L+ KNG  CI+D GL++  +            R+G 
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178
Query: 523 --YKAPE----QAEVKRLS--QKADVYSFGVLLLEV 550
             Y APE       +K     ++AD+Y+ G++  E+
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G V++     G  VAVK        +  +E E Y  V+  L+H N++     
Sbjct: 35  ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILG---- 87
Query: 421 YYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           + A + K         LV DY  +GSL   L+      R  +     I L L  A GLA 
Sbjct: 88  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 141
Query: 473 IHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA------RLGG 522
           +H E     G   + H ++KS N+L+ KNG  CI+D GL++  +            R+G 
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201
Query: 523 --YKAPE----QAEVKRLS--QKADVYSFGVLLLEV 550
             Y APE       +K     ++AD+Y+ G++  E+
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E LG G+  TVYK +    G+ VA+K +K D+         + + ++ +LKH N+V+L  
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 420 YYYAKEEKLLVYDYLPNG---SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
             + + +  LV++++ N     + S   GN  P  + L+        L   +GLA  H+ 
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNT-PRGLELNLVKYFQWQL--LQGLAFCHEN 127
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLS----LLLNPVQAIARLGGYKAPEQAEVK 532
               K+ H ++K  N+L++K G   + DFGL+    + +N   +      Y+AP+     
Sbjct: 128 ----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 533 R-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ 572
           R  S   D++S G +L E++TG+       P  P  ++EEQ
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGK-------PLFPGTNDEEQ 217

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG+GS G+VYKA+  + G IVA+K++   +    +E  + + ++ +   P+VVK    
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVKYYGS 92
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y+   +  +V +Y   GS+  ++          L      +++    +GL  +H      
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKT----LTEDEIATILQSTLKGLEYLH----FM 144
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVKRLSQ 536
           +  H ++K+ N+LL+  G A ++DFG++  L    A    +     + APE  +    + 
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNC 204
Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
            AD++S G+  +E+  G+ P     P R
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMR 232

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G V++     G  VAVK        +  +E E Y  V+  L+H N++     
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILG---- 61
Query: 421 YYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           + A + K         LV DY  +GSL   L+      R  +     I L L  A GLA 
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAH 115
Query: 473 IHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA------RLGG 522
           +H E     G   + H ++KS N+L+ KNG  CI+D GL++  +            R+G 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 523 --YKAPE----QAEVKRLS--QKADVYSFGVLLLEV 550
             Y APE       +K     ++AD+Y+ G++  E+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 25/224 (11%)
Query: 351 FELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA-----RKEFEQYMDV 405
           F+  ++LRA    +GKGS G V     +D   +   +  +   C      R  F++ + +
Sbjct: 14  FDHFEILRA----IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE-LQI 68
Query: 406 IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           +  L+HP +V L   +  +E+  +V D L  G L   L  N     +     T    +  
Sbjct: 69  MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-----VHFKEETVKLFICE 123
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
               L  +  +    ++ H ++K  N+LLD++G   I+DF ++ +L     I  + G   
Sbjct: 124 LVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKP 179
Query: 523 YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAPSQYPSPT 563
           Y APE    ++    S   D +S GV   E+L GR P    S T
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST 223

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +G+GS G V+K    D G IVA+K+  ++  +P  +K   + + ++ +LKHPN+V L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +  K    LV++Y  +  LH L    RG   +P      I+     A      H      
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN----- 122
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGGYKAPE-QAEVKRLS 535
              H +VK  N+L+ K+ V  + DFG + LL    +          Y++PE      +  
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 536 QKADVYSFGVLLLEVLTG 553
              DV++ G +  E+L+G
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 352 ELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH 411
           E  ++   + +++G GS G V++A L +   VA+K++        +E  Q M ++   KH
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNREL-QIMRIV---KH 91
Query: 412 PNVVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL- 464
           PNVV L+A++Y+  +K       LV +Y+P     +  H  +    +P+     I L + 
Sbjct: 92  PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM---LLIKLYMY 148
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLL---NPVQAIARL 520
              R LA IH    +  + H ++K  N+LLD  +GV  + DFG + +L    P  +    
Sbjct: 149 QLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICS 204
Query: 521 GGYKAPEQAE-VKRLSQKADVYSFGVLLLEVLTGR 554
             Y+APE        +   D++S G ++ E++ G+
Sbjct: 205 RYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 16/214 (7%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNV 414
           L    E +GKGS G V+K + +    V   ++ D        ++ +Q + V+ +     V
Sbjct: 24  LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            K    Y    +  ++ +YL  GS   LL         P D     +++    +GL  +H
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLH 137
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAE 530
            E    K  H ++K++NVLL + G   ++DFG++  L   Q           + APE  +
Sbjct: 138 SE----KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ 193
Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
                 KAD++S G+  +E+  G  P+    P R
Sbjct: 194 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRAY 420
           LG G+ G VYKA   + G +A  ++ +    + +E E Y+   +++    HP +VKL   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 421 YYAKEEKLLVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
           YY   +  ++ ++ P G++ + +L  +RG     +    R  L       L  +H    +
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLH----S 127
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQAEVKRLS 535
            ++ H ++K+ NVL+   G   ++DFG+S   L  +Q      G   + APE    + + 
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 536 Q-----KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
                 KAD++S G+ L+E+     P    +P R
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRAY 420
           LG G+ G VYKA   + G +A  ++ +    + +E E Y+   +++    HP +VKL   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 421 YYAKEEKLLVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
           YY   +  ++ ++ P G++ + +L  +RG     +    R  L       L  +H    +
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLH----S 135
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQAEVKRLS 535
            ++ H ++K+ NVL+   G   ++DFG+S   L  +Q      G   + APE    + + 
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 536 Q-----KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
                 KAD++S G+ L+E+     P    +P R
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 91
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 143
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 144 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 256
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 257 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 297
Query: 646 GEEY 649
           GE Y
Sbjct: 298 GEHY 301

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 98
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 150
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 151 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 263
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 264 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 304
Query: 646 GEEY 649
           GE Y
Sbjct: 305 GEHY 308

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDANPCARKEFE---QYMDVIGKLKHPN 413
           ++LG G  GTV+K V    G      V +K ++D +   R+ F+    +M  IG L H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAH 94
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLA 471
           +V+L         +L V  YLP GSL   +  +RG    ++ L+W  +I      A+G+ 
Sbjct: 95  IVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMY 147
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP----- 526
            + +E+G     H N+ + NVLL       ++DFG++ LL P          K P     
Sbjct: 148 YL-EEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLT 552
            E     + + ++DV+S+GV + E++T
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 145
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 146 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 258
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 259 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 299
Query: 646 GEEY 649
           GE Y
Sbjct: 300 GEHY 303

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 152
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 204
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 205 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 317
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 318 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 358
Query: 646 GEEY 649
           GE Y
Sbjct: 359 GEHY 362

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V KA +   G+    A+KR+K+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 417 L------RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP-----------LDWTTR 459
           L      R Y Y      L  +Y P+G+L   L  +R     P           L     
Sbjct: 81  LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAI 517
           +      ARG+  + Q+    +  H ++ + N+L+ +N VA I+DFGLS    +   + +
Sbjct: 135 LHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 190
Query: 518 ARL-GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            RL   + A E       +  +DV+S+GVLL E+++
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 145
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 146 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 258
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 259 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 299
Query: 646 GEEY 649
           GE Y
Sbjct: 300 GEHY 303

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 36/221 (16%)
Query: 364 LGKGSLGTVYKAV------LDDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V++A        +   +VAVK LK+ A+   + +F++   ++ +  +PN+VK
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLL------------HGN-------RGPGRIPLDWT 457
           L       +   L+++Y+  G L+  L            H +         PG  PL   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI 517
            ++ +    A G+A + +     K  H ++ + N L+ +N V  I+DFGLS  +      
Sbjct: 175 EQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 518 ARLGG------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
              G       +  PE     R + ++DV+++GV+L E+ +
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 94
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 146
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 147 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 259
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 260 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 300
Query: 646 GEEY 649
           GE Y
Sbjct: 301 GEHY 304

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 35/216 (16%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V KA +   G+    A+KR+K+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 417 L------RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP-----------LDWTTR 459
           L      R Y Y      L  +Y P+G+L   L  +R     P           L     
Sbjct: 91  LLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 460 ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAI 517
           +      ARG+  + Q+    +  H ++ + N+L+ +N VA I+DFGLS    +   + +
Sbjct: 145 LHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 200
Query: 518 ARL-GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            RL   + A E       +  +DV+S+GVLL E+++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDANPCARKEFE---QYMDVIGKLKHPN 413
           ++LG G  GTV+K V    G      V +K ++D +   R+ F+    +M  IG L H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAH 76
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLA 471
           +V+L         +L V  YLP GSL   +  +RG    ++ L+W  +I      A+G+ 
Sbjct: 77  IVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMY 129
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP----- 526
            + +E+G     H N+ + NVLL       ++DFG++ LL P          K P     
Sbjct: 130 YL-EEHGMV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLT 552
            E     + + ++DV+S+GV + E++T
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 37/234 (15%)
Query: 352 ELEDLLRASAE-----MLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQY 402
           +LED+L    +     MLGKG  G+V +A L  +DG  V  AVK LK A+  A  + E++
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK-ADIIASSDIEEF 72
Query: 403 MD---VIGKLKHPNVVKLRAYYYAKEEK------LLVYDYLPNGSLHSLLHGNR---GPG 450
           +     + +  HP+V KL         K      +++  ++ +G LH+ L  +R    P 
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 451 RIPLDWTTRISLVLGAARGLARIHQEYGTAK-VPHGNVKSSNVLLDKNGVACISDFGLSL 509
            +PL   T +  ++  A G+     EY +++   H ++ + N +L ++   C++DFGLS 
Sbjct: 133 NLPLQ--TLVRFMVDIACGM-----EYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 510 LLNPVQAIARLGGYKAP------EQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
            +       +    K P      E       +  +DV++FGV + E++T G+ P
Sbjct: 186 KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 92
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 144
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 145 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 257
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 258 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 298
Query: 646 GEEY 649
           GE Y
Sbjct: 299 GEHY 302

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 88
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +        +       I   L  A+G+  +
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV----KDLIGFGLQVAKGMKYL 144
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
                + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 145 ----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 253
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 254 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 294
Query: 646 GEEY 649
           GE Y
Sbjct: 295 GEHY 298

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 106/232 (45%), Gaps = 25/232 (10%)
Query: 361 AEMLGKGSLGTVYKAVLDDGG-----IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
            ++LG G+ GTVYK +    G      VA+K L++  +P A KE      V+  +  P V
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLAR 472
            +L         +L V   +P G L   +  NRG    +  L+W  +I      A+G++ 
Sbjct: 82  SRLLGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSY 134
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------ 526
           +       ++ H ++ + NVL+       I+DFGL+ LL+  +      G K P      
Sbjct: 135 LED----VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 190
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
           E    +R + ++DV+S+GV + E++T  A      P R   D  E+   LP+
Sbjct: 191 ESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ 242

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 74/304 (24%), Positives = 130/304 (42%), Gaps = 52/304 (17%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 145
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 146 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
            E  + ++ + K+DV+SFGVLL E++T  AP        P V+  +  V L +  R +++
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQG-RRLLQ 258
Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            E+  +                  +  V L C   + E RP+ +E+   I  I    + +
Sbjct: 259 PEYCPD-----------------PLYEVMLKCWHPKAEMRPSFSELVSRISAIF--STFI 299
Query: 646 GEEY 649
           GE Y
Sbjct: 300 GEHY 303

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 92
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 144
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 145 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            E  + ++ + K+DV+SFGVLL E++T  AP  YP
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 238

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKL 417
           E+LG G +  V+ A  L D   VAVK L+     +P     F +       L HP +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 418 ----RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
                A   A     +V +Y+   +L  ++H        P+     I ++  A + L   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 132
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGG---YKAP 526
           HQ      + H +VK +N+L+       + DFG++  +    N V   A + G   Y +P
Sbjct: 133 HQN----GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSP 188
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
           EQA    +  ++DVYS G +L EVLTG  P    SP
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L + +  +   G IPL      S +    +GLA  H   
Sbjct: 71  LDVIHTENKLYLVFEFL-HQDLKTFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 125
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVV 415
           + LG+G   TVYKA   +   IVA+K++K     +A     +   + + ++ +L HPN++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR---GPGRIPLDWTTRISLVLGAARGLAR 472
            L   +  K    LV+D++    L  ++  N     P  I        + +L   +GL  
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK-------AYMLMTLQGLEY 127
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP------VQAIARLGGYKAP 526
           +HQ +    + H ++K +N+LLD+NGV  ++DFGL+            Q + R   Y+AP
Sbjct: 128 LHQHW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRW--YRAP 181
Query: 527 EQAEVKRL-SQKADVYSFGVLLLEVL 551
           E     R+     D+++ G +L E+L
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAV-KRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG G+ G V++ V    G V V K +    P  +   +  + ++ +L HP ++ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +  K E +L+ ++L  G L   +          +     I+ +  A  GL  +H+     
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH---- 168
Query: 481 KVPHGNVKSSNVLLDKNGVACIS--DFGLSLLLNP---VQAIARLGGYKAPEQAEVKRLS 535
            + H ++K  N++ +    + +   DFGL+  LNP   V+       + APE  + + + 
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 228
Query: 536 QKADVYSFGVLLLEVLTGRAP 556
              D+++ GVL   +L+G +P
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSP 249

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 34/211 (16%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR-KEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +GKG  G V+      G  VAVK        +  +E E Y  V+  ++H N++   A   
Sbjct: 45  IGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAADI 101
Query: 423 ----AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY- 477
               +  +  L+ DY  NGSL+  L          LD  + + L   +  GL  +H E  
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 478 ---GTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-LLNPVQAI-----ARLGG--YKAP 526
              G   + H ++KS N+L+ KNG  CI+D GL++  ++    +      R+G   Y  P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 527 EQAEVKRLSQK-------ADVYSFGVLLLEV 550
           E  + + L++        AD+YSFG++L EV
Sbjct: 216 EVLD-ESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 72/275 (26%), Positives = 119/275 (43%), Gaps = 44/275 (16%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDAN--PCARKE-----FEQYMDVIGKLKHPNVVK 416
           LG G + TVY A   +  I+ +K    A   P   KE     FE+ +    +L H N+V 
Sbjct: 19  LGGGGMSTVYLA---EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           +       +   LV +Y+   +L   +  HG       PL   T I+       G+   H
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-------PLSVDTAINFTNQILDGIKHAH 128
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---QAIARLGG--YKAPEQA 529
                 ++ H ++K  N+L+D N    I DFG++  L+     Q    LG   Y +PEQA
Sbjct: 129 D----MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV---------DLPKWV 580
           + +   +  D+YS G++L E+L G  P    +     +   + +V         D+P+ +
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL 244
Query: 581 RSVVKEEWTAEVFDQELLRYKNIEE---ELVSMLH 612
            +V+      +  +    RYK I+E   +L S+LH
Sbjct: 245 SNVILRATEKDKAN----RYKTIQEMKDDLSSVLH 275

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKL 417
           E+LG G +  V+ A  L D   VAVK L+     +P     F +       L HP +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 418 ----RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
                A   A     +V +Y+   +L  ++H        P+     I ++  A + L   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 132
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGG---YKAP 526
           HQ      + H +VK +N+++       + DFG++  +    N V   A + G   Y +P
Sbjct: 133 HQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
           EQA    +  ++DVYS G +L EVLTG  P    SP
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 72  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 124
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 125 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 364 LGKGSLGTVYKAVLD-----DGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V     D      G +VAVK LK+   P  R  +++ ++++  L H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 418 RAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---GLAR 472
           +     + EK   LV +Y+P GSL   L         P        L+L A +   G+A 
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---------PRHCVGLAQLLLFAQQICEGMAY 126
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKA 525
           +H ++      H  + + NVLLD + +  I DFGL+  +       R+         + A
Sbjct: 127 LHAQHYI----HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 182
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
           PE  +  +    +DV+SFGV L E+LT    +Q P
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 217

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 364 LGKGSLGTVYKAVLD-----DGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V     D      G +VAVK LK+   P  R  +++ ++++  L H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 418 RAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR---GLAR 472
           +     + EK   LV +Y+P GSL   L         P        L+L A +   G+A 
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---------PRHCVGLAQLLLFAQQICEGMAY 127
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKA 525
           +H ++      H  + + NVLLD + +  I DFGL+  +       R+         + A
Sbjct: 128 LHAQHYI----HRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 183
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
           PE  +  +    +DV+SFGV L E+LT    +Q P
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 218

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKL 417
           E+LG G +  V+ A  L D   VAVK L+     +P     F +       L HP +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 418 ----RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
                A   A     +V +Y+   +L  ++H        P+     I ++  A + L   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 132
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGG---YKAP 526
           HQ      + H +VK +N+++       + DFG++  +    N V   A + G   Y +P
Sbjct: 133 HQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
           EQA    +  ++DVYS G +L EVLTG  P    SP
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 67  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 119
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 67  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 119
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 93
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 145
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 146 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            E  + ++ + K+DV+SFGVLL E++T  AP  YP
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 239

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 75  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 127
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 69  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 15  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 74
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 75  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 127
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 128 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 187 YYSTAVDIWSLGCIFAEMVTRRA 209

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 111
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 163
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 164 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            E  + ++ + K+DV+SFGVLL E++T  AP  YP
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 257

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 85
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +        +       I   L  A+G+  +
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV----KDLIGFGLQVAKGMKYL 141
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
                + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 142 ----ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            E  + ++ + K+DV+SFGVLL E++T  AP  YP
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 231

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 67  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 119
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 71  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 123
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 70  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 123 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 91
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 143
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 144 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            E  + ++ + K+DV+SFGVLL E++T  AP  YP
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 237

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 71  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 123
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 124 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 67  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 119
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 120 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKDFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 112
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 164
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 165 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            E  + ++ + K+DV+SFGVLL E++T  AP  YP
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 258

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 362 EMLGKGSLGTVYKAVL--DDGGIV--AVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           E++G+G  G VY   L  +DG  +  AVK L         E  Q++    ++    HPNV
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNV 90
Query: 415 VKLRAYYYAKE-EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           + L       E   L+V  Y+ +G L + +   R     P      +  ++G    +A+ 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNP-----TVKDLIGFGLQVAKG 142
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYKAP----- 526
            +   + K  H ++ + N +LD+     ++DFGL+  +      ++    G K P     
Sbjct: 143 MKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 527 -EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            E  + ++ + K+DV+SFGVLL E++T  AP  YP
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YP 236

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 70  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 123 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 69  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 122 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 69  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 12  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 71
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 72  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 126
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 184 YYSTAVDIWSLGCIFAEMVTRRA 206

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 70  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 123 -SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 69  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 122 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 71  LDVIHTENKLYLVFEFL-SMDLKDFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 125
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVLDDGGI----VAVKRLKDANPCARKE-FEQYMDVIGK 408
           E ++  S  ++GKG  G VY     D        A+K L       + E F +   ++  
Sbjct: 19  ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 409 LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGA 466
           L HPNV+ L       E   L +  LP      LL   R P R P   T +  IS  L  
Sbjct: 79  LNHPNVLALIGIMLPPEG--LPHVLLPYMCHGDLLQFIRSPQRNP---TVKDLISFGLQV 133
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAI-----AR 519
           ARG+  + ++    K  H ++ + N +LD++    ++DFGL+  +L     ++     AR
Sbjct: 134 ARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 520 LG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           L   + A E  +  R + K+DV+SFGVLL E+LT  AP
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 20/184 (10%)
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHS-LLHGNRGPGRIPLDWTTRISLV 463
           V+  L HPN++KL  ++  K    LV +    G L   ++H      R+  +      ++
Sbjct: 89  VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH------RMKFNEVDAAVII 142
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLL-NPVQAIAR 519
                G+  +H+      + H ++K  N+LL+   K+ +  I DFGLS +  N  +   R
Sbjct: 143 KQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198
Query: 520 LGG--YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVD 575
           LG   Y APE    K+  +K DV+S GV+L  +L G  P   Q       +V++ +   D
Sbjct: 199 LGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 576 LPKW 579
            P+W
Sbjct: 258 SPEW 261

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 10  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 70  LDVIHTENKLYLVFEFL-SMDLKDFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 124
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRA 204

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 34/217 (15%)
Query: 364 LGKGSLGTVYKAV--LDDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           LG+G  G V++A   +DD    A+KR++  N   AR++  + +  + KL+HP +V+    
Sbjct: 13  LGRGGFGVVFEAKNKVDDCN-YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 421 YYAKE--EKLL-----VYDYLPNGSLHSLLHGNRGPGRIPLDWTTR---ISLVLGAARGL 470
           +  K   EKL      VY Y+           +   GR  ++   R   + + L  A  +
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL----------SLLLNPVQAIARL 520
             +H    +  + H ++K SN+    + V  + DFGL            +L P+ A AR 
Sbjct: 132 EFLH----SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 521 GG------YKAPEQAEVKRLSQKADVYSFGVLLLEVL 551
            G      Y +PEQ      S K D++S G++L E+L
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L      
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    ++ +Y+ NG L + L   R           +   +L   + +    +   + +  
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L++  GV  +SDFGLS  +   +  + +G      +  PE     + S K+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQEL 597
           D+++FGVL+ E+ + G+ P +       R    E A  + + +R               L
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLR---------------L 240
Query: 598 LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS 643
            R     E++ ++++   +C   + ++RPT   +   I D+  E+S
Sbjct: 241 YRPHLASEKVYTIMY---SCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 9   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 68
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 69  LDVIHTENKLYLVFEFL-SMDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 123
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRA 203

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L      
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    ++ +Y+ NG L + L   R           +   +L   + +    +   + +  
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L++  GV  +SDFGLS  +   +  + +G      +  PE     + S K+
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQEL 597
           D+++FGVL+ E+ + G+ P +       R    E A  + + +R               L
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLR---------------L 240
Query: 598 LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS 643
            R     E++ ++++   +C   + ++RPT   +   I D+  E+S
Sbjct: 241 YRPHLASEKVYTIMY---SCWHEKADERPTFKILLSNILDVMDEES 283

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 71  LDVIHTENKLYLVFEFL-SMDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 125
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 126 ---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV++++ +  L + +  +   G IPL      S +    +GLA  H   
Sbjct: 67  LDVIHTENKLYLVFEHV-HQDLKTFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 69/264 (26%), Positives = 115/264 (43%), Gaps = 51/264 (19%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E+  +G  G V+KA +L++   V +  ++D     + E+E Y   +  +KH N+++    
Sbjct: 30  EVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-QNEYEVY--SLPGMKHENILQ---- 82
Query: 421 YYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           +   E++         L+  +   GSL   L  N       + W     +    ARGLA 
Sbjct: 83  FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAY 136
Query: 473 IHQEYGTAK------VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
           +H++    K      + H ++KS NVLL  N  ACI+DFGL+L     ++     G    
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGT 196
Query: 523 --YKAPEQAEVKRLSQ-----KADVYSFGVLLLEVLTGRAPS------QYPSPTRPRVD- 568
             Y APE  E     Q     + D+Y+ G++L E L  R  +      +Y  P    +  
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE-LASRCTAADGPVDEYMLPFEEEIGQ 255
Query: 569 ----EEEQAVDLPKWVRSVVKEEW 588
               E+ Q V + K  R V+++ W
Sbjct: 256 HPSLEDMQEVVVHKKKRPVLRDYW 279

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAV--LDDGGI-VAVKRLKDANPCA-RKEFEQ 401
           ++K   + ++LL A  E LG G+ G+V + V  +    I VA+K LK     A  +E  +
Sbjct: 327 DKKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
              ++ +L +P +V+L     A E  +LV +    G LH  L G R    IP+  +    
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--EIPV--SNVAE 440
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--IAR 519
           L+   + G+  + ++       H N+ + NVLL     A ISDFGLS  L    +   AR
Sbjct: 441 LLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496
Query: 520 LGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             G     + APE    ++ S ++DV+S+GV + E L+ G+ P
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L      
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    ++ +Y+ NG L + L   R           +   +L   + +    +   + +  
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L++  GV  +SDFGLS  +   +  + +G      +  PE     + S K+
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           D+++FGVL+ E+ + G+ P +
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYE 207

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GL+  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLSFCH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
            + +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 121 -SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVK 416
           A  E +GKG  G V++  L  G  VAVK    +D     R E E Y  V+  L+H N++ 
Sbjct: 11  ALVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFR-ETEIYNTVL--LRHDNILG 66
Query: 417 LRAYYY----AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
             A       +  +  L+  Y  +GSL+  L       R  L+    + L + AA GLA 
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQ------RQTLEPHLALRLAVSAACGLAH 120
Query: 473 IHQE-YGTAKVP---HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------ 522
           +H E +GT   P   H + KS NVL+  N   CI+D GL+++ +       +G       
Sbjct: 121 LHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGT 180
Query: 523 --YKAPE------QAEVKRLSQKADVYSFGVLLLEV 550
             Y APE      + +     +  D+++FG++L E+
Sbjct: 181 KRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 34/237 (14%)
Query: 350 QFELEDL-----LRASAEMLGKGSLGTVYKAVL--DDGGI--VAVKRLKDANPCARKEFE 400
           Q +LED+     L    ++LG+G  G+V +  L  +DG    VAVK +K  N  +++E E
Sbjct: 23  QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIE 81
Query: 401 QYMDVIGKLK---HPNVVKLRAYYYAKEEK-----LLVYDYLPNGSLHSLLHGNR---GP 449
           +++     +K   HPNV++L         +     +++  ++  G LH+ L  +R   GP
Sbjct: 82  EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGP 141
Query: 450 GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL 509
             IPL   T +  ++  A G+  +          H ++ + N +L  +   C++DFGLS 
Sbjct: 142 KHIPLQ--TLLKFMVDIALGMEYL----SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
Query: 510 LLNPVQA-----IARL-GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP 560
            +          IA++   + A E    +  + K+DV++FGV + E+ T R  + YP
Sbjct: 196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT-RGMTPYP 251

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L      
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    ++ +Y+ NG L + L   R           +   +L   + +    +   + +  
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L++  GV  +SDFGLS  +   +  + +G      +  PE     + S K+
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           D+++FGVL+ E+ + G+ P +
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYE 203

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/286 (21%), Positives = 121/286 (42%), Gaps = 40/286 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L      
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    ++ +Y+ NG L + L   R           +   +L   + +    +   + +  
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFL 133
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L++  GV  +SDFGLS  +   +  + +G      +  PE     + S K+
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 539 DVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQEL 597
           D+++FGVL+ E+ + G+ P +       R    E A  + + +R               L
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLR---------------L 231
Query: 598 LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS 643
            R     E++ ++++   +C   + ++RPT   +   I D+  E+S
Sbjct: 232 YRPHLASEKVYTIMY---SCWHEKADERPTFKILLSNILDVMDEES 274

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 364 LGKGSLGTV-YKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG+G    V     L DG   A+KR+       R+E ++  D+     HPN+++L AY  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 423 ----AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
               AK E  L+  +   G+L + +   +  G   L     + L+LG  RGL  IH + G
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIHAK-G 154
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFG-------------LSLLLNPVQAIARLGGYKA 525
            A   H ++K +N+LL   G   + D G              +L L    A      Y+A
Sbjct: 155 YA---HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 526 PEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP 556
           PE   V+    + ++ DV+S G +L  ++ G  P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 20/216 (9%)
Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DV 405
           + ++ED +    +MLGKGS G V+ A         A+K LK        + E  M    V
Sbjct: 13  KLKIEDFI--LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 406 IG-KLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           +    +HP +  +   +  KE    V +YL  G L   +           D +       
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAA 125
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG- 521
               GL  +H    +  + + ++K  N+LLDK+G   I+DFG+    +L   +     G 
Sbjct: 126 EIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGT 181
Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y APE    ++ +   D +SFGVLL E+L G++P
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L      
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    ++ +Y+ NG L + L   R           +   +L   + +    +   + +  
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L++  GV  +SDFGLS  +   +  + +G      +  PE     + S K+
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           D+++FGVL+ E+ + G+ P +
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYE 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+   RL            + + ++ +L HPN+VKL
Sbjct: 8   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 68  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA 202

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+   RL            + + ++ +L HPN+VKL
Sbjct: 7   VEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV+++L +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 67  LDVIHTENKLYLVFEFL-HQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRA 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 18/204 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYM---DVIG-KLKHPNVVK 416
           +MLGKGS G V+ A         A+K LK        + E  M    V+    +HP +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           +   +  KE    V +YL  G L   +           D +           GL  +H  
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLH-- 136
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GYKAPEQAEVK 532
             +  + + ++K  N+LLDK+G   I+DFG+    +L   +     G   Y APE    +
Sbjct: 137 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ 194
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
           + +   D +SFGVLL E+L G++P
Sbjct: 195 KYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E++G G+ G VYK      G +A  ++ D      +E +Q ++++ K  H   +   A Y
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI---ATY 86
Query: 422 YA----------KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           Y            ++  LV ++   GS+  L+   +G   +  +W   I   +   RGL+
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREI--LRGLS 143
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGY------KA 525
            +HQ     KV H ++K  NVLL +N    + DFG+S  L+  + + R   +       A
Sbjct: 144 HLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMA 197
Query: 526 PEQAEVKR-----LSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           PE              K+D++S G+  +E+  G  P     P R
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV----YKAVLDDGGIVAVKRLKDANPCAR 396
           K+V   R  Q + ED      +++G+G+ G V    +KA      + A+K L       R
Sbjct: 62  KIVKKIRGLQMKAEDY--DVVKVIGRGAFGEVQLVRHKA---SQKVYAMKLLSKFEMIKR 116
Query: 397 KE---FEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP 453
            +   F +  D++     P VV+L   +   +   +V +Y+P G L +L+     P +  
Sbjct: 117 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA 176
Query: 454 LDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP 513
             +T  + L L A   +  IH++          VK  N+LLDK+G   ++DFG  + ++ 
Sbjct: 177 KFYTAEVVLALDAIHSMGLIHRD----------VKPDNMLLDKHGHLKLADFGTCMKMDE 226
Query: 514 ---VQAIARLG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              V     +G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 227 TGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG G+ G V++      G   A K +   +   ++   + +  +  L+HP +V L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +    E +++Y+++  G L   +          +     +  +    +GL  +H+     
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHEN---- 274
Query: 481 KVPHGNVKSSNVLL--DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              H ++K  N++    ++    + DFGL+  L+P Q++    G   + APE AE K + 
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 536 QKADVYSFGVLLLEVLTGRAP 556
              D++S GVL   +L+G +P
Sbjct: 335 YYTDMWSVGVLSYILLSGLSP 355

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            E +G+G+ G VYKA     G +VA+K  RL            + + ++ +L HPN+VKL
Sbjct: 11  VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               + + +  LV++++ +  L   +  +   G IPL      S +    +GLA  H   
Sbjct: 71  LDVIHTENKLYLVFEHV-DQDLKKFMDASALTG-IPLPLIK--SYLFQLLQGLAFCHSH- 125
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPE-QAEVK 532
              +V H ++K  N+L++  G   ++DFGL+     PV+          Y+APE     K
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             S   D++S G +  E++T RA
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA 205

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 39/224 (17%)
Query: 357 LRASAE------MLGKGSLGTV----YKAVLDDGGIVAVKRLKDANPCARKE---FEQYM 403
           LR  AE      ++G+G+ G V    +K+      + A+K L       R +   F +  
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
           D++     P VV+L  +Y  ++++ L  V +Y+P G L +L+     P +    +T  + 
Sbjct: 126 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV 183
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIA 518
           L L A   +  IH++          VK  N+LLDK+G   ++DFG  + +N    V+   
Sbjct: 184 LALDAIHSMGFIHRD----------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 519 RLG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            +G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 39/224 (17%)
Query: 357 LRASAE------MLGKGSLGTV----YKAVLDDGGIVAVKRLKDANPCARKE---FEQYM 403
           LR  AE      ++G+G+ G V    +K+      + A+K L       R +   F +  
Sbjct: 64  LRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
           D++     P VV+L  +Y  ++++ L  V +Y+P G L +L+     P +    +T  + 
Sbjct: 121 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV 178
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIA 518
           L L A   +  IH++          VK  N+LLDK+G   ++DFG  + +N    V+   
Sbjct: 179 LALDAIHSMGFIHRD----------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 519 RLG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            +G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKL 417
           E+LG G +  V+ A  L     VAVK L+     +P     F +       L HP +V +
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 418 RAYYYAKEEK----LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            A   A+        +V +Y+   +L  ++H        P+     I ++  A + L   
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 132
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGG---YKAP 526
           HQ      + H +VK +N+++       + DFG++  +    N V   A + G   Y +P
Sbjct: 133 HQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
           EQA    +  ++DVYS G +L EVLTG  P    SP
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG G+ G V++      G   A K +   +   ++   + +  +  L+HP +V L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +    E +++Y+++  G L   +          +     +  +    +GL  +H+     
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGLCHMHEN---- 168
Query: 481 KVPHGNVKSSNVLL--DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              H ++K  N++    ++    + DFGL+  L+P Q++    G   + APE AE K + 
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 536 QKADVYSFGVLLLEVLTGRAP 556
              D++S GVL   +L+G +P
Sbjct: 229 YYTDMWSVGVLSYILLSGLSP 249

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 39/224 (17%)
Query: 357 LRASAE------MLGKGSLGTV----YKAVLDDGGIVAVKRLKDANPCARKE---FEQYM 403
           LR  AE      ++G+G+ G V    +K+      + A+K L       R +   F +  
Sbjct: 69  LRMKAEDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEER 125
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
           D++     P VV+L  +Y  ++++ L  V +Y+P G L +L+     P +    +T  + 
Sbjct: 126 DIMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV 183
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---VQAIA 518
           L L A   +  IH++          VK  N+LLDK+G   ++DFG  + +N    V+   
Sbjct: 184 LALDAIHSMGFIHRD----------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 519 RLG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            +G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           +LGKG+ G VY    L +   +A+K + + +    +   + + +   LKH N+V+    +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGP---GRIPLDWTTRISLVLGAARGLARIHQEYG 478
                  +  + +P GSL +LL    GP       + + T+  L      GL  +H    
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN-- 141
Query: 479 TAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLL---NP-VQAIARLGGYKAPEQAEV-- 531
             ++ H ++K  NVL++  +GV  ISDFG S  L   NP  +       Y APE  +   
Sbjct: 142 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
           +   + AD++S G  ++E+ TG+ P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA 423
           LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L      
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 424 KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP 483
           +    ++ +Y+ NG L + L   R           +   +L   + +    +   + +  
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKRLSQKA 538
           H ++ + N L++  GV  +SDFGLS  +   +  +  G      +  PE     + S K+
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 539 DVYSFGVLLLEVLT-GRAPSQ 558
           D+++FGVL+ E+ + G+ P +
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYE 208

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAV--LDDGGI-VAVKRLKDANPCA-RKEFEQ 401
           ++K   + ++LL A  E LG G+ G+V + V  +    I VA+K LK     A  +E  +
Sbjct: 1   DKKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 59
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
              ++ +L +P +V+L     A E  +LV +    G LH  L G R    IP+  +    
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--EIPV--SNVAE 114
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA--IAR 519
           L+   + G+  + ++       H ++ + NVLL     A ISDFGLS  L    +   AR
Sbjct: 115 LLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
Query: 520 LGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             G     + APE    ++ S ++DV+S+GV + E L+ G+ P
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V  A V   G +VAVK++       R+     + ++   +H NVV++   Y 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
             +E  +V ++L  G+L  ++   R      ++     ++ L   + L+ +H +     V
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQ----GV 268
Query: 483 PHGNVKSSNVLLDKNGVACISDFGL-SLLLNPVQAIARLGG---YKAPEQAEVKRLSQKA 538
            H ++KS ++LL  +G   +SDFG  + +   V     L G   + APE         + 
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 539 DVYSFGVLLLEVLTGRAP 556
           D++S G++++E++ G  P
Sbjct: 329 DIWSLGIMVIEMVDGEPP 346

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           +LGKG+ G VY    L +   +A+K + + +    +   + + +   LKH N+V+    +
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGP---GRIPLDWTTRISLVLGAARGLARIHQEYG 478
                  +  + +P GSL +LL    GP       + + T+  L      GL  +H    
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDN-- 127
Query: 479 TAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLL---NP-VQAIARLGGYKAPEQAEV-- 531
             ++ H ++K  NVL++  +GV  ISDFG S  L   NP  +       Y APE  +   
Sbjct: 128 --QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
           +   + AD++S G  ++E+ TG+ P
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPP 210

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V  A V   G +VAVK++       R+     + ++   +H NVV++   Y 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
             +E  +V ++L  G+L  ++   R      ++     ++ L   + L+ +H +     V
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQ----GV 148
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVKRLSQKA 538
            H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE         + 
Sbjct: 149 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 539 DVYSFGVLLLEVLTGRAP 556
           D++S G++++E++ G  P
Sbjct: 209 DIWSLGIMVIEMVDGEPP 226

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V  A V   G +VAVK++       R+     + ++   +H NVV++   Y 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
             +E  +V ++L  G+L  ++   R      ++     ++ L   + L+ +H +     V
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQ----GV 191
Query: 483 PHGNVKSSNVLLDKNGVACISDFGL-SLLLNPVQAIARLGG---YKAPEQAEVKRLSQKA 538
            H ++KS ++LL  +G   +SDFG  + +   V     L G   + APE         + 
Sbjct: 192 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 539 DVYSFGVLLLEVLTGRAP 556
           D++S G++++E++ G  P
Sbjct: 252 DIWSLGIMVIEMVDGEPP 269

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V  A V   G +VAVK++       R+     + ++   +H NVV++   Y 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
             +E  +V ++L  G+L  ++   R      ++     ++ L   + L+ +H +     V
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQ----GV 146
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVKRLSQKA 538
            H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE         + 
Sbjct: 147 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 539 DVYSFGVLLLEVLTGRAP 556
           D++S G++++E++ G  P
Sbjct: 207 DIWSLGIMVIEMVDGEPP 224

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKL 417
           E+LG G +  V+ A  L     VAVK L+     +P     F +       L HP +V +
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 418 ----RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
                A   A     +V +Y+   +L  ++H        P+     I ++  A + L   
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 132
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGG---YKAP 526
           HQ      + H +VK +N+++       + DFG++  +    N V   A + G   Y +P
Sbjct: 133 HQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP 562
           EQA    +  ++DVYS G +L EVLTG  P    SP
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V  A V   G +VAVK++       R+     + ++   +H NVV++   Y 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
             +E  +V ++L  G+L  ++   R      ++     ++ L   + L+ +H +     V
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQ----GV 137
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVKRLSQKA 538
            H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE         + 
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 539 DVYSFGVLLLEVLTGRAP 556
           D++S G++++E++ G  P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 15/198 (7%)
Query: 364 LGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V  A V   G +VAVK++       R+     + ++   +H NVV++   Y 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
             +E  +V ++L  G+L  ++   R      ++     ++ L   + L+ +H +     V
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHAQ----GV 141
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVKRLSQKA 538
            H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE         + 
Sbjct: 142 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 539 DVYSFGVLLLEVLTGRAP 556
           D++S G++++E++ G  P
Sbjct: 202 DIWSLGIMVIEMVDGEPP 219

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF---EQYMDVIGKLKHPNVVKLR 418
           E LGKG+   V + V    G+    ++ +    + ++F   E+   +  KL+HPN+V+L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    LV+D +  G L   +           D +  I  +L     +A  H    
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQIL---ESIAYCH---- 122
Query: 479 TAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQA---IARLGGYKAPEQAEVK 532
           +  + H N+K  N+LL    K     ++DFGL++ +N  +A    A   GY +PE  +  
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
             S+  D+++ GV+L  +L G  P
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF---EQYMDVIGKLKHPNVVKLR 418
           E LGKG+   V + V    G+    ++ +    + ++F   E+   +  KL+HPN+V+L 
Sbjct: 11  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 70
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    LV+D +  G L   +           D +  I  +L     +A  H    
Sbjct: 71  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQIL---ESIAYCH---- 121
Query: 479 TAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQA---IARLGGYKAPEQAEVK 532
           +  + H N+K  N+LL    K     ++DFGL++ +N  +A    A   GY +PE  +  
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 181
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
             S+  D+++ GV+L  +L G  P
Sbjct: 182 PYSKPVDIWACGVILYILLVGYPP 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF---EQYMDVIGKLKHPNVVKLR 418
           E LGKG+   V + V    G+    ++ +    + ++F   E+   +  KL+HPN+V+L 
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    LV+D +  G L   +           D +  I  +L     +A  H    
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQIL---ESIAYCH---- 145
Query: 479 TAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQA---IARLGGYKAPEQAEVK 532
           +  + H N+K  N+LL    K     ++DFGL++ +N  +A    A   GY +PE  +  
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
             S+  D+++ GV+L  +L G  P
Sbjct: 206 PYSKPVDIWACGVILYILLVGYPP 229

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF---EQYMDVIGKLKHPNVVKLR 418
           E LGKG+   V + V    G+    ++ +    + ++F   E+   +  KL+HPN+V+L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    LV+D +  G L   +           D +  I  +L     +A  H    
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA--DASHCIQQIL---ESIAYCH---- 122
Query: 479 TAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQA---IARLGGYKAPEQAEVK 532
           +  + H N+K  N+LL    K     ++DFGL++ +N  +A    A   GY +PE  +  
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
             S+  D+++ GV+L  +L G  P
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPP 206

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 69/298 (23%)
Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E++G G  G V+KA    DG    +KR+K  N  A +E    +  + KL H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72
Query: 421 Y---------------YAKEEKLLV-YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           +                +K + L +  ++   G+L   +   RG     LD    + L  
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALELFE 129
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
              +G+  IH    + K+ + ++K SN+ L       I DFGL   L       R  G  
Sbjct: 130 QITKGVDYIH----SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTL 185
Query: 523 -YKAPEQAEVKRLSQKADVYSFGVLLLEVL----TGRAPSQYPSPTRPRVDEEEQAVDLP 577
            Y +PEQ   +   ++ D+Y+ G++L E+L    T    S++ +  R  +          
Sbjct: 186 RYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI---------- 235
Query: 578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
                       +++FD+   + K + ++L+S           +PE RP  +E+ + +
Sbjct: 236 -----------ISDIFDK---KEKTLLQKLLS----------KKPEDRPNTSEILRTL 269

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 31/191 (16%)
Query: 380 GGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGS 438
           GG  + + +++      KE    +D++ K+  HPN+++L+  Y       LV+D +  G 
Sbjct: 42  GGSFSAEEVQELREATLKE----VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 97
Query: 439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA----KVPHGNVKSSNVLL 494
           L   L             T +++L     R + R   E   A     + H ++K  N+LL
Sbjct: 98  LFDYL-------------TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL 144
Query: 495 DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKR------LSQKADVYSFGV 545
           D +    ++DFG S  L+P + +  + G   Y APE  E           ++ D++S GV
Sbjct: 145 DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 204
Query: 546 LLLEVLTGRAP 556
           ++  +L G  P
Sbjct: 205 IMYTLLAGSPP 215

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +G+GS  TVYK +  +  + VA   L+D       R+ F++  + +  L+HPN+V+    
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 421 YYA----KEEKLLVYDYLPNGSLHSLLHGNR-GPGRIPLDWTTRISLVLGAARGLARIHQ 475
           + +    K+  +LV +   +G+L + L   +    ++   W  +I       +GL  +H 
Sbjct: 94  WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFLHT 147
Query: 476 EYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNPVQAIARLGG--YKAPEQAEVK 532
              T  + H ++K  N+ +    G   I D GL+ L     A A +G   + APE  E +
Sbjct: 148 R--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFXAPEXYE-E 204
Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYP 560
           +  +  DVY+FG   LE     A S+YP
Sbjct: 205 KYDESVDVYAFGXCXLEX----ATSEYP 228

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 31/191 (16%)
Query: 380 GGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGS 438
           GG  + + +++      KE    +D++ K+  HPN+++L+  Y       LV+D +  G 
Sbjct: 55  GGSFSAEEVQELREATLKE----VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110
Query: 439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA----KVPHGNVKSSNVLL 494
           L   L             T +++L     R + R   E   A     + H ++K  N+LL
Sbjct: 111 LFDYL-------------TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL 157
Query: 495 DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKR------LSQKADVYSFGV 545
           D +    ++DFG S  L+P + +  + G   Y APE  E           ++ D++S GV
Sbjct: 158 DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
Query: 546 LLLEVLTGRAP 556
           ++  +L G  P
Sbjct: 218 IMYTLLAGSPP 228

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKL 417
           E+LG G +  V+ A  L     VAVK L+     +P     F +       L HP +V  
Sbjct: 35  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV-- 92
Query: 418 RAYYYAKEEK-------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
            A Y   E +        +V +Y+   +L  ++H        P+     I ++  A + L
Sbjct: 93  -AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQAL 146
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL----NPVQAIARLGG---Y 523
              HQ      + H +VK +N+++       + DFG++  +    N V   A + G   Y
Sbjct: 147 NFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPT 563
            +PEQA    +  ++DVYS G +L EVLTG  P    SP 
Sbjct: 203 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 31/191 (16%)
Query: 380 GGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGS 438
           GG  + + +++      KE    +D++ K+  HPN+++L+  Y       LV+D +  G 
Sbjct: 55  GGSFSAEEVQELREATLKE----VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 110
Query: 439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA----KVPHGNVKSSNVLL 494
           L   L             T +++L     R + R   E   A     + H ++K  N+LL
Sbjct: 111 LFDYL-------------TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL 157
Query: 495 DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKR------LSQKADVYSFGV 545
           D +    ++DFG S  L+P + +  + G   Y APE  E           ++ D++S GV
Sbjct: 158 DDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
Query: 546 LLLEVLTGRAP 556
           ++  +L G  P
Sbjct: 218 IMYTLLAGSPP 228

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---- 128
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRR 188
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 109/231 (47%), Gaps = 30/231 (12%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYM 403
           E+   F  EDL       +G+G+ G+V K V    G I+AVKR++   +   +K+    +
Sbjct: 14  EQHWDFTAEDLKDLGE--IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71
Query: 404 DVIGKLKH-PNVVKLRAYYYAKEEKLLVYDYLPNG------SLHSLLHGNRGPGRIPLDW 456
           DV+ +    P +V+     + + +  +  + +          ++S+L        IP + 
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDD-----VIPEEI 126
Query: 457 TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA 516
             +I+L     + L  + +     K+ H ++K SN+LLD++G   + DFG+S  L    A
Sbjct: 127 LGKITL--ATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA 181
Query: 517 IARLGG---YKAPEQAEVKRLSQ----KADVYSFGVLLLEVLTGRAPSQYP 560
             R  G   Y APE+ +     Q    ++DV+S G+ L E+ TGR P  YP
Sbjct: 182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YP 230

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 359 ASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +  E+LG G  G V+K      G+ +A K +K      ++E +  + V+ +L H N+++L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              + +K + +LV +Y+  G L   +  +       LD    I  +     G+  +HQ Y
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRI-IDESYNLTELD---TILFMKQICEGIRHMHQMY 207
Query: 478 GTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+L    D   +  I DFGL+    P + +    G   + APE    
Sbjct: 208 ----ILHLDLKPENILCVNRDAKQIKII-DFGLARRYKPREKLKVNFGTPEFLAPEVVNY 262
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
             +S   D++S GV+   +L+G +P
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V  A     G  VAVK++       R+     + ++    H NVV + + Y 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKV 482
             +E  +V ++L  G+L  ++   R      ++     ++ L   R L+ +H +     V
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHNQ----GV 162
Query: 483 PHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQAEVKRLSQKA 538
            H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE         + 
Sbjct: 163 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 539 DVYSFGVLLLEVLTGRAP 556
           D++S G++++E++ G  P
Sbjct: 223 DIWSLGIMVIEMIDGEPP 240

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 21/221 (9%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLK-DANPCARKEFEQYMD 404
           ++ Q E+ DL       +G G+ G V+K      G ++AVK+++   N    K     +D
Sbjct: 18  QRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD 75
Query: 405 VIGKLKH-PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           V+ K    P +V+    +    +  +  + +  G+    L   R  G IP     ++++ 
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLK-KRMQGPIPERILGKMTVA 132
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG- 522
           +   + L  + +++G   V H +VK SN+LLD+ G   + DFG+S  L   +A  R  G 
Sbjct: 133 I--VKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC 187
Query: 523 --YKAPEQAEVKRLSQ-----KADVYSFGVLLLEVLTGRAP 556
             Y APE+ +    ++     +ADV+S G+ L+E+ TG+ P
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E LG G  G V + +  D G  VA+K+ + + +P  R+ +   + ++ KL HPNVV  R 
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 80
Query: 420 Y------YYAKEEKLLVYDYLPNGSLHSLLHG-------NRGPGRIPLDWTTRISLVLGA 466
                      +  LL  +Y   G L   L+          GP R         +L+   
Sbjct: 81  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR---------TLLSDI 131
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIARLGG- 522
           +  L  +H+     ++ H ++K  N++L    +  +  I D G +  L+  +      G 
Sbjct: 132 SSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 187
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y APE  E K+ +   D +SFG L  E +TG  P
Sbjct: 188 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 34/216 (15%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E LG G  G V + +  D G  VA+K+ + + +P  R+ +   + ++ KL HPNVV  R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79
Query: 420 Y------YYAKEEKLLVYDYLPNGSLHSLLHG-------NRGPGRIPLDWTTRISLVLGA 466
                      +  LL  +Y   G L   L+          GP R         +L+   
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR---------TLLSDI 130
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIARLGG- 522
           +  L  +H+     ++ H ++K  N++L    +  +  I D G +  L+  +      G 
Sbjct: 131 SSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             Y APE  E K+ +   D +SFG L  E +TG  P
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL--R 418
           +G GS G   K      G + V +  D       E +  +   +++ +LKHPN+V+   R
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                     +V +Y   G L S++  G +    +  ++  R+   L  A  L   H+  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHRRS 131
Query: 478 -GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQAEVK 532
            G   V H ++K +NV LD      + DFGL+ +LN   + A+  +G   Y +PEQ    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 533 RLSQKADVYSFGVLLLEV 550
             ++K+D++S G LL E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR----KEFEQYMDVIGKLKHPNVVKLR 418
           +LGKGS   VY+A     G+    ++ D     +    +  +  + +  +LKHP++++L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            Y+       LV +   NG ++  L  NR     P         +     G+  +H    
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYL-KNRVK---PFSENEARHFMHQIITGMLYLH---- 129
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGG---YKAPEQAEVKRL 534
           +  + H ++  SN+LL +N    I+DFGL+  L  P +    L G   Y +PE A     
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 535 SQKADVYSFGVLLLEVLTGRAP 556
             ++DV+S G +   +L GR P
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP 211

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL--R 418
           +G GS G   K      G + V +  D       E +  +   +++ +LKHPN+V+   R
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                     +V +Y   G L S++  G +    +  ++  R+   L  A  L   H+  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHRRS 131
Query: 478 -GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQAEVK 532
            G   V H ++K +NV LD      + DFGL+ +LN  +  A+  +G   Y +PEQ    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRM 191
Query: 533 RLSQKADVYSFGVLLLEV 550
             ++K+D++S G LL E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL--R 418
           +G GS G   K      G + V +  D       E +  +   +++ +LKHPN+V+   R
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                     +V +Y   G L S++  G +    +  ++  R+   L  A  L   H+  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA--LKECHRRS 131
Query: 478 -GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LGG--YKAPEQAEVK 532
            G   V H ++K +NV LD      + DFGL+ +LN   + A+  +G   Y +PEQ    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 191
Query: 533 RLSQKADVYSFGVLLLEV 550
             ++K+D++S G LL E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 44/223 (19%)
Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E++G G  G V+KA    DG    ++R+K  N  A +E    +  + KL H N+V     
Sbjct: 18  ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 73
Query: 421 Y-------YAKEEKLLVYDYLP----------------------NGSLHSLLHGNRGPGR 451
           +          ++ L   DY P                       G+L   +   RG   
Sbjct: 74  WDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-- 131
Query: 452 IPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL 511
             LD    + L     +G+  IH    + K+ H ++K SN+ L       I DFGL   L
Sbjct: 132 -KLDKVLALELFEQITKGVDYIH----SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 512 NPVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVL 551
                  R  G   Y +PEQ   +   ++ D+Y+ G++L E+L
Sbjct: 187 KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 356 LLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKE--FEQYMDVIGKLKHPN 413
           LL  S   +G+GS G V  A     G     ++ D     R+E  F + + ++   +H N
Sbjct: 45  LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHFN 103
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           VV++   Y   EE  ++ ++L  G+L  ++       ++ L+     ++     + LA +
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVLQALAYL 157
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-VQAIARLGG---YKAPEQA 529
           H +     V H ++KS ++LL  +G   +SDFG    ++  V     L G   + APE  
Sbjct: 158 HAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI 213
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
                + + D++S G++++E++ G  P    SP +
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 26/226 (11%)
Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCA------RKE 398
           E  KQ ++ED      E LG G    V K      G+  A K +K     A      R+E
Sbjct: 3   ETFKQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 399 FEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTT 458
            E+ + ++ ++ HPN++ L   Y  + + +L+ + +  G L   L       +  L    
Sbjct: 62  IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEE 116
Query: 459 RISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNP 513
             S +     G+  +H    T K+ H ++K  N+ LLDKN     +  I DFGL+  +  
Sbjct: 117 ATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI-DFGLAHEIED 171
Query: 514 VQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                 + G   + APE    + L  +AD++S GV+   +L+G +P
Sbjct: 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG          P +  +   LV  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV-S 154
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRL 214
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 254

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---- 128
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+  +   R++F Q    + +  HP++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---- 508
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 27/223 (12%)
Query: 368 SLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK---HPNVVKLRAYYYAK 424
           ++  + K+  D G      R  D N    K  E+  + I  LK   HPN++KL   +  K
Sbjct: 65  AIKVIKKSQFDKG------RYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK 118
Query: 425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPH 484
           +   LV ++   G L   +       R   D     +++     G+  +H+      + H
Sbjct: 119 KYFYLVTEFYEGGELFEQI-----INRHKFDECDAANIMKQILSGICYLHKH----NIVH 169
Query: 485 GNVKSSNVLLD-KNGVACIS--DFGLSLLLNPVQAI-ARLGG--YKAPEQAEVKRLSQKA 538
            ++K  N+LL+ KN +  I   DFGLS   +    +  RLG   Y APE  + K+ ++K 
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKC 228
Query: 539 DVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
           DV+S GV++  +L G  P   Q       +V++ +   D   W
Sbjct: 229 DVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 80  GVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---- 130
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 131 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 190
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 191 FTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 106 GVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---- 156
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 157 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 216
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 217 FTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 81  GVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---- 131
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 132 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 191
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 192 FTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 75  GVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---- 125
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---- 128
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 129 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 83  GVI-TENPVWIIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---- 133
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+  N    + DFGLS  +          G     + APE    +R
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 193
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 194 FTSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG          P +  +   LV  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-S 143
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 144 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 203
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 204 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 243

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG          P +  +   LV  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-S 147
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 148 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 207
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 208 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 247

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 28/231 (12%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQ-------YMDVIGKLKHPNVV 415
           ++G+G  G VY     D G +   +  D      K+ E         + ++     P +V
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +   ++  ++   + D +  G LH  L  HG      +   +   I L      GL  +
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL------GLEHM 307
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPE--QA 529
           H  +    V + ++K +N+LLD++G   ISD GL+   +  +  A +G  GY APE  Q 
Sbjct: 308 HNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 363
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVDEE--EQAVDLP 577
            V   S  AD +S G +L ++L G +P  Q+ +  +  +D      AV+LP
Sbjct: 364 GVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 413

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG          P +  +   LV  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV-S 139
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 199
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 200 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 239

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 118/293 (40%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H ++ + N ++  +    I DFG++  +    A  R GG       + 
Sbjct: 145 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET-AYYRKGGKGLLPVRWM 199
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 242
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P+ RPT  E+  +++D
Sbjct: 243 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 28/231 (12%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQ-------YMDVIGKLKHPNVV 415
           ++G+G  G VY     D G +   +  D      K+ E         + ++     P +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +   ++  ++   + D +  G LH  L  HG      +   +   I L      GL  +
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL------GLEHM 308
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPE--QA 529
           H  +    V + ++K +N+LLD++G   ISD GL+   +  +  A +G  GY APE  Q 
Sbjct: 309 HNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVDEE--EQAVDLP 577
            V   S  AD +S G +L ++L G +P  Q+ +  +  +D      AV+LP
Sbjct: 365 GVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 28/231 (12%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQ-------YMDVIGKLKHPNVV 415
           ++G+G  G VY     D G +   +  D      K+ E         + ++     P +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +   ++  ++   + D +  G LH  L  HG      +   +   I L      GL  +
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL------GLEHM 308
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPE--QA 529
           H  +    V + ++K +N+LLD++G   ISD GL+   +  +  A +G  GY APE  Q 
Sbjct: 309 HNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVDEE--EQAVDLP 577
            V   S  AD +S G +L ++L G +P  Q+ +  +  +D      AV+LP
Sbjct: 365 GVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 102/231 (44%), Gaps = 28/231 (12%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQ-------YMDVIGKLKHPNVV 415
           ++G+G  G VY     D G +   +  D      K+ E         + ++     P +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +   ++  ++   + D +  G LH  L  HG      +   +   I L      GL  +
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIIL------GLEHM 308
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPE--QA 529
           H  +    V + ++K +N+LLD++G   ISD GL+   +  +  A +G  GY APE  Q 
Sbjct: 309 HNRF----VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVDEE--EQAVDLP 577
            V   S  AD +S G +L ++L G +P  Q+ +  +  +D      AV+LP
Sbjct: 365 GVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKA--VLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +GKG+   V  A  VL  G  VAVK +     NP + ++  + + ++  L HPN+VKL  
Sbjct: 23  IGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
               ++   LV +Y   G +   L  HG          +   +S V          HQ+Y
Sbjct: 82  VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV-------QYCHQKY 134
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRL 534
               + H ++K+ N+LLD +    I+DFG S        +    G   Y APE  + K+ 
Sbjct: 135 ----IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKY 190
Query: 535 SQ-KADVYSFGVLLLEVLTGRAP 556
              + DV+S GV+L  +++G  P
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG          P +  +   LV  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-S 154
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG          P +  +   LV  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-S 146
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 147 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 206
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 207 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 246

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 137
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 138 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L   R PG          P +  +   LV  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV-S 154
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 254

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H N+ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 146 YLNAK----KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 200
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 243
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P  RPT  E+  +++D
Sbjct: 244 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 289

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 84  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 137 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 134
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 135 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/293 (24%), Positives = 116/293 (39%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H N+ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 145 YLNAK----KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 199
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 242
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P  RPT  E+  +++D
Sbjct: 243 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 136 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 82  RLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 134
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 135 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 190
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 191 SILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H ++ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 142 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX-XRKGGKGLLPVRWM 196
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 239
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P+ RPT  E+  +++D
Sbjct: 240 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 285

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 81  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 134 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 90/195 (46%), Gaps = 20/195 (10%)
Query: 383 VAVKRLK-DANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH 440
           VAVK LK DA      +    M+++  + KH N++ L           ++ +Y   G+L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 441 SLLHGNRGPG--------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV 492
             L   R PG          P +  +   LV   A  +AR  +   + K  H ++ + NV
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLV-SCAYQVARGMEYLASKKCIHRDLAARNV 222
Query: 493 LLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEVKRLSQKADVYSFGVL 546
           L+ ++ V  I+DFGL+  ++ +    +         + APE    +  + ++DV+SFGVL
Sbjct: 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 282
Query: 547 LLEVLT-GRAPSQYP 560
           L E+ T G +P  YP
Sbjct: 283 LWEIFTLGGSP--YP 295

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 87  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 139
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 140 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 195
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 196 SILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H ++ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 145 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX-XRKGGKGLLPVRWM 199
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 242
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P+ RPT  E+  +++D
Sbjct: 243 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 106 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 158
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 159 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 214
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 215 SILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 141 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 137 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 363 MLGKGSLGTVYKAVLDDGG----IVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVV 415
           +LG+G  G VY+ V  +       VAVK  K    C     E++M    ++  L HP++V
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK--KDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           KL      +E   ++ +  P G L   L  N+   ++     T +   L   + +A +  
Sbjct: 73  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV----LTLVLYSLQICKAMAYLE- 126
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLG-GYKAPEQAE 530
              +    H ++   N+L+       + DFGLS  +        ++ RL   + +PE   
Sbjct: 127 ---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 183
Query: 531 VKRLSQKADVYSFGVLLLEVLT-GRAP 556
            +R +  +DV+ F V + E+L+ G+ P
Sbjct: 184 FRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 363 MLGKGSLGTVYKAVLDDGG----IVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVV 415
           +LG+G  G VY+ V  +       VAVK  K    C     E++M    ++  L HP++V
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK--KDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           KL      +E   ++ +  P G L   L  N+   ++     T +   L   + +A +  
Sbjct: 89  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV----LTLVLYSLQICKAMAYLE- 142
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLG-GYKAPEQAE 530
              +    H ++   N+L+       + DFGLS  +        ++ RL   + +PE   
Sbjct: 143 ---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 199
Query: 531 VKRLSQKADVYSFGVLLLEVLT-GRAP 556
            +R +  +DV+ F V + E+L+ G+ P
Sbjct: 200 FRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 137 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 134 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           ++ K+    VV L   Y  K+   LV   +  G L   ++ + G    P         V 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFP-----EARAVF 290
Query: 465 GAAR---GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARL 520
            AA    GL  +H+E    ++ + ++K  N+LLD +G   ISD GL++ +   Q I  R+
Sbjct: 291 YAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 521 G--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
           G  GY APE  + +R +   D ++ G LL E++ G++P Q       R + E    ++P+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 84  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 137 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 192
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 193 SILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 136 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 91  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 143
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 144 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 199
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 200 SILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 134 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 75  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 127
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 128 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 134 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 116/293 (39%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H ++ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 145 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDX-XRKGGKGLLPVRWM 199
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 242
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P  RPT  E+  +++D
Sbjct: 243 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLKD 288

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 18/204 (8%)
Query: 363 MLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           M G+G+ GTV        G+ VA+K++   +P  R    Q M  +  L HPN+V+L++Y+
Sbjct: 30  MAGQGTFGTVQLGKEKSTGMSVAIKKVIQ-DPRFRNRELQIMQDLAVLHHPNIVQLQSYF 88
Query: 422 YAKEEK-------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           Y   E+        +V +Y+P+ +LH            P     ++ L     R +  +H
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL-FQLIRSIGCLH 146
Query: 475 QEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNPVQA-IARLGG--YKAPEQAE 530
               +  V H ++K  NVL+++ +G   + DFG +  L+P +  +A +    Y+APE   
Sbjct: 147 --LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF 204
Query: 531 -VKRLSQKADVYSFGVLLLEVLTG 553
             +  +   D++S G +  E++ G
Sbjct: 205 GNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/262 (24%), Positives = 114/262 (43%), Gaps = 46/262 (17%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK--LKHPNVVKLR 418
           E+  +G  G V+KA +++D   V +  L+D     ++ ++   ++     +KH N+++  
Sbjct: 21  EIKARGRFGCVWKAQLMNDFVAVKIFPLQD-----KQSWQSEREIFSTPGMKHENLLQFI 75
Query: 419 AYYY----AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           A        + E  L+  +   GSL   L GN       + W     +    +RGL+ +H
Sbjct: 76  AAEKRGSNLEVELWLITAFHDKGSLTDYLKGN------IITWNELCHVAETMSRGLSYLH 129
Query: 475 QEYGTAK-------VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
           ++    +       + H + KS NVLL  +  A ++DFGL++   P +      G     
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTR 189
Query: 523 -YKAPEQAEVKRLSQ-----KADVYSFGVLLLEVLT----GRAP-SQYPSPTRPRVD--- 568
            Y APE  E     Q     + D+Y+ G++L E+++       P  +Y  P    +    
Sbjct: 190 RYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHP 249
Query: 569 --EEEQAVDLPKWVRSVVKEEW 588
             EE Q V + K +R  +K+ W
Sbjct: 250 SLEELQEVVVHKKMRPTIKDHW 271

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 363 MLGKGSLGTVYKAVLDDGG----IVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVV 415
           +LG+G  G VY+ V  +       VAVK  K    C     E++M    ++  L HP++V
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK--KDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           KL      +E   ++ +  P G L   L  N+   ++     T +   L   + +A +  
Sbjct: 77  KLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKV----LTLVLYSLQICKAMAYLE- 130
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLG-GYKAPEQAE 530
              +    H ++   N+L+       + DFGLS  +        ++ RL   + +PE   
Sbjct: 131 ---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESIN 187
Query: 531 VKRLSQKADVYSFGVLLLEVLT-GRAP 556
            +R +  +DV+ F V + E+L+ G+ P
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 85/180 (47%), Gaps = 16/180 (8%)
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           ++ K+    VV L   Y  K+   LV   +  G L   ++ + G    P         V 
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY-HMGQAGFP-----EARAVF 290
Query: 465 GAAR---GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI-ARL 520
            AA    GL  +H+E    ++ + ++K  N+LLD +G   ISD GL++ +   Q I  R+
Sbjct: 291 YAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV 346
Query: 521 G--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
           G  GY APE  + +R +   D ++ G LL E++ G++P Q       R + E    ++P+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE 406

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCA 395
           K V+ +RK       LL    + LG G+ GTV   Y  +      VAVK LK+   +P  
Sbjct: 19  KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 71
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI- 129
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 130 ----IELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCA 395
           K V+ +RK       LL    + LG G+ GTV   Y  +      VAVK LK+   +P  
Sbjct: 19  KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 71
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI- 129
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 130 ----IELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 181
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 182 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+      R++F Q    + +  HP++VKL 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 78  GVI-TENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---- 128
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+       + DFGLS  +          G     + APE    +R
Sbjct: 129 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 188
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 189 FTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCARKEFEQYMDV 405
           EDL+    E LG+G+   ++K V  + G         V +K L  A+    + F +   +
Sbjct: 8   EDLI--FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 406 IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           + KL H ++V      +  +E +LV +++  GSL + L  N+            I   L 
Sbjct: 66  MSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKN--------CINILWKLE 117
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLL-----DKNG---VACISDFGLSLLLNPVQAI 517
            A+ LA          + HGNV + N+LL      K G      +SD G+S+ + P   +
Sbjct: 118 VAKQLAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 518 ARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTG 553
                +  PE  E  K L+   D +SFG  L E+ +G
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLD-----DGGIVAVKRLKDANPCA 395
           K V+ +RK       LL    + LG G+ GTV K             V + + +  +P  
Sbjct: 361 KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 413
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-----VK 467
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 468 DKNIIELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLD-----DGGIVAVKRLKDANPCA 395
           K V+ +RK       LL    + LG G+ GTV K             V + + +  +P  
Sbjct: 362 KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 414
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH-----VK 468
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 469 DKNIIELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 524
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 525 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 92/200 (46%), Gaps = 19/200 (9%)
Query: 363 MLGKGSLGTVYKAVLDDGG-IVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           ++G+GS G V K    D G IVA+K+    D +   +K   + + ++ +L+H N+V L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
               K+   LV++++ +  L  L     G     LD+      +     G+   H    +
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNG-----LDYQVVQKYLFQIINGIGFCH----S 142
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI----ARLGGYKAPEQ--AEVKR 533
             + H ++K  N+L+ ++GV  + DFG +  L     +         Y+APE    +VK 
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK- 201
Query: 534 LSQKADVYSFGVLLLEVLTG 553
             +  DV++ G L+ E+  G
Sbjct: 202 YGKAVDVWAIGCLVTEMFMG 221

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 19/227 (8%)
Query: 362 EMLGKGSLGTVY--KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E+LG G+   V+  K  L  G + A+K +K +        E  + V+ K+KH N+V L  
Sbjct: 15  EVLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            Y +     LV   +  G L   +   RG      D +  I  VL A + L     E G 
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRI-LERGV-YTEKDASLVIQQVLSAVKYL----HENG- 126
Query: 480 AKVPHGNVKSSNVLL---DKNGVACISDFGLSLL-LNPVQAIA-RLGGYKAPEQAEVKRL 534
             + H ++K  N+L    ++N    I+DFGLS +  N + + A    GY APE    K  
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPY 184
Query: 535 SQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
           S+  D +S GV+   +L G  P   +  S    ++ E     + P W
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW 231

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A G+  +
Sbjct: 78  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEGMNYL 130
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 131 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 186
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 187 SILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLL---NPVQAIARLGGYKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  +   N  + I     + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCA 395
           K V+ +RK       LL    + LG G+ GTV   Y  +      VAVK LK+   +P  
Sbjct: 17  KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 69
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI- 127
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 128 ----IELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 179
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 180 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 363 MLGKGSLGTVYKA----VLDDGGIVAVKRL----KDANPCARKEFEQYMDVIGKLKHPNV 414
           MLGKGS G V K        +  +  + +     KD +   R+     ++++ KL HPN+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE-----VELLKKLDHPNI 83
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           +KL           +V +    G L   +   +   R       RI  +     G+  +H
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARI--IKQVFSGITYMH 138
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVAC---ISDFGLSLLLNPVQAIA-RLGG--YKAPEQ 528
           +      + H ++K  N+LL+     C   I DFGLS        +  R+G   Y APE 
Sbjct: 139 KH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE- 193
Query: 529 AEVKR--LSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
             V R    +K DV+S GV+L  +L+G  P   +       RV+  + A DLP+W
Sbjct: 194 --VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/206 (23%), Positives = 87/206 (42%), Gaps = 20/206 (9%)
Query: 364 LGKGSLGTVYKAVL----DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G  G V++ +     +    VA+K  K+  +   R++F Q    + +  HP++VKL 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    ++ +    G L S L   +      LD  + I      +  LA +     
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---- 508
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
           + +  H ++ + NVL+       + DFGLS  +          G     + APE    +R
Sbjct: 509 SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 568
Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQ 558
            +  +DV+ FGV + E+L  G  P Q
Sbjct: 569 FTSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 382 IVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH 440
           +VA+K + K+A        E  + V+ K+KHPN+V L   Y +     L+   +  G L 
Sbjct: 45  LVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 441 SLL-----HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL-- 493
             +     +  R   R+       I  VL A + L  +        + H ++K  N+L  
Sbjct: 105 DRIVEKGFYTERDASRL-------IFQVLDAVKYLHDL-------GIVHRDLKPENLLYY 150
Query: 494 -LDKNGVACISDFGLSLLLNPVQAIARLG---GYKAPEQAEVKRLSQKADVYSFGVLLLE 549
            LD++    ISDFGLS + +P   ++      GY APE    K  S+  D +S GV+   
Sbjct: 151 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 550 VLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
           +L G  P   +  +    ++ + E   D P W
Sbjct: 211 LLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEIXINKMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEIXINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 386 KRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG 445
           ++L++     R+E      V G   HP+++ L   Y +     LV+D +  G L   L  
Sbjct: 137 EQLEEVREATRRETHILRQVAG---HPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-- 191
Query: 446 NRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF 505
                ++ L      S++      ++ +H       + H ++K  N+LLD N    +SDF
Sbjct: 192 ---TEKVALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRLSDF 244
Query: 506 GLSLLLNPVQAIARLG---GYKAPEQAEVKR------LSQKADVYSFGVLLLEVLTGRAP 556
           G S  L P + +  L    GY APE  +           ++ D+++ GV+L  +L G  P
Sbjct: 245 GFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 83/193 (43%), Gaps = 35/193 (18%)
Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
           P+     IS     ARG+  +     + K  H ++ + N+LL +N V  I DFGL+  + 
Sbjct: 195 PITMEDLISYSFQVARGMEFL----SSRKCIHRDLAARNILLSENNVVKICDFGLARDIY 250
Query: 513 PVQAIARLGG------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRP 565
                 R G       + APE    K  S K+DV+S+GVLL E+ + G +P  YP     
Sbjct: 251 KNPDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSP--YPGVQM- 307
Query: 566 RVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKR 625
              +E+    L + +R    E  T E++                   + L C    P++R
Sbjct: 308 ---DEDFCSRLREGMRMRAPEYSTPEIY------------------QIMLDCWHRDPKER 346
Query: 626 PTMAEVAKMIEDI 638
           P  AE+ + + D+
Sbjct: 347 PRFAELVEKLGDL 359

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H ++ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 145 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 199
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 242
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P+ RPT  E+  +++D
Sbjct: 243 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 288

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINAMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 71/293 (24%), Positives = 117/293 (39%), Gaps = 48/293 (16%)
Query: 364 LGKGSLGTVYKAVLDD------GGIVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY+    D         VAVK + + A+   R EF     V+      +VV+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L+V + + +G L S L   R      PGR P      I +    A G+A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++ +    K  H ++ + N ++  +    I DFG++  +       R GG       + 
Sbjct: 144 YLNAK----KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 198
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE  +    +  +D++SFGV+L E+ T  A   Y   +                   V+
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEI-TSLAEQPYQGLSN----------------EQVL 241
Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
           K        DQ      N  E +  ++ +   C    P+ RPT  E+  +++D
Sbjct: 242 KFVMDGGYLDQP----DNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 287

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCA 395
           K V+ +RK       LL    + LG G+ GTV   Y  +      VAVK LK+   +P  
Sbjct: 9   KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 61
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI- 119
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 120 ----IELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 171
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 172 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCA 395
           K V+ +RK       LL    + LG G+ GTV   Y  +      VAVK LK+   +P  
Sbjct: 3   KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 55
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI- 113
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 114 ----IELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 166 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEIXINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 33/235 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDG---GIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           ++LG G+   V  A  +D     +VA+K + K+A        E  + V+ K+KHPN+V L
Sbjct: 24  DVLGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL-----HGNRGPGRIPLDWTTRISLVLGAARGLAR 472
              Y +     L+   +  G L   +     +  R   R+       I  VL A + L  
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-------IFQVLDAVKYLHD 134
Query: 473 IHQEYGTAKVPHGNVKSSNVL---LDKNGVACISDFGLSLLLNPVQAIARLG---GYKAP 526
           +        + H ++K  N+L   LD++    ISDFGLS + +P   ++      GY AP
Sbjct: 135 L-------GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
           E    K  S+  D +S GV+   +L G  P   +  +    ++ + E   D P W
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 356 LLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLK 410
           LL    + LG G+ GTV   Y  +      VAVK LK+   +P  + E     +V+ +L 
Sbjct: 5   LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 64
Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
           +P +V++     A E  +LV +    G L+  L  NR      +     I LV   + G+
Sbjct: 65  NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGM 118
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI--ARLGG-----Y 523
             + +    +   H ++ + NVLL     A ISDFGLS  L   +    A+  G     +
Sbjct: 119 KYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 174
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
            APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 175 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 30/229 (13%)
Query: 341 KLVFYERKKQFELEDLLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCA 395
           K V+ +RK       LL    + LG G+ GTV   Y  +      VAVK LK+   +P  
Sbjct: 3   KEVYLDRK-------LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPAL 55
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           + E     +V+ +L +P +V++     A E  +LV +    G L+  L  NR      + 
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI- 113
Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
               I LV   + G+  + +    +   H ++ + NVLL     A ISDFGLS  L   +
Sbjct: 114 ----IELVHQVSMGMKYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 165
Query: 516 AI--ARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
               A+  G     + APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 166 NXYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 128
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 129 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 33/235 (14%)
Query: 362 EMLGKGSLGTVYKAVLDDG---GIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           ++LG G+   V  A  +D     +VA+K + K+A        E  + V+ K+KHPN+V L
Sbjct: 24  DVLGTGAFSEVILA--EDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL 81
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL-----HGNRGPGRIPLDWTTRISLVLGAARGLAR 472
              Y +     L+   +  G L   +     +  R   R+       I  VL A + L  
Sbjct: 82  DDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL-------IFQVLDAVKYLHD 134
Query: 473 IHQEYGTAKVPHGNVKSSNVL---LDKNGVACISDFGLSLLLNPVQAIARLG---GYKAP 526
           +        + H ++K  N+L   LD++    ISDFGLS + +P   ++      GY AP
Sbjct: 135 L-------GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
           E    K  S+  D +S GV+   +L G  P   +  +    ++ + E   D P W
Sbjct: 188 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 14  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 74  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 128
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 129 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 356 LLRASAEMLGKGSLGTV---YKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLK 410
           LL    + LG G+ GTV   Y  +      VAVK LK+   +P  + E     +V+ +L 
Sbjct: 7   LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD 66
Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
           +P +V++     A E  +LV +    G L+  L  NR      +     I LV   + G+
Sbjct: 67  NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGM 120
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI--ARLGG-----Y 523
             + +    +   H ++ + NVLL     A ISDFGLS  L   +    A+  G     +
Sbjct: 121 KYLEE----SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
            APE     + S K+DV+SFGVL+ E  + G+ P
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 28/222 (12%)
Query: 364 LGKGSLGTVYKAV---LDDG-----GIVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A    LD         VAVK LK DA      +    M+++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG--------RIPLDWTTRISLVLG 465
           ++ L           ++ +Y   G+L   L     PG          P +  +   LV  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV-S 154
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            A  +AR  +   + K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    +      
Sbjct: 155 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL 214
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              + APE    +  + ++DV+SFGVLL E+ T G +P  YP
Sbjct: 215 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YP 254

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 31/233 (13%)
Query: 363 MLGKGSLGTVYKA----VLDDGGIVAVKRL----KDANPCARKEFEQYMDVIGKLKHPNV 414
           MLGKGS G V K        +  +  + +     KD +   R+     ++++ KL HPN+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE-----VELLKKLDHPNI 83
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           +KL           +V +    G L   +   +   R       RI  +     G+  +H
Sbjct: 84  MKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARI--IKQVFSGITYMH 138
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVAC---ISDFGLSLLLNPVQAIA-RLGG--YKAPEQ 528
           +      + H ++K  N+LL+     C   I DFGLS        +  R+G   Y APE 
Sbjct: 139 KH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
                  +K DV+S GV+L  +L+G  P   +       RV+  + A DLP+W
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 10  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 68
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 120
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 229
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 230 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 259

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 53/275 (19%)
Query: 361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLK--------- 410
            + LG G+ G V     +  G  VAVK L       R++    +DV+GK++         
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILN------RQKIRS-LDVVGKIRREIQNLKLF 73
Query: 411 -HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
            HP+++KL        +  +V +Y+  G L   +  N   GR  LD      L      G
Sbjct: 74  RHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN---GR--LDEKESRRLFQQILSG 128
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAP 526
           +   H+      V H ++K  NVLLD +  A I+DFGLS +++  + +    G   Y AP
Sbjct: 129 VDYCHRHM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAP 184
Query: 527 EQAEVKRLS-QKADVYSFGVLLLEVLTGRAP--------------------SQYPSPTRP 565
           E    +  +  + D++S GV+L  +L G  P                     QY +P+  
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 566 RVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY 600
            + +    VD  K  R+ +K+    E F Q+L +Y
Sbjct: 245 SLLKHMLQVDPMK--RATIKDIREHEWFKQDLPKY 277

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L       +  L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 119/284 (41%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV-DEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS +     D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 94/228 (41%), Gaps = 21/228 (9%)
Query: 363 MLGKGSLGTVYKA---VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           MLGKGS G V K    +      V V     A         + ++++ KL HPN++KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
                    +V +    G L   +   +   R       RI  +     G+  +H+    
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARI--IKQVFSGITYMHKH--- 140
Query: 480 AKVPHGNVKSSNVLLDKNGVAC---ISDFGLSLLLNPVQAIA-RLGG--YKAPEQAEVKR 533
             + H ++K  N+LL+     C   I DFGLS        +  R+G   Y APE      
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GT 198
Query: 534 LSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
             +K DV+S GV+L  +L+G  P   +       RV+  + A DLP+W
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 70
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 122
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 123 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 231
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 232 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 261

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 48/298 (16%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 36  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 93
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNRG---PGRIPLD-WTTRISL--VLGA 466
           VV L          L+V  ++   G+L + L   R    P + P D +   ++L  ++  
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
           +  +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G     
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
             + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        + 
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FC 261
Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 262 RRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCA------RKEFEQ 401
           KQ ++ED      E LG G    V K      G+  A K +K     A      R+E E+
Sbjct: 6   KQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
            + ++ ++ H NV+ L   Y  + + +L+ + +  G L   L       +  L      S
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATS 119
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQA 516
            +     G+  +H    T K+ H ++K  N+ LLDKN     +  I DFGL+  +     
Sbjct: 120 FIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI-DFGLAHEIEDGVE 174
Query: 517 IARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              + G   + APE    + L  +AD++S GV+   +L+G +P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCA------RKEFEQ 401
           KQ ++ED      E LG G    V K      G+  A K +K     A      R+E E+
Sbjct: 6   KQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
            + ++ ++ H NV+ L   Y  + + +L+ + +  G L   L       +  L      S
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATS 119
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQA 516
            +     G+  +H    T K+ H ++K  N+ LLDKN     +  I DFGL+  +     
Sbjct: 120 FIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI-DFGLAHEIEDGVE 174
Query: 517 IARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              + G   + APE    + L  +AD++S GV+   +L+G +P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCA------RKEFEQ 401
           KQ ++ED      E LG G    V K      G+  A K +K     A      R+E E+
Sbjct: 6   KQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
            + ++ ++ H NV+ L   Y  + + +L+ + +  G L   L          L      S
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-----LSEEEATS 119
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQA 516
            +     G+  +H    T K+ H ++K  N+ LLDKN     +  I DFGL+  +     
Sbjct: 120 FIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI-DFGLAHEIEDGVE 174
Query: 517 IARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              + G   + APE    + L  +AD++S GV+   +L+G +P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCA------RKEFEQ 401
           KQ ++ED      E LG G    V K      G+  A K +K     A      R+E E+
Sbjct: 6   KQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
            + ++ ++ H NV+ L   Y  + + +L+ + +  G L   L       +  L      S
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATS 119
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQA 516
            +     G+  +H    T K+ H ++K  N+ LLDKN     +  I DFGL+  +     
Sbjct: 120 FIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI-DFGLAHEIEDGVE 174
Query: 517 IARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              + G   + APE    + L  +AD++S GV+   +L+G +P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCA------RKEFEQ 401
           KQ ++ED      E LG G    V K      G+  A K +K     A      R+E E+
Sbjct: 6   KQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
            + ++ ++ H NV+ L   Y  + + +L+ + +  G L   L       +  L      S
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL-----AQKESLSEEEATS 119
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQA 516
            +     G+  +H    T K+ H ++K  N+ LLDKN     +  I DFGL+  +     
Sbjct: 120 FIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI-DFGLAHEIEDGVE 174
Query: 517 IARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              + G   + APE    + L  +AD++S GV+   +L+G +P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++L  G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 88  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 141 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFG + LL   +      G K P      E
Sbjct: 136 EDR----RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+  L++A +P A KE      V+  + +P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 115 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 167
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 168 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 224 SILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 110/235 (46%), Gaps = 23/235 (9%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +G+G+ GTV+KA   +   IVA+KR  L D +        + + ++ +LKH N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++ ++  LV+++  +  L        G     LD     S +    +GL   H    
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCH---- 118
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPEQAEVKRL 534
           +  V H ++K  N+L+++NG   ++DFGL+     PV+  +       Y+ P+     +L
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 535 -SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
            S   D++S G +  E+      +    P  P  D ++Q   + + + +  +E+W
Sbjct: 179 YSTSIDMWSAGCIFAEL------ANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 45/284 (15%)
Query: 361 AEMLGKGSLGTVYKAV---LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            + LG+G+ G V  AV    ++   V +  +K A  C  +  ++ + +   L H NVVK 
Sbjct: 11  VQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKF 69
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             +      + L  +Y   G L   +  + G   +P     R    L A  G+  +H   
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMA--GVVYLH--- 121
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG---YKAPEQAEV 531
               + H ++K  N+LLD+     ISDFGL+ +    N  + + ++ G   Y APE  + 
Sbjct: 122 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 180
Query: 532 KRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-RPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +   ++  DV+S G++L  +L G  P   PS + +   D +E+   L  W          
Sbjct: 181 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW---------- 230
Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                      K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 231 -----------KKIDSAPLALLH---KILVENPSARITIPDIKK 260

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 85  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 137
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFG + LL   +      G K P      E
Sbjct: 138 EDR----RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 193
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 194 SILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 382 IVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH 440
           +VA+K + K A        E  + V+ K+KHPN+V L   Y +     L+   +  G L 
Sbjct: 45  LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 441 SLL-----HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL-- 493
             +     +  R   R+       I  VL A + L  +        + H ++K  N+L  
Sbjct: 105 DRIVEKGFYTERDASRL-------IFQVLDAVKYLHDL-------GIVHRDLKPENLLYY 150
Query: 494 -LDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLE 549
            LD++    ISDFGLS + +P   ++   G   Y APE    K  S+  D +S GV+   
Sbjct: 151 SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 210
Query: 550 VLTGRAP--SQYPSPTRPRVDEEEQAVDLPKW 579
           +L G  P   +  +    ++ + E   D P W
Sbjct: 211 LLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L++   +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 83  RLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFG + LL   +      G K P      E
Sbjct: 136 EDR----RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 153 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 259
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 260 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++L  G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 141 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 127/298 (42%), Gaps = 49/298 (16%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 37  LGRGAFGQVIEA--DAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNRG------PGRIPLDWTTRISLVLGA 466
           VV L          L+V  ++   G+L + L   R       P  +  D+ T   L+  +
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
            + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G     
Sbjct: 155 FQ-VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
             + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        + 
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FC 261
Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 262 RRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKNG---VACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++L  G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFGL+ LL   +      G K P      E
Sbjct: 134 EDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 26  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 144 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 250
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 251 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 27/217 (12%)
Query: 354 EDLLRASAEMLGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCARKEFEQYMDV 405
           EDL+    E LG+G+   ++K V  + G         V +K L  A+    + F +   +
Sbjct: 8   EDLI--FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASM 65
Query: 406 IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           + KL H ++V         +E +LV +++  GSL + L  N+    I + W   ++  L 
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLA 123
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLL-----DKNG---VACISDFGLSLLLNPVQAI 517
           AA              + HGNV + N+LL      K G      +SD G+S+ + P   +
Sbjct: 124 AAMHFLE------ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 518 ARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTG 553
                +  PE  E  K L+   D +SFG  L E+ +G
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 26  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 144 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 250
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 251 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VAVK +     N  + ++  + + ++  L HPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   LV +Y   G +   L  HG          +   +S V          HQ++ 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV-------QYCHQKF- 133
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLS---LLLNPVQAIARLGGYKAPEQAEVKRLS 535
              + H ++K+ N+LLD +    I+DFG S      N + A      Y APE  + K+  
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 536 Q-KADVYSFGVLLLEVLTGRAP 556
             + DV+S GV+L  +++G  P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 81  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFG + LL   +      G K P      E
Sbjct: 134 EDR----RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 364 LGKGSLGTVYKAVLDDGGIVA-VKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           L +   G ++K       IV  V +++D +    ++F +    +    HPNV+ +     
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 423 A--KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +       L+  ++P GSL+++LH   G   + +D +  +   L  ARG+A +H      
Sbjct: 78  SPPAPHPTLITHWMPYGSLYNVLH--EGTNFV-VDQSQAVKFALDMARGMAFLHTL--EP 132
Query: 481 KVPHGNVKSSNVLLDKNGVACIS--DFGLSLLLNPVQAIARL--GGYKAPEQAEVK---R 533
            +P   + S +V++D++  A IS  D   S      Q+  R+    + APE  + K    
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRMYAPAWVAPEALQKKPEDT 187
Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
             + AD++SF VLL E++T   P
Sbjct: 188 NRRSADMWSFAVLLWELVTREVP 210

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 88  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFG + LL   +      G K P      E
Sbjct: 141 EDR----RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 197 SILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +L         +L+    +P G L   +  H +    +  L+W  +I      A+G+  +
Sbjct: 83  RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAP------E 527
                  ++ H ++ + NVL+       I+DFG + LL   +      G K P      E
Sbjct: 136 EDR----RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 191
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT 552
               +  + ++DV+S+GV + E++T
Sbjct: 192 SILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 94/211 (44%), Gaps = 23/211 (10%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI------VAVKRLKDANP-CARKEFEQYMDVIGKLKHP 412
           + E LG G    V K      G+      +  +R K +    +R++ E+ + ++ +++HP
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ L   Y  K + +L+ + +  G L   L          L        +     G+  
Sbjct: 75  NVITLHEVYENKTDVILIGELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYY 129
Query: 473 IHQEYGTAKVPHGNVKSSNV-LLDKN---GVACISDFGLSLLLNPVQAIARLGG---YKA 525
           +H    + ++ H ++K  N+ LLD+N       I DFGL+  ++       + G   + A
Sbjct: 130 LH----SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 37  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 94
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 155 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 261
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 262 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 28/257 (10%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDV 405
           ++ Q   ED      +++G+G+ G V    + +   I A+K L       R E   + + 
Sbjct: 83  KEMQLHREDF--EIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREE 140
Query: 406 IGKLKHPNVVKLRAYYYAKEEK---LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
              L + +   + A +YA +++    LV DY   G L +LL  ++   ++P D       
Sbjct: 141 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLPEDMA---RF 195
Query: 463 VLG-AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN---PVQAIA 518
            +G     +  IHQ +      H ++K  NVLLD NG   ++DFG  L +N    VQ+  
Sbjct: 196 YIGEMVLAIDSIHQLHYV----HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV 251
Query: 519 RLG--GYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPS--PTRPRVDE 569
            +G   Y +PE  +     + +   + D +S GV + E+L G  P    S   T  ++  
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 311
Query: 570 EEQAVDLPKWVRSVVKE 586
            E+    P  V  V +E
Sbjct: 312 HEERFQFPSHVTDVSEE 328

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/257 (25%), Positives = 112/257 (43%), Gaps = 28/257 (10%)
Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDV 405
           ++ Q   ED      +++G+G+ G V    + +   I A+K L       R E   + + 
Sbjct: 67  KEMQLHREDF--EIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREE 124
Query: 406 IGKLKHPNVVKLRAYYYAKEEK---LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
              L + +   + A +YA +++    LV DY   G L +LL  ++   ++P D       
Sbjct: 125 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL--SKFEDKLPEDMA---RF 179
Query: 463 VLG-AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN---PVQAIA 518
            +G     +  IHQ +      H ++K  NVLLD NG   ++DFG  L +N    VQ+  
Sbjct: 180 YIGEMVLAIDSIHQLHYV----HRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV 235
Query: 519 RLG--GYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPS--PTRPRVDE 569
            +G   Y +PE  +     + +   + D +S GV + E+L G  P    S   T  ++  
Sbjct: 236 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295
Query: 570 EEQAVDLPKWVRSVVKE 586
            E+    P  V  V +E
Sbjct: 296 HEERFQFPSHVTDVSEE 312

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 153 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 259
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 260 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 153 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 259
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 260 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 34/224 (15%)
Query: 353 LEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKD-----ANPCARKEFEQYMDVIG 407
           +EDL       +G+G+ G VYKA   DG       LK       +  A +E    + ++ 
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLR 73
Query: 408 KLKHPNVVKLRAYY--YAKEEKLLVYDYLPNGSLHSL-LH----GNRGPGRIPLDWTTRI 460
           +LKHPNV+ L+  +  +A  +  L++DY  +   H +  H     N+ P ++P       
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK-- 131
Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLN-PVQ 515
           SL+     G+  +H  +    V H ++K +N+L+     + G   I+D G + L N P++
Sbjct: 132 SLLYQILDGIHYLHANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 516 AIARLG------GYKAPEQAEVKRLSQKA-DVYSFGVLLLEVLT 552
            +A L        Y+APE     R   KA D+++ G +  E+LT
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 231

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 26  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 144 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 250
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 251 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 72  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 129
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 190 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 296
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 297 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 147 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX-XRKGGKGLLPVRWM 201
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 138 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDX-XRKGGKGLLPVRWM 192
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 193 SPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 127/300 (42%), Gaps = 51/300 (17%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 26  LGRGAFGQVIEA--DAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 83
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVL 464
           VV L          L+V  ++   G+L + L   R         P  +  D+ T   L+ 
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
            + + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 144 YSFQ-VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 250
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 251 FCRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 93/229 (40%), Gaps = 26/229 (11%)
Query: 344 FYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKE---F 399
           F  + KQ  L        +++G+G+ G V    L +   + A+K L       R E   F
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121
Query: 400 EQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWT 457
            +  DV+       +  L   +       LV DY   G L +LL    +R P  +   + 
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181
Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPV 514
             + + + +   L  +H++          +K  N+L+D NG   ++DFG  L L     V
Sbjct: 182 AEMVIAIDSVHQLHYVHRD----------IKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231
Query: 515 QAIARLG--GYKAPEQAEVK-----RLSQKADVYSFGVLLLEVLTGRAP 556
           Q+   +G   Y +PE  +       R   + D +S GV + E+L G  P
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG------IVAVKRLKDANP-CARKEFEQ 401
           +Q ++ED      E LG G    V K      G       +  +RL  +    +R+E E+
Sbjct: 6   RQEDVEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIER 64
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
            ++++ +++HPN++ L   +  K + +L+ + +  G L   L        +  D  T+  
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQ-- 119
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQA 516
            +     G+  +H    + ++ H ++K  N+ LLDKN     +  I DFG++  +     
Sbjct: 120 FLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLI-DFGIAHKIEAGNE 174
Query: 517 IARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              + G   + APE    + L  +AD++S GV+   +L+G +P
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 361 AEMLGKGSLGTVYKAVLDDGG------IVAVKRLKDANP-CARKEFEQYMDVIGKLKHPN 413
            E LG G    V K      G       +  +RL  +    +R+E E+ ++++ +++HPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++ L   +  K + +L+ + +  G L   L        +  D  T+   +     G+  +
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQ--FLKQILDGVHYL 124
Query: 474 HQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQAIARLGG---YKA 525
           H    + ++ H ++K  N+ LLDKN     +  I DFG++  +        + G   + A
Sbjct: 125 H----SKRIAHFDLKPENIMLLDKNVPNPRIKLI-DFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 20/204 (9%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLR 418
           + +GKG+   V  A  +  G  VAVK +     N  + ++  + + +   L HPN+VKL 
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
                ++   LV +Y   G +   L  HG          +   +S V          HQ+
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAV-------QYCHQK 132
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLS---LLLNPVQAIARLGGYKAPEQAEVKR 533
           +    + H ++K+ N+LLD +    I+DFG S      N + A      Y APE  + K+
Sbjct: 133 F----IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKK 188
Query: 534 LSQ-KADVYSFGVLLLEVLTGRAP 556
               + DV+S GV+L  +++G  P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           V+ +L HPN++KL  ++  K    LV +    G L   +   +    +  D    +  VL
Sbjct: 57  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV--DAAVIMKQVL 114
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIA-RL 520
               G   +H+      + H ++K  N+LL+   ++ +  I DFGLS        +  RL
Sbjct: 115 S---GTTYLHKH----NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 167
Query: 521 GG--YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDL 576
           G   Y APE    K+  +K DV+S GV+L  +L G  P   Q       RV++ + + D 
Sbjct: 168 GTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDP 226
Query: 577 PKWVR 581
           P W +
Sbjct: 227 PDWTQ 231

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 22/215 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VA+K +     NP + ++  + + ++  L HPN+VKL   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   L+ +Y   G +   L  HG          +   +S V          HQ+  
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV-------QYCHQK-- 130
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
             ++ H ++K+ N+LLD +    I+DFG S        +    G   Y APE  + K+  
Sbjct: 131 --RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 536 Q-KADVYSFGVLLLEVLTGRAP--SQYPSPTRPRV 567
             + DV+S GV+L  +++G  P   Q     R RV
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 223

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VA+K +     NP + ++  + + ++  L HPN+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   L+ +Y   G +   L  HG          +   +S V          HQ+  
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAV-------QYCHQK-- 133
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEVK 532
             ++ H ++K+ N+LLD +    I+DFG S   N      +L        Y APE  + K
Sbjct: 134 --RIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPYAAPELFQGK 188
Query: 533 RLSQ-KADVYSFGVLLLEVLTGRAP--SQYPSPTRPRV 567
           +    + DV+S GV+L  +++G  P   Q     R RV
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV 226

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 18/185 (9%)
Query: 405 VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
           V+ +L HPN++KL  ++  K    LV +    G L   +   +    +  D    +  VL
Sbjct: 74  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEV--DAAVIMKQVL 131
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIA-RL 520
               G   +H+      + H ++K  N+LL+   ++ +  I DFGLS        +  RL
Sbjct: 132 S---GTTYLHKH----NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 184
Query: 521 GG--YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDL 576
           G   Y APE    K+  +K DV+S GV+L  +L G  P   Q       RV++ + + D 
Sbjct: 185 GTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDP 243
Query: 577 PKWVR 581
           P W +
Sbjct: 244 PDWTQ 248

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 14/201 (6%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           LG G+ G V+       G+  V +   KD +    ++ E  ++V+  L HPN++K+   +
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
                  +V +    G L   +   +  G+  L       L+      LA  H ++    
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGK-ALSEGYVAELMKQMMNALAYFHSQH---- 144
Query: 482 VPHGNVKSSNVLLDKNGVAC---ISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
           V H ++K  N+L           I DFGL+ L    +      G   Y APE  + + ++
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVT 203
Query: 536 QKADVYSFGVLLLEVLTGRAP 556
            K D++S GV++  +LTG  P
Sbjct: 204 FKCDIWSAGVVMYFLLTGCLP 224

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 364 LGKGSLGTVYKAV-LDDGG-IVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA  L +GG  VA+KR++     +  P +       +  +   +HPNVV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 417 L----RAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           L          +E KL LV++++ +  L + L     PG +P +  T   ++    RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG-VPTE--TIKDMMFQLLRGLD 134
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG---GYKAPEQ 528
            +H    + +V H ++K  N+L+  +G   ++DFGL+ + +   A+  +     Y+APE 
Sbjct: 135 FLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 529 AEVKRLSQKADVYSFGVLLLEVL 551
                 +   D++S G +  E+ 
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 99/242 (40%), Gaps = 26/242 (10%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRL-KDANPCARKEFEQYMDV 405
           KK FE +       E LG G+   V  A     G + AVK + K A        E  + V
Sbjct: 21  KKIFEFK-------ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAV 73
Query: 406 IGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           + K+KH N+V L   Y +     LV   +  G L   +   +G      D +T I  VL 
Sbjct: 74  LRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI-VEKG-FYTEKDASTLIRQVLD 131
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG 522
           A   L R+        + H ++K  N+L    D+     ISDFGLS +      ++   G
Sbjct: 132 AVYYLHRM-------GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACG 184
Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLP 577
              Y APE    K  S+  D +S GV+   +L G  P   +  S    ++ + E   D P
Sbjct: 185 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSP 244
Query: 578 KW 579
            W
Sbjct: 245 YW 246

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 94/211 (44%), Gaps = 25/211 (11%)
Query: 361 AEMLGKGSLGTVYKAVLDDGG------IVAVKRLKDANP-CARKEFEQYMDVIGKLKHPN 413
            E LG G    V K      G       +  +RL  +    +R+E E+ ++++ +++HPN
Sbjct: 31  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPN 90
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           ++ L   +  K + +L+ + +  G L   L       +  L        +     G+  +
Sbjct: 91  IITLHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYL 145
Query: 474 HQEYGTAKVPHGNVKSSNV-LLDKN----GVACISDFGLSLLLNPVQAIARLGG---YKA 525
           H    + ++ H ++K  N+ LLDKN     +  I DFG++  +        + G   + A
Sbjct: 146 H----SKRIAHFDLKPENIMLLDKNVPNPRIKLI-DFGIAHKIEAGNEFKNIFGTPEFVA 200
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    + L  +AD++S GV+   +L+G +P
Sbjct: 201 PEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC---ARKEFEQYMDVIGKLKHPNVVKL 417
           E +G G+ G V  A     G  VA+K++ +A      A++   + + ++   KH N++ +
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRE-LKILKHFKHDNIIAI 119
Query: 418 RAYY-----YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           +        Y + + + V   L    LH ++H ++     PL        +    RGL  
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKY 174
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLG------GYK 524
           +H    +A+V H ++K SN+L+++N    I DFG++  L  +P +    +        Y+
Sbjct: 175 MH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 230
Query: 525 APE-QAEVKRLSQKADVYSFGVLLLEVLTGR 554
           APE    +   +Q  D++S G +  E+L  R
Sbjct: 231 APELMLSLHEYTQAIDLWSVGCIFGEMLARR 261

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 111/236 (47%), Gaps = 25/236 (10%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +G+G+ GTV+KA   +   IVA+KR  L D +        + + ++ +LKH N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++ ++  LV+++  +  L        G     LD     S +    +GL   H    
Sbjct: 68  DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCH---- 118
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIAR---LGGYKAPEQAEVKRL 534
           +  V H ++K  N+L+++NG   +++FGL+     PV+  +       Y+ P+     +L
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 535 -SQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
            S   D++S G +  E+   GR       P  P  D ++Q   + + + +  +E+W
Sbjct: 179 YSTSIDMWSAGCIFAELANAGR-------PLFPGNDVDDQLKRIFRLLGTPTEEQW 227

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 153 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 207
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 364 LGKGSLGTVYKAV-LDDGG-IVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA  L +GG  VA+KR++     +  P +       +  +   +HPNVV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 417 L----RAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           L          +E KL LV++++ +  L + L     PG +P +  T   ++    RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG-VPTE--TIKDMMFQLLRGLD 134
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG---GYKAPEQ 528
            +H    + +V H ++K  N+L+  +G   ++DFGL+ + +   A+  +     Y+APE 
Sbjct: 135 FLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 529 AEVKRLSQKADVYSFGVLLLEVL 551
                 +   D++S G +  E+ 
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 153 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 207
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG+G+ G V K   +  G I+AVKR++ A   ++++    MD+   ++  +      +Y 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 423 A--KEEKLLVYDYLPNGSLHSLLHGNRGPGR-IPLDWTTRISLVLGAARGLARIHQEYGT 479
           A  +E  + +   L + SL          G+ IP D   +I++ +   + L  +H +   
Sbjct: 118 ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI--VKALEHLHSKLS- 174
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG--YKAPE----QAEVK 532
             V H +VK SNVL++  G   + DFG+S  L++ V      G   Y APE    +   K
Sbjct: 175 --VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
             S K+D++S G+ ++E+   R P
Sbjct: 233 GYSVKSDIWSLGITMIELAILRFP 256

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 144 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 198
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 199 SPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VAVK +     N  + ++  + + ++  L HPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   LV +Y   G +   L  HG          +   +S V          HQ++ 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV-------QYCHQKF- 133
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              + H ++K+ N+LLD +    I+DFG S        +    G   Y APE  + K+  
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 536 Q-KADVYSFGVLLLEVLTGRAP 556
             + DV+S GV+L  +++G  P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VAVK +     N  + ++  + + ++  L HPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   LV +Y   G +   L  HG          +   +S V          HQ++ 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV-------QYCHQKF- 133
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              + H ++K+ N+LLD +    I+DFG S        +    G   Y APE  + K+  
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 536 Q-KADVYSFGVLLLEVLTGRAP 556
             + DV+S GV+L  +++G  P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 23/203 (11%)
Query: 364 LGKGSLGTVYKAV-LDDGG-IVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA  L +GG  VA+KR++     +  P +       +  +   +HPNVV+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 417 L----RAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
           L          +E KL LV++++ +  L + L     PG +P +  T   ++    RGL 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPG-VPTE--TIKDMMFQLLRGLD 134
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG---GYKAPEQ 528
            +H    + +V H ++K  N+L+  +G   ++DFGL+ + +   A+  +     Y+APE 
Sbjct: 135 FLH----SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 190
Query: 529 AEVKRLSQKADVYSFGVLLLEVL 551
                 +   D++S G +  E+ 
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 146 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 200
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 140 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 194
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 147 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 201
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 202 SPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNRGPGRIPL-----DWTTRISLVLGAA 467
           VV L          L+V  ++   G+L + L   R    +P      D+ T   L+  + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLICYSF 151
Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
           + +A+  +   + K  H ++ + N+LL +  V  I DFGL+  +       R G      
Sbjct: 152 Q-VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 210
Query: 523 -YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR 581
            + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        + R
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FCR 258
Query: 582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
            +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 259 RL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 146 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 200
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 201 SPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 111/249 (44%), Gaps = 33/249 (13%)
Query: 364 LGKGSLGTVYK--AVLDDGGIVAVKRLK----DANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+G+  TVYK  + L D  +VA+K ++    +  PC A +E    + ++  LKH N+V 
Sbjct: 10  LGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIVT 64
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L    + ++   LV++YL       L       G I      ++ L     RGLA  H++
Sbjct: 65  LHDIIHTEKSLTLVFEYLDKDLKQYL----DDCGNIINMHNVKLFL-FQLLRGLAYCHRQ 119
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGL----SLLLNPVQAIARLGGYKAPE-QAEV 531
               KV H ++K  N+L+++ G   ++DFGL    S+             Y+ P+     
Sbjct: 120 ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
              S + D++  G +  E+ TGR       P  P    EEQ   + + + +  +E W   
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR-------PLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 592 VFDQELLRY 600
           + ++E   Y
Sbjct: 229 LSNEEFKTY 237

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 143 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 197
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 198 SPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I KL H N+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKLNHQNI 96
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 154
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 213
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 257

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 136
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 194
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGGYKA------ 525
           Q        H ++ + N LL   G   VA I DFG++      + I R G Y+       
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGCAML 248
Query: 526 ------PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
                 PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 297

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC---ARKEFEQYMDVIGKLKHPNVVKL 417
           E +G G+ G V  A     G  VA+K++ +A      A++   + + ++   KH N++ +
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRE-LKILKHFKHDNIIAI 118
Query: 418 RAYY-----YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           +        Y + + + V   L    LH ++H ++     PL        +    RGL  
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKY 173
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLG------GYK 524
           +H    +A+V H ++K SN+L+++N    I DFG++  L  +P +    +        Y+
Sbjct: 174 MH----SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYR 229
Query: 525 APE-QAEVKRLSQKADVYSFGVLLLEVLTGR 554
           APE    +   +Q  D++S G +  E+L  R
Sbjct: 230 APELMLSLHEYTQAIDLWSVGCIFGEMLARR 260

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VAV+ +     N  + ++  + + ++  L HPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   LV +Y   G +   L  HG          +   +S V          HQ++ 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV-------QYCHQKF- 133
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              + H ++K+ N+LLD +    I+DFG S        +    G   Y APE  + K+  
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYD 190
Query: 536 Q-KADVYSFGVLLLEVLTGRAP 556
             + DV+S GV+L  +++G  P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 97/231 (41%), Gaps = 37/231 (16%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 113
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 114 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 171
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGGYKA------ 525
           Q        H ++ + N LL   G   VA I DFG++      + I R G Y+       
Sbjct: 172 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGCAML 225
Query: 526 ------PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
                 PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 226 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 274

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I KL H N+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKLNHQNI 110
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 111 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 168
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 227
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 271

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG+GS G V++      G   AVK+++          E+ +   G L  P +V L     
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAG-LSSPRIVPLYGAVR 134
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARIHQEYGTAK 481
                 +  + L  GSL  L+   +  G +P D   R    LG A  GL  +H    T +
Sbjct: 135 EGPWVNIFMELLEGGSLGQLI---KQMGCLPED---RALYYLGQALEGLEYLH----TRR 184
Query: 482 VPHGNVKSSNVLLDKNGV-ACISDFGLSLLLNPVQAIARL--GGY-------KAPEQAEV 531
           + HG+VK+ NVLL  +G  A + DFG +L L P      L  G Y        APE    
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 244
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP-SQY 559
           K    K D++S   ++L +L G  P +QY
Sbjct: 245 KPCDAKVDIWSSCCMMLHMLNGCHPWTQY 273

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 363 MLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           +LGKGS G V     K    +  +  + + +      ++   + + ++ +L HPN++KL 
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            ++  K    LV +    G L   +   +    +  D    I  VL    G+  +H+   
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLS---GITYMHKN-- 151
Query: 479 TAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVK 532
             K+ H ++K  N+LL+   K+    I DFGLS      + +    G   Y APE     
Sbjct: 152 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-G 208
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP----SQYPSPTRPRVDEEEQAVDLPKW 579
              +K DV+S GV+L  +L+G  P    ++Y      +V++ +   +LP+W
Sbjct: 209 TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKYTFELPQW 257

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 37/231 (16%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 96
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 154
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGGYKA------ 525
           Q        H ++ + N LL   G   VA I DFG++      Q I R   Y+       
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------QDIYRASYYRKGGCAML 208
Query: 526 ------PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
                 PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 257

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 115 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 174
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N ++ ++    I DFG++  +       R GG       + 
Sbjct: 175 YLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 229
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 230 SPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARKE 398
           Y  K +F   +L     + LG G+ G V +A       +D  + VAVK LK       KE
Sbjct: 29  YNEKWEFPRNNL--QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 86
Query: 399 -FEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG------NRGPG 450
                + ++  L +H N+V L          L++ +Y   G L + L        ++  G
Sbjct: 87  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 146
Query: 451 RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL- 509
           R PL+    +      A+G+A +     +    H +V + NVLL    VA I DFGL+  
Sbjct: 147 R-PLELRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 201
Query: 510 LLNP----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           ++N     V+  ARL   + APE       + ++DV+S+G+LL E+ +
Sbjct: 202 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 103/231 (44%), Gaps = 26/231 (11%)
Query: 363 MLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           +LGKGS G V     K    +  +  + + +      ++   + + ++ +L HPN++KL 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            ++  K    LV +    G L   +   +    +  D    I  VL    G+  +H+   
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLS---GITYMHKN-- 145
Query: 479 TAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVK 532
             K+ H ++K  N+LL+   K+    I DFGLS      + +    G   Y APE     
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP----SQYPSPTRPRVDEEEQAVDLPKW 579
              +K DV+S GV+L  +L+G  P    ++Y      +V++ +   +LP+W
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKYTFELPQW 251

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 22/229 (9%)
Query: 363 MLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           +LGKGS G V     K    +  +  + + +      ++   + + ++ +L HPN++KL 
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            ++  K    LV +    G L   +   +    +  D    I  VL    G+  +H+   
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLS---GITYMHKN-- 169
Query: 479 TAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVK 532
             K+ H ++K  N+LL+   K+    I DFGLS      + +    G   Y APE     
Sbjct: 170 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-G 226
Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSP--TRPRVDEEEQAVDLPKW 579
              +K DV+S GV+L  +L+G  P    +      +V++ +   +LP+W
Sbjct: 227 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 275

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VAV+ +     N  + ++  + + ++  L HPN+VKL   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   LV +Y   G +   L  HG          +   +S V          HQ++ 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAV-------QYCHQKF- 133
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              + H ++K+ N+LLD +    I+DFG S        +    G   Y APE  + K+  
Sbjct: 134 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 190
Query: 536 Q-KADVYSFGVLLLEVLTGRAP 556
             + DV+S GV+L  +++G  P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 55/300 (18%)
Query: 364 LGKGSLGTVYKAVLDDGGI--------VAVKRLKDANPCA--RKEFEQYMDVIGKLKHPN 413
           LG+G+ G V +A  D  GI        VAVK LK+    +  R    +   +I    H N
Sbjct: 35  LGRGAFGQVIEA--DAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 414 VVKLRAYYYAKEEKLLVY-DYLPNGSLHSLLHGNRGPGRIPL-----DWTTRISLV---L 464
           VV L          L+V  ++   G+L + L   R    +P      D+ T   L+    
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIXYSF 151
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
             A+G+  +     + K  H ++ + N+LL +  V  I DFGL+  +       R G   
Sbjct: 152 QVAKGMEFL----ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
               + APE    +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE-------- 255
Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           + R +           +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 256 FXRRL-----------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 101/229 (44%), Gaps = 22/229 (9%)
Query: 363 MLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           +LGKGS G V     K    +  +  + + +      ++   + + ++ +L HPN++KL 
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            ++  K    LV +    G L   +   +    +  D    I  VL    G+  +H+   
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLS---GITYMHKN-- 168
Query: 479 TAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVK 532
             K+ H ++K  N+LL+   K+    I DFGLS      + +    G   Y APE     
Sbjct: 169 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-G 225
Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSP--TRPRVDEEEQAVDLPKW 579
              +K DV+S GV+L  +L+G  P    +      +V++ +   +LP+W
Sbjct: 226 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW 274

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 109/246 (44%), Gaps = 44/246 (17%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           LGKG+ G V+K++    G +VAVK++ DA   +  A++ F + M +     H N+V L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 420 YYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              A  ++   LV+DY+    LH+++  N       L+   +  +V    + +  +H   
Sbjct: 77  VLRADNDRDVYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH--- 126
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------------------ 519
            +  + H ++K SN+LL+      ++DFGLS     ++ +                    
Sbjct: 127 -SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 520 -------LGGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE 571
                     Y+APE      + ++  D++S G +L E+L G+ P    S T  +++   
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERII 244
Query: 572 QAVDLP 577
             +D P
Sbjct: 245 GVIDFP 250

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARKE 398
           Y  K +F   +L     + LG G+ G V +A       +D  + VAVK LK       KE
Sbjct: 37  YNEKWEFPRNNL--QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 399 -FEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG------NRGPG 450
                + ++  L +H N+V L          L++ +Y   G L + L        ++  G
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDG 154
Query: 451 RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL- 509
           R PL+    +      A+G+A +     +    H +V + NVLL    VA I DFGL+  
Sbjct: 155 R-PLELRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 209
Query: 510 LLNP----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           ++N     V+  ARL   + APE       + ++DV+S+G+LL E+ +
Sbjct: 210 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 364 LGKGSLGTVYKAVLD-----DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V     D      G  VAVK LK ++      + ++ ++++  L H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 418 RAYYYAKEEK----LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +      E+      L+ ++LP+GSL   L  N+      ++   ++   +   +G+  +
Sbjct: 89  KGI--CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKAP 526
               G+ +  H ++ + NVL++      I DFGL+  +   +    +         + AP
Sbjct: 143 ----GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLT 552
           E     +    +DV+SFGV L E+LT
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 95
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 153
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 212
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 256

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VAVK +     N  + ++  + + ++  L HPN+VKL   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 421 YYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++   LV +Y   G +   L  HG          +   +S V          HQ++ 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAV-------QYCHQKF- 126
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              + H ++K+ N+LLD +    I+DFG S        +    G   Y APE  + K+  
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 536 Q-KADVYSFGVLLLEVLTGRAP 556
             + DV+S GV+L  +++G  P
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLP 205

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLKHPNVV 415
           L  S ++LG GS GTV       G  VAVKR L D    A  E +   +      HPNV+
Sbjct: 34  LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVI 90
Query: 416 KLRAYYYAKEEKLLVYDYLP--NGSLHSLLHG-NRGPGRIPLDWTTR-ISLVLGAARGLA 471
           +   YY ++     +Y  L   N +L  L+   N     + L      ISL+   A G+A
Sbjct: 91  R---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLD-------------KNGVACISDFGLSLLLNPVQAIA 518
            +H    + K+ H ++K  N+L+              +N    ISDFGL   L+  Q   
Sbjct: 148 HLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 519 RLG--------GYKAP---EQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
           R          G++AP   E++  +RL++  D++S G +   +L+ G+ P
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF----EQYMDVIGKLKHPNVVKLRA 419
           LG+GS G V  A     G     ++ +    A+ +     E+ +  +  L+HP+++KL  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
              +K+E ++V +Y  N     ++  ++   +    +  +I   + A     R       
Sbjct: 82  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI---ISAVEYCHR------- 131
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS- 535
            K+ H ++K  N+LLD++    I+DFGLS ++     +    G   Y APE    K  + 
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 191
Query: 536 QKADVYSFGVLLLEVLTGRAP 556
            + DV+S GV+L  +L  R P
Sbjct: 192 PEVDVWSCGVILYVMLCRRLP 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 403 MDVIGKLK----------HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
           +DV+GK+K          HP+++KL        +  +V +Y+  G L   +  +   GR+
Sbjct: 52  LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRV 108
Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
                 R+   + +A      H       V H ++K  NVLLD +  A I+DFGLS +++
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHM------VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 513 PVQAIARLGG---YKAPEQAEVKRLSQ-KADVYSFGVLLLEVLTGRAP 556
             + +    G   Y APE    +  +  + D++S GV+L  +L G  P
Sbjct: 163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF----EQYMDVIGKLKHPNVVK 416
            + LG+GS G V  A     G     ++ +    A+ +     E+ +  +  L+HP+++K
Sbjct: 9   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L     +K+E ++V +Y  N     ++  ++   +    +  +I   + A     R    
Sbjct: 69  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI---ISAVEYCHR---- 121
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKR 533
               K+ H ++K  N+LLD++    I+DFGLS ++     +    G   Y APE    K 
Sbjct: 122 ---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 178
Query: 534 LS-QKADVYSFGVLLLEVLTGRAP 556
            +  + DV+S GV+L  +L  R P
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLP 202

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 96
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 97  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 154
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 155 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 213
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 257

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 361 AEMLGKGSLGTVYKAVLDD-GGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNV 414
           +++LG+G+   V++      G + A+K   + +         +EFE    V+ KL H N+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNI 69
Query: 415 VKLRAYYYAKEE------KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           VKL    +A EE      K+L+ ++ P GSL+++L        +P    +   +VL    
Sbjct: 70  VKL----FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLRDVV 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLNPVQAIARLGG-- 522
           G     +E G   + H N+K  N++     D   V  ++DFG +  L   +    L G  
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 523 -YKAP---EQAEVKRLSQK-----ADVYSFGVLLLEVLTGRAPSQ-YPSPTRPR 566
            Y  P   E+A +++  QK      D++S GV      TG  P + +  P R +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 40/230 (17%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLKHPNVV 415
           L  S ++LG GS GTV       G  VAVKR L D    A  E +   +      HPNV+
Sbjct: 34  LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVI 90
Query: 416 KLRAYYYAKEEKLLVYDYLP--NGSLHSLLHG-NRGPGRIPLDWTTR-ISLVLGAARGLA 471
           +   YY ++     +Y  L   N +L  L+   N     + L      ISL+   A G+A
Sbjct: 91  R---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLD-------------KNGVACISDFGLSLLLNPVQAIA 518
            +H    + K+ H ++K  N+L+              +N    ISDFGL   L+  Q   
Sbjct: 148 HLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 519 RLG--------GYKAP---EQAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
           R          G++AP   E++  +RL++  D++S G +   +L+ G+ P
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 95
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 96  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 153
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 212
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 256

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 364 LGKGSLGTVYKAVLD-----DGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G  G V     D      G  VAVK LK ++      + ++ ++++  L H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 418 RAYYYAKEEK----LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +      E+      L+ ++LP+GSL   L  N+      ++   ++   +   +G+  +
Sbjct: 77  KGI--CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 130
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YKAP 526
               G+ +  H ++ + NVL++      I DFGL+  +   +    +         + AP
Sbjct: 131 ----GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLT 552
           E     +    +DV+SFGV L E+LT
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 361 AEMLGKGSLGTVYKAVLDD-GGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNV 414
           +++LG+G+   V++      G + A+K   + +         +EFE    V+ KL H N+
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNI 69
Query: 415 VKLRAYYYAKEE------KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           VKL    +A EE      K+L+ ++ P GSL+++L        +P    +   +VL    
Sbjct: 70  VKL----FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP---ESEFLIVLRDVV 122
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLNPVQAIARLGG-- 522
           G     +E G   + H N+K  N++     D   V  ++DFG +  L   +    L G  
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTE 179
Query: 523 -YKAP---EQAEVKRLSQK-----ADVYSFGVLLLEVLTGRAPSQ-YPSPTRPR 566
            Y  P   E+A +++  QK      D++S GV      TG  P + +  P R +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 122
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 123 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 180
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 181 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 239
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 283

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 45/111 (40%), Gaps = 2/111 (1%)
Query: 119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPX 178
           +S N  S  IP +I S+  +  L+L  N+I G IP++V                 GRIP 
Sbjct: 636 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 695
Query: 179 XXXXXXXXXXXXXXXXXXYGRVPE-GLLKKFGEQSFIGNEGLCGSSPLPAC 228
                              G +PE G  + F    F+ N GLCG  PLP C
Sbjct: 696 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG-YPLPRC 745

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG+G+ G V K   +  G I+AVKR++ A   ++++    MD+   ++  +      +Y 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 423 A--KEEKLLVYDYLPNGSLHSLLHGNRGPGR-IPLDWTTRISLVLGAARGLARIHQEYGT 479
           A  +E  + +   L + SL          G+ IP D   +I++ +   + L  +H +   
Sbjct: 74  ALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI--VKALEHLHSKLS- 130
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG--YKAPE----QAEVK 532
             V H +VK SNVL++  G   + DFG+S  L++ V      G   Y APE    +   K
Sbjct: 131 --VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
             S K+D++S G+ ++E+   R P
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFP 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF----EQYMDVIGKLKHPNVVK 416
            + LG+GS G V  A     G     ++ +    A+ +     E+ +  +  L+HP+++K
Sbjct: 18  VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L     +K+E ++V +Y  N     ++  ++   +    +  +I   + A     R    
Sbjct: 78  LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI---ISAVEYCHR---- 130
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKR 533
               K+ H ++K  N+LLD++    I+DFGLS ++     +    G   Y APE    K 
Sbjct: 131 ---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL 187
Query: 534 LSQ-KADVYSFGVLLLEVLTGRAP 556
            +  + DV+S GV+L  +L  R P
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 112
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 113 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 170
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 171 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 229
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 273

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 45/111 (40%), Gaps = 2/111 (1%)
Query: 119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVXXXXXXXXXXXXXXXXXGRIPX 178
           +S N  S  IP +I S+  +  L+L  N+I G IP++V                 GRIP 
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 179 XXXXXXXXXXXXXXXXXXYGRVPE-GLLKKFGEQSFIGNEGLCGSSPLPAC 228
                              G +PE G  + F    F+ N GLCG  PLP C
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG-YPLPRC 748

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 110
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 111 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 168
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 169 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 227
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 271

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 87
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 88  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 145
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 146 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 204
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 248

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 23/168 (13%)
Query: 403 MDVIGKLK----------HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
           +DV+GK+K          HP+++KL        +  +V +Y+  G L   +  +   GR+
Sbjct: 52  LDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRV 108
Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
                 R+   + +A      H       V H ++K  NVLLD +  A I+DFGLS +++
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHM------VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162
Query: 513 PVQAIARLGG---YKAPEQAEVKRLSQ-KADVYSFGVLLLEVLTGRAP 556
             + +    G   Y APE    +  +  + D++S GV+L  +L G  P
Sbjct: 163 DGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           A+   ++A+P    E E  ++++ KL HP ++K++ ++ A E+  +V + +  G L   +
Sbjct: 48  AIGSAREADPALNVETE--IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV 104
Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-- 501
            GN+      L   T           +  +H+      + H ++K  NVLL      C  
Sbjct: 105 VGNKR-----LKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLI 155
Query: 502 -ISDFGLSLLLNPVQAIARLGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
            I+DFG S +L     +  L G   Y APE          ++  D +S GV+L   L+G 
Sbjct: 156 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 215
Query: 555 AP 556
            P
Sbjct: 216 PP 217

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           A+   ++A+P    E E  ++++ KL HP ++K++ ++ A E+  +V + +  G L   +
Sbjct: 55  AIGSAREADPALNVETE--IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV 111
Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-- 501
            GN+      L   T           +  +H+      + H ++K  NVLL      C  
Sbjct: 112 VGNKR-----LKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLI 162
Query: 502 -ISDFGLSLLLNPVQAIARLGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
            I+DFG S +L     +  L G   Y APE          ++  D +S GV+L   L+G 
Sbjct: 163 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 222
Query: 555 AP 556
            P
Sbjct: 223 PP 224

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF----EQYMDVIGKLKHPNVVKLRA 419
           LG+GS G V  A     G     ++ +    A+ +     E+ +  +  L+HP+++KL  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
              +K+E ++V +Y  N     ++  ++   +    +  +I   + A     R       
Sbjct: 76  VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQI---ISAVEYCHR------- 125
Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS- 535
            K+ H ++K  N+LLD++    I+DFGLS ++     +    G   Y APE    K  + 
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAG 185
Query: 536 QKADVYSFGVLLLEVLTGRAP 556
            + DV+S GV+L  +L  R P
Sbjct: 186 PEVDVWSCGVILYVMLCRRLP 206

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           A+   ++A+P    E E  ++++ KL HP ++K++ ++ A E+  +V + +  G L   +
Sbjct: 49  AIGSAREADPALNVETE--IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV 105
Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-- 501
            GN+      L   T           +  +H+      + H ++K  NVLL      C  
Sbjct: 106 VGNKR-----LKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLI 156
Query: 502 -ISDFGLSLLLNPVQAIARLGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
            I+DFG S +L     +  L G   Y APE          ++  D +S GV+L   L+G 
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 555 AP 556
            P
Sbjct: 217 PP 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           A+   ++A+P    E E  ++++ KL HP ++K++ ++ A E+  +V + +  G L   +
Sbjct: 49  AIGSAREADPALNVETE--IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV 105
Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-- 501
            GN+      L   T           +  +H+      + H ++K  NVLL      C  
Sbjct: 106 VGNKR-----LKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLI 156
Query: 502 -ISDFGLSLLLNPVQAIARLGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
            I+DFG S +L     +  L G   Y APE          ++  D +S GV+L   L+G 
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 555 AP 556
            P
Sbjct: 217 PP 218

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           A+   ++A+P    E E  ++++ KL HP ++K++ ++ A E+  +V + +  G L   +
Sbjct: 49  AIGSAREADPALNVETE--IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV 105
Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-- 501
            GN+      L   T           +  +H+      + H ++K  NVLL      C  
Sbjct: 106 VGNKR-----LKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLI 156
Query: 502 -ISDFGLSLLLNPVQAIARLGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
            I+DFG S +L     +  L G   Y APE          ++  D +S GV+L   L+G 
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 555 AP 556
            P
Sbjct: 217 PP 218

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 92/209 (44%), Gaps = 28/209 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           +G+GS G V++      G   AVK+++          E+ +   G L  P +V L     
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAG-LSSPRIVPLYGAVR 136
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARIHQEYGTAK 481
                 +  + L  GSL  L+   +  G +P D   R    LG A  GL  +H    T +
Sbjct: 137 EGPWVNIFMELLEGGSLGQLI---KQMGCLPED---RALYYLGQALEGLEYLH----TRR 186
Query: 482 VPHGNVKSSNVLLDKNGV-ACISDFGLSLLLNPVQAIARL--GGY-------KAPEQAEV 531
           + HG+VK+ NVLL  +G  A + DFG +L L P      L  G Y        APE    
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 246
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP-SQY 559
           K    K D++S   ++L +L G  P +QY
Sbjct: 247 KPCDAKVDIWSSCCMMLHMLNGCHPWTQY 275

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 364 LGKGSLGTVY----KAVLDDG--GIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           LG+GS G VY    K V+ D     VA+K + +A     R EF     V+ +    +VV+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLA 471
           L       +  L++ + +  G L S L   R      P   P   +  I +    A G+A
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-------YK 524
            ++      K  H ++ + N  + ++    I DFG++  +       R GG       + 
Sbjct: 140 YLN----ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY-RKGGKGLLPVRWM 194
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +PE  +    +  +DV+SFGV+L E+ T
Sbjct: 195 SPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARK-EFEQYMD--VIGKLKHPNV 414
           LG G+ G VY+  +     D   + VAVK L +   C+ + E +  M+  +I K  H N+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNI 102
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+          + ++ + +  G L S L   R     P   +  +  +L  AR +A   
Sbjct: 103 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGC 160
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YK 524
           Q        H ++ + N LL   G   VA I DFG++  +    +  R GG       + 
Sbjct: 161 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWM 219
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 263

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D        VAVK LK    + P A  +F + ++ +  L H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G     L   +R ++ +    G     
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 138
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG-----GYKAPE 527
               + +  H ++ + N+LL    +  I DFGL  +L  N    + +        + APE
Sbjct: 139 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             + +  S  +D + FGV L E+ T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 32/211 (15%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIG--KLKHPNVVKLRAY 420
           +G+GS G V++      G   AVK++       R E  +  +++    L  P +V L   
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARIHQEYGT 479
                   +  + L  GSL  L+   +  G +P D   R    LG A  GL  +H    T
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPED---RALYYLGQALEGLEYLH----T 168
Query: 480 AKVPHGNVKSSNVLLDKNGV-ACISDFGLSLLLNPVQAIARL--GGY-------KAPEQA 529
            ++ HG+VK+ NVLL  +G  A + DFG +L L P      L  G Y        APE  
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP-SQY 559
             K    K D++S   ++L +L G  P +QY
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 81/183 (44%), Gaps = 21/183 (11%)
Query: 383 VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSL 442
            A+   ++A+P    E E  ++++ KL HP ++K++ ++ A E+  +V + +  G L   
Sbjct: 173 FAIGSAREADPALNVETE--IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDK 229
Query: 443 LHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC- 501
           + GN+      L   T           +  +H+      + H ++K  NVLL      C 
Sbjct: 230 VVGNKR-----LKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCL 280
Query: 502 --ISDFGLSLLLNPVQAIARLGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTG 553
             I+DFG S +L     +  L G   Y APE          ++  D +S GV+L   L+G
Sbjct: 281 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
Query: 554 RAP 556
             P
Sbjct: 341 YPP 343

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 83/205 (40%), Gaps = 18/205 (8%)
Query: 363 MLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL----KHPNVVKL 417
           +LGKGS G V  A V + G + AVK LK        + E  M     L     HP + +L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              +   +    V +++  G L   +  +R       D              L  +H + 
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEIISALMFLHDK- 143
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GYKAPEQAEVKR 533
               + + ++K  NVLLD  G   ++DFG+    + N V      G   Y APE  +   
Sbjct: 144 ---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQ 558
                D ++ GVLL E+L G AP +
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 27/210 (12%)
Query: 361 AEMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHP 412
            ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHP 92
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
             VKL   +   E+      Y  NG L   L   R  G    D T            L  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGCL---LKYIRKIGS--FDETCTRFYTAEIVSALEY 147
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAP 526
           +H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +P
Sbjct: 148 LHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 203
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E    K  S+ +D+++ G ++ +++ G  P
Sbjct: 204 ELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D        VAVK LK    + P A  +F + ++ +  L H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G     L   +R ++ +    G     
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 132
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG-----GYKAPE 527
               + +  H ++ + N+LL    +  I DFGL  +L  N    + +        + APE
Sbjct: 133 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             + +  S  +D + FGV L E+ T G+ P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 43/239 (17%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARKE 398
           Y  K +F   +L     + LG G+ G V +A       +D  + VAVK LK       KE
Sbjct: 37  YNEKWEFPRNNL--QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 399 -FEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG------ 450
                + ++  L +H N+V L          L++ +Y   G L + L   R PG      
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYN 154
Query: 451 -----------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV 499
                      R  L +++++      A+G+A +     +    H +V + NVLL    V
Sbjct: 155 PSHNPEEQLSSRDLLHFSSQV------AQGMAFL----ASKNCIHRDVAARNVLLTNGHV 204
Query: 500 ACISDFGLSL-LLNP----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           A I DFGL+  ++N     V+  ARL   + APE       + ++DV+S+G+LL E+ +
Sbjct: 205 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 21/182 (11%)
Query: 384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           A+   ++A+P    E E  ++++ KL HP ++K++ ++ A E+  +V + +  G L   +
Sbjct: 188 AIGSAREADPALNVETE--IEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKV 244
Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-- 501
            GN+      L   T           +  +H+      + H ++K  NVLL      C  
Sbjct: 245 VGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLI 295
Query: 502 -ISDFGLSLLLNPVQAIARLGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
            I+DFG S +L     +  L G   Y APE          ++  D +S GV+L   L+G 
Sbjct: 296 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 355
Query: 555 AP 556
            P
Sbjct: 356 PP 357

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D        VAVK LK    + P A  +F + ++ +  L H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G     L   +R ++ +    G     
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 128
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG-----GYKAPE 527
               + +  H ++ + N+LL    +  I DFGL  +L  N    + +        + APE
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             + +  S  +D + FGV L E+ T G+ P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D        VAVK LK    + P A  +F + ++ +  L H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G     L   +R ++ +    G     
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 138
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG-----GYKAPE 527
               + +  H ++ + N+LL    +  I DFGL  +L  N    + +        + APE
Sbjct: 139 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             + +  S  +D + FGV L E+ T G+ P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 27/205 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG+GS G V++      G   AVK+++          E+ M   G L  P +V L     
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAG-LTSPRIVPLYGAVR 155
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARIHQEYGTAK 481
                 +  + L  GSL  L+   +  G +P D   R    LG A  GL  +H    + +
Sbjct: 156 EGPWVNIFMELLEGGSLGQLV---KEQGCLPED---RALYYLGQALEGLEYLH----SRR 205
Query: 482 VPHGNVKSSNVLLDKNGV-ACISDFGLSLLLNP---------VQAIARLGGYKAPEQAEV 531
           + HG+VK+ NVLL  +G  A + DFG ++ L P            I     + APE    
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
           +    K DV+S   ++L +L G  P
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D        VAVK LK    + P A  +F + ++ +  L H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G     L   +R ++ +    G     
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 128
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG-----GYKAPE 527
               + +  H ++ + N+LL    +  I DFGL  +L  N    + +        + APE
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             + +  S  +D + FGV L E+ T G+ P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 16  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 72
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L   L   R        +T   +   GA     L  
Sbjct: 73  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEY 125
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL    ++    +    G   Y APE 
Sbjct: 126 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV 181
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 352 ELEDLLRASAEMLGKGSLGTVYKAV----LDDGGIVAVKRLK------DANPCARKEFEQ 401
           E  +LLR    +LGKG  G V++       + G I A+K LK      +A   A  + E+
Sbjct: 17  ECFELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD----WT 457
             +++ ++KHP +V L   +    +  L+ +YL  G L   L      G    D    + 
Sbjct: 73  --NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYL 127
Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL---SLLLNPV 514
             IS+ LG       +HQ+     + + ++K  N++L+  G   ++DFGL   S+    V
Sbjct: 128 AEISMALG------HLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                    Y APE       ++  D +S G L+ ++LTG  P
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 22/205 (10%)
Query: 362 EMLGKGSLGTV-----YKAVLDDG-GIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           E LG+GS G V     YK         ++ + LK ++   R E E  +  +  L+HP+++
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE--ISYLKLLRHPHII 72
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           KL        + ++V +Y   G L   +   +   R+  D   R    +  A      H 
Sbjct: 73  KLYDVITTPTDIVMVIEY-AGGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRH- 127
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVK 532
                K+ H ++K  N+LLD N    I+DFGLS ++     +    G   Y APE    K
Sbjct: 128 -----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGK 182
Query: 533 RLS-QKADVYSFGVLLLEVLTGRAP 556
             +  + DV+S G++L  +L GR P
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 27/205 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           LG+GS G V++      G   AVK+++          E+ M   G L  P +V L     
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR----LEVFRAEELMACAG-LTSPRIVPLYGAVR 136
Query: 423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARIHQEYGTAK 481
                 +  + L  GSL  L+   +  G +P D   R    LG A  GL  +H    + +
Sbjct: 137 EGPWVNIFMELLEGGSLGQLV---KEQGCLPED---RALYYLGQALEGLEYLH----SRR 186
Query: 482 VPHGNVKSSNVLLDKNGV-ACISDFGLSLLLNP---------VQAIARLGGYKAPEQAEV 531
           + HG+VK+ NVLL  +G  A + DFG ++ L P            I     + APE    
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLG 246
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
           +    K DV+S   ++L +L G  P
Sbjct: 247 RSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK 408
           K++ + D  + S ++LG G  G V +      G     +L   +P AR+E + +    G 
Sbjct: 3   KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG 62
Query: 409 LKHPNVVKLRAYY----YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
              P++V +   Y    + K   L++ + +  G L S +   RG           I   +
Sbjct: 63  ---PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDI 118
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLS--LLLNPVQAIAR 519
           G A      H       + H +VK  N+L    +K+ V  ++DFG +     N +Q    
Sbjct: 119 GTAIQFLHSH------NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 172
Query: 520 LGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              Y APE    ++  +  D++S GV++  +L G  P
Sbjct: 173 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L   L   R        +T   +   GA     L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEY 120
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL    ++    +    G   Y APE 
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV 176
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 362 EMLGKGSLGTVYKAVLD--DGGIV--AVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D   G  V  AVK LK    + P A  +F + ++ +  L H N+
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G     L   +R ++ +    G     
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 132
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG-----GYKAPE 527
               + +  H ++ + N+LL    +  I DFGL  +L  N    + +        + APE
Sbjct: 133 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             + +  S  +D + FGV L E+ T G+ P
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 15  KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 71
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+  +   R     GA     L  
Sbjct: 72  TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARF---YGAEIVSALDY 124
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H E     V + ++K  N++LDK+G   I+DFGL    +     +    G   Y APE 
Sbjct: 125 LHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 181
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 128/319 (40%), Gaps = 56/319 (17%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLK-DANPCARK 397
           Y+ K +F    L  +  + LG G+ G V +A        D    VAVK LK  A+   R+
Sbjct: 14  YDHKWEFPRNRL--SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71
Query: 398 EFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--------G 448
                + V+  L  H N+V L          L++ +Y   G L + L   R         
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 449 PGRIPLDWTTRI-----SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
           P  +  D          S     A+G+A +     +    H ++ + N+LL    +  I 
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKIC 187
Query: 504 DFGLSLLLNP-----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
           DFGL+  +       V+  ARL   + APE       + ++DV+S+G+ L E+ +  +  
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 246
Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLAC 617
             P P  P VD +   + + +  R +  E   AE++D                  +   C
Sbjct: 247 --PYPGMP-VDSKFYKM-IKEGFRMLSPEHAPAEMYD------------------IMKTC 284
Query: 618 VVSQPEKRPTMAEVAKMIE 636
             + P KRPT  ++ ++IE
Sbjct: 285 WDADPLKRPTFKQIVQLIE 303

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 16  KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 72
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+   ++   +   GA     L  
Sbjct: 73  TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RV---FSEDRARFYGAEIVSALDY 125
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H E     V + ++K  N++LDK+G   I+DFGL    +     +    G   Y APE 
Sbjct: 126 LHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 182
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 24/210 (11%)
Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D        VAVK LK    + P A  +F + ++ +  L H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G     L   +R ++ +    G     
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLE-- 128
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG-----GYKAPE 527
               + +  H ++ + N+LL    +  I DFGL  +L  N    + +        + APE
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAP 556
             + +  S  +D + FGV L E+ T G+ P
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 352 ELEDLLRASAEMLGKGSLGTVYKAV----LDDGGIVAVKRLK------DANPCARKEFEQ 401
           E  +LLR    +LGKG  G V++       + G I A+K LK      +A   A  + E+
Sbjct: 17  ECFELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 402 YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD----WT 457
             +++ ++KHP +V L   +    +  L+ +YL  G L   L      G    D    + 
Sbjct: 73  --NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE---GIFMEDTACFYL 127
Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL---SLLLNPV 514
             IS+ LG       +HQ+     + + ++K  N++L+  G   ++DFGL   S+    V
Sbjct: 128 AEISMALG------HLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                    Y APE       ++  D +S G L+ ++LTG  P
Sbjct: 178 THXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNVVKL 417
           +G G+ GTVYKA     G  VA+K ++  N     P +       +  +   +HPNVV+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 418 RAYYYA----KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
                     +E K+ LV++++ +  L + L     PG   L   T   L+    RGL  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG---LPAETIKDLMRQFLRGLDF 127
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG---GYKAPEQA 529
           +H       + H ++K  N+L+   G   ++DFGL+ + +   A+A +     Y+APE  
Sbjct: 128 LHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 530 EVKRLSQKADVYSFGVLLLEVL 551
                +   D++S G +  E+ 
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMF 205

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 14  KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 70
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+  +   R     GA     L  
Sbjct: 71  TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARF---YGAEIVSALDY 123
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H E     V + ++K  N++LDK+G   I+DFGL    +     +    G   Y APE 
Sbjct: 124 LHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 180
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 364 LGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARKEFEQYMD--VIGKLKHPNVV 415
           LG G+ G VY+  +     D   + VAVK L +     + E +  M+  +I K  H N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVY-SEQDELDFLMEALIISKFNHQNIV 111
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +          + ++ + +  G L S L   R     P   +  +  +L  AR +A   Q
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS--SLAMLDLLHVARDIACGCQ 169
Query: 476 EYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGG-------YKA 525
                   H ++ + N LL   G   VA I DFG++  +    +  R GG       +  
Sbjct: 170 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SYYRKGGCAMLPVKWMP 228
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
           PE       + K D +SFGVLL E+ + G  P  YPS +   V E
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLE 271

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 19/217 (8%)
Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK 408
           K++ + D  + S ++LG G  G V +      G     +L   +P AR+E + +    G 
Sbjct: 22  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGG 81
Query: 409 LKHPNVVKLRAYY----YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
              P++V +   Y    + K   L++ + +  G L S +   RG           I   +
Sbjct: 82  ---PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDI 137
Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLS--LLLNPVQAIAR 519
           G A      H       + H +VK  N+L    +K+ V  ++DFG +     N +Q    
Sbjct: 138 GTAIQFLHSH------NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY 191
Query: 520 LGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              Y APE    ++  +  D++S GV++  +L G  P
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 18/204 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGGIV-AVKRLKDANPCARKEFEQYMD----VIGKLKHPNVVK 416
           +++GKGS G V  A      +  AVK L+      +KE +  M     ++  +KHP +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L   +   ++   V DY+  G L    H  R   R  L+   R       A  L  +H  
Sbjct: 104 LHFSFQTADKLYFVLDYINGGEL--FYHLQRE--RCFLEPRARF-YAAEIASALGYLH-- 156
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGL---SLLLNPVQA-IARLGGYKAPEQAEVK 532
             +  + + ++K  N+LLD  G   ++DFGL   ++  N   +       Y APE    +
Sbjct: 157 --SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
              +  D +  G +L E+L G  P
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 44/234 (18%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLKHPNVV 415
           L  S ++LG GS GTV       G  VAVKR L D    A  E +   +      HPNV+
Sbjct: 16  LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVI 72
Query: 416 KLRAYYYAKEEKLLVYDYLP--NGSLHSLLHG-NRGPGRIPLDWTTR-ISLVLGAARGLA 471
           +   YY ++     +Y  L   N +L  L+   N     + L      ISL+   A G+A
Sbjct: 73  R---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLD-------------KNGVACISDFGLSLLLNPVQAIA 518
            +H    + K+ H ++K  N+L+              +N    ISDFGL   L+  Q   
Sbjct: 130 HLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 519 RLG--------GYKAPEQAE-------VKRLSQKADVYSFGVLLLEVLT-GRAP 556
           R          G++APE  E        +RL++  D++S G +   +L+ G+ P
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L   L   R        +T   +   GA     L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEY 120
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL    ++    +    G   Y APE 
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L   L   R        +T   +   GA     L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEY 120
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL    ++    +    G   Y APE 
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV 176
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 128/319 (40%), Gaps = 56/319 (17%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLK-DANPCARK 397
           Y+ K +F    L  +  + LG G+ G V +A        D    VAVK LK  A+   R+
Sbjct: 37  YDHKWEFPRNRL--SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 94
Query: 398 EFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--------G 448
                + V+  L  H N+V L          L++ +Y   G L + L   R         
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 449 PGRIPLDWTTRI-----SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
           P  +  D          S     A+G+A +     +    H ++ + N+LL    +  I 
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKIC 210
Query: 504 DFGLSLLLNP-----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
           DFGL+  +       V+  ARL   + APE       + ++DV+S+G+ L E+ +  +  
Sbjct: 211 DFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 269
Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLAC 617
             P P  P VD +   + + +  R +  E   AE++D                  +   C
Sbjct: 270 --PYPGMP-VDSKFYKM-IKEGFRMLSPEHAPAEMYD------------------IMKTC 307
Query: 618 VVSQPEKRPTMAEVAKMIE 636
             + P KRPT  ++ ++IE
Sbjct: 308 WDADPLKRPTFKQIVQLIE 326

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 357 LRASAEMLGKGSLGTVYKAVLDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLKHPNVV 415
           L  S ++LG GS GTV       G  VAVKR L D    A  E +   +      HPNV+
Sbjct: 16  LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVI 72
Query: 416 KLRAYYYAKEEKLLVYDYLP--NGSLHSLLHG-NRGPGRIPLDWTTR-ISLVLGAARGLA 471
           +   YY ++     +Y  L   N +L  L+   N     + L      ISL+   A G+A
Sbjct: 73  R---YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 472 RIHQEYGTAKVPHGNVKSSNVLLD-------------KNGVACISDFGLSLLLNPVQAIA 518
            +H    + K+ H ++K  N+L+              +N    ISDFGL   L+  Q+  
Sbjct: 130 HLH----SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 519 RLG--------GYKAPEQAE-------VKRLSQKADVYSFGVLLLEVLT-GRAP 556
           R          G++APE  E        +RL++  D++S G +   +L+ G+ P
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 157 KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 213
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+  +   R     GA     L  
Sbjct: 214 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARF---YGAEIVSALDY 266
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H E     V + ++K  N++LDK+G   I+DFGL    +     +    G   Y APE 
Sbjct: 267 LHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 323
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 14  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 70
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L   L   R        +T   +   GA     L  
Sbjct: 71  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEY 123
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL    ++    +    G   Y APE 
Sbjct: 124 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 179
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K LK     A+ E    +    V+   +HP +
Sbjct: 154 KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L    H +R   R+  +   R     GA     L  
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARF---YGAEIVSALDY 263
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H E     V + ++K  N++LDK+G   I+DFGL    +     +    G   Y APE 
Sbjct: 264 LHSE---KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L   L   R        +T   +   GA     L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEY 120
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL    ++    +    G   Y APE 
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV 176
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 29/213 (13%)
Query: 362 EMLGKGSLGTVYK----AVLDDGGIVAVKRLKDANPCARKEFEQYM----DVIGKLKH-P 412
           ++LG G+ G V+     +  D G + A+K LK A    + +  ++      V+  ++  P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 413 NVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGL 470
            +V L  Y +  E KL L+ DY+  G L + L    R        +   I L L     L
Sbjct: 120 FLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGG---YKA 525
             I++          ++K  N+LLD NG   ++DFGLS   + +  +      G   Y A
Sbjct: 179 GIIYR----------DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 526 PE--QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           P+  +       +  D +S GVL+ E+LTG +P
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 128/319 (40%), Gaps = 56/319 (17%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLK-DANPCARK 397
           Y+ K +F    L  +  + LG G+ G V +A        D    VAVK LK  A+   R+
Sbjct: 30  YDHKWEFPRNRL--SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 87
Query: 398 EFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--------G 448
                + V+  L  H N+V L          L++ +Y   G L + L   R         
Sbjct: 88  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 147
Query: 449 PGRIPLDWTTRI-----SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
           P  +  D          S     A+G+A +     +    H ++ + N+LL    +  I 
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKIC 203
Query: 504 DFGLSLLLNP-----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
           DFGL+  +       V+  ARL   + APE       + ++DV+S+G+ L E+ +  +  
Sbjct: 204 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 262
Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLAC 617
             P P  P VD +   + + +  R +  E   AE++D                  +   C
Sbjct: 263 --PYPGMP-VDSKFYKM-IKEGFRMLSPEHAPAEMYD------------------IMKTC 300
Query: 618 VVSQPEKRPTMAEVAKMIE 636
             + P KRPT  ++ ++IE
Sbjct: 301 WDADPLKRPTFKQIVQLIE 319

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 27/208 (12%)
Query: 362 EMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNV 414
           ++LGKG+ G V     KA    G   A+K L+     A+ E    +    V+   +HP +
Sbjct: 11  KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA--ARGLAR 472
             L+  +   +    V +Y   G L   L   R        +T   +   GA     L  
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSALEY 120
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKAPEQ 528
           +H    +  V + ++K  N++LDK+G   I+DFGL    ++    +    G   Y APE 
Sbjct: 121 LH----SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            E     +  D +  GV++ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 128/319 (40%), Gaps = 56/319 (17%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLK-DANPCARK 397
           Y+ K +F    L  +  + LG G+ G V +A        D    VAVK LK  A+   R+
Sbjct: 37  YDHKWEFPRNRL--SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 94
Query: 398 EFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--------G 448
                + V+  L  H N+V L          L++ +Y   G L + L   R         
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 449 PGRIPLDWTTRI-----SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
           P  +  D          S     A+G+A +     +    H ++ + N+LL    +  I 
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKIC 210
Query: 504 DFGLSLLLNP-----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
           DFGL+  +       V+  ARL   + APE       + ++DV+S+G+ L E+ +  +  
Sbjct: 211 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 269
Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLAC 617
             P P  P VD +   + + +  R +  E   AE++D                  +   C
Sbjct: 270 --PYPGMP-VDSKFYKM-IKEGFRMLSPEHAPAEMYD------------------IMKTC 307
Query: 618 VVSQPEKRPTMAEVAKMIE 636
             + P KRPT  ++ ++IE
Sbjct: 308 WDADPLKRPTFKQIVQLIE 326

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 91
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 146
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 147 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 77/319 (24%), Positives = 128/319 (40%), Gaps = 56/319 (17%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLK-DANPCARK 397
           Y+ K +F    L  +  + LG G+ G V +A        D    VAVK LK  A+   R+
Sbjct: 32  YDHKWEFPRNRL--SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 89
Query: 398 EFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR--------G 448
                + V+  L  H N+V L          L++ +Y   G L + L   R         
Sbjct: 90  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 149
Query: 449 PGRIPLDWTTRI-----SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
           P  +  D          S     A+G+A +     +    H ++ + N+LL    +  I 
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRITKIC 205
Query: 504 DFGLSLLLNP-----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
           DFGL+  +       V+  ARL   + APE       + ++DV+S+G+ L E+ +  +  
Sbjct: 206 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 264
Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLAC 617
             P P  P VD +   + + +  R +  E   AE++D                  +   C
Sbjct: 265 --PYPGMP-VDSKFYKM-IKEGFRMLSPEHAPAEMYD------------------IMKTC 302
Query: 618 VVSQPEKRPTMAEVAKMIE 636
             + P KRPT  ++ ++IE
Sbjct: 303 WDADPLKRPTFKQIVQLIE 321

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        KE E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+++D+ G   ++DFGL+  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 71
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 126
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 127 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 183 LLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        KE E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+++D+ G   ++DFGL+  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGIVA-VKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY 422
           L +   G ++K       IV  V +++D +    ++F +    +    HPNV+ +     
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 423 A--KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +       L+  + P GSL+++LH         +D +  +   L  ARG A +H      
Sbjct: 78  SPPAPHPTLITHWXPYGSLYNVLHEGTN---FVVDQSQAVKFALDXARGXAFLHTL--EP 132
Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSL-LLNPVQAIARLGGYKAPEQAEVKRLS---Q 536
            +P   + S +V +D++  A IS   +     +P +  A    + APE  + K      +
Sbjct: 133 LIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYA--PAWVAPEALQKKPEDTNRR 190
Query: 537 KADVYSFGVLLLEVLTGRAP 556
            AD +SF VLL E++T   P
Sbjct: 191 SADXWSFAVLLWELVTREVP 210

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 70
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 125
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 126 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 182 LLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 68
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIG--SFDETCTRFYTAEIVSALEYL 123
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 124 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 180 LLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 28/205 (13%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNVVKL 417
           +G G+ GTVYKA     G  VA+K ++  N     P +       +  +   +HPNVV+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 418 RAYYYA----KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
                     +E K+ LV++++ +  L + L     PG   L   T   L+    RGL  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG---LPAETIKDLMRQFLRGLDF 127
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS------LLLNPVQAIARLGGYKAP 526
           +H       + H ++K  N+L+   G   ++DFGL+      + L+PV        Y+AP
Sbjct: 128 LHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTL---WYRAP 180
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVL 551
           E       +   D++S G +  E+ 
Sbjct: 181 EVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 69
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIG--SFDETCTRFYTAEIVSALEYL 124
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 125 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 94
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 149
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 150 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 91
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 146
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 147 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 27/210 (12%)
Query: 361 AEMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHP 412
            ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP
Sbjct: 37  GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHP 92
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
             VKL   +   E+      Y  NG L   L   R  G    D T            L  
Sbjct: 93  FFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEY 147
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAP 526
           +H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +P
Sbjct: 148 LHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 203
Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           E    K   + +D+++ G ++ +++ G  P
Sbjct: 204 ELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 93
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 148
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 149 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 94
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 149
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 150 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 93
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 148
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 149 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 75
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIG--SFDETCTRFYTAEIVSALEYL 130
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 131 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 34/209 (16%)
Query: 364 LGKGSLGTVYKAVLD-DGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G V  AV    G  VA+K+L     +   A++ + + + ++  ++H NV+ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMRHENVIGLLD 91
Query: 420 YYYAKE------EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +   E      +  LV  ++       + H   G  RI         LV    +GL  I
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF-------LVYQMLKGLRYI 144
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPE 527
           H     A + H ++K  N+ ++++    I DFGL+      QA + + G      Y+APE
Sbjct: 145 H----AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPE 195
Query: 528 QA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
                 R +Q  D++S G ++ E++TG+ 
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 92/229 (40%), Gaps = 25/229 (10%)
Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           E LGKG+   V + V    G      I+  K+L   +    ++ E+   +   LKHPN+V
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD---HQKLEREARICRLLKHPNIV 73
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L      +    L++D +  G L   +           D +  I  +L A   +   HQ
Sbjct: 74  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA--DASHCIQQILEA---VLHCHQ 128
Query: 476 EYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQ 528
                 V H N+K  N+LL    K     ++DFGL++ +   Q      A   GY +PE 
Sbjct: 129 ----MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEV 184
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
                  +  D+++ GV+L  +L G  P       R     +  A D P
Sbjct: 185 LRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 91
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 146
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 147 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 98
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 153
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 154 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 26/231 (11%)
Query: 363 MLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           +LGKGS G V     K    +  +  + + +      ++   + + ++ +L HPN+ KL 
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            ++  K    LV +    G L   +   +    +  D    I  VL    G+   H+   
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV--DAARIIRQVLS---GITYXHKN-- 145
Query: 479 TAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVK 532
             K+ H ++K  N+LL+   K+    I DFGLS      +      G   Y APE     
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLH-G 202
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP----SQYPSPTRPRVDEEEQAVDLPKW 579
              +K DV+S GV+L  +L+G  P    ++Y      +V++ +   +LP+W
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKYTFELPQW 251

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 151
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 152 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGY 201
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 202 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 231

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 93
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 148
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 149 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 205 LLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 90
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIG--SFDETCTRFYTAEIVSALEYL 145
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 146 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 93
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 148
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 149 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 96
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYTAEIVSALEYL 151
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 152 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLKDAN-------PCARKEFEQYMDVIGKLKHPN 413
           ++LG+GS  TV  A  L      A+K L+  +       P   +E     DV+ +L HP 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE----RDVMSRLDHPF 90
Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            VKL   +   E+      Y  NG L   L   R  G    D T            L  +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIG--SFDETCTRFYTAEIVSALEYL 145
Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR------LGGYKAPE 527
           H +     + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE
Sbjct: 146 HGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               K   + +D+++ G ++ +++ G  P
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEV 531
            + K  H ++ + N+LL +  V  I DFGL+  +       R G       + APE    
Sbjct: 217 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 276
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        + R +        
Sbjct: 277 RVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FCRRL-------- 316
Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
              +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 317 ---KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEV 531
            + K  H ++ + N+LL +  V  I DFGL+  +       R G       + APE    
Sbjct: 215 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 274
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        + R +        
Sbjct: 275 RVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FCRRL-------- 314
Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
              +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 315 ---KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           DV+ +L HP  VKL   +   E+      Y  NG L   L   R  G    D T      
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---LKYIRKIGS--FDETCTRFYT 136
Query: 464 LGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR---- 519
                 L  +H +     + H ++K  N+LL+++    I+DFG + +L+P    AR    
Sbjct: 137 AEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 520 --LGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                Y +PE    K   + +D+++ G ++ +++ G  P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEV 531
            + K  H ++ + N+LL +  V  I DFGL+  +       R G       + APE    
Sbjct: 208 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 267
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        + R +        
Sbjct: 268 RVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FCRRL-------- 307
Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
              +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 308 ---KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 29/167 (17%)
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQAEV 531
            + K  H ++ + N+LL +  V  I DFGL+  +       R G       + APE    
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           +  + ++DV+SFGVLL E+ +  A S YP     ++DEE        + R +        
Sbjct: 270 RVYTIQSDVWSFGVLLWEIFSLGA-SPYPG---VKIDEE--------FCRRL-------- 309
Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
              +E  R +  +     M    L C   +P +RPT +E+ + + ++
Sbjct: 310 ---KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 15/151 (9%)
Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARG 469
           HP +V L + +  +     V +Y+  G L   +   R  P      ++  ISL L     
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 139
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKA 525
              I++          ++K  NVLLD  G   ++D+G+    L P    +   G   Y A
Sbjct: 140 RGIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 189
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    +      D ++ GVL+ E++ GR+P
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           +G GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           +G GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 19/227 (8%)
Query: 342 LVFYERKKQFELE-DLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKE 398
           L F    + FE++ D L    E LG+G+ G V K   +  G I AVKR++   N   +K 
Sbjct: 20  LYFQGAXENFEVKADDLEPIXE-LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKR 78
Query: 399 FEQYMDVIGK-LKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGR-IPLDW 456
               +D+  + +  P  V      + +E  + +   L + SL          G+ IP D 
Sbjct: 79  LLXDLDISXRTVDCPFTVTFYGALF-REGDVWICXELXDTSLDKFYKQVIDKGQTIPEDI 137
Query: 457 TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQ 515
             +I++ +   + L  +H +     V H +VK SNVL++  G     DFG+S  L++ V 
Sbjct: 138 LGKIAVSI--VKALEHLHSKLS---VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA 192
Query: 516 AIARLGG--YKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                G   Y APE    +   K  S K+D++S G+  +E+   R P
Sbjct: 193 KDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFP 239

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 104/240 (43%), Gaps = 38/240 (15%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARKE 398
           Y  K +F   +L     + LG G+ G V +A       +D  + VAVK LK       KE
Sbjct: 22  YNEKWEFPRNNL--QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 79
Query: 399 -FEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSL--------HSLLHGNRG 448
                + ++  L +H N+V L          L++ +Y   G L         ++L  +  
Sbjct: 80  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLA 139
Query: 449 PGRIP----------LDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG 498
           PG+ P          L+    +      A+G+A +     +    H +V + NVLL    
Sbjct: 140 PGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGH 195
Query: 499 VACISDFGLSL-LLNP----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           VA I DFGL+  ++N     V+  ARL   + APE       + ++DV+S+G+LL E+ +
Sbjct: 196 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 15/151 (9%)
Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARG 469
           HP +V L + +  +     V +Y+  G L   +   R  P      ++  ISL L     
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKA 525
              I++          ++K  NVLLD  G   ++D+G+    L P    +   G   Y A
Sbjct: 172 RGIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    +      D ++ GVL+ E++ GR+P
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/155 (24%), Positives = 63/155 (40%), Gaps = 16/155 (10%)
Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
           HPN+VKL   ++ +    LV + L  G L   +   +        +  R          +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-----KLVSAV 119
Query: 471 ARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLL----NPVQAIARLGGY 523
           + +H       V H ++K  N+L    + N    I DFG + L      P++       Y
Sbjct: 120 SHMHD----VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            APE        +  D++S GV+L  +L+G+ P Q
Sbjct: 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 31/208 (14%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDAN--------PCARKEFEQYMDVIGKLKHPNV 414
           +G G+ GTVYKA     G  VA+K ++  N        P +       +  +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 415 VKLRAYYYA----KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           V+L          +E K+ LV++++ +  L + L     PG   L   T   L+    RG
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG---LPAETIKDLMRQFLRG 132
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS------LLLNPVQAIARLGGY 523
           L  +H       + H ++K  N+L+   G   ++DFGL+      + L PV        Y
Sbjct: 133 LDFLHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL---WY 185
Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVL 551
           +APE       +   D++S G +  E+ 
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 91/202 (45%), Gaps = 22/202 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLKHPNVVKL 417
           +G G+ GTVYKA     G  VA+K ++  N     P +       +  +   +HPNVV+L
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 418 RAYYYA----KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
                     +E K+ LV++++ +  L + L     PG   L   T   L+    RGL  
Sbjct: 72  MDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPG---LPAETIKDLMRQFLRGLDF 127
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG---GYKAPEQA 529
           +H       + H ++K  N+L+   G   ++DFGL+ + +   A+  +     Y+APE  
Sbjct: 128 LHANC----IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 530 EVKRLSQKADVYSFGVLLLEVL 551
                +   D++S G +  E+ 
Sbjct: 184 LQSTYATPVDMWSVGCIFAEMF 205

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/168 (23%), Positives = 70/168 (41%), Gaps = 14/168 (8%)
Query: 398 EFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL-----HSLLHGNRGPGRI 452
           +F+  + +I  +K+   +         +E  ++Y+Y+ N S+     +  +        I
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
           P+       ++       + IH E     + H +VK SN+L+DKNG   +SDFG S  + 
Sbjct: 149 PIQVIK--CIIKSVLNSFSYIHNE---KNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 513 PVQAIARLGGYKA--PE--QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             +     G Y+   PE    E      K D++S G+ L  +     P
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 15/151 (9%)
Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARG 469
           HP +V L + +  +     V +Y+  G L   +   R  P      ++  ISL L     
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKA 525
              I++          ++K  NVLLD  G   ++D+G+    L P    +   G   Y A
Sbjct: 129 RGIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 178
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    +      D ++ GVL+ E++ GR+P
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 64/151 (42%), Gaps = 15/151 (9%)
Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARG 469
           HP +V L + +  +     V +Y+  G L   +   R  P      ++  ISL L     
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL-LNPVQAIARLGG---YKA 525
              I++          ++K  NVLLD  G   ++D+G+    L P    +   G   Y A
Sbjct: 125 RGIIYR----------DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIA 174
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    +      D ++ GVL+ E++ GR+P
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 205

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           +G GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 25/208 (12%)
Query: 362 EMLGKGSLGTVYKAVLDD------GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           E LGKG+   V + V           I+  K+L   +    ++ E+   +   LKHPN+V
Sbjct: 37  EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARD---HQKLEREARICRLLKHPNIV 93
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L      +    LV+D +  G L   +           D +  I  +L     +  IHQ
Sbjct: 94  RLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA--DASHCIHQIL---ESVNHIHQ 148
Query: 476 EYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQ 528
                 + H ++K  N+LL    K     ++DFGL++ +   Q      A   GY +PE 
Sbjct: 149 H----DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                  +  D+++ GV+L  +L G  P
Sbjct: 205 LRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 34/230 (14%)
Query: 347 RKKQFELEDLLRASAEM---------LGKGSLGTVYKAVLDDGG-IVAVKRLK---DANP 393
           RKK F  +D+ + + E+         +G G+ G+V  A+    G  VA+K+L     +  
Sbjct: 24  RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 83
Query: 394 CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD-YLPNGSLHSLLHGNRGPGRI 452
            A++ + + + ++  ++H NV+ L   +         YD YL    + + L    G   +
Sbjct: 84  FAKRAYRELL-LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---M 139
Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
                    LV    +GL  IH    +A V H ++K  N+ ++++    I DFGL+    
Sbjct: 140 EFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--- 192
Query: 513 PVQAIARLGGY------KAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
              A A + GY      +APE        +Q  D++S G ++ E+LTG+ 
Sbjct: 193 --HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 240

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 34/230 (14%)
Query: 347 RKKQFELEDLLRASAEM---------LGKGSLGTVYKAVLDDGG-IVAVKRLK---DANP 393
           RKK F  +D+ + + E+         +G G+ G+V  A+    G  VA+K+L     +  
Sbjct: 6   RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI 65
Query: 394 CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD-YLPNGSLHSLLHGNRGPGRI 452
            A++ + + + ++  ++H NV+ L   +         YD YL    + + L    G   +
Sbjct: 66  FAKRAYRELL-LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---L 121
Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
                    LV    +GL  IH    +A V H ++K  N+ ++++    I DFGL+    
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--- 174
Query: 513 PVQAIARLGGY------KAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
              A A + GY      +APE        +Q  D++S G ++ E+LTG+ 
Sbjct: 175 --HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 98/229 (42%), Gaps = 25/229 (10%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARKE 398
           Y  K +F   +L     + LG G+ G V +A       +D  + VAVK LK       KE
Sbjct: 37  YNEKWEFPRNNL--QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 399 -FEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDW 456
                + ++  L +H N+V L          L++ +Y   G L + L   R    +  D 
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLR--RKSRVLETDP 152
Query: 457 TTRISLVLGAARGLARIHQE-------YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL 509
              I+    + R L     +         +    H +V + NVLL    VA I DFGL+ 
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 510 -LLNP----VQAIARL-GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            ++N     V+  ARL   + APE       + ++DV+S+G+LL E+ +
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 76/169 (44%), Gaps = 27/169 (15%)
Query: 401 QYMDVIGKLKHPNVVKLRAYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTT 458
           Q + ++ KL HPNVVKL        E  L  V++ +  G +  +      P   PL    
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPLSEDQ 138
Query: 459 RISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--------LL 510
                    +G+  +H +    K+ H ++K SN+L+ ++G   I+DFG+S        LL
Sbjct: 139 ARFYFQDLIKGIEYLHYQ----KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL 194
Query: 511 LNPVQAIARLGGYKAPEQAEVKR--LSQKA-DVYSFGVLLLEVLTGRAP 556
            N V   A    + APE     R   S KA DV++ GV L   + G+ P
Sbjct: 195 SNTVGTPA----FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 19/226 (8%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGKLKHPNVVKLR 418
           E LGKG+   V + V +  G   A K +      AR  ++ E+   +   LKHPN+V+L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    L++D +  G L   +           D +  I  +L A   +   HQ   
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA--DASHCIQQILEA---VLHCHQ--- 139
Query: 479 TAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAEV 531
              V H ++K  N+LL    K     ++DFGL++ +   Q      A   GY +PE    
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
               +  D+++ GV+L  +L G  P       R     +  A D P
Sbjct: 199 DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 244

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+++D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 159 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 382 IVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS 438
           IVA+K   +   ++P  R   ++     G+L+ P+VV +  +    + +L V   L NG 
Sbjct: 61  IVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFG-EIDGQLYVDXRLINGV 119
Query: 439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG 498
             +     +GP   P          +   R +         A   H +VK  N+L+  + 
Sbjct: 120 DLAAXLRRQGPLAPPR--------AVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD 171
Query: 499 VACISDFGLSLLLNPVQAIARLGG------YKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            A + DFG++      + + +LG       Y APE+      + +AD+Y+   +L E LT
Sbjct: 172 FAYLVDFGIASATTD-EKLTQLGNTVGTLYYXAPERFSESHATYRADIYALTCVLYECLT 230
Query: 553 GRAPSQ 558
           G  P Q
Sbjct: 231 GSPPYQ 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 187 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 236
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+P G + S L   R  GR        +  +I L       L  I++
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 158
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 159 D----------LKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 208
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 209 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 238

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 108
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +  +L    L+ LL          L        +    RGL  IH 
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 161
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 162 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+++D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 39/218 (17%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKR-------------LKDANPCARKEFEQYMDVIGKL 409
            +  GS G V   V  +G  VA+KR             L D+  C R   E  + ++   
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE--IRLLNHF 86
Query: 410 KHPNVVKLRAYYYAKEE----KLLVYDYLPNGSLHSLLHGNR---GPGRIPLDWTTRISL 462
            HPN++ LR  +   EE    KL +   L    L  ++H  R    P  I   +   I L
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-FMYHILL 145
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL----SLLLNPVQAIA 518
                 GL  +H+    A V H ++   N+LL  N    I DF L    +   N    + 
Sbjct: 146 ------GLHVLHE----AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 519 RLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
               Y+APE   + K  ++  D++S G ++ E+   +A
Sbjct: 196 H-RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+++D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 D----------LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 88/218 (40%), Gaps = 39/218 (17%)
Query: 363 MLGKGSLGTVYKAVLDDGGIVAVKR-------------LKDANPCARKEFEQYMDVIGKL 409
            +  GS G V   V  +G  VA+KR             L D+  C R   E  + ++   
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE--IRLLNHF 86
Query: 410 KHPNVVKLRAYYYAKEE----KLLVYDYLPNGSLHSLLHGNR---GPGRIPLDWTTRISL 462
            HPN++ LR  +   EE    KL +   L    L  ++H  R    P  I   +   I L
Sbjct: 87  HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQY-FMYHILL 145
Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL----SLLLNPVQAIA 518
                 GL  +H+    A V H ++   N+LL  N    I DF L    +   N    + 
Sbjct: 146 ------GLHVLHE----AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT 195
Query: 519 RLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
               Y+APE   + K  ++  D++S G ++ E+   +A
Sbjct: 196 H-RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 28/208 (13%)
Query: 363 MLGKGSLGTVYKAVLDDGG---IVAVKRLKDANPCARKEFEQYM---DVIGKL-KHPNVV 415
           +LGKGS G V  A  D  G   + A+K LK        + E  M    V+  L K P + 
Sbjct: 26  VLGKGSFGKVMLA--DRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-GPGRIP--LDWTTRISLVLGAARGLAR 472
           +L + +   +    V +Y+  G L  + H  + G  + P  + +   IS+      GL  
Sbjct: 84  QLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISI------GLFF 135
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL--SLLLNPVQAIARLG--GYKAPEQ 528
           +H+      + + ++K  NV+LD  G   I+DFG+    +++ V      G   Y APE 
Sbjct: 136 LHKR----GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEI 191
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              +   +  D +++GVLL E+L G+ P
Sbjct: 192 IAYQPYGKSVDWWAYGVLLYEMLAGQPP 219

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 145 ----SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYK 524
           GL  +HQ      + + ++K  NVLLD +G   ISD GL++ L   Q      A   G+ 
Sbjct: 301 GLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           APE    +      D ++ GV L E++  R P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYK 524
           GL  +HQ      + + ++K  NVLLD +G   ISD GL++ L   Q      A   G+ 
Sbjct: 301 GLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           APE    +      D ++ GV L E++  R P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 8/92 (8%)
Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYK 524
           GL  +HQ      + + ++K  NVLLD +G   ISD GL++ L   Q      A   G+ 
Sbjct: 301 GLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFM 356
Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           APE    +      D ++ GV L E++  R P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 84/204 (41%), Gaps = 17/204 (8%)
Query: 363 MLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLR 418
           +LG+G  G V+   +   G + A K+L       RK ++  M    ++ K+    +V L 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHG--NRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
             +  K +  LV   +  G +   ++      PG         I        GL  +HQ 
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG---FQEPRAIFYTAQIVSGLEHLHQR 308
Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAEVK 532
                + + ++K  NVLLD +G   ISD GL++ L   Q      A   G+ APE    +
Sbjct: 309 ----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE 364
Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
                 D ++ GV L E++  R P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL    +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/208 (21%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           E++GKG+   V + +  + G      IV V +   +   + ++ ++   +   LKHP++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L   Y +     +V++++    L   +      G     +    ++     R +    +
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMRQILEALR 144
Query: 476 EYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIA--RLGG--YKAPEQ 528
                 + H +VK  NVLL   + +    + DFG+++ L     +A  R+G   + APE 
Sbjct: 145 YCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEV 204
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            + +   +  DV+  GV+L  +L+G  P
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 148
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 149 ----SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT 227

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNAM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 148 ----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 21/227 (9%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVL-----DDGGI-VAVKRLKDANPCARKE 398
           Y  K +F   +L     + LG G+ G V +A       +D  + VAVK LK       KE
Sbjct: 37  YNEKWEFPRNNL--QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE 94
Query: 399 -FEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGR 451
                + ++  L +H N+V L          L++ +Y   G L + L          P  
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154
Query: 452 IPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL-L 510
              + T     +L  +  +A+      +    H +V + NVLL    VA I DFGL+  +
Sbjct: 155 AIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 511 LNP----VQAIARLG-GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
           +N     V+  ARL   + APE       + ++DV+S+G+LL E+ +
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+    + +        Y+APE      
Sbjct: 150 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWM 205
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/84 (30%), Positives = 39/84 (46%), Gaps = 16/84 (19%)
Query: 484 HGNVKSSNVLLDKNGVACISDFGL----------SLLLNPVQAIARLGG------YKAPE 527
           H ++K SN+    + V  + DFGL            +L P+ A A   G      Y +PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPE 246
Query: 528 QAEVKRLSQKADVYSFGVLLLEVL 551
           Q      S K D++S G++L E+L
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+    + +        Y+APE      
Sbjct: 150 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWM 205
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY-AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            +  A+  +     YL    + + L+      ++  D      L+    RGL  IH    
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQ--FLIYQILRGLKYIH---- 142
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVKRLSQ 536
           +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE        +Q
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 202
Query: 537 KADVYSFGVLLLEVLTGRA 555
             D++S G ++ E+LTGR 
Sbjct: 203 TVDIWSVGCIMAELLTGRT 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 148 ----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 148 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT 226

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 88
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 141
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 87
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 141
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 142 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 197
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGRT 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPC---ARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L         A++ + + + ++  +KH NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 154
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 155 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT 233

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+    + +        Y+APE      
Sbjct: 150 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWM 205
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 145 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 145 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 154
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 155 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT 233

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 100
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 154
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 155 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 210
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGRT 233

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-IARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +   A     
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT 185
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 88
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 141
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 111
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 165
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 166 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIMLNWM 221
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 99
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 153
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 154 ----SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRT 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 90
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 144
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 145 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 200
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGRT 223

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           + +G+G+ G V  A        VA+K++   +    C R   E  + ++ + +H NV+ +
Sbjct: 49  QYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLRE--IQILLRFRHENVIGI 106
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
           R    A   + +   Y+    + + L+      ++  D       +    RGL  IH   
Sbjct: 107 RDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHIC--YFLYQILRGLKYIH--- 161
Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE-QA 529
            +A V H ++K SN+L++      I DFGL+ + +P       +        Y+APE   
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGR 554
             K  ++  D++S G +L E+L+ R
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-IARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +   A     
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT 185
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 90
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 143
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 96
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 149
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 150 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 88
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 141
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 30/236 (12%)
Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAV---LDDGGI---VAVKRLKD-ANPCARK 397
           Y+ K +F  E+L     ++LG G+ G V  A    +   G+   VAVK LK+ A+   R+
Sbjct: 36  YDLKWEFPRENL--EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE 93
Query: 398 EFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR---GPGRIP 453
                + ++ +L  H N+V L           L+++Y   G L + L   R       I 
Sbjct: 94  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153
Query: 454 LDWTTRISL-----------VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI 502
            +   R+             +L  A  +A+  +        H ++ + NVL+    V  I
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 213
Query: 503 SDFGLSLLLNP-----VQAIARL-GGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT 552
            DFGL+  +       V+  ARL   + APE       + K+DV+S+G+LL E+ +
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 99
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 153
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 154 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 209
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 162
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 163 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 218
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 111
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 165
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 166 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 221
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGRT 244

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 95
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 149
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 150 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 205
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGRT 228

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 107
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 161
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 162 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRT 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 148
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 149 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT 227

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 88
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 141
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 108
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 161
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 162 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 138
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 139 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 85
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 139
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 140 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRT 218

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 92
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 145
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 86
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 139
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 93
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 146
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 94
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 147
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 148 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 85
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 138
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 139 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 92
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 145
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 85
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 139
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 140 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 195
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGRT 218

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 93
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 147
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 148 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 203
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 88
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 141
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 86
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 139
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 34/213 (15%)
Query: 363 MLGKGSLGTVY---KAVLDDGGIVAVKRLK-------DANPCARKEFEQYMDVIGKLKHP 412
           +LGKGS G V    +   D+  + AVK LK       D   C   E ++ + + GK   P
Sbjct: 348 VLGKGSFGKVMLSERKGTDE--LYAVKILKKDVVIQDDDVECTMVE-KRVLALPGK--PP 402
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG---NRGPGRIPLDWTTRISLVLGAARG 469
            + +L + +   +    V +Y+  G L   +      + P  +       I L    ++G
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GYKA 525
           +             + ++K  NV+LD  G   I+DFG+    + + V      G   Y A
Sbjct: 463 II------------YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIA 510
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
           PE    +   +  D ++FGVLL E+L G+AP +
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 92
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 145
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-IARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +   A     
Sbjct: 126 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVAT 181
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+  G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 93
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH- 146
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 94
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 148
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 149 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 204
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKE---FEQYMDVIGKLKHPNVVKL 417
           +++G+G+   V    +   G + A+K +   +   R E   F +  DV+       + +L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
              +  +    LV +Y   G L +LL   G R P  +   +   I + + +   L  +H+
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLG--GYKAPEQAE 530
                     ++K  N+LLD+ G   ++DFG  L L     V+++  +G   Y +PE  +
Sbjct: 187 ----------DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 531 V-------KRLSQKADVYSFGVLLLEVLTGRAP 556
                        + D ++ GV   E+  G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 91/207 (43%), Gaps = 28/207 (13%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL-- 417
           +G+G+ G V  A  +   + VA+K++   +    C R   E  + ++ + +H N++ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE--IKILLRFRHENIIGIND 92
Query: 418 --RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
             RA    + + + +   L    L+ LL          L        +    RGL  IH 
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKCQH------LSNDHICYFLYQILRGLKYIH- 145
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE- 527
              +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGR 554
               K  ++  D++S G +L E+L+ R
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARL 520
           RGL  IH    +A V H ++K SN+LL+      I DFGL+ + +P       +      
Sbjct: 137 RGLKYIH----SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGR 554
             Y+APE     K  ++  D++S G +L E+L+ R
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 86
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 140
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 141 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 196
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGRT 219

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+  G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +A    Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQY----MDVIGKLKHPNVVKL- 417
           +G+G+ G V  A  +   + VA+K++   +P   + + Q     + ++ + +H N++ + 
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYXQRTLREIKILLRFRHENIIGIN 91
Query: 418 ---RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
              RA    + + + +   L    L+ LL          L        +    RGL  IH
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH------LSNDHICYFLYQILRGLKYIH 145
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARLGGYKAPE 527
               +A V H ++K SN+LL+      I DFGL+ + +P       +        Y+APE
Sbjct: 146 ----SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 528 -QAEVKRLSQKADVYSFGVLLLEVLTGR 554
                K  ++  D++S G +L E+L+ R
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 19/205 (9%)
Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGKLKHPNVVKLR 418
           E +GKG+   V + V L  G   A K +      AR  ++ E+   +   LKH N+V+L 
Sbjct: 10  EDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLH 69
Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
                +    LV+D +  G L   +           D +  I  +L A   +   HQ   
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA--DASHCIQQILEA---VLHCHQ--- 121
Query: 479 TAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNPVQ----AIARLGGYKAPEQAEV 531
              V H ++K  N+LL    K     ++DFGL++ +   Q      A   GY +PE    
Sbjct: 122 -MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 532 KRLSQKADVYSFGVLLLEVLTGRAP 556
           +   +  D+++ GV+L  +L G  P
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPP 205

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P + KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+++D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 D----------LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P + KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+++D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 D----------LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKDANPCARKEFEQYMDVIGKLKHP------ 412
           +++GKGS G V KA   D  +   VA+K +++     R+  E+ + ++  L+        
Sbjct: 103 KVIGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDNTM 159
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ +   +  +    + ++ L + +L+ L+  N+  G         + LV   A  + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-------FSLPLVRKFAHSILQ 211
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACIS--DFGLSLLLNP-VQAIARLGGYKAPEQA 529
                   ++ H ++K  N+LL + G + I   DFG S   +  V    +   Y+APE  
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ 572
              R     D++S G +L E+LTG        P  P  DE +Q
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTG-------YPLLPGEDEGDQ 307

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 111/286 (38%), Gaps = 46/286 (16%)
Query: 360 SAEMLGKGSLGTVYKAVLDDGGI-VAVKRLKD---ANPCARKEFEQYMDVIGKLKH-PNV 414
           +++ LG+G    V + +    G   A K LK       C R E    + V+   K  P V
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC-RAEILHEIAVLELAKSCPRV 91
Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           + L   Y    E +L+ +Y   G + SL            D    I L+     G+  +H
Sbjct: 92  INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND---VIRLIKQILEGVYYLH 148
Query: 475 QEYGTAKVPHGNVKSSNVLLDKN---GVACISDFGLSLLLNPVQAIARLGG---YKAPEQ 528
           Q      + H ++K  N+LL      G   I DFG+S  +     +  + G   Y APE 
Sbjct: 149 QN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
                ++   D+++ G++   +LT          T P V E+ Q   L     S V  ++
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTH---------TSPFVGEDNQETYLNI---SQVNVDY 252
Query: 589 TAEVFDQELLRYKNIEEELVSMLHVGL--ACVVSQPEKRPTMAEVA 632
           + E F              VS L      + +V  PEKRPT AE+ 
Sbjct: 253 SEETFSS------------VSQLATDFIQSLLVKNPEKRPT-AEIC 285

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/249 (18%), Positives = 104/249 (41%), Gaps = 30/249 (12%)
Query: 361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           AE LG+G  G V++ V        + +        +   ++ + ++   +H N++ L   
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           + + EE +++++++    +   +          L+    +S V      L  +H    + 
Sbjct: 70  FESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLH----SH 121
Query: 481 KVPHGNVKSSNVLLD--KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
            + H +++  N++    ++    I +FG +  L P      L     Y APE  +   +S
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
              D++S G L+  +L+G  P  + + T  ++            + +++  E+T   FD+
Sbjct: 182 TATDMWSLGTLVYVLLSGINP--FLAETNQQI------------IENIMNAEYT---FDE 224
Query: 596 ELLRYKNIE 604
           E  +  +IE
Sbjct: 225 EAFKEISIE 233

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V     ++ G   A+K L        K+ E  ++   ++  +  P + KL  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
           +          +K  N+++D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 D----------LKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y P G + S L   R  GR        +  +I L       L  I++
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 166
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+++D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 167 ----------DLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 246

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 91/213 (42%), Gaps = 34/213 (15%)
Query: 363 MLGKGSLGTVY---KAVLDDGGIVAVKRLK-------DANPCARKEFEQYMDVIGKLKHP 412
           +LGKGS G V    +   D+  + AVK LK       D   C   E ++ + + GK   P
Sbjct: 27  VLGKGSFGKVMLSERKGTDE--LYAVKILKKDVVIQDDDVECTMVE-KRVLALPGK--PP 81
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG---NRGPGRIPLDWTTRISLVLGAARG 469
            + +L + +   +    V +Y+  G L   +      + P  +       I L    ++G
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL--LLNPVQAIARLG--GYKA 525
           +             + ++K  NV+LD  G   I+DFG+    + + V      G   Y A
Sbjct: 142 II------------YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIA 189
Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
           PE    +   +  D ++FGVLL E+L G+AP +
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 362 EMLGKGSLGTVYKAVLDDGGI---VAVKRLKDANPCARKEFEQYMDVIGKLKHP------ 412
           +++GKGS G V KA   D  +   VA+K +++     R+  E+ + ++  L+        
Sbjct: 103 KVIGKGSFGQVVKAY--DHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDNTM 159
Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           NV+ +   +  +    + ++ L + +L+ L+  N+  G         + LV   A  + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-------FSLPLVRKFAHSILQ 211
Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACIS--DFGLSLLLNP-VQAIARLGGYKAPEQA 529
                   ++ H ++K  N+LL + G + I   DFG S   +  V    +   Y+APE  
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRFYRAPEVI 271
Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ 572
              R     D++S G +L E+LTG        P  P  DE +Q
Sbjct: 272 LGARYGMPIDMWSLGCILAELLTG-------YPLLPGEDEGDQ 307

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 16/101 (15%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV    RGL  IH    +A + H ++K SNV ++++    I DFGL+      QA   + 
Sbjct: 136 LVYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMT 186
Query: 522 G------YKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
           G      Y+APE        +Q  D++S G ++ E+L G+A
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 16/101 (15%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV    RGL  IH    +A + H ++K SNV ++++    I DFGL+      QA   + 
Sbjct: 136 LVYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMT 186
Query: 522 G------YKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
           G      Y+APE        +Q  D++S G ++ E+L G+A
Sbjct: 187 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 227

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 34/163 (20%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL-----KDANP-CARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA     G  VA+K++     K+  P  A +E +    ++  LKH NVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVVN 81
Query: 417 L--------RAYYYAKEEKLLVYDYLPN---GSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           L          Y   K    LV+D+  +   G L ++L       +  L    R+  +L 
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQML- 134
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
              GL  IH+     K+ H ++K++NVL+ ++GV  ++DFGL+
Sbjct: 135 -LNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 26/212 (12%)
Query: 364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 70  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+  G + S L   R  GR        +  +I L       L  I++
Sbjct: 130 SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 186
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVK 532
                     ++K  N+L+D+ G   ++DFG +  +    A   L G   Y APE    K
Sbjct: 187 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKG--ATWTLCGTPEYLAPEIILSK 234
Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
             ++  D ++ GVL+ E+  G  P     P +
Sbjct: 235 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 266

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +  +      
Sbjct: 140 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 195
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +  +      
Sbjct: 130 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 185
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G  VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 84
Query: 420 YYY-AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
            +  A+  +     YL    + + L+      ++  D      L+    RGL  IH    
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQ--FLIYQILRGLKYIH---- 138
Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVKRLSQ 536
           +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE        +Q
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQ 198
Query: 537 KADVYSFGVLLLEVLTGRA 555
             D++S G ++ E+LTGR 
Sbjct: 199 TVDIWSVGCIMAELLTGRT 217

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +  +      
Sbjct: 136 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 191
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARL 520
           RGL  IH    +A V H ++K SN+LL+      I DFGL+ + +P       +      
Sbjct: 137 RGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 192
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGR 554
             Y+APE     K  ++  D++S G +L E+L+ R
Sbjct: 193 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 70/305 (22%)
Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKA-VLDDGGIVAVK-----------RLKDANPCA 395
           ++ FE E  L     +LGKG  GTV+    L D   VA+K            L D+  C 
Sbjct: 26  REAFEAEYRL---GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 396 RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY-LPNGSLHSLLHGN----RGPG 450
             E      V     HP V++L  ++  +E  +LV +  LP   L   +        GP 
Sbjct: 83  L-EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS 141
Query: 451 RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSL 509
           R           V+ A        Q   +  V H ++K  N+L+D + G A + DFG   
Sbjct: 142 R------CFFGQVVAAI-------QHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188
Query: 510 LLN--PVQAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR 566
           LL+  P         Y  PE     +  +  A V+S G+LL +++ G  P          
Sbjct: 189 LLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--------- 239
Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP 626
             E +Q                  E+ + EL    ++  +  +++     C+  +P  RP
Sbjct: 240 --ERDQ------------------EILEAELHFPAHVSPDCCALIR---RCLAPKPSSRP 276
Query: 627 TMAEV 631
           ++ E+
Sbjct: 277 SLEEI 281

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 12/95 (12%)
Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-------VQAIARL 520
           RGL  IH    +A V H ++K SN+LL+      I DFGL+ + +P       +      
Sbjct: 139 RGLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGR 554
             Y+APE     K  ++  D++S G +L E+L+ R
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 34/163 (20%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL-----KDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA     G  VA+K++     K+  P  A +E +    ++  LKH NVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVVN 81
Query: 417 L--------RAYYYAKEEKLLVYDYLPN---GSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           L          Y   K    LV+D+  +   G L ++L       +  L    R+  +L 
Sbjct: 82  LIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQML- 134
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
              GL  IH+     K+ H ++K++NVL+ ++GV  ++DFGL+
Sbjct: 135 -LNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 352 ELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKL 409
           + ED+ + ++E+LG+G+   V  AV L +G   AVK + K A     + F +   +    
Sbjct: 9   KFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQ 68
Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
            + N+++L  ++       LV++ L  GS+ + +   +       +      +V   A  
Sbjct: 69  GNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQK-----HFNEREASRVVRDVAAA 123
Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVA-----CISDFGLSLLLN----PV---QAI 517
           L  +H    T  + H ++K  N+L +          C  D G  + LN    P+   +  
Sbjct: 124 LDFLH----TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELT 179
Query: 518 ARLGG--YKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAP 556
              G   Y APE  EV         ++ D++S GV+L  +L+G  P
Sbjct: 180 TPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +  +      
Sbjct: 126 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 181
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARL 520
           L+    RGL  IH    +A + H ++K SN+ ++++    I DFGL+   +  +      
Sbjct: 150 LIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 205
Query: 521 GGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
             Y+APE        +Q  D++S G ++ E+LTGR 
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G  VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 108
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 162
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 163 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATRWYRAPEIMLNWM 218
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGRT 241

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G  VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 107
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 161
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I DFGL+   +  +        Y+APE      
Sbjct: 162 ----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM 217
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGRT 240

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 364 LGKGSLGTVYKAVLDDGGI-VAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +G G+ G+V  A     G+ VAVK+L     +   A++ + + + ++  +KH NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 88
Query: 420 YYY---AKEEKLLVY--DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +    + EE   VY   +L    L++++   +      L       L+    RGL  IH
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYIH 142
Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPE-QAEVK 532
               +A + H ++K SN+ ++++    I D+GL+   +  +        Y+APE      
Sbjct: 143 ----SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIMLNWM 198
Query: 533 RLSQKADVYSFGVLLLEVLTGRA 555
             +Q  D++S G ++ E+LTGR 
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 16/101 (15%)
Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           LV    RGL  IH    +A + H ++K SNV ++++    I DFGL+      QA   + 
Sbjct: 128 LVYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMT 178
Query: 522 G------YKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
           G      Y+APE        +Q  D++S G ++ E+L G+A
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKA 219

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 34/163 (20%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL-----KDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA     G  VA+K++     K+  P  A +E +    ++  LKH NVV 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVVN 80
Query: 417 L--------RAYYYAKEEKLLVYDYLPN---GSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           L          Y   K    LV+D+  +   G L ++L       +  L    R+  +L 
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQML- 133
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
              GL  IH+     K+ H ++K++NVL+ ++GV  ++DFGL+
Sbjct: 134 -LNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 34/163 (20%)
Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL-----KDANPC-ARKEFEQYMDVIGKLKHPNVVK 416
           +G+G+ G V+KA     G  VA+K++     K+  P  A +E +    ++  LKH NVV 
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK----ILQLLKHENVVN 81
Query: 417 L--------RAYYYAKEEKLLVYDYLPN---GSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           L          Y   K    LV+D+  +   G L ++L       +  L    R+  +L 
Sbjct: 82  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQML- 134
Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
              GL  IH+     K+ H ++K++NVL+ ++GV  ++DFGL+
Sbjct: 135 -LNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+  G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 364 LGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRA 419
           LG GS G V      + G   A+K L        K+ E  ++   ++  +  P +VKL  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI----PLDWTTRISLVLGAARGLARIHQ 475
            +       +V +Y+  G + S L   R  GR        +  +I L       L  I++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGGYKAPEQAEVKRL 534
                     ++K  N+L+D+ G   ++DFG +  +      +     Y APE    K  
Sbjct: 166 ----------DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
           ++  D ++ GVL+ E+  G  P     P +
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	670
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-86
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-76
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-72
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-65
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-49
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-47
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-46
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-46
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-45
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-45
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-44
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-42
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-41
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-39
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-38
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-27
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-31
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-30
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-29
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-29
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-29
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-28
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-28
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-28
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	8e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-28
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-28
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	9e-28
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-27
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-27
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-27
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-27
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-27
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-26
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-26
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-26
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-26
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-26
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-26
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-26
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-25
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	8e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-25
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-24
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-24
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-24
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-24
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-22
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-09
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-22
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-22
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-22
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-22
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-06
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-22
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-22
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-21
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-21
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-21
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-20
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	8e-04
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-19
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-18
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-14
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-13
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-06
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-19
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-18
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-16
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-18
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-13
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-17
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-17
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-16
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-16
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	9e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-08
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-16
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	7e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-08
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	4e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	7e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-16
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-15
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-14
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-09
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-16
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-04
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-12
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-11
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-15
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-14
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-15
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-14
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-11
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-15
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-15
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	8e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-04
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-15
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-14
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-14
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-04
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-04
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-14
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-04
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-09
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-14
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-09
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-10
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	9e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	8e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-13
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-13
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-13
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-13
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-08
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-13
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-12
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-08
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-12
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-12
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-12
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	9e-12
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-12
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-11
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-10
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-11
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-11
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	8e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-08
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-10
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-10
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-10
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	6e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-10
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	8e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-09
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-09
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-04
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-07
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	7e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	3e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-06
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-05
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-05
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	3e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	2e-05
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	1e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	6e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  271 bits (696), Expect = 5e-86
 Identities = 108/317 (34%), Positives = 171/317 (53%), Gaps = 21/317 (6%)

Query: 349 KQFELEDLLRA-----SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN-PCARKEFEQY 402
           K+F L +L  A     +  +LG+G  G VYK  L DG +VAVKRLK+        +F+  
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++I    H N+++LR +     E+LLVY Y+ NGS+ S L   R   + PLDW  R  +
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRI 136

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-----AI 517
            LG+ARGLA +H      K+ H +VK++N+LLD+   A + DFGL+ L++        A+
Sbjct: 137 ALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 518 ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
               G+ APE     + S+K DV+ +GV+LLE++TG+                +  V L 
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ------RAFDLARLANDDDVMLL 249

Query: 578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE- 636
            WV+ ++KE+    + D + L+    +EE+  ++ V L C  S P +RP M+EV +M+E 
Sbjct: 250 DWVKGLLKEKKLEALVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

Query: 637 DIRVEQSPLGEEYDESR 653
           D   E+    ++ +  R
Sbjct: 309 DGLAERWEEWQKEEMFR 325

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  245 bits (628), Expect = 5e-76
 Identities = 95/332 (28%), Positives = 148/332 (44%), Gaps = 47/332 (14%)

Query: 329 NDSDGTSGTDTSKLVFYERKKQFELEDLLRA-----SAEMLGKGSLGTVYKAVLDDGGIV 383
             ++  +   +S  +      +  L DL  A        ++G G  G VYK VL DG  V
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66

Query: 384 AVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           A+KR    +    +EFE  ++ +   +HP++V L  +   + E +L+Y Y+ NG+L   L
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126

Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
           +G      + + W  R+ + +GAARGL  +H    T  + H +VKS N+LLD+N V  I+
Sbjct: 127 YG-SDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKIT 181

Query: 504 DFGLSLLLNPVQAIARLG----------------GYKAPEQAEVKRLSQKADVYSFGVLL 547
           DFG+S          + G                GY  PE     RL++K+DVYSFGV+L
Sbjct: 182 DFGIS----------KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVL 231

Query: 548 LEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELL-RYKNIEEE 606
            EVL  R+       + PR  E     +   W           ++ D  L  + +   E 
Sbjct: 232 FEVLCARSAI---VQSLPR--EMVNLAE---WAVESHNNGQLEQIVDPNLADKIR--PES 281

Query: 607 LVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           L       + C+    E RP+M +V   +E  
Sbjct: 282 LRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  235 bits (602), Expect = 2e-72
 Identities = 87/306 (28%), Positives = 140/306 (45%), Gaps = 51/306 (16%)

Query: 354 EDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCA----RKEFEQYMDVIGKL 409
           E  +      +G+G  G VYK  ++    VAVK+L           +++F+Q + V+ K 
Sbjct: 29  ERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87

Query: 410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           +H N+V+L  +    ++  LVY Y+PNGSL   L      G  PL W  R  +  GAA G
Sbjct: 88  QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANG 145

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-------- 521
           +  +H+        H ++KS+N+LLD+   A ISDFGL          AR          
Sbjct: 146 INFLHEN----HHIHRDIKSANILLDEAFTAKISDFGL----------ARASEKFAQTVM 191

Query: 522 --------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQA 573
                    Y APE      ++ K+D+YSFGV+LLE++TG             VDE  + 
Sbjct: 192 TSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA----------VDEHREP 240

Query: 574 VDLPKWVRSVVKEEWT-AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVA 632
             L      +  EE T  +  D+++         + +M  V   C+  +  KRP + +V 
Sbjct: 241 QLLLDIKEEIEDEEKTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQ 298

Query: 633 KMIEDI 638
           ++++++
Sbjct: 299 QLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  216 bits (552), Expect = 4e-65
 Identities = 73/338 (21%), Positives = 121/338 (35%), Gaps = 49/338 (14%)

Query: 327 GGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVK 386
           G +    +SG D      Y +    +L        E+  +G  G V+KA L     VAVK
Sbjct: 2   GHHHHHHSSGVDLGTENLYFQSMPLQLL-------EVKARGRFGCVWKAQLL-NEYVAVK 53

Query: 387 RLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY----YYAKEEKLLVYDYLPNGSLHSL 442
                +     + E  +  +  +KH N+++             +  L+  +   GSL   
Sbjct: 54  IFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112

Query: 443 LHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE----YGTAKVP--HGNVKSSNVLLDK 496
           L  N       + W     +    ARGLA +H++        K    H ++KS NVLL  
Sbjct: 113 LKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166

Query: 497 NGVACISDFGLSLLL----NPVQAIARLG--GYKAPEQAE-----VKRLSQKADVYSFGV 545
           N  ACI+DFGL+L      +      ++G   Y APE  E      +    + D+Y+ G+
Sbjct: 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226

Query: 546 LLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYK---- 601
           +L E+ +    +  P          E  +   + +      E   EV   +  R      
Sbjct: 227 VLWELASRCTAADGPVD--------EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDY 278

Query: 602 -NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                 +  +      C     E R +   V + I  +
Sbjct: 279 WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  174 bits (442), Expect = 3e-49
 Identities = 78/314 (24%), Positives = 123/314 (39%), Gaps = 53/314 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEF--EQYMDVIGKLKHPNVVKL-- 417
           E++G+G  G VYK  LD    VAVK    AN   R+ F  E+ +  +  ++H N+ +   
Sbjct: 19  ELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIV 74

Query: 418 ---RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
              R     + E LLV +Y PNGSL   L  +        DW +   L     RGLA +H
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH 128

Query: 475 QE--YGTAKVP---HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA----------R 519
            E   G    P   H ++ S NVL+  +G   ISDFGLS+ L   + +            
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 520 LG--GYKAPE-------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE 570
           +G   Y APE         + +   ++ D+Y+ G++  E+          +   P     
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC------TDLFPGESVP 242

Query: 571 EQAVDLPKWVRSVVKEEWTAEVFDQELLR------YKNIEEELVSMLHVGLACVVSQPEK 624
           E  +     V +    E    +  +E  R      +K     + S+      C     E 
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302

Query: 625 RPTMAEVAKMIEDI 638
           R T     + + ++
Sbjct: 303 RLTAQXAEERMAEL 316

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  169 bits (430), Expect = 9e-48
 Identities = 74/302 (24%), Positives = 127/302 (42%), Gaps = 37/302 (12%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E++G+G+ G V KA       VA+K+++  +   RK F   +  + ++ HPN+VKL    
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
                  LV +Y   GSL+++LHG              +S  L  ++G+A +H     A 
Sbjct: 71  --LNPVCLVMEYAEGGSLYNVLHGAEPL--PYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 482 VPHGNVKSSNVLLDKNGVAC-ISDFGLSLLLNPVQAIARLG--GYKAPEQAEVKRLSQKA 538
           + H ++K  N+LL   G    I DFG +  +         G   + APE  E    S+K 
Sbjct: 127 I-HRDLKPPNLLLVAGGTVLKICDFGTACDIQ-THMTNNKGSAAWMAPEVFEGSNYSEKC 184

Query: 539 DVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELL 598
           DV+S+G++L EV+T R P  +               ++      ++       V +    
Sbjct: 185 DVFSWGIILWEVITRRKP--FD--------------EIGGPAFRIM-----WAVHNGTRP 223

Query: 599 RY-KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLS 657
              KN+ + + S++     C    P +RP+M E+ K++  +        E          
Sbjct: 224 PLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSL 280

Query: 658 PS 659
           P 
Sbjct: 281 PP 282

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  168 bits (427), Expect = 2e-47
 Identities = 74/309 (23%), Positives = 119/309 (38%), Gaps = 54/309 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +GKG  G V++     G  VAVK     +     +E E Y  V   L+H N++   A 
Sbjct: 14  ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV--MLRHENILGFIAS 70

Query: 421 ----YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
                ++  +  L+  Y   GSL+  L          LD  + + +VL  A GLA +H E
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIE 124

Query: 477 Y----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--------YK 524
                G   + H ++KS N+L+ KNG  CI+D GL+++ +       +G         Y 
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 525 APE------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR-PRVDEEEQAVDLP 577
           APE      Q +     ++ D+++FG++L EV      +      + P  D         
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 578 KWVRSVVKE--------EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
              + V  +         W +   D  L     + +E          C    P  R T  
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFS---DPTLTSLAKLMKE----------CWYQNPSARLTAL 291

Query: 630 EVAKMIEDI 638
            + K +  I
Sbjct: 292 RIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  168 bits (428), Expect = 4e-47
 Identities = 79/349 (22%), Positives = 123/349 (35%), Gaps = 67/349 (19%)

Query: 330 DSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK 389
                SG+    LV     KQ ++        + +GKG  G V+      G  VAVK   
Sbjct: 18  SQSSGSGSGLPLLVQRTIAKQIQMV-------KQIGKGRYGEVWMGKWR-GEKVAVKVFF 69

Query: 390 DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK--------LLVYDYLPNGSLHS 441
                A    E  +     ++H N++     + A + K         L+ DY  NGSL+ 
Sbjct: 70  TTE-EASWFRETEIYQTVLMRHENILG----FIAADIKGTGSWTQLYLITDYHENGSLYD 124

Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE-YGTAKVP---HGNVKSSNVLLDKN 497
            L          LD  + + L   +  GL  +H E + T   P   H ++KS N+L+ KN
Sbjct: 125 YLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178

Query: 498 GVACISDFGLSLLLNP------VQAIARLG--GYKAPE------QAEVKRLSQKADVYSF 543
           G  CI+D GL++          +    R+G   Y  PE           +    AD+YSF
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238

Query: 544 GVLLLEVLTGRAPSQYPSPTR-PRVDEEEQAVDLPKWVRSVVKE--------EWTAEVFD 594
           G++L EV             + P  D              V  +         W+++   
Sbjct: 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298

Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS 643
           +++   K + E           C    P  R T   V K +  +   Q 
Sbjct: 299 RQMG--KLMTE-----------CWAHNPASRLTALRVKKTLAKMSESQD 334

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  164 bits (417), Expect = 2e-46
 Identities = 60/291 (20%), Positives = 111/291 (38%), Gaps = 46/291 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGKLKHPNVVKLRA 419
             L +   G ++K     G  + VK LK  +   R  ++F +    +    HPNV+ +  
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 420 YYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              +        +  ++P GSL+++LH         +D +  +   L  ARG+A +H   
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMARGMAFLHTL- 130

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK--APE---QAEVK 532
               +P   + S +V++D++  A IS   +       Q+  R+      APE   +    
Sbjct: 131 -EPLIPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRMYAPAWVAPEALQKKPED 186

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR--PRVDEEEQAVDLPKWVRSVVKEEWTA 590
              + AD++SF VLL E++T   P    S      +V  E     +P             
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP------------- 233

Query: 591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
                       I   +  ++     C+   P KRP    +  ++E ++ +
Sbjct: 234 ----------PGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQDK 271

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  165 bits (420), Expect = 6e-46
 Identities = 71/347 (20%), Positives = 123/347 (35%), Gaps = 61/347 (17%)

Query: 330 DSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLK 389
               TSG+ +   +  +R     +        E +GKG  G V++     G  VAVK   
Sbjct: 21  YDMTTSGSGSGLPLLVQRTIARTIVLQ-----ESIGKGRFGEVWRGKWR-GEEVAVKIFS 74

Query: 390 DANPCARKEF--EQYMDVIGKLKHPNVVKLRA----YYYAKEEKLLVYDYLPNGSLHSLL 443
                  + +  E  +     L+H N++   A          +  LV DY  +GSL   L
Sbjct: 75  SRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 131

Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY----GTAKVPHGNVKSSNVLLDKNGV 499
           +         +     I L L  A GLA +H E     G   + H ++KS N+L+ KNG 
Sbjct: 132 NRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185

Query: 500 ACISDFGLSLLLNPVQAIARLGG--------YKAPE------QAEVKRLSQKADVYSFGV 545
            CI+D GL++  +       +          Y APE        +     ++AD+Y+ G+
Sbjct: 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 245

Query: 546 LLLEVLTGRAPSQYPSPTR-PRVDEEEQAVDLPKWVRSVVKE--------EWTAEVFDQE 596
           +  E+    +        + P  D       + +  + V ++         W +    + 
Sbjct: 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQS---CEA 302

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS 643
           L     I  E          C  +    R T   + K +  +  ++ 
Sbjct: 303 LRVMAKIMRE----------CWYANGAARLTALRIKKTLSQLSQQEG 339

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  164 bits (417), Expect = 7e-46
 Identities = 80/291 (27%), Positives = 134/291 (46%), Gaps = 39/291 (13%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +G GS GTV++A    G  VAVK L   D +     EF + + ++ +L+HPN+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
                    +V +YL  GSL+ LLH +    R  LD   R+S+    A+G+  +H     
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNR--N 157

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGGYK--APEQAEVKRLS 535
             + H N+KS N+L+DK     + DFGLS L     + + +  G  +  APE    +  +
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTR--PRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
           +K+DVYSFGV+L E+ T + P    +P +    V  + + +++P+ +   V         
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVA-------- 269

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
              ++                  C  ++P KRP+ A +  ++  +     P
Sbjct: 270 --AIIE----------------GCWTNEPWKRPSFATIMDLLRPLIKSAVP 302

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  163 bits (415), Expect = 1e-45
 Identities = 64/321 (19%), Positives = 124/321 (38%), Gaps = 53/321 (16%)

Query: 362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E+LGKG  G   K    + G ++ +K L   +   ++ F + + V+  L+HPNV+K    
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
            Y  +    + +Y+  G+L  ++            W+ R+S     A G+A +H      
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLHSM---- 127

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLL----------------NPVQAIARLGGYK 524
            + H ++ S N L+ +N    ++DFGL+ L+                +  +    +G   
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 525 --APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
             APE    +   +K DV+SFG++L E++          P           +++  ++  
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----GLNVRGFLD- 241

Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE- 641
                              N       +    + C    PEKRP+  ++   +E +R+  
Sbjct: 242 --------------RYCPPNCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWLETLRMHL 284

Query: 642 --QSPLGEEYDESRNSLSPSL 660
               PLG + ++       + 
Sbjct: 285 AGHLPLGPQLEQLDRGFWETY 305

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  161 bits (410), Expect = 4e-45
 Identities = 68/295 (23%), Positives = 124/295 (42%), Gaps = 56/295 (18%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + +G GS GTVYK      G VAVK L      P   + F+  + V+ K +H N++    
Sbjct: 30  QRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
           Y  +   +L +V  +    SL+  LH +        +    I +    ARG+  +H +  
Sbjct: 88  Y--STAPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTARGMDYLHAK-- 139

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLS----LLLNPVQAIARLGGYK--APE---QA 529
              + H ++KS+N+ L ++    I DFGL+          Q     G     APE     
Sbjct: 140 --SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
           +    S ++DVY+FG++L E++TG+ P  Y +     ++  +Q +               
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLP--YSN-----INNRDQII--------------- 235

Query: 590 AEVFDQELLR------YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
            E+  +  L         N  + +  ++     C+  + ++RP+   +   IE++
Sbjct: 236 -EMVGRGSLSPDLSKVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEEL 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  159 bits (405), Expect = 1e-44
 Identities = 71/291 (24%), Positives = 114/291 (39%), Gaps = 46/291 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC----ARKEFEQYMDVIGKLKHPNVVKL 417
           E++G G  G VY+A    G  VAVK  +           +   Q   +   LKHPN++ L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
           R     +    LV ++   G L+ +L G R      +     ++  +  ARG+  +H E 
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIARGMNYLHDE- 124

Query: 478 GTAKVPHGNVKSSNVLLDK--------NGVACISDFGLSLLLNPVQAIARLGGYK--APE 527
               + H ++KSSN+L+ +        N +  I+DFGL+   +    ++  G Y   APE
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE 184

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
                  S+ +DV+S+GVLL E+LTG  P  +              +D       V    
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP--FRG------------IDGLAVAYGVAMN- 229

Query: 588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                    L       E    ++     C    P  RP+   +   +  I
Sbjct: 230 ------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  157 bits (399), Expect = 1e-43
 Identities = 69/297 (23%), Positives = 131/297 (44%), Gaps = 54/297 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCAR-------KEFEQYMDVIGKLKHPN 413
           + +GKG  G V+K   + D  +VA+K L   +           +EF++ + ++  L HPN
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           +VKL           +V +++P G L+  L         P+ W+ ++ L+L  A G+  +
Sbjct: 85  IVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYM 138

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVAC-----ISDFGLSLLLNPVQAIARLGGYK--AP 526
             +     + H +++S N+ L            ++DFGLS       +   LG ++  AP
Sbjct: 139 QNQ--NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-GLLGNFQWMAP 195

Query: 527 E--QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           E   AE +  ++KAD YSF ++L  +LTG  P  +   +  ++          K++  + 
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP--FDEYSYGKI----------KFINMIR 243

Query: 585 KEEWTAEVFDQELLR---YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
           +E           LR    ++    L +++     C    P+KRP  + + K + ++
Sbjct: 244 EEG----------LRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  155 bits (393), Expect = 2e-42
 Identities = 62/314 (19%), Positives = 117/314 (37%), Gaps = 55/314 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E++GKG  G VY       G VA++ +     N    K F++ +    + +H NVV    
Sbjct: 39  ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
              +     ++       +L+S++   +    I LD      +     +G+  +H +   
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK--- 149

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK---------APE--- 527
             + H ++KS NV  D   V  I+DFGL  +   +QA  R    +         APE   
Sbjct: 150 -GILHKDLKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 528 ------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR 581
                 + +    S+ +DV++ G +  E+     P  + +         E  +       
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--FKTQPA------EAII------- 252

Query: 582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE 641
                 W      +  L    + +E+  +L   L C   + E+RPT  ++  M+E +   
Sbjct: 253 ------WQMGTGMKPNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDMLEKLPKR 303

Query: 642 QSPLGEEYDESRNS 655
              L       +++
Sbjct: 304 NRRLSHPGHFWKSA 317

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  152 bits (387), Expect = 1e-41
 Identities = 57/191 (29%), Positives = 87/191 (45%), Gaps = 8/191 (4%)

Query: 22  HPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSP--KSERVVSLSLPSHSLR 79
           +P D  AL   +        L S     D C   W GV+C    ++ RV +L L   +L 
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63

Query: 80  G--PIAP-LSLLDQLRFLDLHD-NRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISS 134
              PI   L+ L  L FL +   N L G I P +   T L   Y++  + S  IP  +S 
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

Query: 135 LKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKE-LNLSN 193
           +K ++ LD S N + G +P  +++L  L+ +    N ++G IPD   S   L   + +S 
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183

Query: 194 NELYGRVPEGL 204
           N L G++P   
Sbjct: 184 NRLTGKIPPTF 194

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  121 bits (306), Expect = 1e-30
 Identities = 47/166 (28%), Positives = 77/166 (46%), Gaps = 32/166 (19%)

Query: 68  VVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDF 124
             S+++  + L G I P +   L+ L F+DL  N L G       +  N +  +L+ N  
Sbjct: 176 FTSMTISRNRLTGKI-PPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233

Query: 125 SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK 184
           + ++  ++   K +  LDL +N I G +P+ +T L                         
Sbjct: 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK------------------------ 268

Query: 185 DLKELNLSNNELYGRVPE-GLLKKFGEQSFIGNEGLCGSSPLPACS 229
            L  LN+S N L G +P+ G L++F   ++  N+ LCG SPLPAC+
Sbjct: 269 FLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG-SPLPACT 313

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  152 bits (386), Expect = 9e-39
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 13/210 (6%)

Query: 30  TLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLL 88
            +F+       N ++  +            + +   ++    +      +G  +  L+ L
Sbjct: 557 AMFKQSGKIAANFIAGKRYVY---------IKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607

Query: 89  DQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN 147
                 ++      G   P   N  ++    +S N  S  IP +I S+  +  L+L  N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667

Query: 148 IRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG-LLK 206
           I G IP++V +L  L  L L +N+L GRIP   S+L  L E++LSNN L G +PE    +
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727

Query: 207 KFGEQSFIGNEGLCGSSPLPACSFSGDTPP 236
            F    F+ N GLCG  PLP C  S     
Sbjct: 728 TFPPAKFLNNPGLCG-YPLPRCDPSNADGY 756

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  150 bits (380), Expect = 5e-38
 Identities = 50/202 (24%), Positives = 78/202 (38%), Gaps = 16/202 (7%)

Query: 17  SVSSSHPNDTDALTLFRLQTDTHGNLLSNWK-GADACAAAWTGVVCSPKSERVVSLSLPS 75
           S S S   +   L  F+       NLL +W    + C   + GV C    ++V S+ L S
Sbjct: 5   SPSQSLYREIHQLISFK-DVLPDKNLLPDWSSNKNPCT--FDGVTCR--DDKVTSIDLSS 59

Query: 76  HSLR---GPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP-- 129
             L      ++  L  L  L  L L ++ +NG++       +L    LS N  S  +   
Sbjct: 60  KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTL 119

Query: 130 HQISSLKGILRLDLSDNNIRGRIP-EQVTNLTRLLTLRLQNNELTGRIPD---LSSSLKD 185
             + S  G+  L++S N +           L  L  L L  N ++G       LS    +
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179

Query: 186 LKELNLSNNELYGRVPEGLLKK 207
           LK L +S N++ G V       
Sbjct: 180 LKHLAISGNKISGDVDVSRCVN 201

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  129 bits (326), Expect = 3e-31
 Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 4/139 (2%)

Query: 67  RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSA 126
            +  L++  + + G +  +S    L FLD+  N  +  I  L +C+ L+   +SGN  S 
Sbjct: 179 ELKHLAISGNKISGDV-DVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSG 237

Query: 127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD-LSSSLKD 185
           +    IS+   +  L++S N   G IP     L  L  L L  N+ TG IPD LS +   
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDT 295

Query: 186 LKELNLSNNELYGRVPEGL 204
           L  L+LS N  YG VP   
Sbjct: 296 LTGLDLSGNHFYGAVPPFF 314

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  125 bits (315), Expect = 6e-30
 Identities = 49/138 (35%), Positives = 69/138 (50%), Gaps = 4/138 (2%)

Query: 70  SLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSA 126
            L L ++   G I P +L    +L  L L  N L+GTI   L + + L+   L  N    
Sbjct: 398 ELYLQNNGFTGKI-PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG 456

Query: 127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           EIP ++  +K +  L L  N++ G IP  ++N T L  + L NN LTG IP     L++L
Sbjct: 457 EIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENL 516

Query: 187 KELNLSNNELYGRVPEGL 204
             L LSNN   G +P  L
Sbjct: 517 AILKLSNNSFSGNIPAEL 534

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  122 bits (309), Expect = 3e-29
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)

Query: 67  RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP----LTNCTNLKLAYLSGN 122
           + +++S  +    G ++    L+ L  LDL  N ++G  +        C  LK   +SGN
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188

Query: 123 DFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSS 182
             S ++   +S    +  LD+S NN    IP  + + + L  L +  N+L+G      S+
Sbjct: 189 KISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAIST 245

Query: 183 LKDLKELNLSNNELYGRVPEGLLKK 207
             +LK LN+S+N+  G +P   LK 
Sbjct: 246 CTELKLLNISSNQFVGPIPPLPLKS 270

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (306), Expect = 8e-29
 Identities = 50/146 (34%), Positives = 72/146 (49%), Gaps = 4/146 (2%)

Query: 70  SLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSA 126
           SL L  + L G I P SL  L +LR L L  N L G I   L     L+   L  ND + 
Sbjct: 422 SLHLSFNYLSGTI-PSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480

Query: 127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           EIP  +S+   +  + LS+N + G IP+ +  L  L  L+L NN  +G IP      + L
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSL 540

Query: 187 KELNLSNNELYGRVPEGLLKKFGEQS 212
             L+L+ N   G +P  + K+ G+ +
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQSGKIA 566

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (305), Expect = 1e-28
 Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 5/142 (3%)

Query: 69  VSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSA 126
             L++ S+   GPI P   L  L++L L +N+  G I       C  L    LSGN F  
Sbjct: 250 KLLNISSNQFVGPI-PPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308

Query: 127 EIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPD-LSSSLK 184
            +P    S   +  L LS NN  G +P      +  L  L L  NE +G +P+ L++   
Sbjct: 309 AVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA 368

Query: 185 DLKELNLSNNELYGRVPEGLLK 206
            L  L+LS+N   G +   L +
Sbjct: 369 SLLTLDLSSNNFSGPILPNLCQ 390

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  117 bits (295), Expect = 2e-27
 Identities = 44/142 (30%), Positives = 64/142 (45%), Gaps = 4/142 (2%)

Query: 69  VSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAE 127
             L + S++    I  L     L+ LD+  N+L+G     ++ CT LKL  +S N F   
Sbjct: 203 EFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVT-NLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           IP     LK +  L L++N   G IP+ ++     L  L L  N   G +P    S   L
Sbjct: 263 IPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLL 320

Query: 187 KELNLSNNELYGRVPEGLLKKF 208
           + L LS+N   G +P   L K 
Sbjct: 321 ESLALSSNNFSGELPMDTLLKM 342

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  116 bits (294), Expect = 3e-27
 Identities = 50/141 (35%), Positives = 70/141 (49%), Gaps = 7/141 (4%)

Query: 70  SLSLPSHSLRGPIAPLS---LLDQLRFLDLHDNRLNGTILP-LTNC--TNLKLAYLSGND 123
            L L  +   G + P S   L   L  LDL  N  +G ILP L       L+  YL  N 
Sbjct: 347 VLDLSFNEFSGEL-PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405

Query: 124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
           F+ +IP  +S+   ++ L LS N + G IP  + +L++L  L+L  N L G IP     +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465

Query: 184 KDLKELNLSNNELYGRVPEGL 204
           K L+ L L  N+L G +P GL
Sbjct: 466 KTLETLILDFNDLTGEIPSGL 486

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  130 bits (328), Expect = 5e-33
 Identities = 68/322 (21%), Positives = 123/322 (38%), Gaps = 48/322 (14%)

Query: 330 DSDGTSGTDTSKLVFYERKKQFELEDLLRASAEM---LGKGSLGTVYKAVLDDGGI-VAV 385
                +      L     K ++ L         +   +G+G+ G V+   L      VAV
Sbjct: 88  TQQPLTKKSGVVLHRAVPKDKWVLN---HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAV 144

Query: 386 KRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLH 444
           K  +    P  + +F Q   ++ +  HPN+V+L      K+   +V + +  G   + L 
Sbjct: 145 KSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLR 204

Query: 445 GNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD 504
                    L   T + +V  AA G+  +  +       H ++ + N L+ +  V  ISD
Sbjct: 205 TEGAR----LRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISD 256

Query: 505 FGLSLLLNPVQAIARLGGYK------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPS 557
           FG+S         A  G  +      APE     R S ++DV+SFG+LL E  + G +P 
Sbjct: 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP- 315

Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLAC 617
            YP+ +  +                V K           L   +   + +  ++     C
Sbjct: 316 -YPNLSNQQT------------REFVEKGGR--------LPCPELCPDAVFRLM---EQC 351

Query: 618 VVSQPEKRPTMAEVAKMIEDIR 639
              +P +RP+ + + + ++ IR
Sbjct: 352 WAYEPGQRPSFSTIYQELQSIR 373

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  123 bits (312), Expect = 2e-31
 Identities = 63/307 (20%), Positives = 125/307 (40%), Gaps = 51/307 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL 417
           + +G+G    VY+A  L DG  VA+K+++  +    K     +   D++ +L HPNV+K 
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGR-IP----LDWTTRISLVLGAARGLAR 472
            A +    E  +V +    G L  ++   +   R IP      +  ++         L  
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS------ALEH 151

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-LGG---YKAPEQ 528
           +H      +V H ++K +NV +   GV  + D GL    +     A  L G   Y +PE+
Sbjct: 152 MHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
                 + K+D++S G LL E+   ++P                 ++L    + + + ++
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFY------------GDKMNLYSLCKKIEQCDY 255

Query: 589 T---AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
               ++ + +EL   + +   +   ++         PEKRP +  V  + + +    +  
Sbjct: 256 PPLPSDHYSEEL---RQL---VNMCINP-------DPEKRPDVTYVYDVAKRMHACTASS 302

Query: 646 GEEYDES 652
            E +   
Sbjct: 303 LEHHHHH 309

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  121 bits (305), Expect = 8e-31
 Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 52/288 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
             +G GS G   K     DG I+  K           ++     ++++ +LKHPN+V+  
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 419 AYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGR-IP----LDWTTRISLVLGAARGLA 471
                +    L  V +Y   G L S++       + +     L   T+++L       L 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL------ALK 125

Query: 472 RIHQE-YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LG--GYKAP 526
             H+   G   V H ++K +NV LD      + DFGL+ +LN   + A+  +G   Y +P
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
           EQ      ++K+D++S G LL E+     P                A    +    + + 
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPPF--------------TAFSQKELAGKIREG 231

Query: 587 EWTA--EVFDQELLRYKNIEEELV-SMLHVGLACVVSQPEKRPTMAEV 631
           ++      +  EL        E++  ML++       +   RP++ E+
Sbjct: 232 KFRRIPYRYSDEL-------NEIITRMLNL-------KDYHRPSVEEI 265

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  121 bits (305), Expect = 1e-30
 Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 23/214 (10%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            +LGKG+ G VY    L +   +A+K + + +    +   + + +   LKH N+V+   Y
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---Y 84

Query: 421 Y--YAKEEKLLVY-DYLPNGSLHSLLHGNRGPGRIPLDWTTRISL-VLGAARGLARIHQE 476
              +++   + ++ + +P GSL +LL    GP +         +  +L    GL  +H  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDN 141

Query: 477 YGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNPVQAIAR-LGG---YKAPE--QA 529
               ++ H ++K  NVL++  +GV  ISDFG S  L  +        G   Y APE    
Sbjct: 142 ----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSP 562
             +   + AD++S G  ++E+ TG+ P  +   P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP 231

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (305), Expect = 2e-30
 Identities = 63/272 (23%), Positives = 104/272 (38%), Gaps = 41/272 (15%)

Query: 302 SSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASA 361
               S     ++ S+  ++ +       D++G   T+  K V YE +++           
Sbjct: 8   GQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ---- 63

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
             +G+GS G V++      G   AVK  RL+           + +     L  P +V   
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVP-- 114

Query: 419 AYY--YAKEEKLLVY-DYLPNGSLHSLLHGNRGPGRIPLDWTTRISL-VLGAARGLARIH 474
             Y    +   + ++ + L  GSL  L+   +  G +P D         L    GL  +H
Sbjct: 115 -LYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQAL---EGLEYLH 167

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVAC-ISDFGLSLLLNPVQAIARLGGYK--------- 524
                 ++ HG+VK+ NVLL  +G    + DFG +L L P      L             
Sbjct: 168 TR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           APE    K    K D++S   ++L +L G  P
Sbjct: 224 APEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  119 bits (300), Expect = 4e-30
 Identities = 63/283 (22%), Positives = 122/283 (43%), Gaps = 49/283 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
             +G+GS  TVYK +  +    VA    + +      R+ F++  +++  L+HPN+V+  
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 419 AYY---YAKEEKLLVY-DYLPNGSLHSLLHGNRGPGRIPLD----WTTRISLVLGAARGL 470
             +      ++ +++  + + +G+L + L   +    + +     W  +I       +GL
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQI------LKGL 142

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNPVQAIARLG--GYKAPE 527
             +H    T  + H ++K  N+ +    G   I D GL+ L     A A +G   + APE
Sbjct: 143 QFLHTR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPE 200

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
             E K   +  DVY+FG+ +LE+ T   P  Y         E + A  + + V S VK  
Sbjct: 201 MYEEK-YDESVDVYAFGMCMLEMATSEYP--YS--------ECQNAAQIYRRVTSGVKPA 249

Query: 588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
              +V   E+       +E++        C+    ++R ++ +
Sbjct: 250 SFDKVAIPEV-------KEIIEG------CIRQNKDERYSIKD 279

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  119 bits (301), Expect = 1e-29
 Identities = 68/317 (21%), Positives = 127/317 (40%), Gaps = 57/317 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK--RLKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           + +G+GS G        +DG    +K   +   +   R+E  + + V+  +KHPN+V+ R
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP----LDWTTRISLVLGAARGLARIH 474
             +       +V DY   G L   ++  +G         LDW  +I L       L  +H
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICL------ALKHVH 142

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR--LG--GYKAPEQAE 530
                 K+ H ++KS N+ L K+G   + DFG++ +LN    +AR  +G   Y +PE  E
Sbjct: 143 DR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA 590
            K  + K+D+++ G +L E+ T +                 +A  +   V  ++   +  
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA--------------FEAGSMKNLVLKIISGSFPP 244

Query: 591 --EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE------VAKMIEDIRVEQ 642
               +  +L   +++   +  +           P  RP++        +AK IE     Q
Sbjct: 245 VSLHYSYDL---RSL---VSQLFKR-------NPRDRPSVNSILEKGFIAKRIEKFLSPQ 291

Query: 643 SPLGEEYDESRNSLSPS 659
               E   ++ +     
Sbjct: 292 LIAEEFCLKTFSKFGSQ 308

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  118 bits (298), Expect = 1e-29
 Identities = 71/326 (21%), Positives = 130/326 (39%), Gaps = 51/326 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVK 416
             LGKG+ G+V     D  G     +VAVK+L+ + P  +++F++ + ++  L    +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 417 LRA--YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            R   Y   ++   LV +YLP+G L   L  +R      LD +  +       +G+  + 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLG 144

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYK------AP 526
                 +  H ++ + N+L++      I+DFGL+  L L+    + R  G +      AP
Sbjct: 145 SR----RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG-QSPIFWYAP 199

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
           E       S+++DV+SFGV+L E+ T         +     +  E     L + +  + +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 586 -------EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                      AEV   EL            M      C    P+ RP+ + +   ++ +
Sbjct: 260 GQRLPAPPACPAEVH--EL------------MKL----CWAPSPQDRPSFSALGPQLDML 301

Query: 639 RVEQSPL-GEEYDESRNSLSPSLATT 663
                      +         SL+ +
Sbjct: 302 WSGSRGCETHAFTAHPEGKHHSLSFS 327

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  118 bits (299), Expect = 1e-29
 Identities = 53/229 (23%), Positives = 89/229 (38%), Gaps = 58/229 (25%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L+   +P A KE      V+  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 416 KLRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL-- 470
           +L              L+   +P G L   +  ++      +     ++  +  A+G+  
Sbjct: 81  RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNY 132

Query: 471 ------------ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA 518
                       AR                  NVL+       I+DFGL+ LL   +   
Sbjct: 133 LEDRRLVHRDLAAR------------------NVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 519 RLGGYK------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              G K      A E    +  + ++DV+S+GV + E++T G  P  Y 
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YD 221

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  120 bits (303), Expect = 3e-29
 Identities = 79/300 (26%), Positives = 135/300 (45%), Gaps = 51/300 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + LG G  G V+ A  +    VAVK +K  +  + + F    +V+  L+H  +VKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKL---- 248

Query: 422 YA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
           +A   KE   ++ +++  GSL   L  + G           I      A G+A I Q   
Sbjct: 249 HAVVTKEPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQR-- 303

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKR 533
                H +++++N+L+  + V  I+DFGL+ ++   +  AR G     K  APE      
Sbjct: 304 --NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS 361

Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAE 591
            + K+DV+SFG+LL+E++T GR P  YP  + P V    E+   +P+       E    E
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEVIRALERGYRMPR------PENCPEE 413

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDE 651
           +++               M+     C  ++PE+RPT   +  +++D          +Y+E
Sbjct: 414 LYNI--------------MMR----CWKNRPEERPTFEYIQSVLDDFYTATES---QYEE 452

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  116 bits (292), Expect = 5e-29
 Identities = 61/297 (20%), Positives = 112/297 (37%), Gaps = 69/297 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E++G G  G V+KA    DG    +KR+K  N  A +E    +  + KL H N+V     
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72

Query: 421 YYAKEEKL----------------LVYDYLPNGSLHSLLHGNRGPGRIP----LDWTTRI 460
           +   +                   +  ++   G+L   +   RG  ++     L+   +I
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQI 131

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
           +       G+  IH +    K+ + ++K SN+ L       I DFGL   L       R 
Sbjct: 132 TK------GVDYIHSK----KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS 181

Query: 521 GG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
            G   Y +PEQ   +   ++ D+Y+ G++L E+L     +             E +    
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA------------FETSKFFT 229

Query: 578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
                ++ + +  +   + LL+          +L         +PE RP  +E+ + 
Sbjct: 230 DLRDGIISDIFDKKE--KTLLQ---------KLLSK-------KPEDRPNTSEILRT 268

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  120 bits (302), Expect = 5e-29
 Identities = 74/301 (24%), Positives = 123/301 (40%), Gaps = 54/301 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             LG G  G VY+ V     + VAVK LK+      +EF +   V+ ++KHPN+V+L   
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +    ++ +++  G+L   L   R   R  +     + +    +  +  + ++    
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---- 337

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKRLS 535
              H N+ + N L+ +N +  ++DFGLS L+      A  G     K  APE     + S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397

Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-------EQAVDLPKWVRSVVKEE 587
            K+DV++FGVLL E+ T G +P  YP     +V E        E+    P+ V  +++  
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455

Query: 588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGE 647
           W                                 P  RP+ AE+ +  E +  E S   E
Sbjct: 456 WQWN------------------------------PSDRPSFAEIHQAFETMFQESSISDE 485

Query: 648 E 648
            
Sbjct: 486 V 486

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  113 bits (286), Expect = 3e-28
 Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 51/300 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRL---- 73

Query: 422 YA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
           YA   +E   ++ +Y+ NGSL   L    G     L     + +    A G+A I +   
Sbjct: 74  YAVVTQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEER-- 128

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKR 533
                H +++++N+L+       I+DFGL+ L+   +  AR G     K  APE      
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAE 591
            + K+DV+SFG+LL E++T GR P  YP  T P V +  E+   + +       +    E
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQNLERGYRMVR------PDNCPEE 238

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDE 651
           ++                M      C   +PE RPT   +  ++ED          +Y  
Sbjct: 239 LYQL--------------MRL----CWKERPEDRPTFDYLRSVLEDFFTATEG---QYQP 277

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  115 bits (290), Expect = 3e-28
 Identities = 69/322 (21%), Positives = 139/322 (43%), Gaps = 48/322 (14%)

Query: 339 TSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-IVAVKRLK-DANPCAR 396
            + L   ++  + + +D  +     LG G+ G V+K      G ++A K +  +  P  R
Sbjct: 18  EAFLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75

Query: 397 KEFEQYMDVIGKLKHPNVVKLRAYY--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIP 453
            +  + + V+ +   P +V    +Y  +  + ++ +  +++  GSL  +L   +  GRIP
Sbjct: 76  NQIIRELQVLHECNSPYIVG---FYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP 129

Query: 454 LDWTTRISL-VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
                ++S+ V+   +GL  + +++   K+ H +VK SN+L++  G   + DFG+S  L 
Sbjct: 130 EQILGKVSIAVI---KGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183

Query: 513 PVQAIARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE 570
              A + +G   Y +PE+ +    S ++D++S G+ L+E+  GR P   P P    ++  
Sbjct: 184 DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKELELM 241

Query: 571 EQAVDLPKWVRSVVKEEWTAEVFDQ------------ELLRYKNIEEELVSMLHVGL--- 615
                      +  +        ++            ELL Y  I  E    L  G+   
Sbjct: 242 FGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY--IVNEPPPKLPSGVFSL 299

Query: 616 -------ACVVSQPEKRPTMAE 630
                   C++  P +R  + +
Sbjct: 300 EFQDFVNKCLIKNPAERADLKQ 321

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  117 bits (294), Expect = 4e-28
 Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 48/300 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
             LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQL---- 244

Query: 422 YA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
           YA   +E   +V +Y+  GSL   L G  G     L     + +    A G+A + +   
Sbjct: 245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERM-- 299

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
                H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R
Sbjct: 300 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAE 591
            + K+DV+SFG+LL E+ T GR P  YP      V ++ E+   +P         E    
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMPC------PPECPES 409

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDE 651
           + D               M      C   +PE+RPT   +   +ED      P  +  + 
Sbjct: 410 LHDL--------------MCQ----CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 451

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  112 bits (283), Expect = 5e-28
 Identities = 71/291 (24%), Positives = 125/291 (42%), Gaps = 44/291 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + +G G  G V+     +   VA+K +++    + ++F +  +V+ KL HP +V+L    
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +    LV +++ +G L   L   RG         T + + L    G+A + +      
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEEA----C 124

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKRLSQ 536
           V H ++ + N L+ +N V  +SDFG++  +   Q  +  G     K  +PE     R S 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 537 KADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVFD 594
           K+DV+SFGVL+ EV + G+ P  Y + +   V E+      L K          +  V+ 
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLYK------PRLASTHVYQ 236

Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
                          M H    C   +PE RP  + + + + +I   +S L
Sbjct: 237 I--------------MNH----CWRERPEDRPAFSRLLRQLAEIA--ESGL 267

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (285), Expect = 5e-28
 Identities = 62/308 (20%), Positives = 110/308 (35%), Gaps = 79/308 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + LG+G  G V++A    D    A+KR++      AR++  + +  + KL+HP +V+   
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR--- 67

Query: 420 YYYAKEEK------------LLVY---DYLPNGSLHSLLHGNRGPGRIP----LDWTTRI 460
           Y+ A  EK            + +Y         +L   ++G            L    +I
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
                 A  +  +H +     + H ++K SN+    + V  + DFGL   ++  +    +
Sbjct: 128 ------AEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177

Query: 521 GG----------------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR 564
                             Y +PEQ      S K D++S G++L E+L             
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------------ 225

Query: 565 PRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELV-SMLHVGLACVVSQPE 623
           P   + E+   L   VR+          F     +    E  +V  ML          P 
Sbjct: 226 PFSTQMERVRTLTD-VRN--------LKFPPLFTQKYPCEYVMVQDMLSP-------SPM 269

Query: 624 KRPTMAEV 631
           +RP    +
Sbjct: 270 ERPEAINI 277

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  113 bits (284), Expect = 6e-28
 Identities = 64/308 (20%), Positives = 124/308 (40%), Gaps = 63/308 (20%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVK 416
           + LGKG+ G+V     D        +VAVK+L+ +     ++FE+ ++++  L+H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 417 LRA--YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
            +   Y   +    L+ +YLP GSL   L  ++      +D    +       +G+  + 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLG 131

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYK------AP 526
            +    +  H ++ + N+L++      I DFGL+  L  +      +  G +      AP
Sbjct: 132 TK----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG-ESPIFWYAP 186

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
           E     + S  +DV+SFGV+L E+ T    S+ P     R+   +      +    V   
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-----KQGQMIV--- 238

Query: 587 EWTAEVFDQELLRYKNIEE---------------ELVSMLHVGLACVVSQPEKRPTMAEV 631
                + +        ++                 +  M      C  +   +RP+  ++
Sbjct: 239 ---FHLIEL-------LKNNGRLPRPDGCPDEIYMI--MTE----CWNNNVNQRPSFRDL 282

Query: 632 AKMIEDIR 639
           A  ++ IR
Sbjct: 283 ALRVDQIR 290

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  113 bits (284), Expect = 6e-28
 Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 42/295 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI-VAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             LG G  G VY+ V     + VAVK LK+      +EF +   V+ ++KHPN+V+L   
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +    ++ +++  G+L   L   R   R  +     + +    +  +  + ++    
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---- 130

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKRLS 535
              H ++ + N L+ +N +  ++DFGLS L+      A  G     K  APE     + S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVF 593
            K+DV++FGVLL E+ T G +P  YP     +V E  E+   + +       E    +V+
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP--YPGIDLSQVYELLEKDYRMER------PEGCPEKVY 242

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEE 648
           +               M      C    P  RP+ AE+ +  E +  E S   E 
Sbjct: 243 EL--------------MRA----CWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  113 bits (285), Expect = 8e-28
 Identities = 69/304 (22%), Positives = 125/304 (41%), Gaps = 55/304 (18%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVK 416
           + LGKG+ G+V     D        +VAVK+L+ +     ++FE+ ++++  L+H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 417 LRA--YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG---LA 471
            +   Y   +    L+ +YLP GSL   L  ++      +D    +       +G   L 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLG 162

Query: 472 R---IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYK-- 524
               IH++  T           N+L++      I DFGL+  L  +      +  G +  
Sbjct: 163 TKRYIHRDLATR----------NILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG-ESP 211

Query: 525 ----APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
               APE     + S  +DV+SFGV+L E+ T    S+ P     R+   +      +  
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND-----KQGQ 266

Query: 581 RSVVKEEWTAEVFDQ-----ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
             V        + +       L R     +E+  ++     C  +   +RP+  ++A  +
Sbjct: 267 MIV------FHLIELLKNNGRLPRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLALRV 317

Query: 636 EDIR 639
           + IR
Sbjct: 318 DQIR 321

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  113 bits (285), Expect = 8e-28
 Identities = 70/324 (21%), Positives = 126/324 (38%), Gaps = 56/324 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L+   +P A KE      V+  + +P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 416 KLRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           +L              L+   +P G L   +  ++      +     ++  +  A+G+  
Sbjct: 81  RL----LGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNY 132

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------AP 526
           +       ++ H ++ + NVL+       I+DFGL+ LL   +      G K      A 
Sbjct: 133 LEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVV 584
           E    +  + ++DV+S+GV + E++T G  P  Y       +    E+   LP+      
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSILEKGERLPQ------ 240

Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI-RVEQS 643
               T +V+                M+     C +   + RP   E+      + R  Q 
Sbjct: 241 PPICTIDVYM--------------IMVK----CWMIDADSRPKFRELIIEFSKMARDPQR 282

Query: 644 PLGEEYDESRNSLSPSLATTEDGL 667
            L  + DE  +  SP+ +     L
Sbjct: 283 YLVIQGDERMHLPSPTDSNFYRAL 306

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  112 bits (283), Expect = 8e-28
 Identities = 79/323 (24%), Positives = 123/323 (38%), Gaps = 61/323 (18%)

Query: 349 KQFEL--EDLLRASAEMLGKGSLGTVYKAVLDDGG---IVAVKRLK-DANPCARKEFEQY 402
           K+  L  ++LL A  E LG G+ G+V + V         VA+K LK        +E  + 
Sbjct: 2   KKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 60

Query: 403 MDVIGKLKHPNVVKLRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR 459
             ++ +L +P +V+L          E  +LV +    G LH  L G R      +  +  
Sbjct: 61  AQIMHQLDNPYIVRL----IGVCQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNV 112

Query: 460 ISLVLGAARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQA 516
             L+   + G+      Y       H ++ + NVLL     A ISDFGLS  L  +    
Sbjct: 113 AELLHQVSMGMK-----YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167

Query: 517 IARLGGYK------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            AR  G K      APE    ++ S ++DV+S+GV + E L+ G+ P  Y     P V  
Sbjct: 168 TARSAG-KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMA 224

Query: 570 E-EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM 628
             EQ   +          E   E++                M      C + + E RP  
Sbjct: 225 FIEQGKRMEC------PPECPPELYA--------------LMSD----CWIYKWEDRPDF 260

Query: 629 AEVAKMIEDIRVEQSPLGEEYDE 651
             V + +       +   E +  
Sbjct: 261 LTVEQRMRACYYSLASKVEGHHH 283

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (285), Expect = 8e-28
 Identities = 67/304 (22%), Positives = 120/304 (39%), Gaps = 44/304 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
             LG+G  G V     D        +VAVK LK DA P  R  ++Q +D++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 416 KLRA--YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           K +            LV +Y+P GSL   L  +       +     +        G+   
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGM--- 147

Query: 474 HQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYK------ 524
              Y       H ++ + NVLLD + +  I DFGL+  +         R  G        
Sbjct: 148 --AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG-DSPVFWY 204

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV 583
           APE  +  +    +DV+SFGV L E+LT   +    P+     +   +  + + + +  +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTEL 263

Query: 584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE-- 641
           ++         + L R      E+  ++     C  ++   RPT   +  +++ +  +  
Sbjct: 264 LER-------GERLPRPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKTVHEKYQ 313

Query: 642 -QSP 644
            Q+P
Sbjct: 314 GQAP 317

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  112 bits (283), Expect = 9e-28
 Identities = 82/324 (25%), Positives = 123/324 (37%), Gaps = 61/324 (18%)

Query: 347 RKKQFELE-DLLRASAEMLGKGSLGTVYKAVLDDGGI---VAVKRLKDA--NPCARKEFE 400
           R K+  L+  LL    + LG G+ GTV K       +   VAVK LK+   +P  + E  
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66

Query: 401 QYMDVIGKLKHPNVVKLRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWT 457
              +V+ +L +P +V++          E  +LV +    G L+  L  NR      +   
Sbjct: 67  AEANVMQQLDNPYIVRM----IGICEAESWMLVMEMAELGPLNKYLQQNR-----HVKDK 117

Query: 458 TRISLVLGAARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPV 514
             I LV   + G+      Y   +   H ++ + NVLL     A ISDFGLS  L  +  
Sbjct: 118 NIIELVHQVSMGMK-----YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

Query: 515 QAIARLGGYK------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRV 567
              A+  G K      APE     + S K+DV+SFGVL+ E  + G+ P  Y       V
Sbjct: 173 YYKAQTHG-KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEV 229

Query: 568 DEE-EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP 626
               E+   +              E++D               M      C     E RP
Sbjct: 230 TAMLEKGERMGC------PAGCPREMYDL--------------MNL----CWTYDVENRP 265

Query: 627 TMAEVAKMIEDIRVEQSPLGEEYD 650
             A V   + +   +    G  + 
Sbjct: 266 GFAAVELRLRNYYYDVVNEGHHHH 289

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  112 bits (282), Expect = 2e-27
 Identities = 58/217 (26%), Positives = 95/217 (43%), Gaps = 34/217 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G  GTV+K V    G      V +K ++  +   + +    +M  IG L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 416 KLRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIP--LDWTTRISLVLGAARGL 470
           +L              LV  YLP GSL   +  +RG       L+W  +I      A+G+
Sbjct: 79  RL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGM 128

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------ 524
             + +      + H N+ + NVLL       ++DFG++ LL P          K      
Sbjct: 129 YYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
           A E     + + ++DV+S+GV + E++T G  P  Y 
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YA 219

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  111 bits (280), Expect = 2e-27
 Identities = 64/310 (20%), Positives = 122/310 (39%), Gaps = 37/310 (11%)

Query: 345 YERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG-----IVAVKRLK-DANPCARKE 398
                 FE   L R     LG+G  G V     D  G      VAVK LK ++      +
Sbjct: 12  EVDPTHFEKRFLKRI--RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD 69

Query: 399 FEQYMDVIGKLKHPNVVKLRAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDW 456
            ++ ++++  L H N+VK +            L+ ++LP+GSL   L  N+      ++ 
Sbjct: 70  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INL 125

Query: 457 TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPV 514
             ++   +   +G+  +       +  H ++ + NVL++      I DFGL+  +  +  
Sbjct: 126 KQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

Query: 515 QAIARLGG-----YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVD 568
               +        + APE     +    +DV+SFGV L E+LT   + S   +     + 
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

Query: 569 EEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM 628
                + + + + + +KE        + L    N  +E+  ++     C   QP  R + 
Sbjct: 242 PTHGQMTVTR-LVNTLKE-------GKRLPCPPNCPDEVYQLM---RKCWEFQPSNRTSF 290

Query: 629 AEVAKMIEDI 638
             + +  E +
Sbjct: 291 QNLIEGFEAL 300

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  111 bits (279), Expect = 3e-27
 Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 40/247 (16%)

Query: 333 GTSGTDTSKLVFYERK-KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI----VAVKR 387
           G++G    + +      K   L        E LG GS G V +   D        VAVK 
Sbjct: 1   GSAGEGPLQSLTCLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKC 53

Query: 388 LKD---ANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA---KEEKLLVYDYLPNGSLHS 441
           LK    + P A  +F + ++ +  L H N+++L    Y         +V +  P GSL  
Sbjct: 54  LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL----YGVVLTPPMKMVTELAPLGSLLD 109

Query: 442 LLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC 501
            L  ++  G   L   T     +  A G+  +  +    +  H ++ + N+LL    +  
Sbjct: 110 RLRKHQ--GHFLL--GTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVK 161

Query: 502 ISDFGLS--LLLNPVQAIARLGG---YK--APEQAEVKRLSQKADVYSFGVLLLEVLT-G 553
           I DFGL   L  N    + +      +   APE  + +  S  +D + FGV L E+ T G
Sbjct: 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221

Query: 554 RAPSQYP 560
           + P  + 
Sbjct: 222 QEP--WI 226

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  114 bits (288), Expect = 4e-27
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 46/299 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
             LG+G  G V+    +    VA+K LK     + + F Q   V+ KL+H  +V+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQL---- 327

Query: 422 YA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
           YA   +E   +V +Y+  GSL   L G  G     L     + +    A G+A + +   
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERM-- 382

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEVKR 533
                H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      + APE A   R
Sbjct: 383 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 534 LSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
            + K+DV+SFG+LL E+ T GR P  YP      V            +  V +       
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVP--YPGMVNREV------------LDQVERGYR---- 482

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDE 651
               +       E L  ++     C   +PE+RPT   +   +ED      P  +  + 
Sbjct: 483 ----MPCPPECPESLHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 534

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  115 bits (290), Expect = 4e-27
 Identities = 60/273 (21%), Positives = 107/273 (39%), Gaps = 37/273 (13%)

Query: 302 SSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASA 361
              +++KQ  RS +   SE   YA   ++ D  +           R  + + E +     
Sbjct: 345 KLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP-------STRDYEIQRERIELG-- 395

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
             +G+G  G V++ +          VA+K  K   +   R++F Q    + +  HP++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 417 LRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           L         +    ++ +    G L S L   +      LD  + I      +  LA +
Sbjct: 456 L----IGVITENPVWIIMELCTLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYL 507

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQ 528
             +    +  H ++ + NVL+  N    + DFGLS  +          G     + APE 
Sbjct: 508 ESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 563

Query: 529 AEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              +R +  +DV+ FGV + E+L  G  P  + 
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKP--FQ 594

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  110 bits (277), Expect = 6e-27
 Identities = 72/305 (23%), Positives = 124/305 (40%), Gaps = 54/305 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           E++G+G  G VY   L D        AVK L    +     +F     ++    HPNV+ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 417 LRAYYYAKEEKLL-VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           L       E   L V  Y+ +G L + +                I   L  A+G+     
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGM----- 141

Query: 476 EYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLSLLL---NPVQAIARLGG-----YKA 525
           +Y  +K  V H ++ + N +LD+     ++DFGL+  +          + G      + A
Sbjct: 142 KYLASKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 200

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
            E  + ++ + K+DV+SFGVLL E++T G  P  YP      V+  +        +   +
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPD-----VNTFD--------ITVYL 245

Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
            +        + LL+ +   + L  ++   L C   + E RP+ +E+   I  I    + 
Sbjct: 246 LQ-------GRRLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIF--STF 293

Query: 645 LGEEY 649
           +GE Y
Sbjct: 294 IGEHY 298

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  110 bits (276), Expect = 6e-27
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
             +G+G  G V++ +          VA+K  K   +   R++F Q    + +  HP++VK
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 417 LRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           L         +    ++ +    G L S L   +      LD  + I      +  LA  
Sbjct: 81  L----IGVITENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALA-- 130

Query: 474 HQEYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------A 525
              Y  +K  V H ++ + NVL+  N    + DFGLS  +          G K      A
Sbjct: 131 ---YLESKRFV-HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMA 185

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
           PE    +R +  +DV+ FGV + E+L  G  P  + 
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQ 219

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  109 bits (274), Expect = 8e-27
 Identities = 69/289 (23%), Positives = 119/289 (41%), Gaps = 42/289 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + LG G  G V          VAVK +K+ +  +  EF Q    + KL HP +VK     
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +    +V +Y+ NG L + L  +       L+ +  + +      G+A +       +
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESH----Q 124

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKRLSQ 536
             H ++ + N L+D++    +SDFG++  +   Q ++ +G     K  APE     + S 
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184

Query: 537 KADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVFD 594
           K+DV++FG+L+ EV + G+ P  Y   T   V  +  Q   L +          +  ++ 
Sbjct: 185 KSDVWAFGILMWEVFSLGKMP--YDLYTNSEVVLKVSQGHRLYR------PHLASDTIYQ 236

Query: 595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS 643
                          M      C    PEKRPT  ++   IE +R +  
Sbjct: 237 I--------------MYS----CWHELPEKRPTFQQLLSSIEPLREKDK 267

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  110 bits (278), Expect = 8e-27
 Identities = 76/307 (24%), Positives = 120/307 (39%), Gaps = 52/307 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L   G     VA+K LK       R++F     ++G+  HPN+++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          ++V +Y+ NGSL + L  + G           + ++ G   G+      
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMR----- 165

Query: 477 Y-GTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYK------APE 527
           Y       H ++ + NVL+D N V  +SDFGLS  L  +P  A    GG K      APE
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGG-KIPIRWTAPE 224

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVK 585
               +  S  +DV+SFGV++ EVL  G  P  Y + T   V    E+   LP        
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERP--YWNMTNRDVISSVEEGYRLPA------P 276

Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
                 +                 ML     C      +RP  +++  +++ +      L
Sbjct: 277 MGCPHALHQL--------------MLD----CWHKDRAQRPRFSQIVSVLDALIRSPESL 318

Query: 646 GEEYDES 652
                 S
Sbjct: 319 RATATVS 325

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  109 bits (275), Expect = 8e-27
 Identities = 47/205 (22%), Positives = 89/205 (43%), Gaps = 17/205 (8%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + LG G  G V          VA+K +K+ +  +  EF +   V+  L H  +V+L    
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +    ++ +Y+ NG L + L   R            + +       +  +  +    +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESK----Q 140

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKRLSQ 536
             H ++ + N L++  GV  +SDFGLS  +   +  + +G     +   PE     + S 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 537 KADVYSFGVLLLEVLT-GRAPSQYP 560
           K+D+++FGVL+ E+ + G+ P  Y 
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMP--YE 223

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  108 bits (273), Expect = 1e-26
 Identities = 63/303 (20%), Positives = 109/303 (35%), Gaps = 55/303 (18%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI----VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
            +LG+G  G VY+ V  +       VAVK  K D     +++F     ++  L HP++VK
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 417 LRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           L         +E   ++ +  P G L   L  N+      L   T +   L   + +A +
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYL 129

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------APE 527
                     H ++   N+L+       + DFGLS  +            +      +PE
Sbjct: 130 ESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVT-RLPIKWMSPE 184

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVK 585
               +R +  +DV+ F V + E+L+ G+ P  +       V    E+   LPK       
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP--FFWLENKDVIGVLEKGDRLPK------P 236

Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
           +     ++   L            M      C    P  RP   E+   + D+   +  +
Sbjct: 237 DLCPPVLY--TL------------MTR----CWDYDPSDRPRFTELVCSLSDVYQMEKDI 278

Query: 646 GEE 648
             E
Sbjct: 279 AME 281

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  111 bits (278), Expect = 2e-26
 Identities = 81/365 (22%), Positives = 141/365 (38%), Gaps = 54/365 (14%)

Query: 302 SSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASA 361
             I S ++   S       + +Y  G N           +LV   +        L+    
Sbjct: 35  DGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFN 94

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
           E++G+G  G VY   L D        AVK L    +     +F     ++    HPNV+ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 417 LRAYYYAKEEKLL-VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           L       E   L V  Y+ +G L + +                I   L  A+G+     
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGM----- 205

Query: 476 EYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGGYK------A 525
           ++  +K  V H ++ + N +LD+     ++DFGL+  +      ++    G K      A
Sbjct: 206 KFLASKKFV-HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
            E  + ++ + K+DV+SFGVLL E++T G  P  YP      V+  +        +   +
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPD-----VNTFD--------ITVYL 309

Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
            +        + LL+ +   + L  ++   L C   + E RP+ +E+   I  I    + 
Sbjct: 310 LQ-------GRRLLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIF--STF 357

Query: 645 LGEEY 649
           +GE Y
Sbjct: 358 IGEHY 362

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  109 bits (274), Expect = 2e-26
 Identities = 68/287 (23%), Positives = 102/287 (35%), Gaps = 58/287 (20%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKL-KHPNVVKL 417
             LG GS G V+K    +DG + AVKR       P  R      +    K+ +HP  V+ 
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR- 121

Query: 418 RAYYYAKEEKLLVY---DYLPNGSLHSLLHGNRGPGRIP----LDWTTRISLVLGAARGL 470
                A EE  ++Y   +     SL            +P      +     L       L
Sbjct: 122 --LEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLL------AL 170

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPE 527
           A +H +     + H +VK +N+ L   G   + DFGL + L    A     G   Y APE
Sbjct: 171 AHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
             +       ADV+S G+ +LEV           P               +  +  +  E
Sbjct: 227 LLQ-GSYGTAADVFSLGLTILEVACNM-----ELP--------HGGEGWQQLRQGYLPPE 272

Query: 588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
           +TA     EL   +++   LV ML          P+ R T   +  +
Sbjct: 273 FTAG-LSSEL---RSV---LVMMLEP-------DPKLRATAEALLAL 305

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  113 bits (283), Expect = 2e-26
 Identities = 69/232 (29%), Positives = 102/232 (43%), Gaps = 33/232 (14%)

Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAVL--DDGGI-VAVKRLK-DANPCARKEFEQ 401
           + KK F   D L  +   LG G+ G+V + V       I VA+K LK        +E  +
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385

Query: 402 YMDVIGKLKHPNVVKLRAYYYA---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTT 458
              ++ +L +P +V+L          E  +LV +    G LH  L G R      +  + 
Sbjct: 386 EAQIMHQLDNPYIVRL----IGVCQAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSN 437

Query: 459 RISLVLGAARGLARIHQEYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPV 514
              L+   + G+      Y   K  V H N+ + NVLL     A ISDFGLS  L  +  
Sbjct: 438 VAELLHQVSMGMK-----YLEEKNFV-HRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

Query: 515 QAIARLGG---YK--APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
              AR  G    K  APE    ++ S ++DV+S+GV + E L+ G+ P  Y 
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YK 541

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  108 bits (273), Expect = 3e-26
 Identities = 64/320 (20%), Positives = 108/320 (33%), Gaps = 91/320 (28%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           + LG+G    V     L DG   A+KR+       R+E ++  D+     HPN+++L AY
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 421 YY----AKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIP----LDWTTRISLVLGAARGLA 471
                 AK E  L+  +   G+L + +         +     L     I       RGL 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI------CRGLE 148

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-----------QAIARL 520
            IH +       H ++K +N+LL   G   + D G                      A+ 
Sbjct: 149 AIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 521 G--GYKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP----------------SQY 559
               Y+APE   V+    + ++ DV+S G +L  ++ G  P                +Q 
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264

Query: 560 PSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVV 619
             P  PR             +  ++                        SM+ V      
Sbjct: 265 SIPQSPRHSSA---------LWQLLN-----------------------SMMTV------ 286

Query: 620 SQPEKRPTMAEVAKMIEDIR 639
             P +RP +  +   +E ++
Sbjct: 287 -DPHQRPHIPLLLSQLEALQ 305

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  108 bits (271), Expect = 3e-26
 Identities = 51/243 (20%), Positives = 94/243 (38%), Gaps = 48/243 (19%)

Query: 343 VFYE-RKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGI--------VAVKRLKDANP 393
           VF++ R +            E LG+G+   ++K V  + G         V +K L  A+ 
Sbjct: 1   VFHKIRNEDLIFN-------ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR 53

Query: 394 CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP 453
              + F +   ++ KL H ++V         +E +LV +++  GSL + L  N+      
Sbjct: 54  NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----C 109

Query: 454 LDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC--------ISDF 505
           ++   ++ +    A  +  + +      + HGNV + N+LL +             +SD 
Sbjct: 110 INILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 506 GLSLLLNPVQAIARLGGYK------APEQ-AEVKRLSQKADVYSFGVLLLEVLT-GRAPS 557
           G+S        +      +       PE     K L+   D +SFG  L E+ + G  P 
Sbjct: 166 GIS------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP- 218

Query: 558 QYP 560
              
Sbjct: 219 -LS 220

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  107 bits (270), Expect = 5e-26
 Identities = 69/313 (22%), Positives = 132/313 (42%), Gaps = 66/313 (21%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
             LG+G+ G V+ A   +        +VAVK LKD    ARK+F++  +++  L+H ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-----------ISLVL 464
           K        +  ++V++Y+ +G L+  L  +     I +D   R           + +  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 465 GAARG---LAR---IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA 518
             A G   LA    +H++  T           N L+  N +  I DFG+S  +       
Sbjct: 141 QIASGMVYLASQHFVHRDLATR----------NCLVGANLLVKIGDFGMSRDVYSTDYYR 190

Query: 519 RLGGYK------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEE 571
             G          PE    ++ + ++DV+SFGV+L E+ T G+ P  +   +    + E 
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP--WFQLS----NTE- 243

Query: 572 QAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
                   V   + +        + L R +   +E+  ++   L C   +P++R  + E+
Sbjct: 244 --------VIECITQ-------GRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKEI 285

Query: 632 AKMIEDIRVEQSP 644
            K++  +  + +P
Sbjct: 286 YKILHALG-KATP 297

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  110 bits (277), Expect = 6e-26
 Identities = 78/299 (26%), Positives = 118/299 (39%), Gaps = 62/299 (20%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + +GKG  G V       G  VAVK +K+      + F     V+ +L+H N+V+L    
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQL---- 251

Query: 422 YA--KEEKLLVY---DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
                EEK  +Y   +Y+  GSL   L   R  GR  L     +   L     +  +   
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK--APEQAEVKRL 534
                  H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   K  APE    K+ 
Sbjct: 309 ----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKF 363

Query: 535 SQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-------EQAVDLPKWVRSVVKE 586
           S K+DV+SFG+LL E+ + GR P  YP      V          +     P  V  V+K 
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
            W  +                                 RPT  ++ + +E IR  +  L
Sbjct: 422 CWHLD------------------------------AATRPTFLQLREQLEHIRTHELHL 450

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (273), Expect = 6e-26
 Identities = 39/218 (17%), Positives = 77/218 (35%), Gaps = 27/218 (12%)

Query: 362 EMLGKGSLGTVYKAVLDD------GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
            +LG+G+   VY+A   D           +K  K ANP       Q M+ +        +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           K  + +  +   +LV +    G+L + ++  +      +     IS  +     + ++H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 476 EYGTAKVPHGNVKSSNVLL-----------DKNGVACISDFGLS----LLLNPVQAIARL 520
                ++ HG++K  N +L           D +    + D G S    L        A+ 
Sbjct: 191 ----CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246

Query: 521 G--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              G++  E    K  + + D +     +  +L G   
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (268), Expect = 6e-26
 Identities = 72/292 (24%), Positives = 119/292 (40%), Gaps = 48/292 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + +GKG  G V       G  VAVK +K+      + F     V+ +L+H N+V+L    
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 422 YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
             ++  L +V +Y+  GSL   L   R  GR  L     +   L     +  +       
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---- 136

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YK--APEQAEVKRLS 535
              H ++ + NVL+ ++ VA +SDFGL+       +  +  G    K  APE    K+ S
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 192

Query: 536 QKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSVVKEEWTAEVF 593
            K+DV+SFG+LL E+ + GR P  YP      V    E+   +         +     V+
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRVEKGYKMDA------PDGCPPAVY 244

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPL 645
           +               M +    C       RP+  ++ + +E I+  +  L
Sbjct: 245 EV--------------MKN----CWHLDAAMRPSFLQLREQLEHIKTHELHL 278

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  109 bits (273), Expect = 9e-26
 Identities = 56/311 (18%), Positives = 105/311 (33%), Gaps = 53/311 (17%)

Query: 362 EMLGKG--SLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVK 416
            ++GKG   L TV  A     G  V V+R  L+  +       +  + V     HPN+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 417 LRAYY--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLAR 472
              Y   +  + +L +V  ++  GS   L+        +       I+ +L G  + L  
Sbjct: 91  ---YRATFIADNELWVVTSFMAYGSAKDLIC-THFMDGMNELA---IAYILQGVLKALDY 143

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-------- 524
           IH         H +VK+S++L+  +G   +S    +L +       R+            
Sbjct: 144 IHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 525 ---APE--QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTR----------PRVDE 569
              +PE  Q  ++    K+D+YS G+   E+  G  P +    T+          P + +
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGL----------ACVV 619
                     +        +           +    +  S  +              C+ 
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319

Query: 620 SQPEKRPTMAE 630
             P+ RP+ + 
Sbjct: 320 RNPDARPSAST 330

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (268), Expect = 1e-25
 Identities = 68/305 (22%), Positives = 117/305 (38%), Gaps = 54/305 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNVVK 416
            ++GKG  G VY     D        A+K L         + F +   ++  L HPNV+ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 417 LRAYYYAKEE-KLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           L       E    ++  Y+ +G L   +   +            IS  L  ARG+     
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGME---- 138

Query: 476 EYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK--------A 525
            Y   +  V H ++ + N +LD++    ++DFGL+  +   +  +              A
Sbjct: 139 -YLAEQKFV-HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
            E  +  R + K+DV+SFGVLL E+LT G  P  Y       +D  +        +   +
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP--YRH-----IDPFD--------LTHFL 241

Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
            +        + L + +   + L  ++     C  + P  RPT   +   +E I    + 
Sbjct: 242 AQ-------GRRLPQPEYCPDSLYQVM---QQCWEADPAVRPTFRVLVGEVEQIV--SAL 289

Query: 645 LGEEY 649
           LG+ Y
Sbjct: 290 LGDHY 294

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  106 bits (267), Expect = 3e-25
 Identities = 71/318 (22%), Positives = 130/318 (40%), Gaps = 57/318 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGGI-----VAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
           +++G G  G VYK +L          VA+K LK       R +F     ++G+  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L       +  +++ +Y+ NG+L   L    G           + ++ G A G+     
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMK---- 161

Query: 476 EYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGGYK------A 525
            Y      V H ++ + N+L++ N V  +SDFGLS +L  +P       GG K      A
Sbjct: 162 -YLANMNYV-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG-KIPIRWTA 218

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE-EQAVDLPKWVRSV 583
           PE    ++ +  +DV+SFG+++ EV+T G  P  Y   +   V +       LP      
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP--YWELSNHEVMKAINDGFRLPT----- 271

Query: 584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS 643
              +  + ++                M+     C   +  +RP  A++  +++ +     
Sbjct: 272 -PMDCPSAIYQL--------------MMQ----CWQQERARRPKFADIVSILDKLIRAPD 312

Query: 644 PLGE--EYDESRNSLSPS 659
            L    ++D   +   PS
Sbjct: 313 SLKTLADFDPRVSIRLPS 330

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  107 bits (268), Expect = 3e-25
 Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 27/214 (12%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L         VA+K LK       R++F     ++G+  HPN+++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L       +  ++V +Y+ NGSL S L  +             + ++ G A G+      
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMK----- 161

Query: 477 Y-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL--NPVQAIARLGGYK------APE 527
           Y       H ++ + N+L++ N V  +SDFGL  +L  +P  A    GG K      +PE
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG-KIPIRWTSPE 220

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
               ++ +  +DV+S+G++L EV++ G  P  Y 
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERP--YW 252

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  105 bits (265), Expect = 3e-25
 Identities = 68/317 (21%), Positives = 118/317 (37%), Gaps = 48/317 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
             LG+GS G VY+ V            VA+K + + A+   R EF     V+ +    +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARG 469
           V+L       +  L++ + +  G L S L   R      P   P   +  I +    A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK----- 524
           +A ++      K  H ++ + N ++ ++    I DFG++  +       + G        
Sbjct: 151 MAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206

Query: 525 -APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            +PE  +    +  +DV+SFGV+L E+ T    P  Y   +    +E+         V  
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLS----NEQ---------VLR 251

Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
            V E          L +  N  + L  ++     C    P+ RP+  E+   I++     
Sbjct: 252 FVME-------GGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIISSIKEEMEPG 301

Query: 643 SPLGEEYDESRNSLSPS 659
                 Y    N L   
Sbjct: 302 FREVSFYYSEENKLPEP 318

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  105 bits (263), Expect = 5e-25
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 55/291 (18%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPN--VVKL 417
           + +G G    V++ + +   I A+K   L++A+      +   +  + KL+  +  +++L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             Y    +   +V +   N  L+S L        I           +     +  IHQ  
Sbjct: 94  YDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH- 146

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYKAPE---- 527
               + H ++K +N L+  +G+  + DFG++  + P               Y  PE    
Sbjct: 147 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202

Query: 528 -------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
                       ++S K+DV+S G +L  +  G+ P Q             Q   L   +
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISKLHAII 253

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
               + E+               E++L  +L     C+   P++R ++ E+
Sbjct: 254 DPNHEIEF-----------PDIPEKDLQDVLK---CCLKRDPKQRISIPEL 290

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  104 bits (261), Expect = 8e-25
 Identities = 62/249 (24%), Positives = 105/249 (42%), Gaps = 43/249 (17%)

Query: 362 EMLGKGSLGTVYKA---VLDDGGIVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNVV 415
           + LG G + TVY A   +L+    VA+K +           K FE+ +    +L H N+V
Sbjct: 17  DKLGGGGMSTVYLAEDTILNI--KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 416 KLRAYYYAKEEKL--LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +      +E+    LV +Y+   +L   +  +      PL   T I+       G+   
Sbjct: 75  SM--IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHA 127

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---QAIARLG--GYKAPEQ 528
           H      ++ H ++K  N+L+D N    I DFG++  L+     Q    LG   Y +PEQ
Sbjct: 128 HD----MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ 183

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAP-------------SQYPSPTRPRVDEEEQAVD 575
           A+ +   +  D+YS G++L E+L G  P              Q   P        +   D
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT----DVRKD 239

Query: 576 LPKWVRSVV 584
           +P+ + +V+
Sbjct: 240 IPQSLSNVI 248

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (264), Expect = 8e-25
 Identities = 76/327 (23%), Positives = 116/327 (35%), Gaps = 73/327 (22%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
             LG G+ G VY+  +           VAVK L +  +     +F     +I K  H N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLAR 472
           V+          + ++ + +  G L S L   R     P        + +    A G   
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC-- 194

Query: 473 IHQEY-GTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGGYK---- 524
              +Y       H ++ + N LL   G   VA I DFG++      + I R G Y+    
Sbjct: 195 ---QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKGGC 245

Query: 525 --------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVD 575
                    PE       + K D +SFGVLL E+ + G  P  YPS +    ++E     
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKS----NQE----- 294

Query: 576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
               V   V            +   KN    +  ++     C   QPE RP  A + + I
Sbjct: 295 ----VLEFVTS-------GGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERI 340

Query: 636 EDIR-----------VEQSPLGEEYDE 651
           E              +E  PL EE ++
Sbjct: 341 EYCTQDPDVINTALPIEYGPLVEEEEK 367

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  104 bits (262), Expect = 9e-25
 Identities = 68/319 (21%), Positives = 125/319 (39%), Gaps = 51/319 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNVV 415
            MLGKG  G+V +A L         VAVK LK         +EF +    + +  HP+V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 416 KL------RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGR-IPLDWTTRISLVLGAAR 468
           KL                +++  ++ +G LH+ L  +R       L   T +  ++  A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 469 GLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK--- 524
           G+     EY  +    H ++ + N +L ++   C++DFGLS  +       +    K   
Sbjct: 149 GM-----EYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 525 ---APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
              A E       +  +DV++FGV + E++T G+ P  Y       ++  E        +
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAG-----IENAE--------I 248

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV 640
            + +            L +     EE+  ++     C  + P++RP+   +   +E+I  
Sbjct: 249 YNYLIG-------GNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELENILG 298

Query: 641 EQSPLGEEYDESRNSLSPS 659
             S L    D    ++  +
Sbjct: 299 HLSVLSTSQDPLYINIERA 317

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (261), Expect = 9e-25
 Identities = 81/328 (24%), Positives = 139/328 (42%), Gaps = 80/328 (24%)

Query: 337 TDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPC 394
            D+S L +   +  +EL+       E++G G+   V  A        VA+KR+  +    
Sbjct: 3   EDSSALPWSINRDDYELQ-------EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQT 55

Query: 395 ARKEFEQYMDVIGKLKHPNVVKLRAYY--YAKEEKL-LVYDYLPNGSLHSLL-----HGN 446
           +  E  + +  + +  HPN+V    YY  +  +++L LV   L  GS+  ++      G 
Sbjct: 56  SMDELLKEIQAMSQCHHPNIVS---YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGE 112

Query: 447 RGPGRIPLDWTTRISLVL-GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF 505
              G +       I+ +L     GL  +H+        H +VK+ N+LL ++G   I+DF
Sbjct: 113 HKSGVLDEST---IATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADF 165

Query: 506 GLSLLLNPVQAIARLGGYK---------APEQAEVKRLS---QKADVYSFGVLLLEVLTG 553
           G+S  L     I R    K         APE   ++++     KAD++SFG+  +E+ TG
Sbjct: 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPE--VMEQVRGYDFKADIWSFGITAIELATG 223

Query: 554 RAP-SQYPSPTR----------PRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKN 602
            AP  +YP P +          P ++   Q  ++ K        ++    F         
Sbjct: 224 AAPYHKYP-PMKVLMLTLQNDPPSLETGVQDKEMLK--------KYGKS-F--------- 264

Query: 603 IEEELVSMLHVGLACVVSQPEKRPTMAE 630
              +++S+      C+   PEKRPT AE
Sbjct: 265 --RKMISL------CLQKDPEKRPTAAE 284

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  104 bits (261), Expect = 9e-25
 Identities = 65/303 (21%), Positives = 120/303 (39%), Gaps = 62/303 (20%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG+G  G+V +  L         VAVK +K   ++    +EF      +    HPNV+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 416 KL-----RAYYYAKEEKLLVYDYLPNGSLHSLLHGNR-GPGRIPLDWTTRISLVLGAARG 469
           +L             + +++  ++  G LH+ L  +R   G   +   T +  ++  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 470 LARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK---- 524
           +     EY       H ++ + N +L  +   C++DFGLS      + I     Y+    
Sbjct: 160 M-----EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208

Query: 525 --------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVD 575
                   A E    +  + K+DV++FGV + E+ T G  P  YP      V   E    
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPG-----VQNHE---- 257

Query: 576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
               +   +            L + ++  +EL  ++    +C  + P  RPT + +   +
Sbjct: 258 ----MYDYLLH-------GHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQL 303

Query: 636 EDI 638
           E +
Sbjct: 304 EKL 306

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  103 bits (260), Expect = 2e-24
 Identities = 69/318 (21%), Positives = 108/318 (33%), Gaps = 52/318 (16%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
             LG G+ G VY+  +           VAVK L +  +     +F     +I K  H N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLAR 472
           V+          + ++ + +  G L S L   R     P        + +    A G   
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ- 154

Query: 473 IHQEYGTAK--VPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPVQAIARLGGYK--- 524
               Y      + H ++ + N LL   G   VA I DFG++  +       + G      
Sbjct: 155 ----YLEENHFI-HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209

Query: 525 ---APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
               PE       + K D +SFGVLL E+ + G  P  YPS +    ++E         V
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKS----NQE---------V 254

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV 640
              V            +   KN    +  ++     C   QPE RP  A + + IE    
Sbjct: 255 LEFVTS-------GGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQ 304

Query: 641 EQSPLGEEYDESRNSLSP 658
           +   +          L  
Sbjct: 305 DPDVINTALPIEYGPLVE 322

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  102 bits (257), Expect = 2e-24
 Identities = 60/308 (19%), Positives = 107/308 (34%), Gaps = 81/308 (26%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKL-KHPNVVKL 417
           E +G G  G+V+K V   DG I A+KR     A     +   + +     L +H +VV+ 
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75

Query: 418 RAYY--YAKEEKLLVY-DYLPNGSLHSLL-HGNRGPGRIP----LDWTTRISLVLGAARG 469
             Y+  +A+++ +L+  +Y   GSL   +    R           D   ++        G
Sbjct: 76  --YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR------G 127

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-------------------ISDFGLSLL 510
           L  IH       + H ++K SN+ + +  +                     I D G    
Sbjct: 128 LRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 511 LNPVQAIARLGG---YKAPEQ-AEVKRLSQKADVYSFGVLLLEVLTGR-APSQYPSPTRP 565
           ++  Q      G   + A E   E      KAD+++  + ++        P         
Sbjct: 184 ISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240

Query: 566 RVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKR 625
           R   + +   +P        +  + E    ELL+          M+H         PE+R
Sbjct: 241 R---QGRLPRIP--------QVLSQEF--TELLK---------VMIHP-------DPERR 271

Query: 626 PTMAEVAK 633
           P+   + K
Sbjct: 272 PSAMALVK 279

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  103 bits (259), Expect = 3e-24
 Identities = 53/291 (18%), Positives = 107/291 (36%), Gaps = 55/291 (18%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPN--VVKL 417
           + +G G    V++ + +   I A+K   L++A+      +   +  + KL+  +  +++L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             Y    +   +V +   N  L+S L        I           +     +  IHQ  
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH- 127

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYKAPE---- 527
               + H ++K +N L+  +G+  + DFG++  + P               Y  PE    
Sbjct: 128 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183

Query: 528 -------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
                       ++S K+DV+S G +L  +  G+ P Q             Q   L   +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISKLHAII 234

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
               + E+               E++L  +L     C+   P++R ++ E+
Sbjct: 235 DPNHEIEF-----------PDIPEKDLQDVLK---CCLKRDPKQRISIPEL 271

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  103 bits (258), Expect = 3e-24
 Identities = 62/301 (20%), Positives = 127/301 (42%), Gaps = 54/301 (17%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV 415
             LG+G+ G V+ A   +        +VAVK LK+A+  AR++F++  +++  L+H ++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR----------GPGRIPLDWTTRISLVLG 465
           +           L+V++Y+ +G L+  L  +                PL     +++   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 466 AARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK 524
            A G+      Y       H ++ + N L+ +  V  I DFG+S  +         G   
Sbjct: 167 VAAGM-----VYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221

Query: 525 ------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLP 577
                  PE    ++ + ++DV+SFGV+L E+ T G+ P  +   +    + E       
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLS----NTE------- 268

Query: 578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED 637
                 + +        +EL R +    E+ +++     C   +P++R ++ +V   ++ 
Sbjct: 269 --AIDCITQ-------GRELERPRACPPEVYAIM---RGCWQREPQQRHSIKDVHARLQA 316

Query: 638 I 638
           +
Sbjct: 317 L 317

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  102 bits (257), Expect = 3e-24
 Identities = 50/218 (22%), Positives = 87/218 (39%), Gaps = 46/218 (21%)

Query: 362 EMLGKGSLGTVYKA---VLDDGGIVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNVV 415
            ++G+G +G VY+A   V +   IVA+K + +   ++P  R   ++     G+L+ P+VV
Sbjct: 40  RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 416 KLRAYYYAKEEKL--LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
            +  + + + +    +    +    L ++L      G +       I  V      L   
Sbjct: 98  PI--HDFGEIDGQLYVDMRLINGVDLAAMLRRQ---GPLAPPRAVAI--VRQIGSALDAA 150

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----------- 522
           H     A   H +VK  N+L+  +  A + DFG          IA               
Sbjct: 151 HA----AGATHRDVKPENILVSADDFAYLVDFG----------IASATTDEKLTQLGNTV 196

Query: 523 ----YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               Y APE+      + +AD+Y+   +L E LTG  P
Sbjct: 197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (262), Expect = 4e-24
 Identities = 61/288 (21%), Positives = 117/288 (40%), Gaps = 54/288 (18%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKL-KHPNVVKLRA 419
           ++LG G+ GT+    + D   VAVKR L +    A +E    + ++ +  +HPNV++   
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQLLRESDEHPNVIRYFC 85

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
               ++ + +  +     +L   +   +    + L+    I+L+     GLA +H     
Sbjct: 86  TEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHS---- 136

Query: 480 AKVPHGNVKSSNVLLDKNG-----VACISDFGLSLLLNPVQ-AIARLG------GYKAPE 527
             + H ++K  N+L+          A ISDFGL   L   + + +R        G+ APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 528 ---QAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV 583
              +   +  +   D++S G +   V++ G  P  +    + + +    A  L       
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP--FGKSLQRQANILLGACSLDC----- 249

Query: 584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           +  E   +V  +EL+           M+ +        P+KRP+   V
Sbjct: 250 LHPEKHEDVIARELIE---------KMIAM-------DPQKRPSAKHV 281

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  102 bits (256), Expect = 6e-24
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 48/230 (20%)

Query: 362 EMLGKGSLGTVYKAVLDDGG---IVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V KA +   G     A+KR+K+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-----------ISLVLG 465
           L      +    L  +Y P+G+L   L  +R     P                 +     
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 466 AARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK 524
            ARG+     +Y    +  H ++ + N+L+ +N VA I+DFGLS          R     
Sbjct: 151 VARGM-----DYLSQKQFIHRDLAARNILVGENYVAKIADFGLS----------RGQEVY 195

Query: 525 -------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYP 560
                        A E       +  +DV+S+GVLL E+++ G  P  Y 
Sbjct: 196 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YC 243

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  101 bits (253), Expect = 6e-24
 Identities = 76/297 (25%), Positives = 120/297 (40%), Gaps = 51/297 (17%)

Query: 347 RKKQFELED--LLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYM 403
           +K+Q+ LED  + R     LGKG  G VY A       I+A+K L  A         Q  
Sbjct: 2   KKRQWALEDFEIGR----PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLR 57

Query: 404 DVI---GKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI 460
             +     L+HPN+++L  Y++      L+ +Y P G+++  L   +   +     T   
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATY 114

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
              L  A  L+  H +    +V H ++K  N+LL   G   I+DFG S+     +     
Sbjct: 115 ITEL--ANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC 168

Query: 521 G--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDL 576
           G   Y  PE  E +   +K D++S GVL  E L G+ P  +     T  R+   E     
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--FTF 226

Query: 577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
           P +V    +                    +L+S L      +   P +RP + EV +
Sbjct: 227 PDFVTEGAR--------------------DLISRL------LKHNPSQRPMLREVLE 257

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  101 bits (254), Expect = 8e-24
 Identities = 65/249 (26%), Positives = 115/249 (46%), Gaps = 35/249 (14%)

Query: 331 SDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK 389
           S G+SG  T  L    ++ Q E+ DL       +G G+ G V+K      G ++AVK+++
Sbjct: 2   SSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59

Query: 390 -DANPCARKEFEQYMDVIGKL-KHPNVVKLRAYY--YAKEEKL-LVYDYLPNGSLHSLLH 444
              N    K     +DV+ K    P +V+    +  +     + +  + +       L  
Sbjct: 60  RSGNKEENKRILMDLDVVLKSHDCPYIVQ---CFGTFITNTDVFIAMELM-GTCAEKLK- 114

Query: 445 GNRGPGRIPLDWTTRISL-VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS 503
             R  G IP     ++++ ++   + L  + +++    V H +VK SN+LLD+ G   + 
Sbjct: 115 -KRMQGPIPERILGKMTVAIV---KALYYLKEKH---GVIHRDVKPSNILLDERGQIKLC 167

Query: 504 DFGLSLLLNPVQAIAR---LG--GYKAPEQAEVKRLSQ-----KADVYSFGVLLLEVLTG 553
           DFG+S  L  V   A+    G   Y APE+ +    ++     +ADV+S G+ L+E+ TG
Sbjct: 168 DFGISGRL--VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225

Query: 554 RAPSQYPSP 562
           + P  Y + 
Sbjct: 226 QFP--YKNC 232

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =   99 bits (250), Expect = 2e-23
 Identities = 68/309 (22%), Positives = 112/309 (36%), Gaps = 66/309 (21%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNV 414
           E LG+   G VYK  L           VA+K LK  A    R+EF     +  +L+HPNV
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI-----------PLDWTTRISLV 463
           V L       +   +++ Y  +G LH  L        +            L+    + LV
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 464 LGAARG---LAR---IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI 517
              A G   L+    +H++  T           NVL+       ISD GL   +      
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATR----------NVLVYDKLNVKISDLGLFREVYAADYY 184

Query: 518 ARLGGYK------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE 570
             LG         APE     + S  +D++S+GV+L EV + G  P  Y   +    +++
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP--YCGYS----NQD 238

Query: 571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
                    V  +++         Q L    +    + +++   + C    P +RP   +
Sbjct: 239 ---------VVEMIRN-------RQVLPCPDDCPAWVYALM---IECWNEFPSRRPRFKD 279

Query: 631 VAKMIEDIR 639
           +   +    
Sbjct: 280 IHSRLRAWG 288

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  100 bits (252), Expect = 2e-23
 Identities = 65/235 (27%), Positives = 110/235 (46%), Gaps = 34/235 (14%)

Query: 346 ERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYM 403
           E+   F  EDL       +G+G+ G+V K V    G I+AVKR++   +   +K+    +
Sbjct: 14  EQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL 71

Query: 404 DVIGKL-KHPNVVKLRAYY--YAKEEKL-LVYDYLPNGSLHSLLH--GNRGPGRIPLDWT 457
           DV+ +    P +V+   +Y    +E    +  + + + S         +     IP +  
Sbjct: 72  DVVMRSSDCPYIVQ---FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL 127

Query: 458 TRISL-VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA 516
            +I+L  +   + L  + +     K+ H ++K SN+LLD++G   + DFG+S  L  V +
Sbjct: 128 GKITLATV---KALNHLKENL---KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDS 179

Query: 517 IAR---LG--GYKAPE--QAEVKRL--SQKADVYSFGVLLLEVLTGRAPSQYPSP 562
           IA+    G   Y APE       R     ++DV+S G+ L E+ TGR P  YP  
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP--YPKW 232

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  101 bits (253), Expect = 3e-23
 Identities = 54/351 (15%), Positives = 122/351 (34%), Gaps = 62/351 (17%)

Query: 302 SSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASA 361
             +      + + +     + + +      D    + ++      + + + +        
Sbjct: 9   GLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL------- 61

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPN--VVKL 417
           + +G G    V++ + +   I A+K   L++A+      +   +  + KL+  +  +++L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             Y    +   +V +   N  L+S L        I           +     +  IHQ  
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKK---KSIDPWERKSYWKNM--LEAVHTIHQH- 174

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYKAPE---- 527
               + H ++K +N L+  +G+  + DFG++  + P               Y  PE    
Sbjct: 175 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230

Query: 528 -------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
                       ++S K+DV+S G +L  +  G+ P Q             Q   L   +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---------QIINQISKLHAII 281

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
               + E+               E++L  +L     C+   P++R ++ E+
Sbjct: 282 DPNHEIEF-----------PDIPEKDLQDVL---KCCLKRDPKQRISIPEL 318

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 63/213 (29%), Positives = 101/213 (47%), Gaps = 40/213 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR--LKDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +GKGS G V+K +      +VA+K   L++A     ++ +Q + V+ +   P V K  
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTK-- 84

Query: 419 AYY--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLARIH 474
            YY  Y K+ KL ++ +YL  GS   LL     PG +       I+ +L    +GL  +H
Sbjct: 85  -YYGSYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQ---IATILREILKGLDYLH 136

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK---------- 524
            E    K  H ++K++NVLL ++G   ++DFG++  L   Q        K          
Sbjct: 137 SE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-------KRNTFVGTPFW 185

Query: 525 -APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            APE  +      KAD++S G+  +E+  G  P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  101 bits (254), Expect = 1e-22
 Identities = 28/145 (19%), Positives = 53/145 (36%), Gaps = 4/145 (2%)

Query: 67  RVVSLSLPSHSLRGPIAPLSL-LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS 125
             + LS    S +G  +        L++LDL  N +            L+      ++  
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK 409

Query: 126 AEIPHQI-SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRI-PDLSSSL 183
                 +  SL+ ++ LD+S  + R         L+ L  L++  N       PD+ + L
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 184 KDLKELNLSNNELYGRVPEGLLKKF 208
           ++L  L+LS  +L   +        
Sbjct: 470 RNLTFLDLSQCQLEQ-LSPTAFNSL 493

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 97.0 bits (242), Expect = 4e-21
 Identities = 29/143 (20%), Positives = 59/143 (41%), Gaps = 3/143 (2%)

Query: 65  SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGN 122
                +L L  + LR   +       +L+ LDL    +         + ++L    L+GN
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 123 DFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSS 181
              +      S L  + +L   + N+       + +L  L  L + +N +   ++P+  S
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 182 SLKDLKELNLSNNELYGRVPEGL 204
           +L +L+ L+LS+N++       L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDL 169

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 94.3 bits (235), Expect = 2e-20
 Identities = 28/114 (24%), Positives = 43/114 (37%), Gaps = 1/114 (0%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
           P +L    + LDL  N L         +   L++  LS  +          SL  +  L 
Sbjct: 23  PDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLI 82

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           L+ N I+       + L+ L  L      L          LK LKELN+++N +
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 94.3 bits (235), Expect = 2e-20
 Identities = 25/126 (19%), Positives = 46/126 (36%), Gaps = 2/126 (1%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGI 138
             +    L  L +LD+                ++L++  ++GN F       I + L+ +
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472

Query: 139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG 198
             LDLS   +    P    +L+ L  L + +N            L  L+ L+ S N +  
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 532

Query: 199 RVPEGL 204
              + L
Sbjct: 533 SKKQEL 538

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 90.9 bits (226), Expect = 3e-19
 Identities = 31/144 (21%), Positives = 56/144 (38%), Gaps = 8/144 (5%)

Query: 70  SLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAE 127
            L L    ++         L  L  L L  N +    L   +  ++L+       + ++ 
Sbjct: 56  VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115

Query: 128 IPHQISSLKGILRLDLSDNNIRG-RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
               I  LK +  L+++ N I+  ++PE  +NLT L  L L +N++          L  +
Sbjct: 116 ENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175

Query: 187 K----ELNLSNNELYGRVPEGLLK 206
                 L+LS N +   +  G  K
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFK 198

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.9 bits (208), Expect = 5e-17
 Identities = 22/110 (20%), Positives = 34/110 (30%), Gaps = 2/110 (1%)

Query: 95  DLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPE 154
              +       +P     + K   LS N       +   S   +  LDLS   I+     
Sbjct: 13  QCMELNFYK--IPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 155 QVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL 204
              +L+ L TL L  N +        S L  L++L      L       +
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 34/135 (25%), Positives = 50/135 (37%), Gaps = 9/135 (6%)

Query: 70  SLSLPSHSLRGPI-APLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSA 126
            L     +L      P+  L  L+ L++  N +    LP   +N TNL+   LS N   +
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163

Query: 127 EIPHQISSLKGI----LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-S 181
                +  L  +    L LDLS N +   I        RL  L L+NN  +  +      
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222

Query: 182 SLKDLKELNLSNNEL 196
            L  L+   L   E 
Sbjct: 223 GLAGLEVHRLVLGEF 237

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 80.8 bits (200), Expect = 5e-16
 Identities = 27/131 (20%), Positives = 42/131 (32%), Gaps = 8/131 (6%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
            L+   + L   I   + L  +    L    +   +   +     +   L    F     
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPT 321

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT--GRIPDLSSSLKDLK 187
            ++ SLK   RL  + N       E   +L  L  L L  N L+  G           LK
Sbjct: 322 LKLKSLK---RLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376

Query: 188 ELNLSNNELYG 198
            L+LS N +  
Sbjct: 377 YLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 70.8 bits (174), Expect = 6e-13
 Identities = 31/161 (19%), Positives = 60/161 (37%), Gaps = 14/161 (8%)

Query: 69  VSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSA 126
           +SL L  + +           +L  L L +N  +  ++   +     L++  L   +F  
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239

Query: 127 EI---PHQISSLKGILRLDLSDNNIR------GRIPEQVTNLTRLLTLRLQNNELTGRIP 177
           E        S+L+G+  L + +  +         I +    LT + +  L +  +   + 
Sbjct: 240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VK 298

Query: 178 DLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEG 218
           D  S     + L L N +  G+ P   LK     +F  N+G
Sbjct: 299 DF-SYNFGWQHLELVNCKF-GQFPTLKLKSLKRLTFTSNKG 337

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 26/153 (16%), Positives = 42/153 (27%), Gaps = 17/153 (11%)

Query: 67  RVVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNG-------TILPLTNCTNLKLA 117
           R+  L+L ++     +    +  L  L    L                  L    NL + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 118 YLSGN---DFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG 174
                    +  +I    + L  +    L    I        +       L L N +   
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ 318

Query: 175 RIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
             P L   LK LK L  ++N+      E  L  
Sbjct: 319 -FPTL--KLKSLKRLTFTSNKGGNAFSEVDLPS 348

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 60.4 bits (147), Expect = 1e-09
 Identities = 23/122 (18%), Positives = 42/122 (34%), Gaps = 12/122 (9%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP----HQISSLKGILRL 141
            +      LDL  N +N           L    L  N  S  +       ++ L+ + RL
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE-VHRL 232

Query: 142 DLSDNNIRGRIPE-QVTNLTRLLTLRLQNNELT------GRIPDLSSSLKDLKELNLSNN 194
            L +    G + +   + L  L  L ++   L         I DL + L ++   +L + 
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292

Query: 195 EL 196
            +
Sbjct: 293 TI 294

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 54/305 (17%), Positives = 108/305 (35%), Gaps = 66/305 (21%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            +LG+G+ G V KA    D    A+K+++             + ++  L H  VV+  A 
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAA 70

Query: 421 Y------------YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           +              K+  L +  +Y  NG+L+ L+H      +    W     ++    
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA-- 128

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
             L+ IH +     + H ++K  N+ +D++    I DFGL+  ++    I +L       
Sbjct: 129 --LSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 523 -------------YKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVD 568
                        Y A E  +     ++K D+YS G++  E++     S           
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKK 240

Query: 569 EEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM 628
               +++ P        +       +++++R          ++          P KRP  
Sbjct: 241 LRSVSIEFPPDFDDNKMKV------EKKIIR---------LLIDH-------DPNKRPGA 278

Query: 629 AEVAK 633
             +  
Sbjct: 279 RTLLN 283

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 98.5 bits (246), Expect = 2e-22
 Identities = 62/328 (18%), Positives = 120/328 (36%), Gaps = 86/328 (26%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNV 414
             +G+G+ G V++A            +VAVK LK +A+   + +F++   ++ +  +PN+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           VKL       +   L+++Y+  G L+  L          L  +   +    ++ G   + 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 475 Q--------------EY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR 519
                           Y    K  H ++ + N L+ +N V  I+DFGLS      + I  
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------RNIYS 226

Query: 520 LGGYK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPR 566
              YK             PE     R + ++DV+++GV+L E+ + G  P  Y       
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP--YYGMA--- 281

Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY----------KNIEEELVSMLHVGLA 616
                                       +E++ Y          +N   EL +++     
Sbjct: 282 ---------------------------HEEVIYYVRDGNILACPENCPLELYNLM---RL 311

Query: 617 CVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
           C    P  RP+   + ++++ +      
Sbjct: 312 CWSKLPADRPSFCSIHRILQRMCERAEG 339

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 62/233 (26%), Positives = 105/233 (45%), Gaps = 33/233 (14%)

Query: 350 QFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIG 407
           + + +DL       LG+G+ G V K   +  G I+AVKR++   N   +K     +D+  
Sbjct: 3   EVKADDLEPI--MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 408 KL-KHPNVVKLRAYY--YAKEEKL-LVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISL 462
           +    P  V    +Y    +E  + +  + + + SL             IP D   +I++
Sbjct: 61  RTVDCPFTVT---FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAV 116

Query: 463 -VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-- 519
            ++   + L  +H +     V H +VK SNVL++  G   + DFG+S  L  V  +A+  
Sbjct: 117 SIV---KALEHLHSKL---SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDI 168

Query: 520 -LG--GYKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRP 565
             G   Y APE    +   K  S K+D++S G+ ++E+   R P  Y S   P
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP--YDSWGTP 219

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 79/328 (24%), Positives = 123/328 (37%), Gaps = 83/328 (25%)

Query: 362 EMLGKGSLGTVYKAVLDDGG--------IVAVKRLKD-ANPCARKEFEQYMDVIGKL-KH 411
           + LG+G+ G V  A               VAVK LKD A      +    M+++  + KH
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-----------I 460
            N++ L           ++ +Y   G+L   L   R PG        R           +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 461 SLVLGAARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR 519
           S     ARG+     EY  + K  H ++ + NVL+ +N V  I+DFGL+      + I  
Sbjct: 161 SCTYQLARGM-----EYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 209

Query: 520 LGGYK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPR 566
           +  YK            APE    +  + ++DV+SFGVL+ E+ T G +P  YP      
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIP--- 264

Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY-----KNIEEELVSMLHVGLACVVSQ 621
                                   E+F      +      N   EL  M+     C  + 
Sbjct: 265 ----------------------VEELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAV 299

Query: 622 PEKRPTMAEVAKMIEDIRVEQSPLGEEY 649
           P +RPT  ++ + ++ I        EEY
Sbjct: 300 PSQRPTFKQLVEDLDRIL--TLTTNEEY 325

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  100 bits (251), Expect = 3e-22
 Identities = 38/236 (16%), Positives = 88/236 (37%), Gaps = 33/236 (13%)

Query: 362 EMLGKGSLGTVYKAVLD---DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKL 417
             +  G LG +Y A+ D   +G  V +K L  + +  A+         + ++ HP++V++
Sbjct: 86  GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 418 RAYYYAKEEKL-------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
             + + +           +V +Y+   SL           ++P+        +L     L
Sbjct: 145 --FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAY--LLEILPAL 195

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQ 528
           + +H       + + ++K  N++L +  +  + D G    +N    +   G  G++APE 
Sbjct: 196 SYLHS----IGLVYNDLKPENIMLTEEQLK-LIDLGAVSRINSFGYL--YGTPGFQAPEI 248

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
                 +   D+Y+ G  L  +                + E++  +        ++
Sbjct: 249 VR-TGPTVATDIYTVGRTLAALTLDLPT--RNGRYVDGLPEDDPVLKTYDSYGRLL 301

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 74/321 (23%), Positives = 122/321 (38%), Gaps = 76/321 (23%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKD-ANPCARKEFEQYMDVIGKLKHPNV 414
           + LG+G  G V KA             VAVK LK+ A+P   ++     +V+ ++ HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           +KL          LL+ +Y   GSL   L  +R  G   L      +           + 
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 475 Q--------------EY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR 519
                          +Y    K+ H ++ + N+L+ +     ISDFGLS      + +  
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS------RDVYE 202

Query: 520 LGGYK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPR 566
              Y             A E       + ++DV+SFGVLL E++T G  P  YP      
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIP--- 257

Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY-----KNIEEELVSMLHVGLACVVSQ 621
                                    +F+     +      N  EE+  ++   L C   +
Sbjct: 258 ----------------------PERLFNLLKTGHRMERPDNCSEEMYRLM---LQCWKQE 292

Query: 622 PEKRPTMAEVAKMIEDIRVEQ 642
           P+KRP  A+++K +E + V++
Sbjct: 293 PDKRPVFADISKDLEKMMVKR 313

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 98.2 bits (244), Expect = 3e-22
 Identities = 36/310 (11%), Positives = 71/310 (22%), Gaps = 63/310 (20%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           E L  G    V+    ++     A+K      + +    +   +      +L   +  + 
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 418 RAYY--------------------------YAKEEKLLVYDYLPNGSLHSLLH--GNRGP 449
           R                             YA    LL+     +  L  L         
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYV 186

Query: 450 GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL 509
            R          L     R  A +     +  + HG+    N+ +  +G   + D     
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQ----SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 510 LLNPVQAIARLGG---YKAPE--QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP-T 563
            +              Y   E   A     +   + +  G+ +  V     P    +P  
Sbjct: 243 KVGTRGPA--SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300

Query: 564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPE 623
           +         V     +           V  + L+            L+           
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFV--KTLIG---------RFLNF-------DRR 342

Query: 624 KRPTMAEVAK 633
           +R    E  +
Sbjct: 343 RRLLPLEAME 352

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 40/218 (18%)

Query: 362 EMLGKGSLGTVYKA---VLDDGGIVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNVV 415
           E+LG G +  V+ A          VAVK L+     +P     F +       L HP +V
Sbjct: 18  EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 416 ----------KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
                           Y      +V +Y+   +L  ++H     G +       +  +  
Sbjct: 76  AVYDTGEAETPAGPLPY------IVMEYVDGVTLRDIVHTE---GPMTPKRAIEV--IAD 124

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-----QAIARL 520
           A + L   HQ      + H +VK +N+++       + DFG++  +        Q  A +
Sbjct: 125 ACQALNFSHQ----NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

Query: 521 G--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           G   Y +PEQA    +  ++DVYS G +L EVLTG  P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (250), Expect = 4e-22
 Identities = 21/176 (11%), Positives = 50/176 (28%), Gaps = 12/176 (6%)

Query: 41  NLLSNWKGADACAA--AWTGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLH 97
              +NW          A  GV  +    RV  LSL      G +   +  L +L  L L 
Sbjct: 55  QPGANWNFNKELDMWGAQPGVSLNSNG-RVTGLSLEGFGASGRVPDAIGQLTELEVLALG 113

Query: 98  DNRLNGTILP-----LTNCTNLKLAYLSGNDFSAEIPHQISSLK--GILRLDLSDNNIRG 150
            +             ++   + +        +               +++  ++ +  + 
Sbjct: 114 SHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173

Query: 151 RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
            I +      +   +   +N +T  +      L  L++  + N+           +
Sbjct: 174 SIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 95.9 bits (239), Expect = 1e-20
 Identities = 25/134 (18%), Positives = 51/134 (38%), Gaps = 13/134 (9%)

Query: 80  GPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKG 137
            P+   L  + +L  L+   N+L G +    +   L    L+ N  + EIP       + 
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT-EIPANFCGFTEQ 378

Query: 138 ILRLDLSDNNIRGRIPE--QVTNLTRLLTLRLQNNELTG-------RIPDLSSSLKDLKE 188
           +  L  + N ++  IP      +++ +  +    NE+          +        ++  
Sbjct: 379 VENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437

Query: 189 LNLSNNELYGRVPE 202
           +NLSNN++     E
Sbjct: 438 INLSNNQISKFPKE 451

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 95.1 bits (237), Expect = 1e-20
 Identities = 25/132 (18%), Positives = 48/132 (36%), Gaps = 15/132 (11%)

Query: 77  SLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPH--Q 131
            L G +       +L  L+L  N++    +P         ++    + N     IP+   
Sbjct: 341 QLEGKLPAFGSEIKLASLNLAYNQITE--IPANFCGFTEQVENLSFAHNKLK-YIPNIFD 397

Query: 132 ISSLKGILRLDLSDNNIRG-------RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK 184
             S+  +  +D S N I          +         + ++ L NN+++    +L S+  
Sbjct: 398 AKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGS 457

Query: 185 DLKELNLSNNEL 196
            L  +NL  N L
Sbjct: 458 PLSSINLMGNML 469

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 94.7 bits (236), Expect = 2e-20
 Identities = 27/143 (18%), Positives = 49/143 (34%), Gaps = 12/143 (8%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI--LPLTNCTNLKLAYLSGNDFSAEIP 129
            +P +SL+           L  +DL  N+L         T    L    LS N FS + P
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFS-KFP 529

Query: 130 HQISSLKGILRL------DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
            Q  +   +         D   N      PE +T    L  L++ +N++   + +     
Sbjct: 530 TQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE--KIT 586

Query: 184 KDLKELNLSNNELYGRVPEGLLK 206
            ++  L++ +N         +  
Sbjct: 587 PNISVLDIKDNPNISIDLSYVCP 609

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 28/155 (18%), Positives = 55/155 (35%), Gaps = 20/155 (12%)

Query: 70  SLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNG------TILP--LTNCTNLKLAYLS 120
           S++L ++ +        S    L  ++L  N L                N   L    L 
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496

Query: 121 GNDFSAEIPHQI--SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN------NEL 172
            N  + ++      ++L  ++ +DLS N+     P Q  N + L    ++N      N  
Sbjct: 497 FNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRT 554

Query: 173 TGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
               P+  +    L +L + +N++   V E +   
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPN 588

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.9 bits (200), Expect = 4e-16
 Identities = 18/147 (12%), Positives = 45/147 (30%), Gaps = 29/147 (19%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--------------------LTNCTNLKLAYLSGNDF 124
           +  L +LR   + ++      +                       N  +L    +     
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261

Query: 125 SAEIPHQISSLKGILRLDLSDNNIR--------GRIPEQVTNLTRLLTLRLQNNEL-TGR 175
             ++P  + +L  +  ++++ N            +         ++  + +  N L T  
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321

Query: 176 IPDLSSSLKDLKELNLSNNELYGRVPE 202
           +      +K L  L    N+L G++P 
Sbjct: 322 VETSLQKMKKLGMLECLYNQLEGKLPA 348

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 76.2 bits (188), Expect = 1e-14
 Identities = 19/115 (16%), Positives = 38/115 (33%), Gaps = 9/115 (7%)

Query: 88  LDQLRFLDLHDNRLNG---TILPLTNCTNLKLAY---LSGNDFSAEIPHQISSLKGILRL 141
           L  L  +DL  N  +      L  +      +       GN    E P  I+    + +L
Sbjct: 512 LPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            +  N+IR  + E++     +  L +++N              +     L  ++ 
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 67.4 bits (165), Expect = 7e-12
 Identities = 19/143 (13%), Positives = 45/143 (31%), Gaps = 10/143 (6%)

Query: 70  SLSLPSHSLRGPIAPL-SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEI 128
           +L+  + S +G      +  +  + LD+   +   ++      T L    L G   S  +
Sbjct: 41  ALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGL---SLEGFGASGRV 97

Query: 129 PHQISSLKGILRLDLSDNNIRG----RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK 184
           P  I  L  +  L L  +  +       P+ ++        +           D      
Sbjct: 98  PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPRED 157

Query: 185 --DLKELNLSNNELYGRVPEGLL 205
             DL +  ++++     + +   
Sbjct: 158 FSDLIKDCINSDPQQKSIKKSSR 180

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 18/91 (19%), Positives = 27/91 (29%), Gaps = 6/91 (6%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
           L         D   NR      P  +T C +L    +  ND   ++  +I     I  LD
Sbjct: 538 LKGFGIRNQRDAQGNRTLREW-PEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLD 593

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELT 173
           + DN         V          L  ++  
Sbjct: 594 IKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.0 bits (120), Expect = 2e-06
 Identities = 12/56 (21%), Positives = 21/56 (37%)

Query: 158 NLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSF 213
           +  R+  L L+    +GR+PD    L +L+ L L ++           K       
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMS 134

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 96.1 bits (240), Expect = 4e-22
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 57/297 (19%)

Query: 348 KKQFELED--LLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQY-- 402
           K++F ++D  + R     LGKG  G VY A    +  I+A+K L  +         Q   
Sbjct: 8   KRKFTIDDFDIGR----PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63

Query: 403 -MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
            +++   L+HPN++++  Y++ ++   L+ ++ P G L+  L   +  GR     +    
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFM 120

Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-- 519
             L  A  L   H+     KV H ++K  N+L+   G   I+DFG S+      ++ R  
Sbjct: 121 EEL--ADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVH---APSLRRRT 171

Query: 520 LGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAV 574
           + G   Y  PE  E K   +K D++  GVL  E L G  P  S   + T  R+   +  +
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVD--L 229

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
             P ++    K          +L+           +L          P +R  +  V
Sbjct: 230 KFPPFLSDGSK----------DLIS---------KLL-------RYHPPQRLPLKGV 260

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 66/320 (20%), Positives = 114/320 (35%), Gaps = 87/320 (27%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPN 413
           + LG+G+ G V +A             VAVK LK+ A     +     + ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 414 VVKLRAYYYA---KEEK--LLVYDYLPNGSLHSLLHGNRGPGRI-----------PLDWT 457
           VV L         K     +++ ++   G+L + L   R                 L   
Sbjct: 93  VVNL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 458 TRISLVLGAARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA 516
             I      A+G+     E+  + K  H ++ + N+LL +  V  I DFGL+      + 
Sbjct: 149 HLICYSFQVAKGM-----EFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD 197

Query: 517 IARLGGYK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPT 563
           I +   Y             APE    +  + ++DV+SFGVLL E+ + G +P  YP   
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVK 255

Query: 564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY-----KNIEEELVSMLHVGLACV 618
                                      E   +               E+   +   L C 
Sbjct: 256 IDE------------------------EFCRRLKEGTRMRAPDYTTPEMYQTM---LDCW 288

Query: 619 VSQPEKRPTMAEVAKMIEDI 638
             +P +RPT +E+ + + ++
Sbjct: 289 HGEPSQRPTFSELVEHLGNL 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 97.8 bits (244), Expect = 4e-22
 Identities = 77/341 (22%), Positives = 126/341 (36%), Gaps = 79/341 (23%)

Query: 364 LGKGSLGTVYKAVL--------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPN 413
           LG+G+ G V  A          +    VAVK LK  A      +    M+++  + KH N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-----------ISL 462
           ++ L           ++ +Y   G+L   L   R PG       +            +S 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
               ARG+  +  +    K  H ++ + NVL+ ++ V  I+DFGL+      + I  +  
Sbjct: 197 AYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADFGLA------RDIHHIDY 246

Query: 523 YK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
           YK            APE    +  + ++DV+SFGVLL E+ T G +P  YP         
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--YPGVP------ 298

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRY-----KNIEEELVSMLHVGLACVVSQPEK 624
                                E+F      +      N   EL  M+     C  + P +
Sbjct: 299 -------------------VEELFKLLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQ 336

Query: 625 RPTMAEVAKMIEDIRVEQSPLGEEYDESRNSLSPSLATTED 665
           RPT  ++ + ++ I    S     Y    +     + TTE+
Sbjct: 337 RPTFKQLVEDLDRIVALTSNQEMGYYHHHHHHDYDIPTTEN 377

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 97.4 bits (243), Expect = 5e-22
 Identities = 75/317 (23%), Positives = 120/317 (37%), Gaps = 81/317 (25%)

Query: 362 EMLGKGSLGTVYKAVLDDGG--------IVAVKRLKD-ANPCARKEFEQYMDVIGKL-KH 411
           + LG+G  G V  A               VAVK LKD A      +    M+++  + KH
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI-----------PLDWTTRI 460
            N++ L           ++ +Y   G+L   L   R PG              + +   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 461 SLVLGAARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR 519
           S     ARG+     EY  + K  H ++ + NVL+ +N V  I+DFGL+      + I  
Sbjct: 207 SCTYQLARGM-----EYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 255

Query: 520 LGGYK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPR 566
           +  YK            APE    +  + ++DV+SFGVL+ E+ T G +P  YP      
Sbjct: 256 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGIP--- 310

Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRY-----KNIEEELVSMLHVGLACVVSQ 621
                                   E+F      +      N   EL  M+     C  + 
Sbjct: 311 ----------------------VEELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAV 345

Query: 622 PEKRPTMAEVAKMIEDI 638
           P +RPT  ++ + ++ I
Sbjct: 346 PSQRPTFKQLVEDLDRI 362

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 97.0 bits (241), Expect = 7e-22
 Identities = 36/315 (11%), Positives = 84/315 (26%), Gaps = 81/315 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQY------------------ 402
            +LG+       +A   + G    V              +Q                   
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 403 ----------MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY-LPNGSLHSLLH--GNRGP 449
                      D++   +   ++++R            + Y     +L +      +   
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 450 GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL 509
               L    R+ L L   R LA +H       + H  ++  +++LD+ G   ++ F   +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH----YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 254

Query: 510 LLNPVQAIARLGGYKAPE-----------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
                   +   G++ PE           +     ++   D ++ G+++  +     P  
Sbjct: 255 RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP-- 312

Query: 559 YPSPTRPRVDEE--EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLA 616
                     E       ++P+ VR++++                         L     
Sbjct: 313 ITKDAALGGSEWIFRSCKNIPQPVRALLE-----------------------GFLRY--- 346

Query: 617 CVVSQPEKRPTMAEV 631
                 E R    + 
Sbjct: 347 ----PKEDRLLPLQA 357

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 96.8 bits (241), Expect = 1e-21
 Identities = 68/304 (22%), Positives = 112/304 (36%), Gaps = 65/304 (21%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLK-HPNVVKLRA 419
           ++LG GS GTV       G  VAVKR L D    A  E    + ++ +   HPNV++   
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALME----IKLLTESDDHPNVIRYYC 76

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLL--HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                    +  +   N +L  L+                  ISL+   A G+A +H   
Sbjct: 77  SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL- 134

Query: 478 GTAKVPHGNVKSSNVLLDKNGVAC-------------ISDFGLSLLLNPVQAIARLG--- 521
              K+ H ++K  N+L+  +                 ISDFGL   L+  Q+  R     
Sbjct: 135 ---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191

Query: 522 -----GYKAPEQ-------AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
                G++APE           +RL++  D++S G +   +L+         P   +   
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-----PFGDKYSR 246

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIE-EELVS-MLHVGLACVVSQPEKRPT 627
           E            +++  ++ +       R    E  +L+S M+          P KRPT
Sbjct: 247 ESN----------IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDH-------DPLKRPT 289

Query: 628 MAEV 631
             +V
Sbjct: 290 AMKV 293

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 68/309 (22%), Positives = 114/309 (36%), Gaps = 68/309 (22%)

Query: 364 LGKGSLGTVYKAVLDDGG------IVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVV 415
           LG G+ G V +A             VAVK LK  A+   R+     + V+  L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-------------ISL 462
            L          L++ +Y   G L + L   R                         +S 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG 522
               A+G+A +  +       H ++ + N+LL    +  I DFGL+      + I     
Sbjct: 151 SYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDFGLA------RDIKNDSN 200

Query: 523 YK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
           Y             APE       + ++DV+S+G+ L E+ + G +P  YP      VD 
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YPGMP---VDS 255

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
           +            ++KE          +L  ++   E+  ++     C  + P KRPT  
Sbjct: 256 K---------FYKMIKE-------GFRMLSPEHAPAEMYDIM---KTCWDADPLKRPTFK 296

Query: 630 EVAKMIEDI 638
           ++ ++IE  
Sbjct: 297 QIVQLIEKQ 305

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 47/216 (21%), Positives = 91/216 (42%), Gaps = 40/216 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             LG G+ G VYKA   + G + A K ++  +    +++   ++++    HP +VK    
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK---L 81

Query: 421 Y--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLARIHQE 476
              Y  + KL ++ ++ P G++ +++          L    +I +V       L  +H +
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLT-EPQIQVVCRQMLEALNFLHSK 136

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-----------A 525
               ++ H ++K+ NVL+   G   ++DFG+S               K           A
Sbjct: 137 ----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-------KRDSFIGTPYWMA 185

Query: 526 PEQAEVKRLSQ-----KADVYSFGVLLLEVLTGRAP 556
           PE    + +       KAD++S G+ L+E+     P
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 94.4 bits (235), Expect = 3e-21
 Identities = 64/346 (18%), Positives = 121/346 (34%), Gaps = 87/346 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRA 419
            +L +G    VY+A  +  G   A+KRL        +   Q +  + KL  HPN+V+  +
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 420 YYYAKEEK-------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
                +E+        L+   L  G L   L      G +  D   +I       R +  
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI--FYQTCRAVQH 151

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS--LLLNPVQAIARLGG-------- 522
           +H++     + H ++K  N+LL   G   + DFG +  +   P  + +            
Sbjct: 152 MHRQ--KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 523 ------YKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAP-----------SQYPSP 562
                 Y+ PE  ++     + +K D+++ G +L  +   + P            +Y  P
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIP 269

Query: 563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQP 622
                                               +Y      + +ML V        P
Sbjct: 270 PHDT--------------------------------QYTVFHSLIRAMLQV-------NP 290

Query: 623 EKRPTMAEVAKMIEDIRVEQ-----SPLGEEYDESRNSLSPSLATT 663
           E+R ++AEV   +++I   +     SP+ E  +++    S +L+  
Sbjct: 291 EERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRG 336

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.5 bits (233), Expect = 4e-21
 Identities = 54/211 (25%), Positives = 96/211 (45%), Gaps = 37/211 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V    Y
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN---Y 82

Query: 421 Y--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLARIHQE 476
              Y   ++L +V +YL  GSL  ++        +       I+ V     + L  +H  
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQ---IAAVCRECLQALEFLHSN 135

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-----------A 525
               +V H ++KS N+LL  +G   ++DFG    + P Q+       K           A
Sbjct: 136 ----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-------KRSTMVGTPYWMA 184

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE    K    K D++S G++ +E++ G  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 62/324 (19%), Positives = 107/324 (33%), Gaps = 79/324 (24%)

Query: 362 EMLGKGSLGTVYKAVLDDGG------IVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPN 413
           ++LG G+ G V  A             VAVK LK+ A+   R+     + ++ +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA------- 466
           +V L           L+++Y   G L + L   R               +          
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 467 -----------ARG---LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
                      A+G   L             H ++ + NVL+    V  I DFGL+    
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK-------SCVHRDLAARNVLVTHGKVVKICDFGLA---- 219

Query: 513 PVQAIARLGGYK------------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQY 559
             + I     Y             APE       + K+DV+S+G+LL E+ + G  P  Y
Sbjct: 220 --RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--Y 275

Query: 560 PSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVV 619
           P      +  +     L       ++          ++ +     EE+  ++    +C  
Sbjct: 276 PG-----IPVDANFYKL-------IQNG-------FKMDQPFYATEEIYIIM---QSCWA 313

Query: 620 SQPEKRPTMAEVAKMIEDIRVEQS 643
               KRP+   +   +     +  
Sbjct: 314 FDSRKRPSFPNLTSFLGCQLADAE 337

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 94.9 bits (236), Expect = 5e-21
 Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 40/305 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG+G+   V++      G + A+K               +EFE    V+ KL H N+V
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIV 70

Query: 416 KLRAYYYAKEEKL--LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           KL A       +   L+ ++ P GSL+++L        +P      +   +     +  +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHL 128

Query: 474 HQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLNPVQAIARLGG---YKAP 526
            +      + H N+K  N++     D   V  ++DFG +  L   +    L G   Y  P
Sbjct: 129 REN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 527 E--------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE----QAV 574
           +        +   K+     D++S GV      TG  P  +     PR ++E        
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGPRRNKEVMYKIITG 242

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACV-VSQPEKRPTMAEVAK 633
                +  V K E     +  ++    ++   L  +L   LA +  +  EK     +   
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 634 MIEDI 638
              DI
Sbjct: 303 ETSDI 307

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 62/305 (20%), Positives = 112/305 (36%), Gaps = 40/305 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG+G+   V++      G + A+K               +EFE    V+ KL H N+V
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFE----VLKKLNHKNIV 70

Query: 416 KLRAYYYAKEEKL--LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
           KL A       +   L+ ++ P GSL+++L        +P      +   +     +  +
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHL 128

Query: 474 HQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLNPVQAIARLGG---YKAP 526
            +      + H N+K  N++     D   V  ++DFG +  L   +    L G   Y  P
Sbjct: 129 REN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 527 E--------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE----QAV 574
           +        +   K+     D++S GV      TG  P  +     PR ++E        
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPFEGPRRNKEVMYKIITG 242

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACV-VSQPEKRPTMAEVAK 633
                +  V K E     +  ++    ++   L  +L   LA +  +  EK     +   
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302

Query: 634 MIEDI 638
              DI
Sbjct: 303 ETSDI 307

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 94.7 bits (235), Expect = 6e-21
 Identities = 33/266 (12%), Positives = 79/266 (29%), Gaps = 46/266 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQ------------------- 401
            +LG+       +A   + G    V              +Q                   
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 402 ------YMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL----PNGSLHSLLH--GNRGP 449
                 ++     +K P   K+      + +  ++  +        +L +      +   
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 450 GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL 509
               L    R+ L L   R LA +H       + H  ++  +++LD+ G   ++ F   +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH----YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 510 LLNPVQAIARLGGYKAPE----------QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQY 559
                       G+  PE          Q     ++   D ++ G+ +  +     P+  
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD 319

Query: 560 PSPTRPRVDEEEQAVDLPKWVRSVVK 585
            +             ++P+ VR++++
Sbjct: 320 DAALGGSEWIFRSCKNIPQPVRALLE 345

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.8 bits (239), Expect = 9e-21
 Identities = 28/113 (24%), Positives = 44/113 (38%), Gaps = 4/113 (3%)

Query: 88  LDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
           L  L  LDL  N +   +         N+   YLS N +     +  + +  + RL L  
Sbjct: 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463

Query: 146 NNIRG--RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             ++     P     L  L  L L NN +     D+   L+ L+ L+L +N L
Sbjct: 464 VALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNL 516

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 94.3 bits (235), Expect = 3e-20
 Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 7/136 (5%)

Query: 70  SLSLPSHSLRGPIA-PLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAE 127
            L L S+S++     P      L  LDL  N L+ T L       NL+   LS N   A 
Sbjct: 101 ELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160

Query: 128 IPHQISSLKG--ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD---LSSS 182
              ++       + +L+LS N I+   P     + RL  L L N +L   + +   L  +
Sbjct: 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220

Query: 183 LKDLKELNLSNNELYG 198
              ++ L+LSN++L  
Sbjct: 221 NTSIRNLSLSNSQLST 236

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.9 bits (234), Expect = 4e-20
 Identities = 28/123 (22%), Positives = 43/123 (34%), Gaps = 2/123 (1%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
           P  L   +  L+L  N+L        T  + L    +  N  S   P     L  +  L+
Sbjct: 20  PDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLN 79

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           L  N +     +     T L  L L +N +     +     K+L  L+LS+N L      
Sbjct: 80  LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-TKL 138

Query: 203 GLL 205
           G  
Sbjct: 139 GTQ 141

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 92.8 bits (231), Expect = 9e-20
 Identities = 33/144 (22%), Positives = 53/144 (36%), Gaps = 4/144 (2%)

Query: 70  SLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAE 127
            L+L  + L        +    L  L L  N +      P     NL    LS N  S+ 
Sbjct: 77  VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSST 136

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPE--QVTNLTRLLTLRLQNNELTGRIPDLSSSLKD 185
                  L+ +  L LS+N I+    E   +   + L  L L +N++    P    ++  
Sbjct: 137 KLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196

Query: 186 LKELNLSNNELYGRVPEGLLKKFG 209
           L  L L+N +L   + E L  +  
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELA 220

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 92.4 bits (230), Expect = 1e-19
 Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 2/131 (1%)

Query: 68  VVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFS 125
           +  L+L  + LR   A   +   QL  LD+  N ++            LK+  L  N+ S
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86

Query: 126 AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKD 185
                  +    +  L L  N+I+            L+TL L +N L+         L++
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 186 LKELNLSNNEL 196
           L+EL LSNN++
Sbjct: 147 LQELLLSNNKI 157

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.4 bits (225), Expect = 6e-19
 Identities = 31/120 (25%), Positives = 47/120 (39%), Gaps = 3/120 (2%)

Query: 88  LDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN 146
           L  L+ L+L  N L+         CTNL   +L  N       +     K ++ LDLS N
Sbjct: 72  LPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN 131

Query: 147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKD--LKELNLSNNELYGRVPEGL 204
            +          L  L  L L NN++     +      +  LK+L LS+N++    P   
Sbjct: 132 GLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 89.7 bits (223), Expect = 8e-19
 Identities = 31/134 (23%), Positives = 50/134 (37%), Gaps = 7/134 (5%)

Query: 70  SLSLPSHSLRGPIA-PLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAE 127
             S+   SL          L  L  L++ DN + G      T   NLK   LS +  S  
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368

Query: 128 IPHQIS----SLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SS 182
                +    +   +  L+L+ N I     +  + L  L  L L  NE+   +       
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428

Query: 183 LKDLKELNLSNNEL 196
           L+++ E+ LS N+ 
Sbjct: 429 LENIFEIYLSYNKY 442

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 89.3 bits (222), Expect = 1e-18
 Identities = 32/157 (20%), Positives = 59/157 (37%), Gaps = 7/157 (4%)

Query: 70  SLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP----LTNCTNLKLAYLSGNDF 124
            L L S+ ++         + +L  L L++ +L  ++          T+++   LS +  
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234

Query: 125 SAEIPHQISSLKG--ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSS 182
           S         LK   +  LDLS NN+     +    L +L    L+ N +          
Sbjct: 235 STTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHG 294

Query: 183 LKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGL 219
           L +++ LNL  +     +    L K  + SF   + L
Sbjct: 295 LFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 87.0 bits (216), Expect = 6e-18
 Identities = 29/134 (21%), Positives = 44/134 (32%), Gaps = 9/134 (6%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLK--------LAYLSGNDFSAEIPHQISS 134
           P   L  L  LDL +N +       L     L+        LA L  +       + +  
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534

Query: 135 LKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
           L  +  L+L  N       E   +L  L  + L  N L      + ++   LK LNL  N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594

Query: 195 ELYGRVPEGLLKKF 208
            +     +     F
Sbjct: 595 LITSVEKKVFGPAF 608

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.3 bits (209), Expect = 4e-17
 Identities = 30/137 (21%), Positives = 46/137 (33%), Gaps = 12/137 (8%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFS--AEIPHQISSLKG 137
                  L+ +  + L  N+             +L+   L           P     L+ 
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481

Query: 138 ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT--------GRIPDLSSSLKDLKEL 189
           +  LDLS+NNI     + +  L +L  L LQ+N L         G        L  L  L
Sbjct: 482 LTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541

Query: 190 NLSNNELYGRVPEGLLK 206
           NL +N     +P  + K
Sbjct: 542 NLESNGFDE-IPVEVFK 557

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 84.3 bits (209), Expect = 4e-17
 Identities = 28/153 (18%), Positives = 54/153 (35%), Gaps = 15/153 (9%)

Query: 70  SLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTI----------LPLTNCTNLKLAY 118
              L  ++++   +  L  L  +R+L+L  +    +I                  L+   
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLN 335

Query: 119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVT----NLTRLLTLRLQNNELTG 174
           +  ND      +  + L  +  L LS++    R     T      + L  L L  N+++ 
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK 395

Query: 175 RIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
              D  S L  L+ L+L  NE+   +     + 
Sbjct: 396 IESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 81.6 bits (202), Expect = 3e-16
 Identities = 25/117 (21%), Positives = 44/117 (37%), Gaps = 10/117 (8%)

Query: 90  QLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKG---------IL 139
            L  LDL  N LN            L+  +L  N+      H +  L             
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFT 308

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           +  +S  ++          L  L  L +++N++ G   ++ + L +LK L+LSN+  
Sbjct: 309 KQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.5 bits (194), Expect = 3e-15
 Identities = 32/145 (22%), Positives = 51/145 (35%), Gaps = 15/145 (10%)

Query: 69  VSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNG----TILPLTNCTNLKLAY----- 118
             L L  ++L        + L QL +  L  N +      ++  L N   L L       
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310

Query: 119 -LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIP 177
            +S              LK +  L++ DN+I G      T L  L  L L N+  + R  
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370

Query: 178 DLSS----SLKDLKELNLSNNELYG 198
              +    +   L  LNL+ N++  
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISK 395

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.9 bits (182), Expect = 8e-14
 Identities = 25/132 (18%), Positives = 46/132 (34%), Gaps = 3/132 (2%)

Query: 72  SLPSHSLRG-PIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIP 129
            L  H+  G PI  L  L  L  L+L  N  +   +    +   LK+  L  N+ +    
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKE 188
              ++   +  L+L  N I     +        L  L ++ N        ++  +  + E
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637

Query: 189 LNLSNNELYGRV 200
            + +  EL    
Sbjct: 638 THTNIPELSSHY 649

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 92.7 bits (231), Expect = 1e-20
 Identities = 66/305 (21%), Positives = 114/305 (37%), Gaps = 64/305 (20%)

Query: 364 LGKGSLGTVYKAVLDDGG------IVAVKRLK-DANPCARKEFEQYMDVIGKL-KHPNVV 415
           LG G+ G V +A     G       VAVK LK  A+   ++     + ++  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR---------GPGRIPLDWTTRISLVLGA 466
            L          L++ +Y   G L + L                         +      
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-- 524
           A+G+A +  +       H +V + NVLL    VA I DFGL+      + I     Y   
Sbjct: 174 AQGMAFLASK----NCIHRDVAARNVLLTNGHVAKIGDFGLA------RDIMNDSNYIVK 223

Query: 525 ----------APEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQA 573
                     APE       + ++DV+S+G+LL E+ + G  P  YP      V+ +   
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP--YPG---ILVNSK--- 275

Query: 574 VDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                    +VK+         ++ +     + + S++    AC   +P  RPT  ++  
Sbjct: 276 ------FYKLVKD-------GYQMAQPAFAPKNIYSIM---QACWALEPTHRPTFQQICS 319

Query: 634 MIEDI 638
            +++ 
Sbjct: 320 FLQEQ 324

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 94.7 bits (235), Expect = 2e-20
 Identities = 60/286 (20%), Positives = 108/286 (37%), Gaps = 26/286 (9%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E LG G  G V + +  D G  VA+K+  ++ +P  R+ +   + ++ KL HPNVV  R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 420 YY------YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
                      +  LL  +Y   G L   L+       +       +   + +A  L  +
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYL 137

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVAC---ISDFGLSLLLNPVQAIARLGG---YKAPE 527
           H+     ++ H ++K  N++L          I D G +  L+  +      G   Y APE
Sbjct: 138 HEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
             E K+ +   D +SFG L  E +TG  P    +          E+    +  +      
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253

Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
            ++++ +          +  +L   L   L   +    +R T  + 
Sbjct: 254 VKFSSVLPT-PNHLSGILAGKLERWLQCML---MWHQRQRGTDPQN 295

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 37/211 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             +G+GS G V  A     G  VAVK +       R+     + ++   +H NVV+    
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---M 107

Query: 421 Y--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA-RGLARIHQE 476
           Y  Y   E+L ++ ++L  G+L  ++       R+  +    I+ V  A  + LA +H +
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQ---IATVCEAVLQALAYLHAQ 160

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-----------A 525
                V H ++KS ++LL  +G   +SDFG    ++           K           A
Sbjct: 161 ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-------KRKSLVGTPYWMA 209

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE       + + D++S G++++E++ G  P
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 88.1 bits (219), Expect = 3e-20
 Identities = 22/115 (19%), Positives = 52/115 (45%), Gaps = 2/115 (1%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           +  +     ++ L +++        P++  +NL+   + G D +++    +S L  +  L
Sbjct: 59  LTGIEYAHNIKDLTINNIHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           D+S +     I  ++  L ++ ++ L  N     I  L  +L +LK LN+  + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 18/94 (19%), Positives = 37/94 (39%), Gaps = 4/94 (4%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           I  LS L  L  LD+  +  + +IL  +     +    LS N    +I   + +L  +  
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKS 163

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG 174
           L++  + +       + +  +L  L   +  + G
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 61.5 bits (150), Expect = 5e-11
 Identities = 15/117 (12%), Positives = 39/117 (33%), Gaps = 27/117 (23%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN 147
           ++ L ++ L +  +   +  +    N+K   ++            ++   I         
Sbjct: 43  MNSLTYITLANINVT-DLTGIEYAHNIKDLTINNI--------HATNYNPI--------- 84

Query: 148 IRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL 204
                    + L+ L  LR+   ++T       S L  L  L++S++     +   +
Sbjct: 85  ---------SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 14/83 (16%), Positives = 28/83 (33%), Gaps = 9/83 (10%)

Query: 70  SLSLPSHSLRG-PIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGN---DFS 125
            L +   +     +  ++ L ++  +DL  N     I+PL     LK   +  +   D+ 
Sbjct: 116 LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYR 175

Query: 126 AEIPHQISSLKGILRLDLSDNNI 148
                 I     + +L      I
Sbjct: 176 G-----IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 10/55 (18%), Positives = 19/55 (34%), Gaps = 9/55 (16%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLK 136
           I PL  L +L+ L++  + ++     + +   L   Y             I   K
Sbjct: 152 IMPLKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQ--------TIGGKK 197

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 39.9 bits (94), Expect = 8e-04
 Identities = 15/66 (22%), Positives = 28/66 (42%), Gaps = 9/66 (13%)

Query: 133 SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS--SSLKDLKELN 190
           S+ K  L   L  ++       Q+ +LT    + L N  +T    DL+      ++K+L 
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVT----DLTGIEYAHNIKDLT 72

Query: 191 LSNNEL 196
           ++N   
Sbjct: 73  INNIHA 78

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 37/211 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG+GS G+VYKA+  + G IVA+K++   +    +E  + + ++ +   P+VVK   Y
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK---Y 89

Query: 421 Y--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLARIHQE 476
           Y  Y K   L +V +Y   GS+  ++          L     I+ +L    +GL  +H  
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLT-EDEIATILQSTLKGLEYLHFM 144

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-----------A 525
               +  H ++K+ N+LL+  G A ++DFG++  L    A       K           A
Sbjct: 145 ----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-------KRNTVIGTPFWMA 193

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE  +    +  AD++S G+  +E+  G+ P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 92.8 bits (231), Expect = 7e-20
 Identities = 27/141 (19%), Positives = 49/141 (34%), Gaps = 4/141 (2%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAE 127
            L L  +      A    L++L+ LD   + L          +   L    +S  +   +
Sbjct: 380 HLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
                  L  +  L ++ N+ +      V  N T L  L L   +L      +  +L  L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499

Query: 187 KELNLSNNELYGRVPEGLLKK 207
           + LN+S+N L   +      +
Sbjct: 500 QLLNMSHNNLLF-LDSSHYNQ 519

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 91.6 bits (228), Expect = 2e-19
 Identities = 29/127 (22%), Positives = 38/127 (29%), Gaps = 9/127 (7%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
                   G       L  L  L +  N      L     N TNL    LS         
Sbjct: 438 IDFDGIFLG-------LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
               +L  +  L++S NN+          L  L TL    N +      L    K L   
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550

Query: 190 NLSNNEL 196
           NL+NN +
Sbjct: 551 NLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 87.4 bits (217), Expect = 4e-18
 Identities = 22/129 (17%), Positives = 39/129 (30%), Gaps = 5/129 (3%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNG---TILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGI 138
                 L  L +LDL  N L+             +L+   LS N     +      L+ +
Sbjct: 343 SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL 401

Query: 139 LRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
             LD   + ++         +L +LL L +           +   L  L  L ++ N   
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461

Query: 198 GRVPEGLLK 206
                 +  
Sbjct: 462 DNTLSNVFA 470

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 86.6 bits (215), Expect = 7e-18
 Identities = 26/127 (20%), Positives = 48/127 (37%), Gaps = 9/127 (7%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPH 130
            L S+S            +L++LDL    +            +L    L+GN   +  P 
Sbjct: 46  ILKSYSFSN-------FSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPG 98

Query: 131 QISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKEL 189
             S L  +  L   +  +       +  L  L  L + +N +   ++P   S+L +L  +
Sbjct: 99  SFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHV 158

Query: 190 NLSNNEL 196
           +LS N +
Sbjct: 159 DLSYNYI 165

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.2 bits (206), Expect = 9e-17
 Identities = 26/115 (22%), Positives = 44/115 (38%), Gaps = 3/115 (2%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           P  +    + +DL  N L   +     +N + L+   LS  +           L  +  L
Sbjct: 27  PDDIPSSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNL 85

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L+ N I+   P   + LT L  L     +L          L  LK+LN+++N +
Sbjct: 86  ILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFI 140

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 26/133 (19%), Positives = 51/133 (38%), Gaps = 17/133 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
           ++   +  G       L  L  L L  N +     P   +  T+L+         ++   
Sbjct: 70  TIEDKAWHG-------LHHLSNLILTGNPIQS-FSPGSFSGLTSLENLVAVETKLASLES 121

Query: 130 HQISSLKGILRLDLSDNNIRG-RIPEQVTNLTRLLTLRLQNNELTGRIPD-----LSSSL 183
             I  L  + +L+++ N I   ++P   +NLT L+ + L  N +   I       L  + 
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENP 180

Query: 184 KDLKELNLSNNEL 196
           +    L++S N +
Sbjct: 181 QVNLSLDMSLNPI 193

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 77.4 bits (191), Expect = 6e-15
 Identities = 34/134 (25%), Positives = 50/134 (37%), Gaps = 15/134 (11%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
           SL S  +         L  L+ L++  N ++   LP   +N TNL    LS N       
Sbjct: 118 SLESFPIGQ-------LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 170

Query: 130 HQISSLKG----ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLK 184
           + +  L+      L LD+S N I   I +Q     +L  L L+ N  +  I      +L 
Sbjct: 171 NDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLA 229

Query: 185 DLKELNLSNNELYG 198
            L    L   E   
Sbjct: 230 GLHVHRLILGEFKD 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.8 bits (187), Expect = 2e-14
 Identities = 32/143 (22%), Positives = 52/143 (36%), Gaps = 14/143 (9%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDF-SAEIP 129
           S    S  G       L  L  L   + +L      P+     LK   ++ N   S ++P
Sbjct: 94  SFSPGSFSG-------LTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLP 146

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRL----LTLRLQNNELTGRIPDLSSSLKD 185
              S+L  ++ +DLS N I+      +  L       L+L +  N +   I D +     
Sbjct: 147 AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIK 205

Query: 186 LKELNLSNNELYGRVPEGLLKKF 208
           L EL L  N     + +  L+  
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNL 228

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 73.9 bits (182), Expect = 7e-14
 Identities = 24/113 (21%), Positives = 38/113 (33%), Gaps = 3/113 (2%)

Query: 94  LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP 153
               D +L  + +P    ++ K   LS N       +  S+   +  LDLS   I     
Sbjct: 16  YQCMDQKL--SKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIED 73

Query: 154 EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
           +    L  L  L L  N +    P   S L  L+ L     +L   +    + 
Sbjct: 74  KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-LESFPIG 125

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.4 bits (165), Expect = 8e-12
 Identities = 26/130 (20%), Positives = 41/130 (31%), Gaps = 4/130 (3%)

Query: 71  LSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAE 127
           L +  +S +        +    L FLDL   +L             L+L  +S N+    
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
                + L  +  LD S N I             L    L NN +   I +    L+ +K
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC-ICEHQKFLQWVK 571

Query: 188 ELNLSNNELY 197
           E       + 
Sbjct: 572 EQKQFLVNVE 581

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 61.6 bits (150), Expect = 5e-10
 Identities = 20/117 (17%), Positives = 35/117 (29%), Gaps = 10/117 (8%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           +  L  +   +      N             N+    L+G          +        L
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK--YLEDVPKHFKWQSL 312

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG 198
            +    ++   P    +L  L +L L  N+ +  I     +L  L  L+LS N L  
Sbjct: 313 SIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 60.0 bits (146), Expect = 2e-09
 Identities = 17/134 (12%), Positives = 39/134 (29%), Gaps = 12/134 (8%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP-H 130
           ++  + L+              LD+  N ++           L    L GN  S+ I   
Sbjct: 167 TITVNDLQFLR---ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKT 223

Query: 131 QISSLKGILRLDLSDNNIRGRIPEQVTNLT--------RLLTLRLQNNELTGRIPDLSSS 182
            + +L G+    L     +     ++   +         +   RL               
Sbjct: 224 CLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHC 283

Query: 183 LKDLKELNLSNNEL 196
           L ++  ++L+   +
Sbjct: 284 LANVSAMSLAGVSI 297

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 90.3 bits (225), Expect = 1e-19
 Identities = 34/127 (26%), Positives = 66/127 (51%), Gaps = 6/127 (4%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
           SL + ++ +   ++PL+ L QL +L++  N+++  I  + + T LK+  +  N  S +I 
Sbjct: 225 SLKIGNNKITD-LSPLANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQIS-DIS 281

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
             +++L  +  L L++N +     E +  LT L TL L  N +T  I  L +SL  +   
Sbjct: 282 V-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPL-ASLSKMDSA 338

Query: 190 NLSNNEL 196
           + +N  +
Sbjct: 339 DFANQVI 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 88.4 bits (220), Expect = 4e-19
 Identities = 34/127 (26%), Positives = 65/127 (51%), Gaps = 7/127 (5%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
           SL+L ++     ++PLS +  L +L + ++++   + P+ N T+L    L+ N      P
Sbjct: 136 SLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD-VTPIANLTDLYSLSLNYNQIEDISP 194

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
             ++SL  +       N I    P  V N+TRL +L++ NN++T  +  L ++L  L  L
Sbjct: 195 --LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSPL-ANLSQLTWL 248

Query: 190 NLSNNEL 196
            +  N++
Sbjct: 249 EIGTNQI 255

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.1 bits (214), Expect = 2e-18
 Identities = 37/135 (27%), Positives = 66/135 (48%), Gaps = 8/135 (5%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
           SLSL  + +   I+PL+ L  L +   + N++   I P+ N T L    +  N  +   P
Sbjct: 181 SLSLNYNQIED-ISPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSP 238

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
             +++L  +  L++  N I       V +LT+L  L + +N+++  I  L++ L  L  L
Sbjct: 239 --LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNN-LSQLNSL 292

Query: 190 NLSNNELYGRVPEGL 204
            L+NN+L     E +
Sbjct: 293 FLNNNQLGNEDMEVI 307

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 31/115 (26%), Positives = 58/115 (50%), Gaps = 6/115 (5%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I+ L  L  LR L L+++ ++  I PL N T +    L  N   +++   +S++ G+  L
Sbjct: 103 ISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYL 160

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            ++++ ++   P  + NLT L +L L  N++   I  L +SL  L       N++
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPL-ASLTSLHYFTAYVNQI 211

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.9 bits (211), Expect = 6e-18
 Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 7/129 (5%)

Query: 68  VVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAE 127
           +  L +    +   I  +  L  L +L+L+ N++   I PL+N   L   Y+  N  +  
Sbjct: 46  ITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKIT-- 101

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
               + +L  +  L L+++NI    P  + NLT++ +L L  N     +  L S++  L 
Sbjct: 102 DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPL-SNMTGLN 158

Query: 188 ELNLSNNEL 196
            L ++ +++
Sbjct: 159 YLTVTESKV 167

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 84.5 bits (210), Expect = 8e-18
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 6/115 (5%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I+PL+ L ++  L+L  N     + PL+N T L    ++ +      P  I++L  +  L
Sbjct: 125 ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L+ N I    P  + +LT L       N++T  I  + +++  L  L + NN++
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPV-ANMTRLNSLKIGNNKI 233

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 26/115 (22%), Positives = 51/115 (44%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I P + L +     L    +   ++      ++    ++G   +  I   I  L  +  L
Sbjct: 15  IFPDADLAEGIRAVLQKASVTD-VVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           +L+ N I    P  ++NL +L  L +  N++T  I  L  +L +L+EL L+ + +
Sbjct: 72  NLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISAL-QNLTNLRELYLNEDNI 122

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 22/92 (23%), Positives = 42/92 (45%), Gaps = 3/92 (3%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I  +  L +L+ L++  N+++  I  L N + L   +L+ N    E    I  L  +  L
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT 173
            LS N+I    P  + +L+++ +    N  + 
Sbjct: 317 FLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 88.7 bits (221), Expect = 1e-19
 Identities = 62/280 (22%), Positives = 110/280 (39%), Gaps = 46/280 (16%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVK---RLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           LGKGS   VY+A  +  G  VA+K   +         +  +  + +  +LKHP++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
           Y+       LV +   NG ++  L           +   R   +     G+  +H     
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFS-ENEAR-HFMHQIITGMLYLHSH--- 131

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAPEQAEVKRLS 535
             + H ++  SN+LL +N    I+DFGL+  L  P +    L G   Y +PE A      
Sbjct: 132 -GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190

Query: 536 QKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
            ++DV+S G +   +L GR P  +     T  +V   +   ++P ++    K        
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLAD--YEMPSFLSIEAK-------- 240

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
             +L+           +L          P  R +++ V  
Sbjct: 241 --DLIH---------QLLRR-------NPADRLSLSSVLD 262

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 89.4 bits (222), Expect = 1e-19
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 41/228 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVK--- 416
           E++G G+ G VYK   +  G + A+K + D      +E +Q ++++ K   H N+     
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88

Query: 417 --LRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLAR 472
             ++      +++L LV ++   GS+  L+   +G   +  +W   I+ +     RGL+ 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEW---IAYICREILRGLSH 144

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK-------- 524
           +HQ     KV H ++K  NVLL +N    + DFG+S  L+           +        
Sbjct: 145 LHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG-------RRNTFIGTP 193

Query: 525 ---APEQAEVKRLSQ-----KADVYSFGVLLLEVLTGRAPSQYPSPTR 564
              APE              K+D++S G+  +E+  G  P     P R
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 61/307 (19%), Positives = 105/307 (34%), Gaps = 60/307 (19%)

Query: 337 TDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVK---RLKDAN 392
            D      Y R +              LGKG     ++    D   + A K   +     
Sbjct: 9   VDPRSRRRYVRGR-------------FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK 55

Query: 393 PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
           P  R++    + +   L H +VV    ++   +   +V +     SL  L         +
Sbjct: 56  PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KAL 112

Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLL 511
                      +    G   +H+     +V H ++K  N+ L+++    I DFGL+  + 
Sbjct: 113 TEPEARYYLRQI--VLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166

Query: 512 NPVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPS--PTRPR 566
              +    L G   Y APE    K  S + DV+S G ++  +L G+ P +      T  R
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR 226

Query: 567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP 626
           + + E    +PK +  V             L++          ML          P  RP
Sbjct: 227 IKKNE--YSIPKHINPVAA----------SLIQ---------KMLQT-------DPTARP 258

Query: 627 TMAEVAK 633
           T+ E+  
Sbjct: 259 TINELLN 265

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 90.7 bits (225), Expect = 6e-19
 Identities = 27/133 (20%), Positives = 50/133 (37%), Gaps = 12/133 (9%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI--LPLTNCTNLKLAYLSGNDFSAEIP 129
           S+P +SL+           L  +DL  N+L         T    L    +S N FS   P
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFP 769

Query: 130 HQISSLKGILRLDL------SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
            Q  +   +    +        N I  + P  +T    L+ L++ +N++   + +     
Sbjct: 770 TQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDE--KLT 826

Query: 184 KDLKELNLSNNEL 196
             L  L++++N  
Sbjct: 827 PQLYILDIADNPN 839

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 89.2 bits (221), Expect = 1e-18
 Identities = 18/132 (13%), Positives = 44/132 (33%), Gaps = 13/132 (9%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           +  L +L+ +   ++             + + A               S+LK +  ++L 
Sbjct: 444 IQRLTKLQIIYFANSPFTY----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTG---------RIPDLSSSLKDLKELNLSNNE 195
           +     ++P+ + +L  L +L +  N             R+ D   +   ++   +  N 
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559

Query: 196 LYGRVPEGLLKK 207
           L        L+K
Sbjct: 560 LEEFPASASLQK 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 87.2 bits (216), Expect = 6e-18
 Identities = 25/160 (15%), Positives = 59/160 (36%), Gaps = 24/160 (15%)

Query: 67  RVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP----------LTNCTNLK 115
              +++L  + ++       +    +  + L +N +  T +P            N   L 
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM--TSIPENSLKPKDGNYKNTYLLT 731

Query: 116 LAYLSGNDFSAEIPHQI--SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQ----- 168
              L  N  +  +      ++L  +  +D+S N      P Q  N ++L    ++     
Sbjct: 732 TIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789

Query: 169 -NNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
             N +  + P   ++   L +L + +N++  +V E L  +
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQ 828

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 84.5 bits (209), Expect = 5e-17
 Identities = 27/133 (20%), Positives = 46/133 (34%), Gaps = 14/133 (10%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPH--QISSLKGI 138
                 +L  L L  N++    +P         ++    S N     IP+     S+  +
Sbjct: 590 AFGTNVKLTDLKLDYNQI--EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM 646

Query: 139 LRLDLSDNNIRGRIPEQVT-----NLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN 193
             +D S N I                    T+ L  NE+     +L ++   +  + LSN
Sbjct: 647 GSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSN 706

Query: 194 NELYGRVPEGLLK 206
           N +   +PE  LK
Sbjct: 707 NLM-TSIPENSLK 718

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 82.6 bits (204), Expect = 2e-16
 Identities = 22/160 (13%), Positives = 49/160 (30%), Gaps = 21/160 (13%)

Query: 62  SPKSERVVSLSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTILP--LTNCTNLKLA 117
              +      +            LS   L  L  ++L++      + P  L +   L+  
Sbjct: 463 DNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQL-PDFLYDLPELQSL 520

Query: 118 YLSGNDFS---------AEIPHQISSLKGILRLDLSDNNIRGRIPEQVT--NLTRLLTLR 166
            ++ N              +     +   I    +  NN+    P   +   + +L  L 
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLD 579

Query: 167 LQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
             +N++   +     +   L +L L  N++   +PE    
Sbjct: 580 CVHNKVRH-LEAF-GTNVKLTDLKLDYNQIEE-IPEDFCA 616

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 81.8 bits (202), Expect = 3e-16
 Identities = 15/138 (10%), Positives = 39/138 (28%), Gaps = 15/138 (10%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEI 128
            +   +         +   D     +    +         +N  +L    L       ++
Sbjct: 452 IIYFANSPFTYDNIAVDWED----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

Query: 129 PHQISSLKGILRLDLSDNNIRG---------RIPEQVTNLTRLLTLRLQNNELTGRIPDL 179
           P  +  L  +  L+++ N             R+ +      ++    +  N L       
Sbjct: 508 PDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASA 567

Query: 180 S-SSLKDLKELNLSNNEL 196
           S   +  L  L+  +N++
Sbjct: 568 SLQKMVKLGLLDCVHNKV 585

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 76.1 bits (187), Expect = 2e-14
 Identities = 33/215 (15%), Positives = 59/215 (27%), Gaps = 53/215 (24%)

Query: 42  LLSNWKGADACAA--AWTGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHD 98
              NW             GV       RV  LSL     +G +   +  L +L+ L    
Sbjct: 298 HSLNWNFNKELDMWGDQPGVDLDNNG-RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGT 356

Query: 99  NRLNGTILPLT-NCTNLKLAYLSGNDFSAEIPH-----------------------QISS 134
           +    +            ++    +                               ++  
Sbjct: 357 HSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKP 416

Query: 135 LKGILRLDLSDNNIRG------RIPEQVTNLTRLLTLRLQNNELTGRIPDLS-------- 180
           +K   R+ L D  I         I + +  LT+L  +   N+  T     +         
Sbjct: 417 IKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY 476

Query: 181 -----------SSLKDLKELNLSNNELYGRVPEGL 204
                      S+LKDL ++ L N     ++P+ L
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 66.4 bits (162), Expect = 2e-11
 Identities = 21/118 (17%), Positives = 46/118 (38%), Gaps = 15/118 (12%)

Query: 88  LDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYL------SGNDFSAEIPHQISSLKGIL 139
           L  L  +D+  N    +  P    N + LK   +       GN    + P  I++   ++
Sbjct: 752 LPYLSNMDVSYNCF--SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI 809

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT-GRIPDLSSSLKDLKELNLSNNEL 196
           +L +  N+IR  + E++    +L  L + +N      +  +   ++      L  ++ 
Sbjct: 810 QLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE-AGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 58.0 bits (140), Expect = 9e-09
 Identities = 16/122 (13%), Positives = 35/122 (28%), Gaps = 2/122 (1%)

Query: 85  LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            +L      LD  + R     +    +  N        + +  +    + +   +  L L
Sbjct: 272 KALKAIWEALDGKNWRYYSGTINNTIHSLNWNFN-KELDMWGDQPGVDLDNNGRVTGLSL 330

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           +    +GR+P+ +  LT L  L    +  T                    + +     + 
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390

Query: 204 LL 205
            L
Sbjct: 391 FL 392

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 21/198 (10%), Positives = 47/198 (23%), Gaps = 34/198 (17%)

Query: 42  LLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLD--QLRFLDLHDN 99
           L + W+  D     +     +     +         + G    + L +  ++  L L   
Sbjct: 274 LKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333

Query: 100 RLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPE-QV 156
              G + P  +   T LK+     +  +                +   + IR    +  +
Sbjct: 334 GAKGRV-PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392

Query: 157 TNLTRLLTLRLQNNELTG----------------------------RIPDLSSSLKDLKE 188
               RL    L  + +                               I      L  L+ 
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452

Query: 189 LNLSNNELYGRVPEGLLK 206
           +  +N+           +
Sbjct: 453 IYFANSPFTYDNIAVDWE 470

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 4/90 (4%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
           L         D   NR+       +T C +L    +  ND   ++  ++     +  LD+
Sbjct: 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDI 834

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELT 173
           +DN         V          L  ++  
Sbjct: 835 ADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 12/68 (17%), Positives = 23/68 (33%)

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV 200
            +   +    +    + N  R+  L L      GR+PD    L +LK L+   +      
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 201 PEGLLKKF 208
                ++ 
Sbjct: 364 RLFGDEEL 371

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 87.9 bits (218), Expect = 6e-19
 Identities = 46/252 (18%), Positives = 94/252 (37%), Gaps = 40/252 (15%)

Query: 334 TSGTDTSKLVFYERKKQFELED--LLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA 391
           ++ ++   L  Y ++K   + D  ++R     L +G    +      D    A+K+ + +
Sbjct: 11  SNYSNLIYLNKYVKEKDKYINDYRIIR----TLNQGKFNKIILCE-KDNKFYALKKYEKS 65

Query: 392 NPCARKEFEQYMDVIG-----------------KLKHPNVVKLRAYYYAKEEKLLVYDYL 434
               +++F +  +                     +K+   +         +E  ++Y+Y+
Sbjct: 66  LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125

Query: 435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA------ARGLARIHQEYGTAKVPHGNVK 488
            N S+            +  ++T  I + +            + IH E     + H +VK
Sbjct: 126 ENDSILKFDEYF---FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVK 179

Query: 489 SSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQAEVKRL--SQKADVYSFG 544
            SN+L+DKNG   +SDFG S  +   +     G   +  PE    +      K D++S G
Sbjct: 180 PSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239

Query: 545 VLLLEVLTGRAP 556
           + L  +     P
Sbjct: 240 ICLYVMFYNVVP 251

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 88.5 bits (220), Expect = 2e-18
 Identities = 25/127 (19%), Positives = 43/127 (33%), Gaps = 10/127 (7%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLT--NCTNLKLAYLSGNDFSAEIP 129
           ++ + +          L  L FLDL   ++   I   T  +   L    L+ N       
Sbjct: 47  TIQNTTFSR-------LINLTFLDLTRCQIY-WIHEDTFQSQHRLDTLVLTANPLIFMAE 98

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
             +S  K +  L      I       + N   L +L L +N ++          + LK L
Sbjct: 99  TALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVL 158

Query: 190 NLSNNEL 196
           +  NN +
Sbjct: 159 DFQNNAI 165

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 40/206 (19%), Positives = 57/206 (27%), Gaps = 14/206 (6%)

Query: 4   ASLFLLSLALSLLSVSSSHPNDTDALTLFRLQT-DTHGNLLSNWKGADACAAAWTGVVCS 62
            S    SL                  T+  L           +             V   
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP---------AVFEG 250

Query: 63  PKSERVVSLSLPSHSLRG-PIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSG 121
                V S++L  H               L+ LDL    L+     L   + LK   LS 
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSA 310

Query: 122 NDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELT--GRIPD 178
           N F        S+   +  L +  N  R  +      NL  L  L L ++++        
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 179 LSSSLKDLKELNLSNNELYGRVPEGL 204
              +L  L+ LNLS NE      E  
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAF 396

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 21/115 (18%), Positives = 37/115 (32%), Gaps = 3/115 (2%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           P +L +    L+   N L  TI     +   NL    L+             S   +  L
Sbjct: 28  PGTLPNSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTL 86

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L+ N +       ++    L  L      ++        + K L+ L L +N +
Sbjct: 87  VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI 141

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 22/124 (17%), Positives = 47/124 (37%), Gaps = 1/124 (0%)

Query: 83  APLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
           + +  L    F D+ D  ++  +       +++   L  + F     +      G+  LD
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELD 284

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           L+  ++   +P  +  L+ L  L L  N+        +S+   L  L++  N     +  
Sbjct: 285 LTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343

Query: 203 GLLK 206
           G L+
Sbjct: 344 GCLE 347

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.6 bits (202), Expect = 3e-16
 Identities = 28/122 (22%), Positives = 45/122 (36%), Gaps = 4/122 (3%)

Query: 88  LDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN 146
             +L  L L  N L       L+    LK  +      S+     + + K +  L L  N
Sbjct: 80  QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139

Query: 147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK--ELNLSNNELYGRVPEGL 204
           +I      +     +L  L  QNN +     +  SSL+      LNL+ N++ G +  G 
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGA 198

Query: 205 LK 206
             
Sbjct: 199 FD 200

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.2 bits (201), Expect = 3e-16
 Identities = 28/133 (21%), Positives = 48/133 (36%), Gaps = 14/133 (10%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAE 127
           +    +  LR        L  L+ L+L  N    ++       C  L+L  L+      +
Sbjct: 364 TSDCCNLQLRN-------LSHLQSLNLSYNEPL-SLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 128 IPH-QISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKD- 185
                  +L  +  L+LS + +     +    L  L  L LQ N         ++SL+  
Sbjct: 416 DAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475

Query: 186 --LKELNLSNNEL 196
             L+ L LS  +L
Sbjct: 476 GRLEILVLSFCDL 488

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 78.1 bits (193), Expect = 3e-15
 Identities = 21/136 (15%), Positives = 43/136 (31%), Gaps = 8/136 (5%)

Query: 67  RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP------LTNCTNLKLAYLS 120
             +SL+L  + + G           + L+    +    I        + +        + 
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239

Query: 121 GNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS 180
             D S  +   +  +  +  ++L  +             + L  L L    L+  +P   
Sbjct: 240 DEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGL 297

Query: 181 SSLKDLKELNLSNNEL 196
             L  LK+L LS N+ 
Sbjct: 298 VGLSTLKKLVLSANKF 313

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 77.7 bits (192), Expect = 4e-15
 Identities = 33/132 (25%), Positives = 54/132 (40%), Gaps = 10/132 (7%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKG 137
             +P   L  L+ L+L  + L   I           L+   L GN F      + +SL+ 
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLL--DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474

Query: 138 ILR---LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
           + R   L LS  ++        T+L  +  + L +N LT    +  S LK +  LNL++N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN 533

Query: 195 ELYGRVPEGLLK 206
            +   +   LL 
Sbjct: 534 HISI-ILPSLLP 544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.4 bits (186), Expect = 2e-14
 Identities = 23/105 (21%), Positives = 34/105 (32%), Gaps = 2/105 (1%)

Query: 92  RFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGR 151
           +  +  +  L    +P T   + +    S N          S L  +  LDL+   I   
Sbjct: 15  KTYNCENLGL--NEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 152 IPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             +   +  RL TL L  N L        S  K LK L      +
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 58/282 (20%), Positives = 101/282 (35%), Gaps = 47/282 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK---RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
             LGKG     ++    D   + A K   +     P  R++    + +   L H +VV  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
             ++   +   +V +     SL  L         +           +    G   +H+  
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQI--VLGCQYLHRN- 160

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAPEQAEVKR 533
              +V H ++K  N+ L+++    I DFGL+  +    +    L G   Y APE    K 
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG 217

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPS--PTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
            S + DV+S G ++  +L G+ P +      T  R+ + E    +PK +  V        
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--YSIPKHINPVAA------ 269

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                L++          ML          P  RPT+ E+  
Sbjct: 270 ----SLIQ---------KMLQT-------DPTARPTINELLN 291

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 30/209 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL 417
             +G GS G VY A  + +  +VA+K++  +   + ++++  +     + KL+HPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ- 118

Query: 418 RAYY--YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL-GAARGLARI 473
             Y   Y +E    LV +Y   GS   LL  ++ P    L     I+ V  GA +GLA +
Sbjct: 119 --YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP----LQ-EVEIAAVTHGALQGLAYL 170

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAE 530
           H       + H +VK+ N+LL + G+  + DFG + ++ P  +     G   + APE   
Sbjct: 171 HSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV---GTPYWMAPEVIL 223

Query: 531 VKRLSQ---KADVYSFGVLLLEVLTGRAP 556
                Q   K DV+S G+  +E+   + P
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPP 252

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 86.9 bits (216), Expect = 3e-18
 Identities = 40/126 (31%), Positives = 64/126 (50%), Gaps = 7/126 (5%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           +APLS L +L  L L  N+++  I PL   T L    L+ N      P  IS+LK +  L
Sbjct: 258 LAPLSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP 201
            L  NNI    P  V++LT+L  L   NN+++  +  L++ L ++  L+  +N++    P
Sbjct: 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLAN-LTNINWLSAGHNQISDLTP 370

Query: 202 EGLLKK 207
              L +
Sbjct: 371 LANLTR 376

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 83.5 bits (207), Expect = 5e-17
 Identities = 34/115 (29%), Positives = 55/115 (47%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           + PL+ L  L  LD+  N+++  I  L   TNL+    + N  S   P  +  L  +  L
Sbjct: 170 LKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISDITP--LGILTNLDEL 226

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L+ N ++      + +LT L  L L NN+++  +  L S L  L EL L  N++
Sbjct: 227 SLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPL-SGLTKLTELKLGANQI 277

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 83.1 bits (206), Expect = 6e-17
 Identities = 40/115 (34%), Positives = 53/115 (46%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I PL +L  L  L L+ N+L   I  L + TNL    L+ N  S   P  +S L  +  L
Sbjct: 214 ITPLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L  N I    P  +  LT L  L L  N+L   I  + S+LK+L  L L  N +
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLED-ISPI-SNLKNLTYLTLYFNNI 321

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.5 bits (202), Expect = 2e-16
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 8/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I PL+ L  L  L L +N++   I PL N TNL    LS N  S +I   +S L  + +L
Sbjct: 105 ITPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTIS-DISA-LSGLTSLQQL 161

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
               N +    P  + NLT L  L + +N+++  I  L + L +L+ L  +NN++
Sbjct: 162 SFG-NQVTDLKP--LANLTTLERLDISSNKVSD-ISVL-AKLTNLESLIATNNQI 211

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.5 bits (202), Expect = 2e-16
 Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 7/113 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I  +  L+ L  ++  +N+L   I PL N T L    ++ N  +   P  +++L  +  L
Sbjct: 61  IDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
            L +N I    P  + NLT L  L L +N ++  I  L S L  L++L+  N 
Sbjct: 118 TLFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISAL-SGLTSLQQLSFGNQ 166

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 35/127 (27%), Positives = 62/127 (48%), Gaps = 9/127 (7%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
            ++  ++ L   I PL  L +L  + +++N++   I PL N TNL    L  N  +   P
Sbjct: 72  QINFSNNQLTD-ITPLKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDP 129

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
             + +L  + RL+LS N I       ++ LT L  L   N      +  L ++L  L+ L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPL-ANLTTLERL 182

Query: 190 NLSNNEL 196
           ++S+N++
Sbjct: 183 DISSNKV 189

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 76.9 bits (190), Expect = 5e-15
 Identities = 22/115 (19%), Positives = 47/115 (40%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I   + L +     L    +    +  T+   +                 +  L  + ++
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTD-TVSQTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           + S+N +    P  + NLT+L+ + + NN++   I  L ++L +L  L L NN++
Sbjct: 74  NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPL-ANLTNLTGLTLFNNQI 124

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 75.4 bits (186), Expect = 2e-14
 Identities = 26/115 (22%), Positives = 49/115 (42%), Gaps = 5/115 (4%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I+P+S L +L+ L  ++N+++  +  L N TN+       N  S   P  +++L  I +L
Sbjct: 324 ISPVSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L+D            N++   T++     L    P   S      E +++ N  
Sbjct: 381 GLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLP 433

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 21/101 (20%), Positives = 38/101 (37%), Gaps = 7/101 (6%)

Query: 96  LHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQ 155
             D  +N  I   T         L   + +  +    + L  +  L      I+    + 
Sbjct: 9   TQDTPIN-QIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDG 63

Query: 156 VTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           V  L  L  +   NN+LT  I  L  +L  L ++ ++NN++
Sbjct: 64  VEYLNNLTQINFSNNQLTD-ITPL-KNLTKLVDILMNNNQI 102

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.1 bits (110), Expect = 3e-05
 Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 4/97 (4%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEI-PHQISSLKGILR 140
           + PL+ L ++  L L+D     T  P+    N+ +     N   A I P  IS       
Sbjct: 368 LTPLANLTRITQLGLNDQAW--TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTE 425

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIP 177
            D++ N       E     ++ +T+       +G + 
Sbjct: 426 PDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 41/215 (19%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKR-LKDANPCARKEFE----QYMDVIGKLKHPNVVK 416
           +++G GS G V++A L +   VA+K+ L+D      K F+    Q M     +KHPNVV 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQD------KRFKNRELQIMR---IVKHPNVVD 96

Query: 417 LRAYYYAKEEKL------LVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARG 469
           L+A++Y+  +K       LV +Y+P  +++    H  +    +P+         L   R 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL--LRS 153

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLNPVQA----IA-RLGGY 523
           LA IH    +  + H ++K  N+LLD   GV  + DFG + +L   +     I  R   Y
Sbjct: 154 LAYIH----SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY--Y 207

Query: 524 KAPE---QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
           +APE    A     +   D++S G ++ E++ G+ 
Sbjct: 208 RAPELIFGA--TNYTTNIDIWSTGCVMAELMQGQP 240

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 85.9 bits (213), Expect = 5e-18
 Identities = 66/271 (24%), Positives = 110/271 (40%), Gaps = 31/271 (11%)

Query: 300 DRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELED--LL 357
           +R   ++  Q    G    +   +    G+ SD  SG +  ++   + K +  + +   L
Sbjct: 95  EREEWTTAIQTVADGLKKQAAAEMDFRSGSPSD-NSGAEEMEVSLAKPKHRVTMNEFEYL 153

Query: 358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPN 413
           +    +LGKG+ G V        G   A+K LK     A+ E    +    V+   +HP 
Sbjct: 154 K----LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 414 VVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI---SLVLGAARG 469
           +  L+ Y +   ++L  V +Y   G L   L   R       D   R     +V      
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRER---VFSED-RARFYGAEIVSA---- 260

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKA 525
           L  +H E     V + ++K  N++LDK+G   I+DFGL    +     +    G   Y A
Sbjct: 261 LDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLA 317

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           PE  E     +  D +  GV++ E++ GR P
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 84.6 bits (210), Expect = 7e-18
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 28/211 (13%)

Query: 362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
            M G+G+ GTV        G  VA+K++        +E  Q M  +  L HPN+V+L++Y
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSY 87

Query: 421 YYAKEEK-------LLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           +Y   E+        +V +Y+P+ +LH    +  R     P          L   R +  
Sbjct: 88  FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL--IRSIGC 144

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNPVQA----IA-RLGGYKAP 526
           +H    +  V H ++K  NVL+++ +G   + DFG +  L+P +     I  R   Y+AP
Sbjct: 145 LHLP--SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY--YRAP 200

Query: 527 E---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
           E       +  +   D++S G +  E++ G 
Sbjct: 201 ELIFGN--QHYTTAVDIWSVGCIFAEMMLGE 229

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 86.1 bits (213), Expect = 1e-17
 Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 35/229 (15%)

Query: 345 YERKKQFELED--LLRASAEMLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCARKEFEQ 401
            E      + D  + R    ++G+G  G VY     D G + A+K L       ++    
Sbjct: 180 VELNIHLTMNDFSVHR----IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL 235

Query: 402 YMD------VIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPL 454
            ++      ++     P +V + +Y +   +KL  + D +  G LH  L  +   G    
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSE 291

Query: 455 D----WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL 510
                +   I L      GL  +H       V + ++K +N+LLD++G   ISD GL+  
Sbjct: 292 ADMRFYAAEIIL------GLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACD 341

Query: 511 LNPVQAIARLG--GYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAP 556
            +  +  A +G  GY APE  +        AD +S G +L ++L G +P
Sbjct: 342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 83.0 bits (206), Expect = 2e-17
 Identities = 56/228 (24%), Positives = 96/228 (42%), Gaps = 37/228 (16%)

Query: 347 RKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM 403
           + ++   ED    +    +LG+GS  TV  A         A+K L+  +     +     
Sbjct: 23  QPRKKRPEDFKFGK----ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVT 78

Query: 404 ---DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR 459
              DV+ +L HP  VKL  + +  +EKL     Y  NG L   +   R  G       TR
Sbjct: 79  RERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDET-CTR 133

Query: 460 -----ISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV 514
                I   L        +H +     + H ++K  N+LL+++    I+DFG + +L+P 
Sbjct: 134 FYTAEIVSALEY------LHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

Query: 515 QAIAR---LGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              AR     G   Y +PE    K   + +D+++ G ++ +++ G  P
Sbjct: 184 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 85.2 bits (211), Expect = 2e-17
 Identities = 26/126 (20%), Positives = 47/126 (37%), Gaps = 7/126 (5%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           L  L FLDL  N L+            T+LK   LS N     +      L+ +  LD  
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 404

Query: 145 DNNIRGRIPEQVT--NLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
            +N++ ++ E     +L  L+ L + +         + + L  L+ L ++ N        
Sbjct: 405 HSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463

Query: 203 GLLKKF 208
            +  + 
Sbjct: 464 DIFTEL 469

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 78.2 bits (193), Expect = 3e-15
 Identities = 29/130 (22%), Positives = 58/130 (44%), Gaps = 15/130 (11%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRL----NGTILPLTNCTNLKLAYLSGNDFSAE 127
            L S+S            +L+ LDL    +    +G    L++ + L    L+GN   + 
Sbjct: 42  HLGSYSFFS-------FPELQVLDLSRCEIQTIEDGAYQSLSHLSTL---ILTGNPIQSL 91

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT-GRIPDLSSSLKDL 186
                S L  + +L   + N+       + +L  L  L + +N +   ++P+  S+L +L
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 187 KELNLSNNEL 196
           + L+LS+N++
Sbjct: 152 EHLDLSSNKI 161

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 29/145 (20%), Positives = 57/145 (39%), Gaps = 18/145 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           ++   + +        L  L  L L  N +    L     +  ++L+       + ++  
Sbjct: 66  TIEDGAYQS-------LSHLSTLILTGNPI--QSLALGAFSGLSSLQKLVAVETNLASLE 116

Query: 129 PHQISSLKGILRLDLSDNNIR-GRIPEQVTNLTRLLTLRLQNNELT----GRIPDLSSSL 183
              I  LK +  L+++ N I+  ++PE  +NLT L  L L +N++       +  L    
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176

Query: 184 KDLKELNLSNNELYGRVPEGLLKKF 208
                L+LS N +   +  G  K+ 
Sbjct: 177 LLNLSLDLSLNPM-NFIQPGAFKEI 200

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 29/126 (23%), Positives = 51/126 (40%), Gaps = 8/126 (6%)

Query: 88  LDQLRFLDLHDNRLNGTILP----LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
           L+QL  LD   + L    +       +  NL    +S            + L  +  L +
Sbjct: 395 LEQLEHLDFQHSNL--KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           + N+ +      + T L  L  L L   +L    P   +SL  L+ LN+++N+L   VP+
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPD 511

Query: 203 GLLKKF 208
           G+  + 
Sbjct: 512 GIFDRL 517

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 29/116 (25%), Positives = 44/116 (37%), Gaps = 5/116 (4%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           P +L    + LDL  N L    L      +   L++  LS  +          SL  +  
Sbjct: 23  PDNLPFSTKNLDLSFNPL--RHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           L L+ N I+       + L+ L  L      L          LK LKELN+++N +
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.1 bits (185), Expect = 3e-14
 Identities = 23/119 (19%), Positives = 48/119 (40%), Gaps = 8/119 (6%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLK 136
             +    L  L +LD+        +         ++L++  ++GN F       I + L+
Sbjct: 413 EFSVFLSLRNLIYLDISHTHT--RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 470

Query: 137 GILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
            +  LDLS   +  ++      +L+ L  L + +N+L      +   L  L+++ L  N
Sbjct: 471 NLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 73.2 bits (180), Expect = 1e-13
 Identities = 33/142 (23%), Positives = 55/142 (38%), Gaps = 14/142 (9%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDF-SAEIP 129
           SL   +  G       L  L+ L   +  L      P+ +   LK   ++ N   S ++P
Sbjct: 90  SLALGAFSG-------LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRL----LTLRLQNNELTGRIPDLSSSLKD 185
              S+L  +  LDLS N I+      +  L ++    L+L L  N +   I   +     
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIR 201

Query: 186 LKELNLSNNELYGRVPEGLLKK 207
           L +L L NN     V +  ++ 
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQG 223

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 22/113 (19%), Positives = 35/113 (30%), Gaps = 3/113 (2%)

Query: 95  DLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPE 154
              +       +P     + K   LS N       +   S   +  LDLS   I+     
Sbjct: 13  QCMELNF--YKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70

Query: 155 QVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
              +L+ L TL L  N +        S L  L++L      L   +    +  
Sbjct: 71  AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.8 bits (166), Expect = 5e-12
 Identities = 35/194 (18%), Positives = 58/194 (29%), Gaps = 11/194 (5%)

Query: 5   SLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPK 64
            L  L+L  +  S++         L    +     G   +         +A  G      
Sbjct: 201 RLHKLTLRNNFDSLNVM-KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG--LCNL 257

Query: 65  SERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDF 124
           +     L+   + L   I   + L  +    L    +   +   +     +   L    F
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKF 316

Query: 125 SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT--GRIPDLSSS 182
                 ++ SLK   RL  + N       E   +L  L  L L  N L+  G        
Sbjct: 317 GQFPTLKLKSLK---RLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 183 LKDLKELNLSNNEL 196
              LK L+LS N +
Sbjct: 372 TTSLKYLDLSFNGV 385

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 24/111 (21%), Positives = 38/111 (34%), Gaps = 11/111 (9%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
              +    G       L  L  L +  N      LP   T   NL    LS        P
Sbjct: 435 VAFNGIFNG-------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDL 179
              +SL  +  L+++ N ++  +P+ +   LT L  + L  N      P +
Sbjct: 488 TAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 537

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 43/201 (21%), Positives = 66/201 (32%), Gaps = 26/201 (12%)

Query: 5   SLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPK 64
            L  LSL LSL  ++   P     + L +L       L +N+   +       G+     
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKL------TLRNNFDSLNVMKTCIQGLAGL-- 227

Query: 65  SERVVSLSLPSHSLRGPIA--PLSLLDQLRFLDLHDNRLN-------GTILPLTNCTNLK 115
              V  L L      G +     S L+ L  L + + RL          I      TN+ 
Sbjct: 228 --EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285

Query: 116 LAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR 175
              L        +    S   G   L+L +     + P     L  L  L   +N+    
Sbjct: 286 SFSLVSVTIE-RVKD-FSYNFGWQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNKGGNA 340

Query: 176 IPDLSSSLKDLKELNLSNNEL 196
             ++   L  L+ L+LS N L
Sbjct: 341 FSEVD--LPSLEFLDLSRNGL 359

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 45.9 bits (109), Expect = 4e-05
 Identities = 21/124 (16%), Positives = 42/124 (33%), Gaps = 16/124 (12%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLA--YLSGNDFSAEIP----HQISSLKGIL 139
            +      LDL  N +    +       ++L    L  N  S  +       ++ L+ + 
Sbjct: 174 QMPLLNLSLDLSLNPM--NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLE-VH 230

Query: 140 RLDL----SDNNIRGRIPEQVTNLTRLLTLRLQNNELTG---RIPDLSSSLKDLKELNLS 192
           RL L    ++ N+       +  L  L     +   L      I DL + L ++   +L 
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290

Query: 193 NNEL 196
           +  +
Sbjct: 291 SVTI 294

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 84.0 bits (208), Expect = 2e-17
 Identities = 67/211 (31%), Positives = 107/211 (50%), Gaps = 34/211 (16%)

Query: 362 EMLGKGSLGTVYKAVL-DDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           +++G GS G VY+A L D G +VA+K+ L+D     R E +    ++ KL H N+V+LR 
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-ELQ----IMRKLDHCNIVRLRY 114

Query: 420 YYYAKEEKL------LVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLAR 472
           ++Y+  EK       LV DY+P  +++ +  H +R    +P+ +       L   R LA 
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAY 171

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLNPVQA----IA-RLGGYKAP 526
           IH    +  + H ++K  N+LLD +  V  + DFG +  L   +     I  R   Y+AP
Sbjct: 172 IH----SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--YRAP 225

Query: 527 E---QAEVKRLSQKADVYSFGVLLLEVLTGR 554
           E    A     +   DV+S G +L E+L G+
Sbjct: 226 ELIFGA--TDYTSSIDVWSAGCVLAELLLGQ 254

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 83.3 bits (206), Expect = 4e-17
 Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 40/232 (17%)

Query: 347 RKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM 403
           ++ +   ED  +L+    ++G+G+ G V    L +   + A+K L       R E   + 
Sbjct: 67  KQMRLHREDFEILK----VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR 122

Query: 404 ---DVIGKLKHPNVVKLRAYYYA--KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWT 457
              DV+       +  L   +YA   +  L LV DY   G L +LL  ++   R+P +  
Sbjct: 123 EERDVLVNGDSKWITTL---HYAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEMA 177

Query: 458 TRI---SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV 514
            R     +V+     +  +HQ        H ++K  N+L+D NG   ++DFG  L L   
Sbjct: 178 -RFYLAEMVIA----IDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228

Query: 515 QAIAR--LGG---YKAPE-----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             +      G   Y +PE     +    R   + D +S GV + E+L G  P
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.1 bits (208), Expect = 4e-17
 Identities = 54/233 (23%), Positives = 95/233 (40%), Gaps = 31/233 (13%)

Query: 344 FYERKKQFELEDLLRASAE------MLGKGSLGTVYKA-VLDDGGIVAVKRLKDANPCAR 396
           ++ R  Q++  +      +      +LG+G  G V+   +   G + A K+L       R
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR 226

Query: 397 KEFEQYM---DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHS-LLHGNRGPGR 451
           K ++  M    ++ K+    +V L AY +  +  L LV   +  G +   + + +     
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG 285

Query: 452 IPLD----WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL 507
                   +T +I        GL  +HQ      + + ++K  NVLLD +G   ISD GL
Sbjct: 286 FQEPRAIFYTAQIVS------GLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGL 335

Query: 508 S--LLLNPVQAIARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           +  L     +     G  G+ APE    +      D ++ GV L E++  R P
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 33/242 (13%), Positives = 62/242 (25%), Gaps = 49/242 (20%)

Query: 362 EMLGKGSLGTVYKA---VLDDGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVV 415
              G       ++A    LD    VA+  +           +E       + ++  P V 
Sbjct: 37  IFHGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 416 KLRAYYYAKEEKL--LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
             R            +V +++  GSL  +   +  P          I  +   A      
Sbjct: 95  --RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA-------IRAMQSLAAAADAA 145

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKR 533
           H+    A V       S V +  +G   ++                          +   
Sbjct: 146 HR----AGVALSIDHPSRVRVSIDGDVVLAYPA----------------TMPDANPQ--- 182

Query: 534 LSQKADVYSFGVLLLEVLTGRAP---SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA 590
                D+   G  L  +L  R P   +   S   P   +       P  +   +  + +A
Sbjct: 183 ----DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238

Query: 591 EV 592
             
Sbjct: 239 VA 240

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 83.2 bits (206), Expect = 6e-17
 Identities = 67/296 (22%), Positives = 111/296 (37%), Gaps = 74/296 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL---KDANPCARKEFEQYMDVIGKLKHPNVVKL 417
            +LGKGS G V        G   AVK +   +      ++   + + ++ +L HPN++KL
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLG 465
             ++  K    LV +    G L               D    I             ++  
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL--------------FD---EIISRKRFSEVDAARIIRQ 134

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG 522
              G+  +H+     K+ H ++K  N+LL    K+    I DFGLS      + +    G
Sbjct: 135 VLSGITYMHK----NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190

Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
              Y APE        +K DV+S GV+L  +L+G      P    P     E  +     
Sbjct: 191 TAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSG-----CP----PFNGANEYDI----- 235

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           ++ V K ++T   F+    ++K + E    L+  ML          P  R +  + 
Sbjct: 236 LKKVEKGKYT---FELP--QWKKVSESAKDLIRKMLTY-------VPSMRISARDA 279

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.9 bits (205), Expect = 8e-17
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 30/243 (12%)

Query: 332 DGTSGTDTSKLVFYERKKQFELEDLLRASAE------MLGKGSLGTVYKA-VLDDGGIVA 384
                 D    +++ R  Q++  +    +        +LGKG  G V    V   G + A
Sbjct: 154 SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYA 213

Query: 385 VKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLH 440
            K+L+      RK     +    ++ K+    VV L AY Y  ++ L LV   +  G L 
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLK 272

Query: 441 SLLHGNRGPGRIPLD----WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK 496
             ++ + G    P      +   I        GL  +H+E    ++ + ++K  N+LLD 
Sbjct: 273 FHIY-HMGQAGFPEARAVFYAAEICC------GLEDLHRE----RIVYRDLKPENILLDD 321

Query: 497 NGVACISDFGLSL-LLNPVQAIARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTG 553
           +G   ISD GL++ +        R+G  GY APE  + +R +   D ++ G LL E++ G
Sbjct: 322 HGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381

Query: 554 RAP 556
           ++P
Sbjct: 382 QSP 384

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 30/138 (21%), Positives = 55/138 (39%), Gaps = 18/138 (13%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            +      G       L+Q+  ++L  N L  + +          L    ++  + +  I
Sbjct: 135 KVRKSVFNG-------LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TI 186

Query: 129 PHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDL 186
           P        +  L L  N I  ++       L  L  L L  N ++  + + S ++   L
Sbjct: 187 PQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHL 242

Query: 187 KELNLSNNELYGRVPEGL 204
           +EL+L+NN+L  +VP GL
Sbjct: 243 RELHLNNNKLV-KVPGGL 259

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 26/130 (20%), Positives = 51/130 (39%), Gaps = 13/130 (10%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           P  L   L  L L  N++  T +    L    NL    LS N  SA     +++   +  
Sbjct: 187 PQGLPPSLTELHLDGNKI--TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG------RIPDLSSSLKDLKELNLSNN 194
           L L++N +  ++P  + +   +  + L NN ++         P  ++       ++L +N
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303

Query: 195 EL-YGRVPEG 203
            + Y  +   
Sbjct: 304 PVQYWEIQPS 313

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 27/135 (20%), Positives = 49/135 (36%), Gaps = 23/135 (17%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            + + SL+G       L+ L  L L  N +  + +    L N  +L+  +L+ N    ++
Sbjct: 206 KVDAASLKG-------LNNLAKLGLSFNSI--SAVDNGSLANTPHLRELHLNNNKLV-KV 255

Query: 129 PHQISSLKGILRLDLSDNNIRGRIPEQV-------TNLTRLLTLRLQNNELTGRI--PDL 179
           P  ++  K I  + L +NNI   I           T       + L +N +      P  
Sbjct: 256 PGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPST 314

Query: 180 SSSLKDLKELNLSNN 194
              +     + L N 
Sbjct: 315 FRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 33/135 (24%), Positives = 52/135 (38%), Gaps = 8/135 (5%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQ 131
            +P     GP+ P      LR +   D  L    +P     +  L  L  N  +      
Sbjct: 14  EVPEIEPMGPVCPFRCQCHLRVVQCSDLGL--EKVPKDLPPDTALLDLQNNKITEIKDGD 71

Query: 132 ISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELN 190
             +LK +  L L +N I  +I       L +L  L L  N+L   +P      K L+EL 
Sbjct: 72  FKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELP--EKMPKTLQELR 127

Query: 191 LSNNELYGRVPEGLL 205
           +  NE+  +V + + 
Sbjct: 128 VHENEIT-KVRKSVF 141

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 9/100 (9%)

Query: 110 NCT-NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRL 167
            C  +L++   S      ++P  +        LDL +N I   I +    NL  L TL L
Sbjct: 28  RCQCHLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKIT-EIKDGDFKNLKNLHTLIL 83

Query: 168 QNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEGLLK 206
            NN+++ +I   + + L  L+ L LS N+L   +PE + K
Sbjct: 84  INNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 25/130 (19%), Positives = 50/130 (38%), Gaps = 11/130 (8%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L  L +LD+        +         ++L++  ++GN F       I + L+ +  LDL
Sbjct: 125 LRNLIYLDISHTHT--RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVP 201
           S   +  ++      +L+ L  L + +N     +       L  L+ L+ S N +     
Sbjct: 183 SQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHI-MTSK 239

Query: 202 EGLLKKFGEQ 211
           +  L+ F   
Sbjct: 240 KQELQHFPSS 249

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 28/142 (19%), Positives = 49/142 (34%), Gaps = 16/142 (11%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           SLP             L QL  L L  N L+            T+LK   LS N     +
Sbjct: 42  SLPHGVFDK-------LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 93

Query: 129 PHQISSLKGILRLDLSDNNIRGRIPEQVT--NLTRLLTLRLQNNELTGRIPDLS-SSLKD 185
                 L+ +  LD   +N++ ++ E     +L  L+ L + +        +   + L  
Sbjct: 94  SSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSS 151

Query: 186 LKELNLSNNELYGRVPEGLLKK 207
           L+ L ++ N         +  +
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTE 173

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 31/130 (23%), Positives = 49/130 (37%), Gaps = 12/130 (9%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSA-EIPHQI-SSLKGI 138
           P  +      L+L  N+L    LP       T L    LS N  S      Q       +
Sbjct: 23  PTGIPSSATRLELESNKL--QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSL 80

Query: 139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS--SSLKDLKELNLSNNEL 196
             LDLS N +   +      L +L  L  Q++ L  ++ + S   SL++L  L++S+   
Sbjct: 81  KYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHT 138

Query: 197 YGRVPEGLLK 206
                 G+  
Sbjct: 139 -RVAFNGIFN 147

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 28/129 (21%), Positives = 39/129 (30%), Gaps = 16/129 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
              +    G       L  L  L +  N      LP   T   NL    LS      ++ 
Sbjct: 140 VAFNGIFNG-------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS 191

Query: 130 HQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPD--LSSSLKD 185
               +SL  +  L++S NN    +       L  L  L    N +        L      
Sbjct: 192 PTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSS 249

Query: 186 LKELNLSNN 194
           L  LNL+ N
Sbjct: 250 LAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 27/125 (21%), Positives = 48/125 (38%), Gaps = 10/125 (8%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L+QL  LD   + L   +       +  NL    +S         + I + L  +  L +
Sbjct: 100 LEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKM 157

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIP-DLSSSLKDLKELNLSNNELYGRVP 201
           + N+ +      + T L  L  L L   +L  ++     +SL  L+ LN+S+N     + 
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNF-FSLD 215

Query: 202 EGLLK 206
               K
Sbjct: 216 TFPYK 220

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 24/124 (19%), Positives = 51/124 (41%), Gaps = 9/124 (7%)

Query: 88  LDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLS 144
              L++LDL  N +    +         L+      ++        +  SL+ ++ LD+S
Sbjct: 77  TTSLKYLDLSFNGV--ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134

Query: 145 DNNIRGRIPEQV-TNLTRLLTLRLQ-NNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
             + R      +   L+ L  L++  N+     +PD+ + L++L  L+LS  +L  ++  
Sbjct: 135 HTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSP 192

Query: 203 GLLK 206
               
Sbjct: 193 TAFN 196

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 6/88 (6%)

Query: 111 CTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNN 170
           C+  ++   +    ++ +P  I S     RL+L  N ++         LT+L  L L +N
Sbjct: 7   CSGTEI-RCNSKGLTS-VPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSN 62

Query: 171 ELTGR--IPDLSSSLKDLKELNLSNNEL 196
            L+ +            LK L+LS N +
Sbjct: 63  GLSFKGCCSQSDFGTTSLKYLDLSFNGV 90

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 29/116 (25%), Positives = 51/116 (43%), Gaps = 8/116 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
              L  L  LR LDL++N +   +L   +   L   + + N+ S  +    S  +G   +
Sbjct: 73  TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETL---HAANNNIS-RVS--CSRGQGKKNI 125

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNEL 196
            L++N I           +R+  L L+ NE+      +L++S   L+ LNL  N +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 22/127 (17%), Positives = 46/127 (36%), Gaps = 13/127 (10%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
            L                ++++LDL  N ++         +   L+   L  N    ++ 
Sbjct: 134 MLRDLDEGC-------RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKEL 189
            Q+     +  LDLS N +   +  +  +   +  + L+NN+L   I       ++L+  
Sbjct: 186 GQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 190 NLSNNEL 196
           +L  N  
Sbjct: 243 DLRGNGF 249

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 26/122 (21%), Positives = 50/122 (40%), Gaps = 13/122 (10%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
            ++ +   + D+ L           +  N+K   LSGN  S      ++    +  L+LS
Sbjct: 9   GNRYKIEKVTDSSL--KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL 204
            N +     + + +L+ L TL L NN +   +    S    ++ L+ +NN +  RV    
Sbjct: 67  SNVLYE-TLD-LESLSTLRTLDLNNNYVQ-ELLVGPS----IETLHAANNNI-SRVSCSR 118

Query: 205 LK 206
            +
Sbjct: 119 GQ 120

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 22/143 (15%), Positives = 43/143 (30%), Gaps = 4/143 (2%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
            +  D L  L+L  N +   +        LK   LS N  +  +  +  S  G+  + L 
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL 204
           +N +   I + +     L    L+ N             K+ +   ++   +     +  
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280

Query: 205 LKKFGEQSFIGNEGLCGSSPLPA 227
            +             C   P P 
Sbjct: 281 EECTVPTLGHYGAYCCEDLPAPF 303

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 32/135 (23%), Positives = 57/135 (42%), Gaps = 16/135 (11%)

Query: 66  ERVVSLSLPSHSLRG-PIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSG 121
            R     +   SL+    +       ++ LDL  N L  + +    L   T L+L  LS 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL--SQISAADLAPFTKLELLNLSS 67

Query: 122 NDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSS 181
           N    E    + SL  +  LDL++N +     +++     + TL   NN ++ R+    S
Sbjct: 68  NVLY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CS 117

Query: 182 SLKDLKELNLSNNEL 196
             +  K + L+NN++
Sbjct: 118 RGQGKKNIYLANNKI 132

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 23/87 (26%), Positives = 37/87 (42%), Gaps = 2/87 (2%)

Query: 110 NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN 169
           N    K+  ++ +     +     S   +  LDLS N +       +   T+L  L L +
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 170 NELTGRIPDLSSSLKDLKELNLSNNEL 196
           N L     DL  SL  L+ L+L+NN +
Sbjct: 68  NVLYE-TLDL-ESLSTLRTLDLNNNYV 92

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 15/70 (21%), Positives = 29/70 (41%), Gaps = 3/70 (4%)

Query: 127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           EI    +  K      ++D++++  +     +   +  L L  N L+       +    L
Sbjct: 4   EIKQNGNRYK---IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 187 KELNLSNNEL 196
           + LNLS+N L
Sbjct: 61  ELLNLSSNVL 70

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 14/45 (31%), Positives = 22/45 (48%)

Query: 152 IPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           I E   N  R    ++ ++ L   +  L  S  ++KEL+LS N L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 26/115 (22%), Positives = 52/115 (45%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           +APL  L ++  L+L  N L   +  +    ++K   L+    + ++   ++ L  +  L
Sbjct: 78  LAPLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQIT-DVT-PLAGLSNLQVL 134

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L  N I   I   +  LT L  L + N +++  +  L ++L  L  L   +N++
Sbjct: 135 YLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPL-ANLSKLTTLKADDNKI 185

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.2 bits (193), Expect = 6e-16
 Identities = 30/115 (26%), Positives = 63/115 (54%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           ++ ++ L  ++ LDL   ++   + PL   +NL++ YL  N  +  I   ++ L  +  L
Sbjct: 100 VSAIAGLQSIKTLDLTSTQIT-DVTPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYL 156

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            + +  +    P  + NL++L TL+  +N+++  I  L+S L +L E++L NN++
Sbjct: 157 SIGNAQVSDLTP--LANLSKLTTLKADDNKISD-ISPLAS-LPNLIEVHLKNNQI 207

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 26/131 (19%), Positives = 54/131 (41%), Gaps = 8/131 (6%)

Query: 66  ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS 125
              + ++    ++       + LD +  L      +  TI  +    NL    L  N  +
Sbjct: 19  ANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQIT 76

Query: 126 AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKD 185
            ++   + +L  I  L+LS N +  +    +  L  + TL L + ++T  +  L + L +
Sbjct: 77  -DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD-VTPL-AGLSN 130

Query: 186 LKELNLSNNEL 196
           L+ L L  N++
Sbjct: 131 LQVLYLDLNQI 141

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 29/118 (24%), Positives = 56/118 (47%), Gaps = 13/118 (11%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGN---DFSAEIPHQISSLKGI 138
           + PL+ L  L+ L L  N++   I PL   TNL+   +      D +      +++L  +
Sbjct: 122 VTPLAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQVSDLTP-----LANLSKL 175

Query: 139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             L   DN I   I   + +L  L+ + L+NN+++  +  L++   +L  + L+N  +
Sbjct: 176 TTLKADDNKISD-ISP-LASLPNLIEVHLKNNQISD-VSPLAN-TSNLFIVTLTNQTI 229

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 22/115 (19%), Positives = 47/115 (40%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I P   L     +    + +    +   +   +      G   +  I   +  L  ++ L
Sbjct: 12  IFPDPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           +L DN I   +   + NLT++  L L  N L   +  + + L+ +K L+L++ ++
Sbjct: 69  ELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSAI-AGLQSIKTLDLTSTQI 119

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 8/113 (7%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I+PL+ L  L++L + + +++  + PL N + L       N  S +I   ++SL  ++ +
Sbjct: 144 ISPLAGLTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEV 200

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
            L +N I    P  + N + L  + L N  +T   P       +L   N+   
Sbjct: 201 HLKNNQISDVSP--LANTSNLFIVTLTNQTITN-QPVF--YNNNLVVPNVVKG 248

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 25/113 (22%), Positives = 45/113 (39%), Gaps = 5/113 (4%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           + PL+ L +L  L   DN+++  I PL +  NL   +L  N  S   P  +++   +  +
Sbjct: 166 LTPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
            L++  I  +      NL     ++  +       P   S        NL+ N
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWN 273

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 26/116 (22%), Positives = 51/116 (43%), Gaps = 7/116 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           ++ L++   +  LD   N +   ++       L +  L  N+ + +    + +  G++ +
Sbjct: 198 LSTLAIPIAVEELDASHNSI--NVVRGPVNVELTILKLQHNNLT-DTA-WLLNYPGLVEV 253

Query: 142 DLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           DLS N +  +I       + RL  L + NN L   +      +  LK L+LS+N L
Sbjct: 254 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 307

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 6/125 (4%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLD 142
              +  +L  L L  N L      L N   L    LS N+   +I +     ++ + RL 
Sbjct: 221 RGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLY 278

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           +S+N +   +      +  L  L L +N L   +         L+ L L +N +   +  
Sbjct: 279 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL 335

Query: 203 GLLKK 207
                
Sbjct: 336 STHHT 340

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 33/141 (23%), Positives = 57/141 (40%), Gaps = 17/141 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            LP+  L           Q+  L+L+D ++    +          ++  Y+  N      
Sbjct: 59  KLPAALLDS-------FRQVELLNLNDLQI--EEIDTYAFAYAHTIQKLYMGFNAIRYLP 109

Query: 129 PHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDL 186
           PH   ++  +  L L  N++   +P  +  N  +L TL + NN L  RI D +  +   L
Sbjct: 110 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL 167

Query: 187 KELNLSNNELYGRVPEGLLKK 207
           + L LS+N L   V   L+  
Sbjct: 168 QNLQLSSNRL-THVDLSLIPS 187

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.5 bits (173), Expect = 4e-13
 Identities = 26/114 (22%), Positives = 45/114 (39%), Gaps = 11/114 (9%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            LSL+  L   ++  N L+     L     ++    S N  +  +   +     +  L L
Sbjct: 181 DLSLIPSLFHANVSYNLLST----LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 233

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL 196
             NN+       + N   L+ + L  NEL  +I       ++ L+ L +SNN L
Sbjct: 234 QHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 284

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 25/149 (16%), Positives = 45/149 (30%), Gaps = 35/149 (23%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQ 131
            +  H           + +L  L + +NRL                          +   
Sbjct: 262 KIMYHPFVK-------MQRLERLYISNNRL------------------------VALNLY 290

Query: 132 ISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNL 191
              +  +  LDLS N++   +        RL  L L +N +   +    S+   LK L L
Sbjct: 291 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTL 346

Query: 192 SNNELYGRVPEGLLKKFGEQSFIGNEGLC 220
           S+N+        L +     +    +  C
Sbjct: 347 SHNDWDCNSLRALFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 9/109 (8%), Positives = 44/109 (40%), Gaps = 8/109 (7%)

Query: 101 LNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNL 159
           ++  +       ++ +   + + +       +++ K    +   ++ +R ++P  +  + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQK---IVTFKNSTMR-KLPAALLDSF 68

Query: 160 TRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEGLLKK 207
            ++  L L + ++   I   + +    +++L +  N +   +P  + + 
Sbjct: 69  RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 115

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 52/234 (22%), Positives = 99/234 (42%), Gaps = 42/234 (17%)

Query: 347 RKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM 403
           ++ + + +D  +L+    ++G+G+   V    +   G + A+K +   +   R E   + 
Sbjct: 54  KEVRLQRDDFEILK----VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFR 109

Query: 404 ---DVIGKLKHPNVVKLRAYYYA--KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWT 457
              DV+       + +L   ++A   E  L LV +Y   G L +LL  ++   RIP +  
Sbjct: 110 EERDVLVNGDRRWITQL---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEMA 164

Query: 458 TRI---SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP- 513
            R     +V+     +  +H+        H ++K  N+LLD+ G   ++DFG  L L   
Sbjct: 165 -RFYLAEIVMA----IDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215

Query: 514 --VQAIARLG--GYKAPEQAEVKRLSQKADVY-------SFGVLLLEVLTGRAP 556
             V+++  +G   Y +PE  +          Y       + GV   E+  G+ P
Sbjct: 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 80.8 bits (200), Expect = 3e-16
 Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 11/111 (9%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
            L   L +L + +N+L   +  L N + LK+  +  N    ++P    SL+    +   +
Sbjct: 128 DLPPLLEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGN 182

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           N +   +PE + NL  L  +   NN L      L      L+ +   NN L
Sbjct: 183 NQLE-ELPE-LQNLPFLTAIYADNNSLK----KLPDLPLSLESIVAGNNIL 227

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 34/145 (23%), Positives = 48/145 (33%), Gaps = 37/145 (25%)

Query: 84  PLSLLDQLRFLDLHDNRLNG------------------TILP-LTNCTNLKLAYLSGNDF 124
            L  L  L  +   +N L                      LP L N   L   Y   N  
Sbjct: 190 ELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLL 249

Query: 125 SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG---------- 174
              +P    SL+    L++ DN +   +PE   +LT L       + L+           
Sbjct: 250 K-TLPDLPPSLE---ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 304

Query: 175 ---RIPDLSSSLKDLKELNLSNNEL 196
               I  L      L+ELN+SNN+L
Sbjct: 305 SSNEIRSLCDLPPSLEELNVSNNKL 329

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 70.8 bits (174), Expect = 5e-13
 Identities = 25/125 (20%), Positives = 54/125 (43%), Gaps = 16/125 (12%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGIL 139
           +  L     L+ +D+ +N L    LP    +   +       N    E+P ++ +L  + 
Sbjct: 146 LPELQNSSFLKIIDVDNNSL--KKLPDLPPSLEFI---AAGNNQLE-ELP-ELQNLPFLT 198

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR 199
            +   +N+++ ++P+   +L    ++   NN L   +P+L  +L  L  +   NN L   
Sbjct: 199 AIYADNNSLK-KLPDLPLSLE---SIVAGNNILE-ELPEL-QNLPFLTTIYADNNLL-KT 251

Query: 200 VPEGL 204
           +P+  
Sbjct: 252 LPDLP 256

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 28/111 (25%), Positives = 46/111 (41%), Gaps = 15/111 (13%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
            L   L FLD+ +N  +G  L      NL     S N+    +     SL+    L++S+
Sbjct: 274 ELPQSLTFLDVSENIFSG--LS-ELPPNLYYLNASSNEIR-SLCDLPPSLE---ELNVSN 326

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           N +   +P     L RL       N L     ++    ++LK+L++  N L
Sbjct: 327 NKLI-ELPALPPRLERL---IASFNHLA----EVPELPQNLKQLHVEYNPL 369

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.9 bits (156), Expect = 6e-11
 Identities = 26/127 (20%), Positives = 50/127 (39%), Gaps = 28/127 (22%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
            L   L  L++ +N+L    LP      L+    S N  + E+P    +LK   +L +  
Sbjct: 314 DLPPSLEELNVSNNKL--IELP-ALPPRLERLIASFNHLA-EVPELPQNLK---QLHVEY 366

Query: 146 NNIRGRIPEQVTNLTRLL----------------TLRLQNNELTGRIPDLSSSLKDLKEL 189
           N +R   P+   ++  L                  L ++ N L    PD+  S   +++L
Sbjct: 367 NPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES---VEDL 421

Query: 190 NLSNNEL 196
            +++  +
Sbjct: 422 RMNSERV 428

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 25/152 (16%), Positives = 46/152 (30%), Gaps = 37/152 (24%)

Query: 84  PLSL--LDQLRFLDLHDNRLNGTILP------------LTNCTNLKLAYL--SGNDFSAE 127
           P+    +          +       P            L +C + +   L  +    S  
Sbjct: 27  PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-S 85

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSS------ 181
           +P     L+    L  S N++   +PE   +L  LL        L+   P L        
Sbjct: 86  LPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNN 141

Query: 182 ---------SLKDLKELNLSNNELYGRVPEGL 204
                    +   LK +++ NN L  ++P+  
Sbjct: 142 QLEKLPELQNSSFLKIIDVDNNSL-KKLPDLP 172

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 20/113 (17%), Positives = 42/113 (37%), Gaps = 16/113 (14%)

Query: 86  SLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            L   L+ L +  N L     P    +  +L++     N   AE+P    +LK   +L +
Sbjct: 354 ELPQNLKQLHVEYNPL--REFPDIPESVEDLRM-----NSHLAEVPELPQNLK---QLHV 403

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             N +R   P+   ++  L   R+ +  +         +   L++    ++  
Sbjct: 404 ETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 54.2 bits (131), Expect = 8e-08
 Identities = 14/94 (14%), Positives = 29/94 (30%), Gaps = 10/94 (10%)

Query: 112 TNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNE 171
           T L+      ++ + E+P +  ++K       + +      P        +   RL++  
Sbjct: 11  TFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL 69

Query: 172 LTG---------RIPDLSSSLKDLKELNLSNNEL 196
                        +  L      L+ L  S N L
Sbjct: 70  DRQAHELELNNLGLSSLPELPPHLESLVASCNSL 103

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 80.5 bits (199), Expect = 4e-16
 Identities = 65/295 (22%), Positives = 113/295 (38%), Gaps = 73/295 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           + LG G+ G V            A+K +     +  +  +  + + V+  L HPN++KL 
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGA 466
            ++  K    LV +    G L               D    I             ++   
Sbjct: 103 DFFEDKRNYYLVMECYKGGEL--------------FD---EIIHRMKFNEVDAAVIIKQV 145

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG- 522
             G+  +H+      + H ++K  N+LL   +K+ +  I DFGLS +    + +    G 
Sbjct: 146 LSGVTYLHK----HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201

Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
             Y APE    K+  +K DV+S GV+L  +L G           P   + +Q +     +
Sbjct: 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY---------PPFGGQTDQEI-----L 246

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           R V K ++T   FD     +KN+ E    L+  ML           ++R +  + 
Sbjct: 247 RKVEKGKYT---FDSP--EWKNVSEGAKDLIKQMLQF-------DSQRRISAQQA 289

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 39/138 (28%), Positives = 59/138 (42%), Gaps = 19/138 (13%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYL--SGNDFSAEIP 129
            +P     G       L  +  +++  N L  +         LKL YL  S    +  IP
Sbjct: 137 KVPKGVFSG-------LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIP 188

Query: 130 HQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDL 186
             +  +L     L L  N I+  I  +     ++L  L L +N++   I + S S L  L
Sbjct: 189 KDLPETLN---ELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTL 243

Query: 187 KELNLSNNELYGRVPEGL 204
           +EL+L NN+L  RVP GL
Sbjct: 244 RELHLDNNKLS-RVPAGL 260

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 72.4 bits (178), Expect = 7e-14
 Identities = 23/135 (17%), Positives = 43/135 (31%), Gaps = 23/135 (17%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           ++    L           +L  L L  N++   ++    L+    L+  +L  N  S  +
Sbjct: 207 AIELEDLLR-------YSKLYRLGLGHNQI--RMIENGSLSFLPTLRELHLDNNKLS-RV 256

Query: 129 PHQISSLKGILRLDLSDNNIRGRIPEQV-------TNLTRLLTLRLQNNELTGRI--PDL 179
           P  +  LK +  + L  NNI  ++                   + L NN +      P  
Sbjct: 257 PAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPAT 315

Query: 180 SSSLKDLKELNLSNN 194
              + D   +   N 
Sbjct: 316 FRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 27/131 (20%), Positives = 46/131 (35%), Gaps = 15/131 (11%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           P  L + L  L L  N++    +    L   + L    L  N         +S L  +  
Sbjct: 188 PKDLPETLNELHLDHNKI--QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE 245

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD-------LSSSLKDLKELNLSN 193
           L L +N +  R+P  + +L  L  + L  N +T ++                   ++L N
Sbjct: 246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFN 303

Query: 194 NEL-YGRVPEG 203
           N + Y  V   
Sbjct: 304 NPVPYWEVQPA 314

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 31/140 (22%), Positives = 56/140 (40%), Gaps = 17/140 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
            L     +G       L  L  L L +N+++  I     +    L+  Y+S N    EIP
Sbjct: 68  ELRKDDFKG-------LQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIP 118

Query: 130 HQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELT-GRIPDLSSSLKDLK 187
             +     ++ L + DN IR ++P+ V + L  +  + +  N L        +     L 
Sbjct: 119 PNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLN 175

Query: 188 ELNLSNNELYGRVPEGLLKK 207
            L +S  +L   +P+ L + 
Sbjct: 176 YLRISEAKL-TGIPKDLPET 194

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 27/101 (26%), Positives = 47/101 (46%), Gaps = 9/101 (8%)

Query: 110 NCT-NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRL 167
            C  +L++   S       +P +IS       LDL +N+I   + +     L  L  L L
Sbjct: 30  GCHCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVL 85

Query: 168 QNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEGLLKK 207
            NN+++ +I + + S L+ L++L +S N L   +P  L   
Sbjct: 86  VNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSS 124

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 24/122 (19%), Positives = 49/122 (40%), Gaps = 7/122 (5%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN 147
           L +L+ L +  N L    +P    ++L    +  N          S L+ +  +++  N 
Sbjct: 101 LRKLQKLYISKNHL--VEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158

Query: 148 IR-GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
           +          +  +L  LR+   +LT  IP      + L EL+L +N++   +    L 
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLT-GIP--KDLPETLNELHLDHNKI-QAIELEDLL 214

Query: 207 KF 208
           ++
Sbjct: 215 RY 216

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 10/117 (8%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           P  +      LDL +N +  + L         +L    L  N  S       S L+ + +
Sbjct: 49  PKEISPDTTLLDLQNNDI--SELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQK 106

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL 196
           L +S N++   IP  +   + L+ LR+ +N +  ++P    S L+++  + +  N L
Sbjct: 107 LYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 80.0 bits (197), Expect = 7e-16
 Identities = 30/143 (20%), Positives = 49/143 (34%), Gaps = 10/143 (6%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKG 137
             A L     L  +DL  N L    +          L+  Y+S N     +      +  
Sbjct: 246 DTAWLLNYPGLVEVDLSYNEL--EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 302

Query: 138 ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
           +  LDLS N++   +        RL  L L +N +   +    S+   LK L LS+N+  
Sbjct: 303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358

Query: 198 GRVPEGLLKKFGEQSFIGNEGLC 220
                 L +     +    +  C
Sbjct: 359 CNSLRALFRNVARPAVDDADQHC 381

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 80.0 bits (197), Expect = 9e-16
 Identities = 26/116 (22%), Positives = 51/116 (43%), Gaps = 7/116 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           ++ L++   +  LD   N +   ++       L +  L  N+ + +    + +  G++ +
Sbjct: 204 LSTLAIPIAVEELDASHNSI--NVVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEV 259

Query: 142 DLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           DLS N +  +I       + RL  L + NN L   +      +  LK L+LS+N L
Sbjct: 260 DLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 79.2 bits (195), Expect = 2e-15
 Identities = 25/124 (20%), Positives = 43/124 (34%), Gaps = 4/124 (3%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
              +  +L  L L  N L      L N   L    LS N+    + H    ++ + RL +
Sbjct: 227 RGPVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 285

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           S+N +   +      +  L  L L +N L   +         L+ L L +N +   +   
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKLS 342

Query: 204 LLKK 207
               
Sbjct: 343 THHT 346

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 78.0 bits (192), Expect = 3e-15
 Identities = 33/141 (23%), Positives = 57/141 (40%), Gaps = 17/141 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            LP+  L           Q+  L+L+D ++    +          ++  Y+  N      
Sbjct: 65  KLPAALLDS-------FRQVELLNLNDLQI--EEIDTYAFAYAHTIQKLYMGFNAIRYLP 115

Query: 129 PHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDL 186
           PH   ++  +  L L  N++   +P  +  N  +L TL + NN L  RI D +  +   L
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL 173

Query: 187 KELNLSNNELYGRVPEGLLKK 207
           + L LS+N L   V   L+  
Sbjct: 174 QNLQLSSNRL-THVDLSLIPS 193

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 26/114 (22%), Positives = 45/114 (39%), Gaps = 11/114 (9%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            LSL+  L   ++  N L+     L     ++    S N  +  +   +     +  L L
Sbjct: 187 DLSLIPSLFHANVSYNLLST----LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKL 239

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL 196
             NN+       + N   L+ + L  NEL  +I       ++ L+ L +SNN L
Sbjct: 240 QHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL 290

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 22/128 (17%), Positives = 42/128 (32%), Gaps = 6/128 (4%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTI---LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
             +L     F D+H +     +          N K+     +         + S + +  
Sbjct: 20  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 79

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR 199
           L+L+D  I   I          +  L +  N +    P +  ++  L  L L  N+L   
Sbjct: 80  LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL-SS 137

Query: 200 VPEGLLKK 207
           +P G+   
Sbjct: 138 LPRGIFHN 145

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 8/72 (11%), Positives = 25/72 (34%), Gaps = 2/72 (2%)

Query: 126 AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLK 184
             I   +        + +           +   L     +  +N+ +  ++P     S +
Sbjct: 17  KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFR 75

Query: 185 DLKELNLSNNEL 196
            ++ LNL++ ++
Sbjct: 76  QVELLNLNDLQI 87

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 23/114 (20%), Positives = 44/114 (38%), Gaps = 4/114 (3%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
           ++ L  L+ L + ++ L  + L   + +   L+   L G       P        + RL 
Sbjct: 202 IANLQNLKSLKIRNSPL--SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           L D +    +P  +  LT+L  L L+      R+P L + L     + +  +  
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 27/120 (22%), Positives = 50/120 (41%), Gaps = 15/120 (12%)

Query: 88  LDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
           L  L+ + +    L    LP  +     L+   L+ N     +P  I+SL  +  L +  
Sbjct: 103 LSHLQHMTIDAAGL--MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRA 159

Query: 146 NNIRGRIPEQVTN---------LTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
                 +PE + +         L  L +LRL+   +   +P   ++L++LK L + N+ L
Sbjct: 160 CPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPL 218

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 24/137 (17%), Positives = 43/137 (31%), Gaps = 5/137 (3%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYL--SGNDFSAE 127
                  +        +  +  +        L  T   L + T      L         +
Sbjct: 37  RHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-Q 95

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
            P Q   L  +  + +    +   +P+ +     L TL L  N L   +P   +SL  L+
Sbjct: 96  FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLR 153

Query: 188 ELNLSNNELYGRVPEGL 204
           EL++        +PE L
Sbjct: 154 ELSIRACPELTELPEPL 170

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 28/131 (21%), Positives = 47/131 (35%), Gaps = 15/131 (11%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGIL--- 139
           +     L  L L  N L    LP  + +   L+   +       E+P  ++S        
Sbjct: 123 MQQFAGLETLTLARNPL--RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180

Query: 140 ------RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN 193
                  L L    IR  +P  + NL  L +L+++N+ L+  +      L  L+EL+L  
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRG 238

Query: 194 NELYGRVPEGL 204
                  P   
Sbjct: 239 CTALRNYPPIF 249

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 21/113 (18%), Positives = 39/113 (34%), Gaps = 5/113 (4%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLK--GILRLDL 143
            +L Q +     D     +     N  N ++   +G          +      G + L+L
Sbjct: 30  DVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALEL 88

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
               +  + P+Q   L+ L  + +    L   +PD       L+ L L+ N L
Sbjct: 89  RSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 19/99 (19%), Positives = 29/99 (29%), Gaps = 5/99 (5%)

Query: 88  LDQLRFLDLHD-NRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           L +L  LDL     L     P        LK   L        +P  I  L  + +LDL 
Sbjct: 228 LPKLEELDLRGCTAL--RNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
                 R+P  +  L     + +  +           + 
Sbjct: 286 GCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 47.2 bits (113), Expect = 1e-05
 Identities = 12/108 (11%), Positives = 33/108 (30%), Gaps = 22/108 (20%)

Query: 110 NCTNLKLAYLSGNDFSAEIPHQISSLK-------------------GILRLDLSDNNIRG 150
           + +  +  Y  G+         +S  +                      +++        
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK 69

Query: 151 RIPEQVTNLTR--LLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
              + + + T+   + L L++  L  + PD +  L  L+ + +    L
Sbjct: 70  ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.1 bits (97), Expect = 7e-04
 Identities = 14/76 (18%), Positives = 25/76 (32%), Gaps = 5/76 (6%)

Query: 88  LDQLRFLDLHD-NRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
              L+ L L D + L    LP  +   T L+   L G    + +P  I+ L     + + 
Sbjct: 252 RAPLKRLILKDCSNL--LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309

Query: 145 DNNIRGRIPEQVTNLT 160
            +        +     
Sbjct: 310 PHLQAQLDQHRPVARP 325

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 79.5 bits (196), Expect = 8e-16
 Identities = 21/114 (18%), Positives = 45/114 (39%), Gaps = 6/114 (5%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
                ++++LDL  N ++         +   L+   L  N    ++  Q+     +  LD
Sbjct: 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLD 197

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           LS N +   +  +  +   +  + L+NN+L   I       ++L+  +L  N  
Sbjct: 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 26/123 (21%), Positives = 50/123 (40%), Gaps = 13/123 (10%)

Query: 87  LLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
             ++ +   + D+ L           +  N+K   LSGN  S      ++    +  L+L
Sbjct: 8   NGNRYKIEKVTDSSL--KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           S N +     + + +L+ L TL L NN +   +    S    ++ L+ +NN +  RV   
Sbjct: 66  SSNVLYE-TLD-LESLSTLRTLDLNNNYVQ-ELLVGPS----IETLHAANNNI-SRVSCS 117

Query: 204 LLK 206
             +
Sbjct: 118 RGQ 120

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 78.4 bits (193), Expect = 2e-15
 Identities = 29/116 (25%), Positives = 51/116 (43%), Gaps = 8/116 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
              L  L  LR LDL++N +   +L   +   L   + + N+ S  +    S  +G   +
Sbjct: 73  TLDLESLSTLRTLDLNNNYVQ-ELLVGPSIETL---HAANNNIS-RVS--CSRGQGKKNI 125

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNEL 196
            L++N I           +R+  L L+ NE+      +L++S   L+ LNL  N +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 33/133 (24%), Positives = 57/133 (42%), Gaps = 14/133 (10%)

Query: 67  RVVSLSLPSHSLRG-PIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGND 123
           R     +   SL+    +       ++ LDL  N L+  I    L   T L+L  LS N 
Sbjct: 11  RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKLELLNLSSNV 69

Query: 124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
              E    + SL  +  LDL++N +     +++     + TL   NN ++ R+    S  
Sbjct: 70  LY-ETLD-LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS--CSRG 119

Query: 184 KDLKELNLSNNEL 196
           +  K + L+NN++
Sbjct: 120 QGKKNIYLANNKI 132

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 21/112 (18%), Positives = 41/112 (36%), Gaps = 4/112 (3%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
            +  D L  L+L  N +   +        LK   LS N  +  +  +  S  G+  + L 
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLR 222

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNEL-TGRIPDLSSSLKDLKELNLSNNE 195
           +N +   I + +     L    L+ N    G + D  S  + ++ +     +
Sbjct: 223 NNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 13/140 (9%), Positives = 25/140 (17%), Gaps = 28/140 (20%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           L     L   DL  N  +   L      N ++  ++                        
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292

Query: 145 DNNIR----------------------------GRIPEQVTNLTRLLTLRLQNNELTGRI 176
                                             R+  +  N  R   +     +    I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352

Query: 177 PDLSSSLKDLKELNLSNNEL 196
             ++   +    L      L
Sbjct: 353 DQVTLRKQAKITLEQKKKAL 372

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 15/70 (21%), Positives = 29/70 (41%), Gaps = 3/70 (4%)

Query: 127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           EI    +  K      ++D++++  +     +   +  L L  N L+       +    L
Sbjct: 4   EIKQNGNRYK---IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 187 KELNLSNNEL 196
           + LNLS+N L
Sbjct: 61  ELLNLSSNVL 70

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 10/131 (7%), Positives = 29/131 (22%), Gaps = 8/131 (6%)

Query: 71  LSLPSHSLRG-PIAPLSLLDQLRFLDLHDNRLNGT------ILPLTNCTNLKLAYLSGND 123
            ++   +++                                 L         L    G++
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSE 324

Query: 124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
               +  +  +      +D      R  I +        +TL  +   L  ++ +   + 
Sbjct: 325 TE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAH 383

Query: 184 KDLKELNLSNN 194
            +L        
Sbjct: 384 AELDGTLQQAV 394

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 14/45 (31%), Positives = 22/45 (48%)

Query: 152 IPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           I E   N  R    ++ ++ L   +  L  S  ++KEL+LS N L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL 46

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 20/193 (10%), Positives = 57/193 (29%), Gaps = 9/193 (4%)

Query: 8   LLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSER 67
             S    + +V+                  T G+  +     +   A +   + + K + 
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC--CEDLPAPFADRLIALKRKE 314

Query: 68  VVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRL----NGTILPLTNCTNLKLAYLSGND 123
              LS                 + R +D    +     +   L       L+    + ++
Sbjct: 315 HALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDE 374

Query: 124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
             +      + L G L+  +    ++    E+ + L  L  +  +  E+   +   S   
Sbjct: 375 QVSNGRRAHAELDGTLQQAVGQIELQ-HATEEQSPLQLLRAIVKRYEEMY--VEQQSVQN 431

Query: 184 KDLKELNLSNNEL 196
             +++ ++  ++ 
Sbjct: 432 NAIRDWDMYQHKE 444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 13/133 (9%), Positives = 32/133 (24%), Gaps = 4/133 (3%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN 147
             +   L    +          N    +        +   I       +  + L+     
Sbjct: 312 RKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371

Query: 148 IRGRIP---EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL 204
           +  ++         L   L   +   EL     +  S L+ L+ +     E+Y       
Sbjct: 372 LDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQ-SPLQLLRAIVKRYEEMYVEQQSVQ 430

Query: 205 LKKFGEQSFIGNE 217
                +     ++
Sbjct: 431 NNAIRDWDMYQHK 443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 35/234 (14%)

Query: 340 SKLVFYERKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCAR 396
           S    ++  +    +   +LRA    +GKGS G V      D   + A+K +       R
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA----IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVER 56

Query: 397 KEFEQYM---DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRI 452
            E         ++  L+HP +V L  Y +  EE + +V D L  G L   L   +     
Sbjct: 57  NEVRNVFKELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHF 112

Query: 453 PLD----WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
             +    +   + +       L  +  +    ++ H ++K  N+LLD++G   I+DF ++
Sbjct: 113 KEETVKLFICELVM------ALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIA 162

Query: 509 LLLNPVQAIARLGG---YKAPEQAEVKRL---SQKADVYSFGVLLLEVLTGRAP 556
            +L     I  + G   Y APE    ++    S   D +S GV   E+L GR P
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 79.0 bits (194), Expect = 2e-15
 Identities = 27/131 (20%), Positives = 64/131 (48%), Gaps = 8/131 (6%)

Query: 66  ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS 125
              +  +L   S+       + L+ +  +  +++ +  ++  +    N+   +L+GN  +
Sbjct: 21  AETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 78

Query: 126 AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKD 185
            +I   +++LK +  L L +N I+  +   + +L +L +L L++N ++  I  L   L  
Sbjct: 79  -DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DINGL-VHLPQ 132

Query: 186 LKELNLSNNEL 196
           L+ L L NN++
Sbjct: 133 LESLYLGNNKI 143

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 78.6 bits (193), Expect = 3e-15
 Identities = 36/115 (31%), Positives = 56/115 (48%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           +  +  L  +  L L+ N+L   I PLTN  NL   +L  N    ++   +  LK +  L
Sbjct: 58  VQGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSL 114

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L  N I   I   + +L +L +L L NN++T  I  L S L  L  L+L +N++
Sbjct: 115 SLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITVL-SRLTKLDTLSLEDNQI 165

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 74.8 bits (183), Expect = 3e-14
 Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 17/128 (13%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGN---DFSAEIPHQISSLKGI 138
           ++ L  L +L+ L L  N ++  I  L +   L+  YL  N   D +      +S L  +
Sbjct: 102 LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITDITV-----LSRLTKL 155

Query: 139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS--SSLKDLKELNLSNNEL 196
             L L DN I   I   +  LT+L  L L  N     I DL   + LK+L  L L + E 
Sbjct: 156 DTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQEC 209

Query: 197 YGRVPEGL 204
             +     
Sbjct: 210 LNKPINHQ 217

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 72.8 bits (178), Expect = 1e-13
 Identities = 25/115 (21%), Positives = 46/115 (40%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I P     +    +L    +    +      ++     + +D    +   I  L  + +L
Sbjct: 14  IFPDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L+ N +   I + +TNL  L  L L  N++   +  L   LK LK L+L +N +
Sbjct: 71  FLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSSL-KDLKKLKSLSLEHNGI 121

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 68.2 bits (166), Expect = 4e-12
 Identities = 20/103 (19%), Positives = 41/103 (39%), Gaps = 7/103 (6%)

Query: 94  LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP 153
                  +   I P           L     +  +    + L  I ++  ++++I+  + 
Sbjct: 4   TITVSTPIK-QIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV- 58

Query: 154 EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           + +  L  +  L L  N+LT  I  L++ LK+L  L L  N++
Sbjct: 59  QGIQYLPNVTKLFLNGNKLT-DIKPLTN-LKNLGWLFLDENKI 99

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 32/116 (27%), Positives = 53/116 (45%), Gaps = 11/116 (9%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGN---DFSAEIPHQISSLKGI 138
           I  LS L +L  L L DN+++  I+PL   T L+  YLS N   D  A     ++ LK +
Sbjct: 146 ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHISDLRA-----LAGLKNL 199

Query: 139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
             L+L       +     +NL    T++  +  L    P++ S   D ++ N+  +
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 65.9 bits (160), Expect = 2e-11
 Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 5/116 (4%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I  L  L QL  L L +N++   I  L+  T L    L  N  S +I   ++ L  +  L
Sbjct: 124 INGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 180

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
            LS N+I       +  L  L  L L + E   +  +  S+L     +  ++  L 
Sbjct: 181 YLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 10/124 (8%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQ 131
            +   +  G       L  L++L+L    +   +  LT    L+   +SGN F    P  
Sbjct: 186 YISEGAFEG-------LFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGS 237

Query: 132 ISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELN 190
              L  + +L + ++ +   I       L  L+ L L +N L+    DL + L+ L EL+
Sbjct: 238 FHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELH 296

Query: 191 LSNN 194
           L +N
Sbjct: 297 LHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 34/140 (24%), Positives = 54/140 (38%), Gaps = 18/140 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            +   +  G       L  L  L+L DN L  T++P       + L+  +L  N     I
Sbjct: 113 QIEVGAFNG-------LASLNTLELFDNWL--TVIPSGAFEYLSKLRELWLRNNPIE-SI 162

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           P    + +  ++RLDL +      I E     L  L  L L    +   +P+L + L  L
Sbjct: 163 PSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNL-TPLVGL 220

Query: 187 KELNLSNNELYGRVPEGLLK 206
           +EL +S N     +  G   
Sbjct: 221 EELEMSGNHF-PEIRPGSFH 239

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 18/139 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDL-HDNRLNGTILP---LTNCTNLKLAYLSGNDFSAE 127
           S+PS++          +  L  LDL    +L    +         NLK   L   +   +
Sbjct: 161 SIPSYAFNR-------VPSLMRLDLGELKKL--EYISEGAFEGLFNLKYLNLGMCNIK-D 210

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           +P+ ++ L G+  L++S N+    I       L+ L  L + N++++    +    L  L
Sbjct: 211 MPN-LTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268

Query: 187 KELNLSNNELYGRVPEGLL 205
            ELNL++N L   +P  L 
Sbjct: 269 VELNLAHNNL-SSLPHDLF 286

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 29/129 (22%), Positives = 47/129 (36%), Gaps = 15/129 (11%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            +PS +          L +LR L L +N +    +P        +L    L        I
Sbjct: 137 VIPSGAFEY-------LSKLRELWLRNNPI--ESIPSYAFNRVPSLMRLDLGELKKLEYI 187

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
                  L  +  L+L   NI+  +P  +T L  L  L +  N      P     L  LK
Sbjct: 188 SEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK 245

Query: 188 ELNLSNNEL 196
           +L + N+++
Sbjct: 246 KLWVMNSQV 254

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 67.1 bits (164), Expect = 7e-12
 Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 16/152 (10%)

Query: 60  VCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKL 116
            CS +  +V         L     P  +    R+L+L +N +   ++      +  +L++
Sbjct: 51  SCSNQFSKV---VCTRRGLSE--VPQGIPSNTRYLNLMENNI--QMIQADTFRHLHHLEV 103

Query: 117 AYLSGNDFSAEIPHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTG 174
             L  N    +I     + L  +  L+L DN +   IP      L++L  L L+NN +  
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE- 160

Query: 175 RIPDLS-SSLKDLKELNLSNNELYGRVPEGLL 205
            IP  + + +  L  L+L   +    + EG  
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 30/131 (22%), Positives = 45/131 (34%), Gaps = 17/131 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
            + + + R        L  L  L L  N +   I         +L    L  N  +  IP
Sbjct: 89  MIQADTFRH-------LHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIP 139

Query: 130 HQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQ-NNELTGRIPDLS-SSLKD 185
                 L  +  L L +N I   IP      +  L+ L L    +L   I + +   L +
Sbjct: 140 SGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFN 197

Query: 186 LKELNLSNNEL 196
           LK LNL    +
Sbjct: 198 LKYLNLGMCNI 208

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 7/98 (7%)

Query: 111 CTN-LKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN 169
           C+N       +    S  +P  I S      L+L +NNI+    +   +L  L  L+L  
Sbjct: 52  CSNQFSKVVCTRRGLSE-VPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGR 108

Query: 170 NELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEGLLK 206
           N +  +I   + + L  L  L L +N L   +P G  +
Sbjct: 109 NSIR-QIEVGAFNGLASLNTLELFDNWL-TVIPSGAFE 144

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 26/131 (19%), Positives = 64/131 (48%), Gaps = 8/131 (6%)

Query: 66  ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS 125
              +  +L   S+       + L+ +  +  +++ +  ++  +    N+   +L+GN  +
Sbjct: 24  AETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGNKLT 81

Query: 126 AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKD 185
            +I   +++LK +  L L +N ++  +   + +L +L +L L++N ++  I  L   L  
Sbjct: 82  -DIK-PLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DINGL-VHLPQ 135

Query: 186 LKELNLSNNEL 196
           L+ L L NN++
Sbjct: 136 LESLYLGNNKI 146

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 35/121 (28%), Positives = 55/121 (45%), Gaps = 19/121 (15%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGI--- 138
           +  +  L  +  L L+ N+L   I PL N  NL   +L  N        ++  L  +   
Sbjct: 61  VQGIQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLFLDEN--------KVKDLSSLKDL 111

Query: 139 --LR-LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNE 195
             L+ L L  N I   I   + +L +L +L L NN++T  I  L S L  L  L+L +N+
Sbjct: 112 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKIT-DITVL-SRLTKLDTLSLEDNQ 167

Query: 196 L 196
           +
Sbjct: 168 I 168

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 34/118 (28%), Positives = 53/118 (44%), Gaps = 13/118 (11%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGN---DFSAEIPHQISSLKGI 138
           ++ L  L +L+ L L  N ++  I  L +   L+  YL  N   D +      +S L  +
Sbjct: 105 LSSLKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKITDITV-----LSRLTKL 158

Query: 139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             L L DN I   I   +  LT+L  L L  N ++  +  L + LK+L  L L + E 
Sbjct: 159 DTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQEC 212

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 7/115 (6%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I       +    +L    +    +      ++     + +D    +   I  L  + +L
Sbjct: 17  IFSDDAFAETIKDNLKKKSVT-DAVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L+ N +   I + + NL  L  L L  N++   +  L   LK LK L+L +N +
Sbjct: 74  FLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSSL-KDLKKLKSLSLEHNGI 124

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 30/115 (26%), Positives = 48/115 (41%), Gaps = 5/115 (4%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I  L  L QL  L L +N++   I  L+  T L    L  N  S +I   ++ L  +  L
Sbjct: 127 INGLVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 183

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            LS N+I   +   +  L  L  L L + E   +  +  S+L     +  ++  L
Sbjct: 184 YLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 32/119 (26%), Positives = 52/119 (43%), Gaps = 17/119 (14%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGI--- 138
           I  LS L +L  L L DN+++  I+PL   T L+  YLS N         IS L+ +   
Sbjct: 149 ITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKN--------HISDLRALAGL 199

Query: 139 --LR-LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
             L  L+L       +     +NL    T++  +  L    P++ S   D ++ N+  +
Sbjct: 200 KNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 256

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 67/306 (21%), Positives = 117/306 (38%), Gaps = 84/306 (27%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK---------DANPCARKEFEQYM----DVIG 407
             LG G+ G V      +     A+K +K           +    ++F + +     ++ 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 408 KLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------- 460
            L HPN++KL   +  K+   LV ++   G L               +   +I       
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--------------FE---QIINRHKFD 144

Query: 461 -----SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLN 512
                +++     G+  +H+      + H ++K  N+LL   +      I DFGLS   +
Sbjct: 145 ECDAANIMKQILSGICYLHK----HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

Query: 513 PVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
               +    G   Y APE  + K+ ++K DV+S GV++  +L G     YP    P   +
Sbjct: 201 KDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG-----YP----PFGGQ 250

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKR 625
            +Q +     ++ V K ++    FD     +KNI +E   L+  ML            KR
Sbjct: 251 NDQDI-----IKKVEKGKYY---FDFN--DWKNISDEAKELIKLMLTY-------DYNKR 293

Query: 626 PTMAEV 631
            T  E 
Sbjct: 294 CTAEEA 299

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 76.5 bits (188), Expect = 3e-15
 Identities = 41/255 (16%), Positives = 80/255 (31%), Gaps = 54/255 (21%)

Query: 397 KEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY---DYLPNGSLHSLLHGNRGPGRIP 453
              +     I ++   +             K+ +Y         +L   ++         
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 454 LDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP 513
                 I + +  A  +  +H +     + H ++K SN+    + V  + DFGL   ++ 
Sbjct: 163 HGVCLHIFIQI--AEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216

Query: 514 VQAIARLGG----------------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPS 557
            +    +                  Y +PEQ      S K D++S G++L E+L      
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL------ 270

Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELV-SMLHVGLA 616
            Y   T     + E+   +   VR+          F     +    E  +V  ML     
Sbjct: 271 -YSFST-----QMERVRIITD-VRN--------LKFPLLFTQKYPQEHMMVQDMLSP--- 312

Query: 617 CVVSQPEKRPTMAEV 631
                P +RP   ++
Sbjct: 313 ----SPTERPEATDI 323

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 48.0 bits (114), Expect = 6e-06
 Identities = 16/66 (24%), Positives = 33/66 (50%), Gaps = 2/66 (3%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + +G+G  G V++A    D    A+KR++      AR++  + +  + KL+HP +V+   
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 420 YYYAKE 425
            +    
Sbjct: 72  AWLETP 77

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 62/290 (21%), Positives = 107/290 (36%), Gaps = 61/290 (21%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
             LG G+ G V+       G    +K + KD +    ++ E  ++V+  L HPN++K+  
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR------- 472
            +       +V +    G L           RI        +L  G    L +       
Sbjct: 88  VFEDYHNMYIVMETCEGGELLE---------RIVSAQARGKALSEGYVAELMKQMMNALA 138

Query: 473 -IHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG---YKA 525
             H +     V H ++K  N+L      +    I DFGL+ L    +      G   Y A
Sbjct: 139 YFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMA 194

Query: 526 PEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
           PE  + + ++ K D++S GV++  +LTG           P      + V      +    
Sbjct: 195 PEVFK-RDVTFKCDIWSAGVVMYFLLTG-----CL----PFTGTSLEEV-----QQKATY 239

Query: 586 EEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           +E     +  E    + +  +   L+  ML          PE+RP+ A+V
Sbjct: 240 KEPN---YAVE---CRPLTPQAVDLLKQMLTK-------DPERRPSAAQV 276

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 66/295 (22%), Positives = 106/295 (35%), Gaps = 73/295 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
            MLGKGS G V K          AVK +    A         + ++++ KL HPN++KL 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGA 466
                     +V +    G L               D    I             ++   
Sbjct: 88  EILEDSSSFYIVGELYTGGEL--------------FD---EIIKRKRFSEHDAARIIKQV 130

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG- 522
             G+  +H+      + H ++K  N+LL   +K+    I DFGLS        +    G 
Sbjct: 131 FSGITYMHK----HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186

Query: 523 --YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
             Y APE        +K DV+S GV+L  +L+G      P    P   + E  +     +
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG-----TP----PFYGKNEYDI-----L 231

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           + V   ++    FD    +++ I ++   L+  ML          P  R T  + 
Sbjct: 232 KRVETGKYA---FDLP--QWRTISDDAKDLIRKMLTF-------HPSLRITATQC 274

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 35/124 (28%), Positives = 52/124 (41%), Gaps = 10/124 (8%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQ 131
            +   +  G       L  LR+L+L    L   I  LT    L    LSGN  SA  P  
Sbjct: 175 YISEGAFEG-------LSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGS 226

Query: 132 ISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELN 190
              L  + +L +  + I+  I      NL  L+ + L +N LT    DL + L  L+ ++
Sbjct: 227 FQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIH 285

Query: 191 LSNN 194
           L +N
Sbjct: 286 LHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 18/139 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDL-HDNRLNGTILP---LTNCTNLKLAYLSGNDFSAE 127
           S+PS++          +  LR LDL    RL  + +        +NL+   L+  +   E
Sbjct: 150 SIPSYAFNR-------IPSLRRLDLGELKRL--SYISEGAFEGLSNLRYLNLAMCNLR-E 199

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           IP+ ++ L  +  LDLS N++   I       L  L  L +  +++     +   +L+ L
Sbjct: 200 IPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257

Query: 187 KELNLSNNELYGRVPEGLL 205
            E+NL++N L   +P  L 
Sbjct: 258 VEINLAHNNL-TLLPHDLF 275

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 31/129 (24%), Positives = 57/129 (44%), Gaps = 9/129 (6%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           P  +    R L+LH+N++   I+      +  +L++  LS N          + L  +  
Sbjct: 59  PDGISTNTRLLNLHENQI--QIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNT 116

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYG 198
           L+L DN +   IP      L++L  L L+NN +   IP  + + +  L+ L+L   +   
Sbjct: 117 LELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS 174

Query: 199 RVPEGLLKK 207
            + EG  + 
Sbjct: 175 YISEGAFEG 183

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 54.8 bits (132), Expect = 5e-08
 Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 6/95 (6%)

Query: 113 NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNEL 172
                     +    +P  IS+      L+L +N I+        +L  L  L+L  N +
Sbjct: 44  QFSKVICVRKNLRE-VPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100

Query: 173 TGRIPDLS-SSLKDLKELNLSNNELYGRVPEGLLK 206
              I   + + L +L  L L +N L   +P G   
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRL-TTIPNGAFV 133

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 77.3 bits (190), Expect = 5e-15
 Identities = 32/121 (26%), Positives = 55/121 (45%), Gaps = 15/121 (12%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
              L++Q   L L+   L  + LP      + +  ++ N     +P   +SL+    LD 
Sbjct: 54  KECLINQFSELQLNRLNL--SSLPDNLPPQITVLEITQNALI-SLPELPASLE---YLDA 107

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
            DN +   +PE   +L     L + NN+LT  +P+L +    L+ +N  NN+L   +PE 
Sbjct: 108 CDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPAL---LEYINADNNQL-TMLPEL 158

Query: 204 L 204
            
Sbjct: 159 P 159

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 76.5 bits (188), Expect = 1e-14
 Identities = 32/123 (26%), Positives = 59/123 (47%), Gaps = 20/123 (16%)

Query: 86  SLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            L   L +LD  DNRL  + LP    +  +L    +  N  +  +P   + L+    ++ 
Sbjct: 97  ELPASLEYLDACDNRL--STLPELPASLKHL---DVDNNQLT-MLPELPALLE---YINA 147

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
            +N +   +PE  T+L  L    ++NN+LT  +P+L    + L+ L++S N L   +P  
Sbjct: 148 DNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPEL---PESLEALDVSTNLL-ESLPAV 198

Query: 204 LLK 206
            ++
Sbjct: 199 PVR 201

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 26/123 (21%), Positives = 38/123 (30%), Gaps = 12/123 (9%)

Query: 86  SLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLA----YLSGNDFSAEIPHQISSLKGIL 139
            L + L  LD+  N L    LP       + +          N  +  IP  I SL    
Sbjct: 177 ELPESLEALDVSTNLL--ESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTC 233

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT---GRIPDLSSSLKDLKELNLSNNEL 196
            + L DN +  RI E ++  T            +   G+   L   L D        N+ 
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293

Query: 197 YGR 199
              
Sbjct: 294 SDV 296

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.1 bits (122), Expect = 8e-07
 Identities = 17/107 (15%), Positives = 37/107 (34%), Gaps = 13/107 (12%)

Query: 94  LDLHDNRLNGTILPLTNC----TNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR 149
            +   N ++GT     +         L   + N+  + +      +     L L+  N+ 
Sbjct: 15  QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLK--ECLINQFSELQLNRLNLS 72

Query: 150 GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             +P+ +    ++  L +  N L      L      L+ L+  +N L
Sbjct: 73  -SLPDNL--PPQITVLEITQNALI----SLPELPASLEYLDACDNRL 112

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 16/115 (13%), Positives = 28/115 (24%), Gaps = 6/115 (5%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
               +   F    +NR+  T +P  + +        L  N  S+ I   +S      + D
Sbjct: 203 HHSEETEIFFRCRENRI--THIPENILSLDPTCTIILEDNPLSSRIRESLSQQ--TAQPD 258

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
                I   + +   N                      S +    E     N   
Sbjct: 259 YHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS 313

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 37/128 (28%), Positives = 56/128 (43%), Gaps = 16/128 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            L     RG       L  L++L L DN L    LP     +  NL   +L GN  S+ +
Sbjct: 119 ELGPGLFRG-------LAALQYLYLQDNAL--QALPDDTFRDLGNLTHLFLHGNRISS-V 168

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           P +    L  + RL L  N +   +      +L RL+TL L  N L+    +  + L+ L
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227

Query: 187 KELNLSNN 194
           + L L++N
Sbjct: 228 QYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 72.7 bits (179), Expect = 3e-14
 Identities = 34/140 (24%), Positives = 44/140 (31%), Gaps = 17/140 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           S+   +  G       L +L  L L    L    L          L+  YL  N     +
Sbjct: 95  SVDPATFHG-------LGRLHTLHLDRCGL--QELGPGLFRGLAALQYLYLQDNALQ-AL 144

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           P      L  +  L L  N I   +PE+    L  L  L L  N +    P     L  L
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 187 KELNLSNNELYGRVPEGLLK 206
             L L  N L   +P   L 
Sbjct: 204 MTLYLFANNL-SALPTEALA 222

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 56.9 bits (138), Expect = 5e-09
 Identities = 24/121 (19%), Positives = 39/121 (32%), Gaps = 6/121 (4%)

Query: 89  DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNI 148
           +           L    +P+      +  +L GN  S        + + +  L L  N +
Sbjct: 11  EPKVTTSCPQQGL--QAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68

Query: 149 RGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEGLLK 206
             RI     T L  L  L L +N     +   +   L  L  L+L    L   +  GL +
Sbjct: 69  A-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFR 126

Query: 207 K 207
            
Sbjct: 127 G 127

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 77.0 bits (190), Expect = 5e-15
 Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 12/114 (10%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            ++ L QL + D   N L  T L ++  + L   +    D   EI   ++    ++    
Sbjct: 228 DVTPLTQLTYFDCSVNPL--TELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA 282

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL 196
                   +   VT+ T+L  L  Q   +T    +L  S    L  L L+N EL
Sbjct: 283 EGCRKIKELD--VTHNTQLYLLDCQAAGIT----ELDLSQNPKLVYLYLNNTEL 330

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 12/114 (10%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            ++ L +L +L+   N+L  T L ++    L     + N  + EI   +S    +  LD 
Sbjct: 101 DVTPLTKLTYLNCDTNKL--TKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC 155

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL 196
             N    ++   VT  T+L TL    N++T    +L  S  K L  LN   N +
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFNKIT----ELDVSQNKLLNRLNCDTNNI 203

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 73.2 bits (180), Expect = 9e-14
 Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 12/114 (10%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            L+   QL FLD   N+L  T + +T  T L     S N  + E+   +S+L  +  L  
Sbjct: 207 DLNQNIQLTFLDCSSNKL--TEIDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHC 261

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRL-QNNELTGRIPDLSSSLKDLKELNLSNNEL 196
              ++   I   +T+ T+L+  +     ++     D+ +    L  L+     +
Sbjct: 262 IQTDLL-EID--LTHNTQLIYFQAEGCRKIK--ELDV-THNTQLYLLDCQAAGI 309

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 23/112 (20%), Positives = 39/112 (34%), Gaps = 13/112 (11%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            +S    L  L+   N +  T L L     L     S N  + EI   ++ L  +   D 
Sbjct: 186 DVSQNKLLNRLNCDTNNI--TKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDC 240

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNN 194
           S N +   +   V+ L++L TL     +L     ++  +    L        
Sbjct: 241 SVNPLT-ELD--VSTLSKLTTLHCIQTDLL----EIDLTHNTQLIYFQAEGC 285

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 13/116 (11%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           +  +  L  L  L    N +  T L L+  TNL       N  +  +   ++ L  +  L
Sbjct: 57  MTGIEKLTGLTKLICTSNNI--TTLDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYL 111

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL 196
           +   N +   +   V+    L  L    N LT    ++  S    L EL+   N+ 
Sbjct: 112 NCDTNKLTK-LD--VSQNPLLTYLNCARNTLT----EIDVSHNTQLTELDCHLNKK 160

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 70.5 bits (173), Expect = 5e-13
 Identities = 26/113 (23%), Positives = 43/113 (38%), Gaps = 10/113 (8%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
               L  L  LD H++ +   +  +   T L     + N+ +  +   +S    +  L  
Sbjct: 37  SEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLAC 92

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             N +   +   VT LT+L  L    N+LT  +    S    L  LN + N L
Sbjct: 93  DSNKLT-NLD--VTPLTKLTYLNCDTNKLTK-LDV--SQNPLLTYLNCARNTL 139

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 26/131 (19%), Positives = 45/131 (34%), Gaps = 18/131 (13%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            ++   QL  LD     +  T L L+    L   YL+  + + E+   +S    +  L  
Sbjct: 292 DVTHNTQLYLLDCQAAGI--TELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
            + +I+      V  +  L        +              + +  L+NN L   V   
Sbjct: 347 VNAHIQD-FSS-VGKIPALNNNFEAEGQTI-----------TMPKETLTNNSLTIAVSPD 393

Query: 204 LLKKFGEQSFI 214
           LL +FG    I
Sbjct: 394 LLDQFGNPMNI 404

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 19/113 (16%), Positives = 41/113 (36%), Gaps = 6/113 (5%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            LS   +L +L L++  L  T L +++ T LK           +    +  +  +     
Sbjct: 313 DLSQNPKLVYLYLNNTEL--TELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFE 368

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           ++        E +TN    LT+ +  + L      ++    D    + + N +
Sbjct: 369 AEGQTITMPKETLTNN--SLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTI 419

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 10/104 (9%)

Query: 94  LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP 153
           +           +       L       +  + ++   I  L G+ +L  + NNI   + 
Sbjct: 24  VAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT-LD 80

Query: 154 EQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL 196
             ++  T L  L   +N+LT    +L  + L  L  LN   N+L
Sbjct: 81  --LSQNTNLTYLACDSNKLT----NLDVTPLTKLTYLNCDTNKL 118

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 18/85 (21%), Positives = 31/85 (36%), Gaps = 7/85 (8%)

Query: 113 NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNEL 172
           N      +  +  A        L  +  LD  +++I   +   +  LT L  L   +N +
Sbjct: 19  NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTG-IEKLTGLTKLICTSNNI 76

Query: 173 TGRIPDLS-SSLKDLKELNLSNNEL 196
           T     L  S   +L  L   +N+L
Sbjct: 77  T----TLDLSQNTNLTYLACDSNKL 97

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 6e-15
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 39/230 (16%)

Query: 347 RKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM 403
           R  + + ED  +++    ++G+G+ G V          + A+K L       R +   + 
Sbjct: 62  RDLRMKAEDYEVVK----VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 117

Query: 404 ---DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDW--- 456
              D++     P VV+L  Y +  +  L +V +Y+P G L +L+        +P  W   
Sbjct: 118 EERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARF 172

Query: 457 -TTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
            T  + L L A      IH         H +VK  N+LLDK+G   ++DFG  + +N   
Sbjct: 173 YTAEVVLALDA------IHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222

Query: 516 AIAR--LGG---YKAPE----QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            +      G   Y +PE    Q       ++ D +S GV L E+L G  P
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 29/132 (21%), Positives = 49/132 (37%), Gaps = 24/132 (18%)

Query: 88  LDQLRFLDLHDNRLNGTILP----LTNCTNLKLAYLSGNDFSA--EIPHQISSLKGILRL 141
           L  L FLDL +N +    L          +L+   LS N   +  +    + +LK +  L
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-----------------RIPDLSSSLK 184
           D+S N     +P+      ++  L L +  +                    +   S  L 
Sbjct: 393 DISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLP 451

Query: 185 DLKELNLSNNEL 196
            L+EL +S N+L
Sbjct: 452 RLQELYISRNKL 463

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.6 bits (181), Expect = 7e-14
 Identities = 29/121 (23%), Positives = 45/121 (37%), Gaps = 7/121 (5%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKG 137
               L     L+ L L  +R+    +      +  +L+   LS N  S+        L  
Sbjct: 42  GHGDLRACANLQVLILKSSRI--NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99

Query: 138 ILRLDLSDNNIRG-RIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNE 195
           +  L+L  N  +   +     NLT L TLR+ N E    I  +  + L  L EL +    
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159

Query: 196 L 196
           L
Sbjct: 160 L 160

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 31/129 (24%), Positives = 52/129 (40%), Gaps = 8/129 (6%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           P  L   ++ LDL  N++  T +    L  C NL++  L  +  +        SL  +  
Sbjct: 21  PSGLTAAMKSLDLSFNKI--TYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEH 78

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNELYG 198
           LDLSDN++   +       L+ L  L L  N      +  L  +L +L+ L + N E + 
Sbjct: 79  LDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFS 137

Query: 199 RVPEGLLKK 207
            +       
Sbjct: 138 EIRRIDFAG 146

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 25/109 (22%), Positives = 35/109 (32%), Gaps = 4/109 (3%)

Query: 89  DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNI 148
           D     D        T +P      +K   LS N  +      + +   +  L L  + I
Sbjct: 5   DASGVCDGRSRSF--TSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62

Query: 149 RGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
              I      +L  L  L L +N L+         L  LK LNL  N  
Sbjct: 63  N-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 24/128 (18%), Positives = 49/128 (38%), Gaps = 10/128 (7%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
           SL S            L  L++L+L  N      +     N TNL+   +   +  +EI 
Sbjct: 88  SLSSSWFGP-------LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140

Query: 130 HQ-ISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKE 188
               + L  +  L++   ++R    + + ++  +  L L  +E    +   +  L  ++ 
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200

Query: 189 LNLSNNEL 196
           L L +  L
Sbjct: 201 LELRDTNL 208

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 32/135 (23%), Positives = 54/135 (40%), Gaps = 14/135 (10%)

Query: 76  HSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQIS 133
            S++     L  L  L  LD+  N      +P        ++   LS       +   I 
Sbjct: 374 RSMQKTGEILLTLKNLTSLDISRNTF--HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI- 429

Query: 134 SLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN 193
             + +  LD+S+NN+          L RL  L +  N+L   +PD +S    L  + +S 
Sbjct: 430 -PQTLEVLDVSNNNLD-SFS---LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISR 482

Query: 194 NELYGRVPEGLLKKF 208
           N+L   VP+G+  + 
Sbjct: 483 NQL-KSVPDGIFDRL 496

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 67.4 bits (165), Expect = 7e-12
 Identities = 25/117 (21%), Positives = 43/117 (36%), Gaps = 10/117 (8%)

Query: 88  LDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLS 144
              +R L +    L    L    +    +K   +  +     +P      LK +  LDLS
Sbjct: 285 TVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLS 342

Query: 145 DNNIRGRIPEQ---VTNLTRLLTLRLQNNELT--GRIPDLSSSLKDLKELNLSNNEL 196
           +N +     +          L TL L  N L    +  ++  +LK+L  L++S N  
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 22/98 (22%), Positives = 38/98 (38%), Gaps = 4/98 (4%)

Query: 110 NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN 169
           +C    +       F+  IP  +++   +  LDLS N I       +     L  L L++
Sbjct: 3   SCDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 170 NELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
           + +     D   SL  L+ L+LS+N L   +       
Sbjct: 60  SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGP 96

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 30/184 (16%), Positives = 61/184 (33%), Gaps = 11/184 (5%)

Query: 13  LSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLS 72
           +  L++  S       +    L +  +  L                   SP     VS  
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTN---------LARFQFSPLPVDEVSSP 224

Query: 73  LPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQI 132
           +   + RG +  L+       L L    L  + +   +CT   L   + ++         
Sbjct: 225 MKKLAFRGSV--LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGK 282

Query: 133 SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLS 192
                I RL +    +   +    + L ++  + ++N+++       S  LK L+ L+LS
Sbjct: 283 VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLS 342

Query: 193 NNEL 196
            N +
Sbjct: 343 ENLM 346

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.8 bits (140), Expect = 6e-09
 Identities = 17/114 (14%), Positives = 36/114 (31%), Gaps = 5/114 (4%)

Query: 88  LDQLRFLDLHDNRLNGTILPLT--NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
           L  L+ L + +      I  +     T+L    +            + S++ I  L L  
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNELTG---RIPDLSSSLKDLKELNLSNNEL 196
           +     +      L+ +  L L++  L         +      +K+L    + L
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVL 235

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 18/111 (16%), Positives = 38/111 (34%), Gaps = 29/111 (26%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
              +   L  LD+ +N L+                             +  L+    L +
Sbjct: 426 KTCIPQTLEVLDVSNNNLD------------------------SFSLFLPRLQ---ELYI 458

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
           S N ++  +P+  +    LL +++  N+L      +   L  L+++ L  N
Sbjct: 459 SRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 19/158 (12%), Positives = 43/158 (27%), Gaps = 23/158 (14%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRL----NGTILPLTNCTNLKLAYLSGNDFSAE 127
            +      G       L  L  L++    L    + ++  + +  +L L           
Sbjct: 138 EIRRIDFAG-------LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT-------GRIPDLS 180
               +SS++    L+L D N+       +        ++      +         +  L 
Sbjct: 191 FADILSSVR---YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 181 SSLKDLKELNLSNNELYG--RVPEGLLKKFGEQSFIGN 216
             + +L E+   +  L G             E   +  
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET 285

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 17/156 (10%), Positives = 43/156 (27%), Gaps = 27/156 (17%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLN----GTILPLTNCTNLKLAYLSGNDFSAE 127
           +  S SL+        +  +  L LH +            L++   L+L   +   F   
Sbjct: 162 NYQSQSLKS-------IRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214

Query: 128 IPHQISSLKGILRLDLSDNNIRG-------RIPEQVTNLTRLLTLRLQNNELT------- 173
                     + +L    + +         ++   +  L+ +       N L        
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSES 274

Query: 174 GRIPDLSS-SLKDLKELNLSNNELYGRVPEGLLKKF 208
             + +L       ++ L++    L+      +    
Sbjct: 275 DVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLL 309

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 12/61 (19%), Positives = 24/61 (39%), Gaps = 1/61 (1%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN 147
           L +L+ L +  N+L  T+   +    L +  +S N   +        L  + ++ L  N 
Sbjct: 450 LPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508

Query: 148 I 148
            
Sbjct: 509 W 509

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 33/137 (24%), Positives = 59/137 (43%), Gaps = 21/137 (15%)

Query: 66  ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS 125
              V  +L   S+   +     L  ++  +  ++ +  ++  +   TNLK  +LS N   
Sbjct: 19  ANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHN--- 73

Query: 126 AEIPHQISSLKGI-----LR-LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDL 179
                QIS L  +     L  L ++ N ++  +   + +   L  L L NNEL      L
Sbjct: 74  -----QISDLSPLKDLTKLEELSVNRNRLK-NL-NGIPSAC-LSRLFLDNNELR-DTDSL 124

Query: 180 SSSLKDLKELNLSNNEL 196
              LK+L+ L++ NN+L
Sbjct: 125 -IHLKNLEILSIRNNKL 140

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 17/119 (14%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGIL-- 139
              L  L  L  L + +N+L  +I+ L   + L++  L GN        +I++  G+   
Sbjct: 121 TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGN--------EITNTGGLTRL 171

Query: 140 ----RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
                +DL+         +    L    T++  +       P   S+     +  +   
Sbjct: 172 KKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWE 228

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 17/140 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            +   +  G       L+ L  L L    L  T +P   L++   L +  L   + +  I
Sbjct: 142 YISHRAFSG-------LNSLEQLTLEKCNL--TSIPTEALSHLHGLIVLRLRHLNIN-AI 191

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDL 186
                  L  +  L++S       +         L +L + +  LT  +P L+   L  L
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYL 250

Query: 187 KELNLSNNELYGRVPEGLLK 206
           + LNLS N +   +   +L 
Sbjct: 251 RFLNLSYNPI-STIEGSMLH 269

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 71.7 bits (176), Expect = 3e-13
 Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 10/128 (7%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           P  +  + R LDL  NR+    L      +  +L+   L+ N  SA  P   ++L  +  
Sbjct: 27  PEGIPTETRLLDLGKNRI--KTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRT 84

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYG 198
           L L  N ++  IP  V T L+ L  L +  N++   + D     L +LK L + +N+L  
Sbjct: 85  LGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL-V 141

Query: 199 RVPEGLLK 206
            +      
Sbjct: 142 YISHRAFS 149

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 30/138 (21%), Positives = 57/138 (41%), Gaps = 13/138 (9%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPH 130
           ++  +S +        L +L+ L++       T+ P      NL    ++  + +  +P+
Sbjct: 190 AIRDYSFKR-------LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241

Query: 131 Q-ISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKE 188
             +  L  +  L+LS N I   I   +   L RL  ++L   +L    P     L  L+ 
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300

Query: 189 LNLSNNELYGRVPEGLLK 206
           LN+S N+L   + E +  
Sbjct: 301 LNVSGNQL-TTLEESVFH 317

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 25/111 (22%), Positives = 42/111 (37%), Gaps = 9/111 (8%)

Query: 91  LRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDN 146
           L  L +    L  T +P   + +   L+   LS N  S  I   +   L  +  + L   
Sbjct: 226 LTSLSITHCNL--TAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGG 282

Query: 147 NIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            +   +       L  L  L +  N+LT     +  S+ +L+ L L +N L
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 42.0 bits (99), Expect = 5e-04
 Identities = 13/82 (15%), Positives = 30/82 (36%), Gaps = 14/82 (17%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           ++    L         L +L+ + L   +L   ++          L++  +SGN  +  +
Sbjct: 262 TIEGSMLHE-------LLRLQEIQLVGGQL--AVVEPYAFRGLNYLRVLNVSGNQLTT-L 311

Query: 129 PHQI-SSLKGILRLDLSDNNIR 149
              +  S+  +  L L  N + 
Sbjct: 312 EESVFHSVGNLETLILDSNPLA 333

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 61/296 (20%), Positives = 113/296 (38%), Gaps = 69/296 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK------DANPCARKEFEQYMDVIGKLKHPNV 414
           E LG G    V K      G   A K +K           +R+E E+ + ++ ++ H NV
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR-- 472
           + L   Y  + + +L+ + +  G L            +      + SL    A    +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFD---------FL----AQKESLSEEEATSFIKQI 124

Query: 473 ------IHQEYGTAKVPHGNVKSSNVLL-DKNGVAC---ISDFGLSLLLNPVQAIARLGG 522
                 +H +    K+ H ++K  N++L DKN       + DFGL+  +        + G
Sbjct: 125 LDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
              + APE    + L  +AD++S GV+   +L+G           P + + +Q       
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----AS----PFLGDTKQET----- 226

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           + ++    +    FD+E   + +  E     +  +L       V +  KR T+ E 
Sbjct: 227 LANITSVSYD---FDEE--FFSHTSELAKDFIRKLL-------VKETRKRLTIQEA 270

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 62/287 (21%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +GKG+   V  A  +  G  VA+K +     NP + ++  + + ++  L HPN+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR-------- 472
              ++   L+ +Y   G +   L  +   GR+              AR   R        
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAH---GRMKEK----------EARSKFRQIVSAVQY 129

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQA 529
            HQ+    ++ H ++K+ N+LLD +    I+DFG S        +    G   Y APE  
Sbjct: 130 CHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185

Query: 530 EVKR-LSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
           + K+    + DV+S GV+L  +++G  P   Q     R RV   +    +P ++      
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--YRIPFYM------ 237

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
             + +   + LL+           L +        P KR T+ ++ K
Sbjct: 238 --STDC--ENLLKR---------FLVL-------NPIKRGTLEQIMK 264

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 75.6 bits (186), Expect = 2e-14
 Identities = 35/214 (16%), Positives = 64/214 (29%), Gaps = 15/214 (7%)

Query: 8   LLSLALSLLSVSSSHPNDTDALTLFRLQT-DTHGNLLSN--WKGADACAAAWTGVV---- 60
           L S+  S   +     ++ + L    L       N L +        C   +  +V    
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209

Query: 61  -CSPKSERVVSLSLPSHSLRG-PIAPLSLLDQLRFLDLHDNRL----NGTILPLTNCTNL 114
             S     V      S+++       L L   +       + +      T   L   +++
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR-SSV 268

Query: 115 KLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG 174
           +   LS     +       +LK +  L+L+ N I     E    L  L  L L  N L  
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328

Query: 175 RIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKF 208
                   L  +  ++L  N +   + +   K  
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFL 361

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 75.6 bits (186), Expect = 3e-14
 Identities = 39/202 (19%), Positives = 74/202 (36%), Gaps = 12/202 (5%)

Query: 5   SLFLLSLALSLLS--VSSSHPNDTDALTLFRLQT-DTHGNLLS-NWKGADACAAAWTGVV 60
           +L   SLA + L   VS       +      L+  D  GN  + +  G  + A + +   
Sbjct: 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAF 234

Query: 61  CSPKSERVVSLSLPSHSL----RGPIAPLSLLDQLRFLDLHDNRLNGTILPLT--NCTNL 114
               +  ++      H++    +   A L+    +R LDL    +  ++         +L
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARS-SVRHLDLSHGFVF-SLNSRVFETLKDL 292

Query: 115 KLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG 174
           K+  L+ N  +         L  +  L+LS N +          L ++  + LQ N +  
Sbjct: 293 KVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAI 352

Query: 175 RIPDLSSSLKDLKELNLSNNEL 196
                   L+ L+ L+L +N L
Sbjct: 353 IQDQTFKFLEKLQTLDLRDNAL 374

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 27/117 (23%), Positives = 42/117 (35%), Gaps = 8/117 (6%)

Query: 86  SLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEI-PHQISSLKGILRLD 142
            +L+    L L  N +  T+          L+L  L        I      +L  +  LD
Sbjct: 21  QVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79

Query: 143 LSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRI--PDLSSSLKDLKELNLSNNEL 196
           L  + I   +       L  L  LRL    L+  +       +LK L  L+LS N++
Sbjct: 80  LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 73.7 bits (181), Expect = 1e-13
 Identities = 27/130 (20%), Positives = 47/130 (36%), Gaps = 12/130 (9%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
           ++ + S          L+QL+ L+L       TI      N  NL++  L  +      P
Sbjct: 38  TVTASSFPF-------LEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90

Query: 130 HQISSLKGILRLDLSDNNIRGRI--PEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDL 186
                L  +  L L    +   +       NL  L  L L  N++    +      L  L
Sbjct: 91  DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL 150

Query: 187 KELNLSNNEL 196
           K ++ S+N++
Sbjct: 151 KSIDFSSNQI 160

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 29/115 (25%), Positives = 51/115 (44%), Gaps = 8/115 (6%)

Query: 90  QLRFLDLHDNRLNG--TILPLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDN 146
               + L +NRL     +  L    +L++  L+ N FS+    Q  S    + +L L +N
Sbjct: 402 TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461

Query: 147 NIRGRIPEQV-----TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            ++     ++       L+ L  L L +N L    P + S L  L+ L+L++N L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 37/149 (24%), Positives = 56/149 (37%), Gaps = 12/149 (8%)

Query: 71  LSLPSHSLRGPIAPLSL--LDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSA 126
           L L S      I   +   L  LR LDL  +++   + P       +L    L     S 
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSD 111

Query: 127 EI--PHQISSLKGILRLDLSDNNIRG-RIPEQVTNLTRLLTLRLQNNELTGRIP--DLSS 181
            +       +LK + RLDLS N IR   +      L  L ++   +N++   +   +L  
Sbjct: 112 AVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170

Query: 182 -SLKDLKELNLSNNELYGRVPEGLLKKFG 209
              K L   +L+ N LY RV     K   
Sbjct: 171 LQGKTLSFFSLAANSLYSRVSVDWGKCMN 199

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 64.4 bits (157), Expect = 9e-11
 Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 8/114 (7%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
              L  L+ L+L  N++N  I         NL++  LS N            L  +  +D
Sbjct: 286 FETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           L  N+I     +    L +L TL L++N LT  I  + S    + ++ LS N+L
Sbjct: 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPS----IPDIFLSGNKL 393

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 63.7 bits (155), Expect = 1e-10
 Identities = 24/106 (22%), Positives = 35/106 (33%), Gaps = 4/106 (3%)

Query: 92  RFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGR 151
           R        L  T +P       +   LS N            L+ +  L+L        
Sbjct: 7   RIAFYRFCNL--TQVP-QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 152 IPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           I ++   NL  L  L L ++++    PD    L  L EL L    L
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL 109

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 22/117 (18%), Positives = 40/117 (34%), Gaps = 17/117 (14%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
              L ++ ++DL  N +   I+          L+   L  N  +      I  +  I  +
Sbjct: 334 FYGLPKVAYIDLQKNHI--AIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDI 386

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSS--SLKDLKELNLSNNEL 196
            LS N +   +P+          + L  N L   +  L     +  L+ L L+ N  
Sbjct: 387 FLSGNKLV-TLPKINLTAN---LIHLSENRLEN-LDILYFLLRVPHLQILILNQNRF 438

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.1 bits (99), Expect = 5e-04
 Identities = 11/67 (16%), Positives = 23/67 (34%), Gaps = 6/67 (8%)

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGR 199
                 N+  ++P+    L     L L  N +   +   S   L+ L+ L L +      
Sbjct: 9   AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 200 VPEGLLK 206
           + +   +
Sbjct: 64  IDKEAFR 70

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 52/271 (19%), Positives = 92/271 (33%), Gaps = 50/271 (18%)

Query: 335 SGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVK-----RL 388
             +   + ++++     EL+         +G+GS G V  A+      I A+K     ++
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGA-IGQGSYGVVRVAIENQTRAIRAIKIMNKNKI 64

Query: 389 KDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL--HSLLHGN 446
           +  NP   +  +  + ++ KL HPN+ +L   Y  ++   LV +    G L     +  +
Sbjct: 65  RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFID 124

Query: 447 RGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVP----------------------- 483
              G+  +D               A     +G  +                         
Sbjct: 125 DSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184

Query: 484 ------HGNVKSSNVLL--DKNGVACISDFGLSLLLNPVQAIARLG--------GYKAPE 527
                 H ++K  N L   +K+    + DFGLS     +      G         + APE
Sbjct: 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 528 --QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                 +    K D +S GVLL  +L G  P
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 72.6 bits (178), Expect = 4e-14
 Identities = 45/199 (22%), Positives = 65/199 (32%), Gaps = 19/199 (9%)

Query: 8   LLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSER 67
           L  L L  L V+ + P      T   L      N+    + A      W   +       
Sbjct: 97  LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA------WLAELQQWLKPG 150

Query: 68  VVSLSLP-SHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI-LPLTNC-------TNLKLAY 118
           +  LS+  +HSL      + +   L  LDL DN   G   L    C         L L  
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210

Query: 119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIP 177
                 S       ++   +  LDLS N++R           ++L +L L    L     
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK 270

Query: 178 DLSSSLKDLKELNLSNNEL 196
            L +    L  L+LS N L
Sbjct: 271 GLPAK---LSVLDLSYNRL 286

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 39/215 (18%), Positives = 64/215 (29%), Gaps = 25/215 (11%)

Query: 5   SLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPK 64
           SL  L   +   +      +   +L+L RL   T        +                 
Sbjct: 44  SLEYLLKRVDTEADLGQFTDIIKSLSLKRL---TVRAARIPSRILFGALRVLGIS----- 95

Query: 65  SERVVSLSLPSHSLRGPIAPLSL---LDQLRFLDLHDNRLNGTILPLTNC-----TNLKL 116
              +  L+L +  + G   P  L      L  L+L +         L          LK+
Sbjct: 96  --GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153

Query: 117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVT----NLTRLLTLRLQNNEL 172
             ++          Q+     +  LDLSDN   G               L  L L+N  +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 173 T---GRIPDLSSSLKDLKELNLSNNELYGRVPEGL 204
               G    L+++   L+ L+LS+N L        
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 27/167 (16%), Positives = 51/167 (30%), Gaps = 11/167 (6%)

Query: 46  WKGADACAAAWTG-VVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGT 104
           W  A  C  A    +    +S   +   + + +  G    +     L+ L +   R+   
Sbjct: 24  WSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSR 83

Query: 105 ILP----LTNCTNLKLAYLSGNDFSAEIPHQISSLKG--ILRLDLSDNNIRGRIPE---- 154
           IL     +   + L+   L   + +   P  +    G  +  L+L + +   R       
Sbjct: 84  ILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAEL 143

Query: 155 QVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP 201
           Q      L  L +          +       L  L+LS+N   G   
Sbjct: 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 57.2 bits (138), Expect = 5e-09
 Identities = 35/176 (19%), Positives = 60/176 (34%), Gaps = 20/176 (11%)

Query: 8   LLSLALSLLSVSSSHPNDTDALTLFRLQT----DTHGNLLSNWKGADACAAAWTGVVCSP 63
            L   L +LS++ +H  +     +         D   N     +G               
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI-----SALCPLKF 200

Query: 64  KSERVVSLSLPS-HSLRGPIAPL-SLLDQLRFLDLHDNRLNGTILPLT--NCTNLKLAYL 119
            + +V++L      +  G  + L +   QL+ LDL  N L       +    + L    L
Sbjct: 201 PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNL 260

Query: 120 SGNDFSAEIPHQI-SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG 174
           S      ++P  + + L     LDLS N +  R P     L ++  L L+ N    
Sbjct: 261 SFTGLK-QVPKGLPAKLS---VLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 61/296 (20%), Positives = 112/296 (37%), Gaps = 69/296 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK------DANPCARKEFEQYMDVIGKLKHPNV 414
           E LG G    V K      G   A K +K            R+E E+ + ++ ++ HPN+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR-- 472
           + L   Y  + + +L+ + +  G L            +      + SL    A    +  
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFD---------FL----AQKESLSEEEATSFIKQI 124

Query: 473 ------IHQEYGTAKVPHGNVKSSNVLL-DKNGVAC---ISDFGLSLLLNPVQAIARLGG 522
                 +H +    K+ H ++K  N++L DKN       + DFGL+  +        + G
Sbjct: 125 LDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG 180

Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
              + APE    + L  +AD++S GV+   +L+G           P + + +Q       
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----AS----PFLGDTKQET----- 226

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           + ++    +    FD+E   +    E     +  +L       V +  KR T+ E 
Sbjct: 227 LANITAVSYD---FDEEF--FSQTSELAKDFIRKLL-------VKETRKRLTIQEA 270

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 74.1 bits (182), Expect = 5e-14
 Identities = 65/341 (19%), Positives = 130/341 (38%), Gaps = 50/341 (14%)

Query: 305 SSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRA--SAE 362
             ++++RR        K V   G   S+  +        +Y +  + + + +L      E
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163

Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
            LG G+ G V++      G   A K +   +   ++   + +  +  L+HP +V L   +
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR--ISLVLGAARGLARIHQEYGT 479
               E +++Y+++  G L   +             +    +  +    +GL  +H+    
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHN------KMSEDEAVEYMRQVCKGLCHMHEN--- 274

Query: 480 AKVPHGNVKSSNVLLDKNGVACI--SDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRL 534
               H ++K  N++        +   DFGL+  L+P Q++    G   + APE AE K +
Sbjct: 275 -NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333

Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD 594
               D++S GVL   +L+G           P   E +        +R+V   +W     D
Sbjct: 334 GYYTDMWSVGVLSYILLSG-----LS----PFGGENDDET-----LRNVKSCDWN---MD 376

Query: 595 QELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
                +  I E+    +  +L       ++ P  R T+ + 
Sbjct: 377 DSA--FSGISEDGKDFIRKLL-------LADPNTRMTIHQA 408

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 74.2 bits (182), Expect = 5e-14
 Identities = 24/131 (18%), Positives = 48/131 (36%), Gaps = 21/131 (16%)

Query: 87  LLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN 146
           L +    L++ ++ L  T LP     ++    +  N+ +  +P     L+    L++S N
Sbjct: 38  LNNGNAVLNVGESGL--TTLPDCLPAHITTLVIPDNNLT-SLPALPPELR---TLEVSGN 91

Query: 147 NIRGRIPEQVTNLTRLLTLRLQNNELTG-------------RIPDLSSSLKDLKELNLSN 193
            +   +P     L  L         L               ++  L      L+EL++S+
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSD 150

Query: 194 NELYGRVPEGL 204
           N+L   +P   
Sbjct: 151 NQL-ASLPALP 160

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 72.6 bits (178), Expect = 2e-13
 Identities = 31/129 (24%), Positives = 50/129 (38%), Gaps = 31/129 (24%)

Query: 86  SLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSA----------------E 127
           +L  +LR L++  N+L  T LP        L +         A                 
Sbjct: 78  ALPPELRTLEVSGNQL--TSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS 135

Query: 128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
           +P     L+    L +SDN +   +P   + L +L      NN+LT     L      L+
Sbjct: 136 LPVLPPGLQ---ELSVSDNQLA-SLPALPSELCKL---WAYNNQLT----SLPMLPSGLQ 184

Query: 188 ELNLSNNEL 196
           EL++S+N+L
Sbjct: 185 ELSVSDNQL 193

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 71.5 bits (175), Expect = 4e-13
 Identities = 32/113 (28%), Positives = 47/113 (41%), Gaps = 19/113 (16%)

Query: 86  SLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
            L   L+ L + DN+L    LP   +    L   +   N  +  +P   S L+    L +
Sbjct: 138 VLPPGLQELSVSDNQL--ASLPALPSELCKL---WAYNNQLT-SLPMLPSGLQ---ELSV 188

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           SDN +   +P   + L +L      NN LT     L +    LKEL +S N L
Sbjct: 189 SDNQLA-SLPTLPSELYKL---WAYNNRLT----SLPALPSGLKELIVSGNRL 233

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 69.5 bits (170), Expect = 2e-12
 Identities = 30/111 (27%), Positives = 48/111 (43%), Gaps = 15/111 (13%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
           +L  +L  L  ++N+L  T LP    + L+   +S N  +  +P   S L    +L   +
Sbjct: 158 ALPSELCKLWAYNNQL--TSLP-MLPSGLQELSVSDNQLA-SLPTLPSELY---KLWAYN 210

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           N +   +P   + L  L    +  N LT     L     +LKEL +S N L
Sbjct: 211 NRLT-SLPALPSGLKEL---IVSGNRLT----SLPVLPSELKELMVSGNRL 253

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 23/129 (17%), Positives = 41/129 (31%), Gaps = 7/129 (5%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
            L  +L+ L +  NRL  T LP    + L    +  N  +  +P  +  L     ++L  
Sbjct: 238 VLPSELKELMVSGNRL--TSLP-MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNE---LTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           N +  R  + +  +T                   P  + +L       L         P 
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPA 353

Query: 203 GLLKKFGEQ 211
                FG++
Sbjct: 354 DRWHMFGQE 362

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 73.2 bits (180), Expect = 6e-14
 Identities = 59/285 (20%), Positives = 119/285 (41%), Gaps = 54/285 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG G+ G V++ V    G +   K +    P  +   +  + ++ +L HP ++ L   
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLD---WTTR--ISLVLGAARGLARIHQ 475
           +  K E +L+ ++L  G L           RI  +    +    I+ +  A  GL  +H+
Sbjct: 117 FEDKYEMVLILEFLSGGELFD---------RIAAEDYKMSEAEVINYMRQACEGLKHMHE 167

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVAC--ISDFGLSLLLNPVQAIARLGG---YKAPEQAE 530
                 + H ++K  N++ +    +   I DFGL+  LNP + +        + APE  +
Sbjct: 168 H----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA 590
            + +    D+++ GVL   +L+G           P   E++        +++V + +W  
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSG-----LS----PFAGEDDLET-----LQNVKRCDWE- 268

Query: 591 EVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
             FD++   + ++  E    +  +L         +P KR T+ + 
Sbjct: 269 --FDED--AFSSVSPEAKDFIKNLL-------QKEPRKRLTVHDA 302

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 72.4 bits (178), Expect = 8e-14
 Identities = 68/341 (19%), Positives = 124/341 (36%), Gaps = 76/341 (22%)

Query: 335 SGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP 393
             +    L      K++ + D  + S ++LG G  G V +      G   A+K L D +P
Sbjct: 8   HSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-SP 66

Query: 394 CARKEFEQYMDVIGKLKHPNVVKLRAYY----YAKEEKLLVYDYLPNGSLHSLLHGNRGP 449
            AR+E + +    G    P++V +   Y    + K   L++ + +  G L S        
Sbjct: 67  KARQEVDHHWQASG---GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS-------- 115

Query: 450 GRIPLDWTTRIS------LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVA 500
            RI        +      ++      +  +H       + H +VK  N+L    +K+ V 
Sbjct: 116 -RIQERGDQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVL 170

Query: 501 CISDFGLSLLLNPVQAIARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ 558
            ++DFG +                Y APE    ++  +  D++S GV++  +L G     
Sbjct: 171 KLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG----- 225

Query: 559 YPSPTRPRVDEEEQAVDLPKWVRSVVK-------EEWTAEVFDQELLRYKNIEEE---LV 608
           +P    P      QA+  P   R +          EW              + E+   L+
Sbjct: 226 FP----PFYSNTGQAIS-PGMKRRIRLGQYGFPNPEW------------SEVSEDAKQLI 268

Query: 609 S-MLHVGLACVVSQPEKRPTMAEVAK---MIEDIRVEQSPL 645
             +L          P +R T+ +      + + + V Q+PL
Sbjct: 269 RLLLKT-------DPTERLTITQFMNHPWINQSMVVPQTPL 302

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 71.8 bits (177), Expect = 9e-14
 Identities = 68/238 (28%), Positives = 102/238 (42%), Gaps = 55/238 (23%)

Query: 346 ERKKQFELED--LLRASAEMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEF 399
           E  ++ +     LL+    +LG+GS G V+     +  D   + A+K LK A    R   
Sbjct: 16  EGHEKADPSQFELLK----VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71

Query: 400 EQYM--DVIGKLKHPNVVKLRAYYYA--KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPL 454
              M  D++ ++ HP +VKL   +YA   E KL L+ D+L  G L + L           
Sbjct: 72  RTKMERDILVEVNHPFIVKL---HYAFQTEGKLYLILDFLRGGDLFTRLSKE---VMFTE 125

Query: 455 DWTTRI---SLVLGAARGLARIHQEYGTAKVPHGNV----KSSNVLLDKNGVACISDFGL 507
           +   +     L L     L  +H          G +    K  N+LLD+ G   ++DFGL
Sbjct: 126 ED-VKFYLAELAL----ALDHLHS--------LGIIYRDLKPENILLDEEGHIKLTDFGL 172

Query: 508 SLLLNPVQAIARLGG---------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           S      ++I              Y APE    +  +Q AD +SFGVL+ E+LTG  P
Sbjct: 173 S-----KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.9 bits (177), Expect = 1e-13
 Identities = 59/296 (19%), Positives = 111/296 (37%), Gaps = 69/296 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK------DANPCARKEFEQYMDVIGKLKHPNV 414
           E LG G    V K      G   A K +K           +R++ E+ + ++ +++HPNV
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR-- 472
           + L   Y  K + +L+ + +  G L            +      + SL    A    +  
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFD---------FL----AEKESLTEEEATEFLKQI 123

Query: 473 ------IHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLNPVQAIARLGG 522
                 +H      ++ H ++K  N++L           I DFGL+  ++       + G
Sbjct: 124 LNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179

Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
              + APE    + L  +AD++S GV+   +L+G           P + + +Q       
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----AS----PFLGDTKQET----- 225

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           + +V    +    F+ E   + N        +  +L       V  P+KR T+ + 
Sbjct: 226 LANVSAVNYE---FEDEY--FSNTSALAKDFIRRLL-------VKDPKKRMTIQDS 269

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 9/111 (8%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNC---TNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           +  L+ LD+  N ++       +C    +L    +S N  +  I   +     I  LDL 
Sbjct: 373 MKSLQQLDISQNSVS-YDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLH 429

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNN 194
            N I+  IP+QV  L  L  L + +N+L   +PD     L  L+++ L  N
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 38/155 (24%), Positives = 64/155 (41%), Gaps = 30/155 (19%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILPLTNC---TNLKLAYLSGNDFSA--EIPHQISSL 135
            +   S +     LD  +N L  T     NC   T L+   L  N      +I    + +
Sbjct: 316 HMLCPSKISPFLHLDFSNNLL--TDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373

Query: 136 KGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIP----------DLSS--- 181
           K + +LD+S N++     +   +    LL+L + +N LT  I           DL S   
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI 433

Query: 182 --------SLKDLKELNLSNNELYGRVPEGLLKKF 208
                    L+ L+ELN+++N+L   VP+G+  + 
Sbjct: 434 KSIPKQVVKLEALQELNVASNQL-KSVPDGIFDRL 467

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.9 bits (158), Expect = 4e-11
 Identities = 22/124 (17%), Positives = 42/124 (33%), Gaps = 4/124 (3%)

Query: 88  LDQLRFLDLHDNRLNGT-ILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN 146
              +   +   +      +L  +  +       S N  +  +      L  +  L L  N
Sbjct: 299 FSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN 358

Query: 147 NIR--GRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEG 203
            ++   +I E  T +  L  L +  N ++        S  K L  LN+S+N L   +   
Sbjct: 359 QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418

Query: 204 LLKK 207
           L  +
Sbjct: 419 LPPR 422

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 32/150 (21%), Positives = 48/150 (32%), Gaps = 18/150 (12%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            L +  +         L +LR L +  NR+    L          L+   LS N      
Sbjct: 35  ELWTSDILS-------LSKLRILIISHNRI--QYLDISVFKFNQELEYLDLSHNKLVKIS 85

Query: 129 PHQISSLKGILRLDLSDNNIRGRIPEQVT--NLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
            H   +LK    LDLS N     +P      N+++L  L L    L        + L   
Sbjct: 86  CHPTVNLK---HLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS 141

Query: 187 KELNLSNNELYGRVPEGLLKKFGEQSFIGN 216
           K L +       +     L+ F  +S    
Sbjct: 142 KVLLVLGETYGEKEDPEGLQDFNTESLHIV 171

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 58.7 bits (142), Expect = 3e-09
 Identities = 37/209 (17%), Positives = 72/209 (34%), Gaps = 18/209 (8%)

Query: 5   SLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPK 64
            L  +   L     S          T  +L   T  N+ + W        ++  ++    
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN-------SFIRILQLVW 245

Query: 65  SERVVSLSLPSHSLRGPIAPLSL------LDQLRFLDLHDNRLNG-TILPLTNCTNLKLA 117
              V   S+ +  L+G +           L  L    +  +             +N+ + 
Sbjct: 246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK 305

Query: 118 YLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIP 177
             + +          S +   L LD S+N +   + E   +LT L TL LQ N+L   + 
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364

Query: 178 DLSS---SLKDLKELNLSNNELYGRVPEG 203
            ++     +K L++L++S N +     +G
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKG 393

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 24/121 (19%), Positives = 42/121 (34%), Gaps = 7/121 (5%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQ--ISSLKGILRLDLSD 145
             +L +LDL  N+L    +      NLK   LS N F A +P      ++  +  L LS 
Sbjct: 68  NQELEYLDLSHNKL--VKISCHPTVNLKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLST 124

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL 205
            ++       + +L     L +       +       L+D    +L       +    +L
Sbjct: 125 THLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFIL 182

Query: 206 K 206
            
Sbjct: 183 D 183

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 29/204 (14%), Positives = 69/204 (33%), Gaps = 17/204 (8%)

Query: 5   SLFLLSLALSLLSVSSSHPN-DTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSP 63
                SL +   +    H   D    T+  L+     + +      + C+   + +    
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLEL----SNIKCVLEDNKCSYFLSILAKLQ 217

Query: 64  KSERVVSLSLPSHSLRGP----IAPLSLLDQLRFLDLHDNRLNGTI------LPLTNCTN 113
            + ++ +L+L +          I  L     + +  + + +L G +         T+   
Sbjct: 218 TNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277

Query: 114 LKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNEL 172
           L +  +  + F     +       +   + + +  R  +     + ++  L L   NN L
Sbjct: 278 LSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-MVHMLCPSKISPFLHLDFSNNLL 336

Query: 173 TGRIPDLSSSLKDLKELNLSNNEL 196
           T  + +    L +L+ L L  N+L
Sbjct: 337 TDTVFENCGHLTELETLILQMNQL 360

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 18/78 (23%), Positives = 36/78 (46%), Gaps = 3/78 (3%)

Query: 119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD 178
            S N     +P  +S       L++S N I       + +L++L  L + +N +      
Sbjct: 7   RSKNGLIH-VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 179 LSSSLKDLKELNLSNNEL 196
           +    ++L+ L+LS+N+L
Sbjct: 64  VFKFNQELEYLDLSHNKL 81

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 29/108 (26%), Positives = 40/108 (37%), Gaps = 13/108 (12%)

Query: 93  FLDLHDNRLNGTILPL---TNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR 149
            +D   N L    +P       T L    +S N  S      I SL  +  L +S N I+
Sbjct: 4   LVDRSKNGL--IHVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQ 58

Query: 150 GRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
             +   V      L  L L +N+L   I        +LK L+LS N  
Sbjct: 59  -YLDISVFKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAF 102

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 22/118 (18%), Positives = 35/118 (29%), Gaps = 9/118 (7%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLT----NCTNLKLAYLSGNDFSAEIPHQISSLKGIL 139
                  L+ LDL  N      LP+     N + LK   LS           I+ L    
Sbjct: 85  SCHPTVNLKHLDLSFNAF--DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142

Query: 140 RLDLSDNNIRGRIPE---QVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
            L +       +      Q  N   L  +   N E    +     ++ +L+  N+   
Sbjct: 143 VLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 32/129 (24%), Positives = 48/129 (37%), Gaps = 18/129 (13%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           +L                 L  L L  N +    +        T+L    LS N     I
Sbjct: 289 ALLKSVFSH-------FTDLEQLTLAQNEI--NKIDDNAFWGLTHLLKLNLSQNFLG-SI 338

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKD 185
             ++  +L  +  LDLS N+IR  + +Q    L  L  L L  N+L   +PD     L  
Sbjct: 339 DSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTS 396

Query: 186 LKELNLSNN 194
           L+++ L  N
Sbjct: 397 LQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 30/148 (20%), Positives = 53/148 (35%), Gaps = 15/148 (10%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
            L   S          L  L+FL +        I        ++L +  L  N F   + 
Sbjct: 44  ELNETSFSR-------LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LE 95

Query: 130 HQI-SSLKGILRLDLSDNNIRG-RIPEQV-TNLTRLLTLRLQNNELTGRIPD-LSSSLKD 185
               + L  +  L L+  N+ G  +       LT L  L L++N +    P     +++ 
Sbjct: 96  TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRR 155

Query: 186 LKELNLSNNELYGRVPEGLLKKFGEQSF 213
              L+L+ N++   + E  L  F  + F
Sbjct: 156 FHVLDLTFNKV-KSICEEDLLNFQGKHF 182

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 67.5 bits (165), Expect = 6e-12
 Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 12/120 (10%)

Query: 90  QLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSD 145
            ++  DL  +++    L     ++ T+L+   L+ N+ + +I       L  +L+L+LS 
Sbjct: 276 GVKTCDLSKSKI--FALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQ 332

Query: 146 NNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEG 203
           N + G I  ++  NL +L  L L  N +   + D S   L +LKEL L  N+L   VP+G
Sbjct: 333 NFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDG 389

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 60.5 bits (147), Expect = 8e-10
 Identities = 33/194 (17%), Positives = 58/194 (29%), Gaps = 36/194 (18%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            L + +  G       L  L  L L    L+G +L        T+L++  L  N+     
Sbjct: 93  QLETGAFNG-------LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQ 145

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLT--RLLTLRLQNNELTGRIPDLSSS-- 182
           P     +++    LDL+ N ++  I E+   N        LRL +  L   + +      
Sbjct: 146 PASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWE 203

Query: 183 -------LKDLKELNLSNNELYGRVPEGLLKKFG---------EQSFIGNEGLCGS--SP 224
                     +  L+LS N     + +                  S+        +    
Sbjct: 204 KCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD 263

Query: 225 LPACSFSGDTPPDV 238
               +F G     V
Sbjct: 264 PDNFTFKGLEASGV 277

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 58.6 bits (142), Expect = 4e-09
 Identities = 35/181 (19%), Positives = 65/181 (35%), Gaps = 19/181 (10%)

Query: 29  LTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLL 88
            TL RL + T  ++   W G + C   +     +       +L L  +  +         
Sbjct: 182 FTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT-------TLDLSGNGFK-ESMAKRFF 233

Query: 89  DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNI 148
           D +    +    L+ +    ++  +          F       + +       DLS + I
Sbjct: 234 DAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC------DLSKSKI 287

Query: 149 RGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVPEGLLK 206
              + + V ++ T L  L L  NE+  +I D +   L  L +LNLS N L G +   + +
Sbjct: 288 F-ALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFE 344

Query: 207 K 207
            
Sbjct: 345 N 345

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 21/113 (18%), Positives = 37/113 (32%), Gaps = 16/113 (14%)

Query: 110 NCTNLKLA------------YLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV- 156
            C N  L              LS N  +       S L+ +  L +        I     
Sbjct: 16  ICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTF 75

Query: 157 TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNEL-YGRVPEGLLKK 207
             L+ L+ L+L  N+   ++   + + L +L+ L L+   L    +     K 
Sbjct: 76  RGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 39/213 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E+LG G+   V+       G + A+K +K +        E  + V+ K+KH N+V L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGAAR 468
           Y +     LV   +  G L               D   RI             ++     
Sbjct: 75  YESTTHYYLVMQLVSGGEL--------------FD---RILERGVYTEKDASLVIQQVLS 117

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLG--GY 523
            +  +H+      + H ++K  N+L    ++N    I+DFGLS +          G  GY
Sbjct: 118 AVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY 173

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
            APE    K  S+  D +S GV+   +L G  P
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 73/357 (20%), Positives = 132/357 (36%), Gaps = 66/357 (18%)

Query: 298 RGDRSSISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYER---KKQFELE 354
            GD+ S S   + +   SN    +R+       S            F  R    KQ  + 
Sbjct: 27  SGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVN 86

Query: 355 DLLR-ASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP 412
                +  E+LG G  G V+K      G  +A K +K      ++E +  + V+ +L H 
Sbjct: 87  SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA 146

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG---AAR- 468
           N+++L   + +K + +LV +Y+  G L               D     S  L        
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGEL--------------FDRIIDESYNLTELDTILF 192

Query: 469 ------GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI--SDFGLSLLLNPVQAIARL 520
                 G+  +HQ Y    + H ++K  N+L        I   DFGL+    P + +   
Sbjct: 193 MKQICEGIRHMHQMY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248

Query: 521 GG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP 577
            G   + APE      +S   D++S GV+   +L+G           P + + +      
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG-----LS----PFLGDNDAET--- 296

Query: 578 KWVRSVVKEEWTAEVFDQELLRYKNIEEE---LVSMLHVGLACVVSQPEKRPTMAEV 631
             + +++   W     + E   +++I EE    +S L      ++ +   R + +E 
Sbjct: 297 --LNNILACRWD---LEDEE--FQDISEEAKEFISKL------LIKEKSWRISASEA 340

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 56/284 (19%), Positives = 100/284 (35%), Gaps = 34/284 (11%)

Query: 307 DKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELED--LLRASAEML 364
                       +E   +               +     +      L+D  LLR    ++
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLR----VI 60

Query: 365 GKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM---DVIGK-LKHPNVVKLRA 419
           G+GS   V    L     I A++ +K       ++ +       V  +   HP +V L  
Sbjct: 61  GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH- 119

Query: 420 YYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTT----RISLVLGAARGLARIH 474
             +  E +L  V +Y+  G L   +       ++P +        ISL       L  +H
Sbjct: 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISL------ALNYLH 170

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAPEQAE 530
           +      + + ++K  NVLLD  G   ++D+G+    L P    +   G   Y APE   
Sbjct: 171 ER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILR 226

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
            +      D ++ GVL+ E++ GR+P      +       E  +
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 270

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 55/227 (24%), Positives = 90/227 (39%), Gaps = 57/227 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGK----------LK 410
           ++LG+GS G V + +  +     AVK LK      +K+  +  +              L+
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILK------KKKLRRIPNGEANVKKEIQLLRRLR 64

Query: 411 HPNVVKLR-AYYYAKEEKL-LVYDYLPNGS---LHSLLHGNRGPGRIPLDWTTRISLVLG 465
           H NV++L    Y  +++K+ +V +Y   G    L S+        R P+           
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-----RFPVC---------- 109

Query: 466 AAR--------GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI 517
            A         GL  +H +     + H ++K  N+LL   G   IS  G++  L+P  A 
Sbjct: 110 QAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165

Query: 518 ARL----G--GYKAPEQAEVKRL--SQKADVYSFGVLLLEVLTGRAP 556
                  G   ++ PE A         K D++S GV L  + TG  P
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 69.5 bits (171), Expect = 3e-13
 Identities = 59/296 (19%), Positives = 116/296 (39%), Gaps = 69/296 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK------DANPCARKEFEQYMDVIGKLKHPNV 414
           E LG G    V K      G   A K +K           +R+E E+ ++++ +++HPN+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR-- 472
           + L   +  K + +L+ + +  G L            +      + SL    A    +  
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFD---------FL----AEKESLTEDEATQFLKQI 117

Query: 473 ------IHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLNPVQAIARLGG 522
                 +H +    ++ H ++K  N++L      N    + DFG++  +        + G
Sbjct: 118 LDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 173

Query: 523 ---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
              + APE    + L  +AD++S GV+   +L+G           P + E +Q       
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----AS----PFLGETKQET----- 219

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           + ++    +    FD+E   + N  E     +  +L       V  P++R T+A+ 
Sbjct: 220 LTNISAVNYD---FDEEY--FSNTSELAKDFIRRLL-------VKDPKRRMTIAQS 263

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 69.5 bits (171), Expect = 5e-13
 Identities = 58/219 (26%), Positives = 97/219 (44%), Gaps = 47/219 (21%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK----DANPC-ARKEFEQYMDVIGKLKHPNVV 415
           E LG G+  TVYK +    G  VA+K +K    +  P  A +E    + ++ +LKH N+V
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIV 66

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLL-HGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           +L    + + +  LV++++ N  L   +     G     L+            +GLA  H
Sbjct: 67  RLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------------ 522
           +     K+ H ++K  N+L++K G   + DFGL          AR  G            
Sbjct: 126 EN----KILHRDLKPQNLLINKRGQLKLGDFGL----------ARAFGIPVNTFSSEVVT 171

Query: 523 --YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
             Y+AP   +V    +  S   D++S G +L E++TG+ 
Sbjct: 172 LWYRAP---DVLMGSRTYSTSIDIWSCGCILAEMITGKP 207

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 70.0 bits (172), Expect = 5e-13
 Identities = 55/263 (20%), Positives = 99/263 (37%), Gaps = 46/263 (17%)

Query: 314 GSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELED--LLRASAEMLGKGSLGT 371
           G+   ++K        +    +  D  K      +   +L+    ++     LG GS G 
Sbjct: 1   GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIK----TLGTGSFGR 56

Query: 372 VYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMD---VIGKLKHPNVVKLRAYYYAKEEK 427
           V      + G   A+K L        K+ E  ++   ++  +  P +VKL  + +     
Sbjct: 57  VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFKDNSN 115

Query: 428 L-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI---SLVLGAARGLARIHQEYGTAKVP 483
           L +V +Y+  G + S L   R  GR       R     +VL        +H       + 
Sbjct: 116 LYMVMEYVAGGEMFSHL---RRIGRFSEP-HARFYAAQIVLT----FEYLHSL----DLI 163

Query: 484 HGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----------YKAPEQAEVKR 533
           + ++K  N+L+D+ G   ++DFG +          R+ G            APE    K 
Sbjct: 164 YRDLKPENLLIDQQGYIQVTDFGFA---------KRVKGRTWTLCGTPEALAPEIILSKG 214

Query: 534 LSQKADVYSFGVLLLEVLTGRAP 556
            ++  D ++ GVL+ E+  G  P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPP 237

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 56/243 (23%), Positives = 95/243 (39%), Gaps = 34/243 (13%)

Query: 348 KKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM- 403
                L+D  LLR    ++G+GS   V    L     I A+K +K       ++ +    
Sbjct: 3   MDPLGLQDFDLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 58

Query: 404 --DVIGK-LKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTT- 458
              V  +   HP +V L    +  E +L  V +Y+  G L   +       ++P +    
Sbjct: 59  EKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARF 114

Query: 459 ---RISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPV 514
               ISL       L  +H+      + + ++K  NVLLD  G   ++D+G+    L P 
Sbjct: 115 YSAEISL------ALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164

Query: 515 QAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE 571
              +   G   Y APE    +      D ++ GVL+ E++ GR+P      +       E
Sbjct: 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 224

Query: 572 QAV 574
             +
Sbjct: 225 DYL 227

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 56/239 (23%), Positives = 90/239 (37%), Gaps = 62/239 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYMDVIG-------- 407
           + +GKGS G V  A   +D    A+K     +L       R+   +              
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 408 -------------KLKHPNVVKLR-AYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRI 452
                        KL HPNVVKL        E+ L +V++ +  G +  +         +
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPL 134

Query: 453 PLDWTTRISLVLGAAR--------GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD 504
             D           AR        G+  +H +    K+ H ++K SN+L+ ++G   I+D
Sbjct: 135 SED----------QARFYFQDLIKGIEYLHYQ----KIIHRDIKPSNLLVGEDGHIKIAD 180

Query: 505 FGLSLLLNPVQAIAR-LGG---YKAPE--QAEVKRLS-QKADVYSFGVLLLEVLTGRAP 556
           FG+S       A+     G   + APE      K  S +  DV++ GV L   + G+ P
Sbjct: 181 FGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 24/129 (18%), Positives = 46/129 (35%), Gaps = 10/129 (7%)

Query: 86  SLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRL 141
           SL    + L L +  L    +P    +N  N+   Y+S +    ++      +L  +  +
Sbjct: 28  SLPPSTQTLKLIETHL--RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85

Query: 142 DLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS--SSLKDLKELNLSNNELYG 198
           ++ +      I       L  L  L + N  L    PDL+   S      L +++N    
Sbjct: 86  EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMT 144

Query: 199 RVPEGLLKK 207
            +P    + 
Sbjct: 145 SIPVNAFQG 153

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 23/128 (17%), Positives = 43/128 (33%), Gaps = 12/128 (9%)

Query: 88  LDQLRFLDLHDNRLNGTILP----LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILR-L 141
           L  L+FL + +  L   + P    + +     +  ++ N +   IP      L      L
Sbjct: 104 LPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD--LSSSLKDLKELNLSNNELYGR 199
            L +N     +     N T+L  + L  N+    I              L++S   +   
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TA 219

Query: 200 VPEGLLKK 207
           +P   L+ 
Sbjct: 220 LPSKGLEH 227

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 9/115 (7%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLA-YLSGNDFSAEIPHQISSLKGILRL 141
           +   D    L++ DN    +I         N  L   L  N F+  +     +   +  +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184

Query: 142 DLSDNNIRGRIPEQV-TNLTRLLT-LRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
            L+ N     I +     +    + L +    +T  +P  S  L+ LKEL   N 
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP--SKGLEHLKELIARNT 236

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 34/121 (28%), Positives = 51/121 (42%), Gaps = 5/121 (4%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN 147
             +L  L+L    L   +        L    LS N   + +P    +L  +  LD+S N 
Sbjct: 54  YTRLTQLNLDRAELT-KLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNR 111

Query: 148 IRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
           +   +P      L  L  L L+ NEL    P L +    L++L+L+NN L   +P GLL 
Sbjct: 112 LT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL-TELPAGLLN 169

Query: 207 K 207
            
Sbjct: 170 G 170

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 46/196 (23%), Positives = 68/196 (34%), Gaps = 26/196 (13%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L  L  LD+  NRL  T LP   L     L+  YL GN+    +P  + +    + +L L
Sbjct: 99  LPALTVLDVSFNRL--TSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSL 155

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNE------- 195
           ++NN+   +P  +   L  L TL LQ N L   IP        L    L  N        
Sbjct: 156 ANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCEI 213

Query: 196 LYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPA-----CSFSGDTPPDVASAPET-VPSNP 249
           LY R     L+   E  ++  +G+   +         C  S   P             + 
Sbjct: 214 LYFR---RWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDE 270

Query: 250 SSMPQRPAFGQEKTRS 265
                   + +E T  
Sbjct: 271 GDTDLYDYYPEEDTEG 286

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 66/293 (22%), Positives = 104/293 (35%), Gaps = 65/293 (22%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           + LG+G+ G V  AV       VAVK     R  D     +KE          L H NVV
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINK---MLNHENVV 68

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR------- 468
           K   +      + L  +Y   G L   +  +     +P             A+       
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP----------DAQRFFHQLM 115

Query: 469 -GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------ 521
            G+  +H       + H ++K  N+LLD+     ISDFGL+ +         L       
Sbjct: 116 AGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 522 GYKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
            Y APE  + +   ++  DV+S G++L  +L G  P              +   +   W 
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---------QPSDSCQEYSDWK 222

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                           L  +K I+   +++LH  L   V  P  R T+ ++ K
Sbjct: 223 EK-----------KTYLNPWKKIDSAPLALLHKIL---VENPSARITIPDIKK 261

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 67/297 (22%), Positives = 107/297 (36%), Gaps = 77/297 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
            MLGKGS G V K          AVK +    A         + ++++ KL HPN++KL 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGA 466
                     +V +    G L               D    I             ++   
Sbjct: 88  EILEDSSSFYIVGELYTGGEL--------------FD---EIIKRKRFSEHDAARIIKQV 130

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG- 522
             G+  +H+      + H ++K  N+LL   +K+    I DFGLS        +    G 
Sbjct: 131 FSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGT 186

Query: 523 --YKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK 578
             Y AP   EV      +K DV+S GV+L  +L+G      P    P   + E  +    
Sbjct: 187 AYYIAP---EVLRGTYDEKCDVWSAGVILYILLSG-----TP----PFYGKNEYDI---- 230

Query: 579 WVRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
            ++ V   ++    FD    +++ I ++   L+  ML          P  R T  + 
Sbjct: 231 -LKRVETGKYA---FDLP--QWRTISDDAKDLIRKMLTF-------HPSLRITATQC 274

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 48/223 (21%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--------DANPCARKEFEQYMDVIGKLKHP 412
           + LG G+ G V  A        VA++ +                   E  ++++ KL HP
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 413 NVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDW-TTRISLVLGAARGL 470
            ++K++ ++    E   +V + +  G L               D       L     +  
Sbjct: 201 CIIKIKNFF--DAEDYYIVLELMEGGEL--------------FDKVVGNKRLKEATCKLY 244

Query: 471 AR--------IHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIAR 519
                     +H+      + H ++K  NVLL   +++ +  I+DFG S +L     +  
Sbjct: 245 FYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 300

Query: 520 LGG---YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           L G   Y APE          ++  D +S GV+L   L+G  P
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 29/144 (20%), Positives = 60/144 (41%), Gaps = 22/144 (15%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFS--- 125
            L S+S            +L+ LDL    +    +      + ++L    L+GN      
Sbjct: 42  HLGSYSFFS-------FPELQVLDLSRCEI--QTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 126 AEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTG-RIPDLSSSL 183
                 +SSL+   +L   + N+   +      +L  L  L + +N +   ++P+  S+L
Sbjct: 93  LGAFSGLSSLQ---KLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 184 KDLKELNLSNNELYGRVPEGLLKK 207
            +L+ L+LS+N++   +    L+ 
Sbjct: 149 TNLEHLDLSSNKI-QSIYCTDLRV 171

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 32/132 (24%), Positives = 49/132 (37%), Gaps = 20/132 (15%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPL----TNCTNLKLAYLSGNDFSAE 127
           SL +  +         L  L+ L++  N +      L    +N TNL+   LS N   + 
Sbjct: 114 SLENFPIGH-------LKTLKELNVAHNLI--QSFKLPEYFSNLTNLEHLDLSSNKIQS- 163

Query: 128 IPHQI----SSLKGI-LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSS 182
           I          +  + L LDLS N +   I        RL  L L  N+L      +   
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDR 222

Query: 183 LKDLKELNLSNN 194
           L  L+++ L  N
Sbjct: 223 LTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 34/127 (26%), Positives = 53/127 (41%), Gaps = 14/127 (11%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSA-EIPHQISSLKGILRLDL 143
           L  L+ L   +  L    L    + +   LK   ++ N   + ++P   S+L  +  LDL
Sbjct: 99  LSSLQKLVAVETNL--ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 144 SDNNIRGRIPEQV----TNLTRL-LTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG 198
           S N I+  I          +  L L+L L  N +   I   +     LKEL L  N+L  
Sbjct: 157 SSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQL-K 213

Query: 199 RVPEGLL 205
            VP+G+ 
Sbjct: 214 SVPDGIF 220

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 22/86 (25%), Positives = 32/86 (37%), Gaps = 2/86 (2%)

Query: 112 TNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNN 170
            + K   LS N       +   S   +  LDLS   I+  I +    +L+ L TL L  N
Sbjct: 28  FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86

Query: 171 ELTGRIPDLSSSLKDLKELNLSNNEL 196
            +        S L  L++L      L
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNL 112

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 66.2 bits (162), Expect = 1e-12
 Identities = 35/148 (23%), Positives = 57/148 (38%), Gaps = 15/148 (10%)

Query: 61  CSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLS 120
                   V L      +    A LS L   + L L  N +   I  L+   NL++  L 
Sbjct: 20  VVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKISSLSGMENLRILSLG 78

Query: 121 GNDFSAEIPHQISSLKGILR-LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDL 179
            N    +I + + ++   L  L +S N I   +   +  L  L  L + NN    +I + 
Sbjct: 79  RNLIK-KIEN-LDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNN----KITNW 130

Query: 180 S-----SSLKDLKELNLSNNELYGRVPE 202
                 ++L  L++L L+ N LY    E
Sbjct: 131 GEIDKLAALDKLEDLLLAGNPLYNDYKE 158

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 23/95 (24%), Positives = 43/95 (45%), Gaps = 5/95 (5%)

Query: 102 NGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTR 161
               +  T    ++L +        ++   +S+LK    L LS NNI  +I   ++ +  
Sbjct: 16  ERKSVVATEAEKVEL-HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMEN 71

Query: 162 LLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           L  L L  N +  +I +L +    L+EL +S N++
Sbjct: 72  LRILSLGRNLIK-KIENLDAVADTLEELWISYNQI 105

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 50/218 (22%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK-----DANPC-ARKEFEQYMDVIGKLKHPNVV 415
           E +G+G+ G VYKA    G IVA+KR++     +  P  A +E    + ++ +L HPN+V
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHHPNIV 82

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
            L    +++    LV++++    L  +L  N+      L  +     +    RG+A  HQ
Sbjct: 83  SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQ 137

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------------- 522
                 + H ++K  N+L++ +G   ++DFGL          AR  G             
Sbjct: 138 HR----ILHRDLKPQNLLINSDGALKLADFGL----------ARAFGIPVRSYTHEVVTL 183

Query: 523 -YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
            Y+AP   +V    K+ S   D++S G +  E++TG+ 
Sbjct: 184 WYRAP---DVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 29/178 (16%)

Query: 43  LSNWKGADACAA----AWTGVVCSPKSERVVSLSLPSH----SLRG-------PIAPLSL 87
           L++ +   +C A    A   + CS +    V  SLPS+     L              + 
Sbjct: 3   LASGRSVVSCPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTR 62

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L  L  L L  N L    +         NL+   LS N     +   + S L+ +  L L
Sbjct: 63  LTNLHSLLLSHNHL--NFISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLL 119

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIP----DLSSSLKDLKELNLSNNEL 196
            +N+I   +      ++ +L  L L  N+++ R P       + L  L  L+LS+N+L
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKL 175

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 30/133 (22%), Positives = 49/133 (36%), Gaps = 21/133 (15%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            + S +          +  LR+LDL  N L    L     ++   L++  L  N     +
Sbjct: 78  FISSEAFVP-------VPNLRYLDLSSNHL--HTLDEFLFSDLQALEVLLLYNNHIVV-V 127

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQV----TNLTRLLTLRLQNNELTGRIPDLSSSL 183
                  +  + +L LS N I  R P ++      L +L+ L L +N+L          L
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKL 186

Query: 184 KDLKE--LNLSNN 194
               +  L L NN
Sbjct: 187 PAWVKNGLYLHNN 199

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 62/242 (25%), Positives = 96/242 (39%), Gaps = 47/242 (19%)

Query: 339 TSKLVFYERKKQFELED--LLRASAEMLGKGSLGTVY----KAVLDDGGIVAVKRLKDAN 392
           +S+       ++   E   LLR    +LGKG  G V+        + G I A+K LK A 
Sbjct: 2   SSETSVNRGPEKIRPECFELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM 57

Query: 393 PCAR-KEFEQYM---DVIGKLKHPNVVKLRAYYYA--KEEKL-LVYDYLPNGSLHSLLHG 445
                K+        +++ ++KHP +V L    YA     KL L+ +YL  G L   L  
Sbjct: 58  IVRNAKDTAHTKAERNILEEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGELFMQLER 114

Query: 446 NRGPGRIPLDWTTRI---SLVLGAARGLARIHQEYGTAKVPHGNV----KSSNVLLDKNG 498
               G    D T       + +     L  +HQ         G +    K  N++L+  G
Sbjct: 115 E---GIFMED-TACFYLAEISM----ALGHLHQ--------KGIIYRDLKPENIMLNHQG 158

Query: 499 VACISDFGLS-LLLNPVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR 554
              ++DFGL    ++         G   Y APE       ++  D +S G L+ ++LTG 
Sbjct: 159 HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

Query: 555 AP 556
            P
Sbjct: 219 PP 220

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.9 bits (167), Expect = 2e-12
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 40/218 (18%)

Query: 355 DLLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLK 410
            +LR     LG GS G V+      +G   A+K LK       K+ E       ++  + 
Sbjct: 9   QILR----TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 411 HPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI---SLVLGA 466
           HP ++++    +   +++ ++ DY+  G L SLL   R   R P     +     + L  
Sbjct: 65  HPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNP-VAKFYAAEVCL-- 117

Query: 467 ARGLARIHQEYGTAKVPHGNV----KSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-LG 521
              L  +H            +    K  N+LLDKNG   I+DFG +     V  +   L 
Sbjct: 118 --ALEYLHS--------KDIIYRDLKPENILLDKNGHIKITDFGFA---KYVPDVTYTLC 164

Query: 522 G---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           G   Y APE    K  ++  D +SFG+L+ E+L G  P
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 26/142 (18%), Positives = 48/142 (33%), Gaps = 17/142 (11%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYL--SGNDFSAEIP 129
            +   + +        L  L++L + +  +   +  +    +L+   L    N     I 
Sbjct: 94  YINPEAFQN-------LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145

Query: 130 HQ-ISSLKGILR-LDLSDNNIRGRIPEQVTNLTRLLTLRL-QNNELTGRIPDLS-SSLKD 185
                 L      L L+ N I+  I     N T+L  L L  NN L   +P+        
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASG 203

Query: 186 LKELNLSNNELYGRVPEGLLKK 207
              L++S   +   +P   L+ 
Sbjct: 204 PVILDISRTRI-HSLPSYGLEN 224

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 63.7 bits (155), Expect = 6e-11
 Identities = 27/155 (17%), Positives = 52/155 (33%), Gaps = 9/155 (5%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGIL 139
           P  L      L     +L   ++     +   +L+   +S ND    I   + S+L  + 
Sbjct: 25  PSDLPRNAIELRFVLTKL--RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLH 82

Query: 140 RLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELY 197
            + +   N    I  +   NL  L  L + N  +   +PD+          L++ +N   
Sbjct: 83  EIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINI 141

Query: 198 GRVPEGLLKKFGEQSFIGNEGLCGSSPLPACSFSG 232
             +          +S I      G   +   +F+G
Sbjct: 142 HTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNG 176

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 26/128 (20%), Positives = 47/128 (36%), Gaps = 19/128 (14%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           ++  +S  G      L  +   L L+ N +    +           +L     N+   E+
Sbjct: 143 TIERNSFVG------LSFESVILWLNKNGI--QEIHNSAFNGTQLDELNLSDNNNLE-EL 193

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
           P+ +     G + LD+S   I   +P     NL +L      N +   ++P L   L  L
Sbjct: 194 PNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPTLEK-LVAL 248

Query: 187 KELNLSNN 194
            E +L+  
Sbjct: 249 MEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 20/105 (19%), Positives = 43/105 (40%), Gaps = 4/105 (3%)

Query: 94  LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP 153
               ++++  T +P     N                   S    + ++++S N++   I 
Sbjct: 14  FLCQESKV--TEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71

Query: 154 EQV-TNLTRLLTLRLQN-NELTGRIPDLSSSLKDLKELNLSNNEL 196
             V +NL +L  +R++  N L    P+   +L +L+ L +SN  +
Sbjct: 72  ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGI 116

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 26/114 (22%), Positives = 41/114 (35%), Gaps = 11/114 (9%)

Query: 88  LDQLRFLDL-HDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLD 142
           L +L  + +   N L    +      N  NL+   +S       +P          + LD
Sbjct: 78  LPKLHEIRIEKANNL--LYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLD 134

Query: 143 LSDNNIRGRIPEQV-TNLTRLL-TLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
           + DN     I       L+     L L  N +   I + + +   L ELNLS+N
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 54.1 bits (130), Expect = 7e-08
 Identities = 20/138 (14%), Positives = 46/138 (33%), Gaps = 15/138 (10%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIP 129
            +   +  G          L  +++  N +   I     +N   L    +   +    I 
Sbjct: 44  VIQKGAFSG-------FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYIN 96

Query: 130 HQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSS--LKD 185
            +   +L  +  L +S+  I+  +P+    +  + + L +Q+N     I   S      +
Sbjct: 97  PEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155

Query: 186 LKELNLSNNELYGRVPEG 203
              L L+ N +   +   
Sbjct: 156 SVILWLNKNGIQ-EIHNS 172

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 55/293 (18%), Positives = 107/293 (36%), Gaps = 71/293 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             +G+GS G V  AV        A K++          F+Q ++++  L HPN+++L   
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGAAR 468
           +    +  LV +    G L               +   R+             ++     
Sbjct: 75  FEDNTDIYLVMELCTGGEL--------------FE---RVVHKRVFRESDAARIMKDVLS 117

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIA-RLG--G 522
            +A  H+      V H ++K  N L      +    + DFGL+    P + +  ++G   
Sbjct: 118 AVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
           Y +P+  E      + D +S GV++  +L G     YP    P     +  V     +  
Sbjct: 174 YVSPQVLE-GLYGPECDEWSAGVMMYVLLCG-----YP----PFSAPTDSEV-----MLK 218

Query: 583 VVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           + +  +T   F ++   + N+  +   L+  +L          P++R T  + 
Sbjct: 219 IREGTFT---FPEK--DWLNVSPQAESLIRRLLTK-------SPKQRITSLQA 259

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 54/222 (24%), Positives = 90/222 (40%), Gaps = 33/222 (14%)

Query: 350 QFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM--- 403
           +  + D   L+    +LGKG+ G V        G   A+K L+     A+ E    +   
Sbjct: 1   KVTMNDFDYLK----LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56

Query: 404 DVIGKLKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTT---- 458
            V+   +HP +  L+ Y +   ++L  V +Y   G L    H +R       +       
Sbjct: 57  RVLQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFTEERARFYGA 112

Query: 459 RISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAI 517
            I         L  +H       V + ++K  N++LDK+G   I+DFGL    ++    +
Sbjct: 113 EIVS------ALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162

Query: 518 ARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               G   Y APE  E     +  D +  GV++ E++ GR P
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 50/218 (22%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK-----DANPC-ARKEFEQYMDVIGKLKHPNVV 415
           E +G+G+ G VYKA  + G   A+K+++     +  P    +E    + ++ +LKH N+V
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKHSNIV 63

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           KL    + K+  +LV+++L    L  LL    G     L+  T  S +L    G+A  H 
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD 118

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------------- 522
                +V H ++K  N+L+++ G   I+DFGL          AR  G             
Sbjct: 119 R----RVLHRDLKPQNLLINREGELKIADFGL----------ARAFGIPVRKYTHEIVTL 164

Query: 523 -YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
            Y+AP   +V    K+ S   D++S G +  E++ G  
Sbjct: 165 WYRAP---DVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 34/169 (20%), Positives = 61/169 (36%), Gaps = 28/169 (16%)

Query: 48  GADACAAA----WTGVVCSPKS---------ERVVSLSLPSHSLRG--PIAPLSLLDQLR 92
           G+ AC        T V CS +          +    L L ++             L QLR
Sbjct: 1   GSLACPEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLR 60

Query: 93  FLDLHDNRL----NGTILPLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDNN 147
            ++  +N++     G     +    +    L+ N     + H++   L+ +  L L  N 
Sbjct: 61  KINFSNNKITDIEEGAFEGASGVNEI---LLTSNRLEN-VQHKMFKGLESLKTLMLRSNR 116

Query: 148 IRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNN 194
           I   +       L+ +  L L +N++T  +   +  +L  L  LNL  N
Sbjct: 117 IT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 62/241 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKR-LKDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + LG GS G V +   ++ G   A+K+ L+D     R E +    ++  L H N++KL  
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR-ELD----IMKVLDHVNIIKLVD 67

Query: 420 YYYAKEEKL--------------------------------------LVYDYLPNGSLHS 441
           Y+Y   ++                                       ++ +Y+P+ +LH 
Sbjct: 68  YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126

Query: 442 LL-HGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGV 499
           +L    R    IP++  +     L   R +  IH    +  + H ++K  N+L++ K+  
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQL--FRAVGFIH----SLGICHRDIKPQNLLVNSKDNT 180

Query: 500 ACISDFGLSLLLNPVQA----IA-RLGGYKAPE-QAEVKRLSQKADVYSFGVLLLEVLTG 553
             + DFG +  L P +     I  R   Y+APE        +   D++S G +  E++ G
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILG 238

Query: 554 R 554
           +
Sbjct: 239 K 239

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 57/306 (18%), Positives = 106/306 (34%), Gaps = 63/306 (20%)

Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVK--RLKDANPCARKEFEQYMD 404
           +      +    +++ LG+G    V + +    G   A K  + +      R E    + 
Sbjct: 21  QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80

Query: 405 VIGKLKH-PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLV 463
           V+   K  P V+ L   Y    E +L+ +Y   G + S             +    +S  
Sbjct: 81  VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFS---------LCLPELAEMVSEN 131

Query: 464 LGAARGLAR--------IHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLN 512
                 L +        +HQ      + H ++K  N+LL      G   I DFG+S  + 
Sbjct: 132 --DVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185

Query: 513 PVQAIA-RLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
               +   +G   Y APE      ++   D+++ G++   +LT            P V E
Sbjct: 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH-----TS----PFVGE 236

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKR 625
           + Q         ++ +       + +E   + ++ +     +  +L       V  PEKR
Sbjct: 237 DNQET-----YLNISQVNVD---YSEET--FSSVSQLATDFIQSLL-------VKNPEKR 279

Query: 626 PTMAEV 631
           PT    
Sbjct: 280 PTAEIC 285

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 67.0 bits (164), Expect = 4e-12
 Identities = 66/291 (22%), Positives = 104/291 (35%), Gaps = 65/291 (22%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           LG+G+ G V  AV       VAVK     R  D     +KE      +   L H NVVK 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEI-CINKM---LNHENVVKF 70

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR--------G 469
             +      + L  +Y   G L   +  +     +P             A+        G
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEP----------DAQRFFHQLMAG 117

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GY 523
           +  +H       + H ++K  N+LLD+     ISDFGL+ +         L        Y
Sbjct: 118 VVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173

Query: 524 KAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
            APE  + +   ++  DV+S G++L  +L G  P              +   +   W   
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD---------QPSDSCQEYSDWKEK 224

Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                         L  +K I+   +++LH  L   V  P  R T+ ++ K
Sbjct: 225 -----------KTYLNPWKKIDSAPLALLHKIL---VENPSARITIPDIKK 261

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 51/220 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPC-ARKEFEQYMDVIGKLKHPNV 414
           E +G+G+ GTV+KA   +   IVA+KR++     +  P  A +E    + ++ +LKH N+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHKNI 63

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V+L    ++ ++  LV+++     L        G     LD     S +    +GL   H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCH 118

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------------ 522
                  V H ++K  N+L+++NG   +++FGL          AR  G            
Sbjct: 119 SR----NVLHRDLKPQNLLINRNGELKLANFGL----------ARAFGIPVRCYSAEVVT 164

Query: 523 --YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRAP 556
             Y+ P   +V    K  S   D++S G +  E+     P
Sbjct: 165 LWYRPP---DVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 59/324 (18%), Positives = 116/324 (35%), Gaps = 85/324 (26%)

Query: 353 LEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK- 410
            ED+ +   ++LG+G+   V   + L      AVK ++      R    + ++++ + + 
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69

Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI---------- 460
           H NV++L  ++  ++   LV++ +  GS+              L     I          
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSI--------------LS---HIHKRRHFNELE 112

Query: 461 --SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL-DKNGVAC--ISDFGLSLLLNPVQ 515
              +V   A  L  +H +     + H ++K  N+L    N V+   I DF L   +    
Sbjct: 113 ASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

Query: 516 AIARLG-----------GYKAPE-----QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQY 559
             + +             Y APE       E     ++ D++S GV+L  +L+G  P   
Sbjct: 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228

Query: 560 PSPTRPRVDEEEQAVDLPKWV-RSVVK-------EEWTAEVFDQELLRYKNIEEE---LV 608
              +    D  E        +  S+ +       ++W             +I      L+
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDW------------AHISCAAKDLI 276

Query: 609 S-MLHVGLACVVSQPEKRPTMAEV 631
           S +L           ++R + A+V
Sbjct: 277 SKLLVR-------DAKQRLSAAQV 293

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 66.1 bits (162), Expect = 5e-12
 Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 47/224 (20%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYM----DVIGKLK- 410
           E+LG+G    V + +        AVK          +    +E  +      D++ K+  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 411 HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDW-TTRISLVLGAARG 469
           HPN+++L+  Y       LV+D +  G L               D+ T +++L     R 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGEL--------------FDYLTEKVTLSEKETRK 128

Query: 470 LAR--------IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
           + R        +H+      + H ++K  N+LLD +    ++DFG S  L+P + +  + 
Sbjct: 129 IMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184

Query: 522 G---YKAPE------QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           G   Y APE              ++ D++S GV++  +L G  P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.5 bits (163), Expect = 5e-12
 Identities = 64/232 (27%), Positives = 94/232 (40%), Gaps = 46/232 (19%)

Query: 347 RKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM 403
            + + ++ED  L +    MLGKGS G V+ A         A+K LK        + E  M
Sbjct: 10  LQIKLKIEDFILHK----MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 65

Query: 404 ---DVIGK-LKHPNVVKLRAYYYA--KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDW 456
               V+    +HP +  +   +     +E L  V +YL  G L   +       +  L  
Sbjct: 66  VEKRVLSLAWEHPFLTHM---FCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSR 119

Query: 457 TT----RISLVLGAARGLARIHQEYGTAKVPHGNV----KSSNVLLDKNGVACISDFGLS 508
            T     I L      GL  +H          G V    K  N+LLDK+G   I+DFG+ 
Sbjct: 120 ATFYAAEIIL------GLQFLHS--------KGIVYRDLKLDNILLDKDGHIKIADFGMC 165

Query: 509 -LLLNPVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
              +          G   Y APE    ++ +   D +SFGVLL E+L G++P
Sbjct: 166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 66.3 bits (162), Expect = 7e-12
 Identities = 26/127 (20%), Positives = 47/127 (37%), Gaps = 12/127 (9%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI--SSLKGILRLD 142
           L  L  LDL  N L  + L        ++L    L GN +   +      S L  +  L 
Sbjct: 99  LGSLEHLDLSYNYL--SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILR 155

Query: 143 LSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRV 200
           + + +   +I  +    LT L  L +  ++L       S  S++++  L L   +    +
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LL 213

Query: 201 PEGLLKK 207
            E  +  
Sbjct: 214 LEIFVDV 220

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 34/131 (25%), Positives = 55/131 (41%), Gaps = 12/131 (9%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGIL 139
           P  L + ++ LDL +NR+  T +    L  C NL+   L+ N  +  I     SSL  + 
Sbjct: 47  PSGLTEAVKSLDLSNNRI--TYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLE 103

Query: 140 RLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS--SSLKDLKELNLSNNEL 196
            LDLS N +   +       L+ L  L L  N     + + S  S L  L+ L + N + 
Sbjct: 104 HLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDT 161

Query: 197 YGRVPEGLLKK 207
           + ++       
Sbjct: 162 FTKIQRKDFAG 172

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 22/135 (16%), Positives = 51/135 (37%), Gaps = 23/135 (17%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
           S    SL+        +  +  L LH  +    +L    +   ++++   L   D     
Sbjct: 188 SYEPKSLKS-------IQNVSHLILHMKQH--ILLLEIFVDVTSSVECLELRDTDLDTFH 238

Query: 129 PHQISS--------LKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS 180
             ++S+              + ++D ++  ++ + +  ++ LL L    N+L   +PD  
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGI 296

Query: 181 -SSLKDLKELNLSNN 194
              L  L+++ L  N
Sbjct: 297 FDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 21/130 (16%), Positives = 43/130 (33%), Gaps = 17/130 (13%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L  L  L++  + L         L +  N+    L        +          +  L+L
Sbjct: 173 LTFLEELEIDASDL--QSYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLEL 229

Query: 144 SDNNIRG----RIPEQV----TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNE 195
            D ++       +                +++ +  L  ++  L + +  L EL  S N+
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQ 288

Query: 196 LYGRVPEGLL 205
           L   VP+G+ 
Sbjct: 289 LKS-VPDGIF 297

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 29/143 (20%), Positives = 54/143 (37%), Gaps = 19/143 (13%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEI 128
            + +  L+           L+ L L  N +    +     ++  +L+   LS N  S  +
Sbjct: 66  YISNSDLQR-------CVNLQALVLTSNGI--NTIEEDSFSSLGSLEHLDLSYNYLSN-L 115

Query: 129 PHQI-SSLKGILRLDLSDNNIRGRIPEQVT--NLTRLLTLRLQNNELTGRIPDLS-SSLK 184
                  L  +  L+L  N  +  + E     +LT+L  LR+ N +   +I     + L 
Sbjct: 116 SSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174

Query: 185 DLKELNLSNNELYGRVPEGLLKK 207
            L+EL +  ++L        LK 
Sbjct: 175 FLEELEIDASDL-QSYEPKSLKS 196

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 18/128 (14%), Positives = 45/128 (35%), Gaps = 12/128 (9%)

Query: 80  GPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKG 137
           G  +  S L +L+ L + +      I        T L+   +  +D  +  P  + S++ 
Sbjct: 140 GETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199

Query: 138 ILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTG----RIPDLSSS----LKDLKE 188
           +  L L        + E      + +  L L++ +L       +    ++        + 
Sbjct: 200 VSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN 258

Query: 189 LNLSNNEL 196
           + +++  L
Sbjct: 259 VKITDESL 266

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 26/98 (26%), Positives = 38/98 (38%), Gaps = 6/98 (6%)

Query: 111 CTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQN 169
           C    +   S    ++ IP  ++    +  LDLS+N I   I          L  L L +
Sbjct: 30  CDRNGICKGSSGSLNS-IPSGLTE--AVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTS 85

Query: 170 NELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
           N +     D  SSL  L+ L+LS N L   +     K 
Sbjct: 86  NGINTIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFKP 122

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 53/221 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFE-QYMDVIGKLKHPNV 414
           + LG G+ G V        G  VAVK     +++  +   + + E Q + +    +HP++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL---FRHPHI 73

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR------ 468
           +KL        +  +V +Y+  G L   +  +   GR+              AR      
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYICKH---GRVEEM----------EARRLFQQI 120

Query: 469 --GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
              +   H+      V H ++K  NVLLD +  A I+DFGLS        +   G     
Sbjct: 121 LSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLS-------NMMSDGEFLRT 169

Query: 523 ------YKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAP 556
                 Y APE    +     + D++S GV+L  +L G  P
Sbjct: 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 65.7 bits (161), Expect = 9e-12
 Identities = 55/288 (19%), Positives = 112/288 (38%), Gaps = 61/288 (21%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG+G  G V++ V          K +K      +   ++ + ++   +H N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIP--------LDWTTRISLVLGAARGLAR 472
           + + EE +++++++    +           RI          +  + +  V      L  
Sbjct: 70  FESMEELVMIFEFISGLDIFE---------RINTSAFELNEREIVSYVHQVCE---ALQF 117

Query: 473 IHQEYGTAKVPHGNVKSSNVLL--DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPE 527
           +H       + H +++  N++    ++    I +FG +  L P      L     Y APE
Sbjct: 118 LHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
             +   +S   D++S G L+  +L+G           P + E  Q +     + +++  E
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSG-----IN----PFLAETNQQI-----IENIMNAE 219

Query: 588 WTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTMAEV 631
           +T   FD+E   +K I  E    V  +L       V + + R T +E 
Sbjct: 220 YT---FDEE--AFKEISIEAMDFVDRLL-------VKERKSRMTASEA 255

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 65.8 bits (161), Expect = 9e-12
 Identities = 66/334 (19%), Positives = 111/334 (33%), Gaps = 85/334 (25%)

Query: 357 LRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNV 414
           L    + LG+GS     K V        AVK +           ++ +  +   + HPN+
Sbjct: 12  LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNI 68

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SL 462
           VKL   ++ +    LV + L  G L               +   RI             +
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGEL--------------FE---RIKKKKHFSETEASYI 111

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAI-- 517
           +      ++ +H       V H ++K  N+L    + N    I DFG + L  P      
Sbjct: 112 MRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

Query: 518 ARLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQA 573
                  Y APE        +  D++S GV+L  +L+G+ P  S   S T     E  + 
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK 227

Query: 574 V-----DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEK 624
           +                E W            KN+ +E   L+  +L V        P K
Sbjct: 228 IKKGDFSFE-------GEAW------------KNVSQEAKDLIQGLLTV-------DPNK 261

Query: 625 RPTMAEVAK---MIEDIRVEQSPLGEEYDESRNS 655
           R  M+ +     + +  ++  +PL        + 
Sbjct: 262 RLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSG 295

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 65.7 bits (161), Expect = 9e-12
 Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 51/219 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN-----PC-ARKEFEQYMDVIGKLKHPNV 414
            ++G+GS G V K    D G IVA+K+  +++        A +E    + ++ +L+H N+
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMRE----IKLLKQLRHENL 86

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V L      K+   LV++++ + ++   L          LD+      +     G+   H
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN----GLDYQVVQKYLFQIINGIGFCH 141

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------------ 522
                  + H ++K  N+L+ ++GV  + DFG           AR               
Sbjct: 142 S----HNIIHRDIKPENILVSQSGVVKLCDFGF----------ARTLAAPGEVYDDEVAT 187

Query: 523 --YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
             Y+AP   E+     +  +  DV++ G L+ E+  G  
Sbjct: 188 RWYRAP---ELLVGDVKYGKAVDVWAIGCLVTEMFMGEP 223

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 46/212 (21%), Positives = 91/212 (42%), Gaps = 26/212 (12%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYMDVIGKLKHPNVV 415
           E++GKG    V + +  + G   AVK     +   +   + ++ ++   +   LKHP++V
Sbjct: 30  EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSL-HSLLHGNRGPGRIPL---DWTTRISLVLGAARGLA 471
           +L   Y +     +V++++    L   ++   R            +  +  +L A   L 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVK--RADAGFVYSEAVASHYMRQILEA---LR 144

Query: 472 RIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIA--RLG--GYK 524
             H       + H +VK   VLL   + +    +  FG+++ L     +A  R+G   + 
Sbjct: 145 YCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           APE  + +   +  DV+  GV+L  +L+G  P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 53/282 (18%)

Query: 303 SISSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELED--LLRAS 360
               +++   SG   G+        G +   T   +          ++  +E+  LL+  
Sbjct: 5   HHHHEEEGGSSGGAAGTSAD--GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK-- 60

Query: 361 AEMLGKGSLGTVY----KAVLDDGGIVAVKRLKDANPCARKEFEQYM----DVIGKLKH- 411
             +LG G+ G V+     +  D G + A+K LK A    + +  ++      V+  ++  
Sbjct: 61  --VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118

Query: 412 PNVVKLRAYYYA--KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI---SLVLG 465
           P +V L   +YA   E KL L+ DY+  G L + L       R       +I    +VL 
Sbjct: 119 PFLVTL---HYAFQTETKLHLILDYINGGELFTHL---SQRERFTEH-EVQIYVGEIVL- 170

Query: 466 AARGLARIHQEYGTAKVPHGNV----KSSNVLLDKNGVACISDFGLS--LLLNPVQAIAR 519
               L  +H+         G +    K  N+LLD NG   ++DFGLS   + +  +    
Sbjct: 171 ---ALEHLHK--------LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219

Query: 520 LGG---YKAPE--QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             G   Y AP+  +       +  D +S GVL+ E+LTG +P
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 70/336 (20%), Positives = 124/336 (36%), Gaps = 89/336 (26%)

Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDV 405
           + K+  + D  + ++++LG G  G V +          A+K L+D  P AR+E E +   
Sbjct: 53  QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRA 111

Query: 406 IGKLKHPNVVKLRAYY---YAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
                 P++V++   Y   YA  + L +V + L  G L                   RI 
Sbjct: 112 SQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL--------------FS---RIQ 151

Query: 462 LVLGAARGL--------ARIHQEYGTA-------KVPHGNVKSSNVLL---DKNGVACIS 503
                 RG         + I +  G A        + H +VK  N+L      N +  ++
Sbjct: 152 -----DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 206

Query: 504 DFGLSLLLNPVQAIA-RLG--GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP--SQ 558
           DFG +       ++        Y APE    ++  +  D++S GV++  +L G  P  S 
Sbjct: 207 DFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN 266

Query: 559 YPSPTRPRVDEEEQA--VDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLH 612
           +     P +    +    + P         EW              + EE   L+  +L 
Sbjct: 267 HGLAISPGMKTRIRMGQYEFP-------NPEW------------SEVSEEVKMLIRNLLK 307

Query: 613 VGLACVVSQPEKRPTMAEVAK---MIEDIRVEQSPL 645
                   +P +R T+ E      +++  +V Q+PL
Sbjct: 308 T-------EPTQRMTITEFMNHPWIMQSTKVPQTPL 336

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 50/224 (22%), Positives = 80/224 (35%), Gaps = 49/224 (21%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKE--FEQYMD---------VIGKLK 410
             +  GS G V   V  +G  VA+KR+ +     R                   ++    
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 411 HPNVVKLRAYYYAKEEKL-----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           HPN++ LR  +   EE       LV + +    L  ++H  R    I +        +  
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR----IVISPQHIQYFMYH 142

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
              GL  +H     A V H ++   N+LL  N    I DF L          AR      
Sbjct: 143 ILLGLHVLH----EAGVVHRDLHPGNILLADNNDITICDFNL----------AREDTADA 188

Query: 523 ----------YKAPEQ-AEVKRLSQKADVYSFGVLLLEVLTGRA 555
                     Y+APE   + K  ++  D++S G ++ E+   +A
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 53/220 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN-----PC-ARKEFEQYMDVIGKLKHPNV 414
             +G+GS G V+K    D G IVA+K+  ++         A +E    + ++ +LKHPN+
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALRE----IRMLKQLKHPNL 64

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHG-NRGPGRIPLDWTTRISLVLGAARGLARI 473
           V L   +  K    LV++Y      H++LH  +R    +P      I+      + +   
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQT--LQAVNFC 118

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----------- 522
           H+        H +VK  N+L+ K+ V  + DFG           ARL             
Sbjct: 119 HK----HNCIHRDVKPENILITKHSVIKLCDFGF----------ARLLTGPSDYYDDEVA 164

Query: 523 ---YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
              Y++P   E+     +     DV++ G +  E+L+G  
Sbjct: 165 TRWYRSP---ELLVGDTQYGPPVDVWAIGCVFAELLSGVP 201

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 65.3 bits (160), Expect = 1e-11
 Identities = 55/226 (24%), Positives = 91/226 (40%), Gaps = 34/226 (15%)

Query: 347 RKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYM 403
              +  +++   +R    +LGKGS G V  A + + G + AVK LK        + E  M
Sbjct: 16  SSNRLGIDNFEFIR----VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71

Query: 404 ---DVIGK-LKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTT 458
               ++     HP + +L    +   ++L  V +++  G L  + H  +   R       
Sbjct: 72  TEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKS-RRFDEARAR 127

Query: 459 ----RISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNP 513
                I         L  +H +     + + ++K  NVLLD  G   ++DFG+    +  
Sbjct: 128 FYAAEIIS------ALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177

Query: 514 VQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
               A   G   Y APE  +        D ++ GVLL E+L G AP
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 27/129 (20%), Positives = 51/129 (39%), Gaps = 18/129 (13%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRL----NGTILPLTNCTNLKLAYLSGNDFSAE 127
            +P  +            +LR +DL +N++          L +  +L    L GN  +  
Sbjct: 46  VIPPGAFSP-------YKKLRRIDLSNNQISELAPDAFQGLRSLNSL---VLYGNKITE- 94

Query: 128 IPHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKD 185
           +P  +   L  +  L L+ N I   +      +L  L  L L +N+L        S L+ 
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 186 LKELNLSNN 194
           ++ ++L+ N
Sbjct: 154 IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.9 bits (143), Expect = 5e-10
 Identities = 28/121 (23%), Positives = 48/121 (39%), Gaps = 18/121 (14%)

Query: 94  LDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIP----HQISSLKGILRLDLSDN 146
           + L  N +   ++P    +    L+   LS N  S  +       + SL     L L  N
Sbjct: 37  IRLEQNTI--KVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLN---SLVLYGN 90

Query: 147 NIRGRIPEQV-TNLTRLLTLRLQNNELTGRIP-DLSSSLKDLKELNLSNNELYGRVPEGL 204
            I   +P+ +   L  L  L L  N++   +  D    L +L  L+L +N+L   + +G 
Sbjct: 91  KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKL-QTIAKGT 147

Query: 205 L 205
            
Sbjct: 148 F 148

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 49/217 (22%), Positives = 98/217 (45%), Gaps = 36/217 (16%)

Query: 364 LGKGSLGTVYKAVLDD---GGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLR 418
           +G+G+ G VYKA   D       A+K+++       A +E    + ++ +LKHPNV+ L+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 419 AYYYAKEEKL--LVYDYLPN---GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
             + +  ++   L++DY  +     +            + L      SL+     G+  +
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 474 HQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLS-LLLNPVQAIARLGG------ 522
           H  +    V H ++K +N+L+     + G   I+D G + L  +P++ +A L        
Sbjct: 145 HANW----VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 200

Query: 523 YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
           Y+AP   E+    +  ++  D+++ G +  E+LT   
Sbjct: 201 YRAP---ELLLGARHYTKAIDIWAIGCIFAELLTSEP 234

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 64.9 bits (159), Expect = 2e-11
 Identities = 60/238 (25%), Positives = 96/238 (40%), Gaps = 34/238 (14%)

Query: 335 SGTDTSKLVFYERKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA 391
           +    SK      + + +L D   L     +LGKGS G V  +       + AVK LK  
Sbjct: 1   TTNTVSKFDNNGNRDRMKLTDFNFLM----VLGKGSFGKVMLSERKGTDELYAVKILKKD 56

Query: 392 NPCARKEFEQYM---DVIGK-LKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGN 446
                 + E  M    V+    K P + +L    +   ++L  V +Y+  G L  + H  
Sbjct: 57  VVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQ 113

Query: 447 RGPGRIPLDWTT----RISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI 502
           +  GR            I++      GL  +  +     + + ++K  NV+LD  G   I
Sbjct: 114 Q-VGRFKEPHAVFYAAEIAI------GLFFLQSK----GIIYRDLKLDNVMLDSEGHIKI 162

Query: 503 SDFGLS-LLLNPVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           +DFG+    +          G   Y APE    +   +  D ++FGVLL E+L G+AP
Sbjct: 163 ADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 61/255 (23%), Positives = 95/255 (37%), Gaps = 38/255 (14%)

Query: 320 EKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELED--LLRASAEMLGKGSLGTVYKAVL 377
           E+     G    +  +    SK      + + +L D   L     +LGKGS G V  +  
Sbjct: 307 ERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM----VLGKGSFGKVMLSER 362

Query: 378 -DDGGIVAVKRLKDANPCARKEFEQYM---DVIGK-LKHPNVVKLRAYYYAKEEKL-LVY 431
                + AVK LK        + E  M    V+    K P + +L    +   ++L  V 
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVM 421

Query: 432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRIS--LVLGAARGLARIHQEYGTAKVPHGNV-- 487
           +Y+  G L   +      GR         +  + +    GL  +           G +  
Sbjct: 422 EYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAI----GLFFLQS--------KGIIYR 466

Query: 488 --KSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAPEQAEVKRLSQKADVY 541
             K  NV+LD  G   I+DFG+    +          G   Y APE    +   +  D +
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWW 526

Query: 542 SFGVLLLEVLTGRAP 556
           +FGVLL E+L G+AP
Sbjct: 527 AFGVLLYEMLAGQAP 541

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 30/103 (29%), Positives = 44/103 (42%), Gaps = 4/103 (3%)

Query: 94  LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP 153
           + L    +       TN    +   L G      I +  ++L     +D SDN IR ++ 
Sbjct: 2   VKLTAELIE-QAAQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR-KL- 57

Query: 154 EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           +    L RL TL + NN +      L  +L DL EL L+NN L
Sbjct: 58  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.7 bits (140), Expect = 7e-10
 Identities = 26/122 (21%), Positives = 40/122 (32%), Gaps = 15/122 (12%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPH--QISSLKGIL 139
            A  +   + R LDL   ++                  S N    EI        L+ + 
Sbjct: 12  AAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDN----EIRKLDGFPLLRRLK 67

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-----SSLKDLKELNLSNN 194
            L +++N I          L  L  L L NN     + +L      +SLK L  L +  N
Sbjct: 68  TLLVNNNRICRIGEGLDQALPDLTELILTNN----SLVELGDLDPLASLKSLTYLCILRN 123

Query: 195 EL 196
            +
Sbjct: 124 PV 125

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 64.2 bits (157), Expect = 3e-11
 Identities = 65/325 (20%), Positives = 117/325 (36%), Gaps = 95/325 (29%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRA 419
           E +G GS     + +        AVK +  +     +E    ++++ +  +HPN++ L+ 
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGAA 467
            Y   +   +V + +  G L              LD   +I            +++    
Sbjct: 84  VYDDGKYVYVVTELMKGGEL--------------LD---KILRQKFFSEREASAVLFTIT 126

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLL-DKNGVA---CISDFGLSLLLNPVQAIAR--LG 521
           + +  +H +     V H ++K SN+L  D++G      I DFG +  L     +      
Sbjct: 127 KTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY 182

Query: 522 --GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV----- 574
              + APE  E +      D++S GVLL  +LTG     Y  P     D+  + +     
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG-----YT-PFANGPDDTPEEILARIG 236

Query: 575 ----DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRP 626
                L           W             ++ +    LVS MLHV        P +R 
Sbjct: 237 SGKFSLS-------GGYW------------NSVSDTAKDLVSKMLHV-------DPHQRL 270

Query: 627 TMAEVAK---MIEDIRVEQSPLGEE 648
           T A V +   ++   ++ Q  L  +
Sbjct: 271 TAALVLRHPWIVHWDQLPQYQLNRQ 295

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 64.2 bits (157), Expect = 4e-11
 Identities = 57/228 (25%), Positives = 90/228 (39%), Gaps = 36/228 (15%)

Query: 346 ERKKQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQY 402
                 +  D   L+    ++GKGS G V  A    +    AVK L+      +KE +  
Sbjct: 30  SSNPHAKPSDFHFLK----VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI 85

Query: 403 M---DVIGK-LKHPNVVKLRAYYYA--KEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLD 455
           M   +V+ K +KHP +V L   +++    +KL  V DY+  G L   L   R        
Sbjct: 86  MSERNVLLKNVKHPFLVGL---HFSFQTADKLYFVLDYINGGELFYHLQRER---CFLEP 139

Query: 456 WTTRI---SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLL 511
              R     +       L  +H       + + ++K  N+LLD  G   ++DFGL    +
Sbjct: 140 R-ARFYAAEIAS----ALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190

Query: 512 NPVQAIARLGG---YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
                 +   G   Y APE    +   +  D +  G +L E+L G  P
Sbjct: 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 63.3 bits (155), Expect = 4e-11
 Identities = 55/212 (25%), Positives = 86/212 (40%), Gaps = 34/212 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCAR--KEFEQYMDVIGKLKHPNVVKLR 418
           E LGKG+   V + V    G   A K +      AR  ++ E+   +  KL+HPN+V+L 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR------ 472
                +    LV+D +  G L            I      R       A    +      
Sbjct: 72  DSIQEESFHYLVFDLVTGGELFE---------DI----VAREFYSEADASHCIQQILESI 118

Query: 473 --IHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIA-RLG--GYK 524
              H       + H N+K  N+LL    K     ++DFGL++ +N  +A     G  GY 
Sbjct: 119 AYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYL 174

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           +PE  +    S+  D+++ GV+L  +L G  P
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 50/218 (22%)

Query: 362 EMLGKGSLGTVYKA-VLDDGGIVAVKRLK----DANPC-ARKEFEQYMDVIGKLKHPNVV 415
           + LG+G+  TVYK        +VA+K ++    +  PC A +E    + ++  LKH N+V
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
            L    + ++   LV++YL    L   L          ++       +    RGLA  H+
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHR 118

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------------- 522
                KV H ++K  N+L+++ G   ++DFGL          AR                
Sbjct: 119 ----QKVLHRDLKPQNLLINERGELKLADFGL----------ARAKSIPTKTYDNEVVTL 164

Query: 523 -YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
            Y+ P   ++       S + D++  G +  E+ TGR 
Sbjct: 165 WYRPP---DILLGSTDYSTQIDMWGVGCIFYEMATGRP 199

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 35/247 (14%)

Query: 327 GGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAV 385
           G + +  T G    +   +      +  D      E LGKG+   V + V    G   A 
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVK-EELGKGAFSVVRRCVHKTTGLEFAA 59

Query: 386 KRLKDANPCAR--KEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLL 443
           K +      AR  ++ E+   +  KL+HPN+V+L      +    LV+D +  G L    
Sbjct: 60  KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFE-- 117

Query: 444 HGNRGPGRIPLDWTTRISLVLGAARGLAR--------IHQEYGTAKVPHGNVKSSNVLL- 494
                   I      R       A    +         H       + H N+K  N+LL 
Sbjct: 118 -------DI----VAREFYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLA 162

Query: 495 --DKNGVACISDFGLSLLLNPVQAIA-RLG--GYKAPEQAEVKRLSQKADVYSFGVLLLE 549
              K     ++DFGL++ +N  +A     G  GY +PE  +    S+  D+++ GV+L  
Sbjct: 163 SKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYI 222

Query: 550 VLTGRAP 556
           +L G  P
Sbjct: 223 LLVGYPP 229

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 63.4 bits (155), Expect = 7e-11
 Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 31/160 (19%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIG------------- 407
           + LG+G   TVYKA   +   IVA+K++K  +    K+        G             
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD--------GINRTALREIKLLQ 67

Query: 408 KLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           +L HPN++ L   +  K    LV+D++    L  ++  N     + L  +   + +L   
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTL 122

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL 507
           +GL  +HQ +    + H ++K +N+LLD+NGV  ++DFGL
Sbjct: 123 QGLEYLHQHW----ILHRDLKPNNLLLDENGVLKLADFGL 158

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 63.7 bits (155), Expect = 8e-11
 Identities = 54/221 (24%), Positives = 86/221 (38%), Gaps = 53/221 (23%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFE-QYMDVIGKLKHPNV 414
           + LG G+ G V        G  VAVK     +++  +   +   E Q +      +HP++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK---LFRHPHI 78

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR------ 468
           +KL        +  +V +Y+  G L   +  N   GR+              +R      
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYICKN---GRLDEK----------ESRRLFQQI 125

Query: 469 --GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
             G+   H+      V H ++K  NVLLD +  A I+DFGLS        +   G     
Sbjct: 126 LSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLS-------NMMSDGEFLRT 174

Query: 523 ------YKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAP 556
                 Y APE    +     + D++S GV+L  +L G  P
Sbjct: 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 62.7 bits (153), Expect = 8e-11
 Identities = 48/223 (21%), Positives = 79/223 (35%), Gaps = 48/223 (21%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--------DANPCARKEFEQYMDVIGKLKHP 412
           + LG G+ G V  A        VA+K +                   E  ++++ KL HP
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 413 NVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDW-TTRISLVLGAARGL 470
            ++K++ ++    E   +V + +  G L               D       L     +  
Sbjct: 76  CIIKIKNFF--DAEDYYIVLELMEGGEL--------------FDKVVGNKRLKEATCKLY 119

Query: 471 AR--------IHQEYGTAKVPHGNVKSSNVLLDKNGVAC---ISDFGLSLLLNPVQAIA- 518
                     +H+      + H ++K  NVLL      C   I+DFG S +L     +  
Sbjct: 120 FYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175

Query: 519 RLG--GYKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             G   Y APE          ++  D +S GV+L   L+G  P
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 42/121 (34%), Positives = 56/121 (46%), Gaps = 10/121 (8%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L  L  L + DN+L    LP        NL    L  N   + +P ++  SL  +  L L
Sbjct: 84  LKNLETLWVTDNKL--QALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSL 140

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
             N ++  +P+ V   LT L  LRL NN+L          L +LK L L NN+L  RVPE
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPE 198

Query: 203 G 203
           G
Sbjct: 199 G 199

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 44/122 (36%), Positives = 62/122 (50%), Gaps = 12/122 (9%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L +LR L L+DN+L    LP        NL+  +++ N   A +P  +   L  +  L L
Sbjct: 60  LTKLRLLYLNDNKL--QTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRL 116

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELYGRVP 201
             N ++  +P +V  +LT+L  L L  NEL   +P      L  LKEL L NN+L  RVP
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVP 173

Query: 202 EG 203
           EG
Sbjct: 174 EG 175

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 60.0 bits (146), Expect = 4e-10
 Identities = 38/115 (33%), Positives = 51/115 (44%), Gaps = 15/115 (13%)

Query: 88  LDQLRFLDLHDNRLNGTILP------LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILR 140
           L  L  L L  N+L    LP      LT  T L    L  N+  + +P  +   L  +  
Sbjct: 108 LVNLAELRLDRNQL--KSLPPRVFDSLTKLTYL---SLGYNELQS-LPKGVFDKLTSLKE 161

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN 194
           L L +N ++ R+PE     LT L TL+L NN+L         SL+ LK L L  N
Sbjct: 162 LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 39/120 (32%), Positives = 58/120 (48%), Gaps = 14/120 (11%)

Query: 91  LRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGN---DFSAEIPHQISSLKGILRLDLS 144
            + LDL  N+L  + LP       T L+L YL+ N      A I  ++ +L+    L ++
Sbjct: 39  TKKLDLQSNKL--SSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE---TLWVT 93

Query: 145 DNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           DN ++  +P  V   L  L  LRL  N+L    P +  SL  L  L+L  NEL   +P+G
Sbjct: 94  DNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL-QSLPKG 151

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 10/112 (8%)

Query: 89  DQLRFLDLHDNRLNGTILPL---TNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
           +    +D    +L  T +P     +   L    L  N  S+        L  +  L L+D
Sbjct: 16  NNKNSVDCSSKKL--TAIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLND 70

Query: 146 NNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           N ++  +P  +   L  L TL + +N+L      +   L +L EL L  N+L
Sbjct: 71  NKLQT-LPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL 121

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 58/307 (18%), Positives = 101/307 (32%), Gaps = 95/307 (30%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDV---IGKLK------- 410
            +LGKG  GTV+    L D   VA+K +              +     +  L        
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 411 HPNVVKLRAYYYAKEEKLLVYDY-LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           HP V++L  ++  +E  +LV +  LP   L   +      G +              +R 
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEG----------PSRC 143

Query: 470 LAR--------IHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNPVQAIARL 520
                       H       V H ++K  N+L+D + G A + DFG         A+   
Sbjct: 144 FFGQVVAAIQHCHS----RGVVHRDIKDENILIDLRRGCAKLIDFGSG-------ALLHD 192

Query: 521 GGYK---------APEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE 570
             Y           PE     +  +  A V+S G+LL +++ G  P           + +
Sbjct: 193 EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP----------FERD 242

Query: 571 EQAVD----LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP 626
           ++ ++     P  V        + +     L+R           L         +P  RP
Sbjct: 243 QEILEAELHFPAHV--------SPDC--CALIR---------RCLAP-------KPSSRP 276

Query: 627 TMAEVAK 633
           ++ E+  
Sbjct: 277 SLEEILL 283

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 58.9 bits (143), Expect = 1e-10
 Identities = 29/116 (25%), Positives = 47/116 (40%), Gaps = 13/116 (11%)

Query: 88  LDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
              ++ L L ++R N   L         L+         +  I + +  L  + +L+LSD
Sbjct: 16  PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-----SSLKDLKELNLSNNEL 196
           N + G +         L  L L  N    +I DLS       L++LK L+L N E+
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGN----KIKDLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.1 bits (128), Expect = 1e-08
 Identities = 17/88 (19%), Positives = 38/88 (43%), Gaps = 3/88 (3%)

Query: 110 NCTNLKLAYLSGNDFSA-EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQ 168
             +++K   L  +  +  ++       + +  L   +  +   I   +  L +L  L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72

Query: 169 NNELTGRIPDLSSSLKDLKELNLSNNEL 196
           +N ++G +  L+    +L  LNLS N++
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 4e-04
 Identities = 30/93 (32%), Positives = 40/93 (43%), Gaps = 24/93 (25%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPL-TNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           IA L  L++L+ L+L DNR++G +  L   C NL    LSGN        +I  L  I  
Sbjct: 57  IANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN--------KIKDLSTIEP 108

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT 173
           L                 L  L +L L N E+T
Sbjct: 109 L---------------KKLENLKSLDLFNCEVT 126

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 69/323 (21%), Positives = 112/323 (34%), Gaps = 90/323 (27%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL--KDANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E LGKG+   V + V +  G   A   +  K  +    ++ E+   +   LKHPN+V+L 
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGA 466
                +    L++D +  G L               +    I              +   
Sbjct: 77  DSISEEGHHYLIFDLVTGGEL--------------FE---DIVAREYYSEADASHCIQQI 119

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAI--ARLG 521
              +   HQ      V H N+K  N+LL    K     ++DFGL++ +   Q       G
Sbjct: 120 LEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG 175

Query: 522 --GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
             GY +PE        +  D+++ GV+L  +L G     YP    P  DE++  +     
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG-----YP----PFWDEDQHRL----- 221

Query: 580 VRSVVK-------EEWTAEVFDQELLRYKNIEEE---LVS-MLHVGLACVVSQPEKRPTM 628
            + +          EW              +  E   L++ ML +        P KR T 
Sbjct: 222 YQQIKAGAYDFPSPEW------------DTVTPEAKDLINKMLTI-------NPSKRITA 262

Query: 629 AEVAK---MIEDIRVEQSPLGEE 648
           AE  K   +     V      +E
Sbjct: 263 AEALKHPWISHRSTVASCMHRQE 285

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 62.4 bits (152), Expect = 2e-10
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 46/223 (20%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL--------KDANPCARKEFEQYMDVIGKLK-H 411
           +++G+G    V + V    G   AVK +         +     R+   +   ++ ++  H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDW-TTRISLVLGAARGL 470
           P+++ L   Y +     LV+D +  G L               D+ T +++L     R +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGEL--------------FDYLTEKVALSEKETRSI 205

Query: 471 AR--------IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA-RLG 521
            R        +H       + H ++K  N+LLD N    +SDFG S  L P + +    G
Sbjct: 206 MRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261

Query: 522 --GYKAPE------QAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
             GY APE              ++ D+++ GV+L  +L G  P
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 40/223 (17%), Positives = 84/223 (37%), Gaps = 40/223 (17%)

Query: 305 SSDKQQRRSGSNYGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQ-FELED---LLRAS 360
           SS +       N G++  V  +            +       R    +++ D   +    
Sbjct: 2   SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH-- 59

Query: 361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLK 410
             ++G GS G V +A    +  +VA+K++          FE  +D         ++ +L 
Sbjct: 60  --LIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIAILNRLN 110

Query: 411 HPNVVKLRAYYYAKEEKL-----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLG 465
           H +VVK+      K+ +      +V +   +     L         + L      +L+  
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTP-----VYLTELHIKTLLYN 164

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
              G+  +H    +A + H ++K +N L++++    + DFGL+
Sbjct: 165 LLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 39/214 (18%), Positives = 81/214 (37%), Gaps = 44/214 (20%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKHPN 413
           +G G+ G V  A        VA+K+L          F+             ++  + H N
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 85

Query: 414 VVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           ++ L   +  ++         +V + +   +L  ++       ++ LD      L+    
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-------QMELDHERMSYLLYQML 137

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
            G+  +H    +A + H ++K SN+++  +    I DFGL+           +       
Sbjct: 138 CGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTR 190

Query: 523 -YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA 555
            Y+APE        +  D++S G ++ E++ G  
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 62.5 bits (151), Expect = 2e-10
 Identities = 36/196 (18%), Positives = 58/196 (29%), Gaps = 32/196 (16%)

Query: 3   KASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCS 62
           +    LL++ L + ++               L+                     + +   
Sbjct: 380 ENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKME 439

Query: 63  PKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGN 122
               RV+ L+    ++   +  L  L  +  LDL  NRL      L     L++   S N
Sbjct: 440 YADVRVLHLAHKDLTV---LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDN 496

Query: 123 DFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-- 180
                    + ++ G+                   NL RL  L L NN L      +   
Sbjct: 497 --------ALENVDGV------------------ANLPRLQELLLCNNRLQQ-SAAIQPL 529

Query: 181 SSLKDLKELNLSNNEL 196
            S   L  LNL  N L
Sbjct: 530 VSCPRLVLLNLQGNSL 545

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 30/130 (23%), Positives = 52/130 (40%), Gaps = 20/130 (15%)

Query: 72  SLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNG--TILPLTNC---TNLKLAYLSGNDFSA 126
           +    +L            +  L+  D  LN   +      C    ++ +  LS N  + 
Sbjct: 391 NFFKVALM--------TKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442

Query: 127 EIPHQI-SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLK 184
            +   +   +K    LDL +N I   IP+ VT+L  L  L + +N+L   +PD     L 
Sbjct: 443 SVFRCLPPKVK---VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLT 497

Query: 185 DLKELNLSNN 194
            L+ + L +N
Sbjct: 498 SLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 10/126 (7%)

Query: 88  LDQLRFLDLHDNRL---NGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR-LDL 143
           L +L+ L L  N L       L   N ++L+   +S N  ++    +  +    +  L+L
Sbjct: 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435

Query: 144 SDNNIRGRIPEQVTNLTRLLT-LRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           S N + G +      L   +  L L NN +   IP   + L+ L+ELN+++N+L   VP+
Sbjct: 436 SSNMLTGSVFRC---LPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL-KSVPD 490

Query: 203 GLLKKF 208
           G+  + 
Sbjct: 491 GVFDRL 496

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 25/123 (20%), Positives = 50/123 (40%), Gaps = 4/123 (3%)

Query: 86  SLLDQLRFLDLHDNRLNG-TILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           S+  ++    L  +      ++   + ++      + N F+  +    S+LK +  L L 
Sbjct: 326 SVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385

Query: 145 DNNIR--GRIPEQVTNLTRLLTLRLQNNELT-GRIPDLSSSLKDLKELNLSNNELYGRVP 201
            N ++   ++     N++ L TL +  N L         +  + +  LNLS+N L G V 
Sbjct: 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445

Query: 202 EGL 204
             L
Sbjct: 446 RCL 448

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 30/200 (15%), Positives = 62/200 (31%), Gaps = 15/200 (7%)

Query: 4   ASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSP 63
             L L ++ L+  +        ++      L   T  ++ + WK           +    
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKC-------SVKLFQFF 273

Query: 64  KSERVVSLSLPSHSLRGPIAPLSL---LDQLRFLDLHDNRLNGTILPLTN----CTNLKL 116
               V  L++ + ++   I           L+ L +   +    +            + +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333

Query: 117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRI 176
             LS +D          S      L+ + N     + +  + L RL TL LQ N L    
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NF 392

Query: 177 PDLSSSLKDLKELNLSNNEL 196
             ++   K++  L   +  L
Sbjct: 393 FKVALMTKNMSSLETLDVSL 412

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 51.4 bits (123), Expect = 6e-07
 Identities = 19/98 (19%), Positives = 38/98 (38%), Gaps = 6/98 (6%)

Query: 111 CTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQN 169
                +   S  + +  +P  +        L LS N+I   +     + L+ L  LRL +
Sbjct: 30  NELESMVDYSNRNLTH-VPKDLPP--RTKALSLSQNSIS-ELRMPDISFLSELRVLRLSH 85

Query: 170 NELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
           N +      +    +DL+ L++S+N L   +    +  
Sbjct: 86  NRIRSLDFHVFLFNQDLEYLDVSHNRL-QNISCCPMAS 122

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 31/123 (25%), Positives = 47/123 (38%), Gaps = 12/123 (9%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           L +LR L L  NR+    L         +L+   +S N         ++SL+    LDLS
Sbjct: 75  LSELRVLRLSHNRI--RSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMASLR---HLDLS 129

Query: 145 DNNIRGRIPEQVT--NLTRLLTLRLQNNELTGRIPDLSSSLK-DLKELNLSNNELYGRVP 201
            N+    +P      NLT+L  L L   +         + L      L+L +  + G   
Sbjct: 130 FNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188

Query: 202 EGL 204
           E L
Sbjct: 189 ESL 191

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 48.7 bits (116), Expect = 5e-06
 Identities = 35/133 (26%), Positives = 51/133 (38%), Gaps = 10/133 (7%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLT----NCTNLKLAYLSGNDFSAEIPHQISSLK-GI 138
               +  LR LDL  N     +LP+     N T L    LS   F       ++ L    
Sbjct: 116 SCCPMASLRHLDLSFNDF--DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173

Query: 139 LRLDLSDNNIRGRIPEQVTNL-TRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
           + LDL   +I+G   E +    T +L L    N L     ++  S+  L  L LSN +L 
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM--SVNALGHLQLSNIKLN 231

Query: 198 GRVPEGLLKKFGE 210
               + L+    E
Sbjct: 232 DENCQRLMTFLSE 244

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 22/205 (10%), Positives = 55/205 (26%), Gaps = 15/205 (7%)

Query: 4   ASLFLLSLALSLLSVSSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSP 63
             +  L L+  LL + S H    +  +L    T     +          +      V + 
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN---SLFSVQVNMSVNAL 220

Query: 64  KSERVVSLSL---PSHSLRGPIAPLSLLDQLRFLDLHDNRLNGT----ILPLTNCTNLKL 116
              ++ ++ L       L   ++ L+    L  + L            +        ++ 
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEY 280

Query: 117 AYLSGNDFS-----AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNE 171
             +     +      E  +  ++LK ++   + +           +    +    L  ++
Sbjct: 281 LNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISD 340

Query: 172 LTGRIPDLSSSLKDLKELNLSNNEL 196
                     S      LN + N  
Sbjct: 341 TPFIHMVCPPSPSSFTFLNFTQNVF 365

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 51/224 (22%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDV-----IGKLK----- 410
             +G G+ GTVYKA     G  VA+K ++  N          + +     +  L+     
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVRVPN---GGGGGGGLPISTVREVALLRRLEAF 71

Query: 411 -HPNVVKLR----AYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVL 464
            HPNVV+L          +E K+ LV++++    L + L     PG   L   T   L+ 
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG---LPAETIKDLMR 127

Query: 465 GAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-- 522
              RGL  +H       + H ++K  N+L+   G   ++DFGL          AR+    
Sbjct: 128 QFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADFGL----------ARIYSYQ 173

Query: 523 -----------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA 555
                      Y+APE       +   D++S G +  E+   + 
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 49/214 (22%), Positives = 82/214 (38%), Gaps = 42/214 (19%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             LG+G+   VY+          A+K LK      +K     + V+ +L HPN++KL+  
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI------------SLVLGAAR 468
           +    E  LV + +  G L               D   RI              V     
Sbjct: 117 FETPTEISLVLELVTGGEL--------------FD---RIVEKGYYSERDAADAVKQILE 159

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            +A +H+      + H ++K  N+L      +    I+DFGLS ++     +  + G   
Sbjct: 160 AVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPG 215

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP 556
           Y APE         + D++S G++   +L G  P
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 48/224 (21%), Positives = 87/224 (38%), Gaps = 57/224 (25%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPC-ARKEFEQYMDVIGKLKHPNV 414
             LG+G+ G VYKA+       VA+KR++     +  P  A +E    + ++ +L+H N+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQHRNI 95

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L++  +      L+++Y  N  L   +  N       +      S +     G+   H
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH 149

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVAC-----ISDFGLSLLLNPVQAIARLGG------- 522
                 +  H ++K  N+LL  +  +      I DFGL          AR  G       
Sbjct: 150 SR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL----------ARAFGIPIRQFT 195

Query: 523 -------YKAPEQAEV----KRLSQKADVYSFGVLLLEVLTGRA 555
                  Y+ P   E+    +  S   D++S   +  E+L    
Sbjct: 196 HEIITLWYRPP---EILLGSRHYSTSVDIWSIACIWAEMLMKTP 236

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 60.7 bits (148), Expect = 4e-10
 Identities = 45/204 (22%), Positives = 90/204 (44%), Gaps = 28/204 (13%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYY 421
           LG+G    V++A+ + +   V VK LK   P  +K+ ++ + ++  L+  PN++ L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100

Query: 422 YAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPL-DWTTRISLVLGAARGLARIHQEYG 478
                +   LV++++ N     L           L D+  R   +    + L   H    
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIR-FYMYEILKALDYCH---- 147

Query: 479 TAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNPVQA----IARLGGYKAPE-QAEVK 532
           +  + H +VK  NV++D ++    + D+GL+   +P Q     +A    +K PE   + +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-FKGPELLVDYQ 206

Query: 533 RLSQKADVYSFGVLLLEVLTGRAP 556
                 D++S G +L  ++  + P
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEP 230

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 58.2 bits (141), Expect = 4e-10
 Identities = 33/113 (29%), Positives = 48/113 (42%), Gaps = 7/113 (6%)

Query: 88  LDQLRFLDLHDNRLN-GTILPLT-NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD 145
              +R L L + + N G I  LT    NL+   L        +   +  L  + +L+LS+
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSE 80

Query: 146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS--SSLKDLKELNLSNNEL 196
           N I G +      L  L  L L  N+L   I  L     L+ LK L+L N E+
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 3e-04
 Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 24/93 (25%)

Query: 82  IAPLSLLDQLRFLDLHDNRL-NGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           ++ L  L +L+ L+L +NR+  G  +      NL    LSGN        ++  +  +  
Sbjct: 64  VSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN--------KLKDISTLEP 115

Query: 141 LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT 173
           L                 L  L +L L N E+T
Sbjct: 116 L---------------KKLECLKSLDLFNCEVT 133

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 50/292 (17%), Positives = 102/292 (34%), Gaps = 67/292 (22%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK--------RLKDANPCARKEFEQYMDVIGKLKHP 412
             LG G+ G V+ AV  +    V VK                   +    + ++ +++H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGS-LHSLLHGNRGPGRIPLDWTTRI--SLVLGAARG 469
           N++K+   +  +    LV +   +G  L + +  +    R+     + I   LV      
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLV----SA 142

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAP 526
           +  +  +     + H ++K  N+++ ++    + DFG +  L   +      G   Y AP
Sbjct: 143 VGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198

Query: 527 EQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD----LPKWVR 581
           E          + +++S GV L  ++    P            E E+ V+     P  V 
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENP----------FCELEETVEAAIHPPYLV- 247

Query: 582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                  + E+    L+           +L          PE+R T+ ++  
Sbjct: 248 -------SKELMS--LVS---------GLLQP-------VPERRTTLEKLVT 274

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 53/220 (24%), Positives = 94/220 (42%), Gaps = 45/220 (20%)

Query: 362 EMLGKGSLGTVYKA--VLDDGGIVAVKRLK-----DANPC-ARKEFEQYMDVIGKLKHPN 413
             +G+G+ G V+KA  + + G  VA+KR++     +  P    +E    +  +   +HPN
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV-AVLRHLETFEHPN 75

Query: 414 VVKLR----AYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           VV+L          +E KL LV++++    L + L     PG   +   T   ++    R
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG---VPTETIKDMMFQLLR 131

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------ 522
           GL  +H      +V H ++K  N+L+  +G   ++DFGL          AR+        
Sbjct: 132 GLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL----------ARIYSFQMALT 177

Query: 523 -------YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA 555
                  Y+APE       +   D++S G +  E+   + 
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 53/230 (23%), Positives = 93/230 (40%), Gaps = 61/230 (26%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-----KDANPC-ARKEFEQYMDVIGKLKHPNV 414
             +G+G+ G V+KA     G  VA+K++     K+  P  A +E    + ++  LKH NV
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLKHENV 78

Query: 415 VKLR-------AYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
           V L        + Y   +  + LV+D+  +  L  LL        +    +    ++   
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN----VLVKFTLSEIKRVMQML 133

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
             GL  IH+     K+ H ++K++NVL+ ++GV  ++DFGL          AR       
Sbjct: 134 LNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGL----------ARAFSLAKN 179

Query: 523 --------------YKAPE---QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
                         Y+ PE       +      D++  G ++ E+ T   
Sbjct: 180 SQPNRYTNRVVTLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSP 227

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.0 bits (148), Expect = 7e-10
 Identities = 40/213 (18%), Positives = 83/213 (38%), Gaps = 42/213 (19%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKHPN 413
           +G G+ G V  A        VA+K+L          F+             ++  + H N
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 122

Query: 414 VVKLRAYYYAK------EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           ++ L   +  +      ++  LV + +   +L  ++       ++ LD      L+    
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQML 174

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIA-----RLGG 522
            G+  +H    +A + H ++K SN+++  +    I DFGL+        +      R   
Sbjct: 175 CGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-- 228

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA 555
           Y+APE        +  D++S G ++ E++  + 
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 47/212 (22%), Positives = 86/212 (40%), Gaps = 41/212 (19%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKHPN 413
           +G G+ G+V  A+    G  VA+K+L          F+  +          ++  ++H N
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHEN 84

Query: 414 VVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           V+ L   +             LV  ++    L  ++        +         LV    
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-------GLKFSEEKIQYLVYQML 136

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA---IARLGGYK 524
           +GL  IH    +A V H ++K  N+ ++++    I DFGL+   +       + R   Y+
Sbjct: 137 KGLKYIH----SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--YR 190

Query: 525 APEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
           APE        +Q  D++S G ++ E+LTG+ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 51/220 (23%), Positives = 84/220 (38%), Gaps = 56/220 (25%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKHPN 413
           +G G+ G V  AV    G  VA+K+L          F+  +          ++  ++H N
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHEN 85

Query: 414 VVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           V+ L   +   E         LV  ++    L  L+          L       LV    
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE------KLGEDRIQFLVYQML 138

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG----- 522
           +GL  IH     A + H ++K  N+ ++++    I DFGL          AR        
Sbjct: 139 KGLRYIH----AAGIIHRDLKPGNLAVNEDCELKILDFGL----------ARQADSEMTG 184

Query: 523 ------YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
                 Y+APE      R +Q  D++S G ++ E++TG+ 
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 37/165 (22%), Positives = 68/165 (41%), Gaps = 31/165 (18%)

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYK------APEQAEVKRL 534
           K  H ++ + N+LL +  V  I DFGL+  +       R G  +      APE    +  
Sbjct: 213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272

Query: 535 SQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
           + ++DV+SFGVLL E+ + G +P  YP              +  + ++            
Sbjct: 273 TIQSDVWSFGVLLWEIFSLGASP--YPGVKIDE--------EFCRRLKE----------- 311

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
              +        E+   +   L C   +P +RPT +E+ + + ++
Sbjct: 312 GTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 24/96 (25%), Positives = 39/96 (40%), Gaps = 9/96 (9%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPN 413
           + LG+G+ G V +A             VAVK LK+ A     +     + ++  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 414 VVKLRAYYYAKEEKLLV-YDYLPNGSLHSLLHGNRG 448
           VV L          L+V  ++   G+L + L   R 
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 61/218 (27%), Positives = 89/218 (40%), Gaps = 48/218 (22%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFE-QYMDVIGKLKHPNV 414
           E LG+GS G V  A        VA+K      LK ++   R E E  Y+ +   L+HP++
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL---LRHPHI 71

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR-----ISLVLGAARG 469
           +KL        + ++V +Y   G L   +       R+  D   R     I         
Sbjct: 72  IKLYDVITTPTDIVMVIEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIIC-------A 120

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------- 522
           +   H+     K+ H ++K  N+LLD N    I+DFGLS        I   G        
Sbjct: 121 IEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLS-------NIMTDGNFLKTSCG 169

Query: 523 ---YKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAP 556
              Y APE    K     + DV+S G++L  +L GR P
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 58/310 (18%), Positives = 102/310 (32%), Gaps = 103/310 (33%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLK--------- 410
            +LG G  G+VY  + + D   VA+K + KD     R      +    ++          
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD-----RISDWGELPNGTRVPMEVVLLKKV 103

Query: 411 ---HPNVVKLRAYYYAKEEKLLVYDY-LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
                 V++L  ++   +  +L+ +   P   L   +      G +  +           
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GALQEE----------L 150

Query: 467 ARGLAR--------IHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLNPVQAI 517
           AR             H       V H ++K  N+L+D N G   + DFG         A+
Sbjct: 151 ARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG-------AL 199

Query: 518 ARLGGYK---------APEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV 567
            +   Y           PE     R   + A V+S G+LL +++ G  P           
Sbjct: 200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---------- 249

Query: 568 DEEEQAVD----LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPE 623
           + +E+ +       + V        ++E   Q L+R           L +       +P 
Sbjct: 250 EHDEEIIRGQVFFRQRV--------SSEC--QHLIR---------WCLAL-------RPS 283

Query: 624 KRPTMAEVAK 633
            RPT  E+  
Sbjct: 284 DRPTFEEIQN 293

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 40/212 (18%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKHPN 413
           +G G+ G+V  A     G  VAVK+L          F+  +          ++  +KH N
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHEN 89

Query: 414 VVKLRAYYYAKEEKL------LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           V+ L   +             LV   +    L++++          L       L+    
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ------KLTDDHVQFLIYQIL 142

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA---IARLGGYK 524
           RGL  IH    +A + H ++K SN+ ++++    I DFGL+             R   Y+
Sbjct: 143 RGLKYIH----SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--YR 196

Query: 525 APEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
           APE        +Q  D++S G ++ E+LTGR 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 57.8 bits (140), Expect = 5e-09
 Identities = 44/245 (17%), Positives = 86/245 (35%), Gaps = 59/245 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKH 411
            ++G+GS G VY A   +    VA+K++          FE  +D         ++ +LK 
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLIDCKRILREITILNRLKS 84

Query: 412 PNVVKLRAYYYAKEEKL-----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
             +++L       +        +V +   +  L  L         I L      +++   
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTP-----IFLTEEHIKTILYNL 138

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
             G   IH     + + H ++K +N LL+++    + DFGL+  +N  +    +      
Sbjct: 139 LLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 523 ----------------------YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRAPSQY 559
                                 Y+APE     +  ++  D++S G +  E+L        
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254

Query: 560 PSPTR 564
               R
Sbjct: 255 DPTNR 259

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 57.6 bits (140), Expect = 5e-09
 Identities = 45/224 (20%), Positives = 86/224 (38%), Gaps = 49/224 (21%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKH 411
            +LG+G+ G V  A     G IVA+K++    P     F++ +          ++   KH
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKI---EP-----FDKPLFALRTLREIKILKHFKH 68

Query: 412 PNVVKLRAYYYAKEEKL-----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGA 466
            N++ +         +      ++ + +    LH ++          L        +   
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ------MLSDDHIQYFIYQT 121

Query: 467 ARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---- 522
            R +  +H     + V H ++K SN+L++ N    + DFGL+ +++   A          
Sbjct: 122 LRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 523 ----------YKAPEQ-AEVKRLSQKADVYSFGVLLLEVLTGRA 555
                     Y+APE      + S+  DV+S G +L E+   R 
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.9 bits (135), Expect = 8e-09
 Identities = 50/171 (29%), Positives = 70/171 (40%), Gaps = 28/171 (16%)

Query: 52  CAAAWTGVVCSPKSERVV---------SLSLPSHSL-RGPIAPLSLLDQLRFLDLHDNRL 101
           C      V C  KS   V          L L S  L     A    L +L +L+L  N+L
Sbjct: 12  CNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL 71

Query: 102 NGTILP------LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDNNIRGRIPE 154
               L       LT    L    L+ N  ++ +P  +   L  + +L L  N ++  +P 
Sbjct: 72  --QTLSAGVFDDLTELGTL---GLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLK-SLPS 124

Query: 155 QV-TNLTRLLTLRLQNNELTGRIPD-LSSSLKDLKELNLSNNELYGRVPEG 203
            V   LT+L  LRL  N+L   IP      L +L+ L+LS N+L   VP G
Sbjct: 125 GVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQL-QSVPHG 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 27/88 (30%), Positives = 36/88 (40%), Gaps = 9/88 (10%)

Query: 88  LDQLRFLDLHDNRLNGTILP---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDL 143
           L QL  L L  N+L    LP       T LK   L+ N   + IP      L  +  L L
Sbjct: 106 LTQLDKLYLGGNQL--KSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSL 162

Query: 144 SDNNIRGRIPEQV-TNLTRLLTLRLQNN 170
           S N ++  +P      L +L T+ L  N
Sbjct: 163 STNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 19/65 (29%), Positives = 29/65 (44%), Gaps = 1/65 (1%)

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR 199
           +LDL    +          LT+L  L L  N+L      +   L +L  L L+NN+L   
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL-AS 97

Query: 200 VPEGL 204
           +P G+
Sbjct: 98  LPLGV 102

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 60/297 (20%), Positives = 103/297 (34%), Gaps = 77/297 (25%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVK-----RLKDANPCARKEFEQYMDVIGKLKHPNVVKL 417
           +G G+ G            +VAVK        D N   ++E          L+HPN+V+ 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN--VQREI-INHRS---LRHPNIVRF 81

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR--------G 469
           +          ++ +Y   G L+  +      GR   D           AR        G
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNA---GRFSED----------EARFFFQQLLSG 128

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC--ISDFGLSLLLNPVQAIARLGG----- 522
           ++  H      ++ H ++K  N LLD +      I DFG S         + L       
Sbjct: 129 VSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYS-------KSSVLHSQPKST 177

Query: 523 -----YKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDL 576
                Y APE    +    + ADV+S GV L  +L G  P           ++ E+  D 
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP----------FEDPEEPRDY 227

Query: 577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
            K ++ ++  +++       +     I  E   ++       V+ P  R ++ E+  
Sbjct: 228 RKTIQRILSVKYS-------IPDDIRISPECCHLISRIF---VADPATRISIPEIKT 274

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 14/77 (18%), Positives = 27/77 (35%), Gaps = 3/77 (3%)

Query: 122 NDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS 180
            D + +  H +   + +  L + +      +  +    L  L  L +  + L   +   +
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 181 -SSLKDLKELNLSNNEL 196
                 L  LNLS N L
Sbjct: 76  FHFTPRLSRLNLSFNAL 92

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 5e-08
 Identities = 22/101 (21%), Positives = 31/101 (30%), Gaps = 5/101 (4%)

Query: 99  NRLNGTILP-LTNCTNLKLAYLSGNDFSAEIP-HQISSLKGILRLDLSDNNIRGRIPEQV 156
                  L  L    NL   Y+        +    +  L  +  L +  + +R  +    
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 157 -TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
                RL  L L  N L          L  L+EL LS N L
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 21/119 (17%), Positives = 38/119 (31%), Gaps = 15/119 (12%)

Query: 57  TGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNL 114
           +G+ C+       +L    H L G        + L  L + + +    +    L     L
Sbjct: 11  SGLRCTRDG----ALDSL-HHLPG-------AENLTELYIENQQHLQHLELRDLRGLGEL 58

Query: 115 KLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT 173
           +   +  +      P        + RL+LS N +   +  +      L  L L  N L 
Sbjct: 59  RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 63/339 (18%), Positives = 114/339 (33%), Gaps = 116/339 (34%)

Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDV 405
           + K+  + D  + ++++LG G  G V +          A+K L+D  P AR+E E +   
Sbjct: 9   QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRA 67

Query: 406 IGKLKHPNVVKLRAYY----YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRIS 461
                 P++V++   Y      ++  L+V + L  G L                   RI 
Sbjct: 68  SQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL--------------FS---RI- 106

Query: 462 LVLGAARGLARIHQEYG-------------------TAKVPHGNVKSSNVLL---DKNGV 499
                     R  Q +                    +  + H +VK  N+L      N +
Sbjct: 107 --------QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 158

Query: 500 ACISDFGLSLLLNPVQAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAP- 556
             ++DFG                  A    E   ++  +  D++S GV++  +L G  P 
Sbjct: 159 LKLTDFGF-----------------AK---ETTGEKYDKSCDMWSLGVIMYILLCGYPPF 198

Query: 557 -SQYPSPTRPRVDEE--EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEE---LVS- 609
            S +     P +         + P         EW              + EE   L+  
Sbjct: 199 YSNHGLAISPGMKTRIRMGQYEFP-------NPEW------------SEVSEEVKMLIRN 239

Query: 610 MLHVGLACVVSQPEKRPTMAEVAK---MIEDIRVEQSPL 645
           +L         +P +R T+ E      +++  +V Q+PL
Sbjct: 240 LLKT-------EPTQRMTITEFMNHPWIMQSTKVPQTPL 271

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 42/215 (19%)

Query: 364 LGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKHPN 413
           +G+G+ G V  A    +   VA+K++          FE             ++ + +H N
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHEN 86

Query: 414 VVKLRAYYYAKEEKL-----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           ++ +     A   +      +V D +    L+ LL          L        +    R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQILR 139

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-LGG----- 522
           GL  IH    +A V H ++K SN+LL+      I DFGL+ + +P       L       
Sbjct: 140 GLKYIH----SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 523 -YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
            Y+APE     K  ++  D++S G +L E+L+ R 
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 54.2 bits (131), Expect = 9e-08
 Identities = 29/121 (23%), Positives = 47/121 (38%), Gaps = 15/121 (12%)

Query: 91  LRFLDLHDNRLN--GTILPLTNCTNLKLAYLSGNDFSAE----IPHQISSLKGILRLDLS 144
           ++ LD+    L+       L      ++  L     +      I   +     +  L+L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 145 DNNIRGRIPEQV-----TNLTRLLTLRLQNNELTGR-IPDLSSSLK---DLKELNLSNNE 195
            N +       V     T   ++  L LQN  LTG     LSS+L+    L+EL+LS+N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 196 L 196
           L
Sbjct: 125 L 125

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 33/135 (24%), Positives = 51/135 (37%), Gaps = 27/135 (20%)

Query: 85  LSLLDQLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAE----IPHQIS 133
           L +   L  L+L  N L           L   +C   KL  L     +      +   + 
Sbjct: 52  LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKL-SLQNCCLTGAGCGVLSSTLR 110

Query: 134 SLKGILRLDLSDNNIRGRIPEQVTNL--------TRLLTLRLQNNELTGR-IPDLSSSLK 184
           +L  +  L LSDN +       +  L         RL  L+L+   L+      L+S L+
Sbjct: 111 TLPTLQELHLSDNLLG---DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLR 167

Query: 185 ---DLKELNLSNNEL 196
              D KEL +SNN++
Sbjct: 168 AKPDFKELTVSNNDI 182

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 53.4 bits (129), Expect = 2e-07
 Identities = 30/131 (22%), Positives = 50/131 (38%), Gaps = 19/131 (14%)

Query: 85  LSLLDQLRFLDLHDNRLNGT------ILPLTNCTNLKLAYLSGNDFSAEIPHQISSL--- 135
           L  L  L+ L L DN L            L     L+   L     SA     ++S+   
Sbjct: 109 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRA 168

Query: 136 -KGILRLDLSDNNIRGR----IPEQ-VTNLTRLLTLRLQNNELTGR-IPDLSSSLKD--- 185
                 L +S+N+I       + +    +  +L  L+L++  +T     DL   +     
Sbjct: 169 KPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKAS 228

Query: 186 LKELNLSNNEL 196
           L+EL L +N+L
Sbjct: 229 LRELALGSNKL 239

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 51.9 bits (125), Expect = 4e-07
 Identities = 26/132 (19%), Positives = 49/132 (37%), Gaps = 21/132 (15%)

Query: 85  LSLLDQLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAE----IPHQIS 133
           ++    LR L L  N+L           L   +     L ++     +A+    +   + 
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL-WIWECGITAKGCGDLCRVLR 281

Query: 134 SLKGILRLDLSDNNIRG----RIPEQVTN-LTRLLTLRLQNNELTGR-IPDLSSSLKD-- 185
           + + +  L L+ N +       + E +     +L +L +++   T       SS L    
Sbjct: 282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNR 341

Query: 186 -LKELNLSNNEL 196
            L EL +SNN L
Sbjct: 342 FLLELQISNNRL 353

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 28/132 (21%), Positives = 52/132 (39%), Gaps = 21/132 (15%)

Query: 85  LSLLDQLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAE----IPHQIS 133
           L   + L+ L L  N L           L    C    L ++    F+A         ++
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESL-WVKSCSFTAACCSHFSSVLA 338

Query: 134 SLKGILRLDLSDNNIRGRIPEQV-----TNLTRLLTLRLQNNELTGR-IPDLSSSLKD-- 185
             + +L L +S+N +      ++        + L  L L + +++      L+++L    
Sbjct: 339 QNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANH 398

Query: 186 -LKELNLSNNEL 196
            L+EL+LSNN L
Sbjct: 399 SLRELDLSNNCL 410

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 57/233 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDV------IGKLK---- 410
           + LGKG+ G V+K++    G +VAVK++ DA       F+   D       I  L     
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSG 67

Query: 411 HPNVVKLRAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR 468
           H N+V L     A  ++   LV+DY+    LH+++  N       L+   +  +V    +
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILEPVHKQYVVYQLIK 120

Query: 469 GLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------ 522
            +  +H    +  + H ++K SN+LL+      ++DFGLS     ++ +           
Sbjct: 121 VIKYLH----SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 523 -------------------YKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRA 555
                              Y+APE      + ++  D++S G +L E+L G+ 
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 63/327 (19%), Positives = 116/327 (35%), Gaps = 79/327 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH--------- 411
             LG G   TV+ A  + +   VA+K ++      +   E   D I  L+          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 412 -----PNVVKLRAYYYAKEEKL----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
                 +++KL  ++  K        +V++ L   +L +L+      G IPL +  +IS 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYVKQISK 138

Query: 463 -VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC------ISDFGLSLLLN--- 512
            +L    GL  +H+      + H ++K  NVL++            I+D G +   +   
Sbjct: 139 QLL---LGLDYMHRR---CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 513 --PVQAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRA--PSQYPSPTRP 565
              +Q   R   Y++PE   V         AD++S   L+ E++TG              
Sbjct: 193 TNSIQT--RE--YRSPE---VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245

Query: 566 RVDEEEQAVDL----PKWVRSVVKEEWTAEVFDQEL-------LRYKNIEEELVSMLHVG 614
             D   Q ++L    P ++  +   ++T   F+          L++  +E+ L       
Sbjct: 246 DDDHIAQIIELLGELPSYL--LRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 303

Query: 615 -----------LACVVSQPEKRPTMAE 630
                         +   P KR     
Sbjct: 304 KDEAKEISDFLSPMLQLDPRKRADAGG 330

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 12/125 (9%)

Query: 88  LDQLRFLDLHDNRLNGTILP----LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
           L  +R+L L  N+L    +     LTN T L L           +  ++++LK    L L
Sbjct: 62  LPNVRYLALGGNKL--HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLK---ELVL 116

Query: 144 SDNNIRGRIPEQVTN-LTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
            +N ++  +P+ V + LT L  L L +N+L      +   L +L EL+LS N+L   +PE
Sbjct: 117 VENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-QSLPE 174

Query: 203 GLLKK 207
           G+  K
Sbjct: 175 GVFDK 179

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 38/125 (30%), Positives = 58/125 (46%), Gaps = 18/125 (14%)

Query: 88  LDQLRFLDLHDNRL----NGTILPLTNCTNLKLAYLSGNDFS---AEIPHQISSLKGILR 140
           L  L +L L  N+L    NG    LTN   L    L  N        +  ++++L     
Sbjct: 84  LTNLTYLILTGNQLQSLPNGVFDKLTNLKEL---VLVENQLQSLPDGVFDKLTNLT---Y 137

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPD-LSSSLKDLKELNLSNNELYG 198
           L+L+ N ++  +P+ V   LT L  L L  N+L   +P+ +   L  LK+L L  N+L  
Sbjct: 138 LNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL-K 194

Query: 199 RVPEG 203
            VP+G
Sbjct: 195 SVPDG 199

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 47.7 bits (114), Expect = 5e-06
 Identities = 39/116 (33%), Positives = 56/116 (48%), Gaps = 17/116 (14%)

Query: 88  LDQLRFLDLHDNRLNGTILP------LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILR 140
           L  L+ L L +N+L    LP      LTN T L    L+ N   + +P  +   L  +  
Sbjct: 108 LTNLKELVLVENQL--QSLPDGVFDKLTNLTYL---NLAHNQLQS-LPKGVFDKLTNLTE 161

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNN 194
           LDLS N ++  +PE V   LT+L  LRL  N+L   +PD     L  L+ + L +N
Sbjct: 162 LDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 25/117 (21%), Positives = 50/117 (42%), Gaps = 19/117 (16%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGIL-------R 140
           L+ +  +  +++ +  ++  +    N++   L GN        ++  +   L        
Sbjct: 40  LNSIDQIIANNSDIK-SVQGIQYLPNVRYLALGGN--------KLHDI-SALKELTNLTY 89

Query: 141 LDLSDNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
           L L+ N ++  +P  V   LT L  L L  N+L      +   L +L  LNL++N+L
Sbjct: 90  LILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQL 145

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 28/107 (26%), Positives = 45/107 (42%), Gaps = 10/107 (9%)

Query: 94  LDLHDNRLNGTILPLT----NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR 149
           L L+DN L    +          +L    L  N  +   P+       I  L L +N I+
Sbjct: 34  LLLNDNEL--GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91

Query: 150 GRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNN 194
             I  ++   L +L TL L +N+++  +   S   L  L  LNL++N
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 19/110 (17%)

Query: 110 NCTNLKLA-------------YLSGNDFSAEIPHQI-SSLKGILRLDLSDNNIRGRIPEQ 155
           +CT   L               L+ N+        +   L  +++L+L  N +   I   
Sbjct: 14  DCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPN 72

Query: 156 V-TNLTRLLTLRLQNNELTGRIPD-LSSSLKDLKELNLSNNELYGRVPEG 203
                + +  L+L  N++   I + +   L  LK LNL +N++   V  G
Sbjct: 73  AFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI-SCVMPG 120

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 49/229 (21%), Positives = 84/229 (36%), Gaps = 57/229 (24%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMD---------VIGKLKH 411
           + LG G  G V+ AV  D    VA+K++                         +I +L H
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDH 67

Query: 412 PNVVKLRAYYYAKEEKL--------------LVYDYLPNGSLHSLLHGNRGPGRIPLDWT 457
            N+VK+         +L              +V +Y+    L ++L         PL   
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG------PLLEE 120

Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC---ISDFGLS-LLLNP 513
                +    RGL  IH    +A V H ++K +N+ +  N       I DFGL+ ++   
Sbjct: 121 HARLFMYQLLRGLKYIH----SANVLHRDLKPANLFI--NTEDLVLKIGDFGLARIMDPH 174

Query: 514 VQAIARLGG------YKAPE-QAEVKRLSQKADVYSFGVLLLEVLTGRA 555
                 L        Y++P         ++  D+++ G +  E+LTG+ 
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 51/212 (24%), Positives = 96/212 (45%), Gaps = 35/212 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH--------- 411
           +++GKGS G V KA        VA+K +++     ++   Q  + I  L+H         
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
            NV+ +   +  +    + ++ L + +L+ L+  N+  G   L    + +  +   + L 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG-FSLPLVRKFAHSI--LQCLD 214

Query: 472 RIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNP-----VQAIARLGGY 523
            +H+     ++ H ++K  N+LL    ++G+  I DFG S   +      +Q  +R   Y
Sbjct: 215 ALHK----NRIIHCDLKPENILLKQQGRSGIKVI-DFGSSCYEHQRVYTYIQ--SRF--Y 265

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA 555
           +APE     R     D++S G +L E+LTG  
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGYP 297

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 32/122 (26%), Positives = 43/122 (35%), Gaps = 30/122 (24%)

Query: 88  LDQLRFLDLHDNRLNGTILP------LTNCTNLKLAYLSGNDFSAEIPHQISSL-KGIL- 139
           L  L+ L L  N+L    LP      LT  T L    L  N        Q++ L   +  
Sbjct: 63  LINLKELYLGSNQL--GALPVGVFDSLTQLTVL---DLGTN--------QLTVLPSAVFD 109

Query: 140 ------RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLS 192
                  L +  N +   +P  +  LT L  L L  N+L   IP  +   L  L    L 
Sbjct: 110 RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLF 167

Query: 193 NN 194
            N
Sbjct: 168 GN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 35/117 (29%), Positives = 48/117 (41%), Gaps = 15/117 (12%)

Query: 94  LDLHDNRLNGTILPLT---NCTNLKLAYLSGNDFS---AEIPHQISSLKGILRLDLSDNN 147
           L LHDN++  T L      +  NLK  YL  N        +   ++ L     LDL  N 
Sbjct: 45  LYLHDNQI--TKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT---VLDLGTNQ 99

Query: 148 IRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG 203
           +   +P  V   L  L  L +  N+LT  +P     L  L  L L  N+L   +P G
Sbjct: 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPHG 153

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 3/96 (3%)

Query: 112 TNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTN-LTRLLTLRLQNN 170
           TN ++ YL  N  +   P    SL  +  L L  N +   +P  V + LT+L  L L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 171 ELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
           +LT     +   L  LKEL +  N+L   +P G+ +
Sbjct: 99  QLTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIER 133

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 28/132 (21%), Positives = 46/132 (34%), Gaps = 29/132 (21%)

Query: 90  QLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAE-IPHQISSLK----G 137
            +  L+L  N L+          L     T   L  L  NDFS++       +       
Sbjct: 81  NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVL-DLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 138 ILRLDLSDNNIRGRIPEQVTNL--------TRLLTLRLQNNELTGR-IPDLSSSLKD--- 185
           I  L+L  N++     +    L          + +L L+ N L  +   +L+  L     
Sbjct: 140 ITSLNLRGNDLG---IKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196

Query: 186 -LKELNLSNNEL 196
            +  L+LS N L
Sbjct: 197 SVTSLDLSANLL 208

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 25/137 (18%), Positives = 45/137 (32%), Gaps = 29/137 (21%)

Query: 85  LSLLDQLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAEIPHQISSL-- 135
            S+   +  LDL  N L              T  +   L  LSGN    +   ++  +  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSL-NLSGNSLGFKNSDELVQILA 76

Query: 136 ---KGILRLDLSDNNIRGRIPEQVTNL--------TRLLTLRLQNNELTGR-IPDLSSSL 183
                +  L+LS N +     +    L          +  L L  N+ + +   +   + 
Sbjct: 77  AIPANVTSLNLSGNFLS---YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 184 KD----LKELNLSNNEL 196
            +    +  LNL  N+L
Sbjct: 134 SNLPASITSLNLRGNDL 150

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.9 bits (117), Expect = 3e-06
 Identities = 28/132 (21%), Positives = 43/132 (32%), Gaps = 29/132 (21%)

Query: 90  QLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAEIPHQISSL-----KG 137
            +  L+L  N L          IL         L  LSGN  S +   ++          
Sbjct: 52  SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSL-NLSGNFLSYKSSDELVKTLAAIPFT 110

Query: 138 ILRLDLSDNNIRGRIPEQVTNL--------TRLLTLRLQNNELTGR-IPDLSSSLKD--- 185
           I  LDL  N+      +  +            + +L L+ N+L  +   +L   L     
Sbjct: 111 ITVLDLGWNDFS---SKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167

Query: 186 -LKELNLSNNEL 196
            +  LNL  N L
Sbjct: 168 NVNSLNLRGNNL 179

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 20/131 (15%), Positives = 42/131 (32%), Gaps = 28/131 (21%)

Query: 91  LRFLDLHDNRLNGT-----ILPLTNCTNLKLAYLSGNDFS-------AEIPHQISSLKGI 138
           +  L+L  N L+G       L   +  +L+  YL  +            +     +++ I
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286

Query: 139 LRLDLSDNNIRGRIPEQVTNLTRLL--------TLRLQNNELT-----GRIPDLSSSLKD 185
           + +D +   I    P     ++ L+           L N  L          +  +   +
Sbjct: 287 ILVDKNGKEIH---PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDE 343

Query: 186 LKELNLSNNEL 196
           L+E   +   L
Sbjct: 344 LRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 24/135 (17%), Positives = 41/135 (30%), Gaps = 35/135 (25%)

Query: 90  QLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAE--------IPHQISS 134
            +  LDL  N  +                +   L  L GND   +        +    ++
Sbjct: 110 TITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL-NLRGNDLGIKSSDELIQILAAIPAN 168

Query: 135 LKGILRLDLSDNNIRGRIPEQVTNL--------TRLLTLRLQNNELTGR-IPDLSSSLKD 185
           +     L+L  NN+     +    L          + +L L  N L  +   +L+     
Sbjct: 169 VN---SLNLRGNNLA---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS 222

Query: 186 ----LKELNLSNNEL 196
               +  LNL  N L
Sbjct: 223 IPNHVVSLNLCLNCL 237

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 25/139 (17%), Positives = 46/139 (33%), Gaps = 28/139 (20%)

Query: 90  QLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAEIPHQISSL-----KG 137
            +  L+L  N L          IL         L  L GN+ +++   +++         
Sbjct: 139 SITSLNLRGNDLGIKSSDELIQILAAIPANVNSL-NLRGNNLASKNCAELAKFLASIPAS 197

Query: 138 ILRLDLSDNNIRGRIPEQVTNL--------TRLLTLRLQNNELTGR-IPDLSSSLKD--- 185
           +  LDLS N +     +    L          +++L L  N L G  + +L         
Sbjct: 198 VTSLDLSANLLG---LKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254

Query: 186 LKELNLSNNELYGRVPEGL 204
           L+ + L  + +     E  
Sbjct: 255 LQTVYLDYDIVKNMSKEQC 273

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 28/134 (20%), Positives = 48/134 (35%), Gaps = 23/134 (17%)

Query: 85  LSLLDQLRFLDLHDNRLN----GTIL--PLTNCTNLKLAYLSGNDFSAE----IPHQISS 134
                 L  + +  N +       +L   L  C  LK+  L  N F+      +   + S
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242

Query: 135 LKGILRLDLSDNNIR-------GRIPEQVTNLTRLLTLRLQNNELTGR-IPDLSSSLKD- 185
              +  L L+D  +             ++ N+  L TLRLQ NE+    +  L + + + 
Sbjct: 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNEIELDAVRTLKTVIDEK 301

Query: 186 ---LKELNLSNNEL 196
              L  L L+ N  
Sbjct: 302 MPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 28/129 (21%), Positives = 41/129 (31%), Gaps = 23/129 (17%)

Query: 91  LRFLDLHDNRLNGT-----ILPLTNCTNLKLAYLSGNDFSAE----IPHQISSLKGILRL 141
           +    L  + +           L    ++K   LSGN    E    +   I+S K +   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 142 DLSDNNIRGRIPEQVTNL----------TRLLTLRLQNNELTGR-IPDLSSSLKD---LK 187
           + SD        E    L           +L T+RL +N         L   L     L+
Sbjct: 66  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125

Query: 188 ELNLSNNEL 196
            L L NN L
Sbjct: 126 HLYLHNNGL 134

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 25/139 (17%), Positives = 41/139 (29%), Gaps = 27/139 (19%)

Query: 85  LSLLDQLRFLDLHDNRL-NGTILP----LTNCTNLKLAYLSGNDFSAE----------IP 129
           L    +L  + L DN        P    L+  T L+  YL  N    +            
Sbjct: 90  LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149

Query: 130 HQISSLKG---ILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELT--GRIPDLS 180
                 K    +  +    N +         +   +   L T+++  N +   G    L 
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209

Query: 181 SSLKD---LKELNLSNNEL 196
             L     LK L+L +N  
Sbjct: 210 EGLAYCQELKVLDLQDNTF 228

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.1 bits (122), Expect = 7e-07
 Identities = 63/363 (17%), Positives = 113/363 (31%), Gaps = 107/363 (29%)

Query: 363 MLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDV-IGKLKHPN---V 414
            LG G   TV+ +  +     VA+K +K A      A  E      V       PN   V
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103

Query: 415 VKLRAYYYAKEEK----LLVYDYLPNG-SLHSLLHGNRGPGRIPLDWTTRISLVLGAARG 469
           V+L   +           +V++ L  G  L   +  +     +PL    +I   +   +G
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNY-QGLPLPCVKKIIQQV--LQG 158

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLL----------------------------------- 494
           L  +H +    ++ H ++K  N+LL                                   
Sbjct: 159 LDYLHTK---CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 495 --------------DKNGVACISDFGLSLLLN-----PVQAIARLGGYKAPEQAEVKRLS 535
                          +     I+D G +  ++      +Q       Y++ E       +
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSLEVLIGSGYN 271

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE--EQAVDL-----PKWVRSVVKEEW 588
             AD++S   +  E+ TG    +  S      DE+     ++L      K +      ++
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKY 328

Query: 589 TAEVFDQ--ELLRYKNI----------------EEELVSMLHVGLACVVSQPEKRPTMAE 630
           + E F +  +L     +                +EE        L  +   PEKR T AE
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE 388

Query: 631 VAK 633
             +
Sbjct: 389 CLR 391

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 32/106 (30%), Positives = 49/106 (46%), Gaps = 4/106 (3%)

Query: 94  LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP 153
           L L  N+       L+N  +L L  LS N  S       S++  +L L LS N +R  IP
Sbjct: 36  LYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIP 94

Query: 154 EQVTN-LTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELY 197
            +  + L  L  L L  N+++  +P+ + + L  L  L +  N LY
Sbjct: 95  PRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLY 139

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 44.2 bits (105), Expect = 4e-05
 Identities = 36/128 (28%), Positives = 51/128 (39%), Gaps = 18/128 (14%)

Query: 57  TGVVCSPKSERVV---------SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP 107
           T V CS K  +V+          L L  +        LS    L  +DL +NR+  + L 
Sbjct: 13  TVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI--STLS 70

Query: 108 ---LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDNNIRGRIPEQV-TNLTRL 162
               +N T L    LS N     IP +    LK +  L L  N+I   +PE    +L+ L
Sbjct: 71  NQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSAL 128

Query: 163 LTLRLQNN 170
             L +  N
Sbjct: 129 SHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 43.1 bits (102), Expect = 8e-05
 Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 2/68 (2%)

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR 199
            L L  N     +P++++N   L  + L NN ++       S++  L  L LS N L   
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RC 92

Query: 200 VPEGLLKK 207
           +P      
Sbjct: 93  IPPRTFDG 100

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 45/157 (28%), Positives = 67/157 (42%), Gaps = 27/157 (17%)

Query: 57  TGVVCSPKSERVV---------SLSLPSHSLRG-PIAPLSLLDQLRFLDLHDNRLNGTIL 106
           T V C  +    V          L L ++SL+  P      L  L  L L  N+L    L
Sbjct: 10  TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL--QSL 67

Query: 107 P------LTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDNNIRGRIPEQV-TN 158
           P      LT+ T L    LS N   + +P+ +   L  +  L L+ N ++  +P+ V   
Sbjct: 68  PNGVFNKLTSLTYL---NLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDK 122

Query: 159 LTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNN 194
           LT+L  LRL  N+L   +PD     L  L+ + L +N
Sbjct: 123 LTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 29/100 (29%), Positives = 42/100 (42%), Gaps = 6/100 (6%)

Query: 109 TNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTN-LTRLLTLRL 167
              T L L     N   +        L  + +L L  N ++  +P  V N LT L  L L
Sbjct: 28  AQTTYLDLET---NSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNL 83

Query: 168 QNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
             N+L      +   L  LKEL L+ N+L   +P+G+  K
Sbjct: 84  STNQLQSLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDK 122

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.7 bits (115), Expect = 3e-06
 Identities = 29/186 (15%), Positives = 52/186 (27%), Gaps = 45/186 (24%)

Query: 364 LGKGSLGTVYKAVLDDGGIVAVKRL-----KDANPCARKEFEQYMDVIGKLK-------- 410
           +G+G  G V++ +  D   VA+K +        N   +K FE+ +  I   K        
Sbjct: 28  IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86

Query: 411 ----HPNVVKLRAYY----YAKEEKLLVYDYLP--NGSLHSLLHGNRGP----------- 449
                   + L + +          L  +D+     GS +      +             
Sbjct: 87  VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146

Query: 450 -------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI 502
                          T  S++      LA            H ++   NVLL K  +  +
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKL 203

Query: 503 SDFGLS 508
                 
Sbjct: 204 HYTLNG 209

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.9 bits (110), Expect = 1e-05
 Identities = 20/130 (15%), Positives = 45/130 (34%), Gaps = 20/130 (15%)

Query: 86  SLLDQLRFLDLHDNRLN----------GTILPLTNCTNLKLAYLSGNDFSAEIPHQISS- 134
           S L  L  L L+    +            +       NLK   +   +    +       
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 135 --LKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELTGR-IPDLSSSLKDLK 187
             L  +  +D+S   +       + + V  +  L  + ++ N L+     +L  SL    
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPM-- 333

Query: 188 ELNLSNNELY 197
           ++++S+++ Y
Sbjct: 334 KIDVSDSQEY 343

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 1e-04
 Identities = 23/132 (17%), Positives = 43/132 (32%), Gaps = 19/132 (14%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTIL------PLTNCTNLKLAYLSGNDFSAEIPHQISSL-- 135
                  L+ L++    L  +++       L N   L L     +       +    L  
Sbjct: 188 GKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247

Query: 136 ----KGILRLDLSDNNIRGRIPE---QVTNLTRLLTLRLQNNELTGR----IPDLSSSLK 184
                 +  L + D   +  + E   +   L +L T+ +    LT      + D    +K
Sbjct: 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307

Query: 185 DLKELNLSNNEL 196
            LK +N+  N L
Sbjct: 308 HLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.8 bits (102), Expect = 1e-04
 Identities = 22/138 (15%), Positives = 43/138 (31%), Gaps = 17/138 (12%)

Query: 74  PSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQI 132
            S   +  ++P L  +  L  L +     N   +      NLK   +        +   I
Sbjct: 156 ISWIEQVDLSPVLDAMPLLNNLKIKGT--NNLSIGKKPRPNLKSLEIISGGLPDSVVEDI 213

Query: 133 --SSLKGILRLDL---SDNNIRGRIPEQV------TNLTRLLTLRLQNNELTGRIPDL-- 179
             S L  + +L L    ++                     L  L + + E    + ++  
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273

Query: 180 -SSSLKDLKELNLSNNEL 196
            S  L  L+ +++S   L
Sbjct: 274 ESDILPQLETMDISAGVL 291

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 25/131 (19%), Positives = 46/131 (35%), Gaps = 20/131 (15%)

Query: 85  LSLLDQLRFLDLHDNRLN-------GTILPLTNCTNLKLAYLSGNDFSAE----IPHQIS 133
           L +  + R L L  N L          +L L +   +    LS N  +A     +   ++
Sbjct: 122 LPVFLRARKLGLQLNSLGPEACKDLRDLL-LHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180

Query: 134 SLKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELTGR-IPDLSSSLKD--- 185
               +  L L    +       +  Q+    +L  L +  N         L+ + ++   
Sbjct: 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPS 240

Query: 186 LKELNLSNNEL 196
           L+ L+L  NEL
Sbjct: 241 LELLHLYFNEL 251

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 27/136 (19%), Positives = 43/136 (31%), Gaps = 27/136 (19%)

Query: 78  LRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKG 137
            R  + P  LLD L F                  ++L+   L+G   +   P + + +  
Sbjct: 42  GRQVLPPSELLDHLFFH----YEFQNQRFSAEVLSSLRQLNLAGVRMT---PVKCTVVAA 94

Query: 138 ILR--------LDLSDNNI----RGRIPEQVTNLTRLLTLRLQNNELTGR-IPDLSSSLK 184
           +L         ++L+   +       +            L LQ N L      DL   L 
Sbjct: 95  VLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRAR---KLGLQLNSLGPEACKDLRDLLL 151

Query: 185 D----LKELNLSNNEL 196
                +  L LSNN L
Sbjct: 152 HDQCQITTLRLSNNPL 167

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 41.6 bits (98), Expect = 6e-04
 Identities = 26/142 (18%), Positives = 51/142 (35%), Gaps = 25/142 (17%)

Query: 71  LSLPSH-----SLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGND-- 123
           L    +      L  PI  L  L+  + +     +L   +LP +   +    +    +  
Sbjct: 6   LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQR 65

Query: 124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLL--------TLRLQNNELTGR 175
           FSAE+      L  + +L+L+   +    P + T +  +L         + L + +L   
Sbjct: 66  FSAEV------LSSLRQLNLAGVRMT---PVKCTVVAAVLGSGRHALDEVNLASCQLDPA 116

Query: 176 -IPDLSSSLKDLKELNLSNNEL 196
            +  L       ++L L  N L
Sbjct: 117 GLRTLLPVFLRARKLGLQLNSL 138

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 11/107 (10%)

Query: 94  LDLHDNRLNGTILPLT---NCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDNNIR 149
           L+L  N+L    LP       T L    LS N   + +P  +   L  +  L L +N ++
Sbjct: 33  LELESNKL--QSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ 89

Query: 150 GRIPEQV-TNLTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNN 194
             +P  V   LT+L  L L  N+L   +PD     L  L+++ L  N
Sbjct: 90  -SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 45.2 bits (106), Expect = 7e-05
 Identities = 29/162 (17%), Positives = 56/162 (34%), Gaps = 50/162 (30%)

Query: 97  HDNRLNGTILPLTN-CTNLKLAYLSGNDFSAEIPHQISSLKGILR------------LDL 143
           + N     +  L      +   + S +D S+ I  +I S++  LR            L L
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250

Query: 144 SDN----------NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELN--L 191
             N          N+  +I         LLT R    ++T  +   +++   L   +  L
Sbjct: 251 -LNVQNAKAWNAFNLSCKI---------LLTTR--FKQVTDFLSAATTTHISLDHHSMTL 298

Query: 192 SNNELYGRVPEGLLKKFGEQSFIGNEGL----CGSSPLPACS 229
           + +E+     + LL K+ +      + L      ++P    S
Sbjct: 299 TPDEV-----KSLLLKYLDCRP---QDLPREVLTTNPR-RLS 331

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 3e-04
 Identities = 47/228 (20%), Positives = 78/228 (34%), Gaps = 49/228 (21%)

Query: 18  VSSSHPNDTDAL---TLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLP 74
           +++     TD L   T   +  D H   L+  +        +    C P+        LP
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK-YLD--CRPQD-------LP 319

Query: 75  SHSLRG-PIAPLSLL-DQLR-FLDLHDNRLNGTILPLTNCTNLKLAYLSGNDF------- 124
              L   P   LS++ + +R  L   DN  +     LT      L  L   ++       
Sbjct: 320 REVLTTNPRR-LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378

Query: 125 -----SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTN-LTRLLTLRLQNNELTGRIPD 178
                SA IP  +  L  ++  D+  ++        V N L +   +  Q  E T  IP 
Sbjct: 379 SVFPPSAHIPTIL--L-SLIWFDVIKSD-----VMVVVNKLHKYSLVEKQPKESTISIPS 430

Query: 179 LSSSLK----DLKELNLSNNELY----GRVPEGLLKKFGEQ---SFIG 215
           +   LK    +   L+ S  + Y        + L+  + +Q   S IG
Sbjct: 431 IYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 48/212 (22%), Positives = 90/212 (42%), Gaps = 33/212 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH--------- 411
            ++GKGS G V KA    +   VA+K +K+     +    Q    +  L+          
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMK 115

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
             +V L+ ++  +    LV++ L + +L+ LL      G + L+ T + +  +     L 
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRG-VSLNLTRKFAQQM--CTALL 171

Query: 472 RIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNP-----VQAIARLGGY 523
            +        + H ++K  N+LL    ++ +  + DFG S  L       +Q+  R   Y
Sbjct: 172 FLATP--ELSIIHCDLKPENILLCNPKRSAIKIV-DFGSSCQLGQRIYQYIQS--RF--Y 224

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA 555
           ++PE           D++S G +L+E+ TG  
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 41.0 bits (96), Expect = 8e-04
 Identities = 29/144 (20%), Positives = 63/144 (43%), Gaps = 7/144 (4%)

Query: 57  TGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNL 114
             V     S+ V++   P   +  P+A      +++ +DL ++ +  + L   L+ C+ L
Sbjct: 61  PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKL 120

Query: 115 KLAYLSGNDFSAEIPHQISSLKGILRLDLSD-NNIRGRIPEQV-TNLTRLLTLRLQN-NE 171
           +   L G   S  I + ++    ++RL+LS  +       + + ++ +RL  L L    +
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD 180

Query: 172 LT--GRIPDLSSSLKDLKELNLSN 193
            T       ++   + + +LNLS 
Sbjct: 181 FTEKHVQVAVAHVSETITQLNLSG 204

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	670
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.91
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.9
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.89
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.87
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.85
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.84
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.83
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.79
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.79
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.78
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.77
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.77
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.77
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.76
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.76
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.76
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.75
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.75
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.74
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.74
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.73
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.73
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.73
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.73
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.72
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.72
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.72
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.72
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.72
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.72
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.72
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.71
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.71
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.71
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.71
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.7
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.69
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.69
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.69
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.68
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.68
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.68
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.68
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.68
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.67
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.67
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.67
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.67
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.66
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.66
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.65
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.65
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.65
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.63
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.63
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.63
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.63
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.63
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.62
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.62
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.62
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.61
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.6
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.6
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.6
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.6
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.59
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.58
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.58
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.58
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.58
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.57
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.57
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.57
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.57
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.57
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.57
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.56
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.56
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.56
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.55
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.55
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.55
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.55
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.55
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.54
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.54
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.53
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.53
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.53
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.53
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.53
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.52
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.51
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.51
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.51
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.5
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.5
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.5
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.49
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.48
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.48
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.48
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.47
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.46
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.45
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.44
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.42
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.4
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.38
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.36
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.36
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.36
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.34
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.32
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.28
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.28
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.26
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.23
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.03
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.95
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.9
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.82
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.82
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.68
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.56
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.56
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.54
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.53
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.53
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.37
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.29
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.25
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.24
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.24
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.17
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.16
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.07
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.06
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.01
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.88
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.8
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.44
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.18
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.06
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.04
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.0
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.91
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.9
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.89
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.86
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.83
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.78
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.77
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.74
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.74
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.66
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.57
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.53
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.33
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.31
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.17
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.03
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.42
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.05
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	94.09
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	92.73
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.98
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.94
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	86.96
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.13
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	80.71

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.2e-53  Score=437.75  Aligned_cols=252  Identities=23%  Similarity=0.375  Sum_probs=202.2

Q ss_pred             HhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.||+|+||+||+|+++      +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..+||||||
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~  125 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM  125 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            467999999999999864      47899999999877777889999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          435 PNGSLHSLLHGNRGP----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      ++|+|.++++.....          ...+++|..++.|+.|||+||+|||+.    +||||||||+||||++++.+||+|
T Consensus       126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLKp~NILl~~~~~~Ki~D  201 (329)
T 4aoj_A          126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL----HFVHRDLATRNCLVGQGLVVKIGD  201 (329)
T ss_dssp             TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecccccHhhEEECCCCcEEEcc
Confidence            999999999865321          123689999999999999999999998    999999999999999999999999


Q ss_pred             cccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchh
Q 036639          505 FGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLP  577 (670)
Q Consensus       505 FG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  577 (670)
                      ||+++.....      ....+|+.|||||++.+..++.++|||||||++|||+| |+.||...+              ..
T Consensus       202 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------------~~  267 (329)
T 4aoj_A          202 FGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------------NT  267 (329)
T ss_dssp             CC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------------HH
T ss_pred             cccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------------HH
Confidence            9999876432      23457788999999999999999999999999999999 899996531              11


Q ss_pred             HHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       578 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ..+.........        ......   ..++.+|+.+||+.||++||||+||+++|+.+...
T Consensus       268 ~~~~~i~~g~~~--------~~p~~~---~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          268 EAIDCITQGREL--------ERPRAC---PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHHHHTCCC--------CCCTTC---CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHcCCCC--------CCcccc---cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            112222111110        011112   23466778899999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-53  Score=434.03  Aligned_cols=253  Identities=23%  Similarity=0.403  Sum_probs=206.0

Q ss_pred             HHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.||+|+||+||+|++.      +++.||||+++.......++|.+|++++++++|||||+++|+|.+.+..++||||
T Consensus        17 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey   96 (299)
T 4asz_A           17 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY   96 (299)
T ss_dssp             EEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             EeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEc
Confidence            3467999999999999864      4788999999987776778999999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          434 LPNGSLHSLLHGNR--------GPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       434 ~~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      |++|+|.++++...        ......++|..++.|+.||++||+|||+.    +|+||||||+||||++++.+||+||
T Consensus        97 ~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDlKp~NILl~~~~~~Ki~DF  172 (299)
T 4asz_A           97 MKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ----HFVHRDLATRNCLVGENLLVKIGDF  172 (299)
T ss_dssp             CTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             CCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccCHhhEEECCCCcEEECCc
Confidence            99999999997642        12234699999999999999999999998    9999999999999999999999999


Q ss_pred             ccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhH
Q 036639          506 GLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       506 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      |+|+......      ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||...+              ...
T Consensus       173 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------------~~~  238 (299)
T 4asz_A          173 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------------NNE  238 (299)
T ss_dssp             SCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------------HHH
T ss_pred             ccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------------HHH
Confidence            9998764432      2346778999999999999999999999999999999 899996531              111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .+......... .       ....   ...++.+++.+||+.||++|||++||++.|+++...
T Consensus       239 ~~~~i~~~~~~-~-------~p~~---~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          239 VIECITQGRVL-Q-------RPRT---CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHHHTCCC-C-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCC-C-------CCcc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            22222221110 0       0111   223466778899999999999999999999988654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-52  Score=430.55  Aligned_cols=249  Identities=25%  Similarity=0.325  Sum_probs=201.8

Q ss_pred             HhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..++||||
T Consensus        31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey  110 (308)
T 4gt4_A           31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY  110 (308)
T ss_dssp             EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence            467999999999999863      46789999997543 33568899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEE
Q 036639          434 LPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI  502 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl  502 (670)
                      |++|+|.++|+.....           ....++|..++.|+.|||+||+|||+.    +||||||||+||||++++++||
T Consensus       111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~~~~Ki  186 (308)
T 4gt4_A          111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH----HVVHKDLATRNVLVYDKLNVKI  186 (308)
T ss_dssp             CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEE
T ss_pred             CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCccccceEECCCCCEEE
Confidence            9999999999754211           123589999999999999999999998    9999999999999999999999


Q ss_pred             EecccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccc
Q 036639          503 SDFGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVD  575 (670)
Q Consensus       503 ~DFG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  575 (670)
                      +|||+++.....      ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||...+              
T Consensus       187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------------  252 (308)
T 4gt4_A          187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------------  252 (308)
T ss_dssp             CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------------
T ss_pred             CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------------
Confidence            999999876432      23456778999999999999999999999999999999 899996541              


Q ss_pred             hhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       576 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ....+........ ..          ....+...+.+++.+||+.||++||||+||+++|+..
T Consensus       253 ~~~~~~~i~~~~~-~~----------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 NQDVVEMIRNRQV-LP----------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHHHTTCC-CC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHHcCCC-CC----------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1111211111111 10          1112234566788899999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5e-52  Score=425.05  Aligned_cols=252  Identities=26%  Similarity=0.379  Sum_probs=198.0

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|++++  .||||+++..  .....++|.+|++++++++|||||++++++.+ +..+||||||++|
T Consensus        40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gG  116 (307)
T 3omv_A           40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGS  116 (307)
T ss_dssp             EEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSC
T ss_pred             EeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCC
Confidence            35789999999999999753  5999999754  33456789999999999999999999998754 5689999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.++++...    ..++|..+..|+.|||+||+|||+.    +||||||||+||||++++++||+|||+|+....    
T Consensus       117 sL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~----~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~  188 (307)
T 3omv_A          117 SLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAK----NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS  188 (307)
T ss_dssp             BHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred             CHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence            9999997643    2599999999999999999999998    999999999999999999999999999987643    


Q ss_pred             --cccccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          514 --VQAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                        .....||+.|||||++.+   ..|+.++|||||||++|||+||+.||...+.              ...+...+....
T Consensus       189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------------~~~~~~~~~~~~  254 (307)
T 3omv_A          189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------------RDQIIFMVGRGY  254 (307)
T ss_dssp             -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------------HHHHHHHHHTTC
T ss_pred             eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------------HHHHHHHHhcCC
Confidence              223568899999999853   4689999999999999999999999965321              111222222211


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ..    +....  ....+...+.+++.+||+.||++||||.||+++|+.++...
T Consensus       255 ~~----p~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          255 AS----PDLSK--LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             CC----CCSTT--SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             CC----CCccc--ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            11    00000  01112234666778999999999999999999999887543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1e-51  Score=425.52  Aligned_cols=270  Identities=25%  Similarity=0.326  Sum_probs=201.6

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC----eeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE----EKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||+|+++ |+.||||+++.... ....++.|+..+.+++|||||+++++|.+.+    ..|||||||++
T Consensus         8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~   85 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence            467999999999999984 89999999975432 2223345566667889999999999998764    57999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC----CCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+|.++++..      .++|..+.+++.|+++||+|||+.+    +.++|+||||||+|||||.++++||+|||+|+...
T Consensus        86 gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            9999999865      4899999999999999999999762    34589999999999999999999999999998764


Q ss_pred             ccc--------cccccCcccCccccccC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          513 PVQ--------AIARLGGYKAPEQAEVK------RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       513 ~~~--------~~~~~~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      ...        ...||+.|||||++.+.      .++.|+|||||||++|||+||+.||.....................
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            321        24588899999998654      4678999999999999999999888654332221111111111112


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .+.....+..    +++.+.......+....+.+++.+||+.||++||||.||+++|+++..++
T Consensus       240 ~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~  299 (303)
T 3hmm_A          240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  299 (303)
T ss_dssp             HHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence            2222222111    11111111122345567888999999999999999999999999997654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-51  Score=426.69  Aligned_cols=253  Identities=23%  Similarity=0.241  Sum_probs=203.3

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .++||+|+||+||+|+. .+|+.||||+++....     ..+|+.++++++|||||++++++.+.+..|||||||++|+|
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  137 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL  137 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcH
Confidence            46799999999999996 4699999999975432     24699999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccCcc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPV----  514 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~----  514 (670)
                      .++++...     .+++..+..++.||+.||+|||++    +||||||||+||||+.++ ++||+|||+|+.....    
T Consensus       138 ~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          138 GQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTR----RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99998653     599999999999999999999998    999999999999999998 6999999999876432    


Q ss_pred             -----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          515 -----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       515 -----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                           ....||+.|||||++.+..|+.++|||||||++|||+||+.||...+...           +..   ........
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----------~~~---~i~~~~~~  274 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----------LCL---KIASEPPP  274 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----------CHH---HHHHSCCG
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----------HHH---HHHcCCCC
Confidence                 22468999999999999999999999999999999999999997643221           111   11111110


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCCCCccc
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYD  650 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~~~  650 (670)
                      ..      ...+...+   .+.+++.+||+.||++|||+.|++++|.....+......+|-
T Consensus       275 ~~------~~~~~~s~---~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~  326 (336)
T 4g3f_A          275 IR------EIPPSCAP---LTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWK  326 (336)
T ss_dssp             GG------GSCTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSS
T ss_pred             ch------hcCccCCH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCc
Confidence            00      01112223   345566799999999999999999999888766544444443

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.9e-51  Score=425.96  Aligned_cols=241  Identities=23%  Similarity=0.370  Sum_probs=200.1

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||+++++|.+.+..|||||||++|+|
T Consensus        79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L  158 (346)
T 4fih_A           79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  158 (346)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred             eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence            357999999999999964 7999999999765555567789999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~  515 (670)
                      .+++...      .+++..+..++.||+.||+|||++    +||||||||+||||+.++.+||+|||+|+.....    .
T Consensus       159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            9999764      389999999999999999999998    9999999999999999999999999999876432    3


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...||+.|||||++.+..|+.++|||||||++|||+||+.||...+              ....+.... .....     
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------------~~~~~~~i~-~~~~~-----  288 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------------PLKAMKMIR-DNLPP-----  288 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHH-HSSCC-----
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------------HHHHHHHHH-cCCCC-----
Confidence            4678999999999999999999999999999999999999996531              111111111 11110     


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .........+   .+.+++.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~~~s~---~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          289 RLKNLHKVSP---SLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCSCGGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCccccCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111112223   34556679999999999999999886

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.5e-51  Score=425.75  Aligned_cols=243  Identities=21%  Similarity=0.386  Sum_probs=196.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||+||+|+. .+|+.||||+++..  .....+.+.+|++++++++|||||++++++.+.+..|||||||++
T Consensus        28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~g  107 (350)
T 4b9d_A           28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG  107 (350)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            357899999999999995 47999999999754  333567899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.+++...+   ...+++..+..|+.||+.||+|||++    +|+||||||+||||++++.+||+|||+|+.....  
T Consensus       108 g~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          108 GDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDR----KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             CcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            99999997543   22578999999999999999999998    9999999999999999999999999999987653  


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....||+.|||||++.+..|+.++|||||||++|||+||+.||...              .....+........... 
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~--------------~~~~~~~~i~~~~~~~~-  245 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG--------------SMKNLVLKIISGSFPPV-  245 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS--------------SHHHHHHHHHHTCCCCC-
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc--------------CHHHHHHHHHcCCCCCC-
Confidence              2456899999999999999999999999999999999999999753              22223333333322110 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .....+   ++.+++.+||+.||++|||++|+++|
T Consensus       246 -------~~~~s~---~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          246 -------SLHYSY---DLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------CccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   011222   34566779999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-50  Score=411.58  Aligned_cols=242  Identities=24%  Similarity=0.387  Sum_probs=192.7

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEe----CCeeEEEEecc
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA----KEEKLLVYDYL  434 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~  434 (670)
                      +.||+|+||+||+|... +++.||||++...  .....+.|.+|++++++++|||||+++++|.+    ....|||||||
T Consensus        32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~  111 (290)
T 3fpq_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence            56999999999999964 6899999999643  33356789999999999999999999999876    34579999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccCc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNP  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~  513 (670)
                      ++|+|.++++...     .+++..+..++.||+.||+|||++  .++|+||||||+||||+. ++.+||+|||+|+....
T Consensus       112 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~--~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          112 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS--SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC--CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999998654     589999999999999999999987  124999999999999984 79999999999986543


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....||+.|||||++.+ .|+.++|||||||++|||+||+.||....             ............ ....
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-------------~~~~~~~~i~~~-~~~~  249 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------------NAAQIYRRVTSG-VKPA  249 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------------SHHHHHHHHTTT-CCCG
T ss_pred             CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------------cHHHHHHHHHcC-CCCC
Confidence              334678999999999864 69999999999999999999999996431             111111221111 1111


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .++      ....+   ++.+++.+||+.||++|||++|+++|
T Consensus       250 ~~~------~~~~~---~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          250 SFD------KVAIP---EVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGG------GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCC------ccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111      11112   35567779999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.3e-50  Score=429.81  Aligned_cols=241  Identities=23%  Similarity=0.370  Sum_probs=200.9

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|+||+||+|+.. +|+.||||++........+.+.+|++++++++|||||+++++|.+.+..|||||||++|+|
T Consensus       156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L  235 (423)
T 4fie_A          156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  235 (423)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence            467999999999999964 7999999999866555667899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----cc
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----VQ  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~~  515 (670)
                      .++++..      .+++..+..++.||+.||+|||++    +||||||||+||||+.+|.+||+|||+|+.+..    ..
T Consensus       236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~----~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQ----GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            9999764      389999999999999999999998    999999999999999999999999999987643    23


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...||+.|||||++.+..|+.++|||||||++|||++|+.||...+              ....+..+. ....     +
T Consensus       306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------------~~~~~~~i~-~~~~-----~  365 (423)
T 4fie_A          306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------------PLKAMKMIR-DNLP-----P  365 (423)
T ss_dssp             CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHH-HSCC-----C
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------------HHHHHHHHH-cCCC-----C
Confidence            4678999999999999999999999999999999999999996531              111111111 1111     0


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .+.......+   .+.+++.+||+.||++|||++|+++|
T Consensus       366 ~~~~~~~~s~---~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          366 RLKNLHKVSP---SLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCSCTTSSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCcccccCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            1111122233   34556669999999999999999886

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.9e-50  Score=404.40  Aligned_cols=239  Identities=23%  Similarity=0.343  Sum_probs=186.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++++..   ....+.+.+|++++++++|||||++++++.+.+..|+||||+ 
T Consensus        17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-   95 (275)
T 3hyh_A           17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-   95 (275)
T ss_dssp             EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-
Confidence            457899999999999995 579999999997542   234567999999999999999999999999999999999999 


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||++    +|+||||||+|||+++++.+||+|||+|+..... 
T Consensus        96 ~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           96 GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH----KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            689999997654     599999999999999999999998    9999999999999999999999999999876542 


Q ss_pred             --ccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        ....||+.|||||++.+..+ +.++||||+||++|||+||+.||...              .....+.........  
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------------~~~~~~~~i~~~~~~--  230 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------------SIPVLFKNISNGVYT--  230 (275)
T ss_dssp             --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------------SHHHHHHHHHHTCCC--
T ss_pred             ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------------CHHHHHHHHHcCCCC--
Confidence              34678999999999998876 58999999999999999999999643              122222222222111  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       +      .....+   .+.+++.+||+.||++|||++|+++|
T Consensus       231 -~------p~~~s~---~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          231 -L------PKFLSP---GAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -C------CTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -C------CCCCCH---HHHHHHHHHccCChhHCcCHHHHHcC
Confidence             0      111223   34556779999999999999999985

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.9e-51  Score=416.00  Aligned_cols=241  Identities=22%  Similarity=0.304  Sum_probs=200.0

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||+||+|+. .+|+.||||++.+..   ....+.+.+|++++++++|||||++++++.+.+..|+|||||
T Consensus        35 ~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~  114 (311)
T 4aw0_A           35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA  114 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence            3467899999999999995 579999999997431   224578999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.++++...     .+++.....++.||+.||+|||++    +|+||||||+|||++.++.+||+|||+|+.+.. 
T Consensus       115 ~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          115 KNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             TTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999998654     589999999999999999999998    999999999999999999999999999987643 


Q ss_pred             -----cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          514 -----VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       514 -----~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                           .....||+.|||||++.+..|+.++||||+||++|||+||+.||...              +....+........
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~--------------~~~~~~~~i~~~~~  251 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------------NEGLIFAKIIKLEY  251 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------------SHHHHHHHHHHTCC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC--------------CHHHHHHHHHcCCC
Confidence                 23457899999999999999999999999999999999999999653              11222223332221


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .   +.      ....+   ++.+++.+||+.||++|||++|++.+
T Consensus       252 ~---~p------~~~s~---~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          252 D---FP------EKFFP---KARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             C---CC------TTCCH---HHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             C---CC------cccCH---HHHHHHHHHccCCHhHCcChHHHcCC
Confidence            1   11      11223   34556779999999999999997543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-50  Score=423.71  Aligned_cols=257  Identities=23%  Similarity=0.307  Sum_probs=204.1

Q ss_pred             HHHHhHcCCCCceEEEEEEEcC------CCEEEEEEeCCCCc-chHHHHHHHHHHHhccCC-CCeeeEEEEEEeC-CeeE
Q 036639          358 RASAEMLGKGSLGTVYKAVLDD------GGIVAVKRLKDANP-CARKEFEQYMDVIGKLKH-PNVVKLRAYYYAK-EEKL  428 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~-~~~~  428 (670)
                      +.+.+.||+|+||+||+|.+..      ++.||||+++.... ...++|.+|++++.+++| ||||+++|+|.+. +..+
T Consensus        66 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~  145 (353)
T 4ase_A           66 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM  145 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCE
T ss_pred             eEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEE
Confidence            3456889999999999998542      36899999986543 345789999999999965 8999999999765 5689


Q ss_pred             EEEeccCCCChHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          429 LVYDYLPNGSLHSLLHGNRG-----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      +|||||++|+|.++|+....           .....++|..++.++.|||+||+|||++    +||||||||+|||++++
T Consensus       146 iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~----~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEK  221 (353)
T ss_dssp             EEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGG
T ss_pred             EEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC----CeecCccCccceeeCCC
Confidence            99999999999999975431           1123589999999999999999999998    99999999999999999


Q ss_pred             CcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccc
Q 036639          498 GVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  570 (670)
                      +.+||+|||+|+......      ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.....        
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~--------  293 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--------  293 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC--------
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH--------
Confidence            999999999998764322      2456778999999999999999999999999999998 8999975421        


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                            ...+...+.+.....       .....   ..++.+++.+||+.||++|||+.||+++|+++.+..
T Consensus       294 ------~~~~~~~i~~g~~~~-------~p~~~---~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          294 ------DEEFCRRLKEGTRMR-------APDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             ------SHHHHHHHHHTCCCC-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             ------HHHHHHHHHcCCCCC-------CCccC---CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence                  111222222221111       01111   234566778999999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.1e-50  Score=409.14  Aligned_cols=241  Identities=25%  Similarity=0.312  Sum_probs=190.5

Q ss_pred             HHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      ++.+.||+|+||+||+|+..    +++.||||++++..  ......+.+|++++++++|||||++++++.+.+..|+|||
T Consensus        27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE  106 (304)
T 3ubd_A           27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD  106 (304)
T ss_dssp             EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred             EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence            34578999999999999852    47899999997542  2234568889999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      ||++|+|.+++....     .+++..+..++.|++.||+|||++    +|+||||||+|||+++++.+||+|||+|+...
T Consensus       107 y~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~----~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          107 FLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSL----GIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             CCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999998654     589999999999999999999998    99999999999999999999999999998653


Q ss_pred             c----cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          513 P----VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       513 ~----~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      .    .....||+.|||||++.+..|+.++||||+||++|||+||+.||...+              ....+........
T Consensus       178 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------------~~~~~~~i~~~~~  243 (304)
T 3ubd_A          178 DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------------RKETMTMILKAKL  243 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCC
T ss_pred             CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------------HHHHHHHHHcCCC
Confidence            3    234578999999999999999999999999999999999999997541              1122222222211


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM-----AEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  634 (670)
                      .         ......+   ++.+++.+||+.||++|||+     +|+++|
T Consensus       244 ~---------~p~~~s~---~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 G---------MPQFLSP---EAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             C---------CCTTSCH---HHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             C---------CCCcCCH---HHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            1         0112223   34556779999999999984     677664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-48  Score=399.39  Aligned_cols=242  Identities=21%  Similarity=0.348  Sum_probs=184.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------------
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------------  425 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------------  425 (670)
                      +.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||+++++|.+.+            
T Consensus         9 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~   88 (299)
T 4g31_A            9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV   88 (299)
T ss_dssp             EEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CE
T ss_pred             EeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCc
Confidence            4578999999999999954 79999999997543 334578999999999999999999999987654            


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ..|+|||||++|+|.+++.....  ....++..++.++.||++||+|||++    +|+||||||+|||++.++.+||+||
T Consensus        89 ~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~~----~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           89 YLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             EEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHHC----cCccccCcHHHeEECCCCcEEEccC
Confidence            36899999999999999986542  22456778899999999999999998    9999999999999999999999999


Q ss_pred             ccccccCccc----------------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 036639          506 GLSLLLNPVQ----------------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE  569 (670)
Q Consensus       506 G~a~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~  569 (670)
                      |+|+......                ...||+.|||||++.+..|+.++|||||||++|||++   ||...         
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---------  230 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---------  230 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---------
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---------
Confidence            9998764321                2358999999999999999999999999999999996   76421         


Q ss_pred             cccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          .+....+.......     +.+      ..........+++.+||+.||++|||+.|+++|
T Consensus       231 ----~~~~~~~~~~~~~~-----~p~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          231 ----MERVRTLTDVRNLK-----FPP------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             ----HHHHHHHHHHHTTC-----CCH------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----cHHHHHHHHHhcCC-----CCC------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                00111111111111     011      111122234567789999999999999999884

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-46  Score=394.35  Aligned_cols=191  Identities=26%  Similarity=0.384  Sum_probs=166.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~lv  430 (670)
                      +.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+++|++++|||||++++++...      +..|||
T Consensus        58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv  137 (398)
T 4b99_A           58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV  137 (398)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred             EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence            357899999999999995 479999999997543  23456788999999999999999999998643      578999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      ||||+ |+|.+++....     .+++..+..++.||+.||+|||+.    +||||||||+|||++.++.+||+|||+|+.
T Consensus       138 mE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          138 LDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSA----QVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCcCCCcCccccccCCCCCEEEeecceeee
Confidence            99995 68999997654     599999999999999999999998    999999999999999999999999999987


Q ss_pred             cCc--------cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNP--------VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~--------~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      +..        .....||+.|||||++.+. .++.++||||+||++|||+||++||.+.
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~  266 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK  266 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC
Confidence            632        2245789999999998765 5699999999999999999999999754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.2e-45  Score=386.62  Aligned_cols=188  Identities=24%  Similarity=0.379  Sum_probs=164.5

Q ss_pred             HHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||+||+|+.+    +++.||||++....  ...++.+|+++++.+ +|||||++++++.+.++.|+||||
T Consensus        24 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~  101 (361)
T 4f9c_A           24 KIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPY  101 (361)
T ss_dssp             EEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEEC
T ss_pred             EEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeC
Confidence            34578999999999999853    46889999997654  456788999999988 699999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-CcEEEEecccccccC
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLN  512 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~  512 (670)
                      |++|+|.++++        .+++..+..++.|++.||+|||+.    +|+||||||+|||++.+ +.+||+|||+|+...
T Consensus       102 ~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~----gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A          102 LEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQF----GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             CCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             CCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999984        378999999999999999999998    99999999999999877 799999999997543


Q ss_pred             cc--------------------------------ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          513 PV--------------------------------QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       513 ~~--------------------------------~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                      ..                                ....||+.|+|||++.+. .|+.++||||+||++|||+||+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            21                                123588999999999765 589999999999999999999999965


Q ss_pred             C
Q 036639          560 P  560 (670)
Q Consensus       560 ~  560 (670)
                      .
T Consensus       250 ~  250 (361)
T 4f9c_A          250 A  250 (361)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-44  Score=402.20  Aligned_cols=246  Identities=22%  Similarity=0.382  Sum_probs=202.9

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||+||+|.. .+|+.||||++........+.+.+|+++|+.++|||||+++++|.+....|+|||||++|
T Consensus       160 ~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg  239 (573)
T 3uto_A          160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG  239 (573)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence            3457899999999999996 479999999998776667788999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC--CcEEEEecccccccCcc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN--GVACISDFGLSLLLNPV-  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~a~~~~~~-  514 (670)
                      +|.+++....    ..+++..+..++.||+.||+|||++    +|+||||||+|||++.+  +.+||+|||+|+.+... 
T Consensus       240 ~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~----~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          240 ELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             BHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             cHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999996543    2589999999999999999999998    99999999999999854  89999999999987653 


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....||+.|||||++.+..|+.++||||+||++|||++|+.||...+              ....+.......+..  
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------------~~~~~~~i~~~~~~~--  375 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------------DDETLRNVKSCDWNM--  375 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------------HHHHHHHHHTTCCCC--
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------------HHHHHHHHHhCCCCC--
Confidence              34568999999999999999999999999999999999999997541              112222222221110  


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ..  ..+....+   .+.+|+.+||+.||++|||++|+++|
T Consensus       376 -~~--~~~~~~s~---~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          376 -DD--SAFSGISE---DGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             -CS--GGGTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -Cc--ccccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00  01112233   34456679999999999999999985

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-43  Score=369.84  Aligned_cols=268  Identities=34%  Similarity=0.542  Sum_probs=220.0

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      .+.||+|+||.||+|..++|+.||||++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus        44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  123 (321)
T 2qkw_B           44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK  123 (321)
T ss_dssp             CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred             cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence            46799999999999998889999999998776667788999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc------
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV------  514 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~------  514 (670)
                      +++..... ....+++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||+++.....      
T Consensus       124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTR----AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCC----CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99976532 233589999999999999999999998    9999999999999999999999999999865321      


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....++..|+|||++.+..++.++||||||+++|||+||+.||....+.        +......|.............++
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  270 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--------EMVNLAEWAVESHNNGQLEQIVD  270 (321)
T ss_dssp             CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--------SCCCHHHHTHHHHTTTCCCSSSS
T ss_pred             cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--------HHHHHHHHhhhccccccHHHhcC
Confidence            2234678899999998889999999999999999999999999765322        22233444333333332333333


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      +.... ....+....+.+++.+||+.||++|||+.||+++|+.+...+
T Consensus       271 ~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          271 PNLAD-KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             SSCTT-CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             hhhcc-ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            32221 223456677888999999999999999999999999987544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-44  Score=397.40  Aligned_cols=244  Identities=21%  Similarity=0.279  Sum_probs=192.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHH---HHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEF---EQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~---~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.++||+|+||+||+|+.. +|+.||||++++...   .....+   +.++.+++.++|||||+++++|.+.+..|+||
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm  271 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL  271 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence            34578999999999999954 799999999964311   112223   34466777889999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      |||+||+|.+++....     .+++..+..++.||+.||+|||+.    +||||||||+||||+.+|++||+|||+|+..
T Consensus       272 Ey~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~----gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          272 DLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             CCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999998654     589999999999999999999998    9999999999999999999999999999877


Q ss_pred             Cc--cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          512 NP--VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       512 ~~--~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ..  .....||+.|||||++.. ..|+.++||||+||++|||++|+.||.....           .+.............
T Consensus       343 ~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----------~~~~~i~~~i~~~~~  411 (689)
T 3v5w_A          343 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----------KDKHEIDRMTLTMAV  411 (689)
T ss_dssp             SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----------CCHHHHHHHHHHCCC
T ss_pred             CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----------HHHHHHHHhhcCCCC
Confidence            54  345679999999999964 5799999999999999999999999964311           111111122111110


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                               ........+   +.+++.+||+.||++|++     ++||++|
T Consensus       412 ---------~~p~~~S~~---a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          412 ---------ELPDSFSPE---LRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ---------CCCTTSCHH---HHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ---------CCCccCCHH---HHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                     011122333   445666999999999998     7888875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.7e-42  Score=357.88  Aligned_cols=251  Identities=24%  Similarity=0.458  Sum_probs=207.2

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|+||+||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   94 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL   94 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence            478999999999999964 6899999999877777788999999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .++++...    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++......    
T Consensus        95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  166 (310)
T 3s95_A           95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSM----NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE  166 (310)
T ss_dssp             HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred             HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence            99998643    2589999999999999999999998    99999999999999999999999999998764321    


Q ss_pred             --------------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          516 --------------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       516 --------------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                                    ...+|+.|+|||++.+..++.++||||||+++|||++|..||..........     .........
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----~~~~~~~~~  241 (310)
T 3s95_A          167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----GLNVRGFLD  241 (310)
T ss_dssp             -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----SBCHHHHHH
T ss_pred             ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----hhhhhcccc
Confidence                          3457788999999999999999999999999999999999986543221111     111111111


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ...+.               ..   ...+.+++.+||+.||++|||+.|+++.|++++...
T Consensus       242 ~~~~~---------------~~---~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          242 RYCPP---------------NC---PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HTCCT---------------TC---CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCCC---------------CC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            11111               11   123556778999999999999999999999998554

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-42  Score=357.58  Aligned_cols=241  Identities=24%  Similarity=0.364  Sum_probs=198.5

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus        25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (297)
T 3fxz_A           25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (297)
T ss_dssp             CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence            46799999999999994 57999999999766555678899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----c
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----Q  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~  515 (670)
                      .+++...      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++......    .
T Consensus       105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A          105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            9999764      388999999999999999999998    9999999999999999999999999998876532    2


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...+++.|+|||++.+..++.++|||||||++|||+||+.||....              .............. ...  
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------------~~~~~~~~~~~~~~-~~~--  237 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------------PLRALYLIATNGTP-ELQ--  237 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHHHHCSC-CCS--
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCCC-CCC--
Confidence            3467888999999999999999999999999999999999996431              11111111111110 000  


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                            ........+.+++.+||+.||++|||++|++++
T Consensus       238 ------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          238 ------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ------CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                  011112245567779999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.7e-43  Score=365.71  Aligned_cols=274  Identities=36%  Similarity=0.625  Sum_probs=218.6

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ..+.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++||||+++++++.+....++||||+++|+
T Consensus        34 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  113 (326)
T 3uim_A           34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS  113 (326)
T ss_dssp             STTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCB
T ss_pred             cceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCC
Confidence            3578999999999999988899999999976432 123468999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----  514 (670)
                      |.++++.... ....+++..+..++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+|||+++.....    
T Consensus       114 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (326)
T 3uim_A          114 VASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV  191 (326)
T ss_dssp             HHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSS-SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCE
T ss_pred             HHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccc
Confidence            9999986542 2345999999999999999999999863 248999999999999999999999999999876432    


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....++..|+|||++.+..++.++|||||||++|||+||+.||......      .........|+.............
T Consensus       192 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~  265 (326)
T 3uim_A          192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA------NDDDVMLLDWVKGLLKEKKLEALV  265 (326)
T ss_dssp             ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT------TTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred             cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc------cccchhHHHHHHHHhhchhhhhhc
Confidence             2334788899999998888999999999999999999999999632100      112223445554444443333444


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      +.... .....+....+.+++.+||+.||++|||+.||+++|+......
T Consensus       266 ~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          266 DVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             CTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             Chhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            43322 2234566778899999999999999999999999999765443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.3e-43  Score=364.22  Aligned_cols=269  Identities=25%  Similarity=0.318  Sum_probs=204.3

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC----eeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE----EKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|+.. ++.||||+++.... .....+.|+.++++++||||+++++++.+..    ..++||||++
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~  105 (322)
T 3soc_A           28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHE  105 (322)
T ss_dssp             EEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCT
T ss_pred             hhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCC
Confidence            3578999999999999976 79999999975432 4455667889999999999999999998754    3699999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHh------CCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE------YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      +|+|.++++..      .+++..+..++.|+++||+|||+.      ++..+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~  179 (322)
T 3soc_A          106 KGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL  179 (322)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccc
Confidence            99999999764      389999999999999999999975      223489999999999999999999999999997


Q ss_pred             ccCcc------ccccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccc--ccccch
Q 036639          510 LLNPV------QAIARLGGYKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE--EQAVDL  576 (670)
Q Consensus       510 ~~~~~------~~~~~~~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~  576 (670)
                      .....      ....++..|+|||++.+     ..++.++|||||||++|||+||+.||.............  ......
T Consensus       180 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  259 (322)
T 3soc_A          180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL  259 (322)
T ss_dssp             EECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH
T ss_pred             ccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch
Confidence            65432      22457888999999876     356778999999999999999999997654322211111  111122


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ..+........ ........    .........+.+++.+||+.||++|||+.||++.|+++...
T Consensus       260 ~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          260 EDMQEVVVHKK-KRPVLRDY----WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHHHHHHTTSC-CCCCCCGG----GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccc-CCCCcccc----ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            22222211111 11111111    11123445677888899999999999999999999998753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3e-42  Score=357.26  Aligned_cols=255  Identities=31%  Similarity=0.438  Sum_probs=196.0

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||+|+||+||+|+. +|+.||||++....  ....+++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        40 ~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 3p86_A           40 NIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR  118 (309)
T ss_dssp             EEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTT
T ss_pred             eeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCC
Confidence            3457899999999999987 48899999997654  23446789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      |+|.+++....  ....+++..++.++.|++.||+|||+.    +  |+||||||+|||++.++.+||+|||+++.....
T Consensus       119 ~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~----~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          119 GSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNR----NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             CBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTS----SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             CcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcC----CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999998643  112388999999999999999999998    7  999999999999999999999999999865432


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ....++..|+|||++.+..++.++|||||||++|||+||+.||....              ...............
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--------------~~~~~~~~~~~~~~~  258 (309)
T 3p86_A          193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--------------PAQVVAAVGFKCKRL  258 (309)
T ss_dssp             ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--------------HHHHHHHHHHSCCCC
T ss_pred             ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhcCCCC
Confidence                34567888999999999999999999999999999999999996431              111111111010000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP  644 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~  644 (670)
                      . +      .....   ..+.+++.+||+.||++|||++|+++.|+.+.....+
T Consensus       259 ~-~------~~~~~---~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          259 E-I------PRNLN---PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             C-C------CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             C-C------CccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence            0 0      01112   2455677799999999999999999999999865433

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-42  Score=349.68  Aligned_cols=248  Identities=24%  Similarity=0.410  Sum_probs=203.7

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||+++++|
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (269)
T 4hcu_A           14 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL   92 (269)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred             eeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcH
Confidence            4578999999999999988899999999986543 467899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .+++....    ..+++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||+++......    
T Consensus        93 ~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           93 SDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             HHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             HHHHHhcC----cccCHHHHHHHHHHHHHHHHHHHhC----CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            99997643    2589999999999999999999998    99999999999999999999999999998765422    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ...++..|+|||.+.+..++.++||||+|+++|||+| |+.||....              ........... ...  .
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------------~~~~~~~~~~~-~~~--~  227 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------------NSEVVEDISTG-FRL--Y  227 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHHHHHHHTT-CCC--C
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------------HHHHHHHHhcC-ccC--C
Confidence             2334556999999998999999999999999999999 999986431              11111111111 000  0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .     ....   ...+.+++.+||+.||++|||++|++++|+++...
T Consensus       228 ~-----~~~~---~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          228 K-----PRLA---STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             C-----CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C-----CCcC---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            0     0011   12456677799999999999999999999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-42  Score=359.32  Aligned_cols=240  Identities=24%  Similarity=0.340  Sum_probs=198.1

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~   98 (328)
T 3fe3_A           19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG   98 (328)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCC
Confidence            346899999999999996 57999999999754  334557788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....  
T Consensus        99 ~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  169 (328)
T 3fe3_A           99 GEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQK----RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK  169 (328)
T ss_dssp             CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence            99999997653     489999999999999999999998    9999999999999999999999999999866432  


Q ss_pred             -ccccccCcccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLS-QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       ....+++.|+|||++.+..+. .++||||+||++|||+||+.||...              ................  
T Consensus       170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~--------------~~~~~~~~i~~~~~~~--  233 (328)
T 3fe3_A          170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ--------------NLKELRERVLRGKYRI--  233 (328)
T ss_dssp             GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS--------------SHHHHHHHHHHCCCCC--
T ss_pred             cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC--------------CHHHHHHHHHhCCCCC--
Confidence             345678889999999887765 7999999999999999999999653              1222222222221110  


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .....   ..+.+++.+||..||++|||++|+++|
T Consensus       234 -------p~~~s---~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          234 -------PFYMS---TDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -------CTTSC---HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -------CCCCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   00111   235567779999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.6e-41  Score=350.37  Aligned_cols=240  Identities=22%  Similarity=0.323  Sum_probs=198.3

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      +.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++++|.
T Consensus        51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  130 (321)
T 2c30_A           51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT  130 (321)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence            47999999999999965 79999999998766666788999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----cc
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----QA  516 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----~~  516 (670)
                      +++...      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++......    ..
T Consensus       131 ~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~  200 (321)
T 2c30_A          131 DIVSQV------RLNEEQIATVCEAVLQALAYLHAQ----GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  200 (321)
T ss_dssp             HHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             HHHHhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccc
Confidence            998753      489999999999999999999998    9999999999999999999999999998876432    34


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      ..++..|+|||++.+..++.++||||||+++|||++|+.||....              ........... ....     
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--------------~~~~~~~~~~~-~~~~-----  260 (321)
T 2c30_A          201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--------------PVQAMKRLRDS-PPPK-----  260 (321)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHHHS-SCCC-----
T ss_pred             ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHhcC-CCCC-----
Confidence            567888999999999999999999999999999999999996431              11111111111 1000     


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ........   ..+.+++.+||+.||++|||++|++++
T Consensus       261 ~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          261 LKNSHKVS---PVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             CTTGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCccccCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00001112   235567779999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8.3e-42  Score=362.93  Aligned_cols=253  Identities=26%  Similarity=0.368  Sum_probs=202.0

Q ss_pred             HHhHcCCCCceEEEEEEEc--------CCCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD--------DGGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  429 (670)
                      +.+.||+|+||.||+|+..        ++..||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+..|+
T Consensus        85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l  164 (370)
T 2psq_A           85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV  164 (370)
T ss_dssp             EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred             eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence            4578999999999999852        356799999986532 3456799999999999 89999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC
Q 036639          430 VYDYLPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG  498 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  498 (670)
                      ||||+++|+|.+++......           ....+++..++.++.|+++||+|||+.    +|+||||||+|||++.++
T Consensus       165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~  240 (370)
T 2psq_A          165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTENN  240 (370)
T ss_dssp             EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTC
T ss_pred             EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeccccchhhEEECCCC
Confidence            99999999999999865421           123588999999999999999999998    999999999999999999


Q ss_pred             cEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccc
Q 036639          499 VACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEE  571 (670)
Q Consensus       499 ~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  571 (670)
                      .+||+|||+++......      ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....         
T Consensus       241 ~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---------  311 (370)
T 2psq_A          241 VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---------  311 (370)
T ss_dssp             CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---------
T ss_pred             CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---------
Confidence            99999999998664322      2334567999999999999999999999999999999 9999865311         


Q ss_pred             cccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          572 QAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                        ..+..   . +.......          ........+.+++.+||+.||++|||+.|++++|+++...
T Consensus       312 --~~~~~---~-~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          312 --EELFK---L-LKEGHRMD----------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             --GGHHH---H-HHTTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HHHHH---H-HhcCCCCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence              11111   1 11111000          0011123456677799999999999999999999998743

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-41  Score=350.59  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=191.6

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhc--cCCCCeeeEEEEEEeC----CeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK--LKHPNVVKLRAYYYAK----EEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~~~~~----~~~~lv~e~~  434 (670)
                      .+.||+|+||+||+|.. +|+.||||++...   ..+.+..|.+++..  ++||||+++++++...    ...++||||+
T Consensus        13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~   88 (301)
T 3q4u_A           13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH   88 (301)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             EEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence            46899999999999998 5899999999754   34556666666665  7999999999987653    4578999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------HhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH--------QEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      ++|+|.++++..      .+++..++.++.|++.||+|||        +.    +|+||||||+|||++.++.+||+|||
T Consensus        89 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           89 EMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP----AIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             TTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC----EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             cCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC----CeecCCCChHhEEEcCCCCEEEeeCC
Confidence            999999999643      4899999999999999999999        55    99999999999999999999999999


Q ss_pred             cccccCccc--------cccccCcccCccccccC------CCCCchhHHHHHHHHHHHHcC----------CCCCCCCCC
Q 036639          507 LSLLLNPVQ--------AIARLGGYKAPEQAEVK------RLSQKADVYSFGVLLLEVLTG----------RAPSQYPSP  562 (670)
Q Consensus       507 ~a~~~~~~~--------~~~~~~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~elltg----------~~p~~~~~~  562 (670)
                      +++......        ...++..|+|||++.+.      .++.++|||||||++|||+||          +.||....+
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            997654322        23678889999999766      456799999999999999999          666644321


Q ss_pred             CCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      .         ...... ...............    ...........+.+++.+||+.||++|||++||++.|+++
T Consensus       239 ~---------~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          239 N---------DPSFED-MRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             S---------SCCHHH-HHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------Ccchhh-hhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            1         111111 111111111111111    0001123455677888899999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.1e-41  Score=348.38  Aligned_cols=250  Identities=21%  Similarity=0.330  Sum_probs=201.7

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.+.||+|+||+||++...++..||||+++.... ..+++.+|++++.+++||||+++++++.+.+..++||||+++++
T Consensus        27 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  105 (283)
T 3gen_A           27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC  105 (283)
T ss_dssp             EEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred             HhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence            34578999999999999998888999999986543 45789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++......   
T Consensus       106 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          106 LLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             HHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            999997632    2589999999999999999999998    99999999999999999999999999998765422   


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ...++..|+|||.+.+..++.++||||||+++|||+| |+.||....              ..............   
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--------------~~~~~~~~~~~~~~---  240 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------------NSETAEHIAQGLRL---  240 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--------------HHHHHHHHHTTCCC---
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--------------hhHHHHHHhcccCC---
Confidence              2334566999999998899999999999999999999 999996431              11111111111000   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ..     .....   ..+.+++.+||+.||++|||++|++++|+++..++
T Consensus       241 ~~-----~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          241 YR-----PHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             CC-----CTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CC-----CCcCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            00     00111   24566777999999999999999999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=355.41  Aligned_cols=251  Identities=24%  Similarity=0.387  Sum_probs=201.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|.+.    .+..||||+++.. .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        52 ~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  131 (325)
T 3kul_A           52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEY  131 (325)
T ss_dssp             EEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEEC
T ss_pred             EEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeC
Confidence            34578999999999999964    3456999999865 334567899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.++++...    ..+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus       132 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          132 MENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDL----GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             CTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             CCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            99999999997543    2589999999999999999999998    999999999999999999999999999987653


Q ss_pred             cc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          514 VQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       514 ~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ..       ...++..|+|||++.+..++.++|||||||++|||++ |+.||....              ..........
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--------------~~~~~~~~~~  269 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--------------NRDVISSVEE  269 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--------------HHHHHHHHHT
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--------------HHHHHHHHHc
Confidence            21       1223456999999998899999999999999999999 999996431              1111111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      . ....          ........+.+++.+||..||++|||+.||++.|+.+....
T Consensus       270 ~-~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          270 G-YRLP----------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             T-CCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             C-CCCC----------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            1 0000          00111234666778999999999999999999999997543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6e-42  Score=347.45  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=202.7

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||.||+|..+++..||||+++.... ..+++.+|++++.+++||||+++++++.+....++||||+++++|
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (268)
T 3sxs_A           12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL   90 (268)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBH
T ss_pred             eeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcH
Confidence            4578999999999999998888999999986543 457899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .+++....    ..+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++.......    
T Consensus        91 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  162 (268)
T 3sxs_A           91 LNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLESH----QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS  162 (268)
T ss_dssp             HHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEEC
T ss_pred             HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcc
Confidence            99997642    2489999999999999999999998    99999999999999999999999999998764432    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ...++..|+|||.+.+..++.++||||||+++|||+| |+.||....              ..............   .
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------------~~~~~~~~~~~~~~---~  225 (268)
T 3sxs_A          163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--------------NSEVVLKVSQGHRL---Y  225 (268)
T ss_dssp             CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--------------HHHHHHHHHTTCCC---C
T ss_pred             cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--------------hHHHHHHHHcCCCC---C
Confidence             2233456999999998889999999999999999999 999986431              11111111111100   0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .     .....   ..+.+++.+||+.||++|||+.|++++|+.++...
T Consensus       226 ~-----~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          226 R-----PHLAS---DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             C-----CTTSC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             C-----CCcCh---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            0     00111   24566777999999999999999999999998654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7e-42  Score=361.48  Aligned_cols=244  Identities=23%  Similarity=0.366  Sum_probs=198.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||.||+|... +|+.||+|+++....      ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e   95 (361)
T 2yab_A           16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILE   95 (361)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEE
Confidence            4578999999999999965 689999999975432      135789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC----cEEEEecccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG----VACISDFGLS  508 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~a  508 (670)
                      |+++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++    .+||+|||++
T Consensus        96 ~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           96 LVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             CCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999997543     589999999999999999999998    999999999999998877    7999999999


Q ss_pred             cccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          509 LLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       509 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ......   ....+|+.|+|||++.+..++.++|||||||++|||++|..||....              ....+.....
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------------~~~~~~~i~~  232 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------------KQETLANITA  232 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------------HHHHHHHHHT
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHh
Confidence            876543   34567888999999998899999999999999999999999996531              1112222221


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..+   .++...  +....+   .+.+++.+||..||++|||+.|+++|
T Consensus       233 ~~~---~~~~~~--~~~~s~---~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          233 VSY---DFDEEF--FSQTSE---LAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             TCC---CCCHHH--HTTSCH---HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCC---CCCchh--ccCCCH---HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            111   011111  111222   35567779999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.9e-41  Score=347.24  Aligned_cols=259  Identities=31%  Similarity=0.525  Sum_probs=204.8

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCC----CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDA----NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||+|.. +++.||||++...    .....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        37 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  115 (307)
T 2nru_A           37 NKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG  115 (307)
T ss_dssp             CEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             CccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence            6799999999999987 5889999998753    2334678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++....  ....+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++.....   
T Consensus       116 ~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          116 SLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHEN----HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             BHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             cHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcC----CeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            9999997533  123589999999999999999999998    9999999999999999999999999999866432   


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc-cc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW-TA  590 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  590 (670)
                         ....++..|+|||.+.+ .++.++||||||+++|||+||+.||.......          .+..+......... ..
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----------~~~~~~~~~~~~~~~~~  258 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ----------LLLDIKEEIEDEEKTIE  258 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS----------BTTHHHHHHHTTSCCHH
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH----------HHHHHHHHhhhhhhhhh
Confidence               23457788999998864 58999999999999999999999997542211          11112111111110 11


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ..++..+.  .........+.+++.+||+.||++|||+.||+++|+++.+
T Consensus       259 ~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          259 DYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            11111111  1234455677888899999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.8e-41  Score=346.54  Aligned_cols=258  Identities=24%  Similarity=0.316  Sum_probs=203.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|+.. +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   94 (294)
T 4eqm_A           15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIE   94 (294)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCC
Confidence            3468999999999999954 6899999998543   23345788999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     ++++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++..... 
T Consensus        95 g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           95 GPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDM----RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             SCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            999999997653     589999999999999999999998    9999999999999999999999999999876432 


Q ss_pred             ----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          515 ----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       515 ----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ....+++.|+|||.+.+..++.++||||||+++|||+||+.||.....              ............. 
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------------~~~~~~~~~~~~~-  230 (294)
T 4eqm_A          166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------------VSIAIKHIQDSVP-  230 (294)
T ss_dssp             ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------------HHHHHHHHSSCCC-
T ss_pred             ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHHHhhccCC-
Confidence                234578889999999999999999999999999999999999965411              1111111111100 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhccCCCCCC
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-TMAEVAKMIEDIRVEQSPLGE  647 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~~~~~~  647 (670)
                         ...........   ..+.+++.+||+.||++|| +++++.+.|+.+..+.....+
T Consensus       231 ---~~~~~~~~~~~---~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~  282 (294)
T 4eqm_A          231 ---NVTTDVRKDIP---QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED  282 (294)
T ss_dssp             ---CHHHHSCTTSC---HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred             ---CcchhcccCCC---HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence               00000011112   3455677799999999999 999999999998766544433

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.8e-42  Score=362.68  Aligned_cols=250  Identities=23%  Similarity=0.417  Sum_probs=193.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|+..    ++..||||+++.. .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        48 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  127 (373)
T 2qol_A           48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEY  127 (373)
T ss_dssp             CCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeC
Confidence            34578999999999999864    5778999999864 334567899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.++++...    ..+++..++.++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus       128 ~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          128 MENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDM----GYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             CTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            99999999997643    2589999999999999999999998    999999999999999999999999999987653


Q ss_pred             ccc-------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          514 VQA-------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       514 ~~~-------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ...       ..++..|+|||++.+..++.++|||||||++|||++ |+.||....              ....... +.
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--------------~~~~~~~-i~  264 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--------------NQDVIKA-VD  264 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--------------HHHHHHH-HH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--------------HHHHHHH-HH
Confidence            221       123456999999998999999999999999999998 999986431              1111111 11


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .....          .........+.+++.+||+.||++||++.||++.|+++...
T Consensus       265 ~~~~~----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          265 EGYRL----------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             TTEEC----------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCC----------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            11100          00111223566788899999999999999999999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-41  Score=350.70  Aligned_cols=265  Identities=24%  Similarity=0.392  Sum_probs=200.1

Q ss_pred             HHhHcCCCCceEEEEEEE-----cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL-----DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e  432 (670)
                      +.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...  ...++|||
T Consensus        14 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   93 (295)
T 3ugc_A           14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME   93 (295)
T ss_dssp             EEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEE
T ss_pred             hhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEE
Confidence            457899999999999984     36889999999877766678899999999999999999999998654  56899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           94 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             CCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             eCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            999999999997653    2489999999999999999999998    99999999999999999999999999998764


Q ss_pred             ccc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCC-cccccccchhHHHHHHh
Q 036639          513 PVQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV-DEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       513 ~~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  584 (670)
                      ...       ...++..|+|||.+.+..++.++||||||+++|||+||..|+.......... .................
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            322       2234455999999998999999999999999999999999985421000000 00000000000111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .....          ..........+.+++.+||+.||++|||++|+++.|++++...
T Consensus       246 ~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          246 KNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hccCc----------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            11100          0011112235666778999999999999999999999997653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=354.29  Aligned_cols=246  Identities=23%  Similarity=0.361  Sum_probs=198.9

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      |.+.+.||+|+||.||+|... +|+.||||+++....      ...+.+.+|++++++++||||+++++++.+....++|
T Consensus        13 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   92 (326)
T 2y0a_A           13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI   92 (326)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            345678999999999999965 689999999975422      2467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC----cEEEEecc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG----VACISDFG  506 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG  506 (670)
                      |||+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++    .+||+|||
T Consensus        93 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           93 LELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EECCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEcCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHC----CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999997543     589999999999999999999998    999999999999999887    79999999


Q ss_pred             cccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          507 LSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       507 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      +++.....   ....+++.|+|||++.+..++.++|||||||++|||++|+.||....              ........
T Consensus       164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~~~~~  229 (326)
T 2y0a_A          164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------------KQETLANV  229 (326)
T ss_dssp             TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------------HHHHHHHH
T ss_pred             CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--------------HHHHHHHH
Confidence            99876432   34567888999999998899999999999999999999999996431              11111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ......   +....  .....   ..+.+++.+||+.||++|||++|+++|
T Consensus       230 ~~~~~~---~~~~~--~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          230 SAVNYE---FEDEY--FSNTS---ALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHTCCC---CCHHH--HTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhcCCC---cCccc--cccCC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111100   01100  01112   235567779999999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.9e-41  Score=349.78  Aligned_cols=239  Identities=22%  Similarity=0.303  Sum_probs=196.6

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||+|+.. +|+.||||++++.   .....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g   89 (337)
T 1o6l_A           10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   89 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            468999999999999965 6999999999753   122456788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            99999997643     589999999999999999999998    999999999999999999999999999986432   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....              ..............   
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------------~~~~~~~i~~~~~~---  223 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------------HERLFELILMEEIR---  223 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC---
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------------HHHHHHHHHcCCCC---
Confidence             234567889999999999999999999999999999999999996431              11122222221110   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      +      .....+   .+.+++.+||+.||++||     +++|+++|
T Consensus       224 ~------p~~~s~---~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 F------PRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C------CTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C------CCCCCH---HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            0      011222   345566799999999999     89999886

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.6e-41  Score=359.95  Aligned_cols=260  Identities=25%  Similarity=0.340  Sum_probs=206.4

Q ss_pred             HHHhHcCCCCceEEEEEEEc--------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD--------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  428 (670)
                      .+.+.||+|+||+||+|+..        ++..||||+++... ....+++.+|+++++++ +||||+++++++.+.+..+
T Consensus        72 ~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~  151 (382)
T 3tt0_A           72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY  151 (382)
T ss_dssp             EEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             EeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceE
Confidence            34578999999999999852        23579999998653 33457889999999999 8999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          429 LVYDYLPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      +||||+++|+|.+++......           ....+++..++.++.|++.||+|||+.    +|+||||||+|||++.+
T Consensus       152 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          152 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTED  227 (382)
T ss_dssp             EEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTT
T ss_pred             EEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCcceEEEcCC
Confidence            999999999999999865421           123589999999999999999999998    99999999999999999


Q ss_pred             CcEEEEecccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccc
Q 036639          498 GVACISDFGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  570 (670)
                      +.+||+|||+++.....      ....++..|+|||++.+..++.++|||||||++|||+| |+.||....         
T Consensus       228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---------  298 (382)
T 3tt0_A          228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------  298 (382)
T ss_dssp             CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------
T ss_pred             CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---------
Confidence            99999999999876432      22334567999999999999999999999999999999 999986431         


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCCCC
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGE  647 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~  647 (670)
                           ....... +.......       .....   ...+.+++.+||+.||++|||++||+++|+++.........
T Consensus       299 -----~~~~~~~-~~~~~~~~-------~~~~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  359 (382)
T 3tt0_A          299 -----VEELFKL-LKEGHRMD-------KPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM  359 (382)
T ss_dssp             -----HHHHHHH-HHTTCCCC-------CCSSC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred             -----HHHHHHH-HHcCCCCC-------CCccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence                 1111111 11111100       00111   23456677799999999999999999999999876644444

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-41  Score=351.13  Aligned_cols=245  Identities=20%  Similarity=0.350  Sum_probs=199.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus         9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~   87 (321)
T 1tki_A            9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             eeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence            3467999999999999965 68899999997553 356678999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC--CCcEEEEecccccccCcc--
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK--NGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~~--  514 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.  ++.+||+|||+++.....  
T Consensus        88 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~  159 (321)
T 1tki_A           88 IFERINTSA----FELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             HHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence            999997543    2589999999999999999999998    9999999999999987  789999999999877543  


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+++.|+|||++.+..++.++|||||||++|||++|+.||....              ....+.........   +
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~~~~i~~~~~~---~  222 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------------NQQIIENIMNAEYT---F  222 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHHTCCC---C
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------------HHHHHHHHHcCCCC---C
Confidence             23567888999999998889999999999999999999999996531              11222222222111   1


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      +..  .+....   ..+.+++.+||..||++|||+.|+++|-
T Consensus       223 ~~~--~~~~~s---~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          223 DEE--AFKEIS---IEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             CHH--HHTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             Chh--hhccCC---HHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            110  011122   3455677799999999999999999954

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-41  Score=361.23  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=201.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|.+. +++.||||+++... ....+++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus       118 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  197 (377)
T 3cbl_A          118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG  197 (377)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             EeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCC
Confidence            4578999999999999975 78999999997543 234467889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-  516 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  516 (670)
                      +|.++++...    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       198 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          198 DFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESK----CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             BHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            9999997542    2488999999999999999999998    999999999999999999999999999986543221 


Q ss_pred             -----ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          517 -----IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       517 -----~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                           ..++..|+|||.+.+..++.++|||||||++|||+| |+.||.....               ..+...+......
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---------------~~~~~~~~~~~~~  334 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------------QQTREFVEKGGRL  334 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---------------HHHHHHHHTTCCC
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---------------HHHHHHHHcCCCC
Confidence                 123456999999998889999999999999999999 9999864310               1111111111100


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .       ....   ....+.+++.+||+.||++|||++|+++.|++++..
T Consensus       335 ~-------~~~~---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          335 P-------CPEL---CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             C-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-------CCCC---CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            0       0011   123456677899999999999999999999998754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=347.62  Aligned_cols=270  Identities=25%  Similarity=0.346  Sum_probs=198.4

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc--CCCCeeeEEEEEEeC----CeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL--KHPNVVKLRAYYYAK----EEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~nIv~l~~~~~~~----~~~~lv~e  432 (670)
                      .+.+.||+|+||.||+|+.. |+.||||++...   ....+..|.+++..+  +||||+++++++...    ...++|||
T Consensus        40 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e  115 (337)
T 3mdy_A           40 QMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITD  115 (337)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEEC
T ss_pred             EEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEe
Confidence            45678999999999999986 899999999644   334455566665554  899999999999887    68899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC----CCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY----GTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      |+++|+|.++++..      .+++..++.++.|++.||+|||+.+    +..+|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a  189 (337)
T 3mdy_A          116 YHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  189 (337)
T ss_dssp             CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence            99999999999764      3899999999999999999999751    2348999999999999999999999999999


Q ss_pred             cccCccc--------cccccCcccCccccccCCCCCc------hhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccccc
Q 036639          509 LLLNPVQ--------AIARLGGYKAPEQAEVKRLSQK------ADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV  574 (670)
Q Consensus       509 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~k------sDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  574 (670)
                      +......        ...++..|+|||++.+...+.+      +|||||||++|||+||..|+.................
T Consensus       190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  269 (337)
T 3mdy_A          190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD  269 (337)
T ss_dssp             EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence            7664322        3457888999999987766665      9999999999999999555432211111111111111


Q ss_pred             chhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ..................+...    ....+....+.+++.+||+.||++|||+.||+++|+++....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          270 PSYEDMREIVCIKKLRPSFPNR----WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CchhhhHHHHhhhccCcccccc----chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            1111112211111111111111    111245566778888999999999999999999999998665

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.8e-41  Score=364.98  Aligned_cols=249  Identities=27%  Similarity=0.436  Sum_probs=202.4

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||+||+|.+++++.||||+++... ...+++.+|++++++++||||+++++++. .+..++||||+++|+|
T Consensus       192 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L  269 (454)
T 1qcf_A          192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSL  269 (454)
T ss_dssp             EEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred             EEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcH
Confidence            457899999999999999888999999998654 35788999999999999999999999986 6678999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .++++...   ...+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++......    
T Consensus       270 ~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~  342 (454)
T 1qcf_A          270 LDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQR----NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  342 (454)
T ss_dssp             HHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred             HHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence            99997542   12478899999999999999999998    99999999999999999999999999998765422    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ...++..|+|||++....++.++|||||||++|||+| |+.||....              ......... .....   
T Consensus       343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------------~~~~~~~i~-~~~~~---  404 (454)
T 1qcf_A          343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------------NPEVIRALE-RGYRM---  404 (454)
T ss_dssp             CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------------HHHHHHHHH-HTCCC---
T ss_pred             CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------------HHHHHHHHH-cCCCC---
Confidence             2234456999999998899999999999999999999 999996431              111111111 11100   


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                             .........+.+++.+||+.||++|||+++|++.|+++....
T Consensus       405 -------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          405 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             -------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence                   001112234667778999999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=347.03  Aligned_cols=263  Identities=20%  Similarity=0.278  Sum_probs=204.0

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC--eeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE--EKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++....  ..++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (319)
T 4euu_A           14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC   93 (319)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred             EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence            467999999999999965 58999999997543 234677889999999999999999999998765  77999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe----CCCCcEEEEecccccccC
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLLN  512 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a~~~~  512 (670)
                      ++|.+++.....  ...+++..++.++.|++.||+|||+.    +|+||||||+|||+    +.++.+||+|||+++...
T Consensus        94 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~  167 (319)
T 4euu_A           94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE  167 (319)
T ss_dssp             CBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred             CCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence            999999986532  22489999999999999999999998    99999999999999    888889999999998765


Q ss_pred             ccc---cccccCcccCccccc--------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          513 PVQ---AIARLGGYKAPEQAE--------VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       513 ~~~---~~~~~~~y~aPE~~~--------~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      ...   ...++..|+|||++.        +..++.++|||||||++|||+||+.||......          ......+.
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~  237 (319)
T 4euu_A          168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP----------RRNKEVMY  237 (319)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCG----------GGCHHHHH
T ss_pred             CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc----------chhHHHHH
Confidence            432   345778899999885        567899999999999999999999999643211          11112222


Q ss_pred             HHhhhcc---cccc---------ccHhhhc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          582 SVVKEEW---TAEV---------FDQELLR-YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       582 ~~~~~~~---~~~~---------~d~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      .......   ....         +...+.. ..........+.+++.+||+.||++|||++|++++..+..
T Consensus       238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            2222111   0000         0000000 1122344456777888999999999999999999998765

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-41  Score=354.87  Aligned_cols=240  Identities=23%  Similarity=0.292  Sum_probs=194.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|.. .+++.||||++....   ....+.+.+|+++++.++||||+++++++.+....++||||+ 
T Consensus        13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-   91 (336)
T 3h4j_B           13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-   91 (336)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-
Confidence            346899999999999995 578999999986431   113457889999999999999999999999999999999999 


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++...... 
T Consensus        92 ~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           92 GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            789999887543     589999999999999999999999    9999999999999999999999999999876543 


Q ss_pred             --ccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        ....+++.|+|||++.+..+ ++++|||||||++|||++|+.||..................+               
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~---------------  227 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM---------------  227 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCC---------------
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---------------
Confidence              34567888999999988776 789999999999999999999997643221111110000000               


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                              .....   ..+.+++.+||+.||++|||++|++++-
T Consensus       228 --------p~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          228 --------PDFLS---PGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             --------CTTSC---HHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             --------cccCC---HHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence                    00111   2345677799999999999999999863

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=352.80  Aligned_cols=243  Identities=23%  Similarity=0.337  Sum_probs=194.5

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      +.||+|+||.||+|.. .+|+.||+|+++.......+++.+|++++++++||||+++++++.+.+..++||||+++++|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            5699999999999995 468999999998776667788999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe--CCCCcEEEEecccccccCccc---
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL--DKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      +++....    ..+++..+..++.|+++||+|||+.    +|+||||||+|||+  +.++.+||+|||+++......   
T Consensus       175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~  246 (373)
T 2x4f_A          175 DRIIDES----YNLTELDTILFMKQICEGIRHMHQM----YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK  246 (373)
T ss_dssp             HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence            9887542    2589999999999999999999998    99999999999999  667899999999998765432   


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...+++.|+|||++.+..++.++|||||||++|||+||+.||....              ....+.......+...  ..
T Consensus       247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------------~~~~~~~i~~~~~~~~--~~  310 (373)
T 2x4f_A          247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------------DAETLNNILACRWDLE--DE  310 (373)
T ss_dssp             CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHHTCCCSC--SG
T ss_pred             cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhccCCCC--hh
Confidence            3457888999999998899999999999999999999999996531              1122222222222110  00


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         ......   ..+.+++.+||+.||++|||++|++++
T Consensus       311 ---~~~~~~---~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 ---EFQDIS---EEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ---GGTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---hhccCC---HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               011122   245567779999999999999999984

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1e-40  Score=361.80  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=196.7

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|+||+||+|.. .+|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~   93 (444)
T 3soa_A           14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT   93 (444)
T ss_dssp             EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred             EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCC
Confidence            4467899999999999995 4789999999975432  345678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC---CCCcEEEEecccccccC
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLN  512 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~~  512 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++   .++.+||+|||+++...
T Consensus        94 gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~----givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           94 GGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQM----GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             CCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            999999987654     589999999999999999999998    999999999999998   46789999999998765


Q ss_pred             ccc----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          513 PVQ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       513 ~~~----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ...    ...+++.|+|||++.+..++.++||||+||++|||++|+.||....              .............
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------------~~~~~~~i~~~~~  230 (444)
T 3soa_A          165 GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------------QHRLYQQIKAGAY  230 (444)
T ss_dssp             TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------------HHHHHHHHHHTCC
T ss_pred             CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------------HHHHHHHHHhCCC
Confidence            432    3567889999999998899999999999999999999999996431              1112222222111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..     ....+....+   .+.+++.+||+.||++|||+.|+++|
T Consensus       231 ~~-----~~~~~~~~s~---~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          231 DF-----PSPEWDTVTP---EAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CC-----CTTTTTTSCH---HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CC-----CccccccCCH---HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            10     0001112222   35567779999999999999999985

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-41  Score=339.94  Aligned_cols=248  Identities=24%  Similarity=0.403  Sum_probs=203.4

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   90 (267)
T 3t9t_A           12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL   90 (267)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred             eeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcH
Confidence            3567999999999999988889999999986543 457899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++.......    
T Consensus        91 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           91 SDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             HHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            99997653    2588999999999999999999998    99999999999999999999999999998764321    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ...++..|+|||.+.+..++.++||||||+++|||++ |+.||....              ........... ...  .
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------------~~~~~~~i~~~-~~~--~  225 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------------NSEVVEDISTG-FRL--Y  225 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHHHHHHHTT-CCC--C
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------------HHHHHHHHhcC-CcC--C
Confidence             2334557999999998899999999999999999999 899986431              11111111111 000  0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .     .....   ..+.+++.+||+.||++|||+.|++++|+++...
T Consensus       226 ~-----~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          226 K-----PRLAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             C-----CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C-----CccCc---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            0     01111   2455677799999999999999999999998753

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=355.17  Aligned_cols=254  Identities=24%  Similarity=0.322  Sum_probs=201.6

Q ss_pred             HHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||+||+|.+.      +++.||||+++.. ......++.+|+.++++++||||+++++++.+....++|||
T Consensus        75 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e  154 (367)
T 3l9p_A           75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLE  154 (367)
T ss_dssp             EEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEE
Confidence            3578999999999999953      4678999999754 33455678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEeccc
Q 036639          433 YLPNGSLHSLLHGNRG--PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGL  507 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~  507 (670)
                      |+++|+|.+++.....  .....+++..++.++.|+++||+|||+.    +|+||||||+|||++.++   .+||+|||+
T Consensus       155 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kL~DFG~  230 (367)
T 3l9p_A          155 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM  230 (367)
T ss_dssp             CCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             eCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEEecCCCCceEEECCCcc
Confidence            9999999999976432  1223589999999999999999999998    999999999999999555   599999999


Q ss_pred             ccccCc------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          508 SLLLNP------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       508 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ++....      .....++..|+|||++.+..++.++|||||||++|||+| |+.||....              .....
T Consensus       231 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------------~~~~~  296 (367)
T 3l9p_A          231 ARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------------NQEVL  296 (367)
T ss_dssp             HHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------------HHHHH
T ss_pred             ccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------------HHHHH
Confidence            975422      223445778999999998999999999999999999998 999986531              11111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ......... .       .....   ...+.+++.+||+.||++|||+.||+++|+.+....
T Consensus       297 ~~i~~~~~~-~-------~~~~~---~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          297 EFVTSGGRM-D-------PPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHHTTCCC-C-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHcCCCC-C-------CCccC---CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            111111100 0       00111   224566778999999999999999999999987553

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.1e-40  Score=342.00  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=201.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CC-------CEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DG-------GIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      +.+.||+|+||+||+|... ++       ..||+|++........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        12 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   91 (289)
T 4fvq_A           12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQ   91 (289)
T ss_dssp             EEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEE
T ss_pred             eeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEE
Confidence            3467999999999999854 33       479999998776667788999999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc--------EEEE
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV--------ACIS  503 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~  503 (670)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.        +||+
T Consensus        92 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           92 EFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEEN----TLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             ECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             ECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhC----CeECCCcCcceEEEecCCcccccccceeeec
Confidence            9999999999998653    2488999999999999999999998    9999999999999998887        9999


Q ss_pred             ecccccccCccccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          504 DFGLSLLLNPVQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       504 DFG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      |||++..........++..|+|||.+.+ ..++.++||||||+++|||+||..|+....             ........
T Consensus       164 Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~-------------~~~~~~~~  230 (289)
T 4fvq_A          164 DPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL-------------DSQRKLQF  230 (289)
T ss_dssp             CCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS-------------CHHHHHHH
T ss_pred             cCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc-------------chHHHHHH
Confidence            9999988877667778889999999987 678999999999999999999655543220             01111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .........          ..   ...+.+++.+||+.||++|||+.|++++|+++....
T Consensus       231 ~~~~~~~~~----------~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          231 YEDRHQLPA----------PK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             HHTTCCCCC----------CS---SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             hhccCCCCC----------CC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            000000000          01   123556777999999999999999999999887543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=8.1e-41  Score=354.10  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=198.3

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      |.+.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        31 y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~  110 (362)
T 2bdw_A           31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV  110 (362)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence            345678999999999999964 68999999997543  234567889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEeccccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLL  511 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~  511 (670)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++   .+||+|||++...
T Consensus       111 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~  181 (362)
T 2bdw_A          111 TGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  181 (362)
T ss_dssp             CSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred             CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence            9999999987543     589999999999999999999998    999999999999998654   5999999999877


Q ss_pred             Cccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          512 NPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       512 ~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ....   ...+++.|+|||++.+..++.++|||||||++|||++|+.||....              .............
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------------~~~~~~~i~~~~~  247 (362)
T 2bdw_A          182 NDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------------QHRLYAQIKAGAY  247 (362)
T ss_dssp             TTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHTCC
T ss_pred             cCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------------HHHHHHHHHhCCC
Confidence            5432   3567888999999998899999999999999999999999996431              1112222221111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..   .  ...+....   ..+.+++.+||+.||++|||+.|++++
T Consensus       248 ~~---~--~~~~~~~~---~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          248 DY---P--SPEWDTVT---PEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CC---C--TTGGGGSC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CC---C--cccccCCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00   0  00011122   235567779999999999999999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-41  Score=352.72  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=202.3

Q ss_pred             HHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||.||+|...      +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        51 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  130 (343)
T 1luf_A           51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE  130 (343)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEe
Confidence            4578999999999999964      34889999998653 3345789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeE
Q 036639          433 YLPNGSLHSLLHGNRGP-------------------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL  493 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIl  493 (670)
                      |+++|+|.+++......                   ....+++..++.++.|+++||+|||+.    +|+||||||+|||
T Consensus       131 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl  206 (343)
T 1luf_A          131 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL  206 (343)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred             cCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEE
Confidence            99999999999764311                   114689999999999999999999998    9999999999999


Q ss_pred             eCCCCcEEEEecccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCC
Q 036639          494 LDKNGVACISDFGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPR  566 (670)
Q Consensus       494 l~~~~~~kl~DFG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~  566 (670)
                      ++.++.+||+|||+++.....      ....++..|+|||.+.+..++.++||||||+++|||+| |+.||....     
T Consensus       207 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----  281 (343)
T 1luf_A          207 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-----  281 (343)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----
T ss_pred             ECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC-----
Confidence            999999999999999765432      23345667999999998899999999999999999999 999986431     


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                               .............. . .      ....   ...+.+++.+||+.||++|||+.|++++|+++....
T Consensus       282 ---------~~~~~~~~~~~~~~-~-~------~~~~---~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          282 ---------HEEVIYYVRDGNIL-A-C------PENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             ---------HHHHHHHHHTTCCC-C-C------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             ---------hHHHHHHHhCCCcC-C-C------CCCC---CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence                     11111111111110 0 0      0111   234566777999999999999999999999987543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5e-41  Score=354.50  Aligned_cols=250  Identities=19%  Similarity=0.302  Sum_probs=197.7

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-----CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-----NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      .|.+.+.||+|+||+||+|... +|+.||||++...     .....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus        25 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv  104 (351)
T 3c0i_A           25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMV  104 (351)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            3456688999999999999964 6899999998632     122467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc---EEEEeccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV---ACISDFGL  507 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~  507 (670)
                      |||+++++|.+++..... ....+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.   +||+|||+
T Consensus       105 ~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          105 FEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDN----NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999888764321 122488999999999999999999998    9999999999999987655   99999999


Q ss_pred             ccccCcc----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          508 SLLLNPV----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       508 a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ++.....    ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....               .......
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------------~~~~~~i  244 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------------ERLFEGI  244 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------------HHHHHHH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------------HHHHHHH
Confidence            9876543    23457888999999998899999999999999999999999996420               1111122


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ......   +.+.  .+....   ..+.+++.+||+.||++|||+.|+++|
T Consensus       245 ~~~~~~---~~~~--~~~~~s---~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          245 IKGKYK---MNPR--QWSHIS---ESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HHTCCC---CCHH--HHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HcCCCC---CCcc--ccccCC---HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            211110   0110  011112   345567779999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.1e-41  Score=358.75  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=200.5

Q ss_pred             HHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCe-eEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEE-KLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~-~~l  429 (670)
                      .+.+.||+|+||.||+|.+      .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++.+.+. .++
T Consensus        25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i  104 (359)
T 3vhe_A           25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  104 (359)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred             eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence            4457899999999999983      2467899999986533 3456799999999999 79999999999988654 899


Q ss_pred             EEeccCCCChHHHhccCCCCC-----------------------------------------------------------
Q 036639          430 VYDYLPNGSLHSLLHGNRGPG-----------------------------------------------------------  450 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~-----------------------------------------------------------  450 (670)
                      ||||+++|+|.++++......                                                           
T Consensus       105 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (359)
T 3vhe_A          105 IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPED  184 (359)
T ss_dssp             EEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------C
T ss_pred             EEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccc
Confidence            999999999999998654210                                                           


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc------ccccccCc
Q 036639          451 --RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV------QAIARLGG  522 (670)
Q Consensus       451 --~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~------~~~~~~~~  522 (670)
                        ...+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....      ....++..
T Consensus       185 ~~~~~l~~~~~~~~~~ql~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~  260 (359)
T 3vhe_A          185 LYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK  260 (359)
T ss_dssp             TTTTCBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred             hhccccCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence              11288999999999999999999998    9999999999999999999999999999866332      22345667


Q ss_pred             ccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhccc
Q 036639          523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYK  601 (670)
Q Consensus       523 y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  601 (670)
                      |+|||++.+..++.++|||||||++|||+| |+.||......              ..+............       ..
T Consensus       261 y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------------~~~~~~~~~~~~~~~-------~~  319 (359)
T 3vhe_A          261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRA-------PD  319 (359)
T ss_dssp             GCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--------------HHHHHHHHHTCCCCC-------CT
T ss_pred             eEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--------------HHHHHHHHcCCCCCC-------CC
Confidence            999999998999999999999999999999 99999654211              111111111111000       01


Q ss_pred             chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          602 NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       602 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ..   ...+.+++.+||+.||++|||++||+++|+++...
T Consensus       320 ~~---~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          320 YT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            11   12456677799999999999999999999998753

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.3e-41  Score=353.08  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=191.5

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe----eEEEEe
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE----KLLVYD  432 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~----~~lv~e  432 (670)
                      .+.||+|+||.||+|+. .+++.||||+++...   ....+.+.+|++++++++||||+++++++.....    .++|||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e   96 (311)
T 3ork_A           17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   96 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence            46899999999999995 578999999997643   2334678899999999999999999999876553    399999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.++++...     .+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++...
T Consensus        97 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           97 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence            999999999997643     589999999999999999999998    99999999999999999999999999998764


Q ss_pred             cc-------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          513 PV-------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       513 ~~-------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ..       ....++..|+|||++.+..++.++||||||+++|||+||+.||....              ..........
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--------------~~~~~~~~~~  233 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------------PVSVAYQHVR  233 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------------HHHHHHHHHH
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHhc
Confidence            32       22347888999999999999999999999999999999999996531              1111111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHH-HHHHHHhhhccCC
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE-VAKMIEDIRVEQS  643 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-vl~~L~~i~~~~~  643 (670)
                      ....    .+. .......   ..+.+++.+||+.||++||++.+ +...+.++.....
T Consensus       234 ~~~~----~~~-~~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~  284 (311)
T 3ork_A          234 EDPI----PPS-ARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEP  284 (311)
T ss_dssp             CCCC----CHH-HHSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCC
T ss_pred             CCCC----Ccc-cccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCC
Confidence            1110    000 0011122   24556777999999999996555 4456666654443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=340.79  Aligned_cols=256  Identities=27%  Similarity=0.408  Sum_probs=195.3

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      .+.||+|+||+||+|... ++.||||++....  ..+.+.+|++++++++||||+++++++.  +..++||||+++|+|.
T Consensus        13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~   87 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLY   87 (307)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHH
T ss_pred             eeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHH
Confidence            467999999999999986 7899999997543  5678999999999999999999999876  4579999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc-EEEEecccccccCc-ccccc
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV-ACISDFGLSLLLNP-VQAIA  518 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFG~a~~~~~-~~~~~  518 (670)
                      ++++...  ....+++..++.++.|+++||+|||+.. ..+|+||||||+||+++.++. +||+|||++..... .....
T Consensus        88 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (307)
T 2eva_A           88 NVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK  164 (307)
T ss_dssp             HHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred             HHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence            9998653  1224788999999999999999999831 128999999999999998886 79999999986643 23446


Q ss_pred             ccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhh
Q 036639          519 RLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELL  598 (670)
Q Consensus       519 ~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  598 (670)
                      ++..|+|||++.+..++.++||||||+++|||+||+.||.....            ............. ....      
T Consensus       165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------------~~~~~~~~~~~~~-~~~~------  225 (307)
T 2eva_A          165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------------PAFRIMWAVHNGT-RPPL------  225 (307)
T ss_dssp             CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------------SHHHHHHHHHTTC-CCCC------
T ss_pred             CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------------cHHHHHHHHhcCC-CCCc------
Confidence            78889999999999999999999999999999999999964311            0011111111110 0000      


Q ss_pred             cccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCCCC
Q 036639          599 RYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGE  647 (670)
Q Consensus       599 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~  647 (670)
                       .....   ..+.+++.+||+.||++|||++|++++|+.+........+
T Consensus       226 -~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~  270 (307)
T 2eva_A          226 -IKNLP---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE  270 (307)
T ss_dssp             -BTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred             -ccccC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence             01112   2455677799999999999999999999999876644443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.2e-40  Score=361.28  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=200.7

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC-eeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE-EKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|.+. |+.||||+++...  ..+.+.+|++++++++||||+++++++.+.. ..++||||+++|+
T Consensus       197 ~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~  273 (450)
T 1k9a_A          197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS  273 (450)
T ss_dssp             EEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCB
T ss_pred             EEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCc
Confidence            4578999999999999986 7899999998654  4678999999999999999999999988765 7899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-ccc
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-QAI  517 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  517 (670)
                      |.++++...   ...+++..++.++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus       274 L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  346 (450)
T 1k9a_A          274 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG  346 (450)
T ss_dssp             HHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence            999998643   22478999999999999999999998    9999999999999999999999999999865432 223


Q ss_pred             cccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          518 ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       518 ~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      .++..|+|||.+.+..++.++|||||||++|||+| |+.||......           .....    +.......     
T Consensus       347 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----------~~~~~----i~~~~~~~-----  406 (450)
T 1k9a_A          347 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----------DVVPR----VEKGYKMD-----  406 (450)
T ss_dssp             CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----------THHHH----HHTTCCCC-----
T ss_pred             CCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----------HHHHH----HHcCCCCC-----
Confidence            45667999999999999999999999999999999 99999654211           11111    11111000     


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                           ........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       407 -----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          407 -----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             -----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence                 00111234566777999999999999999999999987543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.3e-41  Score=340.00  Aligned_cols=243  Identities=27%  Similarity=0.415  Sum_probs=186.4

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc----chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP----CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||+|... |+.||||+++....    ...+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   90 (271)
T 3dtc_A           12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG   90 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred             eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence            467999999999999975 89999999875422    2357789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC---ccccCCCCCCeEeCC--------CCcEEEEec
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK---VPHGNVKSSNVLLDK--------NGVACISDF  505 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~---ivH~Dlkp~NIll~~--------~~~~kl~DF  505 (670)
                      ++|.+++...      .+++..+..++.|++.||+|||+.    +   |+||||||+||+++.        ++.+||+||
T Consensus        91 ~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~----~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           91 GPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDE----AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHS----SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             CCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC----CCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            9999999643      489999999999999999999998    6   999999999999986        678999999


Q ss_pred             ccccccCcc--ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          506 GLSLLLNPV--QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       506 G~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      |+++.....  ....++..|+|||.+.+..++.++||||||+++|||+||+.||....              ........
T Consensus       161 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------~~~~~~~~  226 (271)
T 3dtc_A          161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------GLAVAYGV  226 (271)
T ss_dssp             CC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--------------HHHHHHHH
T ss_pred             CcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHhh
Confidence            999876442  23567888999999998899999999999999999999999996531              01111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ........ .      ....   ...+.+++.+||+.||++|||+.|++++|+++
T Consensus       227 ~~~~~~~~-~------~~~~---~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          227 AMNKLALP-I------PSTC---PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HTSCCCCC-C------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             hcCCCCCC-C------Cccc---CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            11111000 0      0111   23456677799999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.2e-41  Score=350.36  Aligned_cols=258  Identities=24%  Similarity=0.374  Sum_probs=191.3

Q ss_pred             HHHHHhHcCCCCceEEEEEEEcC-CC---EEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCee---
Q 036639          357 LRASAEMLGKGSLGTVYKAVLDD-GG---IVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK---  427 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~~-g~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~---  427 (670)
                      .|.+.+.||+|+||.||+|.... +.   .||||+++..  .....+.+.+|++++++++||||+++++++......   
T Consensus        24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (323)
T 3qup_A           24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL  103 (323)
T ss_dssp             -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred             HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence            34456789999999999999553 32   8999999764  334567899999999999999999999999887655   


Q ss_pred             ---EEEEeccCCCChHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEE
Q 036639          428 ---LLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS  503 (670)
Q Consensus       428 ---~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~  503 (670)
                         ++||||+++|+|.+++..... .....+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+
T Consensus       104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR----NFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC----CcccCCCCcceEEEcCCCCEEEe
Confidence               999999999999999864321 1223589999999999999999999998    99999999999999999999999


Q ss_pred             ecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccch
Q 036639          504 DFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       504 DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      |||+++......      ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.....           .. 
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------~~-  247 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----------AE-  247 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GG-
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----------HH-
Confidence            999998764322      2334557999999998999999999999999999999 8999865411           11 


Q ss_pred             hHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       577 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                        ............           ........+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus       248 --~~~~~~~~~~~~-----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          248 --IYNYLIGGNRLK-----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             --HHHHHHTTCCCC-----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             --HHHHHhcCCCCC-----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence              111111111000           001112346677789999999999999999999999987653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-40  Score=345.67  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=192.9

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||+||+|...+|+.||||++....  ....+.+.+|++++++++||||+++++++.+....++||||++ ++
T Consensus        26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~  104 (311)
T 3niz_A           26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KD  104 (311)
T ss_dssp             EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EE
T ss_pred             hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CC
Confidence            46799999999999999889999999997542  2245778899999999999999999999999999999999997 48


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----V  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~  514 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....    .
T Consensus       105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  176 (311)
T 3niz_A          105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQH----RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY  176 (311)
T ss_dssp             HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred             HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence            888887543    2489999999999999999999998    999999999999999999999999999987643    2


Q ss_pred             ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh----ccc
Q 036639          515 QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE----EWT  589 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~  589 (670)
                      ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.......          .+.. +......    .|.
T Consensus       177 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----------~~~~-i~~~~~~~~~~~~~  245 (311)
T 3niz_A          177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----------QLPK-IFSILGTPNPREWP  245 (311)
T ss_dssp             -CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----------HHHH-HHHHHCCCCTTTSG
T ss_pred             cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----------HHHH-HHHHHCCCChHHhh
Confidence            23456888999999876 568999999999999999999999997543221          1111 1111100    000


Q ss_pred             c------------ccccHh--hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 A------------EVFDQE--LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~------------~~~d~~--~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .            ..+...  ......   ...++.+++.+||+.||++|||++|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPG---FCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTT---CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhccchhhhcccccccCCcHHHhCcc---cCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0            000000  000001   11345677789999999999999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-40  Score=348.61  Aligned_cols=242  Identities=19%  Similarity=0.313  Sum_probs=191.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------------
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------------  425 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------------  425 (670)
                      +.+.||+|+||.||+|+.. +|+.||||+++.. .....+.+.+|++++++++||||+++++++.+..            
T Consensus        10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~   89 (332)
T 3qd2_B           10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIW   89 (332)
T ss_dssp             EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--
T ss_pred             eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhh
Confidence            4578999999999999975 7999999999753 3345688999999999999999999999986643            


Q ss_pred             ---------------------------------------------eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHH
Q 036639          426 ---------------------------------------------EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRI  460 (670)
Q Consensus       426 ---------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~  460 (670)
                                                                   ..++||||+++++|.+++.....  .....+..++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~  167 (332)
T 3qd2_B           90 LKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCL  167 (332)
T ss_dssp             ------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCHHHHH
T ss_pred             hccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhhHHHH
Confidence                                                         27899999999999999986542  2346778899


Q ss_pred             HHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----------------ccccccCccc
Q 036639          461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----------------QAIARLGGYK  524 (670)
Q Consensus       461 ~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----------------~~~~~~~~y~  524 (670)
                      .++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....                ....+++.|+
T Consensus       168 ~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          168 HIFIQIAEAVEFLHSK----GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHhC----CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            9999999999999998    9999999999999999999999999999876543                1235778899


Q ss_pred             CccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchH
Q 036639          525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIE  604 (670)
Q Consensus       525 aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  604 (670)
                      |||++.+..++.++|||||||++|||++|..|+...                ...........     +..      ...
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----------------~~~~~~~~~~~-----~~~------~~~  296 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----------------VRIITDVRNLK-----FPL------LFT  296 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----------------HHHHHHHHTTC-----CCH------HHH
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----------------HHHHHHhhccC-----CCc------ccc
Confidence            999999999999999999999999999987664210                01111111100     000      111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          605 EELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       605 ~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....+.+++.+||+.||++|||++|++++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            222345678889999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-41  Score=347.54  Aligned_cols=240  Identities=23%  Similarity=0.315  Sum_probs=187.1

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--------------------------chHHHHHHHHHHHhccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--------------------------CARKEFEQYMDVIGKLKHPN  413 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~n  413 (670)
                      .+.||+|+||.||+|.. .+++.||||++.....                          ...+.+.+|++++++++|||
T Consensus        18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   97 (298)
T 2zv2_A           18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN   97 (298)
T ss_dssp             EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence            46799999999999995 4689999999965421                          11356889999999999999


Q ss_pred             eeeEEEEEEe--CCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCC
Q 036639          414 VVKLRAYYYA--KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSN  491 (670)
Q Consensus       414 Iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~N  491 (670)
                      |+++++++.+  .+..++||||+++++|.+++...      .+++..+..++.|+++||+|||+.    +|+||||||+|
T Consensus        98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~N  167 (298)
T 2zv2_A           98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------PLSEDQARFYFQDLIKGIEYLHYQ----KIIHRDIKPSN  167 (298)
T ss_dssp             BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGG
T ss_pred             CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHH
Confidence            9999999987  56789999999999998875432      589999999999999999999998    99999999999


Q ss_pred             eEeCCCCcEEEEecccccccCcc----ccccccCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCC
Q 036639          492 VLLDKNGVACISDFGLSLLLNPV----QAIARLGGYKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAPSQYPSPTR  564 (670)
Q Consensus       492 Ill~~~~~~kl~DFG~a~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~  564 (670)
                      ||++.++.+||+|||+++.....    ....+++.|+|||.+.+..   ++.++|||||||++|||++|+.||...    
T Consensus       168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~----  243 (298)
T 2zv2_A          168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE----  243 (298)
T ss_dssp             EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS----
T ss_pred             EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc----
Confidence            99999999999999999876542    2346788899999997655   478899999999999999999999643    


Q ss_pred             CCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          565 PRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                                ................       .......   ..+.+++.+||+.||++|||+.|+++|
T Consensus       244 ----------~~~~~~~~~~~~~~~~-------~~~~~~~---~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          244 ----------RIMCLHSKIKSQALEF-------PDQPDIA---EDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             ----------SHHHHHHHHHHCCCCC-------CSSSCCC---HHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ----------cHHHHHHHHhcccCCC-------CCccccC---HHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence                      1111111111111000       0001122   245567779999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.3e-41  Score=358.62  Aligned_cols=195  Identities=24%  Similarity=0.321  Sum_probs=170.3

Q ss_pred             HHhHcCCC--CceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKG--SLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|  +||+||+|+.. +|+.||||+++...  ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  108 (389)
T 3gni_B           29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM  108 (389)
T ss_dssp             EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence            34689999  99999999965 79999999997542  334577889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.+++.....   ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||.+..... 
T Consensus       109 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~  181 (389)
T 3gni_B          109 AYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHM----GYVHRSVKASHILISVDGKVYLSGLRSNLSMISH  181 (389)
T ss_dssp             TTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred             CCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence            99999999986531   2489999999999999999999998    999999999999999999999999998865422 


Q ss_pred             ----------cccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 036639          514 ----------VQAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPS  561 (670)
Q Consensus       514 ----------~~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~~  561 (670)
                                .....++..|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  241 (389)
T 3gni_B          182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  241 (389)
T ss_dssp             TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCC
Confidence                      112356777999999987  679999999999999999999999997643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4e-41  Score=351.08  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=192.5

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||+||+|... +++.||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~   91 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence            468999999999999965 789999999964432 234678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----  513 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-----  513 (670)
                      |.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....     
T Consensus        92 L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           92 LFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             GGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            999997653     489999999999999999999998    999999999999999999999999999986532     


Q ss_pred             -cccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                       .....+++.|+|||++.+..+ +.++|||||||++|||+||+.||......         ......+    ......  
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~~~~----~~~~~~--  227 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---------CQEYSDW----KEKKTY--  227 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---------SHHHHHH----HTTCTT--
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---------HHHHHHH----hccccc--
Confidence             123567888999999987765 77999999999999999999999754211         0011111    111000  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ..    ......   ..+.+++.+||+.||++|||++|++++
T Consensus       228 -~~----~~~~~~---~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 -LN----PWKKID---SAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -ST----TGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CC----ccccCC---HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             00    001112   234567779999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=343.81  Aligned_cols=240  Identities=23%  Similarity=0.331  Sum_probs=197.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|+.. +|+.||+|++++..   ....+.+.+|..+++.++||||+++++++.+....|+||||++
T Consensus        10 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~   89 (318)
T 1fot_A           10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE   89 (318)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCC
Confidence            3468999999999999965 79999999997532   1245678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        90 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~  160 (318)
T 1fot_A           90 GGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  160 (318)
T ss_dssp             SCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChheEEEcCCCCEEEeecCcceecCCcc
Confidence            999999998654     589999999999999999999988    9999999999999999999999999999876543 


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||....              ..............   + 
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------------~~~~~~~i~~~~~~---~-  222 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------------TMKTYEKILNAELR---F-  222 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHHCCCC---C-
T ss_pred             ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCCC---C-
Confidence            34568889999999999999999999999999999999999996431              11222222222110   0 


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                           .....+   .+.+++.+||..||++||     +++|+++|
T Consensus       223 -----p~~~~~---~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          223 -----PPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             -----CTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----CCCCCH---HHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                 011222   345567799999999999     89999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=352.26  Aligned_cols=239  Identities=22%  Similarity=0.299  Sum_probs=192.9

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|+||+||+|+.. +|+.||||++++.   .....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus        28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  107 (353)
T 3txo_A           28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN  107 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence            468999999999999965 6899999999753   122456678899999988 79999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....  
T Consensus       108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDK----GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            999999997654     589999999999999999999998    999999999999999999999999999986432  


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+              ..............  
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------------~~~~~~~i~~~~~~--  242 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------------EDDLFEAILNDEVV--  242 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC--
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------------HHHHHHHHHcCCCC--
Confidence              234568889999999998899999999999999999999999996541              11222222222110  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM------AEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  634 (670)
                       +      .....+   .+.+++.+||+.||++||++      +|+++|
T Consensus       243 -~------p~~~~~---~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          243 -Y------PTWLHE---DATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             -C------CTTSCH---HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             -C------CCCCCH---HHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence             0      011122   34557779999999999998      788764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.1e-40  Score=341.69  Aligned_cols=257  Identities=21%  Similarity=0.293  Sum_probs=193.9

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.||+|+||+||+|.. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            5699999999999994 57999999999876555678899999999885 799999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc---EEEEecccccccCcc--
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV---ACISDFGLSLLLNPV--  514 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~~~~~--  514 (670)
                      .+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.   +||+|||++......  
T Consensus        99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNK----GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            99997643     589999999999999999999998    9999999999999998776   999999998765321  


Q ss_pred             ---------ccccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          515 ---------QAIARLGGYKAPEQAEV-----KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       515 ---------~~~~~~~~y~aPE~~~~-----~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                               ....++..|+|||++..     ..++.++|||||||++|||+||+.||......................+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                     12347788999999865     5689999999999999999999999976543322111111110001111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...+..... . +...  ......   ..+.+++.+||+.||++|||++|+++|
T Consensus       250 ~~~i~~~~~-~-~~~~--~~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          250 FESIQEGKY-E-FPDK--DWAHIS---CAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHCCC-C-CCHH--HHTTSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHhccCc-c-cCch--hcccCC---HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            111111100 0 0000  001111   345667779999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=352.73  Aligned_cols=245  Identities=22%  Similarity=0.394  Sum_probs=199.8

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+....++||||+++|+
T Consensus        55 i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~  134 (387)
T 1kob_A           55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE  134 (387)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred             EEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCc
Confidence            4578999999999999964 689999999987666567789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC--CCcEEEEecccccccCcc--
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK--NGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~~--  514 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.  ++.+||+|||+++.....  
T Consensus       135 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          135 LFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             HHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence            999987542    2589999999999999999999998    9999999999999974  477999999999877543  


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+|+.|+|||++.+..++.++|||||||++|||+||+.||....              ....+.......+..   
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------------~~~~~~~i~~~~~~~---  269 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------------DLETLQNVKRCDWEF---  269 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------------HHHHHHHHHHCCCCC---
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCCCC---
Confidence             23467888999999999999999999999999999999999996531              111122222211110   


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +..  ......   ..+.+++.+||+.||++|||+.|++++
T Consensus       270 ~~~--~~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 DED--AFSSVS---PEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CSS--TTTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             Ccc--ccccCC---HHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            000  011122   245567779999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.3e-40  Score=346.63  Aligned_cols=252  Identities=16%  Similarity=0.165  Sum_probs=201.6

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||+||+|.. .+|+.||||++....  ..+.+.+|+++++++ +||||+++++++.+.+..++||||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPS   90 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCC
Confidence            46799999999999995 578999999997543  234688999999999 9999999999999999999999999 999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc-----EEEEecccccccCc
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV-----ACISDFGLSLLLNP  513 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFG~a~~~~~  513 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.     +||+|||+++....
T Consensus        91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           91 LEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSK----NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             HHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            999998642    2589999999999999999999998    9999999999999999887     99999999986533


Q ss_pred             c-----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          514 V-----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       514 ~-----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      .           ....+|..|+|||++.+..++.++|||||||++|||++|+.||.....           ......+..
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-----------~~~~~~~~~  231 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-----------DTLKERYQK  231 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----------SSHHHHHHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-----------ccHHHHHHH
Confidence            2           245678889999999999999999999999999999999999975421           112121211


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .......   ...... .....    .+.+++..||+.||.+||++++|++.|+++....
T Consensus       232 i~~~~~~---~~~~~~-~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          232 IGDTKRA---TPIEVL-CENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHH---SCHHHH-TTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhhhcc---CCHHHH-hccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            1111000   000000 00111    5667777999999999999999999999987654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.4e-41  Score=352.45  Aligned_cols=270  Identities=24%  Similarity=0.365  Sum_probs=201.1

Q ss_pred             HHhHcCCCCceEEEEEEE-----cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL-----DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e  432 (670)
                      +.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....++|||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e  106 (327)
T 3lxl_A           27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME  106 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEE
T ss_pred             hhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEe
Confidence            357899999999999984     3688999999988776677889999999999999999999999874  456889999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.+++....    ..+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++...
T Consensus       107 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          107 YLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSR----RCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             ecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            999999999997643    1489999999999999999999998    99999999999999999999999999998764


Q ss_pred             ccc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          513 PVQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       513 ~~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ...       ...++..|+|||++.+..++.++||||||+++|||++|+.||......................+.....
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            322       2335556999999998889999999999999999999999985421100000000000000011111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCCCC
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGE  647 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~  647 (670)
                      ....          ..........+.+++.+||+.||++|||+.|++++|+.+.........
T Consensus       259 ~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~  310 (327)
T 3lxl_A          259 EGQR----------LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET  310 (327)
T ss_dssp             TTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred             cccC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence            1100          001111223466777799999999999999999999999766544433

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=8.1e-41  Score=347.23  Aligned_cols=254  Identities=29%  Similarity=0.404  Sum_probs=202.4

Q ss_pred             HHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|..      .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  105 (314)
T 2ivs_A           26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIV  105 (314)
T ss_dssp             EEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEE
Confidence            3457899999999999985      245789999997643 334578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCe
Q 036639          432 DYLPNGSLHSLLHGNRGP-------------------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV  492 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NI  492 (670)
                      ||+++++|.+++......                   ....+++..++.++.|+++||+|||+.    +|+||||||+||
T Consensus       106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dikp~NI  181 (314)
T 2ivs_A          106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM----KLVHRDLAARNI  181 (314)
T ss_dssp             ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGE
T ss_pred             eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC----CCcccccchheE
Confidence            999999999999865421                   112478999999999999999999998    999999999999


Q ss_pred             EeCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 036639          493 LLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRP  565 (670)
Q Consensus       493 ll~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~  565 (670)
                      +++.++.+||+|||+++......      ...++..|+|||.+.+..++.++||||||+++|||+| |+.||.....   
T Consensus       182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---  258 (314)
T 2ivs_A          182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP---  258 (314)
T ss_dssp             EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence            99999999999999998764322      2234566999999998889999999999999999999 9999965421   


Q ss_pred             CCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          566 RVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                              ..+...    +.......       ......   ..+.+++.+||+.||++|||+.|++++|+++..+
T Consensus       259 --------~~~~~~----~~~~~~~~-------~~~~~~---~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 --------ERLFNL----LKTGHRME-------RPDNCS---EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             --------GGHHHH----HHTTCCCC-------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------HHHHHH----hhcCCcCC-------CCccCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence                    111111    11111000       001112   3456677799999999999999999999998754

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.9e-41  Score=346.41  Aligned_cols=256  Identities=25%  Similarity=0.361  Sum_probs=204.6

Q ss_pred             HHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      .+.+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        26 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  105 (313)
T 1t46_A           26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI  105 (313)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEE
Confidence            4567899999999999985      3468899999986533 3457899999999999 999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          431 YDYLPNGSLHSLLHGNRGP-------------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      |||+++|+|.+++......             ....+++..++.++.|+++||+|||+.    +|+||||||+||+++.+
T Consensus       106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~  181 (313)
T 1t46_A          106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHG  181 (313)
T ss_dssp             EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETT
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCccceEEEcCC
Confidence            9999999999999865421             123589999999999999999999998    99999999999999999


Q ss_pred             CcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccc
Q 036639          498 GVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  570 (670)
                      +.+||+|||+++......      ...++..|+|||.+.+..++.++||||||+++|||+| |+.||......       
T Consensus       182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------  254 (313)
T 1t46_A          182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-------  254 (313)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-------
T ss_pred             CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-------
Confidence            999999999998765432      2234567999999988899999999999999999999 99998654110       


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                             ..+........... .      ....   ...+.+++.+||+.||++|||+.|++++|+++..+.
T Consensus       255 -------~~~~~~~~~~~~~~-~------~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 -------SKFYKMIKEGFRML-S------PEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             -------HHHHHHHHHTCCCC-C------CTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -------hHHHHHhccCCCCC-C------cccC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence                   11111121111100 0      0111   234566777999999999999999999999987654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9e-41  Score=341.36  Aligned_cols=249  Identities=24%  Similarity=0.367  Sum_probs=190.0

Q ss_pred             HHHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||.||+|....    +..||+|+++... ....+.+.+|+.++++++||||+++++++ ..+..++||||
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~   96 (281)
T 1mp8_A           18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMEL   96 (281)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred             EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEec
Confidence            445789999999999999642    4579999987643 33467889999999999999999999997 45678999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++++|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           97 CTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             CTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecccccHHHEEECCCCCEEECccccccccCc
Confidence            99999999997543    2589999999999999999999998    999999999999999999999999999987654


Q ss_pred             cc-----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 VQ-----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 ~~-----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ..     ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....           ....   .......
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----------~~~~---~~i~~~~  234 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVI---GRIENGE  234 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHH---HHHHTTC
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----------HHHH---HHHHcCC
Confidence            22     2234557999999998899999999999999999997 9999965311           1111   1111111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .. . .      .....   ..+.+++.+||+.||++|||+.|++++|+++..+
T Consensus       235 ~~-~-~------~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          235 RL-P-M------PPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             CC-C-C------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC-C-C------CCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00 0 0      01112   3455677799999999999999999999998654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.5e-40  Score=364.86  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=203.4

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||.||+|.+. ++..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus       223 ~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g  301 (495)
T 1opk_A          223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG  301 (495)
T ss_dssp             EEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred             eeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCC
Confidence            34578999999999999976 488999999986543 5688999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.++++...   ...+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++......  
T Consensus       302 ~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  374 (495)
T 1opk_A          302 NLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT  374 (495)
T ss_dssp             BHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred             CHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence            9999998643   23589999999999999999999998    99999999999999999999999999998765322  


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ...++..|+|||++....++.++|||||||++|||+| |+.||.....           ..+...    +.......
T Consensus       375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----------~~~~~~----~~~~~~~~  439 (495)
T 1opk_A          375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------SQVYEL----LEKDYRME  439 (495)
T ss_dssp             CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------GGHHHH----HHTTCCCC
T ss_pred             ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----------HHHHHH----HHcCCCCC
Confidence               1223456999999998899999999999999999999 9999865311           111111    11111000


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                             ....   ....+.+++.+||+.||++|||+.||++.|+.+...
T Consensus       440 -------~~~~---~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          440 -------RPEG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             -------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             -------CCCC---CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence                   0111   123456677899999999999999999999988644

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.2e-40  Score=346.20  Aligned_cols=248  Identities=22%  Similarity=0.357  Sum_probs=193.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCC----EEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      ..+.||+|+||+||+|++. +++    .||+|.++.. .....+++.+|++++++++||||+++++++.+.. .++|+||
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~   97 (327)
T 3poz_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL   97 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEEC
T ss_pred             cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEe
Confidence            3478999999999999954 444    3688888643 2345678999999999999999999999998764 7899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.+++....    ..+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           98 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             CTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             cCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            99999999998653    2589999999999999999999998    999999999999999999999999999987643


Q ss_pred             cc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          514 VQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       514 ~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ..      ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....           ..+...    +..
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----------~~~~~~----~~~  234 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------SEISSI----LEK  234 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHHH----HHT
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----------HHHHHH----HHc
Confidence            22      2234557999999999999999999999999999999 9999965311           111111    111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ....          .........+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       235 ~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          235 GERL----------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TCCC----------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCC----------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1000          00111223466788899999999999999999999998653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.9e-40  Score=360.52  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=198.1

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||.||+|.+.++..||||+++.... ..+++.+|++++++++||||+++++++.+ +..++||||+++|+|
T Consensus       188 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL  265 (452)
T 1fmk_A          188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL  265 (452)
T ss_dssp             EEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBH
T ss_pred             eeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCH
Confidence            4568999999999999998888899999986543 46789999999999999999999999866 678999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .++++...   ...+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++......    
T Consensus       266 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          266 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence            99997532   12488999999999999999999998    99999999999999999999999999998764322    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ...++..|+|||.+....++.++|||||||++|||+| |+.||....              ....... +......   
T Consensus       339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~--------------~~~~~~~-i~~~~~~---  400 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------------NREVLDQ-VERGYRM---  400 (452)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--------------HHHHHHH-HHTTCCC---
T ss_pred             cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC--------------HHHHHHH-HHcCCCC---
Confidence             2234557999999998899999999999999999999 999986431              1111111 1111100   


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                             .........+.+++.+||+.||++|||+++|++.|+++....
T Consensus       401 -------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          401 -------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             -------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                   001112234666778999999999999999999999987554

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-40  Score=353.91  Aligned_cols=249  Identities=19%  Similarity=0.263  Sum_probs=193.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||+||+|+.. +++.||||++++...   ...+.+..|..++.++ +||||+++++++.+.+..++||||+
T Consensus        56 ~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~  135 (396)
T 4dc2_A           56 LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYV  135 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcC
Confidence            3578999999999999965 688999999975422   2234578899999877 8999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|..++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.... 
T Consensus       136 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          136 NGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999997643     589999999999999999999998    999999999999999999999999999986322 


Q ss_pred             ---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 ---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                         .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.........      .......+...+..... 
T Consensus       207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~------~~~~~~~~~~~i~~~~~-  279 (396)
T 4dc2_A          207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP------DQNTEDYLFQVILEKQI-  279 (396)
T ss_dssp             TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------------CCHHHHHHHHHHCCC-
T ss_pred             CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccccc------chhhHHHHHHHHhcccc-
Confidence               33456888999999999999999999999999999999999999654221110      00111111111111100 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM------AEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  634 (670)
                             ........   .+.+++.+||+.||++||++      +|+++|
T Consensus       280 -------~~p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 -------RIPRSLSV---KAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             -------CCCTTSCH---HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             -------CCCCcCCH---HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                   00011222   35567779999999999995      677764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.1e-40  Score=344.97  Aligned_cols=240  Identities=22%  Similarity=0.294  Sum_probs=187.6

Q ss_pred             HHhHcCCCCceEEEEEEE----cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      +.+.||+|+||.||+++.    .+|+.||+|+++...    ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        21 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  100 (327)
T 3a62_A           21 LLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLIL  100 (327)
T ss_dssp             EEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             EEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEE
Confidence            347899999999999996    478999999998642    223456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A          101 EYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQK----GIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             ECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             eCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            9999999999997543     488999999999999999999998    9999999999999999999999999999764


Q ss_pred             Cc----cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          512 NP----VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       512 ~~----~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ..    .....+++.|+|||++.+..++.++|||||||++|||++|+.||....              ....+.......
T Consensus       172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------------~~~~~~~i~~~~  237 (327)
T 3a62_A          172 IHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------------RKKTIDKILKCK  237 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------------HHHHHHHHHHTC
T ss_pred             ccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------------HHHHHHHHHhCC
Confidence            32    223467888999999998899999999999999999999999996531              111222222211


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      ..   +      .....   ..+.+++.+||+.||++||     +++|+++|
T Consensus       238 ~~---~------p~~~~---~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 LN---L------PPYLT---QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             CC---C------CTTSC---HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CC---C------CCCCC---HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            10   0      01112   2355677799999999999     78898875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.2e-40  Score=348.74  Aligned_cols=258  Identities=18%  Similarity=0.195  Sum_probs=194.4

Q ss_pred             HhHcCCCCceEEEEEEEcC------CCEEEEEEeCCCCcchH-----------HHHHHHHHHHhccCCCCeeeEEEEEEe
Q 036639          361 AEMLGKGSLGTVYKAVLDD------GGIVAVKRLKDANPCAR-----------KEFEQYMDVIGKLKHPNVVKLRAYYYA  423 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~nIv~l~~~~~~  423 (670)
                      .+.||+|+||.||+|.+..      ++.||||++........           ..+..|+..+..++||||+++++++..
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  119 (364)
T 3op5_A           40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH  119 (364)
T ss_dssp             EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred             EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence            4679999999999999754      47899999876542211           122344556677889999999999887


Q ss_pred             C----CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC--CC
Q 036639          424 K----EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD--KN  497 (670)
Q Consensus       424 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~  497 (670)
                      .    ...++||||+ +++|.+++....    ..+++..++.++.|++.||+|||+.    +|+||||||+|||++  .+
T Consensus       120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~----~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          120 DKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEH----EYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEESSCT
T ss_pred             ccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeEEecCCHHHEEEecCCC
Confidence            5    4579999999 999999998642    2589999999999999999999998    999999999999999  88


Q ss_pred             CcEEEEecccccccCcc-----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 036639          498 GVACISDFGLSLLLNPV-----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR  566 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~  566 (670)
                      +.+||+|||+++.....           ....+|..|+|||++.+..++.++|||||||++|||+||+.||.....    
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~----  266 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK----  266 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT----
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc----
Confidence            99999999999876432           123378889999999999999999999999999999999999974211    


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                            ............... .....+..+.. ....   ..+.+++..||+.||++||++.+|++.|+++....
T Consensus       267 ------~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          267 ------DPKYVRDSKIRYREN-IASLMDKCFPA-ANAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             ------CHHHHHHHHHHHHHC-HHHHHHHHSCT-TCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ------CHHHHHHHHHHhhhh-HHHHHHHhccc-ccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence                  111111111111110 11111111100 1112   34566777999999999999999999999987654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2e-40  Score=345.98  Aligned_cols=246  Identities=22%  Similarity=0.349  Sum_probs=179.3

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.||+|+||+||+|... +|+.||||++...   ....+.+|+.++..+. ||||+++++++.+....++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            67999999999999965 6899999999754   4577889999999997 99999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEecccccccCcc--
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFGLSLLLNPV--  514 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG~a~~~~~~--  514 (670)
                      .+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++   .+||+|||+++.....  
T Consensus        94 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~  164 (325)
T 3kn6_A           94 FERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV----GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ  164 (325)
T ss_dssp             HHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence            99998654     589999999999999999999998    999999999999998766   8999999999866432  


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....++..|+|||++.+..++.++|||||||++|||++|+.||.......       ..................   
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~i~~~~~~---  234 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-------TCTSAVEIMKKIKKGDFS---  234 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------------CCCHHHHHHHHTTTCCC---
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-------ccccHHHHHHHHHcCCCC---
Confidence              23456788999999999999999999999999999999999997542211       111112222222221110   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +...  .+...   ...+.+++.+||+.||++|||++|++++
T Consensus       235 ~~~~--~~~~~---s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          235 FEGE--AWKNV---SQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCSH--HHHTS---CHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCcc--cccCC---CHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            0000  00111   2345667779999999999999999865

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.1e-41  Score=354.41  Aligned_cols=192  Identities=21%  Similarity=0.304  Sum_probs=169.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-----CCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-----HPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.||+|+||+||+|+. .+++.||||+++.. ....+.+..|+++++.++     ||||+++++++...+..++||||
T Consensus        39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~  117 (360)
T 3llt_A           39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEP  117 (360)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcC
Confidence            457899999999999996 57899999999753 234567788999999886     99999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-----------------
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-----------------  496 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----------------  496 (670)
                      + +++|.+++.....   ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.                 
T Consensus       118 ~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~  189 (360)
T 3llt_A          118 L-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKM----SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK  189 (360)
T ss_dssp             C-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred             C-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCcccEEEccccccccccchhcccccc
Confidence            9 9999999986542   2489999999999999999999998    9999999999999975                 


Q ss_pred             --------CCcEEEEecccccccCc-cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          497 --------NGVACISDFGLSLLLNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       497 --------~~~~kl~DFG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                              ++.+||+|||+++.... .....++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          190 KIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             EEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                    78999999999987654 33456788899999999999999999999999999999999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.5e-40  Score=337.51  Aligned_cols=192  Identities=28%  Similarity=0.391  Sum_probs=166.2

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|+..+|+.||+|++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||+++ 
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-   84 (288)
T 1ob3_A            6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-   84 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-
T ss_pred             hhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-
Confidence            3467999999999999998899999999975432  2346788999999999999999999999999999999999975 


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.+++....    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....    
T Consensus        85 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  156 (288)
T 1ob3_A           85 DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (288)
T ss_dssp             EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEeECccccccCccccc
Confidence            9999987643    2588999999999999999999998    999999999999999999999999999986542    


Q ss_pred             cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            223456888999999875 45899999999999999999999999653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=348.77  Aligned_cols=243  Identities=22%  Similarity=0.314  Sum_probs=182.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|... +++.||||+++...  ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus        57 ~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~  134 (349)
T 2w4o_A           57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE  134 (349)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence            3467999999999999965 58899999998653  45678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccccCcc-
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~~~-  514 (670)
                      |.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       135 L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          135 LFDRIVEKG-----YYSERDAADAVKQILEAVAYLHEN----GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             HHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            999997643     489999999999999999999998    9999999999999975   889999999999876543 


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....+++.|+|||++.+..++.++|||||||++|||++|+.||.....             ...............  
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------------~~~~~~~i~~~~~~~--  270 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------------DQFMFRRILNCEYYF--  270 (349)
T ss_dssp             -------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------------HHHHHHHHHTTCCCC--
T ss_pred             ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------------cHHHHHHHHhCCCcc--
Confidence              235578889999999998999999999999999999999999964311             011111222111100  


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..+   ......   ..+.+++.+||+.||++|||+.|++++
T Consensus       271 ~~~---~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          271 ISP---WWDEVS---LNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CTT---TTTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCc---hhhhCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000   001112   345567779999999999999999985

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-39  Score=330.91  Aligned_cols=248  Identities=23%  Similarity=0.345  Sum_probs=198.9

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|+.+ ++.||||+++...  ....+.+.+|++++++++||||+++++++.+.  ...++||||++
T Consensus        14 ~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   92 (271)
T 3kmu_A           14 FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP   92 (271)
T ss_dssp             EEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCT
T ss_pred             HHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccC
Confidence            3468999999999999986 8899999998653  33457799999999999999999999999887  77899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK--VPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +|+|.++++...   ...+++..+..++.|++.||+|||+.    +  |+||||||+||+++.++.++|+|||++.....
T Consensus        93 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           93 YGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTL----EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             TCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTS----SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             CCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcC----CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            999999998653   22589999999999999999999987    6  99999999999999999999999998765433


Q ss_pred             cccccccCcccCccccccCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQ---KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~---ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                       ....+++.|+|||.+.+..++.   ++||||||+++|||+||+.||....              ...............
T Consensus       166 -~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------------~~~~~~~~~~~~~~~  230 (271)
T 3kmu_A          166 -PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------------NMEIGMKVALEGLRP  230 (271)
T ss_dssp             -TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------------HHHHHHHHHHSCCCC
T ss_pred             -cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------------hHHHHHHHHhcCCCC
Confidence             3356788899999998665544   8999999999999999999996431              111111111111111


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      . ..      ....   ..+.+++.+||+.||++|||++|+++.|+++..
T Consensus       231 ~-~~------~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          231 T-IP------PGIS---PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             C-CC------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             C-CC------CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0 00      1112   245667779999999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.2e-40  Score=345.38  Aligned_cols=245  Identities=25%  Similarity=0.384  Sum_probs=198.1

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ..+.||+|+||+||+|.. .+|+.||||++.....   ...+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus        58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  137 (348)
T 1u5q_A           58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL  137 (348)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence            346799999999999995 5789999999975432   234678899999999999999999999999999999999996


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                       |+|.+++....    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++......
T Consensus       138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~  208 (348)
T 1u5q_A          138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN  208 (348)
T ss_dssp             -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBC
T ss_pred             -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEECCCCCEEEeeccCceecCCCC
Confidence             68888876432    2589999999999999999999998    99999999999999999999999999999887777


Q ss_pred             cccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 AIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                      ...+++.|+|||++.   ...++.++|||||||++|||+||+.||....              ....+......... ..
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------------~~~~~~~~~~~~~~-~~  273 (348)
T 1u5q_A          209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------------AMSALYHIAQNESP-AL  273 (348)
T ss_dssp             CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHHHSCCC-CC
T ss_pred             cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------------hHHHHHHHHhcCCC-CC
Confidence            778899999999984   5678999999999999999999999986431              11111122211110 00


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                      .      .....+   .+.+++.+||+.||++|||++|++++.--
T Consensus       274 ~------~~~~~~---~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          274 Q------SGHWSE---YFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             C------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             C------CCCCCH---HHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence            0      011122   35567779999999999999999987543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.7e-40  Score=346.30  Aligned_cols=239  Identities=18%  Similarity=0.225  Sum_probs=197.4

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+....|+||||+++
T Consensus        46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g  125 (350)
T 1rdq_E           46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG  125 (350)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            467999999999999965 68999999996432   12456788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-c
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-Q  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  515 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... .
T Consensus       126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~  196 (350)
T 1rdq_E          126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW  196 (350)
T ss_dssp             CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBC
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccccCccceEEECCCCCEEEcccccceeccCCcc
Confidence            99999998643     489999999999999999999998    9999999999999999999999999999876543 3


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||....              ..............   +  
T Consensus       197 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------------~~~~~~~i~~~~~~---~--  257 (350)
T 1rdq_E          197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------------PIQIYEKIVSGKVR---F--  257 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC---C--
T ss_pred             cccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------------HHHHHHHHHcCCCC---C--
Confidence            4568889999999999999999999999999999999999996431              11222222221110   0  


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                          .....   ..+.+++.+||+.||++||+     ++|+++|
T Consensus       258 ----p~~~~---~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          258 ----PSHFS---SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----CTTCC---HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCCCC---HHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                01112   23556777999999999998     8999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.1e-40  Score=345.52  Aligned_cols=246  Identities=23%  Similarity=0.340  Sum_probs=199.2

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEE
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      |.+.+.||+|+||.||+|... +|+.||||+++....      ...+++.+|++++++++||||+++++++.+....++|
T Consensus        14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (321)
T 2a2a_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLI   93 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             EEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            345678999999999999965 689999999975422      1467899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC----cEEEEecc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG----VACISDFG  506 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG  506 (670)
                      |||+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++    .+||+|||
T Consensus        94 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           94 LELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTK----KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             ECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999997643     589999999999999999999998    999999999999999888    79999999


Q ss_pred             cccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          507 LSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       507 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      ++......   ....+++.|+|||.+.+..++.++||||||+++|||+||+.||....              ........
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------------~~~~~~~i  230 (321)
T 2a2a_A          165 LAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------------KQETLANI  230 (321)
T ss_dssp             TCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------------HHHHHHHH
T ss_pred             cceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------------HHHHHHHH
Confidence            99876543   23457888999999998999999999999999999999999996431              11111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....   .++....  ....   ..+.+++.+||+.||++|||++|+++|
T Consensus       231 ~~~~~---~~~~~~~--~~~~---~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 TSVSY---DFDEEFF--SHTS---ELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HTTCC---CCCHHHH--TTCC---HHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             Hhccc---ccChhhh--cccC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11110   0111110  1111   245567779999999999999999985

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-40  Score=339.17  Aligned_cols=244  Identities=20%  Similarity=0.298  Sum_probs=197.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++||||++++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (277)
T 3f3z_A           12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG   91 (277)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence            44578999999999999965 57899999998765556788999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe---CCCCcEEEEecccccccCcc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~~~  514 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||++   +.++.+||+|||++......
T Consensus        92 ~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           92 ELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKL----NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             BHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999987643     489999999999999999999998    99999999999999   78899999999999876542


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....+++.|+|||.+.+ .++.++||||||+++|||+||+.||....              ..............  
T Consensus       163 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------~~~~~~~~~~~~~~--  225 (277)
T 3f3z_A          163 KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPT--------------DSEVMLKIREGTFT--  225 (277)
T ss_dssp             SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC--
T ss_pred             cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCC--------------HHHHHHHHHhCCCC--
Confidence               34567888999999875 48999999999999999999999996531              11111111111110  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       +...  .....   ...+.+++.+||+.||++|||+.|++++
T Consensus       226 -~~~~--~~~~~---~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          226 -FPEK--DWLNV---SPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -CCHH--HHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -CCch--hhhcC---CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000  00011   2345667779999999999999999874

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=350.68  Aligned_cols=242  Identities=24%  Similarity=0.347  Sum_probs=194.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+++++.++||||+++++++.+.+..|+||||++
T Consensus        19 i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~   98 (384)
T 4fr4_A           19 ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLL   98 (384)
T ss_dssp             EEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCC
Confidence            3478999999999999955 68999999996432   2245678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....  
T Consensus        99 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           99 GGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQ----RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             TEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            999999998653     589999999999999999999998    999999999999999999999999999987643  


Q ss_pred             -cccccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          514 -VQAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                       .....+|+.|+|||++..   ..++.++|||||||++|||++|+.||......           .....+.........
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----------~~~~~~~~~~~~~~~  238 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----------SSKEIVHTFETTVVT  238 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----------CHHHHHHHHHHCCCC
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----------cHHHHHHHHhhcccC
Confidence             234568888999999863   45899999999999999999999999653211           111111111111000


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-MAEVAK  633 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~  633 (670)
                         +      .....   ..+.+++.+||+.||++||+ ++++++
T Consensus       239 ---~------p~~~s---~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          239 ---Y------PSAWS---QEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---C------CTTSC---HHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---C------CCcCC---HHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               0      01112   34556777999999999998 777765

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.6e-40  Score=334.74  Aligned_cols=246  Identities=27%  Similarity=0.455  Sum_probs=193.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcch-------HHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCA-------RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.||+|+||+||+|.. .+++.||||++.......       .+.+.+|++++++++||||+++++++.+..  ++|||
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e  101 (287)
T 4f0f_A           24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVME  101 (287)
T ss_dssp             EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEE
T ss_pred             hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEE
Confidence            46799999999999996 478999999996543211       167899999999999999999999986554  79999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCCeEeCCCCc-----EEEEec
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK--VPHGNVKSSNVLLDKNGV-----ACISDF  505 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl~DF  505 (670)
                      |+++|+|.+++....    ..+++..++.++.|++.||+|||+.    +  |+||||||+|||++.++.     +||+||
T Consensus       102 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~----~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A          102 FVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQ----NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             CCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             ecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhC----CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            999999999887543    2589999999999999999999998    7  999999999999988876     999999


Q ss_pred             ccccccCcc-ccccccCcccCcccc--ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          506 GLSLLLNPV-QAIARLGGYKAPEQA--EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       506 G~a~~~~~~-~~~~~~~~y~aPE~~--~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      |+++..... ....++..|+|||++  ....++.++|||||||++|||++|+.||......            -......
T Consensus       174 g~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------------~~~~~~~  241 (287)
T 4f0f_A          174 GLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------------KIKFINM  241 (287)
T ss_dssp             TTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC------------HHHHHHH
T ss_pred             CccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc------------HHHHHHH
Confidence            999866543 345678889999998  4456789999999999999999999999653211            1111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ......... +.      ...   ...+.+++.+||+.||++|||++|+++.|+++
T Consensus       242 ~~~~~~~~~-~~------~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 IREEGLRPT-IP------EDC---PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHHSCCCCC-CC------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             HhccCCCCC-CC------ccc---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            111111111 00      111   23456677799999999999999999999864

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.3e-40  Score=345.84  Aligned_cols=247  Identities=25%  Similarity=0.360  Sum_probs=193.3

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCE----EEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGI----VAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.||+|+||+||+|.+. +++.    ||+|.+.... ....+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus        18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   96 (325)
T 3kex_A           18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL   96 (325)
T ss_dssp             EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred             eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence            468999999999999954 4543    8888886432 223456778999999999999999999886 56689999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....
T Consensus        97 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           97 PLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEH----GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             TTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHT----TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             CCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhC----CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            9999999997643    2588899999999999999999998    9999999999999999999999999999876432


Q ss_pred             ------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 ------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 ------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                            ....++..|+|||++.+..++.++|||||||++|||+| |+.||.....           ..+...    +...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----------~~~~~~----~~~~  233 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----------AEVPDL----LEKG  233 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----------THHHHH----HHTT
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----------HHHHHH----HHcC
Confidence                  22345567999999998999999999999999999999 9999975421           111111    1111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .... ..         ......+.+++.+||+.||++|||+.|++++|+++...
T Consensus       234 ~~~~-~~---------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          234 ERLA-QP---------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CBCC-CC---------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCC-CC---------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0000 00         00111345577799999999999999999999998643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.2e-40  Score=345.43  Aligned_cols=248  Identities=20%  Similarity=0.283  Sum_probs=194.3

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|+||.||+|+.. +++.||||++++..   ....+.+.+|..++.++ +||||+++++++.+.+..|+||||++
T Consensus        14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~   93 (345)
T 3a8x_A           14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   93 (345)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence            468999999999999965 68999999997542   23446688899999887 89999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....  
T Consensus        94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~  164 (345)
T 3a8x_A           94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHER----GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  164 (345)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence            999999997643     489999999999999999999998    999999999999999999999999999986422  


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....+|+.|+|||++.+..++.++|||||||++|||++|+.||.........      .......+...+...... 
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~~~~~i~~~~~~-  237 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP------DQNTEDYLFQVILEKQIR-  237 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------------CHHHHHHHHHHCCCC-
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccc------ccccHHHHHHHHHcCCCC-
Confidence              23456788999999999999999999999999999999999999653211100      001111111111111000 


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM------AEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~~  634 (670)
                       +      .....   ..+.+++.+||+.||++||++      +|+++|
T Consensus       238 -~------p~~~s---~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          238 -I------PRSLS---VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -C------CTTSC---HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -C------CCCCC---HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence             0      01122   235567779999999999996      677765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.9e-40  Score=346.38  Aligned_cols=255  Identities=25%  Similarity=0.387  Sum_probs=202.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc--------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD--------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  428 (670)
                      .+.+.||+|+||.||+|...        +++.||||+++... ....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus        38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  117 (334)
T 2pvf_A           38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY  117 (334)
T ss_dssp             EEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCE
T ss_pred             EEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceE
Confidence            45678999999999999863        46789999998653 33457789999999999 8999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPG-----------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      +||||+++|+|.+++......+           ...+++..++.++.|+++||+|||+.    +|+||||||+||+++.+
T Consensus       118 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~  193 (334)
T 2pvf_A          118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ----KCIHRDLAARNVLVTEN  193 (334)
T ss_dssp             EEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTT
T ss_pred             EEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCccceEEEcCC
Confidence            9999999999999998654211           12488999999999999999999998    99999999999999999


Q ss_pred             CcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccc
Q 036639          498 GVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  570 (670)
                      +.+||+|||+++......      ...++..|+|||++.+..++.++||||||+++|||+| |+.||....         
T Consensus       194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---------  264 (334)
T 2pvf_A          194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---------  264 (334)
T ss_dssp             CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---------
T ss_pred             CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---------
Confidence            999999999998765422      2234567999999988889999999999999999999 999986431         


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                           ....... +.......       .....   ...+.+++.+||+.||++|||+.|++++|+++....
T Consensus       265 -----~~~~~~~-~~~~~~~~-------~~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          265 -----VEELFKL-LKEGHRMD-------KPANC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             -----HHHHHHH-HHHTCCCC-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -----HHHHHHH-HhcCCCCC-------CCccC---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence                 1111111 11111000       00111   234566777999999999999999999999997543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.9e-40  Score=344.58  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=199.7

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhc--cCCCCeeeEEEEEEeCC----eeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK--LKHPNVVKLRAYYYAKE----EKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~nIv~l~~~~~~~~----~~~lv~e  432 (670)
                      .+.+.||+|+||.||+|... |+.||||++...   ..+.+.+|.+++..  ++||||+++++++....    ..++|||
T Consensus        45 ~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e  120 (342)
T 1b6c_B           45 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD  120 (342)
T ss_dssp             EEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEEC
T ss_pred             EEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEe
Confidence            34678999999999999984 899999999754   45677888888877  78999999999998876    7899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------HhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH--------QEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      |+++|+|.+++...      .+++..++.++.|++.||+|||        +.    +|+||||||+|||++.++.+||+|
T Consensus       121 ~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~----~ivH~Dlkp~NIll~~~~~~kL~D  190 (342)
T 1b6c_B          121 YHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP----AIAHRDLKSKNILVKKNGTCCIAD  190 (342)
T ss_dssp             CCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC----EEECSCCSGGGEEECTTSCEEECC
T ss_pred             ecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC----CeeeCCCCHHHEEECCCCCEEEEE
Confidence            99999999999764      3899999999999999999999        55    999999999999999999999999


Q ss_pred             cccccccCcc--------ccccccCcccCccccccC------CCCCchhHHHHHHHHHHHHcC----------CCCCCCC
Q 036639          505 FGLSLLLNPV--------QAIARLGGYKAPEQAEVK------RLSQKADVYSFGVLLLEVLTG----------RAPSQYP  560 (670)
Q Consensus       505 FG~a~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~ksDVwS~Gvvl~elltg----------~~p~~~~  560 (670)
                      ||++......        ....++..|+|||++.+.      .++.++|||||||++|||+||          +.||...
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             CTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence            9999766432        233577889999998765      234789999999999999999          5566433


Q ss_pred             CCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          561 SPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       561 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ...         ......+............ +....    ...+....+.+++.+||+.||++|||++||+++|+++..
T Consensus       271 ~~~---------~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~  336 (342)
T 1b6c_B          271 VPS---------DPSVEEMRKVVCEQKLRPN-IPNRW----QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  336 (342)
T ss_dssp             SCS---------SCCHHHHHHHHTTSCCCCC-CCGGG----GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcC---------cccHHHHHHHHHHHHhCCC-Ccccc----cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence            111         1112222222221111111 11100    112445667888889999999999999999999999986


Q ss_pred             cC
Q 036639          641 EQ  642 (670)
Q Consensus       641 ~~  642 (670)
                      +.
T Consensus       337 ~~  338 (342)
T 1b6c_B          337 QE  338 (342)
T ss_dssp             TT
T ss_pred             Hh
Confidence            54

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-40  Score=339.58  Aligned_cols=251  Identities=25%  Similarity=0.383  Sum_probs=204.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        16 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   94 (288)
T 3kfa_A           16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG   94 (288)
T ss_dssp             EEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred             eEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCC
Confidence            34578999999999999965 58899999998643 35678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.+++....   ...+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++.......  
T Consensus        95 ~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  167 (288)
T 3kfa_A           95 NLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  167 (288)
T ss_dssp             EHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHH----TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSE
T ss_pred             cHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHC----CccCCCCCcceEEEcCCCCEEEccCccceeccCCccc
Confidence            9999998643   23589999999999999999999999    99999999999999999999999999998765422  


Q ss_pred             ---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          516 ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ...++..|+|||.+.+..++.++||||||+++|||++ |..||.....           ..+...    ........
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----------~~~~~~----~~~~~~~~  232 (288)
T 3kfa_A          168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----------SQVYEL----LEKDYRME  232 (288)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------GGHHHH----HHTTCCCC
T ss_pred             cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----------HHHHHH----HhccCCCC
Confidence               2334567999999998899999999999999999999 9999865311           111111    11111000


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                             .....   ...+.+++.+||+.||++|||++|+++.|+++..+.
T Consensus       233 -------~~~~~---~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          233 -------RPEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             -------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------CCCCC---CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence                   00111   234566777999999999999999999999887553

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.2e-40  Score=337.93  Aligned_cols=254  Identities=14%  Similarity=0.159  Sum_probs=201.3

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||.||+|.. .+|+.||||++....  ..+.+.+|++++.++ +|+|++++++++.+....++||||+ +++
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   91 (298)
T 1csn_A           15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS   91 (298)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCC
Confidence            46799999999999995 578999999987543  345678899999999 7999999999999999999999999 999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc-----EEEEecccccccCc
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV-----ACISDFGLSLLLNP  513 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFG~a~~~~~  513 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.     +||+|||+++....
T Consensus        92 L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           92 LEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             HHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            999998643    2489999999999999999999988    9999999999999988776     99999999987643


Q ss_pred             c-----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          514 V-----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       514 ~-----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      .           ....++..|+|||++.+..++.++||||||+++|||++|+.||......           .....+..
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----------~~~~~~~~  232 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----------TNKQKYER  232 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----------CHHHHHHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc-----------ccHHHHHH
Confidence            2           2345778899999999999999999999999999999999999764211           11111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      .........  ....  ....   ...+.+++.+||+.||++|||+++|++.|+++.....
T Consensus       233 ~~~~~~~~~--~~~~--~~~~---~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          233 IGEKKQSTP--LREL--CAGF---PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHSC--HHHH--TTTS---CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHhhccCcc--HHHH--HhhC---cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            111100000  0000  0111   2346667779999999999999999999999986543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.4e-40  Score=338.26  Aligned_cols=191  Identities=25%  Similarity=0.356  Sum_probs=164.6

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||+||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   85 (292)
T 3o0g_A            6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC
Confidence            3467999999999999964 68999999997543  23457888999999999999999999999999999999999975


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                       ++.+.+....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....   
T Consensus        86 -~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~----~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           86 -DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             -EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             -CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence             6666655432    2589999999999999999999998    999999999999999999999999999987643   


Q ss_pred             -cccccccCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          514 -VQAIARLGGYKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                       .....++..|+|||++.+.. ++.++|||||||++|||+||+.||..
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence             22345677899999997765 89999999999999999999888643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.1e-40  Score=340.37  Aligned_cols=198  Identities=25%  Similarity=0.354  Sum_probs=160.0

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      |.+.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (317)
T 2pmi_A            7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD   86 (317)
T ss_dssp             ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred             eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence            34567899999999999995 468999999997543 2344778899999999999999999999999999999999997


Q ss_pred             CCChHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          436 NGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                       |+|.+++..... .....+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.... 
T Consensus        87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN----KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence             699998864321 1123589999999999999999999998    999999999999999999999999999987643 


Q ss_pred             ---cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 ---VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                         .....++..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  212 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT  212 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence               223456888999999876 46899999999999999999999999654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=347.75  Aligned_cols=274  Identities=26%  Similarity=0.334  Sum_probs=195.5

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHH--HhccCCCCeeeEEEEEEeC-----CeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDV--IGKLKHPNVVKLRAYYYAK-----EEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~  433 (670)
                      .+.||+|+||.||+|+. +++.||||++...   ....+..|.++  +..++||||+++++++...     ...++||||
T Consensus        18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~   93 (336)
T 3g2f_A           18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY   93 (336)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred             eeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEec
Confidence            46799999999999987 5899999999754   33444445444  4458999999999876532     256899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCC-----CCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG-----TAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +++|+|.+++....      .++..+..++.|+++||+|||+.+.     .++|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a  167 (336)
T 3g2f_A           94 YPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS  167 (336)
T ss_dssp             CTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccce
Confidence            99999999997653      5899999999999999999997521     128999999999999999999999999999


Q ss_pred             cccCcc------------ccccccCcccCcccccc-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcc
Q 036639          509 LLLNPV------------QAIARLGGYKAPEQAEV-------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE  569 (670)
Q Consensus       509 ~~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~  569 (670)
                      +.....            ....+|..|+|||++.+       ..++.++|||||||++|||+||+.||............
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  247 (336)
T 3g2f_A          168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA  247 (336)
T ss_dssp             EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred             eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence            866431            12357788999999876       45678999999999999999998877543222111111


Q ss_pred             cc---cccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCCC
Q 036639          570 EE---QAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLG  646 (670)
Q Consensus       570 ~~---~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~  646 (670)
                      ..   .....................+...   ..........+.+++.+||+.||++|||++||++.|+++........
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             THHHHCSSCCHHHHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             hhcccCCCchHHHHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            00   0001111111111111111111111   11122344567788889999999999999999999999986654444


Q ss_pred             C
Q 036639          647 E  647 (670)
Q Consensus       647 ~  647 (670)
                      .
T Consensus       325 ~  325 (336)
T 3g2f_A          325 S  325 (336)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.4e-40  Score=347.22  Aligned_cols=245  Identities=21%  Similarity=0.285  Sum_probs=189.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||+||+++.. +++.||||++..... ..+.+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus        24 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~  102 (361)
T 3uc3_A           24 FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE  102 (361)
T ss_dssp             EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred             EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCC
Confidence            3467999999999999965 789999999976433 34678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc--EEEEecccccccCc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV--ACISDFGLSLLLNP---  513 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~~~~---  513 (670)
                      |.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.  +||+|||+++....   
T Consensus       103 L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~----~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~  173 (361)
T 3uc3_A          103 LYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSM----QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  173 (361)
T ss_dssp             HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence            999997543     489999999999999999999998    9999999999999987775  99999999975432   


Q ss_pred             cccccccCcccCccccccCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQK-ADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~k-sDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                      .....+++.|+|||++.+..++.+ +|||||||++|||++|+.||.....          .......+........... 
T Consensus       174 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----------~~~~~~~~~~~~~~~~~~~-  242 (361)
T 3uc3_A          174 PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----------PRDYRKTIQRILSVKYSIP-  242 (361)
T ss_dssp             -------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------------CCCHHHHHHHHHTTCCCCC-
T ss_pred             CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----------HHHHHHHHHHHhcCCCCCC-
Confidence            234567889999999988877665 8999999999999999999975421          1122222222222211100 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                            ......   ..+.+++.+||+.||++|||+.|+++|
T Consensus       243 ------~~~~~s---~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 ------DDIRIS---PECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ------TTSCCC---HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ------CcCCCC---HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                  000112   235567779999999999999999987

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.7e-40  Score=347.12  Aligned_cols=239  Identities=25%  Similarity=0.353  Sum_probs=193.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|+||.||+|+.+ +|+.||||++++..   ....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus        22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  101 (345)
T 1xjd_A           22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN  101 (345)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence            468999999999999965 68999999997532   12456678889998877 89999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....  
T Consensus       102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A          102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            999999997643     489999999999999999999998    999999999999999999999999999986432  


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+              ..............  
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------------~~~~~~~i~~~~~~--  236 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------------EEELFHSIRMDNPF--  236 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC--
T ss_pred             CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------------HHHHHHHHHhCCCC--
Confidence              334567889999999999999999999999999999999999996531              11112222111100  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA-EVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~~  634 (670)
                       +.      ....+   .+.+++.+||..||++||++. |+++|
T Consensus       237 -~p------~~~s~---~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          237 -YP------RWLEK---EAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             -CC------TTSCH---HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -CC------cccCH---HHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence             00      11122   345667799999999999997 77653

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=349.03  Aligned_cols=259  Identities=17%  Similarity=0.237  Sum_probs=191.8

Q ss_pred             HHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCCCcch-----------HHHHHHHHHHHhccCCCCeeeEEEEEEe-
Q 036639          360 SAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDANPCA-----------RKEFEQYMDVIGKLKHPNVVKLRAYYYA-  423 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~nIv~l~~~~~~-  423 (670)
                      +.+.||+|+||.||+|...    ++..||||++.......           ...+.+|+..+..++||||+++++++.. 
T Consensus        41 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~  120 (345)
T 2v62_A           41 LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTE  120 (345)
T ss_dssp             EEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEE
T ss_pred             EEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccc
Confidence            3478999999999999965    57889999997653211           1235677888899999999999999988 


Q ss_pred             ---CCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC--
Q 036639          424 ---KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG--  498 (670)
Q Consensus       424 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~--  498 (670)
                         ....++||||+ +++|.+++....     .+++..++.++.|++.||+|||+.    +|+||||||+|||++.++  
T Consensus       121 ~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          121 FKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHEN----EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             SSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEESSSTT
T ss_pred             cCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCcCHHHEEEccCCCC
Confidence               67889999999 999999998653     589999999999999999999998    999999999999999887  


Q ss_pred             cEEEEecccccccCcc-----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCC
Q 036639          499 VACISDFGLSLLLNPV-----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV  567 (670)
Q Consensus       499 ~~kl~DFG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~  567 (670)
                      .+||+|||+++.....           ....++..|+|||++.+..++.++|||||||++|||+||+.||.....     
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-----  265 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK-----  265 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT-----
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-----
Confidence            9999999999876432           234577889999999988999999999999999999999999953210     


Q ss_pred             cccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          568 DEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       568 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                          ..... ..........     +................+.+++.+||+.||++|||++||++.|+++.....
T Consensus       266 ----~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  331 (345)
T 2v62_A          266 ----DPVAV-QTAKTNLLDE-----LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLG  331 (345)
T ss_dssp             ----CHHHH-HHHHHHHHHT-----TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCC
T ss_pred             ----ccHHH-HHHHHhhccc-----ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCccc
Confidence                00001 1111111110     011000000000112346667779999999999999999999998775443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=338.11  Aligned_cols=241  Identities=22%  Similarity=0.262  Sum_probs=187.4

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEe
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .|...+.||+|+||+||+|... +|+.||||++.....  ........|+..+.++ +||||+++++++.+.+..++|||
T Consensus        58 ~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e  137 (311)
T 3p1a_A           58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTE  137 (311)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEe
Confidence            3445678999999999999965 799999999875432  2334445555555555 89999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+ +++|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++....
T Consensus       138 ~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          138 LC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQ----GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             CC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             cc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99 779999887543    2589999999999999999999998    99999999999999999999999999998765


Q ss_pred             cc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          513 PV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       513 ~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ..   ....+|.+|+|||++.+ .++.++|||||||++|||++|..|+....                 ..... .... 
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----------------~~~~~-~~~~-  268 (311)
T 3p1a_A          209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----------------GWQQL-RQGY-  268 (311)
T ss_dssp             ------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------------HHHHH-TTTC-
T ss_pred             cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------------HHHHH-hccC-
Confidence            43   23457888999999875 79999999999999999999977764320                 00111 1110 


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         ..+...  ...   ...+.+++.+||+.||++|||++|++++
T Consensus       269 ---~~~~~~--~~~---~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          269 ---LPPEFT--AGL---SSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---CCHHHH--TTS---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---CCcccc--cCC---CHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence               111110  011   2346667779999999999999999975

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-40  Score=345.14  Aligned_cols=263  Identities=25%  Similarity=0.347  Sum_probs=200.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-----CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-----DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  431 (670)
                      +.+.||+|+||+||++.+.     +++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++||
T Consensus        35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~  114 (318)
T 3lxp_A           35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM  114 (318)
T ss_dssp             EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEE
T ss_pred             hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEE
Confidence            3467999999999998743     68899999998653 34467799999999999999999999999884  5789999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++|+|.+++...      .+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++...
T Consensus       115 e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~----~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          115 EYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQ----HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             CCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             ecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEEcCCCCEEECCccccccc
Confidence            999999999999765      389999999999999999999998    9999999999999999999999999999876


Q ss_pred             Cccc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          512 NPVQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       512 ~~~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ....       ...++..|+|||++.+..++.++||||||+++|||+||+.||..................-...+....
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            5422       234555699999999888999999999999999999999998542100000000000000000011111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ....          ...........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus       265 ~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          265 ERGE----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hccc----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            1100          00011112235667777999999999999999999999987543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.8e-40  Score=336.34  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=188.6

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|...  ..||||+++...  ....+.+.+|++++++++||||+++++++ .....++||||++++
T Consensus        28 ~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~  104 (289)
T 3og7_A           28 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS  104 (289)
T ss_dssp             EEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEE
T ss_pred             eeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCC
Confidence            4578999999999999865  359999997543  33457899999999999999999999965 556789999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.+++....    ..+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++....    
T Consensus       105 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~----~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  176 (289)
T 3og7_A          105 SLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAK----SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS  176 (289)
T ss_dssp             EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred             cHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence            9999997543    2589999999999999999999998    999999999999999999999999999976542    


Q ss_pred             --cccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          514 --VQAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                        .....++..|+|||.+.   ...++.++||||||+++|||++|+.||.....             . ..+........
T Consensus       177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------------~-~~~~~~~~~~~  242 (289)
T 3og7_A          177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------------R-DQIIEMVGRGS  242 (289)
T ss_dssp             -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------------H-HHHHHHHHHTS
T ss_pred             ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------------H-HHHHHHhcccc
Confidence              12345788899999986   56788999999999999999999999965311             1 11111111111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ...    ....  ........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       243 ~~~----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          243 LSP----DLSK--VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CCC----CTTS--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCc----chhh--ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            100    0000  001112346677779999999999999999999999864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-40  Score=347.32  Aligned_cols=257  Identities=21%  Similarity=0.303  Sum_probs=200.0

Q ss_pred             HHHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEE
Q 036639          358 RASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  429 (670)
                      |.+.+.||+|+||.||+|..      .+++.||||+++... ....+.+.+|++++.++ +||||+++++++...+..++
T Consensus        47 y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  126 (344)
T 1rjb_A           47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYL  126 (344)
T ss_dssp             EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             ceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEE
Confidence            34567899999999999995      245689999997542 23457889999999999 89999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCC
Q 036639          430 VYDYLPNGSLHSLLHGNRGP------------------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSN  491 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~N  491 (670)
                      ||||+++|+|.+++......                  ....+++..++.++.|++.||+|||+.    +|+||||||+|
T Consensus       127 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~N  202 (344)
T 1rjb_A          127 IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARN  202 (344)
T ss_dssp             EEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGG
T ss_pred             EEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCChhh
Confidence            99999999999999865321                  012478999999999999999999998    99999999999


Q ss_pred             eEeCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 036639          492 VLLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTR  564 (670)
Q Consensus       492 Ill~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~  564 (670)
                      ||++.++.+||+|||++.......      ...++..|+|||.+.+..++.++|||||||++|||+| |+.||...... 
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-  281 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-  281 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH-
Confidence            999999999999999998664322      2334567999999988899999999999999999998 99999654211 


Q ss_pred             CCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          565 PRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       565 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                                   ..+...........       .....   ...+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       282 -------------~~~~~~~~~~~~~~-------~~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          282 -------------ANFYKLIQNGFKMD-------QPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             -------------HHHHHHHHTTCCCC-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -------------HHHHHHHhcCCCCC-------CCCCC---CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence                         11111122111100       00111   234566777999999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.7e-40  Score=354.52  Aligned_cols=242  Identities=22%  Similarity=0.303  Sum_probs=193.6

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||+|+.. +++.||+|++++..   ....+.+.+|+++++.++||||+++++++.+....|+||||+++
T Consensus        74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g  153 (410)
T 3v8s_A           74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  153 (410)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            468999999999999965 68999999996421   11234578899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.++++..      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~----givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSM----GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            9999999764      388999999999999999999998    9999999999999999999999999999876543  


Q ss_pred             ---ccccccCcccCccccccCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 ---QAIARLGGYKAPEQAEVKR----LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~----~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                         ....+|+.|+|||++.+..    ++.++|||||||++|||+||+.||...+              ............
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------------~~~~~~~i~~~~  289 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------------LVGTYSKIMNHK  289 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHTHH
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------------hhhHHHHHHhcc
Confidence               2456888999999997655    7899999999999999999999996531              112222222211


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEK--RPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  634 (670)
                      ....     ........+   .+.+++.+||..+|++  ||+++||++|
T Consensus       290 ~~~~-----~p~~~~~s~---~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          290 NSLT-----FPDDNDISK---EAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHCC-----CCTTCCCCH---HHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cccc-----CCCcccccH---HHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            0000     000112223   3445666999999988  9999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=339.65  Aligned_cols=249  Identities=22%  Similarity=0.398  Sum_probs=195.3

Q ss_pred             HhHcCCCCceEEEEEEEcC-----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLDD-----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.||+|+||+||+|....     +..||||+++... ......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  128 (333)
T 1mqb_A           49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM  128 (333)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence            4679999999999998542     2469999998643 334567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.+++....    ..+++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||+++.....
T Consensus       129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            9999999997643    2589999999999999999999998    9999999999999999999999999999876432


Q ss_pred             c-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          515 Q-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       515 ~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      .       ...++..|+|||.+.+..++.++||||||+++|||+| |+.||....              ...........
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------------~~~~~~~~~~~  266 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------------NHEVMKAINDG  266 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHHHHHHHTT
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--------------HHHHHHHHHCC
Confidence            1       1223556999999998899999999999999999999 999996431              11111111111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ....        ....   ....+.+++.+||+.||++||++.|++++|+++....
T Consensus       267 ~~~~--------~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          267 FRLP--------TPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             CCCC--------CCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CcCC--------Cccc---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            0000        0011   1234566777999999999999999999999987554

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.1e-40  Score=358.66  Aligned_cols=240  Identities=24%  Similarity=0.364  Sum_probs=197.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~   99 (476)
T 2y94_A           20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVS   99 (476)
T ss_dssp             EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred             EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence            3468999999999999965 79999999997432   1235678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... 
T Consensus       100 gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A          100 GGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             SEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999997543     589999999999999999999998    9999999999999999999999999999876543 


Q ss_pred             --ccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        ....+++.|+|||++.+..+ +.++|||||||++|||++|+.||....              ..............  
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------------~~~~~~~i~~~~~~--  234 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------------VPTLFKKICDGIFY--  234 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------------SHHHHHHHHTTCCC--
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------------HHHHHHHHhcCCcC--
Confidence              24567888999999987765 689999999999999999999996531              12222222221110  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             ......   ..+.+++.+||+.||++|||++|+++|
T Consensus       235 -------~p~~~s---~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          235 -------TPQYLN---PSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -------CCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------CCccCC---HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                   001112   235567779999999999999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-39  Score=332.29  Aligned_cols=247  Identities=25%  Similarity=0.350  Sum_probs=199.1

Q ss_pred             hHcCCCCceEEEEEEEc---CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVLD---DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||+|...   +++.||||+++... ....+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus        16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~   94 (287)
T 1u59_A           16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG   94 (287)
T ss_dssp             EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence            37999999999999853   57889999998653 34567899999999999999999999999 556789999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc--
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--  515 (670)
                      +|.+++....    ..+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++.......  
T Consensus        95 ~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  166 (287)
T 1u59_A           95 PLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  166 (287)
T ss_dssp             EHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             CHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHC----CEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence            9999997543    2589999999999999999999998    99999999999999999999999999998764322  


Q ss_pred             -----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          516 -----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       516 -----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                           ...++..|+|||.+.+..++.++||||||+++|||+| |+.||.....              .............
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------------~~~~~~i~~~~~~  232 (287)
T 1u59_A          167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------------PEVMAFIEQGKRM  232 (287)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------------HHHHHHHHTTCCC
T ss_pred             eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------------HHHHHHHhcCCcC
Confidence                 2234567999999988889999999999999999999 9999965311              1111111111100


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                       . +      ....   ...+.+++.+||+.||++||++.|++++|+++..+.
T Consensus       233 -~-~------~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          233 -E-C------PPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             -C-C------CTTC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -C-C------CCCc---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence             0 0      0111   234566777999999999999999999999997554

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.3e-40  Score=344.48  Aligned_cols=239  Identities=22%  Similarity=0.293  Sum_probs=194.7

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|+||.||+|+.. +|+.||||++++..   ....+.+..|.+++..+ +||||+++++++.+.+..|+||||++
T Consensus        25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  104 (353)
T 2i0e_A           25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  104 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence            468999999999999975 58899999997531   22456788899999888 79999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....  
T Consensus       105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A          105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            999999997643     489999999999999999999998    999999999999999999999999999986432  


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+              ..............  
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------------~~~~~~~i~~~~~~--  239 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------------EDELFQSIMEHNVA--  239 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC--
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------------HHHHHHHHHhCCCC--
Confidence              334568889999999999999999999999999999999999996531              11222222222110  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                       +      ......   .+.+++.+||+.||++||+     ++|+++|
T Consensus       240 -~------p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          240 -Y------PKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -C------CTTSCH---HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -C------CCCCCH---HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             0      011222   3556777999999999995     5888775

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-40  Score=368.20  Aligned_cols=250  Identities=28%  Similarity=0.401  Sum_probs=202.2

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus       270 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gs  347 (535)
T 2h8h_A          270 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGS  347 (535)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred             hhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence            34578999999999999998888999999986543 46789999999999999999999999866 67899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.++++...   ...+++..++.++.||++||+|||+.    +|+||||||+|||+++++.+||+|||+++......   
T Consensus       348 L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          348 LLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             HHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred             HHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence            999997532   12488999999999999999999998    99999999999999999999999999998775422   


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ...++..|+|||++....++.++|||||||++|||+| |+.||....              ....... +....... 
T Consensus       421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------------~~~~~~~-i~~~~~~~-  484 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------------NREVLDQ-VERGYRMP-  484 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------------HHHHHHH-HHTTCCCC-
T ss_pred             ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------------HHHHHHH-HHcCCCCC-
Confidence              2234456999999998899999999999999999999 899986431              1111111 11111000 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                               ........+.+++.+||+.||++|||+++|++.|+++....
T Consensus       485 ---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          485 ---------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence                     00111234666778999999999999999999999887544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.3e-40  Score=340.72  Aligned_cols=262  Identities=24%  Similarity=0.338  Sum_probs=192.7

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.||+|+||+||+|... +|+.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus         8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (311)
T 4agu_A            8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT   87 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence            468999999999999965 589999999865432  23567889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++......   
T Consensus        88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  158 (311)
T 4agu_A           88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKH----NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY  158 (311)
T ss_dssp             HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence            9999887543     589999999999999999999998    9999999999999999999999999999876532   


Q ss_pred             -ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccc-hhHHHHHHhhhccccc
Q 036639          515 -QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD-LPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  591 (670)
                       ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||.................. .+.+........+...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence             23456778999999875 66899999999999999999999999654211000000000000 0000000000000000


Q ss_pred             c--c-----cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 V--F-----DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~--~-----d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .  .     ..........   ...+.+++.+||+.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNI---SYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTC---CHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CcCCCccccchhhhhcccc---cHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0  0     0000001111   2346677889999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=9.2e-41  Score=350.24  Aligned_cols=251  Identities=23%  Similarity=0.336  Sum_probs=185.4

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEe--------CCee
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYA--------KEEK  427 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~--------~~~~  427 (670)
                      |.+.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++.++. ||||+++++++..        ....
T Consensus        30 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~  109 (337)
T 3ll6_A           30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF  109 (337)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEE
T ss_pred             EEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceE
Confidence            34567899999999999995 478999999997766666788999999999996 9999999999953        3357


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCCeEeCCCCcEEEEec
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK--VPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ++||||++ |+|.+++.....  ...+++..++.++.|++.||+|||+.    +  |+||||||+|||++.++.+||+||
T Consensus       110 ~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~----~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          110 LLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQ----KPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTS----SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             EEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC----CCCEEEccCCcccEEECCCCCEEEecC
Confidence            89999995 799998865221  12589999999999999999999988    7  999999999999999999999999


Q ss_pred             ccccccCccc----------------cccccCcccCcccc---ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 036639          506 GLSLLLNPVQ----------------AIARLGGYKAPEQA---EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR  566 (670)
Q Consensus       506 G~a~~~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~  566 (670)
                      |+++......                ...++..|+|||++   .+..++.++|||||||++|||+||+.||.......  
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence            9998765321                23467789999998   56678999999999999999999999996432110  


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                                  ..    ........       .....   ..+.+++.+||+.||++|||+.|++++|+++.....
T Consensus       261 ------------~~----~~~~~~~~-------~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 ------------IV----NGKYSIPP-------HDTQY---TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             ---------------------CCCCT-------TCCSS---GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ------------hh----cCcccCCc-------ccccc---hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                        00    00000000       00001   124557779999999999999999999999986543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.1e-39  Score=336.09  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=192.5

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus        39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 2h34_A           39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING  118 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence            467999999999999965 78999999997542   22357889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      ++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++......  
T Consensus       119 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  189 (309)
T 2h34_A          119 VDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAA----GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL  189 (309)
T ss_dssp             EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence            99999998643     589999999999999999999998    9999999999999999999999999999776432  


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....++..|+|||.+.+..++.++||||||+++|||+||+.||....              . ..+.......... 
T Consensus       190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------------~-~~~~~~~~~~~~~-  253 (309)
T 2h34_A          190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ--------------L-SVMGAHINQAIPR-  253 (309)
T ss_dssp             -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH--------------H-HHHHHHHHSCCCC-
T ss_pred             ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch--------------H-HHHHHHhccCCCC-
Confidence               23456778999999998999999999999999999999999996431              0 1111111111100 


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhhccC
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-TMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~  642 (670)
                         .. ........   .+.+++.+||+.||++|| |++++++.|++.....
T Consensus       254 ---~~-~~~~~~~~---~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          254 ---PS-TVRPGIPV---AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ---GG-GTSTTCCT---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ---cc-ccCCCCCH---HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence               00 00111122   355677799999999999 9999999999886554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=6.7e-40  Score=357.40  Aligned_cols=240  Identities=23%  Similarity=0.291  Sum_probs=188.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|.. .+|+.||||+++..   .......+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus       152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~  231 (446)
T 4ejn_A          152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN  231 (446)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred             EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence            457899999999999995 47899999999743   22234567789999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ-EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||+ .    +|+||||||+|||++.++.+||+|||+++.... 
T Consensus       232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~----giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEK----NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHT----CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcC----CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999997643     58999999999999999999998 6    899999999999999999999999999986432 


Q ss_pred             ---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 ---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                         .....+|+.|+|||++.+..++.++|||||||++|||++|+.||....              .............. 
T Consensus       303 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------------~~~~~~~i~~~~~~-  367 (446)
T 4ejn_A          303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------------HEKLFELILMEEIR-  367 (446)
T ss_dssp             ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC-
T ss_pred             CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------------HHHHHHHHHhCCCC-
Confidence               234567889999999999999999999999999999999999996431              11222222221110 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                        +      .....   ..+.+++.+||+.||++||     |++|+++|
T Consensus       368 --~------p~~~~---~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          368 --F------PRTLG---PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             --C------CTTSC---HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --C------CccCC---HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence              0      01112   2355677799999999999     99999975

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-39  Score=348.30  Aligned_cols=190  Identities=28%  Similarity=0.428  Sum_probs=157.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCC--eeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKE--EKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~--~~~lv~e~  433 (670)
                      +.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.++.++. ||||+++++++...+  ..|+||||
T Consensus        13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~   92 (388)
T 3oz6_A           13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY   92 (388)
T ss_dssp             EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred             EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecc
Confidence            357899999999999995 47899999999653  3345567889999999997 999999999998654  68999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      |+ ++|.++++..      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~----~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  161 (388)
T 3oz6_A           93 ME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG----GLLHRDMKPSNILLNAECHVKVADFGLSRSFVN  161 (388)
T ss_dssp             CS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEESSS
T ss_pred             cC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC----CEEeCCCCHHHeEEcCCCCEEecCCcccccccc
Confidence            97 6999999764      488999999999999999999998    999999999999999999999999999986532


Q ss_pred             -------------------------cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 -------------------------VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 -------------------------~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                                               .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  234 (388)
T 3oz6_A          162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS  234 (388)
T ss_dssp             CCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence                                     122457888999999876 67899999999999999999999999754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=339.11  Aligned_cols=254  Identities=23%  Similarity=0.341  Sum_probs=197.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe----CCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA----KEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||++.. .+|+.||||++........+.+.+|++++++++||||+++++++..    ....++||||+
T Consensus        33 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~  112 (317)
T 2buj_A           33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF  112 (317)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECC
T ss_pred             EEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeC
Confidence            457899999999999996 5799999999977666677889999999999999999999999873    34778999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.+++..... ....+++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++......
T Consensus       113 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          113 KRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAK----GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             TTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             CCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            99999999875321 123589999999999999999999998    9999999999999999999999999998765421


Q ss_pred             -------------ccccccCcccCccccccCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          515 -------------QAIARLGGYKAPEQAEVKR---LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       515 -------------~~~~~~~~y~aPE~~~~~~---~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                                   ....++..|+|||.+.+..   ++.++||||||+++|||++|+.||.....         .......
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---------~~~~~~~  258 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ---------KGDSVAL  258 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH---------TTSCHHH
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc---------ccchhhH
Confidence                         1233578899999987543   78999999999999999999999853100         0001111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ..    .....       .......   ...+.+++.+||+.||++|||+.|++++|+.+...
T Consensus       259 ~~----~~~~~-------~~~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          259 AV----QNQLS-------IPQSPRH---SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HH----HCC---------CCCCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             Hh----hccCC-------CCccccC---CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            10    00000       0000111   13466677799999999999999999999988643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=4.3e-40  Score=343.20  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=201.5

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|...      +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus        28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  107 (322)
T 1p4o_A           28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  107 (322)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             eeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEE
Confidence            34578999999999999854      37889999997543 234567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          432 DYLPNGSLHSLLHGNRG-----PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      ||+++|+|.+++.....     .....+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||
T Consensus       108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~NIli~~~~~~kl~Dfg  183 (322)
T 1p4o_A          108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFG  183 (322)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC----CCccCCCccceEEEcCCCeEEECcCc
Confidence            99999999999875320     1123578999999999999999999998    99999999999999999999999999


Q ss_pred             cccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHH
Q 036639          507 LSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       507 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +++......      ...++..|+|||.+.+..++.++||||||+++|||+| |+.||....              ....
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------------~~~~  249 (322)
T 1p4o_A          184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------------NEQV  249 (322)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------------HHHH
T ss_pred             cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--------------HHHH
Confidence            998664322      2234567999999998899999999999999999999 888886431              1111


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ...........        .....   ...+.+++.+||+.||++|||+.|++++|+++...
T Consensus       250 ~~~~~~~~~~~--------~~~~~---~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          250 LRFVMEGGLLD--------KPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             HHHHHTTCCCC--------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHHcCCcCC--------CCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            11111111100        00111   23456677799999999999999999999988654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7e-41  Score=357.11  Aligned_cols=238  Identities=15%  Similarity=0.179  Sum_probs=183.7

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHH---HHHhccCCCCeeeEE-------EEEEeCCe
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYM---DVIGKLKHPNVVKLR-------AYYYAKEE  426 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~nIv~l~-------~~~~~~~~  426 (670)
                      .+.||+|+||+||+|.. .+|+.||||++...   .....+.+.+|+   +++++++||||++++       +++.+.+.
T Consensus        78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~  157 (377)
T 3byv_A           78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  157 (377)
T ss_dssp             EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred             cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence            46799999999999995 57999999999732   334567899999   455566899999998       77766543


Q ss_pred             -----------------eEEEEeccCCCChHHHhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCC
Q 036639          427 -----------------KLLVYDYLPNGSLHSLLHGNRG--PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNV  487 (670)
Q Consensus       427 -----------------~~lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dl  487 (670)
                                       .|+||||+ +|+|.+++.....  .....+++..++.|+.|++.||+|||+.    +|+||||
T Consensus       158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDi  232 (377)
T 3byv_A          158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL  232 (377)
T ss_dssp             CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred             ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC----CeecCCC
Confidence                             78999999 6899999975321  0112344688889999999999999998    9999999


Q ss_pred             CCCCeEeCCCCcEEEEecccccccCcc-ccccccCcccCccccccC-----------CCCCchhHHHHHHHHHHHHcCCC
Q 036639          488 KSSNVLLDKNGVACISDFGLSLLLNPV-QAIARLGGYKAPEQAEVK-----------RLSQKADVYSFGVLLLEVLTGRA  555 (670)
Q Consensus       488 kp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~y~aPE~~~~~-----------~~~~ksDVwS~Gvvl~elltg~~  555 (670)
                      ||+|||++.++.+||+|||+++..... ....+ ..|+|||++.+.           .++.++|||||||++|||+||+.
T Consensus       233 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~  311 (377)
T 3byv_A          233 RPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL  311 (377)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCC
Confidence            999999999999999999999876543 23445 889999999877           89999999999999999999999


Q ss_pred             CCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          556 PSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       556 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ||............                           ........   ..+.+++.+||+.||++|||+.|++++
T Consensus       312 Pf~~~~~~~~~~~~---------------------------~~~~~~~~---~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          312 PITKDAALGGSEWI---------------------------FRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             CC------CCSGGG---------------------------GSSCCCCC---HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             CCcccccccchhhh---------------------------hhhccCCC---HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99654221111000                           00001122   235567779999999999999999973

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-40  Score=336.03  Aligned_cols=241  Identities=23%  Similarity=0.346  Sum_probs=176.8

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   94 (278)
T 3cok_A           15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH   94 (278)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCC
Confidence            346799999999999996 579999999996432   1234678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....    ..+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++...... 
T Consensus        95 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           95 NGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSH----GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             TEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999998642    2589999999999999999999998    9999999999999999999999999999876432 


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....++..|+|||.+.+..++.++||||||+++|||++|+.||..........              .......   
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--------------~~~~~~~---  229 (278)
T 3cok_A          167 EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--------------KVVLADY---  229 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSSCC---
T ss_pred             CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH--------------HHhhccc---
Confidence               23457788999999998889999999999999999999999997543211100              0000000   


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                            .......   ..+.+++.+||+.||++|||++|++++
T Consensus       230 ------~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          230 ------EMPSFLS---IEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ------CCCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ------CCccccC---HHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                  0001111   235567779999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-40  Score=363.31  Aligned_cols=189  Identities=21%  Similarity=0.290  Sum_probs=160.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~lv  430 (670)
                      +.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      ...|+|
T Consensus        66 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv  145 (464)
T 3ttj_A           66 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV  145 (464)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEE
Confidence            3578999999999999954 6899999999754  334567788999999999999999999999654      356999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++ +|.+.+..       .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.
T Consensus       146 ~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          146 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             EeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            999965 57666643       388999999999999999999998    999999999999999999999999999987


Q ss_pred             cCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ....   ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~  266 (464)
T 3ttj_A          214 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  266 (464)
T ss_dssp             ---CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7543   3456788999999999999999999999999999999999999754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-39  Score=331.18  Aligned_cols=251  Identities=25%  Similarity=0.337  Sum_probs=197.7

Q ss_pred             HhHcCCCCceEEEEEEEc-CC---CEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCee-EEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLD-DG---GIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK-LLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~-~lv~e~~  434 (670)
                      .+.||+|+||+||+|.+. ++   ..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            468999999999999853 33   3799999986433 3457889999999999999999999999877655 9999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      .+|+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++.....
T Consensus       106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQ----KFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999997643    2588999999999999999999998    9999999999999999999999999999865432


Q ss_pred             --------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          515 --------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       515 --------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                              ....++..|+|||.+.+..++.++||||||+++|||+||+.|+....          ....+...+.    .
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~----------~~~~~~~~~~----~  243 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI----------DPFDLTHFLA----Q  243 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS----------CGGGHHHHHH----T
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC----------CHHHHHHHhh----c
Confidence                    22345667999999999999999999999999999999666653221          1111111111    1


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      .....       ......   ..+.+++.+||+.||++|||++|+++.|+++.....
T Consensus       244 ~~~~~-------~~~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          244 GRRLP-------QPEYCP---DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             TCCCC-------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             CCCCC-------CCccch---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            10000       001111   245667779999999999999999999999986653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.4e-40  Score=334.14  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=200.6

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++++++||||+++++++. .+..++||||+++++|
T Consensus        17 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L   94 (279)
T 1qpc_A           17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL   94 (279)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred             heeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCH
Confidence            4578999999999999988888999999976543 5678999999999999999999999876 4568999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||++++++.+||+|||++.......    
T Consensus        95 ~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           95 VDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             HHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             HHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence            99997532   12488999999999999999999998    99999999999999999999999999998765422    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ...++..|+|||.+.+..++.++||||||+++|||+| |+.||....              ......... ......  
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------------~~~~~~~~~-~~~~~~--  230 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------------NPEVIQNLE-RGYRMV--  230 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------------HHHHHHHHH-TTCCCC--
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------------HHHHHHHHh-cccCCC--
Confidence             2234557999999988889999999999999999999 899986431              111111111 111000  


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                           ......   ..+.+++.+||+.||++|||+.++++.|+++....
T Consensus       231 -----~~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          231 -----RPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             -----CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----Cccccc---HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence                 001112   34566777999999999999999999999987543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=341.64  Aligned_cols=242  Identities=21%  Similarity=0.328  Sum_probs=190.0

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCC--CCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKH--PNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||++...+++.||||++...  .....+.+.+|++++.+++|  +||+++++++.+....++|||+ .
T Consensus        13 i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~   91 (343)
T 3dbq_A           13 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-G   91 (343)
T ss_dssp             EEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-C
T ss_pred             EEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-C
Confidence            35789999999999999888999999998754  33345788999999999976  9999999999999999999995 5


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++ ++.+||+|||+++..... 
T Consensus        92 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           92 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             SEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            889999998654     589999999999999999999998    999999999999996 688999999999876432 


Q ss_pred             -----ccccccCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          515 -----QAIARLGGYKAPEQAEV-----------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       515 -----~~~~~~~~y~aPE~~~~-----------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                           ....+++.|+|||++.+           ..++.++|||||||++|||++|+.||....             ....
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------------~~~~  228 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------------NQIS  228 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------------SHHH
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-------------hHHH
Confidence                 23467889999999864           678999999999999999999999996421             1111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      .+............       .....   ..+.+++.+||+.||++|||+.|+++|-
T Consensus       229 ~~~~~~~~~~~~~~-------~~~~~---~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          229 KLHAIIDPNHEIEF-------PDIPE---KDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             HHHHHHCTTSCCCC-------CCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHhcCCcccCC-------cccCC---HHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence            11111111110000       00111   2455677799999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-40  Score=351.07  Aligned_cols=266  Identities=20%  Similarity=0.280  Sum_probs=205.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC--eeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE--EKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|... +|+.||||+++... ....+.+.+|++++++++||||+++++++....  ..++||||++
T Consensus        13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~   92 (396)
T 4eut_A           13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP   92 (396)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCT
T ss_pred             EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCC
Confidence            3467999999999999965 58999999997543 234577889999999999999999999998765  7799999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe----CCCCcEEEEeccccccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGLSLLL  511 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~a~~~  511 (670)
                      +|+|.+++.....  ...+++..++.++.|++.||+|||+.    +|+||||||+|||+    +.++.+||+|||+++..
T Consensus        93 ~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           93 CGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLREN----GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             TEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             CCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC----CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            9999999976431  22489999999999999999999998    99999999999999    78888999999999877


Q ss_pred             Cccc---cccccCcccCcccccc--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          512 NPVQ---AIARLGGYKAPEQAEV--------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       512 ~~~~---~~~~~~~y~aPE~~~~--------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ....   ...++..|+|||++.+        ..++.++|||||||++|||+||+.||.......          .....+
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~----------~~~~~~  236 (396)
T 4eut_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----------RNKEVM  236 (396)
T ss_dssp             CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT----------TCHHHH
T ss_pred             cCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc----------chHHHH
Confidence            5433   3457888999999864        567889999999999999999999996532211          111112


Q ss_pred             HHHhhhccc---ccc---------ccHhhhc-ccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          581 RSVVKEEWT---AEV---------FDQELLR-YKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       581 ~~~~~~~~~---~~~---------~d~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .........   ...         +...... ..........+.+++.+||+.||++|||+.|+++.++++...
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            222211100   000         0000000 011234445677888899999999999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-39  Score=342.91  Aligned_cols=250  Identities=21%  Similarity=0.245  Sum_probs=191.6

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC-----CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA-----NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.+.||+|+||.||+|.. .+++.||+|++...     .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        29 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  108 (345)
T 3hko_A           29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVME  108 (345)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEe
Confidence            3467899999999999996 46889999998643     33456789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHhC
Q 036639          433 YLPNGSLHSLLHGNRGP-----------------------------------GRIPLDWTTRISLVLGAARGLARIHQEY  477 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~  477 (670)
                      |+++|+|.+++......                                   ....+++..+..++.|++.||+|||+. 
T Consensus       109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-  187 (345)
T 3hko_A          109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ-  187 (345)
T ss_dssp             CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence            99999999998621100                                   011235677888999999999999998 


Q ss_pred             CCCCccccCCCCCCeEeCCCC--cEEEEecccccccCc--------cccccccCcccCcccccc--CCCCCchhHHHHHH
Q 036639          478 GTAKVPHGNVKSSNVLLDKNG--VACISDFGLSLLLNP--------VQAIARLGGYKAPEQAEV--KRLSQKADVYSFGV  545 (670)
Q Consensus       478 ~~~~ivH~Dlkp~NIll~~~~--~~kl~DFG~a~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gv  545 (670)
                         +|+||||||+|||++.++  .+||+|||+++....        .....+++.|+|||.+.+  ..++.++|||||||
T Consensus       188 ---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          188 ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             ---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             ---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence               999999999999998776  899999999986532        223457788999999865  67899999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCC
Q 036639          546 LLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKR  625 (670)
Q Consensus       546 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  625 (670)
                      ++|||++|+.||....              ................  .+   ......   ..+.+++.+||+.||++|
T Consensus       265 il~el~~g~~pf~~~~--------------~~~~~~~~~~~~~~~~--~~---~~~~~~---~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVN--------------DADTISQVLNKKLCFE--NP---NYNVLS---PLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCCTT--SG---GGGGSC---HHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHCCCCCCCCC--------------hHHHHHHHHhcccccC--Cc---ccccCC---HHHHHHHHHHcCCChhHC
Confidence            9999999999996531              1111222222111000  00   001112   245567779999999999


Q ss_pred             CCHHHHHHH
Q 036639          626 PTMAEVAKM  634 (670)
Q Consensus       626 Pt~~evl~~  634 (670)
                      ||+.|++++
T Consensus       323 ps~~~~l~h  331 (345)
T 3hko_A          323 FDAMRALQH  331 (345)
T ss_dssp             CCHHHHHHS
T ss_pred             CCHHHHhcC
Confidence            999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-39  Score=332.00  Aligned_cols=247  Identities=23%  Similarity=0.322  Sum_probs=191.3

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus        25 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  104 (285)
T 3is5_A           25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG  104 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred             eecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCC
Confidence            4457899999999999996 468999999987543 33568899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe---CCCCcEEEEecccccccCc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~~  513 (670)
                      |+|.+++..... ....+++..+..++.|++.||+|||+.    +|+||||||+||++   +.++.+||+|||++.....
T Consensus       105 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~----~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          105 GELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQ----HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             CcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            999998864311 112589999999999999999999998    99999999999999   4567899999999987644


Q ss_pred             c---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 V---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .   ....++..|+|||.+. ..++.++||||||+++|||++|+.||....              .............. 
T Consensus       180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------------~~~~~~~~~~~~~~-  243 (285)
T 3is5_A          180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------------LEEVQQKATYKEPN-  243 (285)
T ss_dssp             -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC-
T ss_pred             cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------------HHHHHhhhccCCcc-
Confidence            2   3455778899999986 568999999999999999999999996531              11111111111100 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        +...   .....   ..+.+++.+||+.||++|||+.|++++
T Consensus       244 --~~~~---~~~~~---~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          244 --YAVE---CRPLT---PQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             --CCC-----CCCC---HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             --cccc---cCcCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000   00111   245567779999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=364.26  Aligned_cols=246  Identities=26%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             HcCCCCceEEEEEEEc---CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          363 MLGKGSLGTVYKAVLD---DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .||+|+||.||+|.+.   ++..||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            6999999999999864   46689999998643 3357889999999999999999999999976 56899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.+++....    ..+++..+..++.||+.||+|||+.    +|+||||||+|||++.++.+||+|||+++......   
T Consensus       422 L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~----~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          422 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            999997543    2589999999999999999999998    99999999999999999999999999998764322   


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....              ..... .+......
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------------~~~~~-~i~~~~~~  558 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------------PEVMA-FIEQGKRM  558 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------------HHHHH-HHHTTCCC
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------------HHHHH-HHHcCCCC
Confidence                1223457999999998999999999999999999998 9999975411              11111 11111100


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .          ........+.+++.+||+.||++||++.+|++.|+.+....
T Consensus       559 ~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          559 E----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             C----------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             C----------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            0          01112235667788999999999999999999999986543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.4e-39  Score=347.47  Aligned_cols=244  Identities=18%  Similarity=0.267  Sum_probs=186.2

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhc-cCCCCeeeEEEEEEe----CCeeEEEEeccC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGK-LKHPNVVKLRAYYYA----KEEKLLVYDYLP  435 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~nIv~l~~~~~~----~~~~~lv~e~~~  435 (670)
                      +.||+|+||+||++... +|+.||||+++..     ..+.+|++++.+ .+||||+++++++..    ....|+||||++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~  142 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD  142 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence            57999999999999965 6899999999632     456778887744 489999999999876    567899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccccC
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLN  512 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~  512 (670)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+|||++.   ++.+||+|||+++...
T Consensus       143 gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~  215 (400)
T 1nxk_A          143 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  215 (400)
T ss_dssp             SEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             CCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence            999999998643   23589999999999999999999998    9999999999999998   7899999999998765


Q ss_pred             cc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          513 PV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       513 ~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ..   ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.........       ......   .....+.
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~~~~---i~~~~~~  285 (400)
T 1nxk_A          216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMKTR---IRMGQYE  285 (400)
T ss_dssp             -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-------CSHHHH---HHHTCCC
T ss_pred             CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-------HHHHHH---HHcCccc
Confidence            42   3455688899999999999999999999999999999999999764322110       011111   1111110


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      .   .  ...+....   ..+.+++.+||+.||++|||+.|+++|-
T Consensus       286 ~---~--~~~~~~~s---~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          286 F---P--NPEWSEVS---EEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             C---C--TTTTTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             C---C--CcccccCC---HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            0   0  00011122   2455677799999999999999999974

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-39  Score=340.37  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=200.8

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCE--EEEEEeCCC-CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGI--VAVKRLKDA-NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||+|+.. +|..  ||+|.++.. .....+.+.+|+++++++ +||||+++++++.+.+..++||||+
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~  108 (327)
T 1fvr_A           29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA  108 (327)
T ss_dssp             EEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecC
Confidence            3578999999999999954 5664  499998753 233456789999999999 8999999999999999999999999


Q ss_pred             CCCChHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEE
Q 036639          435 PNGSLHSLLHGNRG-----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACIS  503 (670)
Q Consensus       435 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~  503 (670)
                      ++++|.+++.....           .....+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+
T Consensus       109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kL~  184 (327)
T 1fvr_A          109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIA  184 (327)
T ss_dssp             TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCccceEEEcCCCeEEEc
Confidence            99999999976530           1123589999999999999999999998    99999999999999999999999


Q ss_pred             ecccccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHH
Q 036639          504 DFGLSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       504 DFG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      |||+++.....   ....++..|+|||++.+..++.++||||||+++|||+| |+.||....              ....
T Consensus       185 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------------~~~~  250 (327)
T 1fvr_A          185 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------------CAEL  250 (327)
T ss_dssp             CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHH
T ss_pred             ccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------------HHHH
Confidence            99999755432   22345667999999988889999999999999999998 999996531              1111


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCCCC
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLG  646 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~  646 (670)
                      ... +.......       ......   ..+.+++.+||+.||++|||++|++++|+++..+.....
T Consensus       251 ~~~-~~~~~~~~-------~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  306 (327)
T 1fvr_A          251 YEK-LPQGYRLE-------KPLNCD---DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV  306 (327)
T ss_dssp             HHH-GGGTCCCC-------CCTTBC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB
T ss_pred             HHH-hhcCCCCC-------CCCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCcc
Confidence            111 11111000       001112   345667779999999999999999999999987764433

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.1e-40  Score=333.90  Aligned_cols=241  Identities=26%  Similarity=0.398  Sum_probs=193.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (279)
T 3fdn_A           13 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP   92 (279)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCC
Confidence            3578999999999999955 57899999986432   1235678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~  163 (279)
T 3fdn_A           93 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  163 (279)
T ss_dssp             TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence            999999997643     489999999999999999999988    9999999999999999999999999998765432 


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||...              ...............   +
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------------~~~~~~~~~~~~~~~---~  226 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQETYKRISRVEFT---F  226 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------------SHHHHHHHHHHTCCC---C
T ss_pred             ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC--------------cHHHHHHHHHhCCCC---C
Confidence             3456788899999999999999999999999999999999999643              111111111111100   0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                            .....   ..+.+++.+||+.||++|||+.|+++|-
T Consensus       227 ------~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          227 ------PDFVT---EGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ------CTTSC---HHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ------CCcCC---HHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                  01112   2345677799999999999999999873

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=344.55  Aligned_cols=235  Identities=18%  Similarity=0.254  Sum_probs=193.5

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.+.||+|+||.||+|.. .+++.||||+++....        ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus        27 ~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~l  106 (335)
T 3dls_A           27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQL  106 (335)
T ss_dssp             EEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             EEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEE
Confidence            3457899999999999995 5789999999975431        123467789999999999999999999999999999


Q ss_pred             EEeccCCC-ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          430 VYDYLPNG-SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       430 v~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      ||||+.+| +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++
T Consensus       107 v~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          107 VMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLK----DIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             EEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            99999777 9999998654     589999999999999999999998    9999999999999999999999999999


Q ss_pred             cccCccc---cccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          509 LLLNPVQ---AIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       509 ~~~~~~~---~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      +......   ...++..|+|||++.+..+ +.++|||||||++|||++|+.||......                    .
T Consensus       178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------------~  237 (335)
T 3dls_A          178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------------V  237 (335)
T ss_dssp             EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------------T
T ss_pred             eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------------H
Confidence            8765432   3457888999999988776 78999999999999999999999642100                    0


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...         ........   ..+.+++.+||+.||++|||++|++++
T Consensus       238 ~~~---------~~~~~~~~---~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          238 EAA---------IHPPYLVS---KELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TTC---------CCCSSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hhc---------cCCCcccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000         00000111   235567779999999999999999997

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.8e-40  Score=339.09  Aligned_cols=257  Identities=23%  Similarity=0.353  Sum_probs=192.4

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe----
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE----  426 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~----  426 (670)
                      .|.+.+.||+|+||.||+|...    +++.||||+++...  ....+.+.+|++++++++||||+++++++.+...    
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  114 (313)
T 3brb_A           35 LLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP  114 (313)
T ss_dssp             GEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------
T ss_pred             HeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCc
Confidence            3345678999999999999854    34589999997543  3345778999999999999999999999987653    


Q ss_pred             -eEEEEeccCCCChHHHhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          427 -KLLVYDYLPNGSLHSLLHGNRG-PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       427 -~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                       .++||||+++|+|.+++..... .....+++..++.++.|+++||.|||+.    +|+||||||+||+++.++.+||+|
T Consensus       115 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          115 KPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR----NFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCSGGGEEECTTSCEEECS
T ss_pred             ccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCcceEEEcCCCcEEEee
Confidence             4999999999999999854321 1234689999999999999999999998    999999999999999999999999


Q ss_pred             cccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchh
Q 036639          505 FGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLP  577 (670)
Q Consensus       505 FG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  577 (670)
                      ||+++.....      ....++..|+|||.+.+..++.++||||||+++|||+| |..||.....           ..+ 
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----------~~~-  258 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----------HEM-  258 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----------GGH-
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----------HHH-
Confidence            9999876432      22344567999999998999999999999999999999 8888865311           111 


Q ss_pred             HHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          578 KWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       578 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                        .......... .          ........+.+++.+||+.||++|||+.|++++|+++....
T Consensus       259 --~~~~~~~~~~-~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          259 --YDYLLHGHRL-K----------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             --HHHHHTTCCC-C----------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             --HHHHHcCCCC-C----------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence              1111111100 0          00111234666777999999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-39  Score=333.32  Aligned_cols=243  Identities=22%  Similarity=0.322  Sum_probs=195.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.||+|+||.||+|... +|+.||+|++...  .....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~   90 (284)
T 3kk8_A           11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG   90 (284)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence            467999999999999964 6899999999654  2334577889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc---EEEEecccccccCcc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV---ACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG~a~~~~~~  514 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.   +||+|||++......
T Consensus        91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSN----GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            9999887543     589999999999999999999998    9999999999999987665   999999999876543


Q ss_pred             c---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 Q---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      .   ...+++.|+|||.+.+..++.++||||||+++|||++|+.||....              ............... 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--------------~~~~~~~~~~~~~~~-  226 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------------QHRLYAQIKAGAYDY-  226 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHTCCCC-
T ss_pred             ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--------------hhHHHHHHHhccccC-
Confidence            3   3567788999999999999999999999999999999999996431              111111111111100 


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          .........   ..+.+++.+||+.||++|||++|++++
T Consensus       227 ----~~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 ----PSPEWDTVT---PEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ----CTTTTTTSC---HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----CchhhcccC---HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                000011122   235567779999999999999999985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=7.8e-40  Score=337.90  Aligned_cols=261  Identities=21%  Similarity=0.312  Sum_probs=196.4

Q ss_pred             HHhHcCCCCceEEEEEEE-----cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--CeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-----DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--EEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--~~~~lv~  431 (670)
                      ..+.||+|+||.||+|++     .+++.||||+++... ....+.+.+|++++++++||||+++++++.+.  ...++||
T Consensus        25 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~  104 (302)
T 4e5w_A           25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIM  104 (302)
T ss_dssp             EEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEE
T ss_pred             hhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEE
Confidence            347899999999999984     368899999997542 33457899999999999999999999999877  6689999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++++|.+++....    ..+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++...
T Consensus       105 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A          105 EFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSR----QYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             ECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcC----CcccCCCchheEEEcCCCCEEECcccccccc
Confidence            9999999999996543    2489999999999999999999998    9999999999999999999999999999876


Q ss_pred             Cccc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCC-cccccccchhHHHHHH
Q 036639          512 NPVQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRV-DEEEQAVDLPKWVRSV  583 (670)
Q Consensus       512 ~~~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~  583 (670)
                      ....       ...++..|+|||.+.+..++.++||||||+++|||+||+.|+.......... ............ ...
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  255 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL-VNT  255 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH-HHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH-HHH
Confidence            5422       2345556999999998899999999999999999999998864320000000 000000001111 111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ......          ..........+.+++.+||+.||++|||++|+++.|+++.
T Consensus       256 ~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEGKR----------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTTCC----------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCC----------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111000          0001111234667777999999999999999999999874

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=344.15  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=190.5

Q ss_pred             HHhHcCCCCceEEEEEEEc--CC--CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLD--DG--GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~  433 (670)
                      +.+.||+|+||+||+|.+.  ++  ..||||.++.. .....+++.+|+.++++++||||+++++++.. .+..++||||
T Consensus        93 ~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~  172 (373)
T 3c1x_A           93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  172 (373)
T ss_dssp             EEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEEC
T ss_pred             cCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEEC
Confidence            3467999999999999853  22  46899999754 33456789999999999999999999998765 4578999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.++++...    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus       173 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          173 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             CTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             CCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----CEecCccchheEEECCCCCEEEeeccccccccc
Confidence            99999999997643    2478999999999999999999998    999999999999999999999999999986543


Q ss_pred             c--------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          514 V--------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       514 ~--------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      .        ....++..|+|||.+.+..++.++|||||||++|||+| |.+||.....           .+....+   .
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----------~~~~~~~---~  310 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVYL---L  310 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----------SCHHHHH---H
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----------HHHHHHH---H
Confidence            2        12334557999999999999999999999999999999 6667754321           1111111   1


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      .....   ..     ....   ...+.+++.+||+.||++|||+.|++++|+++.....
T Consensus       311 ~~~~~---~~-----p~~~---~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          311 QGRRL---LQ-----PEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             TTCCC---CC-----CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             cCCCC---CC-----CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            11000   00     0111   1245667779999999999999999999999986553

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.3e-40  Score=347.33  Aligned_cols=245  Identities=16%  Similarity=0.185  Sum_probs=194.7

Q ss_pred             HHhHcCCCCceEEEEEE------EcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC---CCCeeeEEEEEEeCCeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAV------LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK---HPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+.||+|+||+||+|.      ..+++.||||+++..   ...++..|++++.+++   |+||+++++++...+..++|
T Consensus        69 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv  145 (365)
T 3e7e_A           69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV  145 (365)
T ss_dssp             EEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred             EEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence            34689999999999994      456899999999865   3567778888887776   99999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-----------CCc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-----------NGV  499 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----------~~~  499 (670)
                      |||+++|+|.+++..........+++..++.++.|+++||+|||+.    +|+||||||+|||++.           ++.
T Consensus       146 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~----~ivHrDiKp~NIll~~~~~~~~~~~~~~~~  221 (365)
T 3e7e_A          146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC----EIIHGDIKPDNFILGNGFLEQDDEDDLSAG  221 (365)
T ss_dssp             ECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred             EeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC----CeecCCCCHHHEEecccccCccccccccCC
Confidence            9999999999999753222233699999999999999999999998    9999999999999998           899


Q ss_pred             EEEEecccccccCc------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccc
Q 036639          500 ACISDFGLSLLLNP------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQA  573 (670)
Q Consensus       500 ~kl~DFG~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  573 (670)
                      +||+|||+++....      .....+|..|+|||++.+..++.++|||||||++|||+||+.||.......         
T Consensus       222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------  292 (365)
T 3e7e_A          222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---------  292 (365)
T ss_dssp             EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---------
T ss_pred             EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---------
Confidence            99999999975431      233567889999999999999999999999999999999999985431110         


Q ss_pred             cchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHhhhcc
Q 036639          574 VDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKR-PTMAEVAKMIEDIRVE  641 (670)
Q Consensus       574 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~evl~~L~~i~~~  641 (670)
                                    +.   ....+... ...+...   +++..|+..+|.+| |+++++.+.|+++...
T Consensus       293 --------------~~---~~~~~~~~-~~~~~~~---~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          293 --------------CK---PEGLFRRL-PHLDMWN---EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             --------------EE---ECSCCTTC-SSHHHHH---HHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------------ee---echhcccc-CcHHHHH---HHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                          00   00000011 1123333   45558999999998 5788999888888754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-39  Score=332.93  Aligned_cols=252  Identities=23%  Similarity=0.377  Sum_probs=199.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||.||+|... +|+.||+|+++....      ...+.+.+|++++++++||||+++++++.+....++||
T Consensus         8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   87 (283)
T 3bhy_A            8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLIL   87 (283)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEE
Confidence            44578999999999999965 689999999875321      24688999999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC----cEEEEeccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG----VACISDFGL  507 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~  507 (670)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++    .+||+|||+
T Consensus        88 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           88 ELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSK----RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             eecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            9999999999997543     589999999999999999999998    999999999999999877    899999999


Q ss_pred             ccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          508 SLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       508 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      +......   ....++..|+|||.+.+..++.++||||||+++|||++|+.||....              .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------------~~~~~~~~~  224 (283)
T 3bhy_A          159 AHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--------------KQETLTNIS  224 (283)
T ss_dssp             CEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHH
T ss_pred             ceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--------------hHHHHHHhH
Confidence            9876542   23457778999999998899999999999999999999999996531              111111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhcc
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRVE  641 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~  641 (670)
                      ....   .+....  .....   ..+.+++.+||+.||++|||+.|++++  ++.++..
T Consensus       225 ~~~~---~~~~~~--~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          225 AVNY---DFDEEY--FSNTS---ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             TTCC---CCCHHH--HTTCC---HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             hccc---CCcchh--cccCC---HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence            1100   011110  01111   245667779999999999999999984  5666544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-39  Score=351.78  Aligned_cols=245  Identities=22%  Similarity=0.286  Sum_probs=193.1

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .++||+|+||+||+|+.. +++.||||++++...   ...+.+.+|..++..++||||++++++|.+.+..|+||||+++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g  158 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG  158 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence            468999999999999965 578999999974321   1223488899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      |+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQL----HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            99999998632    2589999999999999999999998    99999999999999999999999999997664322 


Q ss_pred             ----cccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          516 ----AIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                          ...+|+.|+|||++.     ...++.++|||||||++|||+||+.||...+              ...........
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------------~~~~~~~i~~~  296 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------------LVETYGKIMNH  296 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHTH
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------------hhHHHHhhhhc
Confidence                246888999999986     5678999999999999999999999997531              11112222211


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEK--RPTMAEVAKM  634 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  634 (670)
                      ..... +..   ......+   .+.+++.+||..+|++  ||+++|+++|
T Consensus       297 ~~~~~-~p~---~~~~~s~---~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          297 KERFQ-FPT---QVTDVSE---NAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHCC-CCS---SCCCSCH---HHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ccccc-CCc---ccccCCH---HHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            00000 000   0011223   3445666899888888  9999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-39  Score=332.17  Aligned_cols=244  Identities=23%  Similarity=0.379  Sum_probs=196.6

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe--------------
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--------------  423 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--------------  423 (670)
                      ...+.||+|+||.||+|... +|+.||+|+++...    +.+.+|++++++++||||+++++++..              
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   89 (284)
T 2a19_B           14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR   89 (284)
T ss_dssp             EEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred             ceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence            34578999999999999975 79999999997553    356789999999999999999999865              


Q ss_pred             --CCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          424 --KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       424 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                        ....++||||+++++|.+++....   ...+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+|
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           90 SKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSK----KLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             CEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEE
T ss_pred             cCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCCHHHEEEcCCCCEE
Confidence              345789999999999999997542   12589999999999999999999998    999999999999999999999


Q ss_pred             EEecccccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          502 ISDFGLSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       502 l~DFG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      |+|||++......   ....++..|+|||.+.+..++.++||||||+++|||++|..|+...                ..
T Consensus       163 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------------~~  226 (284)
T 2a19_B          163 IGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------------SK  226 (284)
T ss_dssp             ECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------------HH
T ss_pred             ECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------------HH
Confidence            9999999876543   2345778899999999889999999999999999999999876311                11


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      ..... ........          ..   ..+.+++.+||+.||++|||+.|++++|+.+.....
T Consensus       227 ~~~~~-~~~~~~~~----------~~---~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          227 FFTDL-RDGIISDI----------FD---KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHH-HTTCCCTT----------SC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHHHh-hccccccc----------CC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            11111 11111111          11   234567779999999999999999999999875543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-39  Score=366.74  Aligned_cols=244  Identities=28%  Similarity=0.357  Sum_probs=195.8

Q ss_pred             hHcCCCCceEEEEEEEc---CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD---DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|.+.   +++.||||+++..  .....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            46999999999999753   4678999999854  23346889999999999999999999999864 568899999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      |+|.++++...     .+++..++.++.||+.||+|||+.    +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       454 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~----~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          454 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             CCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHC----CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            99999997654     589999999999999999999998    99999999999999999999999999998764322 


Q ss_pred             ------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          516 ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       516 ------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                            ...++..|+|||++.+..++.++|||||||++|||+| |+.||.....              .. +...+....
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------------~~-~~~~i~~~~  589 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------SE-VTAMLEKGE  589 (635)
T ss_dssp             ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HH-HHHHHHTTC
T ss_pred             ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------------HH-HHHHHHcCC
Confidence                  1234456999999998999999999999999999999 9999965411              11 111111111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ...          ........+.+++..||+.||++|||+++|++.|+++..
T Consensus       590 ~~~----------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          590 RMG----------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCC----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCC----------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            000          001122346677789999999999999999999998754

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.3e-39  Score=346.45  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=190.8

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccC--CCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLK--HPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|...+++.||||++...  .....+.+.+|++++.+++  ||||+++++++...+..++||| +.
T Consensus        60 ~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~  138 (390)
T 2zmd_A           60 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG  138 (390)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CC
T ss_pred             EEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cC
Confidence            45789999999999999888999999999654  3335578999999999996  5999999999999999999999 56


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     .+++..+..++.||+.||+|||+.    +|+||||||+|||++ ++.+||+|||+++..... 
T Consensus       139 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~----~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          139 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTT----TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            889999998654     588999999999999999999998    999999999999995 589999999999876532 


Q ss_pred             -----ccccccCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          515 -----QAIARLGGYKAPEQAEV-----------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       515 -----~~~~~~~~y~aPE~~~~-----------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                           ....+|+.|+|||++.+           ..++.++|||||||++|||++|+.||....             ....
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------------~~~~  275 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------------NQIS  275 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-------------CHHH
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-------------HHHH
Confidence                 23457888999999864           368999999999999999999999996431             1111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      .+........... +      ....   ...+.+++.+||+.||++|||+.|++++-
T Consensus       276 ~~~~~~~~~~~~~-~------~~~~---~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          276 KLHAIIDPNHEIE-F------PDIP---EKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             HHHHHHCTTSCCC-C------CCCS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHhCccccCC-C------Cccc---hHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            1222221111100 0      0011   12455677799999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-39  Score=333.38  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=195.3

Q ss_pred             HHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~  433 (670)
                      +.+.||+|+||+||+|...+    +..||+|.+.... ....+.+.+|++++++++||||+++++++.. .+..++||||
T Consensus        29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  108 (298)
T 3f66_A           29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  108 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEEC
T ss_pred             hcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeC
Confidence            34789999999999998542    2368999998643 3345788999999999999999999998654 5678999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.++++...    ..+++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||+++....
T Consensus       109 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          109 MKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             CTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999997543    2578999999999999999999998    999999999999999999999999999987643


Q ss_pred             cc--------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          514 VQ--------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTG-RAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       514 ~~--------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ..        ...++..|+|||.+.+..++.++||||||+++|||++| .+||.....           ......   ..
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----------~~~~~~---~~  246 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----------FDITVY---LL  246 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-----------TTHHHH---HH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-----------HHHHHH---Hh
Confidence            22        23345679999999989999999999999999999995 555543211           111111   11


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .....   ..     .....   ..+.+++.+||+.||++|||++|+++.|+++....
T Consensus       247 ~~~~~---~~-----~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          247 QGRRL---LQ-----PEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             TTCCC---CC-----CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             cCCCC---CC-----CccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            11000   00     01111   24566777999999999999999999999998654

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.7e-39  Score=328.16  Aligned_cols=241  Identities=24%  Similarity=0.398  Sum_probs=191.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEe----CCeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA----KEEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~  433 (670)
                      .+.||+|+||.||+|.. .++..||+|++...  .....+.+.+|++++++++||||+++++++..    ....++||||
T Consensus        31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~  110 (290)
T 1t4h_A           31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL  110 (290)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred             eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence            35799999999999996 46889999998753  33456788999999999999999999999876    3457899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC--ccccCCCCCCeEeC-CCCcEEEEecccccc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK--VPHGNVKSSNVLLD-KNGVACISDFGLSLL  510 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~  510 (670)
                      +++++|.+++....     .+++..+..++.|++.||+|||+.    +  |+||||||+||+++ .++.+||+|||++..
T Consensus       111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR----TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS----SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcC----CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            99999999997643     588999999999999999999998    6  99999999999998 789999999999976


Q ss_pred             cCcc--ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          511 LNPV--QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       511 ~~~~--~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ....  ....++..|+|||.+. ..++.++||||||+++|||+||+.||....             ............ .
T Consensus       182 ~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~-------------~~~~~~~~~~~~-~  246 (290)
T 1t4h_A          182 KRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-------------NAAQIYRRVTSG-V  246 (290)
T ss_dssp             CCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------------SHHHHHHHHTTT-C
T ss_pred             ccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcC-------------cHHHHHHHHhcc-C
Confidence            5442  3456788899999887 459999999999999999999999996431             111111111111 1


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ....++      ...   ...+.+++.+||+.||++|||++|+++|
T Consensus       247 ~~~~~~------~~~---~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          247 KPASFD------KVA---IPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             CCGGGG------GCC---CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CccccC------CCC---CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            111011      011   1246667779999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.9e-39  Score=335.54  Aligned_cols=245  Identities=22%  Similarity=0.329  Sum_probs=195.4

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||.||+++.. +|+.||+|+++.......+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        12 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (304)
T 2jam_A           12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG   91 (304)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence            34578999999999999965 79999999998665445677899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe---CCCCcEEEEecccccccCcc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~~~  514 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||++   +.++.+||+|||++......
T Consensus        92 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           92 ELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHEN----GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             BHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999987543     588999999999999999999998    99999999999999   78899999999999865442


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....++..|+|||.+.+..++.++||||||+++|||++|+.||....              ..............   
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------------~~~~~~~i~~~~~~---  225 (304)
T 2jam_A          163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------------ESKLFEKIKEGYYE---  225 (304)
T ss_dssp             TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHHHCCCC---
T ss_pred             ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------------HHHHHHHHHcCCCC---
Confidence              23457888999999999999999999999999999999999996431              11111111111110   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +...  ......   ..+.+++.+||+.||++|||++|++++
T Consensus       226 ~~~~--~~~~~~---~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          226 FESP--FWDDIS---ESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCTT--TTTTSC---HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCcc--ccccCC---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000  001112   345567779999999999999999985

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=332.38  Aligned_cols=254  Identities=23%  Similarity=0.297  Sum_probs=191.3

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-----cchHHHHHHHHHHHhccC---CCCeeeEEEEEEeCC-----
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-----PCARKEFEQYMDVIGKLK---HPNVVKLRAYYYAKE-----  425 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~-----  425 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++....     ......+.+|++++++++   ||||+++++++....     
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~   92 (308)
T 3g33_A           13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI   92 (308)
T ss_dssp             EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence            457899999999999995 578999999986322     112356677777777664   999999999998765     


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ..++||||++ ++|.+++.....   ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+||
T Consensus        93 ~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           93 KVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHAN----CIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             EEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             eEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEcCCCCEEEeeC
Confidence            5789999996 699999986542   2489999999999999999999998    9999999999999999999999999


Q ss_pred             ccccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          506 GLSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       506 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      |+++.....   ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......          ..+......
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------~~~~~i~~~  234 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----------DQLGKIFDL  234 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH----------HHHHHHHHH
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHHH
Confidence            999876532   3356788899999999899999999999999999999999999654210          001111110


Q ss_pred             H---hhhccccccc------cHh-----hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          583 V---VKEEWTAEVF------DQE-----LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       583 ~---~~~~~~~~~~------d~~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .   ....|.....      ...     .......   ...+.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEM---EESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSC---CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccc---cHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0   0011110000      000     0000111   2345667779999999999999999975

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-40  Score=341.74  Aligned_cols=248  Identities=22%  Similarity=0.357  Sum_probs=192.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCC----EEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.||+|+||+||+|... +++    +||+|.+... .....+.+.+|+.++++++||||+++++++.... .++|+||
T Consensus        19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~   97 (327)
T 3lzb_A           19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQL   97 (327)
T ss_dssp             EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECC
T ss_pred             EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEe
Confidence            3478999999999999954 454    3588887643 3346788999999999999999999999998765 7899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.+++.....    .+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           98 MPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             CSSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             cCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhC----CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999986532    589999999999999999999998    999999999999999999999999999987643


Q ss_pred             cc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          514 VQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       514 ~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ..      ...++..|+|||.+.+..++.++|||||||++|||++ |+.||.....           ..+...    +..
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----------~~~~~~----~~~  234 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------SEISSI----LEK  234 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHHH----HHT
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----------HHHHHH----HHc
Confidence            22      2234557999999999999999999999999999999 9999965411           111111    111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .....       ....   ....+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       235 ~~~~~-------~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          235 GERLP-------QPPI---CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TCCCC-------CCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCC-------CCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            10000       0011   122456677799999999999999999999998744

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=5e-39  Score=328.41  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             HHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||+||+|...+    +..||||.+... .....+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus        16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   94 (281)
T 3cc6_A           16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELY   94 (281)
T ss_dssp             EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecC
Confidence            34679999999999998542    346999999865 33456789999999999999999999999764 4578999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++++|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++......
T Consensus        95 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           95 PYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESI----NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             TTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            9999999997543    2489999999999999999999998    9999999999999999999999999999876542


Q ss_pred             c-----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          515 Q-----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       515 ~-----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      .     ...++..|+|||.+.+..++.++||||||+++|||+| |+.||.....           ......+   .....
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----------~~~~~~~---~~~~~  232 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----------KDVIGVL---EKGDR  232 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----------GGHHHHH---HHTCC
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----------HHHHHHH---hcCCC
Confidence            2     2344567999999988899999999999999999998 9999964311           1111111   11100


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ..        ......   ..+.+++.+||+.||++|||+.|++++|+++..
T Consensus       233 ~~--------~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          233 LP--------KPDLCP---PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             CC--------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC--------CCCCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            00        001111   245667779999999999999999999998864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=7e-39  Score=332.19  Aligned_cols=256  Identities=22%  Similarity=0.373  Sum_probs=193.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|.. .+|+.||||+++..   .....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  115 (310)
T 2wqm_A           36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD  115 (310)
T ss_dssp             EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCC
Confidence            357899999999999995 57999999999753   33456778999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++..... ....+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++...... 
T Consensus       116 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          116 AGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSR----RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             SCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             CCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC----CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            9999999864211 122588999999999999999999998    9999999999999999999999999999876432 


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....++..|+|||.+.+..++.++||||||+++|||++|+.||....            ................. 
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------------~~~~~~~~~~~~~~~~~-  257 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------------MNLYSLCKKIEQCDYPP-  257 (310)
T ss_dssp             --------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------------CCHHHHHHHHHTTCSCC-
T ss_pred             ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------------hhHHHHHHHhhcccCCC-
Confidence               23456788999999998899999999999999999999999986431            11111111111111110 


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ..      .....   ..+.+++.+||+.||++|||+.||+++|+++.+..
T Consensus       258 ~~------~~~~~---~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          258 LP------SDHYS---EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             CC------TTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             Cc------ccccC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            00      01112   24556777999999999999999999999998654

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-39  Score=338.04  Aligned_cols=255  Identities=24%  Similarity=0.320  Sum_probs=200.7

Q ss_pred             HHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCC-eeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKE-EKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~-~~~l  429 (670)
                      .+.+.||+|+||.||+|..      .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++...+ ..++
T Consensus        30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~l  109 (316)
T 2xir_A           30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV  109 (316)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEE
T ss_pred             eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEE
Confidence            4567899999999999984      3468999999986533 3456789999999999 7999999999988765 4899


Q ss_pred             EEeccCCCChHHHhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC
Q 036639          430 VYDYLPNGSLHSLLHGNRGPG-----------RIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG  498 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  498 (670)
                      ||||+++++|.+++.......           ...+++..+..++.|+++||+|||+.    +|+||||||+||+++.++
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~----~i~H~dikp~Nil~~~~~  185 (316)
T 2xir_A          110 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN  185 (316)
T ss_dssp             EEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGG
T ss_pred             EEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC----CcccccCccceEEECCCC
Confidence            999999999999998654210           12378999999999999999999998    999999999999999999


Q ss_pred             cEEEEecccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccc
Q 036639          499 VACISDFGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEE  571 (670)
Q Consensus       499 ~~kl~DFG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  571 (670)
                      .+||+|||+++.....      ....++..|+|||++.+..++.++||||||+++|||+| |+.||......        
T Consensus       186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------  257 (316)
T 2xir_A          186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------  257 (316)
T ss_dssp             CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS--------
T ss_pred             CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh--------
Confidence            9999999999876432      12345667999999998899999999999999999998 99998653210        


Q ss_pred             cccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          572 QAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                            ..+............       ....   ...+.+++.+||+.||++|||+.|++++|+++...
T Consensus       258 ------~~~~~~~~~~~~~~~-------~~~~---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          258 ------EEFCRRLKEGTRMRA-------PDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             ------HHHHHHHHHTCCCCC-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHhccCccCCC-------CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence                  111111111110000       0011   12456677799999999999999999999998754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.1e-39  Score=333.66  Aligned_cols=255  Identities=17%  Similarity=0.195  Sum_probs=198.2

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEE-EeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY-YAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||.||+|+. .+|+.||||++....  ..+++.+|+++++.++|++++..+.++ ......++||||+ +++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~   90 (296)
T 3uzp_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS   90 (296)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred             EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCC
Confidence            46799999999999995 679999999987543  234688999999999988866666555 5667889999999 999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe---CCCCcEEEEecccccccCcc-
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||+   +.++.+||+|||+++..... 
T Consensus        91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            999997543    2589999999999999999999998    99999999999999   48899999999999876432 


Q ss_pred             ----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          515 ----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       515 ----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                                ....++..|+|||.+.+..++.++|||||||++|||+||+.||........       ...+........
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~~~~~~~  235 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-------RQKYERISEKKM  235 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-------SSHHHHHHHHHH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-------hhhhhhhccccc
Confidence                      234577789999999999999999999999999999999999976422111       011111111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP  644 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~  644 (670)
                      ...  .    +..  .....   ..+.+++.+||+.||++|||++||++.|+++..+...
T Consensus       236 ~~~--~----~~~--~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          236 STP--I----EVL--CKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HSC--H----HHH--TTTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CCc--h----HHH--HhhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            000  0    000  01111   3466677799999999999999999999999876643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.7e-39  Score=331.11  Aligned_cols=243  Identities=21%  Similarity=0.284  Sum_probs=194.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||+||+|... +++.||||+++..  ......++.+|+..+.++ +||||+++++++.+.+..++||||+
T Consensus        14 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   93 (289)
T 1x8b_A           14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYC   93 (289)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEec
Confidence            34578999999999999965 7999999999754  233557788899999998 9999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-----------------
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-----------------  497 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-----------------  497 (670)
                      ++++|.+++..... ....+++..+..++.|++.||+|||+.    +|+||||||+||+++.+                 
T Consensus        94 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           94 NGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSM----SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             TTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEC-------------------
T ss_pred             CCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhC----CEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            99999999975421 012589999999999999999999998    99999999999999844                 


Q ss_pred             --CcEEEEecccccccCccccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccccc
Q 036639          498 --GVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV  574 (670)
Q Consensus       498 --~~~kl~DFG~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  574 (670)
                        ..+||+|||.+..........++..|+|||.+.+. .+++++|||||||++|||++|.+|+...              
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------------  234 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG--------------  234 (289)
T ss_dssp             -CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS--------------
T ss_pred             CceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch--------------
Confidence              47999999999988777777789999999999765 5678999999999999999999776422              


Q ss_pred             chhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..   ........ ....       .....   ..+.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~---~~~~~~~~-~~~~-------~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          235 DQ---WHEIRQGR-LPRI-------PQVLS---QEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HH---HHHHHTTC-CCCC-------SSCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             hH---HHHHHcCC-CCCC-------CcccC---HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            00   11111111 0000       01112   245567779999999999999999876

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-39  Score=354.52  Aligned_cols=184  Identities=22%  Similarity=0.350  Sum_probs=149.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----CeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~  431 (670)
                      +.+.||+|+||+||+|... +|+.||||++...  .....+.+.+|++++++++||||+++++++...     ...|+||
T Consensus        57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~  136 (458)
T 3rp9_A           57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL  136 (458)
T ss_dssp             ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence            3578999999999999954 7899999999753  333557889999999999999999999998543     5689999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+ +++|.+++....     .+++..+..++.||+.||+|||+.    +|+||||||+||||+.++.+||+|||+++..
T Consensus       137 e~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~----~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          137 EIA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSA----GILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             CCC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             ecc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            998 579999997643     589999999999999999999998    9999999999999999999999999999876


Q ss_pred             Ccc-------------------------------ccccccCcccCcccc-ccCCCCCchhHHHHHHHHHHHHcC
Q 036639          512 NPV-------------------------------QAIARLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTG  553 (670)
Q Consensus       512 ~~~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~ksDVwS~Gvvl~elltg  553 (670)
                      ...                               ....+|+.|+|||++ ....++.++|||||||++|||+||
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            421                               223568889999976 566799999999999999999994

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-39  Score=330.16  Aligned_cols=249  Identities=26%  Similarity=0.403  Sum_probs=192.7

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-CeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-EEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||.||++... |+.||||+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||++++
T Consensus        24 ~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~  100 (278)
T 1byg_A           24 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG  100 (278)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             eEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence            34578999999999999875 8899999998653  567899999999999999999999997654 4789999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-cc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-QA  516 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~  516 (670)
                      +|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++...... ..
T Consensus       101 ~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  173 (278)
T 1byg_A          101 SLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT  173 (278)
T ss_dssp             EHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhC----CccccCCCcceEEEeCCCcEEEeeccccccccccccC
Confidence            9999997542   11378899999999999999999998    9999999999999999999999999999866543 23


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ..++..|+|||.+.+..++.++||||||+++|||+| |+.||.....           ..+   .... .......    
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----------~~~---~~~~-~~~~~~~----  234 (278)
T 1byg_A          174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----------KDV---VPRV-EKGYKMD----  234 (278)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----------GGH---HHHH-TTTCCCC----
T ss_pred             CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----------HHH---HHHH-hcCCCCC----
Confidence            455678999999998899999999999999999998 9999864311           011   1111 1111000    


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                         ......   ..+.+++.+||+.||++|||+.|+++.|++++...
T Consensus       235 ---~~~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          235 ---APDGCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             ---CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---CcccCC---HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence               001112   34556777999999999999999999999997654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.9e-40  Score=342.65  Aligned_cols=265  Identities=22%  Similarity=0.314  Sum_probs=191.9

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.||+|+||.||+|... +|+.||||++....  ....+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  109 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT  109 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence            468999999999999965 58999999986543  234566889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++.....   
T Consensus       110 ~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~----~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          110 ILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSH----NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             HHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             hHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC----CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            9998876543     489999999999999999999998    9999999999999999999999999999876432   


Q ss_pred             -ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh-ccccc
Q 036639          515 -QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE-EWTAE  591 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  591 (670)
                       ....++..|+|||++.+. .++.++|||||||++|||++|+.||............................. .....
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence             234577889999998765 789999999999999999999999975421100000000000000000000000 00000


Q ss_pred             cccHhhhcccch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNI----EEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...+........    ......+.+++.+||+.||++|||++|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000000000    0112356677789999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.1e-39  Score=329.46  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=192.8

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      ..||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            4799999999999995 568999999998766656788999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-CCcEEEEecccccccCc----cc
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLSLLLNP----VQ  515 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a~~~~~----~~  515 (670)
                      +++....  ....+++..+..++.|++.||+|||+.    +|+||||||+||+++. ++.+||+|||++.....    ..
T Consensus       108 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          108 ALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDN----QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             HHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred             HHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhC----CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence            9998653  223567899999999999999999998    9999999999999987 89999999999987643    23


Q ss_pred             cccccCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 AIARLGGYKAPEQAEVKR--LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      ...++..|+|||.+.+..  ++.++||||||+++|||+||+.||.....            .......... ...... +
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~~~~~-~~~~~~-~  247 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE------------PQAAMFKVGM-FKVHPE-I  247 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS------------HHHHHHHHHH-HCCCCC-C
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc------------hhHHHHhhcc-cccccc-c
Confidence            345778899999987643  88999999999999999999999853210            0000000000 000000 0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                            .....   ..+.+++.+||+.||++|||++|++++
T Consensus       248 ------~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          248 ------PESMS---AEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ------CTTSC---HHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ------cccCC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  01112   245567779999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.5e-39  Score=334.66  Aligned_cols=255  Identities=17%  Similarity=0.200  Sum_probs=196.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEE-EeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY-YAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~-~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|.. .+++.||||++....  ..+.+.+|+++++.++|++++..+.++ ...+..++||||+ ++
T Consensus        13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~   89 (296)
T 4hgt_A           13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   89 (296)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CC
Confidence            457899999999999995 578999999876543  234578899999999988777766655 5677889999999 99


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe---CCCCcEEEEecccccccCcc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~~~  514 (670)
                      +|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        90 ~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           90 SLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             BHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            9999997543    2589999999999999999999998    99999999999999   78999999999999876432


Q ss_pred             -----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          515 -----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       515 -----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                                 ....++..|+|||.+.+..++.++|||||||++|||++|+.||.........       ..+.......
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~  234 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-------QKYERISEKK  234 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-------SHHHHHHHHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-------hhhhhhhccc
Confidence                       2345677899999999999999999999999999999999999764322110       1111111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      ....       ... .....   ...+.+++.+||+.||++|||++||++.|+++..+..
T Consensus       235 ~~~~-------~~~-~~~~~---~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          235 MSTP-------IEV-LCKGY---PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHSC-------HHH-HTTTS---CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             ccch-------hhh-hhccC---CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            1000       000 00011   1346667779999999999999999999999986654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.5e-39  Score=341.82  Aligned_cols=192  Identities=25%  Similarity=0.421  Sum_probs=170.0

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||+||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  117 (360)
T 3eqc_A           38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS  117 (360)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence            467999999999999965 7899999999765 33456789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--ccc
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--VQA  516 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--~~~  516 (670)
                      |.+++....     .+++..+..++.|++.||+|||+.   .+|+||||||+|||++.++.+||+|||++.....  ...
T Consensus       118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  189 (360)
T 3eqc_A          118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  189 (360)
T ss_dssp             HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC---
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHh---CCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccC
Confidence            999997653     488999999999999999999984   2899999999999999999999999999976532  234


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          190 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             -CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             CCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            56788899999999999999999999999999999999999654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=337.06  Aligned_cols=264  Identities=24%  Similarity=0.396  Sum_probs=201.0

Q ss_pred             HHhHcCCCCceEEEEEEE-----cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC--eeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL-----DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE--EKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~--~~~lv~e  432 (670)
                      +.+.||+|+||.||+|++     .+|+.||||++........+.+.+|++++++++||||+++++++...+  ..++|||
T Consensus        45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e  124 (326)
T 2w1i_A           45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME  124 (326)
T ss_dssp             EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred             eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence            457899999999999984     368899999998776666788999999999999999999999987654  6799999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.+++....    ..+++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||+++...
T Consensus       125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTK----RYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            999999999998653    2489999999999999999999998    99999999999999999999999999998765


Q ss_pred             ccc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCC-CcccccccchhHHHHHHh
Q 036639          513 PVQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR-VDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       513 ~~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  584 (670)
                      ...       ...++..|+|||.+.+..++.++||||||+++|||+||..||......... .............+...+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            432       123445699999998888999999999999999999999887532000000 000000000000111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .....          ..........+.+++.+||+.||++|||+.||++.|++++..
T Consensus       277 ~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          277 KNNGR----------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HTTCC----------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCCC----------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11100          000111223466677899999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.9e-39  Score=344.10  Aligned_cols=236  Identities=23%  Similarity=0.302  Sum_probs=183.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHH-HhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDV-IGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||+|+.+ +++.||||++++...   ...+.+..|..+ ++.++||||+++++++.+.+..|+||||+
T Consensus        42 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~  121 (373)
T 2r5t_A           42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI  121 (373)
T ss_dssp             EEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence            3478999999999999965 688999999975432   233455666666 46789999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.... 
T Consensus       122 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          122 NGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSL----NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999997643     488999999999999999999998    999999999999999999999999999986422 


Q ss_pred             ---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 ---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                         .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...              ............... 
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~--------------~~~~~~~~i~~~~~~-  257 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR--------------NTAEMYDNILNKPLQ-  257 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS--------------BHHHHHHHHHHSCCC-
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC--------------CHHHHHHHHHhcccC-
Confidence               23456888999999999999999999999999999999999999643              111222222221110 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE  630 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  630 (670)
                        +      ......   .+.+++.+||+.||++||++.+
T Consensus       258 --~------~~~~~~---~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 --L------KPNITN---SARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --C------CSSSCH---HHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --C------CCCCCH---HHHHHHHHHcccCHHhCCCCCC
Confidence              0      112222   3455667999999999999853

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-39  Score=346.35  Aligned_cols=244  Identities=18%  Similarity=0.244  Sum_probs=192.0

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||+|+.+ +|+.||||++++...   ...+.+.+|.+++..++||||+++++++.+.+..|+||||+++
T Consensus        66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g  145 (412)
T 2vd5_A           66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG  145 (412)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence            468999999999999964 799999999975321   1234578899999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      |+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++++||+|||+++...... 
T Consensus       146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~----giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRL----GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            99999997532    1489999999999999999999998    99999999999999999999999999998765422 


Q ss_pred             ----cccccCcccCccccc-------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          516 ----AIARLGGYKAPEQAE-------VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~-------~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                          ...+|+.|+|||++.       ...++.++|||||||++|||++|+.||...+              .........
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------------~~~~~~~i~  283 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------------TAETYGKIV  283 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHH
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--------------HHHHHHHHH
Confidence                346888999999987       3568999999999999999999999996531              111122222


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKR---PTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~evl~~  634 (670)
                      ....... +. ..  .....+   .+.+++.+||. +|++|   |+++|+++|
T Consensus       284 ~~~~~~~-~p-~~--~~~~s~---~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          284 HYKEHLS-LP-LV--DEGVPE---EARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             THHHHCC-CC-------CCCH---HHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             hcccCcC-CC-cc--ccCCCH---HHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1100000 00 00  011222   34556679999 99998   599999886

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.7e-39  Score=329.27  Aligned_cols=243  Identities=24%  Similarity=0.356  Sum_probs=195.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|... +++.||||++... .....+.+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (276)
T 2yex_A           11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG   90 (276)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence            4578999999999999965 7899999999643 2335678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||.+.....    
T Consensus        91 ~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           91 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999997543     589999999999999999999998    999999999999999999999999999976532    


Q ss_pred             --cccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                        .....++..|+|||.+.+..+ +.++||||||+++|||+||+.||......         ...+..+    ...... 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------~~~~~~~----~~~~~~-  227 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---------CQEYSDW----KEKKTY-  227 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---------SHHHHHH----HTTCTT-
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---------HHHHHHh----hhcccc-
Confidence              223456778999999987665 78999999999999999999999754211         0011111    110000 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        ..    ......   ..+.+++.+||+.||++|||++|++++
T Consensus       228 --~~----~~~~~~---~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 --LN----PWKKID---SAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             --ST----TGGGSC---HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --cC----chhhcC---HHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence              00    001112   235567779999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3e-39  Score=332.33  Aligned_cols=240  Identities=22%  Similarity=0.325  Sum_probs=196.7

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   99 (294)
T 2rku_A           20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR   99 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence            467999999999999965 5889999998654   233567789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      ++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++.....   
T Consensus       100 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  170 (294)
T 2rku_A          100 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  170 (294)
T ss_dssp             CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence            99999987543     589999999999999999999998    999999999999999999999999999987642   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||.+.+..++.++||||||+++|||+||+.||....              ..............   
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------~~~~~~~~~~~~~~---  233 (294)
T 2rku_A          171 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------------LKETYLRIKKNEYS---  233 (294)
T ss_dssp             CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHTTCCC---
T ss_pred             ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHhhccCC---
Confidence             223457788999999998889999999999999999999999996431              11111111111110   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                            ......   ..+.+++.+||+.||++|||++|++++-
T Consensus       234 ------~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          234 ------IPKHIN---PVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             ------CCTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ------CccccC---HHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                  001112   2355677799999999999999999863

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7e-39  Score=329.08  Aligned_cols=244  Identities=27%  Similarity=0.352  Sum_probs=194.8

Q ss_pred             HcCCCCceEEEEEEE---cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          363 MLGKGSLGTVYKAVL---DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .||+|+||+||+|.+   .+++.||||+++...  ....+++.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~  102 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG  102 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence            799999999999964   346889999997543  23467899999999999999999999999 667789999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA-  516 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  516 (670)
                      +|.+++....     .+++..++.++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++........ 
T Consensus       103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (291)
T 1xbb_A          103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  173 (291)
T ss_dssp             EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence            9999998654     489999999999999999999998    999999999999999999999999999987643221 


Q ss_pred             ------ccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          517 ------IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       517 ------~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                            ..++..|+|||.+.+..++.++||||||+++|||+| |+.||.....              ... ...+.....
T Consensus       174 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------------~~~-~~~~~~~~~  238 (291)
T 1xbb_A          174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------------SEV-TAMLEKGER  238 (291)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------------HHH-HHHHHTTCC
T ss_pred             ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------------HHH-HHHHHcCCC
Confidence                  223466999999988889999999999999999999 9999965311              111 111111100


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .. .      ....   ...+.+++.+||+.||++|||+.|+++.|+++...
T Consensus       239 ~~-~------~~~~---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          239 MG-C------PAGC---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CC-C------CTTC---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CC-C------CCCC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            00 0      0111   23456677799999999999999999999988643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.9e-39  Score=340.78  Aligned_cols=246  Identities=19%  Similarity=0.274  Sum_probs=191.9

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||+|+||.||+|... +|+.||||+++....    ...+|++++.++ +||||+++++++.+.+..|+||||+++
T Consensus        25 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~g  100 (342)
T 2qr7_A           25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG  100 (342)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCC
Confidence            44578999999999999965 689999999976533    234678888887 799999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC----CcEEEEecccccccC
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN----GVACISDFGLSLLLN  512 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~~~  512 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||+.++    +.+||+|||+++...
T Consensus       101 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A          101 GELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQ----GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999997653     589999999999999999999998    99999999999998543    359999999998764


Q ss_pred             cc----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          513 PV----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       513 ~~----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ..    ....+++.|+|||++.+..++.++|||||||++|||++|+.||.....           ...............
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----------~~~~~~~~~i~~~~~  240 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----------DTPEEILARIGSGKF  240 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----------SCHHHHHHHHHHCCC
T ss_pred             CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----------CCHHHHHHHHccCCc
Confidence            32    234568889999999888899999999999999999999999964311           111122222222111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                      ..   .  ...+....+   .+.+++.+||..||++|||+.|+++|--
T Consensus       241 ~~---~--~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          241 SL---S--GGYWNSVSD---TAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             CC---C--STTTTTSCH---HHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             cc---C--ccccccCCH---HHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence            10   0  000112223   3455677999999999999999998643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=342.68  Aligned_cols=255  Identities=16%  Similarity=0.182  Sum_probs=197.1

Q ss_pred             HhHcCCCCceEEEEEEEcC---------CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeee---------------
Q 036639          361 AEMLGKGSLGTVYKAVLDD---------GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVK---------------  416 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~---------------  416 (670)
                      .+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++               
T Consensus        47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~  121 (352)
T 2jii_A           47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT  121 (352)
T ss_dssp             EEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred             EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence            4679999999999999653         789999999754     46788999999999999887               


Q ss_pred             EEEEEEe-CCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC
Q 036639          417 LRAYYYA-KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD  495 (670)
Q Consensus       417 l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~  495 (670)
                      +++++.. ....++||||+ +++|.+++....   ...+++..++.++.|++.||+|||+.    +|+||||||+|||++
T Consensus       122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHEN----EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCCGGGEEEE
T ss_pred             hhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhC----CccCCCCCHHHEEEc
Confidence            6788876 67889999999 999999998652   12589999999999999999999998    999999999999999


Q ss_pred             CCC--cEEEEecccccccCccc-----------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC
Q 036639          496 KNG--VACISDFGLSLLLNPVQ-----------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP  562 (670)
Q Consensus       496 ~~~--~~kl~DFG~a~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~  562 (670)
                      .++  .+||+|||+++......           ...++..|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  89999999998765322           23577789999999998999999999999999999999999964311


Q ss_pred             CCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          563 TRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .         ...+..........  .....+. ........   ..+.+++.+||+.||++|||++||++.|+++....
T Consensus       274 ~---------~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          274 N---------TEDIMKQKQKFVDK--PGPFVGP-CGHWIRPS---ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             C---------HHHHHHHHHHHHHS--CCCEECT-TSCEECCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             C---------HHHHHHHHHhccCC--hhhhhhh-ccccCCCc---HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            0         11111111111111  0111110 00011112   34556777999999999999999999999998665


Q ss_pred             C
Q 036639          643 S  643 (670)
Q Consensus       643 ~  643 (670)
                      .
T Consensus       339 ~  339 (352)
T 2jii_A          339 R  339 (352)
T ss_dssp             T
T ss_pred             C
Confidence            3

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.6e-39  Score=339.32  Aligned_cols=239  Identities=22%  Similarity=0.334  Sum_probs=196.3

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus        46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  125 (335)
T 2owb_A           46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR  125 (335)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence            467999999999999965 5889999998754   233567889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc---
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP---  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~---  513 (670)
                      ++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||++.....   
T Consensus       126 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          126 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRN----RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            99999987643     589999999999999999999998    999999999999999999999999999987642   


Q ss_pred             -cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          514 -VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       514 -~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                       .....++..|+|||++.+..++.++||||||+++|||++|+.||....              ..............   
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------------~~~~~~~~~~~~~~---  259 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------------LKETYLRIKKNEYS---  259 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHHTCCC---
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------------HHHHHHHHhcCCCC---
Confidence             223457788999999998889999999999999999999999996431              11111111111110   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +      .....   ..+.+++.+||+.||++|||++|++++
T Consensus       260 ~------~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          260 I------PKHIN---PVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             C------CTTSC---HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C------CccCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      01112   234567779999999999999999985

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.5e-39  Score=332.99  Aligned_cols=244  Identities=21%  Similarity=0.327  Sum_probs=191.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++
T Consensus        23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  102 (302)
T 2j7t_A           23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA  102 (302)
T ss_dssp             EEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEE
T ss_pred             ecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCc
Confidence            3467999999999999965 689999999987666667889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----V  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~  514 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +++||||||+||+++.++.+||+|||++.....    .
T Consensus       103 l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A          103 VDAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSK----RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcC----CcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999987532    2489999999999999999999998    999999999999999999999999998764322    2


Q ss_pred             ccccccCcccCcccc-----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          515 QAIARLGGYKAPEQA-----EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~-----~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ....++..|+|||++     ....++.++||||||+++|||++|+.||....              ..............
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------------~~~~~~~~~~~~~~  240 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------------PMRVLLKIAKSDPP  240 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHHHSCCC
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------------HHHHHHHHhccCCc
Confidence            334677889999988     46678999999999999999999999986431              11111111111110


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      . ...     ....   ...+.+++.+||+.||++|||+.|+++|
T Consensus       241 ~-~~~-----~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 T-LLT-----PSKW---SVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             C-CSS-----GGGS---CHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             c-cCC-----cccc---CHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0 000     0111   1245667779999999999999999875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.2e-39  Score=338.94  Aligned_cols=191  Identities=22%  Similarity=0.315  Sum_probs=159.2

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||+||+|.. .+++.||||+++....  ...+.+.+|++++++++||||+++++++.+.+..++||||++ 
T Consensus        38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  116 (329)
T 3gbz_A           38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-  116 (329)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-
Confidence            347899999999999995 4789999999975432  234567899999999999999999999999999999999997 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe-----CCCCcEEEEeccccccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL-----DKNGVACISDFGLSLLL  511 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll-----~~~~~~kl~DFG~a~~~  511 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||+     +.++.+||+|||+++..
T Consensus       117 ~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          117 NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSR----RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            59999998654     489999999999999999999998    99999999999999     45556999999999866


Q ss_pred             Cc----cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          512 NP----VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       512 ~~----~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..    .....++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence            43    2234568889999999764 4899999999999999999999999653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.3e-39  Score=338.22  Aligned_cols=255  Identities=24%  Similarity=0.305  Sum_probs=200.8

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CC-----CEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DG-----GIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g-----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      .+.+.||+|+||.||+|... ++     ..||+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++|
T Consensus        49 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv  128 (333)
T 2i1m_A           49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI  128 (333)
T ss_dssp             EEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEE
Confidence            34578999999999999964 22     479999998653 33557789999999999 899999999999999999999


Q ss_pred             EeccCCCChHHHhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          431 YDYLPNGSLHSLLHGNRG---------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                      |||+++|+|.+++.....         .....+++..++.++.|++.||+|||+.    +|+||||||+|||++.++.+|
T Consensus       129 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~k  204 (333)
T 2i1m_A          129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK----NCIHRDVAARNVLLTNGHVAK  204 (333)
T ss_dssp             EECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGCEEEGGGEEE
T ss_pred             EecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC----CcccCCcccceEEECCCCeEE
Confidence            999999999999874310         0012578999999999999999999998    999999999999999999999


Q ss_pred             EEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccccccc
Q 036639          502 ISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAV  574 (670)
Q Consensus       502 l~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  574 (670)
                      |+|||+++......      ...++..|+|||.+.+..++.++||||||+++|||+| |..||.....            
T Consensus       205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------------  272 (333)
T 2i1m_A          205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV------------  272 (333)
T ss_dssp             BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS------------
T ss_pred             ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch------------
Confidence            99999998664322      2334567999999988899999999999999999999 8999865311            


Q ss_pred             chhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       575 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                        ...+...........       .....   ...+.+++.+||+.||++|||+.||+++|+++..+
T Consensus       273 --~~~~~~~~~~~~~~~-------~~~~~---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          273 --NSKFYKLVKDGYQMA-------QPAFA---PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             --SHHHHHHHHHTCCCC-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --hHHHHHHHhcCCCCC-------CCCCC---CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence              011111222111100       00011   13456677799999999999999999999988754

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-39  Score=340.81  Aligned_cols=190  Identities=25%  Similarity=0.373  Sum_probs=161.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~lv  430 (670)
                      ..+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++....      ..|+|
T Consensus        29 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv  108 (367)
T 1cm8_A           29 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV  108 (367)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEE
Confidence            346799999999999996 47999999999653  2334577889999999999999999999998653      45999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+ +++|.++++..      .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          109 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            9999 88999999764      488999999999999999999998    999999999999999999999999999987


Q ss_pred             cCc-cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNP-VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ... .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  229 (367)
T 1cm8_A          178 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS  229 (367)
T ss_dssp             CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC
Confidence            654 234567888999999876 67999999999999999999999999754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=9.1e-39  Score=346.75  Aligned_cols=189  Identities=22%  Similarity=0.322  Sum_probs=162.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----CeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~  431 (670)
                      +.+.||+|+||.||+|... +|+.||||+++..  .....+.+.+|++++++++||||+++++++...     ...|+||
T Consensus        30 ~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~  109 (432)
T 3n9x_A           30 IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL  109 (432)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred             EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEE
Confidence            3578999999999999954 6889999999754  333557889999999999999999999999876     5789999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||++ ++|.+++....     .+++..+..++.||++||+|||+.    +|+||||||+|||++.++.+||+|||+++..
T Consensus       110 e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~----givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          110 EIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHES----GIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             ECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            9995 69999997643     589999999999999999999998    9999999999999999999999999999876


Q ss_pred             Ccc--------------------------ccccccCcccCcccc-ccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 036639          512 NPV--------------------------QAIARLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       512 ~~~--------------------------~~~~~~~~y~aPE~~-~~~~~~~ksDVwS~Gvvl~elltg~~p~~  558 (670)
                      ...                          ....+|+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            432                          335678889999986 56679999999999999999999766654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.8e-39  Score=355.04  Aligned_cols=245  Identities=24%  Similarity=0.331  Sum_probs=197.2

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||+|+.. +|+.||||++....   ......+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus       189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g  268 (576)
T 2acx_A          189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG  268 (576)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence            467999999999999964 79999999996431   22356788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.+++....   ...+++..+..++.||+.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....  
T Consensus       269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~----gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~  341 (576)
T 2acx_A          269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRE----RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  341 (576)
T ss_dssp             CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred             CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC----CEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence            99999997643   22489999999999999999999998    9999999999999999999999999999876543  


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+|+.|+|||++.+..++.++|||||||++|||++|+.||......          ... ..+...+....  ..+
T Consensus       342 ~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----------~~~-~~i~~~i~~~~--~~~  408 (576)
T 2acx_A          342 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----------IKR-EEVERLVKEVP--EEY  408 (576)
T ss_dssp             EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----------CCH-HHHHHHHHHCC--CCC
T ss_pred             ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----------hhH-HHHHHHhhccc--ccC
Confidence             3456788999999999889999999999999999999999999754211          011 11111111110  000


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      .      .....   .+.+++.+||+.||++||     +++||++|
T Consensus       409 p------~~~s~---~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          409 S------ERFSP---QARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             C------TTSCH---HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             C------ccCCH---HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0      11122   355567799999999999     78999876

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=6.5e-39  Score=326.54  Aligned_cols=239  Identities=23%  Similarity=0.346  Sum_probs=188.9

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||+|... +|+.||||++....   ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (276)
T 2h6d_A           16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG   95 (276)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence            467999999999999965 79999999996432   22456789999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++....... 
T Consensus        96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  166 (276)
T 2h6d_A           96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRH----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  166 (276)
T ss_dssp             CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC---
T ss_pred             CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChhhEEECCCCCEEEeecccccccCCCcc
Confidence            99999997643     488999999999999999999998    99999999999999999999999999998765432 


Q ss_pred             --cccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ...++..|+|||.+.+..+ +.++||||||+++|||++|+.||...              ...............   
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--------------~~~~~~~~~~~~~~~---  229 (276)
T 2h6d_A          167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE--------------HVPTLFKKIRGGVFY---  229 (276)
T ss_dssp             ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS--------------SHHHHHHHHHHCCCC---
T ss_pred             eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC--------------cHHHHHHHhhcCccc---
Confidence              3456778999999987765 68999999999999999999999643              111111111111100   


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +      .....   ..+.+++.+||+.||++|||+.|++++
T Consensus       230 ~------~~~~~---~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 I------PEYLN---RSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             C------CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             C------chhcC---HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0      01111   235567779999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.6e-39  Score=336.21  Aligned_cols=254  Identities=24%  Similarity=0.311  Sum_probs=197.9

Q ss_pred             HHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||.||+|.+      .+++.||||++... ......++.+|+.++++++||||+++++++.+....++|||
T Consensus        34 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  113 (327)
T 2yfx_A           34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILME  113 (327)
T ss_dssp             EEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEe
Confidence            457899999999999984      25778999999754 33455778999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEeccc
Q 036639          433 YLPNGSLHSLLHGNRGP--GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGL  507 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~  507 (670)
                      |+++++|.+++......  ....+++..++.++.|++.||+|||+.    +|+||||||+|||++.   +..+||+|||+
T Consensus       114 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~----~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~  189 (327)
T 2yfx_A          114 LMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN----HFIHRDIAARNCLLTCPGPGRVAKIGDFGM  189 (327)
T ss_dssp             CCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECCCHH
T ss_pred             cCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC----CeecCcCCHhHEEEecCCCcceEEECcccc
Confidence            99999999999865421  123589999999999999999999998    9999999999999984   44699999999


Q ss_pred             ccccCc------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          508 SLLLNP------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       508 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ++....      .....++..|+|||.+.+..++.++||||||+++|||+| |+.||....              .....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------------~~~~~  255 (327)
T 2yfx_A          190 ARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------------NQEVL  255 (327)
T ss_dssp             HHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------------HHHHH
T ss_pred             ccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------------HHHHH
Confidence            875432      223345678999999988899999999999999999998 999986431              11111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ......... .       .....   ...+.+++.+||+.||++|||+.|++++|+.+....
T Consensus       256 ~~~~~~~~~-~-------~~~~~---~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          256 EFVTSGGRM-D-------PPKNC---PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHTTCCC-C-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHhcCCCC-C-------CCCCC---CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            111111100 0       00111   124566777999999999999999999999987544

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.1e-39  Score=331.77  Aligned_cols=240  Identities=25%  Similarity=0.362  Sum_probs=196.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||+|... +++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        18 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   97 (284)
T 2vgo_A           18 IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAP   97 (284)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             eeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCC
Confidence            3578999999999999965 67899999986431   1235678999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+||+++.++.+||+|||++.....  
T Consensus        98 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           98 RGELYKELQKHG-----RFDEQRSATFMEELADALHYCHER----KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            999999997653     488999999999999999999988    999999999999999999999999999876543  


Q ss_pred             cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||....              ..............    
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------------~~~~~~~~~~~~~~----  230 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--------------HTETHRRIVNVDLK----  230 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHTTCCC----
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--------------HhHHHHHHhccccC----
Confidence            234567788999999999899999999999999999999999996431              11111111111100    


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           ......   ..+.+++.+||+.||++|||++|+++|
T Consensus       231 -----~~~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          231 -----FPPFLS---DGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -----CCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -----CCCcCC---HHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                 001112   235567779999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.2e-39  Score=347.82  Aligned_cols=245  Identities=23%  Similarity=0.357  Sum_probs=184.5

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--------cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--------PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.+.||+|+||+||+|.. .+++.||||++....        ......+.+|++++++++||||+++++++. .+..++
T Consensus       138 ~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~l  216 (419)
T 3i6u_A          138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYI  216 (419)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEE
T ss_pred             EEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEE
Confidence            3457899999999999995 468999999986431        112235789999999999999999999975 456899


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEEEecc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACISDFG  506 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFG  506 (670)
                      ||||+++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++   .+||+|||
T Consensus       217 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          217 VLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             EEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             EEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCCCcceEEEeecc
Confidence            999999999999987543     589999999999999999999998    999999999999997544   59999999


Q ss_pred             cccccCcc---ccccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          507 LSLLLNPV---QAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       507 ~a~~~~~~---~~~~~~~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      +++.....   ....+++.|+|||++.+   ..++.++|||||||++|||+||+.||......          ..+...+
T Consensus       288 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----------~~~~~~i  357 (419)
T 3i6u_A          288 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----------VSLKDQI  357 (419)
T ss_dssp             TTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----------CCHHHHH
T ss_pred             cceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----------HHHHHHH
Confidence            99887543   24567889999999853   56889999999999999999999999653211          1111111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          ......  +.+..  ....   ...+.+++.+||+.||++|||++|+++|
T Consensus       358 ----~~~~~~--~~~~~--~~~~---~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 ----TSGKYN--FIPEV--WAEV---SEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             ----HTTCCC--CCHHH--HTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ----hcCCCC--CCchh--hccc---CHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                110000  00000  0111   2345667779999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.2e-39  Score=338.96  Aligned_cols=243  Identities=22%  Similarity=0.372  Sum_probs=194.0

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--------chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--------CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      .+.||+|+||.||+|... +|+.||||++.....        ...+.+.+|++++.++ +||||+++++++......++|
T Consensus        99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  178 (365)
T 2y7j_A           99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV  178 (365)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred             ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence            478999999999999975 799999999865431        1245678999999999 799999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+++++|.+++....     .+++..+..++.|++.||.|||+.    +|+||||||+|||++.++.+||+|||++..
T Consensus       179 ~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~  249 (365)
T 2y7j_A          179 FDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHAN----NIVHRDLKPENILLDDNMQIRLSDFGFSCH  249 (365)
T ss_dssp             ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence            99999999999997543     589999999999999999999998    999999999999999999999999999987


Q ss_pred             cCcc---ccccccCcccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          511 LNPV---QAIARLGGYKAPEQAEV------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       511 ~~~~---~~~~~~~~y~aPE~~~~------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      ....   ....+++.|+|||++.+      ..++.++|||||||++|||+||+.||....              ......
T Consensus       250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------------~~~~~~  315 (365)
T 2y7j_A          250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------------QILMLR  315 (365)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHH
T ss_pred             cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------------HHHHHH
Confidence            6543   33567888999998853      358899999999999999999999996431              111111


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ........   +..  ..+....   ..+.+++.+||+.||++|||+.|++++
T Consensus       316 ~i~~~~~~---~~~--~~~~~~~---~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          316 MIMEGQYQ---FSS--PEWDDRS---STVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHHHTCCC---CCH--HHHSSSC---HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhCCCC---CCC--cccccCC---HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111110   000  0001111   245667779999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.7e-39  Score=334.97  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=193.5

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||+|... +|+.||||+++..  .......+.+|+.++.++ +||||+++++++.+.+..++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            78999999999999965 6899999999753  233467899999999999 5699999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccccCcc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~~~  514 (670)
                      +|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~----givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  187 (327)
T 3lm5_A          115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQN----NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA  187 (327)
T ss_dssp             EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred             cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC----CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence            9999986542   23589999999999999999999998    9999999999999998   789999999999877543


Q ss_pred             ---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 ---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                         ....+++.|+|||++.+..++.++||||||+++|||+||+.||....              ..............  
T Consensus       188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~~~~i~~~~~~--  251 (327)
T 3lm5_A          188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--------------NQETYLNISQVNVD--  251 (327)
T ss_dssp             ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHTCCC--
T ss_pred             cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------chHHHHHHHhcccc--
Confidence               23467888999999999999999999999999999999999996531              11111111111000  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       +.  ........   ..+.+++.+||+.||++|||++|++++
T Consensus       252 -~~--~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          252 -YS--EETFSSVS---QLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -CC--TTTTTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -cC--chhhcccC---HHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             00  00001112   345567779999999999999999986

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=342.38  Aligned_cols=246  Identities=23%  Similarity=0.329  Sum_probs=194.0

Q ss_pred             HHHhHcCCCCceEEEEEEE----cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.+.||+|+||.||+|+.    .+|+.||||+++...    ....+.+.+|++++.++ +||||+++++++...+..++
T Consensus        57 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l  136 (355)
T 1vzo_A           57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  136 (355)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEE
Confidence            3457899999999999996    378999999997532    12345677899999999 69999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+++|+|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++
T Consensus       137 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          137 ILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999997643     589999999999999999999998    99999999999999999999999999998


Q ss_pred             ccCcc-----ccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          510 LLNPV-----QAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       510 ~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      .....     ....+|..|+|||++.+  ..++.++|||||||++|||+||+.||......          .........
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----------~~~~~~~~~  277 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----------NSQAEISRR  277 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----------CCHHHHHHH
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----------chHHHHHHH
Confidence            65432     23467889999999975  34789999999999999999999999653211          111122222


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKMI  635 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L  635 (670)
                      .......   +      .....   ..+.+++.+||..||++||     |++|++++.
T Consensus       278 ~~~~~~~---~------~~~~~---~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          278 ILKSEPP---Y------PQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHCCCC---C------CTTSC---HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HhccCCC---C------CcccC---HHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            2111100   0      01111   2355677799999999999     999999875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-38  Score=351.57  Aligned_cols=245  Identities=23%  Similarity=0.309  Sum_probs=196.0

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      |.+.+.||+|+||+||+|... +++.||||++...  .......+.+|++++++++||||+++++++.+....++||||+
T Consensus        24 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  103 (486)
T 3mwu_A           24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELY  103 (486)
T ss_dssp             EEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcC
Confidence            344678999999999999965 7899999998642  1234678899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC---CCCcEEEEeccccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLL  511 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~  511 (670)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++   .++.+||+|||+++..
T Consensus       104 ~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          104 TGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999887543     589999999999999999999998    999999999999995   4567999999999876


Q ss_pred             Ccc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          512 NPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       512 ~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ...   ....+++.|+|||++.+ .++.++||||+||++|||++|+.||....              ....+.......+
T Consensus       175 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~~~~i~~~~~  239 (486)
T 3mwu_A          175 QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------------EYDILKRVETGKY  239 (486)
T ss_dssp             CCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHTCC
T ss_pred             CCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCC
Confidence            543   23467888999999875 59999999999999999999999996531              1111222222111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...     ...+....+   .+.+++.+||+.||++|||+.|+++|
T Consensus       240 ~~~-----~~~~~~~s~---~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          240 AFD-----LPQWRTISD---DAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             CSC-----SGGGGGSCH---HHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCC-----CcccCCCCH---HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            100     011112222   35567779999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.4e-39  Score=337.61  Aligned_cols=185  Identities=22%  Similarity=0.333  Sum_probs=163.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEe--CCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYA--KEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~--~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|.. .+++.||||+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++||||++
T Consensus        40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~  116 (330)
T 3nsz_A           40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN  116 (330)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred             EEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence            347899999999999985 57899999999754   4578999999999997 9999999999998  567899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccCcc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNPV  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~~  514 (670)
                      +++|.+++..        +++..+..++.|++.||+|||+.    +|+||||||+|||++.++ .+||+|||+++.....
T Consensus       117 ~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          117 NTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             CCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             chhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhC----CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            9999999852        78899999999999999999998    999999999999999777 8999999999876542


Q ss_pred             ---ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          515 ---QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                         ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence               23456777999999876 6789999999999999999999999954

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.9e-39  Score=353.86  Aligned_cols=245  Identities=25%  Similarity=0.354  Sum_probs=198.0

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      |.+.+.||+|+||.||+|... +|+.||||++....   ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus        28 y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  107 (484)
T 3nyv_A           28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEV  107 (484)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence            345678999999999999965 78999999996432   33567899999999999999999999999999999999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe---CCCCcEEEEecccccc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLL  510 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~  510 (670)
                      +++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||+   +.++.+||+|||+++.
T Consensus       108 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          108 YTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKN----KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             CCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999987654     589999999999999999999998    99999999999999   5678999999999987


Q ss_pred             cCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          511 LNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       511 ~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      ....   ....+++.|+|||++.+ .++.++||||+||++|||++|+.||....              ....+.......
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~~~~i~~~~  243 (484)
T 3nyv_A          179 FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------------EYDILKKVEKGK  243 (484)
T ss_dssp             BCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCC
T ss_pred             cccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------------HHHHHHHHHcCC
Confidence            6543   23467888999999875 69999999999999999999999997531              111122222211


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +..     ....+....+   .+.+++.+||+.||++|||+.|+++|
T Consensus       244 ~~~-----~~~~~~~~s~---~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          244 YTF-----ELPQWKKVSE---SAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             CCC-----CSGGGGGSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCC-----CCcccccCCH---HHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            110     0011112222   35567779999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-38  Score=328.16  Aligned_cols=242  Identities=26%  Similarity=0.394  Sum_probs=197.7

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  106 (303)
T 3a7i_A           27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS  106 (303)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence            46799999999999995 468999999997543 3356889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----  514 (670)
                      |.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++......    
T Consensus       107 L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  176 (303)
T 3a7i_A          107 ALDLLEPG------PLDETQIATILREILKGLDYLHSE----KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  176 (303)
T ss_dssp             HHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence            99999753      489999999999999999999998    9999999999999999999999999999876432    


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||....              ...... ......... +.
T Consensus       177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------------~~~~~~-~~~~~~~~~-~~  240 (303)
T 3a7i_A          177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------------PMKVLF-LIPKNNPPT-LE  240 (303)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHH-HHHHSCCCC-CC
T ss_pred             CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------------HHHHHH-HhhcCCCCC-Cc
Confidence            23456778999999999999999999999999999999999986431              011111 111111100 00


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHh
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIED  637 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  637 (670)
                            ....   ..+.+++.+||+.||++|||+.|++++.--
T Consensus       241 ------~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  274 (303)
T 3a7i_A          241 ------GNYS---KPLKEFVEACLNKEPSFRPTAKELLKHKFI  274 (303)
T ss_dssp             ------SSCC---HHHHHHHHHHCCSSGGGSCCHHHHTTCHHH
T ss_pred             ------cccC---HHHHHHHHHHcCCChhhCcCHHHHhhChhh
Confidence                  1112   235567779999999999999999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.3e-39  Score=344.49  Aligned_cols=264  Identities=19%  Similarity=0.235  Sum_probs=187.1

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~lv  430 (670)
                      +.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+      ..++|
T Consensus        29 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv  108 (371)
T 2xrw_A           29 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV  108 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEE
T ss_pred             EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEE
Confidence            3468999999999999954 6899999999753  2334567889999999999999999999998665      67999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||++ ++|.+++..       .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.
T Consensus       109 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          109 MELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             EEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHC----CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            99996 578888853       378999999999999999999998    999999999999999999999999999987


Q ss_pred             cCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchh-------HH
Q 036639          511 LNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLP-------KW  579 (670)
Q Consensus       511 ~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~-------~~  579 (670)
                      ....   ....++..|+|||++.+..++.++|||||||++|||++|+.||...+........... ....+       ..
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  256 (371)
T 2xrw_A          177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  256 (371)
T ss_dssp             -------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHH
T ss_pred             cccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            6543   2356788899999999989999999999999999999999999754211000000000 00000       00


Q ss_pred             HHHHhhhccc--cc----cccHhhhccc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          580 VRSVVKEEWT--AE----VFDQELLRYK--NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       580 ~~~~~~~~~~--~~----~~d~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      +.........  ..    .+........  ........+.+++.+||..||++|||++|+++|=
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            1111110000  00    0000000000  0112234677888899999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-38  Score=345.28  Aligned_cols=192  Identities=23%  Similarity=0.323  Sum_probs=167.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhcc------CCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKL------KHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||+||+|... +++.||||+++... ...+++.+|+++++.+      +|+||+++++++......++|||
T Consensus       101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e  179 (429)
T 3kvw_A          101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFE  179 (429)
T ss_dssp             EEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEEC
T ss_pred             EEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEe
Confidence            3578999999999999854 68999999997642 3456778888888777      57799999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc--EEEEecccccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV--ACISDFGLSLL  510 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~  510 (670)
                      |+. ++|.+++.....   ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.  +||+|||++..
T Consensus       180 ~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          180 LLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKN----RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             CCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHH----TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             ccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            995 699999886542   2489999999999999999999998    9999999999999999987  99999999976


Q ss_pred             cCc-cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ... .....+++.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          252 EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            654 33456788899999999999999999999999999999999999754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.1e-39  Score=329.42  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=194.7

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  435 (670)
                      .+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|++++++++||||+++++++.+  ....++||||++
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   90 (279)
T 2w5a_A           11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE   90 (279)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred             ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence            467999999999999965 78999999997543  3356778999999999999999999998865  567899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCC-----ccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK-----VPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +++|.+++..... ....+++..++.++.|++.||+|||+.    +     |+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRR----SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH----C------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcc----cCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            9999999975321 123589999999999999999999998    6     99999999999999999999999999987


Q ss_pred             cCccc----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          511 LNPVQ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       511 ~~~~~----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      .....    ...++..|+|||.+.+..++.++||||||+++|||+||+.||....              ...........
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------------~~~~~~~i~~~  231 (279)
T 2w5a_A          166 LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------------QKELAGKIREG  231 (279)
T ss_dssp             C---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHT
T ss_pred             eccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------------HHHHHHHHhhc
Confidence            65422    3457888999999998899999999999999999999999996431              11111111111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      . ... +.      ....   ..+.+++.+||+.||++|||+.||++++...
T Consensus       232 ~-~~~-~~------~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~  272 (279)
T 2w5a_A          232 K-FRR-IP------YRYS---DELNEIITRMLNLKDYHRPSVEEILENPLIL  272 (279)
T ss_dssp             C-CCC-CC------TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred             c-ccc-CC------cccC---HHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence            1 100 00      0112   2455677799999999999999999986543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.7e-39  Score=334.54  Aligned_cols=251  Identities=22%  Similarity=0.315  Sum_probs=187.3

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc-hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC-ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .+.||+|+||+||+|... +++.||||++...... ....+.+|++++++++||||+++++++.+.+..++||||++ |+
T Consensus         7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (324)
T 3mtl_A            7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD   85 (324)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EE
T ss_pred             EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cC
Confidence            467999999999999965 7899999999754321 11245579999999999999999999999999999999996 59


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----  514 (670)
                      |.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....    
T Consensus        86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~  157 (324)
T 3mtl_A           86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQ----KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  157 (324)
T ss_dssp             HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCcCHHHEEECCCCCEEEccCcccccccCCcccc
Confidence            999887653    2589999999999999999999998    9999999999999999999999999999866432    


Q ss_pred             ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh----hccc
Q 036639          515 QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK----EEWT  589 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  589 (670)
                      ....++..|+|||++.+ ..++.++|||||||++|||+||+.||......           .....+.....    +.|.
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~i~~~~~~~~~~~~~  226 (324)
T 3mtl_A          158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-----------EQLHFIFRILGTPTEETWP  226 (324)
T ss_dssp             -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------HHHHHHHHHHCCCCTTTST
T ss_pred             ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHHHhCCCChHhch
Confidence            23456788999999876 56899999999999999999999999754210           11111111110    0010


Q ss_pred             cccccHh--------------hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQE--------------LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~--------------~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...-...              ........   ..+.+++.+||+.||++|||++|+++|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          227 GILSNEEFKTYNYPKYRAEALLSHAPRLD---SDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             TGGGCHHHHHTCCCCCCCCCHHHHCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcchhhcccccccccchhhhhhcCCCC---HHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0000000              00011112   345667779999999999999999984

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.1e-39  Score=353.38  Aligned_cols=245  Identities=23%  Similarity=0.350  Sum_probs=192.2

Q ss_pred             HHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          358 RASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      |.+.+.||+|+||+||+|+.. +++.||||++....  ......+.+|+++++.++||||+++++++.+....++||||+
T Consensus        39 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  118 (494)
T 3lij_A           39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECY  118 (494)
T ss_dssp             EEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecC
Confidence            345678999999999999965 78999999997542  234577899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEeccccccc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLL  511 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~  511 (670)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.   ++.+||+|||+++..
T Consensus       119 ~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          119 KGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKH----NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999887543     589999999999999999999998    9999999999999976   455999999999876


Q ss_pred             Ccc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          512 NPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       512 ~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                      ...   ....+++.|+|||++. ..++.++||||+||++|||++|+.||....              ....+........
T Consensus       190 ~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~~~~i~~~~~  254 (494)
T 3lij_A          190 ENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--------------DQEILRKVEKGKY  254 (494)
T ss_dssp             BTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHTCC
T ss_pred             CCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCC
Confidence            543   3356788899999986 569999999999999999999999996531              1122222222111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..   +  ...+....+   .+.+++.+||+.||++|||+.|+++|
T Consensus       255 ~~---~--~~~~~~~s~---~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          255 TF---D--SPEWKNVSE---GAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CC---C--SGGGTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CC---C--chhcccCCH---HHHHHHHHHCCCChhhCccHHHHhcC
Confidence            10   0  001112222   35566779999999999999999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.8e-38  Score=351.55  Aligned_cols=243  Identities=24%  Similarity=0.352  Sum_probs=193.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-------------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-------------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE  425 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  425 (670)
                      +.+.||+|+||+||+|... +++.||||++.....             ...+.+.+|++++++++||||+++++++.+..
T Consensus        40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  119 (504)
T 3q5i_A           40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKK  119 (504)
T ss_dssp             EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            3578999999999999965 688999999975421             23577899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC---cEEE
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG---VACI  502 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~---~~kl  502 (670)
                      ..++||||+++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++   .+||
T Consensus       120 ~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          120 YFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKH----NIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999987543     589999999999999999999998    999999999999998876   6999


Q ss_pred             EecccccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHH
Q 036639          503 SDFGLSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       503 ~DFG~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +|||++......   ....+++.|+|||++. ..++.++||||+||++|||++|+.||....              ....
T Consensus       191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------------~~~~  255 (504)
T 3q5i_A          191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--------------DQDI  255 (504)
T ss_dssp             CCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHH
T ss_pred             EECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--------------HHHH
Confidence            999999876543   3456788899999987 569999999999999999999999997531              1112


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +.........   ++  ...+....+   .+.+++.+||+.||++|||++|+++|
T Consensus       256 ~~~i~~~~~~---~~--~~~~~~~s~---~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          256 IKKVEKGKYY---FD--FNDWKNISD---EAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHHHHCCCC---CC--HHHHTTSCH---HHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcCCCC---CC--ccccCCCCH---HHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            2222211110   01  001112222   35567779999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.6e-39  Score=341.68  Aligned_cols=248  Identities=13%  Similarity=0.048  Sum_probs=176.0

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhcc--CCCCeeeEE-------EEEEeCC--
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKL--KHPNVVKLR-------AYYYAKE--  425 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l--~h~nIv~l~-------~~~~~~~--  425 (670)
                      .+.||+|+||+||+|... +|+.||||++.....   ...+.+.+|+++++.+  +||||++++       +++...+  
T Consensus        67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~  146 (371)
T 3q60_A           67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP  146 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSC
T ss_pred             eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCC
Confidence            468999999999999964 789999999987542   3456677885544444  699988855       5554432  


Q ss_pred             ---------------eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHHhCCCCCccc
Q 036639          426 ---------------EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTR------ISLVLGAARGLARIHQEYGTAKVPH  484 (670)
Q Consensus       426 ---------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~~~ivH  484 (670)
                                     ..++||||++ |+|.+++.....    .+.+..+      ..++.|+++||+|||+.    +|+|
T Consensus       147 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~----~ivH  217 (371)
T 3q60_A          147 PFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSK----GLVH  217 (371)
T ss_dssp             SSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT----TEEE
T ss_pred             CeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC----CCcc
Confidence                           3799999998 899999986421    2344555      77889999999999998    9999


Q ss_pred             cCCCCCCeEeCCCCcEEEEecccccccCccc-cccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 036639          485 GNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-AIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPSQYPS  561 (670)
Q Consensus       485 ~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~~~~~  561 (670)
                      |||||+|||++.++.+||+|||+++...... ...++..|+|||++.+  ..++.++|||||||++|||+||+.||....
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            9999999999999999999999999876654 5566788999999987  679999999999999999999999997653


Q ss_pred             CCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          562 PTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       562 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +...........           .......   ..........   ..+.+++.+||+.||++|||+.|+++|
T Consensus       298 ~~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          298 PGIKGSWKRPSL-----------RVPGTDS---LAFGSCTPLP---DFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TTCTTCCCBCCT-----------TSCCCCS---CCCTTSSCCC---HHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             cccccchhhhhh-----------hhccccc---cchhhccCCC---HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            321110000000           0000000   0000011222   245567779999999999999999863

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-38  Score=350.78  Aligned_cols=246  Identities=22%  Similarity=0.319  Sum_probs=196.1

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.||+|+||.||+|+.. +|+.||||++.+..   ....+.+.+|++++++++||||+++++++.+....|+||||+++|
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            56999999999999965 69999999997432   123467889999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.+++..... ....+++..+..++.||+.||+|||+.    +|+||||||+|||++.++.+||+|||+++.....   
T Consensus       271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~----gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~  345 (543)
T 3c4z_A          271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQR----NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK  345 (543)
T ss_dssp             BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred             CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHc----CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence            99999875431 123589999999999999999999998    9999999999999999999999999999876542   


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+|+.|+|||++.+..++.++|||||||++|||+||+.||......          ................   +
T Consensus       346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----------~~~~~~~~~i~~~~~~---~  412 (543)
T 3c4z_A          346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----------VENKELKQRVLEQAVT---Y  412 (543)
T ss_dssp             BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----------CCHHHHHHHHHHCCCC---C
T ss_pred             cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----------hhHHHHHHHHhhcccC---C
Confidence             2347888999999999999999999999999999999999999754211          1111222222211100   0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM-----AEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  634 (670)
                            ......   .+.+++.+||+.||++||++     +|+++|
T Consensus       413 ------p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          413 ------PDKFSP---ASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ------CTTSCH---HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ------CcccCH---HHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                  011222   34556779999999999965     677653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=345.57  Aligned_cols=193  Identities=24%  Similarity=0.399  Sum_probs=153.2

Q ss_pred             HhHcCCCCceEEEEEEEc---CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD---DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~  435 (670)
                      +++||+|+||+||+|+..   +++.||||++....  ....+.+|++++++++||||+++++++..  ....++||||++
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            568999999999999965   57899999998653  34578899999999999999999999965  568899999996


Q ss_pred             CCChHHHhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe----CCCCcEEEEeccc
Q 036639          436 NGSLHSLLHGNR----GPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL----DKNGVACISDFGL  507 (670)
Q Consensus       436 ~g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFG~  507 (670)
                       ++|.+++....    ......+++..+..++.|++.||+|||+.    +|+||||||+|||+    +.++.+||+|||+
T Consensus       104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~----~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  178 (405)
T 3rgf_A          104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN----WVLHRDLKPANILVMGEGPERGRVKIADMGF  178 (405)
T ss_dssp             -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECCSSTTTTCEEECCTTC
T ss_pred             -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----CEeCCCcCHHHeEEecCCCCCCcEEEEECCC
Confidence             58888775321    11223589999999999999999999998    99999999999999    7788999999999


Q ss_pred             ccccCcc-------ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          508 SLLLNPV-------QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       508 a~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ++.....       ....+|+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus       179 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             CC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             ceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9876432       234678889999999874 5899999999999999999999999754

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.2e-39  Score=342.22  Aligned_cols=254  Identities=22%  Similarity=0.292  Sum_probs=190.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--------CeeE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--------EEKL  428 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--------~~~~  428 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++....  ......+.+|++++++++||||+++++++...        +..+
T Consensus        21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~  100 (351)
T 3mi9_A           21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY  100 (351)
T ss_dssp             EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred             EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence            347899999999999996 578999999986543  22346788999999999999999999999873        4689


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +||||+++ +|.+.+....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||++
T Consensus       101 lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A          101 LVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             EEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            99999975 7877776543    2589999999999999999999998    9999999999999999999999999999


Q ss_pred             cccCc--------cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHH
Q 036639          509 LLLNP--------VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       509 ~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +....        .....+++.|+|||++.+ ..++.++|||||||++|||+||+.||......           .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----------~~~~~  240 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----------HQLAL  240 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----------HHHHH
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----------HHHHH
Confidence            86542        123456778999999875 45899999999999999999999999754210           11111


Q ss_pred             HHHHhhhccccccccH----h--------hhcccchHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          580 VRSVVKEEWTAEVFDQ----E--------LLRYKNIEEE------LVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~----~--------~~~~~~~~~~------~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +...... .....+..    .        ........+.      ...+.+++.+||+.||++|||++|+++|
T Consensus       241 i~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          241 ISQLCGS-ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHHCC-CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCC-CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            1111100 00000000    0        0000011111      1236678889999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=326.17  Aligned_cols=242  Identities=24%  Similarity=0.379  Sum_probs=191.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|... +|+.||||++....  ..+++.+|++++++++||||+++++++...+..++||||+++++
T Consensus        33 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  110 (314)
T 3com_A           33 VLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS  110 (314)
T ss_dssp             EEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             hheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence            3467999999999999965 58999999997643  35678999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc----
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV----  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~----  514 (670)
                      |.+++....    ..+++..+..++.|++.||.|||+.    +|+||||||+||+++.++.+||+|||++......    
T Consensus       111 L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (314)
T 3com_A          111 VSDIIRLRN----KTLTEDEIATILQSTLKGLEYLHFM----RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR  182 (314)
T ss_dssp             HHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCB
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcccc
Confidence            999987322    2589999999999999999999998    9999999999999999999999999999766432    


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....++..|+|||.+.+..++.++||||||+++|||++|+.||.....              ...... .......... 
T Consensus       183 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------~~~~~~-~~~~~~~~~~-  246 (314)
T 3com_A          183 NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------------MRAIFM-IPTNPPPTFR-  246 (314)
T ss_dssp             CCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------------HHHHHH-HHHSCCCCCS-
T ss_pred             CccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------------HHHHHH-HhcCCCcccC-
Confidence            234567789999999988999999999999999999999999964310              011111 1111100000 


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          .....   ...+.+++.+||..||++|||+.|++++
T Consensus       247 ----~~~~~---~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          247 ----KPELW---SDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ----SGGGS---CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----CcccC---CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                00111   1345667779999999999999999884

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.8e-39  Score=339.40  Aligned_cols=190  Identities=26%  Similarity=0.351  Sum_probs=149.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~lv  430 (670)
                      +.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...      ...++|
T Consensus        33 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv  112 (367)
T 2fst_X           33 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV  112 (367)
T ss_dssp             EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEE
T ss_pred             EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEE
Confidence            357899999999999995 57899999999753  233557788999999999999999999998754      567999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      +||+ +++|.++++..      .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++.
T Consensus       113 ~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~----givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          113 THLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             EECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            9999 78999988753      489999999999999999999998    999999999999999999999999999987


Q ss_pred             cCc-cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNP-VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~-~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus       182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  233 (367)
T 2fst_X          182 TADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  233 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            654 234567888999999876 67899999999999999999999999754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-38  Score=330.55  Aligned_cols=245  Identities=24%  Similarity=0.361  Sum_probs=189.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc--------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP--------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.+.||+|+||.||+|... +++.||||++.....        .....+.+|++++++++||||+++++++.... .++
T Consensus        13 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~l   91 (322)
T 2ycf_A           13 IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYI   91 (322)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             eEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEE
Confidence            44678999999999999964 689999999975321        12345889999999999999999999987655 899


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc---EEEEecc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV---ACISDFG  506 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG  506 (670)
                      ||||+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.   +||+|||
T Consensus        92 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           92 VLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHEN----GIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             EEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             EEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            999999999999987543     589999999999999999999998    9999999999999987664   9999999


Q ss_pred             cccccCccc---cccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          507 LSLLLNPVQ---AIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       507 ~a~~~~~~~---~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      +++......   ...++..|+|||++.   ...++.++|||||||++|||++|+.||......          ..+...+
T Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~~~~~~  232 (322)
T 2ycf_A          163 HSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----------VSLKDQI  232 (322)
T ss_dssp             TCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----------SCHHHHH
T ss_pred             cceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----------HHHHHHH
Confidence            998775432   345788999999973   567899999999999999999999999653211          1111111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .   .....   +.+..  ....   ...+.+++.+||+.||++|||+.|++++
T Consensus       233 ~---~~~~~---~~~~~--~~~~---~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          233 T---SGKYN---FIPEV--WAEV---SEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             H---HTCCC---CCHHH--HTTS---CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             H---hCccc---cCchh--hhhc---CHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1   11000   00000  0011   2345667779999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.3e-39  Score=329.19  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=189.0

Q ss_pred             HHhHcCCCCceEEEEEEEc--CCC--EEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD--DGG--IVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||+||+|.+.  +++  .||||+++..   .....+.+.+|++++++++||||+++++++.+.. .++|+|
T Consensus        22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e  100 (291)
T 1u46_A           22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTE  100 (291)
T ss_dssp             EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEE
T ss_pred             eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEe
Confidence            3468999999999999853  333  6999998754   2335678899999999999999999999988765 889999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++....
T Consensus       101 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~----~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A          101 LAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             CCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             cccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhC----CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            999999999997542    2488999999999999999999998    99999999999999999999999999998764


Q ss_pred             ccc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          513 PVQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       513 ~~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ...       ...++..|+|||.+.+..++.++||||||+++|||++ |+.||....              .........
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------------~~~~~~~~~  238 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------------GSQILHKID  238 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHHHHHHH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------------HHHHHHHHH
Confidence            322       2334557999999988889999999999999999999 999996431              112222221


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      .......       ....   ....+.+++.+||+.||++|||+.|++++|+++....
T Consensus       239 ~~~~~~~-------~~~~---~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          239 KEGERLP-------RPED---CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             TSCCCCC-------CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             ccCCCCC-------CCcC---cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            1111000       0011   1234666777999999999999999999999887543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.8e-39  Score=332.99  Aligned_cols=189  Identities=25%  Similarity=0.373  Sum_probs=158.5

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEE--------------eCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYY--------------AKE  425 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~--------------~~~  425 (670)
                      .+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.              +..
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~   95 (320)
T 2i6l_A           16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN   95 (320)
T ss_dssp             EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred             EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence            467999999999999965 58999999998776666788999999999999999999999874              346


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC-CCCcEEEEe
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISD  504 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~D  504 (670)
                      ..++||||++ |+|.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+||+++ +++.+||+|
T Consensus        96 ~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           96 SVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSA----NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             EEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhC----CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            7899999997 6999999653      488999999999999999999998    999999999999997 567999999


Q ss_pred             cccccccCcc-------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          505 FGLSLLLNPV-------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       505 FG~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ||+++.....       ....++..|+|||.+.. ..++.++||||||+++|||+||+.||...
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  228 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA  228 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCC
Confidence            9999876432       22345677999998865 67899999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-38  Score=334.69  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=191.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc-----hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC-----ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.+.||+|+||.||+|... +|+.||||++......     ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        13 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   92 (346)
T 1ua2_A           13 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   92 (346)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             EEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEE
Confidence            44578999999999999964 6899999999753221     12467899999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++ +|.+++....    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           93 FMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             CCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             cCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHC----CEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            9975 8998887543    2578889999999999999999998    99999999999999999999999999998764


Q ss_pred             cc----ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh---
Q 036639          513 PV----QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV---  584 (670)
Q Consensus       513 ~~----~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  584 (670)
                      ..    ....+++.|+|||++.+. .++.++|||||||++|||++|.+||.....          ...+...+....   
T Consensus       164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----------~~~~~~i~~~~~~~~  233 (346)
T 1ua2_A          164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----------LDQLTRIFETLGTPT  233 (346)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----------HHHHHHHHHHHCCCC
T ss_pred             CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----------HHHHHHHHHHcCCCC
Confidence            32    234567889999998654 589999999999999999999999865411          000111111000   


Q ss_pred             hhccccccccHhhh---ccc--ch----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          585 KEEWTAEVFDQELL---RYK--NI----EEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       585 ~~~~~~~~~d~~~~---~~~--~~----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      .+.|......+...   ...  ..    ......+.+++.+||+.||++|||++|+++|-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            00111000000000   000  00    11123566777799999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-38  Score=346.26  Aligned_cols=254  Identities=17%  Similarity=0.230  Sum_probs=197.8

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCC-CCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH-PNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|.. .+++.||||++.....  ..++..|++++..++| ++|..+..++...+..++||||+ ++
T Consensus        11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~   87 (483)
T 3sv0_A           11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP   87 (483)
T ss_dssp             CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence            346799999999999995 5799999999875432  3457889999999976 56666777777888899999999 99


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe---CCCCcEEEEecccccccCcc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFG~a~~~~~~  514 (670)
                      +|.+++....    ..+++..++.|+.||+.||+|||+.    +|+||||||+||||   +.++.+||+|||+++.....
T Consensus        88 sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~----gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           88 SLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSK----SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC----CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            9999997543    2589999999999999999999998    99999999999999   68899999999999876432


Q ss_pred             c-----------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          515 Q-----------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       515 ~-----------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      .           ...++..|+|||++.+..++.++|||||||++|||++|+.||......           .....+...
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----------~~~~~~~~i  228 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----------TKKQKYEKI  228 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----------SHHHHHHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----------hHHHHHHHH
Confidence            2           456788899999999999999999999999999999999999754211           111111111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ...... .... .+.  ...   ..++.+++..||+.||++||++++|++.|+++....
T Consensus       229 ~~~~~~-~~~~-~l~--~~~---p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          229 SEKKVA-TSIE-ALC--RGY---PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHH-SCHH-HHH--TTS---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhcccc-ccHH-HHh--cCC---cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            111100 0000 000  011   235667778999999999999999999999986543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1e-38  Score=334.78  Aligned_cols=192  Identities=22%  Similarity=0.333  Sum_probs=167.7

Q ss_pred             HHhHcCCCCceEEEEEEE--cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCC------CeeeEEEEEEeCCeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL--DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP------NVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------nIv~l~~~~~~~~~~~lv~  431 (670)
                      +.+.||+|+||+||+|..  .+++.||||+++... ...+.+.+|+++++.++|+      +|+++++++.+.+..++||
T Consensus        18 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~   96 (339)
T 1z57_A           18 IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVF   96 (339)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEE
T ss_pred             EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEE
Confidence            346799999999999986  368899999997543 3457788999999888665      4999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---------------
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---------------  496 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---------------  496 (670)
                      ||+ +++|.+++....   ...+++..+..++.|+++||+|||+.    +|+||||||+|||++.               
T Consensus        97 e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           97 ELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSN----KLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             cCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            999 889999997653   23588999999999999999999998    9999999999999987               


Q ss_pred             ----CCcEEEEecccccccCcc-ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          497 ----NGVACISDFGLSLLLNPV-QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       497 ----~~~~kl~DFG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                          ++.+||+|||+++..... ....++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  237 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH  237 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                668999999999876543 3456788899999999999999999999999999999999999654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.7e-38  Score=336.80  Aligned_cols=191  Identities=24%  Similarity=0.338  Sum_probs=158.5

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc-----------chHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP-----------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----  424 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----  424 (670)
                      .+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|++++++++||||+++++++...     
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  106 (362)
T 3pg1_A           27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM  106 (362)
T ss_dssp             EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred             eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence            468999999999999988899999999964321           1237899999999999999999999998653     


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      ...++||||++ |+|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|
T Consensus       107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEA----GVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHC----cCEecCCChHHEEEcCCCCEEEEe
Confidence            35799999997 68888887543    2589999999999999999999998    999999999999999999999999


Q ss_pred             cccccccCcc---ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          505 FGLSLLLNPV---QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       505 FG~a~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ||+++.....   ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       178 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          178 FNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             TTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999765432   23456778999999876 67899999999999999999999999754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-38  Score=329.39  Aligned_cols=252  Identities=28%  Similarity=0.399  Sum_probs=177.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|.. .+++.||||++.... ....+++.+|++++++++||||+++++++...+..++||||++++
T Consensus        19 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   98 (303)
T 2vwi_A           19 LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG   98 (303)
T ss_dssp             EEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTC
T ss_pred             hhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCC
Confidence            346799999999999994 478999999987543 234567889999999999999999999999999999999999999


Q ss_pred             ChHHHhccC---CCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          438 SLHSLLHGN---RGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~---~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      +|.+++...   .......+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++......
T Consensus        99 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  174 (303)
T 2vwi_A           99 SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN----GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATG  174 (303)
T ss_dssp             BHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC--
T ss_pred             chHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CCCCCCCChhhEEEcCCCCEEEEeccchheeccC
Confidence            999998641   111123589999999999999999999998    9999999999999999999999999998765432


Q ss_pred             ---------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          515 ---------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       515 ---------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                               ....++..|+|||.+.+ ..++.++||||||+++|||+||+.||......           .   ......
T Consensus       175 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----------~---~~~~~~  240 (303)
T 2vwi_A          175 GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----------K---VLMLTL  240 (303)
T ss_dssp             -------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----------G---HHHHHH
T ss_pred             CCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----------h---HHHHHh
Confidence                     23457788999999875 56899999999999999999999999653211           0   011111


Q ss_pred             hhccc---cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWT---AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~---~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....   ....+..  ......   ..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~~~~~~~~~~~~~~--~~~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          241 QNDPPSLETGVQDKE--MLKKYG---KSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TSSCCCTTC-----C--CCCCCC---HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccCCCccccccccch--hhhhhh---HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            11100   0000000  001112   245567779999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.8e-38  Score=325.56  Aligned_cols=243  Identities=23%  Similarity=0.353  Sum_probs=193.6

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---------cchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEE
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---------PCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.||+|+||.||+|... +|+.||||+++...         ....+.+.+|+++++++. ||||+++++++.+....++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (298)
T 1phk_A           22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL  101 (298)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence            467999999999999965 68999999997543         123466789999999995 9999999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ||||+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++.
T Consensus       102 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A          102 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCcceEEEcCCCcEEEecccchh
Confidence            999999999999997643     589999999999999999999998    99999999999999999999999999998


Q ss_pred             ccCcc---ccccccCcccCccccc------cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHH
Q 036639          510 LLNPV---QAIARLGGYKAPEQAE------VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       510 ~~~~~---~~~~~~~~y~aPE~~~------~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      .....   ....++..|+|||++.      ...++.++||||||+++|||++|+.||....              .....
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------~~~~~  238 (298)
T 1phk_A          173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------------QMLML  238 (298)
T ss_dssp             ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHH
T ss_pred             hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------------HHHHH
Confidence            76542   2345677899999874      4568899999999999999999999996431              11111


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...........  .+   ....   ....+.+++.+||+.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~--~~---~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          239 RMIMSGNYQFG--SP---EWDD---YSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHHHTCCCCC--TT---TGGG---SCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhcCCcccC--cc---cccc---cCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            12222111100  00   0011   12345667779999999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3e-38  Score=338.97  Aligned_cols=263  Identities=20%  Similarity=0.229  Sum_probs=196.5

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC--------CCCeeeEEEEEE----eCC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK--------HPNVVKLRAYYY----AKE  425 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~nIv~l~~~~~----~~~  425 (670)
                      .+.+.||+|+||+||+|+. .+++.||||+++.. ....+.+.+|++++++++        |+||+++++++.    +..
T Consensus        40 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~  118 (397)
T 1wak_A           40 HVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGT  118 (397)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEE
T ss_pred             EEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCc
Confidence            3457899999999999995 46889999999754 335677889999999885        788999999988    456


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-------
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-------  498 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-------  498 (670)
                      ..++||||+ +++|.+++....   ...+++..+..++.|++.||+|||+.+   +|+||||||+|||++.++       
T Consensus       119 ~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          119 HICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKC---RIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             eEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHeeEeccchhhhhhh
Confidence            789999999 667766665432   125899999999999999999999862   899999999999999775       


Q ss_pred             ------------------------------------------cEEEEecccccccCcc-ccccccCcccCccccccCCCC
Q 036639          499 ------------------------------------------VACISDFGLSLLLNPV-QAIARLGGYKAPEQAEVKRLS  535 (670)
Q Consensus       499 ------------------------------------------~~kl~DFG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~  535 (670)
                                                                .+||+|||+++..... ....+|..|+|||++.+..++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~  271 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYN  271 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCC
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCC
Confidence                                                      7999999999876542 345678889999999999999


Q ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh---------hhccccccccH-----------
Q 036639          536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV---------KEEWTAEVFDQ-----------  595 (670)
Q Consensus       536 ~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~d~-----------  595 (670)
                      .++|||||||++|||+||+.||...+......    . ......+....         ...+....+..           
T Consensus       272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~----~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          272 TPADIWSTACMAFELATGDYLFEPHSGEEYTR----D-EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCH----H-HHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             cHHHHHHHHHHHHHHhhCCCCCCCCcccccCc----h-HHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            99999999999999999999997653221110    0 00000000000         00000000000           


Q ss_pred             -------hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 -------ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 -------~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .........+....+.+++.+||+.||++|||++|+++|
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                   001112234555678889999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.5e-39  Score=339.00  Aligned_cols=190  Identities=25%  Similarity=0.352  Sum_probs=165.0

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----CeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e  432 (670)
                      +.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++...     ...++|||
T Consensus        31 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e  110 (364)
T 3qyz_A           31 NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD  110 (364)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             EEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEc
Confidence            3468999999999999954 68899999997543 33457889999999999999999999999765     36899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |++ |+|.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++...
T Consensus       111 ~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          111 LME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             CCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            996 5999999764      389999999999999999999998    99999999999999999999999999998765


Q ss_pred             cc-------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          513 PV-------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       513 ~~-------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..       ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  235 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  235 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence            43       22367888999998654 45899999999999999999999999754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-38  Score=360.65  Aligned_cols=240  Identities=22%  Similarity=0.293  Sum_probs=195.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||.||+|+.. +++.||||++++.   .....+.+..|.+++..+ +||+|+++++++.+.+..|+||||+
T Consensus       345 ~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~  424 (674)
T 3pfq_A          345 FLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYV  424 (674)
T ss_dssp             EEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred             EEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence            3468999999999999954 6889999999743   122346678889999887 7999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.++++...     .+++..+..++.||+.||+|||+.    +|+||||||+||||+.++.+||+|||+++.... 
T Consensus       425 ~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~----gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          425 NGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSK----GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            9999999998653     589999999999999999999998    999999999999999999999999999986422 


Q ss_pred             ---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 ---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                         .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+              .......+...... 
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------------~~~~~~~i~~~~~~-  560 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------------EDELFQSIMEHNVA-  560 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHSSCCC-
T ss_pred             CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------------HHHHHHHHHhCCCC-
Confidence               334568899999999999999999999999999999999999997531              11222222222110 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTM-----AEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  634 (670)
                        +      ......   ++.+++.+||+.||++||++     +||++|
T Consensus       561 --~------p~~~s~---~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          561 --Y------PKSMSK---EAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             --C------CTTSCH---HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             --C------CccCCH---HHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence              0      111222   35556779999999999997     777764

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.1e-38  Score=323.26  Aligned_cols=241  Identities=22%  Similarity=0.344  Sum_probs=188.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhccCCCCeeeEEEEEE--eCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKLKHPNVVKLRAYYY--AKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~--~~~~~~lv~e  432 (670)
                      +.+.||+|+||.||++.. .+++.||+|+++...    ....+.+.+|++++++++||||+++++++.  +....++|||
T Consensus         9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (305)
T 2wtk_C            9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME   88 (305)
T ss_dssp             CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEE
T ss_pred             EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEeh
Confidence            356899999999999996 468999999997532    234678999999999999999999999985  3457899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |++++ |.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++....
T Consensus        89 ~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~----~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           89 YCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQ----GIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             hccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHC----CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            99876 777776543   22589999999999999999999998    99999999999999999999999999998764


Q ss_pred             c------cccccccCcccCccccccCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          513 P------VQAIARLGGYKAPEQAEVKR--LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       513 ~------~~~~~~~~~y~aPE~~~~~~--~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      .      .....++..|+|||++.+..  ++.++||||||+++|||++|+.||...              ..........
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--------------~~~~~~~~i~  226 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD--------------NIYKLFENIG  226 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS--------------SHHHHHHHHH
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc--------------hHHHHHHHHh
Confidence            2      12345778899999987644  478999999999999999999999643              1112222211


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....         ......   ..+.+++.+||+.||++|||++|++++
T Consensus       227 ~~~~~---------~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          227 KGSYA---------IPGDCG---PPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HCCCC---------CCSSSC---HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cCCCC---------CCCccC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11110         001112   245567779999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=8.7e-39  Score=340.10  Aligned_cols=189  Identities=24%  Similarity=0.342  Sum_probs=161.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCee------EEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEK------LLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~------~lv  430 (670)
                      +.+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..      ++|
T Consensus        46 ~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv  125 (371)
T 4exu_A           46 SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV  125 (371)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEE
T ss_pred             EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEE
Confidence            3568999999999999954 68999999997642  33457888999999999999999999999877654      999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||++ ++|.+++..       .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++.
T Consensus       126 ~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          126 MPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             EECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             Ecccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            99996 688888742       388999999999999999999998    999999999999999999999999999987


Q ss_pred             cCcc-ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNPV-QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .... ....+++.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  245 (371)
T 4exu_A          194 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  245 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            6543 34567888999999876 67899999999999999999999999754

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.2e-38  Score=326.07  Aligned_cols=254  Identities=23%  Similarity=0.325  Sum_probs=189.6

Q ss_pred             HHhHcCCCCceEEEEEEE--cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhcc---CCCCeeeEEEEEE-----eCCee
Q 036639          360 SAEMLGKGSLGTVYKAVL--DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKL---KHPNVVKLRAYYY-----AKEEK  427 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~-----~~~~~  427 (670)
                      +.+.||+|+||.||+|..  .+|+.||||+++...  ......+.+|+.+++.+   +||||+++++++.     .....
T Consensus        15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~   94 (326)
T 1blx_A           15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   94 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred             eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence            346799999999999997  468899999986432  11223566777777666   8999999999987     45678


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      ++||||++ |+|.+++.....   ..+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+
T Consensus        95 ~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~----gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           95 TLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             EEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             EEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHC----CceeccCCHHHeEEcCCCCEEEecCcc
Confidence            99999997 699999976532   2488999999999999999999998    999999999999999999999999999


Q ss_pred             ccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          508 SLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       508 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ++.....   ....++..|+|||++.+..++.++|||||||++|||+||+.||......          ..+...+....
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----------~~~~~i~~~~~  236 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----------DQLGKILDVIG  236 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------HHHHHHHHHHC
T ss_pred             cccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH----------HHHHHHHHHcC
Confidence            9876543   2345677899999999889999999999999999999999999754210          00111110000


Q ss_pred             ---hhccccccccH----------hh-hcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 ---KEEWTAEVFDQ----------EL-LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ---~~~~~~~~~d~----------~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         ...|......+          .. .......   ..+.+++.+||+.||++|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID---ELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCC---HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCC---HHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence               01111100000          00 0001122   345567779999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=329.10  Aligned_cols=243  Identities=23%  Similarity=0.372  Sum_probs=187.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEe------CCeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYA------KEEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~------~~~~~lv~  431 (670)
                      +.+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+++++++ +||||+++++++..      .+..++||
T Consensus        28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~  106 (326)
T 2x7f_A           28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM  106 (326)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred             EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence            346899999999999996 4789999999975432 457889999999999 79999999999987      46789999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++++|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||++...
T Consensus       107 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          107 EFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQH----KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             ECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            9999999999998643   22588999999999999999999998    9999999999999999999999999999876


Q ss_pred             Ccc----ccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          512 NPV----QAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       512 ~~~----~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      ...    ....++..|+|||++.     ...++.++|||||||++|||+||+.||.....              ......
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------------~~~~~~  245 (326)
T 2x7f_A          180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------------MRALFL  245 (326)
T ss_dssp             -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------------HHHHHH
T ss_pred             CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------------HHHHHH
Confidence            432    2345778899999986     56789999999999999999999999964310              011111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..... .....      .....   ..+.+++.+||..||++|||+.|++++
T Consensus       246 ~~~~~-~~~~~------~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 IPRNP-APRLK------SKKWS---KKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHHSC-CCCCS------CSCSC---HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhcCc-cccCC------ccccC---HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11110 00000      01112   245567779999999999999999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.6e-38  Score=358.14  Aligned_cols=251  Identities=23%  Similarity=0.345  Sum_probs=198.8

Q ss_pred             HHHHHhHcCCCCceEEEEEEEc----CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          357 LRASAEMLGKGSLGTVYKAVLD----DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       357 ~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.+.||+|+||.||+|.+.    .+..||||+++... ....+.+.+|+.++++++||||+++++++. .+..++||
T Consensus       391 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~  469 (656)
T 2j0j_A          391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM  469 (656)
T ss_dssp             GEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             cEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEE
Confidence            3455678999999999999964    24679999987643 334578999999999999999999999984 56789999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++|+|.++++...    ..+++..++.++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++..
T Consensus       470 E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~----givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          470 ELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             ECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            9999999999997543    2589999999999999999999998    9999999999999999999999999999877


Q ss_pred             Cccc-----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          512 NPVQ-----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       512 ~~~~-----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ....     ...++..|+|||++.+..++.++|||||||++|||++ |..||....              ..........
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--------------~~~~~~~i~~  607 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--------------NNDVIGRIEN  607 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHHHHHHHH
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--------------HHHHHHHHHc
Confidence            5432     2234567999999998899999999999999999997 999986531              1111111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .... .       .....   ...+.+++.+||+.||++|||+.|+++.|+++..+
T Consensus       608 ~~~~-~-------~~~~~---~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          608 GERL-P-------MPPNC---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             TCCC-C-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC-C-------CCccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            1100 0       00111   23456677899999999999999999999998643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-37  Score=319.84  Aligned_cols=247  Identities=22%  Similarity=0.288  Sum_probs=178.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc-ch-HHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP-CA-RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||+||+|.. .+|+.||||+++.... .. .+.+.++...++.++||||+++++++.+.+..++||||++ 
T Consensus        11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-   89 (290)
T 3fme_A           11 PIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-   89 (290)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-
T ss_pred             hHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-
Confidence            346899999999999996 5789999999976432 12 2334455556788899999999999999999999999997 


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      |+|.+++..... ....+++..+..++.|++.||+|||+.   .+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        90 ~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  165 (290)
T 3fme_A           90 TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSK---LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA  165 (290)
T ss_dssp             EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHH---SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhc---CCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence            588887754211 112589999999999999999999986   389999999999999999999999999998765432 


Q ss_pred             --cccccCcccCcccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          516 --AIARLGGYKAPEQA----EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       516 --~~~~~~~y~aPE~~----~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                        ...+++.|+|||++    .+..++.++||||||+++|||+||+.||....             .....+.........
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------------~~~~~~~~~~~~~~~  232 (290)
T 3fme_A          166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-------------TPFQQLKQVVEEPSP  232 (290)
T ss_dssp             ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-------------CHHHHHHHHHHSCCC
T ss_pred             ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-------------chHHHHHHHhccCCC
Confidence              34678889999996    56678999999999999999999999996421             111111111111111


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .. ..      ...   ...+.+++.+||+.||++|||++|+++|
T Consensus       233 ~~-~~------~~~---~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          233 QL-PA------DKF---SAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             CC-CT------TTS---CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             Cc-cc------ccC---CHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            00 00      011   1245667779999999999999999984

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.1e-38  Score=332.23  Aligned_cols=268  Identities=21%  Similarity=0.294  Sum_probs=176.9

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe-------eEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE-------KLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-------~~lv~  431 (670)
                      +.+.||+|+||+||+|... +|+.||||++..... ......++++.+..++||||+++++++...+.       .++||
T Consensus        27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~  105 (360)
T 3e3p_A           27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVM  105 (360)
T ss_dssp             EC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEe
Confidence            3568999999999999964 689999999865432 33456677888888999999999999976543       78999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--HhCCCCCccccCCCCCCeEeCC-CCcEEEEecccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH--QEYGTAKVPHGNVKSSNVLLDK-NGVACISDFGLS  508 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFG~a  508 (670)
                      ||+++ +|.+.+..... ....+++..+..++.|++.||.|||  +.    +|+||||||+|||++. ++.+||+|||++
T Consensus       106 e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~----~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a  179 (360)
T 3e3p_A          106 EYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSV----NVCHRDIKPHNVLVNEADGTLKLCDFGSA  179 (360)
T ss_dssp             ECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTT----CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred             ecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCC----CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence            99976 55444432110 1225889999999999999999999  65    9999999999999997 899999999999


Q ss_pred             cccCccc---cccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchhHHHHHH
Q 036639          509 LLLNPVQ---AIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLPKWVRSV  583 (670)
Q Consensus       509 ~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~  583 (670)
                      +......   ...++..|+|||++.+. .++.++|||||||++|||+||+.||............... ......++...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            8775432   34567889999998654 4899999999999999999999999754210000000000 00000011111


Q ss_pred             hhhccccccccHh-----hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQE-----LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~-----~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..........+..     .............+.+++.+||+.||++|||+.|+++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0000000000000     00000001123456778889999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-38  Score=337.37  Aligned_cols=191  Identities=24%  Similarity=0.363  Sum_probs=158.3

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC--------------
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK--------------  424 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~--------------  424 (670)
                      +.+.||+|+||+||+|.. .+|+.||||++.....    ...+|+++++.++||||+++++++...              
T Consensus        11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~   86 (383)
T 3eb0_A           11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH   86 (383)
T ss_dssp             EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------------
T ss_pred             EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccccccccc
Confidence            357899999999999995 5799999999865422    234799999999999999999998543              


Q ss_pred             ------------------------CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCC
Q 036639          425 ------------------------EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA  480 (670)
Q Consensus       425 ------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  480 (670)
                                              ...++||||++ |+|.+.+..... ....+++..+..++.|+++||+|||+.    
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~----  160 (383)
T 3eb0_A           87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSL----  160 (383)
T ss_dssp             -----------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----
T ss_pred             ccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC----
Confidence                                    34789999997 588777653111 112589999999999999999999988    


Q ss_pred             CccccCCCCCCeEeC-CCCcEEEEecccccccCcc---ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCC
Q 036639          481 KVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNPV---QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRA  555 (670)
Q Consensus       481 ~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~  555 (670)
                      +|+||||||+|||++ .++.+||+|||+++.....   ....++..|+|||.+.+. .++.++||||+||++|||++|+.
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            999999999999998 6899999999999876432   344567789999998764 48999999999999999999999


Q ss_pred             CCCCC
Q 036639          556 PSQYP  560 (670)
Q Consensus       556 p~~~~  560 (670)
                      ||...
T Consensus       241 pf~~~  245 (383)
T 3eb0_A          241 LFSGE  245 (383)
T ss_dssp             SSCCS
T ss_pred             CCCCC
Confidence            99754

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=331.44  Aligned_cols=250  Identities=21%  Similarity=0.312  Sum_probs=189.6

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||.||+|...+  .||+|+++...  ....+.+.+|+.++++++||||+++++++.+.+..++||||++++
T Consensus        37 ~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~  114 (319)
T 2y4i_B           37 IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR  114 (319)
T ss_dssp             CCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSE
T ss_pred             EeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCC
Confidence            35789999999999999763  49999987532  223456788999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.+++....    ..+++..+..++.|++.||+|||+.    +|+||||||+||+++ ++.+||+|||+++....    
T Consensus       115 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~----~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          115 TLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAK----GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             EHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHT----TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC----CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            9999997643    2588999999999999999999998    999999999999998 68999999999876532    


Q ss_pred             -----cccccccCcccCcccccc---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHH
Q 036639          514 -----VQAIARLGGYKAPEQAEV---------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       514 -----~~~~~~~~~y~aPE~~~~---------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                           .....++..|+|||.+..         ..++.++||||||+++|||+||+.||....              ....
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------------~~~~  251 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--------------AEAI  251 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC--------------HHHH
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------------HHHH
Confidence                 122346778999999864         457899999999999999999999996431              1111


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCCC
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP  644 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~  644 (670)
                      ....... .......      ....   ..+.+++.+||..||++|||+.|++++|+++......
T Consensus       252 ~~~~~~~-~~~~~~~------~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~  306 (319)
T 2y4i_B          252 IWQMGTG-MKPNLSQ------IGMG---KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR  306 (319)
T ss_dssp             HHHHHTT-CCCCCCC------SSCC---TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred             HHHhccC-CCCCCCc------CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            1111111 1100000      0111   2355677799999999999999999999999866533

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.8e-38  Score=334.68  Aligned_cols=254  Identities=18%  Similarity=0.245  Sum_probs=194.8

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcc-----------------hHHHHHHHHHHHhccCCCCeeeEEEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPC-----------------ARKEFEQYMDVIGKLKHPNVVKLRAYYY  422 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~nIv~l~~~~~  422 (670)
                      +.+.||+|+||.||+|.. +|+.||||++......                 ..+.+.+|++++++++||||+++++++.
T Consensus        35 ~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~  113 (348)
T 2pml_X           35 IIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT  113 (348)
T ss_dssp             EEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEE
T ss_pred             EEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            356899999999999999 8999999999643211                 1178999999999999999999999999


Q ss_pred             eCCeeEEEEeccCCCChHHH------hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-hCCCCCccccCCCCCCeEeC
Q 036639          423 AKEEKLLVYDYLPNGSLHSL------LHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ-EYGTAKVPHGNVKSSNVLLD  495 (670)
Q Consensus       423 ~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~~ivH~Dlkp~NIll~  495 (670)
                      +.+..++||||+++++|.++      +....   ...+++..+..++.|++.||+|||+ .    +|+||||||+||+++
T Consensus       114 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~----~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEK----NICHRDVKPSNILMD  186 (348)
T ss_dssp             SSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTS----CEECCCCCGGGEEEC
T ss_pred             eCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccC----CEeecCCChHhEEEc
Confidence            99999999999999999998      54321   2368999999999999999999998 6    999999999999999


Q ss_pred             CCCcEEEEecccccccCc--cccccccCcccCccccccC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccc
Q 036639          496 KNGVACISDFGLSLLLNP--VQAIARLGGYKAPEQAEVK-RLSQ-KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEE  571 (670)
Q Consensus       496 ~~~~~kl~DFG~a~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~-ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~  571 (670)
                      .++.+||+|||.+.....  .....++..|+|||.+.+. .++. ++||||||+++|||++|+.||......        
T Consensus       187 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------  258 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--------  258 (348)
T ss_dssp             TTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--------
T ss_pred             CCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--------
Confidence            999999999999987543  3345677889999999877 6666 999999999999999999999754221        


Q ss_pred             cccchhHHHHHHhhhcccccc----ccHhhhcc---cchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          572 QAVDLPKWVRSVVKEEWTAEV----FDQELLRY---KNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~----~d~~~~~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                           ................    +.......   .........+.+++.+||+.||++|||++|++++
T Consensus       259 -----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          259 -----VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             -----HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             -----HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 1111111111000000    00000000   0001112345667779999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-38  Score=340.87  Aligned_cols=268  Identities=22%  Similarity=0.334  Sum_probs=187.2

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe------eEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE------KLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~------~~lv~e~  433 (670)
                      +.+.||+|+||+||+|+..++..||+|++.....    ...+|+++++.++||||+++++++...+.      .++||||
T Consensus        44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~  119 (394)
T 4e7w_A           44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY  119 (394)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEEC
T ss_pred             EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeec
Confidence            4578999999999999987777799998864322    22368999999999999999999976543      7899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC-CCCcEEEEecccccccC
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLN  512 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~  512 (670)
                      ++++.+........  ....+++..+..++.|+++||+|||+.    +|+||||||+|||++ .++.+||+|||+++...
T Consensus       120 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          120 VPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI----GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             CSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             cCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC----CccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            97754443332111  112589999999999999999999998    999999999999999 79999999999998764


Q ss_pred             c---cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchhHHHHHHhhhc
Q 036639          513 P---VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLPKWVRSVVKEE  587 (670)
Q Consensus       513 ~---~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  587 (670)
                      .   .....+++.|+|||++.+. .++.++|||||||++|||++|+.||...+........... .......+... ...
T Consensus       194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~-~~~  272 (394)
T 4e7w_A          194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM-NPN  272 (394)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH-CGG
T ss_pred             CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-Chh
Confidence            3   2345667889999998764 5899999999999999999999999754211000000000 00000000000 000


Q ss_pred             cccccccHhhhcccchH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhc
Q 036639          588 WTAEVFDQELLRYKNIE-----EELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRV  640 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~  640 (670)
                      +....+.. . ......     .....+.+++.+||+.||++|||+.|+++|  +++++.
T Consensus       273 ~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          273 YMEHKFPQ-I-RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT  330 (394)
T ss_dssp             GSSSCCCC-C-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred             hhhhcccc-c-cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence            00000000 0 000000     012356677779999999999999999986  555543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-37  Score=319.68  Aligned_cols=244  Identities=23%  Similarity=0.297  Sum_probs=193.9

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.+.||+|+||.||+|... +++.||||++...  .....+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus        25 ~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  104 (287)
T 2wei_A           25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT  104 (287)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccC
Confidence            34578999999999999965 7899999998643  22356789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC---CcEEEEecccccccC
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN---GVACISDFGLSLLLN  512 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFG~a~~~~  512 (670)
                      +++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+||+++.+   +.+||+|||++....
T Consensus       105 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          105 GGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKH----NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            999999887543     489999999999999999999998    99999999999999764   469999999998765


Q ss_pred             ccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          513 PVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       513 ~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ...   ...++..|+|||.+.+ .++.++||||||+++|||++|+.||....              ..............
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------------~~~~~~~~~~~~~~  240 (287)
T 2wei_A          176 QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------------EYDILKRVETGKYA  240 (287)
T ss_dssp             CCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC
T ss_pred             CCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHcCCCC
Confidence            432   2346677999999875 48999999999999999999999996531              11111111111111


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ..     ........   ..+.+++.+||+.||++|||+.|++++
T Consensus       241 ~~-----~~~~~~~~---~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 FD-----LPQWRTIS---DDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CC-----SGGGTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CC-----chhhhhcC---HHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            00     00111122   245567779999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-37  Score=330.90  Aligned_cols=194  Identities=23%  Similarity=0.283  Sum_probs=165.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CC-----CeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HP-----NVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||+||+|... +++.||||+++... ...+++..|+++++.++ |+     +|+++++++...+..++|||
T Consensus        58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e  136 (382)
T 2vx3_A           58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE  136 (382)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEE
T ss_pred             EEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEe
Confidence            3578999999999999955 68899999998542 34567788888888875 44     49999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC--CCCcEEEEecccccc
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD--KNGVACISDFGLSLL  510 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~  510 (670)
                      |++ ++|.+++.....   ..+++..+..++.|++.||+|||.+  ..+|+||||||+|||++  .++.+||+|||+++.
T Consensus       137 ~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~  210 (382)
T 2vx3_A          137 MLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ  210 (382)
T ss_dssp             CCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             cCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence            995 599999986531   2489999999999999999999953  24899999999999995  477899999999987


Q ss_pred             cCcc-ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNPV-QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~~-~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .... ....+++.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       211 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          211 LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             TTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7542 3456788899999999999999999999999999999999999754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.4e-38  Score=340.88  Aligned_cols=257  Identities=25%  Similarity=0.341  Sum_probs=185.5

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~lv~e~  433 (670)
                      .+.||+|+||.||+|+.. +|+.||||++....    ....+|++++++++||||+++++++....      ..++||||
T Consensus        59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~  134 (420)
T 1j1b_A           59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  134 (420)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence            468999999999999975 69999999986542    22347999999999999999999986532      35799999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-CcEEEEecccccccC
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLN  512 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~a~~~~  512 (670)
                      +++ +|.+.+..... ....+++..+..++.|+++||+|||+.    +|+||||||+|||++.+ +.+||+|||+++...
T Consensus       135 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~----~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          135 VPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             CCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             ccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC----CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            975 66666542110 122589999999999999999999988    99999999999999965 578999999998764


Q ss_pred             cc---ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH-----
Q 036639          513 PV---QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV-----  583 (670)
Q Consensus       513 ~~---~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  583 (670)
                      ..   ....++..|+|||++.+. .++.++|||||||++|||++|+.||......          ..+...+...     
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~----------~~l~~i~~~lg~p~~  278 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----------DQLVEIIKVLGTPTR  278 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----------HHHHHHHHHHCSCCH
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----------HHHHHHHHHhCCCCH
Confidence            32   245678889999998764 7999999999999999999999999754210          0111111100     


Q ss_pred             -----hhhccccccccHhhhcccch-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036639          584 -----VKEEWTAEVFDQELLRYKNI-----EEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIR  639 (670)
Q Consensus       584 -----~~~~~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~  639 (670)
                           ....+....+ +.+.. ...     ......+.+|+.+||+.||++|||+.|+++|  ++++.
T Consensus       279 ~~~~~~~~~~~~~~~-p~~~~-~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          279 EQIREMNPNYTEFKF-PQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             HHHHHHCSCCCCCCC-CCCCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             HHHHhhChhhhhhcc-CccCC-CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence                 0000000000 00000 000     0112346677789999999999999999975  44443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3e-37  Score=320.42  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=188.7

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccC--CCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLK--HPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||.||++...+++.||||++...  .....+.+.+|++++.+++  |+||+++++++.+.+..++||| +.
T Consensus        32 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~  110 (313)
T 3cek_A           32 ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CG  110 (313)
T ss_dssp             EEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CC
T ss_pred             EEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cC
Confidence            34689999999999999888999999999654  3335578899999999997  5999999999999999999999 55


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++ ++.+||+|||+++..... 
T Consensus       111 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~----~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          111 NIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQH----GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             SEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            889999998654     588999999999999999999998    999999999999996 589999999999876432 


Q ss_pred             -----ccccccCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          515 -----QAIARLGGYKAPEQAEV-----------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       515 -----~~~~~~~~y~aPE~~~~-----------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                           ....++..|+|||.+.+           ..++.++||||||+++|||++|+.||....             ....
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------------~~~~  247 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-------------NQIS  247 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC-------------SHHH
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH-------------HHHH
Confidence                 23457888999999865           468889999999999999999999996431             1111


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      .+............       .....   ..+.+++.+||+.||++|||+.|++++-
T Consensus       248 ~~~~~~~~~~~~~~-------~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          248 KLHAIIDPNHEIEF-------PDIPE---KDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HHHHHHCTTSCCCC-------CCCSC---HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHHhcccccCC-------cccch---HHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            11111111110000       01111   2455677799999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-37  Score=338.56  Aligned_cols=244  Identities=24%  Similarity=0.305  Sum_probs=181.6

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      +.||+|+||+||.+...+|+.||||++...   ..+.+.+|++++.++ +||||+++++++.+....++||||++ |+|.
T Consensus        21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~   96 (434)
T 2rio_A           21 KILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ   96 (434)
T ss_dssp             EEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred             CeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence            579999999998877778999999998753   345678899999876 89999999999999999999999995 6999


Q ss_pred             HHhccCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-------------CcEEEEec
Q 036639          441 SLLHGNRGPGR--IPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-------------GVACISDF  505 (670)
Q Consensus       441 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl~DF  505 (670)
                      +++........  ....+..++.++.|++.||+|||+.    +|+||||||+|||++.+             +.+||+||
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF  172 (434)
T 2rio_A           97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL----KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF  172 (434)
T ss_dssp             HHHHTC------------CCHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred             HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC----CccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence            99986542111  0113334678999999999999998    99999999999999754             48999999


Q ss_pred             ccccccCccc--------cccccCcccCcccccc-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcc
Q 036639          506 GLSLLLNPVQ--------AIARLGGYKAPEQAEV-------KRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE  569 (670)
Q Consensus       506 G~a~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~  569 (670)
                      |+++......        ...+|+.|+|||++.+       ..++.++|||||||++|||+| |+.||......      
T Consensus       173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------  246 (434)
T 2rio_A          173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR------  246 (434)
T ss_dssp             TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH------
T ss_pred             ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh------
Confidence            9998765422        2457888999999865       568999999999999999999 99998643110      


Q ss_pred             cccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       570 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                            .    .............     ...........+.+++.+||+.||++|||+.||++|
T Consensus       247 ------~----~~i~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          247 ------E----SNIIRGIFSLDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ------H----HHHHHTCCCCCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------H----HHHhcCCCCcccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence                  0    0111111100000     001112233456778889999999999999999874

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.1e-37  Score=327.20  Aligned_cols=189  Identities=23%  Similarity=0.377  Sum_probs=163.5

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----CeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv~e~  433 (670)
                      .+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++...     ...++||||
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~   95 (353)
T 2b9h_A           16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL   95 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred             eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence            467999999999999965 68999999997543 33456788999999999999999999998764     678999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      ++ ++|.+++...      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~----~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGS----NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC----CeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            96 6999998764      489999999999999999999998    999999999999999999999999999987643


Q ss_pred             cc--------------cccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 VQ--------------AIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ~~--------------~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ..              ...++..|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            11              2346778999998754 67899999999999999999999999754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.7e-38  Score=331.46  Aligned_cols=192  Identities=22%  Similarity=0.340  Sum_probs=165.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CC-CEEEEEEeCCCCcchHHHHHHHHHHHhccCCCC------eeeEEEEEEeCCeeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DG-GIVAVKRLKDANPCARKEFEQYMDVIGKLKHPN------VVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------Iv~l~~~~~~~~~~~lv~  431 (670)
                      +.+.||+|+||+||+|... ++ +.||||+++... ...+.+.+|++++++++|++      ++.+++++...+..++||
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T 2eu9_A           23 IVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF  101 (355)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEE
T ss_pred             EEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEE
Confidence            3578999999999999964 44 689999997542 35677889999999987665      999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEe-----------------
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLL-----------------  494 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll-----------------  494 (670)
                      ||+ +++|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+|||+                 
T Consensus       102 e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~----~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A          102 ELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHEN----QLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             ECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             ecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEEEecccccccccccccccc
Confidence            999 667777776543   12589999999999999999999988    99999999999999                 


Q ss_pred             --CCCCcEEEEecccccccCc-cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          495 --DKNGVACISDFGLSLLLNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       495 --~~~~~~kl~DFG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                        +.++.+||+|||+++.... .....++..|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence              5678999999999987644 23456788899999999999999999999999999999999999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=326.08  Aligned_cols=188  Identities=24%  Similarity=0.336  Sum_probs=160.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe------eEEEE
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE------KLLVY  431 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~------~~lv~  431 (670)
                      .+.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++.....      .++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  108 (353)
T 3coi_A           29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  108 (353)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence            467999999999999964 68999999997542  2345778899999999999999999999987654      49999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||++ ++|.+++..       .+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.+||+|||+++..
T Consensus       109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~----~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSA----GVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC----CcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence            9996 688887742       388999999999999999999998    9999999999999999999999999999876


Q ss_pred             Ccc-ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          512 NPV-QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       512 ~~~-~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       177 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  227 (353)
T 3coi_A          177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  227 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSS
T ss_pred             CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            542 33467888999999876 67899999999999999999999999754

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.2e-38  Score=327.17  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=171.8

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC-cchHHHHHHHHH-HHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN-PCARKEFEQYMD-VIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      ..+.||+|+||.||+|... +|+.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||||+++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~  105 (327)
T 3aln_A           26 DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST  105 (327)
T ss_dssp             C-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred             ehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence            3467999999999999964 78999999997643 223445555665 67778999999999999999999999999975


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                       +|.+++..........+++..+..++.|++.||.|||+.   .+|+||||||+||+++.++.+||+|||+++...... 
T Consensus       106 -~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  181 (327)
T 3aln_A          106 -SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN---LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA  181 (327)
T ss_dssp             -EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH---HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             -ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc---CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence             888877631111123589999999999999999999986   389999999999999999999999999998765422 


Q ss_pred             --cccccCcccCcccc----ccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          516 --AIARLGGYKAPEQA----EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       516 --~~~~~~~y~aPE~~----~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                        ...++..|+|||++    .+..++.++||||||+++|||++|+.||..............             ... .
T Consensus       182 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------~~~-~  247 (327)
T 3aln_A          182 KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV-------------KGD-P  247 (327)
T ss_dssp             ------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-------------CSC-C
T ss_pred             cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-------------cCC-C
Confidence              23577889999998    456789999999999999999999999975321111000000             000 0


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .. +..  .......   ..+.+++.+||+.||++|||+.|++++
T Consensus       248 ~~-~~~--~~~~~~~---~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          248 PQ-LSN--SEEREFS---PSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CC-CCC--CSSCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CC-CCC--cccccCC---HHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            00 000  0000111   245667779999999999999999885

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.4e-37  Score=328.03  Aligned_cols=262  Identities=18%  Similarity=0.231  Sum_probs=193.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-----------CCCeeeEEEEEEeCC--
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-----------HPNVVKLRAYYYAKE--  425 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~nIv~l~~~~~~~~--  425 (670)
                      +.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|++++++++           |+||+++++++...+  
T Consensus        23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  101 (373)
T 1q8y_A           23 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPN  101 (373)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETT
T ss_pred             EEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCC
Confidence            457899999999999995 57899999999754 235677889999998886           899999999998654  


Q ss_pred             --eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC------CC
Q 036639          426 --EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD------KN  497 (670)
Q Consensus       426 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~------~~  497 (670)
                        ..++||||+ +++|.+++.....   ..+++..+..++.|++.||+|||+.   .+|+||||||+|||++      ..
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~~ivH~Dikp~NIll~~~~~~~~~  174 (373)
T 1q8y_A          102 GVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRR---CGIIHTDIKPENVLMEIVDSPENL  174 (373)
T ss_dssp             EEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCEECSCCSGGGEEEEEEETTTTE
T ss_pred             CceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhc---CCEEecCCChHHeEEeccCCCcCc
Confidence              788999999 8999999986432   2489999999999999999999985   2899999999999994      44


Q ss_pred             CcEEEEecccccccCcc-ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccch
Q 036639          498 GVACISDFGLSLLLNPV-QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDL  576 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  576 (670)
                      +.+||+|||++...... ....++..|+|||++.+..++.++|||||||++|||+||+.||..........    ....+
T Consensus       175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~----~~~~~  250 (373)
T 1q8y_A          175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK----DDDHI  250 (373)
T ss_dssp             EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C----HHHHH
T ss_pred             ceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC----hHHHH
Confidence            48999999999876543 34567888999999999999999999999999999999999997543211100    00000


Q ss_pred             hHHHHHHhhh---------cccccccc------------------HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH
Q 036639          577 PKWVRSVVKE---------EWTAEVFD------------------QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA  629 (670)
Q Consensus       577 ~~~~~~~~~~---------~~~~~~~d------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  629 (670)
                      .... .....         .+....++                  ...............+.+++.+||+.||++|||++
T Consensus       251 ~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  329 (373)
T 1q8y_A          251 AQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  329 (373)
T ss_dssp             HHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence            0000 00000         00000000                  00001112244556788899999999999999999


Q ss_pred             HHHHH
Q 036639          630 EVAKM  634 (670)
Q Consensus       630 evl~~  634 (670)
                      |+++|
T Consensus       330 ell~h  334 (373)
T 1q8y_A          330 GLVNH  334 (373)
T ss_dssp             HHHTC
T ss_pred             HHhhC
Confidence            99985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.3e-37  Score=324.50  Aligned_cols=245  Identities=19%  Similarity=0.261  Sum_probs=166.5

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe----CCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA----KEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|... +|+.||||++....    ....+....++.++||||+++++++..    ....++||||+++
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~g  110 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEG  110 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTT
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCC
Confidence            56999999999999965 79999999997532    222233344566799999999999976    4457999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccccCc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLNP  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~~  513 (670)
                      |+|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+|||++.   ++.+||+|||+++....
T Consensus       111 g~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~----~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          111 GELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSH----NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             EEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             CCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            99999998653   23589999999999999999999998    9999999999999976   45599999999987654


Q ss_pred             c--ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 V--QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 ~--~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      .  ....+++.|+|||++.+..++.++||||||+++|||++|+.||..........          ............  
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------~~~~~~~~~~~~--  251 (336)
T 3fhr_A          184 NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----------GMKRRIRLGQYG--  251 (336)
T ss_dssp             --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------C--
T ss_pred             cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----------hHHHhhhccccc--
Confidence            2  34456788999999988889999999999999999999999996542211000          000000000000  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                       +.  ........   ..+.+++.+||+.||++|||++|++++-
T Consensus       252 -~~--~~~~~~~~---~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          252 -FP--NPEWSEVS---EDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             -CC--TTTSTTCC---HHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             -cC--chhhccCC---HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence             00  00001112   2455677799999999999999999853

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=5.1e-37  Score=314.08  Aligned_cols=226  Identities=13%  Similarity=0.097  Sum_probs=177.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.||+|+||.||+|... +|+.||||++.....   ...+.+.+|+.++.+++||||+++++++.+.+..|+||||+++
T Consensus        36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g  115 (286)
T 3uqc_A           36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG  115 (286)
T ss_dssp             EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred             EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence            467999999999999965 589999999986532   2347889999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA  516 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  516 (670)
                      ++|.++++..       .......+++.|++.||+|||+.    +|+||||||+|||++.++.+||+++|          
T Consensus       116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~----givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRA----GVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHC----CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            9999999542       24456888999999999999998    99999999999999999999998543          


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCc---ccccccchhHHHHHHhhhccccccc
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVD---EEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                            |++|       ++.++|||||||++|||+||+.||...........   ........+.               
T Consensus       175 ------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------------  226 (286)
T 3uqc_A          175 ------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA---------------  226 (286)
T ss_dssp             ------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHH---------------
T ss_pred             ------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChh---------------
Confidence                  4443       68899999999999999999999987543321100   0000000000               


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                          .......+   .+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       227 ----~~~~~~~~---~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          227 ----DIDRDIPF---QISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             ----HHCTTSCH---HHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             ----hcccCCCH---HHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence                00011122   35567779999999999 99999999999986553

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3e-37  Score=318.34  Aligned_cols=242  Identities=21%  Similarity=0.322  Sum_probs=184.2

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe-------------CC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-------------KE  425 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-------------~~  425 (670)
                      +.+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|++++++++||||+++++++.+             ..
T Consensus        10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~   88 (303)
T 1zy4_A           10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS   88 (303)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEE
T ss_pred             hhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCC
Confidence            457899999999999996 47999999999643 2345778999999999999999999999865             34


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ..++||||+++|+|.+++....    ..+++..++.++.|+++||+|||+.    +|+||||||+||+++.++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~----~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           89 TLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQ----GIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             EEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhC----CeecccCCHHhEEEcCCCCEEEeeC
Confidence            6789999999999999998543    2478889999999999999999998    9999999999999999999999999


Q ss_pred             ccccccCcc------------------ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCC
Q 036639          506 GLSLLLNPV------------------QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPR  566 (670)
Q Consensus       506 G~a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~  566 (670)
                      |++......                  ....++..|+|||.+.+. .++.++|||||||++|||++   ||...      
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------  231 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------  231 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH------
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc------
Confidence            999876421                  223467789999998754 68999999999999999998   54311      


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                          .   ..............   .+.+..     .......+.+++.+||+.||++|||+.|++++
T Consensus       232 ----~---~~~~~~~~~~~~~~---~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          232 ----M---ERVNILKKLRSVSI---EFPPDF-----DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             ----H---HHHHHHHHHHSTTC---CCCTTC-----CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ----h---hHHHHHHhcccccc---ccCccc-----cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence                0   01111111111000   000000     01112345567779999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=325.37  Aligned_cols=235  Identities=24%  Similarity=0.396  Sum_probs=184.9

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcc------hHHHHHHHHHHHhcc----CCCCeeeEEEEEEeCCee
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPC------ARKEFEQYMDVIGKL----KHPNVVKLRAYYYAKEEK  427 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~nIv~l~~~~~~~~~~  427 (670)
                      .+.+.||+|+||.||+|.. .+++.||||++......      ....+.+|+.++.++    +||||+++++++.+.+..
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~  113 (312)
T 2iwi_A           34 RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGF  113 (312)
T ss_dssp             EEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----C
T ss_pred             EEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeE
Confidence            3457899999999999985 57899999999754321      223456788888888    899999999999999999


Q ss_pred             EEEEec-cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC-CCCcEEEEec
Q 036639          428 LLVYDY-LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDF  505 (670)
Q Consensus       428 ~lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DF  505 (670)
                      ++|+|| +++++|.+++....     .+++..++.++.|+++||+|||+.    +|+||||||+||+++ .++.+||+||
T Consensus       114 ~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~kl~df  184 (312)
T 2iwi_A          114 MLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSR----GVVHRDIKDENILIDLRRGCAKLIDF  184 (312)
T ss_dssp             EEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHH----TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeecCCChhhEEEeCCCCeEEEEEc
Confidence            999999 78999999998643     589999999999999999999998    999999999999999 8899999999


Q ss_pred             ccccccCcc--ccccccCcccCccccccCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          506 GLSLLLNPV--QAIARLGGYKAPEQAEVKRLS-QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       506 G~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~-~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      |+++.....  ....++..|+|||++.+..+. .++||||||+++|||++|+.||....                .    
T Consensus       185 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------------~----  244 (312)
T 2iwi_A          185 GSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------------E----  244 (312)
T ss_dssp             SSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------------H----
T ss_pred             chhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----------------H----
Confidence            999876542  344577889999998776664 58999999999999999999985320                0    


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .......   +      .....   ..+.+++.+||+.||++|||++|++++
T Consensus       245 ~~~~~~~---~------~~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 ILEAELH---F------PAHVS---PDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHHTCCC---C------CTTSC---HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HhhhccC---C------cccCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0010000   0      01111   235567779999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.1e-38  Score=327.98  Aligned_cols=234  Identities=21%  Similarity=0.383  Sum_probs=189.3

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcc------hHHHHHHHHHHHhccC--CCCeeeEEEEEEeCCeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPC------ARKEFEQYMDVIGKLK--HPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+.||+|+||.||+|.. .+++.||||++......      ..+.+.+|+.++++++  |+||+++++++.+.+..++|
T Consensus        47 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv  126 (320)
T 3a99_A           47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI  126 (320)
T ss_dssp             EEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEE
Confidence            346899999999999995 57899999999754211      2245678999999996  59999999999999999999


Q ss_pred             EeccCC-CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC-CCCcEEEEecccc
Q 036639          431 YDYLPN-GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLS  508 (670)
Q Consensus       431 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a  508 (670)
                      +||+.+ ++|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++ +++.+||+|||++
T Consensus       127 ~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          127 LERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             EECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999976 89999997643     589999999999999999999998    999999999999999 7899999999999


Q ss_pred             cccCcc--ccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          509 LLLNPV--QAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       509 ~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      +.....  ....++..|+|||++.+..+ +.++||||||+++|||+||+.||....                    ....
T Consensus       198 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------------------~~~~  257 (320)
T 3a99_A          198 ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------------EIIR  257 (320)
T ss_dssp             EECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------------HHHH
T ss_pred             cccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------------------hhhc
Confidence            876543  23457888999999877665 688999999999999999999985320                    0001


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...   .+.      ....   ..+.+++.+||+.||++|||++|++++
T Consensus       258 ~~~---~~~------~~~~---~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 GQV---FFR------QRVS---SECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CCC---CCS------SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccc---ccc------ccCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000   000      1112   235567779999999999999999885

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.3e-37  Score=330.16  Aligned_cols=239  Identities=22%  Similarity=0.291  Sum_probs=179.0

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.+....|+||||++ |+|
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L  104 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL  104 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence            467999999997766666799999999976432   2356799999999 79999999999999999999999995 699


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-----CCcEEEEecccccccCcc
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-----NGVACISDFGLSLLLNPV  514 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFG~a~~~~~~  514 (670)
                      .+++.....    ...+..+..++.|+++||+|||+.    +|+||||||+|||++.     ...+||+|||+++.....
T Consensus       105 ~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~----~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          105 QEYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSL----NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             HHHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHT----TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             HHHHHhcCC----CccchhHHHHHHHHHHHHHHHHHC----cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            999986542    234445678999999999999998    9999999999999953     235889999999876532


Q ss_pred             -------ccccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          515 -------QAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       515 -------~~~~~~~~y~aPE~~~---~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                             ....+|+.|+|||++.   ...++.++|||||||++|||+| |..||.....               ......
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------------~~~~~~  241 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------------RQANIL  241 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------------HHHHHH
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------------HHHHHH
Confidence                   2345788999999997   4567889999999999999999 8888853210               011111


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .. ........       ........+.+++.+||+.||++|||++||++|
T Consensus       242 ~~-~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          242 LG-ACSLDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TT-CCCCTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hc-cCCccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            11 10000000       011122335567789999999999999999964

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.1e-37  Score=318.10  Aligned_cols=246  Identities=22%  Similarity=0.316  Sum_probs=173.2

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcc-h-HHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPC-A-RKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~-~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ...+.||+|+||.||+|... +|+.||||++...... . .+.+.++..+++.++||||+++++++.+.+..++||||+ 
T Consensus        28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-  106 (318)
T 2dyl_A           28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-  106 (318)
T ss_dssp             EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred             cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence            34578999999999999965 7899999999754321 2 233445556778889999999999999999999999999 


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      ++.+..+.....    ..+++..+..++.|+++||+|||+.   .+|+||||||+||+++.++.+||+|||++...... 
T Consensus       107 ~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          107 GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEK---HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHH---HCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhh---CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            556665554322    2589999999999999999999983   18999999999999999999999999999766432 


Q ss_pred             --ccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 --QAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                        ....++..|+|||++.     ...++.++||||||+++|||++|+.||....             .....+.......
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------------~~~~~~~~~~~~~  246 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-------------TDFEVLTKVLQEE  246 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-------------SHHHHHHHHHHSC
T ss_pred             cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-------------ccHHHHHHHhccC
Confidence              2345778899999984     4568899999999999999999999996421             1111122222211


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...      ........   ..+.+++.+||+.||++|||++|++++
T Consensus       247 ~~~------~~~~~~~~---~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          247 PPL------LPGHMGFS---GDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCC------CCSSSCCC---HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCC------CCccCCCC---HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            100      00001112   235567779999999999999999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.8e-37  Score=350.87  Aligned_cols=235  Identities=19%  Similarity=0.270  Sum_probs=189.3

Q ss_pred             HHhHcCCCCceEEEEEEEc--CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCe-----eEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD--DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEE-----KLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~-----~~lv~  431 (670)
                      +.+.||+|+||+||+|...  +|+.||||++... .....+.+.+|++++++++||||+++++++...+.     .|+||
T Consensus        84 i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~  163 (681)
T 2pzi_A           84 VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVM  163 (681)
T ss_dssp             EEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred             EEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEE
Confidence            4568999999999999965  6899999998754 33455678999999999999999999999988765     69999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++++|.+++..       .+++..++.++.|+++||+|||+.    +|+||||||+|||++.+ .+||+|||+++..
T Consensus       164 E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~----giiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          164 EYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSI----GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             ECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             EeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC----CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence            99999999987753       489999999999999999999998    99999999999999885 8999999999988


Q ss_pred             CccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          512 NPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       512 ~~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      .......+|++|+|||++.+. ++.++|||||||++|||++|..||.......           ++        ..    
T Consensus       232 ~~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~--------~~----  287 (681)
T 2pzi_A          232 NSFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP--------ED----  287 (681)
T ss_dssp             TCCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC--------TT----
T ss_pred             ccCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------cc--------cc----
Confidence            777777889999999998755 4899999999999999999998876421100           00        00    


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHHHHhhh
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-MAEVAKMIEDIR  639 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~~L~~i~  639 (670)
                        .       ........+.+++.+||+.||++||+ ++++...|..+.
T Consensus       288 --~-------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          288 --D-------PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             --C-------HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             --c-------cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence              0       00011134566788999999999995 666766666654

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.5e-37  Score=342.43  Aligned_cols=196  Identities=28%  Similarity=0.393  Sum_probs=170.1

Q ss_pred             HHHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEe------CCeeEE
Q 036639          358 RASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA------KEEKLL  429 (670)
Q Consensus       358 ~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~------~~~~~l  429 (670)
                      |.+.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++..      .+..++
T Consensus        16 Y~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~L   95 (676)
T 3qa8_A           16 WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLL   95 (676)
T ss_dssp             -CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEE
Confidence            34567899999999999995 46899999999764 34456779999999999999999999998765      667799


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc---EEEEecc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV---ACISDFG  506 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFG  506 (670)
                      ||||+++|+|.+++.....  ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.++.   +||+|||
T Consensus        96 VmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~----gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           96 AMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHEN----RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             EEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHT----TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC----CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            9999999999999986542  23588889999999999999999998    9999999999999997765   9999999


Q ss_pred             cccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          507 LSLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       507 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                      ++......   ....++..|+|||.+.+..++.++|||||||++|||+||+.||..
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            99876543   234678889999999999999999999999999999999999964

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-36  Score=323.84  Aligned_cols=238  Identities=15%  Similarity=0.166  Sum_probs=173.2

Q ss_pred             HhHcCCCCceEEEEEE-EcCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCC-CCe----------e----------
Q 036639          361 AEMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKH-PNV----------V----------  415 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~nI----------v----------  415 (670)
                      .+.||+|+||+||+|. ..+|+.||||+++....   ...+.+.+|+.+++.++| +|.          +          
T Consensus        83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (413)
T 3dzo_A           83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK  162 (413)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred             ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence            3679999999999999 45799999999984322   235778999999999977 211          1          


Q ss_pred             -eEEEEEEe-----CCeeEEEEeccCCCChHHHhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCC
Q 036639          416 -KLRAYYYA-----KEEKLLVYDYLPNGSLHSLLHGNR--GPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNV  487 (670)
Q Consensus       416 -~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dl  487 (670)
                       .++.++..     ....+++|+++ +++|.++++...  ......+++..++.++.|+++||+|||+.    +|+||||
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----~iiHrDi  237 (413)
T 3dzo_A          163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY----GLVHTYL  237 (413)
T ss_dssp             --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT----TEECSCC
T ss_pred             CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCc
Confidence             11111111     12456777766 789999885210  00122578889999999999999999998    9999999


Q ss_pred             CCCCeEeCCCCcEEEEecccccccCccc-cccccCcccCcccc----------ccCCCCCchhHHHHHHHHHHHHcCCCC
Q 036639          488 KSSNVLLDKNGVACISDFGLSLLLNPVQ-AIARLGGYKAPEQA----------EVKRLSQKADVYSFGVLLLEVLTGRAP  556 (670)
Q Consensus       488 kp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~y~aPE~~----------~~~~~~~ksDVwS~Gvvl~elltg~~p  556 (670)
                      ||+|||++.++.+||+|||+++...... ...+ ..|+|||++          ....++.++|||||||++|||+||+.|
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P  316 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP  316 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred             ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999998765532 3445 889999998          556688999999999999999999999


Q ss_pred             CCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          557 SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       557 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      |.........                           ...+.......   ..+.+++.+||+.||++|||+.|++++
T Consensus       317 f~~~~~~~~~---------------------------~~~~~~~~~~~---~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          317 NTDDAALGGS---------------------------EWIFRSCKNIP---QPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             CCTTGGGSCS---------------------------GGGGSSCCCCC---HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCcchhhhH---------------------------HHHHhhcccCC---HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9754211100                           00000111122   245567779999999999998887654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-35  Score=305.67  Aligned_cols=226  Identities=17%  Similarity=0.269  Sum_probs=172.5

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHH-hccCCCCeeeEEEEEEe----CCeeEEEEeccC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVI-GKLKHPNVVKLRAYYYA----KEEKLLVYDYLP  435 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~  435 (670)
                      +.||+|+||.||+|.. .+++.||||+++.     ...+.+|++++ +.++||||+++++++..    ....++||||++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~   98 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   98 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence            5699999999999996 5789999999964     24567888887 55589999999999987    667899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccccC
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLN  512 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~  512 (670)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+||+++.   ++.+||+|||++....
T Consensus        99 ~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~----~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           99 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             SCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             CCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            999999998653   22589999999999999999999998    9999999999999998   7889999999986543


Q ss_pred             ccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          513 PVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       513 ~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                                        +..++.++|||||||++|||+||+.||................               ....
T Consensus       172 ------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~---------------~~~~  218 (299)
T 3m2w_A          172 ------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---------------RMGQ  218 (299)
T ss_dssp             ------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSS---------------CTTC
T ss_pred             ------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHH---------------hhcc
Confidence                              2457889999999999999999999996543221100000000               0000


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI  635 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  635 (670)
                      ...........   ...+.+++.+||+.||++|||+.|+++|-
T Consensus       219 ~~~~~~~~~~~---~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          219 YEFPNPEWSEV---SEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             CSSCHHHHTTS---CHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ccCCchhcccC---CHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            00000000111   13455677799999999999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-35  Score=311.46  Aligned_cols=190  Identities=17%  Similarity=0.147  Sum_probs=160.5

Q ss_pred             HHHHHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCC--------cchHHHHHHHHHHHhccC---------CCCeeeEE
Q 036639          356 LLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN--------PCARKEFEQYMDVIGKLK---------HPNVVKLR  418 (670)
Q Consensus       356 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~nIv~l~  418 (670)
                      -.|.+.+.||+|+||+||+|+. +|+.||||+++...        ....+.+.+|+++++.++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            3467788999999999999998 68999999997542        223478889999988885         88888888


Q ss_pred             EEEE------------------------------eCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHH
Q 036639          419 AYYY------------------------------AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAAR  468 (670)
Q Consensus       419 ~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  468 (670)
                      +++.                              +.+..|+||||+++|++.+.+...      .+++..+..++.|++.
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~------~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK------LSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT------CCCHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc------CCCHHHHHHHHHHHHH
Confidence            7753                              267889999999999777766432      4799999999999999


Q ss_pred             HHHHHH-HhCCCCCccccCCCCCCeEeCCCC--------------------cEEEEecccccccCccccccccCcccCcc
Q 036639          469 GLARIH-QEYGTAKVPHGNVKSSNVLLDKNG--------------------VACISDFGLSLLLNPVQAIARLGGYKAPE  527 (670)
Q Consensus       469 ~L~~LH-~~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~y~aPE  527 (670)
                      ||+||| +.    +|+||||||+|||++.++                    .+||+|||+++..... ...+|+.|+|||
T Consensus       173 aL~~lH~~~----~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE  247 (336)
T 2vuw_A          173 SLAVAEASL----RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHHHH----CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSG
T ss_pred             HHHHHHHhC----CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChh
Confidence            999999 88    999999999999999887                    8999999999877543 457888999999


Q ss_pred             ccccCCCCCchhHHHHHHH-HHHHHcCCCCCC
Q 036639          528 QAEVKRLSQKADVYSFGVL-LLEVLTGRAPSQ  558 (670)
Q Consensus       528 ~~~~~~~~~ksDVwS~Gvv-l~elltg~~p~~  558 (670)
                      ++.+.. +.++||||+|++ .+++++|..||.
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            998666 899999998777 778888998873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.2e-29  Score=282.93  Aligned_cols=181  Identities=15%  Similarity=0.038  Sum_probs=130.1

Q ss_pred             HcCCCCceEEEEEE-EcCCCEEEEEEeCCCC----------cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          363 MLGKGSLGTVYKAV-LDDGGIVAVKRLKDAN----------PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      ..+.|++|.+..++ .-.|+.||||++.+..          ....++|.+|+++|+++ .|+||+++++++++.+..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35667777777665 4468999999996531          12346799999999999 799999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||++|++|.++|....     +++..   +|+.||+.||+|+|++    |||||||||+|||++++|.+||+|||+|+.
T Consensus       321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~----GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQ----GFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHT----TCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHC----CceeccCchHhEEECCCCCEEEeecccCee
Confidence            99999999999998654     35543   5889999999999998    999999999999999999999999999987


Q ss_pred             cCcc----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 036639          511 LNPV----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP  556 (670)
Q Consensus       511 ~~~~----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p  556 (670)
                      ....    ....+|++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus       389 ~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            6542    23567889999999975 567889999999998887766544

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.95  E-value=3.1e-28  Score=252.33  Aligned_cols=184  Identities=30%  Similarity=0.575  Sum_probs=167.8

Q ss_pred             CCCcchHHHHHHHHhccCCCCCCCCCCCCCCCC-CCCcceEEecCCC--CcEEEEEcCCCCccc--cCCC-CCCCCCccE
Q 036639           20 SSHPNDTDALTLFRLQTDTHGNLLSNWKGADAC-AAAWTGVVCSPKS--ERVVSLSLPSHSLRG--PIAP-LSLLDQLRF   93 (670)
Q Consensus        20 ~~~~~~~~~l~~~~~~~~~~~~~l~~W~~~~~~-~~~w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~-~~~l~~L~~   93 (670)
                      .|.++|.+||+.||.++.+|. .+++|..+++| .|.|.||+|+..+  ++|+.|+|++|++.|  .+|. ++.+++|++
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~   80 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHhcCCcc-cccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence            467789999999999997665 78899765443 3449999998755  799999999999998  7766 999999999


Q ss_pred             EEccC-CCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccc
Q 036639           94 LDLHD-NRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNE  171 (670)
Q Consensus        94 L~L~~-N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  171 (670)
                      |+|++ |++.+.++. ++++++|++|+|++|.+++.+|..|+++++|++|+|++|+|++.+|..+.++++|++|+|++|+
T Consensus        81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~  160 (313)
T 1ogq_A           81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence            99995 999988765 9999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcCCCC-CCCEEEccCCCCcCCCcchh
Q 036639          172 LTGRIPDLSSSLK-DLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       172 l~g~~p~~~~~l~-~L~~l~l~~N~l~g~ip~~~  204 (670)
                      ++|.+|..+..++ +|+.|++++|+++|.+|..+
T Consensus       161 l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~  194 (313)
T 1ogq_A          161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF  194 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGG
T ss_pred             ccCcCCHHHhhhhhcCcEEECcCCeeeccCChHH
Confidence            9999999999998 99999999999999999877

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=4.1e-26  Score=252.97  Aligned_cols=177  Identities=16%  Similarity=0.197  Sum_probs=144.9

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc--------chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP--------CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      .+.||+|+||+||+|.. .++.+++|+......        ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            57899999999999954 478899998654221        113458999999999999999976666667888899999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+++++|.++++.             +..++.|+++||+|||+.    +|+||||||+|||++.  .+||+|||+++...
T Consensus       420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~----gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKN----DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHT----TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHC----cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            9999999999874             458999999999999998    9999999999999998  99999999999876


Q ss_pred             cc-----------ccccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHcCCCCC
Q 036639          513 PV-----------QAIARLGGYKAPEQAEV--KRLSQKADVYSFGVLLLEVLTGRAPS  557 (670)
Q Consensus       513 ~~-----------~~~~~~~~y~aPE~~~~--~~~~~ksDVwS~Gvvl~elltg~~p~  557 (670)
                      ..           ....+|+.|||||++..  ..|+.++|+|+..+-.++-+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            53           24567889999999976  56888999999999999988887766

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.91  E-value=5.2e-25  Score=255.95  Aligned_cols=178  Identities=26%  Similarity=0.370  Sum_probs=111.2

Q ss_pred             cCCCcchHHHHHHHHhccCCCCCCCCCCCCCCCCCCCcceEEecCCCCcEEEEEcCCCCcccc---CCC-CC--------
Q 036639           19 SSSHPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSHSLRGP---IAP-LS--------   86 (670)
Q Consensus        19 ~~~~~~~~~~l~~~~~~~~~~~~~l~~W~~~~~~~~~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~~-~~--------   86 (670)
                      +.+.++|.+||+.||+++.+|. .+++|+.+++| |+|.||+|+  .++|+.|+|+++++.|.   +++ ++        
T Consensus         7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~~~~~~-C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l   82 (768)
T 3rgz_A            7 SQSLYREIHQLISFKDVLPDKN-LLPDWSSNKNP-CTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL   82 (768)
T ss_dssp             -CCHHHHHHHHHHHHTTCSCTT-SSTTCCTTSCG-GGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred             ccCCHHHHHHHHHHHhhCCCcc-cccCCCCCCCC-cCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence            3445678999999999998787 89999865555 899999998  58999999999999986   433 44        


Q ss_pred             ---------------CCCCccEEEccCCCCccccC---CCccccccceeeccCCcccccCCccc-cCCCCCCEEeCCCCc
Q 036639           87 ---------------LLDQLRFLDLHDNRLNGTIL---PLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDNN  147 (670)
Q Consensus        87 ---------------~l~~L~~L~L~~N~l~~~~~---~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~L~l~~N~  147 (670)
                                     .+++|++|||++|.++|.++   .+++|++|++|+|++|.+++.+|..+ .++++|++|||++|+
T Consensus        83 ~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~  162 (768)
T 3rgz_A           83 FLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANS  162 (768)
T ss_dssp             ECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSC
T ss_pred             CCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCc
Confidence                           44555555555555554332   24455555555555555555444443 445555555555555


Q ss_pred             ccccCCCC---CcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcc
Q 036639          148 IRGRIPEQ---VTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       148 l~g~~p~~---~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~  202 (670)
                      +++.+|..   +.++++|++|+|++|++++.+|.  ..+++|++|+|++|++++.+|.
T Consensus       163 l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~  218 (768)
T 3rgz_A          163 ISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF  218 (768)
T ss_dssp             CEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB
T ss_pred             cCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc
Confidence            55444444   44555555555555555544442  4456666666666666655554

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.90  E-value=3.7e-25  Score=256.37  Aligned_cols=174  Identities=21%  Similarity=0.351  Sum_probs=137.4

Q ss_pred             CcchHHHHHHHHhccCCCCCCCCCCCCCC------CCCCCc------------ceEEecCCCCcEEEEEcCCCCccccCC
Q 036639           22 HPNDTDALTLFRLQTDTHGNLLSNWKGAD------ACAAAW------------TGVVCSPKSERVVSLSLPSHSLRGPIA   83 (670)
Q Consensus        22 ~~~~~~~l~~~~~~~~~~~~~l~~W~~~~------~~~~~w------------~gv~C~~~~~~v~~l~l~~~~l~~~~~   83 (670)
                      ...|.+||+.||.++++|     +|+.++      +|+|.|            .||+|+. .++|+.|+|++|+|.|.+|
T Consensus       267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip  340 (876)
T 4ecn_A          267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVP  340 (876)
T ss_dssp             HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEEC
T ss_pred             chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCc
Confidence            446999999999999766     786543      455999            9999986 5899999999999999988


Q ss_pred             C-CCCCCCccEEEc-cCCCCccc---------------------------------------------------------
Q 036639           84 P-LSLLDQLRFLDL-HDNRLNGT---------------------------------------------------------  104 (670)
Q Consensus        84 ~-~~~l~~L~~L~L-~~N~l~~~---------------------------------------------------------  104 (670)
                      + +++|++|++||| ++|.++|.                                                         
T Consensus       341 ~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~  420 (876)
T 4ecn_A          341 DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD  420 (876)
T ss_dssp             GGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred             hHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence            7 999999999999 88876654                                                         


Q ss_pred             -------------------cC-CCccccccceeeccCCcccc-----------------cCCcccc--CCCCCCEEeCCC
Q 036639          105 -------------------IL-PLTNCTNLKLAYLSGNDFSA-----------------EIPHQIS--SLKGILRLDLSD  145 (670)
Q Consensus       105 -------------------~~-~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~--~l~~L~~L~l~~  145 (670)
                                         +| .+++|++|+.|+|++|+|+|                 .+|..++  ++++|++|+|++
T Consensus       421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~  500 (876)
T 4ecn_A          421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN  500 (876)
T ss_dssp             CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred             cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence                               33 36777778888888888877                 3777776  788888888888


Q ss_pred             CcccccCCCCCcccccccceeccccc-ccc-cCCCCcCCC-------CCCCEEEccCCCCcCCCcc
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNE-LTG-RIPDLSSSL-------KDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~l-------~~L~~l~l~~N~l~g~ip~  202 (670)
                      |++.|.+|..|+++++|+.|+|++|+ |+| .+|..++.+       ++|+.|+|++|+|+ .+|.
T Consensus       501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~  565 (876)
T 4ecn_A          501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA  565 (876)
T ss_dssp             CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred             CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence            88777788777778888888888887 777 666544433       47777777777777 7776

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.89  E-value=2.1e-24  Score=245.20  Aligned_cols=177  Identities=20%  Similarity=0.292  Sum_probs=135.4

Q ss_pred             cchHHHHHHHHhccCCCCC--------CCCCCCCCCCCCCCc---ceEEecCCCCcEEEEEcCCCCccccCCC-CCCCCC
Q 036639           23 PNDTDALTLFRLQTDTHGN--------LLSNWKGADACAAAW---TGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLLDQ   90 (670)
Q Consensus        23 ~~~~~~l~~~~~~~~~~~~--------~l~~W~~~~~~~~~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~-~~~l~~   90 (670)
                      ..|.+||..++.+++++..        ...+|....+| |.|   .||+|+.. ++|+.|+|+++++.|.+|+ ++.|++
T Consensus        29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~-c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~  106 (636)
T 4eco_A           29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL-DMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE  106 (636)
T ss_dssp             HHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCG-GGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred             HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc-ccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence            3689999999999865432        23479865444 889   99999865 8999999999999999887 999999


Q ss_pred             ccEEEccCCCC---------------------------------------------------------------------
Q 036639           91 LRFLDLHDNRL---------------------------------------------------------------------  101 (670)
Q Consensus        91 L~~L~L~~N~l---------------------------------------------------------------------  101 (670)
                      |++|+|++|++                                                                     
T Consensus       107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l  186 (636)
T 4eco_A          107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT  186 (636)
T ss_dssp             CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred             ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence            99999999954                                                                     


Q ss_pred             ---------ccccCCCccccccceeeccCCccccc-----------------CCcccc--CCCCCCEEeCCCCcccccCC
Q 036639          102 ---------NGTILPLTNCTNLKLAYLSGNDFSAE-----------------IPHQIS--SLKGILRLDLSDNNIRGRIP  153 (670)
Q Consensus       102 ---------~~~~~~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~g~~p  153 (670)
                               +|.+..++++++|++|+|++|+|+|.                 +|..++  ++++|++|+|++|++.|.+|
T Consensus       187 ~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p  266 (636)
T 4eco_A          187 QIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLP  266 (636)
T ss_dssp             TTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCC
T ss_pred             hhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccCh
Confidence                     34223377777777777777777775                 777777  77777777777777777777


Q ss_pred             CCCcccccccceeccccc-ccc-cCCCCcCCC------CCCCEEEccCCCCcCCCcc
Q 036639          154 EQVTNLTRLLTLRLQNNE-LTG-RIPDLSSSL------KDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       154 ~~~~~l~~L~~L~l~~N~-l~g-~~p~~~~~l------~~L~~l~l~~N~l~g~ip~  202 (670)
                      ..|+++++|++|+|++|+ ++| .+|..++.+      ++|+.|++++|+++ .+|.
T Consensus       267 ~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~  322 (636)
T 4eco_A          267 TFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPV  322 (636)
T ss_dssp             TTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCC
T ss_pred             HHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCc
Confidence            777777777777777777 777 666665554      67777777777776 6665

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.87  E-value=7.2e-23  Score=237.93  Aligned_cols=163  Identities=40%  Similarity=0.637  Sum_probs=141.3

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-------------------------------------
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-------------------------------------  107 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-------------------------------------  107 (670)
                      ..+..|+|++|.+.|.+|. ++.+++|+.|+|++|.++|.+|.                                     
T Consensus       514 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (768)
T 3rgz_A          514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNL  593 (768)
T ss_dssp             TTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEE
T ss_pred             CCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccc
Confidence            3577777777777777766 77788888888888887765542                                     


Q ss_pred             ----------------------------------CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCC
Q 036639          108 ----------------------------------LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP  153 (670)
Q Consensus       108 ----------------------------------~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p  153 (670)
                                                        +.++++|+.|||++|+|+|.+|..|+++++|+.|+|++|+|+|.+|
T Consensus       594 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip  673 (768)
T 3rgz_A          594 LEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP  673 (768)
T ss_dssp             EECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCC
T ss_pred             cccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCC
Confidence                                              3345778999999999999999999999999999999999999999


Q ss_pred             CCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcch-hhhhcCcccccccCCCcCCCCCCCCC
Q 036639          154 EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG-LLKKFGEQSFIGNEGLCGSSPLPACS  229 (670)
Q Consensus       154 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~-~~~~~~~~~~~~n~~~c~~~~~~~~~  229 (670)
                      ..|+++++|+.|||++|+++|.+|..+..+++|++|||++|+|+|.||.. .+..+...+|.||+++|| .|++.|.
T Consensus       674 ~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg-~~l~~C~  749 (768)
T 3rgz_A          674 DEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG-YPLPRCD  749 (768)
T ss_dssp             GGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEES-TTSCCCC
T ss_pred             hHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcC-CCCcCCC
Confidence            99999999999999999999999999999999999999999999999964 467888889999999999 4566675

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=3.6e-23  Score=210.29  Aligned_cols=140  Identities=19%  Similarity=0.216  Sum_probs=114.0

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc------------------chHHHHHHHHHHHhccCCCCeeeEEEEEE
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP------------------CARKEFEQYMDVIGKLKHPNVVKLRAYYY  422 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~nIv~l~~~~~  422 (670)
                      .+.||+|+||.||+|...+|+.||||+++....                  .....+.+|++++++++|   +++.+++.
T Consensus        95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~~~  171 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKVYA  171 (282)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCEEE
T ss_pred             cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeEEe
Confidence            378999999999999997799999999974321                  135678999999999984   55555443


Q ss_pred             eCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEE
Q 036639          423 AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACI  502 (670)
Q Consensus       423 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl  502 (670)
                      . +..++||||+++++|.+ +...           ....++.|+++||+|||+.    +|+||||||+|||++ ++.+||
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~~~-----------~~~~i~~qi~~~l~~lH~~----giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VRVE-----------NPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CCCS-----------CHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEE-TTEEEE
T ss_pred             c-cceEEEEEecCCCcHHH-cchh-----------hHHHHHHHHHHHHHHHHHC----CCEeCCCCHHHEEEE-CCcEEE
Confidence            3 55699999999999998 4321           2346999999999999998    999999999999999 999999


Q ss_pred             EecccccccCccccccccCcccCccccc
Q 036639          503 SDFGLSLLLNPVQAIARLGGYKAPEQAE  530 (670)
Q Consensus       503 ~DFG~a~~~~~~~~~~~~~~y~aPE~~~  530 (670)
                      +|||+++..         ..|+|||++.
T Consensus       234 ~DFG~a~~~---------~~~~a~e~l~  252 (282)
T 1zar_A          234 IDFPQSVEV---------GEEGWREILE  252 (282)
T ss_dssp             CCCTTCEET---------TSTTHHHHHH
T ss_pred             EECCCCeEC---------CCCCHHHHHH
Confidence            999999743         3478899875

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.87  E-value=3.4e-23  Score=215.75  Aligned_cols=196  Identities=20%  Similarity=0.272  Sum_probs=164.0

Q ss_pred             cCCCcchHHHHHHHHhcc-CCCCCCCCCCC---CCCCCCCCcceEEecC--------CCCcEEEEEcCCCCccccCCCCC
Q 036639           19 SSSHPNDTDALTLFRLQT-DTHGNLLSNWK---GADACAAAWTGVVCSP--------KSERVVSLSLPSHSLRGPIAPLS   86 (670)
Q Consensus        19 ~~~~~~~~~~l~~~~~~~-~~~~~~l~~W~---~~~~~~~~w~gv~C~~--------~~~~v~~l~l~~~~l~~~~~~~~   86 (670)
                      ..+..++.++|+.||..+ .++.+.+.+|.   .....+|.|.|+.|..        ...+|+.|+|++|++...++.++
T Consensus        22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~~lp~~l~  101 (328)
T 4fcg_A           22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAF  101 (328)
T ss_dssp             -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCSSCCSCGG
T ss_pred             cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCchhcChhhh
Confidence            345668999999999987 45667788994   3344557899999952        34689999999999996555588


Q ss_pred             CCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcc--------
Q 036639           87 LLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTN--------  158 (670)
Q Consensus        87 ~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~--------  158 (670)
                      .+++|++|+|++|+|+..+..++++++|++|+|++|.++ .+|..|+++++|++|+|++|++.+.+|..+..        
T Consensus       102 ~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~  180 (328)
T 4fcg_A          102 RLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ  180 (328)
T ss_dssp             GGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred             hCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence            999999999999999954455999999999999999999 88999999999999999999999999998875        


Q ss_pred             -cccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh--hhcCcccccccC
Q 036639          159 -LTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL--KKFGEQSFIGNE  217 (670)
Q Consensus       159 -l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~~~n~  217 (670)
                       +++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++ +|..+.  ..+....+.+|.
T Consensus       181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~  240 (328)
T 4fcg_A          181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT  240 (328)
T ss_dssp             ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCT
T ss_pred             cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCc
Confidence             999999999999999 899999999999999999999995 666552  234444555554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.85  E-value=3.4e-21  Score=188.49  Aligned_cols=154  Identities=21%  Similarity=0.261  Sum_probs=130.4

Q ss_pred             CCCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC--CCCCCCccEEEccCCCCccccC-CCccccccce
Q 036639           49 ADACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKL  116 (670)
Q Consensus        49 ~~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~  116 (670)
                      ++.|.|.|..+.|+..         ...++.|+|++|.|++..+.  +..+++|++|+|++|+|++..+ .|.++++|+.
T Consensus         6 P~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~   85 (220)
T 2v70_A            6 PEKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE   85 (220)
T ss_dssp             CTTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             CCCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence            4567788999999753         13467889999999887654  7888999999999999988776 4888999999


Q ss_pred             eeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCC
Q 036639          117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       117 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      |+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|.+
T Consensus        86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  165 (220)
T 2v70_A           86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF  165 (220)
T ss_dssp             EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred             EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence            99999999888888888999999999999999988888899999999999999999988888888899999999999998


Q ss_pred             cCCCcc
Q 036639          197 YGRVPE  202 (670)
Q Consensus       197 ~g~ip~  202 (670)
                      ++..+-
T Consensus       166 ~c~c~l  171 (220)
T 2v70_A          166 NCNCYL  171 (220)
T ss_dssp             ECSGGG
T ss_pred             cCCCch
Confidence            877663

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.84  E-value=1e-20  Score=183.47  Aligned_cols=153  Identities=24%  Similarity=0.265  Sum_probs=133.1

Q ss_pred             CCCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Ccccccccee
Q 036639           49 ADACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLA  117 (670)
Q Consensus        49 ~~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L  117 (670)
                      ++.|.|.|.+|.|+..         ..+++.|+|++|++.+..+. +..+++|++|+|++|+|++.++. +.++++|++|
T Consensus         2 p~~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L   81 (208)
T 2o6s_A            2 PSRCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL   81 (208)
T ss_dssp             CTTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEE
Confidence            3568899999999753         23688999999999986665 78999999999999999977655 7899999999


Q ss_pred             eccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          118 YLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       118 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +|++|++++..+..|.++++|++|+|++|+|++..+..+.++++|++|+|++|++++..+..+..+++|+.|++++|.++
T Consensus        82 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  161 (208)
T 2o6s_A           82 NLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD  161 (208)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred             ECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence            99999999777777899999999999999999777777899999999999999999777777888999999999999999


Q ss_pred             CCCc
Q 036639          198 GRVP  201 (670)
Q Consensus       198 g~ip  201 (670)
                      +..|
T Consensus       162 ~~~~  165 (208)
T 2o6s_A          162 CTCP  165 (208)
T ss_dssp             CCTT
T ss_pred             cCCC
Confidence            8777

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.84  E-value=1.6e-20  Score=187.86  Aligned_cols=156  Identities=24%  Similarity=0.278  Sum_probs=137.1

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ..++.|+|++|++.+..+. +..+++|++|+|++|+|++..+. +.++++|+.|+|++|+|++..+..|.++++|++|+|
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            3588999999999997775 89999999999999999998765 899999999999999999888888999999999999


Q ss_pred             CCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCcC
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLCG  221 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c~  221 (670)
                      ++|+|++..+..+.++++|++|+|++|+|++..+..+..+++|+.|+|++|+|++..|..+  +..+....+.+|++.|.
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            9999997777778999999999999999997777789999999999999999996555444  23455667789998887

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.83  E-value=1.9e-20  Score=184.37  Aligned_cols=151  Identities=21%  Similarity=0.222  Sum_probs=127.4

Q ss_pred             CCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cccccccceee
Q 036639           50 DACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAY  118 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~  118 (670)
                      ..|.|+|.+|.|+..         ...++.|+|++|.+.+..+. +..+++|++|+|++|+|+...+. |.++++|+.|+
T Consensus        15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~   94 (229)
T 3e6j_A           15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD   94 (229)
T ss_dssp             TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence            345689999999853         24688899999999987665 88899999999999999776654 78899999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcC
Q 036639          119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       119 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      |++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..+..+++|+.|+|++|.+++
T Consensus        95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  173 (229)
T 3e6j_A           95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC  173 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred             CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence            9999999777777888999999999999998 788888999999999999999997666778888999999999999887


Q ss_pred             CCc
Q 036639          199 RVP  201 (670)
Q Consensus       199 ~ip  201 (670)
                      ..+
T Consensus       174 ~c~  176 (229)
T 3e6j_A          174 ECR  176 (229)
T ss_dssp             TBG
T ss_pred             Ccc
Confidence            665

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=1.8e-20  Score=183.27  Aligned_cols=160  Identities=21%  Similarity=0.240  Sum_probs=87.1

Q ss_pred             CCCCCCCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC-CCccccccceeeccCCccccc
Q 036639           49 ADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAE  127 (670)
Q Consensus        49 ~~~~~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~  127 (670)
                      +..|.|.|..|.|+.            ++++..+..+.  ++|+.|+|++|+|++..+ .|.++++|+.|+|++|++++.
T Consensus         6 P~~C~C~~~~v~c~~------------~~l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~   71 (220)
T 2v9t_B            6 PAACTCSNNIVDCRG------------KGLTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL   71 (220)
T ss_dssp             CTTSEEETTEEECTT------------SCCSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE
T ss_pred             CCCCEECCCEEEcCC------------CCcCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc
Confidence            345667787777764            33333222222  455666666666655543 355556666666666666655


Q ss_pred             CCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--h
Q 036639          128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--L  205 (670)
Q Consensus       128 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~  205 (670)
                      .|..|.++++|++|+|++|+|+...+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+  +
T Consensus        72 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  151 (220)
T 2v9t_B           72 APDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL  151 (220)
T ss_dssp             CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             CHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCC
Confidence            55556666666666666666653333344556666666666666665555555556666666666666653333222  1


Q ss_pred             hhcCcccccccCCCcCC
Q 036639          206 KKFGEQSFIGNEGLCGS  222 (670)
Q Consensus       206 ~~~~~~~~~~n~~~c~~  222 (670)
                      ..+....+.+|++.|+|
T Consensus       152 ~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B          152 RAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             TTCCEEECCSSCEECSG
T ss_pred             CCCCEEEeCCCCcCCCC
Confidence            22333445556655553

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.83  E-value=3.4e-20  Score=177.29  Aligned_cols=149  Identities=21%  Similarity=0.268  Sum_probs=125.8

Q ss_pred             EEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC--CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcc
Q 036639           71 LSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNI  148 (670)
Q Consensus        71 l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l  148 (670)
                      |++++|+|+..+..+.  .+|++|+|++|+|++..+.  +.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus        13 l~~s~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l   90 (192)
T 1w8a_A           13 VDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI   90 (192)
T ss_dssp             EECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred             EEcCCCCcCcCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcC
Confidence            4445566755443343  3999999999999988864  89999999999999999999999999999999999999999


Q ss_pred             cccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh-hhcCcccccccCCCcC
Q 036639          149 RGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL-KKFGEQSFIGNEGLCG  221 (670)
Q Consensus       149 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~-~~~~~~~~~~n~~~c~  221 (670)
                      ++..|..|.++++|++|+|++|+|++.+|..+..+++|++|+|++|.|++..+-..+ ..+....+.++...|+
T Consensus        91 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~  164 (192)
T 1w8a_A           91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG  164 (192)
T ss_dssp             CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred             CccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence            999998999999999999999999999999999999999999999999998884432 2333334555655665

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.82  E-value=6.9e-21  Score=196.95  Aligned_cols=161  Identities=32%  Similarity=0.522  Sum_probs=108.9

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Ccccc-ccceeeccCCcccccCC-------------
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCT-NLKLAYLSGNDFSAEIP-------------  129 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~-~L~~L~l~~N~l~g~~p-------------  129 (670)
                      ..++.|+|++|.+.+.+|. ++.+++|++|+|++|+|++.++. +.+++ +|+.|+|++|+++|.+|             
T Consensus       125 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~L  204 (313)
T 1ogq_A          125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL  204 (313)
T ss_dssp             TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEEC
T ss_pred             CCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEEC
Confidence            3566777777777765554 66677777777777777655543 55555 55666655555555544             


Q ss_pred             ----------ccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCC
Q 036639          130 ----------HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       130 ----------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                                ..|.++++|+.|+|++|++++.+|. +..+++|++|+|++|+|+|.+|..+..+++|+.|+|++|+|+|.
T Consensus       205 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~  283 (313)
T 1ogq_A          205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE  283 (313)
T ss_dssp             CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred             cCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccccc
Confidence                      4455555566666666666554444 56677777788888888888888888888888888888888888


Q ss_pred             Ccchh-hhhcCcccccccCCCcCCCCCCCC
Q 036639          200 VPEGL-LKKFGEQSFIGNEGLCGSSPLPAC  228 (670)
Q Consensus       200 ip~~~-~~~~~~~~~~~n~~~c~~~~~~~~  228 (670)
                      +|..- +..+....+.+|+++|| .|.+.|
T Consensus       284 ip~~~~l~~L~~l~l~~N~~lc~-~p~~~C  312 (313)
T 1ogq_A          284 IPQGGNLQRFDVSAYANNKCLCG-SPLPAC  312 (313)
T ss_dssp             CCCSTTGGGSCGGGTCSSSEEES-TTSSCC
T ss_pred             CCCCccccccChHHhcCCCCccC-CCCCCC
Confidence            88642 35566677888999998 355555

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=2.4e-20  Score=197.01  Aligned_cols=174  Identities=25%  Similarity=0.245  Sum_probs=147.5

Q ss_pred             CCCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CC-CCCCccEEEccCCCCccccCC-Cccccccce
Q 036639           49 ADACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LS-LLDQLRFLDLHDNRLNGTILP-LTNCTNLKL  116 (670)
Q Consensus        49 ~~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~-~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~  116 (670)
                      +..|.|.+..|.|...         ...++.|+|++|.|++..+. +. .+++|+.|+|++|+|++..+. |.++++|+.
T Consensus        13 p~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~   92 (361)
T 2xot_A           13 PANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY   92 (361)
T ss_dssp             CTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             CCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCE
Confidence            3457788999999753         23578899999999998776 65 999999999999999998764 999999999


Q ss_pred             eeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCc---CCCCCCCEEEccC
Q 036639          117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS---SSLKDLKELNLSN  193 (670)
Q Consensus       117 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~---~~l~~L~~l~l~~  193 (670)
                      |+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+   ..+++|+.|+|++
T Consensus        93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~  172 (361)
T 2xot_A           93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS  172 (361)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCS
T ss_pred             EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCC
Confidence            9999999998888889999999999999999999889999999999999999999996444444   5799999999999


Q ss_pred             CCCcCCCcchhhhhc-----CcccccccCCCcCCC
Q 036639          194 NELYGRVPEGLLKKF-----GEQSFIGNEGLCGSS  223 (670)
Q Consensus       194 N~l~g~ip~~~~~~~-----~~~~~~~n~~~c~~~  223 (670)
                      |+|+ .+|...+..+     ....+.+|++.|+|.
T Consensus       173 N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~  206 (361)
T 2xot_A          173 NKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDCK  206 (361)
T ss_dssp             SCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred             CCCC-ccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence            9999 5665444444     345778999999874

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=7.4e-20  Score=178.99  Aligned_cols=164  Identities=18%  Similarity=0.218  Sum_probs=141.2

Q ss_pred             CCCCCCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC--CccccccceeeccCCccccc
Q 036639           50 DACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAE  127 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~l~~N~l~g~  127 (670)
                      ..||   .+-+|..     ..+++++|.++..+..+  ...++.|+|++|+|++.++.  |.++++|+.|+|++|.|++.
T Consensus         3 ~~CP---~~C~C~~-----~~l~~s~n~l~~iP~~~--~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i   72 (220)
T 2v70_A            3 LACP---EKCRCEG-----TTVDCSNQKLNKIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDI   72 (220)
T ss_dssp             -CCC---TTCEEET-----TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEE
T ss_pred             CCCC---CCCEECC-----CEeEeCCCCcccCccCC--CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEE
Confidence            4565   5567764     37999999999855444  34578999999999998654  89999999999999999998


Q ss_pred             CCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--h
Q 036639          128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--L  205 (670)
Q Consensus       128 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~  205 (670)
                      .|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|+|++..|..+  +
T Consensus        73 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  152 (220)
T 2v70_A           73 EEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTL  152 (220)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTC
T ss_pred             CHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCC
Confidence            88899999999999999999998888889999999999999999999999999999999999999999998778766  3


Q ss_pred             hhcCcccccccCCCcCCC
Q 036639          206 KKFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       206 ~~~~~~~~~~n~~~c~~~  223 (670)
                      ..+....+.+|++.|.|.
T Consensus       153 ~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          153 HSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             TTCCEEECCSCCEECSGG
T ss_pred             CCCCEEEecCcCCcCCCc
Confidence            355567788999999864

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.79  E-value=5.2e-19  Score=180.63  Aligned_cols=156  Identities=27%  Similarity=0.309  Sum_probs=111.8

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .+++.|+|++|.+++..+ .+.+++|++|+|++|+|+..+..+.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus        55 ~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~  133 (290)
T 1p9a_G           55 TRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG  133 (290)
T ss_dssp             TTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTT
T ss_pred             CCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCC
Confidence            345556666666555322 3566667777777777765544577778888888888888876667788888888888888


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhh--cCcccccccCCCcCCC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK--FGEQSFIGNEGLCGSS  223 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~--~~~~~~~~n~~~c~~~  223 (670)
                      |+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|..++..  +....+.+|+|.|.|.
T Consensus       134 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~  212 (290)
T 1p9a_G          134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE  212 (290)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             CCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence            8888666666778888888888888888555556677888888888888887 777766443  3445567888888863

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.79  E-value=6.6e-19  Score=178.26  Aligned_cols=158  Identities=25%  Similarity=0.245  Sum_probs=138.1

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      ..++.|+|++|.+.+ ++.++.+++|++|+|++|+|++.++. +.++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus        63 ~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  141 (272)
T 3rfs_A           63 PNVRYLALGGNKLHD-ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA  141 (272)
T ss_dssp             TTCCEEECTTSCCCC-CGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCcEEECCCCCCCC-chhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECC
Confidence            578999999999988 45789999999999999999987765 7999999999999999998888889999999999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCcCC
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLCGS  222 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c~~  222 (670)
                      +|+|++..|..+.++++|+.|+|++|++++..|..+..+++|+.|++++|+|++..|..+  +..+....+.+|++.|.|
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  221 (272)
T 3rfs_A          142 HNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  221 (272)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             CCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence            999998777778999999999999999998878888999999999999999997666443  345566677899988886


Q ss_pred             CC
Q 036639          223 SP  224 (670)
Q Consensus       223 ~~  224 (670)
                      ..
T Consensus       222 ~~  223 (272)
T 3rfs_A          222 PG  223 (272)
T ss_dssp             TT
T ss_pred             cH
Confidence            53

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.78  E-value=1.4e-18  Score=175.54  Aligned_cols=144  Identities=29%  Similarity=0.348  Sum_probs=103.3

Q ss_pred             CcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCc
Q 036639           55 AWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGND  123 (670)
Q Consensus        55 ~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~  123 (670)
                      .|..|.|+..         ...++.|+|++|++.+..+. +..+++|++|+|++|+|+...+. +.++++|++|+|++|.
T Consensus        17 ~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~   96 (270)
T 2o6q_A           17 NKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK   96 (270)
T ss_dssp             TTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSC
T ss_pred             CCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCc
Confidence            4666777632         23578899999998876654 88888888888888888766544 5777788888888888


Q ss_pred             ccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcC
Q 036639          124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       124 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      +++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|++++
T Consensus        97 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  171 (270)
T 2o6q_A           97 LQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKR  171 (270)
T ss_dssp             CCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcE
Confidence            776666666777777777777777776666666777777777777777765555556666667777777666664

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.77  E-value=1.9e-18  Score=162.87  Aligned_cols=138  Identities=21%  Similarity=0.252  Sum_probs=119.0

Q ss_pred             CCCCCCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccC
Q 036639           50 DACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEI  128 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~  128 (670)
                      +.|.|+|.+|.|+.            ++++..+.  ...++|+.|+|++|+|++.++. +.++++|++|+|++|+|++..
T Consensus         3 ~~C~C~~~~l~~~~------------~~l~~~p~--~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~   68 (177)
T 2o6r_A            3 SRCSCSGTEIRCNS------------KGLTSVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP   68 (177)
T ss_dssp             TTCEEETTEEECCS------------SCCSSCCT--TCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred             CCCEeCCCEEEecC------------CCCccCCC--CCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeC
Confidence            56778899999875            34444322  3347999999999999987765 799999999999999999877


Q ss_pred             CccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          129 PHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       129 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      +..|.++++|++|+|++|+|++..+..+.++++|++|+|++|+|++..+..+..+++|+.|++++|.+++..|
T Consensus        69 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           69 DGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             hhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            7778999999999999999998777788999999999999999997666668889999999999999998877

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.77  E-value=2.7e-18  Score=168.95  Aligned_cols=159  Identities=25%  Similarity=0.304  Sum_probs=135.1

Q ss_pred             cceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccC
Q 036639           56 WTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISS  134 (670)
Q Consensus        56 w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~  134 (670)
                      |..-.|+.     +.++.+++++...+..+.  ++|++|+|++|+|++..+. +.++++|+.|+|++|+|++..+..|.+
T Consensus        14 ~~~~~Cs~-----~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~   86 (229)
T 3e6j_A           14 PSQCSCSG-----TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDS   86 (229)
T ss_dssp             CTTCEEET-----TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CCCCEEeC-----CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhccc
Confidence            55667874     358889999887655443  8999999999999998754 899999999999999998766677899


Q ss_pred             CCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcc
Q 036639          135 LKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQ  211 (670)
Q Consensus       135 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~  211 (670)
                      +++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|...+.   .+...
T Consensus        87 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L  164 (229)
T 3e6j_A           87 LTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHA  164 (229)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCC-CCTTTTTTCTTCCEE
T ss_pred             CCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCc-cCHHHHhCCCCCCEE
Confidence            999999999999999777777899999999999999999 889999999999999999999994 5544333   45556


Q ss_pred             cccccCCCcCCC
Q 036639          212 SFIGNEGLCGSS  223 (670)
Q Consensus       212 ~~~~n~~~c~~~  223 (670)
                      .+.+|++.|.|.
T Consensus       165 ~l~~N~~~c~c~  176 (229)
T 3e6j_A          165 YLFGNPWDCECR  176 (229)
T ss_dssp             ECTTSCBCTTBG
T ss_pred             EeeCCCccCCcc
Confidence            778999999863

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.77  E-value=1.3e-18  Score=173.80  Aligned_cols=159  Identities=22%  Similarity=0.227  Sum_probs=134.4

Q ss_pred             CCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccc
Q 036639           54 AAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQI  132 (670)
Q Consensus        54 ~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~  132 (670)
                      |.|.|++|..   ....+++++++++..++.+.  +.|+.|+|++|+|++..+. +.++++|++|+|++|.|++..|..|
T Consensus         5 p~~~gC~C~~---~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~   79 (251)
T 3m19_A            5 ETVTGCTCNE---GKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVF   79 (251)
T ss_dssp             HHHHSSEEEG---GGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             CCCCceEcCC---CCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHh
Confidence            5799999964   24568999999997665554  6999999999999998764 9999999999999999999888889


Q ss_pred             cCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCc
Q 036639          133 SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGE  210 (670)
Q Consensus       133 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~  210 (670)
                      .++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|+|++..|..+  +..+..
T Consensus        80 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  159 (251)
T 3m19_A           80 DDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQT  159 (251)
T ss_dssp             TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             ccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCE
Confidence            999999999999999998877889999999999999999997777778999999999999999995444333  233444


Q ss_pred             ccccccC
Q 036639          211 QSFIGNE  217 (670)
Q Consensus       211 ~~~~~n~  217 (670)
                      ..+.+|.
T Consensus       160 L~L~~N~  166 (251)
T 3m19_A          160 LSLSTNQ  166 (251)
T ss_dssp             EECCSSC
T ss_pred             EECCCCc
Confidence            4555553

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.76  E-value=2.8e-18  Score=186.93  Aligned_cols=174  Identities=22%  Similarity=0.278  Sum_probs=112.0

Q ss_pred             CCCCCCC--cceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cccccccc
Q 036639           49 ADACAAA--WTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLK  115 (670)
Q Consensus        49 ~~~~~~~--w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~  115 (670)
                      +..|.|.  |..|.|...         ...++.|+|++|++++..+. |..+++|+.|+|++|+|++..+. |.++++|+
T Consensus        47 p~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~  126 (452)
T 3zyi_A           47 PSVCSCSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN  126 (452)
T ss_dssp             CTTSEECSSSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             CCCCEECCCCcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCC
Confidence            4456564  578889753         23678888888888876655 77777777777777777766533 66666666


Q ss_pred             eeeccCCcccccCCccccCCCCCCEEeCCCCccc----------------------------------------------
Q 036639          116 LAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR----------------------------------------------  149 (670)
Q Consensus       116 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~----------------------------------------------  149 (670)
                      .|+|++|+|++..+..|.++++|++|+|++|+|+                                              
T Consensus       127 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n  206 (452)
T 3zyi_A          127 TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC  206 (452)
T ss_dssp             EEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTS
T ss_pred             EEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCC
Confidence            6666666666544444554555555544444443                                              


Q ss_pred             -------------------------ccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          150 -------------------------GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       150 -------------------------g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                                               +..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|+ .+|...
T Consensus       207 ~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~  285 (452)
T 3zyi_A          207 NIKDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL  285 (452)
T ss_dssp             CCSSCCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-CCCTTS
T ss_pred             cccccccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC-ccChHH
Confidence                                     333344455555566666666666656666777788888888888887 444443


Q ss_pred             h---hhcCcccccccCCCcCCC
Q 036639          205 L---KKFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       205 ~---~~~~~~~~~~n~~~c~~~  223 (670)
                      +   ..+....+.+|++.|+|.
T Consensus       286 ~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          286 FTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             STTCTTCCEEECCSSCEECSTT
T ss_pred             hccccCCCEEEccCCCcCCCCC
Confidence            3   344556778999999985

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.76  E-value=3.4e-18  Score=185.55  Aligned_cols=173  Identities=21%  Similarity=0.304  Sum_probs=100.3

Q ss_pred             CCCCCC--cceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccce
Q 036639           50 DACAAA--WTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKL  116 (670)
Q Consensus        50 ~~~~~~--w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~  116 (670)
                      ..|.|.  |..|.|...         ...++.|+|++|++.+..+. |..+++|++|+|++|+|++..+ .|.++++|+.
T Consensus        37 ~~C~C~~~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~  116 (440)
T 3zyj_A           37 SVCSCSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNT  116 (440)
T ss_dssp             SSSEECTTSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCE
T ss_pred             CCCEeCCCCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCE
Confidence            345554  668888742         23466677777777765543 5666666666666666554432 2444444444


Q ss_pred             eeccCCcccccCCccccCCCC-----------------------------------------------------------
Q 036639          117 AYLSGNDFSAEIPHQISSLKG-----------------------------------------------------------  137 (670)
Q Consensus       117 L~l~~N~l~g~~p~~~~~l~~-----------------------------------------------------------  137 (670)
                      |+|++|+|++..+..|.++++                                                           
T Consensus       117 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~  196 (440)
T 3zyj_A          117 LELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN  196 (440)
T ss_dssp             EECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSC
T ss_pred             EECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCc
Confidence            444444444332223333333                                                           


Q ss_pred             ------------CCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh
Q 036639          138 ------------ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL  205 (670)
Q Consensus       138 ------------L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~  205 (670)
                                  |+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|...+
T Consensus       197 l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~  275 (440)
T 3zyj_A          197 LREIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLF  275 (440)
T ss_dssp             CSSCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC-CCCTTTT
T ss_pred             CccccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC-ccChhHh
Confidence                        333333334444444555555666666666666666666666777788888888888888 4454433


Q ss_pred             ---hhcCcccccccCCCcCCC
Q 036639          206 ---KKFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       206 ---~~~~~~~~~~n~~~c~~~  223 (670)
                         ..+....+.+|++.|+|.
T Consensus       276 ~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          276 TPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             SSCTTCCEEECCSSCEECSST
T ss_pred             ccccCCCEEEcCCCCccCCCC
Confidence               345556778999999985

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.76  E-value=3.3e-18  Score=174.36  Aligned_cols=158  Identities=23%  Similarity=0.221  Sum_probs=106.4

Q ss_pred             CcEEEEEcCCCC-ccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEe
Q 036639           66 ERVVSLSLPSHS-LRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD  142 (670)
Q Consensus        66 ~~v~~l~l~~~~-l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~  142 (670)
                      ..+..|+|++|. +....+. +..+++|++|+|++|++++..+. +.++++|++|+|++|.+++..+..|+++++|++|+
T Consensus        80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  159 (285)
T 1ozn_A           80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF  159 (285)
T ss_dssp             TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence            356666666665 5444333 66667777777777777665443 66777777777777777765556677777777777


Q ss_pred             CCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCc
Q 036639          143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLC  220 (670)
Q Consensus       143 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c  220 (670)
                      |++|+|++..+..+.++++|+.|+|++|++++..|..+..+++|+.|++++|++++..|..+  +..+....+.+|++.|
T Consensus       160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence            77777775555567777777777777777777777777777778888888887775433333  2334455667787777


Q ss_pred             CCC
Q 036639          221 GSS  223 (670)
Q Consensus       221 ~~~  223 (670)
                      +|.
T Consensus       240 ~~~  242 (285)
T 1ozn_A          240 DCR  242 (285)
T ss_dssp             SGG
T ss_pred             CCC
Confidence            653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=9.3e-19  Score=175.53  Aligned_cols=134  Identities=16%  Similarity=0.197  Sum_probs=104.0

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCE--EEEEEeCCCCcc------------------------hHHHHHHHHHHHhccCCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGI--VAVKRLKDANPC------------------------ARKEFEQYMDVIGKLKHPN  413 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~n  413 (670)
                      .+.||+|+||.||+|.. .+|+.  ||||+++.....                        ....+.+|++++.+++|++
T Consensus        52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~  131 (258)
T 1zth_A           52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG  131 (258)
T ss_dssp             EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence            46799999999999997 68999  999997543111                        1236789999999998875


Q ss_pred             e--eeEEEEEEeCCeeEEEEeccCC-C----ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HhCCCCCcccc
Q 036639          414 V--VKLRAYYYAKEEKLLVYDYLPN-G----SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH-QEYGTAKVPHG  485 (670)
Q Consensus       414 I--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~~ivH~  485 (670)
                      +  +.++++    ...++||||+.+ |    +|.++...        .++.....++.|++.||.||| +.    +|+||
T Consensus       132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~----givHr  195 (258)
T 1zth_A          132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEA----ELVHA  195 (258)
T ss_dssp             CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTS----CEECS
T ss_pred             CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHC----CEEeC
Confidence            4  444442    356899999942 4    67666432        123456789999999999999 76    99999


Q ss_pred             CCCCCCeEeCCCCcEEEEecccccccC
Q 036639          486 NVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       486 Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      ||||+|||++.  .++|+|||+|....
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCCHHHEEEcC--cEEEEECcccccCC
Confidence            99999999988  99999999997653

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.75  E-value=7.3e-18  Score=170.32  Aligned_cols=160  Identities=27%  Similarity=0.352  Sum_probs=126.2

Q ss_pred             CCCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCcc
Q 036639           53 AAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQ  131 (670)
Q Consensus        53 ~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~  131 (670)
                      .|.|.|+.|... ..++.+++++++++..+..+.  ++|+.|+|++|+|++..+ .|.++++|++|+|++|.++...+..
T Consensus         4 ~C~~~~~~C~c~-~~~~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~   80 (270)
T 2o6q_A            4 LCKKDGGVCSCN-NNKNSVDCSSKKLTAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI   80 (270)
T ss_dssp             CBGGGTCSBEEE-TTTTEEECTTSCCSSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTT
T ss_pred             cCCCCCCCCEeC-CCCCEEEccCCCCCccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhh
Confidence            367999888653 345678999999987544343  689999999999988775 4889999999999999998665666


Q ss_pred             ccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hc
Q 036639          132 ISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KF  208 (670)
Q Consensus       132 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~  208 (670)
                      |.++++|++|+|++|++++..+..+.++++|++|+|++|++++..|..+..+++|++|+|++|+|++ +|...+.   .+
T Consensus        81 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L  159 (270)
T 2o6q_A           81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSL  159 (270)
T ss_dssp             TSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC-CCTTTTTTCTTC
T ss_pred             hcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCc-cCHhHccCCccc
Confidence            7889999999999999997766778899999999999999998777888899999999999999984 5544333   33


Q ss_pred             Cccccccc
Q 036639          209 GEQSFIGN  216 (670)
Q Consensus       209 ~~~~~~~n  216 (670)
                      ....+.+|
T Consensus       160 ~~L~L~~n  167 (270)
T 2o6q_A          160 KELRLYNN  167 (270)
T ss_dssp             CEEECCSS
T ss_pred             ceeEecCC
Confidence            34444455

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.75  E-value=5.6e-18  Score=165.55  Aligned_cols=136  Identities=20%  Similarity=0.237  Sum_probs=124.5

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ..++.|+|++|.+++..+. +..+++|+.|+|++|+|++..+ .|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            4689999999999997775 8999999999999999998865 4999999999999999999766666899999999999


Q ss_pred             CCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      ++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.++..-+
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  169 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH  169 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence            9999999989999999999999999999998888889999999999999999975433

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.74  E-value=3.3e-18  Score=176.16  Aligned_cols=148  Identities=22%  Similarity=0.264  Sum_probs=87.7

Q ss_pred             CCCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccc---cCCCccccccc
Q 036639           49 ADACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGT---ILPLTNCTNLK  115 (670)
Q Consensus        49 ~~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~---~~~~~~l~~L~  115 (670)
                      ++.|.|.|.+|.|+..         ...++.|+|++|.+....+. +..+++|++|+|++|+++..   ...+..+++|+
T Consensus         2 P~~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~   81 (306)
T 2z66_A            2 PSRCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK   81 (306)
T ss_dssp             CTTCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred             cCCCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccC
Confidence            3568899999999863         24799999999999976555 78999999999999998743   12234455555


Q ss_pred             eeeccCCcccccCCccccCCCCCCEEeCCCCcccccCC-CCCcccccccceecccccccccCCCCcCCCCCCCEEEccCC
Q 036639          116 LAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP-EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN  194 (670)
Q Consensus       116 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  194 (670)
                      +|+|++|.++ .+|..+.++++|++|+|++|++++..+ ..+.++++|++|+|++|++++..|..+..+++|+.|++++|
T Consensus        82 ~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  160 (306)
T 2z66_A           82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN  160 (306)
T ss_dssp             EEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTC
T ss_pred             EEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCC
Confidence            5555555554 244444444444444444444443322 23444444444444444444444444444444444444444


Q ss_pred             CCc
Q 036639          195 ELY  197 (670)
Q Consensus       195 ~l~  197 (670)
                      .++
T Consensus       161 ~l~  163 (306)
T 2z66_A          161 SFQ  163 (306)
T ss_dssp             EEG
T ss_pred             ccc
Confidence            444

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.74  E-value=1.2e-17  Score=170.16  Aligned_cols=151  Identities=22%  Similarity=0.190  Sum_probs=126.6

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccceeeccCCc-ccccCCccccCCCCCCEEe
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGND-FSAEIPHQISSLKGILRLD  142 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~L~  142 (670)
                      ..++.|+|++|.+++..+. +..+++|++|+|++|.+++..+ .+.++++|++|+|++|. +++..|..|.++++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            4689999999999987765 8999999999999999998864 48999999999999997 7776688899999999999


Q ss_pred             CCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCccccccc
Q 036639          143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGN  216 (670)
Q Consensus       143 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n  216 (670)
                      |++|++++..|..+.++++|++|+|++|++++..+..+..+++|+.|+|++|++++..+..+  +..+....+.+|
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  187 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN  187 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC
Confidence            99999998888899999999999999999997777778899999999999999984433333  123334444444

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.73  E-value=1.4e-17  Score=168.51  Aligned_cols=147  Identities=22%  Similarity=0.222  Sum_probs=131.1

Q ss_pred             cceEEecCCCCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCcccc
Q 036639           56 WTGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQIS  133 (670)
Q Consensus        56 w~gv~C~~~~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~  133 (670)
                      ..++.......++..|+|++|.+++..+. ++.+++|++|+|++|++++.++. +.++++|+.|+|++|++++..|..++
T Consensus        75 l~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  154 (272)
T 3rfs_A           75 LHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFD  154 (272)
T ss_dssp             CCCCGGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CCCchhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhc
Confidence            34433223346799999999999987776 79999999999999999988765 89999999999999999988888889


Q ss_pred             CCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcc
Q 036639          134 SLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       134 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~  202 (670)
                      ++++|++|+|++|+|++..|..+.++++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|.
T Consensus       155 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  223 (272)
T 3rfs_A          155 KLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG  223 (272)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             cCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCcH
Confidence            999999999999999988778889999999999999999998888899999999999999999998883

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.73  E-value=1.2e-17  Score=169.27  Aligned_cols=154  Identities=20%  Similarity=0.240  Sum_probs=134.0

Q ss_pred             CCCCCcc--eEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCcccccccee
Q 036639           51 ACAAAWT--GVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLA  117 (670)
Q Consensus        51 ~~~~~w~--gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L  117 (670)
                      +|.|.+.  .|.|...         ...++.|+|++|++++..+. +..+++|++|+|++|++++..+ .+.++++|+.|
T Consensus         2 ~C~~~~~~~~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L   81 (276)
T 2z62_A            2 PCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTL   81 (276)
T ss_dssp             CSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred             CceeccCCceEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEE
Confidence            4444343  4677642         23589999999999998774 9999999999999999998775 49999999999


Q ss_pred             eccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccccccc-CCCCcCCCCCCCEEEccCCCC
Q 036639          118 YLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR-IPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       118 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      +|++|.+++..|..|.++++|++|+|++|++++..+..+.++++|++|+|++|++++. +|..+..+++|+.|++++|++
T Consensus        82 ~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l  161 (276)
T 2z62_A           82 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI  161 (276)
T ss_dssp             ECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred             ECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCC
Confidence            9999999998889999999999999999999987777899999999999999999874 689999999999999999999


Q ss_pred             cCCCcchh
Q 036639          197 YGRVPEGL  204 (670)
Q Consensus       197 ~g~ip~~~  204 (670)
                      ++..+..+
T Consensus       162 ~~~~~~~~  169 (276)
T 2z62_A          162 QSIYCTDL  169 (276)
T ss_dssp             CEECGGGG
T ss_pred             CcCCHHHh
Confidence            96655544

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.73  E-value=8e-18  Score=191.11  Aligned_cols=147  Identities=20%  Similarity=0.239  Sum_probs=131.8

Q ss_pred             eEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccc
Q 036639           58 GVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSA  126 (670)
Q Consensus        58 gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g  126 (670)
                      -|.|+..         +..++.|+|++|.|++..+. |..+++|++|||++|+|++..+. |.+|++|++|+|++|+|++
T Consensus        35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~  114 (635)
T 4g8a_A           35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS  114 (635)
T ss_dssp             EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred             EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence            4678742         24689999999999997765 99999999999999999998765 9999999999999999998


Q ss_pred             cCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccc-cCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       127 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      ..|..|.+|++|++|+|++|+|++..+..|+++++|++|+|++|++++ .+|..+..+++|++|++++|+|++..|..+
T Consensus       115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l  193 (635)
T 4g8a_A          115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  193 (635)
T ss_dssp             ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGG
T ss_pred             CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccc
Confidence            878889999999999999999998777789999999999999999986 467888999999999999999997777665

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.73  E-value=7e-18  Score=173.75  Aligned_cols=154  Identities=19%  Similarity=0.264  Sum_probs=73.3

Q ss_pred             EEEEEcCCCCccccCC--CCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccc-cCCccccCCCCCCEEeC
Q 036639           68 VVSLSLPSHSLRGPIA--PLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSA-EIPHQISSLKGILRLDL  143 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l  143 (670)
                      +..|+|++|.+.+..+  .+..+++|++|+|++|.+++..+. +.++++|+.|+|++|.+++ .+|..+..+++|++|+|
T Consensus       103 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~L  182 (306)
T 2z66_A          103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL  182 (306)
T ss_dssp             CCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred             CCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEEC
Confidence            4444444444444332  244445555555555554444332 4445555555555555544 34445555555555555


Q ss_pred             CCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh---hhcCcccccccCCCc
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL---KKFGEQSFIGNEGLC  220 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~~c  220 (670)
                      ++|++++..|..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|++++.+|..+.   ..+....+.+|++.|
T Consensus       183 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~  262 (306)
T 2z66_A          183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  262 (306)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred             CCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence            55555544455555555555555555555544333444455555555555555544443331   122333444555444


Q ss_pred             C
Q 036639          221 G  221 (670)
Q Consensus       221 ~  221 (670)
                      +
T Consensus       263 ~  263 (306)
T 2z66_A          263 T  263 (306)
T ss_dssp             S
T ss_pred             c
Confidence            4

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.72  E-value=6.1e-18  Score=191.34  Aligned_cols=164  Identities=18%  Similarity=0.178  Sum_probs=128.7

Q ss_pred             CcEEEEEcCCCCccccCC--CCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccc-cCCccccCCCCCCEE
Q 036639           66 ERVVSLSLPSHSLRGPIA--PLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSA-EIPHQISSLKGILRL  141 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L  141 (670)
                      ..++.|+|++|.+.+.++  .+..+++|++|+|++|.+++.++. +.++++|+.|+|++|.+++ .+|..|+++++|++|
T Consensus       399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  478 (606)
T 3vq2_A          399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL  478 (606)
T ss_dssp             TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEE
Confidence            356666677777766655  367777888888888888776644 7888888888888888887 478888888899999


Q ss_pred             eCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcccccccCC
Q 036639          142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGNEG  218 (670)
Q Consensus       142 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~  218 (670)
                      +|++|++++.+|..+.++++|+.|+|++|++++.+|..+..+++|+.|+|++|+|+ .+|..+..   .+....+.+|++
T Consensus       479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~  557 (606)
T 3vq2_A          479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSV  557 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCC
T ss_pred             ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCc
Confidence            99999998888888889999999999999999888888888999999999999998 78876522   245567789999


Q ss_pred             CcCCCCCCCCCC
Q 036639          219 LCGSSPLPACSF  230 (670)
Q Consensus       219 ~c~~~~~~~~~~  230 (670)
                      .|+|.......|
T Consensus       558 ~c~c~~~~~~~~  569 (606)
T 3vq2_A          558 ACICEHQKFLQW  569 (606)
T ss_dssp             CCSSTTHHHHTT
T ss_pred             ccCCccHHHHHH
Confidence            999765333334

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.72  E-value=8.3e-18  Score=183.27  Aligned_cols=154  Identities=21%  Similarity=0.275  Sum_probs=135.6

Q ss_pred             CCCCCcceEEecCCC--------CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC--CCccccccceeec
Q 036639           51 ACAAAWTGVVCSPKS--------ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL--PLTNCTNLKLAYL  119 (670)
Q Consensus        51 ~~~~~w~gv~C~~~~--------~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~l  119 (670)
                      .|.|.+..|.|+...        .+++.|+|++|.+++..+. ++.+++|++|+|++|.+.+.++  .|.++++|++|+|
T Consensus         7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L   86 (455)
T 3v47_A            7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL   86 (455)
T ss_dssp             CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred             eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence            343444448897542        5699999999999998665 9999999999999999987664  3999999999999


Q ss_pred             cCCcccccCCccccCCCCCCEEeCCCCcccccCCCC--CcccccccceecccccccccCCCC-cCCCCCCCEEEccCCCC
Q 036639          120 SGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQ--VTNLTRLLTLRLQNNELTGRIPDL-SSSLKDLKELNLSNNEL  196 (670)
Q Consensus       120 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~l~~N~l  196 (670)
                      ++|.+++..|..|+++++|++|+|++|++++.+|..  +.++++|++|+|++|++++..|.. +..+++|++|++++|++
T Consensus        87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l  166 (455)
T 3v47_A           87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV  166 (455)
T ss_dssp             TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred             CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence            999999999999999999999999999999866655  999999999999999999888876 88999999999999999


Q ss_pred             cCCCcchh
Q 036639          197 YGRVPEGL  204 (670)
Q Consensus       197 ~g~ip~~~  204 (670)
                      ++..|..+
T Consensus       167 ~~~~~~~l  174 (455)
T 3v47_A          167 KSICEEDL  174 (455)
T ss_dssp             SCCCTTTS
T ss_pred             cccChhhh
Confidence            98888665

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.72  E-value=6.2e-17  Score=156.68  Aligned_cols=159  Identities=23%  Similarity=0.250  Sum_probs=132.3

Q ss_pred             eEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCC
Q 036639           58 GVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLK  136 (670)
Q Consensus        58 gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~  136 (670)
                      +-.|..     +.++..+++++..+..+  .++|++|+|++|+|++..+. +.++++|++|+|++|++++..+..|.+++
T Consensus         4 ~C~C~~-----~~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~   76 (208)
T 2o6s_A            4 RCSCSG-----TTVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLT   76 (208)
T ss_dssp             TCEEET-----TEEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCEECC-----CEEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCC
Confidence            446753     46788888888755433  56999999999999987765 78999999999999999977777789999


Q ss_pred             CCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCccccc
Q 036639          137 GILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFI  214 (670)
Q Consensus       137 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~  214 (670)
                      +|++|+|++|+|++..+..+.++++|++|+|++|+|++..+..+..+++|+.|++++|+|++..+..+  +..+....+.
T Consensus        77 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~  156 (208)
T 2o6s_A           77 SLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH  156 (208)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEec
Confidence            99999999999997777778999999999999999998777778999999999999999995444333  2355566778


Q ss_pred             ccCCCcCCC
Q 036639          215 GNEGLCGSS  223 (670)
Q Consensus       215 ~n~~~c~~~  223 (670)
                      +|++.|.+.
T Consensus       157 ~N~~~~~~~  165 (208)
T 2o6s_A          157 DNPWDCTCP  165 (208)
T ss_dssp             SCCBCCCTT
T ss_pred             CCCeecCCC
Confidence            999988764

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.72  E-value=7e-18  Score=177.49  Aligned_cols=153  Identities=24%  Similarity=0.250  Sum_probs=130.4

Q ss_pred             CCCCCCcceEEecCC-----------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cccccccce
Q 036639           50 DACAAAWTGVVCSPK-----------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKL  116 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~-----------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~  116 (670)
                      ..|.|.|.|+ |+..           ...++.|+|++|++++..+. +..+++|++|+|++|++++..+. +.++++|++
T Consensus        26 ~~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  104 (353)
T 2z80_A           26 ASLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH  104 (353)
T ss_dssp             -CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cCCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence            3556789988 6532           23789999999999987764 99999999999999999988754 999999999


Q ss_pred             eeccCCcccccCCccccCCCCCCEEeCCCCcccccCCC--CCcccccccceecccc-cccccCCCCcCCCCCCCEEEccC
Q 036639          117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPE--QVTNLTRLLTLRLQNN-ELTGRIPDLSSSLKDLKELNLSN  193 (670)
Q Consensus       117 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~l~l~~  193 (670)
                      |+|++|.+++..+..|+++++|++|+|++|+++ .+|.  .+.++++|++|+|++| .+++..|..+..+++|+.|++++
T Consensus       105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~  183 (353)
T 2z80_A          105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDA  183 (353)
T ss_dssp             EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred             EECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCC
Confidence            999999999755556999999999999999999 4555  7899999999999999 57766778899999999999999


Q ss_pred             CCCcCCCcchh
Q 036639          194 NELYGRVPEGL  204 (670)
Q Consensus       194 N~l~g~ip~~~  204 (670)
                      |++++..|..+
T Consensus       184 n~l~~~~~~~l  194 (353)
T 2z80_A          184 SDLQSYEPKSL  194 (353)
T ss_dssp             TTCCEECTTTT
T ss_pred             CCcCccCHHHH
Confidence            99998777665

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.72  E-value=7e-18  Score=175.49  Aligned_cols=150  Identities=19%  Similarity=0.256  Sum_probs=120.7

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-Cc---------cccccceeeccCCcccccCCccccCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LT---------NCTNLKLAYLSGNDFSAEIPHQISSL  135 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~---------~l~~L~~L~l~~N~l~g~~p~~~~~l  135 (670)
                      .++..|+|++|.+...++.++.+++|++|+|++|++.+.++. +.         ++++|+.|+|++|.|+ .+|..++++
T Consensus       127 ~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l  205 (328)
T 4fcg_A          127 AGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANL  205 (328)
T ss_dssp             TTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGC
T ss_pred             CCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCC
Confidence            468899999999984433488899999999999888777654 44         4888999999999888 788888888


Q ss_pred             CCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh--hhcCcccc
Q 036639          136 KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL--KKFGEQSF  213 (670)
Q Consensus       136 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~  213 (670)
                      ++|++|+|++|++++ +|..+.++++|++|+|++|++.+.+|..+..+++|+.|+|++|++.+.+|..+.  ..+....+
T Consensus       206 ~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L  284 (328)
T 4fcg_A          206 QNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL  284 (328)
T ss_dssp             TTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEEC
T ss_pred             CCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeC
Confidence            899999999998884 677788888899999999888888888888888899999998888888887762  23334445


Q ss_pred             cccC
Q 036639          214 IGNE  217 (670)
Q Consensus       214 ~~n~  217 (670)
                      .+|+
T Consensus       285 ~~n~  288 (328)
T 4fcg_A          285 RGCV  288 (328)
T ss_dssp             TTCT
T ss_pred             CCCC
Confidence            5554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.72  E-value=2.3e-17  Score=157.63  Aligned_cols=129  Identities=24%  Similarity=0.249  Sum_probs=112.0

Q ss_pred             EEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccc
Q 036639           71 LSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRG  150 (670)
Q Consensus        71 l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g  150 (670)
                      +++++|+++..+..+  .++|+.|+|++|+|+..+..+.++++|+.|+|++|.|++..|..|.++++|++|+|++|+|++
T Consensus        15 l~~~~~~l~~ip~~~--~~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~   92 (193)
T 2wfh_A           15 VRCSNKGLKVLPKGI--PRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC   92 (193)
T ss_dssp             EECTTSCCSSCCSCC--CTTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCB
T ss_pred             EEcCCCCCCcCCCCC--CCCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCE
Confidence            455566776544333  368999999999999666669999999999999999999888899999999999999999998


Q ss_pred             cCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          151 RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       151 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      ..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|.+...-.
T Consensus        93 i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            888899999999999999999997666779999999999999999975443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.72  E-value=2.6e-17  Score=180.50  Aligned_cols=154  Identities=21%  Similarity=0.270  Sum_probs=136.8

Q ss_pred             CCCCC--CcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccce
Q 036639           50 DACAA--AWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKL  116 (670)
Q Consensus        50 ~~~~~--~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~  116 (670)
                      ..|.|  .|..|.|...         ...++.|+|++|.+++..+. |..+++|++|+|++|.+++..+ .|.++++|+.
T Consensus         5 ~~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~   84 (477)
T 2id5_A            5 PRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRT   84 (477)
T ss_dssp             TTCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             CCCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCE
Confidence            34556  4789999753         24688999999999998765 9999999999999999999865 4999999999


Q ss_pred             eeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCC
Q 036639          117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       117 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      |+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|++
T Consensus        85 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  164 (477)
T 2id5_A           85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL  164 (477)
T ss_dssp             EECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred             EECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence            99999999976667789999999999999999999999999999999999999999999899999999999999999999


Q ss_pred             cCCCcchh
Q 036639          197 YGRVPEGL  204 (670)
Q Consensus       197 ~g~ip~~~  204 (670)
                      ++ +|...
T Consensus       165 ~~-~~~~~  171 (477)
T 2id5_A          165 TS-IPTEA  171 (477)
T ss_dssp             SS-CCHHH
T ss_pred             cc-cChhH
Confidence            95 55443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.71  E-value=8.1e-18  Score=187.97  Aligned_cols=152  Identities=24%  Similarity=0.235  Sum_probs=134.7

Q ss_pred             CCCCcceEEecCC-----------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cccccccceee
Q 036639           52 CAAAWTGVVCSPK-----------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAY  118 (670)
Q Consensus        52 ~~~~w~gv~C~~~-----------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~  118 (670)
                      +.|.|.|| |+..           ...++.|+|++|.+++..+. ++.+++|++|+|++|++++.++. |.++++|++|+
T Consensus         2 ~~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   80 (549)
T 2z81_A            2 LSCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLD   80 (549)
T ss_dssp             CEECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred             ccCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEE
Confidence            34679998 8642           23799999999999998765 99999999999999999998754 99999999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEeCCCCcccc-cCCCCCcccccccceecccccccccCC-CCcCCCCCCCEEEccCCCC
Q 036639          119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRG-RIPEQVTNLTRLLTLRLQNNELTGRIP-DLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       119 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l  196 (670)
                      |++|++++..|..|+++++|++|+|++|++++ .+|..+.++++|++|+|++|++.+.+| ..+..+++|+.|++++|++
T Consensus        81 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A           81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             CTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            99999998888889999999999999999997 567899999999999999999555665 6799999999999999999


Q ss_pred             cCCCcchh
Q 036639          197 YGRVPEGL  204 (670)
Q Consensus       197 ~g~ip~~~  204 (670)
                      ++.+|..+
T Consensus       161 ~~~~~~~l  168 (549)
T 2z81_A          161 RNYQSQSL  168 (549)
T ss_dssp             CEECTTTT
T ss_pred             cccChhhh
Confidence            99888766

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.71  E-value=2.5e-17  Score=186.30  Aligned_cols=147  Identities=19%  Similarity=0.231  Sum_probs=133.9

Q ss_pred             eEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccc
Q 036639           58 GVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSA  126 (670)
Q Consensus        58 gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g  126 (670)
                      .|.|+..         ..+++.|+|++|.+++..+. +..+++|++|+|++|++++..+. |.++++|++|+|++|.+++
T Consensus        15 ~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~   94 (606)
T 3vq2_A           15 TYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS   94 (606)
T ss_dssp             EEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCC
T ss_pred             ceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccc
Confidence            5778642         35799999999999998874 99999999999999999998764 9999999999999999999


Q ss_pred             cCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccc-cCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       127 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      ..|..|+++++|++|+|++|++++..|..++++++|++|+|++|++++ .+|..++.+++|++|++++|++++..|..+
T Consensus        95 ~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~  173 (606)
T 3vq2_A           95 FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL  173 (606)
T ss_dssp             CCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTT
T ss_pred             cChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhh
Confidence            889999999999999999999998887899999999999999999986 679999999999999999999998777655

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.71  E-value=1.3e-17  Score=178.02  Aligned_cols=173  Identities=19%  Similarity=0.198  Sum_probs=134.9

Q ss_pred             CCCCCCCCCCCCCcceEEecCC-------------------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCc
Q 036639           43 LSNWKGADACAAAWTGVVCSPK-------------------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLN  102 (670)
Q Consensus        43 l~~W~~~~~~~~~w~gv~C~~~-------------------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~  102 (670)
                      +++|.....|+|.|.+..|.-.                   -..+..|++.+|.+...++. +..+++|++|+|++|+++
T Consensus         3 ~~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~   82 (390)
T 3o6n_A            3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE   82 (390)
T ss_dssp             ----CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC
T ss_pred             cCCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc
Confidence            5789888888776555555210                   14577899999988876555 788999999999999999


Q ss_pred             cccC-CCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcC
Q 036639          103 GTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSS  181 (670)
Q Consensus       103 ~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  181 (670)
                      +..+ .+.++++|+.|+|++|.+++..|..|+++++|++|+|++|+|+...+..+.++++|++|+|++|++++..|..+.
T Consensus        83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  162 (390)
T 3o6n_A           83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ  162 (390)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred             ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence            8875 599999999999999999998888999999999999999999944444468999999999999999988888899


Q ss_pred             CCCCCCEEEccCCCCcCCCcchhhhhcCccccccc
Q 036639          182 SLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGN  216 (670)
Q Consensus       182 ~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n  216 (670)
                      .+++|+.|++++|++++ ++...+..+....+.+|
T Consensus       163 ~l~~L~~L~l~~n~l~~-~~~~~l~~L~~L~l~~n  196 (390)
T 3o6n_A          163 ATTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYN  196 (390)
T ss_dssp             SCTTCCEEECCSSCCSB-CCGGGCTTCSEEECCSS
T ss_pred             CCCCCCEEECCCCcCCc-cccccccccceeecccc
Confidence            99999999999999985 45444455555555444

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.71  E-value=1.5e-17  Score=187.53  Aligned_cols=175  Identities=19%  Similarity=0.206  Sum_probs=141.4

Q ss_pred             CCCCCCCCCCCCCCC---cceEEecCC----------------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCC
Q 036639           41 NLLSNWKGADACAAA---WTGVVCSPK----------------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNR  100 (670)
Q Consensus        41 ~~l~~W~~~~~~~~~---w~gv~C~~~----------------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~  100 (670)
                      ..+++|.+...|++.   |.++.|+..                -..+..|++.+|.+...++. +..+++|++|+|++|.
T Consensus         7 ~~l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~   86 (597)
T 3oja_B            7 YNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ   86 (597)
T ss_dssp             ----CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSC
T ss_pred             ccccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCC
Confidence            356789877777543   666665411                13467788999988886655 7889999999999999


Q ss_pred             CccccC-CCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCC
Q 036639          101 LNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDL  179 (670)
Q Consensus       101 l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~  179 (670)
                      |++.++ .|+++++|+.|+|++|.+++..|..|+++++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..
T Consensus        87 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  166 (597)
T 3oja_B           87 IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT  166 (597)
T ss_dssp             CCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTT
T ss_pred             CCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhh
Confidence            999876 5999999999999999999988889999999999999999999655556799999999999999999988989


Q ss_pred             cCCCCCCCEEEccCCCCcCCCcchhhhhcCccccccc
Q 036639          180 SSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGN  216 (670)
Q Consensus       180 ~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n  216 (670)
                      +..+++|+.|+|++|+|++ +|...+..+....+.+|
T Consensus       167 ~~~l~~L~~L~L~~N~l~~-~~~~~l~~L~~L~l~~n  202 (597)
T 3oja_B          167 FQATTSLQNLQLSSNRLTH-VDLSLIPSLFHANVSYN  202 (597)
T ss_dssp             TTTCTTCCEEECTTSCCSB-CCGGGCTTCSEEECCSS
T ss_pred             hhcCCcCcEEECcCCCCCC-cChhhhhhhhhhhcccC
Confidence            9999999999999999996 45444455555554444

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.70  E-value=1.8e-17  Score=164.19  Aligned_cols=165  Identities=16%  Similarity=0.163  Sum_probs=137.6

Q ss_pred             CCCCCCc-ce--EEecC------CCCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCC-CccccC-CCcccccccee
Q 036639           50 DACAAAW-TG--VVCSP------KSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNR-LNGTIL-PLTNCTNLKLA  117 (670)
Q Consensus        50 ~~~~~~w-~g--v~C~~------~~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~-l~~~~~-~~~~l~~L~~L  117 (670)
                      ..|.|.+ .+  |.|..      -...++.|+|++|++++..+. +..+++|++|+|++|+ +++..+ .|.++++|+.|
T Consensus         6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L   85 (239)
T 2xwt_C            6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI   85 (239)
T ss_dssp             SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred             CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence            4566754 54  55964      234789999999999998774 8999999999999997 887765 48999999999


Q ss_pred             eccC-CcccccCCccccCCCCCCEEeCCCCcccccCCCCCccccccc---ceecccc-cccccCCCCcCCCCCCC-EEEc
Q 036639          118 YLSG-NDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLL---TLRLQNN-ELTGRIPDLSSSLKDLK-ELNL  191 (670)
Q Consensus       118 ~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~---~L~l~~N-~l~g~~p~~~~~l~~L~-~l~l  191 (670)
                      +|++ |.+++..+..|.++++|++|+|++|++++ +|. +..+++|+   +|+|++| ++++..+..+..+++|+ .|++
T Consensus        86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l  163 (239)
T 2xwt_C           86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL  163 (239)
T ss_dssp             EEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEEC
T ss_pred             ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEc
Confidence            9999 99998777899999999999999999996 777 88888888   9999999 99977777899999999 9999


Q ss_pred             cCCCCcCCCcchhhhh--cCcccccccC
Q 036639          192 SNNELYGRVPEGLLKK--FGEQSFIGNE  217 (670)
Q Consensus       192 ~~N~l~g~ip~~~~~~--~~~~~~~~n~  217 (670)
                      ++|+++ .+|...+..  +....+.+|.
T Consensus       164 ~~n~l~-~i~~~~~~~~~L~~L~L~~n~  190 (239)
T 2xwt_C          164 YNNGFT-SVQGYAFNGTKLDAVYLNKNK  190 (239)
T ss_dssp             CSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred             CCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence            999999 888765443  3334445553

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.69  E-value=1.3e-17  Score=191.39  Aligned_cols=179  Identities=20%  Similarity=0.174  Sum_probs=120.4

Q ss_pred             CcchHHHHHHHHhccCC-CCCCCCCCCCCCCCCCCcceEEecCCCCcEEEEEcCCC------------------Ccccc-
Q 036639           22 HPNDTDALTLFRLQTDT-HGNLLSNWKGADACAAAWTGVVCSPKSERVVSLSLPSH------------------SLRGP-   81 (670)
Q Consensus        22 ~~~~~~~l~~~~~~~~~-~~~~l~~W~~~~~~~~~w~gv~C~~~~~~v~~l~l~~~------------------~l~~~-   81 (670)
                      ...+.++|+.+...+.. ....-.+|.......+.|.++.++.  .+++.|+|.+|                  .|.+. 
T Consensus       130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~  207 (727)
T 4b8c_D          130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD  207 (727)
T ss_dssp             --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred             cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence            34577788877766521 1223345654444346788888775  44555555433                  33321 


Q ss_pred             --------CCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccC
Q 036639           82 --------IAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRI  152 (670)
Q Consensus        82 --------~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~  152 (670)
                              ++. +..+..|+.|+|++|.|......+.++++|+.|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+
T Consensus       208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l  285 (727)
T 4b8c_D          208 DIENRMVMPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL  285 (727)
T ss_dssp             --------------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred             ccccceecChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence                    122 67889999999999999966666889999999999999999 89999999999999999999999 88


Q ss_pred             CCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh
Q 036639          153 PEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL  205 (670)
Q Consensus       153 p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~  205 (670)
                      |..|++|++|++|+|++|+|+ .+|..|+.+++|+.|+|++|+|+|.+|..+.
T Consensus       286 p~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~  337 (727)
T 4b8c_D          286 PAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILT  337 (727)
T ss_dssp             CSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHH
T ss_pred             ChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHh
Confidence            999999999999999999998 8898899999999999999999999997763

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.69  E-value=6.6e-17  Score=163.84  Aligned_cols=155  Identities=24%  Similarity=0.288  Sum_probs=80.1

Q ss_pred             cEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccc-cCCccccCCCCCCEEeC
Q 036639           67 RVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSA-EIPHQISSLKGILRLDL  143 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L~l  143 (670)
                      ++..|+|++|.+.+..+. +..+++|++|+|++|++++..+ .+.++++|+.|+|++|.+++ .+|..|+++++|++|+|
T Consensus        77 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~L  156 (276)
T 2z62_A           77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL  156 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEEC
T ss_pred             CCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEEC
Confidence            344444444444443332 4444444444444444444332 24444555555555555543 23445555555555555


Q ss_pred             CCCcccccCCCCCccccccc----ceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCccccccc
Q 036639          144 SDNNIRGRIPEQVTNLTRLL----TLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGN  216 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~----~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n  216 (670)
                      ++|++++..+..+..+++|+    .|+|++|++++..+..+. ..+|+.|+|++|+|+ .+|...+.   .+....+.+|
T Consensus       157 s~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N  234 (276)
T 2z62_A          157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN  234 (276)
T ss_dssp             CSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCS-CCCTTTTTTCCSCCEEECCSS
T ss_pred             CCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCcee-ecCHhHhcccccccEEEccCC
Confidence            55555544444444444444    445555555543333333 337888888888888 44544433   4445667888


Q ss_pred             CCCcCCC
Q 036639          217 EGLCGSS  223 (670)
Q Consensus       217 ~~~c~~~  223 (670)
                      ++.|+|.
T Consensus       235 ~~~c~c~  241 (276)
T 2z62_A          235 PWDCSCP  241 (276)
T ss_dssp             CBCCCTT
T ss_pred             cccccCC
Confidence            8888864

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=1.6e-17  Score=155.02  Aligned_cols=135  Identities=25%  Similarity=0.237  Sum_probs=119.9

Q ss_pred             CcEEEEEcCCCCcc-ccCCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLR-GPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~-~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ..++.|+|++|.+. +.+|. +..+++|++|+|++|.|++. ..+..+++|+.|+|++|++++.+|..+.++++|++|+|
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            56899999999998 66766 69999999999999999987 77999999999999999999888988888999999999


Q ss_pred             CCCccccc-CCCCCcccccccceecccccccccCC---CCcCCCCCCCEEEccCCCCcCCCcc
Q 036639          144 SDNNIRGR-IPEQVTNLTRLLTLRLQNNELTGRIP---DLSSSLKDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       144 ~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p---~~~~~l~~L~~l~l~~N~l~g~ip~  202 (670)
                      ++|+|++. .+..+..+++|+.|+|++|++++..+   ..+..+++|+.|++++|.++ .+|.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            99999963 22789999999999999999996554   37889999999999999987 5664

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.69  E-value=9.1e-17  Score=163.95  Aligned_cols=149  Identities=26%  Similarity=0.263  Sum_probs=129.0

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      ..++.|+|++|.+++..+. +..+++|++|+|++|+|++... .+.+++|+.|+|++|+|+ .+|..+.++++|++|+|+
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~  108 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS  108 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence            4689999999999987665 8999999999999999988654 488999999999999998 789999999999999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhc---CcccccccC
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKF---GEQSFIGNE  217 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~---~~~~~~~n~  217 (670)
                      +|+|++..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|++|+|+ .+|...+..+   ....+.+|.
T Consensus       109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~  183 (290)
T 1p9a_G          109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENS  183 (290)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEECCCCc
Confidence            99999877788999999999999999999877778889999999999999999 6776654433   344445554

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.68  E-value=1.4e-17  Score=195.40  Aligned_cols=137  Identities=22%  Similarity=0.236  Sum_probs=118.0

Q ss_pred             CCCCCCccEEEccCCCCccccCC--CccccccceeeccCCccc-----ccCCccccCCCCCCEEeCCCCcccccCCCCCc
Q 036639           85 LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFS-----AEIPHQISSLKGILRLDLSDNNIRGRIPEQVT  157 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  157 (670)
                      +..+++|+.|+|++|++++..+.  +..+++|+.|+|++|.++     +..|..|.++++|+.|+|++|+|++..|..|.
T Consensus       422 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  501 (844)
T 3j0a_A          422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS  501 (844)
T ss_dssp             HTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSS
T ss_pred             hhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHcc
Confidence            34788999999999999876543  667899999999999997     45566788999999999999999998888999


Q ss_pred             ccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcCcccccccCCCcCCCC
Q 036639          158 NLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSP  224 (670)
Q Consensus       158 ~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~c~~~~  224 (670)
                      ++++|+.|+|++|+|++..|..+.  ++|+.|+|++|+|+|.+|..+ ..+....+.+|++.|+|..
T Consensus       502 ~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~-~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          502 HLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF-VSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC-SSCCEEEEEEECCCCSSSC
T ss_pred             chhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh-CCcCEEEecCCCccccccc
Confidence            999999999999999987776664  899999999999998888765 6777788899999999864

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.68  E-value=7.7e-17  Score=182.27  Aligned_cols=155  Identities=24%  Similarity=0.223  Sum_probs=88.7

Q ss_pred             EEEEEcCCCCccccCCC--CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCccccc---CCccccCCCCCCEE
Q 036639           68 VVSLSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAE---IPHQISSLKGILRL  141 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~---~p~~~~~l~~L~~L  141 (670)
                      ++.|+|++|.+.+..+.  +..+++|+.|+|++|.+++.++. +.++++|+.|+|++|.+++.   .+..+..+++|++|
T Consensus       402 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L  481 (606)
T 3t6q_A          402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL  481 (606)
T ss_dssp             CSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEE
T ss_pred             CCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEE
Confidence            44444444444443322  44455555555555555444332 45555555555555555541   22345556666666


Q ss_pred             eCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCC
Q 036639          142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGL  219 (670)
Q Consensus       142 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~  219 (670)
                      +|++|++++.+|..|.++++|+.|+|++|++++.+|..+..++.| .|++++|++++.+|..+  +..+....+.+|++.
T Consensus       482 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  560 (606)
T 3t6q_A          482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLD  560 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEE
T ss_pred             ECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcc
Confidence            666666666666666666666666666666666666666666666 66666666665555433  234555666778887


Q ss_pred             cCCC
Q 036639          220 CGSS  223 (670)
Q Consensus       220 c~~~  223 (670)
                      |.|.
T Consensus       561 c~c~  564 (606)
T 3t6q_A          561 CTCS  564 (606)
T ss_dssp             CSGG
T ss_pred             ccCC
Confidence            7753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.68  E-value=2.7e-17  Score=186.73  Aligned_cols=159  Identities=19%  Similarity=0.260  Sum_probs=136.8

Q ss_pred             CcEEEEEcCCCCccccCCC--CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcc-cccCCccccCCCCCCEE
Q 036639           66 ERVVSLSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDF-SAEIPHQISSLKGILRL  141 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l-~g~~p~~~~~l~~L~~L  141 (670)
                      ..+..+++..+++....+.  +..+.+|+.++++.|.+.+..+. +..+++|+.|+|++|.+ .+.+|..|..+++|++|
T Consensus       420 ~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L  499 (635)
T 4g8a_A          420 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL  499 (635)
T ss_dssp             TTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             ccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEE
Confidence            3456667777766665544  77889999999999999887755 88899999999999985 45678899999999999


Q ss_pred             eCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh---hhcCcccccccCC
Q 036639          142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL---KKFGEQSFIGNEG  218 (670)
Q Consensus       142 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~---~~~~~~~~~~n~~  218 (670)
                      ||++|+|++.+|..|.++++|++|+|++|+|++..|..+..+++|++|+|++|+|++..|..+.   ..+....+.+|||
T Consensus       500 ~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~  579 (635)
T 4g8a_A          500 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF  579 (635)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCB
T ss_pred             ECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCC
Confidence            9999999999999999999999999999999988888899999999999999999988887663   3455677899999


Q ss_pred             CcCCCC
Q 036639          219 LCGSSP  224 (670)
Q Consensus       219 ~c~~~~  224 (670)
                      .|+|..
T Consensus       580 ~C~C~~  585 (635)
T 4g8a_A          580 ACTCEH  585 (635)
T ss_dssp             CCSGGG
T ss_pred             cccCCc
Confidence            999863

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.68  E-value=1.2e-16  Score=152.59  Aligned_cols=130  Identities=18%  Similarity=0.273  Sum_probs=114.6

Q ss_pred             cEEEccCCCCccccCCCccccccceeeccCCcccccCCc-cccCCCCCCEEeCCCCcccccCCCCCcccccccceecccc
Q 036639           92 RFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPH-QISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNN  170 (670)
Q Consensus        92 ~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  170 (670)
                      +.|++++|+|+..+..+..  +|+.|+|++|+|++..+. .|+++++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus        11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A           11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            6899999999776554543  899999999999977665 4899999999999999999999999999999999999999


Q ss_pred             cccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCcCCC
Q 036639          171 ELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       171 ~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c~~~  223 (670)
                      +|++..|..+..+++|++|+|++|+|++.+|..+  +..+....+.+|++.|.|.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            9999999889999999999999999998888766  3455667788999998853

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.68  E-value=9.7e-17  Score=184.03  Aligned_cols=165  Identities=24%  Similarity=0.258  Sum_probs=140.8

Q ss_pred             CCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cccccccceeecc
Q 036639           52 CAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLS  120 (670)
Q Consensus        52 ~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~  120 (670)
                      |.|.++-|.|+..         ..+++.|+|++|.+++.++. ++.+++|++|+|++|++++..+. ++++++|++|+|+
T Consensus         2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~   81 (680)
T 1ziw_A            2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ   81 (680)
T ss_dssp             --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred             ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence            6677777888642         25799999999999997765 99999999999999999998766 8999999999999


Q ss_pred             CCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCC
Q 036639          121 GNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV  200 (670)
Q Consensus       121 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~i  200 (670)
                      +|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..+..+++|++|++++|++++..
T Consensus        82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  161 (680)
T 1ziw_A           82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALK  161 (680)
T ss_dssp             SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBC
T ss_pred             CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccC
Confidence            99999766667999999999999999999877789999999999999999999999999999999999999999999877


Q ss_pred             cchhh----hhcCccccccc
Q 036639          201 PEGLL----KKFGEQSFIGN  216 (670)
Q Consensus       201 p~~~~----~~~~~~~~~~n  216 (670)
                      |..+.    ..+....+.+|
T Consensus       162 ~~~~~~~~~~~L~~L~L~~n  181 (680)
T 1ziw_A          162 SEELDIFANSSLKKLELSSN  181 (680)
T ss_dssp             HHHHGGGTTCEESEEECTTC
T ss_pred             HHHhhccccccccEEECCCC
Confidence            76541    23444444555

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.68  E-value=1.5e-16  Score=173.36  Aligned_cols=109  Identities=24%  Similarity=0.286  Sum_probs=56.1

Q ss_pred             CCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceec
Q 036639           89 DQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRL  167 (670)
Q Consensus        89 ~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  167 (670)
                      ++|+.|+|++|++++.++. +.++++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+.++++|++|+|
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            3455555555555544432 445555555555555555544555555555555555555555444445555555555555


Q ss_pred             ccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          168 QNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       168 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      ++|++++..|..+..+++|++|+|++|+|+
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  384 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLK  384 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCcccccChhhccccccccEEECCCCccc
Confidence            555555444555555555555555555555

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.67  E-value=1.9e-16  Score=179.13  Aligned_cols=155  Identities=19%  Similarity=0.142  Sum_probs=134.3

Q ss_pred             CCCCCC--cceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cccccccce
Q 036639           50 DACAAA--WTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKL  116 (670)
Q Consensus        50 ~~~~~~--w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~  116 (670)
                      ..|.|.  +.-|.|...         ...++.|+|++|.+++..+. |+.+++|++|+|++|++++..+. |.++++|++
T Consensus         6 ~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   85 (606)
T 3t6q_A            6 QKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDT   85 (606)
T ss_dssp             CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred             CceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCe
Confidence            345453  456888642         24789999999999998765 99999999999999999988754 999999999


Q ss_pred             eeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCC
Q 036639          117 AYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       117 L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      |+|++|++++..|..|+++++|++|+|++|++++..|..+.++++|++|+|++|++++..+..+..+++|+.|++++|++
T Consensus        86 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  165 (606)
T 3t6q_A           86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI  165 (606)
T ss_dssp             EECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC
T ss_pred             eeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc
Confidence            99999999999999999999999999999999987788999999999999999999974434444599999999999999


Q ss_pred             cCCCcchh
Q 036639          197 YGRVPEGL  204 (670)
Q Consensus       197 ~g~ip~~~  204 (670)
                      ++..|..+
T Consensus       166 ~~~~~~~~  173 (606)
T 3t6q_A          166 HYLSKEDM  173 (606)
T ss_dssp             CEECHHHH
T ss_pred             cccChhhh
Confidence            97767655

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.67  E-value=2.1e-16  Score=164.74  Aligned_cols=163  Identities=23%  Similarity=0.322  Sum_probs=137.3

Q ss_pred             CCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccceee
Q 036639           50 DACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAY  118 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~  118 (670)
                      ..|.|.|+.+.|+..         ...++.|+|++|.+.+..+. +..+++|++|+|++|++++..+ .+.++++|++|+
T Consensus        29 ~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           29 FGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             SSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             CCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            456688999999743         24689999999999987764 9999999999999999998865 499999999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccccc--ccCCCCcCCCCCCCEEEccCCCC
Q 036639          119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT--GRIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       119 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~--g~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      |++|.++ .+|..+.  ++|++|+|++|++++..+..+.++++|+.|+|++|+++  +..|..+..+ +|+.|++++|++
T Consensus       109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l  184 (332)
T 2ft3_A          109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKL  184 (332)
T ss_dssp             CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBC
T ss_pred             CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCC
Confidence            9999998 6777766  89999999999999766667899999999999999996  4678888888 999999999999


Q ss_pred             cCCCcchhhhhcCcccccccC
Q 036639          197 YGRVPEGLLKKFGEQSFIGNE  217 (670)
Q Consensus       197 ~g~ip~~~~~~~~~~~~~~n~  217 (670)
                      + .+|..+...+....+.+|.
T Consensus       185 ~-~l~~~~~~~L~~L~l~~n~  204 (332)
T 2ft3_A          185 T-GIPKDLPETLNELHLDHNK  204 (332)
T ss_dssp             S-SCCSSSCSSCSCCBCCSSC
T ss_pred             C-ccCccccCCCCEEECCCCc
Confidence            8 4887776666666666653

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.67  E-value=1.8e-16  Score=165.05  Aligned_cols=164  Identities=21%  Similarity=0.331  Sum_probs=135.3

Q ss_pred             CCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccceee
Q 036639           50 DACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAY  118 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~  118 (670)
                      ..|.|.|+.+.|+..         ...++.|+|++|.+++..+. ++.+++|++|+|++|++++..+ .+.++++|++|+
T Consensus        27 ~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           27 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            456688999999742         24688999999999997774 9999999999999999998865 499999999999


Q ss_pred             ccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccccc--ccCCCCcCCCCCCCEEEccCCCC
Q 036639          119 LSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT--GRIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       119 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~--g~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      |++|.++ .+|..+.  ++|++|+|++|++++..+..+.++++|+.|+|++|+++  +..+..+..+++|+.|++++|++
T Consensus       107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l  183 (330)
T 1xku_A          107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI  183 (330)
T ss_dssp             CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred             CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence            9999998 5777665  78999999999999777777888999999999999985  36777888888999999999988


Q ss_pred             cCCCcchhhhhcCcccccccC
Q 036639          197 YGRVPEGLLKKFGEQSFIGNE  217 (670)
Q Consensus       197 ~g~ip~~~~~~~~~~~~~~n~  217 (670)
                      + .+|..+...+....+.+|.
T Consensus       184 ~-~l~~~~~~~L~~L~l~~n~  203 (330)
T 1xku_A          184 T-TIPQGLPPSLTELHLDGNK  203 (330)
T ss_dssp             C-SCCSSCCTTCSEEECTTSC
T ss_pred             c-cCCccccccCCEEECCCCc
Confidence            8 5776665555555555553

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.67  E-value=3.3e-17  Score=149.60  Aligned_cols=127  Identities=24%  Similarity=0.253  Sum_probs=105.8

Q ss_pred             CcEEEEEcCCCCcc-ccCCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLR-GPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~-~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      .+++.|++++|.+. +.++. +..+++|++|+|++|.+++. ..+.++++|+.|+|++|.+++.+|..+.++++|++|+|
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            46888999999988 56665 68889999999999998877 66888899999999999998878888888899999999


Q ss_pred             CCCccccc-CCCCCcccccccceecccccccccCC---CCcCCCCCCCEEEccC
Q 036639          144 SDNNIRGR-IPEQVTNLTRLLTLRLQNNELTGRIP---DLSSSLKDLKELNLSN  193 (670)
Q Consensus       144 ~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p---~~~~~l~~L~~l~l~~  193 (670)
                      ++|++++. .|..+.++++|++|+|++|++++..+   ..+..+++|+.|++++
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            99998863 45788889999999999999986555   4678888899888864

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.67  E-value=1e-16  Score=179.79  Aligned_cols=159  Identities=20%  Similarity=0.208  Sum_probs=135.3

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC--CCccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL--PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ..+..|+|++|.+.+..+.+..+++|+.|+|++|.+.+.++  .+.++++|+.|+|++|.+++.+|..+.++++|++|+|
T Consensus       373 ~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  452 (570)
T 2z63_A          373 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM  452 (570)
T ss_dssp             SCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEEC
T ss_pred             CccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEEC
Confidence            45777777777777765557788899999999999887765  4889999999999999999999999999999999999


Q ss_pred             CCCccc-ccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCc
Q 036639          144 SDNNIR-GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLC  220 (670)
Q Consensus       144 ~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c  220 (670)
                      ++|.++ +.+|..+..+++|++|+|++|++++..|..+..+++|+.|++++|+|++..|..+  +..+....+.+|++.|
T Consensus       453 ~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~  532 (570)
T 2z63_A          453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  532 (570)
T ss_dssp             TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             cCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccC
Confidence            999998 6899999999999999999999999889999999999999999999997666544  2455566778999998


Q ss_pred             CCCC
Q 036639          221 GSSP  224 (670)
Q Consensus       221 ~~~~  224 (670)
                      .|..
T Consensus       533 ~~~~  536 (570)
T 2z63_A          533 SCPR  536 (570)
T ss_dssp             CTTT
T ss_pred             CCcc
Confidence            8654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.67  E-value=2.4e-16  Score=176.59  Aligned_cols=156  Identities=24%  Similarity=0.329  Sum_probs=135.0

Q ss_pred             CCCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCcccc---CCCccccccceeeccCCcccccCCcc-ccCCCCC
Q 036639           64 KSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTI---LPLTNCTNLKLAYLSGNDFSAEIPHQ-ISSLKGI  138 (670)
Q Consensus        64 ~~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~---~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L  138 (670)
                      ....++.|+|++|.+++.++. ++.+++|+.|+|++|++++..   ..+.++++|+.|+|++|.+++.+|.. +..+++|
T Consensus       351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L  430 (562)
T 3a79_B          351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI  430 (562)
T ss_dssp             SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred             CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence            346799999999999997665 899999999999999999753   24899999999999999999867764 8889999


Q ss_pred             CEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcccccc
Q 036639          139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIG  215 (670)
Q Consensus       139 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~  215 (670)
                      ++|+|++|+|++.+|..+.  ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|...+.   .+....+.+
T Consensus       431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~  506 (562)
T 3a79_B          431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHD  506 (562)
T ss_dssp             CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCS
T ss_pred             CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecC
Confidence            9999999999998888765  79999999999999 78887779999999999999999 78876333   445567789


Q ss_pred             cCCCcCCC
Q 036639          216 NEGLCGSS  223 (670)
Q Consensus       216 n~~~c~~~  223 (670)
                      |++.|+|.
T Consensus       507 N~~~c~c~  514 (562)
T 3a79_B          507 NPWDCTCP  514 (562)
T ss_dssp             CCBCCCHH
T ss_pred             CCcCCCcc
Confidence            99999864

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.66  E-value=8.3e-17  Score=154.39  Aligned_cols=148  Identities=16%  Similarity=0.241  Sum_probs=117.1

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .+++.|++++|.+.. ++.+..+++|++|+|++|.++.. +.+.++++|+.|+|++|.+++..|..|+++++|++|+|++
T Consensus        44 ~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~  121 (197)
T 4ezg_A           44 NSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH  121 (197)
T ss_dssp             HTCCEEEEESSCCSC-CTTGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred             CCccEEeccCCCccC-hHHHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence            357889999998884 45788889999999999976543 4688899999999999999988888899999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc-chhhhhcCcccccccC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP-EGLLKKFGEQSFIGNE  217 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip-~~~~~~~~~~~~~~n~  217 (670)
                      |++++..|..+.++++|++|+|++|++.+.+| .+..+++|+.|++++|++++ +| -.-+..+....+.+|+
T Consensus       122 n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          122 SAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YRGIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             SBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CTTGGGCSSCCEEEECBC-
T ss_pred             CccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hHHhccCCCCCEEEeeCcc
Confidence            99998888888999999999999998333666 67888999999999999985 44 1112334444555554

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.66  E-value=8e-16  Score=162.18  Aligned_cols=146  Identities=25%  Similarity=0.284  Sum_probs=127.1

Q ss_pred             CCCCCCCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-Cc-cccccceeeccCCcccc
Q 036639           49 ADACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LT-NCTNLKLAYLSGNDFSA  126 (670)
Q Consensus        49 ~~~~~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~-~l~~L~~L~l~~N~l~g  126 (670)
                      ...||   .+-.|..     ..+++++++|+..+..+.  ..|+.|+|++|+|++..+. +. ++++|+.|+|++|+|++
T Consensus         9 ~~~Cp---~~C~C~~-----~~l~c~~~~l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~   78 (361)
T 2xot_A            9 VVSCP---ANCLCAS-----NILSCSKQQLPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF   78 (361)
T ss_dssp             CTTCC---TTCEEET-----TEEECCSSCCSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCE
T ss_pred             CCCCC---CCCEECC-----CEEEeCCCCcCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCc
Confidence            45665   4567764     268999999998654443  4689999999999998766 65 99999999999999999


Q ss_pred             cCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh
Q 036639          127 EIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL  205 (670)
Q Consensus       127 ~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~  205 (670)
                      ..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+ .+|..++
T Consensus        79 i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~  156 (361)
T 2xot_A           79 ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI  156 (361)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGT
T ss_pred             cChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHh
Confidence            88889999999999999999999887888999999999999999999888999999999999999999999 5776653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.65  E-value=2.2e-16  Score=185.30  Aligned_cols=162  Identities=22%  Similarity=0.242  Sum_probs=138.8

Q ss_pred             CCcceEEecCCCCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCcccc-C-CCccccccceeeccCCcccccCCc
Q 036639           54 AAWTGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTI-L-PLTNCTNLKLAYLSGNDFSAEIPH  130 (670)
Q Consensus        54 ~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~-~-~~~~l~~L~~L~l~~N~l~g~~p~  130 (670)
                      |.|..|.+  ...+++.|+|++|.+++..+. +..+++|++|||++|.+.+.+ + .|.+|++|++|+|++|.+++..|.
T Consensus        14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            45666666  346899999999999997665 999999999999999877766 3 399999999999999999999999


Q ss_pred             cccCCCCCCEEeCCCCcccccCCCC--CcccccccceecccccccccCC-CCcCCCCCCCEEEccCCCCcCCCcchhh--
Q 036639          131 QISSLKGILRLDLSDNNIRGRIPEQ--VTNLTRLLTLRLQNNELTGRIP-DLSSSLKDLKELNLSNNELYGRVPEGLL--  205 (670)
Q Consensus       131 ~~~~l~~L~~L~l~~N~l~g~~p~~--~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~ip~~~~--  205 (670)
                      .|+++++|++|+|++|++++.+|..  +.++++|++|+|++|++++..| ..++++++|++|+|++|++++..|..+.  
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l  171 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL  171 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence            9999999999999999999877776  9999999999999999998765 5789999999999999999988887763  


Q ss_pred             --hhcCcccccccC
Q 036639          206 --KKFGEQSFIGNE  217 (670)
Q Consensus       206 --~~~~~~~~~~n~  217 (670)
                        ..+....+.+|.
T Consensus       172 ~~~~L~~L~L~~n~  185 (844)
T 3j0a_A          172 QGKTLSFFSLAANS  185 (844)
T ss_dssp             HHCSSCCCEECCSB
T ss_pred             cCCccceEECCCCc
Confidence              233444444443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.65  E-value=1.8e-16  Score=175.90  Aligned_cols=155  Identities=25%  Similarity=0.326  Sum_probs=132.3

Q ss_pred             CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccc--cC-CCccccccceeeccCCcccccCCcc-ccCCCCCC
Q 036639           65 SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGT--IL-PLTNCTNLKLAYLSGNDFSAEIPHQ-ISSLKGIL  139 (670)
Q Consensus        65 ~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~--~~-~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~  139 (670)
                      ...++.|+|++|.+.+.++. ++.+++|+.|+|++|++++.  ++ .+.++++|+.|+|++|.+++.+|.. +..+++|+
T Consensus       323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~  402 (520)
T 2z7x_B          323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL  402 (520)
T ss_dssp             CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred             CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence            45789999999999996665 89999999999999999873  23 3889999999999999999867765 88899999


Q ss_pred             EEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCccccccc
Q 036639          140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGN  216 (670)
Q Consensus       140 ~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n  216 (670)
                      +|+|++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .+|...+.   .+....+.+|
T Consensus       403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N  478 (520)
T 2z7x_B          403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN  478 (520)
T ss_dssp             EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred             EEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCC
Confidence            999999999988888775  78999999999999 88887779999999999999999 68876433   4555677899


Q ss_pred             CCCcCCC
Q 036639          217 EGLCGSS  223 (670)
Q Consensus       217 ~~~c~~~  223 (670)
                      ++.|.|.
T Consensus       479 ~~~c~c~  485 (520)
T 2z7x_B          479 PWDCSCP  485 (520)
T ss_dssp             CBCCCHH
T ss_pred             CCcccCC
Confidence            9999864

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.65  E-value=6.4e-16  Score=177.23  Aligned_cols=157  Identities=20%  Similarity=0.201  Sum_probs=122.9

Q ss_pred             EEEEEcCCCCcc--ccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCC--------ccccCC
Q 036639           68 VVSLSLPSHSLR--GPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIP--------HQISSL  135 (670)
Q Consensus        68 v~~l~l~~~~l~--~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p--------~~~~~l  135 (670)
                      +..|++.+|.+.  +.+|. +..+++|+.|+|++|+|++.++. +.++++|+.|+|++|++++..+        ..|.++
T Consensus       456 L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l  535 (680)
T 1ziw_A          456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL  535 (680)
T ss_dssp             CCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTC
T ss_pred             cccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCC
Confidence            444444444444  23333 77888899999999999887655 8889999999999999886422        237888


Q ss_pred             CCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh---hhhcCccc
Q 036639          136 KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL---LKKFGEQS  212 (670)
Q Consensus       136 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~---~~~~~~~~  212 (670)
                      ++|++|+|++|+|+...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..+   +..+....
T Consensus       536 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~  615 (680)
T 1ziw_A          536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD  615 (680)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEE
T ss_pred             CCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEE
Confidence            999999999999994333468999999999999999997667778899999999999999997666543   35666778


Q ss_pred             ccccCCCcCCCC
Q 036639          213 FIGNEGLCGSSP  224 (670)
Q Consensus       213 ~~~n~~~c~~~~  224 (670)
                      +.+|||.|+|..
T Consensus       616 l~~N~~~c~c~~  627 (680)
T 1ziw_A          616 MRFNPFDCTCES  627 (680)
T ss_dssp             CTTCCCCBCCCC
T ss_pred             ccCCCcccCCcc
Confidence            899999999864

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=4.9e-16  Score=148.34  Aligned_cols=128  Identities=28%  Similarity=0.415  Sum_probs=112.4

Q ss_pred             cEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccc
Q 036639           92 RFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNE  171 (670)
Q Consensus        92 ~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  171 (670)
                      +.+++++|+|+..+..+.  ++|+.|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            579999999987665443  68999999999998 788999999999999999999998888899999999999999999


Q ss_pred             ccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcccccccCCCcCCC
Q 036639          172 LTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       172 l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~c~~~  223 (670)
                      |++..|..|..+++|+.|+|++|+|+ .+|...+.   .+....+.+|++.|+|.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCCc
Confidence            99888889999999999999999999 56654433   45566778999999864

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.63  E-value=2.3e-16  Score=173.07  Aligned_cols=151  Identities=18%  Similarity=0.143  Sum_probs=105.3

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCcccc-CCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQIS-SLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l  143 (670)
                      ..+..|+|++|.+++.++.  .+++|+.|+|++|.|++.++ .++++++|+.|+|++|.|++.+|..+. ++++|+.|+|
T Consensus        99 ~~L~~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~L  176 (487)
T 3oja_A           99 PSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL  176 (487)
T ss_dssp             TTCCEEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEEC
T ss_pred             CCcCEEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEec
Confidence            4567777777777765543  45677888888888877654 477777888888888888777777775 6778888888


Q ss_pred             CCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCcC
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLCG  221 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c~  221 (670)
                      ++|.|++. |. +..+++|+.|+|++|+|++.+| .+..+++|+.|+|++|+|++ +|..+  +..+....+.+|++.|+
T Consensus       177 s~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          177 QYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             TTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             CCCccccc-cc-cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCc
Confidence            88887755 22 3357778888888888876444 46677778888888888774 66554  23445556677777766


Q ss_pred             C
Q 036639          222 S  222 (670)
Q Consensus       222 ~  222 (670)
                      +
T Consensus       253 ~  253 (487)
T 3oja_A          253 T  253 (487)
T ss_dssp             H
T ss_pred             c
Confidence            4

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.63  E-value=1.9e-16  Score=173.77  Aligned_cols=154  Identities=18%  Similarity=0.116  Sum_probs=124.3

Q ss_pred             CcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccC
Q 036639           55 AWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISS  134 (670)
Q Consensus        55 ~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~  134 (670)
                      ...|+.-......+..|+|++|.|++..+.    ++|++|+|++|.|++.++.  .+++|+.|+|++|.|++..|..+++
T Consensus        69 ~l~~~~~l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L~~N~l~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~  142 (487)
T 3oja_A           69 VLYETLDLESLSTLRTLDLNNNYVQELLVG----PSIETLHAANNNISRVSCS--RGQGKKNIYLANNKITMLRDLDEGC  142 (487)
T ss_dssp             CCEEEEECTTCTTCCEEECCSSEEEEEEEC----TTCCEEECCSSCCCCEEEC--CCSSCEEEECCSSCCCSGGGBCGGG
T ss_pred             CCCCCcccccCCCCCEEEecCCcCCCCCCC----CCcCEEECcCCcCCCCCcc--ccCCCCEEECCCCCCCCCCchhhcC
Confidence            344444344446899999999999885533    8999999999999987653  4688999999999999999999999


Q ss_pred             CCCCCEEeCCCCcccccCCCCCc-ccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcc
Q 036639          135 LKGILRLDLSDNNIRGRIPEQVT-NLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQ  211 (670)
Q Consensus       135 l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~  211 (670)
                      +++|++|+|++|.|++.+|..+. ++++|+.|+|++|+|++..+  ...+++|+.|+|++|+|++..| .+  +..+...
T Consensus       143 l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L  219 (487)
T 3oja_A          143 RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWI  219 (487)
T ss_dssp             GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEE
T ss_pred             CCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEE
Confidence            99999999999999998998886 79999999999999997743  3358999999999999996544 44  2334445


Q ss_pred             cccccC
Q 036639          212 SFIGNE  217 (670)
Q Consensus       212 ~~~~n~  217 (670)
                      .+.+|.
T Consensus       220 ~Ls~N~  225 (487)
T 3oja_A          220 SLRNNK  225 (487)
T ss_dssp             ECTTSC
T ss_pred             EecCCc
Confidence            555554

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.63  E-value=6.7e-16  Score=175.20  Aligned_cols=152  Identities=20%  Similarity=0.225  Sum_probs=117.7

Q ss_pred             cEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cc-------cccccceeeccCCcccccCCcccc--CC
Q 036639           67 RVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LT-------NCTNLKLAYLSGNDFSAEIPHQIS--SL  135 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~-------~l~~L~~L~l~~N~l~g~~p~~~~--~l  135 (670)
                      +++.|+|++|.++..++. +..+++|+.|+|++|+|+..+.. +.       ++++|+.|+|++|+++ .+|..+.  .+
T Consensus       434 ~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l  512 (636)
T 4eco_A          434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTL  512 (636)
T ss_dssp             CEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTC
T ss_pred             CCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccC
Confidence            577777777777743333 45678888888888888744333 22       2338888888888888 6888887  88


Q ss_pred             CCCCEEeCCCCcccccCCCCCcccccccceec------ccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcC
Q 036639          136 KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRL------QNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFG  209 (670)
Q Consensus       136 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l------~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~  209 (670)
                      ++|+.|+|++|+|++ +|..+.++++|+.|+|      ++|++.+.+|..+..+++|+.|+|++|+| +.||..+...+.
T Consensus       513 ~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~~~L~  590 (636)
T 4eco_A          513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKITPNIS  590 (636)
T ss_dssp             TTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCTTCC
T ss_pred             CCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHhCcCC
Confidence            888899999998887 8888888888888888      56778888888888888899999999988 688887777777


Q ss_pred             cccccccCCCcC
Q 036639          210 EQSFIGNEGLCG  221 (670)
Q Consensus       210 ~~~~~~n~~~c~  221 (670)
                      ...+.+|+..|-
T Consensus       591 ~L~Ls~N~l~~~  602 (636)
T 4eco_A          591 VLDIKDNPNISI  602 (636)
T ss_dssp             EEECCSCTTCEE
T ss_pred             EEECcCCCCccc
Confidence            777778877653

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.63  E-value=3.5e-16  Score=161.34  Aligned_cols=148  Identities=21%  Similarity=0.153  Sum_probs=65.5

Q ss_pred             cEEEEEcCCCCccccCCC-----CCCCCCccEEEccCCCCccccC-CCccccccceeeccCCccccc--CC--ccccCCC
Q 036639           67 RVVSLSLPSHSLRGPIAP-----LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAE--IP--HQISSLK  136 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-----~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~--~p--~~~~~l~  136 (670)
                      .+..|+|++|.+.+..+.     +..+++|++|+|++|++++.++ .++++++|++|+|++|++.+.  ++  ..+++++
T Consensus       118 ~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~  197 (310)
T 4glp_A          118 ALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFP  197 (310)
T ss_dssp             CCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSC
T ss_pred             CCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCC
Confidence            344455555555543331     2344555555555555544442 244555555555555554431  11  1123444


Q ss_pred             CCCEEeCCCCcccccCCC----CCcccccccceecccccccccCCCCcCCC---CCCCEEEccCCCCcCCCcchhhhhcC
Q 036639          137 GILRLDLSDNNIRGRIPE----QVTNLTRLLTLRLQNNELTGRIPDLSSSL---KDLKELNLSNNELYGRVPEGLLKKFG  209 (670)
Q Consensus       137 ~L~~L~l~~N~l~g~~p~----~~~~l~~L~~L~l~~N~l~g~~p~~~~~l---~~L~~l~l~~N~l~g~ip~~~~~~~~  209 (670)
                      +|++|+|++|+|+ .+|.    .+.++++|++|+|++|+|++.+|..+..+   ++|+.|+|++|+|+ .+|..+...+.
T Consensus       198 ~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~  275 (310)
T 4glp_A          198 AIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLR  275 (310)
T ss_dssp             CCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCS
T ss_pred             CCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCC
Confidence            5555555555554 1111    12344455555555555554444443333   34555555555554 44444433333


Q ss_pred             ccccccc
Q 036639          210 EQSFIGN  216 (670)
Q Consensus       210 ~~~~~~n  216 (670)
                      ...+.+|
T Consensus       276 ~L~Ls~N  282 (310)
T 4glp_A          276 VLDLSSN  282 (310)
T ss_dssp             CEECCSC
T ss_pred             EEECCCC
Confidence            3333333

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=2.4e-16  Score=164.17  Aligned_cols=136  Identities=11%  Similarity=0.101  Sum_probs=98.5

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc--------------chHH--------HHHHHHHHHhccCCCCeeeE
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP--------------CARK--------EFEQYMDVIGKLKHPNVVKL  417 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~nIv~l  417 (670)
                      +.+.||+|++|.||+|...+|+.||||+++....              ....        ...+|...+.++.+.++.-.
T Consensus        99 I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp  178 (397)
T 4gyi_A           99 VGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVP  178 (397)
T ss_dssp             EEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCC
T ss_pred             ecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCC
Confidence            4578999999999999988999999998753210              0011        12356677777755544322


Q ss_pred             EEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       418 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      .-+...  ..+|||||+++++|.++...           .....++.|++.+|.|||+.    +||||||||.|||++++
T Consensus       179 ~p~~~~--~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~----gIVHrDLKp~NILl~~d  241 (397)
T 4gyi_A          179 EPIAQS--RHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKH----GLIHGDFNEFNILIREE  241 (397)
T ss_dssp             CEEEEE--TTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEEEE
T ss_pred             eeeecc--CceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHC----CCcCCCCCHHHEEEeCC
Confidence            212122  34799999999888765432           12346789999999999988    99999999999999887


Q ss_pred             C----------cEEEEecccccccC
Q 036639          498 G----------VACISDFGLSLLLN  512 (670)
Q Consensus       498 ~----------~~kl~DFG~a~~~~  512 (670)
                      +          .+.|+||+-+....
T Consensus       242 gd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          242 KDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             ECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCcccccccccceEEEEeCCcccCC
Confidence            7          38999999776543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.63  E-value=2.4e-16  Score=174.72  Aligned_cols=154  Identities=23%  Similarity=0.292  Sum_probs=121.2

Q ss_pred             CCCCCCC-CCCCC---CcceE-EecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCcccccccee
Q 036639           43 LSNWKGA-DACAA---AWTGV-VCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLA  117 (670)
Q Consensus        43 l~~W~~~-~~~~~---~w~gv-~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L  117 (670)
                      +.+|... ++|..   .|.|+ .|..  .+++.|+|++|+|++.++.+  +++|++|+|++|+|+.. +  ..+++|+.|
T Consensus        33 l~~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~lp~~l--~~~L~~L~Ls~N~l~~i-p--~~l~~L~~L  105 (571)
T 3cvr_A           33 WDKWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSSLPDNL--PPQITVLEITQNALISL-P--ELPASLEYL  105 (571)
T ss_dssp             HHHHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSCCCSCC--CTTCSEEECCSSCCSCC-C--CCCTTCCEE
T ss_pred             HHHHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCccCHhH--cCCCCEEECcCCCCccc-c--cccCCCCEE
Confidence            4567542 23322   69999 7875  57999999999999844435  38899999999999954 4  668999999


Q ss_pred             eccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          118 YLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       118 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +|++|+|++ +|. +.+  +|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|+
T Consensus       106 ~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~  173 (571)
T 3cvr_A          106 DACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLT  173 (571)
T ss_dssp             ECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS
T ss_pred             EccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCC
Confidence            999999997 787 766  89999999999997 777   68899999999999996 666   4789999999999998


Q ss_pred             CCCcchhhhhcCcccccccC
Q 036639          198 GRVPEGLLKKFGEQSFIGNE  217 (670)
Q Consensus       198 g~ip~~~~~~~~~~~~~~n~  217 (670)
                      + +|. +..++....+.+|.
T Consensus       174 ~-lp~-l~~~L~~L~Ls~N~  191 (571)
T 3cvr_A          174 F-LPE-LPESLEALDVSTNL  191 (571)
T ss_dssp             C-CCC-CCTTCCEEECCSSC
T ss_pred             C-cch-hhCCCCEEECcCCC
Confidence            6 787 54455555555553

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.62  E-value=1.1e-16  Score=165.37  Aligned_cols=136  Identities=22%  Similarity=0.253  Sum_probs=80.9

Q ss_pred             CcEEEEEcCCCCccccCCC-C--CCCCCccEEEccCCCCccccCCCccc-----cccceeeccCCcccccCCccccCCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-L--SLLDQLRFLDLHDNRLNGTILPLTNC-----TNLKLAYLSGNDFSAEIPHQISSLKG  137 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~--~~l~~L~~L~L~~N~l~~~~~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l~~  137 (670)
                      .+++.|+|++|.+++.+|. +  +.+++|++|+|++|+|++.+..++.+     ++|++|+|++|++++..|..|+++++
T Consensus        95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~  174 (312)
T 1wwl_A           95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA  174 (312)
T ss_dssp             SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred             CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence            3566677777777665555 3  66677777777777776653234444     66666666666666666666666666


Q ss_pred             CCEEeCCCCccccc--CCCCC--cccccccceecccccccc--cCC-CCcCCCCCCCEEEccCCCCcCCCc
Q 036639          138 ILRLDLSDNNIRGR--IPEQV--TNLTRLLTLRLQNNELTG--RIP-DLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       138 L~~L~l~~N~l~g~--~p~~~--~~l~~L~~L~l~~N~l~g--~~p-~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      |++|+|++|+++|.  +|..+  .++++|++|+|++|+|++  .++ ..+..+++|+.|+|++|+|++.+|
T Consensus       175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  245 (312)
T 1wwl_A          175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAG  245 (312)
T ss_dssp             CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCC
T ss_pred             CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccc
Confidence            66666666666554  22233  556666666666666652  111 223345566666666666665554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.62  E-value=9.8e-16  Score=167.94  Aligned_cols=157  Identities=22%  Similarity=0.194  Sum_probs=119.7

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCcccc------------------------ccceeec
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCT------------------------NLKLAYL  119 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~------------------------~L~~L~l  119 (670)
                      ..+..|+|++|.+++..+. +..+++|+.|+|++|++.+..+ .+.+++                        +|+.|+|
T Consensus       152 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l  231 (477)
T 2id5_A          152 NSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSI  231 (477)
T ss_dssp             TTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEE
T ss_pred             CCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEEC
Confidence            3566677777766654433 5566666666666666655443 233333                        5666666


Q ss_pred             cCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCC
Q 036639          120 SGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       120 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      ++|++++..+..|.++++|+.|+|++|.|++..+..|.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++ 
T Consensus       232 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~-  310 (477)
T 2id5_A          232 THCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-  310 (477)
T ss_dssp             ESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSC-
T ss_pred             cCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCce-
Confidence            7777775444678899999999999999998888899999999999999999999999999999999999999999995 


Q ss_pred             Ccchhh---hhcCcccccccCCCcCCC
Q 036639          200 VPEGLL---KKFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       200 ip~~~~---~~~~~~~~~~n~~~c~~~  223 (670)
                      +|...+   ..+....+.+|++.|+|.
T Consensus       311 ~~~~~~~~l~~L~~L~l~~N~l~c~c~  337 (477)
T 2id5_A          311 LEESVFHSVGNLETLILDSNPLACDCR  337 (477)
T ss_dssp             CCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred             eCHhHcCCCcccCEEEccCCCccCccc
Confidence            554443   456667789999999874

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.62  E-value=9.7e-17  Score=165.70  Aligned_cols=150  Identities=23%  Similarity=0.244  Sum_probs=111.6

Q ss_pred             cEEEEEcCCCCcc-ccCCC-CC-------CCCCccEEEccCCCCccccCC-C--ccccccceeeccCCcccccCCccccC
Q 036639           67 RVVSLSLPSHSLR-GPIAP-LS-------LLDQLRFLDLHDNRLNGTILP-L--TNCTNLKLAYLSGNDFSAEIPHQISS  134 (670)
Q Consensus        67 ~v~~l~l~~~~l~-~~~~~-~~-------~l~~L~~L~L~~N~l~~~~~~-~--~~l~~L~~L~l~~N~l~g~~p~~~~~  134 (670)
                      .++.|+|++|.+. +.++. +.       .+++|++|+|++|++++.++. +  .++++|+.|+|++|++++. |..+++
T Consensus        64 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~  142 (312)
T 1wwl_A           64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAE  142 (312)
T ss_dssp             HHHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHH
T ss_pred             HHhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHH
Confidence            3677888888884 44554 33       688888899998888876654 4  7888889999999988876 777777


Q ss_pred             C-----CCCCEEeCCCCcccccCCCCCcccccccceecccccccccC--CCCc--CCCCCCCEEEccCCCCcC--CCcch
Q 036639          135 L-----KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRI--PDLS--SSLKDLKELNLSNNELYG--RVPEG  203 (670)
Q Consensus       135 l-----~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~--p~~~--~~l~~L~~l~l~~N~l~g--~ip~~  203 (670)
                      +     ++|++|+|++|+|++..|..|+++++|++|+|++|++.|.+  |..+  ..+++|+.|+|++|+|++  .+|..
T Consensus       143 l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  222 (312)
T 1wwl_A          143 LQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA  222 (312)
T ss_dssp             HHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHH
T ss_pred             HHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHH
Confidence            6     88889999999888877788888888999999888887652  3333  778888889999888873  33434


Q ss_pred             hh---hhcCcccccccC
Q 036639          204 LL---KKFGEQSFIGNE  217 (670)
Q Consensus       204 ~~---~~~~~~~~~~n~  217 (670)
                      ++   ..+....+.+|.
T Consensus       223 ~~~~l~~L~~L~Ls~N~  239 (312)
T 1wwl_A          223 LAAARVQLQGLDLSHNS  239 (312)
T ss_dssp             HHHTTCCCSEEECTTSC
T ss_pred             HHhcCCCCCEEECCCCc
Confidence            33   234444555554

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.61  E-value=1.9e-15  Score=169.47  Aligned_cols=139  Identities=21%  Similarity=0.242  Sum_probs=127.0

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ..++.|+|++|.+++..+. |..+++|++|+|++|++++..+. |.++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus        28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  107 (570)
T 2z63_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (570)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence            4689999999999997765 99999999999999999988754 999999999999999999988899999999999999


Q ss_pred             CCCcccccCCCCCcccccccceecccccccc-cCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      ++|++++..+..++++++|++|+|++|++++ .+|..+..+++|+.|++++|++++..|..+
T Consensus       108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~  169 (570)
T 2z63_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL  169 (570)
T ss_dssp             TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGG
T ss_pred             cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHc
Confidence            9999997666679999999999999999997 479999999999999999999997666555

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.60  E-value=1.2e-15  Score=157.30  Aligned_cols=150  Identities=19%  Similarity=0.153  Sum_probs=124.7

Q ss_pred             cEEEEEcCCCCccccCCC-C--CCCCCccEEEccCCCCccccCC-----CccccccceeeccCCcccccCCccccCCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAP-L--SLLDQLRFLDLHDNRLNGTILP-----LTNCTNLKLAYLSGNDFSAEIPHQISSLKGI  138 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-~--~~l~~L~~L~L~~N~l~~~~~~-----~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  138 (670)
                      +++.|+|++|.+.+.++. +  ..+++|++|+|++|++++..+.     +..+++|+.|+|++|++++..|..|+++++|
T Consensus        92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L  171 (310)
T 4glp_A           92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPAL  171 (310)
T ss_dssp             CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTC
T ss_pred             ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCC
Confidence            489999999999998877 5  8999999999999999986542     5679999999999999999889999999999


Q ss_pred             CEEeCCCCccccc--C--CCCCcccccccceecccccccccCCC----CcCCCCCCCEEEccCCCCcCCCcchhh-----
Q 036639          139 LRLDLSDNNIRGR--I--PEQVTNLTRLLTLRLQNNELTGRIPD----LSSSLKDLKELNLSNNELYGRVPEGLL-----  205 (670)
Q Consensus       139 ~~L~l~~N~l~g~--~--p~~~~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~l~l~~N~l~g~ip~~~~-----  205 (670)
                      ++|+|++|++.+.  +  +..+.++++|++|+|++|+++ .+|.    .+..+++|++|+|++|+|++.+|..+.     
T Consensus       172 ~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~  250 (310)
T 4glp_A          172 TSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS  250 (310)
T ss_dssp             CEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred             CEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence            9999999998763  3  234578999999999999997 3333    356789999999999999988886652     


Q ss_pred             hhcCcccccccC
Q 036639          206 KKFGEQSFIGNE  217 (670)
Q Consensus       206 ~~~~~~~~~~n~  217 (670)
                      ..+....+.+|.
T Consensus       251 ~~L~~L~Ls~N~  262 (310)
T 4glp_A          251 SALNSLNLSFAG  262 (310)
T ss_dssp             TTCCCEECCSSC
T ss_pred             CcCCEEECCCCC
Confidence            244445555554

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.60  E-value=3.7e-15  Score=155.04  Aligned_cols=135  Identities=21%  Similarity=0.326  Sum_probs=88.0

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCcc--ccC-CCccccccceeeccCCcccccCCccccCCCCCCEE
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNG--TIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL  141 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~--~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L  141 (670)
                      ..+..|++++|.+.+..+. +..+++|+.|+|++|.++.  ..+ .+.++++|+.|+|++|.++. +|..+.  ++|++|
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L  197 (330)
T 1xku_A          121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTEL  197 (330)
T ss_dssp             TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEE
T ss_pred             ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEE
Confidence            3678888888888876554 7778888888888887753  222 36667777777777766663 454443  566666


Q ss_pred             eCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       142 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      +|++|++++..|..+.++++|+.|+|++|++++..+..+..+++|+.|+|++|+|+ .+|..+
T Consensus       198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l  259 (330)
T 1xku_A          198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL  259 (330)
T ss_dssp             ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred             ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhh
Confidence            66666666655666666666666666666666555555666666666666666666 555544

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.60  E-value=1.1e-15  Score=151.18  Aligned_cols=135  Identities=16%  Similarity=0.197  Sum_probs=101.1

Q ss_pred             CcEEEEEcCCCC-ccccCCC-CCCCCCccEEEccC-CCCccccCC-CccccccceeeccCCcccccCCccccCCCCCC--
Q 036639           66 ERVVSLSLPSHS-LRGPIAP-LSLLDQLRFLDLHD-NRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGIL--  139 (670)
Q Consensus        66 ~~v~~l~l~~~~-l~~~~~~-~~~l~~L~~L~L~~-N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~--  139 (670)
                      .+++.|+|++|. ++...+. +..+++|++|+|++ |+|++..+. |.++++|+.|+|++|.+++ +|. +.++++|+  
T Consensus        55 ~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L  132 (239)
T 2xwt_C           55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIF  132 (239)
T ss_dssp             TTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSE
T ss_pred             CCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccc
Confidence            568888888886 7765553 77888888888887 888876643 7788888888888888886 665 77777777  


Q ss_pred             -EEeCCCC-cccccCCCCCccccccc-ceecccccccccCCCCcCCCCCCCEEEccCCC-CcCCCcchh
Q 036639          140 -RLDLSDN-NIRGRIPEQVTNLTRLL-TLRLQNNELTGRIPDLSSSLKDLKELNLSNNE-LYGRVPEGL  204 (670)
Q Consensus       140 -~L~l~~N-~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~-l~g~ip~~~  204 (670)
                       +|+|++| ++++..+..|.++++|+ .|+|++|+++ .+|......++|+.|++++|+ ++ .+|...
T Consensus       133 ~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~-~i~~~~  199 (239)
T 2xwt_C          133 FILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT-VIDKDA  199 (239)
T ss_dssp             EEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCC-EECTTT
T ss_pred             cEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcc-cCCHHH
Confidence             8888888 88866666788888888 8888888887 555443333778888888884 77 454443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.60  E-value=2.2e-15  Score=174.69  Aligned_cols=149  Identities=16%  Similarity=0.194  Sum_probs=98.3

Q ss_pred             cEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCCCc--------cccccceeeccCCcccccCCcccc--CC
Q 036639           67 RVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLT--------NCTNLKLAYLSGNDFSAEIPHQIS--SL  135 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~--------~l~~L~~L~l~~N~l~g~~p~~~~--~l  135 (670)
                      ++..|+|++|.+...++. +..+++|+.|+|++|+|+..+..+.        +|++|+.|+|++|+|+ .+|..+.  ++
T Consensus       674 ~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l  752 (876)
T 4ecn_A          674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTL  752 (876)
T ss_dssp             CEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTC
T ss_pred             CcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccC
Confidence            455555555555532222 2356677777777777764333221        3347777777777777 6777776  77


Q ss_pred             CCCCEEeCCCCcccccCCCCCcccccccceeccc------ccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcC
Q 036639          136 KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN------NELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFG  209 (670)
Q Consensus       136 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~------N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~  209 (670)
                      ++|+.|+|++|+|++ +|..+.++++|+.|+|++      |++.+.+|..+..+++|+.|+|++|+| +.||..+...+.
T Consensus       753 ~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~~~L~  830 (876)
T 4ecn_A          753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLTPQLY  830 (876)
T ss_dssp             TTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCCSSSC
T ss_pred             CCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhcCCCC
Confidence            777777777777775 677777777777777755      667777777777777777777777777 577776655555


Q ss_pred             cccccccCC
Q 036639          210 EQSFIGNEG  218 (670)
Q Consensus       210 ~~~~~~n~~  218 (670)
                      ...+.+|+.
T Consensus       831 ~LdLs~N~l  839 (876)
T 4ecn_A          831 ILDIADNPN  839 (876)
T ss_dssp             EEECCSCTT
T ss_pred             EEECCCCCC
Confidence            555566653

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.59  E-value=9.7e-16  Score=144.04  Aligned_cols=128  Identities=18%  Similarity=0.175  Sum_probs=111.2

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCC-CccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLD-QLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      ..++.|+|++|+++. ++.+..+. +|++|+|++|+|++. ..+.++++|+.|+|++|.|++..|..+.++++|++|+|+
T Consensus        19 ~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~   96 (176)
T 1a9n_A           19 VRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT   96 (176)
T ss_dssp             TSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred             CCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECC
Confidence            468999999999996 46666655 999999999999987 779999999999999999997655556999999999999


Q ss_pred             CCcccccCCC--CCcccccccceecccccccccCCCC----cCCCCCCCEEEccCCCCc
Q 036639          145 DNNIRGRIPE--QVTNLTRLLTLRLQNNELTGRIPDL----SSSLKDLKELNLSNNELY  197 (670)
Q Consensus       145 ~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~----~~~l~~L~~l~l~~N~l~  197 (670)
                      +|+|+ .+|.  .+.++++|+.|+|++|.++ .+|..    +..+++|+.||+++|.+.
T Consensus        97 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           97 NNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             SCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            99996 6776  7899999999999999998 56764    888999999999999875

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.58  E-value=2.2e-15  Score=144.43  Aligned_cols=129  Identities=20%  Similarity=0.237  Sum_probs=111.6

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCcccc-CCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      .++..|+|++|.+.. ++.+..+++|++|+|++|++++.. ..+.++++|+.|+|++|.+++..|..++++++|++|+|+
T Consensus        66 ~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~  144 (197)
T 4ezg_A           66 HNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS  144 (197)
T ss_dssp             TTCSEEEEESCCCSC-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred             CCCCEEEccCCCCCc-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence            478999999997654 356899999999999999999844 569999999999999999999899999999999999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcC
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      +|.+.+.+| .+.++++|+.|+|++|++++ ++ .+..+++|+.|++++|++.+
T Consensus       145 ~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          145 YNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             SCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             CCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            998434666 69999999999999999996 55 68889999999999999864

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.58  E-value=4.4e-15  Score=167.35  Aligned_cols=110  Identities=20%  Similarity=0.159  Sum_probs=95.9

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ..+..|+|++|.+.+.++. ++.+++|++|+|++|.|++.++. |+++++|+.|+|++|.|++..+..|+++++|++|+|
T Consensus        75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  154 (597)
T 3oja_B           75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM  154 (597)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence            4688899999999987774 89999999999999999988765 789999999999999999665566789999999999


Q ss_pred             CCCcccccCCCCCcccccccceeccccccccc
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR  175 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  175 (670)
                      ++|.|++..|..|.++++|++|+|++|+|++.
T Consensus       155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  186 (597)
T 3oja_B          155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  186 (597)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence            99999988888899999999999999998864

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.58  E-value=3.2e-15  Score=152.57  Aligned_cols=142  Identities=27%  Similarity=0.368  Sum_probs=116.7

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .+++.|+|++|.+++..+ +..+++|++|+|++|++++. +.+.++++|+.|+|++|++++.  +.+..+++|+.|+|++
T Consensus        68 ~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~  143 (291)
T 1h6t_A           68 PNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGN  143 (291)
T ss_dssp             TTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCS
T ss_pred             CCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCC-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccC
Confidence            578899999999988655 88999999999999999874 5588999999999999999863  5688999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNE  217 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~  217 (670)
                      |++++.  ..+..+++|+.|+|++|++++..|  +..+++|+.|++++|+|++ +|. +  +..+....+.+|+
T Consensus       144 n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~-l~~l~~L~~L~l~~n~  211 (291)
T 1h6t_A          144 NKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQE  211 (291)
T ss_dssp             SCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEEEEEEE
T ss_pred             CcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Chh-hccCCCCCEEECcCCc
Confidence            999864  678899999999999999997655  8889999999999999984 553 2  2334445556665

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.58  E-value=6.5e-15  Score=137.50  Aligned_cols=90  Identities=27%  Similarity=0.303  Sum_probs=68.0

Q ss_pred             cccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEc
Q 036639          112 TNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNL  191 (670)
Q Consensus       112 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  191 (670)
                      ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..+..+++|+.|+|
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            56666777777777666777777778888888888887665566777888888888888888666666778888888888


Q ss_pred             cCCCCcCCCc
Q 036639          192 SNNELYGRVP  201 (670)
Q Consensus       192 ~~N~l~g~ip  201 (670)
                      ++|.++...+
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            8888876544

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.57  E-value=2.6e-15  Score=154.55  Aligned_cols=126  Identities=21%  Similarity=0.327  Sum_probs=85.8

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .+++.|+|++|.+.+..+ +..+++|++|+|++|++++. +.+.++++|+.|+|++|++++ +|. +.++++|++|+|++
T Consensus        63 ~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~  138 (308)
T 1h6u_A           63 NNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDL  138 (308)
T ss_dssp             TTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCS
T ss_pred             CCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCC
Confidence            457777777777776544 77777777777777777664 456777777777777777765 332 67777777777777


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      |++++..+  +.++++|+.|+|++|++++..+  +..+++|+.|++++|++++.
T Consensus       139 n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~  188 (308)
T 1h6u_A          139 NQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKISDI  188 (308)
T ss_dssp             SCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred             CccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccCcC
Confidence            77764433  6677777777777777764333  66677777777777777643

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.57  E-value=1.6e-15  Score=159.33  Aligned_cols=152  Identities=18%  Similarity=0.186  Sum_probs=130.9

Q ss_pred             CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCC-ccccCCCCCCEE
Q 036639           65 SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIP-HQISSLKGILRL  141 (670)
Q Consensus        65 ~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L  141 (670)
                      -.+++.|+|++|.+++..+. ++.+++|++|+|++|+|++..+. +.++++|++|+|++|++++..+ ..+.++++|++|
T Consensus        75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L  154 (353)
T 2z80_A           75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQIL  154 (353)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEE
Confidence            35799999999999998766 99999999999999999987655 8999999999999999995433 479999999999


Q ss_pred             eCCCC-cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcccccccC
Q 036639          142 DLSDN-NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGNE  217 (670)
Q Consensus       142 ~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n~  217 (670)
                      +|++| .+++..|..+.++++|++|+|++|++++..|..+..+++|++|++++|+++ .+|..++.   .+....+.+|.
T Consensus       155 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~  233 (353)
T 2z80_A          155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTD  233 (353)
T ss_dssp             EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCB
T ss_pred             ECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCc
Confidence            99999 577777889999999999999999999999999999999999999999996 67766543   33444455553

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.57  E-value=3.5e-15  Score=156.60  Aligned_cols=156  Identities=19%  Similarity=0.247  Sum_probs=111.1

Q ss_pred             CCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC--Cccccccce-e
Q 036639           51 ACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKL-A  117 (670)
Q Consensus        51 ~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~-L  117 (670)
                      .|.|+|+.|.|+..         ...++.|+|++|.|+...+. |..+++|++|+|++|++.+.++.  |.++++|.. +
T Consensus         6 ~C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l   85 (350)
T 4ay9_X            6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR   85 (350)
T ss_dssp             SSEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEE
T ss_pred             ccEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhh
Confidence            47799999999753         14689999999999987665 89999999999999999776643  778877664 6


Q ss_pred             eccCCcccccCCccccCCCCCCEEeCCCCcccccCCCC-------------------------Cccc-ccccceeccccc
Q 036639          118 YLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQ-------------------------VTNL-TRLLTLRLQNNE  171 (670)
Q Consensus       118 ~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-------------------------~~~l-~~L~~L~l~~N~  171 (670)
                      ++++|++++..|..|.++++|++|++++|+|++..+..                         +..+ ..|+.|+|++|+
T Consensus        86 ~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~  165 (350)
T 4ay9_X           86 IEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG  165 (350)
T ss_dssp             EEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred             cccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence            66778888777788888888888888888777433321                         2222 246667788888


Q ss_pred             ccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhh
Q 036639          172 LTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK  207 (670)
Q Consensus       172 l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~  207 (670)
                      |+. +|.......+|+.|++++|+.-+.||...+..
T Consensus       166 i~~-i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~  200 (350)
T 4ay9_X          166 IQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHG  200 (350)
T ss_dssp             CCE-ECTTSSTTEEEEEEECTTCTTCCCCCTTTTTT
T ss_pred             ccC-CChhhccccchhHHhhccCCcccCCCHHHhcc
Confidence            774 44433345567777776544334677655443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.57  E-value=1.1e-14  Score=136.95  Aligned_cols=129  Identities=22%  Similarity=0.256  Sum_probs=109.6

Q ss_pred             ccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccc
Q 036639           91 LRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNN  170 (670)
Q Consensus        91 L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  170 (670)
                      .+.+++++|+++..+..+  .++|+.|+|++|++++..+..|.++++|++|+|++|+|++..+..+.++++|++|+|++|
T Consensus         9 ~~~l~~~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TTEEECCSSCCSSCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEecCCCCccCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            468999999998765443  379999999999999877778899999999999999999777777899999999999999


Q ss_pred             cccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcccccccCCCcCC
Q 036639          171 ELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGNEGLCGS  222 (670)
Q Consensus       171 ~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n~~~c~~  222 (670)
                      +|++..+..+..+++|++|++++|+|+ .+|...+.   .+....+.+|++.|.+
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence            999877778899999999999999999 55655433   4555677889888764

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.57  E-value=7.2e-15  Score=137.17  Aligned_cols=106  Identities=20%  Similarity=0.196  Sum_probs=91.4

Q ss_pred             EEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcc
Q 036639           70 SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNI  148 (670)
Q Consensus        70 ~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l  148 (670)
                      .|++++|+|+..+..+  .++|++|+|++|+|++..+. |.++++|+.|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus        13 ~l~~s~n~l~~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l   90 (170)
T 3g39_A           13 TVDCSGKSLASVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQL   90 (170)
T ss_dssp             EEECTTSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             EEEeCCCCcCccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCcc
Confidence            3555667777754444  38999999999999998765 99999999999999999987777889999999999999999


Q ss_pred             cccCCCCCcccccccceecccccccccCC
Q 036639          149 RGRIPEQVTNLTRLLTLRLQNNELTGRIP  177 (670)
Q Consensus       149 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p  177 (670)
                      ++..|..|.++++|++|+|++|.++...+
T Consensus        91 ~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           91 KSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            97777789999999999999999986543

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.57  E-value=8.1e-15  Score=152.64  Aligned_cols=149  Identities=26%  Similarity=0.317  Sum_probs=88.9

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCccc--ccCCccccCC-------
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFS--AEIPHQISSL-------  135 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~--g~~p~~~~~l-------  135 (670)
                      ..+..|+|++|.+....+.+.  ++|++|+|++|++++..+. +.++++|+.|+|++|.++  +..|..+..+       
T Consensus       102 ~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l  179 (332)
T 2ft3_A          102 RKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI  179 (332)
T ss_dssp             TTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBC
T ss_pred             CCCCEEECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEEC
Confidence            345566666665553322222  4455555555555443332 444444444444444443  1233332222       


Q ss_pred             -------------CCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcc
Q 036639          136 -------------KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       136 -------------~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~  202 (670)
                                   ++|++|+|++|++++..|..+.++++|+.|+|++|++++..|..+..+++|+.|+|++|+|+ .+|.
T Consensus       180 ~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~  258 (332)
T 2ft3_A          180 SEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA  258 (332)
T ss_dssp             CSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred             cCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence                         56777777778887777777888888888888888888776767777888888888888887 7776


Q ss_pred             hhh--hhcCcccccccC
Q 036639          203 GLL--KKFGEQSFIGNE  217 (670)
Q Consensus       203 ~~~--~~~~~~~~~~n~  217 (670)
                      .+.  ..+....+.+|.
T Consensus       259 ~l~~l~~L~~L~l~~N~  275 (332)
T 2ft3_A          259 GLPDLKLLQVVYLHTNN  275 (332)
T ss_dssp             TGGGCTTCCEEECCSSC
T ss_pred             hhhcCccCCEEECCCCC
Confidence            652  233344445554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.56  E-value=7.9e-15  Score=150.97  Aligned_cols=144  Identities=22%  Similarity=0.403  Sum_probs=83.2

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .++..|+|++|.+.+. +.+..+++|++|+|++|++++. +.+.++++|+.|+|++|.+++..+  ++++++|++|+|++
T Consensus        85 ~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~  160 (308)
T 1h6u_A           85 TKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV-TPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGN  160 (308)
T ss_dssp             CSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             CCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccC
Confidence            4566666666666653 3466666666666666666653 336666666666666666664332  66666666666666


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcCcccccccC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNE  217 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~  217 (670)
                      |++++. |. +.++++|+.|+|++|++++..+  +..+++|+.|+|++|++++..|-.-+..+....+.+|+
T Consensus       161 n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~  228 (308)
T 1h6u_A          161 AQVSDL-TP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT  228 (308)
T ss_dssp             SCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEE
T ss_pred             CcCCCC-hh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCe
Confidence            666643 22 6666666666666666664332  55566666666666666643331112233334444454

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.56  E-value=2.7e-15  Score=155.22  Aligned_cols=148  Identities=18%  Similarity=0.141  Sum_probs=93.9

Q ss_pred             EEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCcccc-CCCCCCEEeCCC
Q 036639           68 VVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQIS-SLKGILRLDLSD  145 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~L~l~~  145 (670)
                      +..|++++|.+++..+  ..+++|+.|+|++|++++..+ .+..+++|+.|+|++|.+++..|..+. .+++|++|+|++
T Consensus       101 L~~L~l~~n~l~~~~~--~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~  178 (317)
T 3o53_A          101 IETLHAANNNISRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY  178 (317)
T ss_dssp             CCEEECCSSCCSEEEE--CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTT
T ss_pred             cCEEECCCCccCCcCc--cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCC
Confidence            3444444444444322  235667777777777776654 467777777777777777776666653 677777777777


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCcC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLCG  221 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c~  221 (670)
                      |+|++. |. ...+++|++|+|++|++++. |..+..+++|+.|+|++|+|+ .+|..+  +..+....+.+|++.|+
T Consensus       179 N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          179 NFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             SCCCEE-EC-CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             CcCccc-cc-ccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence            777744 32 23477777777777777743 334667777777777777777 466544  23444555666766655

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.56  E-value=1.1e-14  Score=157.90  Aligned_cols=132  Identities=26%  Similarity=0.277  Sum_probs=112.2

Q ss_pred             CcEEEEEcCCCCccccCCC--------------------------CCCCCCccEEEccCCCCccccCCCccccccceeec
Q 036639           66 ERVVSLSLPSHSLRGPIAP--------------------------LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYL  119 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~--------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l  119 (670)
                      .++..|+|++|.+....+.                          +..+++|++|+|++|+|+.. +.+..+++|+.|+|
T Consensus       136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~L  214 (440)
T 3zyj_A          136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDL  214 (440)
T ss_dssp             SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEEC
T ss_pred             ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-cccCCCcccCEEEC
Confidence            4577777777776654331                          45566777777777777643 56788889999999


Q ss_pred             cCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcC
Q 036639          120 SGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       120 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      ++|.|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.-
T Consensus       215 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             CCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            9999999999999999999999999999999999999999999999999999998778889999999999999999863

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.55  E-value=1.2e-14  Score=158.23  Aligned_cols=133  Identities=23%  Similarity=0.262  Sum_probs=114.6

Q ss_pred             CcEEEEEcCCCCccccCCC--------------------------CCCCCCccEEEccCCCCccccCCCccccccceeec
Q 036639           66 ERVVSLSLPSHSLRGPIAP--------------------------LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYL  119 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~--------------------------~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l  119 (670)
                      .++..|+|++|.+....+.                          +..+++|++|+|++|+|++. +.+..+++|+.|+|
T Consensus       147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~L  225 (452)
T 3zyi_A          147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEM  225 (452)
T ss_dssp             TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEEC
Confidence            4678888888877754431                          45567777777777777754 56888899999999


Q ss_pred             cCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCC
Q 036639          120 SGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       120 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      ++|.|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|.+.-.
T Consensus       226 s~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd  305 (452)
T 3zyi_A          226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD  305 (452)
T ss_dssp             TTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred             cCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence            99999999999999999999999999999999999999999999999999999987778899999999999999998643

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.55  E-value=2.1e-14  Score=134.44  Aligned_cols=104  Identities=21%  Similarity=0.250  Sum_probs=71.1

Q ss_pred             EEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccccc
Q 036639           94 LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT  173 (670)
Q Consensus        94 L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  173 (670)
                      +++++|+|+..+..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+
T Consensus        17 l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~   94 (174)
T 2r9u_A           17 VNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLK   94 (174)
T ss_dssp             EECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccc
Confidence            4444444433332232  56667777777777666777777777777777777777654455677788888888888887


Q ss_pred             ccCCCCcCCCCCCCEEEccCCCCcCC
Q 036639          174 GRIPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       174 g~~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      +..+..+..+++|+.|+|++|.|...
T Consensus        95 ~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           95 SIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             eeCHHHhccccCCCEEEeCCCCcccc
Confidence            65555677788888888888888743

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.55  E-value=1.6e-14  Score=153.91  Aligned_cols=110  Identities=20%  Similarity=0.159  Sum_probs=84.4

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      .++..|+|++|.+.+..+. +..+++|++|+|++|++++.++. ++++++|++|+|++|.++...+..|.++++|++|+|
T Consensus        69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  148 (390)
T 3o6n_A           69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM  148 (390)
T ss_dssp             CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence            4577888888888776653 78888888888888888877655 778888888888888887444444677888888888


Q ss_pred             CCCcccccCCCCCcccccccceeccccccccc
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR  175 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  175 (670)
                      ++|++++..|..+.++++|++|+|++|++++.
T Consensus       149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~  180 (390)
T 3o6n_A          149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV  180 (390)
T ss_dssp             CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred             CCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence            88888877777788888888888888887753

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.55  E-value=3.2e-16  Score=179.87  Aligned_cols=138  Identities=21%  Similarity=0.191  Sum_probs=121.5

Q ss_pred             CCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           65 SERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        65 ~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      ...+..|+|++|.+....+.+..+++|++|+|++|.|+..+..|++|++|++|+|++|.|+ .+|..|++|++|++|+|+
T Consensus       223 l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          223 DQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred             CCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence            3578999999999996555588999999999999999955556999999999999999999 889999999999999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCC-CCEEEccCCCCcCCCcchh
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKD-LKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~-L~~l~l~~N~l~g~ip~~~  204 (670)
                      +|.|+ .+|..|++|++|+.|+|++|+|+|.+|..+..+.. +..|+|++|.++|.+|..+
T Consensus       302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l  361 (727)
T 4b8c_D          302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHER  361 (727)
T ss_dssp             SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred             CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccc
Confidence            99998 88999999999999999999999999987654322 2347899999999999866

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.55  E-value=3.7e-15  Score=135.86  Aligned_cols=113  Identities=21%  Similarity=0.278  Sum_probs=101.4

Q ss_pred             CCCCccEEEccCCCCc-cccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccc
Q 036639           87 LLDQLRFLDLHDNRLN-GTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT  164 (670)
Q Consensus        87 ~l~~L~~L~L~~N~l~-~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  164 (670)
                      ..++|+.|+|++|+++ +.++. +..+++|+.|+|++|.+++.  ..++++++|++|+|++|++++.+|..+.++++|++
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            4578999999999998 56654 79999999999999999976  78999999999999999999889988888999999


Q ss_pred             eeccccccccc-CCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          165 LRLQNNELTGR-IPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       165 L~l~~N~l~g~-~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      |+|++|++++. .|..+..+++|+.|++++|++++..+
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  130 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND  130 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTT
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHH
Confidence            99999999974 45788999999999999999996544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.54  E-value=4e-15  Score=153.85  Aligned_cols=144  Identities=18%  Similarity=0.207  Sum_probs=122.2

Q ss_pred             cceEEecCCCCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-C-ccccccceeeccCCcccccCCccc
Q 036639           56 WTGVVCSPKSERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-L-TNCTNLKLAYLSGNDFSAEIPHQI  132 (670)
Q Consensus        56 w~gv~C~~~~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~-~~l~~L~~L~l~~N~l~g~~p~~~  132 (670)
                      ..++.+.. ...+..|+|++|.+++..+. ++.+++|++|+|++|.+++..+. + ..+++|+.|+|++|.+++. | ..
T Consensus       111 l~~~~~~~-~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~  187 (317)
T 3o53_A          111 ISRVSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQ  187 (317)
T ss_dssp             CSEEEECC-CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CC
T ss_pred             cCCcCccc-cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cc
Confidence            44455443 35699999999999997664 88999999999999999987654 4 5799999999999999965 3 34


Q ss_pred             cCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc-CCCcchh
Q 036639          133 SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY-GRVPEGL  204 (670)
Q Consensus       133 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~-g~ip~~~  204 (670)
                      ..+++|++|+|++|+|++ +|..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.++ +.+|..+
T Consensus       188 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~  258 (317)
T 3o53_A          188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF  258 (317)
T ss_dssp             CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHH
T ss_pred             cccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHH
Confidence            459999999999999995 5666999999999999999999 57888999999999999999998 6666554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.54  E-value=1.3e-14  Score=148.09  Aligned_cols=143  Identities=24%  Similarity=0.328  Sum_probs=119.7

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .+++.|++++|.+... +.+..+++|++|+|++|++++..+ +.++++|+.|+|++|.+++ +| .+.++++|++|+|++
T Consensus        46 ~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~  121 (291)
T 1h6t_A           46 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEH  121 (291)
T ss_dssp             HTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTT
T ss_pred             CcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCC
Confidence            4689999999999875 668999999999999999998765 9999999999999999986 44 499999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcCccccccc
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGN  216 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n  216 (670)
                      |++++.  +.+.++++|+.|+|++|++++.  ..+..+++|+.|++++|++++..|-.-+..+....+.+|
T Consensus       122 n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N  188 (291)
T 1h6t_A          122 NGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN  188 (291)
T ss_dssp             SCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSS
T ss_pred             CcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCC
Confidence            999963  5789999999999999999965  568889999999999999996555111233334444444

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.53  E-value=1.2e-14  Score=162.73  Aligned_cols=142  Identities=28%  Similarity=0.387  Sum_probs=117.4

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..+..|+|++|.|.+..+ +..+++|+.|+|++|+|++. +.+..|++|+.|+|++|+|++ + +.+.+|++|+.|+|++
T Consensus        65 ~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~  140 (605)
T 1m9s_A           65 PNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGN  140 (605)
T ss_dssp             TTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCC-TTSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCS
T ss_pred             CCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCCC-hhhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCC
Confidence            578999999999998655 88999999999999999874 578999999999999999986 3 4688999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNE  217 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~  217 (670)
                      |+|++.  ..+..+++|+.|+|++|+|++..|  +..+++|+.|+|++|+|++ +|. +  +..+..+.+.+|+
T Consensus       141 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l~~-l~~l~~L~~L~L~~N~  208 (605)
T 1m9s_A          141 NKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRA-LAGLKNLDVLELFSQE  208 (605)
T ss_dssp             SCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGG-GTTCTTCSEEECCSEE
T ss_pred             CccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-ChH-HccCCCCCEEEccCCc
Confidence            999965  678899999999999999997766  8889999999999999985 443 2  2344444555554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.53  E-value=5.9e-15  Score=164.68  Aligned_cols=152  Identities=20%  Similarity=0.214  Sum_probs=132.5

Q ss_pred             CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccc-cCCccccCCCCCCEE
Q 036639           65 SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSA-EIPHQISSLKGILRL  141 (670)
Q Consensus        65 ~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~L  141 (670)
                      -.+++.|+|++|.+++..+. ++.+++|++|+|++|++++.++. ++++++|++|+|++|.+++ .+|..++++++|++|
T Consensus        49 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L  128 (549)
T 2z81_A           49 CANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL  128 (549)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEE
T ss_pred             CCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEE
Confidence            35799999999999998765 99999999999999999998876 9999999999999999997 468899999999999


Q ss_pred             eCCCCcccccCC-CCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---hcCcccccccC
Q 036639          142 DLSDNNIRGRIP-EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---KFGEQSFIGNE  217 (670)
Q Consensus       142 ~l~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---~~~~~~~~~n~  217 (670)
                      +|++|++.+.+| ..+.++++|++|+|++|++++.+|..+..+++|+.|++++|.++ .+|..++.   .+....+.+|.
T Consensus       129 ~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~  207 (549)
T 2z81_A          129 RIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTN  207 (549)
T ss_dssp             EEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCB
T ss_pred             ECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCc
Confidence            999999665666 68999999999999999999999999999999999999999986 67766533   34444455553

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.53  E-value=1.3e-14  Score=145.60  Aligned_cols=125  Identities=22%  Similarity=0.309  Sum_probs=82.6

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..++.|++++|++.. ++.+..+++|+.|+|++|+|++..+ +.++++|+.|+|++|++++ +|....  ++|+.|+|++
T Consensus        41 ~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~L~~  115 (263)
T 1xeu_A           41 SGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLFLDN  115 (263)
T ss_dssp             TTCSEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEECCS
T ss_pred             CcCcEEECcCCCccc-chHHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-cCcccc--CcccEEEccC
Confidence            356677777777664 3456667777777777777766544 7777777777777777765 343222  6777777777


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      |+|++ +| .+.++++|+.|+|++|+|++. | .+..+++|+.|+|++|++++.
T Consensus       116 N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A          116 NELRD-TD-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             SCCSB-SG-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CccCC-Ch-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            77774 33 466777777777777777643 3 466677777777777777654

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.53  E-value=8.4e-15  Score=162.33  Aligned_cols=122  Identities=20%  Similarity=0.188  Sum_probs=58.4

Q ss_pred             EEcCCCCccccCCCCCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCccc
Q 036639           71 LSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR  149 (670)
Q Consensus        71 l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  149 (670)
                      |++++|+|+..+..+.  ++|++|+|++|++++.++ .|.++++|++|+|++|++++..|..|+++++|++|+|++|+|+
T Consensus         5 l~ls~n~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~   82 (520)
T 2z7x_B            5 VDRSKNGLIHVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV   82 (520)
T ss_dssp             EECTTSCCSSCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC
T ss_pred             EecCCCCccccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee
Confidence            4445555543222232  455555555555544432 2444555555555555555444445555555555555555554


Q ss_pred             ccCCCCCcccccccceecccccccc-cCCCCcCCCCCCCEEEccCCCCc
Q 036639          150 GRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       150 g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                       .+|..  .+++|++|+|++|++++ .+|..++.+++|++|++++|+++
T Consensus        83 -~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~  128 (520)
T 2z7x_B           83 -KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLE  128 (520)
T ss_dssp             -EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCC
T ss_pred             -ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccc
Confidence             34433  44555555555555544 24444445555555555555544

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.53  E-value=1.1e-14  Score=135.73  Aligned_cols=114  Identities=25%  Similarity=0.269  Sum_probs=101.1

Q ss_pred             CCCCCccEEEccCCCCc-cccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCccccccc
Q 036639           86 SLLDQLRFLDLHDNRLN-GTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLL  163 (670)
Q Consensus        86 ~~l~~L~~L~L~~N~l~-~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~  163 (670)
                      ...++|+.|+|++|+++ +.++. +..+++|+.|+|++|.+++.  ..++.+++|++|+|++|++++.+|..+.++++|+
T Consensus        21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   98 (168)
T 2ell_A           21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT   98 (168)
T ss_dssp             SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred             CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence            34589999999999998 55655 79999999999999999976  8899999999999999999988888888899999


Q ss_pred             ceecccccccccC-CCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          164 TLRLQNNELTGRI-PDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       164 ~L~l~~N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      +|+|++|++++.. +..+..+++|+.|++++|++++..+
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~  137 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND  137 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTT
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHH
Confidence            9999999999642 2678999999999999999995544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.52  E-value=1.1e-14  Score=162.11  Aligned_cols=108  Identities=29%  Similarity=0.293  Sum_probs=93.2

Q ss_pred             CccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccc
Q 036639           90 QLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN  169 (670)
Q Consensus        90 ~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  169 (670)
                      .|+.|+|++|+|++. +.++++++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++++++|+.|+|++
T Consensus       442 ~L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~  517 (567)
T 1dce_A          442 DVRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN  517 (567)
T ss_dssp             TCSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred             CceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence            488899999999885 45888899999999999998 788889999999999999999986 67 788899999999999


Q ss_pred             ccccccC-CCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          170 NELTGRI-PDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       170 N~l~g~~-p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      |+|++.+ |..+..+++|+.|+|++|+|++.+|
T Consensus       518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~  550 (567)
T 1dce_A          518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG  550 (567)
T ss_dssp             SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred             CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence            9998776 8888889999999999999987655

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.51  E-value=3.9e-14  Score=158.55  Aligned_cols=125  Identities=19%  Similarity=0.183  Sum_probs=72.2

Q ss_pred             EEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCc
Q 036639           69 VSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN  147 (670)
Q Consensus        69 ~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  147 (670)
                      ..+++++|+|++.+..+.  ++|+.|+|++|+|++.++ .|.++++|++|+|++|++++..|..|+++++|++|||++|+
T Consensus        34 ~~l~ls~~~L~~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  111 (562)
T 3a79_B           34 SMVDYSNRNLTHVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNR  111 (562)
T ss_dssp             CEEECTTSCCCSCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             cEEEcCCCCCccCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCc
Confidence            455666666665332232  556666666666655543 35666666666666666665556666666666666666666


Q ss_pred             ccccCCCCCcccccccceecccccccc-cCCCCcCCCCCCCEEEccCCCCcC
Q 036639          148 IRGRIPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       148 l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      |+ .+|..  .+++|++|+|++|++++ .+|..+..+++|++|++++|++++
T Consensus       112 l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~  160 (562)
T 3a79_B          112 LQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ  160 (562)
T ss_dssp             CC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT
T ss_pred             CC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc
Confidence            65 45544  56666666666666654 234556666666666666666553

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.51  E-value=3.1e-14  Score=142.90  Aligned_cols=128  Identities=21%  Similarity=0.305  Sum_probs=113.0

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..++.|+|++|.+++..+ +..+++|++|+|++|+|++. +.+.. ++|+.|+|++|++++ +| .+.++++|+.|+|++
T Consensus        63 ~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~l-~~~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~  137 (263)
T 1xeu_A           63 TNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKNL-NGIPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRN  137 (263)
T ss_dssp             TTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSCC-TTCCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTT
T ss_pred             CCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCCc-Ccccc-CcccEEEccCCccCC-Ch-hhcCcccccEEECCC
Confidence            579999999999998666 99999999999999999885 34444 999999999999997 44 699999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcch
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEG  203 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~  203 (670)
                      |+|++. | .+..+++|+.|+|++|++++.  ..+..+++|+.|++++|++++. |..
T Consensus       138 N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~-~~~  190 (263)
T 1xeu_A          138 NKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE-PVK  190 (263)
T ss_dssp             SCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC-CEE
T ss_pred             CcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC-ccc
Confidence            999964 4 789999999999999999976  6788999999999999999854 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.51  E-value=2.1e-14  Score=159.84  Aligned_cols=128  Identities=24%  Similarity=0.358  Sum_probs=101.4

Q ss_pred             CCCCCCccEEE-ccCCCCccccC------CCcc--ccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCC
Q 036639           85 LSLLDQLRFLD-LHDNRLNGTIL------PLTN--CTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQ  155 (670)
Q Consensus        85 ~~~l~~L~~L~-L~~N~l~~~~~------~~~~--l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~  155 (670)
                      ++.+++|+.|+ ++.|.+.....      .+..  ...|+.|+|++|.|++ +|. |+++++|+.|+|++|+|+ .+|..
T Consensus       405 l~~l~~L~~L~~l~~n~~~~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~  481 (567)
T 1dce_A          405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPA  481 (567)
T ss_dssp             HHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGG
T ss_pred             HHHHHhcccCcchhhcccchhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchh
Confidence            56778888888 66665432210      0111  1258999999999996 776 999999999999999999 89999


Q ss_pred             CcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCC-cchh--hhhcCcccccccC
Q 036639          156 VTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV-PEGL--LKKFGEQSFIGNE  217 (670)
Q Consensus       156 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~i-p~~~--~~~~~~~~~~~n~  217 (670)
                      |+++++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.+ |..+  +..+....+.+|+
T Consensus       482 ~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~  544 (567)
T 1dce_A          482 LAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS  544 (567)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred             hhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence            9999999999999999996 77 8899999999999999999876 8776  2344555666665

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.50  E-value=2.3e-14  Score=158.82  Aligned_cols=133  Identities=19%  Similarity=0.246  Sum_probs=90.1

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .++..|+|++|.|++ +|.+..  +|++|+|++|+|++. +.  .+++|+.|+|++|.|++ +|.   .+++|++|+|++
T Consensus       100 ~~L~~L~Ls~N~l~~-ip~l~~--~L~~L~Ls~N~l~~l-p~--~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  169 (571)
T 3cvr_A          100 ASLEYLDACDNRLST-LPELPA--SLKHLDVDNNQLTML-PE--LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN  169 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCCCCT--TCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             CCCCEEEccCCCCCC-cchhhc--CCCEEECCCCcCCCC-CC--cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence            467788888888887 444444  888888888888874 33  67788888888888876 665   567778888888


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCC-------CEEEccCCCCcCCCcchhhh--hcCccccccc
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL-------KELNLSNNELYGRVPEGLLK--KFGEQSFIGN  216 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L-------~~l~l~~N~l~g~ip~~~~~--~~~~~~~~~n  216 (670)
                      |+|++ +|. |.  ++|+.|+|++|+|+ .+|. +..  +|       +.|+|++|+|+ .||..++.  .+....+.+|
T Consensus       170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N  240 (571)
T 3cvr_A          170 NQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN  240 (571)
T ss_dssp             SCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSS
T ss_pred             CCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCC
Confidence            88775 666 55  77777777777777 5665 433  56       77777777777 57766533  2223344555


Q ss_pred             C
Q 036639          217 E  217 (670)
Q Consensus       217 ~  217 (670)
                      +
T Consensus       241 ~  241 (571)
T 3cvr_A          241 P  241 (571)
T ss_dssp             S
T ss_pred             c
Confidence            4

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.50  E-value=2.6e-14  Score=149.65  Aligned_cols=144  Identities=23%  Similarity=0.310  Sum_probs=93.2

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..+..|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|+|++|.+++..+  +..+++|++|+|++
T Consensus       177 ~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~  252 (347)
T 4fmz_A          177 TDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT  252 (347)
T ss_dssp             TTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred             CCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCC
Confidence            467788888888776433 6677777777777777765543 6677777777777777765333  66777777777777


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNE  217 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~  217 (670)
                      |.+++.  +.+..+++|++|+|++|++++. | .+..+++|+.|++++|++++..|..+  +..+....+.+|+
T Consensus       253 n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~  322 (347)
T 4fmz_A          253 NQISDI--NAVKDLTKLKMLNVGSNQISDI-S-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH  322 (347)
T ss_dssp             SCCCCC--GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS
T ss_pred             CccCCC--hhHhcCCCcCEEEccCCccCCC-h-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc
Confidence            777642  3566677777777777777643 2 45666777777777777765555444  1233334445554

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.50  E-value=3.2e-14  Score=155.33  Aligned_cols=126  Identities=29%  Similarity=0.344  Sum_probs=58.2

Q ss_pred             EEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCc
Q 036639           68 VVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN  147 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  147 (670)
                      +..|+|++|.+.+..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..|  ++.+++|+.|+|++|+
T Consensus       245 L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~  320 (466)
T 1o6v_A          245 LTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNN  320 (466)
T ss_dssp             CSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSC
T ss_pred             CCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCc
Confidence            3344444444433222 4444444444444444443322 4444444444444444443222  4444555555555555


Q ss_pred             ccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          148 IRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       148 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      +++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++.+|
T Consensus       321 l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~  370 (466)
T 1o6v_A          321 ISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP  370 (466)
T ss_dssp             CSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG
T ss_pred             CCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch
Confidence            554333  44455555555555555432  234445555555555555554444

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.49  E-value=1.1e-13  Score=129.65  Aligned_cols=105  Identities=21%  Similarity=0.235  Sum_probs=92.1

Q ss_pred             EEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCc
Q 036639           69 VSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN  147 (670)
Q Consensus        69 ~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  147 (670)
                      +.+++++|+|...+..+.  ++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        15 ~~l~~~~n~l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~   92 (174)
T 2r9u_A           15 TLVNCQNIRLASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH   92 (174)
T ss_dssp             SEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cEEEeCCCCCCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence            568899999976554454  8999999999999998764 8999999999999999998666678999999999999999


Q ss_pred             ccccCCCCCcccccccceeccccccccc
Q 036639          148 IRGRIPEQVTNLTRLLTLRLQNNELTGR  175 (670)
Q Consensus       148 l~g~~p~~~~~l~~L~~L~l~~N~l~g~  175 (670)
                      |++..+..|.++++|++|+|++|.+...
T Consensus        93 l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           93 LKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             CCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             cceeCHHHhccccCCCEEEeCCCCcccc
Confidence            9976666699999999999999999843

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.48  E-value=1.1e-13  Score=150.26  Aligned_cols=122  Identities=22%  Similarity=0.226  Sum_probs=58.1

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      +++.|+|++|.+++. |.++.+++|++|+|++|+|++.  +++++++|++|+|++|.|++. |  ++++++|++|+|++|
T Consensus        43 ~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~--~~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N  116 (457)
T 3bz5_A           43 TLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTN  116 (457)
T ss_dssp             TCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSS
T ss_pred             CCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCCeE--ccccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCC
Confidence            345555555555543 3444555555555555555443  244555555555555555542 2  445555555555555


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCC
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV  200 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~i  200 (670)
                      +|++ +|  ++++++|++|+|++|+|++ +|  ++.+++|+.|++++|++.+.+
T Consensus       117 ~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~  164 (457)
T 3bz5_A          117 KLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL  164 (457)
T ss_dssp             CCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC
T ss_pred             cCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc
Confidence            5553 22  4455555555555555543 22  334444444444444333333

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.48  E-value=4.9e-14  Score=157.82  Aligned_cols=144  Identities=26%  Similarity=0.347  Sum_probs=122.3

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..+..|+|++|.+... +.+..+++|+.|+|++|+|++.++ +.+|++|+.|+|++|.|++ +| .|.++++|+.|+|++
T Consensus        43 ~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~  118 (605)
T 1m9s_A           43 NSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEH  118 (605)
T ss_dssp             TTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTT
T ss_pred             CCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecC
Confidence            5688899999998874 579999999999999999998765 9999999999999999996 44 799999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcCcccccccC
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNE  217 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~  217 (670)
                      |+|++ + +.+..|++|+.|+|++|+|++.  ..+..+++|+.|+|++|+|++..|-.-+..+..+.+.+|.
T Consensus       119 N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          119 NGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             SCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred             CCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCC
Confidence            99996 3 4689999999999999999965  5788999999999999999977662223444455555553

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.48  E-value=3.5e-14  Score=133.31  Aligned_cols=116  Identities=22%  Similarity=0.152  Sum_probs=100.6

Q ss_pred             CCCCCCCCccEEEccCCCCccccCCCcccc-ccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCccccc
Q 036639           83 APLSLLDQLRFLDLHDNRLNGTILPLTNCT-NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTR  161 (670)
Q Consensus        83 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~  161 (670)
                      +.+..+.+|+.|+|++|+++.. +.+..+. +|+.|+|++|.|++.  ..|+++++|++|+|++|+|++..|..+..+++
T Consensus        13 ~~~~~~~~L~~L~l~~n~l~~i-~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           13 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             HhcCCcCCceEEEeeCCCCchh-HHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            3367789999999999999965 6677766 999999999999975  68999999999999999999654444599999


Q ss_pred             ccceecccccccccCCC--CcCCCCCCCEEEccCCCCcCCCcch
Q 036639          162 LLTLRLQNNELTGRIPD--LSSSLKDLKELNLSNNELYGRVPEG  203 (670)
Q Consensus       162 L~~L~l~~N~l~g~~p~--~~~~l~~L~~l~l~~N~l~g~ip~~  203 (670)
                      |++|+|++|+|+ .+|.  .+..+++|+.|++++|.++ .+|..
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~  131 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHY  131 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhH
Confidence            999999999996 5676  7889999999999999998 66764

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.47  E-value=1.2e-13  Score=144.77  Aligned_cols=112  Identities=25%  Similarity=0.293  Sum_probs=59.5

Q ss_pred             CCC-CCCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccC-CCCccccCCCccccccceeeccCCccccc
Q 036639           50 DAC-AAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHD-NRLNGTILPLTNCTNLKLAYLSGNDFSAE  127 (670)
Q Consensus        50 ~~~-~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~l~~L~~L~l~~N~l~g~  127 (670)
                      +.| .|.|.+|.|+..           |+|++.++ +..+++|+.|+|++ |+|++.                       
T Consensus         3 ~~c~~C~~~~v~~~~~-----------n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~-----------------------   47 (347)
T 2ifg_A            3 DACCPHGSSGLRCTRD-----------GALDSLHH-LPGAENLTELYIENQQHLQHL-----------------------   47 (347)
T ss_dssp             SSSCCSSSSCEECCSS-----------CCCTTTTT-SCSCSCCSEEECCSCSSCCEE-----------------------
T ss_pred             CcCccccCCEEEcCCC-----------CCCCccCC-CCCCCCeeEEEccCCCCCCCc-----------------------
Confidence            456 688888877641           24554333 55555555555553 555544                       


Q ss_pred             CCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       128 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      .|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|++|+|++..+..+..++ |+.|+|++|.|+
T Consensus        48 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           48 ELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            444455555555555555555544444455555555555555555543333343333 666666666665

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.46  E-value=1.9e-13  Score=148.50  Aligned_cols=125  Identities=26%  Similarity=0.192  Sum_probs=107.6

Q ss_pred             CCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           65 SERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        65 ~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      ..++..|+|++|.+++.  +++.+++|++|+|++|+..+.+ ++..+++|+.|+|++|++++ +|  ++.+++|+.|+++
T Consensus       126 l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~  199 (457)
T 3bz5_A          126 NPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCD  199 (457)
T ss_dssp             CTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECC
T ss_pred             CCcCCEEECCCCcccee--ccccCCcCCEEECCCCCccccc-ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECc
Confidence            35789999999999984  4889999999999999776665 68889999999999999997 55  8889999999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      +|+|++.   .+.++++|+.|+|++|+|++ +|  +..+++|+.|++++|+|++..+
T Consensus       200 ~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~  250 (457)
T 3bz5_A          200 TNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV  250 (457)
T ss_dssp             SSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred             CCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence            9999964   38889999999999999997 66  7788999999999999987543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.45  E-value=6.4e-14  Score=146.68  Aligned_cols=147  Identities=20%  Similarity=0.268  Sum_probs=125.9

Q ss_pred             CCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           65 SERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        65 ~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      ...+..|++.+|.+.+..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|.+++.  +.+..+++|++|+|+
T Consensus       198 l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~  273 (347)
T 4fmz_A          198 LTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVG  273 (347)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECC
T ss_pred             CCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEcc
Confidence            3578999999999988655 8899999999999999987655 99999999999999999863  578999999999999


Q ss_pred             CCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcCcccccccC
Q 036639          145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNE  217 (670)
Q Consensus       145 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~  217 (670)
                      +|++++.  +.+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++..|-.-+..+....+.+|+
T Consensus       274 ~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          274 SNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQV  344 (347)
T ss_dssp             SSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTTCSEESSSCC-
T ss_pred             CCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhccceeehhhhc
Confidence            9999964  4689999999999999999988888899999999999999999977773334555556666664

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.44  E-value=1.8e-16  Score=152.10  Aligned_cols=133  Identities=28%  Similarity=0.351  Sum_probs=115.0

Q ss_pred             CcEEEEEcCCCCccccCCC-------CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-------LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGI  138 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-------~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  138 (670)
                      ..++.+++..+.+.|.++.       ++.+++|++|+|++|+|++. +.+.++++|+.|+|++|.++ .+|..+..+++|
T Consensus        18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L   95 (198)
T 1ds9_A           18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred             ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence            3566777777788877664       67789999999999999984 48999999999999999999 689888889999


Q ss_pred             CEEeCCCCcccccCCCCCcccccccceecccccccccCC-CCcCCCCCCCEEEccCCCCcCCCcc
Q 036639          139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIP-DLSSSLKDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       139 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~ip~  202 (670)
                      ++|+|++|+|++ +| .+.++++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+|.
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            999999999996 55 68999999999999999995332 4688899999999999999887764

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.43  E-value=1.8e-13  Score=149.40  Aligned_cols=126  Identities=32%  Similarity=0.390  Sum_probs=58.6

Q ss_pred             EEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCc
Q 036639           68 VVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN  147 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  147 (670)
                      +..|++++|.+.+..+ ++.+++|+.|+|++|++++. +.+..+++|+.|+|++|.+++..|  +.++++|+.|+|++|+
T Consensus       201 L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~  276 (466)
T 1o6v_A          201 LESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ  276 (466)
T ss_dssp             CSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSC
T ss_pred             CCEEEecCCccccccc-ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCc
Confidence            3344444444433222 33344444444444444332 234444555555555555544332  4455555555555555


Q ss_pred             ccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          148 IRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       148 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      +++..|  +..+++|+.|+|++|++++..|  +..+++|+.|++++|++++..|
T Consensus       277 l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~  326 (466)
T 1o6v_A          277 ISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP  326 (466)
T ss_dssp             CCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG
T ss_pred             cCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh
Confidence            553322  4455555555555555554332  4445555555555555554444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.42  E-value=7.7e-13  Score=143.55  Aligned_cols=120  Identities=25%  Similarity=0.410  Sum_probs=65.4

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      .++.|++++|.+++. +.+  .++|++|+|++|++++ ++.++++++|++|+|++|++++ +|..+   .+|++|+|++|
T Consensus       112 ~L~~L~l~~n~l~~l-~~~--~~~L~~L~L~~n~l~~-lp~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n  183 (454)
T 1jl5_A          112 SLKSLLVDNNNLKAL-SDL--PPLLEYLGVSNNQLEK-LPELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNN  183 (454)
T ss_dssp             TCCEEECCSSCCSCC-CSC--CTTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSS
T ss_pred             CCcEEECCCCccCcc-cCC--CCCCCEEECcCCCCCC-CcccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCC
Confidence            344445544444431 111  1466666666666665 3356666666666666666664 44432   35666666666


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      ++++ +| .++++++|+.|++++|++++ +|...   ++|+.|++++|+++ .+|
T Consensus       184 ~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp  231 (454)
T 1jl5_A          184 QLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP  231 (454)
T ss_dssp             CCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC
T ss_pred             cCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc
Confidence            6664 44 45666666666666666654 33321   35555555555555 444

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.40  E-value=7.6e-15  Score=152.98  Aligned_cols=152  Identities=18%  Similarity=0.274  Sum_probs=119.6

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccc-cC-CCccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGT-IL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ..++.|++++|.+.+.++.+..+++|++|+|++|.+++. ++ .+.++++|+.|+|++|.+++..|..++++++|++|+|
T Consensus        70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  149 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  149 (336)
T ss_dssp             TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence            467888899999988888888899999999999998764 43 3788899999999999999888888999999999999


Q ss_pred             CCC-cccc-cCCCCCcccccccceecccc-ccccc-CCCCcCCCC-CCCEEEccCC--CCc-CCCcchh--hhhcCcccc
Q 036639          144 SDN-NIRG-RIPEQVTNLTRLLTLRLQNN-ELTGR-IPDLSSSLK-DLKELNLSNN--ELY-GRVPEGL--LKKFGEQSF  213 (670)
Q Consensus       144 ~~N-~l~g-~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l~-~L~~l~l~~N--~l~-g~ip~~~--~~~~~~~~~  213 (670)
                      ++| .+++ .+|..+.++++|++|+|++| ++++. ++..+..++ +|+.|++++|  .++ +.+|..+  +..+....+
T Consensus       150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l  229 (336)
T 2ast_B          150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL  229 (336)
T ss_dssp             TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEEC
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeC
Confidence            999 7886 36777888899999999999 88864 566677788 8999999988  455 4555443  223344444


Q ss_pred             cccC
Q 036639          214 IGNE  217 (670)
Q Consensus       214 ~~n~  217 (670)
                      .+|.
T Consensus       230 ~~~~  233 (336)
T 2ast_B          230 SDSV  233 (336)
T ss_dssp             TTCT
T ss_pred             CCCC
Confidence            5554

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.38  E-value=1.3e-13  Score=154.58  Aligned_cols=137  Identities=26%  Similarity=0.358  Sum_probs=91.7

Q ss_pred             CCCCCCCCCCCCCCCcceEE--------ecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCcccc
Q 036639           41 NLLSNWKGADACAAAWTGVV--------CSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCT  112 (670)
Q Consensus        41 ~~l~~W~~~~~~~~~w~gv~--------C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~  112 (670)
                      ...+.|....+| |.|+|..        |..  ..++.|++++|+|+..+..+.  ++|+.|+|++|+|+..+.   .++
T Consensus        10 ~~w~~W~~~~~~-~~~~~r~~~~~~~~~c~~--~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~   81 (622)
T 3g06_A           10 AVWSAWRRAAPA-EESRGRAAVVQKMRACLN--NGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA---LPP   81 (622)
T ss_dssp             CHHHHHHHTCCG-GGHHHHHHHHHHHHHHHH--HCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC---CCT
T ss_pred             HHHHHHHhcCCc-chhccccccCcccccccC--CCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC---cCC
Confidence            445678665555 7886643        332  347888888888885433344  788888888888875433   567


Q ss_pred             ccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEcc
Q 036639          113 NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLS  192 (670)
Q Consensus       113 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  192 (670)
                      +|+.|+|++|+|+ .+|.   .+++|++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|..   +++|++|+|+
T Consensus        82 ~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls  149 (622)
T 3g06_A           82 ELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVS  149 (622)
T ss_dssp             TCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECC
T ss_pred             CCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECc
Confidence            8888888888887 3565   56777888888887774 454   45666777777777763 4443   3566666666


Q ss_pred             CCCCc
Q 036639          193 NNELY  197 (670)
Q Consensus       193 ~N~l~  197 (670)
                      +|+|+
T Consensus       150 ~N~l~  154 (622)
T 3g06_A          150 DNQLA  154 (622)
T ss_dssp             SSCCS
T ss_pred             CCcCC
Confidence            66666

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.36  E-value=1.1e-12  Score=147.08  Aligned_cols=73  Identities=29%  Similarity=0.411  Sum_probs=44.7

Q ss_pred             CCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhh--hhcCcccc
Q 036639          136 KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLL--KKFGEQSF  213 (670)
Q Consensus       136 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~--~~~~~~~~  213 (670)
                      ++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .||..+.  ..+....+
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            566777777777774 55   34466777777777776 4554   3567777777777777 6666542  22333344


Q ss_pred             cccC
Q 036639          214 IGNE  217 (670)
Q Consensus       214 ~~n~  217 (670)
                      .+|+
T Consensus       292 ~~N~  295 (622)
T 3g06_A          292 EGNP  295 (622)
T ss_dssp             CSCC
T ss_pred             cCCC
Confidence            5554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.36  E-value=7.8e-15  Score=152.88  Aligned_cols=147  Identities=16%  Similarity=0.169  Sum_probs=127.6

Q ss_pred             CCcceEEecCCCCcEEEEEcCCCCccccCCCCCCC--CCccEEEccCCCCccccCCCccccccceeeccCCccccc-CCc
Q 036639           54 AAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLL--DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAE-IPH  130 (670)
Q Consensus        54 ~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~-~p~  130 (670)
                      .+|.++.|++  ..++.|+++++.+..  ..+..+  +.|+.|+|++|.+.+.++.+.++++|+.|+|++|.+++. +|.
T Consensus        37 ~~W~~~~~~~--~~~~~l~l~~~~~~~--~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~  112 (336)
T 2ast_B           37 KRWYRLASDE--SLWQTLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHG  112 (336)
T ss_dssp             HHHHHHHTCS--TTSSEEECTTCBCCH--HHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHH
T ss_pred             HHHHHHhcCc--hhheeeccccccCCH--HHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHH
Confidence            4699998874  457889999998773  225555  899999999999999988888999999999999999977 899


Q ss_pred             cccCCCCCCEEeCCCCcccccCCCCCcccccccceecccc-ccccc-CCCCcCCCCCCCEEEccCC-CCcCC-Ccchh
Q 036639          131 QISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNN-ELTGR-IPDLSSSLKDLKELNLSNN-ELYGR-VPEGL  204 (670)
Q Consensus       131 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~l~l~~N-~l~g~-ip~~~  204 (670)
                      .+.++++|++|+|++|++++.+|..+.++++|++|+|++| .+++. +|..+..+++|+.|++++| ++++. +|..+
T Consensus       113 ~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~  190 (336)
T 2ast_B          113 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV  190 (336)
T ss_dssp             HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred             HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence            9999999999999999999999999999999999999999 78863 6777888999999999999 99864 45433

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.36  E-value=2.8e-12  Score=139.09  Aligned_cols=135  Identities=21%  Similarity=0.265  Sum_probs=107.0

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..++.|+|++|.+++ +|.  .+++|++|+|++|++++.. .+  .++|++|+|++|++++ +| .|+++++|++|++++
T Consensus        91 ~~L~~L~l~~n~l~~-lp~--~~~~L~~L~l~~n~l~~l~-~~--~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~  162 (454)
T 1jl5_A           91 PHLESLVASCNSLTE-LPE--LPQSLKSLLVDNNNLKALS-DL--PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDN  162 (454)
T ss_dssp             TTCSEEECCSSCCSS-CCC--CCTTCCEEECCSSCCSCCC-SC--CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCS
T ss_pred             CCCCEEEccCCcCCc-ccc--ccCCCcEEECCCCccCccc-CC--CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCC
Confidence            468888999998888 443  2478999999999888643 22  1689999999999996 78 699999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcCccccccc
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGN  216 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n  216 (670)
                      |++++ +|..+   .+|++|+|++|++++ +| .+..+++|+.|++++|++++ +|... ..+....+.+|
T Consensus       163 N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~-~~L~~L~l~~n  225 (454)
T 1jl5_A          163 NSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP-LSLESIVAGNN  225 (454)
T ss_dssp             SCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-TTCCEEECCSS
T ss_pred             CcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-CcccEEECcCC
Confidence            99995 77654   589999999999996 67 58899999999999999985 66433 34444555555

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.34  E-value=3.2e-14  Score=151.35  Aligned_cols=134  Identities=24%  Similarity=0.314  Sum_probs=82.3

Q ss_pred             CcEEEEEcCCCCccc----cCCC-CCCCCCccEEEccCCCCccccCC-----Cccc---------cccceeeccCCccc-
Q 036639           66 ERVVSLSLPSHSLRG----PIAP-LSLLDQLRFLDLHDNRLNGTILP-----LTNC---------TNLKLAYLSGNDFS-  125 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~----~~~~-~~~l~~L~~L~L~~N~l~~~~~~-----~~~l---------~~L~~L~l~~N~l~-  125 (670)
                      .+++.|+|++|.+.+    .++. +..+++|++|+|++|.|+...+.     +..+         ++|+.|+|++|+++ 
T Consensus        94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~  173 (386)
T 2ca6_A           94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN  173 (386)
T ss_dssp             TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred             CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence            456677777777665    2332 56666777777777766532211     3333         66777777777765 


Q ss_pred             ccCC---ccccCCCCCCEEeCCCCccc--c---cCCCCCcccccccceeccccccc----ccCCCCcCCCCCCCEEEccC
Q 036639          126 AEIP---HQISSLKGILRLDLSDNNIR--G---RIPEQVTNLTRLLTLRLQNNELT----GRIPDLSSSLKDLKELNLSN  193 (670)
Q Consensus       126 g~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~l~l~~  193 (670)
                      +.+|   ..+..+++|++|+|++|+|+  |   .+|..+.++++|+.|+|++|+|+    +.+|..+..+++|+.|+|++
T Consensus       174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~  253 (386)
T 2ca6_A          174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND  253 (386)
T ss_dssp             GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred             HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence            3444   35556667777777777666  2   34446666677777777777765    45566666666777777777


Q ss_pred             CCCcCC
Q 036639          194 NELYGR  199 (670)
Q Consensus       194 N~l~g~  199 (670)
                      |+|++.
T Consensus       254 n~i~~~  259 (386)
T 2ca6_A          254 CLLSAR  259 (386)
T ss_dssp             CCCCHH
T ss_pred             CCCchh
Confidence            776644

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.32  E-value=7.3e-14  Score=148.59  Aligned_cols=152  Identities=21%  Similarity=0.202  Sum_probs=121.7

Q ss_pred             CcEEEEEcCCCCccccC----CC-CCCC---------CCccEEEccCCCCc-cccC----CCccccccceeeccCCccc-
Q 036639           66 ERVVSLSLPSHSLRGPI----AP-LSLL---------DQLRFLDLHDNRLN-GTIL----PLTNCTNLKLAYLSGNDFS-  125 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~----~~-~~~l---------~~L~~L~L~~N~l~-~~~~----~~~~l~~L~~L~l~~N~l~-  125 (670)
                      .+++.|+|++|.+++..    +. +..+         ++|++|+|++|+|+ +.++    .+.++++|+.|+|++|+++ 
T Consensus       122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~  201 (386)
T 2ca6_A          122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP  201 (386)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred             CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence            57999999999997432    22 5555         89999999999997 3333    3678899999999999998 


Q ss_pred             -c---cCCccccCCCCCCEEeCCCCccc----ccCCCCCcccccccceeccccccccc----CCCCc--CCCCCCCEEEc
Q 036639          126 -A---EIPHQISSLKGILRLDLSDNNIR----GRIPEQVTNLTRLLTLRLQNNELTGR----IPDLS--SSLKDLKELNL  191 (670)
Q Consensus       126 -g---~~p~~~~~l~~L~~L~l~~N~l~----g~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~--~~l~~L~~l~l  191 (670)
                       |   .+|..+..+++|+.|+|++|.|+    +.+|..+..+++|+.|+|++|+|++.    +|..+  +.+++|+.|+|
T Consensus       202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L  281 (386)
T 2ca6_A          202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL  281 (386)
T ss_dssp             HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred             hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEEC
Confidence             3   45668899999999999999997    67888899999999999999999876    56665  44899999999


Q ss_pred             cCCCCcC----CCcchhh---hhcCcccccccC
Q 036639          192 SNNELYG----RVPEGLL---KKFGEQSFIGNE  217 (670)
Q Consensus       192 ~~N~l~g----~ip~~~~---~~~~~~~~~~n~  217 (670)
                      ++|++++    .+|..+.   ..+....+.+|+
T Consensus       282 ~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~  314 (386)
T 2ca6_A          282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR  314 (386)
T ss_dssp             CSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred             cCCcCCHHHHHHHHHHHHhcCCCceEEEccCCc
Confidence            9999997    4887773   344445556665

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.28  E-value=2.1e-13  Score=143.69  Aligned_cols=138  Identities=22%  Similarity=0.251  Sum_probs=84.1

Q ss_pred             cEEEEEcCCCCccccCC----C-CCCCC-CccEEEccCCCCccccC-CCccc-----cccceeeccCCcccccCCccccC
Q 036639           67 RVVSLSLPSHSLRGPIA----P-LSLLD-QLRFLDLHDNRLNGTIL-PLTNC-----TNLKLAYLSGNDFSAEIPHQISS  134 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~----~-~~~l~-~L~~L~L~~N~l~~~~~-~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~  134 (670)
                      .++.|+|++|.+++..+    . +..++ +|++|+|++|+|++..+ .+..+     ++|+.|+|++|.+++..+..++.
T Consensus        23 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~  102 (362)
T 3goz_A           23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVK  102 (362)
T ss_dssp             TCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH
T ss_pred             CceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHH
Confidence            46777777777766543    2 55566 67777777777766532 23333     67777777777777666554433


Q ss_pred             ----C-CCCCEEeCCCCcccccCCCCCcc-----cccccceecccccccccC----CCCcCCCC-CCCEEEccCCCCcCC
Q 036639          135 ----L-KGILRLDLSDNNIRGRIPEQVTN-----LTRLLTLRLQNNELTGRI----PDLSSSLK-DLKELNLSNNELYGR  199 (670)
Q Consensus       135 ----l-~~L~~L~l~~N~l~g~~p~~~~~-----l~~L~~L~l~~N~l~g~~----p~~~~~l~-~L~~l~l~~N~l~g~  199 (670)
                          + ++|++|+|++|+|++..+..+..     .++|++|+|++|+|++..    +..+..++ +|+.|+|++|+|++.
T Consensus       103 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~  182 (362)
T 3goz_A          103 TLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASK  182 (362)
T ss_dssp             HHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGS
T ss_pred             HHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchh
Confidence                3 67777777777776554444332     246777777777776432    22233343 677777777777665


Q ss_pred             Ccchh
Q 036639          200 VPEGL  204 (670)
Q Consensus       200 ip~~~  204 (670)
                      .+..+
T Consensus       183 ~~~~l  187 (362)
T 3goz_A          183 NCAEL  187 (362)
T ss_dssp             CHHHH
T ss_pred             hHHHH
Confidence            55444

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.28  E-value=4.1e-12  Score=132.92  Aligned_cols=106  Identities=18%  Similarity=0.208  Sum_probs=92.0

Q ss_pred             ceeeccCC-cccccCCccccCCCCCCEEeCCC-CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEcc
Q 036639          115 KLAYLSGN-DFSAEIPHQISSLKGILRLDLSD-NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLS  192 (670)
Q Consensus       115 ~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  192 (670)
                      ..+++++| +|++ +|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++.+|..|..|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35688888 8884 888 99999999999996 99998888899999999999999999999999999999999999999


Q ss_pred             CCCCcCCCcchhhhh--cCcccccccCCCcCCC
Q 036639          193 NNELYGRVPEGLLKK--FGEQSFIGNEGLCGSS  223 (670)
Q Consensus       193 ~N~l~g~ip~~~~~~--~~~~~~~~n~~~c~~~  223 (670)
                      +|+|+ .+|...+..  +..+.+.+|++.|.|.
T Consensus        89 ~N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           89 FNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA  120 (347)
T ss_dssp             SSCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred             CCccc-eeCHHHcccCCceEEEeeCCCccCCCc
Confidence            99999 566555444  4556678999999874

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.26  E-value=1.3e-14  Score=139.19  Aligned_cols=127  Identities=23%  Similarity=0.283  Sum_probs=109.5

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..++.|+|++|.+.+ ++.+..+++|++|+|++|+|+..+..+..+++|+.|+|++|++++ +| .+.++++|++|+|++
T Consensus        48 ~~L~~L~ls~n~l~~-l~~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~  124 (198)
T 1ds9_A           48 KACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSN  124 (198)
T ss_dssp             TTCSEEECSEEEESC-CCCHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESE
T ss_pred             CCCCEEECCCCCCcc-ccccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCC
Confidence            478999999999998 558889999999999999999654447778999999999999997 55 689999999999999


Q ss_pred             CcccccCC-CCCcccccccceecccccccccCCCC----------cCCCCCCCEEEccCCCCc
Q 036639          146 NNIRGRIP-EQVTNLTRLLTLRLQNNELTGRIPDL----------SSSLKDLKELNLSNNELY  197 (670)
Q Consensus       146 N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~----------~~~l~~L~~l~l~~N~l~  197 (670)
                      |+|++..+ ..+..+++|++|+|++|.+++.+|..          +..+++|+.||  +|.++
T Consensus       125 N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~  185 (198)
T 1ds9_A          125 NKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD  185 (198)
T ss_dssp             EECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred             CcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence            99995332 47889999999999999999887763          77899999987  66665

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.23  E-value=6.9e-13  Score=139.75  Aligned_cols=135  Identities=21%  Similarity=0.272  Sum_probs=111.7

Q ss_pred             EEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-----CCcccc-ccceeeccCCcccccCCccccCC-----CC
Q 036639           70 SLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-----PLTNCT-NLKLAYLSGNDFSAEIPHQISSL-----KG  137 (670)
Q Consensus        70 ~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-----~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~~  137 (670)
                      .++|+.|+++|.+|. +...++|++|||++|.|++...     .+.+++ +|+.|+|++|.+++..+..|..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            468899999999888 4555669999999999988663     377888 99999999999999888888775     99


Q ss_pred             CCEEeCCCCcccccCCCCCccc-----ccccceecccccccccCCCCc----CC-CCCCCEEEccCCCCcCCCcchh
Q 036639          138 ILRLDLSDNNIRGRIPEQVTNL-----TRLLTLRLQNNELTGRIPDLS----SS-LKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       138 L~~L~l~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~----~~-l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      |++|+|++|+|++..+..+...     ++|++|+|++|+|++..+..+    .. .++|++|+|++|+|++.-+..+
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l  158 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL  158 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence            9999999999998777655544     899999999999997665443    33 3699999999999996555444

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=2.1e-11  Score=122.11  Aligned_cols=138  Identities=16%  Similarity=0.070  Sum_probs=106.8

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      ..++.|+.+.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++.+.+..|+||||++|.+|.
T Consensus        20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   98 (263)
T 3tm0_A           20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS   98 (263)
T ss_dssp             ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred             eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence            34677788999999855 6899999987532123346889999998884 677889999999999999999999999998


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY-------------------------------------------  477 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------------  477 (670)
                      +.+...          .....++.+++++|+.||+.-                                           
T Consensus        99 ~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (263)
T 3tm0_A           99 EEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR  168 (263)
T ss_dssp             HHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred             hccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence            764211          123478889999999999810                                           


Q ss_pred             ------------CCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          478 ------------GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       478 ------------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                                  ....++|+|++|.||+++++..+.|+||+.+..
T Consensus       169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                        013589999999999998766677999987643

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.18  E-value=3.8e-11  Score=125.70  Aligned_cols=136  Identities=17%  Similarity=0.083  Sum_probs=106.7

Q ss_pred             EEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCc-cccCCC
Q 036639           59 VVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPH-QISSLK  136 (670)
Q Consensus        59 v~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~  136 (670)
                      -+|+.   +  .++-++++|+..+..+  .++|+.|+|++|+|+...+. |.++++|+.|+|++|++.+.+|. .|.+++
T Consensus         7 C~C~~---~--~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~   79 (350)
T 4ay9_X            7 CHCSN---R--VFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP   79 (350)
T ss_dssp             SEEET---T--EEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred             cEeeC---C--EEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence            46764   2  3567888998755445  46899999999999987764 89999999999999999877765 678999


Q ss_pred             CCCE-EeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccC-CCCcCCCcc
Q 036639          137 GILR-LDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN-NELYGRVPE  202 (670)
Q Consensus       137 ~L~~-L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~-N~l~g~ip~  202 (670)
                      +|.. +++++|+|+...|..|.++++|++|++++|+|++..+..+.....+..|++.+ |+++ .+|.
T Consensus        80 ~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~  146 (350)
T 4ay9_X           80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIER  146 (350)
T ss_dssp             TCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECT
T ss_pred             hhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccc
Confidence            8875 67788999988889999999999999999999976665555555666666654 3443 4443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=7.5e-11  Score=117.73  Aligned_cols=130  Identities=16%  Similarity=0.128  Sum_probs=97.5

Q ss_pred             CCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCC--eeeEEEEEEeCCeeEEEEeccCCCChHHH
Q 036639          365 GKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPN--VVKLRAYYYAKEEKLLVYDYLPNGSLHSL  442 (670)
Q Consensus       365 g~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~  442 (670)
                      +.|..+.||++...+|+.+++|.....   ....+..|+++++.+.+.+  +.+++++....+..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            355569999998777888999998654   2346788999998886444  556889888888899999999998884  


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 036639          443 LHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY---------------------------------------------  477 (670)
Q Consensus       443 l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------------  477 (670)
                      ...        ..   ...++.++++.|+.||+.-                                             
T Consensus       104 ~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (264)
T 1nd4_A          104 SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA  172 (264)
T ss_dssp             TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred             cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence            211        11   2356777788888888641                                             


Q ss_pred             ---------CCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          478 ---------GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       478 ---------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                               ....++|+|++|.||++++++.+.|+||+.+..
T Consensus       173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          173 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                     012399999999999998776677999998753

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.06  E-value=2.8e-12  Score=139.57  Aligned_cols=136  Identities=18%  Similarity=0.220  Sum_probs=82.7

Q ss_pred             cEEEEEcCCCCcccc----CCC-CCCCCCccEEEccCCCCcccc-----CC-CccccccceeeccCCccccc----CCcc
Q 036639           67 RVVSLSLPSHSLRGP----IAP-LSLLDQLRFLDLHDNRLNGTI-----LP-LTNCTNLKLAYLSGNDFSAE----IPHQ  131 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~----~~~-~~~l~~L~~L~L~~N~l~~~~-----~~-~~~l~~L~~L~l~~N~l~g~----~p~~  131 (670)
                      ++..|+|++|.+++.    ++. +..+++|++|+|++|.++...     +. +..+++|+.|+|++|.+++.    ++..
T Consensus       200 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  279 (461)
T 1z7x_W          200 QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV  279 (461)
T ss_dssp             CCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             CceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHH
Confidence            577777777777753    222 556677777777777776431     11 33567777777777777654    5666


Q ss_pred             ccCCCCCCEEeCCCCcccccCCCCCccc-----ccccceeccccccccc----CCCCcCCCCCCCEEEccCCCCcCCCcc
Q 036639          132 ISSLKGILRLDLSDNNIRGRIPEQVTNL-----TRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELYGRVPE  202 (670)
Q Consensus       132 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~ip~  202 (670)
                      +.++++|++|+|++|.+++..+..+...     ++|+.|+|++|++++.    +|..+..+++|+.|++++|++++..+.
T Consensus       280 l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  359 (461)
T 1z7x_W          280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR  359 (461)
T ss_dssp             HHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHH
T ss_pred             HhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHH
Confidence            6667777777777777664433333322     4666666666666644    344445556666666666666544333

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.03  E-value=4.5e-12  Score=137.99  Aligned_cols=152  Identities=19%  Similarity=0.145  Sum_probs=109.0

Q ss_pred             CcEEEEEcCCCCccccC-----CC-CCCCCCccEEEccCCCCccc-----cCCCccccccceeeccCCcccccCCccccC
Q 036639           66 ERVVSLSLPSHSLRGPI-----AP-LSLLDQLRFLDLHDNRLNGT-----ILPLTNCTNLKLAYLSGNDFSAEIPHQISS  134 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~-----~~-~~~l~~L~~L~L~~N~l~~~-----~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~  134 (670)
                      ..++.|+|++|.+....     +. +..+++|++|+|++|+++..     ...+.++++|+.|+|++|.+++..+..+..
T Consensus       227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  306 (461)
T 1z7x_W          227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  306 (461)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence            56889999999887642     12 44688999999999988863     233677888999999999887665555543


Q ss_pred             -----CCCCCEEeCCCCccccc----CCCCCcccccccceecccccccccCCCCcC-----CCCCCCEEEccCCCCcC--
Q 036639          135 -----LKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELTGRIPDLSS-----SLKDLKELNLSNNELYG--  198 (670)
Q Consensus       135 -----l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-----~l~~L~~l~l~~N~l~g--  198 (670)
                           .++|++|+|++|.+++.    +|..+..+++|+.|+|++|++++..+..+.     ..++|+.|++++|++++  
T Consensus       307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~  386 (461)
T 1z7x_W          307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSS  386 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHH
T ss_pred             HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhh
Confidence                 36889999999988865    566677788899999999988865443332     26688899999998885  


Q ss_pred             --CCcchhh--hhcCcccccccC
Q 036639          199 --RVPEGLL--KKFGEQSFIGNE  217 (670)
Q Consensus       199 --~ip~~~~--~~~~~~~~~~n~  217 (670)
                        .+|..+.  ..+....+.+|+
T Consensus       387 ~~~l~~~l~~~~~L~~L~l~~N~  409 (461)
T 1z7x_W          387 CSSLAATLLANHSLRELDLSNNC  409 (461)
T ss_dssp             HHHHHHHHHHCCCCCEEECCSSS
T ss_pred             HHHHHHHHHhCCCccEEECCCCC
Confidence              6666552  334444555553

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.02  E-value=1.8e-12  Score=128.71  Aligned_cols=146  Identities=21%  Similarity=0.229  Sum_probs=96.4

Q ss_pred             CCCcceEEecCCCCcEEEEEcCC---CCccccCCC--CCCCCCccEEEccCCCCcccc--CCCccccccce--eeccCCc
Q 036639           53 AAAWTGVVCSPKSERVVSLSLPS---HSLRGPIAP--LSLLDQLRFLDLHDNRLNGTI--LPLTNCTNLKL--AYLSGND  123 (670)
Q Consensus        53 ~~~w~gv~C~~~~~~v~~l~l~~---~~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~--~~~~~l~~L~~--L~l~~N~  123 (670)
                      .|+|.|+.|+....+|+.+..++   ..+.+.+.+  +..++.  .|....|..++.+  ..+...+.|..  ++++.|+
T Consensus        77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~  154 (267)
T 3rw6_A           77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNR  154 (267)
T ss_dssp             HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTS
T ss_pred             HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCCH
Confidence            36799999997666777666655   233343332  212211  2233334433333  22556666766  7788884


Q ss_pred             cc---ccCCccccCCCCCCEEeCCCCcccc--cCCCCCcccccccceecccccccccCCCCcCCCC--CCCEEEccCCCC
Q 036639          124 FS---AEIPHQISSLKGILRLDLSDNNIRG--RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK--DLKELNLSNNEL  196 (670)
Q Consensus       124 l~---g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l  196 (670)
                      ..   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|++|+|++|.+
T Consensus       155 ~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl  232 (267)
T 3rw6_A          155 RSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSL  232 (267)
T ss_dssp             HHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTT
T ss_pred             HHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcC
Confidence            33   3223333568899999999999997  6677788899999999999999865  2233344  899999999999


Q ss_pred             cCCCcc
Q 036639          197 YGRVPE  202 (670)
Q Consensus       197 ~g~ip~  202 (670)
                      ++.+|.
T Consensus       233 ~~~~~~  238 (267)
T 3rw6_A          233 CDTFRD  238 (267)
T ss_dssp             GGGCSS
T ss_pred             ccccCc
Confidence            988873

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=6.9e-10  Score=116.52  Aligned_cols=143  Identities=15%  Similarity=0.197  Sum_probs=106.5

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeC--CCC-cchHHHHHHHHHHHhccC--CCCeeeEEEEEEeC---CeeEEEEec
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK--DAN-PCARKEFEQYMDVIGKLK--HPNVVKLRAYYYAK---EEKLLVYDY  433 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~---~~~~lv~e~  433 (670)
                      +.++.|.++.||+....+ ..+++|+..  ... ......+.+|+++++.+.  +..+++++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            357889999999998764 678888876  332 123457888999999886  45688899988776   458999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY------------------------------------  477 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------  477 (670)
                      ++|..+.+...       ..++...+..++.++++.|+.||+.-                                    
T Consensus       123 v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          123 VSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             CCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             cCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99877754211       13677888899999999999999731                                    


Q ss_pred             ------------------CCCCccccCCCCCCeEeCCCCc--EEEEecccccccC
Q 036639          478 ------------------GTAKVPHGNVKSSNVLLDKNGV--ACISDFGLSLLLN  512 (670)
Q Consensus       478 ------------------~~~~ivH~Dlkp~NIll~~~~~--~kl~DFG~a~~~~  512 (670)
                                        ....++|||+++.||+++.++.  +.|+||+.+..-.
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~  250 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH  250 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence                              0246899999999999997753  6899999887544

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.95  E-value=2e-11  Score=128.53  Aligned_cols=131  Identities=20%  Similarity=0.199  Sum_probs=57.5

Q ss_pred             cEEEEEcCCCCccccCCC--CCCCCCccEEEccCCCCccccCC-----C-ccccccceeeccCCcccc----cCCccccC
Q 036639           67 RVVSLSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLNGTILP-----L-TNCTNLKLAYLSGNDFSA----EIPHQISS  134 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~-----~-~~l~~L~~L~l~~N~l~g----~~p~~~~~  134 (670)
                      .++.|+|++|.++.....  ...+++|+.|+|++|+|+.....     + ...++|+.|+|++|.|+.    .++..+..
T Consensus       102 ~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~  181 (372)
T 3un9_A          102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAG  181 (372)
T ss_dssp             CEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHT
T ss_pred             CceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhc
Confidence            455555555554431111  12234455555555555432111     1 223445555555555543    12333344


Q ss_pred             CCCCCEEeCCCCccccc----CCCCCcccccccceeccccccccc----CCCCcCCCCCCCEEEccCCCCc
Q 036639          135 LKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       135 l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +++|++|||++|.|+..    ++..+..+++|+.|+|++|+|+..    ++..+...++|++|+|++|.|+
T Consensus       182 ~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          182 NTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             CSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             CCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            55555555555555431    233344444555555555555431    1222233445555555555554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.90  E-value=9.9e-10  Score=112.47  Aligned_cols=182  Identities=16%  Similarity=0.160  Sum_probs=121.7

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCC--eeeEEEEEEeCC---eeEEEEeccCC
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPN--VVKLRAYYYAKE---EKLLVYDYLPN  436 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--Iv~l~~~~~~~~---~~~lv~e~~~~  436 (670)
                      .++.|.+..||+..    ..+++|+....  .....+.+|.++++.+. +..  +.+++......+   ..|+|||+++|
T Consensus        27 ~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             EEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             ecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            47889999999864    55889986533  34577899999998873 332  445555443333   34799999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE----------------------------------------  476 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------------------  476 (670)
                      .+|.+....       .++...+..++.++++.|+.||+.                                        
T Consensus       101 ~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          101 VPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             EECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             eECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            888653321       256677788888888888888861                                        


Q ss_pred             --------------CCCCCccccCCCCCCeEeCC--CCcEEEEecccccccCccccccccCcc---cCcccccc------
Q 036639          477 --------------YGTAKVPHGNVKSSNVLLDK--NGVACISDFGLSLLLNPVQAIARLGGY---KAPEQAEV------  531 (670)
Q Consensus       477 --------------~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~~~~~~~~~~y---~aPE~~~~------  531 (670)
                                    ...+.++|+|++|.||++++  +..+.|+||+.+..-...........+   ..|+....      
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~  253 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK  253 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence                          01135799999999999998  456889999988764432111111111   12221100      


Q ss_pred             --------CCCCCchhHHHHHHHHHHHHcCCCCC
Q 036639          532 --------KRLSQKADVYSFGVLLLEVLTGRAPS  557 (670)
Q Consensus       532 --------~~~~~ksDVwS~Gvvl~elltg~~p~  557 (670)
                              .......+.|++|.++|.+.+|..+|
T Consensus       254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                    01122368999999999999998765

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.82  E-value=6.9e-11  Score=124.46  Aligned_cols=133  Identities=20%  Similarity=0.156  Sum_probs=103.2

Q ss_pred             CcEEEEEcCCCCccccCCC-----C-CCCCCccEEEccCCCCcccc-CC-CccccccceeeccCCcccccCCccc-----
Q 036639           66 ERVVSLSLPSHSLRGPIAP-----L-SLLDQLRFLDLHDNRLNGTI-LP-LTNCTNLKLAYLSGNDFSAEIPHQI-----  132 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-----~-~~l~~L~~L~L~~N~l~~~~-~~-~~~l~~L~~L~l~~N~l~g~~p~~~-----  132 (670)
                      ..+..|+|++|.++.....     + ....+|+.|+|++|.|+..- .. ...+++|+.|+|++|.|+..-...+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            4688999999999864322     2 23479999999999997532 22 3457789999999999986555554     


Q ss_pred             cCCCCCCEEeCCCCcccc----cCCCCCcccccccceeccccccccc----CCCCcCCCCCCCEEEccCCCCcC
Q 036639          133 SSLKGILRLDLSDNNIRG----RIPEQVTNLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       133 ~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      ...++|+.|+|++|.|+.    .++..+..+++|++|+|++|+|+..    ++..+...++|+.|+|++|.|+.
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~  225 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGD  225 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCH
Confidence            346889999999999975    3445567789999999999999853    34556677899999999999974

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.82  E-value=9.9e-09  Score=106.24  Aligned_cols=135  Identities=15%  Similarity=0.168  Sum_probs=90.5

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Ccc---------------------------------
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTN---------------------------------  110 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~---------------------------------  110 (670)
                      ..++.|+|++ +++...+. |..+++|+.|+|++|.+....+. |.+                                 
T Consensus       101 ~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~  179 (329)
T 3sb4_A          101 QTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE  179 (329)
T ss_dssp             TTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred             CCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence            4588888988 77765444 88999999999999986422211 222                                 


Q ss_pred             ---------------------------------------------ccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639          111 ---------------------------------------------CTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus       111 ---------------------------------------------l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                                                                   +++|+.|+|++|+++..-+..|.++.+|+.|+|.+
T Consensus       180 ~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~  259 (329)
T 3sb4_A          180 TTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPH  259 (329)
T ss_dssp             EEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCT
T ss_pred             eeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCc
Confidence                                                         56777777777777755555677777777777777


Q ss_pred             CcccccCCCCCccccccc-ceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          146 NNIRGRIPEQVTNLTRLL-TLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      | ++..-+..|.+|.+|+ .|+|.+ +++..-+..|.++++|+.|++++|+++ .|+...
T Consensus       260 n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~-~I~~~a  316 (329)
T 3sb4_A          260 N-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT-TLGDEL  316 (329)
T ss_dssp             T-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC-EECTTT
T ss_pred             c-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC-ccchhh
Confidence            6 6645555677777777 777766 666444566777777777777777776 455433

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.68  E-value=5.5e-10  Score=125.46  Aligned_cols=113  Identities=10%  Similarity=0.066  Sum_probs=55.7

Q ss_pred             CCCCCccEEEccCCCCccccC-CCcc-ccccceeecc----CCccccc-----CCccccCCCCCCEEeCCCC--cccccC
Q 036639           86 SLLDQLRFLDLHDNRLNGTIL-PLTN-CTNLKLAYLS----GNDFSAE-----IPHQISSLKGILRLDLSDN--NIRGRI  152 (670)
Q Consensus        86 ~~l~~L~~L~L~~N~l~~~~~-~~~~-l~~L~~L~l~----~N~l~g~-----~p~~~~~l~~L~~L~l~~N--~l~g~~  152 (670)
                      ..+++|++|+|+.|++++... .++. +++|+.|+|+    .|.+++.     ++..+.++++|+.|+|+++  .+++..
T Consensus       375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~  454 (592)
T 3ogk_B          375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG  454 (592)
T ss_dssp             HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred             hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence            345666666666666654332 2332 5556666664    4555542     2333444555555555432  244433


Q ss_pred             CCCCcc-cccccceecccccccc-cCCCCcCCCCCCCEEEccCCCCcC
Q 036639          153 PEQVTN-LTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       153 p~~~~~-l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      +..+.. +++|+.|+|++|++++ .++..+..+++|+.|+|++|.|++
T Consensus       455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~  502 (592)
T 3ogk_B          455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE  502 (592)
T ss_dssp             HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred             HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence            333332 4555555555555554 223334445555555555555543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.54  E-value=7e-09  Score=116.44  Aligned_cols=127  Identities=11%  Similarity=0.092  Sum_probs=77.5

Q ss_pred             cEEEEEcCCCC-ccc-cCCC-CCCCCCccEEEccCCCCccc----cCC-CccccccceeeccCCccc----ccCCccccC
Q 036639           67 RVVSLSLPSHS-LRG-PIAP-LSLLDQLRFLDLHDNRLNGT----ILP-LTNCTNLKLAYLSGNDFS----AEIPHQISS  134 (670)
Q Consensus        67 ~v~~l~l~~~~-l~~-~~~~-~~~l~~L~~L~L~~N~l~~~----~~~-~~~l~~L~~L~l~~N~l~----g~~p~~~~~  134 (670)
                      +++.|+|.++. +.. .++. ...+++|++|+|++|.+++.    ++. +.++++|+.|+|++|.++    +.++..+.+
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~  218 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN  218 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence            37888887765 111 1111 34677888888888877654    211 456778888888888876    344555667


Q ss_pred             CCCCCEEeCCCCcccccCCCCCcccccccceeccccccc---ccCCCCcCCCCCCCEEEccCC
Q 036639          135 LKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT---GRIPDLSSSLKDLKELNLSNN  194 (670)
Q Consensus       135 l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~---g~~p~~~~~l~~L~~l~l~~N  194 (670)
                      +++|+.|+|++|.+.+ +|..+.++++|+.|+++++...   +..+..+..+++|+.|+++++
T Consensus       219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~  280 (592)
T 3ogk_B          219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYM  280 (592)
T ss_dssp             CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTC
T ss_pred             CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCcccc
Confidence            7888888888887774 5566666777777776643222   122233444555555555543

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.53  E-value=2.5e-08  Score=98.84  Aligned_cols=105  Identities=21%  Similarity=0.250  Sum_probs=79.9

Q ss_pred             CCCCCCccE--EEccCCCCccc---cCC-CccccccceeeccCCcccc--cCCccccCCCCCCEEeCCCCcccccCCCCC
Q 036639           85 LSLLDQLRF--LDLHDNRLNGT---ILP-LTNCTNLKLAYLSGNDFSA--EIPHQISSLKGILRLDLSDNNIRGRIPEQV  156 (670)
Q Consensus        85 ~~~l~~L~~--L~L~~N~l~~~---~~~-~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~  156 (670)
                      +...+.|..  ++++.|+....   +.- ..++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+
T Consensus       137 l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l  214 (267)
T 3rw6_A          137 LRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--REL  214 (267)
T ss_dssp             GGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGG
T ss_pred             cCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhh
Confidence            455556665  77788854322   211 2578899999999999998  6678888999999999999999965  445


Q ss_pred             cccc--cccceecccccccccCCC-------CcCCCCCCCEEEc
Q 036639          157 TNLT--RLLTLRLQNNELTGRIPD-------LSSSLKDLKELNL  191 (670)
Q Consensus       157 ~~l~--~L~~L~l~~N~l~g~~p~-------~~~~l~~L~~l~l  191 (670)
                      ..+.  +|+.|+|++|.+++.+|.       .+..+++|+.||=
T Consensus       215 ~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg  258 (267)
T 3rw6_A          215 DKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG  258 (267)
T ss_dssp             GGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred             hhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence            5555  899999999999988874       3567888888763

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.53  E-value=2.8e-09  Score=100.44  Aligned_cols=113  Identities=17%  Similarity=0.185  Sum_probs=84.8

Q ss_pred             CCCCCCccEEEccCC-CCccc----c-CCCccccccceeeccCCccccc----CCccccCCCCCCEEeCCCCccccc---
Q 036639           85 LSLLDQLRFLDLHDN-RLNGT----I-LPLTNCTNLKLAYLSGNDFSAE----IPHQISSLKGILRLDLSDNNIRGR---  151 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N-~l~~~----~-~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~---  151 (670)
                      +...++|++|+|++| .|...    + ..+...++|++|+|++|.|+..    +...+...++|++|+|++|.|+..   
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~  111 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL  111 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence            566788999999998 88642    1 2266678899999999998753    344455668899999999998853   


Q ss_pred             -CCCCCcccccccceec--cccccccc----CCCCcCCCCCCCEEEccCCCCc
Q 036639          152 -IPEQVTNLTRLLTLRL--QNNELTGR----IPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       152 -~p~~~~~l~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                       +...+...++|++|+|  ++|.|+..    +...+...++|+.|+|++|.+.
T Consensus       112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence             4566777888999999  88998743    2334555678999999999885

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.50  E-value=2.4e-07  Score=95.79  Aligned_cols=102  Identities=13%  Similarity=0.002  Sum_probs=91.7

Q ss_pred             CCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCC-EEeCCCCcccccCCCCCcccccccce
Q 036639           88 LDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGIL-RLDLSDNNIRGRIPEQVTNLTRLLTL  165 (670)
Q Consensus        88 l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~L  165 (670)
                      +++|+.|+|++|+++..... |.+|++|+.|+|.+| ++..-+..|.++.+|+ .|+|.+ +++..-+..|.+|++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            78999999999999877654 999999999999998 8877778899999999 999999 7886667899999999999


Q ss_pred             ecccccccccCCCCcCCCCCCCEEEc
Q 036639          166 RLQNNELTGRIPDLSSSLKDLKELNL  191 (670)
Q Consensus       166 ~l~~N~l~g~~p~~~~~l~~L~~l~l  191 (670)
                      +|++|+++..-+..|.++++|+.++.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EeCCCccCccchhhhcCCcchhhhcc
Confidence            99999999777778999999999864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=5.9e-07  Score=89.89  Aligned_cols=135  Identities=17%  Similarity=0.216  Sum_probs=97.5

Q ss_pred             cCCCCce-EEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          364 LGKGSLG-TVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       364 lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      +..|..+ .||+.... ++..+++|+-...   ...++..|...++.+. +--+.++++++.+.+..++|||++++.++.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            3345544 68988754 5678999987533   4567888999988774 334778899999999999999999998887


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY-------------------------------------------  477 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------------  477 (670)
                      +......         .....+..++++.|+.||..-                                           
T Consensus       109 ~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          109 QVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            7654321         123455666777777777520                                           


Q ss_pred             -----------CCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          478 -----------GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       478 -----------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                                 ..+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       012378999999999999877778999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.37  E-value=2e-06  Score=87.81  Aligned_cols=136  Identities=16%  Similarity=0.109  Sum_probs=94.7

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCC---CeeeEEEEEE-eCCeeEEEEeccCCCC
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP---NVVKLRAYYY-AKEEKLLVYDYLPNGS  438 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~~~g~  438 (670)
                      .++.|....||+.    |+.+++|+-..  ......+..|.++++.+.+.   .+.+++.+.. ..+..++||||++|.+
T Consensus        26 ~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           26 SLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             ecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            4677888899988    56788898532  23457889999999998642   3566777765 3456789999999988


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY-----------------------------------------  477 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------------------------------  477 (670)
                      +.+..-.       .++...+..++.++++.|+.||+.-                                         
T Consensus       100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A          100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            8763211       1344455555555555555555421                                         


Q ss_pred             ---------------CCCCccccCCCCCCeEeCC---CCc-EEEEeccccccc
Q 036639          478 ---------------GTAKVPHGNVKSSNVLLDK---NGV-ACISDFGLSLLL  511 (670)
Q Consensus       478 ---------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFG~a~~~  511 (670)
                                     ..+.++|+|++|.||+++.   ++. +.|+||+.+..-
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                           2335699999999999987   455 589999987643

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.29  E-value=1.1e-08  Score=114.74  Aligned_cols=109  Identities=14%  Similarity=0.130  Sum_probs=54.6

Q ss_pred             CCCccEEEccCCCCccccC-CCc-cccccceeecc--C----Ccccc-----cCCccccCCCCCCEEeCCCCcccccCCC
Q 036639           88 LDQLRFLDLHDNRLNGTIL-PLT-NCTNLKLAYLS--G----NDFSA-----EIPHQISSLKGILRLDLSDNNIRGRIPE  154 (670)
Q Consensus        88 l~~L~~L~L~~N~l~~~~~-~~~-~l~~L~~L~l~--~----N~l~g-----~~p~~~~~l~~L~~L~l~~N~l~g~~p~  154 (670)
                      +++|+.|+++.|++++... .+. ++++|+.|+|+  +    |.+++     .++..+.++++|+.|+|++ ++++..+.
T Consensus       371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~  449 (594)
T 2p1m_B          371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE  449 (594)
T ss_dssp             CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred             chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence            5566666666666654321 122 35566666666  3    44442     1112244555666666654 44444444


Q ss_pred             CCcc-cccccceecccccccccCCCCc-CCCCCCCEEEccCCCCc
Q 036639          155 QVTN-LTRLLTLRLQNNELTGRIPDLS-SSLKDLKELNLSNNELY  197 (670)
Q Consensus       155 ~~~~-l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N~l~  197 (670)
                      .+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.++
T Consensus       450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~  494 (594)
T 2p1m_B          450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG  494 (594)
T ss_dssp             HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred             HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence            4433 5556666666666544332222 34555666666666554

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.24  E-value=1.5e-07  Score=98.21  Aligned_cols=63  Identities=24%  Similarity=0.283  Sum_probs=26.3

Q ss_pred             CCCCCEEeCCCCcccccCCCCCc---ccccccceeccccccccc----CCCCcCCCCCCCEEEccCCCCc
Q 036639          135 LKGILRLDLSDNNIRGRIPEQVT---NLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       135 l~~L~~L~l~~N~l~g~~p~~~~---~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +++|++|+|++|.++...+..+.   .+++|++|+|+.|+|++.    ++..+..+++|+.|+|++|.++
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            44455555544444432221111   244455555555544431    2222233444555555544443

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.24  E-value=8.4e-08  Score=90.23  Aligned_cols=108  Identities=16%  Similarity=0.188  Sum_probs=85.6

Q ss_pred             CcEEEEEcCCC-Ccccc----CCC-CCCCCCccEEEccCCCCccc----c-CCCccccccceeeccCCccccc----CCc
Q 036639           66 ERVVSLSLPSH-SLRGP----IAP-LSLLDQLRFLDLHDNRLNGT----I-LPLTNCTNLKLAYLSGNDFSAE----IPH  130 (670)
Q Consensus        66 ~~v~~l~l~~~-~l~~~----~~~-~~~l~~L~~L~L~~N~l~~~----~-~~~~~l~~L~~L~l~~N~l~g~----~p~  130 (670)
                      ..++.|+|++| .+...    +.. +...++|++|+|++|.|...    + ..+...++|++|+|++|.|+..    +..
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~  115 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE  115 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence            57999999999 88753    122 66789999999999999642    1 2256678999999999999864    566


Q ss_pred             cccCCCCCCEEeC--CCCccccc----CCCCCcccccccceeccccccc
Q 036639          131 QISSLKGILRLDL--SDNNIRGR----IPEQVTNLTRLLTLRLQNNELT  173 (670)
Q Consensus       131 ~~~~l~~L~~L~l--~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~  173 (670)
                      .+...+.|++|+|  ++|.|+..    +...+...++|++|+|++|.+.
T Consensus       116 ~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          116 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            7788889999999  88999854    3345566689999999999986

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.17  E-value=1.2e-06  Score=91.50  Aligned_cols=79  Identities=10%  Similarity=0.043  Sum_probs=55.5

Q ss_pred             hHc-CCCCceEEEEEEEc-------CCCEEEEEEeCCCC---cchHHHHHHHHHHHhccC-C--CCeeeEEEEEEeC---
Q 036639          362 EML-GKGSLGTVYKAVLD-------DGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLK-H--PNVVKLRAYYYAK---  424 (670)
Q Consensus       362 ~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~nIv~l~~~~~~~---  424 (670)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            346 78889999998764       26789999875432   101245778888888774 3  3577788877655   


Q ss_pred             CeeEEEEeccCCCChH
Q 036639          425 EEKLLVYDYLPNGSLH  440 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~  440 (670)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999887654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.16  E-value=2.6e-08  Score=111.70  Aligned_cols=137  Identities=14%  Similarity=0.134  Sum_probs=77.4

Q ss_pred             CcEEEEEcCCCCccc-cCCC-CCCCCCccEEEc---------cCCCCcccc-CCC-ccccccceeeccCCcccccCCccc
Q 036639           66 ERVVSLSLPSHSLRG-PIAP-LSLLDQLRFLDL---------HDNRLNGTI-LPL-TNCTNLKLAYLSGNDFSAEIPHQI  132 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~-~~~~-~~~l~~L~~L~L---------~~N~l~~~~-~~~-~~l~~L~~L~l~~N~l~g~~p~~~  132 (670)
                      .++..|+|.+| +.. .++. ...+++|+.|+|         +.|.+++.. ..+ .++++|+.|+++.|++++..+..+
T Consensus       314 ~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l  392 (594)
T 2p1m_B          314 PKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITI  392 (594)
T ss_dssp             TTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHH
T ss_pred             CCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHH
Confidence            45677777766 332 1222 234677777777         234444321 112 246777777777777776655555


Q ss_pred             c-CCCCCCEEeCC--C----Ccccc-----cCCCCCcccccccceecccccccccCCCCcCC-CCCCCEEEccCCCCcCC
Q 036639          133 S-SLKGILRLDLS--D----NNIRG-----RIPEQVTNLTRLLTLRLQNNELTGRIPDLSSS-LKDLKELNLSNNELYGR  199 (670)
Q Consensus       133 ~-~l~~L~~L~l~--~----N~l~g-----~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~-l~~L~~l~l~~N~l~g~  199 (670)
                      . ++++|+.|+|+  +    |++++     .++..+.++++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.
T Consensus       393 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~  471 (594)
T 2p1m_B          393 ARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDL  471 (594)
T ss_dssp             HHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred             HhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence            4 47777777777  3    45552     1122245667777777765 555443333333 66777777777777654


Q ss_pred             Ccchh
Q 036639          200 VPEGL  204 (670)
Q Consensus       200 ip~~~  204 (670)
                      .+..+
T Consensus       472 ~~~~l  476 (594)
T 2p1m_B          472 GMHHV  476 (594)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44333

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.07  E-value=1.5e-05  Score=84.34  Aligned_cols=125  Identities=13%  Similarity=0.127  Sum_probs=75.7

Q ss_pred             EEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           68 VVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      ++.|.|++ .+....+. |..+.+|+.++|++|+++........+.+|+.+.|..| ++..-...|.++++|+.|+|.+|
T Consensus       159 L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~  236 (401)
T 4fdw_A          159 VQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN  236 (401)
T ss_dssp             CCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT
T ss_pred             ceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC
Confidence            55666664 44433333 77778888888888777765544222567777777643 55455566777777777777654


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                       ++..-...|.+ .+|+.+.| .|.++..-+..|.++++|+.+++.+|.+.
T Consensus       237 -l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          237 -VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             -CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred             -ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence             44333344444 56666666 34455344556667777777777666653

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.06  E-value=1.3e-05  Score=84.98  Aligned_cols=131  Identities=10%  Similarity=0.115  Sum_probs=78.6

Q ss_pred             cEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCccccCCCCCCEEeCC
Q 036639           67 RVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS  144 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  144 (670)
                      .+..+.|+.+ +...... |..+++|+.|+|..| ++.... .|.+ .+|+.+.| .|.++..-+..|.++++|+.|+|.
T Consensus       204 ~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~  279 (401)
T 4fdw_A          204 GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTY  279 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEE
T ss_pred             ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeC
Confidence            4677777744 5443333 778888888888765 433222 2555 56777777 344554445666777777777776


Q ss_pred             CCccc-----ccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          145 DNNIR-----GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       145 ~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      +|.+.     ..-+..|.+|++|+.++|. |+++-.-...|.++.+|+.++|.+| ++ .|+...
T Consensus       280 ~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~-~I~~~a  341 (401)
T 4fdw_A          280 GSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT-QINFSA  341 (401)
T ss_dssp             SSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC-EECTTS
T ss_pred             CccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc-EEcHHh
Confidence            66654     2334566677777777776 3455344455666777777777444 43 444333

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.01  E-value=2.5e-05  Score=80.65  Aligned_cols=142  Identities=19%  Similarity=0.243  Sum_probs=80.3

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC--CCCeeeEEE------EEEeCCeeEEEEecc
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK--HPNVVKLRA------YYYAKEEKLLVYDYL  434 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~nIv~l~~------~~~~~~~~~lv~e~~  434 (670)
                      .|+.|..+.||+....+| .+++|+....    ..++..|..+++.+.  .-.+.+++.      +....+..++||||+
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            355567889999987655 4899998752    234445555555542  112333332      123466789999999


Q ss_pred             CCCChH--------------HHhccC--CC--CC-----CCCCCHHHHH-------------------------------
Q 036639          435 PNGSLH--------------SLLHGN--RG--PG-----RIPLDWTTRI-------------------------------  460 (670)
Q Consensus       435 ~~g~L~--------------~~l~~~--~~--~~-----~~~l~~~~~~-------------------------------  460 (670)
                      +|..+.              ..+|..  ..  +.     .....|....                               
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              112211  00  00     0112343211                               


Q ss_pred             HHHHHHHHHHHHHHH--------h-CCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          461 SLVLGAARGLARIHQ--------E-YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       461 ~i~~~ia~~L~~LH~--------~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      .+...+.+++++|+.        . .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            011123345666663        0 013589999999999999888899999999764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.93  E-value=1.8e-06  Score=89.89  Aligned_cols=132  Identities=15%  Similarity=0.139  Sum_probs=87.7

Q ss_pred             CcEEEEEcCCCCcc---------ccCCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCcccc--
Q 036639           66 ERVVSLSLPSHSLR---------GPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQIS--  133 (670)
Q Consensus        66 ~~v~~l~l~~~~l~---------~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~--  133 (670)
                      .++..|.+..+...         +.+.. +..+++|+.|+|++|.-. .++.+ .+++|+.|+|..|.++......++  
T Consensus       139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~~-~~~~L~~L~L~~~~l~~~~l~~l~~~  216 (362)
T 2ra8_A          139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGKK-PRPNLKSLEIISGGLPDSVVEDILGS  216 (362)
T ss_dssp             TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCSC-BCTTCSEEEEECSBCCHHHHHHHHHS
T ss_pred             chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eeccc-cCCCCcEEEEecCCCChHHHHHHHHc
Confidence            36777877655331         11222 467789999999988311 22334 388999999999888765545554  


Q ss_pred             CCCCCCEEeCCC--Cccccc-----CCCCC--cccccccceecccccccccCCCCc---CCCCCCCEEEccCCCCcCC
Q 036639          134 SLKGILRLDLSD--NNIRGR-----IPEQV--TNLTRLLTLRLQNNELTGRIPDLS---SSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       134 ~l~~L~~L~l~~--N~l~g~-----~p~~~--~~l~~L~~L~l~~N~l~g~~p~~~---~~l~~L~~l~l~~N~l~g~  199 (670)
                      .+++|+.|+|+.  |...|.     +...+  ..+++|++|+|++|.+++..+..+   ..+++|+.|+|+.|.|++.
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~  294 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE  294 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence            789999999863  332221     11122  357899999999999875433222   2478999999999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.88  E-value=1.6e-05  Score=84.23  Aligned_cols=74  Identities=14%  Similarity=0.104  Sum_probs=48.9

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-------chHHHHHHHHHHHhccCC--C-CeeeEEEEEEeCCeeEEE
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-------CARKEFEQYMDVIGKLKH--P-NVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+|.|.++.||++... +++.|+||.......       .....+..|.++++.+..  + .+.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            45899999999999854 478899998653211       123456778888887732  3 34455543  45567899


Q ss_pred             EeccCCC
Q 036639          431 YDYLPNG  437 (670)
Q Consensus       431 ~e~~~~g  437 (670)
                      |||+++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.83  E-value=7.4e-05  Score=75.96  Aligned_cols=139  Identities=15%  Similarity=0.145  Sum_probs=91.6

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC---CCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK---HPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .|+.|....+|+.... ++.+++|+....   ....+..|.+.++.|.   ...+++++++....+..++||||+++..+
T Consensus        43 ~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           43 KLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             EeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4788888999998864 678889987643   3667889998888873   35788899988888889999999998764


Q ss_pred             H-----------HHhccCCC-C----------------CCCCCCHHHHH---HHHH--H-----------HHHHHHHHHH
Q 036639          440 H-----------SLLHGNRG-P----------------GRIPLDWTTRI---SLVL--G-----------AARGLARIHQ  475 (670)
Q Consensus       440 ~-----------~~l~~~~~-~----------------~~~~l~~~~~~---~i~~--~-----------ia~~L~~LH~  475 (670)
                      .           ..+|.... .                +...-+|....   ++..  +           +.+.++.+..
T Consensus       119 ~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~  198 (312)
T 3jr1_A          119 KQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVAD  198 (312)
T ss_dssp             CTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHH
T ss_pred             CchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHH
Confidence            2           12332211 0                00112564322   1111  1           1112222222


Q ss_pred             h----CCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          476 E----YGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       476 ~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      .    ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus       199 ~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          199 TLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1    1246799999999999999887 8899974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.80  E-value=4.6e-05  Score=81.36  Aligned_cols=75  Identities=13%  Similarity=0.139  Sum_probs=50.7

Q ss_pred             CCCccccCCCCCCeEeCCCCcEEEEecccccccCccccccc-----cCcccCccccccC---CCCCchhHHHHHHHHHHH
Q 036639          479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIAR-----LGGYKAPEQAEVK---RLSQKADVYSFGVLLLEV  550 (670)
Q Consensus       479 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~-----~~~y~aPE~~~~~---~~~~ksDVwS~Gvvl~el  550 (670)
                      ...++|||++|.|||++.++ ++|+||+.+..-.+......     ...|++|+.....   .-....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            45899999999999998876 99999999876553221111     1236777655321   112245666888888888


Q ss_pred             HcCC
Q 036639          551 LTGR  554 (670)
Q Consensus       551 ltg~  554 (670)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=4.1e-05  Score=77.14  Aligned_cols=74  Identities=19%  Similarity=0.262  Sum_probs=55.2

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-C--CCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-H--PNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+|.|..+.||+.+..+|+.|+||+-..........|+.|++.|+.|. .  -.+.+++++    +..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence            3578899999999999999999999977555444567889999888774 2  234555554    23478999998764


Q ss_pred             h
Q 036639          439 L  439 (670)
Q Consensus       439 L  439 (670)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.44  E-value=0.00075  Score=69.10  Aligned_cols=144  Identities=14%  Similarity=0.098  Sum_probs=83.0

Q ss_pred             cCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCC--CeeeEEEE-----EEeCCeeEEEEeccCC
Q 036639          364 LGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHP--NVVKLRAY-----YYAKEEKLLVYDYLPN  436 (670)
Q Consensus       364 lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--nIv~l~~~-----~~~~~~~~lv~e~~~~  436 (670)
                      ++ |....||+....+|+.+++|...... .....+..|..++..+...  .+++++..     ....+..+++|||++|
T Consensus        34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G  111 (328)
T 1zyl_A           34 LN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  111 (328)
T ss_dssp             EC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence            45 77788999887778789999987432 1356677788887777421  23444432     2234566889999987


Q ss_pred             CChH-----HH---------hcc----CCCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHHhC--
Q 036639          437 GSLH-----SL---------LHG----NRGPGRIPLDWTTR----ISL---------------VLGAARGLARIHQEY--  477 (670)
Q Consensus       437 g~L~-----~~---------l~~----~~~~~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~~~--  477 (670)
                      ..+.     .+         +|.    .........++...    ..+               ...+.+.++.+....  
T Consensus       112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  191 (328)
T 1zyl_A          112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  191 (328)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence            5431     10         111    11001112232211    001               111122234444332  


Q ss_pred             -CCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          478 -GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       478 -~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                       ....++|+|+++.||+++ + .+.|+||+.+..-
T Consensus       192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence             234689999999999998 4 8999999877543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.32  E-value=0.0012  Score=67.46  Aligned_cols=145  Identities=9%  Similarity=0.060  Sum_probs=80.7

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCC--eeeEEEE------EEeCCeeEEEEecc
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPN--VVKLRAY------YYAKEEKLLVYDYL  434 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~~------~~~~~~~~lv~e~~  434 (670)
                      .|+.|....+|+....+| .+++|......  ..+++..|..++..+....  +.+++..      ....+..+++++|+
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l  105 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  105 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence            467788889999987766 58899887531  2245566777776663211  2333321      12345678999999


Q ss_pred             CCCChHH--------------HhccC----CCCCCCC---CCHHHHHHH------------HHHHHHHHHHHHHhC---C
Q 036639          435 PNGSLHS--------------LLHGN----RGPGRIP---LDWTTRISL------------VLGAARGLARIHQEY---G  478 (670)
Q Consensus       435 ~~g~L~~--------------~l~~~----~~~~~~~---l~~~~~~~i------------~~~ia~~L~~LH~~~---~  478 (670)
                      +|..+..              .+|..    .......   ..|.....-            ...+.+.+++++...   .
T Consensus       106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~  185 (322)
T 2ppq_A          106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  185 (322)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence            8865311              12211    1000000   123321110            112445566666432   1


Q ss_pred             CCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       479 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      ...++|+|+.+.|||++.+..+.|+||+.+..
T Consensus       186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          186 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            34689999999999998876668999987643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.18  E-value=0.0011  Score=68.00  Aligned_cols=143  Identities=16%  Similarity=0.131  Sum_probs=73.2

Q ss_pred             cCCCCceE-EEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-C-CCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          364 LGKGSLGT-VYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-H-PNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       364 lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      |+.|+... +|+....+|+.+++|......   ..++..|+.+++.+. + -.+.+++.+..+  ..+++||++.+..+.
T Consensus        26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~l~  100 (333)
T 3csv_A           26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDALFT  100 (333)
T ss_dssp             --------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCBHH
T ss_pred             CCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcchH
Confidence            44454444 667765446778888765432   133445666666653 2 235566665332  237899999776665


Q ss_pred             HHhccC---------------------CCCCCCCCCHHHHH-------H-------------HHHHHHHHHHHHHHh--C
Q 036639          441 SLLHGN---------------------RGPGRIPLDWTTRI-------S-------------LVLGAARGLARIHQE--Y  477 (670)
Q Consensus       441 ~~l~~~---------------------~~~~~~~l~~~~~~-------~-------------i~~~ia~~L~~LH~~--~  477 (670)
                      +++...                     .......++.....       .             ....+.+.++.+...  .
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            443211                     00000011111100       0             001112223333221  1


Q ss_pred             CCCCccccCCCCCCeEeCCC----CcEEEEeccccccc
Q 036639          478 GTAKVPHGNVKSSNVLLDKN----GVACISDFGLSLLL  511 (670)
Q Consensus       478 ~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~~  511 (670)
                      ....++|||+.+.|||++.+    +.+.|+||+.+..-
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            23578999999999999875    67999999987654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.06  E-value=7.1e-05  Score=68.68  Aligned_cols=33  Identities=9%  Similarity=0.092  Sum_probs=14.0

Q ss_pred             CccEEEccCCCCccc-cCCCccccccceeeccCC
Q 036639           90 QLRFLDLHDNRLNGT-ILPLTNCTNLKLAYLSGN  122 (670)
Q Consensus        90 ~L~~L~L~~N~l~~~-~~~~~~l~~L~~L~l~~N  122 (670)
                      .|+.|||+++.++.. +..+.+|++|+.|+|+++
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            344455554444321 122344444444444444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.04  E-value=0.0018  Score=67.49  Aligned_cols=143  Identities=13%  Similarity=0.131  Sum_probs=83.3

Q ss_pred             HcCCCCceEEEEEEEc--------CCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEec
Q 036639          363 MLGKGSLGTVYKAVLD--------DGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+..|-...+|++...        +++.|++|+.... ......+.+|.++++.+. +.-..++++++.+    .+||||
T Consensus        57 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~  131 (379)
T 3feg_A           57 PVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQY  131 (379)
T ss_dssp             EC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEEC
T ss_pred             EcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEE
Confidence            4666778889998864        3578999986432 223566678998888774 3334566666543    289999


Q ss_pred             cCCCChHHH-----------------hccCCCCCCCCCC--HHHHHHHHHHHH-------------------HHHHHHHH
Q 036639          434 LPNGSLHSL-----------------LHGNRGPGRIPLD--WTTRISLVLGAA-------------------RGLARIHQ  475 (670)
Q Consensus       434 ~~~g~L~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~L~~LH~  475 (670)
                      ++|.+|..-                 +|....+......  |.+..++..++.                   +.+..|..
T Consensus       132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~  211 (379)
T 3feg_A          132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK  211 (379)
T ss_dssp             CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred             ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence            987554310                 1221111111122  444444544332                   22344433


Q ss_pred             h----CCCCCccccCCCCCCeEeCCC----CcEEEEecccccc
Q 036639          476 E----YGTAKVPHGNVKSSNVLLDKN----GVACISDFGLSLL  510 (670)
Q Consensus       476 ~----~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFG~a~~  510 (670)
                      .    -....++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    123468999999999999876    7899999987754

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.00  E-value=9e-05  Score=67.97  Aligned_cols=84  Identities=14%  Similarity=0.136  Sum_probs=65.1

Q ss_pred             cccceeeccCCcccccCCccccCCCCCCEEeCCCCc-ccccCCCCCccc----ccccceeccccc-ccccCCCCcCCCCC
Q 036639          112 TNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN-IRGRIPEQVTNL----TRLLTLRLQNNE-LTGRIPDLSSSLKD  185 (670)
Q Consensus       112 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~~  185 (670)
                      .+|+.|||+++.++..--..+.++++|+.|+|+++. ++..-=..+..+    ++|+.|+|++|. +|..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            479999999999887666678899999999999984 775333345553    479999999975 76432234667999


Q ss_pred             CCEEEccCCC
Q 036639          186 LKELNLSNNE  195 (670)
Q Consensus       186 L~~l~l~~N~  195 (670)
                      |+.|+|++..
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            9999999875

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.91  E-value=0.002  Score=67.89  Aligned_cols=109  Identities=12%  Similarity=0.142  Sum_probs=83.2

Q ss_pred             CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccc
Q 036639           85 LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT  164 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  164 (670)
                      |..+..|+.+.+.++-.+-....|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+|.+|.+|+.
T Consensus       261 F~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~  338 (394)
T 4gt6_A          261 FDSCAYLASVKMPDSVVSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLER  338 (394)
T ss_dssp             TTTCSSCCEEECCTTCCEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCE
T ss_pred             eeecccccEEecccccceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCE
Confidence            778899999999876543222348899999999996 4566555667889999999999765 66455678899999999


Q ss_pred             eecccccccccCCCCcCCCCCCCEEEccCCCC
Q 036639          165 LRLQNNELTGRIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       165 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      +.|..+ ++..-..+|.++.+|+.+++.+|..
T Consensus       339 i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          339 IAIPSS-VTKIPESAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             EEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred             EEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence            999654 6633345788999999999988753

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.90  E-value=0.0011  Score=57.70  Aligned_cols=17  Identities=24%  Similarity=0.313  Sum_probs=7.1

Q ss_pred             cCCCCCCCEEEccCCCC
Q 036639          180 SSSLKDLKELNLSNNEL  196 (670)
Q Consensus       180 ~~~l~~L~~l~l~~N~l  196 (670)
                      |..+++|+.|+|++|.+
T Consensus        51 f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           51 LDALPALRTAHLGANPW   67 (130)
T ss_dssp             GGGCTTCCEEECCSSCC
T ss_pred             hhhccccCEEEecCCCe
Confidence            33344444444444433

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.89  E-value=0.001  Score=67.24  Aligned_cols=142  Identities=13%  Similarity=0.073  Sum_probs=75.1

Q ss_pred             hHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCe-eeEEEEEEeCCeeEEEEecc-CCCCh
Q 036639          362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNV-VKLRAYYYAKEEKLLVYDYL-PNGSL  439 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~-~~g~L  439 (670)
                      +.|+.|....+|+.     +.+++|+....... ..+...|..+++.+....+ .+++++  +.+..++++||+ ++.++
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence            45788999999998     55888988643211 1123457777766642222 455543  444567899999 65444


Q ss_pred             HH------------------HhccCCCCCCCCCCH-HHHHHHHH--------------HHHHHHHHHH----HhCCCCCc
Q 036639          440 HS------------------LLHGNRGPGRIPLDW-TTRISLVL--------------GAARGLARIH----QEYGTAKV  482 (670)
Q Consensus       440 ~~------------------~l~~~~~~~~~~l~~-~~~~~i~~--------------~ia~~L~~LH----~~~~~~~i  482 (670)
                      ..                  .+|............ .....+..              .+.+.+..+.    .......+
T Consensus        96 ~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l  175 (301)
T 3dxq_A           96 SPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAA  175 (301)
T ss_dssp             CHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEE
T ss_pred             CHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCcee
Confidence            21                  112111100000111 11111110              0111112221    11123458


Q ss_pred             cccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          483 PHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       483 vH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      +|+|+.+.||+ ..++.+.|+||..+..-.
T Consensus       176 ~HgDl~~~Nil-~~~~~~~lID~e~a~~g~  204 (301)
T 3dxq_A          176 CHCDPLCENFL-DTGERMWIVDWEYSGMND  204 (301)
T ss_dssp             ECSCCCGGGEE-ECSSCEEECCCTTCEEEC
T ss_pred             eccCCCcCCEE-ECCCCEEEEecccccCCC
Confidence            99999999999 566778999998876543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.86  E-value=0.0039  Score=66.36  Aligned_cols=71  Identities=11%  Similarity=0.125  Sum_probs=48.3

Q ss_pred             hHcCCCCceEEEEEEEcC--------CCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEe
Q 036639          362 EMLGKGSLGTVYKAVLDD--------GGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.|+.|....+|++...+        ++.|++|+.....  ....+..|..+++.+. +.-..++++.+.  +  .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            357788889999998753        5789999985421  2245557888888774 333356776543  2  38999


Q ss_pred             ccCCCC
Q 036639          433 YLPNGS  438 (670)
Q Consensus       433 ~~~~g~  438 (670)
                      |++|.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            998643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.83  E-value=0.001  Score=69.47  Aligned_cols=72  Identities=10%  Similarity=0.067  Sum_probs=43.0

Q ss_pred             HcCCCCceEEEEEEEcC---------CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCC-eeeEEEEEEeCCeeEEEEe
Q 036639          363 MLGKGSLGTVYKAVLDD---------GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPN-VVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-Iv~l~~~~~~~~~~~lv~e  432 (670)
                      .++.|....+|+....+         ++.+++|+...... ...+...|.++++.+...+ +.++++..  .  .++|||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e  114 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEE  114 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEE
Confidence            46778888999998654         26888998764321 1112456777777774223 44666543  2  368999


Q ss_pred             ccCCCCh
Q 036639          433 YLPNGSL  439 (670)
Q Consensus       433 ~~~~g~L  439 (670)
                      |++|..+
T Consensus       115 ~i~G~~l  121 (369)
T 3c5i_A          115 WLYGDPL  121 (369)
T ss_dssp             CCCSEEC
T ss_pred             EecCCcC
Confidence            9987543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.78  E-value=0.0046  Score=65.02  Aligned_cols=105  Identities=11%  Similarity=0.241  Sum_probs=76.7

Q ss_pred             CCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCC
Q 036639          107 PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL  186 (670)
Q Consensus       107 ~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  186 (670)
                      .|.++.+|+.+.+..+..+ .-...|.++.+|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+|.++.+|
T Consensus       260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L  336 (394)
T 4gt6_A          260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQL  336 (394)
T ss_dssp             TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred             eeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCC
Confidence            3888999999999876543 556678889999999996 5566455567899999999999764 664445678899999


Q ss_pred             CEEEccCCCCcCCCcchhhhh---cCccccccc
Q 036639          187 KELNLSNNELYGRVPEGLLKK---FGEQSFIGN  216 (670)
Q Consensus       187 ~~l~l~~N~l~g~ip~~~~~~---~~~~~~~~n  216 (670)
                      +.+.+..| ++ .|+...|..   +....+.+|
T Consensus       337 ~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~  367 (394)
T 4gt6_A          337 ERIAIPSS-VT-KIPESAFSNCTALNNIEYSGS  367 (394)
T ss_dssp             CEEEECTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred             CEEEECcc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence            99999755 55 677655443   333444443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.77  E-value=0.0021  Score=55.92  Aligned_cols=37  Identities=24%  Similarity=0.334  Sum_probs=21.1

Q ss_pred             ccceeeccCCcccccCCccccCCCCCCEEeCCCCccc
Q 036639          113 NLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR  149 (670)
Q Consensus       113 ~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  149 (670)
                      +|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3555555555555444444556666666666666553

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.74  E-value=0.0039  Score=65.58  Aligned_cols=82  Identities=15%  Similarity=0.128  Sum_probs=42.6

Q ss_pred             CccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCC
Q 036639          108 LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK  187 (670)
Q Consensus       108 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~  187 (670)
                      +..+.+|+.+.+..+ ++..-...|.++.+|+.++|.++ ++-.-..+|.+|.+|+.++|..| ++..-..+|.++.+|+
T Consensus       293 F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~  369 (394)
T 4fs7_A          293 FYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLK  369 (394)
T ss_dssp             TTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCC
T ss_pred             ccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCC
Confidence            445555555555443 33333444555666666666433 44333445566666666666544 4423334555666666


Q ss_pred             EEEcc
Q 036639          188 ELNLS  192 (670)
Q Consensus       188 ~l~l~  192 (670)
                      .+++.
T Consensus       370 ~i~lp  374 (394)
T 4fs7_A          370 KVELP  374 (394)
T ss_dssp             EEEEE
T ss_pred             EEEEC
Confidence            66554

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.74  E-value=0.0053  Score=64.10  Aligned_cols=105  Identities=10%  Similarity=0.087  Sum_probs=49.1

Q ss_pred             CCCCCCccEEEccCCCCcccc-CCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCccccccc
Q 036639           85 LSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLL  163 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~  163 (670)
                      +.....|+.+.+..+ +.... ..+.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++.+|+
T Consensus       213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~  289 (379)
T 4h09_A          213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT  289 (379)
T ss_dssp             TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred             cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence            444555555555443 11111 22455555555555443 33333344455555555555432 3322233455555555


Q ss_pred             ceecccccccccCCCCcCCCCCCCEEEcc
Q 036639          164 TLRLQNNELTGRIPDLSSSLKDLKELNLS  192 (670)
Q Consensus       164 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  192 (670)
                      .+.+.+|.++..-...|.++.+|+.++|.
T Consensus       290 ~i~l~~~~i~~I~~~aF~~c~~L~~i~lp  318 (379)
T 4h09_A          290 KVVMDNSAIETLEPRVFMDCVKLSSVTLP  318 (379)
T ss_dssp             EEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred             cccccccccceehhhhhcCCCCCCEEEcC
Confidence            55555555543333445555555555554

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.66  E-value=0.01  Score=63.54  Aligned_cols=73  Identities=10%  Similarity=0.095  Sum_probs=46.4

Q ss_pred             hHcCCCCceEEEEEEEcC-CCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCe-eeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          362 EMLGKGSLGTVYKAVLDD-GGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNV-VKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI-v~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.|+.|-...+|++...+ +..|++|+...... ..-+...|..+++.|...++ .++++++.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            357788889999999765 57889998754321 11112578888888864444 56777662  2  259999987443

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.57  E-value=0.022  Score=53.44  Aligned_cols=103  Identities=12%  Similarity=0.089  Sum_probs=67.4

Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcccc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA  516 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  516 (670)
                      -+|.++|....    .++++.+++.++.|.+++|.-+-..-   .-..+=+.|..|++..+|.+.+.+ ..+.       
T Consensus        33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc-------
Confidence            47899988654    37999999999999999887762210   111233456899999999988764 1111       


Q ss_pred             ccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC
Q 036639          517 IARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP  556 (670)
Q Consensus       517 ~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p  556 (670)
                       .....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence             1223477898764 4567899999999999999875443

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.53  E-value=0.00029  Score=65.81  Aligned_cols=112  Identities=11%  Similarity=0.137  Sum_probs=66.4

Q ss_pred             CCCCCCccEEEccCC-CCccc----c-CCCccccccceeeccCCcccccCCcc----ccCCCCCCEEeCCCCccccc---
Q 036639           85 LSLLDQLRFLDLHDN-RLNGT----I-LPLTNCTNLKLAYLSGNDFSAEIPHQ----ISSLKGILRLDLSDNNIRGR---  151 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N-~l~~~----~-~~~~~l~~L~~L~l~~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~g~---  151 (670)
                      +.+-+.|+.|+|++| +|...    + ..+..-+.|+.|+|++|+|...--..    +..=+.|+.|+|++|.|+..   
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            345577888888875 76421    1 22555677888888888886432222    33446788888888888742   


Q ss_pred             -CCCCCcccccccceeccccc---cccc----CCCCcCCCCCCCEEEccCCCC
Q 036639          152 -IPEQVTNLTRLLTLRLQNNE---LTGR----IPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       152 -~p~~~~~l~~L~~L~l~~N~---l~g~----~p~~~~~l~~L~~l~l~~N~l  196 (670)
                       +-..+..-+.|+.|+|++|.   +...    +-..+..=+.|+.|+++.|.+
T Consensus       117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence             22334455667778877542   2211    222233345677777776654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.33  E-value=0.018  Score=59.15  Aligned_cols=140  Identities=15%  Similarity=0.204  Sum_probs=78.8

Q ss_pred             CCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC---CCCeeeEEEE------EEeCCeeEEEEeccC
Q 036639          365 GKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK---HPNVVKLRAY------YYAKEEKLLVYDYLP  435 (670)
Q Consensus       365 g~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~nIv~l~~~------~~~~~~~~lv~e~~~  435 (670)
                      |.|....||+....+| .+++|+......      ..|+.++..|.   -|++++++..      ....+..++||+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            4444678999997777 899998765432      34555555442   2224444432      233567789999998


Q ss_pred             CCChH----------------HHhccCCCCC-------C--CCCCHHHHH-HH---------------------------
Q 036639          436 NGSLH----------------SLLHGNRGPG-------R--IPLDWTTRI-SL---------------------------  462 (670)
Q Consensus       436 ~g~L~----------------~~l~~~~~~~-------~--~~l~~~~~~-~i---------------------------  462 (670)
                      |..+.                ..+|......       .  ....|...+ .+                           
T Consensus       105 G~~~~~~~~~~~~~~~lg~~La~LH~~~~~~~~~~~~~~~~~~~~w~~~i~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (339)
T 3i1a_A          105 APNGFTQNLTGKQWKQLGKVLRQIHETSVPISIQQQLRKEIYSPKWREIVRSFYNQIEFDNSDDKLTAAFKSFFNQNSAA  184 (339)
T ss_dssp             CCBTTTSCCCHHHHHHHHHHHHHHHTCCCCHHHHTTSEECCCCCHHHHHHHHHGGGGSCCTTCCHHHHHHHHHHHHTHHH
T ss_pred             CCcCcccCCCHHHHHHHHHHHHHHhCcCCCCCCccCccccccCcchHHHHHHHHHhhhccccCCcHHHHHHHHHHHhHHH
Confidence            86551                1122221100       0  011121111 00                           


Q ss_pred             HHHHHHHHHHHHHhCC----CCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          463 VLGAARGLARIHQEYG----TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       463 ~~~ia~~L~~LH~~~~----~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      +..+...+..+.....    ...++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       185 l~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          185 IHRLVDTSEKLSKKIQPDLDKYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             HHHHHHHHHHHHHHCCCCGGGCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             HHHHHHHHHHHHHHHhhCCCCceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            1112222233332221    346899999999999998888999999877644

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.31  E-value=0.00051  Score=64.19  Aligned_cols=108  Identities=6%  Similarity=0.147  Sum_probs=76.7

Q ss_pred             CcEEEEEcCCC-Ccccc----CCC-CCCCCCccEEEccCCCCcccc-C----CCccccccceeeccCCcccccC----Cc
Q 036639           66 ERVVSLSLPSH-SLRGP----IAP-LSLLDQLRFLDLHDNRLNGTI-L----PLTNCTNLKLAYLSGNDFSAEI----PH  130 (670)
Q Consensus        66 ~~v~~l~l~~~-~l~~~----~~~-~~~l~~L~~L~L~~N~l~~~~-~----~~~~l~~L~~L~l~~N~l~g~~----p~  130 (670)
                      ..++.|+|++| ++...    +.. +..-+.|+.|+|++|+|...- .    .+..-+.|+.|+|+.|+|+..-    -.
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~  120 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR  120 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence            57899999986 66532    112 566789999999999997321 1    1556688999999999998542    23


Q ss_pred             cccCCCCCCEEeCCCCc---ccc----cCCCCCcccccccceeccccccc
Q 036639          131 QISSLKGILRLDLSDNN---IRG----RIPEQVTNLTRLLTLRLQNNELT  173 (670)
Q Consensus       131 ~~~~l~~L~~L~l~~N~---l~g----~~p~~~~~l~~L~~L~l~~N~l~  173 (670)
                      .+..=+.|+.|+|++|.   +..    .+-..+..-+.|+.|+|+.|.+.
T Consensus       121 aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          121 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence            34455679999998763   332    13344566688999999988764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.17  E-value=0.043  Score=57.04  Aligned_cols=107  Identities=15%  Similarity=0.155  Sum_probs=77.8

Q ss_pred             CCCCCCccEEEccCCCCcccc-CCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCccccccc
Q 036639           85 LSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLL  163 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~  163 (670)
                      +..+..|+.+.+..+ ++..- ..+.++.+|+.+.+..+ ++..-...|.++.+|+.+.+.+|.++..-...|.+|.+|+
T Consensus       236 f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~  313 (379)
T 4h09_A          236 FYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS  313 (379)
T ss_dssp             TTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred             ccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCC
Confidence            667788888888765 44332 23788888888888654 5544456678888999999988888855567888889999


Q ss_pred             ceecccccccccCCCCcCCCCCCCEEEccCC
Q 036639          164 TLRLQNNELTGRIPDLSSSLKDLKELNLSNN  194 (670)
Q Consensus       164 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  194 (670)
                      .+.|..| ++..-..+|.++.+|+.+.+..|
T Consensus       314 ~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          314 SVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             EEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             EEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            9988654 65333456888888888866443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.03  E-value=0.029  Score=58.77  Aligned_cols=113  Identities=14%  Similarity=0.118  Sum_probs=77.7

Q ss_pred             CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccc
Q 036639           85 LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT  164 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  164 (670)
                      +..+..|+.+.+..|...-....+.++..|+.+.+..+.+   ....|.++.+|+.+.+.+| ++..-..+|.++.+|+.
T Consensus       249 f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~  324 (394)
T 4fs7_A          249 FYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVS  324 (394)
T ss_dssp             TTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred             ccccccceeEEcCCCcceeeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCE
Confidence            5667777777777665443333477777777777766543   2345778888999888765 66455567888999999


Q ss_pred             eecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          165 LRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       165 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                      ++|.++ ++..-..+|.++.+|+.+++..| ++ .|+...
T Consensus       325 i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~a  361 (394)
T 4fs7_A          325 IDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANA  361 (394)
T ss_dssp             ECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTT
T ss_pred             EEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHH
Confidence            998644 66444567888999999988766 54 454433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.05  E-value=0.033  Score=58.81  Aligned_cols=143  Identities=11%  Similarity=0.125  Sum_probs=83.5

Q ss_pred             HcCCCCceEEEEEEEcC--------CCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEec
Q 036639          363 MLGKGSLGTVYKAVLDD--------GGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+..|-...+|+....+        ++.|++|+...... ..-+..+|..+++.+. +.-..++++.+  .  .++||||
T Consensus        77 ~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ef  151 (424)
T 3mes_A           77 QIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEF  151 (424)
T ss_dssp             EECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEE
Confidence            46678888899998753        57899998754321 1123356777777774 33345566533  2  3789999


Q ss_pred             cCCCChHH-------H----------hccCCC-----C---CCCCCCHHHHHHHHHHH-------------------HHH
Q 036639          434 LPNGSLHS-------L----------LHGNRG-----P---GRIPLDWTTRISLVLGA-------------------ARG  469 (670)
Q Consensus       434 ~~~g~L~~-------~----------l~~~~~-----~---~~~~l~~~~~~~i~~~i-------------------a~~  469 (670)
                      ++|.+|..       .          +|....     +   ...+.-|..+.++..++                   ...
T Consensus       152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e  231 (424)
T 3mes_A          152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE  231 (424)
T ss_dssp             CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred             eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence            98865321       0          111000     0   11122344444433222                   223


Q ss_pred             HHHHHHhC--------------------CCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          470 LARIHQEY--------------------GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       470 L~~LH~~~--------------------~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      +.+|....                    ....++|+|+.+.||+ +.++.+.++||..+..-
T Consensus       232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~~  292 (424)
T 3mes_A          232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAIN  292 (424)
T ss_dssp             HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCcC
Confidence            44443221                    1245789999999999 78889999999887643

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=94.09  E-value=0.046  Score=35.62  Aligned_cols=31  Identities=23%  Similarity=0.398  Sum_probs=21.8

Q ss_pred             CCCchhhhHHHHHHHHHHHHHHHHHhheeee
Q 036639          267 KGLSTAAIVAIVLGNCVALLVVTSFVVAYCC  297 (670)
Q Consensus       267 ~~~~~~~iv~~v~g~~~~~~~~~~~~~~~~~  297 (670)
                      ++++...|.++++|.++.+++++.+++++++
T Consensus         6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~r   36 (38)
T 2k1k_A            6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSR   36 (38)
T ss_dssp             TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence            4567889999999888777666655554433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=92.73  E-value=0.099  Score=35.06  Aligned_cols=31  Identities=29%  Similarity=0.314  Sum_probs=16.0

Q ss_pred             hhhhHHHHHHHHHHHHHHHHHhheeeecCcC
Q 036639          271 TAAIVAIVLGNCVALLVVTSFVVAYCCRGDR  301 (670)
Q Consensus       271 ~~~iv~~v~g~~~~~~~~~~~~~~~~~~~~~  301 (670)
                      +..|++.++|.++++++++..++++++||++
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            4556666666555554444444444444433

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.98  E-value=0.11  Score=34.86  Aligned_cols=28  Identities=25%  Similarity=0.274  Sum_probs=13.3

Q ss_pred             hhHHHHHHHHHHHHHHHHHhheeeecCc
Q 036639          273 AIVAIVLGNCVALLVVTSFVVAYCCRGD  300 (670)
Q Consensus       273 ~iv~~v~g~~~~~~~~~~~~~~~~~~~~  300 (670)
                      .|++.++|.++++++++..++++++||+
T Consensus        12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             SSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             eEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            4555566555544444433344444433

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.94  E-value=0.87  Score=47.56  Aligned_cols=30  Identities=23%  Similarity=0.341  Sum_probs=25.0

Q ss_pred             CccccCCCCCCeEe------CCCCcEEEEecccccc
Q 036639          481 KVPHGNVKSSNVLL------DKNGVACISDFGLSLL  510 (670)
Q Consensus       481 ~ivH~Dlkp~NIll------~~~~~~kl~DFG~a~~  510 (670)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567799999987754

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=86.96  E-value=0.46  Score=31.78  Aligned_cols=9  Identities=33%  Similarity=0.774  Sum_probs=5.8

Q ss_pred             hhhHHHHHH
Q 036639          272 AAIVAIVLG  280 (670)
Q Consensus       272 ~~iv~~v~g  280 (670)
                      ..++++++|
T Consensus        12 ~~Ia~~vVG   20 (44)
T 2jwa_A           12 TSIISAVVG   20 (44)
T ss_dssp             HHHHHHHHH
T ss_pred             cchHHHHHH
Confidence            456666777

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.13  E-value=1.8  Score=40.54  Aligned_cols=115  Identities=10%  Similarity=0.158  Sum_probs=77.8

Q ss_pred             CCCCeeeEEEEEEeCCeeEEEEeccCCC-ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCC
Q 036639          410 KHPNVVKLRAYYYAKEEKLLVYDYLPNG-SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVK  488 (670)
Q Consensus       410 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlk  488 (670)
                      .||+.++. .+-.+.+...+.|+.-+.+ ++.. ++        ..+...+++++.+|+....+++.      -+|--|.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik--------~~~~~eKlr~l~ni~~l~~~~~~------r~tf~L~  106 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK--------SFTKNEKLRYLLNIKNLEEVNRT------RYTFVLA  106 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG--------GSCHHHHHHHHHHGGGGGGGGGS------SEECCCS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH--------hcCHHHHHHHHHHHHHHHHHhcC------ceEEEEe
Confidence            58888876 5666667666666654322 2222 32        36778999999999887755553      3577899


Q ss_pred             CCCeEeCCCCcEEEEecccccccCccccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 036639          489 SSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       489 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~  558 (670)
                      |+||++|.++.+++.-.|+-..+             +|.     ..++.-=.-.+=+++..+++++..|+
T Consensus       107 P~NL~f~~~~~p~i~~RGik~~l-------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          107 PDELFFTRDGLPIAKTRGLQNVV-------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGGEEECTTSCEEESCCEETTTB-------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cceEEEcCCCCEEEEEccCccCC-------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999999987764433             222     11222223367788899999998874

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=80.71  E-value=2.9  Score=39.21  Aligned_cols=114  Identities=11%  Similarity=0.086  Sum_probs=76.5

Q ss_pred             CCCCeeeEEEEEEeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HHHHhCCCCCccccCCC
Q 036639          410 KHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA-RIHQEYGTAKVPHGNVK  488 (670)
Q Consensus       410 ~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~~ivH~Dlk  488 (670)
                      .||+.  -..+-.+.+...+.++.-+++.=...++        .++...+++++.+++.-.. +++      .-+|--+.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~------~r~tf~l~  111 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSA------RRLIFIVC  111 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCS------SSEECCCC
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhh------CceeEEEe
Confidence            58888  4445567777777777654433333343        3677889999888876555 444      44677899


Q ss_pred             CCCeEeCCCCcEEEEecccccccCccccccccCcccCccccccCCCCCchhHH-HHHHHHHHHHcCCCCCC
Q 036639          489 SSNVLLDKNGVACISDFGLSLLLNPVQAIARLGGYKAPEQAEVKRLSQKADVY-SFGVLLLEVLTGRAPSQ  558 (670)
Q Consensus       489 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~ksDVw-S~Gvvl~elltg~~p~~  558 (670)
                      |+||++|.++.+++.-.|+-..             ++|.-+     + .-|.| .+=+++..++.++..|+
T Consensus       112 P~NL~f~~~~~p~i~hRGi~~~-------------lpP~e~-----~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          112 PENLMFNRALEPFFLHVGVKES-------------LPPDEW-----D-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGGEEECTTCCEEESCCEETTT-------------BSSCSC-----C-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CceEEEeCCCcEEEEEcCCccc-------------CCCCCC-----C-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999998776433             333221     1 22333 66778888888887764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	670
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-52
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-51
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-50
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	6e-49
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-48
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-48
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-47
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-46
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-46
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	8e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-46
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-45
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-42
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-41
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-39
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-35
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-34
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-30
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-24
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-15
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-11
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.004
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-15
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-07
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-14
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	6e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	9e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-56
 Identities = 56/287 (19%), Positives = 117/287 (40%), Gaps = 38/287 (13%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + +G GS GTVYK        V +  +    P   + F+  + V+ K +H N++    Y 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
               +  +V  +    SL+  LH          +    I +    A+G+  +H +     
Sbjct: 74  T-APQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAK----S 124

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYKAPEQAEVKR-- 533
           + H ++KS+N+ L ++    I DFGL+ + +      +         + APE   ++   
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 534 -LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
             S ++DVY+FG++L E++TG+ P                 ++    +  +V   + +  
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP--------------YSNINNRDQIIFMVGRGYLSPD 230

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
             +      N  + +  ++     C+  + ++RP   ++   IE + 
Sbjct: 231 LSK---VRSNCPKAMKRLM---AECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 1e-54
 Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 38/282 (13%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E LG G  G V+    +    VAVK LK  +  +   F    +++ +L+H  +V+L A  
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +E   ++ +Y+ NGSL   L    G   I L     + +    A G+A I +      
Sbjct: 78  T-QEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEER----N 129

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-----GYKAPEQAEVKRLSQ 536
             H +++++N+L+       I+DFGL+ L+   +  AR G      + APE       + 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
           K+DV+SFG+LL E++T            P +   E   +L +  R V  +    E++   
Sbjct: 190 KSDVWSFGILLTEIVTHG------RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ-- 241

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                           +   C   +PE RPT   +  ++ED 
Sbjct: 242 ----------------LMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 5e-54
 Identities = 67/293 (22%), Positives = 115/293 (39%), Gaps = 43/293 (14%)

Query: 349 KQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGK 408
           K+ +L        + +GKG  G V       G  VAVK +K  N    + F     V+ +
Sbjct: 7   KELKLL-------QTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQ 56

Query: 409 LKHPNVVKLRAYYYAKEEKL-LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           L+H N+V+L      ++  L +V +Y+  GSL   L      GR  L     +   L   
Sbjct: 57  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVC 113

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-GYKAP 526
             +  +          H ++ + NVL+ ++ VA +SDFGL+   +  Q   +L   + AP
Sbjct: 114 EAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAP 169

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
           E    K+ S K+DV+SFG+LL E+ +         P +  V   E+   +          
Sbjct: 170 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP------- 222

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
                               +  ++     C       RP+  ++ + +E I+
Sbjct: 223 --------------DGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLEHIK 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-53
 Identities = 65/304 (21%), Positives = 112/304 (36%), Gaps = 34/304 (11%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           E +GKG  G V++     G  VAVK             E  +     L+H N++   A  
Sbjct: 9   ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 422 Y----AKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                   +  LV DY  +GSL   L+      R  +     I L L  A GLA +H E 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 478 GTA----KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP------VQAIARLG--GYKA 525
                   + H ++KS N+L+ KNG  CI+D GL++  +       +    R+G   Y A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 526 PEQAEVK------RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW 579
           PE  +           ++AD+Y+ G++  E+    +        +    +    +     
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD----LVPSDP 236

Query: 580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
               +++    +     +       E L  M  +   C  +    R T   + K +  + 
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296

Query: 640 VEQS 643
            ++ 
Sbjct: 297 QQEG 300

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-52
 Identities = 61/283 (21%), Positives = 114/283 (40%), Gaps = 38/283 (13%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + +G G  G V+     +   VA+K +++    + ++F +  +V+ KL HP +V+L    
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +    LV++++ +G L   L       R      T + + L    G+A + +      
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEA----C 121

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-----GYKAPEQAEVKRLSQ 536
           V H ++ + N L+ +N V  +SDFG++  +   Q  +  G      + +PE     R S 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
           K+DV+SFGVL+ EV +                  E   D+    R       +  V+   
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFRLYKPRLASTHVYQ-- 233

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
                           +   C   +PE RP  + + + + +I 
Sbjct: 234 ----------------IMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 5e-52
 Identities = 59/295 (20%), Positives = 116/295 (39%), Gaps = 36/295 (12%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
             LG G+ G V+K      G ++A K +  +  P  R +  + + V+ +   P +V    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            +Y+  E  +  +++  GSL  +L          +       + +   +GL  + +++  
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK- 125

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQAEVKRLSQK 537
             + H +VK SN+L++  G   + DFG+S  L    A + +G   Y +PE+ +    S +
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183

Query: 538 ADVYSFGVLLLEVLTGRAP----------SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
           +D++S G+ L+E+  GR P            +         E       P    S    +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 588 WTAEVFDQELLRY-----------KNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
               +   ELL Y                E    ++    C++  P +R  + ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN---KCLIKNPAERADLKQL 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-52
 Identities = 56/283 (19%), Positives = 112/283 (39%), Gaps = 40/283 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYY 421
           + LG G  G V          VA+K +K+    +  EF +   V+  L H  +V+L    
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAK 481
             +    ++ +Y+ NG L + L   R            + +       +  +  +    +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESK----Q 120

Query: 482 VPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-----GYKAPEQAEVKRLSQ 536
             H ++ + N L++  GV  +SDFGLS  +   +  + +G      +  PE     + S 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 537 KADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
           K+D+++FGVL+ E+ + G+ P +  +         E A  + + +R       + +V+  
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLRLYRPHLASEKVYT- 232

Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                            +  +C   + ++RPT   +   I D+
Sbjct: 233 -----------------IMYSCWHEKADERPTFKILLSNILDV 258

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 7e-52
 Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 48/302 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVK 416
           E++G+G  G VY   L D        AVK L +  +     +F     ++    HPNV+ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 417 LRAYYYAKEEK-LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           L       E   L+V  Y+ +G L + +                I   L  A+G+  +  
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLAS 148

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--------GYKAPE 527
           +    K  H ++ + N +LD+     ++DFGL+  +   +  +            + A E
Sbjct: 149 K----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
             + ++ + K+DV+SFGVLL E++T  AP             +    D+  ++       
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP----------YPDVNTFDITVYLLQ----- 249

Query: 588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGE 647
                  + LL+ +   + L     V L C   + E RP+ +E+   I  I    + +GE
Sbjct: 250 ------GRRLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIF--STFIGE 298

Query: 648 EY 649
            Y
Sbjct: 299 HY 300

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 8e-51
 Identities = 77/302 (25%), Positives = 127/302 (42%), Gaps = 45/302 (14%)

Query: 348 KKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIG 407
           ++   LE         LG+G  G V+    +    VA+K LK     + + F Q   V+ 
Sbjct: 16  RESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMK 67

Query: 408 KLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
           KL+H  +V+L A    +E   +V +Y+  GSL   L G  G     L     + +    A
Sbjct: 68  KLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIA 123

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-----G 522
            G+A + +        H +++++N+L+ +N V  ++DFGL+ L+   +  AR G      
Sbjct: 124 SGMAYVER----MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK 179

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
           + APE A   R + K+DV+SFG+LL E+ T           R  +D+ E+   +P     
Sbjct: 180 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP--- 236

Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
                                 E L  ++     C   +PE+RPT   +   +ED     
Sbjct: 237 ------------------PECPESLHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTST 275

Query: 643 SP 644
            P
Sbjct: 276 EP 277

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  176 bits (446), Expect = 1e-50
 Identities = 59/309 (19%), Positives = 120/309 (38%), Gaps = 60/309 (19%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNV 414
             +G+G+ G V++A        +   +VAVK LK +A+   + +F++   ++ +  +PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-------------------PGRIPLD 455
           VKL       +   L+++Y+  G L+  L                        PG  PL 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 456 WTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ 515
              ++ +    A G+A + +     K  H ++ + N L+ +N V  I+DFGLS  +    
Sbjct: 139 CAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 194

Query: 516 AIARLG------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
                G       +  PE     R + ++DV+++GV+L E+ +      Y       V  
Sbjct: 195 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-YYGMAHEEVIY 253

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
             +  ++     +   E                       + ++   C    P  RP+  
Sbjct: 254 YVRDGNILACPENCPLE-----------------------LYNLMRLCWSKLPADRPSFC 290

Query: 630 EVAKMIEDI 638
            + ++++ +
Sbjct: 291 SIHRILQRM 299

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  172 bits (436), Expect = 2e-49
 Identities = 67/296 (22%), Positives = 125/296 (42%), Gaps = 39/296 (13%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             LG G  G VY+ V       VAVK LK+ +    +EF +   V+ ++KHPN+V+L   
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
              +    ++ +++  G+L   L       R  +     + +    +  +  + ++    
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKK---- 134

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-----GYKAPEQAEVKRLS 535
              H ++ + N L+ +N +  ++DFGLS L+      A  G      + APE     + S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
            K+DV++FGVLL E+ T       P P                 V  +++++        
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS---PYPGID-----------LSQVYELLEKD-------- 232

Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLGEEYDE 651
              R +  E     +  +  AC    P  RP+ AE+ +  E +  ++S + +E ++
Sbjct: 233 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM-FQESSISDEVEK 285

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-49
 Identities = 69/309 (22%), Positives = 122/309 (39%), Gaps = 47/309 (15%)

Query: 347 RKKQFELEDLLRASAEMLGKGSLGTVYKAVL---DDGGIVAVKRLK-DANPCARKEFEQY 402
           +K   + ++LL A  E LG G+ G+V + V         VA+K LK        +E  + 
Sbjct: 1   KKLFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE 59

Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
             ++ +L +P +V+L       E  +LV +    G LH  L G R      +  +    L
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAEL 114

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   + G+  + ++       H ++ + NVLL     A ISDFGLS  L    +      
Sbjct: 115 LHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170

Query: 522 ------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAV 574
                  + APE    ++ S ++DV+S+GV + E L+ G+ P  Y     P         
Sbjct: 171 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGP--------- 219

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
           ++  ++    + E                  EL +++     C + + E RP    V + 
Sbjct: 220 EVMAFIEQGKRMECP-----------PECPPELYALM---SDCWIYKWEDRPDFLTVEQR 265

Query: 635 IEDIRVEQS 643
           +       +
Sbjct: 266 MRACYYSLA 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 6e-49
 Identities = 76/309 (24%), Positives = 116/309 (37%), Gaps = 55/309 (17%)

Query: 343 VFYERKKQFELEDLLRASAEMLGKGSLGTVYKAVLDDGG---IVAVKRLKDA--NPCARK 397
           V+ +RK    LED      + LG G+ GTV K           VAVK LK+   +P  + 
Sbjct: 1   VYLDRK-LLTLED------KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD 53

Query: 398 EFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWT 457
           E     +V+ +L +P +V++       E  +LV +    G L+  L  NR      +   
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDK 107

Query: 458 TRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAI 517
             I LV   + G+  + +        H ++ + NVLL     A ISDFGLS  L   +  
Sbjct: 108 NIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163

Query: 518 ARLG-------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDE 569
            +          + APE     + S K+DV+SFGVL+ E  + G+ P  Y       V  
Sbjct: 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEVTA 221

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
             +  +         +E                       M  +   C     E RP  A
Sbjct: 222 MLEKGERMGCPAGCPRE-----------------------MYDLMNLCWTYDVENRPGFA 258

Query: 630 EVAKMIEDI 638
            V   + + 
Sbjct: 259 AVELRLRNY 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  170 bits (432), Expect = 1e-48
 Identities = 60/291 (20%), Positives = 116/291 (39%), Gaps = 46/291 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVVK 416
           +++G G  G V    L   G     VA+K LK       R++F     ++G+  HPNV+ 
Sbjct: 32  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L          +++ +++ NGSL S L  N G           + ++ G A G+  +   
Sbjct: 92  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLADM 147

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG---------GYKAPE 527
                  H ++ + N+L++ N V  +SDFGLS  L    +               + APE
Sbjct: 148 ----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 203

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
             + ++ +  +DV+S+G+++ EV++            P  D   Q V     + ++ ++ 
Sbjct: 204 AIQYRKFTSASDVWSYGIVMWEVMSYGER--------PYWDMTNQDV-----INAIEQD- 249

Query: 588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                      R     +   ++  + L C       RP   ++   ++ +
Sbjct: 250 ----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 3e-48
 Identities = 60/280 (21%), Positives = 110/280 (39%), Gaps = 36/280 (12%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLR 418
             +G GS G   K     DG I+  K L         ++     ++++ +LKHPN+V+  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 419 AYYYAKEEKLL--VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
                +    L  V +Y   G L S++       R  LD    + ++      L   H+ 
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRR 128

Query: 477 -YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG----GYKAPEQAEV 531
             G   V H ++K +NV LD      + DFGL+ +LN   + A+       Y +PEQ   
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
              ++K+D++S G LL E+     P            ++E A  + +     +   ++ E
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPP-------FTAFSQKELAGKIREGKFRRIPYRYSDE 241

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           + +  ++                   +  +   RP++ E+
Sbjct: 242 LNE--IIT----------------RMLNLKDYHRPSVEEI 263

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 7e-48
 Identities = 57/296 (19%), Positives = 117/296 (39%), Gaps = 47/296 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNVV 415
           +++G G  G VYK +L          VA+K LK       R +F     ++G+  H N++
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L       +  +++ +Y+ NG+L   L    G           + ++ G A G+  +  
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN 128

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-------GYKAPEQ 528
                   H ++ + N+L++ N V  +SDFGLS +L                  + APE 
Sbjct: 129 ----MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 529 AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
              ++ +  +DV+SFG+++ EV+T      +                    V   + +  
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--------------NHEVMKAINDG- 229

Query: 589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSP 644
                     R     +   ++  + + C   +  +RP  A++  +++ +   ++P
Sbjct: 230 ---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI--RAP 274

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (420), Expect = 7e-47
 Identities = 64/302 (21%), Positives = 122/302 (40%), Gaps = 48/302 (15%)

Query: 338 DTSKLVFYER-KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK---DAN 392
           D ++L F +  +K F            +G GS G VY A  + +  +VA+K++      +
Sbjct: 3   DVAELFFKDDPEKLFSDL-------REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55

Query: 393 PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
               ++  + +  + KL+HPN ++ R  Y  +    LV +Y    +   L    +     
Sbjct: 56  NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----- 110

Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
           PL      ++  GA +GLA +H       + H +VK+ N+LL + G+  + DFG + ++ 
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166

Query: 513 PVQAIARLGGYKAPEQAE---VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
           P  +      + APE        +   K DV+S G+  +E+   + P    +        
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------- 219

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA 629
                     +  + + E  A       L+  +  E   + +    +C+   P+ RPT  
Sbjct: 220 -------MSALYHIAQNESPA-------LQSGHWSEYFRNFV---DSCLQKIPQDRPTSE 262

Query: 630 EV 631
            +
Sbjct: 263 VL 264

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 7e-47
 Identities = 66/310 (21%), Positives = 117/310 (37%), Gaps = 55/310 (17%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLK-HPN 413
           + LG G+ G V +A        D    VAVK LK  A+   R+     + V+  L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 414 VVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGP-------------GRIPLDWTTRI 460
           +V L          L++ +Y   G L + L   R                 + LD    +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
           S     A+G+A +  +       H ++ + N+LL    +  I DFGL+  +         
Sbjct: 149 SFSYQVAKGMAFLASK----NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 521 G------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
           G       + APE       + ++DV+S+G+ L E+ +  +      P            
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----------- 253

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
                   ++KE +        +L  ++   E+  ++     C  + P KRPT  ++ ++
Sbjct: 254 --DSKFYKMIKEGF-------RMLSPEHAPAEMYDIM---KTCWDADPLKRPTFKQIVQL 301

Query: 635 IEDIRVEQSP 644
           IE   + +S 
Sbjct: 302 IEKQ-ISEST 310

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 3e-46
 Identities = 68/291 (23%), Positives = 114/291 (39%), Gaps = 47/291 (16%)

Query: 349 KQFELED--LLRASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQY 402
           +Q+ LED  + R     LGKG  G VY A       I+A+K L  A         +  + 
Sbjct: 1   RQWALEDFEIGR----PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 56

Query: 403 MDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISL 462
           +++   L+HPN+++L  Y++      L+ +Y P G+++  L           D     + 
Sbjct: 57  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 111

Query: 463 VLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG- 521
           +   A  L+  H      +V H ++K  N+LL   G   I+DFG S+     +     G 
Sbjct: 112 ITELANALSYCHS----KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 167

Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
             Y  PE  E +   +K D++S GVL  E L G+ P +  +                   
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------------------ 209

Query: 581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
                +E    +   E      + E    ++      +   P +RP + EV
Sbjct: 210 -----QETYKRISRVEFTFPDFVTEGARDLI---SRLLKHNPSQRPMLREV 252

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 6e-46
 Identities = 62/302 (20%), Positives = 122/302 (40%), Gaps = 47/302 (15%)

Query: 362 EMLGKGSLGTVYKAVLDDGG---IVAVKRLKD-ANPCARKEFEQYMDVIGKL-KHPNVVK 416
           +++G+G+ G V KA +   G     A+KR+K+ A+    ++F   ++V+ KL  HPN++ 
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGN-----------RGPGRIPLDWTTRISLVLG 465
           L      +    L  +Y P+G+L   L  +                  L     +     
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 466 AARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG--- 522
            ARG+  + Q+    +  H ++ + N+L+ +N VA I+DFGLS                 
Sbjct: 136 VARGMDYLSQK----QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 191

Query: 523 YKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS 582
           + A E       +  +DV+S+GVLL E+++                     +   +    
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------------YCGMTCAELYEK 238

Query: 583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
           + +           L +  N ++E+  ++     C   +P +RP+ A++   +  +  E+
Sbjct: 239 LPQ--------GYRLEKPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSLNRMLEER 287

Query: 643 SP 644
             
Sbjct: 288 KT 289

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (416), Expect = 6e-46
 Identities = 55/276 (19%), Positives = 111/276 (40%), Gaps = 36/276 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG G+ G V++      G   A K +   +   ++   + +  +  L+HP +V L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +    E +++Y+++  G L   +          +     +  +    +GL  +H+     
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHE----N 143

Query: 481 KVPHGNVKSSNVLL--DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
              H ++K  N++    ++    + DFGL+  L+P Q++    G   + APE AE K + 
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 203

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
              D++S GVL   +L+G +P  +                    +R+V   +W     D 
Sbjct: 204 YYTDMWSVGVLSYILLSGLSP--FGGENDDET------------LRNVKSCDWN---MDD 246

Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
               +  I E+    +      +++ P  R T+ + 
Sbjct: 247 SA--FSGISEDGKDFI---RKLLLADPNTRMTIHQA 277

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 8e-46
 Identities = 65/280 (23%), Positives = 122/280 (43%), Gaps = 41/280 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-IVAVKRLKD--ANPCARKEFEQYMDVIGKLKHPNVVKLR 418
             +G+GS  TVYK +  +    VA   L+D       R+ F++  +++  L+HPN+V+  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 419 AYYYA----KEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
             + +    K+  +LV + + +G+L + L   +      +      S      +GL  +H
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129

Query: 475 QEYGTAKVPHGNVKSSNVLL-DKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQAEV 531
               T  + H ++K  N+ +    G   I D GL+ L     A A +G   + APE  E 
Sbjct: 130 TR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE- 186

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           ++  +  DVY+FG+ +LE+ T   P            E + A  + + V S VK     +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP----------YSECQNAAQIYRRVTSGVKPASFDK 236

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           V   E+       +E++        C+    ++R ++ ++
Sbjct: 237 VAIPEV-------KEIIEG------CIRQNKDERYSIKDL 263

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 9e-46
 Identities = 55/280 (19%), Positives = 109/280 (38%), Gaps = 41/280 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             LG G+ G VYKA   +   + A K +   +    +++   +D++    HPN+VKL   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +Y +    ++ ++   G++ +++         PL  +    +       L  +H      
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHD----N 129

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGG---YKAPE-----QAEV 531
           K+ H ++K+ N+L   +G   ++DFG+S      +Q      G   + APE      ++ 
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           +    KADV+S G+ L+E+     P    +P               + +  + K E    
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNP--------------MRVLLKIAKSEP--- 232

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
                L +           L     C+    + R T +++
Sbjct: 233 ---PTLAQPSRWSSNFKDFL---KKCLEKNVDARWTTSQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 3e-45
 Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 48/293 (16%)

Query: 362 EMLGKGSLGTVYKAVLD----DGGIVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNV 414
           E LG GS G V +   D        VAVK LK    + P A  +F + ++ +  L H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           ++L         K+ V +  P GSL   L  ++G         T     +  A G+  + 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLE 128

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-------GYKAPE 527
            +    +  H ++ + N+LL    +  I DFGL   L        +         + APE
Sbjct: 129 SK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
             + +  S  +D + FGV L E+ T G+ P    +                + +  + KE
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------------SQILHKIDKE 230

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
                   + L R ++  +++    +V + C   +PE RPT   +   + + +
Sbjct: 231 -------GERLPRPEDCPQDIY---NVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-45
 Identities = 69/352 (19%), Positives = 124/352 (35%), Gaps = 62/352 (17%)

Query: 317 YGSEKRVYANGGNDSDGTSGTDTSKLVFYERKKQFELEDLLRASAEMLGKGSLGTVYKAV 376
           Y S+ ++    G+  +     D  +   Y+ K +F  E+L     ++LG G+ G V  A 
Sbjct: 1   YESQLQMVQVTGSSDNEYFYVDFREYE-YDLKWEFPRENLEFG--KVLGSGAFGKVMNAT 57

Query: 377 LDDGG------IVAVKRL-KDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKL 428
                       VAVK L + A+   R+     + ++ +L  H N+V L           
Sbjct: 58  AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117

Query: 429 LVYDYLPNGSLHSLLHGNRGP------------------GRIPLDWTTRISLVLGAARGL 470
           L+++Y   G L + L   R                        L +   +      A+G+
Sbjct: 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGM 177

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYK 524
             +  +       H ++ + NVL+    V  I DFGL+  +         G       + 
Sbjct: 178 EFLEFK----SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWM 233

Query: 525 APEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV 584
           APE       + K+DV+S+G+LL E+ +       P P  P            K +++  
Sbjct: 234 APESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPVDAN------FYKLIQNGF 284

Query: 585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
           K +                 EE+  ++    +C      KRP+   +   + 
Sbjct: 285 KMDQP-----------FYATEEIYIIM---QSCWAFDSRKRPSFPNLTSFLG 322

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-44
 Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 46/295 (15%)

Query: 362 EMLGKGSLGTVYKAVL------DDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNV 414
             LG+GS G VY+ V       +    VA+K + + A+   R EF     V+ +    +V
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRG-----PGRIPLDWTTRISLVLGAARG 469
           V+L       +  L++ + +  G L S L   R      P   P   +  I +    A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 470 LARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GY 523
           +A ++      K  H ++ + N ++ ++    I DFG++  +       + G       +
Sbjct: 146 MAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 201

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV 583
            +PE  +    +  +DV+SFGV+L E+ T      Y   +  +V        L     + 
Sbjct: 202 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVMEGGLLDKPDNC 260

Query: 584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI 638
                                     +  +   C    P+ RP+  E+   I++ 
Sbjct: 261 PDM-----------------------LFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 6e-44
 Identities = 60/275 (21%), Positives = 110/275 (40%), Gaps = 38/275 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E +G+G+ GTVY A+ +  G  VA++++       ++     + V+ + K+PN+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           Y   +E  +V +YL  GSL  ++                 ++     + L  +H      
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMD------EGQIAAVCRECLQALEFLHSN---- 135

Query: 481 KVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG----GYKAPEQAEVKRLSQ 536
           +V H ++KS N+LL  +G   ++DFG    + P Q+          + APE    K    
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE 596
           K D++S G++ +E++ G  P  Y +    R             +  +            E
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP--YLNENPLRA------------LYLIATNGT------PE 235

Query: 597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           L   + +       L     C+    EKR +  E+
Sbjct: 236 LQNPEKLSAIFRDFL---NRCLDMDVEKRGSAKEL 267

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 7e-44
 Identities = 60/291 (20%), Positives = 105/291 (36%), Gaps = 43/291 (14%)

Query: 362 EMLGKGSLGTVYKAVL----DDGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVK 416
             +G+G  G V++ +     +    VA+K  K+  +   R++F Q    + +  HP++VK
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           L      +    ++ +    G L S L   +      LD  + I      +  LA +  +
Sbjct: 73  LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLESK 127

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG-----YKAPEQAEV 531
               +  H ++ + NVL+  N    + DFGLS  +          G     + APE    
Sbjct: 128 ----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           +R +  +DV+ FGV + E+L               +   E    LP              
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP------------ 231

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ 642
                     N    L S++     C    P +RP   E+   +  I  E+
Sbjct: 232 ---------PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-43
 Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 41/281 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           + LG+G+ G V  AV       VAVK +         +  ++ + +   L H NVVK   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
           +      + L  +Y   G L   +  + G     +              G+  +H     
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG---- 121

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYKAPEQAEVKR 533
             + H ++K  N+LLD+     ISDFGL+ +         L        Y APE  + + 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 534 L-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
             ++  DV+S G++L  +L G  P   PS         +   +   W             
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPS---------DSCQEYSDWKEK---------- 222

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
               L  +K I+   +++LH     +V  P  R T+ ++ K
Sbjct: 223 -KTYLNPWKKIDSAPLALLH---KILVENPSARITIPDIKK 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  157 bits (397), Expect = 3e-43
 Identities = 56/276 (20%), Positives = 115/276 (41%), Gaps = 36/276 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG G+ G V++ V    G +   K +    P  +   +  + ++ +L HP ++ L   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           +  K E +L+ ++L  G L   +          +     I+ +  A  GL  +H+     
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHE----H 146

Query: 481 KVPHGNVKSSNVLLD--KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
            + H ++K  N++ +  K     I DFGL+  LNP + +        + APE  + + + 
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
              D+++ GVL   +L+G +P  +                    +++V + +W    FD+
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSP--FAGEDDLET------------LQNVKRCDWE---FDE 249

Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           +   + ++  E    +      +  +P KR T+ + 
Sbjct: 250 DA--FSSVSPEAKDFIK---NLLQKEPRKRLTVHDA 280

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 2e-42
 Identities = 64/311 (20%), Positives = 127/311 (40%), Gaps = 46/311 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGG-----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVV 415
           ++LG G+ GTVYK +    G      VA+K L++A +P A KE      V+  + +P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
           +L           L+   +P G L   +  ++            ++  +  A+G+  +  
Sbjct: 75  RLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYLED 129

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG------YKAPEQA 529
                ++ H ++ + NVL+       I+DFGL+ LL   +      G      + A E  
Sbjct: 130 R----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
             +  + ++DV+S+GV + E++T  +    P    P              + S++++   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIP-----------ASEISSILEK--- 228

Query: 590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI-RVEQSPLGEE 648
                + L +      ++  ++   + C +   + RP   E+      + R  Q  L  +
Sbjct: 229 ----GERLPQPPICTIDVYMIM---VKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQ 281

Query: 649 YDESRNSLSPS 659
            DE  +  SP+
Sbjct: 282 GDERMHLPSPT 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-41
 Identities = 56/285 (19%), Positives = 100/285 (35%), Gaps = 45/285 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK---DANPCARKEFEQYMDVIGKLKHPNVVKL 417
           ++LG+GS  TV  A  L      A+K L+              +  DV+ +L HP  VKL
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              +   E+      Y  NG L   +           D T            L  +H + 
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG 128

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG------GYKAPEQAEV 531
               + H ++K  N+LL+++    I+DFG + +L+P    AR         Y +PE    
Sbjct: 129 ----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
           K   + +D+++ G ++ +++ G  P +  +         +   D P+      +      
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR------ 238

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE 636
               +L+                   +V    KR    E+     
Sbjct: 239 ----DLVE----------------KLLVLDATKRLGCEEMEGYGP 263

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 6e-41
 Identities = 70/304 (23%), Positives = 122/304 (40%), Gaps = 55/304 (18%)

Query: 362 EMLGKGSLGTVYKAVL--------DDGGIVAVKRLK-DANPCARKEFEQYMDVIGKL-KH 411
           + LG+G+ G V  A          +    VAVK LK DA      +    M+++  + KH
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPG-----------RIPLDWTTRI 460
            N++ L           ++ +Y   G+L   L   R PG              L     +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 461 SLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARL 520
           S     ARG+  +  +    K  H ++ + NVL+ ++ V  I+DFGL+  ++ +    + 
Sbjct: 139 SCAYQVARGMEYLASK----KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194

Query: 521 G------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAV 574
                   + APE    +  + ++DV+SFGVLL E+ T       P P  P         
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS---PYPGVP--------- 242

Query: 575 DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
              + +  ++KE          + +  N   EL  M+     C  + P +RPT  ++ + 
Sbjct: 243 --VEELFKLLKE-------GHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLVED 290

Query: 635 IEDI 638
           ++ I
Sbjct: 291 LDRI 294

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-39
 Identities = 52/276 (18%), Positives = 115/276 (41%), Gaps = 37/276 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           E LG+G  G V++ V          K +K      +   ++ + ++   +H N++ L   
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
           + + EE +++++++    +   ++ +       L+    +S V      L  +H      
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHS----H 121

Query: 481 KVPHGNVKSSNVLLD--KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKRLS 535
            + H +++  N++    ++    I +FG +  L P      L     Y APE  +   +S
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 536 QKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ 595
              D++S G L+  +L+G  P  + + T  ++            + +++  E+T   FD+
Sbjct: 182 TATDMWSLGTLVYVLLSGINP--FLAETNQQI------------IENIMNAEYT---FDE 224

Query: 596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           E   +K I  E +  +      +V + + R T +E 
Sbjct: 225 EA--FKEISIEAMDFVD---RLLVKERKSRMTASEA 255

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 6e-39
 Identities = 64/303 (21%), Positives = 112/303 (36%), Gaps = 53/303 (17%)

Query: 362 EMLGKGSLGTVYKAV------LDDGGIVAVKRLK-DANPCARKEFEQYMDVIGKLKHPNV 414
           + LG+G+ G V +A             VAVK LK  A     +     + ++  + H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 415 VKLRAYYYAKEEK--LLVYDYLPNGSLHSLLHGNRGP-----------GRIPLDWTTRIS 461
           V        K     +++ ++   G+L + L   R              +  L     I 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 462 LVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG 521
                A+G+  +       K  H ++ + N+LL +  V  I DFGL+  +       R G
Sbjct: 139 YSFQVAKGMEFLASR----KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 522 ------GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVD 575
                  + APE    +  + ++DV+SFGVLL E+ +  A    P P           V 
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYP----------GVK 241

Query: 576 LPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMI 635
           + +     +KE            R +  +     M    L C   +P +RPT +E+ + +
Sbjct: 242 IDEEFCRRLKEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

Query: 636 EDI 638
            ++
Sbjct: 292 GNL 294

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 62/280 (22%), Positives = 103/280 (36%), Gaps = 43/280 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           ++LG G+   V  A       +VA+K + K A        E  + V+ K+KHPN+V L  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
            Y +     L+   +  G L   +                  L+      +  +H     
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG-- 127

Query: 480 AKVPHGNVKSSNVLL---DKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQAEVKR 533
             + H ++K  N+L    D++    ISDFGLS + +P   ++   G   Y APE    K 
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 185

Query: 534 LSQKADVYSFGVLLLEVLTGRAP--SQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
            S+  D +S GV+   +L G  P   +  +    ++ + E   D P W            
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW------------ 233

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
                     +I +     +      +   PEKR T  + 
Sbjct: 234 ---------DDISDSAKDFI---RHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 61/308 (19%), Positives = 117/308 (37%), Gaps = 61/308 (19%)

Query: 344 FYERKKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK---------DANP 393
           FYE    +E +       E+LG+G    V + +        AVK +          +   
Sbjct: 1   FYEN---YEPK-------EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQ 50

Query: 394 CARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRI 452
             R+   + +D++ K+  HPN+++L+  Y       LV+D +  G L   L         
Sbjct: 51  ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----- 105

Query: 453 PLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN 512
            L       ++      +  +H+      + H ++K  N+LLD +    ++DFG S  L+
Sbjct: 106 TLSEKETRKIMRALLEVICALHK----LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161

Query: 513 PVQAIARLGG---YKAPEQAEVKRL------SQKADVYSFGVLLLEVLTGRAPSQYPSPT 563
           P + +  + G   Y APE  E           ++ D++S GV++  +L G  P  +    
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ- 220

Query: 564 RPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPE 623
                           +R ++        +      + +  + +  ++      +V QP+
Sbjct: 221 -------------MLMLRMIMSGN-----YQFGSPEWDDYSDTVKDLV---SRFLVVQPQ 259

Query: 624 KRPTMAEV 631
           KR T  E 
Sbjct: 260 KRYTAEEA 267

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-37
 Identities = 56/298 (18%), Positives = 111/298 (37%), Gaps = 43/298 (14%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           ++LG G  G V +          A+K L+D  P AR+E E +       + P++V++   
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRA---SQCPHIVRIVDV 73

Query: 421 YYAKEEK----LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           Y          L+V + L  G L S +      G           ++      +  +H  
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSI 130

Query: 477 YGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLNPVQAIARLG---GYKAPEQAE 530
                + H +VK  N+L      N +  ++DFG +       ++        Y APE   
Sbjct: 131 ----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA 590
            ++  +  D++S GV++  +L G  P                       +   +K     
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---------------AISPGMKTRIRM 231

Query: 591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK---MIEDIRVEQSPL 645
             ++     +  + EE+  ++      + ++P +R T+ E      +++  +V Q+PL
Sbjct: 232 GQYEFPNPEWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  138 bits (349), Expect = 2e-37
 Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 25/283 (8%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
           E +G+G+ G VYKA  + G   A+K+++    +        + + ++ +LKH N+VKL  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
             + K+  +LV+++L       L           L+  T  S +L    G+A  H     
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD---- 118

Query: 480 AKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----VQAIARLGGYKAPEQAEVKRL 534
            +V H ++K  N+L+++ G   I+DFGL+             I  L           K+ 
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 535 SQKADVYSFGVLLLEVLTGRAPSQYPSPTRP--RVDEEEQAVDLPKWVRSVVKEEWTAEV 592
           S   D++S G +  E++ G       S      R+       +   W       ++    
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 593 FDQELLRY----KNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
              E L +    K ++E  + +L      +   P +R T  + 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 69/294 (23%), Positives = 117/294 (39%), Gaps = 47/294 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKL 417
           E+LG G +  V+ A  L     VAVK L+     +P     F +       L HP +V +
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 418 RAYYYAKEEKL----LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
                A+        +V +Y+   +L  ++H        P+     I ++  A + L   
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----VQAIARLG--GYKAP 526
           HQ      + H +VK +N+++       + DFG++  +        Q  A +G   Y +P
Sbjct: 128 HQ----NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
           EQA    +  ++DVYS G +L EVLTG  P    SP                     V+E
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------------VSVAYQHVRE 229

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-TMAEVAKMIEDIR 639
           +           R++ +  +L +++   L  +   PE R  T AE+   +  + 
Sbjct: 230 DPIP-----PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLVRVH 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-36
 Identities = 75/329 (22%), Positives = 129/329 (39%), Gaps = 41/329 (12%)

Query: 362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
           +++G GS G VY+A L D G +VA+K++       ++   + + ++ KL H N+V+LR +
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYF 81

Query: 421 YYAKEEK------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           +Y+  EK       LV DY+P        H +R    +P+ +      +    R LA IH
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSLAYIH 139

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVAC-ISDFGLSLLL---NPVQAIARLGGYKAP-EQA 529
                  + H ++K  N+LLD +     + DFG +  L    P  +      Y+AP    
Sbjct: 140 S----FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT 589
                +   DV+S G +L E+L G+      S     V+  +      +     +   +T
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255

Query: 590 AEVFDQ------ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRVE 641
              F Q        +       E +++       +   P  R T  E       +++R  
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFDELRDP 312

Query: 642 QSPLGE--------EYDESRNSLSPSLAT 662
              L           +     S +P LAT
Sbjct: 313 NVKLPNGRDTPALFNFTTQELSSNPPLAT 341

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 7e-36
 Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 45/284 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK------DANPCARKEFEQYMDVIGKLKHPNV 414
           E LG G    V K      G   A K +K           +R++ E+ + ++ +++HPNV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           + L   Y  K + +L+ + +  G L   L          L        +     G+  +H
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH 130

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVA----CISDFGLSLLLNPVQAIARLGG---YKAPE 527
                  + H ++K  N++L    V      I DFGL+  ++       + G   + APE
Sbjct: 131 SLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE 587
               + L  +AD++S GV+   +L+G +P    +        +E   ++         E 
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYEFEDEY 239

Query: 588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
           +             N        +      +V  P+KR T+ + 
Sbjct: 240 F------------SNTSALAKDFIR---RLLVKDPKKRMTIQDS 268

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-35
 Identities = 51/295 (17%), Positives = 108/295 (36%), Gaps = 41/295 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRL-KDANPCARKEFEQYMDVIGKLKHPNVVKLRA 419
             +G+G+ G V  A    +   VA+K++    +    +   + + ++ + +H N++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 420 YY----YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
                   + + + +  +L    L+ LL          L        +    RGL  IH 
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHS 127

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-------GYKAPEQ 528
                 V H ++K SN+LL+      I DFGL+ + +P                Y+APE 
Sbjct: 128 A----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 529 AEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPT-----------RPRVDEEEQAVDL 576
               +  ++  D++S G +L E+L+ R                     P  ++    ++L
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 577 PKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
                 +         +++    + N + + + +L      +   P KR  + + 
Sbjct: 244 KARNYLLSLPHKNKVPWNR---LFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 3e-35
 Identities = 61/289 (21%), Positives = 115/289 (39%), Gaps = 28/289 (9%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNVV 415
           + LG+G   TVYKA   +   IVA+K++K     +A     +   + + ++ +L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 416 KLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQ 475
            L   +  K    LV+D++       +   +       L  +   + +L   +GL  +HQ
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 476 EYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN-PVQAIARLGG---YKAPEQA-E 530
            +    + H ++K +N+LLD+NGV  ++DFGL+     P +A         Y+APE    
Sbjct: 119 HW----ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG 174

Query: 531 VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRP-----RVDEEEQAVDLPKWVRSVVK 585
            +      D+++ G +L E+L         S                    P        
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM 634
             + +         +    ++L+ ++       +  P  R T  +  KM
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 8e-35
 Identities = 65/281 (23%), Positives = 100/281 (35%), Gaps = 44/281 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVI----GKLKHPNVVK 416
           +MLGKGS G V+ A         A+K LK        + E  M          +HP +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 417 LRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE 476
           +   +  KE    V +YL  G L   +           D +           GL  +H +
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122

Query: 477 YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQA----IARLGGYKAPEQAEVK 532
                + + ++K  N+LLDK+G   I+DFG+        A          Y APE    +
Sbjct: 123 ----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ 178

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
           + +   D +SFGVLL E+L G++P                    P+W             
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW------------- 225

Query: 593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK 633
                     +E+E   +L       V +PEKR  +    +
Sbjct: 226 ----------LEKEAKDLLV---KLFVREPEKRLGVRGDIR 253

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (334), Expect = 1e-34
 Identities = 53/288 (18%), Positives = 104/288 (36%), Gaps = 44/288 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK------DANPCARKEFEQYMDVIGKLKHPNV 414
            ++G+G  G VY     D G + A+K L                    + ++     P +
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 415 VKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIH 474
           V +   ++  ++   + D +  G LH  L  +                      GL  +H
Sbjct: 70  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH 124

Query: 475 QEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--GYKAPEQ-AEV 531
                  V + ++K +N+LLD++G   ISD GL+   +  +  A +G  GY APE   + 
Sbjct: 125 NR----FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
                 AD +S G +L ++L G +P +            +   ++ +   ++  E     
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKT--------KDKHEIDRMTLTMAVELP--- 229

Query: 592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
                     +   EL S+L      +     +R       +  ++++
Sbjct: 230 ---------DSFSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVK 263

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 4e-34
 Identities = 48/304 (15%), Positives = 91/304 (29%), Gaps = 46/304 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAY 420
             +G GS G +Y    +  G  VA+K           +      +   ++    +    +
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 421 YYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTA 480
             A+ +  ++   L   SL  L +             T + L       +  IH      
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHS----K 122

Query: 481 KVPHGNVKSSNVL---LDKNGVACISDFGLSLLLNPVQAIARL-----------GGYKAP 526
              H +VK  N L     K  +  I DFGL+      +    +             Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 527 EQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
                   S++ D+ S G +L+    G  P Q                      R   + 
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG---------------LKAATKRQKYER 227

Query: 587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQSPLG 646
               ++     +  K    E  + L+    C   + + +P  + + ++  ++   Q   G
Sbjct: 228 ISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQ---G 281

Query: 647 EEYD 650
             YD
Sbjct: 282 FSYD 285

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 5e-34
 Identities = 58/288 (20%), Positives = 109/288 (37%), Gaps = 28/288 (9%)

Query: 362 EMLGKGSLGTVYKA--VLDDGGIVAVKRLK-----DANPCARKEFEQYMDVIGKLKHPNV 414
             +G+G+ G V+KA  + + G  VA+KR++     +  P +       +  +   +HPNV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 415 VKLRAYYYAKEEKLLVYDYLPN----GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
           V+L                L        L + L     PG   +   T   ++    RGL
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG---VPTETIKDMMFQLLRGL 129

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPE 527
             +H      +V H ++K  N+L+  +G   ++DFGL+ + +   A+  +     Y+APE
Sbjct: 130 DFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 185

Query: 528 QAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSP--TRPRVDEEEQAVDLPKWVRSVVK 585
                  +   D++S G +  E+   +   +  S      ++ +         W R V  
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 586 EEWTAEVFDQELLR--YKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
                     + +     +I+E    +L     C+   P KR +    
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSA 290

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 8e-34
 Identities = 61/284 (21%), Positives = 109/284 (38%), Gaps = 25/284 (8%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +G+G+ G VYKA     G +VA+K+++             + + ++ +L HPN+VKL 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              + + +  LV+++L       +           +      S +    +GLA  H    
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----VQAIARLGGYKAPEQ-AEVKR 533
              V H ++K  N+L++  G   ++DFGL+                  Y+APE     K 
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTR-----PRVDEEEQAVDLPKWVRSVVKEEW 588
            S   D++S G +  E++T RA     S         R       V  P        +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 589 TAEVFDQELLRY-KNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
             +   Q+  +    ++E+  S+L      +   P KR +    
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (321), Expect = 3e-33
 Identities = 52/230 (22%), Positives = 95/230 (41%), Gaps = 14/230 (6%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKD---ANPCARKEFEQYMDVIGKLKHPNVVKL 417
             LG GS G V+      +G   A+K LK          +       ++  + HP ++++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              +   ++  ++ DY+  G L SLL  ++   R P             A  +    +  
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ---RFPNPVAKFY------AAEVCLALEYL 120

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL-NPVQAIARLGGYKAPEQAEVKRLSQ 536
            +  + + ++K  N+LLDKNG   I+DFG +  + +    +     Y APE    K  ++
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE 586
             D +SFG+L+ E+L G  P    +  +         +  P +    VK+
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 5e-33
 Identities = 69/342 (20%), Positives = 129/342 (37%), Gaps = 40/342 (11%)

Query: 344 FYER---KKQFELEDLLRASAEMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARK 397
           FY +   K  +E+  + R   + +G G+ G V  AV    G  VA+K+L     +    K
Sbjct: 4   FYRQEVTKTAWEVRAVYRDL-QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 62

Query: 398 EFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLVYDYLPNGSLHSLLHGNRGPGR 451
              + + ++  ++H NV+ L   +   E      +  LV  ++       + H       
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------ 116

Query: 452 IPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL 511
             L       LV    +GL  IH     A + H ++K  N+ ++++    I DFGL+   
Sbjct: 117 -KLGEDRIQFLVYQMLKGLRYIHA----AGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171

Query: 512 N-PVQAIARLGGYKAPEQA-EVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDE 569
           +  +        Y+APE      R +Q  D++S G ++ E++TG+   +         + 
Sbjct: 172 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231

Query: 570 EEQAVDLPKWVRSVVKEEWTAEVFDQELL--------RYKNIEEELVSMLHVGLACVVSQ 621
            +     P      ++ +                      N     V++L      +V  
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLD 288

Query: 622 PEKRPTMAEVAKM--IEDIR-VEQSPLGEEYDESRNSLSPSL 660
            E+R T  E       E +   E  P  ++YD+S + +  +L
Sbjct: 289 AEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTL 330

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 55/298 (18%), Positives = 102/298 (34%), Gaps = 55/298 (18%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK------DANPCARKEFEQYMDVIGKLK--HP 412
            +LG G  G+VY  + + D   VA+K ++                   + ++ K+     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
            V++L  ++   +  +L+ +              RG     L      S        +  
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGLSLLLNPVQAIARLG--GYKAPEQA 529
            H       V H ++K  N+L+D N G   + DFG   LL         G   Y  PE  
Sbjct: 126 CHN----CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWI 181

Query: 530 EVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW 588
              R   + A V+S G+LL +++ G  P ++                             
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------------------- 214

Query: 589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRVEQSP 644
             E+   ++   + +  E   ++     C+  +P  RPT  E+     ++D+ + Q  
Sbjct: 215 --EIIRGQVFFRQRVSSECQHLI---RWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-31
 Identities = 53/296 (17%), Positives = 106/296 (35%), Gaps = 35/296 (11%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLR 418
             +G+G+ G V+KA     G  VA+K++   +          + + ++  LKH NVV L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 419 AYYYAKEEK--------LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGL 470
                K            LV+D+  +     L +      +  L    R+       + L
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRV------MQML 126

Query: 471 ARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG--------G 522
                     K+ H ++K++NVL+ ++GV  ++DFGL+   +  +               
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 523 YKAPEQ-AEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR 581
           Y+ PE     +      D++  G ++ E+ T     Q  +         +    +   V 
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLA------CVVSQPEKRPTMAEV 631
             V      E  +    + + +++ L + +    A       +V  P +R    + 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  121 bits (304), Expect = 3e-31
 Identities = 40/308 (12%), Positives = 86/308 (27%), Gaps = 48/308 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH-PNVVKLRA 419
             +G+GS G +++   L +   VA+K     +     +          L     +  +  
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 420 YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGT 479
           +       +LV D L       L    R          T           +  IH+    
Sbjct: 69  FGQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHE---- 119

Query: 480 AKVPHGNVKSSNVLLDK-----NGVACISDFGLSLLLNPVQAIARL-----------GGY 523
             + + ++K  N L+ +       +  + DFG+            +             Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 524 KAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV 583
            +      +  S++ D+ + G + +  L G  P Q           +++   + +  +S 
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA----ATNKQKYERIGEKKQST 235

Query: 584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI-RVEQ 642
              E                 EE    +H          +  P    +  +   +     
Sbjct: 236 PLRELC-----------AGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLN 281

Query: 643 SPLGEEYD 650
           +   E +D
Sbjct: 282 TTEDENFD 289

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-30
 Identities = 55/291 (18%), Positives = 110/291 (37%), Gaps = 39/291 (13%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLR 418
           E +G+G+ GTV+KA   +   IVA+KR++  D +        + + ++ +LKH N+V+L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 419 AYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYG 478
              ++ ++  LV+++            N        D     S +    +GL   H    
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSR-- 120

Query: 479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-----VQAIARLGGYKAPEQAEVKR 533
              V H ++K  N+L+++NG   +++FGL+             +  L           K 
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA--- 590
            S   D++S G +  E+           P  P  D ++Q   + + + +  +E+W +   
Sbjct: 179 YSTSIDMWSAGCIFAELANAG------RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232

Query: 591 ----------EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV 631
                           +     +      +L      +   P +R +  E 
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEA 280

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-29
 Identities = 56/277 (20%), Positives = 96/277 (34%), Gaps = 43/277 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL 417
           ++LGKG+ G V        G   A+K L+     A+ E    +    V+   +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
           +  +   +    V +Y   G L   L   R                      L  +H   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHS-- 123

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG----GYKAPEQAEVKR 533
               V + ++K  N++LDK+G   I+DFGL        A  +       Y APE  E   
Sbjct: 124 --RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND 181

Query: 534 LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF 593
             +  D +  GV++ E++ GR P  + +    R+ E     ++                 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLP--FYNQDHERLFELILMEEIRFP-------------- 225

Query: 594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
                  + +  E  S+L      +   P++R     
Sbjct: 226 -------RTLSPEAKSLLA---GLLKKDPKQRLGGGP 252

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 8e-29
 Identities = 58/315 (18%), Positives = 108/315 (34%), Gaps = 34/315 (10%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLK--DANPCARKEFEQYMDVIGKLKHPNVVKLR 418
             +G G+ G+V  A     G  VAVK+L     +    K   + + ++  +KH NV+ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 419 AYYYAKE-----EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARI 473
             +           + +  +L    L++++   +      L       L+    RGL  I
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK------LTDDHVQFLIYQILRGLKYI 137

Query: 474 HQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ--AIARLGGYKAPEQAEV 531
           H       + H ++K SN+ ++++    I DFGL+   +      +A             
Sbjct: 138 HSA----DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 193

Query: 532 KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE 591
              +Q  D++S G ++ E+LTGR                         +   +  E    
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253

Query: 592 VFDQEL--------LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAK---MIEDIRV 640
                           +       V +L      +V   +KR T A+        +    
Sbjct: 254 YIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 641 EQSPLGEEYDESRNS 655
           +  P+ + YD+S  S
Sbjct: 311 DDEPVADPYDQSFES 325

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  115 bits (288), Expect = 8e-29
 Identities = 54/297 (18%), Positives = 110/297 (37%), Gaps = 48/297 (16%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRA 419
             LG+G    V++A+ + +   V VK LK   P  +K+ ++ + ++  L+  PN++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 420 YYYAKEEKL--LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
                  +   LV++++ N     L           L        +    + L   H   
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS-- 147

Query: 478 GTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQ-AEVK 532
               + H +VK  NV++D ++    + D+GL+   +P Q          +K PE   + +
Sbjct: 148 --MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205

Query: 533 RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV 592
                 D++S G +L  ++  +       P     D  +Q V + K + +    ++  + 
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRK------EPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259

Query: 593 FDQELLRYKNI----------------EEELVSMLHVGL--ACVVSQPEKRPTMAEV 631
             +   R+ +I                 + LVS   +      +    + R T  E 
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  114 bits (287), Expect = 2e-28
 Identities = 44/224 (19%), Positives = 78/224 (34%), Gaps = 14/224 (6%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYM---DVIGKLKHPNVVKL 417
           + LG GS G V      + G   A+K L        K+ E  +    ++  +  P +VKL
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 418 RAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY 477
              +       +V +Y+  G + S L                             +H   
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHS-- 159

Query: 478 GTAKVPHGNVKSSNVLLDKNGVACISDFGLS-LLLNPVQAIARLGGYKAPEQAEVKRLSQ 536
               + + ++K  N+L+D+ G   ++DFG +  +      +       APE    K  ++
Sbjct: 160 --LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNK 217

Query: 537 KADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWV 580
             D ++ GVL+ E+  G  P     P +         V  P   
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHF 261

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-26
 Identities = 53/335 (15%), Positives = 116/335 (34%), Gaps = 51/335 (15%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLR 418
           + +G G+ G V  A        VA+K+L     N    K   + + ++  + H N++ L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 419 AYYYAK------EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
             +  +      ++  LV + +       +            D      L+     G+  
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLGG---YKAPEQA 529
           +H         H ++K SN+++  +    I DFGL+        +        Y+APE  
Sbjct: 135 LHSAGII----HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 530 EVKRLSQKADVYSFGVLLLEVLTGRAP--------------SQYPSPTRPRVDEEEQAV- 574
                 +  D++S G ++ E++  +                 Q  +P    + + +  V 
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 575 ----DLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAE 630
               + PK+      + +   +F  +    K    +   +L      +V  P KR ++ +
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDD 307

Query: 631 VA-----KMIEDIRVEQSPLGEEYDESRNSLSPSL 660
                   +  D    ++P  + YD+  +    ++
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTI 342

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-25
 Identities = 57/294 (19%), Positives = 104/294 (35%), Gaps = 49/294 (16%)

Query: 362 EMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKLKH-P 412
           ++LG G+ G V+        D G + A+K LK A         +       V+  ++  P
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 413 NVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLAR 472
            +V L   +  + +  L+ DY+  G L + L       R           V      L  
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144

Query: 473 IHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQAIARLG-----GYKAPE 527
           +H+      + + ++K  N+LLD NG   ++DFGLS      +            Y AP+
Sbjct: 145 LHK----LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 528 QAEVKR--LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK 585
                     +  D +S GVL+ E+LTG +P                            +
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-------------------SQ 241

Query: 586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR 639
            E +  +   E    + +      ++      ++  P+KR       +  ++I+
Sbjct: 242 AEISRRILKSEPPYPQEMSALAKDLI---QRLLMKDPKKRLGCGP--RDADEIK 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (251), Expect = 8e-24
 Identities = 52/316 (16%), Positives = 104/316 (32%), Gaps = 55/316 (17%)

Query: 362 EMLGKGSLGTVYKAV-LDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRA- 419
             LG G   TV+ A  + +   VA+K ++  +    +  E  + ++ ++   +  K  + 
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 420 ------------YYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAA 467
                        +       +V  +   G     L        IPL +  +IS  L   
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL--L 135

Query: 468 RGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC-ISDFGLSLLLNPVQAIARLG----- 521
            GL  +H+  G   + H ++K  NVL++       +    ++ L N              
Sbjct: 136 LGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 522 -GYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP-----------------------S 557
             Y++PE          AD++S   L+ E++TG                           
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 558 QYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT--AEVFDQELLRYKNIEEELVSMLHVGL 615
           + PS             +    +R++ K ++    +V  ++    K+  +E+   L    
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS--- 309

Query: 616 ACVVSQPEKRPTMAEV 631
             +   P KR     +
Sbjct: 310 PMLQLDPRKRADAGGL 325

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 76.6 bits (187), Expect = 1e-15
 Identities = 34/147 (23%), Positives = 59/147 (40%), Gaps = 30/147 (20%)

Query: 70  SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTN---------------- 113
            L L ++ +     PLS L +L  L L  N+++  I PL   T                 
Sbjct: 245 DLDLANNQISNLA-PLSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQLEDISP 302

Query: 114 ------LKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRL 167
                 L    L  N+ S   P  +SSL  + RL  ++N +       + NLT +  L  
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 168 QNNELTGRIPDLSSSLKDLKELNLSNN 194
            +N+++   P   ++L  + +L L++ 
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 63.5 bits (153), Expect = 3e-11
 Identities = 44/168 (26%), Positives = 63/168 (37%), Gaps = 26/168 (15%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
           I PL +L  L  L L+ N+L   I  L + TNL    L+ N  S   P  +S L  +  L
Sbjct: 212 ITPLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268

Query: 142 DLSDNNIRGRIP--------------------EQVTNLTRLLTLRLQNNELTGRIPDLSS 181
            L  N I    P                      ++NL  L  L L  N ++   P   S
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VS 326

Query: 182 SLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGSSPLPACS 229
           SL  L+ L  +NN++        L      S   N+ +   +PL   +
Sbjct: 327 SLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQ-ISDLTPLANLT 373

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 1e-06
 Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 12/91 (13%)

Query: 125 SAEIPHQI--------SSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRI 176
           SA I            ++L   ++  L   N+   + +  T+L ++ TL+     +   I
Sbjct: 3   SATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SI 59

Query: 177 PDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
             +   L +L ++N SNN+L    P   L K
Sbjct: 60  DGVEY-LNNLTQINFSNNQLTDITPLKNLTK 89

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 2e-04
 Identities = 13/82 (15%), Positives = 31/82 (37%), Gaps = 4/82 (4%)

Query: 66  ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS 125
              +   L   ++   +   + LDQ+  L      +  +I  +    NL     S N  +
Sbjct: 22  AEKMKTVLGKTNVTDTV-SQTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNNQLT 79

Query: 126 AEIPHQISSLKGILRLDLSDNN 147
              P  + +L  ++ + +++N 
Sbjct: 80  DITP--LKNLTKLVDILMNNNQ 99

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.004
 Identities = 15/59 (25%), Positives = 26/59 (44%), Gaps = 2/59 (3%)

Query: 57  TGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLK 115
           T  V     ++V +L      ++  I  +  L+ L  ++  +N+L   I PL N T L 
Sbjct: 35  TDTVSQTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLV 91

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 75.2 bits (183), Expect = 2e-15
 Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 7/164 (4%)

Query: 22  HPNDTDALTLFRLQTDTHGNLLSNWKGADACAAAWTGVVCSPKSE--RVVSLSLPSHSLR 79
           +P D  AL   +        L S     D C   W GV+C   ++  RV +L L   +L 
Sbjct: 4   NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63

Query: 80  GPI---APLSLLDQLRFLDLHDN-RLNGTILPLTNC-TNLKLAYLSGNDFSAEIPHQISS 134
            P    + L+ L  L FL +     L G I P     T L   Y++  + S  IP  +S 
Sbjct: 64  KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123

Query: 135 LKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD 178
           +K ++ LD S N + G +P  +++L  L+ +    N ++G IPD
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 74.4 bits (181), Expect = 4e-15
 Identities = 27/88 (30%), Positives = 40/88 (45%), Gaps = 24/88 (27%)

Query: 142 DLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP 201
           DL +N I G +P+ +T L  L +L +  N L G IP   +                    
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-------------------- 289

Query: 202 EGLLKKFGEQSFIGNEGLCGSSPLPACS 229
              L++F   ++  N+ LCG SPLPAC+
Sbjct: 290 ---LQRFDVSAYANNKCLCG-SPLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 49.7 bits (117), Expect = 5e-07
 Identities = 13/58 (22%), Positives = 23/58 (39%), Gaps = 1/58 (1%)

Query: 73  LPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP 129
           L ++ + G +   L+ L  L  L++  N L G I    N     ++  + N      P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.2 bits (171), Expect = 2e-14
 Identities = 27/157 (17%), Positives = 53/157 (33%), Gaps = 23/157 (14%)

Query: 362 EMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARK----------EFEQYMDVIGKLKH 411
           +++G+G    V+    +  G   VK  K  +   +K           F        + + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 412 PNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLA 471
             + KL+     K      Y +  N  L  L+           +      ++      +A
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENP---DEVLDMILEEVA 117

Query: 472 RIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS 508
           + +       + HG++   NVL+ + G+  I DF  S
Sbjct: 118 KFYHRG----IVHGDLSQYNVLVSEEGI-WIIDFPQS 149

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 59.7 bits (143), Expect = 3e-10
 Identities = 26/118 (22%), Positives = 43/118 (36%), Gaps = 2/118 (1%)

Query: 80  GPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGIL 139
           GP+ P      LR +   D  L    +P     +  L  L  N  +        +LK + 
Sbjct: 1   GPVCPFRCQCHLRVVQCSDLGL--EKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLH 58

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
            L L +N I    P     L +L  L L  N+L      +  +L++L+       ++ 
Sbjct: 59  TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.0 bits (136), Expect = 2e-09
 Identities = 36/189 (19%), Positives = 55/189 (29%), Gaps = 39/189 (20%)

Query: 52  CAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTN 110
           C      V CS      V   LP                   LDL +N++         N
Sbjct: 8   CQCHLRVVQCSDLGLEKVPKDLPPD--------------TALLDLQNNKITEIKDGDFKN 53

Query: 111 CTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRL-------- 162
             NL    L  N  S   P   + L  + RL LS N ++    +    L  L        
Sbjct: 54  LKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEIT 113

Query: 163 ---------------LTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
                          + L     + +G        +K L  + +++  +   +P+GL   
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLPPS 172

Query: 208 FGEQSFIGN 216
             E    GN
Sbjct: 173 LTELHLDGN 181

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 53.9 bits (128), Expect = 2e-08
 Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 3/123 (2%)

Query: 74  PSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQIS 133
           P  S          + +L ++ + D  +  T +P     +L   +L GN  +      + 
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNI--TTIPQGLPPSLTELHLDGNKITKVDAASLK 192

Query: 134 SLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN 193
            L  + +L LS N+I       + N   L  L L NN+L  ++P   +  K ++ + L N
Sbjct: 193 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 251

Query: 194 NEL 196
           N +
Sbjct: 252 NNI 254

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.3 bits (124), Expect = 7e-08
 Identities = 27/138 (19%), Positives = 54/138 (39%), Gaps = 8/138 (5%)

Query: 70  SLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEI 128
           +L L ++ +        + L +L  L L  N+L    LP      L+   +  N+ +   
Sbjct: 59  TLILINNKISKISPGAFAPLVKLERLYLSKNQL--KELPEKMPKTLQELRVHENEITKVR 116

Query: 129 PHQISSLKGILRLDLSDNNIR--GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL 186
               + L  ++ ++L  N ++  G        + +L  +R+ +  +T     L  SL   
Sbjct: 117 KSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT-- 174

Query: 187 KELNLSNNELYGRVPEGL 204
            EL+L  N++       L
Sbjct: 175 -ELHLDGNKITKVDAASL 191

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.0 bits (105), Expect = 2e-05
 Identities = 20/113 (17%), Positives = 36/113 (31%), Gaps = 3/113 (2%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLS 144
           L+ +  +                      L    ++  + +        SL     L L 
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLD 179

Query: 145 DNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
            N I       +  L  L  L L  N ++       ++   L+EL+L+NN+L 
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 21/109 (19%), Positives = 40/109 (36%), Gaps = 3/109 (2%)

Query: 90  QLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR 149
           +LR  +    ++  ++    N   +     +    S         +K +  + ++D NI 
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163

Query: 150 GRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYG 198
             IP+       L  L L  N++T         L +L +L LS N +  
Sbjct: 164 -TIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISA 209

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 25/140 (17%), Positives = 40/140 (28%), Gaps = 32/140 (22%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSG--------------------- 121
           P  L   L  L L  N++       L    NL    LS                      
Sbjct: 166 PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 225

Query: 122 --NDFSAEIPHQISSLKGILRLDLSDNNIRG------RIPEQVTNLTRLLTLRLQNNELT 173
             N+   ++P  ++  K I  + L +NNI          P   T       + L +N + 
Sbjct: 226 LNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

Query: 174 -GRIPDLS-SSLKDLKELNL 191
              I   +   +     + L
Sbjct: 286 YWEIQPSTFRCVYVRAAVQL 305

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.7 bits (131), Expect = 1e-09
 Identities = 27/123 (21%), Positives = 41/123 (33%), Gaps = 7/123 (5%)

Query: 71  LSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPH 130
           L L    L   +  L  L  +  LDL  NRL      L     L++   S N        
Sbjct: 3   LHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGV 61

Query: 131 QISSLKGILRLDLSDNNIRG-RIPEQVTNLTRLLTLRLQNNELTGR---IPDLSSSLKDL 186
                     L L +N ++     + + +  RL+ L LQ N L         L+  L  +
Sbjct: 62  ANLPRLQE--LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119

Query: 187 KEL 189
             +
Sbjct: 120 SSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 1e-07
 Identities = 27/106 (25%), Positives = 36/106 (33%), Gaps = 5/106 (4%)

Query: 92  RFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGR 151
           R L L    L   +  L     +    LS N   A  P  +++L+ +  L  SDN +   
Sbjct: 1   RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 152 IPEQVTNLTRLLTLRLQNNELTG-RIPDLSSSLKDLKELNLSNNEL 196
                    +   L L NN L          S   L  LNL  N L
Sbjct: 59  DGVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.3 bits (136), Expect = 3e-09
 Identities = 21/80 (26%), Positives = 30/80 (37%), Gaps = 5/80 (6%)

Query: 138 ILRLDLSDNNIR-GRIPEQVTNLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLS 192
           I  LD+    +   R  E +  L +   +RL +  LT      I         L ELNL 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 193 NNELYGRVPEGLLKKFGEQS 212
           +NEL       +L+     S
Sbjct: 64  SNELGDVGVHCVLQGLQTPS 83

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.9 bits (135), Expect = 4e-09
 Identities = 17/96 (17%), Positives = 33/96 (34%), Gaps = 15/96 (15%)

Query: 110 NCTNLKLAYLSGNDFSAE----IPHQISSLKGILRLDLSDNNIRGRIPEQV-----TNLT 160
             + L++ +L+  D S      +   + +   +  LDLS+N +      Q+         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 161 RLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNEL 196
            L  L L +   +  + D       L+ L      L
Sbjct: 427 LLEQLVLYDIYWSEEMEDR------LQALEKDKPSL 456

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.8 bits (132), Expect = 9e-09
 Identities = 16/92 (17%), Positives = 35/92 (38%), Gaps = 10/92 (10%)

Query: 113 NLKLAYLSGNDFS-AEIPHQISSLKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRL 167
           +++   +   + S A     +  L+    + L D  +       I   +     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 168 QNNELTGR-IPDLSSSLKD----LKELNLSNN 194
           ++NEL    +  +   L+     +++L+L N 
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.2 bits (128), Expect = 3e-08
 Identities = 15/91 (16%), Positives = 28/91 (30%), Gaps = 11/91 (12%)

Query: 91  LRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGNDFSAE----IPHQISSLKGILRLDLS 144
           ++ LD+    L+       L      ++  L     +      I   +     +  L+L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 145 DNNIRGRIPEQV-----TNLTRLLTLRLQNN 170
            N +       V     T   ++  L LQN 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 1e-07
 Identities = 16/93 (17%), Positives = 29/93 (31%), Gaps = 9/93 (9%)

Query: 121 GNDFSAEIPHQISSLKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELTGR- 175
                            +  L L+D ++       +   +     L  L L NN L    
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413

Query: 176 IPDLSSSLKD----LKELNLSNNELYGRVPEGL 204
           I  L  S++     L++L L +      + + L
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 3e-04
 Identities = 20/111 (18%), Positives = 36/111 (32%), Gaps = 9/111 (8%)

Query: 35  QTDTHGNLLSNWKGADACAAAWTGVVCSPKSERVVSLS---LPSHSLRGPIAPLSLLDQL 91
           +      + +N            G+       RV+ L+   +   S     A L     L
Sbjct: 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 399

Query: 92  RFLDLHDNRLNGTILPL------TNCTNLKLAYLSGNDFSAEIPHQISSLK 136
           R LDL +N L    +             L+   L    +S E+  ++ +L+
Sbjct: 400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 12/53 (22%), Positives = 23/53 (43%), Gaps = 4/53 (7%)

Query: 158 NLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELYGRVPEGLLK 206
             + L  L L + +++      +     +   L+EL+LSNN L       L++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.8 bits (135), Expect = 4e-09
 Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 32/100 (32%)

Query: 88  LDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN 147
              L  L++ +N+L                         E+P     L+   RL  S N+
Sbjct: 283 PPSLEELNVSNNKLI------------------------ELPALPPRLE---RLIASFNH 315

Query: 148 IRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLK 187
           +   +PE   NL     L ++ N L    PD+  S++DL+
Sbjct: 316 L-AEVPELPQNLK---QLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.1 bits (128), Expect = 3e-08
 Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 8/79 (10%)

Query: 118 YLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIP 177
               N  S EI         +  L++S+N +   +P     L RL       N L     
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA---- 317

Query: 178 DLSSSLKDLKELNLSNNEL 196
           ++    ++LK+L++  N L
Sbjct: 318 EVPELPQNLKQLHVEYNPL 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 15/57 (26%), Positives = 24/57 (42%), Gaps = 5/57 (8%)

Query: 86  SLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD 142
           +L  +L  L    N L    +P     NLK  ++  N    E P    S++  LR++
Sbjct: 301 ALPPRLERLIASFNHL--AEVP-ELPQNLKQLHVEYNPLR-EFPDIPESVED-LRMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 15/69 (21%), Positives = 23/69 (33%), Gaps = 5/69 (7%)

Query: 111 CTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNN 170
                   L+    S  +P     L+    L  S N++   +PE   +L  LL       
Sbjct: 37  DRQAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91

Query: 171 ELTGRIPDL 179
            L+   P L
Sbjct: 92  ALSDLPPLL 100

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 51.0 bits (120), Expect = 2e-07
 Identities = 21/95 (22%), Positives = 33/95 (34%), Gaps = 5/95 (5%)

Query: 83  APLSLLDQ-LRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAE----IPHQISSLKG 137
           A  S+  + L+   +           L    ++K   LSGN    E    +   I+S K 
Sbjct: 1   ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60

Query: 138 ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNEL 172
           +   + SD        E    L  LL   L+  +L
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.3 bits (100), Expect = 6e-05
 Identities = 17/65 (26%), Positives = 24/65 (36%), Gaps = 11/65 (16%)

Query: 143 LSDNNIRGRIPEQVTN------LTRLLTLRLQNNELTGRIPD-----LSSSLKDLKELNL 191
           L+D  +  R    V +         L TLRLQ NE+           +   + DL  L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 192 SNNEL 196
           + N  
Sbjct: 310 NGNRF 314

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 9e-05
 Identities = 14/88 (15%), Positives = 25/88 (28%), Gaps = 12/88 (13%)

Query: 118 YLSGNDFSAEIPHQIS------SLKGILRLDLSDNNIRGRIPEQV-----TNLTRLLTLR 166
            L+    SA     +          G+  L L  N I       +       +  LL L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 167 LQNNELTGRIPDLSSSLKDLKELNLSNN 194
           L  N  +    D+   ++++        
Sbjct: 309 LNGNRFSE-EDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.2 bits (97), Expect = 1e-04
 Identities = 13/87 (14%), Positives = 30/87 (34%), Gaps = 13/87 (14%)

Query: 96  LHDNRLNGTIL-----PLTNCTNLKLA--YLSGNDFSAEIPHQISS-----LKGILRLDL 143
           L+D  L+           +   N+ L    L  N+   +    + +     +  +L L+L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 144 SDNNIRGRIPEQVTNLTRLLTLRLQNN 170
           + N       + V  +  + + R +  
Sbjct: 310 NGNRF-SEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 4e-04
 Identities = 12/70 (17%), Positives = 29/70 (41%), Gaps = 7/70 (10%)

Query: 134 SLKGI-LRLD-LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGR----IPDLSSSLKDLK 187
           S++G  L+LD ++  + +  +   +     +  + L  N +       + +  +S KDL+
Sbjct: 4   SIEGKSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 62

Query: 188 ELNLSNNELY 197
               S+    
Sbjct: 63  IAEFSDIFTG 72

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.9 bits (91), Expect = 8e-04
 Identities = 11/58 (18%), Positives = 20/58 (34%), Gaps = 7/58 (12%)

Query: 90  QLRFLDLHDNRLNGTILP------LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRL 141
            L+ L L  N +    +            +L    L+GN FS E    +  ++ +   
Sbjct: 274 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS-EEDDVVDEIREVFST 330

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.1 bits (118), Expect = 3e-07
 Identities = 17/98 (17%), Positives = 37/98 (37%), Gaps = 2/98 (2%)

Query: 94  LDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGR-I 152
           LDL    L+  +        +       +     +    S  + +  +DLS++ I    +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTL 63

Query: 153 PEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELN 190
              ++  ++L  L L+   L+  I +  +   +L  LN
Sbjct: 64  HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.3 bits (116), Expect = 6e-07
 Identities = 17/80 (21%), Positives = 39/80 (48%), Gaps = 2/80 (2%)

Query: 65  SERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLAYLSGN 122
           S+ V++   P   +  P+A      +++ +DL ++ +  + L   L+ C+ L+   L G 
Sbjct: 22  SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81

Query: 123 DFSAEIPHQISSLKGILRLD 142
             S  I + ++    ++RL+
Sbjct: 82  RLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 11/68 (16%), Positives = 32/68 (47%), Gaps = 2/68 (2%)

Query: 140 RLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGR 199
            LDL+  N+   +  ++ +   ++  R   + +   + +  S  + ++ ++LSN+ +   
Sbjct: 4   TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61

Query: 200 VPEGLLKK 207
              G+L +
Sbjct: 62  TLHGILSQ 69

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.4 bits (116), Expect = 5e-07
 Identities = 25/134 (18%), Positives = 38/134 (28%), Gaps = 29/134 (21%)

Query: 90  QLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKG----------- 137
            L  L LH NR++           +L    L  N  +   PH    L             
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 138 -------------ILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLK 184
                        +  L L+DN        +      L   R  ++E+   +P     L 
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLP---QRLA 269

Query: 185 DLKELNLSNNELYG 198
                 L+ N+L G
Sbjct: 270 GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.6 bits (101), Expect = 4e-05
 Identities = 38/245 (15%), Positives = 61/245 (24%), Gaps = 33/245 (13%)

Query: 13  LSLLSVSSSHPNDTDALTLFR-----LQTDTHGNLLS-NWKGADACAAAWTGVVCSPKSE 66
             L +V    P  +  + L       +   +     +       +   A           
Sbjct: 21  QGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA 80

Query: 67  RVVSLSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLNGTILPLTNC-TNLKLAYLSGND 123
            +  L L  ++    + P     L +L  L L    L      L      L+  YL  N 
Sbjct: 81  LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA 140

Query: 124 FSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSL 183
             A        L  +  L L  N I          L  L  L L  N +    P     L
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

Query: 184 KD------------------------LKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGL 219
                                     L+ L L++N          L  + ++    +  +
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEV 260

Query: 220 CGSSP 224
             S P
Sbjct: 261 PCSLP 265

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (110), Expect = 1e-06
 Identities = 16/65 (24%), Positives = 29/65 (44%), Gaps = 3/65 (4%)

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
           L+   I      Q TN  R   L L+  ++   I +L ++L     ++ S+NE+      
Sbjct: 3   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF 59

Query: 203 GLLKK 207
            LL++
Sbjct: 60  PLLRR 64

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (102), Expect = 1e-05
 Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 3/93 (3%)

Query: 105 ILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT 164
               TN    +   L G      I +  ++L     +D SDN I  R  +    L RL T
Sbjct: 11  AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKT 67

Query: 165 LRLQNNELTGRIPDLSSSLKDLKELNLSNNELY 197
           L + NN +      L  +L DL EL L+NN L 
Sbjct: 68  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 3e-06
 Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 3/77 (3%)

Query: 131 QISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELN 190
           ++S +   L ++    N+   +P  +   T    L L  N L             L +LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 191 LSNNELYGRVPEGLLKK 207
           L   EL     +G L  
Sbjct: 62  LDRAELTKLQVDGTLPV 78

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 12/63 (19%), Positives = 21/63 (33%), Gaps = 3/63 (4%)

Query: 109 TNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQ 168
           +   +         + +  +P  +   K    L LS+N +       +   TRL  L L 
Sbjct: 7   SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 169 NNE 171
             E
Sbjct: 64  RAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.4 bits (98), Expect = 8e-05
 Identities = 19/73 (26%), Positives = 28/73 (38%), Gaps = 1/73 (1%)

Query: 122 NDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSS 181
           N+     P  ++    + +L L++NN+       +  L  L TL LQ N L   IP    
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFF 192

Query: 182 SLKDLKELNLSNN 194
               L    L  N
Sbjct: 193 GSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 2e-04
 Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 3/81 (3%)

Query: 110 NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN 169
               L+   L+ N+ +      ++ L+ +  L L +N++   IP+       L    L  
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHG 204

Query: 170 NEL--TGRIPDLSSSLKDLKE 188
           N       I      L+D  E
Sbjct: 205 NPWLCNCEILYFRRWLQDNAE 225

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.003
 Identities = 12/67 (17%), Positives = 23/67 (34%), Gaps = 2/67 (2%)

Query: 81  PIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILR 140
           PI  +S +     ++     L  T LP     +  + +LS N         +     + +
Sbjct: 2   PICEVSKVASHLEVNCDKRNL--TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 141 LDLSDNN 147
           L+L    
Sbjct: 60  LNLDRAE 66

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.8 bits (105), Expect = 6e-06
 Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 6/115 (5%)

Query: 90  QLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR 149
             + LDL   R +  ++       L       +  +A +     ++  +L L+LS+N + 
Sbjct: 23  SQQALDLKGLRSDPDLVAQNIDVVLNR----RSSMAATLRIIEENIPELLSLNLSNNRLY 78

Query: 150 GR--IPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE 202
               +   V     L  L L  NEL             L+EL L  N L     +
Sbjct: 79  RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (100), Expect = 2e-05
 Identities = 20/115 (17%), Positives = 34/115 (29%), Gaps = 9/115 (7%)

Query: 85  LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFS--AEIPHQISSLKGILRLD 142
           L   +    L+   +      +   N   L    LS N      ++   +     +  L+
Sbjct: 38  LVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97

Query: 143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLS-------SSLKDLKELN 190
           LS N ++           +L  L L  N L+    D S            L  L+
Sbjct: 98  LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.3 bits (88), Expect = 9e-04
 Identities = 27/116 (23%), Positives = 44/116 (37%), Gaps = 8/116 (6%)

Query: 69  VSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGT---ILPLTNCTNLKLAYLSGNDFS 125
           V L+  S            + +L  L+L +NRL         +    NLK+  LSGN+  
Sbjct: 45  VVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104

Query: 126 AEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTL-----RLQNNELTGRI 176
           +E          +  L L  N++     +Q T ++ +        RL  +EL   I
Sbjct: 105 SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELPPPI 160

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.0 bits (105), Expect = 1e-05
 Identities = 17/63 (26%), Positives = 27/63 (42%), Gaps = 4/63 (6%)

Query: 107 PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLR 166
           PL N + L       N  S   P  ++SL  ++ + L +N I    P  + N + L  + 
Sbjct: 168 PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223

Query: 167 LQN 169
           L N
Sbjct: 224 LTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 15/75 (20%), Positives = 31/75 (41%), Gaps = 4/75 (5%)

Query: 134 SLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN 193
           +L   +++    +N+   + +   +L  + TL      +T  I  +   L +L  L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVTT-IEGV-QYLNNLIGLELKD 72

Query: 194 NELYGRVPEGLLKKF 208
           N++    P   L K 
Sbjct: 73  NQITDLAPLKNLTKI 87

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 6e-05
 Identities = 13/39 (33%), Positives = 24/39 (61%), Gaps = 1/39 (2%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLS 120
           I+PL+ L  L  + L +N+++  + PL N +NL +  L+
Sbjct: 188 ISPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 1e-04
 Identities = 17/62 (27%), Positives = 31/62 (50%), Gaps = 3/62 (4%)

Query: 84  PLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL 143
           PL+ L +L  L   DN+++  I PL +  NL   +L  N  S   P  +++   +  + L
Sbjct: 168 PLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 144 SD 145
           ++
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 4/68 (5%)

Query: 105 ILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT 164
           I P     N        ++ +  +    + L GI  L      +     E V  L  L+ 
Sbjct: 12  IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIG 67

Query: 165 LRLQNNEL 172
           L L++N++
Sbjct: 68  LELKDNQI 75

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 3e-05
 Identities = 13/87 (14%), Positives = 32/87 (36%), Gaps = 10/87 (11%)

Query: 128 IPHQIS------SLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSS 181
           +P  I       +    ++ +L   ++   + +    L  +  +   N+++         
Sbjct: 10  VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQ 65

Query: 182 SLKDLKELNLSNNELYGRVPEGLLKKF 208
            L ++ +L L+ N+L    P   LK  
Sbjct: 66  YLPNVTKLFLNGNKLTDIKPLANLKNL 92

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 1e-04
 Identities = 7/63 (11%), Positives = 25/63 (39%), Gaps = 2/63 (3%)

Query: 63  PKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGN 122
                 +  +L   S+   +   + L+ +  +  +++ +   +  +    N+   +L+GN
Sbjct: 21  DAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGN 78

Query: 123 DFS 125
             +
Sbjct: 79  KLT 81

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 1/40 (2%)

Query: 82  IAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSG 121
           I PL+ L +L+ L L  N ++  +  L    NL +  L  
Sbjct: 171 IVPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.003
 Identities = 12/36 (33%), Positives = 19/36 (52%), Gaps = 2/36 (5%)

Query: 158 NLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSN 193
            LT+L  L L  N ++  +  L + LK+L  L L +
Sbjct: 176 GLTKLQNLYLSKNHISD-LRAL-AGLKNLDVLELFS 209

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 2e-04
 Identities = 10/52 (19%), Positives = 19/52 (36%), Gaps = 1/52 (1%)

Query: 145 DNNIRGRIPEQV-TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNE 195
           DNN    +P  V    +  + L +    +         +LK L+  +  N +
Sbjct: 185 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 13/70 (18%), Positives = 22/70 (31%), Gaps = 3/70 (4%)

Query: 110 NCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQN 169
                +L     N+             G + LD+S   I       + NL +L      N
Sbjct: 175 GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234

Query: 170 NELTGRIPDL 179
            +   ++P L
Sbjct: 235 LK---KLPTL 241

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.002
 Identities = 29/194 (14%), Positives = 47/194 (24%), Gaps = 66/194 (34%)

Query: 52  CAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNC 111
           C    T V C+ +  + +   +P H                 L L+DN L          
Sbjct: 6   CHCEGTTVDCTGRGLKEIPRDIPLH--------------TTELLLNDNELGRISSDGLFG 51

Query: 112 TNLKL--------------------------AYLSGNDFSAEIPHQISSLKGILRLDLSD 145
               L                            L  N            L  +  L+L D
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111

Query: 146 NNIRGRIPEQVTNLTRLLT-----------------------LRLQNNELTGRIPDLSSS 182
           N I   +P    +L  L +                         L         P   S 
Sbjct: 112 NQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP---SK 168

Query: 183 LKDLKELNLSNNEL 196
           ++D++  +L ++E 
Sbjct: 169 VRDVQIKDLPHSEF 182

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (83), Expect = 0.003
 Identities = 26/141 (18%), Positives = 47/141 (33%), Gaps = 4/141 (2%)

Query: 89  DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQI-SSLKGILRLDLSDNN 147
                L    +    ++  L    NL   Y+        +  +    L  +  L +  + 
Sbjct: 8   HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 148 IRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKK 207
           +R   P+      RL  L L  N L   +   +     L+EL LS N L+       L++
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 208 FGEQS--FIGNEGLCGSSPLP 226
           + E+    +  + L      P
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGP 147

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	670
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.87
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.66
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.66
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.65
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.64
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.55
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.54
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.47
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.43
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.42
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.39
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.39
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.39
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.36
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.36
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.35
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.35
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.33
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.26
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.21
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.18
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.16
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.09
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.82
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.62
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.61
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.47
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.38
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.37
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.31
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.31
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.25
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.24
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.12
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.11
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.01
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.55
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.31
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.23
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.12
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.71
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.43
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.09
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.34

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=405.25  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=194.5

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      .+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++||||+++|+|.
T Consensus        10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~   88 (263)
T d1sm2a_          10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLS   88 (263)
T ss_dssp             EEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             EEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHH
Confidence            46799999999999999889999999998644 35678999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-----
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-----  515 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----  515 (670)
                      +++....    ..++|..++.++.|+++||+|||+.    +|+||||||+|||+|+++.+||+|||+++......     
T Consensus        89 ~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          89 DYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEA----CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             HHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             HHhhccc----cCCCHHHHHHHHHHHHHHHHhhhcc----ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            9987643    2589999999999999999999998    99999999999999999999999999998765422     


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...++..|+|||++.+..++.++|||||||++|||+|++.|+...             ......+...... ...  ..+
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~-------------~~~~~~~~~i~~~-~~~--~~p  224 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-------------RSNSEVVEDISTG-FRL--YKP  224 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS-------------CCHHHHHHHHHHT-CCC--CCC
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC-------------CCHHHHHHHHHhc-CCC--CCc
Confidence            245677899999999999999999999999999999965444321             0111122221111 100  000


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                           ...   ..++.+++.+||+.||++||||+||+++|+++.+
T Consensus       225 -----~~~---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         225 -----RLA---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----ccc---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                 111   2345677789999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-51  Score=410.38  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=197.1

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|+++  ..||||+++..  .....+.|.+|++++++++|||||++++++. .+..++|||||++|
T Consensus        12 ~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g   88 (276)
T d1uwha_          12 VGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGS   88 (276)
T ss_dssp             CCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEE
T ss_pred             EEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCC
Confidence            3578999999999999865  35999999743  3445688999999999999999999999875 45689999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc---
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV---  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~---  514 (670)
                      +|.++++...    ..+++..+..++.||++||+|||+.    +|+||||||+||||+.++.+||+|||+|+.....   
T Consensus        89 ~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~----~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          89 SLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAK----SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcC----CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            9999997543    2589999999999999999999998    9999999999999999999999999999876432   


Q ss_pred             ---ccccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          515 ---QAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                         ....+|+.|||||++.+   ..++.++|||||||++|||+||+.||.....              ...+........
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------------~~~~~~~~~~~~  226 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------------RDQIIFMVGRGY  226 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------------HHHHHHHHHHTS
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------------HHHHHHHHhcCC
Confidence               23467888999999864   3589999999999999999999999975311              111112222211


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ...    .....  .......+.+++.+||+.||++||||+||+++|+.+....
T Consensus       227 ~~p----~~~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         227 LSP----DLSKV--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CCC----CGGGS--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCC----cchhc--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            110    00000  0111234566777999999999999999999999987643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=408.15  Aligned_cols=248  Identities=27%  Similarity=0.421  Sum_probs=203.5

Q ss_pred             cccHHHHHHHHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC
Q 036639          350 QFELEDLLRASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE  425 (670)
Q Consensus       350 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~  425 (670)
                      +|++++  |.+.+.||+|+||+||+|+.+ +|+.||||++.+.   .....+.+.+|++++++++|||||++++++.+.+
T Consensus         2 ~~~l~d--y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           2 QWALED--FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             CCCGGG--EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CcchhH--eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            344444  345688999999999999964 6899999998643   2234678899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEec
Q 036639          426 EKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDF  505 (670)
Q Consensus       426 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF  505 (670)
                      ..|+|||||++|+|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+||
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~~kl~DF  150 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSK----RVIHRDIKPENLLLGSAGELKIADF  150 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEEeecCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC----CeeeeeeccccceecCCCCEeeccc
Confidence            9999999999999999998654     589999999999999999999998    9999999999999999999999999


Q ss_pred             ccccccCcc--ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          506 GLSLLLNPV--QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       506 G~a~~~~~~--~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                      |+|+.....  ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+              ........
T Consensus       151 G~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------------~~~~~~~i  216 (263)
T d2j4za1         151 GWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------------YQETYKRI  216 (263)
T ss_dssp             CSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHH
T ss_pred             ceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------------HHHHHHHH
Confidence            999877543  34568889999999999999999999999999999999999996531              11222222


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ......   +      .....+   .+.+++.+||+.||++|||++|+++|
T Consensus       217 ~~~~~~---~------p~~~s~---~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         217 SRVEFT---F------PDFVTE---GARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HTTCCC---C------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HcCCCC---C------CccCCH---HHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            221110   0      111223   34556779999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-50  Score=406.93  Aligned_cols=241  Identities=23%  Similarity=0.354  Sum_probs=199.6

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      .+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+|||||++|+|
T Consensus        25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L  104 (293)
T d1yhwa1          25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  104 (293)
T ss_dssp             CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence            46799999999999995 57999999999866555678899999999999999999999999999999999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----cc
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----VQ  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~~  515 (670)
                      .+++...      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++++||+|||+|+....    ..
T Consensus       105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~  174 (293)
T d1yhwa1         105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSN----QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (293)
T ss_dssp             HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC----CCcccCCcHHHeEECCCCcEeeccchhheeecccccccc
Confidence            9998754      489999999999999999999998    999999999999999999999999999987643    23


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccH
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQ  595 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  595 (670)
                      ...||+.|+|||++.+..++.++|||||||++|||+||+.||...+              ....+...........    
T Consensus       175 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------------~~~~~~~~~~~~~~~~----  236 (293)
T d1yhwa1         175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------------PLRALYLIATNGTPEL----  236 (293)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHHHHCSCCC----
T ss_pred             ccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------------HHHHHHHHHhCCCCCC----
Confidence            4568889999999999999999999999999999999999996431              1111122222111100    


Q ss_pred             hhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          596 ELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       596 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        .......+   .+.+++.+||+.||++|||++|+++|
T Consensus       237 --~~~~~~s~---~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         237 --QNPEKLSA---IFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --SSGGGSCH---HHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --CCcccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence              00111222   34556779999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-50  Score=404.22  Aligned_cols=247  Identities=26%  Similarity=0.399  Sum_probs=198.6

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +.+.||+|+||+||+|.+++++.||||+++... ...++|.+|++++++++|||||++++++. .+..++||||+++|+|
T Consensus        17 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L   94 (272)
T d1qpca_          17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSL   94 (272)
T ss_dssp             EEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBH
T ss_pred             EeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcH
Confidence            457899999999999999888999999997654 35678999999999999999999999875 4567999999999999


Q ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc----
Q 036639          440 HSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ----  515 (670)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~----  515 (670)
                      .+++....   ...++|..+++|+.||++||+|||+.    +|+||||||+||||++++.+||+|||+|+......    
T Consensus        95 ~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~----~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~  167 (272)
T d1qpca_          95 VDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEER----NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (272)
T ss_dssp             HHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             HHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC----CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence            99876442   22589999999999999999999998    99999999999999999999999999998775422    


Q ss_pred             -cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          516 -AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       516 -~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                       ...++..|+|||++.+..++.++|||||||++|||+||+.|+....             ............ ....   
T Consensus       168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------------~~~~~~~~i~~~-~~~~---  230 (272)
T d1qpca_         168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------------TNPEVIQNLERG-YRMV---  230 (272)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------------CHHHHHHHHHTT-CCCC---
T ss_pred             cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-------------CHHHHHHHHHhc-CCCC---
Confidence             3456677999999998899999999999999999999766653221             111111111111 1000   


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                          ......   ..+.+++.+||+.||++||||+||++.|+++-
T Consensus       231 ----~p~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         231 ----RPDNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             ----CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----CcccCh---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence                011122   24566777999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-49  Score=404.41  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=203.5

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||+||+|.+. +|+.||||+++... ...++|.+|++++++++|||||+++++|.+.+..++|||||++|+
T Consensus        21 ~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~   99 (287)
T d1opja_          21 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN   99 (287)
T ss_dssp             EEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             EeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcc
Confidence            3578999999999999965 68899999997654 356789999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.+++....   ...+++..+..++.|+++||+|||+.    +|+||||||+||||++++.+||+|||+|+......   
T Consensus       100 l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~  172 (287)
T d1opja_         100 LLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKK----NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  172 (287)
T ss_dssp             HHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEE
T ss_pred             hHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHC----CcccCccccCeEEECCCCcEEEccccceeecCCCCcee
Confidence            999997643   23689999999999999999999998    99999999999999999999999999998775422   


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                        ...++..|+|||++.+..++.++|||||||++|||+||+.||....             .... +...+.......  
T Consensus       173 ~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-------------~~~~-~~~~i~~~~~~~--  236 (287)
T d1opja_         173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------------DLSQ-VYELLEKDYRME--  236 (287)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-------------CHHH-HHHHHHTTCCCC--
T ss_pred             eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-------------hHHH-HHHHHhcCCCCC--
Confidence              2335667999999999999999999999999999999877764321             1111 112222211111  


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                           ......   ..+.+++.+||+.||++||||+||++.|+.+..+
T Consensus       237 -----~~~~~~---~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         237 -----RPEGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             -----CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             -----CCccch---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                 111122   3456677899999999999999999999988644

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-49  Score=402.93  Aligned_cols=248  Identities=23%  Similarity=0.415  Sum_probs=192.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CC---CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DG---GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|+||+||+|.++ ++   ..||||++... .....++|.+|++++++++|||||+++|++.+.+..++|||||+
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~  110 (299)
T d1jpaa_          31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME  110 (299)
T ss_dssp             EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence            468999999999999964 33   36999998754 33456789999999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ  515 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  515 (670)
                      +|+|.+++....    ..++|..+..++.||++||+|||+.    +|+||||||+||||+.++++||+|||+++......
T Consensus       111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADM----NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhC----CCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence            999999987643    2589999999999999999999998    99999999999999999999999999998765322


Q ss_pred             ---------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          516 ---------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       516 ---------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                               ...++..|+|||.+.+..++.++|||||||++|||+| |+.||....              ....+.....
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--------------~~~~~~~i~~  248 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--------------NQDVINAIEQ  248 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------------HHHHHHHHHT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--------------HHHHHHHHHc
Confidence                     1235667999999999999999999999999999998 899986531              1111111111


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .....           ...+....+.+++.+||+.||++||||.||+++|+++...
T Consensus       249 ~~~~~-----------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 DYRLP-----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             TCCCC-----------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCC-----------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            11100           0111223456677899999999999999999999988643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=405.28  Aligned_cols=243  Identities=23%  Similarity=0.308  Sum_probs=193.5

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|++++++++|||||++++++.+.+..|+||||+++|
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg   88 (271)
T d1nvra_           9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG   88 (271)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCC
Confidence            347899999999999996 479999999997543 224567899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      +|.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||+++++.+||+|||+|+....    
T Consensus        89 ~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~----~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          89 ELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGI----GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             EGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999997543     589999999999999999999998    999999999999999999999999999987642    


Q ss_pred             --cccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                        .....||+.|||||++.+..+ +.++||||+||++|||+||+.||......             ..............
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-------------~~~~~~~~~~~~~~  226 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------------CQEYSDWKEKKTYL  226 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-------------SHHHHHHHTTCTTS
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH-------------HHHHHHHhcCCCCC
Confidence              234568899999999988776 57899999999999999999999654211             01111111110000


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                             .......+   .+.+++.+||+.||++|||++|+++|
T Consensus       227 -------~~~~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         227 -------NPWKKIDS---APLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -------TTGGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -------CccccCCH---HHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                   00111222   34456779999999999999999764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=395.05  Aligned_cols=244  Identities=21%  Similarity=0.344  Sum_probs=201.8

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCChH
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGSLH  440 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~  440 (670)
                      .+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++||||++++|+|.+.+..++||||+++|+|.
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~   87 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLL   87 (258)
T ss_dssp             CCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHH
T ss_pred             eEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHH
Confidence            467999999999999998889999999986543 5678999999999999999999999999999999999999999999


Q ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-----
Q 036639          441 SLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-----  515 (670)
Q Consensus       441 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----  515 (670)
                      +++....    ..+++..+.+++.|+++||+|||+.    +|+||||||+|||+++++.+||+|||+++......     
T Consensus        88 ~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~----~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          88 NYLREMR----HRFQTQQLLEMCKDVCEAMEYLESK----QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             HHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHT----TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred             Hhhhccc----cCCcHHHHHHHHHHHHHHHHHHhhc----CcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence            9976543    2588999999999999999999998    99999999999999999999999999998765422     


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ...++..|+|||.+.+..++.|+|||||||++|||+| |+.||...+              ....... +......  ..
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------------~~~~~~~-i~~~~~~--~~  222 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------------NSETAEH-IAQGLRL--YR  222 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------------HHHHHHH-HHTTCCC--CC
T ss_pred             ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------------HHHHHHH-HHhCCCC--CC
Confidence            2445677999999999999999999999999999998 799986541              1111111 1111110  00


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                           .....   ..+.+++.+||+.||++|||++|++++|.+|
T Consensus       223 -----p~~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         223 -----PHLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----CTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----ccccc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                 01112   3456677799999999999999999999764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=403.35  Aligned_cols=244  Identities=21%  Similarity=0.335  Sum_probs=198.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..++|||||++|+
T Consensus        16 i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~   95 (288)
T d2jfla1          16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGA   95 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCc
Confidence            346799999999999996 4789999999987666667889999999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----c
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----V  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----~  514 (670)
                      |.+++....    ..+++..+..++.|+++||+|||++    +|+||||||+|||++.++.+||+|||+|+....    .
T Consensus        96 L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~----~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          96 VDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDN----KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             HHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence            999976532    2589999999999999999999998    999999999999999999999999999987643    2


Q ss_pred             ccccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          515 QAIARLGGYKAPEQAE-----VKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~-----~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ....||+.|+|||++.     ...|+.++|||||||++|||+||+.||...+..              ..+.........
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------------~~~~~i~~~~~~  233 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------------RVLLKIAKSEPP  233 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------------GHHHHHHHSCCC
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--------------HHHHHHHcCCCC
Confidence            3467888999999983     456899999999999999999999999754211              111122222111


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .      +.......+   .+.+++.+||+.||++|||++|+++|
T Consensus       234 ~------~~~~~~~s~---~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         234 T------LAQPSRWSS---NFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             C------CSSGGGSCH---HHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             C------CCccccCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      001111222   45566779999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=392.10  Aligned_cols=242  Identities=24%  Similarity=0.388  Sum_probs=192.1

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEe----CCeeEEEEecc
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA----KEEKLLVYDYL  434 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~----~~~~~lv~e~~  434 (670)
                      +.||+|+||+||+|... +++.||+|++...  .....+.+.+|++++++++|||||++++++.+    ....|+||||+
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence            46999999999999964 6889999998754  33355779999999999999999999999876    34578999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC-CCCcEEEEecccccccCc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD-KNGVACISDFGLSLLLNP  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFG~a~~~~~  513 (670)
                      ++|+|.+++....     .+++..+..++.||++||+|||++  .++|+||||||+|||++ +++.+||+|||+++....
T Consensus        95 ~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~--~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          95 TSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTR--TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             CSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTS--SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             CCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHC--CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999997654     589999999999999999999987  12399999999999996 578999999999987644


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....||+.|+|||++.+ .++.++|||||||++|||+||+.||....             ......+..... ....
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------------~~~~~~~~i~~~-~~~~  232 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------------NAAQIYRRVTSG-VKPA  232 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------------SHHHHHHHHTTT-CCCG
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------------cHHHHHHHHHcC-CCCc
Confidence              335678999999999875 69999999999999999999999996431             111111111111 1111


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .++      ....+   ++.+++.+||+.||++|||++|+++|
T Consensus       233 ~~~------~~~~~---~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         233 SFD------KVAIP---EVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GGG------GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccC------ccCCH---HHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            111      11122   35567779999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=411.23  Aligned_cols=193  Identities=25%  Similarity=0.417  Sum_probs=172.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|+. .+|+.||+|+++.. .....+.+.+|++++++++|||||+++++|.+.++.|+|||||++|
T Consensus        10 ~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg   89 (322)
T d1s9ja_          10 KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   89 (322)
T ss_dssp             EEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            346899999999999995 47899999999754 3345678999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--cc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--VQ  515 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--~~  515 (670)
                      +|.+++....     .+++..+..++.|+++||.|||+.   .+|+||||||+|||++.++.+||+|||+|+....  ..
T Consensus        90 ~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  161 (322)
T d1s9ja_          90 SLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK---HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  161 (322)
T ss_dssp             EHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHH---HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             cHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHh---CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence            9999997653     489999999999999999999974   2899999999999999999999999999987643  33


Q ss_pred             cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          516 AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       516 ~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ...||+.|+|||++.+..|+.++||||+||++|||+||+.||...
T Consensus       162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            567899999999999999999999999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=394.50  Aligned_cols=243  Identities=28%  Similarity=0.359  Sum_probs=194.3

Q ss_pred             hHcCCCCceEEEEEEEc---CCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          362 EMLGKGSLGTVYKAVLD---DGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.||+|+||+||+|.++   .++.||||+++..  +....+++.+|++++++++|||||+++++|.+ +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999864   3468999999753  33346789999999999999999999999865 467899999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc--
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV--  514 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--  514 (670)
                      |+|.++++...     .+++..++.++.||++||+|||+.    +|+||||||+|||++.++.+||+|||+++.....  
T Consensus        92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~----~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~  162 (277)
T d1xbba_          92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEES----NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  162 (277)
T ss_dssp             EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhC----CcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence            99999998654     599999999999999999999998    9999999999999999999999999999876432  


Q ss_pred             -----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          515 -----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       515 -----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                           ....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||...+              ... +...+....
T Consensus       163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------------~~~-~~~~i~~~~  227 (277)
T d1xbba_         163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------------GSE-VTAMLEKGE  227 (277)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------------HHH-HHHHHHTTC
T ss_pred             ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------------HHH-HHHHHHcCC
Confidence                 12346778999999999999999999999999999998 899996531              111 111111111


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                      ...       ......   ..+.+++.+||+.||++|||++||++.|+..-
T Consensus       228 ~~~-------~p~~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         228 RMG-------CPAGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCC-------CCTTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCC-------CCcccC---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            000       011122   34566778999999999999999999888753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=394.40  Aligned_cols=245  Identities=26%  Similarity=0.361  Sum_probs=197.6

Q ss_pred             HcCCCCceEEEEEEEc---CCCEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          363 MLGKGSLGTVYKAVLD---DGGIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      .||+|+||+||+|.++   ++..||||+++.. .....++|.+|++++++++|||||+++|++.+ +..|+|||||++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            4999999999999854   3568999999754 33456789999999999999999999999865 56899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |.+++...+    ..+++..+..++.|+++||+|||+.    +|+||||||+|||++.++.+||+|||+++......   
T Consensus        95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~----~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  166 (285)
T d1u59a_          95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEK----NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  166 (285)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhC----CeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence            999986543    2589999999999999999999998    99999999999999999999999999998765422   


Q ss_pred             ----cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          516 ----AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       516 ----~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                          ...++..|+|||++.+..++.++|||||||++|||+| |+.||...+.              ...... +......
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------------~~~~~~-i~~~~~~  231 (285)
T d1u59a_         167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------------PEVMAF-IEQGKRM  231 (285)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------------HHHHHH-HHTTCCC
T ss_pred             ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------------HHHHHH-HHcCCCC
Confidence                2345677999999998999999999999999999998 8999965311              111111 1111111


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .       ......   ..+.+++.+||+.||++|||+.+|++.|+.+...
T Consensus       232 ~-------~p~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         232 E-------CPPECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             C-------CCTTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-------CCCcCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            0       011122   3456677799999999999999999999887643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=398.14  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=187.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEe--CCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--KEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--~~~~~lv~e~~  434 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++....  ....+.+.+|++++++++|||||++++++.+  .+..|+|||||
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~   87 (269)
T d2java1           8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC   87 (269)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECC
T ss_pred             EeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecC
Confidence            347899999999999995 479999999997643  3345678999999999999999999999875  45679999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhC-CCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEY-GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      ++|+|.+++..... ....+++..++.++.|++.||+|||+.. ...+|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  166 (269)
T d2java1          88 EGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH  166 (269)
T ss_dssp             TTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC--
T ss_pred             CCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeeccc
Confidence            99999999864321 1225899999999999999999999871 012499999999999999999999999999987654


Q ss_pred             c----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          514 V----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       514 ~----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      .    ....+|+.|+|||++.+..++.++|||||||++|||+||+.||...+              ..............
T Consensus       167 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------------~~~~~~~i~~~~~~  232 (269)
T d2java1         167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------------QKELAGKIREGKFR  232 (269)
T ss_dssp             ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------------HHHHHHHHHHTCCC
T ss_pred             CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------------HHHHHHHHHcCCCC
Confidence            2    34567889999999999999999999999999999999999996431              11112222211111


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ..       .....+   ++.+++.+||+.||++|||++|+++|
T Consensus       233 -~~-------~~~~s~---~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         233 -RI-------PYRYSD---ELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -CC-------CTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -CC-------CcccCH---HHHHHHHHHcCCChhHCcCHHHHHhC
Confidence             00       011222   35567779999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-48  Score=399.53  Aligned_cols=243  Identities=24%  Similarity=0.386  Sum_probs=199.2

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      ...+.||+|+||+||+|+. .+|+.||||+++....   ...+.+.+|++++++++|||||++++++.+.+..|+|||||
T Consensus        18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   97 (309)
T d1u5ra_          18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC   97 (309)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEec
Confidence            3457899999999999995 5789999999975432   23467889999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|..++....     .+++..+..++.||+.||.|||+.    +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        98 ~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          98 LGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH----NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             CCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            9999987766543     589999999999999999999998    9999999999999999999999999999998888


Q ss_pred             ccccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          515 QAIARLGGYKAPEQAEV---KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~---~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                      ....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||....              ....+......... .
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------------~~~~~~~i~~~~~~-~  233 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------------AMSALYHIAQNESP-A  233 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------------HHHHHHHHHHSCCC-C
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------------HHHHHHHHHhCCCC-C
Confidence            88889999999999853   458999999999999999999999996431              11112222221111 0


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...      ....+   .+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~------~~~s~---~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         234 LQS------GHWSE---YFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CSC------TTSCH---HHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCC------CCCCH---HHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            000      11222   35566779999999999999999874

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=391.01  Aligned_cols=248  Identities=21%  Similarity=0.408  Sum_probs=194.2

Q ss_pred             HhHcCCCCceEEEEEEEcCC-----CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLDDG-----GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.||+|+||+||+|.+++.     ..||||+++.. .....++|.+|++++++++|||||+++|++.+.+..++||||+
T Consensus        12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~   91 (283)
T d1mqba_          12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM   91 (283)
T ss_dssp             EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence            36799999999999996532     47999999754 3334567899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      .++++.+++....    ..++|..++.++.|++.||+|||+.    +|+||||||+||||+.++.+||+|||+++.....
T Consensus        92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~----~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANM----NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcccc----ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            9999999887553    2589999999999999999999998    9999999999999999999999999999876432


Q ss_pred             c-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          515 Q-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       515 ~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      .       ...+|..|+|||++.+..++.++|||||||++|||+||+.|+....             .....+.. +.+.
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------------~~~~~~~~-i~~~  229 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------------SNHEVMKA-INDG  229 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------------CHHHHHHH-HHTT
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------------CHHHHHHH-Hhcc
Confidence            1       2345677999999999999999999999999999999776654321             11111111 1111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ...          +........+.+++.+||+.||++||||.||+++|+++..
T Consensus       230 ~~~----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         230 FRL----------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             CCC----------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCC----------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence            110          0111122346678889999999999999999999998864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=393.82  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=198.0

Q ss_pred             HHHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      ++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||+++|+
T Consensus        20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~   97 (285)
T d1fmka3          20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS   97 (285)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred             EEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCc
Confidence            4567899999999999999888899999997553 35688999999999999999999999985 456899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc---
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ---  515 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~---  515 (670)
                      |..++....   ...++|..++.++.||+.||+|||+.    +|+||||||+|||||+++++||+|||+++......   
T Consensus        98 l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~----~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          98 LLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERM----NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             HHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             hhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhh----heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999987532   12589999999999999999999998    99999999999999999999999999998764322   


Q ss_pred             --cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          516 --AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       516 --~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                        ...+++.|+|||++....++.++|||||||++|||+||+.|+....             .....+...... ....  
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------------~~~~~~~~i~~~-~~~~--  234 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------------VNREVLDQVERG-YRMP--  234 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------------CHHHHHHHHHTT-CCCC--
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------------CHHHHHHHHHhc-CCCC--
Confidence              2456778999999999999999999999999999999776664321             111112111111 1100  


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                           ......   .++.+++.+||+.||++||||++|+++|++.....
T Consensus       235 -----~~~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         235 -----CPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             -----CCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             -----CCcccC---HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                 011122   34566778999999999999999999999876543

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=8.8e-48  Score=400.74  Aligned_cols=246  Identities=21%  Similarity=0.381  Sum_probs=202.9

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..|+|||||++|
T Consensus        29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg  108 (350)
T d1koaa2          29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG  108 (350)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            3457899999999999996 479999999998777667788999999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC--CCcEEEEecccccccCcc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK--NGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|.+++....    ..+++..+..++.||+.||+|||+.    +|+||||||+|||++.  ++.+||+|||+++..... 
T Consensus       109 ~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         109 ELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHEN----NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             BHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhc----CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999996543    2589999999999999999999998    9999999999999964  678999999999877543 


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....+|+.|||||++.+..++.++|||||||++|||+||+.||...              .....+.......+... 
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------------~~~~~~~~i~~~~~~~~-  245 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------------NDDETLRNVKSCDWNMD-  245 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------------SHHHHHHHHHHTCCCSC-
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC--------------CHHHHHHHHHhCCCCCC-
Confidence              3467889999999999999999999999999999999999999653              11222222222221110 


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                        .  .......+   .+.+++.+||+.||++|||++|+++|
T Consensus       246 --~--~~~~~~s~---~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         246 --D--SAFSGISE---DGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --C--GGGGGCCH---HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --c--ccccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence              0  00111222   34566779999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.7e-48  Score=397.68  Aligned_cols=245  Identities=24%  Similarity=0.335  Sum_probs=184.5

Q ss_pred             HHHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          359 ASAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      .+.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|++++++++|||||++++++.+.+..|+|||||++
T Consensus        12 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~g   91 (307)
T d1a06a_          12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG   91 (307)
T ss_dssp             EEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            34578999999999999964 789999999975432 2346788999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC---CCCcEEEEecccccccCc
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD---KNGVACISDFGLSLLLNP  513 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFG~a~~~~~  513 (670)
                      |+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++   +++.+||+|||+++....
T Consensus        92 g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          92 GELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDL----GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             CcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhc----eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999997653     599999999999999999999998    999999999999994   578999999999987654


Q ss_pred             c---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 V---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                      .   ....||+.|+|||++.+..++.++|||||||++|||+||+.||....              ...............
T Consensus       163 ~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~~~~~~~i~~~~~~~  228 (307)
T d1a06a_         163 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------------DAKLFEQILKAEYEF  228 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------------HHHHHHHHHTTCCCC
T ss_pred             CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------------HHHHHHHHhccCCCC
Confidence            3   34568899999999999999999999999999999999999996431              111222222221110


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                         ..  .......+   .+.+++.+||+.||++|||++|+++|
T Consensus       229 ---~~--~~~~~~s~---~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         229 ---DS--PYWDDISD---SAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ---CT--TTTTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ---CC--ccccCCCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence               00  01112222   35566779999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=396.40  Aligned_cols=241  Identities=22%  Similarity=0.300  Sum_probs=197.7

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      .+.+.||+|+||+||+|+. .+|+.||||++++..   ....+.+.+|++++++++||||+++++++.+.+..|+|||||
T Consensus        11 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~   90 (288)
T d1uu3a_          11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA   90 (288)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEcc
Confidence            3457899999999999996 479999999997431   224577999999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||+++++.+||+|||+|+.....
T Consensus        91 ~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~----~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          91 KNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGK----GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             TTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             CCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccc----cEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999987654     589999999999999999999998    9999999999999999999999999999876432


Q ss_pred             ------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcc
Q 036639          515 ------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEW  588 (670)
Q Consensus       515 ------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  588 (670)
                            ....||+.|+|||++.+..++.++||||+||++|||+||+.||...+              .............
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~~~~~~~i~~~~~  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------------EYLIFQKIIKLEY  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHTTCC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------------HHHHHHHHHcCCC
Confidence                  23468899999999999999999999999999999999999996431              1111222222211


Q ss_pred             ccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          589 TAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       589 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .   +.      ....+   .+.+++.+||+.||++|||++|++++
T Consensus       228 ~---~p------~~~s~---~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 D---FP------EKFFP---KARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             C---CC------TTCCH---HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             C---CC------ccCCH---HHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            1   11      11222   34567779999999999999998664

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=391.18  Aligned_cols=271  Identities=25%  Similarity=0.318  Sum_probs=202.6

Q ss_pred             HhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC----eeEEEEeccCC
Q 036639          361 AEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE----EKLLVYDYLPN  436 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~~~~  436 (670)
                      .+.||+|+||+||+|++ +|+.||||+++.... .....+.|+..+..++|||||++++++.+.+    ..++|||||++
T Consensus         8 ~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~   85 (303)
T d1vjya_           8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH   85 (303)
T ss_dssp             EEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence            35799999999999997 489999999975421 2222334455556789999999999998754    57899999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHh----CCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQE----YGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      |+|.++++..      .++|..+++++.|++.||+|+|+.    ++..+|+||||||+||||+.++.+||+|||+++...
T Consensus        86 g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~  159 (303)
T d1vjya_          86 GSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence            9999999865      489999999999999999999974    234599999999999999999999999999998763


Q ss_pred             cc--------ccccccCcccCccccccCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhH
Q 036639          513 PV--------QAIARLGGYKAPEQAEVKR------LSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPK  578 (670)
Q Consensus       513 ~~--------~~~~~~~~y~aPE~~~~~~------~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  578 (670)
                      ..        ....+|+.|+|||++.+..      ++.|+|||||||++|||+||..||.....................
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T d1vjya_         160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHH
Confidence            31        2345788999999987542      677999999999999999999888654433322222222222223


Q ss_pred             HHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          579 WVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       579 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      ...........    ++.+.......+....+.+++.+||+.||++|||+.||+++|+++..+++
T Consensus       240 ~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         240 EMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            33333222211    11111111223455668889999999999999999999999999986543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-48  Score=399.51  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=196.9

Q ss_pred             HHHhHcCCCCceEEEEEEEcC-C-----CEEEEEEeCCC-CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD-G-----GIVAVKRLKDA-NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      .+.+.||+|+||+||+|++.. +     ..||||++... .......+.+|+.++.++ +|||||++++++.+.+..++|
T Consensus        40 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv  119 (325)
T d1rjba_          40 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI  119 (325)
T ss_dssp             EEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEE
Confidence            456789999999999999542 2     36999998654 333456789999999998 899999999999999999999


Q ss_pred             EeccCCCChHHHhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCe
Q 036639          431 YDYLPNGSLHSLLHGNRGP------------------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNV  492 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NI  492 (670)
                      ||||++|+|.++++..+..                  ....+++..++.++.||++||+|||+.    +|+||||||+||
T Consensus       120 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~----~IiHRDlKp~Ni  195 (325)
T d1rjba_         120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK----SCVHRDLAARNV  195 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT----TEEETTCSGGGE
T ss_pred             EEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCchhcc
Confidence            9999999999999765321                  123589999999999999999999998    999999999999


Q ss_pred             EeCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCC
Q 036639          493 LLDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRP  565 (670)
Q Consensus       493 ll~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~  565 (670)
                      |++.++.+||+|||+|+......      ...+|+.|||||++.+..++.++|||||||++|||+| |+.||...+..  
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~--  273 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD--  273 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH--
Confidence            99999999999999998765422      2345778999999999999999999999999999998 89999654211  


Q ss_pred             CCcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 036639          566 RVDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIE  636 (670)
Q Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  636 (670)
                                  ..+...+......+       ......   ..+.+|+.+||+.||++|||++||+++|.
T Consensus       274 ------------~~~~~~~~~~~~~~-------~p~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 ------------ANFYKLIQNGFKMD-------QPFYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ------------HHHHHHHHTTCCCC-------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------------HHHHHHHhcCCCCC-------CCCcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                        11122222211110       011122   34566777999999999999999999996

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-48  Score=385.81  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=192.3

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEe-CCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA-KEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~-~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||.||+|+++ |+.||||++++..  ..+++.+|++++++++||||++++|+|.+ .+..++||||+++|+
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~   87 (262)
T d1byga_          11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS   87 (262)
T ss_dssp             EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEE
T ss_pred             EeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCC
Confidence            3577999999999999985 7899999997653  56789999999999999999999999865 456899999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-ccc
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-QAI  517 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~  517 (670)
                      |.+++....   ...++|..+++|+.||+.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        88 L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~----~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~  160 (262)
T d1byga_          88 LVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGN----NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG  160 (262)
T ss_dssp             HHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             HHHHHHhcC---CCCCCHHHHHHHHHHHHhhccccccC----ceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence            999997542   12489999999999999999999998    9999999999999999999999999999976543 334


Q ss_pred             cccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccccHh
Q 036639          518 ARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFDQE  596 (670)
Q Consensus       518 ~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  596 (670)
                      .++..|+|||++.+..+++++|||||||++|||+| |++||....           ..++...+    ......+.    
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-----------~~~~~~~i----~~~~~~~~----  221 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----------LKDVVPRV----EKGYKMDA----  221 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----------GGGHHHHH----TTTCCCCC----
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC-----------HHHHHHHH----HcCCCCCC----
Confidence            56778999999999999999999999999999999 677775431           11222221    11111110    


Q ss_pred             hhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          597 LLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       597 ~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                         .....   ..+.+++.+||+.||++||||.||+++|++++..
T Consensus       222 ---~~~~~---~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         222 ---PDGCP---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ---CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CccCC---HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence               01112   3455677799999999999999999999999754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=394.15  Aligned_cols=245  Identities=23%  Similarity=0.363  Sum_probs=198.7

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC------cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN------PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||+||+|+. .+|+.||||++++..      ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus        13 ~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (293)
T d1jksa_          13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL   92 (293)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4457899999999999996 579999999986432      224688999999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC----cEEEEeccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG----VACISDFGL  507 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFG~  507 (670)
                      |||++|+|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++    .+||+|||+
T Consensus        93 E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~----~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          93 ELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSL----QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhc----ceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999997653     589999999999999999999998    999999999999998877    499999999


Q ss_pred             ccccCcc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          508 SLLLNPV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       508 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ++.....   ....+++.|+|||++.+..++.++|||||||++|||+||+.||...+              ....+....
T Consensus       164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~~~~~~~i~  229 (293)
T d1jksa_         164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------------KQETLANVS  229 (293)
T ss_dssp             CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHH
T ss_pred             hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------------HHHHHHHHH
Confidence            9877543   33567788999999999999999999999999999999999997531              111111111


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .....   +....  .....   ..+.+++.+||+.||++|||++|+++|
T Consensus       230 ~~~~~---~~~~~--~~~~s---~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         230 AVNYE---FEDEY--FSNTS---ALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             TTCCC---CCHHH--HTTSC---HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hcCCC---CCchh--cCCCC---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11110   00000  01122   234567779999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.6e-47  Score=397.53  Aligned_cols=246  Identities=22%  Similarity=0.388  Sum_probs=201.9

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      ++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+..|+|||||++|
T Consensus        32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg  111 (352)
T d1koba_          32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG  111 (352)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence            3457899999999999995 579999999998776666778899999999999999999999999999999999999999


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeC--CCCcEEEEecccccccCcc-
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLD--KNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFG~a~~~~~~-  514 (670)
                      +|.+++....    ..+++..+..++.||+.||+|||+.    +|+||||||+||||+  .++.+||+|||+|+..... 
T Consensus       112 ~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~----~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         112 ELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEH----SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             BHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             hHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC----CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999876543    2589999999999999999999998    999999999999998  6789999999999987643 


Q ss_pred             --ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccc
Q 036639          515 --QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEV  592 (670)
Q Consensus       515 --~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  592 (670)
                        ....+++.|+|||++.+..++.++||||+||++|||+||+.||.+.+              ....+..........  
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------------~~~~~~~i~~~~~~~--  247 (352)
T d1koba_         184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------------DLETLQNVKRCDWEF--  247 (352)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------------HHHHHHHHHHCCCCC--
T ss_pred             ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCCCC--
Confidence              34567888999999999999999999999999999999999996531              111222222211110  


Q ss_pred             ccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          593 FDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       593 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                       ..  .......+   .+.+++.+||+.||++|||++|+++|
T Consensus       248 -~~--~~~~~~s~---~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 -DE--DAFSSVSP---EAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -CS--STTTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -Cc--ccccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence             00  00112222   34567779999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=385.82  Aligned_cols=249  Identities=24%  Similarity=0.359  Sum_probs=191.2

Q ss_pred             HHHhHcCCCCceEEEEEEEcC----CCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD----GGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.+.||+|+||+||+|.+..    +..||||+++... ....+.+.+|++++++++|||||++++++. .+..++||||
T Consensus        10 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~   88 (273)
T d1mp8a_          10 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL   88 (273)
T ss_dssp             EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             EEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEe
Confidence            345789999999999998642    4579999997543 334578999999999999999999999985 5678999999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|+|.+++....    ..+++..++.++.|+++||+|||+.    +|+||||||+||++++++.+||+|||+++....
T Consensus        89 ~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          89 CTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESK----RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             CTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             ccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhccc----CeeccccchhheeecCCCcEEEccchhheeccC
Confidence            99999999877543    2589999999999999999999998    999999999999999999999999999987653


Q ss_pred             c-----ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc
Q 036639          514 V-----QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE  587 (670)
Q Consensus       514 ~-----~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  587 (670)
                      .     ....+|+.|+|||++.+..++.++|||||||++|||+| |.+||...+.           ..+..   ......
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----------~~~~~---~i~~~~  226 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----------NDVIG---RIENGE  226 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----------GGHHH---HHHTTC
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----------HHHHH---HHHcCC
Confidence            2     23345678999999999999999999999999999998 8888865421           11111   111111


Q ss_pred             cccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          588 WTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       588 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      .. .       ......   ..+.+++.+||+.||++|||++||+++|+++..+
T Consensus       227 ~~-~-------~~~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         227 RL-P-------MPPNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CC-C-------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC-C-------CCCCCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            10 0       111222   3455677799999999999999999999998654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-47  Score=390.30  Aligned_cols=241  Identities=22%  Similarity=0.330  Sum_probs=200.0

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      ++.+.||+|+||+||+|+. .+|+.||||++++.   .....+.+.+|+.++++++|||||++++++.+.+..|+|||||
T Consensus         7 ~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~   86 (316)
T d1fota_           7 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI   86 (316)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeec
Confidence            3457899999999999996 57999999999743   1224578899999999999999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|..++....     .+++..+..++.|++.||+|||++    +|+||||||+|||++.++.+||+|||+|+.... 
T Consensus        87 ~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          87 EGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSK----DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             CCccccccccccc-----cccccHHHHHHHHHHHhhhhhccC----cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999998665     478889999999999999999998    999999999999999999999999999988754 


Q ss_pred             cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          514 VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                      .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+              ..............   +
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------------~~~~~~~i~~~~~~---~  220 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------------TMKTYEKILNAELR---F  220 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHHCCCC---C
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------------HHHHHHHHHcCCCC---C
Confidence            345678999999999999999999999999999999999999996531              11222222222111   0


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                            .....+   .+.+++.+||..||++|+     |++|+++|
T Consensus       221 ------p~~~s~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 ------PPFFNE---DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ------CTTSCH---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------CCCCCH---HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                  111222   345567799999999996     99999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-46  Score=386.20  Aligned_cols=251  Identities=23%  Similarity=0.387  Sum_probs=200.6

Q ss_pred             HHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCCc-chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDANP-CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||+||+|+++      +++.||||+++.... ...++|.+|++++++++||||++++++|.+.+..++|||
T Consensus        17 ~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e   96 (301)
T d1lufa_          17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFE   96 (301)
T ss_dssp             EEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEE
Confidence            3578999999999999964      357899999976533 345789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeE
Q 036639          433 YLPNGSLHSLLHGNRG-------------------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVL  493 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIl  493 (670)
                      |+++|+|.+++.....                   .....+++..++.++.|++.||+|||+.    +|+||||||+|||
T Consensus        97 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~----~ivHrDlKp~NIL  172 (301)
T d1lufa_          97 YMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER----KFVHRDLATRNCL  172 (301)
T ss_dssp             CCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEE
T ss_pred             ecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC----CeEeeEEcccceE
Confidence            9999999999974321                   1123589999999999999999999998    9999999999999


Q ss_pred             eCCCCcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCCC
Q 036639          494 LDKNGVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR-APSQYPSPTRPR  566 (670)
Q Consensus       494 l~~~~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~-~p~~~~~~~~~~  566 (670)
                      ||.++.+||+|||+++......      ...++..|+|||.+.+..++.++|||||||++|||++|. +||....     
T Consensus       173 ld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~-----  247 (301)
T d1lufa_         173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-----  247 (301)
T ss_dssp             ECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----
T ss_pred             ECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-----
Confidence            9999999999999998664322      234566799999999999999999999999999999996 5665431     


Q ss_pred             CcccccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhh
Q 036639          567 VDEEEQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIR  639 (670)
Q Consensus       567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  639 (670)
                               ..+......... ...       .....   ..++.+|+.+||+.||++||||.||+++|++|.
T Consensus       248 ---------~~e~~~~v~~~~-~~~-------~p~~~---~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 ---------HEEVIYYVRDGN-ILA-------CPENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             ---------HHHHHHHHHTTC-CCC-------CCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---------HHHHHHHHHcCC-CCC-------CCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                     111122211111 110       01111   234667888999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=383.40  Aligned_cols=249  Identities=24%  Similarity=0.369  Sum_probs=198.3

Q ss_pred             HhHcCCCCceEEEEEEEcCC----CEEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-CeeEEEEecc
Q 036639          361 AEMLGKGSLGTVYKAVLDDG----GIVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-EEKLLVYDYL  434 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-~~~~lv~e~~  434 (670)
                      .++||+|+||+||+|.+.++    ..||||+++.. +....++|.+|++++++++||||++++|++.+. +..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            35799999999999996432    36999999753 444568899999999999999999999998764 5789999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV  514 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~  514 (670)
                      ++|+|.++++...    ...++..+++++.|+++||.|+|+.    +|+||||||+|||+++++.+||+|||+++.....
T Consensus       112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~----~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASK----KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhccc----CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999988653    2578899999999999999999998    9999999999999999999999999999876432


Q ss_pred             c--------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          515 Q--------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       515 ~--------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      .        ...++..|+|||.+....++.++||||||+++|||+||+.||.....          ..++..++   ...
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----------~~~~~~~i---~~g  250 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----------TFDITVYL---LQG  250 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------------CHHHH---HTT
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----------HHHHHHHH---HcC
Confidence            2        23466789999999999999999999999999999998888754311          11111111   111


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      ....        ......   ..+.+++.+||+.||++||||.||+++|+++...
T Consensus       251 ~~~~--------~p~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         251 RRLL--------QPEYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCC--------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCC--------CcccCc---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            1100        001112   3456677899999999999999999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-46  Score=388.91  Aligned_cols=240  Identities=22%  Similarity=0.283  Sum_probs=198.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++++.   .....+.+.+|++++++++||||+++++++.+.+..|+|||||+
T Consensus         9 ~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~   88 (337)
T d1o6la_           9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYAN   88 (337)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccC
Confidence            457899999999999995 57999999999753   12245778899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc--
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP--  513 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~--  513 (670)
                      +|+|.+++....     .+++..+..++.|++.||+|||++    +|+||||||+|||++++|.+||+|||+|+....  
T Consensus        89 gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~----~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          89 GGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSR----DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             TCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             CCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhc----CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            999999998654     588999999999999999999998    999999999999999999999999999987643  


Q ss_pred             --cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccc
Q 036639          514 --VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAE  591 (670)
Q Consensus       514 --~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (670)
                        .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+              ..............  
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------------~~~~~~~i~~~~~~--  223 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------------HERLFELILMEEIR--  223 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC--
T ss_pred             cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------------HHHHHHHHhcCCCC--
Confidence              234678899999999999999999999999999999999999997541              11222222221110  


Q ss_pred             cccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          592 VFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       592 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                             .......   ++.+++.+||+.||++||+     ++|+++|
T Consensus       224 -------~p~~~s~---~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         224 -------FPRTLSP---EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------CCTTSCH---HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------CCccCCH---HHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                   0112223   3455677999999999994     8999885

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-46  Score=384.93  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=194.3

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCC----EEEEEEeCCC-CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGG----IVAVKRLKDA-NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      +.+.||+|+||+||+|.+. +|+    +||+|+++.. .....+++.+|++++++++|||||+++++|.+. ..++++||
T Consensus        13 ~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~   91 (317)
T d1xkka_          13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL   91 (317)
T ss_dssp             EEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEEC
T ss_pred             EeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEe
Confidence            3478999999999999954 444    6899998753 344678899999999999999999999999865 56788999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +.+|+|.+++....    ..+++..++.++.||++||+|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~----~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          92 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDR----RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             CTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             ccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHc----CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            99999999887643    2589999999999999999999998    999999999999999999999999999987643


Q ss_pred             cc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhhh
Q 036639          514 VQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKE  586 (670)
Q Consensus       514 ~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  586 (670)
                      ..      ...+|..|+|||++.+..++.++|||||||++|||+| |+.||...+.           ..+...+.   ..
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----------~~~~~~i~---~~  229 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----------SEISSILE---KG  229 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----------GGHHHHHH---HT
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----------HHHHHHHH---cC
Confidence            22      2346778999999999999999999999999999999 7888864311           11212111   11


Q ss_pred             ccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          587 EWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       587 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ...        ......   ...+.+++.+||+.||++|||+.||+++|+.+..
T Consensus       230 ~~~--------~~p~~~---~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         230 ERL--------PQPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CCC--------CCCTTB---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC--------CCCccc---CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            100        001111   2345667789999999999999999999998853

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.2e-46  Score=377.22  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=196.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC---cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC----eeEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN---PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE----EKLLVY  431 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~  431 (670)
                      +.+.||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|++++++++|||||++++++...+    ..|+||
T Consensus        11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvm   90 (277)
T d1o6ya_          11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVM   90 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEE
Confidence            357899999999999995 579999999997543   334567899999999999999999999998754    378999


Q ss_pred             eccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccccc
Q 036639          432 DYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLL  511 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~  511 (670)
                      ||+++++|.+++....     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++..+|+|||.+...
T Consensus        91 E~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~----~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          91 EYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQN----GIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             ECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             ECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CccCccccCcccccCccccceeehhhhhhhh
Confidence            9999999999987654     589999999999999999999998    9999999999999999999999999998765


Q ss_pred             Cc-------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          512 NP-------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       512 ~~-------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ..       .....||+.|+|||++.+..+++++|||||||++|||+||+.||...+              .........
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------------~~~~~~~~~  227 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------------PVSVAYQHV  227 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------------HHHHHHHHH
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------------HHHHHHHHH
Confidence            32       223467889999999999999999999999999999999999996531              112222222


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHhhh
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-TMAEVAKMIEDIR  639 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~  639 (670)
                      ......     .........+   .+.+++.+||+.||++|| |++++++.|.+++
T Consensus       228 ~~~~~~-----~~~~~~~~s~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         228 REDPIP-----PSARHEGLSA---DLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HCCCCC-----GGGTSSSCCH---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             hcCCCC-----CchhccCCCH---HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            221110     0011122233   345566799999999999 8999999998875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-46  Score=386.32  Aligned_cols=254  Identities=23%  Similarity=0.304  Sum_probs=189.3

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCC-eeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKE-EKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~-~~~l  429 (670)
                      .+.+.||+|+||+||+|.+.      +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++.+.+ ..++
T Consensus        16 ~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~i   95 (299)
T d1ywna1          16 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV   95 (299)
T ss_dssp             EEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred             EEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEE
Confidence            44678999999999999853      34689999997543 33456777888888777 6899999999987654 6799


Q ss_pred             EEeccCCCChHHHhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC
Q 036639          430 VYDYLPNGSLHSLLHGNRG-----------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG  498 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~  498 (670)
                      |||||++|+|.++++....           .....+++..++.++.||++||+|||+.    +|+||||||+||||++++
T Consensus        96 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~----~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          96 IVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR----KCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             EEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECGGG
T ss_pred             EEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC----CCcCCcCCccceeECCCC
Confidence            9999999999999975431           0123589999999999999999999998    999999999999999999


Q ss_pred             cEEEEecccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCCCCcccc
Q 036639          499 VACISDFGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR-APSQYPSPTRPRVDEEE  571 (670)
Q Consensus       499 ~~kl~DFG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~-~p~~~~~~~~~~~~~~~  571 (670)
                      .+||+|||+|+.....      ....+|+.|+|||++.+..++.++|||||||++|||+||. +||....          
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~----------  241 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK----------  241 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----------
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC----------
Confidence            9999999999865432      2345778899999999999999999999999999999975 5665331          


Q ss_pred             cccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          572 QAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       572 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                          ....+...+.........       ...   ..++.+++.+||+.||++|||++||+++|+++.+
T Consensus       242 ----~~~~~~~~~~~~~~~~~~-------~~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         242 ----IDEEFCRRLKEGTRMRAP-------DYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             ----CSHHHHHHHHHTCCCCCC-------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----HHHHHHHHHhcCCCCCCC-------ccC---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                111222222222111110       111   2245677889999999999999999999998864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-45  Score=379.01  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=199.1

Q ss_pred             HhHcCCCCceEEEEEEEc-CCC--EEEEEEeCCC-CcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGG--IVAVKRLKDA-NPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      .+.||+|+||+||+|.++ +|.  .||||+++.. .....+++.+|+++++++ +|||||+++++|.+.+..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            467999999999999965 444  5788888643 333566899999999998 79999999999999999999999999


Q ss_pred             CCChHHHhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEe
Q 036639          436 NGSLHSLLHGNR-----------GPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISD  504 (670)
Q Consensus       436 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~D  504 (670)
                      +|+|.++++...           ......+++..+..++.||++||.|||+.    +|+||||||+|||++.++.+||+|
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~----~iiHrDlkp~NIL~~~~~~~kl~D  170 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK----QFIHRDLAARNILVGENYVAKIAD  170 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECGGGCEEECC
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC----CccccccccceEEEcCCCceEEcc
Confidence            999999997542           11223689999999999999999999998    999999999999999999999999


Q ss_pred             cccccccCccc---cccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCC-CCCCCCCCCCCCcccccccchhHHH
Q 036639          505 FGLSLLLNPVQ---AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRA-PSQYPSPTRPRVDEEEQAVDLPKWV  580 (670)
Q Consensus       505 FG~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~  580 (670)
                      ||+++......   ...++..|+|||.+.+..++.++|||||||++|||++|.. ||...              ......
T Consensus       171 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------------~~~~~~  236 (309)
T d1fvra_         171 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------------TCAELY  236 (309)
T ss_dssp             TTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------------CHHHHH
T ss_pred             ccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------------CHHHHH
Confidence            99998765432   3456778999999999999999999999999999999765 56432              122222


Q ss_pred             HHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccCC
Q 036639          581 RSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQS  643 (670)
Q Consensus       581 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  643 (670)
                      ..... .....       ......+   .+.+++.+||+.||++||||+||+++|+++..+..
T Consensus       237 ~~i~~-~~~~~-------~~~~~~~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~  288 (309)
T d1fvra_         237 EKLPQ-GYRLE-------KPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  288 (309)
T ss_dssp             HHGGG-TCCCC-------CCTTBCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             HHHHh-cCCCC-------CCccCCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence            22221 11100       1112223   45567779999999999999999999999986554

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-46  Score=381.41  Aligned_cols=244  Identities=20%  Similarity=0.347  Sum_probs=198.8

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNGS  438 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g~  438 (670)
                      +.+.||+|+||+||+|... +|+.||||+++.... ....+.+|++++++++|||||++++++.+.+..|+|||||++|+
T Consensus         9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~   87 (321)
T d1tkia_           9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLD   87 (321)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence            4578999999999999964 689999999986543 45678899999999999999999999999999999999999999


Q ss_pred             hHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC--CcEEEEecccccccCcc--
Q 036639          439 LHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN--GVACISDFGLSLLLNPV--  514 (670)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFG~a~~~~~~--  514 (670)
                      |.+++....    ..+++..+..++.||+.||+|||+.    +|+||||||+|||++.+  ..+||+|||+++.....  
T Consensus        88 L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~----~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~  159 (321)
T d1tkia_          88 IFERINTSA----FELNEREIVSYVHQVCEALQFLHSH----NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN  159 (321)
T ss_dssp             HHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc----CCCcccccccceeecCCCceEEEEcccchhhccccCCc
Confidence            999997643    2589999999999999999999998    99999999999999854  47999999999877543  


Q ss_pred             -ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccccccc
Q 036639          515 -QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVF  593 (670)
Q Consensus       515 -~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  593 (670)
                       ....+++.|+|||...+..++.++||||+||++|||++|+.||...+              ....+.......+.   +
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------------~~~~~~~i~~~~~~---~  222 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------------NQQIIENIMNAEYT---F  222 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------------HHHHHHHHHHTCCC---C
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------------HHHHHHHHHhCCCC---C
Confidence             34567888999999999999999999999999999999999997541              11222222222111   1


Q ss_pred             cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          594 DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       594 d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      +...  +....+   ++.+++.+||..||++|||++|+++|
T Consensus       223 ~~~~--~~~~s~---~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         223 DEEA--FKEISI---EAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             CHHH--HTTSCH---HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Chhh--ccCCCH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111  111222   34567779999999999999999985

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.6e-46  Score=375.36  Aligned_cols=244  Identities=23%  Similarity=0.366  Sum_probs=195.8

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc---------chHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP---------CARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~  428 (670)
                      +.+.||+|+||+||+|+. .+|+.||||+++....         ...+.+.+|+.++++++ ||||+++++++.+++..|
T Consensus         7 ~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~   86 (277)
T d1phka_           7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFF   86 (277)
T ss_dssp             EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             EceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceE
Confidence            357899999999999996 5789999999975421         12346889999999997 999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +|||||++|+|.++++...     .+++..+..++.||++||+|||+.    +|+||||||+|||++.++.+||+|||++
T Consensus        87 ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          87 LVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKL----NIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             EEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc----CCcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999997643     589999999999999999999998    9999999999999999999999999999


Q ss_pred             cccCc---cccccccCcccCcccccc------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHH
Q 036639          509 LLLNP---VQAIARLGGYKAPEQAEV------KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       509 ~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +....   .....+|..|+|||.+.+      ..++.++||||+||++|||+||+.||...+              ....
T Consensus       158 ~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------------~~~~  223 (277)
T d1phka_         158 CQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------------QMLM  223 (277)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHH
T ss_pred             eEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--------------HHHH
Confidence            88754   234567888999998853      347889999999999999999999997531              1111


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...........     .........+   ++.+++.+||+.||++|||++||++|
T Consensus       224 ~~~i~~~~~~~-----~~~~~~~~s~---~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         224 LRMIMSGNYQF-----GSPEWDDYSD---TVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHHHTCCCC-----CTTTGGGSCH---HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhCCCCC-----CCcccccCCH---HHHHHHHHHccCChhHCcCHHHHHcC
Confidence            12222221110     0001112233   35556679999999999999999876

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-46  Score=387.39  Aligned_cols=240  Identities=18%  Similarity=0.218  Sum_probs=199.0

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++++.   .....+.+.+|+++++.++|||||++++++.+....++||||+.
T Consensus        45 i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~  124 (350)
T d1rdqe_          45 RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA  124 (350)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccc
Confidence            346899999999999996 47999999998643   12245678899999999999999999999999999999999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-c
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-V  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-~  514 (670)
                      +|+|.+++....     .+++..+..++.||+.||.|||+.    +||||||||+|||++.++.+||+|||+|+.... .
T Consensus       125 ~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~----~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         125 GGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSL----DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             TCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             ccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC----CEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            999999997654     589999999999999999999998    999999999999999999999999999988754 3


Q ss_pred             ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccccccc
Q 036639          515 QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTAEVFD  594 (670)
Q Consensus       515 ~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  594 (670)
                      ....||+.|||||++.+..++.++|||||||++|||+||+.||...              ...............     
T Consensus       196 ~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------------~~~~~~~~i~~~~~~-----  256 (350)
T d1rdqe_         196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------------QPIQIYEKIVSGKVR-----  256 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------------SHHHHHHHHHHCCCC-----
T ss_pred             ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc--------------CHHHHHHHHhcCCCC-----
Confidence            4567899999999999999999999999999999999999999653              111222222222110     


Q ss_pred             HhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          595 QELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       595 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                          ......+   .+.+++.+||+.||++|+     |++|+++|
T Consensus       257 ----~p~~~s~---~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         257 ----FPSHFSS---DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----CCTTCCH---HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----CCccCCH---HHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                0111222   355667799999999994     99999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=380.78  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             HHHhHcCCCCceEEEEEEEcC--------CCEEEEEEeCCCCc-chHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeE
Q 036639          359 ASAEMLGKGSLGTVYKAVLDD--------GGIVAVKRLKDANP-CARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKL  428 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~  428 (670)
                      .+.+.||+|+||.||+|+...        +..||||+++.... ....++.+|...+.++ +|||||+++++|.+++..+
T Consensus        16 ~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~   95 (299)
T d1fgka_          16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLY   95 (299)
T ss_dssp             EEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             EEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEE
Confidence            445789999999999998532        34799999976543 3457788899988888 8999999999999999999


Q ss_pred             EEEeccCCCChHHHhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          429 LVYDYLPNGSLHSLLHGNRGP-----------GRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      +||||+++|+|.+++......           ....+++..++.++.|++.||+|||+.    +|+||||||+|||++.+
T Consensus        96 ~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~----~ivHrDiKp~NiLl~~~  171 (299)
T d1fgka_          96 VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK----KCIHRDLAARNVLVTED  171 (299)
T ss_dssp             EEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEECTT
T ss_pred             EEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC----CEEeeeecccceeecCC
Confidence            999999999999999765321           123589999999999999999999998    99999999999999999


Q ss_pred             CcEEEEecccccccCccc------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCccc
Q 036639          498 GVACISDFGLSLLLNPVQ------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEE  570 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  570 (670)
                      +.+||+|||+++......      ...+++.|+|||.+.+..|++++|||||||++|||+| |.+||....         
T Consensus       172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---------  242 (299)
T d1fgka_         172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------  242 (299)
T ss_dssp             CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---------
T ss_pred             CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---------
Confidence            999999999998775422      2456677999999999999999999999999999998 677775431         


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                           ... +...+.......       ......   ..+.+++.+||+.||++||||.||++.|+++.+
T Consensus       243 -----~~~-~~~~i~~~~~~~-------~p~~~~---~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         243 -----VEE-LFKLLKEGHRMD-------KPSNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             -----HHH-HHHHHHTTCCCC-------CCSSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----HHH-HHHHHHcCCCCC-------CCccch---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                 111 111222211111       011122   245677889999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=372.49  Aligned_cols=245  Identities=26%  Similarity=0.369  Sum_probs=188.1

Q ss_pred             HhHcCCCCceEEEEEEEc--CC--CEEEEEEeCCC---CcchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVLD--DG--GIVAVKRLKDA---NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~  433 (670)
                      .+.||+|+||+||+|++.  ++  ..||||+++..   .....++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~   91 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL   91 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence            467999999999999853  23  37899998753   23345789999999999999999999999965 467899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +++|++.+++....    ..+++..++.++.|+++||.|||+.    +|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~----~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          92 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESK----RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             ecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhC----CEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999877543    2589999999999999999999998    999999999999999999999999999997744


Q ss_pred             cc-------cccccCcccCccccccCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCCCCCcccccccchhHHHHHHhh
Q 036639          514 VQ-------AIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLT-GRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVK  585 (670)
Q Consensus       514 ~~-------~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  585 (670)
                      ..       ...++..|+|||.+.+..++.++|||||||++|||+| |+.||...              .....+.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--------------~~~~~~~~i~~  229 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL--------------NGSQILHKIDK  229 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--------------CHHHHHHHHHT
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc--------------CHHHHHHHHHh
Confidence            22       2235567999999999999999999999999999998 89999643              12222222222


Q ss_pred             hccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhh
Q 036639          586 EEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDI  638 (670)
Q Consensus       586 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  638 (670)
                      ......       ......   ..+.+++.+||+.||++||||+||++.|++.
T Consensus       230 ~~~~~~-------~~~~~~---~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 EGERLP-------RPEDCP---QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             SCCCCC-------CCTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCC-------Cccccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            221111       111122   2455677799999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-45  Score=380.31  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=201.8

Q ss_pred             HHHhHcCCCCceEEEEEEE------cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhcc-CCCCeeeEEEEEEeCCeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL------DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKL-KHPNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~~~~~~lv  430 (670)
                      .+.+.||+|+||.||+|++      .+++.||||+++... .....++.+|+.+++++ +|||||++++++.+.+..++|
T Consensus        26 ~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lv  105 (311)
T d1t46a_          26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVI  105 (311)
T ss_dssp             EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEE
Confidence            4467899999999999985      246789999998643 34556789999999999 699999999999999999999


Q ss_pred             EeccCCCChHHHhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC
Q 036639          431 YDYLPNGSLHSLLHGNRG-------------PGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN  497 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~  497 (670)
                      ||||++|+|.++++....             .....+++..+..++.||++||+|||++    +|+||||||+||+++.+
T Consensus       106 mE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~----~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         106 TEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK----NCIHRDLAARNILLTHG  181 (311)
T ss_dssp             EECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCSGGGEEEETT
T ss_pred             EEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC----Ceeeccccccccccccc
Confidence            999999999999976432             1233589999999999999999999998    99999999999999999


Q ss_pred             CcEEEEecccccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCCCCCCCccc
Q 036639          498 GVACISDFGLSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAP-SQYPSPTRPRVDEE  570 (670)
Q Consensus       498 ~~~kl~DFG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p-~~~~~~~~~~~~~~  570 (670)
                      +.+|++|||.++.....      ....+++.|+|||++.+..++.++|||||||++|||+|++.| |.....        
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--------  253 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--------  253 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--------
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--------
Confidence            99999999999876542      224567789999999999999999999999999999995555 433211        


Q ss_pred             ccccchhHHHHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          571 EQAVDLPKWVRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       571 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                            ...+...+.......       .....   ...+.+|+.+||+.||++||||+||+++|+++..+
T Consensus       254 ------~~~~~~~i~~~~~~~-------~~~~~---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         254 ------DSKFYKMIKEGFRML-------SPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ------SHHHHHHHHHTCCCC-------CCTTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHHHHHHHhcCCCCC-------Ccccc---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence                  111122222211100       00111   23466778899999999999999999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-46  Score=381.57  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=203.0

Q ss_pred             HHHhHcCCCCceEEEEEEEc------CCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVLD------DGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVY  431 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~  431 (670)
                      .+.+.||+|+||+||+|.+.      +++.||||+++... ......|.+|++++++++|||||++++++...+..++||
T Consensus        23 ~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~  102 (308)
T d1p4oa_          23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM  102 (308)
T ss_dssp             EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEE
Confidence            34578999999999999863      35789999997543 334467899999999999999999999999999999999


Q ss_pred             eccCCCChHHHhccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecc
Q 036639          432 DYLPNGSLHSLLHGNR-----GPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFG  506 (670)
Q Consensus       432 e~~~~g~L~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG  506 (670)
                      ||+++|+|.+++....     ......+++..+.+++.|+++||.|||+.    +|+||||||+|||+|+++++||+|||
T Consensus       103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~----~ivHrDlk~~NiLld~~~~~Kl~DFG  178 (308)
T d1p4oa_         103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN----KFVHRDLAARNCMVAEDFTVKIGDFG  178 (308)
T ss_dssp             ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT----TCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred             eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC----CeeeceEcCCceeecCCceEEEeecc
Confidence            9999999999986421     11223578999999999999999999998    99999999999999999999999999


Q ss_pred             cccccCcc------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCCCCCcccccccchhHH
Q 036639          507 LSLLLNPV------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGR-APSQYPSPTRPRVDEEEQAVDLPKW  579 (670)
Q Consensus       507 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~  579 (670)
                      +++.....      ....+++.|+|||.+.+..++.++|||||||++|||+||+ .||...              .....
T Consensus       179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~--------------~~~~~  244 (308)
T d1p4oa_         179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--------------SNEQV  244 (308)
T ss_dssp             CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS--------------CHHHH
T ss_pred             cceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC--------------CHHHH
Confidence            99876542      2234677899999999999999999999999999999985 566432              22233


Q ss_pred             HHHHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhcc
Q 036639          580 VRSVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVE  641 (670)
Q Consensus       580 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  641 (670)
                      +.......... .       ....   ...+.+++.+||+.||++||||+||+++|++..+.
T Consensus       245 ~~~i~~~~~~~-~-------p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         245 LRFVMEGGLLD-K-------PDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             HHHHHTTCCCC-C-------CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             HHHHHhCCCCC-C-------cccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            33222222111 0       0111   23466778899999999999999999999887543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=380.83  Aligned_cols=243  Identities=18%  Similarity=0.263  Sum_probs=189.6

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhcc-CCCCeeeEEEEEEe----CCeeEEEEeccC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKL-KHPNVVKLRAYYYA----KEEKLLVYDYLP  435 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~nIv~l~~~~~~----~~~~~lv~e~~~  435 (670)
                      +.||+|+||+||+|+. .+|+.||||+++.     .+.+.+|++++.++ +|||||+++++|.+    ....|+|||||+
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~   92 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD   92 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCC
Confidence            5699999999999995 5799999999974     35677899887655 89999999999876    356899999999


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccccC
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLN  512 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~  512 (670)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.    +|+||||||+|||++.   ++.+||+|||+|+...
T Consensus        93 gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~----~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          93 GGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSI----NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             SEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             CCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHc----CCccccccccccccccccccccccccccceeeecc
Confidence            999999997642   23589999999999999999999998    9999999999999985   5679999999998765


Q ss_pred             cc---ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          513 PV---QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       513 ~~---~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      ..   ....+|+.|+|||++.+..|+.++|||||||++|||+||+.||..........           .+.....    
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~-----------~~~~~i~----  230 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMKTRIR----  230 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------CCC----
T ss_pred             CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH-----------HHHHHHh----
Confidence            42   34568889999999999999999999999999999999999997543221100           0000000    


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ...++...   .........+.+++.+||+.||++|||+.|+++|
T Consensus       231 ~~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         231 MGQYEFPN---PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             SCSSSCCT---THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCCCCCC---cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            00000000   0001112345667789999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-45  Score=385.65  Aligned_cols=243  Identities=21%  Similarity=0.278  Sum_probs=191.2

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCc---chHHHHH---HHHHHHhccCCCCeeeEEEEEEeCCeeEEEEe
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANP---CARKEFE---QYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~---~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.+.||+|+||+||+|+.. +|+.||||++.+...   .....+.   .++++++.++|||||++++++.+.+..|+|||
T Consensus         8 i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE   87 (364)
T d1omwa3           8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD   87 (364)
T ss_dssp             EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEE
Confidence            3578999999999999964 799999999864211   1223333   44677778889999999999999999999999


Q ss_pred             ccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccC
Q 036639          433 YLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLN  512 (670)
Q Consensus       433 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~  512 (670)
                      ||++|+|.+++....     .+++..+..++.||+.||+|||+.    +|+||||||+|||++.++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~----~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          88 LMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNR----FVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             CCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             ecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHC----CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999997654     588999999999999999999998    99999999999999999999999999998765


Q ss_pred             c--cccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhccc
Q 036639          513 P--VQAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWT  589 (670)
Q Consensus       513 ~--~~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (670)
                      .  .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......           ......+......  
T Consensus       159 ~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----------~~~~~~~~~~~~~--  225 (364)
T d1omwa3         159 KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----------DKHEIDRMTLTMA--  225 (364)
T ss_dssp             SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----------CHHHHHHHSSSCC--
T ss_pred             CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHhcccCC--
Confidence            4  334678999999999864 56899999999999999999999999754211           1111111111110  


Q ss_pred             cccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 036639          590 AEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPT-----MAEVAKM  634 (670)
Q Consensus       590 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  634 (670)
                             ........+   .+.+++.+||+.||++|||     ++|+++|
T Consensus       226 -------~~~~~~~s~---~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         226 -------VELPDSFSP---ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             -------CCCCSSSCH---HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             -------CCCCCCCCH---HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                   001112223   3455667999999999999     7899875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=376.98  Aligned_cols=250  Identities=25%  Similarity=0.338  Sum_probs=188.9

Q ss_pred             hHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcc-----hHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccC
Q 036639          362 EMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPC-----ARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLP  435 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~  435 (670)
                      ++||+|+||+||+|+. .+|+.||||+++.....     ..+.+.+|++++++++|||||++++++.+.+..|+||||++
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            5799999999999995 57999999999754321     12468899999999999999999999999999999999998


Q ss_pred             CCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCcc-
Q 036639          436 NGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPV-  514 (670)
Q Consensus       436 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~-  514 (670)
                      ++++..+.....     .+++..+..++.||+.||+|||+.    +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        84 ~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~----~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          84 TDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH----WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             EEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             chHHhhhhhccc-----CCCHHHHHHHHHHHHHHHHHhhcc----ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            887777665432     578889999999999999999998    9999999999999999999999999999876542 


Q ss_pred             ---ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh----hh
Q 036639          515 ---QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV----KE  586 (670)
Q Consensus       515 ---~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~  586 (670)
                         ....+|+.|+|||++... .++.++|||||||++|||+||+.||...+..           +....+....    .+
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~-----------~~l~~i~~~~~~~~~~  223 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-----------DQLTRIFETLGTPTEE  223 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----------HHHHHHHHHHCCCCTT
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH-----------HHHHHHHHhcCCCChh
Confidence               234578889999998654 5799999999999999999999999654211           0000011100    00


Q ss_pred             cccccc-------c----cHhh-hcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          587 EWTAEV-------F----DQEL-LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       587 ~~~~~~-------~----d~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      .+....       +    ...+ .......   ..+.+++.+||+.||++|||++|+++|
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAG---DDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCC---HHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccchhccchhhhhccCCCCChHHhcccCC---HHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000000       0    0000 0001111   346677789999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-46  Score=381.11  Aligned_cols=239  Identities=25%  Similarity=0.352  Sum_probs=192.7

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC---cchHHHHHHHHHHHh-ccCCCCeeeEEEEEEeCCeeEEEEecc
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN---PCARKEFEQYMDVIG-KLKHPNVVKLRAYYYAKEEKLLVYDYL  434 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~nIv~l~~~~~~~~~~~lv~e~~  434 (670)
                      +.+.||+|+||+||+|+.. +|+.||||++++..   ....+.+..|..++. .++|||||++++++.+++..|+|||||
T Consensus         6 i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~   85 (320)
T d1xjda_           6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYL   85 (320)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             EeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeec
Confidence            4578999999999999964 79999999997431   123455666776665 689999999999999999999999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc-
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP-  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~-  513 (670)
                      ++|+|.++++...     .+++..+..++.||+.||+|||++    +|+||||||+|||+++++.+||+|||+++.... 
T Consensus        86 ~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~----~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          86 NGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK----GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             TTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHT----TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             CCCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC----CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            9999999998654     488999999999999999999998    999999999999999999999999999986543 


Q ss_pred             ---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhcccc
Q 036639          514 ---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEEWTA  590 (670)
Q Consensus       514 ---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (670)
                         .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+              .............. 
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--------------~~~~~~~i~~~~~~-  221 (320)
T d1xjda_         157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------------EEELFHSIRMDNPF-  221 (320)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------------HHHHHHHHHHCCCC-
T ss_pred             cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--------------HHHHHHHHHcCCCC-
Confidence               233567888999999999999999999999999999999999997541              11111121111110 


Q ss_pred             ccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 036639          591 EVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMA-EVAK  633 (670)
Q Consensus       591 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  633 (670)
                        +      .....+   .+.+++.+||+.||++|||+. |+++
T Consensus       222 --~------p~~~s~---~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 --Y------PRWLEK---EAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --C------CTTSCH---HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --C------CccCCH---HHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              0      011222   355677799999999999995 7865

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=369.84  Aligned_cols=192  Identities=26%  Similarity=0.395  Sum_probs=162.8

Q ss_pred             HhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc--chHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          361 AEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP--CARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      .+.||+|+||+||+|+. .+|+.||||+++....  ...+.+.+|++++++++|||||++++++.+.+..|+||||+.+ 
T Consensus         7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-   85 (298)
T d1gz8a_           7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-   85 (298)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred             ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-
Confidence            46899999999999995 5799999999975432  2357889999999999999999999999999999999999965 


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      ++.+++....   ...+++..+..++.|++.||+|||+.    +||||||||+|||++.++.+||+|||.|+....    
T Consensus        86 ~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~----~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          86 DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSH----RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcC----CEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            4544443322   12589999999999999999999998    999999999999999999999999999987643    


Q ss_pred             cccccccCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 VQAIARLGGYKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....+++.|+|||.+.... ++.++||||+||++|||++|+.||...
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence            22346788899999876655 578999999999999999999999754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=372.48  Aligned_cols=235  Identities=22%  Similarity=0.379  Sum_probs=188.8

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCc------chHHHHHHHHHHHhccC--CCCeeeEEEEEEeCCeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANP------CARKEFEQYMDVIGKLK--HPNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.+.||+|+||+||+|+. .+|+.||||+++....      ....++.+|+.++++++  |||||++++++.+.+..++
T Consensus         7 ~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~l   86 (273)
T d1xwsa_           7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVL   86 (273)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEE
T ss_pred             EEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEE
Confidence            3457899999999999995 5799999999864311      12234678999999986  8999999999999999999


Q ss_pred             EEeccCC-CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCC-CcEEEEeccc
Q 036639          430 VYDYLPN-GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKN-GVACISDFGL  507 (670)
Q Consensus       430 v~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFG~  507 (670)
                      ||||+.+ +++.+++....     .+++..+..++.|+++||+|||+.    +|+||||||+|||++.+ +.+||+|||+
T Consensus        87 v~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~----~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          87 ILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNC----GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC----CCccccCcccceEEecCCCeEEECcccc
Confidence            9999976 67888887543     589999999999999999999998    99999999999999854 7999999999


Q ss_pred             ccccCcc--ccccccCcccCccccccCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          508 SLLLNPV--QAIARLGGYKAPEQAEVKRL-SQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       508 a~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      |+.....  ....||+.|+|||++.+..+ +.++||||+||++|||+||+.||....                    ...
T Consensus       158 a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------------~i~  217 (273)
T d1xwsa_         158 GALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------------EII  217 (273)
T ss_dssp             CEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------------HHH
T ss_pred             ceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------------------HHh
Confidence            9876442  34568899999999987765 577999999999999999999996420                    011


Q ss_pred             hhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          585 KEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       585 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ....   .+.      ....+   ++.+++.+||+.||++|||++|+++|
T Consensus       218 ~~~~---~~~------~~~s~---~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         218 RGQV---FFR------QRVSS---ECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             HCCC---CCS------SCCCH---HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hccc---CCC------CCCCH---HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1110   001      11223   34556679999999999999999885

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1e-43  Score=361.47  Aligned_cols=192  Identities=26%  Similarity=0.361  Sum_probs=166.6

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|+.++|+.||||+++...  ....+.+.+|+.++++++|||||++++++.+.+..++++||+.++
T Consensus         6 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~   85 (286)
T d1ob3a_           6 GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD   85 (286)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEE
T ss_pred             eccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhh
Confidence            346799999999999999999999999997543  223578999999999999999999999999999999999999887


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc----
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP----  513 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~----  513 (670)
                      .+..+.....     .+++..+..++.||+.||+|||+.    +|+||||||+|||++.++.+||+|||.+.....    
T Consensus        86 ~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~----~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~  156 (286)
T d1ob3a_          86 LKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR----RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK  156 (286)
T ss_dssp             HHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             hHHHHHhhcC-----CcchhhhHHHHHHHHHHHHHhccC----cEEecCCCCceeeEcCCCCEEecccccceecccCccc
Confidence            7777665443     599999999999999999999998    999999999999999999999999999987654    


Q ss_pred             cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .....+++.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence            2334577789999998654 5689999999999999999999999754

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-43  Score=359.64  Aligned_cols=258  Identities=23%  Similarity=0.327  Sum_probs=188.4

Q ss_pred             HHhHcCCCCceEEEEEEE-cC-CCEEEEEEeCCC--CcchHHHHHHHHHHHhcc---CCCCeeeEEEEEEe-----CCee
Q 036639          360 SAEMLGKGSLGTVYKAVL-DD-GGIVAVKRLKDA--NPCARKEFEQYMDVIGKL---KHPNVVKLRAYYYA-----KEEK  427 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~-g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~nIv~l~~~~~~-----~~~~  427 (670)
                      +.+.||+|+||+||+|+. ++ ++.||||+++..  .......+.+|+.+++.+   +||||++++++|..     ....
T Consensus        11 i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~   90 (305)
T d1blxa_          11 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL   90 (305)
T ss_dssp             EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred             EEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceE
Confidence            456899999999999996 34 667999998643  112233456777776665   79999999999864     2467


Q ss_pred             EEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccc
Q 036639          428 LLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGL  507 (670)
Q Consensus       428 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~  507 (670)
                      +++|||++++++........    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~----~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          91 TLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSH----RVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             EEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             EEEEEeccCCchhhhhhccC----CCCCHHHHHHHHHHHHHHHHHHHhC----CEEecCCCccEEEEcCCCCeeecchhh
Confidence            89999998877765544332    2588999999999999999999998    999999999999999999999999999


Q ss_pred             ccccCc---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHh
Q 036639          508 SLLLNP---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVV  584 (670)
Q Consensus       508 a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  584 (670)
                      ++....   .....||+.|+|||++.+..|+.++||||+||++|||+||+.||...+..          ..+........
T Consensus       163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~----------~~~~~i~~~~~  232 (305)
T d1blxa_         163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----------DQLGKILDVIG  232 (305)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----------HHHHHHHHHHC
T ss_pred             hhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH----------HHHHHHHHhhC
Confidence            987654   23567888999999999999999999999999999999999999754210          00000000000


Q ss_pred             ---hhccccccc-----------cHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhh
Q 036639          585 ---KEEWTAEVF-----------DQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDI  638 (670)
Q Consensus       585 ---~~~~~~~~~-----------d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i  638 (670)
                         ...+.....           .+.........+   .+.+++.+||+.||++|||++|+++|  ++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE---LGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH---HHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CCchhcccccccchhhhhccccccchhhccccCCH---HHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence               001100000           000000112222   34566779999999999999999986  4444

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-43  Score=365.08  Aligned_cols=192  Identities=24%  Similarity=0.301  Sum_probs=160.6

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCC--CcchHHHHHHHHHHHhccCCCCeeeEEEEEEe--------CCeeE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDA--NPCARKEFEQYMDVIGKLKHPNVVKLRAYYYA--------KEEKL  428 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~--------~~~~~  428 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++...  .....+++.+|++++++++||||+++++++..        .+..+
T Consensus        14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~   93 (318)
T d3blha1          14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY   93 (318)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred             EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence            346899999999999996 57999999998643  22345778899999999999999999999865        34679


Q ss_pred             EEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccc
Q 036639          429 LVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLS  508 (670)
Q Consensus       429 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a  508 (670)
                      +||||+.++.+..+.....     .++...+..++.|+++||.|||+.    +|+||||||+|||++.++.+||+|||++
T Consensus        94 iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~----~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          94 LVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN----KILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             EEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCCCccchhhhccc-----ccccHHHHHHHHHHHHHHHHhccC----CEEecCcCchheeecCCCcEEeeeccee
Confidence            9999998776665544332     588899999999999999999998    9999999999999999999999999999


Q ss_pred             cccCc--------cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          509 LLLNP--------VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       509 ~~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      +....        .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            76542        2234578889999998754 6899999999999999999999999653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=363.90  Aligned_cols=267  Identities=25%  Similarity=0.311  Sum_probs=187.8

Q ss_pred             HhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEEEEec
Q 036639          361 AEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLLVYDY  433 (670)
Q Consensus       361 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~lv~e~  433 (670)
                      .++||+|+||+||+|+.. +|+.||||+++....    ...+|++++++++||||++++++|...      .+.++||||
T Consensus        25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey  100 (350)
T d1q5ka_          25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY  100 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred             eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence            367999999999999964 799999999975432    234799999999999999999998653      246899999


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccC
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLN  512 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~  512 (670)
                      |+++.+..+.+...  ....+++..+..++.||+.||+|||+.    +|+||||||+|||++.++ .+||+|||+++...
T Consensus       101 ~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~----~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_         101 VPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSF----GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             CSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             cCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhc----CCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            97764444332111  122589999999999999999999988    999999999999999775 89999999998765


Q ss_pred             cc---ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccccc-ccchhHHHHHHhhhc
Q 036639          513 PV---QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQ-AVDLPKWVRSVVKEE  587 (670)
Q Consensus       513 ~~---~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  587 (670)
                      ..   ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+........... +.....++...... 
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~-  253 (350)
T d1q5ka_         175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN-  253 (350)
T ss_dssp             TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc-
Confidence            42   34567788999998764 56899999999999999999999999654211000000000 00000111111100 


Q ss_pred             cccccccH----hh--hcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhhcc
Q 036639          588 WTAEVFDQ----EL--LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIRVE  641 (670)
Q Consensus       588 ~~~~~~d~----~~--~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~  641 (670)
                      .....+..    ..  .......   .++.+++.+||+.||++|||++|+++|  +++++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s---~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTP---PEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSC---HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhhccccccccCchhhhcccCCC---HHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence            00000000    00  0001112   245667779999999999999999986  6666543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-42  Score=359.22  Aligned_cols=191  Identities=24%  Similarity=0.327  Sum_probs=160.3

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC-cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC----eeEEEEec
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN-PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE----EKLLVYDY  433 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~----~~~lv~e~  433 (670)
                      +.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++||||+++++++....    ..+++++|
T Consensus        12 ~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~   91 (345)
T d1pmea_          12 NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH   91 (345)
T ss_dssp             EEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE
T ss_pred             EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe
Confidence            457899999999999995 589999999997543 334578899999999999999999999997653    23455566


Q ss_pred             cCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCc
Q 036639          434 LPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNP  513 (670)
Q Consensus       434 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~  513 (670)
                      +.+|+|.+++...      .+++..+..++.|++.||+|||++    +|+||||||+|||++.++.+||+|||+++....
T Consensus        92 ~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~----~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          92 LMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSA----NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             CCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHC----CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            6799999999754      389999999999999999999998    999999999999999999999999999987643


Q ss_pred             c-------ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 V-------QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ~-------~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .       ....+++.|+|||.+.. ..++.++||||+||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence            2       23446778999999854 56789999999999999999999999654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-43  Score=367.33  Aligned_cols=266  Identities=21%  Similarity=0.280  Sum_probs=188.9

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCC------eeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKE------EKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~------~~~lv  430 (670)
                      +.+.||+|+||+||+|.. .+|+.||||+++...  ....+.+.+|++++++++|||||+++++|...+      +.|+|
T Consensus        22 ~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  101 (346)
T d1cm8a_          22 DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV  101 (346)
T ss_dssp             EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEE
Confidence            446899999999999995 479999999997542  234567889999999999999999999998654      56999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+ +.+|..+++..      .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+|++|||+++.
T Consensus       102 ~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~----~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_         102 MPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAA----GIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             EECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             Eecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCcchhhcccccccccccccceec
Confidence            9999 66888887654      489999999999999999999998    999999999999999999999999999988


Q ss_pred             cCcc-ccccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHHhhhc-
Q 036639          511 LNPV-QAIARLGGYKAPEQAEV-KRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSVVKEE-  587 (670)
Q Consensus       511 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  587 (670)
                      .... ....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+...............+.......... 
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             CCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             cCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence            7643 34567888999999875 45789999999999999999999999754211000000000000000000000000 


Q ss_pred             ---c---ccccccHhh-hcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHhhh
Q 036639          588 ---W---TAEVFDQEL-LRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM--IEDIR  639 (670)
Q Consensus       588 ---~---~~~~~d~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~  639 (670)
                         .   ......... .......   ..+.+++.+||..||++|||++|+++|  ++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s---~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNAS---PLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCC---HHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhccCCcccccchHHhccCCC---HHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence               0   000000000 0001112   235567779999999999999999997  66554

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-42  Score=352.45  Aligned_cols=252  Identities=17%  Similarity=0.193  Sum_probs=189.2

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCee-eEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNVV-KLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nIv-~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|+. .+|+.||||++....  ..+++..|+++++.++|+|++ .+.+++.+.+..++||||+ ++
T Consensus        11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~   87 (299)
T d1ckia_          11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP   87 (299)
T ss_dssp             EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence            457899999999999995 568999999987543  234678899999999876654 5556667788889999999 56


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC---CCcEEEEecccccccCcc
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK---NGVACISDFGLSLLLNPV  514 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFG~a~~~~~~  514 (670)
                      ++.+.+....    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.   +..+||+|||+|+.....
T Consensus        88 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~----~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          88 SLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSK----NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT----TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             chhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHC----CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            7766665432    2589999999999999999999998    9999999999999863   557999999999876432


Q ss_pred             -----------ccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHHH
Q 036639          515 -----------QAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRSV  583 (670)
Q Consensus       515 -----------~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  583 (670)
                                 ....+|+.|+|||.+.+..++.++|||||||++|||+||+.||.........       ..........
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-------~~~~~~~~~~  232 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-------QKYERISEKK  232 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------------HHHHHHHH
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-------HHHHHhhccc
Confidence                       2346788999999999999999999999999999999999999764222111       0111111110


Q ss_pred             hhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhc
Q 036639          584 VKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRV  640 (670)
Q Consensus       584 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  640 (670)
                      ...       .... ......   ..+.+++..||+.+|++||+++++.+.|+++..
T Consensus       233 ~~~-------~~~~-~~~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         233 MST-------PIEV-LCKGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             HHS-------CHHH-HTTTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCC-------ChhH-hccCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            000       0000 001122   345567779999999999999999999988754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=347.86  Aligned_cols=191  Identities=25%  Similarity=0.341  Sum_probs=167.7

Q ss_pred             HHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeCCeeEEEEeccCC
Q 036639          360 SAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAKEEKLLVYDYLPN  436 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~  436 (670)
                      +.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|+.+++.++||||+++++++.+....++|+|++.+
T Consensus         6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~   85 (292)
T d1unla_           6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ   85 (292)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSE
T ss_pred             eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccc
Confidence            347899999999999995 578999999986442  33567899999999999999999999999999999999999999


Q ss_pred             CChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccccCccc-
Q 036639          437 GSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLLLNPVQ-  515 (670)
Q Consensus       437 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  515 (670)
                      ++|..++...+     .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+||+|||.++...... 
T Consensus        86 ~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~----~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          86 DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR----NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             ccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcC----CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99988887654     588999999999999999999998    99999999999999999999999999998765432 


Q ss_pred             ---cccccCcccCccccccCC-CCCchhHHHHHHHHHHHHcCCCCCCC
Q 036639          516 ---AIARLGGYKAPEQAEVKR-LSQKADVYSFGVLLLEVLTGRAPSQY  559 (670)
Q Consensus       516 ---~~~~~~~y~aPE~~~~~~-~~~ksDVwS~Gvvl~elltg~~p~~~  559 (670)
                         ...++..|+|||.+.... ++.++||||+||++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence               234556699999987655 68999999999999999999999753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.2e-42  Score=355.39  Aligned_cols=187  Identities=21%  Similarity=0.321  Sum_probs=162.6

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeC--CeeEEEEecc
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAK--EEKLLVYDYL  434 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~--~~~~lv~e~~  434 (670)
                      ++.+.||+|+||+||+|+. .+|+.||||+++..   ..+++.+|++++++++ ||||+++++++...  ...++||||+
T Consensus        38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~  114 (328)
T d3bqca1          38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV  114 (328)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred             EEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeec
Confidence            4457899999999999996 57999999999765   3577899999999995 99999999999854  4689999999


Q ss_pred             CCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCC-cEEEEecccccccCc
Q 036639          435 PNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNG-VACISDFGLSLLLNP  513 (670)
Q Consensus       435 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFG~a~~~~~  513 (670)
                      ++++|..+.+        .+++..+..++.||+.||+|||++    +|+||||||+|||++.++ .+||+|||+|+....
T Consensus       115 ~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~----gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         115 NNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSM----GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             CSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHT----TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             CCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhc----ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            9999987642        488999999999999999999998    999999999999998655 699999999987754


Q ss_pred             c---ccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          514 V---QAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       514 ~---~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      .   ....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||...
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCC
Confidence            3   344567789999998765 4799999999999999999999999654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-41  Score=344.50  Aligned_cols=254  Identities=15%  Similarity=0.166  Sum_probs=196.8

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCCcchHHHHHHHHHHHhccCC-CCeeeEEEEEEeCCeeEEEEeccCCC
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDANPCARKEFEQYMDVIGKLKH-PNVVKLRAYYYAKEEKLLVYDYLPNG  437 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~lv~e~~~~g  437 (670)
                      +.+.||+|+||+||+|+.. +|+.||||+++...  ....+.+|+++++.++| +|++.+++++.+....++||||+ ++
T Consensus         9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~   85 (293)
T d1csna_           9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP   85 (293)
T ss_dssp             EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred             EEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence            4578999999999999954 78999999986543  23457788899998865 89999999999999999999999 78


Q ss_pred             ChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCC-----CCcEEEEecccccccC
Q 036639          438 SLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDK-----NGVACISDFGLSLLLN  512 (670)
Q Consensus       438 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFG~a~~~~  512 (670)
                      +|.++++...    ..+++..+..++.|++.||+|||+.    +|+||||||+|||++.     ++.+||+|||+|+...
T Consensus        86 ~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~----giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          86 SLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEK----SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             BHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTT----TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHC----CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            9999987643    2589999999999999999999998    9999999999999974     5789999999998754


Q ss_pred             c-----------cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHH
Q 036639          513 P-----------VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVR  581 (670)
Q Consensus       513 ~-----------~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  581 (670)
                      .           .....||+.|||||++.+..++.++|||||||++|||+||+.||......           .......
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~-----------~~~~~~~  226 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-----------TNKQKYE  226 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC-----------CHHHHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch-----------hHHHHHH
Confidence            2           12345889999999999999999999999999999999999999754211           1111111


Q ss_pred             HHhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHhhhccC
Q 036639          582 SVVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEVAKMIEDIRVEQ  642 (670)
Q Consensus       582 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  642 (670)
                      ........  .....+  .+...+   ++.+++..|++.+|++||+++.+.+.|+++....
T Consensus       227 ~i~~~~~~--~~~~~l--~~~~p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         227 RIGEKKQS--TPLREL--CAGFPE---EFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHH--SCHHHH--TTTSCH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHhccCC--CChHHh--cCCCCH---HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            11110000  000000  011222   3556667899999999999999999998876443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-42  Score=352.35  Aligned_cols=245  Identities=23%  Similarity=0.327  Sum_probs=191.7

Q ss_pred             HHHhHcCCCCceEEEEEEE----cCCCEEEEEEeCCCC----cchHHHHHHHHHHHhccCC-CCeeeEEEEEEeCCeeEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL----DDGGIVAVKRLKDAN----PCARKEFEQYMDVIGKLKH-PNVVKLRAYYYAKEEKLL  429 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~nIv~l~~~~~~~~~~~l  429 (670)
                      .+.+.||+|+||+||+|+.    .+|+.||||+++...    ....+.+.+|++++++++| |||+++++++.+....++
T Consensus        27 ~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~  106 (322)
T d1vzoa_          27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHL  106 (322)
T ss_dssp             EEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEE
T ss_pred             EEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceee
Confidence            4457899999999999984    258899999987432    2245678899999999976 899999999999999999


Q ss_pred             EEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          430 VYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       430 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      +|||+.+|+|.+++....     .+.......++.|++.||+|+|+.    +|+||||||+|||++.++.+||+|||+++
T Consensus       107 v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~----~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         107 ILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKL----GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcC----CEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999998664     467888999999999999999998    99999999999999999999999999998


Q ss_pred             ccCc-----cccccccCcccCccccccC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchhHHHHH
Q 036639          510 LLNP-----VQAIARLGGYKAPEQAEVK--RLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLPKWVRS  582 (670)
Q Consensus       510 ~~~~-----~~~~~~~~~y~aPE~~~~~--~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  582 (670)
                      ....     .....+++.|+|||.+.+.  .++.++|||||||++|||+||+.||.......          ........
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----------~~~~i~~~  247 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----------SQAEISRR  247 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----------CHHHHHHH
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----------HHHHHHHh
Confidence            7643     2235577789999998654  47889999999999999999999997653221          11111111


Q ss_pred             HhhhccccccccHhhhcccchHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 036639          583 VVKEEWTAEVFDQELLRYKNIEEELVSMLHVGLACVVSQPEKRP-----TMAEVAKM  634 (670)
Q Consensus       583 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  634 (670)
                      .......         ......   ..+.+++.+||..||++||     |++|+++|
T Consensus       248 ~~~~~~~---------~~~~~s---~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         248 ILKSEPP---------YPQEMS---ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHHCCCC---------CCTTSC---HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cccCCCC---------CcccCC---HHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            1111000         001122   3455567799999999999     58898864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=356.38  Aligned_cols=263  Identities=19%  Similarity=0.223  Sum_probs=184.4

Q ss_pred             HHhHcCCCCceEEEEEEEc-CCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC------CeeEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLD-DGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK------EEKLLV  430 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~------~~~~lv  430 (670)
                      +.+.||+|+||+||+|+.. +|+.||||+++...  ....+.+.+|+.++++++|||||+++++|...      .+.|+|
T Consensus        21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv  100 (355)
T d2b1pa1          21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV  100 (355)
T ss_dssp             EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred             EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence            3468999999999999965 79999999997542  33456788999999999999999999999643      578999


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      |||+.++ +.+.+..       .+++..+..++.|++.||+|||+.    +|+||||||+|||++.++.+|++|||+++.
T Consensus       101 ~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~----giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1         101 MELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSA----GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EeccchH-HHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhc----ccccccCCccccccccccceeeechhhhhc
Confidence            9999665 4444432       378999999999999999999998    999999999999999999999999999887


Q ss_pred             cCc---cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCccc--------ccccchhHH
Q 036639          511 LNP---VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEE--------EQAVDLPKW  579 (670)
Q Consensus       511 ~~~---~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~  579 (670)
                      ...   .....+|+.|+|||++.+..+++++||||+||++|||++|+.||...+.........        +........
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            654   234567888999999999999999999999999999999999996542110000000        000000011


Q ss_pred             HHHHhhhccccc------cccHhhhccc--chHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 036639          580 VRSVVKEEWTAE------VFDQELLRYK--NIEEELVSMLHVGLACVVSQPEKRPTMAEVAKM  634 (670)
Q Consensus       580 ~~~~~~~~~~~~------~~d~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  634 (670)
                      ............      .+........  ........+.+++.+||..||++||||+||++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            111111110000      0000000000  112234467788889999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-42  Score=358.89  Aligned_cols=192  Identities=25%  Similarity=0.322  Sum_probs=160.9

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCC--cchHHHHHHHHHHHhccCCCCeeeEEEEEEeC-----CeeEEE
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDAN--PCARKEFEQYMDVIGKLKHPNVVKLRAYYYAK-----EEKLLV  430 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~nIv~l~~~~~~~-----~~~~lv  430 (670)
                      ++.+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|++++++++|||||++++++...     ...+++
T Consensus        21 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i  100 (348)
T d2gfsa1          21 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL  100 (348)
T ss_dssp             EEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred             EEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEE
Confidence            3457899999999999995 579999999997543  33456788999999999999999999998643     234667


Q ss_pred             EeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          431 YDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       431 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      ++|+.+|+|.++++..      .+++..+..++.||+.||+|||+.    +|+||||||+|||++.++.+|++|||++..
T Consensus       101 ~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~----giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1         101 VTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSA----DIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             EEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT----TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             EEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhC----CCcccccCCccccccccccccccccchhcc
Confidence            7788899999999654      489999999999999999999998    999999999999999999999999999987


Q ss_pred             cCc-cccccccCcccCccccccC-CCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 036639          511 LNP-VQAIARLGGYKAPEQAEVK-RLSQKADVYSFGVLLLEVLTGRAPSQYP  560 (670)
Q Consensus       511 ~~~-~~~~~~~~~y~aPE~~~~~-~~~~ksDVwS~Gvvl~elltg~~p~~~~  560 (670)
                      ... .....++..|+|||...+. .++.++||||+||++|||++|+.||.+.
T Consensus       171 ~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         171 TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             CTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            654 3345567779999987655 4689999999999999999999999654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.8e-37  Score=324.97  Aligned_cols=266  Identities=17%  Similarity=0.190  Sum_probs=186.3

Q ss_pred             HHHhHcCCCCceEEEEEEE-cCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-----------CCCeeeEEEEEEeC--
Q 036639          359 ASAEMLGKGSLGTVYKAVL-DDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-----------HPNVVKLRAYYYAK--  424 (670)
Q Consensus       359 ~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~nIv~l~~~~~~~--  424 (670)
                      .+.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+++++.++           |+||+++++++...  
T Consensus        16 ~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~   94 (362)
T d1q8ya_          16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP   94 (362)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc
Confidence            4467899999999999996 579999999998653 24567788998888775           57899999988653  


Q ss_pred             CeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCc-----
Q 036639          425 EEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGV-----  499 (670)
Q Consensus       425 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~-----  499 (670)
                      ...+++++++..+..........  ....+++..+..++.|++.||+|||+.   .+|+||||||+|||++.++.     
T Consensus        95 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~---~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          95 NGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR---CGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             TEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             cceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhh---cCcccccCChhHeeeeccCcccccc
Confidence            45667777665544333222111  123578899999999999999999984   28999999999999987653     


Q ss_pred             -EEEEecccccccCc-cccccccCcccCccccccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCcccccccchh
Q 036639          500 -ACISDFGLSLLLNP-VQAIARLGGYKAPEQAEVKRLSQKADVYSFGVLLLEVLTGRAPSQYPSPTRPRVDEEEQAVDLP  577 (670)
Q Consensus       500 -~kl~DFG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~ksDVwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  577 (670)
                       +|++|||.+..... .....+++.|+|||++....++.++||||+||+++||++|+.||..........    ....+.
T Consensus       170 ~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~----~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK----DDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C----HHHHHH
T ss_pred             eeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc----hhHHHH
Confidence             99999999986654 344568888999999999999999999999999999999999997542211100    000011


Q ss_pred             HHHHHH-------h-hhcccccccc------------------HhhhcccchHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 036639          578 KWVRSV-------V-KEEWTAEVFD------------------QELLRYKNIEEELVSMLHVGLACVVSQPEKRPTMAEV  631 (670)
Q Consensus       578 ~~~~~~-------~-~~~~~~~~~d------------------~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  631 (670)
                      ..+...       . ........++                  ...............+.+++.+||+.||++||||+|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            110000       0 0000000000                  0001122334556678889999999999999999999


Q ss_pred             HHH
Q 036639          632 AKM  634 (670)
Q Consensus       632 l~~  634 (670)
                      ++|
T Consensus       326 L~H  328 (362)
T d1q8ya_         326 VNH  328 (362)
T ss_dssp             HTC
T ss_pred             hcC
Confidence            876

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=1.9e-31  Score=274.16  Aligned_cols=208  Identities=36%  Similarity=0.634  Sum_probs=167.9

Q ss_pred             CCCcchHHHHHHHHhccCCCCCCCCCCCCC-CCCCCCcceEEecCCC--CcEEEEEcCCCCcccc--CCC-CCCCCCccE
Q 036639           20 SSHPNDTDALTLFRLQTDTHGNLLSNWKGA-DACAAAWTGVVCSPKS--ERVVSLSLPSHSLRGP--IAP-LSLLDQLRF   93 (670)
Q Consensus        20 ~~~~~~~~~l~~~~~~~~~~~~~l~~W~~~-~~~~~~w~gv~C~~~~--~~v~~l~l~~~~l~~~--~~~-~~~l~~L~~   93 (670)
                      -|.++|++||+.||+++.+|. .+++|..+ |+|.|.|.||+|+..+  .||+.|+|++|+++|.  +|+ +++|++|++
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~   80 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF   80 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG-GGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred             CCCHHHHHHHHHHHHHCCCCC-cCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence            367899999999999997664 68899754 4444579999998754  4899999999999984  555 999999999


Q ss_pred             EEccC-CCCccccCC-CccccccceeeccCCccccc------------------------CCccccCCCCCCEEeCCCCc
Q 036639           94 LDLHD-NRLNGTILP-LTNCTNLKLAYLSGNDFSAE------------------------IPHQISSLKGILRLDLSDNN  147 (670)
Q Consensus        94 L~L~~-N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~------------------------~p~~~~~l~~L~~L~l~~N~  147 (670)
                      |+|++ |+|+|.+|+ |++|++|++|+|++|+|.+.                        +|..++++++|+.+++++|.
T Consensus        81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~  160 (313)
T d1ogqa_          81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR  160 (313)
T ss_dssp             EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence            99997 899988764 99999999998888776654                        44556667777777777777


Q ss_pred             ccccCCCC-----------------------------------------------------------------------C
Q 036639          148 IRGRIPEQ-----------------------------------------------------------------------V  156 (670)
Q Consensus       148 l~g~~p~~-----------------------------------------------------------------------~  156 (670)
                      ++|.+|..                                                                       +
T Consensus       161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~  240 (313)
T d1ogqa_         161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV  240 (313)
T ss_dssp             CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            76666542                                                                       2


Q ss_pred             cccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh-hhhcCcccccccCCCcCCCCCCCCC
Q 036639          157 TNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL-LKKFGEQSFIGNEGLCGSSPLPACS  229 (670)
Q Consensus       157 ~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~-~~~~~~~~~~~n~~~c~~~~~~~~~  229 (670)
                      ..+++|+.|+|++|+|+|.+|..++++++|++|+|++|+|+|.||..- +..+....+.+|+.+|| .|+|.|+
T Consensus       241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g-~plp~c~  313 (313)
T d1ogqa_         241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG-SPLPACT  313 (313)
T ss_dssp             CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES-TTSSCCC
T ss_pred             ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC-CCCCCCC
Confidence            345678889999999999999999999999999999999999999642 46777788899999999 6778874

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.87  E-value=1.7e-23  Score=197.91  Aligned_cols=163  Identities=17%  Similarity=0.152  Sum_probs=120.0

Q ss_pred             HHhHcCCCCceEEEEEEEcCCCEEEEEEeCCCCc------------------chHHHHHHHHHHHhccCCCCeeeEEEEE
Q 036639          360 SAEMLGKGSLGTVYKAVLDDGGIVAVKRLKDANP------------------CARKEFEQYMDVIGKLKHPNVVKLRAYY  421 (670)
Q Consensus       360 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~nIv~l~~~~  421 (670)
                      +++.||+|+||+||+|...+|+.||||+++....                  ........|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            4678999999999999988999999998753210                  0123445688889999999999987653


Q ss_pred             EeCCeeEEEEeccCCCChHHHhccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHhCCCCCccccCCCCCCeEeCCCCcEE
Q 036639          422 YAKEEKLLVYDYLPNGSLHSLLHGNRGPGRIPLDWTTRISLVLGAARGLARIHQEYGTAKVPHGNVKSSNVLLDKNGVAC  501 (670)
Q Consensus       422 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~~ivH~Dlkp~NIll~~~~~~k  501 (670)
                          ..+++|||+++..+.++            +......++.|++++|+|||+.    +|+||||||+|||++++ .++
T Consensus        84 ----~~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~----giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          84 ----GNAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHR----GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             ----TTEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHT----TEECSCCSTTSEEEETT-EEE
T ss_pred             ----CCEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhC----CEEEccCChhheeeeCC-CEE
Confidence                24799999987655432            2233567899999999999998    99999999999999865 489


Q ss_pred             EEecccccccCccccccccCcccCc------cccccCCCCCchhHHHHHHHHH
Q 036639          502 ISDFGLSLLLNPVQAIARLGGYKAP------EQAEVKRLSQKADVYSFGVLLL  548 (670)
Q Consensus       502 l~DFG~a~~~~~~~~~~~~~~y~aP------E~~~~~~~~~ksDVwS~Gvvl~  548 (670)
                      |+|||.|.........    .|...      |. ....|+.++||||..--++
T Consensus       143 liDFG~a~~~~~~~~~----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         143 IIDFPQSVEVGEEGWR----EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             ECCCTTCEETTSTTHH----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EEECCCcccCCCCCcH----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            9999999776432211    01110      11 1356788999999865443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=5.8e-19  Score=166.40  Aligned_cols=158  Identities=23%  Similarity=0.286  Sum_probs=127.6

Q ss_pred             CCCCCCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC--CCccccccceeeccCCccccc
Q 036639           50 DACAAAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL--PLTNCTNLKLAYLSGNDFSAE  127 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~g~  127 (670)
                      ..|.|+|..|.|+            +++|+..++.+.  +++++|+|++|+|++.++  .|.++++|+.|+|++|++.+.
T Consensus         4 ~~C~C~~~~v~Cs------------~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~   69 (192)
T d1w8aa_           4 AMCHCEGTTVDCT------------GRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI   69 (192)
T ss_dssp             TTSEEETTEEECT------------TSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB
T ss_pred             CCCEEcCCEEEEe------------CCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccc
Confidence            3455666666664            466665444443  689999999999987663  389999999999999999999


Q ss_pred             CCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh-hh
Q 036639          128 IPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL-LK  206 (670)
Q Consensus       128 ~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~-~~  206 (670)
                      .+..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+..+ ..
T Consensus        70 ~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~  149 (192)
T d1w8aa_          70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE  149 (192)
T ss_dssp             CTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHH
T ss_pred             cccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhh
Confidence            99999999999999999999998888899999999999999999998888899999999999999999986655333 23


Q ss_pred             hcCcccccccCCCcC
Q 036639          207 KFGEQSFIGNEGLCG  221 (670)
Q Consensus       207 ~~~~~~~~~n~~~c~  221 (670)
                      .+....+..|.-.|.
T Consensus       150 ~l~~~~l~~~~~~c~  164 (192)
T d1w8aa_         150 WLRKKSLNGGAARCG  164 (192)
T ss_dssp             HHHHHCCSGGGCBBC
T ss_pred             hhhhhcccCCCeEeC
Confidence            333334445555554

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=1.1e-18  Score=173.60  Aligned_cols=155  Identities=26%  Similarity=0.299  Sum_probs=114.5

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeC-
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL-  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l-  143 (670)
                      ..++.|+|++|.|++..+. |..+++|++|+|++|+|+.. +.++.+++|+.|+|++|++++ +|..+.++++|++|++ 
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECC
T ss_pred             cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-ccccccccccccccccccccc-ccccccccccccccccc
Confidence            3577788888888775544 77777778888877777643 345666777777777777663 3445555555555555 


Q ss_pred             -----------------------CCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCC
Q 036639          144 -----------------------SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRV  200 (670)
Q Consensus       144 -----------------------~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~i  200 (670)
                                             ++|.++...+..+..+++|+.|++++|+|++..+..+..+++|++|+|++|+|+ .|
T Consensus       109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l  187 (266)
T d1p9ag_         109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI  187 (266)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred             ccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence                                   455555444555677889999999999999888888999999999999999999 89


Q ss_pred             cchhhh--hcCcccccccCCCcCCC
Q 036639          201 PEGLLK--KFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       201 p~~~~~--~~~~~~~~~n~~~c~~~  223 (670)
                      |+.++.  .+....+.||||.|+|.
T Consensus       188 p~~~~~~~~L~~L~L~~Np~~CdC~  212 (266)
T d1p9ag_         188 PKGFFGSHLLPFAFLHGNPWLCNCE  212 (266)
T ss_dssp             CTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred             ChhHCCCCCCCEEEecCCCCCCCcc
Confidence            988754  44556779999999974

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.66  E-value=2.6e-17  Score=154.92  Aligned_cols=155  Identities=19%  Similarity=0.206  Sum_probs=128.7

Q ss_pred             CcEEEEEcCCCCccccCCC--CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEe
Q 036639           66 ERVVSLSLPSHSLRGPIAP--LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLD  142 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~  142 (670)
                      ..++.|+|++|.|++.++.  |..+++|+.|+|++|++.+.++. +..+++|+.|+|++|+|++..|..|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            4689999999999886654  78999999999999999988755 88999999999999999988888999999999999


Q ss_pred             CCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhhhcCcccccccCCCcCC
Q 036639          143 LSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLKKFGEQSFIGNEGLCGS  222 (670)
Q Consensus       143 l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~~~~~~~~~~n~~~c~~  222 (670)
                      |++|+|++..|..|..+++|++|+|++|.+....+..+ -...|+.+.+..|.++...|..+ .......+..|...|.+
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~~l-~~~~l~~L~~n~l~C~~  186 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKV-RDVQIKDLPHSEFKCSS  186 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTTT-TTSBGGGSCTTTCCCCC
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCChhh-cCCEeeecCHhhCcCCC
Confidence            99999998888899999999999999999986443221 12346667788888888888765 44555556666666754

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.66  E-value=1.8e-16  Score=157.31  Aligned_cols=140  Identities=26%  Similarity=0.289  Sum_probs=114.3

Q ss_pred             EecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCccccCCCCC
Q 036639           60 VCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGI  138 (670)
Q Consensus        60 ~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  138 (670)
                      .|+.. .....++.++++|+..++.+.  +.|++|||++|+|++..+ .|.++++|+.|+|++|+|+. +| .++.+++|
T Consensus         5 ~~~~~-~~~~~v~C~~~~L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L   79 (266)
T d1p9ag_           5 EVSKV-ASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVL   79 (266)
T ss_dssp             EEECS-TTCCEEECTTSCCSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTC
T ss_pred             EEccc-CCCeEEEccCCCCCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccc
Confidence            45543 334556888888887544453  689999999999998775 49999999999999999984 55 46889999


Q ss_pred             CEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh
Q 036639          139 LRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK  206 (670)
Q Consensus       139 ~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~  206 (670)
                      ++|+|++|+|+ .+|..+.++++|+.|++++|++.+..+..+..+.+|..|++++|.++ .+|...+.
T Consensus        80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~-~l~~~~~~  145 (266)
T d1p9ag_          80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLT  145 (266)
T ss_dssp             CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTT
T ss_pred             ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccc-eecccccc
Confidence            99999999999 56788999999999999999999777777888899999999999988 55554434

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.65  E-value=5.1e-16  Score=157.20  Aligned_cols=153  Identities=24%  Similarity=0.328  Sum_probs=104.7

Q ss_pred             CCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-Cccccccceee
Q 036639           50 DACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAY  118 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~  118 (670)
                      -.|.|.|++|.|+..         ...++.|+|++|+++...+. |..+++|++|++++|.+....+. |.++++|+.|+
T Consensus         6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~   85 (305)
T d1xkua_           6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY   85 (305)
T ss_dssp             TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence            457789999999753         24688999999999987764 88999999999999999877554 88888888888


Q ss_pred             ccCCcccccCCc------------------------------------------------cccCC---------------
Q 036639          119 LSGNDFSAEIPH------------------------------------------------QISSL---------------  135 (670)
Q Consensus       119 l~~N~l~g~~p~------------------------------------------------~~~~l---------------  135 (670)
                      |++|+++. +|.                                                .+..+               
T Consensus        86 l~~n~l~~-l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~  164 (305)
T d1xkua_          86 LSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  164 (305)
T ss_dssp             CCSSCCSB-CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             ccCCccCc-CccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence            88877652 221                                                11112               


Q ss_pred             ------CCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh
Q 036639          136 ------KGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL  204 (670)
Q Consensus       136 ------~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~  204 (670)
                            ++|+.|++++|.+++.++..+.+++.++.|++++|++++..|..+..+++|++|+|++|+|+ .||..+
T Consensus       165 l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l  238 (305)
T d1xkua_         165 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL  238 (305)
T ss_dssp             CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTT
T ss_pred             cCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccc
Confidence                  23444444444444455555666666666666666666666666666666666666666666 556544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=4.4e-16  Score=156.05  Aligned_cols=148  Identities=23%  Similarity=0.211  Sum_probs=126.9

Q ss_pred             CCccccCCC-CCCCCCccEEEccCCCCccccC-CCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCC
Q 036639           76 HSLRGPIAP-LSLLDQLRFLDLHDNRLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIP  153 (670)
Q Consensus        76 ~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p  153 (670)
                      +.++...+. +..+++|++|+|++|.+..... .+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..|
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~  170 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE  170 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred             cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence            334443333 7889999999999999987664 48889999999999999998777889999999999999999998888


Q ss_pred             CCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchh--hhhcCcccccccCCCcCCC
Q 036639          154 EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGL--LKKFGEQSFIGNEGLCGSS  223 (670)
Q Consensus       154 ~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~--~~~~~~~~~~~n~~~c~~~  223 (670)
                      ..|.++++|+.|++++|++++..|..|..+++|++|++++|++++..|..+  ...+....+.+|++.|+|.
T Consensus       171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            999999999999999999999999999999999999999999997666554  2345566778999999864

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=2.5e-15  Score=150.38  Aligned_cols=136  Identities=26%  Similarity=0.311  Sum_probs=125.8

Q ss_pred             CcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           66 ERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      .++..|+|++|.+....+. +..+.+|+.+++++|+|++.++. |..+++|+.|+|++|+|++..|..|.++++|++|++
T Consensus       105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l  184 (284)
T d1ozna_         105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL  184 (284)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence            4789999999999876555 88899999999999999987654 889999999999999999988999999999999999


Q ss_pred             CCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      ++|++++..|..|.++++|++|++++|++++..|..+..+++|++|+|++|.+.+.-+
T Consensus       185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            9999999999999999999999999999998888889999999999999999997655

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=3.7e-15  Score=128.81  Aligned_cols=103  Identities=30%  Similarity=0.318  Sum_probs=82.7

Q ss_pred             cEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccc
Q 036639           92 RFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNE  171 (670)
Q Consensus        92 ~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  171 (670)
                      |.|||++|+|+.. +.+.++++|++|+|++|.|+ .+|+.++.+++|+.|++++|.|++ +| .+.++++|+.|++++|+
T Consensus         1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCCCC-cccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence            5788888888744 56888888888899988887 577788888889999999998884 44 48888889999999998


Q ss_pred             ccccCC-CCcCCCCCCCEEEccCCCCcC
Q 036639          172 LTGRIP-DLSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       172 l~g~~p-~~~~~l~~L~~l~l~~N~l~g  198 (670)
                      |+.... ..+..+++|++|++++|+++.
T Consensus        77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             cCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            884322 357788889999999998873

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.54  E-value=1.5e-15  Score=154.30  Aligned_cols=118  Identities=29%  Similarity=0.497  Sum_probs=110.5

Q ss_pred             CCccEEEccCCCCccc--c-CCCccccccceeeccC-CcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccc
Q 036639           89 DQLRFLDLHDNRLNGT--I-LPLTNCTNLKLAYLSG-NDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT  164 (670)
Q Consensus        89 ~~L~~L~L~~N~l~~~--~-~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  164 (670)
                      .+++.|||++|+++|.  + +.+++|++|++|+|++ |+|+|.+|.+|++|++|++|+|++|+|++..|..+.++.+|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            4789999999999984  3 4599999999999997 8999999999999999999999999999999999999999999


Q ss_pred             eecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh
Q 036639          165 LRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK  206 (670)
Q Consensus       165 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~  206 (670)
                      +++++|++.+.+|..+..++.|+.+++++|.++|.+|..+..
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~  171 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS  171 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGC
T ss_pred             cccccccccccCchhhccCcccceeecccccccccccccccc
Confidence            999999999999999999999999999999999999987743

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=9e-15  Score=126.34  Aligned_cols=117  Identities=24%  Similarity=0.310  Sum_probs=97.6

Q ss_pred             EEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCccc
Q 036639           70 SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIR  149 (670)
Q Consensus        70 ~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  149 (670)
                      .|+|++|+++. ++.+..+++|++|||++|+|+..++.++.+++|+.|++++|.|++ +| .++++++|+.|++++|+|+
T Consensus         2 ~L~Ls~n~l~~-l~~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~   78 (124)
T d1dcea3           2 VLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ   78 (124)
T ss_dssp             EEECTTSCCSS-CCCGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCC
T ss_pred             EEEcCCCCCCC-CcccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccC
Confidence            58999999985 567999999999999999999876679999999999999999995 55 5999999999999999999


Q ss_pred             ccC-CCCCcccccccceecccccccccC--CC-CcCCCCCCCEE
Q 036639          150 GRI-PEQVTNLTRLLTLRLQNNELTGRI--PD-LSSSLKDLKEL  189 (670)
Q Consensus       150 g~~-p~~~~~l~~L~~L~l~~N~l~g~~--p~-~~~~l~~L~~l  189 (670)
                      ... +..+..+++|+.|+|++|+++...  +. ....+++|+.|
T Consensus        79 ~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          79 QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            543 256899999999999999998432  12 23446777665

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.47  E-value=2e-14  Score=130.53  Aligned_cols=110  Identities=22%  Similarity=0.150  Sum_probs=54.8

Q ss_pred             CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccc
Q 036639           85 LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT  164 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  164 (670)
                      +.+..+|+.|||++|+|+....-+..+++|+.|||++|+++. ++ .|..+++|++|+|++|+|+...+..+..+++|+.
T Consensus        14 ~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             EECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             ccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence            344445555555555555442223445555555555555552 32 3555555555555555555332233344555555


Q ss_pred             eecccccccccCC--CCcCCCCCCCEEEccCCCCc
Q 036639          165 LRLQNNELTGRIP--DLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       165 L~l~~N~l~g~~p--~~~~~l~~L~~l~l~~N~l~  197 (670)
                      |+|++|+|+. ++  ..+..+++|++|++++|.++
T Consensus        92 L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          92 LILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             EECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ceeccccccc-cccccccccccccchhhcCCCccc
Confidence            5555555542 22  23445555555555555554

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.43  E-value=5.6e-14  Score=127.46  Aligned_cols=124  Identities=18%  Similarity=0.164  Sum_probs=104.6

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .++..|+|++|+++.....+..+++|+.|||++|+|+.. +.+..+++|+.|+|++|+++...+..+..+++|+.|+|++
T Consensus        18 ~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~   96 (162)
T d1a9na_          18 VRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN   96 (162)
T ss_dssp             TSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred             CcCcEEECCCCCCCccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceecc
Confidence            467899999999988633257899999999999999865 6799999999999999999976666677899999999999


Q ss_pred             CcccccCC--CCCcccccccceecccccccccCCC----CcCCCCCCCEEEcc
Q 036639          146 NNIRGRIP--EQVTNLTRLLTLRLQNNELTGRIPD----LSSSLKDLKELNLS  192 (670)
Q Consensus       146 N~l~g~~p--~~~~~l~~L~~L~l~~N~l~g~~p~----~~~~l~~L~~l~l~  192 (670)
                      |+|+. ++  ..+..+++|++|++++|.++ ..|.    .+..+++|++||-.
T Consensus        97 N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~~  147 (162)
T d1a9na_          97 NSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQ  147 (162)
T ss_dssp             CCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTE
T ss_pred             ccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCCC
Confidence            99984 44  46889999999999999998 4554    46778999998743

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.42  E-value=3.2e-13  Score=127.15  Aligned_cols=122  Identities=28%  Similarity=0.440  Sum_probs=53.8

Q ss_pred             EEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCc
Q 036639           68 VVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNN  147 (670)
Q Consensus        68 v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~  147 (670)
                      ++.|++++|++.. ++.+..+++|++|+|++|+|++.. +++++++|+.|++++|.+.. +| .+.++++|+.|++++|.
T Consensus        42 l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~-~l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~  117 (199)
T d2omxa2          42 VTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQ  117 (199)
T ss_dssp             CCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSC
T ss_pred             CCEEECCCCCCCC-ccccccCCCcCcCccccccccCcc-cccCCccccccccccccccc-cc-ccccccccccccccccc
Confidence            4444444444442 233444445555555555444332 24444455555555544442 22 24444444444444444


Q ss_pred             ccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          148 IRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       148 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      +...  ..+.++++|+.|++++|++. .+| .+..+++|+.|++++|+++
T Consensus       118 ~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2         118 ITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             CCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCC
T ss_pred             cccc--cccchhhhhHHhhhhhhhhc-ccc-ccccccccccccccccccc
Confidence            4421  12344444444444444443 122 2334444444444444444

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.39  E-value=3.2e-13  Score=131.30  Aligned_cols=100  Identities=17%  Similarity=0.248  Sum_probs=76.1

Q ss_pred             CCCCCCcceEEecCC---------CCcEEEEEcCCCCccccCCC-CCCCCCccEEEccCCCCccccCC--Ccccccccee
Q 036639           50 DACAAAWTGVVCSPK---------SERVVSLSLPSHSLRGPIAP-LSLLDQLRFLDLHDNRLNGTILP--LTNCTNLKLA  117 (670)
Q Consensus        50 ~~~~~~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~--~~~l~~L~~L  117 (670)
                      -.|.|+...|.|...         ...++.|+|++|.++...+. |..+++|++|+|++|.+...++.  |.++++++.|
T Consensus         4 ~~C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l   83 (242)
T d1xwdc1           4 RICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI   83 (242)
T ss_dssp             SSEEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEE
T ss_pred             CcCCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccc
Confidence            357789999999743         13689999999999886654 89999999999999998775533  6677777777


Q ss_pred             ecc-CCcccccCCccccCCCCCCEEeCCCCccc
Q 036639          118 YLS-GNDFSAEIPHQISSLKGILRLDLSDNNIR  149 (670)
Q Consensus       118 ~l~-~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  149 (670)
                      ++. .|++....+..|.++++|+.|++++|++.
T Consensus        84 ~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~  116 (242)
T d1xwdc1          84 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK  116 (242)
T ss_dssp             EEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred             cccccccccccccccccccccccccccchhhhc
Confidence            654 45666666666777777777777777665

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.39  E-value=4.5e-13  Score=126.13  Aligned_cols=127  Identities=26%  Similarity=0.399  Sum_probs=110.5

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .+++.|+|++|.+++.. +++.+++|++|++++|.+... +.+.++++|+.|++++|.+...  ..+..+++|+.|++++
T Consensus        62 ~nL~~L~Ls~N~l~~~~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~  137 (199)
T d2omxa2          62 NNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADI-TPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSS  137 (199)
T ss_dssp             TTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCS
T ss_pred             CCcCcCccccccccCcc-cccCCcccccccccccccccc-cccccccccccccccccccccc--cccchhhhhHHhhhhh
Confidence            57999999999999854 599999999999999998764 4689999999999999999853  3588999999999999


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      |++.. +| .+..+++|+.|++++|++++. + .+.++++|+.|++++|+++ .+|
T Consensus       138 n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~i~-~i~  188 (199)
T d2omxa2         138 NTISD-IS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNKVS-DIS  188 (199)
T ss_dssp             SCCCC-CG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCC-CCG
T ss_pred             hhhcc-cc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCCCC-CCc
Confidence            99983 43 688999999999999999964 3 3788999999999999998 455

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.39  E-value=4.5e-13  Score=127.24  Aligned_cols=127  Identities=30%  Similarity=0.402  Sum_probs=85.5

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .+++.|+|++|.+++ +++++.+++|++|+|++|+|++. +.+.++++|+.|++++|.+.. + ..+.++++|+.+++++
T Consensus        68 ~~L~~L~L~~n~i~~-l~~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~  143 (210)
T d1h6ta2          68 PNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGN  143 (210)
T ss_dssp             TTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCS
T ss_pred             CCCCEEeCCCccccC-ccccccCcccccccccccccccc-ccccccccccccccccccccc-c-cccccccccccccccc
Confidence            356777777777766 33466777777777777777653 356677777777777777652 2 3466777777777777


Q ss_pred             CcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          146 NNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       146 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                      |.+++  +..+.++++|+.+++++|++++ ++. +.++++|+.|+|++|+++ .+|
T Consensus       144 n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~~-l~~l~~L~~L~Ls~N~i~-~l~  194 (210)
T d1h6ta2         144 NKITD--ITVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHIS-DLR  194 (210)
T ss_dssp             SCCCC--CGGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-BCG
T ss_pred             ccccc--cccccccccccccccccccccc-ccc-ccCCCCCCEEECCCCCCC-CCh
Confidence            77763  2346667777777777777774 332 666777777777777776 455

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.36  E-value=1.8e-12  Score=130.57  Aligned_cols=151  Identities=19%  Similarity=0.241  Sum_probs=121.1

Q ss_pred             cEEEEEcCCCCccccC--CC-CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeC
Q 036639           67 RVVSLSLPSHSLRGPI--AP-LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDL  143 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~--~~-~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l  143 (670)
                      ....++...|......  .. +..+++|+.+++++|+++....  ..+++|+.|++++|..++..+..|.+++.+++|++
T Consensus       125 ~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~--~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~  202 (305)
T d1xkua_         125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL  202 (305)
T ss_dssp             TCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS--SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEEC
T ss_pred             cccccccccccccccCCCccccccccccCccccccCCccccCc--ccCCccCEEECCCCcCCCCChhHhhcccccccccc
Confidence            4556777766544332  22 7778999999999999876433  23688999999999999999999999999999999


Q ss_pred             CCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcchhhh---------hcCccccc
Q 036639          144 SDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPEGLLK---------KFGEQSFI  214 (670)
Q Consensus       144 ~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~~~~~---------~~~~~~~~  214 (670)
                      ++|.+++..|..+.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .|+...+.         .+....+.
T Consensus       203 s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~  280 (305)
T d1xkua_         203 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLF  280 (305)
T ss_dssp             CSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred             ccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhccCcchhcccCCCCEEECC
Confidence            999999888889999999999999999998 67888999999999999999998 66654332         23345567


Q ss_pred             ccCCCcC
Q 036639          215 GNEGLCG  221 (670)
Q Consensus       215 ~n~~~c~  221 (670)
                      +|++.+.
T Consensus       281 ~N~~~~~  287 (305)
T d1xkua_         281 SNPVQYW  287 (305)
T ss_dssp             SSSSCGG
T ss_pred             CCcCccC
Confidence            8888664

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.36  E-value=1.5e-12  Score=116.93  Aligned_cols=89  Identities=24%  Similarity=0.254  Sum_probs=50.2

Q ss_pred             CccccccceeeccCC-cccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCC
Q 036639          108 LTNCTNLKLAYLSGN-DFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDL  186 (670)
Q Consensus       108 ~~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L  186 (670)
                      +..+++|+.|+|++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+ .+|.......+|
T Consensus        27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l  105 (156)
T d2ifga3          27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSL  105 (156)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCC
T ss_pred             ccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhccccc
Confidence            334444555555433 254444455666666666666666666555555666666666666666666 333332223357


Q ss_pred             CEEEccCCCCc
Q 036639          187 KELNLSNNELY  197 (670)
Q Consensus       187 ~~l~l~~N~l~  197 (670)
                      +.|+|++|.|.
T Consensus       106 ~~L~L~~Np~~  116 (156)
T d2ifga3         106 QELVLSGNPLH  116 (156)
T ss_dssp             CEEECCSSCCC
T ss_pred             cccccCCCccc
Confidence            77777777764

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=1.9e-12  Score=116.41  Aligned_cols=107  Identities=19%  Similarity=0.199  Sum_probs=86.4

Q ss_pred             CCcceEEecCCCCcEEEEEcCCCCccccCCCCCCCCCccEEEccCC-CCccccC-CCccccccceeeccCCcccccCCcc
Q 036639           54 AAWTGVVCSPKSERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDN-RLNGTIL-PLTNCTNLKLAYLSGNDFSAEIPHQ  131 (670)
Q Consensus        54 ~~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N-~l~~~~~-~~~~l~~L~~L~l~~N~l~g~~p~~  131 (670)
                      +.+.+|+|..            +++...+..+..+++|+.|+|++| .|+...+ .|.++++|+.|+|++|+|+...|..
T Consensus         8 ~~~~~l~c~~------------~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~   75 (156)
T d2ifga3           8 HGSSGLRCTR------------DGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA   75 (156)
T ss_dssp             SSSSCEECCS------------SCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTG
T ss_pred             CCCCeEEecC------------CCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccc
Confidence            3466777754            455555555788899999999876 4877654 4999999999999999999888888


Q ss_pred             ccCCCCCCEEeCCCCcccccCCCCCcccccccceeccccccc
Q 036639          132 ISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELT  173 (670)
Q Consensus       132 ~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  173 (670)
                      |.++++|++|+|++|+|+ .+|..+....+|+.|+|++|.+.
T Consensus        76 f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          76 FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             GGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ccccccccceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            999999999999999999 66665555557999999999885

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.35  E-value=1.3e-12  Score=124.01  Aligned_cols=141  Identities=25%  Similarity=0.368  Sum_probs=115.6

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      .++.|++++|.+.. ++.+..+++|++|+|++|+|++. ++++++++|+.|+|++|++++ +| .+.++++|+.|++++|
T Consensus        47 ~L~~L~l~~~~i~~-l~~l~~l~~L~~L~L~~n~i~~l-~~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~  122 (210)
T d1h6ta2          47 SIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDI-KPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHN  122 (210)
T ss_dssp             TCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTS
T ss_pred             CccEEECcCCCCCC-chhHhhCCCCCEEeCCCccccCc-cccccCccccccccccccccc-cc-cccccccccccccccc
Confidence            57889999999886 45688999999999999999875 468899999999999999985 55 5899999999999999


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcc-hhhhhcCccccccc
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE-GLLKKFGEQSFIGN  216 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~~~~~~~~~~~~~n  216 (670)
                      .++. + ..+.+++.|+.+++++|++++.  ..+..+++|+.+++++|++++ ++. .-+..+....+.+|
T Consensus       123 ~~~~-~-~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~~l~~l~~L~~L~Ls~N  188 (210)
T d1h6ta2         123 GISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKN  188 (210)
T ss_dssp             CCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSS
T ss_pred             cccc-c-cccccccccccccccccccccc--ccccccccccccccccccccc-cccccCCCCCCEEECCCC
Confidence            9873 3 4688999999999999999853  346779999999999999995 443 11234444455555

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.33  E-value=7.7e-13  Score=137.59  Aligned_cols=130  Identities=31%  Similarity=0.406  Sum_probs=83.1

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCC----------------
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP----------------  129 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p----------------  129 (670)
                      ..+..|++++|.++. ++.+..+++|+.|++++|.+++.. +++.+++|+.|++++|.+++..+                
T Consensus       219 ~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~  296 (384)
T d2omza2         219 TNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ  296 (384)
T ss_dssp             TTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSC
T ss_pred             CCCCEEECCCCCCCC-cchhhcccccchhccccCccCCCC-cccccccCCEeeccCcccCCCCccccccccccccccccc
Confidence            456777777777765 345667777777777777777643 46677777777777777765322                


Q ss_pred             ----ccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCc
Q 036639          130 ----HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVP  201 (670)
Q Consensus       130 ----~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip  201 (670)
                          ..+..+++++.|+|++|+|++..  .+..+++|++|+|++|+|++ +| .+..+++|++|++++|+|++..|
T Consensus       297 l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~  368 (384)
T d2omza2         297 LEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP  368 (384)
T ss_dssp             CSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred             cccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence                22445566666666666666432  25666667777777776663 33 45666677777777777664433

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.26  E-value=3e-12  Score=133.06  Aligned_cols=122  Identities=27%  Similarity=0.392  Sum_probs=99.4

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCcccc---------------------CCCccccccceeeccCCcc
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTI---------------------LPLTNCTNLKLAYLSGNDF  124 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~---------------------~~~~~l~~L~~L~l~~N~l  124 (670)
                      ..+..|++.+|.+++. ++++.+++|+.|++++|.+++..                     ..+..+++|+.|+|++|++
T Consensus       241 ~~L~~L~l~~n~l~~~-~~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l  319 (384)
T d2omza2         241 TNLTDLDLANNQISNL-APLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI  319 (384)
T ss_dssp             TTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCC
T ss_pred             cccchhccccCccCCC-CcccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCC
Confidence            4577778888877764 34677777777777777776532                     2256678999999999999


Q ss_pred             cccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCC
Q 036639          125 SAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNN  194 (670)
Q Consensus       125 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  194 (670)
                      ++..  .+..+++|++|+|++|+|++ +| .+.++++|++|+|++|+|++.+|  +.++++|+.|+|++|
T Consensus       320 ~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         320 SDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             SCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            9753  38999999999999999994 44 69999999999999999997665  888999999999998

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.21  E-value=1.4e-11  Score=118.14  Aligned_cols=126  Identities=23%  Similarity=0.422  Sum_probs=61.8

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCC----------------
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIP----------------  129 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p----------------  129 (670)
                      .++..|+|++|.+.+. .++..+++|++|++++|.++. ++.+.++++|+.+++++|...+..+                
T Consensus        63 ~~L~~L~ls~n~i~~~-~~l~~l~~l~~l~~~~n~~~~-i~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~  140 (227)
T d1h6ua2          63 NNLIGLELKDNQITDL-APLKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQ  140 (227)
T ss_dssp             TTCCEEECCSSCCCCC-GGGTTCCSCCEEECCSCCCSC-CGGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred             CCCcEeecCCceeecc-ccccccccccccccccccccc-cccccccccccccccccccccccchhccccchhhhhchhhh
Confidence            3456666666665543 235555666666666665542 2345555566666655555443211                


Q ss_pred             ----ccccCCCCCCEEeCCCCcccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          130 ----HQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       130 ----~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                          ..+.++++|+.|++++|.+++..  .+.++++|+.|+|++|++++ +|. +..+++|++|+|++|+|+
T Consensus       141 ~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         141 ITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             CCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTSCCC
T ss_pred             hchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCCcCC
Confidence                11233444555555555444221  24445555555555555543 221 444555555555555554

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.18  E-value=3.3e-11  Score=115.50  Aligned_cols=144  Identities=26%  Similarity=0.372  Sum_probs=111.9

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      ..++.|++.+|+++. ++.+..+++|++|+|++|++++.. ++.++++|+.|++++|.++. ++ .+.++++|+.|++++
T Consensus        41 ~~L~~L~l~~~~i~~-l~~l~~l~~L~~L~ls~n~i~~~~-~l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~  116 (227)
T d1h6ua2          41 DGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLA-PLKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTS  116 (227)
T ss_dssp             HTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCG-GGTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTT
T ss_pred             CCcCEEECCCCCCCc-chhHhcCCCCcEeecCCceeeccc-cccccccccccccccccccc-cc-ccccccccccccccc
Confidence            468999999999986 477999999999999999998754 58999999999999999983 44 588999999999999


Q ss_pred             CcccccCC--------------------CCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCcCCCcc-hh
Q 036639          146 NNIRGRIP--------------------EQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELYGRVPE-GL  204 (670)
Q Consensus       146 N~l~g~~p--------------------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~ip~-~~  204 (670)
                      |.+.+..+                    ..+.++++|+.|++++|++++..  .+.++++|+.|+|++|++++ +|. .-
T Consensus       117 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~~l~~  193 (227)
T d1h6ua2         117 TQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISD-ISPLAS  193 (227)
T ss_dssp             SCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CGGGGG
T ss_pred             ccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCC-ChhhcC
Confidence            88764322                    12456778899999999887433  37788999999999999984 553 11


Q ss_pred             hhhcCccccccc
Q 036639          205 LKKFGEQSFIGN  216 (670)
Q Consensus       205 ~~~~~~~~~~~n  216 (670)
                      +..+....+.+|
T Consensus       194 l~~L~~L~Ls~N  205 (227)
T d1h6ua2         194 LPNLIEVHLKNN  205 (227)
T ss_dssp             CTTCCEEECTTS
T ss_pred             CCCCCEEECcCC
Confidence            233444444444

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.16  E-value=1.5e-13  Score=129.06  Aligned_cols=111  Identities=27%  Similarity=0.340  Sum_probs=94.7

Q ss_pred             CCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccc
Q 036639           85 LSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLT  164 (670)
Q Consensus        85 ~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  164 (670)
                      ++.|++|++|+|++|+|+.. +.+.+|++|+.|+|++|.++ .+|..+..+++|+.|++++|+|+. ++ .+.++++|+.
T Consensus        44 l~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~  119 (198)
T d1m9la_          44 LSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRV  119 (198)
T ss_dssp             HHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSE
T ss_pred             HhcccccceeECcccCCCCc-ccccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccc
Confidence            67789999999999999854 67999999999999999998 577766777889999999999994 43 4889999999


Q ss_pred             eecccccccccCC-CCcCCCCCCCEEEccCCCCcCC
Q 036639          165 LRLQNNELTGRIP-DLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       165 L~l~~N~l~g~~p-~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      |+|++|+|+.... ..+..+++|+.|+|++|.++..
T Consensus       120 L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_         120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             EEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             cccccchhccccccccccCCCccceeecCCCccccC
Confidence            9999999984322 3578899999999999998743

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.09  E-value=2.4e-13  Score=127.64  Aligned_cols=122  Identities=24%  Similarity=0.302  Sum_probs=100.0

Q ss_pred             CcEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCC
Q 036639           66 ERVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSD  145 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~  145 (670)
                      .++..|+|++|.++. ++.+..+++|+.|+|++|+|+....-...+++|+.|++++|+++. + +.+.++++|+.|+|++
T Consensus        48 ~~L~~L~Ls~n~I~~-i~~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~L~~  124 (198)
T d1m9la_          48 KACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLYMSN  124 (198)
T ss_dssp             TTCCEEECSEEEESC-CCCHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEEESE
T ss_pred             cccceeECcccCCCC-cccccCCccccChhhcccccccccccccccccccccccccccccc-c-cccccccccccccccc
Confidence            468999999999985 567899999999999999997643324556789999999999985 3 3588899999999999


Q ss_pred             CcccccCC-CCCcccccccceecccccccccCCCC----------cCCCCCCCEEE
Q 036639          146 NNIRGRIP-EQVTNLTRLLTLRLQNNELTGRIPDL----------SSSLKDLKELN  190 (670)
Q Consensus       146 N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~----------~~~l~~L~~l~  190 (670)
                      |+|+.... ..+..+++|+.|+|++|.++...+..          +..+++|+.||
T Consensus       125 N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         125 NKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             EECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             chhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            99984322 46889999999999999998665543          45688888886

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.82  E-value=4.9e-09  Score=100.92  Aligned_cols=131  Identities=17%  Similarity=0.084  Sum_probs=101.1

Q ss_pred             EEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCC-CccccccceeeccCCcccccCC-ccccCCCCCCEEeCC-CC
Q 036639           70 SLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILP-LTNCTNLKLAYLSGNDFSAEIP-HQISSLKGILRLDLS-DN  146 (670)
Q Consensus        70 ~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~L~l~-~N  146 (670)
                      .++.++.+++..++.+  .+++++|||++|+|+...+. |.++++|++|+|++|.+...+| ..|.+++++++|++. .|
T Consensus        12 ~i~c~~~~l~~iP~~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n   89 (242)
T d1xwdc1          12 VFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   89 (242)
T ss_dssp             EEEEESCSCSSCCSCS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred             EEEEeCCCCCCcCCCC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence            4566777788544333  25899999999999887654 8999999999999999987654 468899999999986 57


Q ss_pred             cccccCCCCCcccccccceecccccccccCCC-CcCCCCCCCEEEccCCCCcCCCcch
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPD-LSSSLKDLKELNLSNNELYGRVPEG  203 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g~ip~~  203 (670)
                      ++....+..|.++++|+.|++++|++....+. .+..+..|..+..++++++ .++..
T Consensus        90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~  146 (242)
T d1xwdc1          90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERN  146 (242)
T ss_dssp             TCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTT
T ss_pred             cccccccccccccccccccccchhhhcccccccccccccccccccccccccc-ccccc
Confidence            88888888899999999999999999843332 3445566666677777776 44433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.62  E-value=9.6e-08  Score=96.64  Aligned_cols=115  Identities=24%  Similarity=0.294  Sum_probs=83.1

Q ss_pred             cEEEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCC
Q 036639           67 RVVSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N  146 (670)
                      +++.|+|++++|+. +|.  .+++|++|+|++|+|+..+..   +.+|+.|++++|+++ .++. +  .+.|++|+|++|
T Consensus        39 ~l~~LdLs~~~L~~-lp~--~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n  108 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPE--LPPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNN  108 (353)
T ss_dssp             TCSEEECTTSCCSC-CCS--CCTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSS
T ss_pred             CCCEEEeCCCCCCC-CCC--CCCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccc-hhhh-h--cccccccccccc
Confidence            57789999999986 443  357899999999999855322   457888899999887 3442 1  146899999999


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCCcCCCCCCCEEEccCCCCc
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      .++ .+|. ++++++|+.|++++|.++.. |..   ...+..+++.++...
T Consensus       109 ~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~  153 (353)
T d1jl5a_         109 QLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE  153 (353)
T ss_dssp             CCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS
T ss_pred             ccc-cccc-hhhhccceeecccccccccc-ccc---cccccchhhcccccc
Confidence            998 5664 67899999999999988743 322   344555665555443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.61  E-value=6.4e-08  Score=98.02  Aligned_cols=98  Identities=23%  Similarity=0.291  Sum_probs=80.6

Q ss_pred             CCccEEEccCCCCccccCCCccccccceeeccCCcccccCCccccCCCCCCEEeCCCCcccccCCCCCcccccccceecc
Q 036639           89 DQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAEIPHQISSLKGILRLDLSDNNIRGRIPEQVTNLTRLLTLRLQ  168 (670)
Q Consensus        89 ~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~L~l~  168 (670)
                      .+|+.|||++|.|+..+ +  .+++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++..   .+.|++|+|+
T Consensus        38 ~~l~~LdLs~~~L~~lp-~--~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~  106 (353)
T d1jl5a_          38 RQAHELELNNLGLSSLP-E--LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS  106 (353)
T ss_dssp             HTCSEEECTTSCCSCCC-S--CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred             cCCCEEEeCCCCCCCCC-C--CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence            46889999999998654 3  3578999999999999 788764   57899999999998 45532   1469999999


Q ss_pred             cccccccCCCCcCCCCCCCEEEccCCCCcCC
Q 036639          169 NNELTGRIPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       169 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                      +|+++ .+|. +..+++|+.|++++|.+++.
T Consensus       107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~  135 (353)
T d1jl5a_         107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKL  135 (353)
T ss_dssp             SSCCS-SCCC-CTTCTTCCEEECCSSCCSCC
T ss_pred             ccccc-cccc-hhhhccceeecccccccccc
Confidence            99998 5675 57799999999999999843

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.47  E-value=1.6e-08  Score=99.90  Aligned_cols=44  Identities=20%  Similarity=0.206  Sum_probs=29.9

Q ss_pred             cccccccceecccc-cccccCCCCcCCCCCCCEEEccC-CCCcCCC
Q 036639          157 TNLTRLLTLRLQNN-ELTGRIPDLSSSLKDLKELNLSN-NELYGRV  200 (670)
Q Consensus       157 ~~l~~L~~L~l~~N-~l~g~~p~~~~~l~~L~~l~l~~-N~l~g~i  200 (670)
                      .++++|++|+|++| .+++..+..+..+++|++|+|++ +.++...
T Consensus       172 ~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~  217 (284)
T d2astb2         172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPET  217 (284)
T ss_dssp             HHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGG
T ss_pred             cccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHH
Confidence            34677888888775 46666666677778888888887 3555433

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.38  E-value=5.5e-09  Score=93.83  Aligned_cols=65  Identities=28%  Similarity=0.310  Sum_probs=27.0

Q ss_pred             cCCCCCCEEeCCCCccccc--CCCCCcccccccceecccccccccCCC-CcCCCCCCCEEEccCCCCcC
Q 036639          133 SSLKGILRLDLSDNNIRGR--IPEQVTNLTRLLTLRLQNNELTGRIPD-LSSSLKDLKELNLSNNELYG  198 (670)
Q Consensus       133 ~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~l~~L~~l~l~~N~l~g  198 (670)
                      ..+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+++. +++ .+.....|+.|++++|.++.
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCc
Confidence            3444444444444444421  12223344445555555555442 221 11122234455555555543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.37  E-value=5.1e-08  Score=96.08  Aligned_cols=139  Identities=24%  Similarity=0.258  Sum_probs=97.0

Q ss_pred             CcEEEEEcCCCCccccC-CC-CCCCCCccEEEccCCCCcccc-CCCccccccceeeccCC-ccccc-CCccccCCCCCCE
Q 036639           66 ERVVSLSLPSHSLRGPI-AP-LSLLDQLRFLDLHDNRLNGTI-LPLTNCTNLKLAYLSGN-DFSAE-IPHQISSLKGILR  140 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~-~~-~~~l~~L~~L~L~~N~l~~~~-~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~  140 (670)
                      .++..|+|+++.+.... .. +..+++|++|+|+++.++... ..++.+++|+.|+|+++ .++.. +..-+.++++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            46899999998876532 22 788999999999999987544 34788999999999984 56532 2233457899999


Q ss_pred             EeCCCC-cccc-cCCCCCcc-cccccceecccc--ccccc-CCCCcCCCCCCCEEEccCC-CCcCCCcchh
Q 036639          141 LDLSDN-NIRG-RIPEQVTN-LTRLLTLRLQNN--ELTGR-IPDLSSSLKDLKELNLSNN-ELYGRVPEGL  204 (670)
Q Consensus       141 L~l~~N-~l~g-~~p~~~~~-l~~L~~L~l~~N--~l~g~-~p~~~~~l~~L~~l~l~~N-~l~g~ip~~~  204 (670)
                      |+|+++ +++. .++..+.. .++|+.|+++++  .++.. +...+..+++|+.|++++| .+++..+..+
T Consensus       126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l  196 (284)
T d2astb2         126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEF  196 (284)
T ss_dssp             EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGG
T ss_pred             cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhh
Confidence            999984 5553 22223333 468999999864  34321 2333456889999999986 4776655554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=1.5e-08  Score=106.76  Aligned_cols=108  Identities=22%  Similarity=0.299  Sum_probs=75.2

Q ss_pred             CccEEEccCCCCcccc-C-CCccccccceeeccCCcccc----cCCccccCCCCCCEEeCCCCccccc----CCCCCc-c
Q 036639           90 QLRFLDLHDNRLNGTI-L-PLTNCTNLKLAYLSGNDFSA----EIPHQISSLKGILRLDLSDNNIRGR----IPEQVT-N  158 (670)
Q Consensus        90 ~L~~L~L~~N~l~~~~-~-~~~~l~~L~~L~l~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~-~  158 (670)
                      +|+.||++.|+++... . -+..+++|+.|+|++|.++.    .+...+..+++|++|||++|+|+..    +...+. .
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~   82 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP   82 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence            5777888888887532 1 25667778888888887762    3455567788888888888887521    222232 2


Q ss_pred             cccccceeccccccccc----CCCCcCCCCCCCEEEccCCCCc
Q 036639          159 LTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELY  197 (670)
Q Consensus       159 l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~  197 (670)
                      ..+|++|+|++|+++..    ++..+..+++|+.|+|++|.++
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence            34788888888888743    3455677888999999998886

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.31  E-value=1.1e-06  Score=84.96  Aligned_cols=131  Identities=16%  Similarity=0.094  Sum_probs=91.8

Q ss_pred             ceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEeccCCCChHHHhccCC
Q 036639          369 LGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYDYLPNGSLHSLLHGNR  447 (670)
Q Consensus       369 ~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  447 (670)
                      .+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..+.+..++||+++++.++.+......
T Consensus        27 ~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~  105 (263)
T d1j7la_          27 PAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ  105 (263)
T ss_dssp             SSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS
T ss_pred             CCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc
Confidence            468998875 46677889887554334456778888877663 4446778888888899999999999988866543211


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 036639          448 GPGRIPLDWTTRISLVLGAARGLARIHQEY--------------------------------------------------  477 (670)
Q Consensus       448 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------------------  477 (670)
                                ....++.++++.++.||+..                                                  
T Consensus       106 ----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  175 (263)
T d1j7la_         106 ----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLK  175 (263)
T ss_dssp             ----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHH
T ss_pred             ----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHH
Confidence                      12334556666666666421                                                  


Q ss_pred             -----CCCCccccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          478 -----GTAKVPHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       478 -----~~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                           ....++|+|+.|.|||+++++..-|+||+.+..
T Consensus       176 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         176 TEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                 011278999999999999877677999987753

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.25  E-value=4.2e-08  Score=99.61  Aligned_cols=132  Identities=20%  Similarity=0.182  Sum_probs=78.4

Q ss_pred             CcEEEEEcCCCCcccc--------CCC------CCCCCCccEEEccCCCCcccc-----CCCccccccceeeccCCcccc
Q 036639           66 ERVVSLSLPSHSLRGP--------IAP------LSLLDQLRFLDLHDNRLNGTI-----LPLTNCTNLKLAYLSGNDFSA  126 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~--------~~~------~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~g  126 (670)
                      ..+..|+|++|.+...        +..      ....+.|+.|++++|+++..-     ..+..++.|+.|+|++|.++.
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~  200 (344)
T d2ca6a1         121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP  200 (344)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred             ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence            4577888888876421        000      134566777777777765221     114556677777777777653


Q ss_pred             c-----CCccccCCCCCCEEeCCCCccccc----CCCCCcccccccceecccccccccCCC----CcC--CCCCCCEEEc
Q 036639          127 E-----IPHQISSLKGILRLDLSDNNIRGR----IPEQVTNLTRLLTLRLQNNELTGRIPD----LSS--SLKDLKELNL  191 (670)
Q Consensus       127 ~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~----~~~--~l~~L~~l~l  191 (670)
                      .     +...+..+++|+.|+|++|.|+..    +...+..+++|++|+|++|.|++.-..    .+.  ....|+.|++
T Consensus       201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~l  280 (344)
T d2ca6a1         201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL  280 (344)
T ss_dssp             HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred             cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEEC
Confidence            2     234456677777777777776532    334456667777777777777643111    111  1346777777


Q ss_pred             cCCCCc
Q 036639          192 SNNELY  197 (670)
Q Consensus       192 ~~N~l~  197 (670)
                      ++|+++
T Consensus       281 s~N~i~  286 (344)
T d2ca6a1         281 QYNEIE  286 (344)
T ss_dssp             CSSCCB
T ss_pred             CCCcCC
Confidence            777765

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.24  E-value=2.3e-08  Score=89.61  Aligned_cols=119  Identities=18%  Similarity=0.135  Sum_probs=77.8

Q ss_pred             EEEEcCCCCccccCCCCCCCCCccEEEccCCCCccccCCCccccccceeeccCCccccc--CCccccCCCCCCEEeCCCC
Q 036639           69 VSLSLPSHSLRGPIAPLSLLDQLRFLDLHDNRLNGTILPLTNCTNLKLAYLSGNDFSAE--IPHQISSLKGILRLDLSDN  146 (670)
Q Consensus        69 ~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~L~l~~N  146 (670)
                      ..|+++++...   +.+..+..+..|++.+|.......-..++++|++|+|++|+|+..  ++..+..+++|+.|+|++|
T Consensus        25 ~~Ldls~l~~~---~~l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N  101 (162)
T d1koha1          25 QALDLKGLRSD---PDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGN  101 (162)
T ss_dssp             CCBCCCCCSSC---TTTTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTS
T ss_pred             CeeecccCCCC---chhhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccC
Confidence            34555544321   223444444444444443322111145789999999999999863  3456778999999999999


Q ss_pred             cccccCCCCCcccccccceecccccccccCCCC-------cCCCCCCCEEE
Q 036639          147 NIRGRIPEQVTNLTRLLTLRLQNNELTGRIPDL-------SSSLKDLKELN  190 (670)
Q Consensus       147 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-------~~~l~~L~~l~  190 (670)
                      +|+..-+-......+|+.|+|++|.++......       +..+++|+.||
T Consensus       102 ~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1         102 ELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             ccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            999433223334457999999999998765532       56788998885

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.12  E-value=1.1e-07  Score=96.40  Aligned_cols=131  Identities=22%  Similarity=0.251  Sum_probs=65.6

Q ss_pred             cEEEEEcCCCCccccCC----C-CCCCCCccEEEccCCCCcccc--------CC------CccccccceeeccCCccccc
Q 036639           67 RVVSLSLPSHSLRGPIA----P-LSLLDQLRFLDLHDNRLNGTI--------LP------LTNCTNLKLAYLSGNDFSAE  127 (670)
Q Consensus        67 ~v~~l~l~~~~l~~~~~----~-~~~l~~L~~L~L~~N~l~~~~--------~~------~~~l~~L~~L~l~~N~l~g~  127 (670)
                      +++.|+|++|.+...-.    . +...++|++|+|++|.|...-        ..      ....+.|+.|++++|+++..
T Consensus        94 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~  173 (344)
T d2ca6a1          94 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG  173 (344)
T ss_dssp             TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred             CcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccccccccc
Confidence            45555665555543211    0 234455666666655553110        00      12334555666666655421


Q ss_pred             ----CCccccCCCCCCEEeCCCCccccc-----CCCCCcccccccceeccccccccc----CCCCcCCCCCCCEEEccCC
Q 036639          128 ----IPHQISSLKGILRLDLSDNNIRGR-----IPEQVTNLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNN  194 (670)
Q Consensus       128 ----~p~~~~~l~~L~~L~l~~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N  194 (670)
                          +...+...+.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|+|++|
T Consensus       174 ~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n  253 (344)
T d2ca6a1         174 SMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC  253 (344)
T ss_dssp             GHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTC
T ss_pred             ccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcC
Confidence                222334455666666666666421     233455566666666666665422    2233445566666666666


Q ss_pred             CCc
Q 036639          195 ELY  197 (670)
Q Consensus       195 ~l~  197 (670)
                      .|+
T Consensus       254 ~i~  256 (344)
T d2ca6a1         254 LLS  256 (344)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            665

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.11  E-value=1.7e-06  Score=83.27  Aligned_cols=73  Identities=12%  Similarity=0.100  Sum_probs=53.5

Q ss_pred             cCCCCc-eEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccC--CCCeeeEEEEEEeCCeeEEEEeccCCCCh
Q 036639          364 LGKGSL-GTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLK--HPNVVKLRAYYYAKEEKLLVYDYLPNGSL  439 (670)
Q Consensus       364 lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~g~L  439 (670)
                      +..|.. +.||+...+++..+++|......   ...+..|...++.+.  .-.+.+++++..+.+..++||+|++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344443 67999998888889999876543   234667777777663  33467788888888899999999988654

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.01  E-value=2.3e-07  Score=97.34  Aligned_cols=134  Identities=20%  Similarity=0.223  Sum_probs=86.3

Q ss_pred             CcEEEEEcCCCCccccCCC-----CCCCCCccEEEccCCCCccccC----C--CccccccceeeccCCcccccCCccc--
Q 036639           66 ERVVSLSLPSHSLRGPIAP-----LSLLDQLRFLDLHDNRLNGTIL----P--LTNCTNLKLAYLSGNDFSAEIPHQI--  132 (670)
Q Consensus        66 ~~v~~l~l~~~~l~~~~~~-----~~~l~~L~~L~L~~N~l~~~~~----~--~~~l~~L~~L~l~~N~l~g~~p~~~--  132 (670)
                      ..+..|++++|.+......     +...+.++.+++++|.++....    .  ......|+.+++++|.++..-...+  
T Consensus       255 ~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~  334 (460)
T d1z7xw1         255 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSS  334 (460)
T ss_dssp             CCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhccc
Confidence            4688888988887653221     4556778888888888763211    0  2234578888888887775433333  


Q ss_pred             --cCCCCCCEEeCCCCccccc----CCCCCc-ccccccceeccccccccc----CCCCcCCCCCCCEEEccCCCCcCC
Q 036639          133 --SSLKGILRLDLSDNNIRGR----IPEQVT-NLTRLLTLRLQNNELTGR----IPDLSSSLKDLKELNLSNNELYGR  199 (670)
Q Consensus       133 --~~l~~L~~L~l~~N~l~g~----~p~~~~-~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~g~  199 (670)
                        ....+|++|+|++|+|+..    ++..+. ..+.|++|+|++|+|+..    ++..+..+++|++|+|++|+|+..
T Consensus       335 ~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~  412 (460)
T d1z7xw1         335 VLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA  412 (460)
T ss_dssp             HHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred             ccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHH
Confidence              3456788888888887642    233332 355688888888888632    334455567888888888887643

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.55  E-value=5.3e-06  Score=74.14  Aligned_cols=110  Identities=10%  Similarity=0.105  Sum_probs=65.3

Q ss_pred             CCCCccEEEccC-CCCcccc-----CCCccccccceeeccCCcccccCC----ccccCCCCCCEEeCCCCccccc----C
Q 036639           87 LLDQLRFLDLHD-NRLNGTI-----LPLTNCTNLKLAYLSGNDFSAEIP----HQISSLKGILRLDLSDNNIRGR----I  152 (670)
Q Consensus        87 ~l~~L~~L~L~~-N~l~~~~-----~~~~~l~~L~~L~l~~N~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~----~  152 (670)
                      +.++|+.|+|++ |.++..-     ..+...+.|+.|+|++|.++..-.    ..+...+.|+.|+|++|.|+..    +
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            446777788876 3454311     125566777788888877764322    2334556778888888877642    1


Q ss_pred             CCCCcccccccceeccccccccc-------CCCCcCCCCCCCEEEccCCCC
Q 036639          153 PEQVTNLTRLLTLRLQNNELTGR-------IPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       153 p~~~~~l~~L~~L~l~~N~l~g~-------~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      -..+...++|++|+|++|++...       +...+..-++|+.|+++.+..
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence            12355566777777777765421       222334456777887766543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.31  E-value=0.00017  Score=73.50  Aligned_cols=75  Identities=15%  Similarity=0.112  Sum_probs=47.7

Q ss_pred             hHcCCCCceEEEEEEEc-CCCEEEEEEeCCC-------CcchHHHHHHHHHHHhccC-C--CCeeeEEEEEEeCCeeEEE
Q 036639          362 EMLGKGSLGTVYKAVLD-DGGIVAVKRLKDA-------NPCARKEFEQYMDVIGKLK-H--PNVVKLRAYYYAKEEKLLV  430 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--~nIv~l~~~~~~~~~~~lv  430 (670)
                      +.+|.|....||++... +++.|+||.-...       -+....+...|.+.++.+. +  ..+++++.+  +.+..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            35899999999999855 4678999975321       1112334556777776552 2  345566543  56667899


Q ss_pred             EeccCCCC
Q 036639          431 YDYLPNGS  438 (670)
Q Consensus       431 ~e~~~~g~  438 (670)
                      ||++++..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.23  E-value=0.00046  Score=68.22  Aligned_cols=138  Identities=12%  Similarity=0.081  Sum_probs=79.8

Q ss_pred             eEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCCe--eeEE-----EEEEeCCeeEEEEeccCCCCh---
Q 036639          370 GTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPNV--VKLR-----AYYYAKEEKLLVYDYLPNGSL---  439 (670)
Q Consensus       370 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~nI--v~l~-----~~~~~~~~~~lv~e~~~~g~L---  439 (670)
                      -.||++..++|+.|++|+.+.... ..+++..|.+.+..|....|  +..+     ..+...+..+.++++++|..+   
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            369999999999999999875432 56778889888877742221  1111     122345677899999976322   


Q ss_pred             ---------------HHHhccCCCCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHHhC---CCCCc
Q 036639          440 ---------------HSLLHGNRGPGRIPLDWTT-------------------RISLVLGAARGLARIHQEY---GTAKV  482 (670)
Q Consensus       440 ---------------~~~l~~~~~~~~~~l~~~~-------------------~~~i~~~ia~~L~~LH~~~---~~~~i  482 (670)
                                     +..........+...++..                   +..+...+.+.++.+....   ...++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                           1111111111122222211                   1112222233344444332   13468


Q ss_pred             cccCCCCCCeEeCCCCcEEEEecccccc
Q 036639          483 PHGNVKSSNVLLDKNGVACISDFGLSLL  510 (670)
Q Consensus       483 vH~Dlkp~NIll~~~~~~kl~DFG~a~~  510 (670)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899997764

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.12  E-value=3.3e-05  Score=68.72  Aligned_cols=108  Identities=6%  Similarity=0.122  Sum_probs=77.8

Q ss_pred             CcEEEEEcCCC-Ccccc----CC-CCCCCCCccEEEccCCCCcccc-CC----CccccccceeeccCCcccccC----Cc
Q 036639           66 ERVVSLSLPSH-SLRGP----IA-PLSLLDQLRFLDLHDNRLNGTI-LP----LTNCTNLKLAYLSGNDFSAEI----PH  130 (670)
Q Consensus        66 ~~v~~l~l~~~-~l~~~----~~-~~~~l~~L~~L~L~~N~l~~~~-~~----~~~l~~L~~L~l~~N~l~g~~----p~  130 (670)
                      ..++.|+|+++ .+...    +. .+...+.|+.|+|++|.+...- ..    +...+.|+.|+|++|.++..-    -.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~   94 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR   94 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence            57899999874 45432    11 1667789999999999997421 22    566789999999999998542    23


Q ss_pred             cccCCCCCCEEeCCCCccccc-------CCCCCcccccccceeccccccc
Q 036639          131 QISSLKGILRLDLSDNNIRGR-------IPEQVTNLTRLLTLRLQNNELT  173 (670)
Q Consensus       131 ~~~~l~~L~~L~l~~N~l~g~-------~p~~~~~l~~L~~L~l~~N~l~  173 (670)
                      .+..-+.|++|+|++|.+...       +...+...++|+.|+++.+...
T Consensus        95 aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~~  144 (167)
T d1pgva_          95 STLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  144 (167)
T ss_dssp             HTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCch
Confidence            456678899999999976521       3344556788999999776553

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.71  E-value=8.1e-05  Score=65.98  Aligned_cols=111  Identities=16%  Similarity=0.177  Sum_probs=68.0

Q ss_pred             CCCCCccEEEccC-CCCcccc-----CCCccccccceeeccCCcccccCC----ccccCCCCCCEEeCCCCccccc----
Q 036639           86 SLLDQLRFLDLHD-NRLNGTI-----LPLTNCTNLKLAYLSGNDFSAEIP----HQISSLKGILRLDLSDNNIRGR----  151 (670)
Q Consensus        86 ~~l~~L~~L~L~~-N~l~~~~-----~~~~~l~~L~~L~l~~N~l~g~~p----~~~~~l~~L~~L~l~~N~l~g~----  151 (670)
                      .+.++|+.|+|++ |.++...     ..+...+.|+.|+|++|.++..--    ..+...+.|+.|++++|.++..    
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~   93 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA   93 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence            3456777888876 4564221     125566778888888887764322    2344567788888888877632    


Q ss_pred             CCCCCcccccccce--ecccccccc----cCCCCcCCCCCCCEEEccCCCC
Q 036639          152 IPEQVTNLTRLLTL--RLQNNELTG----RIPDLSSSLKDLKELNLSNNEL  196 (670)
Q Consensus       152 ~p~~~~~l~~L~~L--~l~~N~l~g----~~p~~~~~l~~L~~l~l~~N~l  196 (670)
                      +-..+...++|+.+  ++++|.+..    .+...+...++|+.|+++.|..
T Consensus        94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            22345666777754  445666642    2333455677888888877654

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.43  E-value=0.0023  Score=64.88  Aligned_cols=72  Identities=13%  Similarity=0.147  Sum_probs=48.8

Q ss_pred             hHcCCCCceEEEEEEEcC--------CCEEEEEEeCCCCcchHHHHHHHHHHHhccC-CCCeeeEEEEEEeCCeeEEEEe
Q 036639          362 EMLGKGSLGTVYKAVLDD--------GGIVAVKRLKDANPCARKEFEQYMDVIGKLK-HPNVVKLRAYYYAKEEKLLVYD  432 (670)
Q Consensus       362 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~nIv~l~~~~~~~~~~~lv~e  432 (670)
                      +.|+.|-.-.+|++...+        .+.|++++.....  ...+..+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            357788889999998654        3567777765332  3345668888888774 4444577777642    58999


Q ss_pred             ccCCCCh
Q 036639          433 YLPNGSL  439 (670)
Q Consensus       433 ~~~~g~L  439 (670)
                      |+++..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.09  E-value=0.00025  Score=62.69  Aligned_cols=108  Identities=16%  Similarity=0.196  Sum_probs=77.6

Q ss_pred             CcEEEEEcCC-CCccccC----C-CCCCCCCccEEEccCCCCcccc-----CCCccccccceeeccCCccccc----CCc
Q 036639           66 ERVVSLSLPS-HSLRGPI----A-PLSLLDQLRFLDLHDNRLNGTI-----LPLTNCTNLKLAYLSGNDFSAE----IPH  130 (670)
Q Consensus        66 ~~v~~l~l~~-~~l~~~~----~-~~~~l~~L~~L~L~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~g~----~p~  130 (670)
                      ..++.|+|++ +.++...    . .+...++|+.|+|++|.++..-     ..+...+.|+.|++++|.++..    +-.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence            5788999987 4554321    1 1567899999999999986432     1266778999999999998753    334


Q ss_pred             cccCCCCCCEEeC--CCCcccc----cCCCCCcccccccceeccccccc
Q 036639          131 QISSLKGILRLDL--SDNNIRG----RIPEQVTNLTRLLTLRLQNNELT  173 (670)
Q Consensus       131 ~~~~l~~L~~L~l--~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~  173 (670)
                      .+...++|+.++|  ++|.+..    .+...+...++|+.|+|+.|...
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            5677888987555  5777753    34455667899999999887654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.34  E-value=0.0067  Score=59.08  Aligned_cols=144  Identities=11%  Similarity=0.059  Sum_probs=72.5

Q ss_pred             HcCCCCceEEEEEEEcCCCEEEEEEeCCCCcchHHHHHHHHHHHhccCCCC--eeeEEE------EEEeCCeeEEEEecc
Q 036639          363 MLGKGSLGTVYKAVLDDGGIVAVKRLKDANPCARKEFEQYMDVIGKLKHPN--VVKLRA------YYYAKEEKLLVYDYL  434 (670)
Q Consensus       363 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--Iv~l~~------~~~~~~~~~lv~e~~  434 (670)
                      .|..|---+.|+...++|+ +++|+.....  ..+++..|++++..|...+  +...+.      +.........++.+.
T Consensus        25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~  101 (316)
T d2ppqa1          25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL  101 (316)
T ss_dssp             EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred             cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence            3556666788999877665 8999986532  2345666777776663221  111110      112244556677776


Q ss_pred             CCCChHH--------------Hhc----cCCCCCCCCCCHH------------------HHHHHHHHHHHHHHHHHHhCC
Q 036639          435 PNGSLHS--------------LLH----GNRGPGRIPLDWT------------------TRISLVLGAARGLARIHQEYG  478 (670)
Q Consensus       435 ~~g~L~~--------------~l~----~~~~~~~~~l~~~------------------~~~~i~~~ia~~L~~LH~~~~  478 (670)
                      .+.....              .++    .............                  .....+..+...+...+..--
T Consensus       102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L  181 (316)
T d2ppqa1         102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL  181 (316)
T ss_dssp             CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred             ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence            6532210              011    0000000001100                  011112222222222222112


Q ss_pred             CCCccccCCCCCCeEeCCCCcEEEEeccccc
Q 036639          479 TAKVPHGNVKSSNVLLDKNGVACISDFGLSL  509 (670)
Q Consensus       479 ~~~ivH~Dlkp~NIll~~~~~~kl~DFG~a~  509 (670)
                      ..++||+|+.++||+++.+...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            3479999999999999988878899999774